PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Cahill, LM; Murdoch, BE; Theodoros, DG				Cahill, LM; Murdoch, BE; Theodoros, DG			Variability in speech outcome following severe childhood traumatic brain injury: A report of three cases	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article								The aim of the present paper was to demonstrate the variation in the nature and extent of the physiological and perceptual speech impairments that can occur in children following traumatic brain injury (TBI). Three children who presented with different speech profiles following severe TBI were discussed. The four speech subsystems were comprehensively evaluated using physiological measures of respiratory (Respitrace), laryngeal (Laryngograph, Aerophone II), velopharyngeal (accelerometry), and articulatory (lip and tongue pressure transduction systems) function. Perceptual speech evaluations included the Frenchay Dysarthria Assessment, the Assessment of Intelligibility of Dysarthric Speech, and a perceptual analysis of a speech sample. The findings for each case were compared with those of a non-neurologically impaired control group or a control subject matched for age and sex. Although demonstrating similar severity of injury, each subject was found to have a differing profile of speech subsystem deficits, highlighting the need for a full physiological and perceptual assessment of speech production.	Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia		Cahill, LM (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia.		Theodoros, Deborah/F-1362-2010; Murdoch, Bruce E/C-1397-2012	Cahill, Louise/0000-0003-3662-896X			Costeff H, 1985, Scand J Rehabil Med Suppl, V12, P10; Enderby P, 1983, FRENCHAY DYSARTHRIA; MALKMUS DD, 1989, TOP LANG DISORD, V9, P50, DOI 10.1097/00011363-198903000-00006; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; [No title captured]	5	11	11	0	12	SINGULAR PUBLISHING GROUP INC	SAN DIEGO	401 WEST A ST, STE 325, SAN DIEGO, CA 92101-7904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	DEC	2000	8	4					347	352					6	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	388EU	WOS:000166165100020					2022-02-06	
J	Leathem, JM; Babbage, DR				Leathem, JM; Babbage, DR			Affective disorders after traumatic brain injury: Cautions in the use of the Symptom Checklist-90-R	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cognitive impairment; psychological assessment; psychopathology	BECK-DEPRESSION-INVENTORY; MULTIPLE-SCLEROSIS; SCALE; PREVALENCE; SCL-90-R; IMPACT; TUMOR	Design: The current study compared the Symptom Checklist 90-Revised (SCL-30-R) results from a population of 88 individuals with traumatic brain injury (TBI) to those of a normative group. Setting: Individuals with traumatic brain injury referred to a university-based psychology clinic. Results: Results corroborated those from a smaller study,(1) where a considerable proportion of the elevations found on the subscales was attributed to endorsement of items identified as having a neurological basis. Conclusion: This reinforces the view that the results of neurological groups on clinical measures of emotional distress that have been standardized on physically healthy populations can be distorted because many of the items can be answered from physical and emotional perspectives.	Massey Univ, Sch Psychol, Palmerston North, New Zealand; Mid Cent Hlth, Serv Elderly, Palmerston North, New Zealand		Leathem, JM (corresponding author), Massey Univ, Sch Psychol, Private Bag 11-222, Palmerston North, New Zealand.	J.M.Leathem@massey.ac.nz	Babbage, Duncan/D-8866-2012	Babbage, Duncan/0000-0002-9259-9246			Aikens JE, 1998, INT J PSYCHIAT MED, V28, P265, DOI 10.2190/RJ82-3JKB-YKEM-BNU0; Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; ATKINS JE, 1999, J BEHAV MED, V27, P142; ATKINS JE, 1999, J BEHAV MED, V2, P122; Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; Beck AT, 1987, BECK DEPRESSION INVE; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Broocks A, 1998, AM J PSYCHIAT, V155, P555, DOI 10.1176/ajp.155.4.555; DAHLSTROM WG, 1975, MMPI HDB, V1; Derogatis LR., 1983, SCL 90 R ADM SCORING; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Kaplan CP, 1998, J HEAD TRAUMA REHAB, V13, P94, DOI 10.1097/00001199-199806000-00009; Kaplan CP, 1998, BRAIN INJURY, V12, P977, DOI 10.1080/026990598122025; Kaplan CP, 1998, BRAIN INJURY, V12, P199, DOI 10.1080/026990598122674; KRAUS JF, 1989, MILD HEAD INJURY, P8; LEZAK MD, 1990, J CLIN EXP NEUROPSYC, V12, P50; LEZAK MD, 1985, NEURPSYCHOLOGICAL AS; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; Mohr DC, 1997, J BEHAV MED, V20, P407, DOI 10.1023/A:1025573315492; MUELIER SR, 1998, PSYCHOL REP, V63, P483; OHARA C, 1998, COGN REHABIL, V6, P26; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; Radnitz CL, 1997, REHABIL PSYCHOL, V42, P93, DOI 10.1037/0090-5550.42.2.93; RUDD MD, 1995, COGNITIVE THER RES, V19, P51; TEASDALE TW, 1997, APPL NEUROPSYCHOL, V2, P116; TEMEN H, 1985, TEST CRITIQUES, V111; WOESSNER R, 1995, J HEAD TRAUMA REHAB, V10, P78, DOI 10.1097/00001199-199504000-00009; WOESSNER R, 1986, ASSESSMENT, V3, P291; WOODY SR, 1995, BEHAV RES THER, V33, P607, DOI 10.1016/0005-7967(94)00090-7; [No title captured]; [No title captured]	33	11	11	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2000	15	6					1246	1255		10.1097/00001199-200012000-00005			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	378ZX	WOS:000165617400005	11056406				2022-02-06	
J	Luiselli, JK; Arons, M; Marchese, N; Potoczny-Gray, A; Rossi, E				Luiselli, JK; Arons, M; Marchese, N; Potoczny-Gray, A; Rossi, E			Incidence of law-violating behavior in a community sample of children and adolescents with traumatic brain injury	INTERNATIONAL JOURNAL OF OFFENDER THERAPY AND COMPARATIVE CRIMINOLOGY			English	Article							VIOLENT	A survey was conducted with children and adolescents (N = 69) who had traumatic brain injury (TBI) and attended a community-based program of education and neurorehabilitation to determine the incidence of law-violating behavior subsequent to sustaining trauma. Thirteen categories of offenses were identified: alcohol use, animal cruelty, breaking and entering, indecent exposure, fire setting, paraphilia, physical assault, sexual assault, substance use, theft. truancy, vandalism, and vehicular homicide. Approximately one third of the sample had documented violations, and of this group, 72% had two or more incidents. Of the individuals who committed offenses, 90% were male. There were no differences in the type of TBI between the groups who did and did not have a history of law violations. The forensic concerns presented by children and adolescents with TBI are discussed.	May Inst Inc, Norwood, MA 02062 USA; May Ctr Educ & Neurorehabil, Training & Clin Serv, Randolph, MA 02368 USA; May Ctr Educ & Neurorehabil, Educ Serv, Randolph, MA 02368 USA; May Ctr Educ & Neurorehabil, Social Serv, Randolph, MA 02368 USA; May Ctr Educ & Neurorehabil, Allied Hlth serv, Randolph, MA 02368 USA		Luiselli, JK (corresponding author), May Inst Inc, 220 Norwood Pk S, Norwood, MA 02062 USA.						BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; Gerring J P, 1986, Pediatr Rev, V8, P115, DOI 10.1542/pir.8-4-115; LEMKUHL G, 1990, BRAIN BEHAV CHILD PS, P267; LINK BG, 1992, AM SOCIOL REV, V57, P275, DOI 10.2307/2096235; LUISELLI JK, 1998, BEHAV INTERVENT, V13, P181; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; MONAHAN J, 1992, AM PSYCHOL, V47, P511, DOI 10.1037/0003-066X.47.4.511; QUINSEY VL, 1998, VIOLENT AFFENDERS AP; RUTTER M, 1977, J CHILD PSYCHOL PSYC, V18, P1, DOI 10.1111/j.1469-7610.1977.tb00413.x; SWANSON J, 1991, HOSPITAL COMMUNITY P, V42, P474; TEASDALE G, 1974, LANCET, V2, P81; WESSELY S, 1991, CRIMINAL BEHAVIOUR M, V1, P193	13	11	11	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0306-624X			INT J OFFENDER THER	Int. J. Offender Ther. Comp. Criminol.	DEC	2000	44	6					647	656		10.1177/0306624X00446002			10	Criminology & Penology; Psychology, Applied	Social Science Citation Index (SSCI)	Criminology & Penology; Psychology	416PK	WOS:000167789200002					2022-02-06	
J	Bruzzone, E; Cocito, L; Pisani, R				Bruzzone, E; Cocito, L; Pisani, R			Intracranial delayed epidural hematoma in a soccer player - A case report	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article							ATHLETIC HEAD-INJURIES; EXTRADURAL HEMATOMA; CONCUSSION; PREVENTION; TRAUMA; SPORT; BRAIN; GUIDELINES; MANAGEMENT; IMPACT		Univ Genoa, Dept Neurosurg, I-16132 Genoa, Italy; Univ Genoa, Dept Neurol & Visual Sci, I-16132 Genoa, Italy		Pisani, R (corresponding author), Univ Genoa, Dept Neurosurg, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.			Cocito, Leonardo/0000-0001-7926-3505			ASHKENAZI E, 1990, J TRAUMA, V30, P613, DOI 10.1097/00005373-199005000-00015; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; BUCCI MN, 1986, NEUROSURGERY, V19, P65, DOI 10.1227/00006123-198607000-00009; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Clarke KS, 1998, CLIN SPORT MED, V17, P1, DOI 10.1016/S0278-5919(05)70056-9; DAILEY SW, 1992, PHYSICIAN SPORTSMED, V20, P79, DOI 10.1080/00913847.1992.11947468; DOMENICUCCI M, 1995, NEUROSURG REV, V18, P109, DOI 10.1007/BF00417668; FANKHAUSER H, 1983, NEUROCHIRURGIE, V29, P255; FRIED T, 1992, SPORTS MED, V14, P269, DOI 10.2165/00007256-199214040-00005; Green GA, 1998, CLIN SPORT MED, V17, P795, DOI 10.1016/S0278-5919(05)70120-4; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; LEHMAN LB, 1987, AM J SPORT MED, V15, P494, DOI 10.1177/036354658701500512; LINDSAY KW, 1980, BRIT MED J, V281, P789, DOI 10.1136/bmj.281.6243.789; MCLATCHIE G, 1994, BRIT MED J, V308, P1620, DOI 10.1136/bmj.308.6944.1620; Metzl JD, 1998, CLIN SPORT MED, V17, P663, DOI 10.1016/S0278-5919(05)70110-1; MILO R, 1987, ACTA NEUROCHIR, V84, P13, DOI 10.1007/BF01456345; Riesgo P, 1997, SURG NEUROL, V48, P226, DOI 10.1016/S0090-3019(97)00194-8; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Warren WL, 1998, CLIN SPORT MED, V17, P13, DOI 10.1016/S0278-5919(05)70057-0	26	11	12	0	1	AMER ORTHOPAEDIC SOC SPORT MED	WALTHAM	230 CALVARY STREET, WALTHAM, MA 02154 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	NOV-DEC	2000	28	6					901	903		10.1177/03635465000280062201			3	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	384ZA	WOS:000165976100022	11101117				2022-02-06	
J	Shewmon, DA				Shewmon, DA			Coma prognosis in children - Part II: Clinical application	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article; Proceedings Paper	Annual Meeting of the American-Neurophysiology-Society	OCT 29-NOV 01, 1999	ST LOUIS, MO	Amer Neurophysiol Soc			SOMATOSENSORY-EVOKED-POTENTIALS; PEDIATRIC HEAD-INJURY; SEVERE BRAIN INJURY; TERM FOLLOW-UP; CARDIOPULMONARY-RESUSCITATION; PERINATAL HYPOXIA; VEGETATIVE STATE; TRAUMATIC COMA; FULL-TERM; EEG		Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA		Shewmon, DA (corresponding author), Olive View UCLA Med Ctr, Dept Neurol, Div Pediat, 14445 Olive View Dr,N Annex, Sylmar, CA 91342 USA.						ALLMAN FD, 1986, AM J DIS CHILD, V140, P571, DOI 10.1001/archpedi.1986.02140200081033; ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; AOKI Y, 1973, NEUROLOGY, V23, P333, DOI 10.1212/WNL.23.4.333; ASHWAL S, 1988, ANN NEUROL, V24, P329; BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; BOLTE RG, 1988, JAMA-J AM MED ASSOC, V260, P377, DOI 10.1001/jama.260.3.377; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; BRITT CW, 1981, NEUROLOGY, V31, P393; CARROLL WM, 1979, ELECTROEN CLIN NEURO, V46, P95, DOI 10.1016/0013-4694(79)90054-3; CHIAPPA KH, 1982, NEW ENGL J MED, V306, P1205, DOI 10.1056/NEJM198205203062004; CHIAPPA KH, 1982, NEW ENGL J MED, V306, P1140, DOI 10.1056/NEJM198205133061904; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; COLLINS AT, 1980, NEUROLOGY, V30, P1316, DOI 10.1212/WNL.30.12.1316; De Meirleir L J, 1986, Pediatr Neurol, V2, P31, DOI 10.1016/0887-8994(86)90036-6; DELATORRE JC, 1978, EXP NEUROL, V60, P304, DOI 10.1016/0014-4886(78)90085-7; DEMEIRLEIR LJ, 1987, PEDIATR NEUROL, V3, P78, DOI 10.1016/0887-8994(87)90031-2; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; FERBERT A, 1986, ELECTROEN CLIN NEURO, V65, P157, DOI 10.1016/0168-5597(86)90049-3; FRANK LM, 1985, NEUROLOGY, V35, P931, DOI 10.1212/WNL.35.6.931; FRISHER S, 1985, CHILD NERV SYST, V1, P208, DOI 10.1007/BF00270763; GANES T, 1987, ELECTROENCEPHALOGR C, V69, P6; GILLIS J, 1986, CRIT CARE MED, V14, P469, DOI 10.1097/00003246-198605000-00007; GOLDIE WD, 1981, NEUROLOGY, V31, P248, DOI 10.1212/WNL.31.3.248; GOODWIN SR, 1991, CRIT CARE MED, V19, P518, DOI 10.1097/00003246-199104000-00011; GOODWIN SR, 1993, CRIT CARE MED, V21, P631, DOI 10.1097/00003246-199304000-00027; GRIGGDAMBERGER MM, 1989, PEDIATR NEUROL, V5, P84, DOI 10.1016/0887-8994(89)90032-5; HANSOTIA P, 1981, NEUROLOGY, V31, P83, DOI 10.1212/WNL.31.1.83; HECOX KE, 1981, NEUROLOGY, V31, P1429, DOI 10.1212/WNL.31.11.1429; HOLMES G, 1982, ELECTROEN CLIN NEURO, V53, P60, DOI 10.1016/0013-4694(82)90106-7; HULIHAN JF, 1994, NEUROLOGY, V44, P758, DOI 10.1212/WNL.44.4.758; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; JONAS RA, 1990, RFETAL NEONATAL INFA, P983; KARNAZE DS, 1982, NEUROLOGY, V32, P289, DOI 10.1212/WNL.32.3.289; KERN FH, 1995, CRITICAL HEART DIS I, P497; KVITTINGEN TD, 1963, BRIT MED J, P1315; LAVELLE JM, 1993, CRIT CARE MED, V21, P368, DOI 10.1097/00003246-199303000-00013; LEVI L, 1991, BRIT J NEUROSURG, V5, P617, DOI 10.3109/02688699109002885; LEWIS JK, 1983, ANN EMERG MED, V12, P297, DOI 10.1016/S0196-0644(83)80512-5; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LUTSCHG J, 1983, AM J DIS CHILD, V137, P421; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MODELL JH, 1980, CAN ANAESTH SOC J, V27, P211, DOI 10.1007/BF03007430; MOLOFSKY WJ, 1982, J NEUROL NEUROSUR PS, V45, P95, DOI 10.1136/jnnp.45.1.95; MONOD N, 1972, ELECTROEN CLIN NEURO, V32, P529, DOI 10.1016/0013-4694(72)90063-6; NATALONI S, 1988, RESUSCITATION, V16, P127, DOI 10.1016/0300-9572(88)90077-9; OCARROLL PW, 1988, JAMA-J AM MED ASSOC, V260, P380, DOI 10.1001/jama.260.3.380; ORLOWSKI JP, 1979, JACEP-J AM COLL EMER, V8, P176, DOI 10.1016/S0361-1124(79)80121-5; ORLOWSKI JP, 1987, PEDIATR CLIN N AM, V34, P75; OROURKE PP, 1986, CRIT CARE MED, V14, P466, DOI 10.1097/00003246-198605000-00006; PAMPIGLI.G, 1968, LANCET, V1, P1261; Pampiglione G, 1978, Ann N Y Acad Sci, V315, P281, DOI 10.1111/j.1749-6632.1978.tb50346.x; PLOUIN P, 1977, REV EEG NEUROPHYSIOL, V7, P410, DOI 10.1016/S0370-4475(77)80027-0; ROSE AL, 1970, PEDIATRICS, V45, P404; SANDERS RA, 1981, J OTOLARYNGOL, V10, P52; SARNAIK AP, 1985, CRIT CARE MED, V13, P224, DOI 10.1097/00003246-198504000-00003; SCHWARZ G, 1988, Klinische Wochenschrift, V66, P48; Shewmon DA, 1999, DEV MED CHILD NEUROL, V41, P364, DOI 10.1017/S0012162299000821; SIEBKE H, 1975, LANCET, V1, P1275; SIMON RP, 1986, ANN NEUROL, V20, P351, DOI 10.1002/ana.410200313; STAUDT F, 1982, NEUROPEDIATRICS, V13, P24, DOI 10.1055/s-2008-1059591; STRICKBINEVANREET P, 1984, AM J DIS CHILD, V138, P492; TAKEUCHI T, 1989, BRAIN DEV-JPN, V11, P115, DOI 10.1016/S0387-7604(89)80079-8; TAKEUCHI T, 1989, BRAIN DEV, V11, P203; TASKER RC, 1988, ARCH DIS CHILD, V63, P895, DOI 10.1136/adc.63.8.895; TAYLOR MJ, 1989, PEDIATR NEUROL, V5, P145, DOI 10.1016/0887-8994(89)90063-5; THARP BR, 1989, NEUROPEDIATRICS, V20, P64, DOI 10.1055/s-2008-1071267; THARP BR, 1981, ELECTROEN CLIN NEURO, V51, P219, DOI 10.1016/0013-4694(81)90136-X; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; VONSEGGERN K, 1986, CRIT CARE MED, V14, P275; WATANABE K, 1981, EUR J PEDIATR, V137, P177; WATANABE K, 1980, ELECTROEN CLIN NEURO, V49, P618, DOI 10.1016/0013-4694(80)90402-2; WERNOVSKY G, 1995, MOSS ADAMS HEART DIS, V1, P398; WHITE LE, 1985, ANN NEUROL, V18, P417; YOUNG RSK, 1980, JAMA-J AM MED ASSOC, V244, P1233, DOI 10.1001/jama.244.11.1233	75	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	SEP	2000	17	5					467	472		10.1097/00004691-200009000-00005			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	371MQ	WOS:000165183100005	11085550				2022-02-06	
J	Jang, SH; Shin, SW; Ahn, SH; Cho, IH; Kim, SH				Jang, SH; Shin, SW; Ahn, SH; Cho, IH; Kim, SH			Radiation therapy for heterotopic ossification in a patient with traumatic brain injury	YONSEI MEDICAL JOURNAL			English	Article						heterotopic ossification; radiation therapy; traumatic brain injury	BONE	Radiation therapy has been known to have a prophylactic effect for heterotopic ossification (HO), but until now it has not been known to have a therapeutic effect for established HO. We report a case of established HO compounded with a sudden increase in activity, that was improved with radiation therapy. A patient with traumatic brain injury had HO in both hips and thighs two months after the initial trauma. The existing level of HO activity suddenly increased seven months after the initial trauma, and was accompanied by severe pain that was refractory to indomethacin. We assumed chat the pain was caused by the increased activity of HO on the basis of clinical symptoms and laboratory results. Initially, che patient received radiation therapy to the left lower extremity, with a total dose of 20 Gy in ten tractions. Next, the patient received radiation therapy at the same dosage to the right lower extremity, after which the pain and level of serum alkaline phosphatase significantly decreased. The patient experienced a mild pancytopenia as a side effect of the radiation therapy, but it was not severe enough to stop the radiation therapy, given the patient's suffering from the increased HO activity.	Yeungnam Univ, Coll Med, Dept Rehabil Med, Taegu 705717, South Korea; Yeungnam Univ, Coll Med, Dept Therapeut Radiol & Oncol, Taegu 705717, South Korea; Yeungnam Univ, Coll Med, Dept Nucl Med, Taegu 705717, South Korea; Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Sch Med, Dept Phys Med & Rehabil, Namku, 317-1 Daemyungdong, Taegu 705717, South Korea.						AYERS DC, 1991, CLIN ORTHOP RELAT R, P87; DJERGAIAN RS, 1996, MED REHABILITATION T, P459; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Hammond FM MJT, 1999, REHABILITATION ADULT, P53; Han Chang Dong, 1997, Yonsei Medical Journal, V38, P96; KEWALRAMANI LS, 1977, AM J PHYS MED REHAB, V56, P99; ORZEL JA, 1985, J NUCL MED, V26, P125; Pittenger D E, 1991, Orthop Rev, V20, P33; SCHAEFFER MA, 1995, ARCH PHYS MED REHAB, V76, P284, DOI 10.1016/S0003-9993(95)80617-2; VARGHESE G, 1992, PHYS MED REH CLIN N, V3, P407	12	11	11	0	1	YONSEI UNIV COLLEGE MEDICINE	SEOUL	C/O KYUN0-IL IM, M.D., PH.D, SHINCHON DONG 134, SEODAEMOON KU, SEOUL 120-752, SOUTH KOREA	0513-5796			YONSEI MED J	Yonsei Med. J.	AUG	2000	41	4					536	539		10.3349/ymj.2000.41.4.536			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351WX	WOS:000089183400018	10992819	gold			2022-02-06	
J	Neese, LE; Caroselli, JS; Klaas, P; High, WM; Becker, LJ; Scheibel, RS				Neese, LE; Caroselli, JS; Klaas, P; High, WM; Becker, LJ; Scheibel, RS			Neuropsychological assessment and the Disability Rating Scale (DRS): a concurrent validity study	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; COMMUNITY INTEGRATION; TESTS	Assessment of current level of functioning among clients with traumatic brain injury (TBI) often guides the establishment of realistic outcome goals for post-acute rehabilitation. Further, data generated from neuropsychological testing provide a clinician with a better understanding of a client's pattern of cognitive strengths and weaknesses. The Disability Rating Scale (DRS) is commonly used by TBI rehabilitation facilities to assess a client's general level of functioning in terms of impairment, disability, and handicap. Previous studies have used clients' neuropsychological test results to predict future level of functioning. These studies have shown mixed results regarding the predictive validity of the test findings; however, they usually employ only a limited number of tests for prediction representing a limited number of cognitive domains. Using a concurrent validity design, the present study investigated the bivariate associations between various neuropsychological testing domains (i.e. intellectual, academic, language, visuoperceptual, memory, and executive functioning) and level of functioning as indexed by the DRS. Participants were administered the DRS and the neuropsychological evaluation during the initial part of post-acute rehabilitation. Composite scores were derived for each of the neuropsychological domains. Most participants were categorized as sustaining a severe TBI. The mean age and education of this predominately male sample was 28.84 years (SD = 9.13) and 11.83 years (SD = 1.7), respectively. Results revealed a significant positive relationship between performances in intellectual, executive, academic, and visuoperceptual domains and level of functioning.	Transit Learning Ctr Galveston, Galveston, TX 77550 USA; Univ Texas, Hlth Sci Ctr, Houston, TX USA; TIRR, Brain Injury Res Ctr, Houston, TX USA		Caroselli, JS (corresponding author), Transit Learning Ctr Galveston, 1528 Post Off, Galveston, TX 77550 USA.						Ashley MJ, 1997, BRAIN INJURY, V11, P677; Benton A., 1978, MULTILINGUAL APHASIA; BENTON A, 1978, CONTRIBUTIONS NEUROP; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BROWN L, 1990, TEST NONVERBAL INTEL; COHEN, 1983, APPL MULTIPLE REGRES, P53; CONZEN M, 1992, Brain Injury, V6, P45, DOI 10.3109/02699059209008121; DELIS D, 1987, CALIFORNIA VERBAL LE; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Heaton RK, 1981, MANUAL WISCONSIN CAR; Johnstone B, 1996, BRAIN INJURY, V10, P627, DOI 10.1080/026990596124052; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; Little AJ, 1996, J CLIN PSYCHOL, V52, P455, DOI 10.1002/(SICI)1097-4679(199607)52:4<455::AID-JCLP11>3.0.CO;2-F; MARKWOOD FC, 1989, PEABODY INDIVIDUAL A; Millis S R, 1994, Int J Neurosci, V79, P165; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan R, 1986, TRAIL MAKING TEST MA; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Wechsler D, 1987, MANUAL WECHSLER MEMO; Wechsler D, 1981, WECHSLER ADULT INTEL; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; ZAFONTE RD, 1996, CME ARTICLE, V13, P364	25	11	11	0	4	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2000	14	8					719	724					6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	342XT	WOS:000088672000005	10969890				2022-02-06	
J	Baumeister, FAM; Pohl-Koppe, A; Hofer, M; Kim, JO; Weiss, M				Baumeister, FAM; Pohl-Koppe, A; Hofer, M; Kim, JO; Weiss, M			IL-6 in CSF during Ventriculitis in preterm infants with posthemorrhagic hydrocephalus	INFECTION			English	Article						CSF; IL-6; ventriculitis; preterm	CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN INJURY; CEREBROSPINAL-FLUID; BACTERIAL-MENINGITIS; INTERLEUKIN-6; INFECTIONS; DIAGNOSIS; CHILDREN; ASPHYXIA	Treatment of infants with posthemorrhagic hydrocephalus by diversion of CSF is frequently complicated by bacterial ventriculitis. We report the CSF values before and during bacterial ventriculitis of four very low birth weight infants with progressive posthemorrhagic ventricular dilatation. Extremely high CSF IL-6 concentrations of between 8,000 and 61,000 pg/ml were observed and compared with values reported in the literature. IL-6 seems to be a useful marker for bacterial ventriculitis in preterm infants. The role of IL-6 monitoring in the CSF of preterm infants with posthemorrhagic hydrocephalus for early diagnosis of bacterial ventriculitis prior to clinical manifestation should be clarified by further studies.	Tech Univ Munich, Pediat Clin Schwabing, D-80804 Munich, Germany; Univ Munich, Dr Von Haunerschen Kinderspital, Dept Infect Immunol, Pediat Clin, D-80337 Munich, Germany		Baumeister, FAM (corresponding author), Tech Univ Munich, Pediat Clin Schwabing, Kolner Pl 1, D-80804 Munich, Germany.						AsiBautista MC, 1997, CRIT CARE MED, V25, P1713, DOI 10.1097/00003246-199710000-00022; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; DIROCCO C, 1994, CHILD NERV SYST, V10, P321, DOI 10.1007/BF00335171; DULKERIAN SJ, 1995, J PEDIATR-US, V126, P872, DOI 10.1016/S0022-3476(95)70199-0; Fassbender K, 1996, J NEUROL NEUROSUR PS, V61, P57, DOI 10.1136/jnnp.61.1.57; Feigin RD, 1992, TXB PEDIAT INFECT DI, P960; FREI K, 1989, EUR J IMMUNOL, V19, P689, DOI 10.1002/eji.1830190418; GIJBELS K, 1990, EUR J IMMUNOL, V20, P233, DOI 10.1002/eji.1830200134; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kuster H, 1998, LANCET, V352, P1271, DOI 10.1016/S0140-6736(98)08148-3; LIN JP, 1992, CHILD NERV SYST, V8, P190, DOI 10.1007/BF00262843; LopezCortes LF, 1997, ANN CLIN BIOCHEM, V34, P165, DOI 10.1177/000456329703400206; LUTSAR I, 1995, INFECTION, V23, P113, DOI 10.1007/BF01833878; MartinAncel A, 1997, PEDIATRICS, V100, P789, DOI 10.1542/peds.100.5.789; MATHIESEN T, 1993, J NEUROSURG, V78, P562, DOI 10.3171/jns.1993.78.4.0562; MATSUZONO Y, 1995, ACTA PAEDIATR, V84, P879, DOI 10.1111/j.1651-2227.1995.tb13784.x; ODIO C, 1984, AM J DIS CHILD, V138, P1103, DOI 10.1001/archpedi.1984.02140500009004; Savman K, 1998, PEDIATR RES, V43, P746; VANNUCCI RC, 1980, DEV MED CHILD NEUROL, V22, P308	20	11	11	0	1	MMV MEDIEN & MEDIZIN VERLAGSGESELLSCHAFT MBH	MUNICH	NEUMARKTER STR 18, D-81673 MUNICH, GERMANY	0300-8126			INFECTION	Infection	JUL-AUG	2000	28	4					234	236		10.1007/s150100070043			3	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	344NW	WOS:000088766600010	10961531				2022-02-06	
J	Chong, ZZ; Feng, YP				Chong, ZZ; Feng, YP			dl-3-n-butylphthalide reduces brain damage in mice with closed head injury	CHINESE MEDICAL JOURNAL			English	Article						dl-3-n-butylphthalide; closed head injury; blood-brain barrier; brain edema; choline acetyltransferase	CHOLINE-ACETYLTRANSFERASE; EDEMA	Objective To investigate the protective effect of dl-3-n-butylphthalide (NBP) as an anti-cerebral ischemic drug on brain damage 24 h after closed head injury in mice. Methods Closed head injury was induced by dropping a 50-g weight from a height of 18 cm on a metal impounder resting on the parietal bone in mice. Results The neurotraumatic model induced impairment of memory function, significant cerebral edema, and disruption of the blood-brain barrier. dl-3-n-butylphthalide (50 mg . kg(-1)) given intraperitoneally 5 minutes and 60 minutes after the onset of closed head injury was found to attenuate the impairment of memory function (P < 0.05), alleviate brain edema in the injured cerebral cortex (P < 0.05), and reduce extravasation of plasma protein bound to Evans blue dye by 63.5% (P < 0.01). NBP was also shown to increase the activity of choline acetyltransferase in the injured cortex to 0.83 +/- 0.21 ng . min(-1) . mg(-1) ( P < 0.01, compared with 0.48 +/- 0.14 ng . min(-1) . mg(-1) of vehicle group). Conclusion NBP provides therapeutic response in experimental closed head injury.	Peking Union Med Coll, Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China		Chong, ZZ (corresponding author), Peking Union Med Coll, Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China.						CHONG ZZ, 1998, ACTA PHARMACOL SINIC, V32, P245; Deng W, 1997, Chin Med Sci J, V12, P102; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; DEWAR D, 1997, J CEREB BLOOD FLO S1, V17, P527; FENG YP, 1995, ACTA PHARMACOL SINIC, V30, P741; Gorman L. K., 1995, Society for Neuroscience Abstracts, V21, P471; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; KAMIYA T, 1993, STROKE, V24, P571, DOI 10.1161/01.STR.24.4.571; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LIU XG, 1995, ACTA PHARMACOL SINIC, V30, P896; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Yan CH, 1998, CHIN J PHARM TOXICOL, V12, P36	13	11	13	0	4	CHINESE MEDICAL ASSOCIATION	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	JUL	2000	113	7					613	616					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342JH	WOS:000088641100010	11776030				2022-02-06	
J	Schlund, MW; Pace, G				Schlund, MW; Pace, G			The effects of traumatic brain injury on reporting and responding to causal relations: an investigation of sensitivity to reinforcement contingencies	BRAIN INJURY			English	Article							MOTIVATIONAL DEFICITS; DAMAGE; BEHAVIOR	Impairments in judging and responding to consequences that follow behaviour are often attributed to changes in various cognitive processes. An alternative conceptualization is that impairments may produce a reduction in sensitivity to reinforcement contingencies. The present investigation employed a methodology commonly used in research on judgements of causality to examine the effects of TBI on sensitivity to reinforcement contingencies. Participants were non-injured control subjects and adults with TBI. The experimental task required subjects to press a response key under a series of concurrent response-reinforcer contingencies that periodically delivered money for responding and not responding. Afterwards, subjects provided a judgement about each response-reinforcer contingency by reporting the amount of money earned for responding and for not responding. Results suggest that TBI reduced the sensitivity of judgements and responding under select contingencies. These results lend some support to the view that TBI may reduce sensitivity to reinforcement contingencies. Furthermore, the investigation highlights the potential benefits of employing methods commonly used in human and animal operant research for the study of TBI.	Kennedy Krieger Inst, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA		Schlund, MW (corresponding author), Kennedy Krieger Inst, 333 Cassell Dr,Triad Technol Bldg,Suite 4200, Baltimore, MD 21224 USA.						Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; Bandura A., 1969, PRINCIPLES BEHAV MOD; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; CHATLOSH DL, 1985, LEARN MOTIV, V16, P1, DOI 10.1016/0023-9690(85)90002-5; Damasio A.R., 1993, CLIN NEUROPSYCHOLOGY, P409; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; HAMMOND LJ, 1980, J EXP ANAL BEHAV, V34, P297, DOI 10.1901/jeab.1980.34-297; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heider F., 1958, PSYCHOL INTERPERSONA; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Mackintosh N.J., 1974, PSYCHOL ANIMAL LEARN; MAIER SF, 1976, J EXP PSYCHOL GEN, V105, P3, DOI 10.1037/0096-3445.105.1.3; MALKMUS D, 1974, RANCHO LOS AMIGOS SC; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; NEWLAND MC, 1994, TOXICOL APPL PHARM, V126, P6, DOI 10.1006/taap.1994.1084; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; OSCARBERMAN M, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P230; Piaget J., 1974, UNDERSTANDING CAUSAL; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; REED P, 1992, Q J EXP PSYCHOL-B, V44B, P81; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; SCHLUND MW, 2000, IN PRESS BEHAV INTER; Skinner BF, 1938, BEHAV ORGANISMS; *STAT U NEW YORK B, 1993, GUID UN DAT SET MED; Wechsler D, 1985, WECHSLER ADULT INTEL	28	11	11	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2000	14	6					573	583		10.1080/026990500120475			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	325WN	WOS:000087699600007	10887890				2022-02-06	
J	del Pozo, NO; Ezquerra-Iribarren, JA; Urruticoechea-Sarriegui, I; Quemada-Ubis, JI; Munoz-Cespedes, JM				del Pozo, NO; Ezquerra-Iribarren, JA; Urruticoechea-Sarriegui, I; Quemada-Ubis, JI; Munoz-Cespedes, JM			Training in social skills in patients with acquired brain damage	REVISTA DE NEUROLOGIA			Spanish	Article						brain damage; neuropsychology; neuropsychological rehabilitation; social skills	SEVERE HEAD-INJURY; ADJUSTMENT; INDIVIDUALS; PERSONALITY; SEQUELAE; PROFILE; SUPPORT; STRESS	Introduction. Brain damaged patients have cognitive deficits, behaviour disorders and personality changes which affect socio-familial behaviour. Frequently, these changes generate considerable disturbance between family members and make it very difficult to return to work Objective. We describe a pilot study which led to the development and application of a focal rehabilitation programme aimed at retraining this group in social skills. Patients and methods. The programme was intensive (3 months) and included 6 outpatients (5 men and 1 woman) who took part in programmes of neuropsychological rehabilitation after traumatic or vascular cerebral lesions (X=19.2 months after the lesion occurred). The average age of the patients was 27.2 years and their average IQ 109.2. Individual and group interventions were combined (role-playing, 'make-believe' work, video filming) emphasizing particularly the processes of learning without making mistakes and the extension of achievements to the natural setting (controlled trials). Results and conclusions. We state and describe the relationship between the nature of neuropsychological and psychopathological deficits, and the characteristics of the limitations in social behaviour The patients showed a significant reduction in the level of anxiety and aggressive behaviour and improvement in consciousness of their defects. Some improvement was seen in expressing opinions and emotions and in ability to adapt social conduct to different situations (flexible behaviour), Finally we describe the conclusions drawn as to this treatment for future review and improvement of the programme.	Hosp Aita Menni, Serv Rehabil Dano Cerebral, Mondragon, Guipuzcoa, Spain; Univ Complutense Madrid, Dept Psicol Basica Procesos Cognit, Hosp Beata Maria Ana, Unidad Dano Cerebral, Madrid, Spain					OJEDA, NATALIA/0000-0002-0952-0649			ALONSO J, 1990, AM J PUBLIC HEALTH, V80, P704, DOI 10.2105/AJPH.80.6.704; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; BEL MTR, 1995, DANO CEREBRAL TRAUMA, P249; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROTHERTON FA, 1988, ARCH PHYS MED REHAB, V69, P827; CABALLO VE, 1987, 7 JORN MOD COND MADR; FERNANDEZGUINEA S, 1997, MAPFRE MED, V8, P191; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; KWASNICA CM, 1994, ARCH PHYS MED REHAB, V75, P384, DOI 10.1016/0003-9993(94)90159-7; Leathem J, 1996, BRAIN INJURY, V10, P27; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lezak, 1989, ASSESSMENT BEHAV CON, V7, P113; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; MUNOZCESPEDES JM, 1999, IN PRESS POLIBEA; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; TURKSTRA IS, 1995, BRAIN INJURY, V10, P329; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; URRUTICOECHEASA.I, 1997, NEUROPSIQUIATRIA DAN, P319; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019	30	11	14	0	11	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	APR 16	2000	30	8					783	787		10.33588/rn.3008.99650			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	313GW	WOS:000086992800015	10893745				2022-02-06	
J	Perri, R; Carlesimo, GA; Loasses, A; Caltagirone, C				Perri, R; Carlesimo, GA; Loasses, A; Caltagirone, C			Deficient intentional access to semantic knowledge in patients with severe closed-head injury	CORTEX			English	Article						closed head injury; semantic memory; priming	SPREADING ACTIVATION; ALZHEIMERS-DISEASE; MEMORY; ATTENTION; FACILITATION; RETRIEVAL; DEMENTIA	Patients after severe closed-head injury (CHI) demonstrate reduced ability to spontaneously utilize semantic memory during word-list memory tests and when requested to answer questions regarding general knowledge. However, they show normal lexical facilitation in both automatic and intentional semantic priming paradigms. The present study was aimed at investigating two alternative hypotheses a) that the deficit in semantic processing after CHIT is the result of impaired access to an otherwise normal semantic system or b) that it reflects a loss of knowledge from a deteriorated semantic store. For this purpose, the performance of 15 CHI patients on an automatic Semantic Priming paradigm and on tests of Picture Naming and Semantic Judgment were compared to those of 14 normal controls (NC). Although CHI patients' reaction times were significantly slower than those of NCs, the semantic priming effect was comparable in the two groups. Instead, CHI patients performed significantly worse than NCs in the naming and semantic judgment casks. These results provide evidence that CHI patients access semantic memory automatically at a normal rate. However, when the task is more demanding in terms of processing requests, then CHI patients' performance becomes defective.	IRCCS S Lucia, I-00179 Rome, Italy; Univ Roma Tor Vergata, Neurol Clin, I-00173 Rome, Italy		Perri, R (corresponding author), IRCCS S Lucia, V Ardeatina 306, I-00179 Rome, Italy.		Caltagirone, Carlo/B-4930-2013				Carlesimo GA, 1997, CORTEX, V33, P131, DOI 10.1016/S0010-9452(97)80009-3; Carlesimo GA, 1998, CORTEX, V34, P1, DOI 10.1016/S0010-9452(08)70734-2; CHENERY HJ, 1994, BRAIN COGNITION, V25, P108, DOI 10.1006/brcg.1994.1026; CHERTKOW H, 1994, J CLIN EXP NEUROPSYC, V16, P608, DOI 10.1080/01688639408402672; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; FAHY TJ, 1967, LANCET, V2, P475; FARAH MJ, 1991, J EXP PSYCHOL GEN, V120, P339, DOI 10.1037/0096-3445.120.4.339; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; HARTMAN M, 1991, NEUROPSYCHOLOGIA, V29, P213, DOI 10.1016/0028-3932(91)90083-K; HAUT MW, 1991, BRAIN COGNITION, V17, P31, DOI 10.1016/0278-2626(91)90064-F; LEVI F, 1988, ANN REV CHRONOPHARMA, V4, P283; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; Miceli G, 1994, BATTERIA ANAL DEFICI; MILBERG W, 1981, BRAIN LANG, V14, P371, DOI 10.1016/0093-934X(81)90086-9; Neely J., 1991, BASIC PROCESSES READ; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; PARISI D, 1967, DATI QUANTITAIVI SUL; Posner MI, 1975, INFORM PROCESSING CO, P55; Silveri MC, 1996, J CLIN EXP NEUROPSYC, V18, P371, DOI 10.1080/01688639608408994; Tognoni G., 1987, ITALIAN J NEUROLOG S, V8, P44	23	11	11	0	5	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex	APR	2000	36	2					213	225		10.1016/S0010-9452(08)70525-2			13	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	308XW	WOS:000086739000005	10815707				2022-02-06	
J	Freeman, J; Godfrey, H				Freeman, J; Godfrey, H			The validity of the NART-RSPM index in detecting intellectual decline following traumatic brain injury: A controlled study	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							ADULT READING TEST; STANDARD PROGRESSIVE MATRICES; PREMORBID INTELLIGENCE; HEAD-INJURY; VALIDATION; DEMENTIA; HOLD; IQ	The present study replicated Van den Broek and Bradshaw's (1994) study by developing a multiple regression equation to predict Ravens Standard Progressive Matrices (RSPM) scores from participants' National Adult Reading Test (NART) stores and demographic variables. A test of the validity of this procedure was undertaken by applying both the Van den Broek and Bradshaw equation and the present study's equation to a mixed sample of orthopedic control (OC) and closed head injury (CHI) participants. Premorbid RSPM scores were estimated using both equations and then compared to obtained scores. Results indicated that both equations had good predictive accuracy in estimating RSPM scores and were able to detect significantly higher rates of impairment in general intelligence in the CHI participants (24%) compared to the OC sample (7%).	Univ Otago, Dept Psychol, Dunedin, New Zealand		Godfrey, H (corresponding author), Univ Otago, Dept Psychol, POB 56, Dunedin, New Zealand.						Crawford J. R., 1992, HDB NEUROPSYCHOLOGIC; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P275, DOI 10.1111/j.2044-8260.1989.tb01377.x; CRAWFORD JR, 1989, PERS INDIV DIFFER, V10, P585, DOI 10.1016/0191-8869(89)90043-3; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P267, DOI 10.1111/j.2044-8260.1989.tb01376.x; ELLEY WB, 1985, NEW ZEAL J EDUC STUD, V20, P115; Garb HN, 1996, PSYCHOL BULL, V120, P140, DOI 10.1037/0033-2909.120.1.140; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; HARTLAGE LC, 1982, J CLIN PSYCHOL, V32, P658; IRVING JC, 1977, NEW ZEAL J EDUC STUD, V12, P154; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; MOSS AR, 1991, BRIT J CLIN PSYCHOL, V30, P179, DOI 10.1111/j.2044-8260.1991.tb00934.x; Nelson H.E., 1982, NATL ADULT READING T; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; OCARROLL RE, 1987, BRIT J CLIN PSYCHOL, V26, P315, DOI 10.1111/j.2044-8260.1987.tb01367.x; OLEARY UM, 1991, J CLIN PSYCHOL, V47, P277, DOI 10.1002/1097-4679(199103)47:2<277::AID-JCLP2270470215>3.0.CO;2-I; ORME JE, 1970, ACTA PSYCHOL, V32, P145, DOI 10.1016/0001-6918(70)90096-X; Raven J. C, 1958, GUIDE USING MILL HIL; Stebbins Glenn T, 1990, Clin Neuropsychol, V4, P64, DOI 10.1080/13854049008401497; VANDENBROEK MD, 1994, BRIT J CLIN PSYCHOL, V33, P509	21	11	11	2	2	BRITISH PSYCHOLOGICAL SOC	LEICESTER	ST ANDREWS HOUSE, 48 PRINCESS RD EAST, LEICESTER LE1 7DR, LEICS, ENGLAND	0144-6657			BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	MAR	2000	39		1				95	103		10.1348/014466500163130			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	296TX	WOS:000086043400010	10789031				2022-02-06	
J	von Oettingen, G; Bergholt, B; Ostergaard, L; Jensen, LC; Gyldensted, C; Astrup, J				von Oettingen, G; Bergholt, B; Ostergaard, L; Jensen, LC; Gyldensted, C; Astrup, J			Xenon CT cerebral blood flow in patients with head injury: influence of pulmonary trauma on the input function	NEURORADIOLOGY			English	Article						head injury; blood flow, cerebral; computed, tomography xenon enhanced	COMPUTED-TOMOGRAPHY; BRAIN; ISCHEMIA; METABOLISM; XE-133	The noninvasive xenon-enhanced CT (Xe CT) cerebral blood flow (CBF) method has been used in patients with severe traumatic brain injury (TBI) to identify the blood-flow thresholds for the development of irreversible ischaemia or infarction following severe TBI. Quantitative regional CBF (rCBF) estimates are based on the assumption of identity between the end-tidal xenon concentration curve, used as the input function, and the arterial xenon concentration curve, being the true input function to the brain. Accordingly, rCBF data addressing the issue of ischaemia should be viewed in relation to possible deviations between the end-tidal and arterial xenon concentration curves. To evaluate this possible source of error, we studied five patients with severe TBI (Glasgow coma score less than or equal to 7) who also bad pulmonary trauma. CBF was studied with the Xe CT CBF method and flow rates were determined, by fitting the Kety equation to each CT voxel using either the end-tidal or the arterial xenon curve as input function. In all patients rCBF estimates were lower using the end-tidal xenon curve than with the arterial xenon curve; the mean underestimation was 20.3% in gray metter and 17.3% in white matter. The deviation between the end-tidal and arterial xenon concentration curves should be considered as a source of error when defining critical flow values according to the flow thresholds of tissue viability.	Aarhus Univ Hosp, Dept Neurosurg, DK-8000 Aarhus C, Denmark; Aarhus Univ Hosp, Dept Neuroradiol, DK-8000 Aarhus C, Denmark; Aarhus Univ Hosp, Dept Bioengn, DK-8000 Aarhus C, Denmark		von Oettingen, G (corresponding author), Aarhus Univ Hosp, Dept Neurosurg, DK-8000 Aarhus C, Denmark.	von_oettingen@dadlnet.dk	Ostergaard, Leif/A-9281-2008; Ostergaard, Lars/AAA-3020-2020	Ostergaard, Leif/0000-0003-2930-6997; Ostergaard, Lars/0000-0003-2459-0511; Ostergaard, Lars/0000-0002-7619-605X			ASTRUP J, 1995, QUANTITATIVE CEREBRAL BLOOD FLOW MEASUREMENTS USING STABLE XENON/CT: CLINICAL APPLICATIONS, P267; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; FATOUROS PP, 1987, INVEST RADIOL, V22, P705, DOI 10.1097/00004424-198709000-00003; GOOD WF, 1987, MED PHYS, V14, P377, DOI 10.1118/1.596051; HANSEN M, 1990, STROKE, V21, P745, DOI 10.1161/01.STR.21.5.745; INGVAR DH, 1962, ACTA PHYSIOL SCAND, V54, P325; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; KELCZ F, 1978, RADIOLOGY, V127, P385, DOI 10.1148/127.2.385; KETY SS, 1951, PHARMACOL REV, V3, P1; LEE TY, 1990, PHYS MED BIOL, V35, P925, DOI 10.1088/0031-9155/35/7/008; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MEYER JS, 1980, AM J ROENTGENOL, V135, P239, DOI 10.2214/ajr.135.2.239; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; NORTH JB, 1974, ARCH NEUROL-CHICAGO, V31, P338, DOI 10.1001/archneur.1974.00490410086010; OBRIST WD, 1990, CEREBROVAS BRAIN MET, V2, P283; OBRIST WD, 1967, CIRC RES, V20, P124, DOI 10.1161/01.RES.20.1.124; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OBRIST WD, 1988, HDB REGIONAL CEREBRA, P37; PRESS WH, 1992, NUMERICAL RECPIES C; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; SHIMODA M, 1992, NEURORADIOLOGY, V35, P66, DOI 10.1007/BF00588282; SUESS C, 1995, QUANTITATIVE CEREBRAL BLOOD FLOW MEASUREMENTS USING STABLE XENON/CT: CLINICAL APPLICATIONS, P27; SUGA S, 1992, CEREBRAL BLOOD FLOW MEASUREMENT WITH STABLE XENON-ENHANCED COMPUTED TOMOGRAPHY, P50; VEALL N, 1965, PHYS MED BIOL, V10, P375, DOI 10.1088/0031-9155/10/3/306; von Oettingen G, 2000, J NEUROSCI METH, V95, P159, DOI 10.1016/S0165-0270(99)00179-X; WINKLER S, 1985, CEREBRAL BLOOD FLOW, P356	27	11	11	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	MAR	2000	42	3					168	173		10.1007/s002340050039			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	300KM	WOS:000086252200002	10772136				2022-02-06	
J	Bombardier, CH; Heinemann, AW				Bombardier, CH; Heinemann, AW			The construct validity of the readiness to change questionnaire for persons with TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol problems; brain injury; measurement of readiness to change	TRAUMATIC BRAIN INJURY; DRINKING	Objective: To examine the reliability and validity of the Readiness to Change Questionnaire (RTC) among persons with recent traumatic brain injury. Design: Survey Setting: Inpatient rehabilitation. Participants: One-hundred twenty-six persons with recent TBI. Results: In the first step of the analyses the RTC measure was rescaled and shortened to produce a coherent Linear measure of readiness to change. Subsequent analyses showed that the linear measure fit a three stage model of change and correlated in meaningful ways with independent measures of alcohol problem severity. Conclusions: The RTC measure can be substantially improved by utilizing results obtained from rating scale analysis. The resulting IO-item Linear scale has good internal consistency a theoretically sound factor structure and meaningful correlations with external variables. Measuring readiness to change may be useful for tailoring treatment and predicting outcomes, though mure research is needed in this area.	Northwestern Univ, Sch Med, Rehabil Inst Chicago, Rehabil Serv Evaluat Unit, Chicago, IL USA; Univ Washington, Sch Med, Seattle, WA USA		Bombardier, CH (corresponding author), Harborview Med Ctr, Box 359740,325 9th Ave, Seattle, WA 98104 USA.		Heinemann, Allen W/K-6283-2012; Heinemann, Allen W./AAI-2790-2021; Bombardier, Charles H./AAZ-3260-2021	Heinemann, Allen W/0000-0003-2782-7326; Heinemann, Allen W./0000-0003-2782-7326; Bombardier, Charles H./0000-0003-4758-6283	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR512721, R49/CCR011714-01] Funding Source: Medline		ALLEN JP, 1995, TREATMENT HDB SERIES, V4; Bombardier CH, 1997, ARCH PHYS MED REHAB, V78, P592, DOI 10.1016/S0003-9993(97)90424-X; Bombardier CH, 1998, ARCH PHYS MED REHAB, V79, P1110, DOI 10.1016/S0003-9993(98)90180-0; CHESS SB, 1971, J GEN PSYCHOL, V85, P93, DOI 10.1080/00221309.1971.9920657; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DENT THS, 1995, ALCOHOL ALCOHOLISM, V30, P577; Dijkstra A, 1999, PREV MED, V28, P203, DOI 10.1006/pmed.1998.0407; Dijkstra A, 1998, ADDICT BEHAV, V23, P339, DOI 10.1016/S0306-4603(97)00070-1; Doherty S C, 1998, J Cardiovasc Risk, V5, P147, DOI 10.1097/00043798-199806000-00002; DONOVAN D, 1995, RES SOC ALCOHOLISM S; DONOVAN DM, 1977, J STUD ALCOHOL, V38, P465, DOI 10.15288/jsa.1977.38.465; HEATHER N, 1993, ADDICTION, V88, P1667, DOI 10.1111/j.1360-0443.1993.tb02042.x; HEATHER N, 1993, 19 U NEW S WAL NAT D; ISENHART CE, 1994, ADDICT BEHAV, V19, P463, DOI 10.1016/0306-4603(94)90002-7; Laforge RG, 1999, PREV MED, V28, P61, DOI 10.1006/pmed.1998.0384; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; MILLER WR, 1993, J CONSULT CLIN PSYCH, V61, P455, DOI 10.1037/0022-006X.61.3.455; Miller WR, 1987, BRIEF DRINKER PROFIL; Miller WR, 1991, MOTIVATIONAL INTERVI; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; SELZER ML, 1975, J STUD ALCOHOL, V36, P127; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; [No title captured]	24	11	11	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	2000	15	1					696	709		10.1097/00001199-200002000-00008			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	287MX	WOS:000085510800009	10745185				2022-02-06	
J	Grisoni, ER; Pillai, SB; Volsko, TA; Mutabagani, K; Garcia, V; Haley, K				Grisoni, ER; Pillai, SB; Volsko, TA; Mutabagani, K; Garcia, V; Haley, K			Pediatric airbag injuries: The Ohio experience	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	30th Annual Meeting of the American-Pediatric-Surgical-Association	MAY 16-19, 1999	RANCHO MIRAGE, CALIFORNIA	Amer Pediat Surg Assoc		pediatric trauma; airbag injury	CHILDREN; PATTERNS	Background/Purpose: We sought to determine if properly restrained children, less than 13 years of age, placed in the front passenger seat are at greater risk for trauma from airbag deployment than unrestrained children. Methods: The charts of children treated at any of 3 regional pediatric trauma centers in Ohio were reviewed for airbag injuries sustained in motor vehicle crashes between January 1995 and September 1998. injury Severity Scores (ISS) were compared with Mann-Whitney Rank Sum Test and outcome data with Fisher's Exact Tests. Statistical significance was set at P less than or equal to.05. Results: Twenty-seven children aged 1 month to 12 years sustained airbag-related injuries. Sixty-one percent were girls. ISS ranged from 1 to 75 with a mean score (+/-SD) of 10 (14.5). All crashes were at reported speeds of less than 45 mph, and 64% were head-on collisions. No significant differences in the mean ISS (P=.074) occurred between groups. Both groups had similar closed head, ocular and facial injuries, extremity fractures, and number of deaths (P=1.0). Abdominal organ injury was exclusive to the restrained group. Decapitation only occurred among unrestrained children. Conclusion: Our data showed that airbags, with or without proper safety restraints, can lead to mortality or serious morbidity in children. J Pediatr Surg 35:160-763. Copyright (C) 2000 by W.B. Saunders Company.	Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, Div Pediat Surg, Cleveland, OH 44106 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA		Grisoni, ER (corresponding author), Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, Div Pediat Surg, 11100 Euclid Ave,RBC Room 122, Cleveland, OH 44106 USA.		Volsko, Teresa/AAE-3009-2019	Volsko, Teresa/0000-0001-5111-898X			Giguere JF, 1998, J PEDIATR SURG, V33, P811, DOI 10.1016/S0022-3468(98)90648-0; Graham JD, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e3; GRAHM JD, 1997, JAMA-J AM MED ASSOC, V178, P1418; Hollands CM, 1996, J TRAUMA, V41, P920, DOI 10.1097/00005373-199611000-00033; Marshall KW, 1998, AM J NEURORADIOL, V19, P1599; McCaffrey M, 1999, J PEDIATR ORTHOPED, V19, P60, DOI 10.1097/00004694-199901000-00014; Mohamed AA, 1998, POSTGRAD MED J, V74, P455, DOI 10.1136/pgmj.74.874.455; *NAT HIGHW TRAFF S, 1996, QUEST FREQ ASK CHILD; *NAT HIGHW TRAFF S, 1998, FAT ACC REP SYST; 1996, MMWR MORB MORTAL WKL, V45, P1073	10	11	11	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0022-3468			J PEDIATR SURG	J. Pediatr. Surg.	FEB	2000	35	2					160	162		10.1016/S0022-3468(00)90002-2			3	Pediatrics; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	280XH	WOS:000085128700003	10693658				2022-02-06	
J	Alexiou, T; Crane, LH; Vink, R				Alexiou, T; Crane, LH; Vink, R			Increased mortality in female rats after severe diffuse traumatic brain injury is significantly attenuated by magnesium administration	NEUROSCIENCE RESEARCH COMMUNICATIONS			English	Article						neurotrauma; brain injury; gender; treatment; hormones	NEUROCHEMICAL SEQUELAE; AXONAL INJURY; NEURONS; RECEPTORS; REDUCTION; BLOCKADE; THERAPY; DEATH; MODEL	Previous studies using focal models of traumatic brain injury have shown that female animals have a higher postinjury mortality than male animals, and that this higher mortality may be due to a worsened magnesium homeostasis in the female animals. The present study examined whether a similar difference in male and female mortality existed following a more diffuse model of traumatic brain injury and whether any mortality could be attenuated by ovariectomy or posttraumatic magnesium administration. Severe impact-acceleration induced diffuse brain trauma resulted in a 20% mortality in male rats as opposed to a 100% mortality in female animals (p< 0.05). This difference was not apparent at less severe injury levels. Administration of 750 mu moles/kg magnesium sulphate intramuscularly at 30 min after severe trauma reduced female mortality to 29% (p< 0.05). Female outcomes were similar in ovariectomised animals suggesting that the protective effects of magnesium were unrelated to cyclic changes in gonadal hormones. We conclude that the higher mortality observed in female animals following brain trauma is dependent on injury severity and that this mortality can be significantly attenuated with posttraumatic administration of magnesium sulphate.	James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia		Alexiou, T (corresponding author), James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia.		Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			AGUS ZS, 1991, ANNU REV PHYSIOL, V53, P299, DOI 10.1146/annurev.physiol.53.1.299; Altura BM, 1998, ALCOHOL, V15, P181, DOI 10.1016/S0741-8329(97)00107-9; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Ciarallo L, 1996, J PEDIATR-US, V129, P809, DOI 10.1016/S0022-3476(96)70023-9; Delivoria-Papadopoulos M, 1998, J PEDIATR-US, V132, pS30, DOI 10.1016/S0022-3476(98)70525-6; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frakes MA, 1997, AM J EMERG MED, V15, P182, DOI 10.1016/S0735-6757(97)90098-X; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; IZUMI Y, 1991, J CEREBR BLOOD F MET, V11, P1025, DOI 10.1038/jcbfm.1991.170; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; Vink R, 1990, Magnes Res, V3, P163; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	22	11	11	0	2	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0893-6609			NEUROSCI RES COMMUN	Neurosci. Res. Commun.	JAN-FEB	2000	26	1					1	8		10.1002/(SICI)1520-6769(200001/02)26:1<1::AID-NRC1>3.0.CO;2-Q			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	287QF	WOS:000085516700001					2022-02-06	
J	Biros, MH; Kukielka, D; Sutton, RL; Rockswold, GL; Bergman, TA				Biros, MH; Kukielka, D; Sutton, RL; Rockswold, GL; Bergman, TA			The effects of acute and chronic alcohol ingestion on outcome following multiple episodes of mild traumatic brain injury in rats	ACADEMIC EMERGENCY MEDICINE			English	Article						ethanol; traumatic brain injury; minor head trauma; fluid percussion injury; Morris Water Maze	CHRONIC ETHANOL; WISTAR RATS; INTOXICATION; MODEL; ABUSE	Objective: Recent studies suggest that in some circumstances, alcohol intoxication at the time of severe head injury may be neuroprotective. The objective of this study was to determine the effect of acute and chronic alcohol ingestion on outcome in rodents sustaining multiple episodes of mild traumatic brain injury while intoxicated. Methods: For two weeks before experimentation, adult male Sprague-Dawley rats received intoxicating levels of 95% ethanol (3 g/kg) or normal saline (NS) every other day by orogastric instillation. On the day of experimentation, the animals were randomized to receive alcohol or NS. Two hours later, the animals received either mild (1.2 +/- 0.4 ATA) fluid percussion injury (FPI) or no injury. The injured animals received a total of three episodes of FPI (once every four days). Mean reflex recovery time (RRT) was determined (seconds +/- SEM) immediately after each episode. Mean latency time (seconds +/- SEM) for Morris Water Maze (MWM) performance was assessed at posttrauma days 11-19. Results: The chronic alcohol-exposed (CA) and the non-alcohol-exposed (NA) animals intoxicated when injured had prolonged escape, righting, and corneal RRTs after each FPI compared with the nonintoxicated injured animals and the noninjured shams. However, the CA animals had significantly shorter RRTs when compared with the NA rats. All the injured animals had MWM deficits on testing days 1-6 compared with the noninjured controls. On the last two MWM testing days, the injured NA animals had significantly better MWM performance than the injured CA rats. Conclusions: The injured intoxicated CA animals had a more rapid recovery of reflexes compared with the injured intoxicated NA animals. Despite initial MWM deficits, the injured NA rodents eventually began to learn the MWM. The injured CA rats never learned the maze. Under the conditions of this study, acute alcohol intoxication at the time of multiple episodes of minor head trauma did not provide neuroprotection for NA or CA rodents.	Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA; Hennepin Cty Med Ctr, Div Neurosurg, Minneapolis, MN 55415 USA		Biros, MH (corresponding author), Hennepin Cty Med Ctr, Dept Emergency Med, 701 Pk Ave S, Minneapolis, MN 55415 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS30322] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030322] Funding Source: NIH RePORTER		ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; Biros MH, 1996, ACAD EMERG MED, V3, P853, DOI 10.1111/j.1553-2712.1996.tb03530.x; CASSON IR, 1982, J NEUROL NEUROSUR PS, V45, P170, DOI 10.1136/jnnp.45.2.170; DACEY RG, 1993, HEAD INJURY, P159; DeCrescito V, 1974, Surg Forum, V25, P438; DILDYMAYFIELD JE, 1991, J NEUROCHEM, V56, P1536, DOI 10.1111/j.1471-4159.1991.tb02048.x; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; GRANT KA, 1990, EUR J PHARMACOL, V176, P289, DOI 10.1016/0014-2999(90)90022-X; Heegaard W, 1997, ACAD EMERG MED, V4, P33, DOI 10.1111/j.1553-2712.1997.tb03640.x; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KOKKA N, 1993, ALCOHOL CLIN EXP RES, V17, P525, DOI 10.1111/j.1530-0277.1993.tb00793.x; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Kraus JF, 1993, HEAD INJURY, P1; Markwiese BJ, 1998, ALCOHOL CLIN EXP RES, V22, P416, DOI 10.1097/00000374-199804000-00018; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; McQueen J D, 1975, Surg Neurol, V4, P375; MICHAELIS EK, 1978, BIOCHEM PHARMACOL, V27, P1685, DOI 10.1016/0006-2952(78)90179-X; MODELL JG, 1990, NEW ENGL J MED, V323, P455, DOI 10.1056/NEJM199008163230706; NURMI M, 1994, ALCOHOL, V11, P315, DOI 10.1016/0741-8329(94)90098-1; Prasad RM, 1997, J NEUROTRAUM, V14, P919, DOI 10.1089/neu.1997.14.919; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; Schulteis G, 1996, ALCOHOL CLIN EXP RES, V20, P164, DOI 10.1111/j.1530-0277.1996.tb01060.x; SILVERBAGECARLS.G, 1987, J NEUROSURG, V67, P197; SONNE NM, 1992, BRIT J NEUROSURG, V6, P125, DOI 10.3109/02688699209002914; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; YAMAKAMI I, 1995, J NEUROSURG, V82, P813, DOI 10.3171/jns.1995.82.5.0813; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275	32	11	11	0	1	HANLEY & BELFUS INC	PHILADELPHIA	210 S 13TH ST, PHILADELPHIA, PA 19107 USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	NOV	1999	6	11					1088	1097		10.1111/j.1553-2712.1999.tb00109.x			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	255NN	WOS:000083676200004	10569379	Bronze			2022-02-06	
J	Vinjamuri, S; O'Driscoll, K; Maltby, P; McEwan, AJ; Wiebe, LI; Critchley, M				Vinjamuri, S; O'Driscoll, K; Maltby, P; McEwan, AJ; Wiebe, LI; Critchley, M			Identification of hypoxic regions in traumatic brain injury	CLINICAL NUCLEAR MEDICINE			English	Article						hypoxic brain injury; I-123 iodoazomycin arabinoside			Royal Liverpool Hosp, Dept Nucl Med, Liverpool L7 8XP, Merseyside, England; Rathbone Hosp, Brain Injury Rehabil Ctr, Liverpool, Merseyside, England; Univ Alberta, Edmonton, AB, Canada; Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada		Vinjamuri, S (corresponding author), Royal Liverpool Hosp, Dept Nucl Med, Prescot St, Liverpool L7 8XP, Merseyside, England.						NUNN A, 1995, EUR J NUCL MED, V22, P265, DOI 10.1007/BF01081524	1	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0363-9762			CLIN NUCL MED	Clin. Nucl. Med.	NOV	1999	24	11					891	892		10.1097/00003072-199911000-00018			2	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	249XC	WOS:000083357600018	10551478				2022-02-06	
J	Banja, J				Banja, J			Patient advocacy at risk: ethical, legal and political dimensions of adverse reimbursement practices in brain injury rehabilitation in the US	BRAIN INJURY			English	Article							MANAGED-CARE; HEALTH-CARE; INSURANCE	This article examines the relationship between the growing challenge of securing reimbursement for delivering traumatic brain injury rehabilitation in the US and the health providers' duty to advocate for the welfare of patients. Following a discussion of live impediments or barriers to reimbursement-namely, the erosion of private insurance, the insurer's refusal to pay, lack of empirical data to justify rehabilitation as 'medically necessary', financial incentives to abbreviate care, and the ERISA pre emption-the article offers a series of recommendations aimed at enhancing patient advocacy. A prominent theme of this article is that health providers cannot forsake their advocacy role and so must be protected from potential penalties imposed by payers for doing so. The degree to which this protection occurs, however, may largely depend on a willingness to agitate for health reform on the state and federal levels.	Emory Univ, Sch Med, Atlanta, GA 30322 USA		Banja, J (corresponding author), Ctr Rehabil Med, 1441 Clifton Rd,NE, Atlanta, GA 30322 USA.	jbanja@emory.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133F980025] Funding Source: Medline		Banja JD, 1997, J HEAD TRAUMA REHAB, V12, P91, DOI 10.1097/00001199-199706000-00010; BEATRICE DF, 1996, STRATEGIC CHOICES CH, P183; Bodenheimer T, 1997, INT J HEALTH SERV, V27, P409, DOI 10.2190/YAGR-4KXN-J50E-B62H; Bontke CF, 1997, J HEAD TRAUMA REHAB, V12, P37, DOI 10.1097/00001199-199702000-00007; Caplan A, 1997, J HEAD TRAUMA REHAB, V12, P29, DOI 10.1097/00001199-199702000-00006; CHESTNUT RM, 1998, NIH CONS DEV C REH P, P73; CHOLLET D, 1996, STRATEGIC CHOICES CH, P33; CLARK J, 1999, COMMERICAL INSURANCE; COPE DN, 1994, J HEAD TRAUMA REHAB, V9, P1, DOI 10.1097/00001199-199409000-00003; DEJONG G, 1996, BNAS MANAGED CARE RE, V2, P138; deLateur BJ, 1997, ARCH PHYS MED REHAB, V78, P237, DOI 10.1016/S0003-9993(97)90026-5; EMANUEL EJ, 1995, JAMA-J AM MED ASSOC, V273, P323, DOI 10.1001/jama.273.4.323; Enthoven AC, 1997, HEALTH AFFAIR, V16, P26, DOI 10.1377/hlthaff.16.6.26; EPSTEIN RA, 1997, MORTAL PERIL OUR IND; Evans RG, 1997, J HEALTH POLIT POLIC, V22, P427, DOI 10.1215/03616878-22-2-427; FUHRER MJ, 1994, AM J PHYS MED REHAB, V73, P358, DOI 10.1097/00002060-199409000-00010; Ginzberg E, 1999, NEW ENGL J MED, V340, P144, DOI 10.1056/NEJM199901143400212; Glazier AK, 1997, AM J LAW MED, V23, P45; Grumbach K, 1998, NEW ENGL J MED, V339, P1516, DOI 10.1056/NEJM199811193392106; Haas JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199702000-00003; HACKEY RB, 1998, RETHINKING HLTH CARE, P58; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; HALL MA, 1992, U PENN LAW REV, V140, P1637, DOI 10.2307/3312428; Iglehart JK, 1999, NEW ENGL J MED, V340, P70, DOI 10.1056/NEJM199901073400122; Iglehart JK, 1999, NEW ENGL J MED, V340, P403, DOI 10.1056/NEJM199902043400525; Iglehart JK, 1997, HEALTH AFFAIR, V16, P36, DOI 10.1377/hlthaff.16.6.36; JOHNSTON MV, 1998, 1998 NIH CONS DEV C; KASSIRER JP, 1994, NEW ENGL J MED, V330, P634, DOI 10.1056/NEJM199403033300910; Kuttner R, 1999, NEW ENGL J MED, V340, P248, DOI 10.1056/NEJM199901213400324; KUTTNER R, 1997, EVERYTHING SALE VIRT, P110; Miller TE, 1998, J LAW MED ETHICS, V26, P89, DOI 10.1111/j.1748-720X.1998.tb01665.x; *NAT CTR POL AN, 1998, PROBL 5 UN; PELLEGRINO ED, 1994, JAMA-J AM MED ASSOC, V271, P1668, DOI 10.1001/jama.271.21.1668; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; RODWIN MA, 1995, NEW ENGL J MED, V332, P604, DOI 10.1056/NEJM199503023320913; Sparer MS, 1998, HEALTH AFFAIR, V17, P7, DOI 10.1377/hlthaff.17.3.7; The Reforming States Group, 1998, HEALTH AFFAIR, V17, P181; White Joseph, 1995, COMPETING SOLUTIONS; YOUNGBERG BJ, 1996, MANAGED HLTH CARE HD, P608	39	11	11	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	1999	13	10					745	758		10.1080/026990599121142			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	247TV	WOS:000083236800001	10576459				2022-02-06	
J	McCrory, PR				McCrory, PR			You can run but you can't hide: the role of concussion severity scales in sport	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CEREBRAL CONCUSSION; GUIDELINES; INJURIES		Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med Neurol, Heidelberg, Vic 3084, Australia		McCrory, PR (corresponding author), Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med Neurol, Heidelberg, Vic 3084, Australia.		McCrory, Paul/Q-8688-2019				CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; GERSOFF W, 1991, SPORTS MED SCH AGE A; JENNETT B, 1975, LANCET, V1, P480; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; KOLB J, 1989, SPORTS TRAINING MED, V1, P165; KULUND D, 1982, INJURED ATHLETE, P225; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; SAAL JA, 1991, SPORTS MED, V12, P132, DOI 10.2165/00007256-199112020-00005; Schneider RC., 1973, HEAD NECK INJURIES F; Torg JS, 1991, ATHLETIC INJURIES HE, Vsecond	13	11	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	OCT	1999	33	5					297	298					2	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	242UY	WOS:000082961100005	10522628				2022-02-06	
J	Rowe, LA				Rowe, LA			Case studies in dysphagia after pediatric brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						dysphagia; head injury; pediatrics		The course of pediatric traumatic brain injury is not homogeneous because the underlying neuropathology can be so variable. Assessment, intervention, and recovery are examined among five individuals whose neuroradiologic imaging differed grossly on initial and early presentations after head trauma. Knowledge of the neuropathology in an overarching sense can be informative to a clinician's management of different swallowing problems after brain injury.	Childrens Hosp Wisconsin, Dept Speech & Hearing, Milwaukee, WI 53201 USA		Rowe, LA (corresponding author), Childrens Hosp Wisconsin, Dept Speech & Hearing, Mail Stn 785,900 Wisconsin Ave,POB 1997, Milwaukee, WI 53201 USA.						ADAMOVICH BLB, 1990, APHASIA RELATED NEUR; Arvedson JC., 1993, PEDIAT SWALLOWING FE, V3; BEHRMAN RE, 1990, ESSENTIALS PEDIAT; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; CHERNEY LR, 1991, CLIN MANAGEMENT COMM; Dodds W J, 1989, Dysphagia, V3, P171, DOI 10.1007/BF02407219; DODDS WJ, 1990, AM J ROENTGENOL, V154, P953, DOI 10.2214/ajr.154.5.2108569; Hagen C, 1981, TOP LANG DIS, V1, P73; LOVE RJ, 1996, NEUROLOGY SPEECH LAN	9	11	11	0	4	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1999	14	5					497	504		10.1097/00001199-199910000-00010			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	245MW	WOS:000083113600010	10653945				2022-02-06	
J	Walker, NW; Boling, MS; Cobb, H				Walker, NW; Boling, MS; Cobb, H			Training of school psychologists in neuropsychology and brain injury: Results of a national survey of training programs	CHILD NEUROPSYCHOLOGY			English	Article								School psychologists are in a primary position to meet the unique assessment and intervention needs of students with brain injury, including traumatic brain injury (TBI). Little research has been done, however, to determine the extent to which school psychology training programs are preparing their graduates to work with this population. All school psychology training programs in the United States were surveyed as to their training practices in neuropsychology and brain injury. Results indicate that (a) relatively few programs offer training in neuropsychology/brain injury, (b) the training appears to be limited in nature and content, and (c) there appear to be few program faculty with neuropsychological expertise. It appears that many school psychology training programs may not see this area as an important addition to their curriculum.	James Madison Univ, Sch Psychol, Harrisonburg, VA 22807 USA		Walker, NW (corresponding author), James Madison Univ, Sch Psychol, MSC 7401, Harrisonburg, VA 22807 USA.						Begali V., 1992, HEAD INJURY CHILDREN; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; CARNEY J, 1994, PEDIATR ANN, V23, P47, DOI 10.3928/0090-4481-19940101-10; HYND GW, 1981, NEUROPSYCHOLOGICAL A, P379; Lehr E, 1990, PSYCHOL MANAGEMENT T; *NAT ASS SCH PSYCH, 1994, STAND TRAIN FIELD PL; Obrzut J. E., 1981, NEUROPSYCHOLOGICAL A, P237; Savage R. C., 1991, HEAD INJURY FAMILY M, P203; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; *VIRG STAT DEP ED, 1991, NAT SERC PROV STUD T; WALKER NW, 1996, BEST PRACTICES ASSES	11	11	11	1	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	JUN	1999	5	2					137	142		10.1076/chin.5.2.137.3168			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	237ME	WOS:000082659500006					2022-02-06	
J	Mautes, AEM; Paschen, W; Rohn, G; Nacimiento, AC				Mautes, AEM; Paschen, W; Rohn, G; Nacimiento, AC			Changes in ornithine decarboxylase activity and putrescine concentrations after spinal cord compression injury in the rat	NEUROSCIENCE LETTERS			English	Article						polyamines; spinal cord compression; ornithine decarboxylase; putrescine; rat	REVERSIBLE CEREBRAL-ISCHEMIA; POLYAMINE LEVELS; CELL-DEATH; BRAIN; DEXAMETHASONE; INDUCTION; CALCIUM	Traumatic spinal cord injury results in direct physical damage to structures and the generation of local factors contributing to secondary pathogenesis. In the present study, we investigated changes in polyamine metabolism after spinal cord compression injury in the rat. This is a stress induced metabolic pathway, of which an activation may indicate both, secondary pathogenesis or induction of neuroprotective response. Ornithine decarboxylase (ODC) activity, the rate limiting step of polyamine synthesis, and levels of the diamine putrescine, the product of ornithine decarboxylase reaction, were analyzed in control (non-laminectomized) animals and at 2 and 4 h after laminectomy or compression injury at the L4 segmental level. ODC activity was significantly increased 4 h after laminectomy in L4 and in adjacent L3 and L5 segments and compression to L4 produced a further increase 4 h after injury as compared with the intact control group. Putrescine levels were likewise significantly elevated to the same extend in the laminectomized and injured cord as compared with the intact control group. These findings demonstrate increased ODC and putrescine levels in the laminectomized and traumatized spinal cord and suggest that laminectomy may be an important 'priming event' that contributes to secondary injury after spinal cord compression injury. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.	Univ Saarland, Sch Med, Neurosurg Res Lab, Homburg, Germany; Max Planck Inst Neurol Res, Dept Expt Neurol, Cologne, Germany		Mautes, AEM (corresponding author), Univ Saarland, Sch Med, Neurosurg Res Lab, Homburg, Germany.						Baskaya MFK, 1996, NEUROSURGERY, V38, P140; CAMPBELL JB, 1974, J NEUROSURG, V40, P726, DOI 10.3171/jns.1974.40.6.0726; DEMEDIUK P, 1987, NEUROCHEM PATHOL, V7, P79, DOI 10.1007/BF02834293; DIENEL GA, 1984, J NEUROCHEM, V42, P1053, DOI 10.1111/j.1471-4159.1984.tb12710.x; GILAD GM, 1991, EXP NEUROL, V111, P349, DOI 10.1016/0014-4886(91)90102-I; GILAD GM, 1994, BRAIN RES, V636, P187, DOI 10.1016/0006-8993(94)91016-2; GONZALEZ S, 1995, J STEROID BIOCHEM, V55, P85, DOI 10.1016/0960-0760(95)00160-2; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; HOLTZ A, 1989, SURG NEUROL, V31, P350, DOI 10.1016/0090-3019(89)90066-9; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Lukkarinen J, 1997, STROKE, V28, P639, DOI 10.1161/01.STR.28.3.639; MOULINOUX JP, 1989, ANTICANCER RES, V9, P1063; MULLER M, 1991, ACTA NEUROPATHOL, V83, P39; NACIMIENTO AC, 1985, J NEUROSURG, V62, P898, DOI 10.3171/jns.1985.62.6.0898; NACIMIENTO AC, 1986, SURG NEUROL, V25, P9; NISTICO G, 1980, BIOCHEM PHARMACOL, V29, P954, DOI 10.1016/0006-2952(80)90228-2; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; PASCHEN W, 1992, MOL CHEM NEUROPATHOL, V16, P241, DOI 10.1007/BF03159973; PASCHEN W, 1990, J CEREBR BLOOD F MET, V10, P236, DOI 10.1038/jcbfm.1990.40; PASCHEN W, 1988, NEUROCHEM PATHOL, P1; SCHMITZ MP, 1993, NEUROSURGERY, V33, P882; SHOHAMI E, 1992, EXP NEUROL, V117, P189, DOI 10.1016/0014-4886(92)90126-B; VERMA AK, 1986, ARCH BIOCHEM BIOPHYS, V247, P272, DOI 10.1016/0003-9861(86)90584-9; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063	25	11	11	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	APR 2	1999	264	1-3					153	156		10.1016/S0304-3940(99)00197-4			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189LR	WOS:000079906900039	10320037				2022-02-06	
J	Toomela, A; Tomberg, T; Orasson, A; Tikk, A; Nomm, M				Toomela, A; Tomberg, T; Orasson, A; Tikk, A; Nomm, M			Paradoxical facilitation of a free recall of nonwords in persons with traumatic brain injury	BRAIN AND COGNITION			English	Article							CLOSED-HEAD-INJURY; WORKING MEMORY; INDIVIDUAL-DIFFERENCES; COGNITIVE SEQUELAE; LIMBIC LESIONS; TERM-MEMORY; MONKEYS; KNOWLEDGE; RECOVERY; BEHAVIOR	Brain damage is usually associated with behavioral deficits. However, there is an increasing amount of evidence that lesions of some brain regions are associated with improvements instead of impairments of certain behaviors. We report the results of a study of free recall performance in subjects with traumatic brain injury. One-fourth of the subjects displayed above-normal performance in recall of nonwords. No such facilitation was found with nine lists of words, (C) 1999 Academic Press.	Tartu State Univ, Dept Psychol, EE-50410 Tartu, Estonia; Tartu State Univ, Dept Neurol & Neurosurg, EE-50410 Tartu, Estonia		Toomela, A (corresponding author), Tartu State Univ, Dept Psychol, 78 Tigi St, EE-50410 Tartu, Estonia.		Toomela, Aaro/H-6033-2018	Toomela, Aaro/0000-0002-8520-9676			BADDELEY A, 1990, HUNAN MNEMORY THEORY; BADDELEY AD, 1995, COGNITIVE NEUROSCIEN; BENNETTLEVY JM, 1984, ACTA NEUROL SCAND, V70, P285; Bergman LR, 1995, SLEIPNER STAT PACKAG; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Carlesimo GA, 1997, CORTEX, V33, P131, DOI 10.1016/S0010-9452(97)80009-3; CRAIK FIM, 1970, J EXP PSYCHOL, V86, P77, DOI 10.1037/h0029799; Hart R. P., 1994, NEUROPSYCHOLOGY, V8, P325, DOI [10.1037/0894-4105.8.3.325, DOI 10.1037/0894-4105.8.3.325]; IRLE E, 1983, BEHAV NEUROSCI, V97, P908, DOI 10.1037/0735-7044.97.6.908; IRLE E, 1987, BRAIN RES REV, V12, P307, DOI 10.1016/0165-0173(87)90003-8; IRLE E, 1990, BRAIN RES BULL, V25, P79, DOI 10.1016/0361-9230(90)90256-Y; IRLE E, 1990, BRAIN RES REV, V15, P181, DOI 10.1016/0165-0173(90)90001-5; IRLE E, 1984, BEHAV NEUROSCI, V98, P884, DOI 10.1037/0735-7044.98.5.884; JENNETT B, 1975, LANCET, V7905, P480; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kapur N, 1996, BRAIN, V119, P1775, DOI 10.1093/brain/119.5.1775; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Labbate L A, 1997, Ann Clin Psychiatry, V9, P27, DOI 10.3109/10401239709147771; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LUCARIELLO J, 1992, CHILD DEV, V63, P978; LURIA AR, 1974, NEIROPSKHOLOGIYA PAM; MACDONALD MC, 1992, COGNITIVE PSYCHOL, V24, P56, DOI 10.1016/0010-0285(92)90003-K; MARTIN RC, 1992, COGNITIVE NEUROPSYCH, V9, P509, DOI 10.1080/02643299208252070; Meunier M, 1996, J NEUROPHYSIOL, V75, P1190, DOI 10.1152/jn.1996.75.3.1190; NELSON K, 1988, HUM DEV, V31, P3, DOI 10.1159/000273198; SELL MA, 1992, J CHILD LANG, V19, P659, DOI 10.1017/S0305000900011612; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; TEASDALE G, 1974, LANCET, V7872, P81; TULVING E, 1964, PSYCHOL REV, V71, P219, DOI 10.1037/h0043186; Tulving E., 1983, ELEMENTS EPISODIC ME; von Eye Alexander, 1990, INTRO CONFIGURATIONA; Wilson BA, 1997, BRAIN INJURY, V11, P259, DOI 10.1080/026990597123566; ZATORRE RJ, 1983, BRAIN COGNITION, V2, P331, DOI 10.1016/0278-2626(83)90017-9	35	11	11	0	3	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	APR	1999	39	3					187	201		10.1006/brcg.1999.1077			15	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	184UW	WOS:000079633000003	10101040				2022-02-06	
J	Rummans, TA; Lauterbach, EC; Coffey, CE; Royall, DR; Cummings, JL; Salloway, S; Duffy, J; Kaufer, D				Rummans, TA; Lauterbach, EC; Coffey, CE; Royall, DR; Cummings, JL; Salloway, S; Duffy, J; Kaufer, D			Pharmacologic efficacy in neuropsychiatry: A review of placebo-controlled treatment trials - A report of the ANPA committee on research	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							DOUBLE-BLIND TRIAL; MENTALLY-HANDICAPPED PATIENTS; TRAUMATIC BRAIN INJURY; NURSING-HOME PATIENTS; ALZHEIMERS-DISEASE; ANTIDEPRESSANT PHARMACOTHERAPY; DEPRESSED-PATIENTS; DEMENTIA; CITALOPRAM; AGGRESSION	Psychiatric disorders frequently compound the disability and complicate the management of neurologic conditions. These disorders result in increased morbidity for the person afflicted, stress for the caregiver, and financial burden. tis study review the randomized double-blind placebo-controlled pharmacologic treatment trials of psychosis, depression, anxiety, and agitation in neurologic conditions from 1966 to 1998. Ten studies involving psychosis, 13 involving depression, and 20 involving anxiety-agitation meeting the committee's criteria were identified. Relatively few randomized double-blind placebo-controlled pharmacologic treatment trials of psychiatric disorders complicating neurologic disease have been conducted. These trials do not strongly support one specific pharmacologic approach to treatment. Further study of newer psychotropic agents, augmentation strategies, and novel use of other agents may help improve the treatment of psychiatric disorders observed in patients with neurologic disease.			Rummans, TA (corresponding author), Mayo Clin & Mayo Fdn, 200 1st St SW, Rochester, MN 55905 USA.						ALBERT JM, 1977, CURR THER RES CLIN E, V21, P786; ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; ANDERSEN J, 1980, ACTA NEUROL SCAND, V62, P210; BARNES R, 1982, AM J PSYCHIAT, V139, P1170; BARTON R, 1966, BRIT J PSYCHIAT, V112, P989, DOI 10.1192/bjp.112.491.989; Bodick NC, 1997, ARCH NEUROL-CHICAGO, V54, P465, DOI 10.1001/archneur.1997.00550160091022; BREIER A, 1991, ARCH GEN PSYCHIAT, V48, P239; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; COFFEY E, 1994, TXB GERIATRIC NEUROP; COLERICK EJ, 1986, J AM GERIATR SOC, V34, P493, DOI 10.1111/j.1532-5415.1986.tb04239.x; CRAFT M, 1987, BRIT J PSYCHIAT, V150, P685, DOI 10.1192/bjp.150.5.685; DECUYPER H, 1985, NEUROPSYCHOBIOLOGY, V13, P1, DOI 10.1159/000118153; DEVANAND DP, 1989, ARCH NEUROL-CHICAGO, V46, P854, DOI 10.1001/archneur.1989.00520440036018; FINKEL SI, 1995, INT J GERIATR PSYCH, V10, P129, DOI 10.1002/gps.930100208; FUCHS A, 1993, PHARMACOPSYCHIATRY, V26, P37, DOI 10.1055/s-2007-1014339; GOTESTAM KG, 1981, ACTA PSYCHIAT SCAND, P46; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; GREENDYKE RM, 1986, J CLIN PSYCHIAT, V47, P423; HAMILTON LD, 1962, J AM GERIATR SOC, V10, P140, DOI 10.1111/j.1532-5415.1962.tb00266.x; KODJIAN A, 1986, CURR THER RES CLIN E, V40, P694; LAWLOR BA, 1994, INT J GERIATR PSYCH, V9, P55, DOI 10.1002/gps.930090112; LIPSEY JR, 1984, LANCET, V1, P297; LYNCH DM, 1985, BRIT J PSYCHIAT, V146, P525, DOI 10.1192/bjp.146.5.525; NYTH AL, 1990, BRIT J PSYCHIAT, V157, P894, DOI 10.1192/bjp.157.6.894; NYTH AL, 1992, ACTA PSYCHIAT SCAND, V86, P138, DOI 10.1111/j.1600-0447.1992.tb03242.x; OLAFSSON K, 1992, ACTA PSYCHIAT SCAND, V85, P453, DOI 10.1111/j.1600-0447.1992.tb03211.x; OYEWUMI LK, 1981, AM J PSYCHIAT, V138, P110; Petracca G, 1996, J NEUROPSYCH CLIN N, V8, P270; PETRIE WM, 1982, J CLIN PSYCHOPHARM, V2, P122; RADA RT, 1976, J AM GERIATR SOC, V24, P105, DOI 10.1111/j.1532-5415.1976.tb04280.x; Raskind MA, 1997, ARCH NEUROL-CHICAGO, V54, P836, DOI 10.1001/archneur.1997.00550190026010; RATEY J, 1991, J CLIN PSYCHIAT, V52, P159; REDING MJ, 1986, ARCH NEUROL-CHICAGO, P763; REIFLER BV, 1989, AM J PSYCHIAT, V146, P45; ROBERTSON MM, 1985, J AFFECT DISORDERS, V9, P127, DOI 10.1016/0165-0327(85)90091-6; SCHIFFER RB, 1990, AM J PSYCHIAT, V147, P1493; SUGERMAN AA, 1964, AM J PSYCHIAT, V120, P1190, DOI 10.1176/ajp.120.12.1190; TARIOT PN, 1994, J AM GERIATR SOC, V42, P1160, DOI 10.1111/j.1532-5415.1994.tb06982.x; Tariot PN, 1998, AM J PSYCHIAT, V155, P54, DOI 10.1176/ajp.155.1.54; WHITE JC, 1992, J CLIN PSYCHIAT, V53, P153; WOLTERS EC, 1990, NEUROLOGY, V40, P832, DOI 10.1212/WNL.40.5.832; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; ZIGARELLI G, 1992, AM J MENT RETARD, V97, P57	43	11	11	0	3	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	1999	11	2					176	189					14	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	194QE	WOS:000080204400002	10333990				2022-02-06	
J	Hussain, A				Hussain, A			Dislocation of the first metatarsophalangeal joint with fracture of fibular sesamoid - A case report	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article								Dorsal dislocations of the first metatarsophalangeal joint are classified by Jahss into two types. In Type 1, the hallux with the intact intersesamoid ligament dislocates dorsally over the metatarsal head. Such cases in the literature have been irreducible by closed manipulation, In Type 2 the hallux is dislocated dorsally with rupture of the intersesamoid ligament, resulting in wide separation of the sesamoids (Type 2A) or a transverse fracture of one or both sesamoids (Type 2B), The importance in classifying these injuries allows one to predict whether closed reduction will be successful as in Type 2, The patient reported had a fracture of the fibular sesamoid in addition to dislocation of the hallux. The clinical findings were consistent with Type 1 injury, including an intact intersesamoid ligament, but the radiographs showed, in addition to the dislocation, that there was a fracture of the fibular sesamoid, Reduction was achieved surgically through a dorsal approach. Although such injuries have been unreported previously, Type 1 injuries may be associated with a fracture of the fibular sesamoid but without rupture of intersesamoid ligament, so the injury reported is classified as Type 1A.	Prince Salman Bin Abdulaziz Hosp, Dept Orthopaed, Riyadh, Saudi Arabia		Hussain, A (corresponding author), 20 Plas Ty Mawr, Penyfai CF31 4NH, Bridgend, Wales.						BROWN TIS, 1980, CLIN ORTHOP RELAT R, P229; GIANNIKAS AC, 1975, J BONE JOINT SURG BR, V57, P384, DOI 10.1302/0301-620X.57B3.384; Jahss M H, 1980, Foot Ankle, V1, P15; KONKEL KF, 1975, J TRAUMA, V15, P733, DOI 10.1097/00005373-197508000-00018; LEWIS AG, 1984, J BONE JOINT SURG AM, V66A, P1120, DOI 10.2106/00004623-198466070-00026; SALAMON PB, 1974, J BONE JOINT SURG AM, VA 56, P1073, DOI 10.2106/00004623-197456050-00022	6	11	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	FEB	1999		359					209	212					4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	171BP	WOS:000078842800023	10078145				2022-02-06	
J	Geldmacher, DS; Alhaj, M				Geldmacher, DS; Alhaj, M			Spatial aspects of letter cancellation performance in Arabic readers	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article							TRAUMATIC BRAIN INJURY; TO-DISTRACTOR RATIO; READING HABITS; STIMULUS NUMBER; LINE BISECTION; TASK; ATTENTION; NEGLECT; BIAS	Studies of visuospatial and directed attention that used subjects drawn from cultures with left-to-right reading patterns have suggested a slight performance bias toward left space. This pattern could reflect an intrinsic, organic, bias in spatial processing or the confounding effect of overlearned reading patterns. We studied the spatial distribution of errors on random array letter cancellation tasks obtained from 128 healthy Syrians who were native readers of Arabic. Fifty-eight of the 128 subjects (45.3%) made a total of 91 errors in which they omitted canceling a target. The distribution of errors was not spatially biased. This differs from the error pattern reported for native readers of English on a similar task. The findings, consistent with results of other approaches, suggest that reading patterns influence visuospatial attention, but are not the sole cause of spatial biases observed in readers of Indo-European languages.	Univ Hosp Cleveland, Univ Alzheimer Ctr, Cleveland, OH 44120 USA; Univ Hosp Cleveland, Alzheimer Ctr, Cleveland, OH 44120 USA; Case Western Reserve Univ, Sch Med, Dept Neurol, Cleveland, OH 44120 USA		Geldmacher, DS (corresponding author), Univ Hosp Cleveland, Univ Alzheimer Ctr, 12200 Fairhill Rd, Cleveland, OH 44120 USA.				NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG008012] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG08012] Funding Source: Medline		BOWERS D, 1976, NEUROPSYCHOLOGIA, V14, P123, DOI 10.1016/0028-3932(76)90013-0; BRAINE LG, 1968, NEUROPSYCHOLOGIA, V6, P73, DOI 10.1016/0028-3932(68)90041-9; CHEDRU F, 1973, Cortex, V9, P94; Chokron S, 1995, COGNITIVE BRAIN RES, V3, P51, DOI 10.1016/0926-6410(95)00018-6; Chokron S, 1997, CORTEX, V33, P47, DOI 10.1016/S0010-9452(97)80004-4; CHOKRON S, 1993, COGNITIVE BRAIN RES, V1, P219, DOI 10.1016/0926-6410(93)90005-P; Dawson DR, 1997, OCCUP THER J RES, V17, P264, DOI 10.1177/153944929701700403; De Renzi E, 1970, Cortex, V6, P191; EVIATAR Z, 1995, BRAIN COGNITION, V29, P137, DOI 10.1006/brcg.1995.1273; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Geldmacher DS, 1996, BRAIN COGNITION, V32, P405, DOI 10.1006/brcg.1996.0073; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; GELDMACHER DS, 1995, NEUROPSY NEUROPSY BE, V8, P259; GELDMACHER DS, 1994, NEUROPSY NEUROPSY BE, V7, P275; Heilman KM, 1993, CLIN NEUROPSYCHOLOGY, P279; Hills EC, 1998, BRAIN INJURY, V12, P69, DOI 10.1080/026990598122872; KINSBOURNE M, 1974, NEUROPSYCHOLOGIA, V12, P270; LINCOLN RS, 1956, J APPL PSYCHOL, V40, P105, DOI 10.1037/h0042392; Mesulam M -M, 1985, PRINCIPLES BEHAV NEU, P125; NACHSHON I, 1985, INT J NEUROSCI, V25, P161, DOI 10.3109/00207458508985369; POSNER MI, 1987, TRENDS NEUROSCI, V10, P13, DOI 10.1016/0166-2236(87)90116-0; Schwartz RL, 1997, NEUROLOGY, V48, P234, DOI 10.1212/WNL.48.1.234; VINGIANO W, 1991, INT J NEUROSCI, V58, P63, DOI 10.3109/00207459108987183; WEINTRAUB S, 1988, J NEUROL NEUROSUR PS, V51, P1481, DOI 10.1136/jnnp.51.12.1481; WEINTRAUB S, 1987, ARCH NEUROL-CHICAGO, V44, P625	25	11	11	0	1	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD, PO BOX 90, READING RG1 8JL, BERKS, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		1999	97	1-2					29	39		10.3109/00207459908994301			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184HK	WOS:000079605200003	10681116				2022-02-06	
J	Lazarus, MD; Guttmann, D; Rich, CE; Keenan, MAE				Lazarus, MD; Guttmann, D; Rich, CE; Keenan, MAE			Heterotopic ossification resection about the elbow	NEUROREHABILITATION			English	Article						heterotopic ossification; surgery for elbow heterotopic ossification; acquired brain injury	TRAUMATIC BRAIN INJURY; SPINAL-CORD INJURY; RISK-FACTORS; BONE	We studied twenty-four patients (twenty-seven elbows) that underwent resection of heterotopic ossification about the elbow. All of the patients had suffered from a traumatic brain injury. In addition, eight of the patients suffered local trauma, either fracture or burn. All patients had surgery performed by one of two surgeons (MAK, MDL). The mean follow-up was 25.9 +/- 2.6 months with a minimum of 12 months. Maximum flexion increased from 80.1 +/- 7.8 degrees preoperative to 111.9 +/- 4.5 degrees postoperative (p = 0.0003). Maximum extension increased from 58.9 +/- 6.2 degrees preoperative to 32.1 +/- 5.3 degrees postoperative (p = 0.0005). Twenty-three of the 27 elbows gained motion, with 4 patients loosing an average of 15.0 +/- 5.8 degrees. Interestingly, in the 17 patients who had ankylosed elbows preoperatively, the average gain in motion was 59.1 +/- 10.6 degrees as compared to a gain of 23.2 +/- 11.0 degrees in the remaining 10 patients (p = 0.03). The time from injury until resection was a significant predictor of outcome, with longer times associated with worse outcome (p = 0.02). Those patients who had continuous passive motion (CPM) after surgery had better motion gain (57.9 +/- 4.3 degrees) than those that did not have CPM (24.1 +/- 7.9 degrees) (p = 0.04). Resection of heterotopic ossification about the elbow is effective in gaining motion in most patients. The surgery can be technically challenging and requires extensive preoperative planning. Patients who have greater loss of motion preoperatively (i.e., ankylosed) have better outcomes than those with less to gain. Continuous passive motion should be considered postoperatively as its use is associated with a better result.	Albert Einstein Med Ctr, Dept Orthopaed Surg WCB4, Philadelphia, PA 19141 USA		Lazarus, MD (corresponding author), Albert Einstein Med Ctr, Dept Orthopaed Surg WCB4, 5501 Old York Rd, Philadelphia, PA 19141 USA.		Keenan, Mary Ann/ABB-1551-2020				ABRAMS RA, 1993, J HAND SURG-AM, V18A, P703, DOI 10.1016/0363-5023(93)90322-T; AYERS DC, 1986, J BONE JOINT SURG AM, V68A, P1423, DOI 10.2106/00004623-198668090-00016; BLANE CE, 1981, SKELETAL RADIOL, V7, P21, DOI 10.1007/BF00347167; BRAVOPAYNO P, 1992, PARAPLEGIA, V30, P740, DOI 10.1038/sc.1992.142; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; CHARNLEY J, 1972, Journal of Bone and Joint Surgery British Volume, V54, P61; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; CONNOR JM, 1983, SOFT TISSUE OSSIFICA; EVANS EB, 1991, CLIN ORTHOP RELAT R, P94; FAILLA JM, 1990, CLIN ORTHOP RELAT R, P133; FINERMAN GAM, 1981, METAB BONE DIS RELAT, V4, P337; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P303; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, V263, P58; HAMBLEN D L, 1971, Journal of Bone and Joint Surgery British Volume, V53, P764; HASTINGS H, 1994, HAND CLIN, V10, P417; HURVITZ EA, 1992, ARCH PHYS MED REHAB, V73, P459; JONES BV, 1980, J BONE JOINT SURG BR, V62, P506, DOI 10.1302/0301-620X.62B4.7430235; JUHN AMB, 1989, T ORTHOP RES SOC, V42; Keenan MAE, 1996, J HEAD TRAUMA REHAB, V11, P8, DOI 10.1097/00001199-199608000-00004; KIM JH, 1978, RADIOLOGY, V129, P501, DOI 10.1148/129.2.501; KOLESSAR DJ, 1996, MUSCULOSKELETAL CONS, P78; MALONEY WJ, 1991, J BONE JOINT SURG AM, V73A, P191, DOI 10.2106/00004623-199173020-00006; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; MCLAREN AC, 1990, J BONE JOINT SURG AM, V72A, P245, DOI 10.2106/00004623-199072020-00012; MORREY BF, 1981, J BONE JOINT SURG AM, V63, P872, DOI 10.2106/00004623-198163060-00002; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1090, DOI 10.2106/00004623-197052060-00002; NOLLEN AJG, 1986, ACTA ORTHOP SCAND, V57, P358, DOI 10.3109/17453678608994411; PETERSON SL, 1989, J TRAUMA, V29, P365, DOI 10.1097/00005373-198903000-00015; Pittenger D E, 1991, Orthop Rev, V20, P33; REIGLER HG, 1976, CLIN ORTHOPAEDICS, V117, P209; RITTER MA, 1977, J BONE JOINT SURG AM, V59, P345, DOI 10.2106/00004623-197759030-00009; RITTER MA, 1985, CLIN ORTHOP RELAT R, P217; SAWYER JR, 1991, CALCIFIED TISSUE INT, V49, P208, DOI 10.1007/BF02556120; SCHMIDT SA, 1988, J BONE JOINT SURG AM, V70A, P834, DOI 10.2106/00004623-198870060-00005; SOBALLE K, 1988, CLIN ORTHOP RELAT R, P57; SODEMANN B, 1988, CLIN ORTHOP RELAT R, P150; Summerfield SL, 1997, J SHOULDER ELB SURG, V6, P321, DOI 10.1016/S1058-2746(97)90025-2; Testa N N, 1988, Orthop Rev, V17, P965; THOMAS BJ, 1985, J BONE JOINT SURG AM, V67A, P400, DOI 10.2106/00004623-198567030-00008; WHARTON GW, 1975, CLIN ORTHOP RELAT R, P142; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215, DOI 10.1302/0301-620X.74B2.1544955	44	11	11	0	0	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		1999	12	2					145	153					9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	218FF	WOS:000081542000006					2022-02-06	
S	van Rossem, K; Garcia-Martinez, S; De Mulder, G; Van Deuren, B; Engelborghs, K; Van Reempts, J; Borgers, M		Eke, A; Delpy, DT		van Rossem, K; Garcia-Martinez, S; De Mulder, G; Van Deuren, B; Engelborghs, K; Van Reempts, J; Borgers, M			Brain oxygenation after experimental closed head injury - A NIRS study	OXYGEN TRANSPORT TO TISSUE XXI	ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY		English	Article; Proceedings Paper	26th Annual Meeting of the International-Society-on-Oxygen-Transport-to-Tissue (ISOTT 98)	AUG 23-28, 1998	BUDAPEST, HUNGARY	Int Soc Oxygen Transport Tissue, Alliance Pharmaceut, Hemox Therapeut, Radiometer Copenhagen, Berlex Biosic			NEAR-INFRARED SPECTROSCOPY; CEREBRAL OXYGENATION; QUANTIFICATION; RATS		Janssen Res Fdn, Dept Life Sci Neuropathol, B-2340 Beerse, Belgium		van Rossem, K (corresponding author), Janssen Res Fdn, Dept Life Sci Neuropathol, B-2340 Beerse, Belgium.						Barzo P, 1997, ACT NEUR S, V70, P115; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BROWN GC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P273, DOI 10.1016/S0005-2728(05)80109-4; Bullock MR, 1996, J NEUROTRAUM, V13, P705; COOPER CE, 1994, BIOCHEM SOC T, V22, P974, DOI 10.1042/bst0220974; Cope M, 1989, Adv Exp Med Biol, V248, P33; Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; ENGELBORGHS K, 1998, IN PRESS J NEUROSURG; Gilbert CL, 1996, WORLD DEV, V24, P1, DOI 10.1016/0305-750X(95)00121-R; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; MACGOVERN GJ, 1984, CIRCULATION S1, V70, P191; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; MATCHER SJ, 1994, PHYS MED BIOL, V39, P1295, DOI 10.1088/0031-9155/39/8/008; Unterberg AW, 1997, ACT NEUR S, V70, P106; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; WYATT JS, 1986, LANCET, V2, P1063, DOI 10.1016/S0140-6736(86)90467-8	19	11	11	0	2	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0065-2598		0-306-46281-8	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		1999	471						209	215					7	Cell Biology; Hematology; Medicine, Research & Experimental; Physiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Hematology; Research & Experimental Medicine; Physiology	BP58J	WOS:000085570200025	10659149				2022-02-06	
J	Rao, AM; Hatcher, JF; Baskaya, MK; Dempsey, RJ				Rao, AM; Hatcher, JF; Baskaya, MK; Dempsey, RJ			Simultaneous assay of ornithine decarboxylase and polyamines after central nervous system injury in gerbil and rat	NEUROSCIENCE LETTERS			English	Article						cerebral ischemia; cortex; hippocampus; ornithine decarboxylase; polyamines; putrescine; traumatic brain injury	BLOOD-BRAIN-BARRIER; FOCAL CEREBRAL-ISCHEMIA; TRANSIENT ISCHEMIA; BREAKDOWN; CORTEX; PHASE; EDEMA	Ornithine decarboxylase (ODC) is considered the rate-limiting enzyme in polyamine biosynthesis. An increase in putrescine (a natural polyamine) synthesis after central nervous system (CNS) injury appears to be involved in blood-brain barrier dysfunction, development of vasogenic edema and neuronal death. An improved method is described to determine the ODC activity as well as polyamine levels from the same brain tissue. The polyamine results showed no significant differences from data obtained with the conventional assay. The advantages of this method are to: (1) minimize the number of animals needed for the study, and (2) eliminate any internal inconsistencies resulting from use of two independent groups of animals for ODC and polyamine measurements. Using this method, ODC activities and polyamine levels were measured in cortices and hippocampi from global transient ischemia of gerbils and traumatic brain injury (TBI) of rats. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.	Univ Wisconsin, Ctr Clin Sci, Dept Neurol Surg, Madison, WI 53792 USA; Vet Adm Hosp, Madison, WI USA; Louisiana State Univ, Med Ctr, Dept Neurosurg, Shreveport, LA 71130 USA		Rao, AM (corresponding author), Univ Wisconsin, Ctr Clin Sci, Dept Neurol Surg, F4-313,600 Highland Ave, Madison, WI 53792 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031220, R01NS028000] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 28000, P01 NS31220] Funding Source: Medline		Baskaya MFK, 1996, NEUROSURGERY, V38, P140; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Baskaya MK, 1997, BRAIN RES, V744, P302; BAUDRY M, 1994, NEUROSCI LETT, V171, P151, DOI 10.1016/0304-3940(94)90627-0; DEMPSEY RJ, 1991, J CEREBR BLOOD F MET, V11, P979, DOI 10.1038/jcbfm.1991.164; deVera N, 1997, AMINO ACIDS, V12, P1; DIENEL GA, 1985, J NEUROCHEM, V44, P600, DOI 10.1111/j.1471-4159.1985.tb05454.x; Henley CM, 1997, J NEUROCHEM, V69, P259; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; KINDY MS, 1994, J CEREBR BLOOD F MET, V14, P1040, DOI 10.1038/jcbfm.1994.136; KOENIG H, 1989, J NEUROCHEM, V52, P101, DOI 10.1111/j.1471-4159.1989.tb10903.x; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; PASCHEN W, 1993, PROG BRAIN RES, V96, P147; Rao AM, 1997, MOL BRAIN RES, V44, P134, DOI 10.1016/S0169-328X(96)00245-8; Rao AM, 1998, BRAIN RES, V793, P265, DOI 10.1016/S0006-8993(98)00183-8; RAO AM, 1995, J NEUROCHEM, V65, P2639; Rao VLR, 1998, BRAIN RES, V783, P163, DOI 10.1016/S0006-8993(97)01301-2; SCHMITZ MP, 1993, NEUROSURGERY, V33, P882; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Zoli M, 1996, MOL BRAIN RES, V38, P122, DOI 10.1016/0169-328X(95)00339-T	22	11	13	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	NOV 6	1998	256	2					65	68		10.1016/S0304-3940(98)00780-0			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	142HQ	WOS:000077195100002	9853704				2022-02-06	
J	Glenn, MB				Glenn, MB			Methylphenidate for cognitive and behavioral dysfunction after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article									Spaulding Rehabil Hosp, Outpatient & Community Brain Injury Programs, Boston, MA 02114 USA		Glenn, MB (corresponding author), Spaulding Rehabil Hosp, Outpatient & Community Brain Injury Programs, Boston, MA 02114 USA.						GLENN MB, 1986, J HEAD TRAUMA REHAB, V1, P74; GLENN MB, 1987, J HEAD TRAUMA REHAB, V2, P71; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Laborde A, 1997, J HEAD TRAUMA REHAB, V12, P90, DOI 10.1097/00001199-199708000-00009; MCDOWELL SK, 1996, J HEAD TRAUMA REHAB, V11, P99; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; WROBLEWSKI BA, 1992, J CLIN PSYCHIAT, V53, P86; WROBLEWSKI BA, 1994, J HEAD TRAUMA REHAB, V9, P19, DOI 10.1097/00001199-199409000-00004	12	11	11	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1998	13	5					87	90		10.1097/00001199-199810000-00010			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	175UU	WOS:000079114600010	9753538				2022-02-06	
J	Rise, IR; Risoe, C; Kirkeby, OJ				Rise, IR; Risoe, C; Kirkeby, OJ			Cerebrovascular effects of high intracranial pressure after moderate hemorrhage	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						cerebral blood flow; hemorrhage; high intracranial pressure; pig	CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; HYDROGEN CLEARANCE; HYPERTENSION; ISCHEMIA	Patients with head injuries often develop increased intracranial pressure after hemorrhage. The authors studied the effect of moderate hemorrhage followed by elevated intracranial pressure on cerebrovascular variables. Cerebral blood flow in la pigs was measured with laser Doppler flowmetry, and cerebral venous blood gases were taken from the sagittal sinus. High intracranial pressure (80% of mean arterial pressure) was induced by infusion of artificial cerebrospinal fluid into the cisterna magna, and blood pressure was reduced by bleeding to a mean of 78% of the prebleeding values in eight pigs. Five pigs served as secondary controls. High intracranial pressure before hemorrhage caused a decrease in cerebral blood flow to 34% of the baseline values, a decrease in sagittal sinus oxygen saturation to 46%, and a decrease in cerebral perfusion pressure to 36%, but did not change cerebrovascular resistance. High intracranial pressure after hemorrhage decreased cerebral blood flow to 14% of baseline values. Sagittal sinus oxygen saturation decreased to 22%, cerebral perfusion pressure decreased to 30%, and the cerebrovascular resistance increased by 355%. The moderate hypotension after hemorrhage caused a considerable enhancement of the effects of high intracranial pressure on cerebral hemodynamics.	Univ Oslo, Ulleval Hosp, Dept Neurosurg, N-0407 Oslo, Norway; Natl Hosp, Inst Surg Res, Oslo, Norway		Kirkeby, OJ (corresponding author), Univ Oslo, Ulleval Hosp, Dept Neurosurg, N-0407 Oslo, Norway.						ALTMAN PL, 1974, BIOL DATA BOOK, V3, P1846; BARZO P, 1991, NEUROSURGERY, V28, P821, DOI 10.1227/00006123-199106000-00006; BENABID AL, 1978, J PHYSIOL-PARIS, V74, P369; BENVENISTE H, 1987, J NEUROCHEM, V49, P729, DOI 10.1111/j.1471-4159.1987.tb00954.x; BRICOLO AP, 1981, J NEUROSURG, V55, P397, DOI 10.3171/jns.1981.55.3.0397; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; CHIANG J, 1968, AM J PATHOL, V52, P455; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DIETRICH WD, 1984, J NEUROPATH EXP NEUR, V43, P72, DOI 10.1097/00005072-198401000-00006; EDVINSSON L, 1993, CEREBRAL BLOOD FLOW, P402; FEUSTEL PJ, 1984, J APPL PHYSIOL, V56, P150, DOI 10.1152/jappl.1984.56.1.150; FIESCHI C, 1969, EXP BRAIN RES, V7, P111; FISHER EG, 1972, STROKE, V3, P538; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; KATO Y, 1989, ACTA NEUROCHIR, V98, P184, DOI 10.1007/BF01407346; KIRKEBY OJ, 1995, J APPL PHYSIOL, V79, P1479, DOI 10.1152/jappl.1995.79.5.1479; KOHELER RC, 1983, INTRACRANIAL PREESSU, V5, P880; KONG DL, 1991, CRIT CARE MED, V19, P532, DOI 10.1097/00003246-199104000-00013; KUMMER R V, 1984, Stroke, V15, P108; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LITTLE RA, 1989, J TRAUMA, V29, P903, DOI 10.1097/00005373-198907000-00001; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARMAROU A, 1991, J NEUROSURG S, V75, P59; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; NILSSON GE, 1980, IEEE T BIO-MED ENG, V27, P12, DOI 10.1109/TBME.1980.326686; NILSSON GE, 1980, IEEE T BIO-MED ENG, V27, P597, DOI 10.1109/TBME.1980.326582; OGILVY CS, 1987, BIOL NEONATE, V52, P327; Pasztor E, 1973, STROKE, V4, P556, DOI 10.1161/01.STR.4.4.556; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PUCHER R, 1991, ACTA NEUROCHIR, V109, P52, DOI 10.1007/BF01405698; REDDY GD, 1974, BIOL NEONATE, V25, P249; SCHALEN W, 1992, ACTA ANAESTH SCAND, V3, P367; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; TOMIDA S, 1989, J CEREBR BLOOD F MET, V9, P79, DOI 10.1038/jcbfm.1989.11; TOMITA M, 1988, J CEREBR BLOOD F MET, V8, P727, DOI 10.1038/jcbfm.1988.120; VERHAEGEN MJ, 1992, J CEREBR BLOOD F MET, V12, P230, DOI 10.1038/jcbfm.1992.33; VONLOON J, 1993, J NEUROSURG, V79, P705; WARNER DS, 1992, NEUROSURGERY SCI BAS, P489; Zierski J, 1987, Acta Neurochir Suppl (Wien), V40, P95	43	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	1998	10	4					224	230					7	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	128CJ	WOS:000076387400004	9796606				2022-02-06	
J	Bisiacchi, PS; Sgaramella, TM; Farinello, C				Bisiacchi, PS; Sgaramella, TM; Farinello, C			Planning strategies and control mechanisms: Evidence from closed head injury and aging	BRAIN AND COGNITION			English	Article; Proceedings Paper	TENNET VIII - Theoretical and Experimental Neuropsychology Conference	JUN 16-18, 1997	MONTREAL, CANADA				FRONTAL-LOBE DAMAGE	The ability to plan a sequence of actions in a fictious environment was studied in young adults, CHI patients and elderly. The planning task consisted in completing 10 errands on a map of a hypothetical town where buildings, shops and public offices were shown. Results revealed significant differences across groups. Error analyses revealed the presence of different heuristics at work when planning was performed by young adults, elderly (older than 80 years) and CHI patients. The results are thought to be relevant for detailing a componential analysis of the planning process and control mechanisms.	Univ Padua, Dipartimento Psicol Gen, Padua, Italy; Osped San Bortolo, Vicenza, Italy		Bisiacchi, PS (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.		BISIACCHI, PATRIZIA/B-8976-2008	BISIACCHI, PATRIZIA/0000-0003-2760-8000			COHEN G, 1988, MEMORY REAL WORLD; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; HAYES-ROTH B, 1979, Cognitive Science, V3, P275, DOI 10.1207/s15516709cog0304_1; Norman D.A., 1986, CONSCIOUSNESS SELF R; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHALLICE T, 1994, ATTENTION PERFORMANC, V15; Shallice T., 1988, NEUROPSYCHOLOGY MENT; VILKKI J, 1991, CORTEX, V27, P203, DOI 10.1016/S0010-9452(13)80124-4	10	11	11	0	2	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	JUN	1998	37	1					113	116					4	Neurosciences; Psychology, Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	ZZ523	WOS:000074737900053					2022-02-06	
J	Samuel, C; Louis-Dreyfus, A; Couillet, J; Roubeau, B; Bakchine, S; Bussel, B; Azouvi, P				Samuel, C; Louis-Dreyfus, A; Couillet, J; Roubeau, B; Bakchine, S; Bussel, B; Azouvi, P			Dysprosody after severe closed head injury: an acoustic analysis	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						dysprosody; head injury; acoustic analysis	SPEECH CHARACTERISTICS; PRACTICAL SCALE; DYSARTHRIA; DYSFUNCTION; DEPRESSION; EXPRESSION; COMA	Objectives-Neurological speech disorders (dysarthria and dysprosody) are known to be frequent sequelae after severe closed head injury. These disorders may dramatically alter communicative intent and accentuate social isolation. The aim was to provide an instrumental evaluation for prosodic production in a group of patients with, severe closed head injury and to determine the correlations between prosodic production and neurobehavioural status. Methods-Fifteen patients, at the subacute stage after severe closed head injury, were studied and compared with 11 controls, matched for age, sex, and duration of education. Each subject was required to read aloud a French sentence "Je m'en vais samedi matin" (I am leaving saturday morning) under six different prosodic intonations (neutral, affirmation, interrogation, happiness, sadness, anger). The recorded sentences were analysed using a sound signal analysis software (Signalyse) allowing the measurement of signal intensity and fundamental frequency. Statistical analyses were carried out using repeated measures analysis of variance (ANOVA). Results-Patients with closed head injury were significantly less able than controls to modulate speech output (pitch and intensity) according to prosodic context. This deficit was particularly pronounced for the intonation feature of anger, question, and statement. No consistent correlations could be found between prosodic production and cognitive or behavioural data. Conclusions-Acoustic analysis of pitch and intensity may show impairments of prosodic production after severe closed head injury, which mag: be useful in rehabilitation planning. This impairment does not seem to reflect the eventual cognitive and behavioural deficits of the patients, but rather a specific disorder of modulation of speech output.	Univ Paris 05, Raymond Poincare Hosp, Dept Neurol Rehabil, Serv Reeduc Neurol, F-92380 Garches, France; Hop Tenon, Serv ORL, F-75970 Paris, France; Hop La Pitie Salpetriere, Federat Neurol, Paris, France		Samuel, C (corresponding author), Univ Paris 05, Raymond Poincare Hosp, Dept Neurol Rehabil, Serv Reeduc Neurol, F-92380 Garches, France.						*AM PSYCH ASS, 1989, LKDIAGN STAT M AN ME; ARONSON AE, 1994, BRAIN INJURY, V8, P663, DOI 10.3109/02699059409151019; CAEKEBEKE JFV, 1991, J NEUROL NEUROSUR PS, V54, P145, DOI 10.1136/jnnp.54.2.145; DANLY M, 1982, BRAIN LANG, V16, P171, DOI 10.1016/0093-934X(82)90082-7; DARBY JK, 1984, J COMMUN DISORD, V17, P75, DOI 10.1016/0021-9924(84)90013-3; DELOCHE G, 1997, TEST DENOMINATION OR; Greenwood R, 1997, LANCET, V349, P1041, DOI 10.1016/S0140-6736(05)62288-X; HIRD K, 1993, BRAIN LANG, V45, P46, DOI 10.1006/brln.1993.1032; Jennett B, 1981, MANAGEMENT HEAD INJU; KELLER E, 1991, BRIT J DISORD COMMUN, V26, P75; KELLER E, 1992, SIGNALYZE SIGNAL ANA; KENT RD, 1982, BRAIN LANG, V15, P259, DOI 10.1016/0093-934X(82)90060-8; LEVIN H S, 1990, Annales de Readaptation et de Medecine Physique, V33, P35; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MONRADKROHN GH, 1947, BRAIN, V70, P405, DOI 10.1093/brain/70.4.405; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; MURPHY D, 1990, J NEUROL NEUROSUR PS, V53, P727, DOI 10.1136/jnnp.53.9.727; NILSONNE A, 1988, ACTA PSYCHIAT SCAND, V77, P253, DOI 10.1111/j.1600-0447.1988.tb05118.x; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; ROSS ED, 1981, ARCH NEUROL-CHICAGO, V38, P561, DOI 10.1001/archneur.1981.00510090055006; ROSS ED, 1997, BEHAV NEUROLOGY NEUR, P699; Stringer AY, 1996, BRAIN INJURY, V10, P583, DOI 10.1080/026990596124151; TEASDALE G, 1974, LANCET, V2, P81; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1994, BRAIN INJURY, V8, P667, DOI 10.3109/02699059409151021; THEODOROS DG, 1995, BRAIN INJURY, V9, P671, DOI 10.3109/02699059509008225; VOGEL M, 1982, FOLIA PHONIATR, V34, P150, DOI 10.1159/000265644; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; ZIEGLER W, 1983, PHONETICA, V40, P63; [No title captured]	32	11	13	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	1998	64	4					482	485		10.1136/jnnp.64.4.482			4	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	ZJ938	WOS:000073268800011	9576539	Green Published, Bronze, Green Submitted			2022-02-06	
J	Ahn, MO; Korst, LM; Phelan, JP				Ahn, MO; Korst, LM; Phelan, JP			Normal fetal heart rate pattern in the brain-damaged infant: A failure of intrapartum fetal monitoring?	JOURNAL OF MATERNAL-FETAL INVESTIGATION			English	Article						asphyxia; fetal heart rate; cerebral palsy; intrapartum fetal monitoring; brain-damaged baby	CEREBRAL-PALSY	Objective: To describe the perinatal characteristics of neurologically impaired infants with normal intrapartum fetal heart rate (FHR) patterns. Methods: In a registry of 300 neurologically impaired singleton term infants, a retrospective chart review was undertaken to analyze those patients with a normal intrapartum FHR pattern, i,e. reactive FHR pattern with a normal baseline rate throughout labor, and a subsequent finding of central nervous system impairment. Neonates with an abnormal intrapartum FHR pattern or a traumatic birth were excluded. In addition, the four criteria necessary for intrapartum asphyxia were as follows: arterial pH <7.00, Apgar score less than or equal to 3 for 5 min, neonatal neurologic sequelae, such as seizures, and multiorgan system dysfunction, Infants were then categorized according to the timing of probable fetal injury. Results: Of the 300 infants in the registry, 24 (8%) neonates were identified. Six (25%) of these were considered postdates. Primary antenatal complications included early pregnancy bleeding (3 (13%)), cigarette and/or alcohol use (4 (17%)), and polyhydramnios (2 (8%)). Meconium was found in 12 patients (50%) during labor; of these, two (8%) patients had meconium aspiration syndrome and required extra corporeal membrane oxygenation (ECMO). None of the infants satisfied the four criteria for intrapartum asphyxia. Sixteen (67%) neonates were discharged with their mothers. The remaining eight neonates were admitted to the neonatal intensive care unit, and two (8%) neonatal deaths occurred due to meconium aspiration syndrome and sudden infant death syndrome. The long term neurologic outcome of the 22 survivors ranged from 3 to 14 years and included the following: developmental delay (10 (45%)), seizure disorder (7 (32%)), cerebral palsy (11 (50%)), and mental retardation (4 (17%)). None of these infants appeared to have been injured during labor. The probable timing of neurologic injury appeared to be early pregnancy (13 (54%)) or postnatally (11 (46%)). Conclusions: Infants who are later found to be neurologically impaired can have normal intrapartum FHR patterns during labor. These neurologic injuries seem to occur in early pregnancy or after birth. In the absence of fetal trauma, these findings suggest that a reactive intrapartum FHR pattern is not associated with intrapartum fetal asphyxia.	Cha Womens Hosp, Dept Obstet & Gynecol, Seoul, South Korea; Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; Pomona Valley Hosp, Med Ctr, Dept Maternal Fetal Med, Pomona, CA 91767 USA		Phelan, JP (corresponding author), Suite 200,959 E Walnut St, Pasadena, CA 91106 USA.			Korst, Lisa/0000-0002-0846-7823			*AM COLL OBST GYN, 1992, TECHNICAL B, V163; Cardosi RJ, 1997, J REPROD MED, V42, P251; Korst LM, 1997, PRENAT NEONAT MED, V2, P286; MARDEN PM, J PEDIAT, V164, P357; MENTICOGLOU SM, 1989, OBSTET GYNECOL, V74, P457; *NAT CTR HLTH STAT, 1993, MONTH VIT STAT REP, V41, P28; Nelson KB, 1996, NEW ENGL J MED, V334, P613, DOI 10.1056/NEJM199603073341001; PHELAN JP, 1994, AM J OBSTET GYNECOL, V171, P424, DOI 10.1016/0002-9378(94)90278-X; PHELAN JP, 1994, CLIN PERINATOL, V21, P879, DOI 10.1016/S0095-5108(18)30324-5; PHELAN JP, 1998, IN PRESS J MATERN FE; SHIELDS JR, 1988, OBSTET GYNECOL, V71, P899; THACKER SB, 1995, OBSTET GYNECOL, V86, P613, DOI 10.1016/S0029-7844(95)80027-1; VANDERMOER PE, 1985, OBSTET GYNECOL, V65, P125; VOLPE JJ, 1995, NEUROLOGY NEWBORN, P172; YEH SY, 1982, AM J OBSTET GYNECOL, V143, P496, DOI 10.1016/0002-9378(82)90536-1	15	11	11	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0939-6322			J MATERN-FETAL INVES	J. Matern.-Fetal Invest.	SPR	1998	8	2					58	60					3	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	ZW485	WOS:000074415700002	9685557				2022-02-06	
J	Kristof, RA; Clusmann, H; Koehler, W; Fink, KB; Schramm, J				Kristof, RA; Clusmann, H; Koehler, W; Fink, KB; Schramm, J			Treatment of accidental high dose intraventricular mezlocillin application by cerebrospinal fluid exchange	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						intrathecal; mezlocillin; seizures; ventricular drainage complication	METHOTREXATE	An accidental high dose of intraventricular mezlocillin was given during antibiotic treatment for pneumonia in a patient admitted because of severe traumatic brain injury and occlusive hydrocephalus. Because of serial epileptic seizures not responsive to antiepileptic drug treatment, CSF exchange was performed. The CSF was drained through a ventricular catheter, while mock CSF was infused into the lumbar subarachnoid space. The patient soon recovered to her clinical status previous to intraventricular mezlocillin application. Side effects of CSF exchange were not seen. Under continued antiepileptic medication no more seizures occurred. It is concluded that high doses of intraventricular mezlocillin have proconvulsive effects. In this patient CSF exchange was a suitable means of preventing putatively permanent impairment of brain function caused by serial epileptic seizures due to intraventricular mezlocillin application.	Univ Bonn, Neurochirurg Klin, Dept Neurosurg, D-53105 Bonn, Germany; Univ Bonn, Inst Pharmacol & Toxicol, D-53113 Bonn, Germany		Clusmann, H (corresponding author), Univ Bonn, Neurochirurg Klin, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.						ANDRIOLE VT, 1981, HOSP FORMUL, V8, P816; Cadeo G P, 1985, G Ital Chemioter, V32, P303; CHEN MN, 1986, JAP J ANTIBIOT, V34, P1234; FRIEDRICH H, 1980, ACTA NEUROCHIR, V52, P136; GLOOR P, 1977, ELECTROEN CLIN NEURO, V43, P79, DOI 10.1016/0013-4694(77)90198-5; GRONDAHL TO, 1993, J NEUROSURG, V78, P938, DOI 10.3171/jns.1993.78.6.0938; GRUNEBERG RN, 1984, J ANTIMICROB CHEMOTH, V13, P49, DOI 10.1093/jac/13.suppl_C.49; HENKER J, 1982, KINDERARZTL PRAX, V6, P288; HILDEBRANDT R, 1982, J CHROMATOGR, V228, P409, DOI 10.1016/S0378-4347(00)80464-8; JOHNSON HC, 1945, JAMA-J AM MED ASSOC, V127, P217, DOI 10.1001/jama.1945.92860040001007; Kataoka Noriaki, 1994, Hokkaido Journal of Medical Science, V69, P84; Kelsey M C, 1982, Eur J Clin Microbiol, V1, P138, DOI 10.1007/BF02019613; KIMELBERG HK, 1978, J NEUROSURG, V48, P883, DOI 10.3171/jns.1978.48.6.0883; KONOPKA CA, 1982, J ANTIMICROB CHEMOTH, V9, P267, DOI 10.1093/jac/9.suppl_A.267; PARRY MF, 1982, J ANTIMICROB CHEMOTH, V9, P273, DOI 10.1093/jac/9.suppl_A.273; RIESELBACH RE, 1962, NEW ENGL J MED, V267, P1273, DOI 10.1056/NEJM196212202672502; SHAPIRO WR, 1975, NEW ENGL J MED, V293, P161, DOI 10.1056/NEJM197507242930402; SIMON C, 1993, ANTIBIOTIKA THERAPIE, P35; SPIEGEL RJ, 1984, NEW ENGL J MED, V311, P386, DOI 10.1056/NEJM198408093110607; YEN J, 1978, J NEUROSURG, V48, P895, DOI 10.3171/jns.1978.48.6.0895	20	11	11	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	1998	64	3					379	381		10.1136/jnnp.64.3.379			3	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	ZD117	WOS:000072653100020	9527154	Bronze, Green Published			2022-02-06	
J	O'Dell, MW; Bell, KR; Sandel, ME				O'Dell, MW; Bell, KR; Sandel, ME			Brain injury rehabilitation. 2. Medical rehabilitation of brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							INTRATHECAL BACLOFEN APPLICATION; PLACEBO-CONTROLLED TRIAL; BOTULINUM TOXIN; DOUBLE-BLIND; POSTTRAUMATIC SEIZURES; VENOUS THROMBOEMBOLISM; NONFLUENT APHASIA; SPASTICITY; PHENYTOIN; HYDROCEPHALUS	This self-directed learning module highlights new advances in the area of medical issues in brain injury rehabilitation, with an emphasis on traumatic etiologies. It is part of the chapter on brain injury rehabilitation in the Self-Directed Physiatric Education Program for practitioners and trainees in physical medicine and rehabilitation. This article contains information on post-traumatic seizures and hydrocephalus, principles of pharmacologic and spasticity management, dizziness, visual disturbances, and language impairment. New advances covered in this section include more conservative approaches to post-traumatic seizure prophylaxis and the use of botulinum toxin and intrathecal baclofen pumps in the management of spasticity, (C) 1998 by the American Academy of Physical Medicine and Rehabilitation.	Southside Hosp, Bay Shore, NY 11706 USA; Long Isl Jewish Med Ctr, New Hyde Park, NY 11040 USA; Washington Univ, Sch Med, St Louis, MO 63130 USA; Kaiser Fdn Rehabil Ctr, Vallejo, CA 94589 USA		O'Dell, MW (corresponding author), Long Isl Jewish Med Ctr, New Hyde Park, NY 11040 USA.			Bell, Kathleen/0000-0002-0928-2046			ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BodineFowler SC, 1996, MUSCLE NERVE, V19, P497, DOI 10.1002/mus.880190404; Bontke C. F., 1993, J HEAD TRAUMA REHAB, V8, P34; BONTKE CF, 1989, PHYS MED REHABIL STA, V3, P43; BOYESON MG, 1994, J HEAD TRAUMA REHAB, V9, P78, DOI 10.1097/00001199-199409000-00007; BRAILOWSKY S, 1986, BRAIN RES, V376, P71, DOI 10.1016/0006-8993(86)90900-5; BUSCHBACHER R, 1992, CRIT REV PHYS MED RE, V4, P199; Cohen A H, 1992, J Am Optom Assoc, V63, P569; COPE DN, 1996, MED REHABILITATION T, P573; COSGROVE JL, 1989, AM J PHYS MED REHAB, V68, P15, DOI 10.1097/00002060-198902000-00005; Dall JT, 1996, BRAIN INJURY, V10, P453; DJERGAIAN RS, 1996, MED REHABILITATION T, P459; Doherty D., 1992, PHYS MED REH CLIN N, V3, P389; Furman JM., 1996, BALANCE DISORDERS CA; Gellman H, 1996, J HEAD TRAUMA REHAB, V11, P23, DOI 10.1097/00001199-199608000-00005; GELLMAN H, 1992, PAIN, V51, P307, DOI 10.1016/0304-3959(92)90214-V; Gil M, 1996, BRAIN INJURY, V10, P39, DOI 10.1080/026990596124700; Gillham R, 1996, EPILEPSY RES, V24, P47, DOI 10.1016/0920-1211(95)00102-6; GIZZI M, 1995, J HEAD TRAUMA REHAB, V10, P60, DOI 10.1097/00001199-199512000-00009; Glantz MJ, 1996, NEUROLOGY, V46, P985, DOI 10.1212/WNL.46.4.985; GOLDSTEIN LB, 1995, NEUROLOGY, V45, P865, DOI 10.1212/WNL.45.5.865; GOLDSTEIN LB, 1996, ATLAS CEREBROVASCULA; GUILTERI CT, 1991, NEUROPSYCHIATRY BEHA; Gupta SR, 1995, NEUROLOGY, V45, P2170, DOI 10.1212/WNL.45.12.2170; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; HERDMAN SJ, 1993, PHYS MED REHABIL STA, V7, P559; JONES RFC, 1994, ACT NEUR S, V61, P79; KATZ RT, 1994, STATE ART REV, V8; KENNEDY MRT, 1991, COMMUNICATION DISORD, P123; KOFLER M, 1994, NEUROLOGY, V44, P25, DOI 10.1212/WNL.44.1.25; Kolessar DJ, 1996, J HEAD TRAUMA REHAB, V11, P78, DOI 10.1097/00001199-199608000-00010; Leach JP, 1997, J NEUROL NEUROSUR PS, V62, P372, DOI 10.1136/jnnp.62.4.372; LONG DF, 1996, MED REHABILITATION T, P333; MANN NR, 1996, MED REHABILITATION T, P479; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MASSAGLI TL, 1991, ARCH PHYS MED REHAB, V72, P219; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; MEADOR KJ, 1995, NEUROLOGY, V45, P1494, DOI 10.1212/WNL.45.8.1494; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; Middleton JW, 1996, ARCH PHYS MED REHAB, V77, P824, DOI 10.1016/S0003-9993(96)90264-6; MONREAL M, 1992, CHEST, V102, P677, DOI 10.1378/chest.102.3.677; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; Pierson SH, 1996, ARCH PHYS MED REHAB, V77, P717, DOI 10.1016/S0003-9993(96)90015-5; Rifici C, 1994, Funct Neurol, V9, P29; ROGERS FB, 1995, SURG CLIN N AM, V75, P279, DOI 10.1016/S0039-6109(16)46588-6; Sabe L, 1995, NEUROLOGY, V45, P2272, DOI 10.1212/WNL.45.12.2272; Sandel ME, 1996, NEUROREHABILITATION, V6, P9, DOI 10.3233/NRE-1996-6103; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; SHEN JL, 1993, PHYS MED REHABIL STA, V7, P503; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; SMALL SL, 1994, STROKE, V25, P1282, DOI 10.1161/01.STR.25.6.1282; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; VANNESTE J, 1992, NEUROLOGY, V42, P54, DOI 10.1212/WNL.42.1.54; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P1094; WROBLEWSKI BA, 1994, J HEAD TRAUMA REHAB, V9, P19, DOI 10.1097/00001199-199409000-00004; WROBLEWSKI BA, 1990, J CLIN PSYCHOPHARM, V10, P124, DOI 10.1097/00004714-199004000-00009; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; ZUBER M, 1993, NEUROLOGY, V43, P1715, DOI 10.1212/WNL.43.9.1715; [No title captured]	61	11	11	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1998	79	3		1			S10	S15		10.1016/S0003-9993(98)90114-9			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	ZC421	WOS:000072576300003					2022-02-06	
J	Stevens, H; Van de Wiele, C; Santens, P; Jansen, HML; De Reuck, J; Dierckx, R; Korf, J				Stevens, H; Van de Wiele, C; Santens, P; Jansen, HML; De Reuck, J; Dierckx, R; Korf, J			Cobalt-57 and technetium-99m-HMPAO-labeled leukocytes for visualization of ischemic infarcts	JOURNAL OF NUCLEAR MEDICINE			English	Article						cerebral ischemia; stroke; leukocyte; cobalt-57; SPECT; technetium-99m-HMPAO	POSITRON EMISSION TOMOGRAPHY; MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN INJURY; PROGRESSIVE MULTIPLE-SCLEROSIS; CALCIUM ACCUMULATION; RAT-BRAIN; STROKE; OCCLUSION; ANTIBODY; NEURONS	Previous studies have shown the usefulness of divalent cobalt isotopes to visualize cerebral damage after stroke, The site of accumulation of cobalt ion is unknown but may be explained by neuronal influx, analogous to that of calcium ion. Additionally, uptake may be due to infiltrating leukocytes or protein-bound cobalt. The aims of this study were to compare Co-57-SPECT with leukocyte SPECT and to compare the SPECT findings with clinical outcome as scored by the Orgogozo scale. Materials: Ten patients with a CT scan positive for middle cerebral artery infarcts were included in the study (7 men, 3 women; mean age 70 yr), Technetium-99m leukocyte and cobalt-SPECT (interval 2-4 days) were made with a double-headed gamma camera, after the injection of 10-15 mCi Tc-99m-HMPAO-labeled leukocytes and 0.4 mCi Co-57, respectively, Scans were performed within 5-30 days after onset of the first symptoms. Regions of interest (ROI) containing the area of infarction in the slices displaying enhanced radioactivity or the middle cerebral artery (MCA) region in four successive slices were defined for calculating enhancement ratios. The (TC)-T-99m leukocyte enhancement ratio (LER) and cobalt enhancement ratio (CER) were defined as the quotient of radioactivity in the ROI and an identical contralateral ROI. The MCA stroke-scale according to Orgogozo was used to assess neurological deficits at the time of scanning and discharge. Results: Cobalt-57 and Tc-99m-HMPAO showed uptake in the infarcted brain area in five patients; the quantitative uptake in the infarcted brain area of the two tracers correlated significantly (p < 0.05). Both the LER and the CER correlated significantly (p < 0.05) with the Orgogozo score at the time of scanning. Only the LER correlated significantly (p < 0.05) with the Orgogozo score at discharge. Conclusion: Uptake of cobalt and leukocytes in the peri-infarct tissue suggests that Co-57 may visualize a component of the inflammatory response. Divalent Co-57 may be convenient to predict clinical prognosis after stroke.	Univ Groningen Hosp, Dept Biol Psychiat, Neuro PET Coordinat, NL-9700 RB Groningen, Netherlands; Univ Hosp Ghent, Dept Nucl Med, Ghent, Belgium; Univ Hosp Ghent, Dept Neurol, Ghent, Belgium		Korf, J (corresponding author), Univ Groningen Hosp, Dept Biol Psychiat, Neuro PET Coordinat, POB 30-001, NL-9700 RB Groningen, Netherlands.		santens, patrick/O-2505-2013	Santens, Patrick/0000-0002-8886-9776			ARAKI T, 1991, ACTA NEUROL SCAND, V83, P244, DOI 10.1111/j.1600-0404.1991.tb04690.x; BOWES MP, 1995, NEUROLOGY, V45, P815, DOI 10.1212/WNL.45.4.815; DIENEL GA, 1984, J NEUROCHEM, V43, P913, DOI 10.1111/j.1471-4159.1984.tb12825.x; Dux E, 1996, ACTA NEUROPATHOL, V92, P264, DOI 10.1007/s004010050517; FASSBENDER K, 1995, STROKE, V26, P1361, DOI 10.1161/01.STR.26.8.1361; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; GRAMSBERGEN JBP, 1994, BRAIN RES, V667, P216, DOI 10.1016/0006-8993(94)91499-0; GRAMSBERGEN JBP, 1988, J NEUROCHEM, V50, P1798, DOI 10.1111/j.1471-4159.1988.tb02481.x; JACOBS A, 1994, J NUCL MED, V35, P942; JANDER S, 1995, J CEREBR BLOOD F MET, V15, P42, DOI 10.1038/jcbfm.1995.5; Jansen HML, 1996, J NEUROL NEUROSUR PS, V60, P221, DOI 10.1136/jnnp.60.2.221; Jansen HML, 1996, J NUCL MED, V37, P2082; JANSEN HML, 1995, J NEUROL SCI, V132, P139, DOI 10.1016/0022-510X(95)00139-S; Jansen HML, 1997, CLIN NEUROL NEUROSUR, V99, P6, DOI 10.1016/S0303-8467(96)00558-6; JANSEN HML, 1994, J NUCL MED, V35, P456; JOOSTEN AAJ, 1995, NUCL MED COMMUN, V16, P703, DOI 10.1097/00006231-199508000-00014; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; LEFER DJ, 1993, CIRCULATION, V88, P1779, DOI 10.1161/01.CIR.88.4.1779; Linde R, 1996, ACT NEUR S, V66, P15; NAGY I, 1993, NEUROSCIENCE, V56, P241, DOI 10.1016/0306-4522(93)90576-2; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; NISHINO H, 1994, BRAIN RES BULL, V35, P51, DOI 10.1016/0361-9230(94)90215-1; ORGOGOZO JM, 1991, CEREBROVASC DIS, V1, P100, DOI 10.1159/000108904; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; SHIROTANI T, 1994, J CEREBR BLOOD F MET, V14, P831, DOI 10.1038/jcbfm.1994.104; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SILVESTRINI M, 1994, STROKE, V25, P1390, DOI 10.1161/01.STR.25.7.1390; Stevens Henk, 1997, P31; WANG PY, 1993, STROKE, V24, P236, DOI 10.1161/01.STR.24.2.236; WILLIAMS LR, 1992, BRAIN RES, V581, P181, DOI 10.1016/0006-8993(92)90707-G; WISE RJS, 1983, BRAIN, V106, P197, DOI 10.1093/brain/106.1.197; ZHANG RL, 1994, NEUROLOGY, V44, P1747, DOI 10.1212/WNL.44.9.1747	32	11	11	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505			J NUCL MED	J. Nucl. Med.	MAR	1998	39	3					495	498					4	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	ZA974	WOS:000072421600026	9529298				2022-02-06	
J	Rao, VLR; Baskaya, MK; Rao, AM; Dogan, A; Dempsey, RJ				Rao, VLR; Baskaya, MK; Rao, AM; Dogan, A; Dempsey, RJ			Increased ornithine decarboxylase activity and protein level in the cortex following traumatic brain injury in rats	BRAIN RESEARCH			English	Article						ornithine decarboxylase; traumatic brain injury; western blotting; polyamine	POSTISCHEMIC BRAIN; BARRIER BREAKDOWN; CEREBRAL-ISCHEMIA; EDEMA FORMATION; POLYAMINES; INDUCTION; DAMAGE	There is increasing evidence that the elevated levels of polyamines play an important role in the secondary injury following traumatic brain injury (TBI). Ornithine decarboxylase (ODC) is the rate-limiting enzyme of polyamine biosynthesis. Presently, we measured the ODC protein levels by Western blot analysis in the cerebral cortex of rats sacrificed at 2 h, 6 h, 24 h, 72 h and 168 h after controlled cortical impact injury. TBI resulted in a significant increase in ODC protein levels (2.5 to 5.5 fold, P < 0.05) and enzyme activity (13 to 21 fold, p < 0.01) between 2 and 6 h after the injury. ODC protein levels and enzyme activity returned to normal, control levels by 72 h after the injury. Increased ODC protein and enzyme activity could contribute to vasogenic edema and the pathogenesis of neuronal dysfunction after TBI by stimulating the formation of polyamines. (C) 1998 Elsevier Science B.V.	Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA; Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA; Vet Adm Hosp, Madison, WI 53792 USA		Dempsey, RJ (corresponding author), Univ Wisconsin, Dept Neurol Surg, H4-336 CSC,600 Highland Ave, Madison, WI 53792 USA.	dempsey@neuro-novell.neurosurg.wisc.edu	Dogan, Aclan/AAF-8305-2019		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS31220] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031220] Funding Source: NIH RePORTER		Baskaya MFK, 1996, NEUROSURGERY, V38, P140; Baskaya MK, 1996, J NEUROTRAUM, V13, P85, DOI 10.1089/neu.1996.13.85; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; DEMPSEY RJ, 1988, J CEREBR BLOOD F MET, V8, P843, DOI 10.1038/jcbfm.1988.141; DIENEL GA, 1984, J NEUROCHEM, V42, P1053, DOI 10.1111/j.1471-4159.1984.tb12710.x; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153, DOI 10.1016/0968-0004(90)90216-X; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; KINDY MS, 1994, J CEREBR BLOOD F MET, V14, P1040, DOI 10.1038/jcbfm.1994.136; KOENIG H, 1983, BIOCHEM BIOPH RES CO, V116, P1039, DOI 10.1016/S0006-291X(83)80247-2; Lindsberg PJ, 1996, J CEREBR BLOOD F MET, V16, P82, DOI 10.1097/00004647-199601000-00010; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MULLER M, 1991, ACTA NEUROPATHOL, V83, P39; Novack TA, 1996, J CLIN EXP NEUROPSYC, V18, P685, DOI 10.1080/01688639608408292; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; RAO AM, 1995, J NEUROCHEM, V65, P2639; SCHMITZ MP, 1993, NEUROSURGERY, V33, P882; SHOHAMI E, 1992, EXP NEUROL, V117, P189, DOI 10.1016/0014-4886(92)90126-B; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; THILMANN R, 1986, ACTA NEUROPATHOL, V71, P88, DOI 10.1007/BF00687967; WAHL M, 1988, J CEREBR BLOOD F MET, V8, P621, DOI 10.1038/jcbfm.1988.109	23	11	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 2	1998	783	1					163	166		10.1016/S0006-8993(97)01301-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZB159	WOS:000072442300021	9479066				2022-02-06	
J	Wiercisiewski, DR; McDeavitt, JT				Wiercisiewski, DR; McDeavitt, JT			Pulmonary complications in traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aspiration; neurogenic pulmonary edema; pulmonary complications; traumatic brain injury; ventilatory failure	HEAD-INJURIES; PERCUTANEOUS TRACHEOSTOMY; EDEMA; DOBUTAMINE	Survivors of traumatic brain injury frequently develop respiratory complications that require specialized knowledge and management skills in both acute and postacute environments. This article discusses the pathophysiology of and treatment options for ventilatory failure, neurogenic pulmonary edema, and aspiration. Management of tracheostomies is also discussed, with particular attention paid to decision making regarding the removal of a tracheal appliance. Long-term tracheal complications are also outlined.	Charlotte Inst Rehabil, Dept Phys Med & Rehabil, Charlotte, NC 28203 USA; Charlotte Inst Rehabil, Brain Injury Rehabil Serv, Charlotte, NC 28203 USA		Wiercisiewski, DR (corresponding author), Charlotte Inst Rehabil, Dept Phys Med & Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA.						Chen HI, 1995, BIOL SIGNAL, V4, P186; CITTAPIETROLUNGO TJ, 1993, ARCH PHYS MED REHAB, V74, P905; COLICE GL, 1985, CLIN CHEST MED, V6, P473; COLICE GL, 1984, AM REV RESPIR DIS, V130, P941; Deehan SC, 1996, INTENS CARE MED, V22, P672, DOI 10.1007/BF01709745; ELL SR, 1991, INVEST RADIOL, V26, P499, DOI 10.1097/00004424-199105000-00022; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; KLINGBEIL GEG, 1988, ARCH PHYS MED REHAB, V69, P493; KNUDSEN F, 1991, NEUROSURGERY, V29, P269, DOI 10.1227/00006123-199108000-00019; LANZA DC, 1990, LARYNGOSCOPE, V100, P958; LANZA DC, 1990, ANN OTO RHINOL LARYN, V99, P38, DOI 10.1177/000348949009900106; LAW JH, 1993, CHEST, V104, P136, DOI 10.1378/chest.104.1.136; MOORE FA, 1992, J TRAUMA, V33, P435, DOI 10.1097/00005373-199209000-00017; NOWAK P, 1987, AM J OTOLARYNG, V8, P91, DOI 10.1016/S0196-0709(87)80030-3; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; ROSEN P, 1992, EMERGENCY MED CONCEP; SAXE JM, 1994, J TRAUMA, V37, P581, DOI 10.1097/00005373-199410000-00010; SCHACHNER A, 1989, CRIT CARE MED, V17, P1052, DOI 10.1097/00003246-198910000-00017; SCHWARZ GR, 1992, PRINCIPLES PRACTICE; SIMON RP, 1993, NEUROL CLIN, V11, P309, DOI 10.1016/S0733-8619(18)30155-5; Spain DA, 1995, J TRAUMA, V39, P1100, DOI 10.1097/00005373-199512000-00015; Woratyla S P, 1995, Conn Med, V59, P643	22	11	16	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1998	13	1					28	35		10.1097/00001199-199802000-00006			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YW212	WOS:000071909700006	9565702				2022-02-06	
J	Oliaro, SM; Guskiewicz, KM; Prentice, WE				Oliaro, SM; Guskiewicz, KM; Prentice, WE			Establishment of normative data on cognitive tests for comparison with athletes sustaining mild head injury	JOURNAL OF ATHLETIC TRAINING			English	Article						neuropsychological testing; concussion	NEUROPSYCHOLOGICAL DEFICITS; CONTACT-SPORTS; CONCUSSION; GUIDELINES; SEQUELAE; SYMPTOMS	Objective: To provide normal data for comparison with objective measures of an athlete's cognitive ability after mild head injury (MHI). Subjects: Seventy-two Division 1 college athletes. Design and Setting: Athletes were assessed on three test dates (two days apart) in a sports medicine research laboratory. Measurements: Normative data were collected on four cognitive tests (Hopkins Verbal Learning Test, Stroop Test, Reitan Trail-Making Tests, and Wechsler Digit Span Tests). Results: A repeated-measures analysis of variance revealed significant learning effects on all tests except the Hopkins Verbal Learning Test. A high correlation was noted between the Stroop and the Trail-Making Tests. Conclusions: These normative data can be used as comparisons to provide an objective measure of an athlete's cognitive ability following MHI. By adding this test battery to the athlete's other physical and neurologic tests, the decision to return an athlete to competition after MHI can be made with greater confidence and with less risk of reinjury.	Univ N Carolina, Dept Phys Educ Exercise & Sport Sci, Chapel Hill, NC 27599 USA		Oliaro, SM (corresponding author), Univ N Carolina, Dept Phys Educ Exercise & Sport Sci, Chapel Hill, NC 27599 USA.			Guskiewicz, Kevin/0000-0002-8682-2130			ALVES WM, 1987, CLIN SPORT MED, V6, P211; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; BREAM T, 1996, ATHL THER TODAY, V1, P7; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1988, SPORTS MED DIGEST, V10, P1; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; DELIS D, 1990, COGNITIVE SCI APPROA, V7; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; INGERSOLL CD, 1993, SPORTS MED, V16, P342, DOI 10.2165/00007256-199316050-00005; JORDAN BD, 1994, P NATA ES ED FDN MIL; Kaplan E., 1991, WAIS R NEUROPSYCHOLO; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN H, 1994, P NATA RES ED FDN MI; LEZAK MD, 1994, NEUROPSYCHOLOGICAL A; Maroon J C, 1980, Clin Neurosurg, V27, P414; MATARAZZO J, 1980, J CLIN NEUROPSYCHOL, V6, P351; *NAT ATHL TRAIN AS, 1994, P NATA RES ED FDN MI; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Spreen O, 1991, COMPENDIUM NEUROPSYC; Torg JS, 1991, ATHLETIC INJURIES HE, Vsecond; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1	28	11	11	0	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	JAN-MAR	1998	33	1					36	40					5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	124PT	WOS:000076191400008	16558482				2022-02-06	
J	Bodjarian, N; Jamali, S; Boisset, N; Tadie, M				Bodjarian, N; Jamali, S; Boisset, N; Tadie, M			Strong expression of GFAP mRNA in rat hippocampus after a closed-head injury	NEUROREPORT			English	Article						astrocytes; axonal damage; closed-head injury; GFAP mRNA; hippocampus; in situ hybridization	TRAUMATIC BRAIN INJURY; DIFFUSE AXONAL INJURY; ACCELERATION; ASTROCYTES; METABOLISM; DAMAGE; MODEL	WE investigated the spatiotemporal GFAP mRNA expression over a period of 11 days following brain injury in rats caused by impact acceleration, which is known to produce diffuse axonal injury (DAI). We observed widespread GFAP mRNA expression throughout the brain, which was more rapid and intense in the hippocampus. This expression was obvious in most animals 2 days after injury and appeared maximal at day 6. Although it decreased by day 11, the level of expression remained high compared with control levels. We noted slight differences in time of onset and the magnitude of the response between hippocampus and white matter structures or cortical areas. The different mechanisms able to trigger this response are discussed in regard to histopathological changes observed in DAI models.	Hop Bicetre, Serv Neurochirurg, Lab Neurochirurg Expt, F-94275 Le Kremlin Bicetre, France; Hop Bicetre, Dept Anesthesiol Reanimat Chirurg, F-94275 Le Kremlin Bicetre, France		Bodjarian, N (corresponding author), Hop Bicetre, Serv Neurochirurg, Lab Neurochirurg Expt, 78 Av Gen Leclerc, F-94275 Le Kremlin Bicetre, France.						BAILLELECROM V, 1995, NEUROREPORT, V7, P355; DIX X, 1996, REST NEUROL NEUROSCI, V9, P231; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; KELLEY MS, 1993, INT J DEV NEUROSCI, V11, P105, DOI 10.1016/0736-5748(93)90071-K; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; McIntosh TK, 1996, LAB INVEST, V74, P315; MCLELLAN DR, 1989, COMA TRAUMATIQUE, P165; MELDRUM B, 1985, BRIT J ANAESTH, V57, P44, DOI 10.1093/bja/57.1.44; MONTGOMERY DL, 1994, VET PATHOL, V31, P145, DOI 10.1177/030098589403100201; MOONEN G, 1990, PROG BRAIN RES, V86, P63; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; NG HK, 1989, ACTA NEUROPATHOL, V78, P438; OCALLAGHAN JP, 1993, ANN NY ACAD SCI, V679, P195, DOI 10.1111/j.1749-6632.1993.tb18299.x; Paxinos G, 1986, RAT BRAIN STEREOTAXI; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; SMITH ME, 1983, BRAIN RES, V264, P241, DOI 10.1016/0006-8993(83)90822-3; Ye ZC, 1996, NEUROREPORT, V7, P2181, DOI 10.1097/00001756-199609020-00025	26	11	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0959-4965			NEUROREPORT	Neuroreport	DEC 22	1997	8	18					3951	3956		10.1097/00001756-199712220-00020			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YN915	WOS:000071221500022	9462472				2022-02-06	
J	Kreutzer, JS; Sander, AM; Fernandez, CC				Kreutzer, JS; Sander, AM; Fernandez, CC			Misperceptions, mishaps, and pitfalls in working with families after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						family therapy; rehabilitation; traumatic brain injury	SEVERE HEAD-INJURY; RELATIVES	Traumatic brain injury often has serious adverse consequences for individual family members and for the family's overall functioning. Rehabilitation environments are often stressful, chaotic, and complicated. Lack of family therapy training, misperceptions, conflicting personal philosophies, and complicated situations challenge professionals' abilities to involve family members as active, effective partners in the rehabilitation process. Presenting case analyses and suggestions for intervention, this article is intended to help clinicians working with family members recognize and avoid common errors in evaluation and intervention.			Kreutzer, JS (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHYS MED & REHABIL,MCV BOX 980542,RICHMOND,VA 23298, USA.						Bowen M., 1978, FAMILY THERAPY CLIN; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Carter B., 1989, CHANGING FAMILY LIFE; CAVALLO MM, 1995, J HEAD TRAUMA REHAB, V10, P66, DOI 10.1097/00001199-199504000-00008; *COMM ACCR REH FAC, 1996, 1996 STAND MED REH; FALICOV CJ, 1988, HDB FAMILY THERAPY T; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; GAW A, 1993, ETHNICITY MENTAL ILL; HALEY J, 1976, PROBLEM SOLVING THER; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; HOSACK KR, 1995, J HEAD TRAUMA REHAB, V10, P57, DOI 10.1097/00001199-199504000-00007; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kreutzer JS, 1990, COMMUNITY INTEGRATIO; LEZAK M, 1978, J CLIN PSYCHIAT, V39, P111; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MAITZ EA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199504000-00003; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCNENY R, 1991, NEUROREHABILITATION, V1, P7; MINUCHIN S, 1996, MASTERING FAMILY THE; Minuchin S., 1974, FAMILIES FAMILY THER; MOORE A, 1993, BRAIN INJURY, V7, P247, DOI 10.3109/02699059309029677; MUIR CA, 1990, REHABILITATION ADULT; Panting A, 1972, REHABILITATION, V38, P33; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; Shaw L R, 1990, Brain Inj, V4, P87, DOI 10.3109/02699059009026152; WATZLAWICK P, 1974, CHANGE PROBLEM FORMA	36	11	11	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1997	12	6					63	73		10.1097/00001199-199712000-00006			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YK459	WOS:A1997YK45900006					2022-02-06	
J	ReiderGroswasser, I; Costeff, H; Sazbon, L; Groswasser, Z				ReiderGroswasser, I; Costeff, H; Sazbon, L; Groswasser, Z			CT findings in persistent vegetative state following blunt traumatic brain injury	BRAIN INJURY			English	Article							VOLUME	The use of linear measurements in the analysis of CT scans of TBI patients was found to contribute to the understanding of brain damage and were correlated with outcome in severe traumatic close brain injured patients. The purpose of the present study was to analyse the data obtained by the linear measurements on CT studies of TBI patients who remained in persistent vegetative state following blunt head trauma. AU 27 patients included in the study were reported to be neurologically normal prior to injury. Thirteen patients, 11 remaining in persistent vegetative state (responsive but unaware) and two who died, constituted the wont outcome group. Fourteen patients who regained consciousness, underwent multidisciplinary evaluation when their recovery reached a plateau and were ranked according to severity of residual symptoms and outcome. The degree of correlation with the overall vocational outcome parameter with the various radiological indices was calculated as the Spearman rank correlation coefficient, with correction for tied scores. Fisher's z transformation was used to combine results with those of our previous analysis. Three radiological parameters showed a statistically significant correlation with clinical outcome. These were the right and left septum-caudate distance and the cerebroventricular index 2; these showed Spearman rank coefficients of 0.52, 0.45 and 0.48; with two-tailed p-values under 0.01, 0.02 and 0.01 respectively. The width of the third ventricle suggested correlation with the clinical scoring. The findings of the present study point to the importance of loss of deep gray matter of the caudate nuclei and widening of the adjacent part of the lateral ventricles in catastrophic brain injury. This finding may highlight the role of localized ischemic changes, in addition to diffuse axonal injury. Values of over 8 mm for the width of the third ventricle and over 11 mm for septum caudate distance are suggestive of catastrophic injury and poor prognosis for recovery.	LOEWENSTEIN HOSP & REHABIL CTR,RAANANA,ISRAEL; TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL		ReiderGroswasser, I (corresponding author), TEL AVIV SOURASKY MED CTR,ICHILOV HOSP,DEPT RADIOL,NEURORADIOL SECT,6 WEIZMAN ST,IL-64239 TEL AVIV,ISRAEL.						Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; AYLWARD EH, 1991, AM J NEURORADIOL, V12, P1217; GLYDENSTED C, 1977, NEURORADIOLOGY, V14, P183; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; MOODY DM, 1990, AM J NEURORADIOL, V11, P431; Ommaya AK, 1996, TRAUMATIC BRAIN INJU, P19; Reider-Groswasser I, 1996, Neurol Neurochir Pol, V30 Suppl 2, P127; REIDERGROSWASSE.I, 1997, NEUROPSYCHOL REHABIL, P73; REIDERGROSWASSE.I, 1995, C RAH MED IST 27 31; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; WOOD DMG, 1995, BRAIN RES BULL, V38, P545, DOI 10.1016/0361-9230(95)02026-0	11	11	12	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	DEC	1997	11	12					865	870		10.1080/026990597122936			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YG767	WOS:A1997YG76700002	9413620				2022-02-06	
J	Striem, S; BarJoseph, A; Berkovitch, Y; Biegon, A				Striem, S; BarJoseph, A; Berkovitch, Y; Biegon, A			Interaction of dexanabinol (HU-211), a novel NMDA receptor antagonist, with the dopaminergic system	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						HU-211; NMDA receptor antagonist; dopamine receptor antagonist; catalepsy; Parkinson's disease	INHIBIT ADENYLATE-CYCLASE; CLOSED-HEAD INJURY; CANNABINOID RECEPTOR; PARKINSONS-DISEASE; BRAIN-DAMAGE; RAT; ISCHEMIA; STRIATUM; NEUROTRANSMITTERS; METHAMPHETAMINE	The interaction of 7-hydroxy-Delta(6)-tetrahydrocannabinol 1,1-dimethylheptyl (Dexanabinol; HU-211), a novel NMDA receptor antagonist, with the dopaminergic system was examined using in vitro and in vivo systems. HU-211 (50 or 100 mu M) inhibited the binding of [H-3]R(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol hydrochloride ([H-3] SCH-23390), a dopamine D-1 receptor antagonist, by 29.7 +/- 1.8% and 52.7 +/- 6.3%, respectively. HU-211 10 mu M, like the dopamine D-1 receptor agonist R(+)-1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrochloride (SKF-38393), enhanced the conversion of [H-3]adenine to cyclic AMP (cAMP) (51.8 +/- 29.7% and 35.6 +/- 21.5% over control, respectively). The HU-211-induced increase was not inhibited by SCH-23390. HU-211 together with the dopamine D-1 receptor agonist caused a synergistic elevation (314.7 +/- 14.3%). HU-211 reduced the catalepsy induced by dopamine receptor antagonists. At 10 mg/kg, HU-211 significantly (P < 0.001) reduced the catalepsy time induced by D-1, D-2 and non-selective dopamine receptor antagonists. Overall, the results of the present study demonstrate that HU-211 interacts with the dopaminergic system and enhances activity at the dopamine D-1 receptor level. This activity may have implications in diseases involving the dopaminergic system, such as Parkinson's disease. (C) 1997 Elsevier Science B.V.	PHARMOS CORP, IL-76326 REHOVOT, ISRAEL								BALDWIN HA, 1993, BRIT J PHARMACOL, V108, P590, DOI 10.1111/j.1476-5381.1993.tb12847.x; BARJOSEPH A, 1994, MOL CHEM NEUROPATHOL, V23, P125, DOI 10.1007/BF02815406; BARJOSEPH A, 1995, J CEREB BLOOD FLO S1, V15, pS429; BARJOSEPH A, 1994, ABSTR SOC NEUROSCI, V82, P11; BELAYEV L, 1995, BRAIN RES, V702, P266, DOI 10.1016/0006-8993(95)01127-9; BELAYEV L, 1995, MOL CHEM NEUROPATHOL, V25, P19, DOI 10.1007/BF02815084; BELAYEV L, 1995, STROKE, V26, P2313, DOI 10.1161/01.STR.26.12.2313; BIEGON A, 1995, NEUROL RES, V17, P275, DOI 10.1080/01616412.1995.11740326; CARLSSON M, 1990, TRENDS NEUROSCI, V13, P272, DOI 10.1016/0166-2236(90)90108-M; DEARRY A, 1990, NATURE, V347, P72, DOI 10.1038/347072a0; DEVANE WA, 1992, J MED CHEM, V35, P2065, DOI 10.1021/jm00089a018; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DICHIARA G, 1994, TRENDS NEUROSCI, V17, P228, DOI 10.1016/0166-2236(94)90005-1; ESHHAR N, 1989, BRAIN RES, V476, P57, DOI 10.1016/0006-8993(89)91536-9; ESHHAR N, 1995, EUR J PHARMACOL, V283, P19, DOI 10.1016/0014-2999(95)00271-L; ESHHAR N, 1993, NEUROREPORT, V5, P237, DOI 10.1097/00001756-199312000-00013; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; GANDOLFI O, 1993, PHARMACOL BIOCHEM BE, V44, P683, DOI 10.1016/0091-3057(93)90186-W; HOWLETT AC, 1988, MOL PHARMACOL, V33, P297; HOWLETT AC, 1990, NEUROPHARMACOLOGY, V29, P161, DOI 10.1016/0028-3908(90)90056-W; IVERSEN LL, 1975, SCIENCE, V188, P1084, DOI 10.1126/science.2976; KLOCKGETHER T, 1990, ANN NEUROL, V28, P539, DOI 10.1002/ana.410280411; KOEK W, 1990, J PHARMACOL EXP THER, V253, P1017; LEANDER JD, 1988, BRAIN RES, V448, P115, DOI 10.1016/0006-8993(88)91107-9; LOSCHER W, 1991, NEUROSCI LETT, V128, P191, DOI 10.1016/0304-3940(91)90258-U; LOSCHER W, 1991, J PHARMACOL EXP THER, V256, P432; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MOORE NA, 1993, EUR J PHARMACOL, V237, P1, DOI 10.1016/0014-2999(93)90085-V; MORELLI M, 1992, J PHARMACOL EXP THER, V260, P402; NADLER V, 1993, NEUROSCI LETT, V162, P43, DOI 10.1016/0304-3940(93)90555-Y; NADLER V, 1993, BRAIN RES, V622, P79, DOI 10.1016/0006-8993(93)90804-V; OLANOW CW, 1993, TRENDS NEUROSCI, V16, P439, DOI 10.1016/0166-2236(93)90070-3; SALOMON Y, 1991, METHOD ENZYMOL, V195, P22; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SINGH NA, 1992, BRAIN RES, V571, P260, DOI 10.1016/0006-8993(92)90663-T; SONSALLA PK, 1989, SCIENCE, V243, P398, DOI 10.1126/science.2563176; ULAS J, 1994, J NEUROSCI, V14, P6317; VANCALKER D, 1978, J NEUROCHEM, V30, P713; WEIHMULLER FB, 1992, NEUROREPORT, V3, P977, DOI 10.1097/00001756-199211000-00007; ZIV I, 1994, NEUROSCI LETT, V170, P136, DOI 10.1016/0304-3940(94)90258-5	41	11	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	NOV 12	1997	338	3					205	213		10.1016/S0014-2999(97)81923-1			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	YJ789	WOS:A1997YJ78900001	9424014				2022-02-06	
J	Tremont, G; Hoffman, RG; Scott, JG; Adams, RL; Nadolne, MJ				Tremont, G; Hoffman, RG; Scott, JG; Adams, RL; Nadolne, MJ			Clinical utility of Wechsler Memory Scale - Revised and predicted IQ discrepancies in closed head injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article								Comparisons between Wechsler Memory Scale-Revised (WMS-R) indexes and Wechsler Adult Intelligence Scale-Revised (WAIS-R) IQ scores have been proposed to identify severity of memory deficits. However, many neurologic conditions reduce both intellectual and memory functioning, and thus, examining differences between these scores may be of little value. Closed head injured subjects who completed the WMS-R were divided into either mild injury (MI, n = 41) or moderate/severe (SI, n = 41) injury groups based on trauma severity indicators and were matched on age and level of education. The Oklahoma Premorbid Intelligence Estimation (OPIE), a regression formula that takes into account demographic variables as well as IQ performance, was calculated for each subject. Discrepancy scores were calculated between predicted IQ scores and WAIS-R IQ and WMS-R indexes. SI head-injured subjects displayed significantly larger discrepancies (19 points) between OPIE scores and Delayed Recall Indexes from the WMS-R than the MI subjects (10 points). Significantly larger percentages of subjects in the SI group displayed significant (>SD) reductions in many of the WMS-R and WAIS-R scores from estimates than subjects in the MI group. Comparing current memory functioning to estimates of premorbid intellectual ability appears to be a sensitive indicator of presence and degree of intellectual and memory dysfunction in head trauma patients. Results also provide evidence that estimates of premorbid intellectual ability can serve as estimates of premorbid memory functioning. (C) 1997 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	UNIV OKLAHOMA, CTR HLTH SCI, NORMAN, OK 73019 USA					Nadolne, Marnie/0000-0002-6259-6722			BORNSTEIN RA, 1989, PSYCHOL ASSESSMENT J, V1, P203; BUTTERS N, 1988, CLIN NEUROPSYCHOL, V2, P133; CROSSEN JR, 1988, CLIN NEUROPSYCHOL, V2, P181; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Mittenberg W, 1991, PSYCHOL ASSESS, V3, P492; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; Wechsler D, 1987, MEMORY SCALE REVISED	8	11	11	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	1997	12	8					757	762		10.1016/S0887-6177(97)00049-8			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	YH876	WOS:A1997YH87600006	14590652	Bronze			2022-02-06	
J	Ball, JW; Binder, H; Brown, CW; Christensen, JR; Dreier, C; Fendya, DG; Ferketic, MM; Forsman, I; Gregory, JL; Healy, MD; HackettWaters, P; Helfer, B; Herrin, K; Jaimovich, DG; Kaufman, J; Lash, M; Magnuson, DK; Marvin, JA; Patton, P; Presler, B; Rushton, DB; Sacchetti, A; SanAgustin, T; Savage, RC; Sells, CJ; Storgion, SA; Tittle, S; Valvano, J; Warnock, L; Weaver, MD; Weiss, D; Wertz, EM				Ball, JW; Binder, H; Brown, CW; Christensen, JR; Dreier, C; Fendya, DG; Ferketic, MM; Forsman, I; Gregory, JL; Healy, MD; HackettWaters, P; Helfer, B; Herrin, K; Jaimovich, DG; Kaufman, J; Lash, M; Magnuson, DK; Marvin, JA; Patton, P; Presler, B; Rushton, DB; Sacchetti, A; SanAgustin, T; Savage, RC; Sells, CJ; Storgion, SA; Tittle, S; Valvano, J; Warnock, L; Weaver, MD; Weiss, D; Wertz, EM			EMS for children: Recommendations for coordinating care for children with special health care needs	ANNALS OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN INJURY	Study objective: To address the need for coordinated care for children and their families during the acute care phase of their hospitalization. Methods: A multidiscipline task force developed this concept paper through a consensus process. The process was coordinated by the Emergency Medical Services for Children Program (a program of the Health Resources and Services Administration and the National Highway Traffic Safety Administration). The task force included representatives from prehospital care, acute care, rehabilitation, primary care, and education, as well as consumers. This representation provided a broad perspective on the needs of children and their families in the transition from hospital care to home. Conclusion: One designated individual is essential during the acute care phase who can assist the family with gaining information and resources to ensure a successful transition to community services and resources. This article provides a framework for acute care facilities and providers to use in planning services and working with acutely ill and injured children. Several recommendations highlight the need for care coordination to be initiated early in the child's hospitalization. An overview of services and resources (both health and educational) that a child and family may need is also provided. Such services and resources include identifying a care coordinator, working with the family to identify a primary care provider before hospital discharge, and building bridges with community-based health and education services.			Ball, JW (corresponding author), EMSC,NATL RESOURCE CTR,WASHINGTON,DC, USA.						*COMM PED EM MED, 1992, EM MED SERV CHILDR R, P251; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; *INST MED, 1993, EM MED SERV CHILDR, P215; LASH M, 1992, EXCEPTIONAL PARENT; SAVAGE R, 1994, ADOLESC MED STATE AR, V5, P311; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P42, DOI 10.1097/00001199-199512000-00007; 1990, AM J DIS CHILD, V144, P627	8	11	11	0	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	SEP	1997	30	3					274	280					7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	XU225	WOS:A1997XU22500005					2022-02-06	
J	Stevens, H; Jansen, HML; DeReuck, J; Lemmerling, M; Strijckmans, K; Goethals, P; Lemahieu, I; DeJong, BM; Willemsen, ATM; Korf, J				Stevens, H; Jansen, HML; DeReuck, J; Lemmerling, M; Strijckmans, K; Goethals, P; Lemahieu, I; DeJong, BM; Willemsen, ATM; Korf, J			Co-55-PET in stroke: relation to bloodflow, oxygen metabolism and gadolinium-MRI	ACTA NEUROLOGICA BELGICA			English	Article; Proceedings Paper	International Symposium on Nuclear Medicine and Clinical Neurology	MAR 07-08, 1997	GHENT, BELGIUM				POSITRON EMISSION TOMOGRAPHY; PROGRESSIVE MULTIPLE-SCLEROSIS; TRAUMATIC BRAIN INJURY; ACUTE ISCHEMIC STROKE; CALCIUM; NEURONS; TISSUE	BACKGROUND: Several studies have shown the feasibility of Co-isotopes (Co-55 and Co-57) in imaging of neuronal damage in stroke, multiple sclerosis, cerebral tumors and trauma. These studies indicate that Co-isotopes allow visualization of brain pathology related to inflammatory processes, reactive gliosis and cell death. Until now, it is not clear if Co-55 accumulation occurs in the core of infarction or in the penumbra. Therefore, in the present study, we compared Co-55-PET with functional parameter such as cerebral bloodflow (rCBF) using (CO2)-O-15, oxygen metabolism (rCMRO(2)) using O-15(2) and cerebral bloodvolume (CBV) using (CO)-O-15 in PET and with the anatomical parameter Gd-MRI. PATIENTS AND METHODS: Seventeen patients (11 male; 6 female) age 43 to 84 (mean 69) with middle cerebral artery (mca) stroke, as proven by CT or MRI, were examined with Co-55-PET (0.5-1.0 mCi (CoCl2)-Co-55), (CO2)-O-15-, O-15(2)- and (CO)-O-15-PET in one session 0-30 days after stroke-onset. Regions of infarction were defined by rCMRO(2) being smaller than 65% or rCBF below 45% of the contralateral value and were subsequently superimposed on the cobalt scan. To compare the Cobalt uptake with the Gd-MRI, a realignment program was used that matches the MRI with the blood-flow images. Clinical status was established using the Orgogozo stroke scale at admission and at discharge (at least 6 weeks after admission) and the Barthel index. RESULTS: Eight patients showed a positive Co-PET scan and were used for further analysis. It appeared that Co accumulates in areas with a diminished oxygen metabolism and with a preserved bloodflow. We found Co-uptake in only a part of the Gd enhanced brain tissue with a tendency to be located peripherally or outside the Gd demarcated brain tissue. CONCLUSION: The results of the present study suggest that Co accumulates into infarcted brain tissue with a rather preserved flow independently of blood-brain barrier breakdown.	UNIV GRONINGEN HOSP,DEPT BIOL PSYCHIAT,NL-9700 RB GRONINGEN,NETHERLANDS; UNIV HOSP,PET CTR,GHENT,BELGIUM; UNIV HOSP,DEPT RADIOL,INST NUCL MED,GHENT,BELGIUM; UNIV HOSP,DEPT NEUROL,INST NUCL MED,GHENT,BELGIUM; STATE UNIV GHENT,DEPT ELECT & INFORMAT SYST,B-9000 GHENT,BELGIUM; UNIV GRONINGEN HOSP,DEPT NEUROL,GRONINGEN,NETHERLANDS; UNIV GRONINGEN HOSP,NATL PET CTR,GRONINGEN,NETHERLANDS				Lemahieu, Ignace/G-8625-2012	Lemahieu, Ignace/0000-0002-0894-9988; de Jong, Bauke M./0000-0002-6568-5739			BARON JC, 1993, CURR OPIN NEUROL, V6, P900, DOI 10.1097/00019052-199312000-00012; CLEMENTI E, 1994, EUR J IMMUNOL, V24, P1365, DOI 10.1002/eji.1830240619; DEREUCK J, 1993, J NEUROL, V240, P430; DUBINSKY JM, 1993, ANN NY ACAD SCI, V679, P34, DOI 10.1111/j.1749-6632.1993.tb18287.x; GIBBONS SJ, 1993, ANN NY ACAD SCI, V679, P22, DOI 10.1111/j.1749-6632.1993.tb18286.x; GRAMSBERGEN JBP, 1988, J NEUROCHEM, V50, P1798, DOI 10.1111/j.1471-4159.1988.tb02481.x; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; HEISS WD, 1994, EUR J NUCL MED, V21, P455; HEISS WD, 1993, STROKE, V24, P1784, DOI 10.1161/01.STR.24.12.1784; HEISS WD, 1993, STROKE S1, V24, P50; Jansen HML, 1996, J NEUROL NEUROSUR PS, V60, P221, DOI 10.1136/jnnp.60.2.221; JANSEN HML, 1995, J NEUROL SCI, V132, P139, DOI 10.1016/0022-510X(95)00139-S; Jansen HML, 1997, CLIN NEUROL NEUROSUR, V99, P6, DOI 10.1016/S0303-8467(96)00558-6; JANSEN HML, 1994, J NUCL MED, V35, P456; JOOSTEN AAJ, 1995, NUCL MED COMMUN, V16, P703, DOI 10.1097/00006231-199508000-00014; MARCHAL G, 1993, LANCET, V341, P925, DOI 10.1016/0140-6736(93)91214-7; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; ORGOGOZO JM, 1991, CEREBROVASC DIS, V1, P100, DOI 10.1159/000108904; PRUSS RM, 1991, NEURON, V7, P509, DOI 10.1016/0896-6273(91)90302-G; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; STEVENS H, 1996, CLIN PHARM CEREBRAL, P31; WANG PY, 1993, STROKE, V24, P236, DOI 10.1161/01.STR.24.2.236; [No title captured]	23	11	11	0	2	ACTA MEDICA BELGICA	BRUSSELS	AVENUE CIRCULAIRE 138-A, B-1180 BRUSSELS, BELGIUM	0300-9009			ACTA NEUROL BELG	Acta Neurol. Belg.	SEP	1997	97	3					172	177					6	Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH226	WOS:A1997YH22600006	9345588				2022-02-06	
J	Emanuelson, IM; vonWendt, L; Bjure, J; Wiklund, LM; Uvebrant, P				Emanuelson, IM; vonWendt, L; Bjure, J; Wiklund, LM; Uvebrant, P			Computed tomography and single photon emission computed tomography as diagnostic tools in acquired brain injury among children and adolescents	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							CLOSED-HEAD-INJURY; HM-PAO-SPECT; TECHNETIUM-99M-HMPAO SPECT; CT; MILD; COMA; MRI	Twenty children with acquired brain injuries were investigated with GT and SPECT. The findings were related to the clinical outcome judged at discharge following acute care after the injury and at follow-up 5 years later, The abnormalities that were found were classifier? for each lobe on a scale ranging from 0 (normal) to 5 (severe abnormality). The patients were divided into two groups showing mild and severe injury. CT and SPECT revealed similar results in the patients with severe injury, but in the group of mildly injured children the number of affected lobes and scores indicated by SPECT were significantly higher than those indicated by CT. SPECT also differentiated more effectively between the two outcome groups. This supports the hypothesis that SPECT could be used as an instrument to objectivise ruiner sequelae and that SPECT and GT are both useful methods for forecasting outcome.	E HOSP GOTHENBURG,DEPT PAEDIAT 2,GOTHENBURG,SWEDEN; E HOSP GOTHENBURG,DEPT PAEDIAT RADIOL,GOTHENBURG,SWEDEN; E HOSP GOTHENBURG,DEPT CLIN PHYSIOL,GOTHENBURG,SWEDEN		Emanuelson, IM (corresponding author), BRACKE OSTERGARD REG PAEDIAT REHABIL CTR,GOTHENBURG,SWEDEN.						ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; BAVETTA S, 1994, NUCL MED COMMUN, V15, P961, DOI 10.1097/00006231-199412000-00007; Costeff H, 1985, Scand J Rehabil Med Suppl, V12, P10; Goshen E, 1996, NUCL MED COMMUN, V17, P418, DOI 10.1097/00006231-199605000-00011; GRAY BG, 1992, J NUCL MED, V33, P52; JACOBS A, 1994, J NUCL MED, V35, P942; JENNETT B, 1975, LANCET, V1, P480; KRIEL RL, 1988, PEDIATR NEUROL, V4, P337, DOI 10.1016/0887-8994(88)90079-3; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; UVEBRANT P, 1991, NEUROPEDIATRICS, V22, P3, DOI 10.1055/s-2008-1071407; UVEBRANT P, 1993, RETT SYNDROME CLIN B; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; [No title captured]	18	11	11	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211	0012-1622			DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	AUG	1997	39	8					502	507					6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	XV650	WOS:A1997XV65000002	9295844				2022-02-06	
J	Zafonte, RD; Watanabe, TK; Mann, NR; Ho, DH				Zafonte, RD; Watanabe, TK; Mann, NR; Ho, DH			Psychogenic polydipsia after traumatic brain injury - A case report	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						hyponatremia; drinking; water intoxication; brain injury	PSYCHIATRIC-PATIENTS; CLOZAPINE; HYPONATREMIA	Electrolyte abnormalities are common medical complications of traumatic brain injury (TBI). Hyponatremia is the most common of these disorders. The syndrome of inappropriate antidiuretic hormone and cerebral salt-wasting are the most well know causes of hyponatremia following TBI. In the presence of polydipsia and polyuria, psychogenic polydipsia should be included in the differential diagnosis. It is important to distinguish among these entities because treatment differs to such an extent that improper diagnosis may lead to a worsening of the patient's condition. We present a patient who presented with a new onset of polyuria and polydipsia after sustaining a TBI. Evaluation, including monitoring of fluid intake and output, serum and urine sodium and osmolarity, as well as a fluid deprivation test revealed the cause to be psychogenic polydipsia. The patient's symptoms improved after institution of a behavioral program and fluid restriction. Various models of drinking behavior have been used to identify the site of dysregulation. Dopaminergic, cholinergic, and hippocampal etiologies have been implicated in this abnormality of fluid homeostasis. If disorders of these systems can lead to psychogenic polydipsia, it is reasonable to believe that a person who has sustained a TBI would be at higher risk of developing psychogenic polydipsia.			Zafonte, RD (corresponding author), WAYNE STATE UNIV,DETROIT MED CTR,DEPT PHYS MED & REHABIL,REHABIL INST MICHIGAN,261 MACK AVE,DETROIT,MI 48201, USA.						Batuev A S, 1993, Neurosci Behav Physiol, V23, P35, DOI 10.1007/BF01182636; BELL KR, 1995, NEUROREHABILITATION, V5, P233, DOI 10.3233/NRE-1995-5306; BLUM A, 1983, AM J PSYCHIAT, V140, P915; CAMBIASSO MJ, 1992, BEHAV NEURAL BIOL, V58, P190, DOI 10.1016/0163-1047(92)90454-C; CRAPANZANO KA, 1993, BIOL PSYCHIAT, V34, P889, DOI 10.1016/0006-3223(93)90057-K; DELEON J, 1995, NEUROPSYCHOPHARMACOL, V12, P133; Elovic E, 1996, J HEAD TRAUMA REHAB, V11, P89, DOI 10.1097/00001199-199606000-00013; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; LEADBETTER RA, 1994, J CLIN PSYCHIAT, V55, P110; LEE HS, 1991, J CLIN PSYCHOPHARM, V11, P222, DOI 10.1097/00004714-199106000-00022; Spears NM, 1996, J CLIN PSYCHIAT, V57, P123; UMBRICHT D, 1994, BIOL PSYCHIAT, V36, P709, DOI 10.1016/0006-3223(94)91183-5; VERGHESE C, 1993, NEUROPSYCHOPHARMACOL, V9, P157, DOI 10.1038/npp.1993.54; ZABIK JE, 1992, PHYSIOL BEHAV, V54, P29	14	11	11	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY-JUN	1997	76	3					246	248		10.1097/00002060-199705000-00018			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XG430	WOS:A1997XG43000015	9207712				2022-02-06	
J	Gurevich, B; Talmor, D; Artru, AA; Katcko, L; Geva, D; Gurman, G; Shapira, Y				Gurevich, B; Talmor, D; Artru, AA; Katcko, L; Geva, D; Gurman, G; Shapira, Y			Brain edema, hemorrhagic necrosis volume, and neurological status with rapid infusion of 0.45% saline or 5% dextrose in 0.9% saline after closed head trauma in rats	ANESTHESIA AND ANALGESIA			English	Article							CEREBRAL-ISCHEMIA; HYPERTONIC SALINE; LACTATED RINGERS; CARDIAC-ARREST; HYPERGLYCEMIA; GLUCOSE; INJURY; DAMAGE; MODEL	We previously reported that in rats with closed head trauma (CHT), intravenous (IV) administration of 0.25 mL/g of 5% dextrose solution (D5W) increased blood glucose (G), decreased blood sodium (Na), caused no change in blood osmolality (Osm), increased brain edema (BE), and worsened neurological severity score (NSS) and mortality rate (MR). D5W in 0.9% saline (D5NS) is isonatremic and hyperosmolar with respect to blood and may avoid the problems reported with D5W. The present study compared the effects of 0.25 mL/g of D5NS or 0.45% saline (0.45 S) after CHT in rats. In 11 groups of rats, the three experimental variables were CHT (yes or no), IV fluid (none, D5NS, or 0.45 S), and time of death (4 or 24 h). D5NS or 0.45 S was given IV at 1 h after surgical preparation with or without CHT, and experimental values were determined at 1, 2, 4, and 24 h. D5NS decreased BE at 4 h compared with the untreated group, increased Osm (380 +/- 2 mOsm/kg) and G (1278 +/- 199 mg/dL), decreased Na (131 +/- 2 mEq/L) in blood, and caused no significant change in hemorrhagic necrosis volume (HNV), NSS, or MR. 0.45 S increased MR (50%) at 2 1 h, decreased Osm (270 +/- 5 mOsm/kg) and Na (123 +/- 1 mEq/L) in blood, and caused no significant change in G, BE, HNV, or NSS. We conclude that after CHT in rats, D5NS decreased BE without changing NSS or MR. 0.45 S increased MR and significantly altered blood chemistries.	SOROKA MED CTR,DEPT ANESTHESIOL,DIV ANESTHESIOL,IL-84101 BEER SHEVA,ISRAEL; KAPLAN HOSP,DEPT ANESTHESIOL,BEER SHEVA,ISRAEL; BEN GURION UNIV NEGEV,FAC HLTH SCI,BEER SHEVA,ISRAEL; UNIV WASHINGTON,SCH MED,DEPT ANESTHESIOL,SEATTLE,WA 98195								ARTRU AA, 1994, ANESTHESIA NEUROSURG, P93; DALECY LG, 1986, SURGERY, V100, P505; DRUMMOND JC, 1989, ANESTHESIOLOGY, V70, P64, DOI 10.1097/00000542-198901000-00014; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; FOXWORTHY JC, 1990, J NEUROSURG ANESTH, V2, P256, DOI 10.1097/00008506-199012000-00002; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LAM AM, 1995, ANESTHETIC MANAGEMEN, P181; LANIER WL, 1987, ANESTHESIOLOGY, V66, P39, DOI 10.1097/00000542-198701000-00008; LEMAY DR, 1988, STROKE, V19, P1411, DOI 10.1161/01.STR.19.11.1411; LONGSTRETH WT, 1984, ANN NEUROL, V15, P59, DOI 10.1002/ana.410150111; MILHORAT TH, 1994, ANESTHESIA NEUROSURG, P136; NEDERGAARD M, 1987, BRAIN RES, V408, P79, DOI 10.1016/0006-8993(87)90360-X; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; ROBERTSON CS, 1991, J NEUROSURG, V74, P43, DOI 10.3171/jns.1991.74.1.0043; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; TODD MM, 1985, J NEUROSURG, V63, P944, DOI 10.3171/jns.1985.63.6.0944; VENABLES GS, 1985, J NEUROL NEUROSUR PS, V48, P663, DOI 10.1136/jnnp.48.7.663; VOLL CL, 1988, ANN NEUROL, V24, P638, DOI 10.1002/ana.410240508; ZASSLOW MA, 1989, STROKE, V20, P519, DOI 10.1161/01.STR.20.4.519; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011; ZORNOW MH, 1994, ANESTHESIA NEUROSURG, P247	25	11	11	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0003-2999			ANESTH ANALG	Anesth. Analg.	MAR	1997	84	3					554	559		10.1097/00000539-199703000-00016			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	WL116	WOS:A1997WL11600016	9052300				2022-02-06	
J	Lubinski, R; Moscato, BS; Willer, BS				Lubinski, R; Moscato, BS; Willer, BS			Prevalence of speaking and hearing disabilities among adults with traumatic brain injury from a national household survey	BRAIN INJURY			English	Article								The purpose of this study is to provide prevalence estimates of the sociodemographic characteristics and extent of speaking and hearing disabilities among a community-based sample of adults (15 years and older) who have survived traumatic brain injury (TBI). This report is based on the Canadian Health and Activity Limitation Survey (1986-87), a national household survey of self-reported disabilities. Results indicate that adults with TBI with speaking or hearing difficulties tend to be male, middle-aged and older, urban dwellers, of relatively low income levels who are limited at work. Over 75% of adults with speaking difficulties report difficulty being understood by people outside their immediate family context. Hearing difficulties rise dramatically from 75% occurring with one communication partner to over 96% occurring with three partners. The mean duration of disabilities is 12.7 years for speaking and 13.5 years for hearing. More than 80% of adults with communicative difficulties have co-occurring disabilities of mobility and agility. Results have specific implications for functional assessment of adults with TBI and service delivery decision-making.			Lubinski, R (corresponding author), SUNY BUFFALO, DEPT COMMUNICAT DISORDERS & SCI, 115 PK HALL, AMHERST, NY 14260 USA.						ADAMS PF, 1992, VITAL HLTH STAT, V10; BERGMAN M, 1987, EAR HEARING, V8, P87, DOI 10.1097/00003446-198704000-00005; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; DOLSON D, 1987, SUURVEY METHODOLOGY, V13, P93; FURRIE A, 1987, NATL DATABASE DISABL; GRIFFITHS M, 1979, J LARYNGOL OTOL, V92, P253; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; HIRDES J, 1993, AUGMENTATIVE ALTERNA, V9, P1; Kewman D G, 1988, Brain Inj, V2, P131, DOI 10.3109/02699058809150937; MCDOWELL I, 1988, DISABILITY SCORE HLT; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; *NAT CTR HLTH STAT, 1988, VIT HLTH STAT, V10; Rothman KJ, 1986, MODERN EPIDEMIOLOGY; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; *STAT CAN, 1991, SPEC TOP SER HLTH AC, V4; *STAT CAN, 1988, DIS DAT PROGR HLTH A; *STAT CAN, 1989, HLTH ACT LIM SURV HA; THEBERGE A, 1988, WEIGHTING HLTH ACTIV; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; World Health Organization, 1980, INT CLASS IMP DIS HA	20	11	11	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1997	11	2					103	114		10.1080/026990597123692			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	WD430	WOS:A1997WD43000002	9012943				2022-02-06	
S	Banik, NL; Matzelle, D; GanttWilford, G; Hogan, EL		Slikker, W		Banik, NL; Matzelle, D; GanttWilford, G; Hogan, EL			Role of calpain and its inhibitors in tissue degeneration and neuroprotection in spinal cord injury	NEUROPROTECTIVE AGENTS - THIRD INTERNATIONAL CONFERENCE	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	3rd International Conference on Neuroprotective Agents - Clinical and Experimental Aspects	SEP 09-12, 1996	VARENNA, ITALY	New York Acad Sci, FDA, Natl Ctr Toxicol Res, Arkansas, Dept Vet Affairs Med Ctr, Togus, Maine			TRAUMATIC BRAIN INJURY; MU-CALPAIN; RAT; METHYLPREDNISOLONE; IMMUNOREACTIVITY; DEGRADATION; ACTIVATION; MYELIN				Banik, NL (corresponding author), MED UNIV S CAROLINA, DEPT NEUROL, 171 ASHLEY AVE, CHARLESTON, SC 29425 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-31622] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031622] Funding Source: NIH RePORTER		BALENTINE JD, 1978, LAB INVEST, V39, P254; BALENTINE JD, 1985, TRAUMA CENTRAL NERVO, P285; BANIK NL, 1982, NEUROCHEM RES, V7, P1465, DOI 10.1007/BF00965089; Banik NL, 1996, GWUMC DEPT, P377; BANIK NL, 1980, J NEUROPATH EXP NEUR, V39, P232, DOI 10.1097/00005072-198005000-00002; BANIK NL, 1986, J NEUROL SCI, V73, P245, DOI 10.1016/0022-510X(86)90149-8; BANIK NL, 1996, IN PRESS PRINCIPLES; BARTUS RT, 1994, J CEREBR BLOOD F MET, V14, P537, DOI 10.1038/jcbfm.1994.67; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRAUGHLER JM, 1984, J NEUROSURG, V61, P290, DOI 10.3171/jns.1984.61.2.0290; BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9; Chakrabarti AK, 1996, J NEUROSCI RES, V44, P374; CONG JY, 1989, J BIOL CHEM, V264, P10096; DESHPANDE RV, 1995, J NEUROSCI RES, V42, P259, DOI 10.1002/jnr.490420214; DESHPANDE RV, 1995, J BIOL CHEM, V270, P2497, DOI 10.1074/jbc.270.6.2497; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; HOGAN EL, 1985, HDB NEUROCHEMISTRY, V10, P285; Kampfl A, 1996, J NEUROCHEM, V67, P1575; KOMATSU K, 1986, EXP NEUROL, V91, P23, DOI 10.1016/0014-4886(86)90022-1; LEE KS, 1991, P NATL ACAD SCI USA, V88, P7233, DOI 10.1073/pnas.88.16.7233; LI ZH, 1995, NEUROCHEM INT, V27, P425, DOI 10.1016/0197-0186(95)00024-3; Li ZH, 1996, NEUROCHEM RES, V21, P441, DOI 10.1007/BF02527708; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; Shields D. C., 1996, Society for Neuroscience Abstracts, V22, P2137; SIMAN R, 1985, BRAIN RES, V347, P399, DOI 10.1016/0006-8993(85)90208-2; STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2; TAMAI M, 1987, J PHARMACOBIO-DYNAM, V10, P678, DOI 10.1248/bpb1978.10.678; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1	31	11	11	0	2	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-093-X	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1997	825						120	127		10.1111/j.1749-6632.1997.tb48421.x			8	Multidisciplinary Sciences; Neurosciences; Pharmacology & Pharmacy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Neurosciences & Neurology; Pharmacology & Pharmacy	BJ99G	WOS:A1997BJ99G00011	9369980				2022-02-06	
J	Johnstone, B; Slaughter, J; Schopp, L; McAllister, JA; Schwake, C; Luebbering, A				Johnstone, B; Slaughter, J; Schopp, L; McAllister, JA; Schwake, C; Luebbering, A			Determining neuropsychological impairment using estimates of premorbid intelligence: Comparing methods based on level of education versus reading scores	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; COGNITIVE DECLINE; NORMATIVE DATA	When inferring brain dysfunction, test scores are typically compared to normative data based on estimates of premorbid intelligence (e.g., by educational level or reading scores). However; these methods are likely to lead to differing results, with important diagnostic and forensic implications. The current study compared estimates of impairment (reported in z-scores) based on educational level versus reading scores in a population,vith traumatic br-ain injury The study included 174 patients (M age = 27.3; M education = 12.3) evaluated as outpatients at a university hospital rehabilitation department. Wilcoxen ranked sign tests indicated that the true methods yielded estimates that were statistically different (p < .0001) for all variables. The education based method yielded greater estimates of impairment than the reading score method for WAIS-R FIQ, Grip Strength, and Finger Tapping, with a pattern of generally consistent impairment across cognitive/motor areas (z-score range = -0.59 to -.97). In contrast, the reading score based method yielded greater estimates of impairment in processing speed (Trails A) and flexibility (Trails B), with a wider range of impairment noted between cognitive and motor domains (z-score range = +0.21 to -2.95). Clinical implications are discussed. (C) 1997 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	UNIV MISSOURI, SCH MED, COLUMBIA, MO 65211 USA					Johnstone, Brick/0000-0001-8845-9649			BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; CHRISTENSEN H, 1991, PSYCHOL ASSESSMENT, V3, P147; Crawford J.R., 1992, HDB NEUROPSYCHOLOGIC, P21; DESMOND DW, 1995, ARCH CLIN NEUROPSYCH, V10, P535; Fastenau PS, 1996, J CLIN EXP NEUROPSYC, V18, P444; FROMMAUCH C, 1993, J CLIN NEUROPSYCHOLO, V5, P221; Heaton RK, 1996, J CLIN EXP NEUROPSYC, V18, P449, DOI 10.1080/01688639608409001; Heaton RK, 1991, COMPREHENSIVE NORMS; HEINRICHS RW, 1990, PROF PSYCHOL-RES PR, V21, P171, DOI 10.1037/0735-7028.21.3.171; Jastak S., 1984, WRAT R WIDE RANGE AC; Johnstone B, 1996, J Int Neuropsychol Soc, V2, P282; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; JOHNSTONE B, 1995, NEUROREHABILITATION, V5, P75, DOI 10.3233/NRE-1995-5107; KARAKEN DA, 1995, ARCH CLIN NEUROPSYCH, V10, P147; KREUTZER JS, 1990, COMMUNITY INTEGRATIO, P49; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MAPOU RL, 1988, J CLIN EXP NEUROPSYC, V10, P271, DOI 10.1080/01688638808408241; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Paque L, 1995, J Int Neuropsychol Soc, V1, P517; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; REITAIN RM, 1985, HALSTEAD REITAN NEUR; Reitan R, 1986, TRAIL MAKING TEST MA; SEIDENBERG M, 1983, J CONSULT CLIN PSYCH, V51, P406, DOI 10.1037/0022-006X.51.3.406; Spreen O, 1991, COMPENDIUM NEUROPSYC; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; WIENS AN, 1993, CLIN NEUROPSYCHOL, V7, P70, DOI 10.1080/13854049308401889; Wilkinson G, 1993, WRAT3 WIDE RANGE ACH; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y	33	11	12	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1997	12	6					591	601		10.1016/S0887-6177(97)00002-4			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	XP931	WOS:A1997XP93100008	14590671	Bronze			2022-02-06	
J	Altmayer, T; ODell, MW; Jones, M; Martin, V; Hawkins, HH				Altmayer, T; ODell, MW; Jones, M; Martin, V; Hawkins, HH			Cisapride as a treatment for gastroparesis in traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							RECOVERY; METOCLOPRAMIDE; REHABILITATION; HALOPERIDOL	Gastroparesis is a well-documented finding among patients with severe traumatic brain injuries. The treatment of choice has been metoclopramide, but it is less than ideal given its central dopaminergic blocking activity. Cisapride is a newer prokinetic agent without side effects on the central nervous system and might be a superior treatment. The case of a healthy 22-year-old man who suffered a severe traumatic brain injury and multiple trauma in a motor vehicle accident is reported. The patient required gastrostomy tube placement but developed recurrent aspiration pneumonia once feeding were initiated. Despite receiving metoclopramide, barium studies revealed gastroparesis, a significant decrease in gastric peristalsis, and reflux. A jejunostomy tube was placed to prevent further aspiration. The administration of cisapride was begun, and 2 days later the patient was changed back to G-tube feedings with no evidence of residual aspirates. Repeat barium study showed definite improved in peristalsis. The case of demonstrates the potential usefulness of cisapride in patients with traumatic brain injury. Although further research is necessary, efficacy without central dopamine blockage may make cisapride the treatment of choice for gastroparesis and reflex in traumatic brain injury. (C) 1996 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation	UNIV CINCINNATI,DEPT PHYS MED & REHABIL,COLL MED,CINCINNATI,OH 45267; UNIV CINCINNATI,DIV GEN INTERNAL MED,COLL MED,CINCINNATI,OH 45267; UNIV CINCINNATI,DEPT RADIOL,COLL MED,CINCINNATI,OH 45267; WASHINGTON UNIV,SCH MED,ST LOUIS,MO								ABELL TL, 1991, DIGEST DIS SCI, V36, P616, DOI 10.1007/BF01297028; BOECKXSTAENS GE, 1990, J PHARMACOL EXP THER, V254, P652; BONFIGLIO R L, 1991, Archives of Physical Medicine and Rehabilitation, V72, P817; BROOKE MM, 1986, ARCH PHYS MED REHAB, V67, P634; BUCCI M N, 1986, Surgical Forum (Chicago), V37, P524; CAMILLERI M, 1989, GASTROENTEROLOGY, V96, P704; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; GOLDSTEIN LB, 1990, STROKE, V21, P179; HAGEN C, 1979, PROFESSIONAL STAFF A, P87; HEYMSFIELD SB, 1979, ANN INTERN MED, V90, P63, DOI 10.7326/0003-4819-90-1-63; JACKSON MD, 1989, ARCH PHYS MED REHAB, V70, P553; KAWAGISHI T, 1993, AM J GASTROENTEROL, V88, P933; LONGO WE, 1993, DIS COLON RECTUM, V36, P696, DOI 10.1007/BF02238599; MCCALLUM RW, 1991, AM J GASTROENTEROL, V86, P135; MCHUGH S, 1992, DIGEST DIS SCI, V37, P997, DOI 10.1007/BF01300277; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; PORCH B, 1985, Society for Neuroscience Abstracts, V11, P52; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; RICHARDS RD, 1993, DIGEST DIS SCI, V38, P811, DOI 10.1007/BF01295905; SCHILLER LR, 1992, MANAGEMENT GASTROINT, V31; SUTTON RL, 1987, J HEAD TRAUMA REHAB, V2, P50; WHITLOCK JA, 1994, J HEAD TRAUMA REHABI, V9, P115	24	11	13	0	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	1996	77	10					1093	1094		10.1016/S0003-9993(96)90075-1			2	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	VL132	WOS:A1996VL13200018	8857893				2022-02-06	
J	Luber, SD; Brady, WJ; Brand, A; Young, J; Guertler, AT; Kefer, M				Luber, SD; Brady, WJ; Brand, A; Young, J; Guertler, AT; Kefer, M			Acute hypoglycemia masquerading as head trauma: A report of four cases	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						hypoglycemia; head trauma; closed head injury; diabetes mellitus; masquerade; altered mental status	HYPERGLYCEMIA; HEMIPLEGIA; EMERGENCY; ADMISSION; GLUCAGON; DEXTROSE; ACCIDENT; STROKE; COMA	Hypoglycemia, a commonly encountered metabolic emergency, is most often easily diagnosed and rapidly treated with satisfactory patient outcome, If not recognized and treated promptly, hypoglycemia may cause irreversible central nervous system injury; it rarely results in death, The classic presentation of hypoglycemia, a patient with diabetes mellitus on medical therapy (insulin or oral hypoglycemic agents) who presents with an altered sensorium, is frequently seen in the emergency department (ED), Less often, patients with this metabolic emergency present to the ED in a manner suggestive of a situation other than hypoglycemia, Patients may present with seizure activity or focal neuro logical deficits, leading the physician to treat a primary neurological syndrome and not immediately recognize the primary cause of the problem, Alternatively, patients with hypoglycemia will present to the ED with an altered mental status after a traumatic event, The physician may again assume that the alteration in consciousness has resulted from a head injury and not a metabolic disorder, Four cases are presented in which the medical history of the event (ie, trauma) suggested head injury as an explanation of the presentation when, in fact, hypoglycemia was responsible for the altered sensorium, The diagnosis of hypoglycemia is easily made with the performance of a bedside screening test which can be subsequently confirmed by laboratory blood analysis, It is imperative that emergency physicians consider hypoglycemia in all patients with any mental status abnormality, focal neurological deficit, or seizure activity, even when the findings seem to be explained initially by other etiologies. Copyright (C) 1996 by W.B. Saunders Company	UNIV VIRGINIA,HLTH SCI CTR,DEPT EMERGENCY MED,CHARLOTTESVILLE,VA 22908								BOYLE PJ, 1988, NEW ENGL J MED, V318, P1487, DOI 10.1056/NEJM198806093182302; BRADY W, 1994, AM J EMERG MED, V12, P383, DOI 10.1016/0735-6757(94)90172-4; CLEMENTS R, 1992, PRINCIPLES PRACTICE, P2087; COLLIER A, 1987, DIABETES CARE, V10, P712, DOI 10.2337/diacare.10.6.712; FILKINS JP, 1974, AM J PHYSIOL, V227, P778, DOI 10.1152/ajplegacy.1974.227.4.778; FOSTER DW, 1991, HARRISONS PRINCIPLES, P1759; FOSTER JW, 1987, STROKE, V18, P944, DOI 10.1161/01.STR.18.5.944; GALE E, 1980, CLIN ENDOCRINOL META, V9, P461; KHANNA PB, 1987, J AM GERIATR SOC, V35, P477, DOI 10.1111/j.1532-5415.1987.tb04683.x; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LONGSTRETH WT, 1984, ANN NEUROL, V15, P59, DOI 10.1002/ana.410150111; MALOUF R, 1985, ANN NEUROL, V17, P421, DOI 10.1002/ana.410170502; PANT SS, 1966, NEUROLOGY, V166, P837; PATRICK AW, 1990, ARCH EMERG MED, V7, P73; PEDEN N, 1983, ORAL HYPOGLYCAEMIC A, V286, P1564; PLUM F, 1979, DIAGNOSIS STUPOR COM, P221; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; RICH LM, 1990, ARCH INTERN MED, V150, P894, DOI 10.1001/archinte.150.4.894; SELTZER HS, 1972, DIABETES, V21, P955, DOI 10.2337/diab.21.9.955; SHOTLIFF K, 1992, POSTGRAD MED J, V68, P843, DOI 10.1136/pgmj.68.804.843; WALLIS WE, 1985, ANN NEUROL, V18, P510, DOI 10.1002/ana.410180415; WATSON AJS, 1981, IRISH J MED SCI, V150, P301, DOI 10.1007/BF02938260; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; ZEE DS, 1974, ARCH NEUROL-CHICAGO, V30, P403, DOI 10.1001/archneur.1974.00490350061010	24	11	11	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	OCT	1996	14	6					543	547		10.1016/S0735-6757(96)90094-7			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	VL732	WOS:A1996VL73200001	8857800				2022-02-06	
J	Srinivas, S; Poole, F; Redpath, J; Underhill, TJ				Srinivas, S; Poole, F; Redpath, J; Underhill, TJ			Review of a computer based telephone helpline in an A&E department	JOURNAL OF ACCIDENT & EMERGENCY MEDICINE			English	Article						accident and emergency department; Helpline; telephone advice; computerisation	EMERGENCY; ADVICE; ACCIDENT	Objective-An audit of use of the telephone Helpline in the accident and emergency (A&E) department was conducted to establish the type of call, time, by whom the calls were made, appropriateness of advice given, and whether callers attended or not as advised, and also to obtain feedback from callers as to the degree of satisfaction with the advice given. Methods-AU calls over a four week period were included in the study. The information logged comprised name, age, telephone number, date and time of call, nature of query, advice given, and name of advisor. Callers whose telephone number had been noted were contacted for feedback. Results-There were 300 calls over the four week period, and 150 callers were available for feedback. Most calls were received between 12.00 and 20.00 hours. The majority of callers were parent or self, 52% of calls were for problems concerning adults, and 40% for children; no age was recorded in 8%. Nursing staff answered 90.7% of the calls. Queries were wide ranging but commonly involved open and closed wounds and head injuries, with 29.3% being advised to attend A&E, 32.3% to ring or see their GP, and 38.4% were reassured or given other advice; 4% of callers attended A&E despite being advised otherwise, 97% were judged to have received appropriate advice, and 91.3% of callers were satisfied with the advice given. Conclusion-The Helpline has proved of benefit to the public. It is necessary and important to have protocols for common problems and to document all details carefully. It is also necessary that nursing staff are trained in handling the telephone queries and using the protocols. The use of a PC based system has improved data collection and also allows immediate access to protocols.			Srinivas, S (corresponding author), CONQUEST HOSP,THE RIDGE,ST LEONARDS TN37 7RD,E SUSSEX,ENGLAND.						AUNER JR, 1993, PEDIATR EMERG CARE, V9, P300; *BAEM, 1992, GUID HANDL TEL ENQ A; EVANS RJ, 1993, ARCH EMERG MED, V10, P216; ISAACMAN DJ, 1992, PEDIATRICS, V89, P35; KERNOHAN S M, 1992, Health Bulletin (Edinburgh), V50, P233; Kunkler R, 1994, Nurs Times, V90, P29; MARSH GN, 1987, J ROY COLL GEN PRACT, V37, P301; MOLYNEUX E, 1994, J ACCID EMERG MED, V11, P246; SINGH G, 1991, J ROY SOC MED, V84, P345, DOI 10.1177/014107689108400613; VEGLESTON C, 1994, BRIT MED J, V308, P31; VERDILE VP, 1989, ANN EMERG MED, V18, P278, DOI 10.1016/S0196-0644(89)80414-7	11	11	11	0	0	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	1351-0622			J ACCID EMERG MED	J. Accid. Emerg. Med.	SEP	1996	13	5					330	333					4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	VM113	WOS:A1996VM11300007	8894858				2022-02-06	
J	Rosenthal, M				Rosenthal, M			1995 Sheldon Berrol, MD senior lectureship: The ethics and efficacy of traumatic brain injury rehabilitation-myths, measurements, and meaning	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	14th Annual Conference of the Brain-Injury-Association	DEC 05, 1995	SAN DIEGO, CA	Brain Injury Assoc		efficacy; ethics; outcome measurement; traumatic brain injury	CLOSED HEAD-INJURY; EARLY INTERVENTION; BENEFIT	The modern age of brain injury rehabilitation has experienced rapid growth as it has moved from the era of enlightenment to the era of consolidation during the past 2 decades. This growth has been character ized by a proliferation of specialized programs, development of innovative treatment methods, and an expansion of the care continuum. Unfortunately, the scientific foundation for much of commonly accepted practice has not kept pace with these developments. In addition, the field has been subjected to increased scrutiny and regulation as consumer allegations of fraud and abuse have been brought to the forefront of public attention. As practitioners attempt to deliver high-quality care under the new cost-reduction philosophy of managed care, there is a need to systematically develop and utilize outcome measurement systems that evaluate the efficacy of our brain injury rehabilitation programs. Outcome measurement in this rehabilitation must meet the needs of a diverse set of customers. It is critical to fully evaluate the physical, neuropsychological, and psychosocial consequences of traumatic brain injury and determine which treatment methods are most effective in ameliorating these problems and result in optimal long-term outcome. ''Meaningful'' measurement systems will need to address customer satisfaction, long-term outcome, quality of life, and cost-effectiveness.	REHABIL INST MICHIGAN, DETROIT, MI USA		Rosenthal, M (corresponding author), WAYNE STATE UNIV, DEPT PHYS MED & REHABIL, 261 MACK BLVD, DETROIT, MI 48201 USA.						BANJA J, 1993, STAFF DEV CLIN INTER; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BENYISHAY Y, 1983, REHABILITATION HEAD; BERROL S, 1982, HEAD INJURY REHABILI; Bush Gerald W., 1988, J HEAD TRAUMA REHAB, V3, P73; *COMM ACCR REH FAC, 1985, STAND MAN MED REH; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; COPE DN, 1985, SEMIN NEUROL, V5, P212, DOI 10.1055/s-2008-1041518; Eames P, 1985, Int Rehabil Med, V7, P130; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; Hall KM, 1994, ARCH PHYS MED REHABI, V75, pSC; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1983, REHABILITATION HEAD; JOHNSTON M V, 1991, Brain Injury, V5, P155, DOI 10.3109/02699059109008086; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Jones M L, 1992, J Insur Med, V24, P186; KERR P, 1992, NY TIMES        0316, P1; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PUTNAM SH, 1992, CLIN NEUROPSYCHOL, V6, P383; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; TEASDALE G, 1974, LANCET, V2, P81; TREXLER LE, 1982, COGNITIVE REHABILITA; [No title captured]	28	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1996	11	4					88	95		10.1097/00001199-199608000-00011			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	VA386	WOS:A1996VA38600011					2022-02-06	
J	Soon, JCC; Kumar, VP; Satkunanartham, K				Soon, JCC; Kumar, VP; Satkunanartham, K			Elbow dislocation with ipsilateral radial shaft fracture - An unusual outcome	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article								The authors describe an uncommon injury of the upper limb, namely, dislocation of the elbow with fracture of the ipsilateral radial shaft, in a young man, After closed reduction of the joint, the radial head was found to be subluxated, and when a nonanatomic internal fixation of the radial shaft was undertaken, the radial head became dislocated, Repeat operation with removal of the implants and internal fixation with correction of rotation and angulation at the fracture site and reconstruction of the annular ligament restored normal anatomy.	NATL UNIV SINGAPORE HOSP, DEPT HAND & RECONSTRUCT MICROSURG, SINGAPORE 117548, SINGAPORE; NATL UNIV SINGAPORE HOSP, DEPT ORTHOPAED SURG, SINGAPORE 117548, SINGAPORE				Kumar, V Prem/A-1678-2010				BEACH PM, 1966, AM J SURG, V112, P941; BURGESS RC, 1984, CLIN ORTHOP RELAT R, P192; DELEE JC, 1984, FRACTURES ADULTS, P606; EVANS EM, 1949, J BONE JOINT SURG BR, V31, P578, DOI 10.1302/0301-620X.31B4.578; MEHARA AK, 1993, J TRAUMA, V35, P958, DOI 10.1097/00005373-199312000-00027; SIMPSON JM, 1991, CLIN ORTHOP RELAT R, P205	6	11	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	AUG	1996		329					212	215					4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	VC566	WOS:A1996VC56600026	8769454				2022-02-06	
J	Andrews, PJD; Murugavel, S; Deehan, S				Andrews, PJD; Murugavel, S; Deehan, S			Conventional multimodality monitoring and failure to detect ischemic cerebral blood flow	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						cerebral blood flow; jugular venous oxygen saturation; head injury; cerebral infarction; cerebral edema; cardiac index	PLATELET-ACTIVATING FACTOR; SEVERE BRAIN INJURY; HEAD-INJURY; RAT-BRAIN; INTERLEUKIN-1; PATIENT; DAMAGE	We report a case of cerebral infarction following traumatic brain injury associated with low cerebral blood flow, but not detected by measurements of jugular venous oxygen saturation, cerebral lactate production, cerebral perfusion pressure, transcranial Doppler ultrasound, or measures of systemic hemodynamics.	WESTERN GEN HOSP,NHS TRUST,DEPT CLIN NEUROSCI,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,EDINBURGH,MIDLOTHIAN,SCOTLAND		Andrews, PJD (corresponding author), WESTERN GEN HOSP,NHS TRUST,DEPT ANESTHESIA & INTENS CARE,CREWE RD,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.						ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; ANDREWS PJD, 1990, BRIT J ANAESTH, V64, P393; ANDREWS PJD, 1995, IN PRESS CURRENT PRA; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BRAQUET P, 1989, INT ARCH ALLER A IMM, V88, P88, DOI 10.1159/000234755; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; FEUERSTEIN GZ, 1990, STROKE S11, V21, P11190; FISHER M, 1995, INTENS CARE MED, V21, P131; FRERICHS KU, 1990, J NEUROSURG, V73, P223, DOI 10.3171/jns.1990.73.2.0223; GLAUSER FL, 1988, AM REV RESPIR DIS, V138, P458, DOI 10.1164/ajrccm/138.2.458; GOPINATH SP, 1993, J NEUROL TRAUMA S1, V10, pS202; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HIRASHIMA Y, 1994, J NEUROSURG, V80, P31, DOI 10.3171/jns.1994.80.1.0031; JONES PA, 1994, J NEUROSURG ANESTHES, V6, P1; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; MARINI JJ, 1992, AM REV RESPIR DIS, V146, P2, DOI 10.1164/ajrccm/146.1.2; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; SCHEINBERG P, 1949, J CLIN INVEST, V28, P1163, DOI 10.1172/JCI102150; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; STAHL WM, 1987, CRIT CARE MED, V15, P545, DOI 10.1097/00003246-198706000-00001; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAMASAKI Y, 1992, NEUROSCI LETT, V142, P45, DOI 10.1016/0304-3940(92)90616-F; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375; [No title captured]	29	11	11	0	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	1996	8	3					220	226		10.1097/00008506-199607000-00006			7	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	UT939	WOS:A1996UT93900006	8803834				2022-02-06	
J	Brzuzy, S; Corrigan, JD				Brzuzy, S; Corrigan, JD			Predictors of living independently after moderate to severe traumatic brain injury: A comparison study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							BLUNT HEAD-INJURY; RELATIVES VIEW	Objective: To identify factors that predict long-term, independent living for adults after traumatic brain injury (TBI). Design: A case-comparison study of unmarried adults who experienced TBI and were either living independently or living with parents. Setting: Cases drawn randomly from a state-wide needs survey of 1,265 Ohioans with brain injuries. Subjects: From a pool of 356 unmarried respondents ages 21 to 49; 32 subjects living alone and 34 living with parents were compared. Primary Measures: Age, time postinjury, education, current and previous income, preinjury living arrangement, history of postinjury living arrangements, current and previous employment, length of loss of consciousness, and functional disabilities. Results: Of those living alone, 98% lived with their parents an average of 3 pears after release from the hospital. Those currently living with parents had lived with them the entire time since being released. Almost 60% of those living with parents were 6 pears or less postinjury versus 30% of those living alone. Of those living with parents, 56% were 30 years old or younger versus 13% of those living alone. Prior living arrangement, current age, time postinjury, education, and current income contributed significantly to discriminant analysis, while length of loss of consciousness and prior employment did not. The contribution of prior income and functional disabilities could not be evaluated due to problems with the self-report format of these variables. Conclusions: Living independently after moderate to severe TBI may be achieved by a complex interaction of prior skills, available resources; current capabilities, and the expectations of both family and individual. The minimal role that severity of injury appeared to play is consistent with the World Health Organization model and suggests that the determinants of independent living may be subject to systematic intervention.	OHIO STATE UNIV,DEPT PHYS MED & REHABIL,COLUMBUS,OH		Brzuzy, S (corresponding author), ARIZONA STATE UNIV,SCH SOCIAL WORK,BOX 871802,TEMPE,AZ 85287, USA.		Corrigan, John D./E-2921-2011				BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; DEJONG G, 1982, ARCH PHYS MED REHAB, V63, P68; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JOHNSTON M V, 1991, Brain Injury, V5, P155, DOI 10.3109/02699059109008086; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Livingston M G, 1987, Brain Inj, V1, P33, DOI 10.3109/02699058709034442; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; *OH REH SERV COMM, 1992, OH HEAD INJ PROGR NE; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; World Health Organization, 1980, INT CLASS IMP DIS HA	21	11	11	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1996	11	3					74	83		10.1097/00001199-199606000-00011			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UP774	WOS:A1996UP77400011					2022-02-06	
J	Murray, S; Bush, M; Tell, LA				Murray, S; Bush, M; Tell, LA			Medical management of postpartum problems in an Asian elephant (Elephas maximus) cow and calf	JOURNAL OF ZOO AND WILDLIFE MEDICINE			English	Article						passive transfer; retained placenta; Asian elephant; Elephas maximus; immunoglobulin	PROGESTERONE; SECRETION; BEER	An 18-yr-old female Asian elephant (Elephas maximus) gave birth to a 120-kg female calf following 22 mo of gestation. immediately after parturition, the cow became agitated and aggressive towards the calf Before the keepers were able to safely intervene and remove the calf, the cow stepped on the calf's head and right front leg. Within 30 min, the cow calmed down, allowing the calf's safe reintroduction under close keeper supervision and control. The cow had a retained placenta, poor mammary development, and low milk production. The calf's injuries, in combination with the cow's low milk production, impeded the calf's ability to nurse and gain weight. Within 10 days, the calf lost 10% of its weight. Serum protein electrophoresis indicated failure of passive transfer of maternal immunoglobulin. On day 10, the calf received a transfusion of concentrated immunoglobulin extracted and concentrated from the cow's previously banked plasma. On day 13, the calf developed a urinary tract infection, as diagnosed by white blood cells and bacteria in the urine. Following immunoglobulin administration and antibiotic therapy, clinical signs slowly resolved and the calf gained weight. The cow passed the fetal membranes during parturition, but the placenta was retained. Despite prophylactic systemic antibiotics and vaginal flushing, the cow became depressed and developed a leukocytosis and an anemia. A mucopurulent vaginal discharge and ventral edema were noted on day 3, and milk production was minimal. Because decreased milk production has been reported as a common sequel to retained placenta, efforts were focused on removing the placenta. Intermittent oxytocin therapy on days 2-14 did not result in expulsion of the placenta and produced only transient abdominal contractions and minimal increases in milk letdown. On day 15, 10 mg estradiol cypionate was administered i.m. followed by 200 IU oxytocin i.v. An additional 10 IU oxytocin was administered i.v. on day 16. The friable placenta was palpable within the vaginal vault on day 17. The remaining placenta was removed by gentle traction applied by a modified weighted blood pressure cuff. Once the placenta was removed, the cow's clinical problems slowly resolved and the calf continued to gain weight.	UNIV CALIF DAVIS,SCH VET MED,DEPT MED & EPIDEMIOL,DAVIS,CA 95616		Murray, S (corresponding author), NATL ZOOL PK,CONSERVAT RES CTR,1500 REMOUNT RD,FRONT ROYAL,VA 22630, USA.						BROWN JL, 1991, J ZOO WILDLIFE MED, V22, P49; CARLSON HE, 1985, J CLIN ENDOCR METAB, V60, P673, DOI 10.1210/jcem-60-4-673; Colahan P.T., 1991, EQUINE MED SURG; DEUTSCH HF, 1957, AM J PHYSIOL, V191, P271, DOI 10.1152/ajplegacy.1957.191.2.271; DUHEM C, 1994, CLIN EXP IMMUNOL, V97, P79; FISCHER GW, 1994, CLIN EXP IMMUNOL, V97, P73; GROSSMAN ER, 1987, JAMA-J AM MED ASSOC, V259, P1016; JEFFCOTT LB, 1972, BIOL REV, V47, P439, DOI 10.1111/j.1469-185X.1972.tb01078.x; LEDERER J, 1980, REV ALCOOL, V26, P215; MCGUIRE TC, 1975, J AM VET MED ASSOC, V166, P71; MCGUIRE TC, 1976, J AM VET MED ASSOC, V169, P713; MENNELLA JA, 1993, DEV PSYCHOBIOL, V26, P459, DOI 10.1002/dev.420260804; MIKOTA SK, 1994, MED MANAGEMEN ELEPHA; OLSEN JH, 1994, J ZOO WILDLIFE MED, V25, P349; ROBERTS SJ, 1971, VET OBSTETRICS GENIT; SAWYER M, 1977, J AM VET MED ASSOC, V171, P1255; SHIDELER RK, 1987, P ANN C AM ASS EQ PR, P763; STICKLE JE, 1992, J ZOO WILDLIFE MED, V23, P245	18	11	11	0	7	AMER ASSOC Z00 VETERINARIANS	MEDIA	6 NORTH PENNELL ROAD, MEDIA, PA 19063	1042-7260			J ZOO WILDLIFE MED	J. Zoo Wildl. Med.	JUN	1996	27	2					255	258					4	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	UZ764	WOS:A1996UZ76400014					2022-02-06	
J	Sokol, DK; Ferguson, CF; Pitcher, GA; Huster, GA; FitzhughBell, K; Luerssen, TG				Sokol, DK; Ferguson, CF; Pitcher, GA; Huster, GA; FitzhughBell, K; Luerssen, TG			Behavioural adjustment and parental stress associated with closed head injury in children	BRAIN INJURY			English	Article							SEQUELAE; RELATIVES	Parental stress and parental perception of children's behavioural problems were determined for 25 caretakers of children with closed head injury. Compared to normative samples a greater proportion of parents in this study were more stressed, and thought that their children were more behaviourally impaired. In contrast to previous studies, injury severity was not related to behavioural impairment. Parental stress was related to perceived behavioural impairment for the brain-injured sample. When compared to low-stressed parents (n = 14), high-stressed parents (n = 11) described their children as more aggressive and with more thought disorders and attention problems. Time since injury, age at injury, number of siblings, and mother's age were not different between the high- and low-stressed groups. Low income and less education were associated with the high stress levels in these parents. Test-retest data showed that, over time, parents perceived their brain-injured children as less behaviourally impaired.	JAMES WHITCOMB RILEY HOSP CHILDREN,DEPT PEDIAT NEUROSURG,INDIANAPOLIS,IN 46202								ABIDIN RR, 1990, MANUAL PARENTING STR; ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CASEY R, 1987, PEDIATRICS, V80, P159; Fletcher J M, 1991, Brain Inj, V5, P337, DOI 10.3109/02699059109008106; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; HINKELDEY NS, 1990, BRAIN INJURY, V4, P114; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; WAALAND PK, 1993, BRAIN INJURY, V8, P135; Ylvisaker M., 1989, MILD MODERATE HEAD I, P203	21	11	11	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUN	1996	10	6					439	451		10.1080/026990596124296			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UR327	WOS:A1996UR32700004	8816097				2022-02-06	
J	ChathamShowalter, PE; Dubov, WE; Barr, MC; Rhodes, M; Sun, JM; Wasser, T				ChathamShowalter, PE; Dubov, WE; Barr, MC; Rhodes, M; Sun, JM; Wasser, T			Alcohol level at head injury and subsequent psychotropic treatment during trauma critical care	PSYCHOSOMATICS			English	Article; Proceedings Paper	150th Annual Meeting of the American-Psychiatric-Association	MAY 21-26, 1994	PHILADELPHIA, PA	Amer Psychiat Assoc			BRAIN INJURY; INTOXICATION; ABUSE	Alcohol intoxication at the time of traumatic brain injury (TBI) presents many complications for critical care treatment. This is the first reported data on psychotropic dosages administered to TBI patients in the critical care setting. In this study, the blood alcohol level (BAL)-positive patients (n = 14) tended to be older (P = 0.095), have lower admission Glascow Coma Scores (P = 0.031), and spent more days on respirators (P = 0.125) than the BAL-zero patients (n = 21). The BAL-positive group received more days of narcotics and benzodiazepines with markedly higher average daily doses, not statistically significant. These results are a basis for studying relationships between medication, treatment variables, and outcomes for TBI patients and then developing specific medication guidelines.	LEHIGH VALLEY HOSP,DEPT PSYCHIAT,ALLENTOWN,PA; LEHIGH VALLEY HOSP,DEPT PHYS MED REHABIL,ALLENTOWN,PA; LEHIGH VALLEY HOSP,DEPT PHARM,ALLENTOWN,PA; LEHIGH VALLEY HOSP,DEPT TRAUMA,ALLENTOWN,PA; LEHIGH VALLEY HOSP,DEPT RES,ALLENTOWN,PA								GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HAYES PE, 1993, PHARMACOTHERAPY, P1098; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; *MED EC COMP, 1993, DUR PHYS DESK REF, P1163; PORKORNY AD, 1972, AM J PSYCHIAT, V129, P342; *ROCH LAB, 1993, VERS DAT ROCH LAB; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; WATSON RR, 1986, ALCOHOL CLIN EXP RES, V10, P364, DOI 10.1111/j.1530-0277.1986.tb05108.x	9	11	11	0	2	AMER PSYCHIATRIC ASSOCIATION	WASHINGTON	1400 K ST NW, WASHINGTON, DC 20005	0033-3182			PSYCHOSOMATICS	Psychosomatics	MAY-JUN	1996	37	3					285	288		10.1016/S0033-3182(96)71567-0			4	Psychiatry; Psychology	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	UG788	WOS:A1996UG78800007	8849505				2022-02-06	
J	Copes, WS; Stark, MM; Lawnick, MM; Tepper, S; Wilkerson, D; DeJong, G; Brannon, R; Hamilton, BB				Copes, WS; Stark, MM; Lawnick, MM; Tepper, S; Wilkerson, D; DeJong, G; Brannon, R; Hamilton, BB			Linking data from national trauma and rehabilitation registries	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						trauma system; continuum of care; evaluation; data base	INJURY SEVERITY SCORE; MAJOR TRAUMA; CARE	Objective: To evaluate the feasibility of retrospectively creating a data base useful in trauma systems evaluations. Materials and Methods: Records for 375 patients in both the Major Trauma Outcome Study and the Uniform Data System for Medical Rehabilitation were linked to create an injury-through-rehabilitation data base, including patients from four impairment groups: traumatic brain injury (TBI); spinal cord injury-paraplegic complete (SCI-PARA) and quadriplegic complete (SCI-QUAD); and hip fracture ((HIP-FX). Measurements and Blain Results: The average ages (25.1 years SCI-QUAD, 72.6 years HIP-PX); Injury Severity Score (10.2 HIP-FX, 31.7 SCI-PARA); Revised Trauma Score (5.9 TBI, 7.8 HIP-FX); and acute care lengths of stay (13.3 days HIP-FX, 24.2 days TBI) varied substantially over the four groups, On average, patients spent from approximately 20 days (HIP-FX) to nearly 100 days (SCI-QUAD) in rehabilitation, Functional gains during rehabilitation were primarily in motor skills, but TBI patients also made substantial cognitive gains, Nearly 90% of TBI and SCI patients were discharged to their homes; the percentage of HIP-FX patients discharged to their homes, however, was lower (74%), Across all impairment groups, more patients lived with their relatives after rather than before injury, The correlation between a summary Major Trauma Outcome Study-Functional Independence Measure assessed at acute rare discharge and the complete Uniform Data System for medical Rehabilitation-Functional Independence Measure assessed on admission to rehabilitation was significant for all study patients and for each impairment group except SCT-PARA. Conclusions: Linking records to create the study data base was arduous and could not be practically accomplished on a large scale or on a continuing basis, Because of the growing emphases on trauma system evaluations and outcomes beyond survival at acute care discharge, we recommend the routine inclusion of rehabilitation data in hospital-based trauma registries.	WASHINGTON HOSP CTR,WASHINGTON,DC 20010; NATL REHABIL HOSP,RES CTR,WASHINGTON,DC; RES GRP,RALEIGH,NC		Copes, WS (corresponding author), TRIANALYT INC,BEL AIR,MD, USA.						APPLE DF, 1989, SPINAL CORD INJURY M; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CALES RH, 1985, JAMA-J AM MED ASSOC, V254, P1059, DOI 10.1001/jama.254.8.1059; CALES RH, 1984, ANN EMERG MED, V13, P15; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CHAMPION HR, 1992, ARCH SURG-CHICAGO, V127, P333; CHAMPION HR, 1989, AM J PUBLIC HEALTH, V79, P1278, DOI 10.2105/AJPH.79.9.1278; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; COPES WS, 1991, P ASS ADV AUT MED AN; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; EMHOFF TA, 1991, J TRAUMA, V31, P1227, DOI 10.1097/00005373-199109000-00005; FIEDLER R, 1993, UDS UPDATE, V7, P1; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GILLOTT AR, 1989, J TRAUMA, V29, P1667, DOI 10.1097/00005373-198912000-00015; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P33, DOI 10.1097/00002060-199302000-00008; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Hamilton BB, 1987, REHABILITATION OUTCO, P137; HEINEMAN AW, 1991, RATING SCALE ANAL FU; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; STINEMAN MG, 1993, ARCH PHYS MED REHAB, V74, P787, DOI 10.1016/0003-9993(93)90001-Q; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P857; 1989, ARCH PHYS MED REHAB, V70, P861; 1993, RESOURCES OPTIMAL CA; 1990, RESOURCES OPTIMAL CA	26	11	11	1	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1996	40	3					428	436		10.1097/00005373-199603000-00018			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	UA973	WOS:A1996UA97300019	8601862				2022-02-06	
J	Harris, JR				Harris, JR			Verbal rehearsal and memory in children with closed head injury: A quantitative and qualitative analysis	JOURNAL OF COMMUNICATION DISORDERS			English	Article							ADOLESCENTS; RECALL	Nine closed head injured (CHI) children (mean age = 11.4 years) with post-onset intervals of seven months to eight years were studied. The CHI children ranged from mild-moderate to severely impaired. Nine normally developing children (mean age = 10.9 years) served as controls. An overt rehearsal free recall task was used. Subjects were instructed to ''think aloud'' following presentation of each item to-be-recalled. Quantitative analyses suggested impaired verbal recall and inefficient, passive rehearsal strategy use in severely injured subjects. Mild-moderate subjects performed similarly to controls and exhibited active rehearsal strategy use. Qualitative analysis revealed differences between CHI subjects and controls' range of rehearsal strategies, monitoring and metamemory. Implications for clinical assessment and intervention with respect to use of rehearsal strategies are discussed.			Harris, JR (corresponding author), OHIO STATE UNIV,DEPT SPEECH & HEARING SCI,110 PRESSEY HALL,1070 CARMACK RD,COLUMBUS,OH 43210, USA.						ARNETT JA, 1986, PSYCHOL REP, V59, P315, DOI 10.2466/pr0.1986.59.1.315; Atkinson R. C., 1968, PSYCHOL LEARN MOTIV, V2, P89, DOI [10.1016/S0079-7421(08)60422-3., DOI 10.1016/S0079-7421(08)60422-3]; Baddeley A.D., 1986, WORKING MEMORY; BATTIG WF, 1969, J EXPT PSYCHOL MON 2, V80; BJORKLUND DF, 1988, J EXP CHILD PSYCHOL, V45, P71, DOI 10.1016/0022-0965(88)90051-3; Entwisle D. R., 1966, WORD ASS YOUNG CHILD; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; FLAVELL JH, 1985, COGNITIVE DEV; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; GUTTENTAG RE, 1987, COGNITIVE DEV, V2, P307, DOI 10.1016/S0885-2014(87)80010-2; HARRIS JR, 1993, UNPUB SCHEMATIC ORG; HAUT MW, 1991, BRAIN COGNITION, V17, P31, DOI 10.1016/0278-2626(91)90064-F; KELLAS G, 1975, J EXP CHILD PSYCHOL, V19, P51, DOI 10.1016/0022-0965(75)90148-4; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; MATEER CA, 1992, SEMINARS SPEECH LANG, V13, P239; MCGILLY K, 1989, CHILD DEV, V60, P172, DOI 10.1111/j.1467-8624.1989.tb02707.x; ORNSTEIN PA, 1977, DEV PSYCHOL, V13, P15, DOI 10.1037/0012-1649.13.1.15; ORNSTEIN PA, 1978, MEMORY ORG STRUCTURE; ORNSTEIN PA, 1975, CHILD DEV, V26, P818; Palermo D. S., 1964, WORD ASS NORMS GRADE; POSNANSKY CJ, 1978, BEHAV RES METH INSTR, V10, P819, DOI 10.3758/BF03205407; Pressley Michael, 1993, Seminars in Speech and Language, V14, P1, DOI 10.1055/s-2008-1064155; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; TEASDALE G, 1974, LANCET, V2, P81; Thorndike EL, 1963, TEACHERS WORD BOOK 3; YLVISAKER M, 1985, HEAD INJURY REHABILI, P311	29	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0021-9924			J COMMUN DISORD	J. Commun. Disord.	MAR-APR	1996	29	2					79	93		10.1016/0021-9924(94)00035-2			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	UF913	WOS:A1996UF91300001	9157177				2022-02-06	
J	Anderson, SI; Wilson, CL; McDowell, IP; Pentland, B; Gray, JM; Robertson, IH				Anderson, SI; Wilson, CL; McDowell, IP; Pentland, B; Gray, JM; Robertson, IH			Late rehabilitation for closed head injury: A follow-up study of patients 1 year from time of discharge	BRAIN INJURY			English	Article							RELATIVES VIEW	Subsequent to the setting up of an outpatient psychological service for head-injured patients, 50 patients were interviewed a year from the time of their discharge from our neurorehabilitation unit. The problems which persisted at this stage are presented and discussed. Some of the difficulties encountered in the evaluation of rehabilitation effects are identified. We conclude that: (1) there is a desperate need in the UK for more long-term support and rehabilitation services for this group of patients and (2) it is essential that such services are carefully monitored and evaluated despite the difficulties involved.	ASTLEY AINSLIE HOSP,EDINBURGH EH9 2HL,MIDLOTHIAN,SCOTLAND; WESTERN GEN HOSP,DEPT CLIN NEUROSCI,EDINBURGH,MIDLOTHIAN,SCOTLAND; NEWCASTLE GEN HOSP,REG NEUROSCI CTR,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND; MRC,APPL PSYCHOL UNIT,CAMBRIDGE,ENGLAND					Robertson, Ian H/0000-0001-8637-561X			AFFLECK JW, 1988, LANCET, V1, P230; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROTHERTON FA, 1989, ARCH PHYSICAL MED RE, V69, P827; GOLDBERG DP, 1974, PSYCHOL MED, V6, P565; HENDERSON EJ, 1990, CLIN REHABIL, V4, P167; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1979, NURS MIRROR, V1, P30; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; *MED DIS SOC, 1988, MAN TRAUM BRAIN INJ; ODDY M, 1989, CLIN REHABIL, V3, P253; Pentland B, 1990, Int Disabil Stud, V12, P86; PENTLAND B, 1988, BRIT J NEUROSURGERY, V2, P601; ROBERTSON I, 1990, APHASIOLOGY, V4, P381, DOI 10.1080/02687039008249090; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wood R. L., 1987, BRAIN INJURY REHABIL; [No title captured]; 1986, J ROYAL COLL PHYSICI, V20, P161; 1982, LANCET, V2, P1034	21	11	11	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1996	10	2					115	124		10.1080/026990596124601			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UB726	WOS:A1996UB72600005	8696311				2022-02-06	
J	Demaree, HA; Harrison, DW				Demaree, HA; Harrison, DW			Case study: Topographical brain mapping in hostility following mild closed head injury	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						brain mapping; closed head injury; hostility; QEEG; self-awareness	AMBULATORY BLOOD-PRESSURE; CARDIOVASCULAR REACTIVITY; EMOTIONAL EXPRESSION; ASYMMETRY; LESIONS; MEN	Previous research suggests that right frontal and temporal lobe arousal may inhibit and elicit hostility, respectively. For example, emotional lability (including rage) has resulted from lesion of the bulbar motor nuclei, and neocortical upper motor neurons in particular (Lieberman & Benson, 1977). Ablation of hypothalamic sites has resulted in sham rage (Flynn, Cummings & Tomiyasu, 1988; Sachdev, Smith, Matheson & Last, 1992; Tonkonogy & Geller, 1992) suggesting that these frontal pathways may inhibit hostility. In the present study, a patient with hostility management problems secondary to closed head injury from a motor vehicle accident was evaluated using topographical brain mapping and quantitative electroencephalograph (QEEG) techniques. Comparisons of beta magnitude were performed between frontal and temporal sites at the right and left cerebrums. The results support the contention of an oppositional anterior to posterior mediation of hostility. The present electroencephalagraphic research supports the predominant neuropsychological theory that the right orbital-frontal region inhibits the right amygdaloid bodies, thereby decreasing hostility level (Kolb & Wishaw, 1990).	VIRGINIA POLYTECH INST & STATE UNIV,DEPT PSYCHOL,BLACKSBURG,VA 24061					Demaree, Heath/0000-0001-9655-8882			BROWN JASON W., 1967, BRAIN RES, V5, P1, DOI 10.1016/0006-8993(67)90215-6; BUTTER CM, 1970, J COMP PHYSIOL PSYCH, V72, P132, DOI 10.1037/h0029303; CONTU RC, 1966, J NEUROSURG, V24, P1024; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; DECSI L, 1974, NEUROPHARMACOLOGY, V13, P1153, DOI 10.1016/0028-3908(74)90065-3; DEMAREE HA, 1996, UNPUB PHYSL NEUROPSY; EVERHART E, 1996, UNPUB DELUSIONS SPAC; FLYNN FG, 1989, BEHAV NEUROL, V1, P49; JAMNER LD, 1991, PSYCHOSOM MED, V53, P393, DOI 10.1097/00006842-199107000-00005; KALAT JW, 1992, BIOL PSYCHOL; KOLB B, 1990, HUMAN NEUROPSYCHOLOG; KRYNICKI VE, 1978, J NERV MENT DIS, V166, P59, DOI 10.1097/00005053-197801000-00009; LIEBERMAN A, 1977, ARCH NEUROL-CHICAGO, V34, P717, DOI 10.1001/archneur.1977.00500230087017; LU CL, 1992, BRAIN RES, V581, P123, DOI 10.1016/0006-8993(92)90351-9; MOYER KE, 1987, VIOLENCE AGGRESSION; NAGY J, 1973, NEUROPHARMACOLOGY, V12, P757, DOI 10.1016/0028-3908(73)90016-6; PANKSEPP J, 1982, BEHAV BRAIN SCI, V5, P407, DOI 10.1017/S0140525X00012759; SACHDEV P, 1992, AUST NZ J PSYCHIAT, V26, P671, DOI 10.3109/00048679209072105; SACKEIM HA, 1978, SCIENCE, V202, P434, DOI 10.1126/science.705335; SCHNEIDER RH, 1989, PSYCHOSOM MED, V51, P290, DOI 10.1097/00006842-198905000-00004; SIEGMAN AW, 1992, J BEHAV MED, V15, P257, DOI 10.1007/BF00845355; SMITH TW, 1984, MOTIV EMOTION, V15, P232; Starkstein S. E., 1991, FRONTAL LOBE FUNCTIO; TONKONOGY JM, 1992, J NEUROPSYCH CLIN N, V4, P45; WEIDNER G, 1989, PSYCHOSOM MED, V51, P36, DOI 10.1097/00006842-198901000-00004; WITTLING W, 1990, NEUROPSYCHOLOGIA, V28, P457, DOI 10.1016/0028-3932(90)90072-V	26	11	11	0	0	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD PO BOX 90, READING, BERKS, ENGLAND RG1 8JL	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		1996	87	1-2					97	101		10.3109/00207459608990757			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	VQ435	WOS:A1996VQ43500009	8913823				2022-02-06	
J	Saveland, H; Uski, T; Sjoholm, H; Sonesson, B; Brandt, L				Saveland, H; Uski, T; Sjoholm, H; Sonesson, B; Brandt, L			SPECT with technetium-99m-HMPAO in relation to late cognitive outcome after surgery for ruptured cerebral aneurysms	ACTA NEUROCHIRURGICA			English	Article						aneurysmal subarachnoid haemorrhage; surgery; SPECT; cognitive outcome	CLOSED-HEAD-INJURY; ANTERIOR COMMUNICATING ARTERY; SUBARACHNOID HEMORRHAGE; EARLY OPERATION; BLOOD-FLOW; DEFICITS; IMPAIRMENT; ADJUSTMENT; SEQUELAE; MEMORY	Fifteen patients with a good neurological outcome after aneurysmal SAH and surgery were collected prospectively. Six months after surgery neurological examination and a SPECT study for evaluation of the three dimensional CBF distribution as well as an extensive neuropsychological test were performed. In all patients with pathological SPECT findings the location of the reduced regional CBF correlated with the location of the ruptured aneurysm and/or side of surgical approach. The volume of the brain tissue with reduced rCBF showed a great variety, from 9-112 cm(3) (mean: 33 cm(3)). Similarly, the maximum flow reduction in the affected areas also varied considerably from 17-95% (mean: 39%). In general, the neuropsychological functioning of the patients post SAH was favourable. Seven individuals had a presumably normal neuropsychological appearance with respect to estimates of premorbid levels of functioning. Another four patients were slightly impaired and the remaining four were moderately affected. Only in five cases did the location of SPECT pathology and the site of neuropsychological impairment appear to coincide, whereas this was not the case in the remaining 10 patients. In general, the extent of SPECT pathology did not differ in the three neuropsychological outcome groups (normal, slight and moderate disability).	UNIV LUND HOSP,DEPT CLIN NEUROPHYSIOL,S-22185 LUND,SWEDEN; UNIV LUND HOSP,DEPT PSYCHIAT,S-22185 LUND,SWEDEN		Saveland, H (corresponding author), UNIV LUND HOSP,DEPT NEUROSURG,S-22185 LUND,SWEDEN.						BENTON AL, 1974, CLIN EXPT APPLICATIO, P1; BORNSTEIN RA, 1987, NEUROSURGERY, V21, P651, DOI 10.1227/00006123-198711000-00008; CRONHOLM B, 1957, ACTA PSYCH NEUROL, V32, P280, DOI 10.1111/j.1600-0447.1957.tb09467.x; DESANTIS A, 1989, J NEUROL NEUROSUR PS, V52, P1123; DUREMAN I, 1971, MANUAL DS BATTERY, P1; FISHER CM, 1980, NEUROSURGERY, V6, P11; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Graham FK, 1960, PERCEPT MOTOR SKILL, V11, P147, DOI DOI 10.2466/PMS.11.6.147-188; HARDEMARK HG, 1989, ACTA NEUROCHIR, V99, P135, DOI 10.1007/BF01402322; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; HUTTER BO, 1992, ACTA NEUROCHIR, V116, P6, DOI 10.1007/BF01541247; HUTTER BO, 1993, NEUROSURGERY, V33, P999; ICHISE M, 1994, J NUCL MED, V35, P217; Larsson C, 1989, BRIT J NEUROSURG, V3, P549, DOI 10.3109/02688698909002846; LJUNGGREN B, 1985, J NEUROSURG, V62, P673, DOI 10.3171/jns.1985.62.5.0673; LJUNGGREN B, 1983, NEUROSURGERY, V12, P525, DOI 10.1227/00006123-198305000-00008; MAURICEWILLIAMS RS, 1991, J NEUROL NEUROSUR PS, V54, P335, DOI 10.1136/jnnp.54.4.335; MCKENNA P, 1989, NEUROSURGERY, V24, P361, DOI 10.1227/00006123-198903000-00009; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; REITAN RM, 1966, CAN PSYCHOLOG-PSYCHO, VA  7, P368, DOI 10.1037/h0083114; Rey A, 1959, TEST COPIE FIGURE CO; ROMNER B, 1989, NEUROSURGERY, V25, P390, DOI 10.1227/00006123-198909000-00012; ROPER SN, 1991, J NUCL MED, V32, P1684; SAVELAND H, 1992, J NEUROSURG, V76, P729, DOI 10.3171/jns.1992.76.5.0729; SAVELAND H, 1986, J NEUROSURG, V64, P191, DOI 10.3171/jns.1986.64.2.0191; SONESSON B, 1987, NEUROSURGERY, V21, P279, DOI 10.1227/00006123-198709000-00001; STENHOUSE LM, 1991, J NEUROL NEUROSUR PS, V54, P909, DOI 10.1136/jnnp.54.10.909; VILKKI J, 1989, NEUROSURGERY, V25, P166, DOI 10.1227/00006123-198908000-00003; Wechsler D., 1958, MEASUREMENT APPRAISA; Wechsler D., 1945, WECHSLER MEMORY SCAL; WITELSON SF, 1992, NEUROLOGY, V42, P709, DOI 10.1212/WNL.42.4.709	33	11	12	0	2	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1996	138	3					301	307		10.1007/BF01411741			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UB183	WOS:A1996UB18300014	8861699				2022-02-06	
J	BLUMBERGER, J; SULLIVAN, SJ; CLEMENT, N				BLUMBERGER, J; SULLIVAN, SJ; CLEMENT, N			DIADOCHOKINETIC RATE IN PERSONS WITH TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article							HEAD-INJURY; SPEECH; DYSARTHRIA; RECOVERY	This study examined diadochokinetic rate (DR) performance in a group of 28 traumatically brain injured (TBI) patients and their matched controls for 16 different articulatory positions in order to determine which articulatory positions distinguished between the two groups. Discriminant function analysis determined (p = 0.000) four variables ('ta','ba','da' and 'ch') as resulting in the successful classification of 82.2% of the subjects. This implies that this subset of variables is adequate for determining DR in this population. The test-retest reliability (ICC) was also established in a group of 12 subjects and their matched controls. The ICCs ranged from 0.12 to 0.93 for the TBI subjects with 13 of 16 variables > 0.60.	INST READAPTAT MONTREAL,CTR RECH,MONTREAL,PQ H3S 2J4,CANADA; INST READAPTAT MONTREAL,SERV ORTHOPHONIE,MONTREAL,PQ H3S 2J4,CANADA; CONCORDIA UNIV,DEPT EXERCISE SCI,MONTREAL,PQ,CANADA; UNIV MONTREAL,ECOLE READAPTAT,MONTREAL,PQ H3C 3J7,CANADA; UNIV MONTREAL,ECOLE ORTHOPHONIE & AUDIOL,MONTREAL,PQ H3C 3J7,CANADA								CANTER GJ, 1965, J SPEECH HEAR DISORD, V30, P217, DOI 10.1044/jshd.3003.217; Chenery H.J., 1990, AUST J HUMAN COMMUN, V18, p19 ; Dongilli P, 1992, J HEAD TRAUMA REHAB, V7, P91; DWORKIN JP, 1980, J SPEECH HEAR RES, V23, P828, DOI 10.1044/jshr.2304.828; ENDERBY P, 1990, BRIT J DISORD COMMUN, V25, P341; GANDOUR J, 1992, BRAIN LANG, V42, P337, DOI 10.1016/0093-934X(92)90105-N; KENT RD, 1987, J SPEECH HEAR DISORD, V52, P367, DOI 10.1044/jshd.5204.367; KONDRASKE G V, 1990, Journal of Clinical Engineering, V15, P467; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; Ludlow C., 1984, DYSARTHRIAS PHYSL AC, P163; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; PORTNOY RA, 1982, J SPEECH HEAR DISORD, V47, P324, DOI 10.1044/jshd.4703.324; Sarno M, 1985, SPEECH LANGUAGE EVAL, P323; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; THEODORAS D, BRAIN INJURY, V9, P237; THEODOROS D, 1993, BRAIN INJURY, V7, P59, DOI 10.3109/02699059309008157; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; TIFFANY WR, 1980, J SPEECH HEAR RES, V23, P894, DOI 10.1044/jshr.2304.894; ZIEGLER W, 1988, BRIT J DISORD COMMUN, V23, P215	19	11	11	0	0	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV-DEC	1995	9	8					797	804		10.3109/02699059509008235			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	TH499	WOS:A1995TH49900004	8605512				2022-02-06	
J	TAYLOR, JS				TAYLOR, JS			NEUROLAW - TOWARDS A NEW MEDICAL JURISPRUDENCE	BRAIN INJURY			English	Article								Traumatic brain injuries and spinal cord injuries occur in a variety of accidents which may become the subject of civil litigation. A new field of medical jurisprudence, called neurolaw, is emerging to join health-care professionals and attorneys in a common quest to employ legal remedies to enhance the quality of life for individuals with neurological injury and their families. Presented here is a review of the underpinnings of this developing area of inquiry.			TAYLOR, JS (corresponding author), TAYLOR HARP & CALLIER,POB 2645,COLUMBUS,GA 31902, USA.						BRAITHWAITE B, 1992, NEW LAW J        JUL, P942; BRAITHWAITE B, 1994, PERSONAL INJURY LAW, V1, P330; BROOKS N, 1982, CLOSED HEAD INJURY P, P123; BUSH DS, 1993, DEFENSE COUNSEL J, V60, P122; COPE DN, 1994, INST RES BN, P201; GOODALL P, 1994, J HEAD TRAUMA REHAB, V9, P61; HEILBRONNER RL, 1994, ANAL UNDERSTANDING P, P65; JENNETT B, 1982, CLOSED HEAD INJURY P, P37; KOLPAN KI, 1989, J HEAT TRAUMA REHABI, V4, P95; LITVAK SB, 1993, ARIZONA TRIAL LA DEC, P1; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; Mohr James C., 1993, DOCTORS LAW MED JURI, P3; OMENN GS, 1994, ENVIRON HEALTH PERSP, V102, P674, DOI 10.2307/3432196; ROBERTS AC, 1991, LITIGATING HEAD TRAU; ROTHENBERG MA, 1994, EMERGENCY MED MALPRA; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; Taylor John G., 1991, INSURANCE SETTLE WIN, P21; TAYLOR JS, 1992, NEUROLAW LETT, V1, P4; TAYLOR JS, 1994, EMERGENCY MED MALPRA, P465; TAYLOR JS, 1994, PERSONAL INJURY LAW, V1, P314; TAYLOR JS, 1991, LITIGATING HEAD TRAU; TAYLOR JS, 1994, IE MAGAZINE, V2, P12; TAYLOR JS, 1993, J HEAD INJURY, V3, P54; TAYLOR JS, 1991, NEUROLAW LETT, V1, P1; TAYLOR JS, 1993, REV FRANCAISE DOMMAG, V19, P149; TAYLOR JS, 1993, NEUROLAW LETT, V2, P4; TAYLOR JS, 1994, VIEWPOINTS, V28, P2; TAYLOR JS, 1994, INTEGRATING COMMUNIT, pH17; TAYLOR JS, 1994, PERSONAL INJURY LAW, V1, P205; TAYLOR S, 1991, J ANXIETY DISORD, V5, P293, DOI 10.1016/0887-6185(91)90030-W; WEED RO, 1994, REHABILITATION CONSU, pB12; 1993, ACQUIRED BRAIN INJUR; 1993, ORTHOPAEDIC MED TEST; 1992, 3RD ANN SEM HELD NEW; 1994, CODE MED ETHICS CURR; [No title captured]; 1994, NATIONAL DIRECTORY H; 1989, QUALIFICATIONS GUIDE; 1995, NEUROLAW COMPREHENSI; NEUROLAW LETT; 1993, NATIONAL DIRECTORY L; 1994, 4TH C STUD TRAUM BRA; 1994, MARTINDALE HUBBELL R	43	11	11	0	5	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1995	9	7					745	751		10.3109/02699059509008230			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	RZ814	WOS:A1995RZ81400007	8680401				2022-02-06	
J	MASANA, Y; YOSHIMINE, T; FUJITA, T; MARUNO, M; KUMURA, E; HAYAKAWA, T				MASANA, Y; YOSHIMINE, T; FUJITA, T; MARUNO, M; KUMURA, E; HAYAKAWA, T			REACTION OF MICROGLIAL CELLS AND MACROPHAGES AFTER CORTICAL INCISION IN RATS - EFFECT OF A SYNTHESIZED FREE-RADICAL SCAVENGER,(+/-)-N,N'-PROPYLENEDINICOTINAMIDE (AVS)	NEUROSCIENCE RESEARCH			English	Article						OXYGEN FREE RADICAL; TRAUMATIC BRAIN INJURY; MICROGLIAL CELL; MACROPHAGE; EDI; (+/-)-N,N'-PROPYLENEDINICOTINAMIDE (AVS)	CENTRAL NERVOUS-SYSTEM; BRAIN MACROPHAGES; ORIGIN; INJURY; ADULT	Reactive microglial cells and macrophages appear after trauma to the brain. To investigate the accumulation patterns of reactive microgial cells and macrophages after cortical incision, these cells were stained immunohistochemically with anti-EDl antibody in the brain sections before and 1, 3, 5, and 7 days after incision. And to ascertain the participation of oxygen free radicals in these cellular reactions, a synthesized free radical scavenger, (+/-)-N,N'-propylenedinicotinamide (AVS) was administered in this model. Rats were administered AVS (300 mg/kg, i.p.) 30 min before, 2.5 h and every 24 h after incision (AVS group), while only saline was administered in the same manner as a control (saline group). In the saline group, both reactive microglial cells and macrophages had already appeared on day 1 post-incision. The former continued to increase in number during the following days, whereas the latter increased in number up to day 3 and thereafter decreased. Both the numbers of reactive microglial cells and macrophages were significantly decreased (P < 0.05) in the AVS group on days 5 and 7. The results suggest the participation of oxygen free radicals in the reaction of microglial cells and macrophages in traumatic brain injury.			MASANA, Y (corresponding author), OSAKA UNIV,SCH MED,DEPT NEUROSURG,2-2 YAMADAOKA,SUITA,OSAKA 565,JAPAN.						Asano T, 1984, Neurol Res, V6, P163; ASANO T, 1984, Neurological Research, V6, P49; BAUER J, 1994, J NEUROSCI RES, V38, P365, DOI 10.1002/jnr.490380402; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; COLTON CA, 1987, FEBS LETT, V223, P284, DOI 10.1016/0014-5793(87)80305-8; GEHRMANN J, 1993, BRAIN PATHOL, V3, P11, DOI 10.1111/j.1750-3639.1993.tb00720.x; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GLENN JA, 1992, J ANAT, V180, P109; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; JORDAN FL, 1988, BRAIN RES REV, V13, P165, DOI 10.1016/0165-0173(88)90019-7; KAUR C, 1987, J ANAT, V154, P215; KOIDE T, 1985, J NEUROCHEM, V44, P85, DOI 10.1111/j.1471-4159.1985.tb07116.x; KOIDE T, 1983, 11TH P S DRUGS ACT S, P121; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; NAKAJIMA K, 1993, NEUROSCI RES, V17, P187, DOI 10.1016/0168-0102(93)90047-T; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; PIANI D, 1994, NEWS PHYSIOL SCI, V9, P80; SCHELPER RL, 1986, J NEUROPATH EXP NEUR, V45, P1, DOI 10.1097/00005072-198601000-00001; SMINIA T, 1987, IMMUNOBIOLOGY, V174, P43, DOI 10.1016/S0171-2985(87)80083-9; STEVENS A, 1993, J NEUROL SCI, V118, P117, DOI 10.1016/0022-510X(93)90100-D; STOLL G, 1989, J NEUROSCI, V9, P2327; THOMAS WE, 1992, BRAIN RES REV, V17, P61; WATANABE T, 1988, J NEUROCHEM, V4, P1145	25	11	11	0	0	ELSEVIER SCI PUBL IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0168-0102			NEUROSCI RES	Neurosci. Res.	SEP	1995	23	2					217	221		10.1016/0168-0102(95)00936-N			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RX055	WOS:A1995RX05500008	8532218				2022-02-06	
J	NUSHOLTZ, GS; WYLIE, EB; GLASCOE, LG				NUSHOLTZ, GS; WYLIE, EB; GLASCOE, LG			INTERNAL CAVITATION IN SIMPLE HEAD IMPACT MODEL	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Head Injury 1994 - International Symposium on Head Injury Research	OCT 12-14, 1994	WASHINGTON, DC	Natl Highway Traff Safety Adm, Head Injury Res Program, George Washington Univ		2-DIMENSIONAL COMPUTATIONAL MODEL; CAVITATION; TRAUMATIC BRAIN INJURY		A two-dimensional computational model is used to evaluate the potential for cavitation to occur inside the brain material during head impact. The model represents a simple water-fined 14-cm-diameter, S-cm-deep cylinder, For the purpose of our study, this cylinder represents the skull while the water inside the cylinder represents the brain material. To ensure that the stress predicted by the model is realistic, it has been calibrated against experimental data, When the cylinder is struck by a free-flying mass cavitation is initiated at the boundary opposite impact, Significant vaporous regions may develop at the boundary, while only limited vaporization occurs internally, Higher accelerations, or an additional loading of the domain by a constant acceleration perpendicular to impact, adds to the likelihood and to the severity of internal cavitation, This indicates that preexisting conditions or complex loading conditions of the head during an impact event may affect the cavitation response, Such conditions could be the result of angular velocity, angular accelerations, or head accelerations as a result of neck loading.	UNIV MICHIGAN,DEPT CIVIL & ENVIRONM ENGN,ANN ARBOR,MI 48109		NUSHOLTZ, GS (corresponding author), CHRYSLER MOTOR CORP,800 CHRYSLER DR E,CIMS 483-05-10,AUBURN HILLS,MI 48326, USA.						BENEDICT JV, 1970, BIOMECHANICS HUMAN F; HENKE R, 1980, THESIS U MICHIGAN; Knapp R.T., 1970, CAVITATION; LUBACK P, 1988, J BIOMECH, V13, P1041; NUSHOLTZ GS, 1984, 28TH P STAPP CAR CRA; NUSHOLTZ GS, 1986, 30TH P STAPP CAR CRA, P237; NUSHOLTZ GS, 1995, AVIAT SPACE ENV MED, V66; NUSHOLTZ GS, 1994, 14TH ESV C MUN; NUSHOLTZ GS, 1987, AVIAT SPACE ENV MED, V88, P9; STALNAKER RL, 1977, 21ST STAPP CAR CRASH, P303; Wylie E.B., 1993, FLUID TRANSIENTS; WYLIE EB, 1980, J FLUID ENG-T ASME, V102, P203, DOI 10.1115/1.3240646; WYLIE EB, 1984, J FLUID ENG-T ASME, V106, P227, DOI 10.1115/1.3243107	13	11	11	0	12	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1995	12	4					707	714		10.1089/neu.1995.12.707			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RY920	WOS:A1995RY92000022	8683622				2022-02-06	
J	ZHOU, YL; RICCIO, DC				ZHOU, YL; RICCIO, DC			CONCUSSION-INDUCED RETROGRADE-AMNESIA IN RATS	PHYSIOLOGY & BEHAVIOR			English	Article						RATS; MEMORY; AMNESIA; CONCUSSION; HEAD INJURY; PASSIVE AVOIDANCE; RETRIEVAL PROCESSES	TRAUMATIC BRAIN INJURY; EXPERIMENTAL CEREBRAL CONCUSSION; LIGHT MICROSCOPIC RESPONSE; HEAD-INJURY; NEURONAL SOMATA; MEMORY; RETRIEVAL; DENDRITES; BREAKDOWN; PROTEIN	Three experiments were conducted to investigate the characteristics of retrograde amnesia (RA) induced by concussion in rats. In Experiment 1, rats receiving experimental concussion shortly after training in a single punishment trial exhibited severe forgetting on a retention test 48 h later. In the second experiment, rats receiving a concussion within 6 h after training showed severe RA, while those receiving concussion one day to five days after training exhibited progressively weaker amnesia. In Experiment 3, amnesic animals in one group received pretest noncontingent foot shock as a reminder treatment. This pretest cue significantly increased the cross-through latency, thus indicating a reduction in the memory deficit resulting from concussion. These results suggest that experimental concussion can be an effective method to induce retrograde memory loss in rats; that the RA caused by concussion is time-dependent; and that concussion-induced RA can be alleviated by a pretest cue,indicating that the underlying mechanism of concussion-induced RA is more likely to be a retrieval deficit than a consolidation failure.	KENT STATE UNIV,DEPT PSYCHOL,KENT,OH 44242						NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R37MH037535, R01MH037535] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [NIMH 37535] Funding Source: Medline		BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BENSON DF, 1967, J NEUROL NEUROSUR PS, V30, P539, DOI 10.1136/jnnp.30.6.539; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DEWEER B, 1980, ANIM LEARN BEHAV, V8, P265, DOI 10.3758/BF03199605; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DUNCAN CP, 1949, J COMP PHYSIOL PSYCH, V42, P32, DOI 10.1037/h0058173; GALLYAS F, 1992, ACTA NEUROPATHOL, V83, P394, DOI 10.1007/BF00713531; GALLYAS F, 1992, ACTA NEUROPATHOL, V83, P386, DOI 10.1007/BF00713530; GOLD PE, 1974, PSYCHOL REV, V8, P465; Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAYES R L, 1988, Society for Neuroscience Abstracts, V14, P1153; HINDERLITER CF, 1975, ANIM LEARN BEHAV, V3, P257, DOI 10.3758/BF03213441; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; KLEIN SB, 1972, J COMP PHYSIOL PSYCH, V79, P341, DOI 10.1037/h0032809; KMIECIAKKOLADA K, 1987, POL J PHARMACOL PHAR, V39, P47; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; MIAZAKI S, 1989, INTRACRANIAL PRESSUR, V7, P651; MILLER RR, 1973, PSYCHOL REV, V80, P69, DOI 10.1037/h0033897; MISANIN JR, 1979, PHYSIOL PSYCHOL, V7, P339; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; OMMAYA A K, 1971, International Journal of Neuroscience, V1, P371, DOI 10.3109/00207457109146986; PAOLINO RM, 1966, J COMP PHYSIOL PSYCH, V62, P270, DOI 10.1037/h0023676; QUARTERMAIN D, 1988, PHYSIOL BEHAV, V43, P239, DOI 10.1016/0031-9384(88)90245-4; RABINOWITZ VC, 1992, 25TH INT C PSYCH BRU; RICCIO DC, 1984, PHYSIOL PSYCHOL, V12, P59; RICCIO DC, 1968, J COMP PHYSIOL PSYCH, V66, P618, DOI 10.1037/h0026530; Russell WR, 1935, LANCET, V2, P762; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Sasaki M, 1993, Nihon Ika Daigaku Zasshi, V60, P215; SECHZER JA, 1992, 25TH INT C PSYHC BRU; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; SHAW NA, 1985, PHYSIOL BEHAV, V35, P637, DOI 10.1016/0031-9384(85)90154-4; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Shohami E., 1992, Journal of Basic and Clinical Physiology and Pharmacology, V3, P99; Spear N.E, 1978, PROCESSING MEMORIES; SPEAR NE, 1976, CODING PROCESSES ANI; SPEAR NE, 1993, PHENOMENA PRINCIPLE; SQUIRE LR, 1984, BEHAV NEUROSCI, V98, P345, DOI 10.1037/0735-7044.98.2.345; SULLIVAN HG, 1976, J NEUROSURG, V45, P52; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; WILSON B, 1987, REHABILITATION MEMOR; ZHOU YL, UNPUB CONCUSSION RAT; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	48	11	13	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	JUN	1995	57	6					1107	1115		10.1016/0031-9384(95)00019-F			9	Psychology, Biological; Behavioral Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	QY764	WOS:A1995QY76400015	7652031				2022-02-06	
J	WILLIAMS, J; HAUT, JS				WILLIAMS, J; HAUT, JS			DIFFERENTIAL PERFORMANCES ON THE WRAML IN CHILDREN AND ADOLESCENTS DIAGNOSED WITH EPILEPSY, HEAD-INJURY, AND SUBSTANCE-ABUSE	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							MEMORY	Assessment of memory in children and adolescents has been limited because of the lack of standardized instruments available. The recently released Wide Range Assessment of Memory and Learning (WRAML; Sheslow & Adams, 1990) was used in this exploratory study to examine memory skills in children and adolescents with conditions affecting neuropsychological functioning. Diagnostic categories included epilepsy, traumatic brain injury, and substance abuse, as well as a nonneurological comparison group with psychiatric disturbance. Results indicated that children with epilepsy scored significantly below those with substance abuse or psychiatric disorders on the Verbal Memory Index. Within-group comparisons suggested that all clinical groups had more difficulty with tasks that purportedly measure auditory attentional skills. Children with epilepsy demonstrated greater variability in memory performances, suggesting possible problems with both attention and memory factors. The WRAML appears to be a potentially useful assessment tool in the measurement of memory processes in children, although further research is needed concerning subtest specificity.	W VIRGINIA UNIV,SCH MED,DEPT BEHAV MED & PSYCHIAT,MORGANTOWN,WV 26506		WILLIAMS, J (corresponding author), UNIV ARKANSAS MED SCI HOSP,DEPT PEDIAT,800 MARSHALL ST,LITTLE ROCK,AR 72202, USA.						ADAMS W, 1991, AUG ANN M AM PSYCH A; ALDENKAMP AP, 1990, EPILEPSIA, V31, pS9, DOI 10.1111/j.1528-1157.1990.tb05874.x; BLENNOW G, 1990, EPILEPSIA, V31, pS50, DOI 10.1111/j.1528-1157.1990.tb05871.x; BOLTER JF, 1986, CHILD NEUROPSYCHOL, V2, P59; BURTON DB, 1993, 21ST ANN M INT NEUR; CALLAHAN TSA, 1993, 101ST ANN M AM PSYCH; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; COHEN M, 1992, BRAIN COGNITION, V20, P315, DOI 10.1016/0278-2626(92)90024-G; DAM M, 1990, EPILEPSIA, V31, pS26, DOI 10.1111/j.1528-1157.1990.tb05866.x; ELLIOT RW, 1989, HDB CLIN CHILD NEURO, P311; Frey, 1994, Adolesc Med, V5, P311; GIOIA GA, 1991, 19TH ANN M INT NEUR; HAUT JS, 1992, 20TH ANN M INT NEUR; HAUT JS, 1992, 12TH ANN M NAT AC NE; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; KASTELEIJNNOLST.DG, 1990, DEV MED CHILD NEUROL, V32, P46; KRULL KR, 1994, 22ND ANN M INT NEUR; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; NOBLE EP, 1987, J SUBST ABUSE TREAT, V4, P145; Osborn RG, 1990, BEHAV DISORDERS, V16, P32; POGGE DL, 1992, J ABNORM CHILD PSYCH, V20, P151, DOI 10.1007/BF00916546; REYNOLDS EH, 1983, EPILEPSIA, V24, pS85, DOI 10.1111/j.1528-1157.1983.tb04651.x; Sheslow D., 1990, WIDE RANGE ASSESSMEN; WASSERMAN JD, 1992, UNDERSTANDING TRAUMA, V7	24	11	11	0	1	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262	8756-5641			DEV NEUROPSYCHOL	Dev. Neuropsychol.		1995	11	2					201	213		10.1080/87565649509540613			13	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	RM650	WOS:A1995RM65000003					2022-02-06	
J	SUN, FY; FADEN, AI				SUN, FY; FADEN, AI			HIGH-AFFINITY AND LOW-AFFINITY NMDA RECEPTOR-BINDING SITES IN RAT SPINAL-CORD - EFFECTS OF TRAUMATIC INJURY	BRAIN RESEARCH			English	Article						NMDA RECEPTOR; RECEPTOR-BINDING; [H-3] MK801; SPINAL CORD INJURY; TRAUMA	D-ASPARTATE RECEPTOR; BRAIN INJURY; AMINO-ACIDS; GLUTAMATE; MK-801; <H-3>MK-801; ISCHEMIA	N-methyl-D-aspartate (NMDA) receptor-mediated events hade been implicated in the pathophysiology of posttraumatic spinal. cord injury. In the present study, [H-3]MK801 was used to analyse the changes in NMDA receptor-binding sites in rat spinal cord after impact trauma at T9. In contrast to brain, which showed only a single binding site, spinal cord showed both high-affinity (K-d1 = 0.47 +/- 0.24 nM) and low-affinity (K-d2 = 7.75 +/- 1.82 nM) binding sites with relatively low binding density (B-max1 = 0.11 +/- 0.04 pmol/mg protein and B-max2 = 0.84 +/- 0.11 pmol/mg protein). Time-course studies demonstrated significant decreases in the binding of [H-3]MK801 at the thoracic and lumbar segments at 4 h after spinal cord injury with recovery by 24 h. Scatchard analyses indicate that these changes likely involve bath high- and low-affinity binding sites. The transitory reduction in [H-3]MK801-binding after trauma may reflect downregulation of NMDA receptors as a consequence of posttraumatic glutamate release and may serve to limit excitotoxin-induced injury.	GEORGETOWN UNIV,SCH MED,DEPT NEUROL,WASHINGTON,DC 20007; GEORGETOWN UNIV,SCH MED,DEPT PHARMACOL,WASHINGTON,DC 20007						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027849] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS27849] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR 306634] Funding Source: Medline		ARAM J, 1986, British Journal of Pharmacology, V89, p778P; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; FADEN AI, 1986, NEUROLOGY, V36, P723, DOI 10.1212/WNL.36.5.723; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FADEN AI, 1988, J NEUROTRAUM, V5, P27; GILL R, 1988, NEUROSCIENCE, V25, P847, DOI 10.1016/0306-4522(88)90040-1; GONZALEZ DL, 1993, NEUROSCI LETT, V151, P134, DOI 10.1016/0304-3940(93)90004-5; HENLEY JM, 1993, NEUROPHARMACOLOGY, V32, P37, DOI 10.1016/0028-3908(93)90127-O; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KRUMINS SA, 1986, ANN NEUROL, V19, P498, DOI 10.1002/ana.410190514; LEACH MJ, 1993, STROKE, V24, P1063, DOI 10.1161/01.STR.24.7.1063; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MELDRUM B, 1990, CEREBROVAS BRAIN MET, V2, P25; MELDRUM BS, 1992, BRAIN RES, V59, P1; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; RANSOM RW, 1988, J NEUROCHEM, V51, P830, DOI 10.1111/j.1471-4159.1988.tb01818.x; REYNOLDS IJ, 1991, J NEUROCHEM, V56, P1731, DOI 10.1111/j.1471-4159.1991.tb02074.x; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHAW PJ, 1991, BRAIN RES, V539, P164, DOI 10.1016/0006-8993(91)90701-V; VINK R, 1989, ANN NEUROL, V25, P26, DOI 10.1002/ana.410250105; WILLIAMS K, 1989, MOL PHARMACOL, V36, P575; WONG EHF, 1988, J NEUROCHEM, V50, P274, DOI 10.1111/j.1471-4159.1988.tb13260.x; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	28	11	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	DEC 12	1994	666	1					88	92		10.1016/0006-8993(94)90285-2			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PV595	WOS:A1994PV59500010	7889371				2022-02-06	
J	DALEO, G; BRAMANTI, P; SILVESTRI, R; SALTUARI, L; GERSTENBRAND, F; DIPERRI, R				DALEO, G; BRAMANTI, P; SILVESTRI, R; SALTUARI, L; GERSTENBRAND, F; DIPERRI, R			SLEEP SPINDLES IN THE INITIAL-STAGES OF THE VEGETATIVE STATE	ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						SLEEP; SPINDLES; VEGETATIVE STATE	PROGNOSTIC VALUE; COMA	The aim of this study was to look for the presence of spindling in the different stages of remission of the vegetative state to underline all possible correlations with lesional sites, severity of coma and final outcome. The nocturnal polygraphic recordings from 30 patients were examined: 20 (15M, 5F, mean age 31.7 years, range 16-41) had originally suffered a traumatic brain injury, 10 (4M, 6F, mean age 40.5 years, range 24-48) had hypoxic brain lesions. Evidence of spindling, always reduced in density and duration, was found in 44% of these patients, prevalently in the traumatic patients (53.3% versus 30% of hypoxic patients). No subjects in the full stage 0, 0-1 of the vegetative state (apallic syndrome) presented spindling. No significant correlation was found between spindling and the following parameters: gender, the time between the onset of coma and the polygraphic recording, or the site of the lesion.	UNIV INNSBRUCK, NEUROL CLIN, A-6020 INNSBRUCK, AUSTRIA; UNIV MESSINA, NEUROL CLIN 1, MESSINA, ITALY		DALEO, G (corresponding author), UNIV MESSINA, CTR STUDIO & TRATTAMENTO NEUROL LUNGODEGENTI, CATTEDRA NEUROFISIOPATOL, I-98124 MESSINA, ITALY.						ANGELERI F, 1990, DIENCEPHALON AND SLEEP, P77; CHATRIAN GE, 1963, ELECTROEN CLIN NEURO, V15, P272, DOI 10.1016/0013-4694(63)90096-8; DOSSI RC, 1992, J PHYSIOL-LONDON, V447, P215, DOI 10.1113/jphysiol.1992.sp018999; Gerstenbrand F., 1967, TRAUMATISCHE APALLIS; HANSOTIA P, 1981, NEUROLOGY, V31, P83, DOI 10.1212/WNL.31.1.83; Rechtschaffen A., 1968, MANUAL STANDARDIZED; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P420, DOI 10.1016/0013-4694(83)90224-9; Stockard JJBRG, 1975, HDB CLIN NEUROLOGY, V23, P217; [No title captured]; [No title captured]	10	11	12	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0392-0461			ITAL J NEUROL SCI	Ital. J. Neurol. Sci.	OCT	1994	15	7					347	351		10.1007/BF02339931			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU513	WOS:A1994PU51300003	7698892				2022-02-06	
J	SILVER, JM; YUDOFSKY, SC				SILVER, JM; YUDOFSKY, SC			PSYCHOPHARMACOLOGICAL APPROACHES TO THE PATIENT WITH AFFECTIVE AND PSYCHOTIC FEATURES	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						AFFECTIVE DISORDERS; PSYCHOPHARMACOLOGY; PSYCHOSIS; TRAUMATIC BRAIN INJURY	CLOSED HEAD-INJURY; NEUROLEPTIC MALIGNANT SYNDROME; TRAUMATIC BRAIN INJURY; TARDIVE-DYSKINESIA; FOLLOW-UP; PARKINSONS-DISEASE; SOCIAL-ADJUSTMENT; DEPRESSION; FLUOXETINE; SCHIZOPHRENIA	Affective and psychotic disorders may occur after traumatic brain injury. These symptoms may arise from the direct effect of the trauma on the brain, from the side effects or withdrawal from drugs and medications, and from the emotional reaction to the event. Patients with TBI are especially sensitive to the side effects of drugs that act on the central nervous system. When appropriate guidelines are followed, psychopharmacological intervention alleviates these symptoms, enhances rehabilitation, and avoids impairment of arousal and attention.	COLUMBIA UNIV,COLL PHYS & SURG,NEW YORK,NY; BAYLOR COLL MED,DEPT PSYCHIAT & BEHAV SCI,HOUSTON,TX		SILVER, JM (corresponding author), COLUMBIA PRESBYTERIAN MED CTR,NEW YORK,NY 10032, USA.						BAREGGI SR, 1975, EUR NEUROL, V13, P528, DOI 10.1159/000114709; BERMAN KF, 1988, ARCH GEN PSYCHIAT, V45, P616; BESSETTE RF, 1992, PSYCHOSOMATICS, V33, P224, DOI 10.1016/S0033-3182(92)72001-5; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROOKS N, 1990, REHABILITATION ADULT; CASSIDY JW, 1989, J HEAD TRAUMA REHAB, V4, P67; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; DAVIDSON J, 1989, J CLIN PSYCHIAT, V50, P256; Davison K, 1969, BRIT J PSYCHIATRY SP, V4, P113; DESMET Y, 1982, J NEUROL NEUROSUR PS, V45, P1161, DOI 10.1136/jnnp.45.12.1161; DUBOIS B, 1990, ANN NEUROL, V28, P117, DOI 10.1002/ana.410280202; DUBOVSKY SL, 1992, AM PSYCHIATRIC PRESS; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GARYFALLOS G, 1988, ACTA PSYCHIAT SCAND, V78, P87, DOI 10.1111/j.1600-0447.1988.tb06305.x; GLAZER WM, 1984, ARCH GEN PSYCHIAT, V41, P623; GRIMSLEY SR, 1991, CLIN PHARMACOL THER, V50, P10, DOI 10.1038/clpt.1991.98; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hillbom E., 1960, ACTA PSYCHIATRICA S, VS142, P1; Hsiao John K., 1987, Convuls Ther, V3, P121; JALIL P, 1992, J NEUROL NEUROSUR PS, V55, P414; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kass F, 1990, J Neuropsychiatry Clin Neurosci, V2, P15; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; LAUTERBACH EC, 1991, J CLIN PSYCHOPHARM, V11, P392, DOI 10.1097/00004714-199112000-00021; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVINE R, 1994, J CLIN PSYCHOPHARM, V14, P145, DOI 10.1097/00004714-199404000-00011; LIEBERMAN JA, 1989, J CLIN PSYCHIAT, V50, P329; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MCKENNA PJ, 1985, AM J PSYCHIAT, V142, P895; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; MORRISON JH, 1979, SCIENCE, V205, P313, DOI 10.1126/science.451605; NASRALLAH HA, 1981, PSYCHOSOMATICS, V22, P359; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; OJEMANN LM, 1987, NEUROLOGY, V37, P1525, DOI 10.1212/WNL.37.9.1525; OLIVER AP, 1982, ARCH GEN PSYCHIAT, V39, P206; Panzer MJ, 1992, J GERIATR PSYCHIAT, V4, P195; PINDER RM, 1977, DRUGS, V13, P321, DOI 10.2165/00003495-197713050-00001; PORTA M, 1975, EUR NEUROL, V13, P545, DOI 10.1159/000114710; ROBINSON RG, 1994, NEUROPSYCHIATRY TRAU; ROSEBUSH P, 1989, AM J PSYCHIAT, V146, P717; ROSEBUSH PI, 1991, BRIT J PSYCHIAT, V159, P709, DOI 10.1192/bjp.159.5.709; ROSS ED, 1981, ARCH GEN PSYCHIAT, V38, P1344; ROSS ED, 1987, J NERV MENT DIS, V176, P165; RUTHERFORD WH, 1977, LANCET, V1, P1; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; SCHIFFER RB, 1985, NEW ENGL J MED, V312, P1480, DOI 10.1056/NEJM198506063122303; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; SELIGER G M, 1992, Brain Injury, V6, P267, DOI 10.3109/02699059209029668; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; SILVER JM, 1990, J CLIN PSYCHIAT, V51, P33; SILVER JM, 1994, AM PSYCHIATRIC PRESS; SILVER JM, 1993, 146TH ANN M AM PSYCH; Silver JM., 1994, NEUROPSYCHIATRY TRAU; SLOAN R L, 1992, Brain Injury, V6, P315, DOI 10.3109/02699059209034945; Smeltzer D., 1994, NEUROPSYCHIATRY TRAU; SOVNER R, 1991, J CLIN PSYCHOPHARM, V11, P389, DOI 10.1097/00004714-199112000-00018; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; VANWOERKOM TCAM, 1977, LANCET, V1, P812; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; VECHT CJ, 1975, ARCH NEUROL-CHICAGO, V32, P792, DOI 10.1001/archneur.1975.00490540036004; VINCENT FM, 1986, NEUROSURGERY, V18, P190, DOI 10.1227/00006123-198602000-00013; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; WOLF B, 1989, COMPR PSYCHIAT, V30, P534, DOI 10.1016/0010-440X(89)90084-9; WROBLEWSKI BA, 1990, J CLIN PSYCHOPHARM, V10, P124, DOI 10.1097/00004714-199004000-00009; YASSA R, 1984, PSYCHOSOMATICS, V25, P852, DOI 10.1016/S0033-3182(84)72946-X; YASSA R, 1984, PSYCHOSOMATICS, V25, P135, DOI 10.1016/S0033-3182(84)73083-0; ZIMMER B, 1992, 145TH ANN M AM PSYCH; 1985, AM J PSYCHIAT, V142, P155	71	11	11	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP	1994	9	3					61	77		10.1097/00001199-199409000-00006			17	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QD376	WOS:A1994QD37600006					2022-02-06	
J	MACNIVEN, E				MACNIVEN, E			INCREASED PREVALENCE OF LEFT-HANDEDNESS IN VICTIMS OF HEAD TRAUMA	BRAIN INJURY			English	Article							INJURY; ABILITY; HAND	Compared to a historical control group, an increased prevalence of left hand preference was found in a population of patients having traumatic brain injuries. The data support the hypothesis that left-handed individuals may be more likely to experience accidents, particularly those involving motor vehicles. There are also implications for prediction of outcome after head trauma.	MCGILL UNIV,MONTREAL H3A 2T5,QUEBEC,CANADA								ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; Bryden M., 1982, LATERALITY FUNCTIONA; COOPER PR, 1982, HEAD INJURY, P1; COREN S, 1989, AM J PUBLIC HEALTH, V79, P1040, DOI 10.2105/AJPH.79.8.1040; COREN S, 1991, PSYCHOL BULL, V109, P90, DOI 10.1037/0033-2909.109.1.90; ELLIS SJ, 1988, CORTEX, V24, P157, DOI 10.1016/S0010-9452(88)80025-X; HAY RK, 1967, CAN MED ASSOC J, V97, P1364; HECAEN H, 1979, BEHAV BRAIN SCI, V2, P503, DOI 10.1017/S0140525X00064050; KLONOFF H, 1969, CAN MED ASSOC J, V100, P235; LANSKY LM, 1988, NEUROPSYCHOLOGIA, V26, P564; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; MACNIVEN E, 1993, MAY CAN PSYCH ASS AN; MILLER E, 1971, BRIT J PSYCHOL, V62, P111, DOI 10.1111/j.2044-8295.1971.tb02018.x; PARKINSON D, 1985, CAN J SURG, V28, P79; Porac C, 1981, LATERAL PREFERENCES, DOI DOI 10.1007/978-1-4613-8139-6; Rasmussen T, 1977, Ann N Y Acad Sci, V299, P355, DOI 10.1111/j.1749-6632.1977.tb41921.x; REITAN RM, 1973, NEUROPSYCHOLOGY HDB, P134; SANDERS B, 1982, CORTEX, V18, P79, DOI 10.1016/S0010-9452(82)80020-8; SARNO J E, 1971, Archives of Physical Medicine and Rehabilitation, V52, P73; SATZ P, 1980, NEUROPSYCHOLOGY LEFT, P189; SNOW WG, 1988, CAN J SURG, V31, P191; SPRINGER SP, 1989, RIGHT BRAIN LEFT BRA; STRICH SJ, 1961, LANCET, V2, P443; SUBIRANA A, 1958, BRAIN, V81, P415, DOI 10.1093/brain/81.3.415; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; YEN WM, 1975, BEHAV GENET, V5, P281, DOI 10.1007/BF01066180	26	11	11	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1994	8	5					457	462		10.3109/02699059409150997			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	NW122	WOS:A1994NW12200007	7951208				2022-02-06	
J	FISHER, JM; WILLIAMS, AD				FISHER, JM; WILLIAMS, AD			NEUROPSYCHOLOGIC INVESTIGATION OF MILD HEAD-INJURY - ENSURING DIAGNOSTIC-ACCURACY IN THE ASSESSMENT PROCESS	SEMINARS IN NEUROLOGY			English	Article							CONCUSSION; SYMPTOMS; TESTS; SEQUELAE; DEFICITS		PEPPERDINE UNIV,GRAD SCH EDUC & PSYCHOL,IRVINE,CA; UNIV ROCHESTER,SCH MED & DENT,DEPT NEUROL,ROCHESTER,NY 14642								Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; ALVES W, 1992, REHABILITATION POSTC, P21; Anastasi A., 1988, PSYCHOL TESTING; [Anonymous], 1990, STRUCTURED CLIN INTE; Armstrong CL, 1987, NEUROPSYCHOLOGY, V1, P15; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Barth J. T., 1986, J HEAD TRAUMA REHAB, V1, P63; BERROL S, 1992, REHABILITATION POST, P1; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; CICERONE K, 1992, REHABILITATION POST, P129; CRIPE LI, 1989, REHABIL PSYCHOL, V34, P93; DAVIDOFF DA, 1988, COGNITIVE REHABILITA, V6, P8; DIAMOND R, 1988, INT J CLIN NEUROPSYC, V10, P35; DICKER BG, 1992, J HEAD TRAUMA REHAB, V7, P83; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Evans R W, 1987, Tex Med, V83, P49; FLORHENRY P, 1983, NEUROPSYCHOLOGY HUMA, P193; GASS C, 1991, J CLIN PSYCHOL, V47, P101; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GREENE RL, 1988, MMPI USE SPECIFIC PO; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; HAYES R, 1992, REHABILITATION POST, P9; Heaton RK, 1991, COMPREHENSIVE NORMS; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; KANE R L, 1991, Neuropsychology Review, V2, P281, DOI 10.1007/BF01108849; KAY T, 1992, REHABILITATION POST, P109; KAY T, 1986, MINOR HEAD INJURY IN; KEYSER D, TEST CRITIQUES; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEININGER B, 1992, REHABILITATION POST, P169; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MACCIOCCHI S, 1988, J HEAD TRAUMA REHABI, V3, P1; MCCAFFREY R, 1993, IN PRESS J HEAD TRAU; MCCAFFREY R, UNPUB FORENSIC NEURO; MCMILLAN TM, 1985, J NEUROL NEUROSUR PS, V48, P847, DOI 10.1136/jnnp.48.8.847-b; MIDDELBOE T, 1992, J PERS DISORD, V6, P246, DOI 10.1521/pedi.1992.6.3.246; MITCHELL J, MENTAL MEASUREMENTS; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; MUTTER SA, 1990, COGNITIVE NEUROPSYCH, V7, P329, DOI 10.1080/02643299008253447; NEWMAN B, 1992, NEW YORK U MED CTR R, V4, P3; NYLANDER I, 1988, ACTA PAEDIATR SCAND, V77, P475, DOI 10.1111/j.1651-2227.1988.tb10685.x; ONORATO VA, 1987, INT J CLIN NEUROPSYC, V9, P125; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; Reitan R.M., 1993, HALSTEADREITAN NEURO; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; SHEWAN CM, 1980, J SPEECH HEAR DISORD, V45, P308, DOI 10.1044/jshd.4503.308; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; TRIMBLE MR, 1981, POST TRAUMATIC NEURO; WILKINSON HA, 1991, J NEUROL NEUROSUR PS, V54, P846; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILLIAMS JM, 1991, MEMORY ASSESSMENT SC; 1985, STANDARDS ED PSYCHOL; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253; 1993, STRUCTURED CLIN ASSE; 1989, PSYCHIATRIC DIAGNOST	63	11	11	0	0	THIEME MEDICAL PUBL INC	NEW YORK	381 PARK AVE SOUTH, NEW YORK, NY 10016	0271-8235			SEMIN NEUROL	Semin. Neurol.	MAR	1994	14	1					53	59		10.1055/s-2008-1041059			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NE151	WOS:A1994NE15100010	8029560				2022-02-06	
J	SCHMOKER, JD; JING, Z; SHACKFORD, SR; PIETROPAOLI, J				SCHMOKER, JD; JING, Z; SHACKFORD, SR; PIETROPAOLI, J			EFFECT OF LESION VOLUME ON CEREBRAL HEMODYNAMICS AFTER FOCAL BRAIN INJURY AND SHOCK	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							SEVERE HEAD-INJURIES; BLOOD-FLOW; INTRACRANIAL-PRESSURE; METABOLISM; EDEMA; FLUID; ICP; CSF	Cerebral blood flow (CBF) varies unpredictably in patients after head injury and hemorrhagic shock. Proper treatment requires knowledge of ischemic versus hyperemic flow. The degree to which the size or severity of the injury may contribute to CBF abnormalities is unknown. We hypothesized that lesion size is a determinant of postinjury CBF. We measured cerebral and systemic variables in a porcine model of focal cryogenic brain injury and hemorrhagic shock over a 5-hour period. Swine were randomized to receive either a large or small lesion followed by hemorrhage. In the small lesion group traumatic brain injury, followed by shock and resuscitation, produced a significant and sustained elevation in bihemispheric regional CBF and cerebral oxygen delivery that was significantly greater than that observed in either the large lesion group or the controls (p < 0.05). There were no significant differences between the experimental groups in volume of hemorrhage, intracranial pressure, cerebral perfusion pressure, arterial oxygen content, or PaCO2. These data suggest that the volume of injured tissue may determine post-resuscitation CBF, and that interventions to reduce cerebral blood volume (i.e., hyperventilation) may not be universally applicable in all head injured patients.	UNIV VERMONT, COLL MED, DEPT SURG, BURLINGTON, VT 05405 USA						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NINDS ROI NS27061-02] Funding Source: Medline; DS NIH HHS [NINDS P2ONS30324-02] Funding Source: Medline		Barie Philip S., 1992, Journal of Trauma, V33, P148, DOI 10.1097/00005373-199207000-00029; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLASEN RA, 1953, SURG GYNECOL OBSTET, V96, P605; ELLIS EF, 1988, AM J PHYSIOL, V255, pH397, DOI 10.1152/ajpheart.1988.255.2.H397; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; Gennarelli T.A., 1985, CENTRAL NERVOUS SYST, P391; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HERRMANN HD, 1972, EXP NEUROL, V34, P115, DOI 10.1016/0014-4886(72)90192-6; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MARMAROU A, 1991, CENTRAL NERVOUS SYST, pS327; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; NELSON SR, 1971, J APPL PHYSIOL, V30, P268, DOI 10.1152/jappl.1971.30.2.268; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; Pasztor E, 1973, STROKE, V4, P556, DOI 10.1161/01.STR.4.4.556; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; SCHMOKER JD, 1992, CIRC SHOCK, V37, P13; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SHIGENO T, 1982, J NEUROSURG, V57, P99, DOI 10.3171/jns.1982.57.1.0099; WALD S, 1991, Journal of Trauma, V31, P1041, DOI 10.1097/00005373-199107000-00102; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; Ward JD, 1989, INTRACRANIAL PRESSUR, P630; YOUNG W, 1980, STROKE, V11, P552, DOI 10.1161/01.STR.11.5.552	32	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	1993	35	4					627	636					10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	MD998	WOS:A1993MD99800020	8411289				2022-02-06	
J	SCHERZER, BP; CHARBONNEAU, S; SOLOMON, CR; LEPORE, F				SCHERZER, BP; CHARBONNEAU, S; SOLOMON, CR; LEPORE, F			ABSTRACT THINKING FOLLOWING SEVERE TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article								Abstract abilities were studied in a sample of 34 individuals with severe TBI and a control group. The results indicate that TBI interferes with performance on tests requiring individuals to process information into new categories. There appears to be a dissociation between verbal abstract abilities and visual-perceptual abstract abilities. There is evidence that Goldstein and Sheerer's [1] postulate of a general 'abstract attitude' was at least partially correct. This attitude does not appear to be related to a general verbal ideational process, as dysphasic subjects were only deficient on a purely verbal abstract task.	CTR RECH,INST READAPTAT,MONTREAL H3S 2J4,PQ,CANADA; UNIV MONTREAL,MONTREAL H3C 3J7,QUEBEC,CANADA; CTR FELDENKREIS,MONTREAL,PQ,CANADA		SCHERZER, BP (corresponding author), UNIV QUEBEC,DEPT PSYCHOL,CP 8888,SUCCURSALE A,MONTREAL H3C 3P8,QUEBEC,CANADA.						BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BENTON AL, 1965, MANUAL TEST RETENTIO; BEST JB, 1986, COGNITIVE PSYCHOL, P369; BIGLER ED, 1981, CLIN NEUROPSYCHOLOGY, V111, P13; De Renzi E., 1966, CORTEX, V2, P399, DOI [10.1016/S0010-9452(66)80017-5, DOI 10.1016/S0010-9452(66)80017-5]; DOEHRING DG, 1962, PERCEPT MOTOR SKILL, V14, P27; FOGEL ML, 1965, J GEN PSYCHOL, V72, P269, DOI 10.1080/00221309.1965.9710697; Golden CJ, 1978, DIAGNOSIS REHABILITA; Goldstein Gerald, 1990, Clin Neuropsychol, V4, P3, DOI 10.1080/13854049008401492; Goldstein K., 1942, AFTEREFFECTS BRAIN I; Goldstein K. H., 1936, J NEUROL PSYCHOPATH, V10, P586; GOLSTEIN KH, 1941, PSYCHOL MONOGRAPHS, V53; GOTT P S, 1973, Cortex, V9, P266; Halstead W.C., 1947, BRAIN INTELLIGENCE; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MCFIE J, 1952, J MENT SCI, V98, P299, DOI 10.1192/bjp.98.411.299; RAPAPORT D, 1968, DIAGNOSTIC PSYCHOL T; Raven J. C., 1960, GUIDE STANDARD PROGR; REITAN TM, 1962, ANNU REV PSYCHOL, V13, P415; Rey A., 1964, EXAMEN CLIN PSYCHOL; RUSSO M, 1967, CORTEX, V3, P113; SMITH A, 1969, NEUROLOGY, V19, P442, DOI 10.1212/WNL.19.5.442; SMITH A, 1975, ADV NEUROLOGY, V7; SMITH HB, 1973, AM J OCCUP THER, V27, P244; TEUBER HL, 1956, ARCH NEURO PSYCHIATR, V76, P369, DOI 10.1001/archneurpsyc.1956.02330280027003; UZZELL BP, 1979, CORTEX, V15, P391, DOI 10.1016/S0010-9452(79)80066-0; VACHON J, 1968, TEST VACHON LECTURE; VIGOTSKY LS, 1962, THOUGHT LANGUAGE, P52; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Weigl E, 1941, J ABNORM SOC PSYCH, V36, P3, DOI 10.1037/h0055544; ZAIDEL E, 1981, CORTEX, V17, P167, DOI 10.1016/S0010-9452(81)80039-1; [No title captured]; [No title captured]; 1979, REHABILITATION MONOG, V61	35	11	11	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	SEP-OCT	1993	7	5					411	423		10.3109/02699059309029684			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MA172	WOS:A1993MA17200004	8401483				2022-02-06	
J	MANARY, MJ; HOLLIFIELD, WC				MANARY, MJ; HOLLIFIELD, WC			CHILDHOOD SLEDDING INJURIES IN 1990-91	PEDIATRIC EMERGENCY CARE			English	Article						SLEDDING INJURIES; SLEDS; CPSC		Sledding injuries are a common wintertime problem. To better characterize these injuries, three analyses were done: a retrospective chart review of all injured sledders at St. Louis Children's Hospital (SLCH) in the winter of 1990-91, a review of Consumer Product Safety Commission (CPSC) injury data for 1990, and measurements of sledding speeds. Analyses of the SLCH data and the CPSC data yielded similar results. Younger children incur more head injuries, while older children incur more extremity injuries. The SLCH data indicate that most injuries occur close to home when a sledder strikes a fixed object in his path. Velocities of 10 to 20 mph may be easily achieved. Injury prevention includes appropriate selection of sledding site, use of protective clothing, and refraining from sledding at times of highest risk.			MANARY, MJ (corresponding author), WASHINGTON UNIV,ST LOUIS CHILDRENS HOSP,SCH MED,DEPT PEDIAT,400 S KINGSHIGHWAY,ST LOUIS,MO 63110, USA.			Manary, Mark/0000-0003-2733-9568				0	11	11	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	JUN	1993	9	3					155	158		10.1097/00006565-199306000-00011			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	LG664	WOS:A1993LG66400010	8346090				2022-02-06	
J	NETZ, J; HOMBERG, V				NETZ, J; HOMBERG, V			INTACT CONDUCTION OF FASTEST CORTICOSPINAL EFFERENTS IS NOT SUFFICIENT FOR NORMAL VOLUNTARY MUSCLE STRENGTH - TRANSCRANIAL MOTOR CORTEX STIMULATION IN PATIENTS WITH TETRAPLEGIA	NEUROSCIENCE LETTERS			English	Article						TRANSCRANIAL MAGNETIC STIMULATION; UPPER MOTOR NEURON; PYRAMIDAL TRACT; EXTRAPYRAMIDAL PATHWAY; TETRAPARESIS; VOLUNTARY MOVEMENT	MULTIPLE-SCLEROSIS; BRAIN IRON; NEURON; ABNORMALITIES	In six patients with chronic severe tetraparesis, caused by closed head injury (3 cases), basilar thrombosis (2 cases) or global hypoxia (1 case), responses of suprathreshold transcranial magnetic stimulation of motor cortex to thenar and abductor hallucis muscles on both sides were studied. Results showed in most patients normal thresholds and latencies (17 out of 24 latencies within normal +/- 2 S.D., 20 thresholds within normal +/- 1 S.D.) and amplitudes of even higher than normal values. Latencies or thresholds did not correlate with severity of pareses and were in marked contrast to the severe pareses of the muscles under investigation. Despite different etiology CT-scans showed diffuse atrophy of cerebral white matter as a common finding. It is concluded that intact descending corticospinal motor pathways are a necessary but not a sufficient condition for voluntary motor function.	HEINRICH HEINE UNIV,CTR NEUROL THERAPY,HOHENSANDWEG 37,W-4000 DUSSELDORF 13,GERMANY								ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1984, GREENFIELDS NEUROPAT, P85; ASANUMA H, 1975, PHYSIOL REV, V55, P143, DOI 10.1152/physrev.1975.55.2.143; BERARDELLI A, 1987, J NEUROL NEUROSUR PS, V50, P861, DOI 10.1136/jnnp.50.7.861; BUCY PC, 1964, J NEUROSURG, V21, P385, DOI 10.3171/jns.1964.21.5.0385; BUCY PC, 1966, J NEUROSURG, V25, P1, DOI 10.3171/jns.1966.25.1.0001; COWAN JMA, 1984, LANCET, V2, P304; CRCEVIC N, 1977, APALLIC SYNDROME, P109; DIMITRIJEVIC MR, 1988, NONINVASIVE STIMULAT, P243; DRAYER B, 1986, AM J ROENTGENOL, V147, P103, DOI 10.2214/ajr.147.1.103; EYRE JA, 1989, J PHYSIOL-LONDON, V414, pP9; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GUNNARELLI TA, 1982, ANN NEUROL, V12, P564; HOMBERG V, 1991, ELECTROEN CLIN NEURO, V81, P377, DOI 10.1016/0168-5597(91)90027-U; INGRAM DA, 1987, J NEUROL NEUROSUR PS, V50, P159, DOI 10.1136/jnnp.50.2.159; INGRAM DA, 1988, J NEUROL NEUROSUR PS, V51, P487, DOI 10.1136/jnnp.51.4.487; MASUR H, 1990, 32 JAHR DTSCH EEG GE; MULLER K, 1992, ELECTROEN CLIN NEURO, V85, P86, DOI 10.1016/0168-5597(92)90073-K; NETZ J, 1989, 23 JAHR DTSCH GES NE; PHILLIPS CG, 1977, MONOGR PHYSL SOC LON, V34, P77; RUTLEDGE JN, 1987, AM J ROENTGENOL, V149, P365, DOI 10.2214/ajr.149.2.365; THOMPSON PD, 1987, J NEUROL SCI, V80, P91, DOI 10.1016/0022-510X(87)90224-3; ULE G, 1977, APALLIC SYNDROME, P104	23	11	11	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	OCT 26	1992	146	1					29	32		10.1016/0304-3940(92)90164-3			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JW568	WOS:A1992JW56800008	1475046				2022-02-06	
J	YOSHIDA, K; BURTON, GF; YOUNG, H; ELLIS, EF				YOSHIDA, K; BURTON, GF; YOUNG, H; ELLIS, EF			BRAIN LEVELS OF POLYETHYLENE GLYCOL-CONJUGATED SUPEROXIDE-DISMUTASE FOLLOWING FLUID PERCUSSION BRAIN INJURY IN RATS	JOURNAL OF NEUROTRAUMA			English	Article							CATALASE; EDEMA	Polyethylene glycol-conjugated superoxide dismutase (PEG-SOD) is being explored as an agent to reduce oxygen radical-mediated damage following brain injury. Yet little is known concerning the site of action of IV-administered PEG-SOD or the capacity of this conjugated enzyme to enter the brain. The purpose of this study was to determine the brain content of PEG-SOD in normal and fluid percussion injured rats. The fluid percussion device was attached over the right parietal cortex and a moderate (2.0 atm) intensity injury was produced. PEG-SOD was conjugated with I-125 and given (2000 U/kg, 5-mu-Ci/kg) to rats either 30 min before or 30 min after brain injury. Another group received [I-125]PEG-SOD but was not injured. Plasma and left and right brain hemispheres were counted for [I-125]PEG-SOD. Plasma levels of [I-125]PEG-SOD declined similarly in all three groups during the 90-min period after IV administration. Brain [I-125]PEG-SOD was low in control animals (0.034 U/g wet wt). In animals given PEG-SOD after injury the brain level was elevated sixfold in both the left and right hemispheres, compared to control. In rats given the drug before injury, [I-125]PEG-SOD was 10 times control level in the right hemisphere, which is the side on which the injury device is attached, and 6 times control level in the left hemisphere. We conclude that traumatic brain injury produces an increase in brain PEG-SOD. The exact cellular site of the increased brain PEG-SOD remains to be clarified.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MICROBIOL & IMMUNOL,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,RICHMOND,VA 23298						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS27214, NS12587] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587, R01NS027214] Funding Source: NIH RePORTER		BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; CAPRO JD, 1978, METHOD ENZYMOL, V53, P382; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; FADEN AI, 1987, CLIN NEUROPHARMACOL, V10, P193, DOI 10.1097/00002826-198706000-00001; HALL ED, 1988, OXYGEN RADICALS TISS, P92; HAUN SE, 1991, STROKE, V22, P655, DOI 10.1161/01.STR.22.5.655; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MEANS ED, 1987, HDB SPINAL CORD, V5, P19; ODLIND B, 1988, PHARMACOL TOXICOL, V62, P95, DOI 10.1111/j.1600-0773.1988.tb01853.x; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185, DOI 10.1152/jappl.1991.71.4.1185; TURRENS JF, 1984, J CLIN INVEST, V73, P87, DOI 10.1172/JCI111210; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; YOSHIDA K, 1992, STROKE, V23, P865, DOI 10.1161/01.STR.23.6.865; ZHANG XM, 1991, STROKE, V22, P489, DOI 10.1161/01.STR.22.4.489	21	11	11	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	SUM	1992	9	2					85	92		10.1089/neu.1992.9.85			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JL725	WOS:A1992JL72500002	1404439				2022-02-06	
J	DEWEY, CW; BUDSBERG, SC; OLIVER, JE				DEWEY, CW; BUDSBERG, SC; OLIVER, JE			PRINCIPLES OF HEAD TRAUMA MANAGEMENT IN DOGS AND CATS .1.	COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN			English	Article								Injury to the brain in dogs and cats is a medical and sometimes surgical emergency. Of great importance in the treatment of head-injured animals is preservation of vital brain stem structures. Before a thorough assessment of the patient's neurologic status and subsequent therapy for brain injury, the trauma patient must be evaluated for other life-threatening injuries and stabilized, if necessary. Brain trauma can be classified as concussion, contusion, or laceration injuries. Brain hemorrhage and edema occur immediately after the traumatic insult, and secondary inflammatory processes perpetuate brain edema and ischemia. The secondary inflammatory mediators in concert with blood gas aberrations in the brain vasculature contribute to successive elevations of intracranial pressure. Accurate assessment and recording of the patient's neurologic status soon after arrival at the emergency room are important for guiding therapy, monitoring progress or deterioration, and making prognostic decisions.			DEWEY, CW (corresponding author), UNIV GEORGIA,COLL VET MED,DEPT SMALL ANIM MED,ATHENS,GA 30602, USA.							0	11	12	0	8	VETERINARY LEARNING SYSTEMS	TRENTON	425 PHILLIPS BLVD #100, TRENTON, NJ 08618	0193-1903			COMP CONT EDUC PRACT	Compend. Contin. Educ. Pract. Vet.	FEB	1992	14	2					199	&					0	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	HD423	WOS:A1992HD42300006					2022-02-06	
J	Maxwell, WL; Irvine, A; Watt, C; Graham, DI; Adams, JH; Gennarelli, TA				Maxwell, William L.; Irvine, Alyson; Watt, Christine; Graham, David I.; Adams, J. Hume; Gennarelli, Thomas A.			The Microvascular Response to Stretch Injury in the Adult Guinea Pig Visual System	JOURNAL OF NEUROTRAUMA			English	Article								In a variety of brain injury models, both reactive axonal change and microvascular abnormalities occur. Development of a stretch injury model in the guinea pig optic nerve has allowed for the characterization of the early axonal response to injury. In this same model, we have now attempted to characterize those morphologic changes occurring in the visual system microvasculature after injury. Thirty adult guinea pigs were subjected to axonal stretch injury and killed at posttraumatic survival periods ranging from 10 minutes to 14 days. Twenty animals were examined by scanning electron microscopy (SEM) for the detection of posttraumatic changes in the surface morphology of the microvasculature, and 10 animals were processed for transmission electron microscopy (TEM) analysis. Through this approach, increased pit vesicle activity and formation of endothelial microvilli were recognized within 10 minutes of injury. Pit vesicle activity returned to control levels by 2 hours. The formation of endothelial microvilli was widespread, affecting the microvessels in both the stretched and unstretched optic nerves and in the chiasm. The greatest response developed most slowly in the stretched nerve, and it was faster but less marked in the unstretched nerve and chiasm. Microvilli were more numerous in larger vessels. Related astrocytic swelling/lucency was not apparent until 6 hours after injury. The astrocyte response was less marked than that documented after brain injury. The results of this investigation demonstrate a widespread microvascular response to stretch injury of the guinea pig optic nerve. Comparison with the documented responses to traumatic brain injury indicates different rates of response to different types of insult.	[Maxwell, William L.; Irvine, Alyson; Watt, Christine] Univ Glasgow, Dept Anat, Glasgow G12 8QQ, Lanark, Scotland; [Graham, David I.; Adams, J. Hume] Univ Glasgow, Dept Neuropathol, Glasgow G12 8QQ, Lanark, Scotland; [Gennarelli, Thomas A.] Univ Penn, Div Neurosurg, Philadelphia, PA 19104 USA		Maxwell, WL (corresponding author), Univ Glasgow, Dept Anat, Glasgow G12 8QQ, Lanark, Scotland.				NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-08803-18]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, P01NS008803] Funding Source: NIH RePORTER	This work was supported by NIH grant number NS-08803-18. The authors are grateful to Caroline A. Morris for drawing Figures 1 and 2.	ALLEN IV, 1983, ACTA NEUROPATHOL, V59, P277, DOI 10.1007/BF00691493; Bradbury M.W.B., 1979, CONCEPT BLOOD BRAIN; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CANCILLA PA, 1979, LAB INVEST, V40, P74; Cheng CLY, 1988, J NEUROTRAUM, V5, P47, DOI 10.1089/neu.1988.5.47; DAVSON H, 1963, ERGEBN PHYSIOL, V52, P21; Dietrich W D, 1986, Cent Nerv Syst Trauma, V3, P265; DIETRICH WD, 1987, ACTA NEUROPATHOL, V72, P315, DOI 10.1007/BF00687262; DIETRICH WD, 1984, J NEUROPATH EXP NEUR, V43, P72, DOI 10.1097/00005072-198401000-00006; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; HILLS CP, 1964, AM J PATHOL, V44, P531; KAWAI K, 1989, ACTA NEUROPATHOL, V78, P449, DOI 10.1007/BF00687705; KAWAI K, 1989, ACTA NEUROPATHOL, V77, P449, DOI 10.1007/BF00687245; LEWIS PD, 1985, SCI BASIS CLIN NEURO, P583; MATHEWSON AJ, 1985, BRAIN RES, V327, P61, DOI 10.1016/0006-8993(85)91499-4; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; MAXWELL WL, 1991, J NEUROCYTOL, V20, P157, DOI 10.1007/BF01186989; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; MAXWELL WL, 1990, J NEUROCYTOL, V19, P235, DOI 10.1007/BF01217301; MORRISON JC, 1989, ARCH OPHTHALMOL-CHIC, V107, P123, DOI 10.1001/archopht.1989.01070010125040; NAG S, 1988, ACTA NEUROPATHOL, V75, P547, DOI 10.1007/BF00686198; NAG S, 1990, ACTA NEUROPATHOL, V80, P7, DOI 10.1007/BF00294215; NAG S, 1986, ACTA NEUROPATHOL, V70, P38, DOI 10.1007/BF00689512; Peters A, 1976, FINE STRUCTURE NERVO, V3rd; POVLISHOCK J, 1982, HEAD INJURY BASIC CL, P15; POVLISHOCK JT, 1980, ACTA NEUROPATHOL, V51, P203, DOI 10.1007/BF00687387; Povlishock JT, 1985, CENTRAL NERVOUS SYST, P443; STEWART PA, 1987, J NEUROSURG, V67, P697, DOI 10.3171/jns.1987.67.5.0697; TROUT JJ, 1986, LAB INVEST, V55, P622; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; ZHANG ET, 1990, J ANAT, V170, P111	32	11	12	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	WIN	1991	8	4					271	279		10.1089/neu.1991.8.271			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	V07UU	WOS:000207286900005	1803035				2022-02-06	
J	HORST, A; RUTTNER, B				HORST, A; RUTTNER, B			ASEPTIC DURAL SINUS AND CEREBRAL VENOUS THROMBOSIS - A CRITICAL-EVALUATION OF 5 CASES	SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT			German	Article							PROTEIN-S DEFICIENCY; CLOSED HEAD-INJURY; ORAL-CONTRACEPTIVES; TOMOGRAPHIC FINDINGS; ARTERIAL THROMBOSIS; MAGNETIC-RESONANCE; MANIFESTATIONS; PREGNANCY; DISEASE; MRI	From 1988 to 1990, we observed five cases of aseptic dural sinus and cerebral venous thrombosis, all in non-smoking women (age 18 to 47 years) receiving low dose oral contraceptives. Treatment consisted of full anticoagulation over 2 to 6 months, over which time the neurologic symptoms disappeared almost completely. Extensive tests of the blood clotting system in 4 patients after 6 to 19 months revealed a reduction of free protein S in 2 patients with a history of contraceptive use over several years, and normal results in 2 patients in which the sinus thrombosis occurred within the first 6 weeks of use of the oral contraceptive. Whether the protein S deficiency was congenital or caused by the oral contraceptive cannot be decided retrospectively. Even modern oral contraceptives seem to lead to an increased incidence of sinus thrombosis. Initial symptoms of sinus thrombosis include headache and somnolence, followed either by focal neurologic deficits (often associated with focal seizures) or by signs of increased intracranial pressure. CT scans show venous infarcts or general brain edema and may specifically show the "empty triangle sign" and "delta sign". The CT scan may also be normal if focal neurologic deficits are absent. MRI is favoured as it can directly show the thrombosed sinus or veins. Differential diagnosis includes arterial stroke, brain tumor, encephalitis or "benign intracranial hypertension", which should only be diagnosed after sinus venous thrombosis has been appropriately ruled out. Recently, full anticoagulation has been recommended as therapy.	UNIV HOSP ZURICH, NEUROCHIRURG KLIN, CH-8091 ZURICH, SWITZERLAND		HORST, A (corresponding author), UNIV HOSP ZURICH, NEUROL KLIN, CH-8091 ZURICH, SWITZERLAND.						ADAMS RD, 1985, PRINCIPLES NEUROLOGY; ATKINSON EA, 1970, LANCET, V1, P914; AVERBACK P, 1978, ANN NEUROL, V3, P81, DOI 10.1002/ana.410030112; BEAUMONT JL, 1976, CLIN EXP IMMUNOL, V24, P455; BEAUMONT V, 1989, PRESSE MED, V18, P1249; BONNAR J, 1987, AM J OBSTET GYNECOL, V157, P1042, DOI 10.1016/S0002-9378(87)80129-1; BOTTIGER LE, 1980, LANCET, V1, P1097; BOUSSER MG, 1985, STROKE, V16, P199, DOI 10.1161/01.STR.16.2.199; BOUSSER MG, 1988, CURR OPIN NEUROL NEU, V1, P69; BUONANNO FS, 1978, J COMPUT ASSIST TOMO, V2, P281, DOI 10.1097/00004728-197807000-00008; BURKHARDT S, 1964, ARCH NEUROL NEUROCHI, V94, P1; DEMAEREL P, 1989, FORTSCHR RONTG NEUEN, V151, P386; DIROCCO C, 1981, ARCH NEUROL-CHICAGO, V38, P431, DOI 10.1001/archneur.1981.00510070065011; DORSTELMANN D, 1981, NERVENARZT, V52, P243; EINHAUPL KM, 1988, THERAPIE VERLAUF NEU, P275; ENGESSER L, 1987, ANN INTERN MED, V106, P677, DOI 10.7326/0003-4819-106-5-677; ESTANOL B, 1979, STROKE, V10, P680, DOI 10.1161/01.STR.10.6.680; FAIRBURN B, 1973, BMJ-BRIT MED J, V2, P647, DOI 10.1136/bmj.2.5867.647; GETTELFINGER DM, 1977, ARCH NEUROL-CHICAGO, V34, P2, DOI 10.1001/archneur.1977.00500130022004; HANLEY DF, 1988, STROKE, V19, P903, DOI 10.1161/01.STR.19.7.903; HESSELBROCK R, 1985, NEUROSURGERY, V16, P825, DOI 10.1227/00006123-198506000-00017; HULCELLE PJ, 1989, NEURORADIOLOGY, V31, P217, DOI 10.1007/BF00344346; KALBAG RM, 1972, HDB CLIN NEUROLOGY, V12, P422; Krayenbuhl H, 1967, CLIN NEUROSURG, V14, P1; LEFKOWITZ D, 1989, HDB CLIN NEUROLOGY 2, V10, P395; LORENTZ IT, 1962, BRIT MED J, P1191; MACCHI PJ, 1986, J COMPUT ASSIST TOMO, V10, P10, DOI 10.1097/00004728-198601000-00002; MALM J, 1988, BRIT J HAEMATOL, V68, P437, DOI 10.1111/j.1365-2141.1988.tb04232.x; MATTLE H, 1990, NEUROLOGY, V40, P813, DOI 10.1212/WNL.40.5.813; MCMURDO SK, 1986, RADIOLOGY, V161, P83, DOI 10.1148/radiology.161.1.3763888; MEADE TW, 1980, BRIT MED J, V280, P1157, DOI 10.1136/bmj.280.6224.1157; PATRONAS NJ, 1981, SURG NEUROL, V15, P11; RAO KCVG, 1981, RADIOLOGY, V140, P391, DOI 10.1148/radiology.140.2.7255715; RAY BS, 1951, ANN SURG, V134, P376, DOI 10.1097/00000658-195113430-00009; SCHAFER HP, 1989, SCHWEIZ MED WSCHR, V119, P489; SCHELL CL, 1988, WESTERN J MED, V149, P304; SIGSBEE B, 1979, NEUROLOGY, V29, P139, DOI 10.1212/WNL.29.2.139; SRINIVASAN K, 1983, ANGIOLOGY, V34, P731, DOI 10.1177/000331978303401107; Stansfield FR, 1942, BMJ-BRIT MED J, V1942, P436, DOI 10.1136/bmj.1.4239.436; STRINGER WL, 1983, NEUROSURGERY, V12, P95; THRON A, 1986, J NEUROL, V233, P283, DOI 10.1007/BF00314160; Towbin A, 1973, STROKE, V4, P419, DOI 10.1161/01.STR.4.3.419; VILLRINGER A, 1989, LANCET, V1, P1086; VILLRINGER A, 1988, STROKE, V19, P135; 1973, NEW ENGL J MED, V288, P871	45	11	11	0	0	E M H SWISS MEDICAL PUBLISHERS LTD	MUTTENZ	FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND	0036-7672			SCHWEIZ MED WSCHR	Schweiz. Med. Wochenschr.	NOV 2	1991	121	44					1601	1611					11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN067	WOS:A1991GN06700002	1947957				2022-02-06	
J	FOX, MA; FABIAN, TC; CROCE, MA; MANGIANTE, EC; CARSON, JP; KUDSK, KA				FOX, MA; FABIAN, TC; CROCE, MA; MANGIANTE, EC; CARSON, JP; KUDSK, KA			ANATOMY OF THE ACCIDENT SCENE - A PROSPECTIVE-STUDY OF INJURY AND MORTALITY	AMERICAN SURGEON			English	Article							SEAT BELTS	This study of the accident scene focuses on the effects of vehicular deformity and restraint devices on occupant injury. In 500 patients evaluated in a Level I trauma center, seatbelts significantly reduced the likelihood of individuals' requiring the trauma center (P < 0.0001). Seatbelts also significantly reduced the mortality rate of those who were transported to the trauma center (P < 0.04). Dashboard intrusion correlated with pelvic (P < 0.001) and femur (P < 0.03) fractures, closed head injuries (P < 0.001), and intra-abdominal injuries (P < 0.02). Steering wheel deformity correlated with pelvic fractures (P < 0.001) and closed head injuries (P < 0.005). Windshield violation correlated with closed head injuries (P < 0.014) and spinal fractures (P < 0.03). Irreparable vehicles correlated with pelvic (P < 0.0001) and femur fractures (P < 0.01), closed head injuries (P < 0.0001) and intra-abdominal injuries (P < 0.0001). The authors conclude that a careful examination of the accident scene for specific mechanisms of injury can lead to better prehospital care, more rapid and consistent diagnosis of injury, and improved patient outcome. Further prospective studies should accumulate data that will improve prehospital care, alert physicians to possible injury, increase community awareness of injury prevention, and improve vehicle construction.	UNIV TENNESSEE,CTR HLTH SCI,DEPT SURG,956 COURT AVE,ROOM E228,MEMPHIS,TN 38163								HUTH JF, 1983, J TRAUMA, V23, P494, DOI 10.1097/00005373-198306000-00009; MCDERMOTT FT, 1979, BRIT J SURG, V66, P518, DOI 10.1002/bjs.1800660721; NEWMAN RJ, 1986, J TRAUMA, V12, P561; RASTOGI S, 1986, J BONE JOINT SURG, V168, P950; SATO TB, 1987, J TRAUMA, V27, P754, DOI 10.1097/00005373-198707000-00011; 1986, FIELD CATEGORIZATION, P38	6	11	11	0	0	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	1776 PEACHTREE RD, NW., SUITE 410N, ATLANTA, GA 30309-2352	0003-1348			AM SURGEON	Am. Surg.	JUN	1991	57	6					394	397					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FT463	WOS:A1991FT46300014	2048854				2022-02-06	
J	WEST, M; WEHMAN, P; KREGEL, J; KREUTZER, J; SHERRON, P; ZASLER, N				WEST, M; WEHMAN, P; KREGEL, J; KREUTZER, J; SHERRON, P; ZASLER, N			COSTS OF OPERATING A SUPPORTED WORK PROGRAM FOR TRAUMATICALLY BRAIN-INJURED INDIVIDUALS	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						EMPLOYMENT; HANDICAPPED; HEAD INJURIES; REHABILITATION; VOCATIONAL		This paper presents a preliminary analysis of costs associated with a return-to-work program emphasizing a supported employment approach for persons who had sustained severe traumatic brain injuries. This analysis spans almost three years. Results indicated that a mean of 237.8 hours of staff intervention time was required to achieve job stabilization, at a cost of $6896. Ongoing follow-along and support services averaged 1.64 hours per week at a cost of $47.56. Over 68% of total staff time and costs were expanded in job-site training and advocacy efforts. Application of these findings to state-level and agency-level policies should be weighed against individual characteristics and needs of clients, program design, and outcomes which clients achieve as a result of services.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT REHABIL MED, RICHMOND, VA 23298 USA								ANDERSON DW, 1980, J NEUROSURG S, V53; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; COHEN J, 1985, J APPLIED REHABILITA, V16, P25; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; HILL M, 1988, VOCATIONAL REHABILIT, P31; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Jennett B., 1983, REHABILITATION HEAD, P3; KREGEL J, 1988, AM J MENT RETARD, V93, P200; KREGEL J, 1989, J ASSOC PERS SEVERE, V14, P293, DOI 10.1177/154079698901400408; KREGEL J, 1989, SUPPORTED EMPLOYMENT, P115; Kreutzer J S, 1988, Brain Inj, V2, P205, DOI 10.3109/02699058809150945; KREUTZER JS, 1988, VOCATIONAL REHABILIT, P291; MANK D, 1986, PATHWAYS EMPLOYMENT, P139; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; MOON MS, 1988, VOCATIONAL REHABILIT, P17; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; STAPLETON MC, 1986, COGNITIVE REHABIL, V4, P34; TRAPHAJAN J, 1988, COMMUNITY REENTRY; Vogenthaler D R, 1987, Brain Inj, V1, P113; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Wehman P, 1989, Brain Inj, V3, P397, DOI 10.3109/02699058909004563; WEHMAN P, 1988, REHABIL COUNS BULL, V31, P298; Wehman P, 1985, J ASSOC PERS SEVERE, V10, P3; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; 1987, FED REGISTER, V52, P30546; 1987, DATA MANAGEMENT SYST	28	11	12	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	1991	72	2					127	131					5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	EX239	WOS:A1991EX23900009	1991014				2022-02-06	
J	CAMPBELL, KB; SUFFIELD, JB; DEACON, DL				CAMPBELL, KB; SUFFIELD, JB; DEACON, DL			ELECTROPHYSIOLOGICAL ASSESSMENT OF COGNITIVE DISORDER IN CLOSED HEAD-INJURED OUTPATIENTS	ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY			English	Article							EVENT-RELATED POTENTIALS; ATTENTION; P300; PROBABILITY; COMPONENT; SURPRISE; STIMULUS; MEMORY	Severe closed head-injury results in a multitude of long-lasting cognitive deficits. ERPs can effectively complement the more traditional behavioural measures to provide information that is not available through any other means. It is now fairly clear that a late positive wave. P3. associated with contextual updating is attenuated and prolonged in a variety of conditions in the head-injured. It is also possible that measures of selective attention such as the processing negativity may be abnormal in this group. A more definitive statement will, however. have to wait the results of further investigations. A number of investigators have now indicated that cognitive processing is slowed in the head-injured. Again, ERPs have been instrumental in explaining why it is slowed. Decision making time as measured by RT is generally longer than P3 latency. Because P3 latency is delayed in the head-injured. the time required for evaluation of the stimulus (recognition and classification) is slowed in the head-injured. The additional delay in RT must, however. be explained by other processes, most probably a response bias that perhaps emphasizes accuracy at a cost of speed. Such a strategy can be manipulated if the patient is provided with cues about their speed of responding. Finally, ERPs have been instrumental in explaining possible reasons for cognitive slowing. A powerful CNV technique may permit the categorization of the head-injured into at least 2 distinctive groups: those that tend to underprocess information (perhaps as a result of apathy or a lack of motivation) and those that tend to overprocess (perhaps as a result of an inefficient and needless processing of irrelevant information resulting in fatigue). The extent to which the different modes of information processing are related to the site of brain injury and possible personality change remains an issue of speculation.	PARKWOOD HOSP,DEPT NEUROPSYCHOL,LONDON N6C 5J1,ONTARIO,CANADA; UNIV OTTAWA,SCH PSYCHOL,OTTAWA K1N 6N5,ONTARIO,CANADA; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461								ALEXANDER MP, 1982, PSYCHIATRIC ASPECTS, V2; Baddeley A.D., 1986, WORKING MEMORY; BARIBEAU J, 1989, 9TH INT C EV REL POT; BROOKS D N, 1975, Cortex, V11, P329; Campbell K., 1986, ELECTROENCEPHALOGR S, V38, P486; Campbell K.S.W., 1985, International Union of Geological Sciences Publication, P117; CAMPBELL KB, 1979, BIOL PSYCHOL, V8, P45, DOI 10.1016/0301-0511(79)90004-8; Coles, 1988, ADV PSYCHOPHYSIOLOGY, P69; CURRY SH, 1980, MOTIVATION MOTOR SEN, P507; Deacon-Elliott D L, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P664; DEACONELLIOTT DL, 1988, THESIS U OTTAWA; DEADWYLER SA, 1985, CRIT REV CLIN NEUROB, V2, P335; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Donchin E, 1984, COGNITIVE PSYCHOPHYS; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; FACCO E, 1990, EEG CL NEUR, V41, pCH36; FITZGERALD PG, 1981, CAN J PSYCHOL, V35, P188, DOI 10.1037/h0081154; GOLDEN CJ, 1983, CLIN NEUROPSYCHOLOGY; HALGREN E, 1980, SCIENCE, V210, P803, DOI 10.1126/science.7434000; HANSEN JC, 1980, ELECTROEN CLIN NEURO, V49, P277, DOI 10.1016/0013-4694(80)90222-9; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; JOHNSON R, 1985, PSYCHOPHYSIOLOGY, V22, P182, DOI 10.1111/j.1469-8986.1985.tb01584.x; JOHNSON R, 1989, PSYCHOPHYSIOLOGY, V26, P633, DOI 10.1111/j.1469-8986.1989.tb03165.x; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; LAPPIN JS, 1978, COGNITIVE THEORY, V3, P179; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; McCallum W., 1988, HDB ELECTROENCEPHALO, V3, P427; MCCARTHY G, 1978, NEUROPSYCHOLOGIA, V16, P571, DOI 10.1016/0028-3932(78)90085-4; MEYER DE, 1988, PSYCHOL REV, V95, P183, DOI 10.1037/0033-295X.95.2.183; NAATANEN R, 1988, BIOL PSYCHOL, V26, P117, DOI 10.1016/0301-0511(88)90017-8; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Pachella R., 1974, HUMAN INFORMATION PR, P41; PAPANICOLAOU AC, 1987, NEUROBEHAVIORAL RECO; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P191, DOI 10.1016/0013-4694(74)90156-4; POSNER MI, 1987, NEUROBEHAVIORAL RECO, P390; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; RIZZO PA, 1978, ELECTROEN CLIN NEURO, V45, P281, DOI 10.1016/0013-4694(78)90012-3; Rohrbaugh JW, 1983, ADV PSYCHOL, V10, P269; SCHWENT VL, 1976, ELECTROEN CLIN NEURO, V40, P615, DOI 10.1016/0013-4694(76)90136-X; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; WOOD CC, 1984, BRAIN INFORMATION EV, P681; [No title captured]	47	11	11	1	2	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0013-4694			ELECTROEN CLIN NEURO	Electroencephalogr. Clin. Neurophysiol.		1990				41			202	215					14	Engineering, Biomedical; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Neurosciences & Neurology	HB513	WOS:A1990HB51300022	2289430				2022-02-06	
J	ANDY, OJ				ANDY, OJ			POST CONCUSSION SYNDROME - BRAIN-STEM SEIZURES, A CASE-REPORT	CLINICAL ELECTROENCEPHALOGRAPHY			English	Article											ANDY, OJ (corresponding author), UNIV MISSISSIPPI,MED CTR,DEPT NEUROSURG,2500 N STATE ST,JACKSON,MS 39216, USA.						ANDERSON LS, 1971, J NEUROSURG, V35, P444, DOI 10.3171/jns.1971.35.4.0444; ANDY OJ, 1987, APPL NEUROPHYSIOL, V50, P455; ANDY OJ, 1986, PAVLOVIAN J BIOL SCI, V21, P50; ANDY OJ, 1987, PAVLOVIAN J BIOL SCI, V22, P132; ANDY OJ, 1985, CLIN ELECTROENCEPHAL, V16, P195, DOI 10.1177/155005948501600406; ANDY OJ, 1985, APPL NEUROPHYSIOL, V48, P432; ANDY OJ, 1985, J MISSISSIPPI ACADEM, V30, P111; ANDY OJ, 1985, CLIN ELECTROENCEPHAL, V17, P52; BRITT RH, 1980, NEUROSURGERY, V6, P623, DOI 10.1227/00006123-198006000-00002; CLIFTON GL, 1981, NEUROSURGERY, V8, P309, DOI 10.1227/00006123-198103000-00002; CROMPTON MR, 1971, LANCET, V1, P669; DENO RL, 1938, J NEUROPHYSIOL, V1, P210; Feldman RS, 1984, FUNDAMENTALS NEUROPS; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Hardman J M, 1979, Adv Neurol, V22, P15; HOUK JC, 1988, FASEB J, V2, P97, DOI 10.1096/fasebj.2.2.3277888; JANE JA, 1982, HEAD INJURY BASIC CL; KELLER EL, 1980, RETICULAR FORMATION, P227; LEGG NJ, 1978, NEUROTRANSMITTER SYS; LINDENBERG R, 1970, ARCH PATHOL, V90, P509; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PARSONS LC, 1981, NEUROSCI LETT, V24, P199, DOI 10.1016/0304-3940(81)90248-2; PILZ P, 1982, J NEUROL NEUROSUR PS, V45, P422, DOI 10.1136/jnnp.45.5.422; ROSENBLUM WI, 1981, NEUROSURGERY, V9, P613, DOI 10.1227/00006123-198112000-00001; SABELLI HC, 1973, CHEM MODULATION BRAI; SCHALTENBRAND G, 1959, INTRO STEREOTAXIS AT; Scheibel M. E., 1958, RETICULAR FORMATION, P31; SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733; VALZELLI L, 1973, PSYCHOPHARMACOLOGY; WESTRUM LE, 1980, EPILEPSY WINDOW BRAI, P137; [No title captured]; [No title captured]	33	11	11	0	2	CLINICAL EEG	ELM GROVE	850 ELM GROVE RD,SUITE 11, ELM GROVE, WI 53122	0009-9155			CLIN ELECTROENCEPHAL	Clin. Electroencephalogr.	JAN	1989	20	1					24	34		10.1177/155005948902000107			11	Engineering, Biomedical; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	R7443	WOS:A1989R744300003	2784362				2022-02-06	
J	ALDEN, PB; SVINGEN, BA; DEUTSCHMAN, CS; JOHNSON, SB; KONSTANTINIDES, FN; HOLMAN, RT; CERRA, FB				ALDEN, PB; SVINGEN, BA; DEUTSCHMAN, CS; JOHNSON, SB; KONSTANTINIDES, FN; HOLMAN, RT; CERRA, FB			ESSENTIAL FATTY-ACID STATUS IN ISOLATED CLOSED HEAD-INJURY	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article									ST PAUL RAMSEY MED CTR,SURG METAB RES LAB,ST PAUL,MN 55101; UNIV MINNESOTA HOSP & CLIN,DEPT SURG,MINNEAPOLIS,MN 55455; HORMEL INST,AUSTIN,MN; JOHNS HOPKINS MED INST,DEPT ANESTHESIOL & CRIT CARE MED,BALTIMORE,MD 21205				Deutschman, Clifford/AAN-2742-2021		NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL08214, HL07311] Funding Source: Medline; NIADDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [AM34931] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007311, P01HL008214] Funding Source: NIH RePORTER		ALDEN PB, 1986, SURGERY, V100, P671; CERRA FB, 1979, J TRAUMA, V19, P621, DOI 10.1097/00005373-197908000-00010; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; DEUTSCHMAN CS, 1986, J NEUROSURG, V64, P89, DOI 10.3171/jns.1986.64.1.0089; HOLMAN RT, 1983, P NATL ACAD SCI-BIOL, V80, P2375, DOI 10.1073/pnas.80.8.2375; HOLMAN RT, 1983, DIETARY FATS HLTH, P247; JELEN S, 1983, JPEN-PARENTER ENTER, V7, P142, DOI 10.1177/0148607183007002142; LANDS WEM, 1982, J BIOL CHEM, V257, P4968; PAULSRUD JR, 1972, AM J CLIN NUTR, V25, P897; SIEGEL JH, 1979, SURGERY, V86, P163; WOLFRAM G, 1983, KLIN WOCHENSCHR, V61, P1181, DOI 10.1007/BF01537429	12	11	11	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	1987	27	9					1039	1043		10.1097/00005373-198709000-00014			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	K2621	WOS:A1987K262100014	3656466				2022-02-06	
J	LARSSON, C; RONNBERG, J				LARSSON, C; RONNBERG, J			MEMORY DISORDERS AS A FUNCTION OF TRAUMATIC BRAIN INJURY - WORD COMPLETION, RECALL OF WORDS AND ACTIONS	SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE			English	Article											LARSSON, C (corresponding author), UNIV UMEA,DEPT PSYCHOL,S-90247 UMEA,SWEDEN.		Ronnberg, Jerker/AAW-5049-2021	Ronnberg, Jerker/0000-0001-7311-9959				0	11	11	0	1	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0036-5505			SCAND J REHABIL MED	Scand. J. Rehabil. Med.		1987	19	3					99	104					6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	L1220	WOS:A1987L122000002	3441777				2022-02-06	
J	COSTEFF, H; GROSWASSER, Z; LANDMAN, Y; BRENNER, T				COSTEFF, H; GROSWASSER, Z; LANDMAN, Y; BRENNER, T			SURVIVORS OF SEVERE TRAUMATIC BRAIN INJURY IN CHILDHOOD .2. LATE RESIDUAL DISABILITY	SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE			English	Article											COSTEFF, H (corresponding author), LEOWENSTEIN REHAB HOSP,POB 3,IL-43100 RAANANA,ISRAEL.							0	11	12	0	1	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0036-5505			SCAND J REHABIL MED	Scand. J. Rehabil. Med.		1985				12			10	15					6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AWU58	WOS:A1985AWU5800002					2022-02-06	
J	RICHARDSON, JTE				RICHARDSON, JTE			THE EFFECTS OF CLOSED HEAD-INJURY UPON INTRUSIONS AND CONFUSIONS IN FREE-RECALL	CORTEX			English	Article											RICHARDSON, JTE (corresponding author), BRUNEL UNIV,DEPT PSYCHOL,UXBRIDGE UB8 3PH,MIDDX,ENGLAND.			Richardson, John/0000-0002-6267-0603			BADDELEY A, 1977, ATTENTION PERFORMANC, V6; BADDELEY AD, 1975, STUDIES LONG TERM ME; BADDELEY AD, 1974, ADV RES THEORY, V8; BROOKS D N, 1974, Cortex, V10, P224; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; CONKEY RC, 1938, ARCH PSYCHOL, V33, P232; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; CROVITZ HF, 1979, CORTEX, V15, P225, DOI 10.1016/S0010-9452(79)80027-1; CROVITZ HF, 1979, CORTEX, V15, P131, DOI 10.1016/S0010-9452(79)80013-1; GLASGOW RE, 1977, J CLIN PSYCHOL, V33, P1049, DOI 10.1002/1097-4679(197710)33:4<1049::AID-JCLP2270330429>3.0.CO;2-V; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; LEVIN HS, 1976, DIS NERV SYST, V37, P68; Levin HS., 1982, NEUROBEHAVIORAL CONS; PARKER SA, 1976, ACTA NEUROCHIR, V34, P71, DOI 10.1007/BF01405864; RICHARDSON JTE, 1979, BRIT J SOC CLIN PSYC, V18, P319, DOI 10.1111/j.2044-8260.1979.tb00342.x; RICHARDSON JTE, 1983, B PSYCHONOMIC SOC, V21, P348; RICHARDSON JTE, 1979, CORTEX, V15, P145, DOI 10.1016/S0010-9452(79)80016-7; RICHARDSON JTE, 1982, PATHOLOGY PSYCHOL CO; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; THOMSEN IV, 1977, SCAND J REHABIL MED, V9, P73; WATKINS MJ, 1974, PSYCHOL BULL, V81, P695, DOI 10.1037/h0036952	24	11	11	0	0	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex		1984	20	3					413	420		10.1016/S0010-9452(84)80009-X			8	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	TL039	WOS:A1984TL03900009	6488817	Bronze			2022-02-06	
J	SHAW, NA; CANT, BR				SHAW, NA; CANT, BR			THE EFFECT OF EXPERIMENTAL CONCUSSION ON SOMATOSENSORY EVOKED-POTENTIALS	AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE			English	Article											SHAW, NA (corresponding author), UNIV AUCKLAND,SCH MED,DEPT PHYSIOL,AUCKLAND,NEW ZEALAND.						ANGEL A, 1977, PROG NEUROBIOL, V9, P1, DOI 10.1016/0301-0082(77)90018-1; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; CROCKARD HA, 1977, SURG NEUROL, V7, P281; DONG WK, 1982, ELECTROEN CLIN NEURO, V53, P143, DOI 10.1016/0013-4694(82)90020-7; FOLTZ EL, 1956, J NEUROSURG, V13, P145, DOI 10.3171/jns.1956.13.2.0145; GOVONS SR, 1972, EXP NEUROL, V34, P121, DOI 10.1016/0014-4886(72)90193-8; GRONWALL DMA, 1974, PSYCHOL EFFECTS CONC, P1; HUME AL, 1979, ANN NEUROL, V5, P379, DOI 10.1002/ana.410050412; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; LETCHER FS, 1973, J NEUROSURG, V39, P167, DOI 10.3171/jns.1973.39.2.0167; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PLUM F, 1980, DIAGNOSIS STUPOR COM, P118; SHAW NA, 1981, ELECTROEN CLIN NEURO, V51, P674, DOI 10.1016/0013-4694(81)90213-3; SYMONDS C, 1962, LANCET, V1, P1; WIEDERHOLT WC, 1977, ELECTROEN CLIN NEURO, V42, P456, DOI 10.1016/0013-4694(77)90209-7	16	11	11	0	2	AUST JRNL EXP BIOL & MED SCI	ADELAIDE SO AUSTRALIA	DEPT MICROBIOLOGY & IMMUNOLOGY UNIV ADELAIDE, ADELAIDE SO AUSTRALIA 5000, AUSTRALIA	0004-945X			AUST J EXP BIOL MED			1984	62	JUN					361	371		10.1038/icb.1984.36			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	SY423	WOS:A1984SY42300012	6093755				2022-02-06	
J	PARKINSON, D				PARKINSON, D			CONCUSSION	MAYO CLINIC PROCEEDINGS			English	Article									UNIV MANITOBA,WINNIPEG R3T 2N2,MANITOBA,CANADA								BERTRAND C, 1951, CAN MED ASSOC J, V65, P225; CHASON JL, 1966, J TRAUM, V6, P767, DOI 10.1097/00005373-196611000-00008; COURVILLE CB, 1953, COMMOTIO CEREBRI CER; DENKER PG, 1954, NEUROLOGY, V4, P912, DOI 10.1212/WNL.4.12.912; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; FULTON JF, 1943, PHYSIOLOGY NERVOUS S; GRONWALL, 1974, LANCET, V2, P605; HUSSEY HH, 1976, JAMA-J AM MED ASSOC, V236, P485; INCH T, 1951, BOXING BEGINNERS NOV; JENNETT B, COMMUNICATION; KAPLAN HA, 1954, JAMA-J AM MED ASSOC, V156, P1138, DOI 10.1001/jama.1954.02950120012004; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; OMMAYA A K, 1971, International Journal of Neuroscience, V1, P371, DOI 10.3109/00207457109146986; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; RICHARDSON JC, 1951, CAN MED ASSOC J, V64, P414; Sherrington CS, 1947, INTEGRATIVE ACTION N; VORIS HC, 1950, AM J SURG, V80, P707, DOI 10.1016/0002-9610(50)90595-2; 1976, LANCET, V1, P401	18	11	11	1	1	MAYO CLINIC PROCEEDINGS	ROCHESTER	660 SIEBENS BLDG MAYO CLINIC, ROCHESTER, MN 55905	0025-6196			MAYO CLIN PROC	Mayo Clin. Proc.		1977	52	8					492	496					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ768	WOS:A1977DQ76800003	881900				2022-02-06	
J	RABOW, L; TIBBLING, G				RABOW, L; TIBBLING, G			SERUM ACTIVITIES OF HYDROXYBUTYRATE DEHYDROGENASE (HBD) AND ISOENZYMES OF LACTATE-DEHYDROGENASE (LD) AS AN INDEX OF TRAUMATIC BRAIN INJURY	ACTA NEUROCHIRURGICA			English	Article									LINKOPING UNIV,DEPT NEUROSURG,LINKOPING,SWEDEN; LINKOPING UNIV,DEPT CLIN CHEM,LINKOPING,SWEDEN								DAWSON DM, 1969, ANN INTERN MED, V70, P799, DOI 10.7326/0003-4819-70-4-799; DUBACH UC, 1965, DEUT MED WOCHENSCHR, V90, P1429, DOI 10.1055/s-0028-1113351; Freedland R A, 1970, Adv Vet Sci Comp Med, V14, P61; Gurdjian E S, 1972, Clin Neurosurg, V19, P1; JOHANSSON BG, 1972, SCAND J CLIN LAB INV, V29, P7, DOI 10.3109/00365517209102747; KOWALEWSKI SL, 1972, ISOENZYME LACTATDEHY; KOWALEWSKI SL, 1969, THESIS BONN; KVAMME E, 1962, SCAND J CLIN LAB INV, V14, P453, DOI 10.3109/00365516209051262; Lindblom U, 1972, Scand J Rehabil Med, V4, P61; Lindblom U, 1967, Nord Med, V77, P337; PFLEIDERER G, 1961, BIOCHEM Z, V334, P185; Rabow L, 1972, Scand J Rehabil Med, V4, P90; RABOW L, 1975, ACTA NEUROCHIR, V32, P199, DOI 10.1007/BF01405453; RABOW L, 1977, ACTA NEUROCHIR, V36, P61, DOI 10.1007/BF01405987; RABOW L, 1971, ACTA CHIR SCAND, V137, P1240; WILKINSON JH, 1970, ISOENZYMES; WILKINSON JH, 1975, METHODS ENZYMATIC AN; WROBLEWSKI F, 1961, ANN NY ACAD SCI, V94, P912, DOI 10.1111/j.1749-6632.1961.tb35584.x; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210; ZONDAG HA, 1967, DETERMINATION DIAGNO	20	11	11	1	1	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1977	37	3-4					245	261		10.1007/BF01402129			17	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DL773	WOS:A1977DL77300005	906904				2022-02-06	
J	BLACK, FW				BLACK, FW			COGNITIVE AND MEMORY PERFORMANCE IN SUBJECTS WITH BRAIN-DAMAGE SECONDARY TO PENETRATING MISSILE WOUNDS AND CLOSED HEAD-INJURY	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article									FITZSIMONS ARMY MED CTR,DENVER,CO 80240								GRAHAM FK, 1960, PERCEPT MOT SKILL S2; KORMAN CD, 1963, J CONSULT PSYCHOL, V27, P303; RUSSELL WR, 1951, J NEUROL NEUROSUR PS, V14, P35, DOI 10.1136/jnnp.14.1.35; SIMPSON CD, 1971, J CLIN PSYCHOL, V27, P204, DOI 10.1002/1097-4679(197104)27:2<204::AID-JCLP2270270214>3.0.CO;2-9; [No title captured]	5	11	11	1	1	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.		1973	29	4					441	442					2	Psychology, Clinical	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology	R3598	WOS:A1973R359800012	4766716				2022-02-06	
J	GORDON, E				GORDON, E			SOME CORRELATIONS BETWEEN CLINICAL OUTCOME AND ACID-BASE STATUS OF BLOOD AND CEREBROSPINAL FLUID IN PATIENTS WITH TRAUMATIC BRAIN INJURY	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article																	CAMPAN L, 1968, ANN ANESTH FRANC, V9, P4; COTEV S, 1969, ANESTH ANALG, V48, P1; FIESCHI C, 1968, NEUROLOGY, V18, P12; FIESCHI C, 1969, CEREBRAL BLOOD FLOW, P120; FROMAN C, 1968, BRIT J ANAESTH, V40, P354, DOI 10.1093/bja/40.5.354; FROWEIN R A, 1964, Zentralbl Neurochir, V25, P39; FROWEIN R A, 1968, Acta Neurochirurgica, V19, P1, DOI 10.1007/BF01402409; GORDON E, 1970, ACTA ANAESTH SCAND, V14, P97, DOI 10.1111/j.1399-6576.1970.tb00763.x; GORDON E, 1968, ACTA ANAESTH SCAND, V12, P51, DOI 10.1111/j.1399-6576.1968.tb00411.x; GORDON E, 1971, ACTA ANAESTH SCAND, V15, P193, DOI 10.1111/j.1399-6576.1971.tb05461.x; GRUNERT V, 1969, NEURO-CHIR, V15, P275; LASSEN NA, 1961, EXPERIENTIA, V17, P42, DOI 10.1007/BF02157946; LASSEN NA, 1969, CEREBRAL BLOOD FLOW, P278; Lassen NA, 1968, SCAND J CLIN LA S102, pXIII; Lassen NA, 1969, CEREBRAL BLOOD FLOW, P117; PLUM F, 1959, ARCH NEURO PSYCHIATR, V81, P535, DOI 10.1001/archneurpsyc.1959.02340170001001; ROSSANDA M, 1970, ACTA ANAESTH SCAND, V14, P173, DOI 10.1111/j.1399-6576.1970.tb00963.x; STEINBEREITHNER K, 1967, KLIN WOCHENSCHR, V45, P126, DOI 10.1007/BF01725067; WOLLMAN H, 1969, CEREBRAL BLOOD FLOW, P273; [No title captured]	20	11	11	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.		1971	15	3					209	&		10.1111/j.1399-6576.1971.tb05462.x			0	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	K5975	WOS:A1971K597500006	5120956				2022-02-06	
J	MULLER, R; NAUMANN, B				MULLER, R; NAUMANN, B			EARLY AMBULATION AND PSYCHOTHERAPY FOR TREATMENT OF CLOSED HEAD INJURY	ARCHIVES OF NEUROLOGY AND PSYCHIATRY			English	Article																	ADLER A, 1945, ARCH NEURO PSYCHIATR, V53, P34, DOI 10.1001/archneurpsyc.1945.02300010044003; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; CEDERMARK J, 1942, ACTA CHIR SCANDI S75, V86, P1; DALSGAARDNIELSEN T, 1954, ACTA PSYCH NEUROL, V29, P28, DOI 10.1111/j.1600-0447.1954.tb05661.x; Denny-Brown D., 1942, NEW ENGL J MED, V227, P771; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; FRIEDMAN AP, 1945, J NEUROSURG, V2, P36, DOI 10.3171/jns.1945.2.1.0036; Guttmann E, 1943, Br Med J, V1, P94; Guttmann E, 1943, LANCET, V1, P10; MCKENZIE KG, 1943, T AM NEUROL A, V69, P103; MULLER R, 1955, Nord Med, V53, P677; Ross WD, 1944, ARCH NEURO PSYCHIATR, V52, P255, DOI 10.1001/archneurpsyc.1944.02290340002001; RUESCH J, 1945, AM J PSYCHIAT, V102, P145, DOI 10.1176/ajp.102.2.145; RUESCH J, 1945, A RES NERV MENT DIS, V24, P507; Russell W Ritchie, 1934, Edinb Med J, V41, P129; Russell WR, 1942, BMJ-BRIT MED J, V1942, P521, DOI 10.1136/bmj.2.4269.521; SHEARBURN EW, 1943, B US ARMY MED DEP, V69, P36; SIMONS DJ, 1946, PSYCHOSOM MED, V8, P227, DOI 10.1097/00006842-194607000-00001; Symonds CP, 1943, LANCET, V1, P7; [No title captured]; [No title captured]	21	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0096-6754			ARCH NEURO PSYCHIATR			1956	76	DEC					597	607					11	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	WD825	WOS:A1956WD82500004	13371975				2022-02-06	
J	Denny-Brown, D				Denny-Brown, D			Post-concussion syndrome - A critique	ANNALS OF INTERNAL MEDICINE			English	Article									Harvard Univ, Med Sch, Dept Neurol, Cambridge, MA USA; Boston City Hosp, Neurol Unit, Boston, MA USA								[Anonymous], 1942, Proc R Soc Med, V35, P601; Bright R., 1831, REPORTS MED CASES 1, V2; Denny-Brown D., 1942, NEW ENGL J MED, V227, P771; HUTCHINSON J, 1877, ILLUSTRATIONS CLIN S, V1; Lemere F, 1936, ARCH NEURO PSYCHIATR, V35, P990, DOI 10.1001/archneurpsyc.1936.02260050064005; Malone JY, 1942, J AMER MED ASSOC, V119, P861, DOI 10.1001/jama.1942.02830280007002; Penfield W, 1936, ARCH NEURO PSYCHIATR, V36, P75, DOI 10.1001/archneurpsyc.1936.02260070083007; PENFIELD W, 1927, SURG GYNECOL OBSTET, V45, P747; RUSSEL C, 1942, ARCH NEUROL PSYCHIAT, V47, P1030; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Schaller WF, 1939, J AMER MED ASSOC, V113, P1779; SCHILDER P, 1940, INJURIES SKULL BRAIN, pCH12; Strauss I, 1934, ARCH NEURO PSYCHIATR, V31, P893, DOI 10.1001/archneurpsyc.1934.02250050011001; Symonds CP, 1943, LANCET, V1, P7; Symonds CP, 1932, LANCET, V1, P820; SYMONDS CP, 1940, INJURIES SKULL BRAIN, pCH4; [No title captured]	17	11	11	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP	1943	19	3					427	432		10.7326/0003-4819-19-3-427			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V07HL	WOS:000200492500003					2022-02-06	
J	Eulion, JF				Eulion, JF			Blast and concussion in the present war	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Yale Univ, Sch Med, Lab Physiol, New Haven, CT USA								ZUCKERMAN S., 1941, Proceedings of the Royal Society of Medicine, V31, P171; ARNOUX, 1915, JOURNAL PARIS   0606; BARCROFT J, 1939, SECTIONAL STEEL SHEL; Bernal JD, 1941, NATURE, V147, P594, DOI 10.1038/147594a0; Bowlby A, 1915, LANCET, V2, P1385; Carver A, 1919, BRAIN, V42, P113, DOI 10.1093/brain/42.2.113; Davis HA, 1941, ARCH SURG-CHICAGO, V43, P1; Dean DM, 1940, LANCET, V2, P224; DEGUTIERREZMAHO.W, 1941, WAR MED, V1, P816; Denny-Brown D, 1940, J PHYSIOL-LONDON, V99, P153, DOI 10.1113/jphysiol.1940.sp003887; Denny-Brown D, 1941, LANCET, V1, P371; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1941, P ROY SOC MED, V34, P685; Eden K., 1941, PROC ROY SOC MED, V34, P685; Falla S T, 1940, Br Med J, V2, P255; FULTON JE, 1940, T STUD COLL PHYS PHI, V8, P157; GITHENS TS, 1919, AM J PHYSIOL, V49, P120; Hadfield G, 1941, BRIT MED J, V1941, P77, DOI 10.1136/bmj.1.4176.77; Hadfield G, 1940, LANCET, V2, P478; Hooker DR, 1924, AM J PHYSIOL, V67, P219; Kretzschmar CH, 1940, LANCET, V1, P832; KROHN PL, 1941, BRIT MED J, V1, P645; Logan DD, 1939, BRIT MED J, V2, P864, DOI 10.1136/bmj.2.4112.864; MARINESCO G, 1918, REV NEUROL, V31, P329; McKibben PS, 1919, AM J PHYSIOL, V48, P331; Mitchell SW., 1864, GUNSHOT WOUNDS OTHER; Mott FW, 1916, LANCET, V1, P441; Mott FW, 1916, LANCET, V1, P331; Mott FW, 1916, LANCET, V1, P545; Myers Charles, 1940, SHELL SHOCK FRANCE 1; O' Reilly JN, 1941, LANCET, V2, P423; Pilcher C, 1937, ARCH SURG-CHICAGO, V35, P512, DOI 10.1001/archsurg.1937.01190150095009; PILCHER CM, 1922, HIST GREAT WAR MED S, V1, P36; Pitres A, 1916, REV NEUROL-FRANCE, V29, P298; RCHWILD E, 1940, MED KLIN, V36, P867; Robb-Smith AHT, 1941, LANCET, V1, P135; ROBBSMITH AHT, 1941, P ROY SOC MED, V34, P639; ROUBINOVITSCH J, 1940, B MED, V54, P65; Rowlands RA, 1941, LANCET, V1, P502; Schaller WF, 1941, ARCH NEURO PSYCHIATR, V45, P1; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; Smith H. W., 1944, BMJ-BRIT MED J, V30, P193; Stewart OW, 1941, LANCET, V1, P172; THOMSON GF, 1940, BRIT MED J, V1, P44; von Sarbo A, 1932, SCHWEIZ ARCH NEUROL, V29, P127; WANKE R, 1940, ARCH KLIN CHIR, V200, P189; Zuckerman S, 1940, LANCET, V2, P219; ZUCKERMAN S, 1941, BRIT MED J, V1, P645	48	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN-JUN	1942	226						1	8					8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V32ZV	WOS:000202230300001					2022-02-06	
J	Robba, C; Ball, L; Battaglini, D; Cardim, D; Moncalvo, E; Brunetti, I; Bassetti, M; Giacobbe, DR; Vena, A; Patroniti, N; Rocco, PRM; Matta, BF; Pelosi, P				Robba, Chiara; Ball, Lorenzo; Battaglini, Denise; Cardim, Danilo; Moncalvo, Emanuela; Brunetti, Iole; Bassetti, Matteo; Giacobbe, Daniele R.; Vena, Antonio; Patroniti, Nicolo; Rocco, Patricia R. M.; Matta, Basil F.; Pelosi, Paolo			Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study	CRITICAL CARE			English	Article						Coronavirus; Cerebral oxygenation; Rescue therapies; Prone position; Recruitment maneuvers; Carbon dioxide removal	END-EXPIRATORY PRESSURE; TRAUMATIC BRAIN-INJURY; INHALED NITRIC-OXIDE; PERFUSION-PRESSURE; PRONE POSITION; ICP	BackgroundIn COVID-19 patients with acute respiratory distress syndrome (ARDS), the effectiveness of ventilatory rescue strategies remains uncertain, with controversial efficacy on systemic oxygenation and no data available regarding cerebral oxygenation and hemodynamics.MethodsThis is a prospective observational study conducted at San Martino Policlinico Hospital, Genoa, Italy. We included adult COVID-19 patients who underwent at least one of the following rescue therapies: recruitment maneuvers (RMs), prone positioning (PP), inhaled nitric oxide (iNO), and extracorporeal carbon dioxide (CO2) removal (ECCO2R). Arterial blood gas values (oxygen saturation [SpO(2)], partial pressure of oxygen [PaO2] and of carbon dioxide [PaCO2]) and cerebral oxygenation (rSO(2)) were analyzed before (T0) and after (T1) the use of any of the aforementioned rescue therapies. The primary aim was to assess the early effects of different ventilatory rescue therapies on systemic and cerebral oxygenation. The secondary aim was to evaluate the correlation between systemic and cerebral oxygenation in COVID-19 patients.ResultsForty-five rescue therapies were performed in 22 patients. The median [interquartile range] age of the population was 62 [57-69] years, and 18/22 [82%] were male. After RMs, no significant changes were observed in systemic PaO2 and PaCO2 values, but cerebral oxygenation decreased significantly (52 [51-54]% vs. 49 [47-50]%, p<0.001). After PP, a significant increase was observed in PaO2 (from 62 [56-71] to 82 [76-87] mmHg, p=0.005) and rSO(2) (from 53 [52-54]% to 60 [59-64]%, p=0.005). The use of iNO increased PaO2 (from 65 [67-73] to 72 [67-73] mmHg, p=0.015) and rSO(2) (from 53 [51-56]% to 57 [55-59]%, p=0.007). The use of ECCO2R decreased PaO2 (from 75 [75-79] to 64 [60-70] mmHg, p=0.009), with reduction of rSO(2) values (59 [56-65]% vs. 56 [53-62]%, p=0.002). In the whole population, a significant relationship was found between SpO(2) and rSO(2) (R=0.62, p<0.001) and between PaO2 and rSO(2) (R0 0.54, p<0.001).ConclusionsRescue therapies exert specific pathophysiological mechanisms, resulting in different effects on systemic and cerebral oxygenation in critically ill COVID-19 patients with ARDS. Cerebral and systemic oxygenation are correlated. The choice of rescue strategy to be adopted should take into account both lung and brain needs.Registration The study protocol was approved by the ethics review board (Comitato Etico Regione Liguria, protocol n. CER Liguria: 23/2020).	[Robba, Chiara; Ball, Lorenzo; Moncalvo, Emanuela; Patroniti, Nicolo; Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost DISC, Genoa, Italy; [Robba, Chiara; Ball, Lorenzo; Battaglini, Denise; Brunetti, Iole; Patroniti, Nicolo; Pelosi, Paolo] Osped Policlin San Martino, IRCCS Oncol & Neurosci, Genoa, Italy; [Cardim, Danilo] Univ Texas Austin, Dept Neurol, Austin, TX 78712 USA; [Bassetti, Matteo; Giacobbe, Daniele R.] Univ Genoa, Dept Hlth Sci DISSAL, Genoa, Italy; [Bassetti, Matteo; Giacobbe, Daniele R.; Vena, Antonio] Osped Policlin San Martino, IRCCS Oncol & Neurosci, Infect Dis Unit, Genoa, Italy; [Rocco, Patricia R. M.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Lab Pulm Invest, Rio De Janeiro, Brazil; [Matta, Basil F.] Addenbrookes Hosp, Neurocrit Care Unit, Cambridge, England; Osped Policlin San Martino, Dept Neurosurg, Genoa, Italy		Robba, C (corresponding author), Univ Genoa, Dept Surg Sci & Integrated Diagnost DISC, Genoa, Italy.; Robba, C (corresponding author), Osped Policlin San Martino, IRCCS Oncol & Neurosci, Genoa, Italy.	kiarobba@gmail.com	Ball, Lorenzo/AAC-2786-2019; Giacobbe, Daniele Roberto/K-2777-2018; Battaglini, Denise/X-6446-2019; Rocco, Patricia/I-7460-2012	Ball, Lorenzo/0000-0002-3876-4730; Giacobbe, Daniele Roberto/0000-0003-2385-1759; Battaglini, Denise/0000-0002-6895-6442; Rocco, Patricia/0000-0003-1412-7136; Magnasco, Laura/0000-0002-6343-3271			[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Bagate F, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00769-2; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Ball L, 2020, INTENS CARE MED EXP, V8, DOI 10.1186/s40635-020-00322-2; Battaglini D, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.602114; Battaglini D, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00845; BLAND JM, 1995, BRIT MED J, V310, P633, DOI 10.1136/bmj.310.6980.633; Cardim D, 2016, J NEUROTRAUM, V33, P792, DOI 10.1089/neu.2015.4134; Chen LN, 2004, CLIN INFECT DIS, V39, P1531, DOI 10.1086/425357; Chiumello D, 2013, INTENS CARE MED, V39, P1377, DOI 10.1007/s00134-013-2969-x; Combes A, 2018, NEW ENGL J MED, V378, P1965, DOI 10.1056/NEJMoa1800385; Cornejo Rodrigo, 2014, Rev. bras. ter. intensiva, V26, P193, DOI 10.5935/0103-507X.20140028; Corradi F, 2018, CRIT ULTRASOUND J, V10, DOI 10.1186/s13089-018-0105-4; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Della Torre V, 2017, J THORAC DIS, V9, P5368, DOI 10.21037/jtd.2017.11.03; Fan E, 2020, LANCET RESP MED, V8, P816, DOI 10.1016/S2213-2600(20)30304-0; Frisvold SK, 2019, INTENS CARE MED, V45, P683, DOI 10.1007/s00134-019-05556-7; Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2; Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE; Germann P, 2005, INTENS CARE MED, V31, P1029, DOI 10.1007/s00134-005-2675-4; Goursaud S, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-020-00784-3; Grasselli G, 2020, LANCET RESP MED, V8, P1201, DOI 10.1016/S2213-2600(20)30370-2; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Grieco DL, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03253-2; Gritti P, 2013, J ANESTH, V27, P293, DOI 10.1007/s00540-012-1495-2; Guerin C, 2020, INTENS CARE MED, V46, P2385, DOI 10.1007/s00134-020-06306-w; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Heinsar S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03386-4; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Hodgson C, 2013, INJURY, V44, P1700, DOI 10.1016/j.injury.2012.11.017; HUANG CL, 2020, LANCET, V395, P497, DOI [DOI 10.1016/S0140-6736(20)30183-5, 10.1016/S0140-6736(20)30183-5]; Husain-Syed F, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.598379; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Li M, 2020, CHINESE MED J-PEKING, V133, P1115, DOI 10.1097/CM9.0000000000000778; Lotz C, 2021, ACTA ANAESTH SCAND, V65, P629, DOI 10.1111/aas.13757; Lumb AB, 2015, ANESTHESIOLOGY, V122, P932, DOI 10.1097/ALN.0000000000000569; Maeda A, 2021, RESPIROL CASE REP, V9, DOI 10.1002/rcr2.700; Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825; Mauri T, 2020, CRIT CARE MED, V48, P1129, DOI 10.1097/CCM.0000000000004386; Mauri T, 2016, INTENS CARE MED, V42, P1576, DOI 10.1007/s00134-016-4467-4; Mauri T, 2013, CRIT CARE MED, V41, P1664, DOI 10.1097/CCM.0b013e318287f6e7; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Munoz-Bendix C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1088-1; Nekludov M, 2006, ACTA ANAESTH SCAND, V50, P932, DOI 10.1111/j.1399-6576.2006.01099.x; Nemer SN, 2011, J CRIT CARE, V26, P22, DOI 10.1016/j.jcrc.2010.04.015; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Picetti E, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02875-w; Pun BT, 2021, LANCET RESP MED, V9, P239, DOI 10.1016/S2213-2600(20)30552-X; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rasulo FA, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2781-2; Rasulo FA, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1632-2; Reinprecht A, 2003, CRIT CARE MED, V31, P1831, DOI 10.1097/01.CCM.0000063453.93855.0A; Robba C, 2016, BRIT J ANAESTH, V117, P783, DOI 10.1093/bja/aew356; Robba C, 2020, INTENS CARE MED, V46, P2397, DOI 10.1007/s00134-020-06283-0; Robba C, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00771; Robba C, 2020, EXPERT REV RESP MED, V14, P865, DOI 10.1080/17476348.2020.1778470; Robba C, 2020, RESP PHYSIOL NEUROBI, V279, DOI 10.1016/j.resp.2020.103455; Robba C, 2020, BMC ANESTHESIOL, V20, DOI 10.1186/s12871-020-00988-x; Robba C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2662-8; Robba C, 2019, INTENS CARE MED, V45, P913, DOI 10.1007/s00134-019-05610-4; Robba C, 2017, J NEUROSURG ANESTH, V29, P243, DOI 10.1097/ANA.0000000000000295; Robba C, 2015, NEUROCRIT CARE, V23, P419, DOI 10.1007/s12028-015-0163-4; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Seethala Raghu R, 2020, Crit Care Explor, V2, pe0293, DOI 10.1097/CCE.0000000000000293; Tavazzi G, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03222-9; Thomson RJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243710; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Yu HY, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.573421; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	69	10	10	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	MAR 19	2021	25	1							111	10.1186/s13054-021-03537-1			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RA6JY	WOS:000631524300001	33741052	Green Published, gold			2022-02-06	
J	Benjamini, D; Iacono, D; Komlosh, ME; Perl, DP; Brody, DL; Basser, PJ				Benjamini, Dan; Iacono, Diego; Komlosh, Michal E.; Perl, Daniel P.; Brody, David L.; Basser, Peter J.			Diffuse axonal injury has a characteristic multidimensional MRI signature in the human brain	BRAIN			English	Article						traumatic brain injury; diffuse axonal injury; traumatic axonal injury; radiological-pathological correlations; multidimensional MRI	AMYLOID PRECURSOR PROTEIN; WHITE-MATTER; HEAD-INJURY; MILD; RELAXATION; DISTRIBUTIONS; DAMAGE; TISSUE; BETA; T-2	Axonal injury is a major contributor to the clinical symptomatology in patients with traumatic brain injury. Conventional neuroradiological tools, such as CT and MRI, are insensitive to diffuse axonal injury (DAI) caused by trauma. Diffusion tensor MRI parameters may change in DAI lesions; however, the nature of these changes is inconsistent. Multidimensional MRI is an emerging approach that combines T-1, T-2, and diffusion, and replaces voxel-averaged values with distributions, which allows selective isolation of specific potential abnormal components. By performing a combined post-mortem multidimensional MRI and histopathology study, we aimed to investigate T-1-T-2-diffusion changes linked to DAI and to define their histopathological correlates. Corpora callosa derived from eight subjects who had sustained traumatic brain injury, and three control brain donors underwent post-mortem ex vivo MRI at 7 T. Multidimensional, diffusion tensor, and quantitative T-1 and T-2 MRI data were acquired and processed. Following MRI acquisition, slices from the same tissue were tested for amyloid precursor protein (APP) immunoreactivity to define DAI severity. A robust image co-registration method was applied to accurately match MRI-derived parameters and histopathology, after which 12 regions of interest per tissue block were selected based on APP density, but blind to MRI. We identified abnormal multidimensional T-1-T-2, diffusion-T-2, and diffusion-T-1 components that are strongly associated with DAI and used them to generate axonal injury images. We found that compared to control white matter, mild and severe DAI lesions contained significantly larger abnormal T-1-T-2 component (P=0.005 and P<0.001, respectively), and significantly larger abnormal diffusion-T-2 component (P=0.005 and P<0.001, respectively). Furthermore, within patients with traumatic brain injury the multidimensional MRI biomarkers differentiated normal-appearing white matter from mild and severe DAI lesions, with significantly larger abnormal T-1-T-2 and diffusion-T-2 components (P=0.003 and P<0.001, respectively, for T-1-T-2; P=0.022 and P<0.001, respectively, for diffusion-T-2). Conversely, none of the conventional quantitative MRI parameters were able to differentiate lesions and normal-appearing white matter. Lastly, we found that the abnormal T-1-T-2, diffusion-T-1, and diffusion-T-2 components and their axonal damage images were strongly correlated with quantitative APP staining (r=0.876, P<0.001; r=0.727, P<0.001; and r=0.743, P<0.001, respectively), while producing negligible intensities in grey matter and in normal-appearing white matter. These results suggest that multidimensional MRI may provide non-invasive biomarkers for detection of DAI, which is the pathological substrate for neurological disorders ranging from concussion to severe traumatic brain injury.	[Benjamini, Dan; Komlosh, Michal E.; Basser, Peter J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Quantitat Imaging & Tissue Sci, NIH, Bethesda, MD USA; [Benjamini, Dan; Iacono, Diego; Komlosh, Michal E.; Perl, Daniel P.; Brody, David L.; Basser, Peter J.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Benjamini, Dan; Iacono, Diego; Komlosh, Michal E.] Henry M Jackson Fdn Adv Mil Med HJF, Bethesda, MD USA; [Iacono, Diego; Brody, David L.] Uniformed Serv Univ USU, F Edward Hebert Sch Med, Dept Neurol, Bethesda, MD USA; [Iacono, Diego; Perl, Daniel P.] Uniformed Serv Univ USU, F Edward Hebert Sch Med, Dept Pathol, Bethesda, MD USA; [Iacono, Diego] Uniformed Serv Univ USU, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Neurosci Grad Program, Bethesda, MD USA; [Iacono, Diego] NINDS, Motor Neuron Disorders Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Brody, David L.] NINDS, Lab Funct & Mol Imaging, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		Benjamini, D (corresponding author), NIH, 13 South Dr,MSC 5772,Bldg 13,Rm 3W16, Bethesda, MD 20892 USA.	dan.benjamini@nih.gov	Iacono, Diego/K-8203-2016	Iacono, Diego/0000-0001-5511-0950	U.S. Department of DefenseUnited States Department of Defense [308430]; CNRM Neuroradiology-Neuropathology Correlations Core; CNRMUnited States Department of Defense; USUHS; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	This research was partially supported by a grant from the U.S. Department of Defense, Program Project 308430 Uniformed Services University of the Health Sciences (USUHS). Support for this work also included funding from the U.S. Department of Defense to the Brain Tissue Repository and Neuropathology Core, Center for Neuroscience and Regenerative Medicine (CNRM). D.B. and M.E.K. were supported by the CNRM NeuroradiologyNeuropathology Correlations Core. D.I., D.P.P., and D.L.B. were supported by the CNRM and USUHS. PJB was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adler DH, 2018, P NATL ACAD SCI USA, V115, P4252, DOI 10.1073/pnas.1801093115; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barmpoutis A, 2010, I S BIOMED IMAGING, P1385, DOI 10.1109/ISBI.2010.5490256; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Benjamini D., 2020, ADV DIFFUSION ENCODI, P278, DOI [10.1039/9781788019910-00278, DOI 10.1039/9781788019910-00278]; Benjamini D, 2020, NEUROIMAGE, V221, DOI 10.1016/j.neuroimage.2020.117195; Benjamini D, 2020, NMR BIOMED, V33, DOI 10.1002/nbm.4226; Benjamini D, 2018, MICROPOR MESOPOR MAT, V269, P93, DOI 10.1016/j.micromeso.2017.02.001; Benjamini D, 2017, NEUROIMAGE, V163, P183, DOI 10.1016/j.neuroimage.2017.09.033; Benjamini D, 2016, J MAGN RESON, V271, P40, DOI 10.1016/j.jmr.2016.08.004; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Budde MD, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00003; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Celik H, 2013, J MAGN RESON, V236, P134, DOI 10.1016/j.jmr.2013.07.008; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Cooper G, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00334; Dennis EL, 2018, I S BIOMED IMAGING, P1386, DOI 10.1109/ISBI.2018.8363830; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Does MD, 2002, MAGNET RESON MED, V47, P274, DOI 10.1002/mrm.10060; Ducreux D, 2005, NEURORADIOLOGY, V47, P604, DOI 10.1007/s00234-005-1389-1; EDZES HT, 1977, NATURE, V265, P521, DOI 10.1038/265521a0; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Filo S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11319-1; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hurlimann MD, 2003, MAGN RESON IMAGING, V21, P305, DOI 10.1016/S0730-725X(03)00159-0; Hutter J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33463-2; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones DK, 2018, NEUROIMAGE, V182, P8, DOI 10.1016/j.neuroimage.2018.05.047; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kim D, 2020, NMR BIOMED, V33, DOI 10.1002/nbm.4244; Kim D, 2017, MAGN RESON MED, V78, P2236, DOI 10.1002/mrm.26629; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; KROEKER RM, 1986, J MAGN RESON, V69, P218, DOI 10.1016/0022-2364(86)90074-0; LABADIE C, 1994, J MAGN RESON SER B, V105, P99, DOI 10.1006/jmrb.1994.1109; Laule C, 2008, NEUROIMAGE, V40, P1575, DOI 10.1016/j.neuroimage.2007.12.008; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Li W, 2016, NMR BIOMED, V29, P896, DOI 10.1002/nbm.3536; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Macenko M, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: FROM NANO TO MACRO, VOLS 1 AND 2, P1107, DOI 10.1109/ISBI.2009.5193250; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; MATTHAEI D, 1985, LANCET, V2, P893; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mitchell J, 2012, PROG NUCL MAG RES SP, V62, P34, DOI 10.1016/j.pnmrs.2011.07.002; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Pas K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60092-5; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Roebroeck A, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3941; Ronen I, 2006, MAGN RESON IMAGING, V24, P61, DOI 10.1016/j.mri.2005.10.023; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sharp DJ, 2016, OXFORD TXB COGNITIVE, P435; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shepherd TM, 2020, FRONT NEUROANAT, V14, DOI 10.3389/fnana.2020.00009; Shepherd TM, 2009, NEUROIMAGE, V44, P820, DOI 10.1016/j.neuroimage.2008.09.054; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Skinner NP, 2017, MAGN RESON MED, V77, P1639, DOI 10.1002/mrm.26243; Slator PJ, 2019, MAGN RESON MED, V82, P95, DOI 10.1002/mrm.27733; Smith DH, 2020, NAT REV NEUROL, V16, P457, DOI 10.1038/s41582-020-0382-y; Song YQ, 2002, J MAGN RESON, V154, P261, DOI 10.1006/jmre.2001.2474; Thompson PM, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0705-1; Topgaard D, 2017, J MAGN RESON, V275, P98, DOI 10.1016/j.jmr.2016.12.007; Wu WC, 2016, NEUROIMAGE, V143, P1, DOI 10.1016/j.neuroimage.2016.08.054; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P18461, DOI 10.1073/pnas.0707647104	84	10	10	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	MAR	2021	144		3				800	816		10.1093/brain/awaa447			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SA6YS	WOS:000649448200024	33739417	Green Published			2022-02-06	
J	Depreitere, B; Citerio, G; Smith, M; Adelson, PD; Aries, MJ; Bleck, TP; Bouzat, P; Chesnut, R; De Sloovere, V; Diringer, M; Dureanteau, J; Ercole, A; Hawryluk, G; Hawthorne, C; Helbok, R; Klein, SP; Neumann, JO; Robba, C; Steiner, L; Stocchetti, N; Taccone, FS; Valadka, A; Wolf, S; Zeiler, FA; Meyfroidt, G				Depreitere, B.; Citerio, G.; Smith, M.; Adelson, P. David; Aries, M. J.; Bleck, T. P.; Bouzat, P.; Chesnut, R.; De Sloovere, V.; Diringer, M.; Dureanteau, J.; Ercole, A.; Hawryluk, G.; Hawthorne, C.; Helbok, R.; Klein, S. P.; Neumann, J. O.; Robba, C.; Steiner, L.; Stocchetti, N.; Taccone, F. S.; Valadka, A.; Wolf, S.; Zeiler, F. A.; Meyfroidt, G.			Cerebrovascular Autoregulation Monitoring in the Management of Adult Severe Traumatic Brain Injury: A Delphi Consensus of Clinicians	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Adult; Cerebral perfusion pressure; Cerebral blood flow; Homeostasis; Consensus development	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; BLOOD-FLOW; CRITICAL THRESHOLDS; REACTIVITY; HYPERTENSION; DYNAMICS; INSULTS; OXYGEN	Background Several methods have been proposed to measure cerebrovascular autoregulation (CA) in traumatic brain injury (TBI), but the lack of a gold standard and the absence of prospective clinical data on risks, impact on care and outcomes of implementation of CA-guided management lead to uncertainty. Aim To formulate statements using a Delphi consensus approach employing a group of expert clinicians, that reflect current knowledge of CA, aspects that can be implemented in TBI management and CA research priorities. Methods A group of 25 international academic experts with clinical expertise in the management of adult severe TBI patients participated in this consensus process. Seventy-seven statements and multiple-choice questions were submitted to the group in two online surveys, followed by a face-to-face meeting and a third online survey. Participants received feedback on average scores and the rationale for resubmission or rephrasing of statements. Consensus on a statement was defined as agreement of more than 75% of participants. Results Consensus amongst participants was achieved on the importance of CA status in adult severe TBI pathophysiology, the dynamic non-binary nature of CA impairment, its association with outcome and the inadvisability of employing universal and absolute cerebral perfusion pressure targets. Consensus could not be reached on the accuracy, reliability and validation of any current CA assessment method. There was also no consensus on how to implement CA information in clinical management protocols, reflecting insufficient clinical evidence. Conclusion The Delphi process resulted in 25 consensus statements addressing the pathophysiology of impaired CA, and its impact on cerebral perfusion pressure targets and outcome. A research agenda was proposed emphasizing the need for better validated CA assessment methods as well as the focused investigation of the application of CA-guided management in clinical care using prospective safety, feasibility and efficacy studies.	[Depreitere, B.] Univ Hosp Leuven, Neurosurg, Herestr 49, B-3000 Leuven, Belgium; [Citerio, G.] Univ Milano Bicocca, Sch Med & Surg, Intens Care Med, Milan, Italy; [Smith, M.] UCL, Neurocrit Care Unit, Natl Hosp Neurol & Neurosurg, London, England; [Adelson, P. David] Univ Arizona, Barrow Neurol Inst, Dept Child Hlth, Coll Med,Phoenix Childrens Hosp, Tucson, AZ USA; [Adelson, P. David] Arizona State Univ, Sch Biol & Hlth Syst Engn, Dept Neurosurg, Sch Med,Mayo Clin, Tempe, AZ USA; [Aries, M. J.] Maastricht Univ, Med Ctr, Dept Intens Care, Maastricht Univ Med Ctr, Maastricht, Netherlands; [Bleck, T. P.] Northwestern Univ, Davee Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Bouzat, P.] Grenoble Univ Hosp, Grenoble Alps Trauma Ctr, Dept Anesthesiol & Intens Care Med, Grenoble, France; [Chesnut, R.] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA USA; [De Sloovere, V.] Univ Hosp Leuven, Anesthesiol, Leuven, Belgium; [Diringer, M.] Washington Univ, Jewish Hosp, Dept Neurol, Sch Med, St Louis, MO USA; [Dureanteau, J.] Univ Paris Sud, Hop Univ Paris, Paris, France; [Ercole, A.; Zeiler, F. A.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge, England; [Hawryluk, G.] Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada; [Hawthorne, C.] Inst Neurol Sci, Head & Neck Anaesthesia & Neurocritical Care, Glasgow, Lanark, Scotland; [Helbok, R.] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Klein, S. P.] Univ Hosp Brussels, Neurosurg, Brussels, Belgium; [Neumann, J. O.] Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany; [Robba, C.] Policlin San Martino, IRCCS Oncol & Neurosci, Genoa, Italy; [Steiner, L.] Univ Hosp Basel, Anesthesiol, Basel, Switzerland; [Steiner, L.] Univ Basel, Dept Clin Res, Basel, Switzerland; [Stocchetti, N.] Milan Univ, Dept Physiopathol & Transplant, Milan, Italy; [Stocchetti, N.] IRCCS Ca Granda Osped Maggiore Policlin, Dept Physiopathol & Transplant, Milan, Italy; [Taccone, F. S.] Univ Libre Bruxelles ULB, Dept Intens Care, Hop Erasme, Brussels, Belgium; [Valadka, A.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Wolf, S.] Univ Hosp Berlin Charite, Dept Neurosurg, Berlin, Germany; [Zeiler, F. A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Zeiler, F. A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, F. A.] Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada; [Zeiler, F. A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Meyfroidt, G.] Univ Hosp Leuven, Intens Care Med, Leuven, Belgium		Depreitere, B (corresponding author), Univ Hosp Leuven, Neurosurg, Herestr 49, B-3000 Leuven, Belgium.	bart.depreitere@uzleuven.be	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093; Depreitere, Bart/0000-0002-7458-0648; Hawthorne, Christopher/0000-0002-9145-9022; Zeiler, Frederick/0000-0003-1737-0510			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; Claassen JAHR, 2016, J CEREBR BLOOD F MET, V36, P665, DOI 10.1177/0271678X15626425; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Depreitere B, 2018, ACTA NEUROCHIR SUPPL, V126, P201, DOI 10.1007/978-3-319-65798-1_41; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Dias C, 2014, J NEUROTRAUM, V31, P1872, DOI 10.1089/neu.2014.3376; Donnelly J, 2018, ACTA NEUROCHIR SUPPL, V126, P209, DOI 10.1007/978-3-319-65798-1_43; EYRE JA, 1988, CLIN PHYS PHYSIOL M, V9, P65, DOI 10.1088/0143-0815/9/1/006; Guiza F, 2017, J NEUROTRAUM, V34, P2425, DOI 10.1089/neu.2016.4807; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hasson F., 2011, DELPHI TECHNIQUE NUR, DOI [10.1002/9781444392029, DOI 10.1002/9781444392029]; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Highton D. T., 2010, J NEUROSURG ANESTHES, V22, P419; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jones PA, 2005, ACT NEUR S, V95, P29; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Klein SP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50046-x; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; Panerai RB, 1998, STROKE, V29, P2341, DOI 10.1161/01.STR.29.11.2341; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Santos E, 2011, ACTA NEUROCHIR, V153, P2189, DOI 10.1007/s00701-011-1148-5; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Ter Minassian A, 2002, CRIT CARE MED, V30, P1616, DOI 10.1097/00003246-200207000-00036; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Trauma ACoSCo, 2015, BOOK BEST PRACT MAN; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zeiler FA, 2017, J NEUROTRAUM, V34, P3070, DOI 10.1089/neu.2017.5129; Zweifel C, 2010, NEUROL RES, V32, P425, DOI 10.1179/174313209X459165	48	10	10	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2021	34	3					731	738		10.1007/s12028-020-01185-x		JAN 2021	8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN4OZ	WOS:000611418300002	33495910	hybrid, Green Submitted, Green Published			2022-02-06	
J	Jolly, AE; Balaet, M; Azor, A; Friedland, D; Sandrone, S; Graham, NSN; Zimmerman, K; Sharp, DJ				Jolly, Amy E.; Balaet, Maria; Azor, Adriana; Friedland, Daniel; Sandrone, Stefano; Graham, Neil S. N.; Zimmerman, Karl; Sharp, David J.			Detecting axonal injury in individual patients after traumatic brain injury	BRAIN			English	Article						traumatic brain injury; diffusion tensor imaging; diffuse axonal injury; diagnostic pipeline	WHITE-MATTER INTEGRITY; HEAD-INJURY; COGNITIVE IMPAIRMENT; MAGNETIC-RESONANCE; DIFFUSION; CLASSIFICATION; ROBUST; OPTIMIZATION; REGISTRATION; ANISOTROPY	Poor outcomes after traumatic brain injury (TBI) are common yet remain difficult to predict. Diffuse axonal injury is important for outcomes, but its assessment remains limited in the clinical setting. Currently, axonal injury is diagnosed based on clinical presentation, visible damage to the white matter or via surrogate markers of axonal injury such as microbleeds. These do not accurately quantify axonal injury leading to misdiagnosis in a proportion of patients. Diffusion tensor imaging provides a quantitative measure of axonal injury in vivo, with fractional anisotropy often used as a proxy for white matter damage. Diffusion imaging has been widely used in TBI but is not routinely applied clinically. This is in part because robust analysis methods to diagnose axonal injury at the individual level have not yet been developed. Here, we present a pipeline for diffusion imaging analysis designed to accurately assess the presence of axonal injury in large white matter tracts in individuals. Average fractional anisotropy is calculated from tracts selected on the basis of high test-retest reliability, good anatomical coverage and their association to cognitive and clinical impairments after TBI. We test our pipeline for common methodological issues such as the impact of varying control sample sizes, focal lesions and age-related changes to demonstrate high specificity, sensitivity and test-retest reliability. We assess 92 patients with moderate-severe TBI in the chronic phase (>= 6 months post-injury), 25 patients in the subacute phase (10 days to 6 weeks post-injury) with 6-month follow-up and a large control cohort (n=103). Evidence of axonal injury is identified in 52% of chronic and 28% of subacute patients. Those classified with axonal injury had significantly poorer cognitive and functional outcomes than those without, a difference not seen for focal lesions or microbleeds. Almost a third of patients with unremarkable standard MRIs had evidence of axonal injury, whilst 40% of patients with visible microbleeds had no diffusion evidence of axonal injury. More diffusion abnormality was seen with greater time since injury, across individuals at various chronic injury times and within individuals between subacute and 6-month scans. We provide evidence that this pipeline can be used to diagnose axonal injury in individual patients at subacute and chronic time points, and that diffusion MRI provides a sensitive and complementary measure when compared to susceptibility weighted imaging, which measures diffuse vascular injury. Guidelines for the implementation of this pipeline in a clinical setting are discussed.	[Jolly, Amy E.; Balaet, Maria; Azor, Adriana; Friedland, Daniel; Sandrone, Stefano; Graham, Neil S. N.; Zimmerman, Karl; Sharp, David J.] Imperial Coll London, Fac Med, Dept Brain Sci, Clin Cognit & Computat Neuroimaging Lab C3NL, London W12 0NN, England; [Jolly, Amy E.; Sharp, David J.] Imperial Coll London, UK Dementia Res Inst, Care Res & Technol Ctr, London W12 0NN, England; [Jolly, Amy E.; Sharp, David J.] Univ Surrey, London W12 0NN, England		Jolly, AE (corresponding author), Imperial Coll London, Computat Cognit & Clin Neuroimaging Lab, 3rd Floor Burlington Danes Bldg, London W12 0NN, England.	amy.jolly@imperial.ac.uk	Zimmerman, Karl/AAL-4988-2020; Graham, Neil/AAN-2754-2021	Zimmerman, Karl/0000-0003-1239-3414; Graham, Neil/0000-0002-0183-3368; Jolly, Amy/0000-0002-7413-9772	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Care Research & Technology Centre, UK Dementia Research Institutee; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIHR-RP-011-048]; National institute of Health Research Clinical Research Facility and Biomedical Research Centre at Imperial College Healthcare NHS Trust; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006] Funding Source: UKRI	This work was supported by the Medical Research Council and the Care Research & Technology Centre, UK Dementia Research Institute. D.J.S. was funded by a National Institute of Health Research Professorship (NIHR-RP-011-048) and the work was supported by the National institute of Health Research Clinical Research Facility and Biomedical Research Centre at Imperial College Healthcare NHS Trust.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Bach M, 2014, MAGN RESON MED, V71, P1108, DOI 10.1002/mrm.24774; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cicuendez M, 2017, NEUROCIRUGIA, V28, P266, DOI [10.1016/j.neucir.2017.06.001, 10.1016/j.neucie.2017.06.007]; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; Costello MG, 2013, J NEUROSCI, V33, P16394, DOI 10.1523/JNEUROSCI.1899-13.2013; De Simoni S, 2018, BRAIN, V141, P148, DOI 10.1093/brain/awx309; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Gallagher MJ, 2007, ANN EMERG MED, V49, P125, DOI 10.1016/j.annemergmed.2006.06.043; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Halabieh O, 2008, LECT NOTES COMPUT SC, V5104, P107, DOI 10.1007/978-3-540-70521-5_12; Hashim E, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00097; Hellstrom T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13628-1; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jo HM, 2012, NEUROREHABILITATION, V31, P207, DOI 10.3233/NRE-2012-0790; Karayumak SC, 2019, NEUROIMAGE, V184, P180, DOI 10.1016/j.neuroimage.2018.08.073; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kramer JH., 2001, DELIS KAPLAN EXECUTI, DOI [10.1037/t15082-000, DOI 10.1037/T15082-000]; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Sairanen V, 2017, NEUROIMAGE, V147, P57, DOI 10.1016/j.neuroimage.2016.11.061; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	67	10	10	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JAN	2021	144		1				92	113		10.1093/brain/awaa372			22	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SA6XJ	WOS:000649444700025	33257929	hybrid, Green Published			2022-02-06	
J	Putukian, M; Riegler, K; Amalfe, S; Bruce, J; Echemendia, R				Putukian, Margot; Riegler, Kaitlin; Amalfe, Stephanie; Bruce, Jared; Echemendia, Ruben			Preinjury and Postinjury Factors That Predict Sports-Related Concussion and Clinical Recovery Time	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						modifiers; sex; neurocognitive evaluation; SCAT; symptoms; return to play		Objectives:To evaluate the relationship between preinjury risk factors (RFs) and subsequent occurrence of concussion and examine whether preinjury RFs or postinjury assessments predict clinical recovery in collegiate athletes. Methods:Risk factors (sex, sport, and self-report history of concussion, migraine, attention-deficit disorder, learning disability, depression, and anxiety) and Sport Concussion Assessment Tool (SCAT), depression/anxiety screenings, and neuropsychological testing were obtained before the season. For athletes who sustained concussion, RFs, postinjury SCAT, neuropsychological assessment, and clinical recovery were assessed. Results:We assessed 1152 athletes (69% male) at baseline and 145 (75% male) after subsequent concussion diagnosis. Only sport type (Wald = 40.29, P = 0.007) and concussion history (Wald = 9.91, P = 0.007) accounted for unique variance in subsequent concussion. Of athletes followed until full recovery, mean days until symptom-free (DUSF) was 9.84 +/- 11.11 days (n = 138, median = 5 days, range = 1-86) and mean days until full return to play (DUFRTP) was 20.21 +/- 19.17 (n = 98, median = 20.21, range = 4-150). None of the RFs or baseline testing measures were associated with DUSF or DUFRTP (P's > 0.05). After injury, athletes who reported more total symptoms (r(s) = 0.31, P < 0.001) and higher symptom severity (r(s) = 0.33, P < 0.001) exhibited longer DUSF. Days until symptom-free correlated with DUFRTP (r(s) = 0.75, P < 0.001). Among athletes assessed within 2 days after injury, DUSF was associated with Immediate Postconcussion Assessment and Cognitive Test visual motor (r(s) = -0.31, P = 0.004), reaction time (r(s) = 0.40, P < 0.001), and symptom score (r(s) = 0.54, P < 0.001). Conclusions:Only sport type and concussion history predicted subsequent occurrence of concussion, and none of the RFs or baseline measures predicted clinical recovery. Immediate postinjury assessments, including symptom number and severity, and select clinical measures predicted longer clinical recovery.	[Putukian, Margot; Riegler, Kaitlin; Amalfe, Stephanie] Princeton Univ, Dept Athlet Med, Univ Hlth Serv, Princeton, NJ 08544 USA; [Putukian, Margot] Univ Med & Dent New Jersey, Rutgers Robert Wood Johnson Med Sch, Princeton, NJ USA; [Riegler, Kaitlin] Penn State Univ, Dept Psychol, State Coll, PA USA; [Amalfe, Stephanie] Fairleigh Dickinson Univ, Teaneck, NJ USA; [Bruce, Jared] Univ Missouri, Dept Psychol, Kansas City, MO 64110 USA; [Bruce, Jared] Univ Missouri, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA; [Echemendia, Ruben] Univ Orthoped Comprehens Concuss Care Clin, State Coll, PA USA		Putukian, M (corresponding author), Princeton Univ, Univ Hlth Serv, Washington Rd, Princeton, NJ 08540 USA.	putukian@princeton.edu			National Collegiate Athletic AssociationDepartment of Defense Grand Alliance: Concussion Assessment, Research and Education (CARE) Consortium study	This study received partial funding from the National Collegiate Athletic AssociationDepartment of Defense Grand Alliance: Concussion Assessment, Research and Education (CARE) Consortium study. Dr. Putukian is a consultant to Major League Soccer's Sporting, Kansas City, Dr. Ruben Echemendia. Dr. Bruce is a part-time employee and consultant to the National Hockey League.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 2013, J SPORTS MED, V47, P259; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnston LH, 1998, J SPORT REHABIL, V7, P206, DOI 10.1123/jsr.7.3.206; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell M, 2000, IMPACT IMMEDIATE POS; Mainwaring L, 1999, CAN J REHABIL, V12, P145; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sufrinko A, 2017, J ATHL TRAINING, V52, P676, DOI 10.4085/1062-6050-52.4.01; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537	43	10	10	2	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2021	31	1					15	22		10.1097/JSM.0000000000000705			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	PR5RY	WOS:000607294800006	30540572				2022-02-06	
J	Floriddia, EM; Lourenco, T; Zhang, SP; van Bruggen, D; Hilscher, MM; Kukanja, P; dos Santos, JPG; Altinkok, M; Yokota, C; Llorens-Bobadilla, E; Mulinyawe, SB; Graos, M; Sun, LO; Frisen, J; Nilsson, M; Castelo-Branco, G				Floriddia, Elisa M.; Lourenco, Tania; Zhang, Shupei; van Bruggen, David; Hilscher, Markus M.; Kukanja, Petra; dos Santos, Joao P. Goncalves; Altinkok, Muge; Yokota, Chika; Llorens-Bobadilla, Enric; Mulinyawe, Sara B.; Graos, Mario; Sun, Lu O.; Frisen, Jonas; Nilsson, Mats; Castelo-Branco, Goncalo			Distinct oligodendrocyte populations have spatial preference and different responses to spinal cord injury	NATURE COMMUNICATIONS			English	Article							MYELINATING OLIGODENDROCYTES; POSTNATAL-DEVELOPMENT; GENE-EXPRESSION; CELLS; CNS; APOPTOSIS; SYSTEM; TISSUE; AXONS; SPECIFICATION	Mature oligodendrocytes (MOLs) show transcriptional heterogeneity, the functional consequences of which are unclear. MOL heterogeneity might correlate with the local environment or their interactions with different neuron types. Here, we show that distinct MOL populations have spatial preference in the mammalian central nervous system (CNS). We found that MOL type 2 (MOL2) is enriched in the spinal cord when compared to the brain, while MOL types 5 and 6 (MOL5/6) increase their contribution to the OL lineage with age in all analyzed regions. MOL2 and MOL5/6 also have distinct spatial preference in the spinal cord regions where motor and sensory tracts run. OL progenitor cells (OPCs) are not specified into distinct MOL populations during development, excluding a major contribution of OPC intrinsic mechanisms determining MOL heterogeneity. In disease, MOL2 and MOL5/6 present different susceptibility during the chronic phase following traumatic spinal cord injury. Our results demonstrate that the distinct MOL populations have different spatial preference and different responses to disease. The oligodendrocyte lineage is known for its transcriptional heterogeneity, but the functional consequences of this are unclear. Here, the authors show that distinct populations of mature oligodendrocytes have spatial preferences in the brain and spinal cord and show different responses to spinal cord injury.	[Floriddia, Elisa M.; Lourenco, Tania; Zhang, Shupei; van Bruggen, David; Kukanja, Petra; dos Santos, Joao P. Goncalves; Altinkok, Muge; Castelo-Branco, Goncalo] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, Biomed, S-17177 Stockholm, Sweden; [Lourenco, Tania; Graos, Mario] Biocant, Technol Transfer Assoc, Cantanhede, Portugal; [Lourenco, Tania; Graos, Mario] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal; [Hilscher, Markus M.; Yokota, Chika; Nilsson, Mats] Stockholm Univ, Dept Biophys & Biochem, Sci Life Lab, S-17165 Solna, Sweden; [Hilscher, Markus M.] Cartana AB, Nobels Vag 16, S-17165 Solna, Sweden; [Llorens-Bobadilla, Enric; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, Biomed, S-17177 Stockholm, Sweden; [Mulinyawe, Sara B.; Sun, Lu O.] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Sun, Lu O.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Castelo-Branco, Goncalo] Karolinska Inst, Ming Wai Lau Ctr Reparat Med, Stockholm Node, S-17177 Stockholm, Sweden		Floriddia, EM; Castelo-Branco, G (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, Biomed, S-17177 Stockholm, Sweden.; Castelo-Branco, G (corresponding author), Karolinska Inst, Ming Wai Lau Ctr Reparat Med, Stockholm Node, S-17177 Stockholm, Sweden.	elisa.floriddia@ki.se; goncalo.castelo-branco@ki.se	; Graos, Mario/O-7273-2017; Hilscher, Markus M./I-5941-2013	Pires Lourenco, Tania Milene/0000-0003-1198-8117; Graos, Mario/0000-0002-2707-1488; Hilscher, Markus M./0000-0001-7782-0830; Kukanja, Petra/0000-0003-1228-5923; Llorens Bobadilla, Enric/0000-0002-7891-1272	Karolinska InstituteKarolinska Institutet	Open Access funding provided by Karolinska Institute.	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Almad A, 2011, NEUROTHERAPEUTICS, V8, P262, DOI 10.1007/s13311-011-0033-5; Assinck P, 2017, J NEUROSCI, V37, P8635, DOI 10.1523/JNEUROSCI.2409-16.2017; Bando Y, 2018, GLIA, V66, P359, DOI 10.1002/glia.23249; Bechler ME, 2015, CURR BIOL, V25, P2411, DOI 10.1016/j.cub.2015.07.056; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bercury KK, 2015, DEV CELL, V32, P447, DOI 10.1016/j.devcel.2015.01.016; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Crawford AH, 2016, CELL REP, V15, P761, DOI 10.1016/j.celrep.2016.03.069; De la Rossa A, 2013, NAT NEUROSCI, V16, P193, DOI 10.1038/nn.3299; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Falcao AM, 2018, NAT MED, V24, P1837, DOI 10.1038/s41591-018-0236-y; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fogarty M, 2005, DEVELOPMENT, V132, P1951, DOI 10.1242/dev.01777; FOX MW, 1967, J COMP NEUROL, V130, P233, DOI 10.1002/cne.901300305; Hughes EG, 2018, NAT NEUROSCI, V21, P696, DOI 10.1038/s41593-018-0121-5; JOOSTEN EAJ, 1989, ANAT EMBRYOL, V179, P449, DOI 10.1007/BF00319587; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; KAPFHAMMER JP, 1994, J COMP NEUROL, V340, P194, DOI 10.1002/cne.903400206; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105; Leslie JR, 2011, DEVELOPMENT, V138, P4085, DOI 10.1242/dev.066076; Li GL, 1999, ACTA NEUROPATHOL, V98, P473, DOI 10.1007/s004010051112; LUDWIN SK, 1992, ACTA NEUROPATHOL, V84, P530, DOI 10.1007/BF00304472; LUDWIN SK, 1990, ACTA NEUROPATHOL, V80, P184, DOI 10.1007/BF00308922; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Lytle JM, 2007, EUR J NEUROSCI, V25, P1711, DOI 10.1111/j.1460-9568.2007.05390.x; Maniatis S, 2019, SCIENCE, V364, P89, DOI 10.1126/science.aav9776; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Marques S, 2018, DEV CELL, V46, P504, DOI 10.1016/j.devcel.2018.07.005; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Martin JH, 2005, NEUROSCIENTIST, V11, P161, DOI 10.1177/1073858404270843; Mayer C, 2018, NATURE, V555, P457, DOI 10.1038/nature25999; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mi D, 2018, SCIENCE, V360, P81, DOI 10.1126/science.aar6821; Micheva KD, 2016, ELIFE, V5, DOI 10.7554/eLife.15784; Murakami K, 2013, NEUROSCIENCE, V236, P1, DOI 10.1016/j.neuroscience.2012.12.073; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Simons M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020479; Soldatov R, 2019, SCIENCE, V364, P971, DOI 10.1126/science.aas9536; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun LO, 2018, CELL, V175, P1811, DOI 10.1016/j.cell.2018.10.044; Tiklova K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08453-1; Tomassy GS, 2016, TRENDS CELL BIOL, V26, P135, DOI 10.1016/j.tcb.2015.09.002; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Tripathi RB, 2017, CELL REP, V21, P316, DOI 10.1016/j.celrep.2017.09.050; Tripathi RB, 2011, J NEUROSCI, V31, P6809, DOI 10.1523/JNEUROSCI.6474-10.2011; Valny M, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00243; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; von Bartheld CS, 2016, J COMP NEUROL, V524, P3865, DOI 10.1002/cne.24040; Winkler CC, 2018, J NEUROSCI, V38, pS237, DOI 10.1523/JNEUROSCI.3392-17.2018; Wolpaw JR, 2007, ACTA PHYSIOL, V189, P155, DOI 10.1111/j.1748-1716.2006.01656.x; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zonouzi M, 2019, CELL REP, V27, P2799, DOI 10.1016/j.celrep.2019.05.018	66	10	10	1	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2041-1723			NAT COMMUN	Nat. Commun.	NOV 17	2020	11	1							5860	10.1038/s41467-020-19453-x			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ1ZB	WOS:000594731600011	33203872	gold, Green Published			2022-02-06	
J	Kochanek, PM; Jackson, TC; Jha, RM; Clark, RSB; Okonkwo, DO; Bayir, H; Poloyac, SM; Wagner, AK; Empey, PE; Conley, YP; Bell, MJ; Kline, AE; Bondi, CO; Simon, DW; Carlson, SW; Puccio, AM; Horvat, CM; Au, AK; Elmer, J; Treble-Barna, A; Ikonomovic, MD; Shutter, LA; Taylor, DL; Stern, AM; Graham, SH; Kagan, VE; Jackson, EK; Wisniewski, SR; Dixon, CE				Kochanek, Patrick M.; Jackson, Travis C.; Jha, Ruchira M.; Clark, Robert S. B.; Okonkwo, David O.; Bayir, Hulya; Poloyac, Samuel M.; Wagner, Amy K.; Empey, Philip E.; Conley, Yvette P.; Bell, Michael J.; Kline, Anthony E.; Bondi, Corina O.; Simon, Dennis W.; Carlson, Shaun W.; Puccio, Ava M.; Horvat, Christopher M.; Au, Alicia K.; Elmer, Jonathan; Treble-Barna, Amery; Ikonomovic, Milos D.; Shutter, Lori A.; Taylor, D. Lansing; Stern, Andrew M.; Graham, Steven H.; Kagan, Valerian E.; Jackson, Edwin K.; Wisniewski, Stephen R.; Dixon, C. Edward			Paths to Successful Translation of New Therapies for Severe Traumatic Brain Injury in the Golden Age of Traumatic Brain Injury Research: A Pittsburgh Vision	JOURNAL OF NEUROTRAUMA			English	Article						clinical trial design; combination therapy; consortium; traumatic brain injury (TBI); neuroprotection; pharmacodynamics; response biomarker; phenotyping; quantitative systems pharmacology; rehabilitation; target engagement	CONTROLLED CORTICAL IMPACT; CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; STRETCH-INJURY; HEAD-INJURY; ENVIRONMENTAL ENRICHMENT; DOPAMINE TRANSPORTER; HEMORRHAGIC-SHOCK; CONTROLLED-TRIAL; ISCHEMIC-STROKE	New neuroprotective therapies for severe traumatic brain injury (TBI) have not translated from pre-clinical to clinical success. Numerous explanations have been suggested in both the pre-clinical and clinical arenas. Coverage of TBI in the lay press has reinvigorated interest, creating a golden age of TBI research with innovative strategies to circumvent roadblocks. We discuss the need for more robust therapies. We present concepts for traditional and novel approaches to defining therapeutic targets. We review lessons learned from the ongoing work of the pre-clinical drug and biomarker screening consortium Operation Brain Trauma Therapy and suggest ways to further enhance pre-clinical consortia. Biomarkers have emerged that empower choice and assessment of target engagement by candidate therapies. Drug combinations may be needed, and it may require moving beyond conventional drug therapies. Precision medicine may also link the right therapy to the right patient, including new approaches to TBI classification beyond the Glasgow Coma Scale or anatomical phenotyping-incorporating new genetic and physiologic approaches. Therapeutic breakthroughs may also come from alternative approaches in clinical investigation (comparative effectiveness, adaptive trial design, use of the electronic medical record, and big data). The full continuum of care must also be represented in translational studies, given the important clinical role of pre-hospital events, extracerebral insults in the intensive care unit, and rehabilitation. TBI research from concussion to coma can cross-pollinate and further advancement of new therapies. Misconceptions can stifle/misdirect TBI research and deserve special attention. Finally, we synthesize an approach to deliver therapeutic breakthroughs in this golden age of TBI research.	[Kochanek, Patrick M.; Jackson, Travis C.; Jha, Ruchira M.; Clark, Robert S. B.; Bayir, Hulya; Poloyac, Samuel M.; Wagner, Amy K.; Empey, Philip E.; Kline, Anthony E.; Bondi, Corina O.; Simon, Dennis W.; Carlson, Shaun W.; Horvat, Christopher M.; Au, Alicia K.; Treble-Barna, Amery] UPMC Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Kochanek, Patrick M.; Jackson, Travis C.; Jha, Ruchira M.; Clark, Robert S. B.; Bayir, Hulya; Simon, Dennis W.; Horvat, Christopher M.; Au, Alicia K.; Shutter, Lori A.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Okonkwo, David O.; Puccio, Ava M.] UPMC Presbyterian Hosp, Dept Neurol Surg, Pittsburgh, PA USA; [Bayir, Hulya; Kagan, Valerian E.] Univ Pittsburgh, Sch Med, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Poloyac, Samuel M.] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA; [Wagner, Amy K.; Kline, Anthony E.; Bondi, Corina O.; Treble-Barna, Amery] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Empey, Philip E.] Univ Pittsburgh, Sch Pharm, Pharm & Therapeut, Pittsburgh, PA USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Hlth Promot & Dev, Pittsburgh, PA 15261 USA; [Bell, Michael J.] Childrens Natl Med Ctr, Dept Crit Care Med, Washington, DC 20010 USA; [Carlson, Shaun W.; Dixon, C. Edward] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Elmer, Jonathan] Univ Pittsburgh, Sch Med, UPMC Presbyterian Hosp, Dept Emergency Med, Pittsburgh, PA USA; [Elmer, Jonathan] Univ Pittsburgh, Sch Med, UPMC Presbyterian Hosp, Dept Crit Care Med, Pittsburgh, PA USA; [Ikonomovic, Milos D.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Taylor, D. Lansing] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA; [Stern, Andrew M.] Univ Pittsburgh, Dept Computat & Syst Biol, Drug Discovery Inst, Pittsburgh, PA USA; [Graham, Steven H.; Dixon, C. Edward] VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Jackson, Edwin K.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Wisniewski, Stephen R.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Ikonomovic, Milos D.; Graham, Steven H.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, John G Rangos Res Ctr, Safar Ctr Resuscitat Res,UPMC Childrens Hosp Pitt, 6th Floor 4401 Penn Ave, Pittsburgh, PA 15224 USA.	kochanekpm@ccm.upmc.edu	Shutter, Lori A/G-2957-2013; Empey, Philip/L-9604-2019	Empey, Philip/0000-0001-7474-2339; Conley, Yvette/0000-0002-1784-6067	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD040686] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS097629, R01 NS102195, K23 NS104133, R01 NS087978, K23 NS101036, R01 NS091062] Funding Source: Medline; RRD VA [I01 RX001778, I01 RX001127] Funding Source: Medline		Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Adams SM, 2017, PHARMACOGENOMICS, V18, P1427, DOI 10.2217/pgs-2017-0073; An N, 2018, MOL NEUROBIOL, V55, P642, DOI 10.1007/s12035-016-0350-0; Anderson KD, 2017, J NEUROTRAUM, V34, P2950, DOI 10.1089/neu.2016.4895; Arnett HA, 2007, ADV DRUG DELIVER REV, V59, P1084, DOI 10.1016/j.addr.2007.06.013; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bombardier CH, 2017, J HEAD TRAUMA REHAB, V32, P343, DOI 10.1097/HTR.0000000000000288; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brayer SW, 2015, NEUROREHAB NEURAL RE, V29, P483, DOI 10.1177/1545968314550367; Brockman EC, 2013, J CEREBR BLOOD F MET, V33, P1457, DOI 10.1038/jcbfm.2013.104; Brophy GM, 2013, J NEUROTRAUM, V30, P1484, DOI 10.1089/neu.2012.2524; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ REL; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Choong K, 2017, PEDIATR CRIT CARE ME, V18, pE546, DOI 10.1097/PCC.0000000000001329; Clark RSB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180280; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Dash R, 2011, MAGN RESON MED, V66, P1152, DOI 10.1002/mrm.22876; de la Tremblaye PB, 2019, NEUROPHARMACOLOGY, V145, P13, DOI 10.1016/j.neuropharm.2018.02.032; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Deveau AP, 2017, EXP HEMATOL, V45, P1, DOI 10.1016/j.exphem.2016.09.012; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Diamond ML, 2015, EPILEPSIA, V56, P991, DOI 10.1111/epi.13100; Dias C, 2014, J NEUROTRAUM, V31, P1872, DOI 10.1089/neu.2014.3376; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Du LN, 2016, J NEUROTRAUM, V33, P1913, DOI 10.1089/neu.2015.4342; Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007; Esenaliev RO, 2018, J NEUROTRAUM, V35, P1510, DOI 10.1089/neu.2017.5249; Ewart L, 2017, EXP BIOL MED, V242, P1579, DOI 10.1177/1535370217715441; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Falco-Walter JJ, 2016, J CLIN MED, V5, P49, DOI 10.3390/jcm5050049; Ferguson NM, 2017, CRIT CARE MED, V45, P1398, DOI 10.1097/CCM.0000000000002378; Ferguson S, 2017, J NEUROTRAUM, V34, P1676, DOI 10.1089/neu.2016.4636; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Hagos FT, 2018, CRIT CARE MED, V46, P1471, DOI 10.1097/CCM.0000000000003203; Hagos FT, 2017, XENOBIOTICA, V47, P346, DOI 10.1080/00498254.2016.1187777; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Horvat CM, 2017, JAMA PEDIATR, V171, P942, DOI 10.1001/jamapediatrics.2017.2390; Hossain I, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00500; Houtrow A, 2017, PEDIATR CRIT CARE ME, V18, P1080, DOI 10.1097/PCC.0000000000001345; Howells T, 2018, CRIT CARE MED, V46, pe235, DOI 10.1097/CCM.0000000000002930; Huijben JA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2000-6; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Ikonomovic MD, 2019, NEUROPHARMACOLOGY, V145, P160, DOI 10.1016/j.neuropharm.2018.06.021; Jackson EK, 2016, J NEUROCHEM, V137, P142, DOI 10.1111/jnc.13551; Jackson TC, 2018, EXP NEUROL, V300, P232, DOI 10.1016/j.expneurol.2017.11.013; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Jha RM, 2018, J NEUROTRAUM, V35, P2125, DOI 10.1089/neu.2016.4696; Jha RM, 2018, CRIT CARE MED, V46, P1792, DOI 10.1097/CCM.0000000000003361; Jha RM, 2017, NEUROCRIT CARE, V26, P213, DOI 10.1007/s12028-016-0309-z; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kannan S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003162; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kochanek PM, 2018, MIL MED, V183, P303, DOI 10.1093/milmed/usx184; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Kochanek PM, 2015, CRIT CARE MED, V43, P1544, DOI 10.1097/CCM.0000000000001041; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; Kurz JE, 2016, PEDIATR CRIT CARE ME, V17, P649, DOI 10.1097/PCC.0000000000000765; Lamade AM, 2019, NEUROPHARMACOLOGY, V145, P209, DOI 10.1016/j.neuropharm.2018.07.014; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Li X, 2018, LAB CHIP, V18, P2614, DOI 10.1039/c8lc00418h; Liao GP, 2015, PEDIATR CRIT CARE ME, V16, P245, DOI 10.1097/PCC.0000000000000324; Lithgow GJ, 2017, NATURE, V548, P387, DOI 10.1038/548387a; Lopez-Garcia I, 2018, BRIT J PHARMACOL, V175, P284, DOI 10.1111/bph.13642; Low LA, 2017, LAB CHIP, V17, P3026, DOI 10.1039/c7lc00462a; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Maria NSS, 2017, J NEUROTRAUM, V34, P1692, DOI 10.1089/neu.2016.4747; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Markos SM, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000224; Matei N, 2018, J NEUROSCI, V38, P6787, DOI 10.1523/JNEUROSCI.2352-17.2018; McCutcheon V, 2017, J NEUROTRAUM, V34, P1382, DOI 10.1089/neu.2016.4497; Medda X, 2016, J BIOMOL SCREEN, V21, P804, DOI 10.1177/1087057116638029; Meinert E, 2018, PEDIATR CRIT CARE ME, V19, P345, DOI 10.1097/PCC.0000000000001471; Mokhtari M, 2018, J CLIN PHARMACOL, V58, P42, DOI 10.1002/jcph.980; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Nudi ET, 2015, J NEUROTRAUM, V32, P1117, DOI 10.1089/neu.2014.3618; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Park JW, 2016, NEW ENGL J MED, V375, P11, DOI 10.1056/NEJMoa1513750; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Pei F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17378-y; Phelps TI, 2017, NEUROREHAB NEURAL RE, V31, P25, DOI 10.1177/1545968316650281; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Pischiutta F, 2016, CRIT CARE MED, V44, pE1118, DOI 10.1097/CCM.0000000000001864; Rakholia MV, 2019, J NEUROTRAUM, V36, P1156, DOI 10.1089/neu.2018.5782; Ritter AC, 2016, EPILEPSIA, V57, P984, DOI 10.1111/epi.13397; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Samhan-Arias AK, 2012, BBA-BIOMEMBRANES, V1818, P2413, DOI 10.1016/j.bbamem.2012.03.014; Sarnaik AA, 2010, J NEUROTRAUM, V27, P465, DOI 10.1089/neu.2009.1171; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Schwerin SC, 2017, J NEUROSCI METH, V285, P82, DOI 10.1016/j.jneumeth.2017.05.010; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shannon RJ, 2014, BRIT J CLIN PHARMACO, V78, P981, DOI 10.1111/bcp.12414; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Shein SL, 2016, PEDIATR CRIT CARE ME, V17, P236, DOI 10.1097/PCC.0000000000000610; Sherman SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34097; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simon DW, 2016, METHODS MOL BIOL, V1462, P393, DOI 10.1007/978-1-4939-3816-2_22; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sorby-Adams AJ, 2018, AM J PHYSIOL-REG I, V315, pR165, DOI 10.1152/ajpregu.00163.2017; Sorger PK., 2011, QUANTITATIVE SYSTEMS; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Springer JE, 2018, J NEUROTRAUM, V35, P492, DOI 10.1089/neu.2017.5167; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Stern AM, 2016, J BIOMOL SCREEN, V21, P521, DOI 10.1177/1087057116635818; Sun P, 2018, J CEREBR BLOOD F MET, V38, P1125, DOI 10.1177/0271678X18773871; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Talisa VB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01502; Thelin EP, 2017, AAPS J, V19, P367, DOI 10.1208/s12248-016-0027-7; Tso D, 2015, NEURAL REGEN RES, V10, P1356, DOI 10.4103/1673-5374.165209; U.S . Food and Drug Administration, 2018, BIOM QUAL; Vaughan L, 2017, J NEUROTRAUM, V34, pA102; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; von Holstein-Rathlou S, 2018, NEUROSCI LETT, V662, P253, DOI 10.1016/j.neulet.2017.10.035; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0791-5; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wagner AK, 2010, EPILEPSY RES, V90, P259, DOI 10.1016/j.eplepsyres.2010.06.001; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Wieczorek B, 2016, PEDIATR CRIT CARE ME, V17, pE559, DOI 10.1097/PCC.0000000000000983; Wilson MS, 2005, J NEUROSCI RES, V80, P85, DOI 10.1002/jnr.20419; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Wipf P, 2005, J AM CHEM SOC, V127, P12460, DOI 10.1021/ja053679l; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yang ZH, 2019, J NEUROTRAUM, V36, P348, DOI 10.1089/neu.2017.5586; Young AMH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148817; Yue JK, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.791; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zivi I, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00559; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	184	10	10	2	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2020	37	22					2353	2371		10.1089/neu.2018.6203			19	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	OP2MH	WOS:000587918100002	30520681	Bronze, Green Published			2022-02-06	
J	Simon, DW; Rogers, MB; Gao, Y; Vincent, G; Firek, BA; Janesko-Feldman, K; Vagni, V; Kochanek, PM; Ozolek, JA; Mollen, KP; Clark, RSB; Morowitz, MJ				Simon, Dennis W.; Rogers, Matthew B.; Gao, Yuan; Vincent, Garret; Firek, Brian A.; Janesko-Feldman, Keri; Vagni, Vincent; Kochanek, Patrick M.; Ozolek, John A.; Mollen, Kevin P.; Clark, Robert S. B.; Morowitz, Michael J.			Depletion of gut microbiota is associated with improved neurologic outcome following traumatic brain injury	BRAIN RESEARCH			English	Article						Head injury; Antibiotic; Microbiome; Inflammation; Gut-brain axis	CONTROLLED CORTICAL IMPACT; RATS; TRANSLOCATION; PERMEABILITY; ANTIBIOTICS; ACTIVATION; DYSBIOSIS; BACTERIA; HEALTH; MICE	Signaling between intestinal microbiota and the brain influences neurologic outcome in multiple forms of brain injury. The impact of gut microbiota following traumatic brain injury (FBI) has not been well established. Our objective was to compare TBI outcomes in specific pathogen-free mice with or without depletion of intestinal bacteria. Adult male C57BL6/J SPF mice (n = 6/group) were randomized to standard drinking water or ampicillin (1 g/L), metronidazole (1 g/L), neomycin (1 g/L), and vancomycin (0.5 g/L) (AMNV) containing drinking water 14 days prior to controlled cortical impact (CCI) model of TBI. 16S rRNA gene sequencing of fecal pellets was performed and alpha and beta diversity determined. Hippocampal neuronal density and microglial activation was assessed 72 h post-injury by immunohistochemistry. In addition, mice (n = 8-12/group) were randomized to AMNV or no treatment initiated immediately after CCI and memory acquisition (fear conditioning) and lesion volume assessed. Mice receiving AMNV had significantly reduced alpha diversity (p < 0.05) and altered microbiota community composition compared to untreated mice (PERMANOVA: p < 0.01). Mice receiving AMNV prior to TBI had increased CAl hippocampal neuronal density (15.2 +/- 1.4 vs. 8.8 +/- 2.1 cells/0.1 mm; p < 0.05) and a 26.6 +/- 6.6% reduction in Iba-1 positive cells (p < 0.05) at 72 h. Mice randomized to AMNV immediately after CCI had attenuated associative learning deficit on fear conditioning test (%freeze Cue: 63.7 +/- 2.7% vs. 41.0 +/- 5.1%, p < 0.05) and decreased lesion volume (27.2 +/- 0.8 vs. 24.6 +/- 0.7 mm(3), p < 0.05). In conclusion, depletion of intestinal microbiota was consistent with a neuroprotective effect whether initiated before or after injury in a murine model of TBI. Further investigations of the role of gut microbiota in TBI are warranted.	[Simon, Dennis W.; Gao, Yuan; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Dept Crit Care Med, Sch Med, Pittsburgh, PA USA; [Simon, Dennis W.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Rogers, Matthew B.; Vincent, Garret; Firek, Brian A.; Mollen, Kevin P.; Morowitz, Michael J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Simon, Dennis W.; Rogers, Matthew B.; Gao, Yuan; Vincent, Garret; Firek, Brian A.; Janesko-Feldman, Keri; Vagni, Vincent; Kochanek, Patrick M.; Ozolek, John A.; Mollen, Kevin P.; Clark, Robert S. B.; Morowitz, Michael J.] Univ Pittsburgh, Dept Environm, Sch Med, Pittsburgh, PA USA; [Simon, Dennis W.; Rogers, Matthew B.; Gao, Yuan; Vincent, Garret; Firek, Brian A.; Janesko-Feldman, Keri; Vagni, Vincent; Kochanek, Patrick M.; Ozolek, John A.; Mollen, Kevin P.; Clark, Robert S. B.; Morowitz, Michael J.] Univ Pittsburgh, Dept Occupat Hlth, Sch Med, Pittsburgh, PA USA; [Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Clin, Pittsburgh, PA USA; [Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Translat Sci Inst, Pittsburgh, PA USA; [Simon, Dennis W.; Janesko-Feldman, Keri; Vagni, Vincent; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Safar, Ctr Resuscitat Res, Pittsburgh, PA USA; [Morowitz, Michael J.] Univ Pittsburgh, Sch Med, Dept Ctr Microbiome & Med, Pittsburgh, PA USA; [Ozolek, John A.] West Virginia Univ, Dept Pathol Anat & Lab Med, Morgantown, WV 26506 USA		Simon, DW (corresponding author), Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	denunis.simon2@chp.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD040686] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01 DK120986, R03 DK114464, K08 DK101753] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS115173] Funding Source: Medline		Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Brockman EC, 2013, J CEREBR BLOOD F MET, V33, P1457, DOI 10.1038/jcbfm.2013.104; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Dinan TG, 2017, GASTROENTEROL CLIN N, V46, P77, DOI 10.1016/j.gtc.2016.09.007; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; Fernandes MR, 2017, MICROB DRUG RESIST, V23, P56, DOI 10.1089/mdr.2015.0320; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hoban AE, 2018, MOL PSYCHIATR, V23, P1134, DOI 10.1038/mp.2017.100; Horai R, 2015, IMMUNITY, V43, P343, DOI 10.1016/j.immuni.2015.07.014; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Kochanek P.M., 2019, J NEUROTRAUMA; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morowitz MJ, 2017, CRIT CARE MED, V45, pE516, DOI [10.1097/CCM.0000000000002291, 10.1097/ccm.0000000000002291]; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; O'Hagan C, 2017, NEUROBIOL LEARN MEM, V144, P36, DOI 10.1016/j.nlm.2017.05.015; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Price R., 2014, BMJ, V348, P348; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Rodrigues RR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02306; Rogers MB, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0211-0; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Simon DW, 2018, J NEUROTRAUM, V35, P130, DOI 10.1089/neu.2017.5093; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Stanley D, 2016, NAT MED, V22, P1277, DOI 10.1038/nm.4194; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Wang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5432; Wang YM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00374; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Winek K, 2016, STROKE, V47, P1354, DOI 10.1161/STROKEAHA.115.011800; Wu SP, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12356; Yeh A, 2016, SHOCK, V46, P649, DOI 10.1097/SHK.0000000000000691; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	50	10	10	2	36	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 15	2020	1747								147056	10.1016/j.brainres.2020.147056			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NR3EY	WOS:000571446800006	32798452	Green Accepted			2022-02-06	
J	Farr, SA; Cuzzocrea, S; Esposito, E; Campolo, M; Niehoff, ML; Doyle, TM; Salvemini, D				Farr, Susan A.; Cuzzocrea, Salvatore; Esposito, Emanuela; Campolo, Michela; Niehoff, Michael L.; Doyle, Timothy M.; Salvemini, Daniela			Adenosine A(3) receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury; A(3)AR; Neuroinflammation; Cognitive impairment; NLRP3	NF-KAPPA-B; CONTROLLED CORTICAL IMPACT; RHEUMATOID-ARTHRITIS; CEREBROSPINAL-FLUID; NLRP3 INFLAMMASOME; NEUROPATHIC PAIN; STAB INJURY; IN-VITRO; ACTIVATION; AGONIST	Background Traumatic brain injury (TBI) is a common pathological condition that presently lacks a specific pharmacological treatment. Adenosine levels rise following TBI, which is thought to be neuroprotective against secondary brain injury. Evidence from stroke and inflammatory disease models suggests that adenosine signaling through the G protein-coupled A(3) adenosine receptor (A(3)AR) can provide antiinflammatory and neuroprotective effects. However, the role of A(3)AR in TBI has not been investigated. Methods Using the selective A(3)AR agonist, MRS5980, we evaluated the effects of A(3)AR activation on the pathological outcomes and cognitive function in CD1 male mouse models of TBI. Results When measured 24 h after controlled cortical impact (CCI) TBI, male mice treated with intraperitoneal injections of MRS5980 (1 mg/kg) had reduced secondary tissue injury and brain infarction than vehicle-treated mice with TBI. These effects were associated with attenuated neuroinflammation marked by reduced activation of nuclear factor of kappa light polypeptide gene enhancer in B cells (NF kappa B) and MAPK (p38 and extracellular signal-regulated kinase (ERK)) pathways and downstream NOD-like receptor pyrin domain-containing 3 inflammasome activation. MRS5980 also attenuated TBI-induced CD4(+) and CD8(+) T cell influx. Moreover, when measured 4-5 weeks after closed head weight-drop TBI, male mice treated with MRS5980 (1 mg/kg) performed significantly better in novel object-placement retention tests (NOPRT) and T maze trials than untreated mice with TBI without altered locomotor activity or increased anxiety. Conclusion Our results provide support for the beneficial effects of small molecule A(3)AR agonists to mitigate secondary tissue injury and cognitive impairment following TBI.	[Farr, Susan A.] Vet Affairs Med Ctr, 915 N Grand Blvd, St Louis, MO 63106 USA; [Farr, Susan A.; Niehoff, Michael L.] St Louis Univ, Sch Med, Div Geriatr Med, Dept Internal Med, 1402 S Grand Blvd, St Louis, MO 63104 USA; [Farr, Susan A.; Doyle, Timothy M.; Salvemini, Daniela] St Louis Univ, Sch Med, Dept Pharmacol & Physiol, 1402 S Grand Blvd, St Louis, MO 63104 USA; [Farr, Susan A.; Doyle, Timothy M.; Salvemini, Daniela] St Louis Univ, Sch Med, Henry & Amelia Nasrallah Ctr Neurosci, 1402 S Grand Blvd, St Louis, MO 63104 USA; [Cuzzocrea, Salvatore; Esposito, Emanuela; Campolo, Michela] Univ Messina, Dept Clin & Expt Med & Pharmacol, I-98122 Messina, Italy		Salvemini, D (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol, 1402 S Grand Blvd, St Louis, MO 63104 USA.; Salvemini, D (corresponding author), St Louis Univ, Sch Med, Henry & Amelia Nasrallah Ctr Neurosci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	daniela.salvemini@health.slu.edu	Campolo, Michela/K-6432-2016	Farr, Susan/0000-0002-0481-2570	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS111120-01A1]	Studies were supported by grants from the National Institute of Neurological Disorders and Stroke (NINDS) 1R01NS111120-01A1 (D. Salvemini and S. Farr).	Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Alvarez G, 1999, FEBS LETT, V453, P260, DOI 10.1016/S0014-5793(99)00685-7; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bell MJ, 2001, CRIT CARE MED, V29, P399, DOI 10.1097/00003246-200102000-00033; Bjelobaba I, 2011, J NEUROSCI RES, V89, P862, DOI 10.1002/jnr.22599; Bjelobaba I, 2009, GEN PHYSIOL BIOPHYS, V28, P62; Boison D, 2013, PHARMACOL REV, V65, P906, DOI 10.1124/pr.112.006361; Borea PA, 2018, PHYSIOL REV, V98, P1591, DOI 10.1152/physrev.00049.2017; Borea PA, 2015, PHARMACOL REV, V67, P74, DOI 10.1124/pr.113.008540; Bruschetta Giuseppe, 2017, Front Neurosci, V11, P6, DOI 10.3389/fnins.2017.00006; Campolo M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0196-1; Casili G, 2018, J NEUROTRAUM, V35, P1437, DOI 10.1089/neu.2017.5260; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Choi IY, 2011, AM J PATHOL, V179, P2042, DOI 10.1016/j.ajpath.2011.07.006; Coppi E, 2019, PAIN; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Cuzzocrea S, 2018, J NEUROTRAUM, V35, P1452, DOI 10.1089/neu.2017.5391; Daglas M, 2019, CELL REP, V29, P1178, DOI 10.1016/j.celrep.2019.09.046; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Demir D, 2019, INJURY, V50, P1586, DOI 10.1016/j.injury.2019.08.036; Effendi WI, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030785; Farr SA, 2000, BRAIN RES, V872, P242, DOI 10.1016/S0006-8993(00)02495-1; Farr SA, 2019, J NEUROTRAUM, V36, P1869, DOI 10.1089/neu.2018.5999; Fedorova IM, 2003, CELL MOL NEUROBIOL, V23, P431, DOI 10.1023/A:1023601007518; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Fishman P, 2012, DRUG DISCOV TODAY, V17, P359, DOI 10.1016/j.drudis.2011.10.007; Fogal B, 2008, J NEUROCHEM, V106, P1, DOI 10.1111/j.1471-4159.2008.05315.x; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Gebril HM, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa017; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Graff HJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026104; Haeusler D, 2015, EUR J NUCL MED MOL I, V42, P928, DOI 10.1007/s00259-014-2985-2; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; He Q, 2012, ASIAN PAC J CANCER P, V13, P1365, DOI 10.7314/APJCP.2012.13.4.1365; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jacobson KA, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00124; Jacobson KA, 2018, MED RES REV, V38, P1031, DOI 10.1002/med.21456; Janes K, 2014, PAIN, V155, P2560, DOI 10.1016/j.pain.2014.09.016; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jin W, 2016, J MOL HISTOL, V47, P259, DOI 10.1007/s10735-016-9670-7; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kiesman William F, 2009, Handb Exp Pharmacol, P25, DOI 10.1007/978-3-540-89615-9_2; Kochanek P, 2013, ADENOSINE; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar D, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2019.134347; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu XF, 2017, PURINERG SIGNAL, V13, P529, DOI 10.1007/s11302-017-9579-y; Lusardi TA, 2009, CURR NEUROPHARMACOL, V7, P228, DOI 10.2174/157015909789152137; Lusardi Theresa A., 2020, Journal of Caffeine and Adenosine Research, V10, P12, DOI 10.1089/caff.2019.0012; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; Nedeljkovic N, 2008, NEUROCHEM RES, V33, P873, DOI 10.1007/s11064-007-9529-0; Newell EA, 2020, J NEUROTRAUM, V37, P635, DOI 10.1089/neu.2019.6675; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Ochaion A, 2008, BIOCHEM PHARMACOL, V76, P482, DOI 10.1016/j.bcp.2008.05.032; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Robertson CL, 2001, CRIT CARE MED, V29, P2287, DOI 10.1097/00003246-200112000-00009; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Salvemini D, 2017, EXPERT OPIN THER PAT, V27, P967, DOI 10.1080/13543776.2017.1341018; Schabitz WR, 1999, STROKE, V30, P427, DOI 10.1161/01.STR.30.2.427; Silverman MH, 2008, J RHEUMATOL, V35, P41; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sochocka M, 2017, MOL NEUROBIOL, V54, P8071, DOI 10.1007/s12035-016-0297-1; Stemmer SM, 2013, ONCOLOGIST, V18, P25, DOI 10.1634/theoncologist.2012-0211; Tosh DK, 2014, J MED CHEM, V57, P9901, DOI 10.1021/jm501021n; Tosh DK, 2020, ACS MED CHEM LETT; Tsuchiya K, 2014, CRIT REV IMMUNOL, V34, P41, DOI 10.1615/CritRevImmunol.2013008686; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; Von Lubitz DKJE, 1999, EUR J PHARMACOL, V367, P157, DOI 10.1016/S0014-2999(98)00977-7; Von Lubitz DKJE, 2001, ANN NY ACAD SCI, V939, P85; VONLUBITZ DKJE, 1994, EUR J PHARMACOL, V263, P59, DOI 10.1016/0014-2999(94)90523-1; Wahlman C, 2018, PAIN, V159, P1025, DOI 10.1097/j.pain.0000000000001177; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Zvejniece L, 2020, J NEUROTRAUM, V37, P295, DOI 10.1089/neu.2019.6524	96	10	11	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	NOV 12	2020	17	1							339	10.1186/s12974-020-02009-7			14	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	OX9DC	WOS:000593855400002	33183330	Green Published, gold			2022-02-06	
J	Dietrick, B; Molloy, E; Massaro, AN; Strickland, T; Zhu, J; Slevin, M; Donoghue, V; Sweetman, D; Kelly, L; O'Dea, M; McGowan, M; Vezina, G; Glass, P; Vaidya, D; Brooks, S; Northington, F; Everett, AD				Dietrick, Barbara; Molloy, Eleanor; Massaro, An N.; Strickland, Tammy; Zhu, Jie; Slevin, Marie; Donoghue, Veronica; Sweetman, Deirdre; Kelly, Lynne; O'Dea, Mary; McGowan, Meaghan; Vezina, Gilbert; Glass, Penny; Vaidya, Dhananjay; Brooks, Sandra; Northington, Frances; Everett, Allen D.			Plasma and Cerebrospinal Fluid Candidate Biomarkers of Neonatal Encephalopathy Severity and Neurodevelopmental Outcomes	JOURNAL OF PEDIATRICS			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; FIBRILLARY ACIDIC PROTEIN; TRAUMATIC BRAIN-INJURY; WHOLE-BODY HYPOTHERMIA; NEUROTROPHIC FACTOR; PERINATAL ASPHYXIA; MR SPECTROSCOPY; TAU-PROTEIN; SERUM; TERM	Objectives: To identify candidate biomarkers in both plasma and cerebrospinal fluid (CSF) that are associated with neonatal encephalopathy severity measured by encephalopathy grade, seizures, brain injury by magnetic resonance imaging (MRI), and neurodevelopmental outcomes at 15-30 months. Study design: A retrospective cohort study of plasma (N = 155, day of life 0-1) and CSF (n = 30, day of life 0-7) from neonates with neonatal encephalopathy and healthy neonates born at term (N = 30, >= 36 weeks of gestation) was conducted. We measured central nervous system necrosis (glial fibrillary acidic protein [GFAP], neurogranin [NRGN], tau), inflammatory (interleukin [IL]-6, IL-8, IL-10), and trophic (brain-derived neurotrophic factor [BDNF], vascular endothelial growth factor) proteins. Clinical outcomes were Sarnat scores of encephalopathy, seizures, MRI scores, and Bayley Scales of Infant and Toddler Development III at 15-30 months. Results: Plasma NRGN, tau, IL-6, IL-8, and IL-10 were greater, whereas BDNF and vascular endothelial growth factor were lower in patients with neonatal encephalopathy vs controls. In plasma, tau, GFAP, and NRGN were directly and BDNF inversely associated with encephalopathy grade. IL-6 was inversely related to seizures. Tau was directly related to MRI abnormalities. Tau was inversely associated with Bayley Scales of Infant and Toddler Development III cognitive and motor outcomes. In CSF, NRGN was inversely associated with cognitive, motor, and language measures. GFAP, IL-6, and IL-10 were inversely related to cognitive and motor outcomes. IL-8 was inversely related to motor outcomes. CSF candidate biomarkers showed no significant relationships with encephalopathy grade, seizures, or MRI abnormalities. Conclusions: Plasma candidate biomarkers predicted encephalopathy severity, seizures, MRI abnormalities, and neurodevelopmental outcomes at 15-30 months.	[Dietrick, Barbara; Zhu, Jie; Vaidya, Dhananjay; Northington, Frances; Everett, Allen D.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Molloy, Eleanor; Strickland, Tammy; Kelly, Lynne; O'Dea, Mary] Univ Dublin, Trinity Coll, Paediat, Dublin, Ireland; [Molloy, Eleanor; Strickland, Tammy; Kelly, Lynne; O'Dea, Mary] Coombe Women & Infants Univ Hosp, Dublin, Ireland; [Massaro, An N.; McGowan, Meaghan; Vezina, Gilbert; Glass, Penny] Childrens Natl Hlth Syst, Washington, DC USA; [Zhu, Jie; Northington, Frances; Everett, Allen D.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Slevin, Marie; Donoghue, Veronica; Sweetman, Deirdre] Natl Matern Hosp, Dublin, Ireland; [Brooks, Sandra] Johns Hopkins All Childrens Hosp, St Petersburg, FL USA		Dietrick, B (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.		Molloy, Eleanor/I-3435-2019	Molloy, Eleanor/0000-0001-6798-2158; Kelly, Lynne/0000-0002-4782-1143; Massaro, An/0000-0002-5543-6165; Strickland, Tammy/0000-0003-4185-446X	National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD086058]; Health Research Board, Ireland; Trinity College Dublin; National Children's Research Centre; Clinical and Translational Science Institute at Children's National [UL1TR000075, 1KL2RR031987-01]; Intellectual and Developmental Disabilities Research Consortium [NIH P30HD040677]	Supported by National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD086058 [to A.E. and F.N.]); Health Research Board, Ireland; Trinity College Dublin; National Children's Research Centre; Clinical and Translational Science Institute at Children's National (UL1TR000075, 1KL2RR031987-01 [to A.M.]); and the Intellectual and Developmental Disabilities Research Consortium (NIH P30HD040677 [to A.M.]). Under a license agreement between ImmunArray Ltd and the Johns Hopkins University, the University and A.E. are entitled to royalties on an invention described in this study and discussed in this publication. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies. The other authors declare no conflicts of interest.	Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P143; Bartha AI, 2004, PEDIATR RES, V56, P960, DOI 10.1203/01.PDR.0000144819.45689.BB; Bayley N., 2006, BAYLEY SCALES INFANT; Bembea MM, 2011, PEDIATR CRIT CARE ME, V12, P572, DOI 10.1097/PCC.0b013e3181fe3ec7; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Blennow K, 2017, NEUROL THER, V6, pS15, DOI 10.1007/s40120-017-0073-9; BLENNOW M, 1995, PEDIATR RES, V37, P260, DOI 10.1203/00006450-199503000-00002; Blennow M, 2001, ACTA PAEDIATR, V90, P1171, DOI 10.1080/080352501317061594; Celik Y, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0188-5; Cevik S, 2019, CLIN NEUROL NEUROSUR, V183, DOI 10.1016/j.clineuro.2019.105380; Chalak LF, 2014, J PEDIATR-US, V164, P468, DOI 10.1016/j.jpeds.2013.10.067; Chaparro-Huerta V, 2017, PEDIATR NEONATOL, V58, P70, DOI 10.1016/j.pedneo.2016.05.001; Cotten CM, 2014, J PEDIATR-US, V164, P973, DOI 10.1016/j.jpeds.2013.11.036; D'Alton ME, 2014, OBSTET GYNECOL, V123, P896; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dingley J, 2014, PEDIATRICS, V133, P809, DOI 10.1542/peds.2013-0787; Douglas-Escobar M, 2015, JAMA PEDIATR, V169, P397, DOI 10.1001/jamapediatrics.2014.3269; Ennen CS, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.025; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gorath M, 2001, GLIA, V36, P89, DOI 10.1002/glia.1098; Grad S, 1998, CLIN CHEM LAB MED, V36, P379, DOI 10.1515/CCLM.1998.064; Graham EM, 2018, CURR OPIN PEDIATR, V30, P199, DOI 10.1097/MOP.0000000000000591; Graham EM, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00196; Guadano-Ferraz A, 2005, J COMP NEUROL, V493, P554, DOI 10.1002/cne.20774; Hinojosa-Rodriguez M, 2017, NEUROIMAGE-CLIN, V16, P355, DOI 10.1016/j.nicl.2017.08.015; Imam S S, 2009, Pak J Biol Sci, V12, P1498, DOI 10.3923/pjbs.2009.1498.1504; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Leifsdottir K, 2018, J NEUROINFLAMM, V15, P1; Liu F, 2013, CELL BIOCHEM BIOPHYS, V66, P389, DOI 10.1007/s12013-012-9478-3; Lv HY, 2015, CLIN CHIM ACTA, V450, P282, DOI 10.1016/j.cca.2015.08.021; Massaro AN, 2018, J PEDIATR-US, V194, P67, DOI 10.1016/j.jpeds.2017.10.060; Massaro AN, 2013, PEDIATR CRIT CARE ME, V14, P310, DOI 10.1097/PCC.0b013e3182720642; McKinstry RC, 2002, NEUROLOGY, V59, P824, DOI 10.1212/WNL.59.6.824; Missler U, 1999, CLIN CHEM, V45, P138; Molloy EJ, 2018, PEDIATR RES, V84, P574, DOI 10.1038/s41390-018-0169-7; Nelson KB, 2012, PEDIATRICS, V130, P878, DOI 10.1542/peds.2012-0714; Numis AL, 2019, PEDIATR RES, V86, P616, DOI 10.1038/s41390-019-0473-x; O'Hare FM, 2017, ACTA PAEDIATR, V106, P561, DOI 10.1111/apa.13745; Okazaki K, 2012, CYTOKINE, V60, P812, DOI 10.1016/j.cyto.2012.08.001; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pinchefsky EF, 2017, CURR OPIN NEUROL, V30, P156, DOI 10.1097/WCO.0000000000000425; Ramaswamy V, 2009, PEDIATR NEUROL, V40, P215, DOI 10.1016/j.pediatrneurol.2008.09.026; REPRESA A, 1990, J NEUROSCI, V10, P3782, DOI 10.1523/JNEUROSCI.10-12-03782.1990; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Savman K, 1998, PEDIATR RES, V43, P746; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2017, JAMA-J AM MED ASSOC, V318, P57, DOI 10.1001/jama.2017.7218; Stewart A, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.02.049; Sweetman D, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00399; Sweetman DU, 2017, NEONATOLOGY, V111, P253, DOI 10.1159/000448702; Takahashi K, 2014, BRAIN DEV-JPN, V36, P670, DOI 10.1016/j.braindev.2013.10.007; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Toorell H, 2018, J MATERN-FETAL NEO M, V31, P2468, DOI 10.1080/14767058.2017.1344964; Volpe JJ, 2012, ANN NEUROL, V72, P156, DOI 10.1002/ana.23647; Wu YNW, 2020, PEDIATR RES, V87, P879, DOI 10.1038/s41390-019-0493-6; Wyatt JS, 2007, PEDIATRICS, V119, P912, DOI 10.1542/peds.2006-2839; Wyrobek J, 2017, BRIT J ANAESTH, V119, P324, DOI 10.1093/bja/aex103; Yang J, 2015, CLIN BIOCHEM, V48, P843, DOI 10.1016/j.clinbiochem.2015.05.015	66	10	10	3	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	NOV	2020	226						71	+		10.1016/j.jpeds.2020.06.078			14	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	OG9WY	WOS:000582226400014	32610169				2022-02-06	
J	Lilja-Cyron, A; Andresen, M; Kelsen, J; Andreasen, TH; Petersen, LG; Fugleholm, K; Juhler, M				Lilja-Cyron, Alexander; Andresen, Morten; Kelsen, Jesper; Andreasen, Trine Hjorslev; Petersen, Lonnie Grove; Fugleholm, Kare; Juhler, Marianne			Intracranial pressure before and after cranioplasty: insights into intracranial physiology	JOURNAL OF NEUROSURGERY			English	Article						cerebrospinal fluid; cranioplasty; decompressive craniectomy; intracranial pressure; telemetry; traumatic brain injury; trauma	DECOMPRESSIVE CRANIECTOMY; PERFUSION; ICP; FEASIBILITY; GUIDELINES; MANAGEMENT; INFARCTION; STATEMENT; HEALTHY; SKULL	OBJECTIVE: Decompressive craniectomy (DC) is an emergency neurosurgical procedure used in cases of severe intracranial hypertension or impending intracranial herniation. The procedure is often lifesaving, but it exposes the brain to atmospheric pressure in the subsequent rehabilitation period, which changes intracranial physiology and probably leads to complications such as hydrocephalus, hygromas, and "syndrome of the trephined." The objective of the study was to study the effect of cranioplasty on intracranial pressure (ICP), postural ICP changes, and intracranial pulse wave amplitude (PWA). METHODS: The authors performed a prospective observational study including patients who underwent DC during a 12-month period. Telemetric ICP sensors were implanted in all patients at the time of DC. ICP was evaluated before and after cranioplasty during weekly measurement sessions including a standardized postural change program. RESULTS: Twelve of the 17 patients enrolled in the study had cranioplasty performed and were included in the present investigation. Their mean ICP in the supine position increased from -0.5 +/- 4.8 mm Hg the week before cranioplasty to 6.3 +/- 2.5 mm Hg the week after cranioplasty (p < 0.0001), whereas the mean ICP in the sitting position was unchanged (-1.2 +/- 4.8 vs -1.1 +/- 3.6 mm Hg, p = 0.90). The difference in ICP between the supine and sitting positions was minimal before cranioplasty (1.1 +/- 1.8 mm Hg) and increased to 7.4 +/- 3.6 mm Hg in the week following cranioplasty (p < 0.0001). During the succeeding 2 weeks of the follow-up period, the mean ICP in the supine and sitting positions decreased in parallel to, respectively, 4.6 +/- 3.0 mm Hg (p = 0.0003) and -3.9 +/- 2.7 mm Hg (p = 0.040), meaning that the postural ICP difference remained constant at around 8 mm Hg. The mean intracranial PWA increased from 0.7 +/- 0.7 mm Hg to 2.9 +/- 0.8 mm Hg after cranioplasty (p < 0.0001) and remained around 3 mm Hg throughout the following weeks. CONCLUSIONS: Cranioplasty restores normal intracranial physiology regarding postural ICP changes and intracranial PWA. These findings complement those of previous investigations on cerebral blood flow and cerebral metabolism in patients after decompressive craniectomy.	[Lilja-Cyron, Alexander; Andresen, Morten; Andreasen, Trine Hjorslev; Fugleholm, Kare; Juhler, Marianne] Univ Copenhagen, Rigshosp, Dept Neurosurg, Copenhagen, Denmark; [Kelsen, Jesper] Univ Copenhagen, Rigshosp, Dept Orthopaed Surg, Spine Sect, Copenhagen, Denmark; [Petersen, Lonnie Grove] Univ Copenhagen, Fac Hlth Serv, Dept Biomed Sci, Copenhagen, Denmark		Lilja-Cyron, A (corresponding author), Rigshosp, Copenhagen, Denmark.	alexander.lilja-cyron@regionh.dk	Andreasen, Trine/AAS-9911-2021; Fugleholm, Kare/AAW-5086-2021	Petersen, Lonnie/0000-0002-5155-9651; Andresen, Morten/0000-0002-3802-6033; Fugleholm, Kare/0000-0002-1520-7122; Lilja-Cyron, Alexander/0000-0003-2915-249X; Hjorslev Andreasen, Trine/0000-0001-5707-8712	Council of the Danish Victims Fund [14-91000016]	This study was funded by the Council of the Danish Victims Fund through a grant to Prof. Marianne Juhler (grant no. 14-91000016), including funding for salary to a clinical research fellow (Alexander Lilja-Cyron) and for purchasing of telemetric intracranial pressure monitoring equipment for the study.	Andresen M, 2015, ACTA NEUROCHIR, V157, P109, DOI 10.1007/s00701-014-2250-2; Andresen M, 2014, J NEUROSURG, V121, P797, DOI 10.3171/2014.2.JNS132209; Antes S, 2016, WORLD NEUROSURG, V91, P133, DOI 10.1016/j.wneu.2016.03.096; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Bozanovic-Sosic R, 2001, AM J PHYSIOL-REG I, V281, pR909, DOI 10.1152/ajpregu.2001.281.3.R909; Carmelo A, 2002, ACT NEUR S, V81, P113; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; Davson H, 1996, PHYSL CSF BLOOD BRAI, P489; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Edsbagge M, 2004, AM J PHYSIOL-REG I, V287, pR1450, DOI 10.1152/ajpregu.00215.2004; EKSTEDT J, 1978, J NEUROL NEUROSUR PS, V41, P345, DOI 10.1136/jnnp.41.4.345; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Freimann FB, 2014, CHILD NERV SYST, V30, P689, DOI 10.1007/s00381-013-2324-0; Holmlund P, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0065-2; Honeybul Stephen, 2014, Surg Neurol Int, V5, P83, DOI 10.4103/2152-7806.133886; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; IWABUCHI T, 1983, NEUROSURGERY, V12, P203, DOI 10.1227/00006123-198302000-00012; Lawley JS, 2017, J PHYSIOL-LONDON, V595, P2115, DOI 10.1113/JP273557; Lee AG, 2017, JAMA OPHTHALMOL, V135, P992, DOI 10.1001/jamaophthalmol.2017.2396; Lilja-Cyron A, 2018, J NEUROTRAUM, V35, P1578, DOI 10.1089/neu.2017.5589; LiljaCyron A, 2019, NEUROSURGERY; Norager NH, 2018, ACTA NEUROCHIR, V160, P2137, DOI 10.1007/s00701-018-3691-9; Orakcioglu Berk, 2012, Acta Neurochir Suppl, V114, P105, DOI 10.1007/978-3-7091-0956-4_19; Paredes I, 2016, J NEUROTRAUM, V33, P1586, DOI 10.1089/neu.2015.4261; Petersen LG, 2016, AM J PHYSIOL-REG I, V310, pR100, DOI 10.1152/ajpregu.00302.2015; Petersen LG, 2019, J PHYSIOL-LONDON, V597, P237, DOI 10.1113/JP276557; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Pollay M, 2012, ACTA NEUROCHIR SUPPL, V113, P47, DOI 10.1007/978-3-7091-0923-6_10; Qvarlander S, 2013, J APPL PHYSIOL, V115, P1474, DOI 10.1152/japplphysiol.00711.2013; Robles LA, 2018, WORLD NEUROSURG, V111, P99, DOI 10.1016/j.wneu.2017.12.061; Scollato A, 2015, BRIT J NEUROSURG, V29, P440, DOI 10.3109/02688697.2014.997671; Shahid AH, 2018, J NEUROSURG, V128, P229, DOI 10.3171/2016.10.JNS16678; SHAPIRO K, 1985, J NEUROSURG, V63, P76, DOI 10.3171/jns.1985.63.1.0076; Smielewski P, 2005, ACT NEUR S, V95, P43; Stiver SI, 2008, ACTA NEUROCHIR SUPPL, V102, P273, DOI 10.1007/978-3-211-85578-2_51; STULA D, 1985, NEUROCHIRURGIA, V28, P164; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Welschehold S, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822dda12; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053	45	10	10	1	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2020	133	5					1548	1558		10.3171/2019.7.JNS191077			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OM6AS	WOS:000586105700032	31628275				2022-02-06	
J	Oldham, JR; Howell, DR; Knight, CA; Crenshaw, JR; Buckley, TA				OLDHAM, J. E. S. S. I. E. R.; HOWELL, D. A. V. I. D. R.; KNIGHT, C. H. R. I. S. T. O. P. H. E. R. A.; CRENSHAW, J. E. R. E. M. Y. R.; BUCKLEY, T. H. O. M. A. S. A.			Gait Performance Is Associated with Subsequent Lower Extremity Injury following Concussion	MEDICINE & SCIENCE IN SPORTS & EXERCISE			English	Article						MILD TRAUMATIC BRAIN INJURY; POSTURAL CONTROL; INJURY; LOCOMOTION	COLLEGIATE FOOTBALL PLAYERS; MUSCULOSKELETAL INJURY; DIVIDED-ATTENTION; POSTURAL CONTROL; CONTROL DEFICITS; RISK; STABILITY; INCREASES; RECOVERY; SPEED	Purpose The purpose was to examine gait characteristics between collegiate athletes who did and did not sustain a lower-extremity musculoskeletal (LEMSK) injury in the year after concussion. Methods Thirty-four NCAA collegiate athletes with diagnosed concussions were divided into two groups based on if they did (n= 16) or did not (n= 18) sustain a LEMSK in the year after concussion. Participants completed baseline testing before the start of the season and again at return to play postconcussion. Injuries were tracked using an electronic medical database. Participants were instrumented with three APDM Opal triaxial accelerometers and performed five single-task (ST) and five dual-task (DT) gait trials. Participants traversed a 10-meter walkway, turned around a specified endpoint, and returned to the original line. During DT, participants simultaneously walked and answered mini-mental style questions. A linear mixed-effects model assessed interactions and/or main effects between groups for gait speed, double support time, cadence, stride length, and cognitive accuracy. Results The LEMSK group walked slower (ST, 1.15 +/- 0.10 m center dot s(-1); DT, 1.01 +/- 0.10 m center dot s(-1)) than the uninjured group (ST, 1.23 +/- 0.11 m center dot s(-1); DT, 1.10 +/- 0.11 m center dot s(-1)) during both ST (P= 0.04) and DT (P= 0.03). The injury group spent longer in double support (ST, 20.19% +/- 2.34%; DT, 21.92% +/- 2.13%) than the uninjured group (ST, 18.16% +/- 2.60%; DT, 20.00% +/- 2.32%) during both ST (P= 0.02) and DT (P= 0.02). The injury group had a significantly lower cognitive accuracy (89.56% +/- 6.48%) than the uninjured group (95.40% +/- 7.08%) across time points (P= 0.02). Conclusions There were significant differences in gait characteristics and cognitive accuracy between those who did and did not sustain a LEMSK injury after concussion. The LEMSK group demonstrated a conservative gait strategy both before and after their concussive injury.	[OLDHAM, J. E. S. S. I. E. R.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [OLDHAM, J. E. S. S. I. E. R.] Boston Childrens Hosp, Div Sports Med, Dept Orthoped, Boston, MA USA; [HOWELL, D. A. V. I. D. R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [HOWELL, D. A. V. I. D. R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [KNIGHT, C. H. R. I. S. T. O. P. H. E. R. A.; CRENSHAW, J. E. R. E. M. Y. R.; BUCKLEY, T. H. O. M. A. S. A.] Univ Delaware, Dept Kinesiol & Appl Physiol, 100 Discovery Blvd, Newark, DE 19716 USA; [KNIGHT, C. H. R. I. S. T. O. P. H. E. R. A.; CRENSHAW, J. E. R. E. M. Y. R.; BUCKLEY, T. H. O. M. A. S. A.] Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, Newark, DE USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, 100 Discovery Blvd, Newark, DE 19716 USA.	TBuckley@udel.edu	Crenshaw, Jeremy/AAC-9197-2019; Buckley, Thomas A/B-7525-2016	Crenshaw, Jeremy/0000-0002-5108-3630; Buckley, Thomas A/0000-0002-0515-0150; Oldham, Jessie/0000-0003-2801-2110	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS104371, R01NS100952, R41NS103698]; Eunice Kennedy Shriver National Institute of Child Health AMP; Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; ElMindA Ltd; Eastern Athletic Trainers Association Inc.; National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS104371]; NCAA/DoD CARE Consortium [W81XWH-14-2-0151]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R03NS104371.r Dr. Oldham, Dr. Crenshaw, and Dr. Knight have no conflicts of interest or financial disclosures to report. Dr. Howell receives research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R03HD094560) and the National Institute of Neurological Disorders and Stroke (R01NS100952 and R41NS103698) of the National Institutes of Health. He has previously received research support from a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindA Ltd, and the Eastern Athletic Trainers Association Inc. Dr. Buckley has received funding from the National Institutes of Health/National Institute of Neurological Disorders and Stroke (R03NS104371) and the NCAA/DoD CARE Consortium (W81XWH-14-2-0151).	APDM, 2014, MOB LAB US GUID; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Burman E, 2016, BMJ OPEN SPORT EXERC, V2, pe000092, DOI DOI 10.1136/BMJSEM-2015-000092; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Caggiano V, 2018, NATURE, V553, P455, DOI 10.1038/nature25448; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Chen HL, 2015, J MED BIOL ENG, V35, P28, DOI 10.1007/s40846-015-0002-2; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Echemendia RJ, 2017, BRIT J SPORT MED, V51, DOI DOI 10.1136/BJSPORTS-2017-097506; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Fulton J, 2014, INT J SPORTS PHYS TH, V9, P583; Gerberding JLBS, 2003, CTR DIS CONTR PREV, P9; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hamacher D, 2015, NEUROSCI BIOBEHAV R, V57, P310, DOI 10.1016/j.neubiorev.2015.08.002; Hass CJ, 2014, J NEUROL PHYS THER, V38, P233, DOI 10.1097/NPT.0000000000000055; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Leone C, 2017, NEUROSCI BIOBEHAV R, V75, P348, DOI 10.1016/j.neubiorev.2017.01.010; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mancini Martina, 2011, J Bioeng Biomed Sci, VSuppl 1, P007; Martin EI, 2009, PSYCHIAT CLIN N AM, V32, P549, DOI 10.1016/j.psc.2009.05.004; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Turner S, 2017, SPORT EXERC PERFORM, V6, P277, DOI 10.1037/spy0000099; Wikstrom EA, 2010, GAIT POSTURE, V32, P82, DOI 10.1016/j.gaitpost.2010.03.015; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zhang S, 2014, GAIT BIOMETRICS, P191	49	10	10	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	NOV	2020	52	11					2279	2285		10.1249/MSS.0000000000002385			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	OA3UT	WOS:000577715400001	33064402				2022-02-06	
J	Bailey, AM; McMurry, TL; Cormier, JM; Funk, JR; Crandall, JR; Mack, CD; Myers, BS; Arbogast, KB				Bailey, Ann M.; McMurry, Timothy L.; Cormier, Joseph M.; Funk, James R.; Crandall, Jeff R.; Mack, Christina D.; Myers, Barry S.; Arbogast, Kristy B.			Comparison of Laboratory and On-Field Performance of American Football Helmets	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Biomechanics; Concussion; American football; Head injury; Helmet	HIGH-SCHOOL FOOTBALL; IMPACT PERFORMANCE; HEAD IMPACTS; PROFESSIONAL FOOTBALL; BRAIN-INJURY; RISK-FACTORS; CONCUSSION; PLAYERS; SPORTS; FREQUENCY	The relationship between laboratory and on-field performance of football helmets was assessed for 31 football helmet models selected from those worn by players in the 2015-2019 National Football League (NFL) seasons. Linear impactor tests were conducted with helmets placed on an instrumented Hybrid III head and neck assembly mounted on a sliding table. Based on impacts to each helmet at six impact locations and three velocities, a helmet performance score (HPS) was calculated using a linear combination of the head injury criterion (HIC) and the diffuse axonal multi-axis general evaluation (DAMAGE). To determine the on-field performance of helmets, helmet model usage, player participation, and incident concussion data were collected from the five NFL seasons and used to calculate helmet model-specific concussion rates. Comparison of laboratory HPS to the helmet model-specific concussion rates on a per play basis showed a positive correlation (r(2) = 0.61,p < 0.001) between laboratory and on-field performance of helmet models, indicating that helmets which exhibited reduced impact severity in the laboratory tests were also generally associated with lower concussion rates on-field. Further analysis showed that NFL-prohibited helmet models exhibited a significantly higher odds of concussion (OR 1.24; 95% CI 1.04-1.47;p = 0.017) relative to other helmet models.	[Bailey, Ann M.; Cormier, Joseph M.; Funk, James R.; Crandall, Jeff R.] Biomech Consulting & Res LLC, Charlottesville, VA 22911 USA; [McMurry, Timothy L.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Mack, Christina D.] IQVIA, Durham, NC USA; [Myers, Barry S.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA		Bailey, AM (corresponding author), Biomech Consulting & Res LLC, Charlottesville, VA 22911 USA.	abailey@bicorellc.com			Football Research, Inc. (FRI); NFL	The research presented in this paper was made possible by a grant from Football Research, Inc. (FRI). FRI is a nonprofit corporation that receives funding from sources including the NFL and is dedicated to the research and development of novel methods to prevent, mitigate, and treat traumatic head injury. The views expressed are solely those of the authors and do not represent those of FRI or any of its affiliates or funding sources. Dr. McMurry's contributions resulted from his affiliation with T.L. McMurry, LLC and the views presented do not represent the views of or an endorsement by the University of Virginia. Authors Arbogast and Myers's contributions resulted from their affiliation as paid consultants to the NFL Players Association. The authors would also like to acknowledge Biokinetics and Associates, Ltd., Next Generation Stats, IQVIA, Helmet Tracker, NFL Information Technology, and NFL team equipment and medical staff for contributing to the data collection and compilation for this study.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Adirim TA, 2007, CLIN PEDIATR EMERG M, V8, P2, DOI 10.1016/j.cpem.2007.02.002; Bailey AM, 2020, ANN BIOMED ENG, V48, P2566, DOI 10.1007/s10439-020-02626-6; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Collins CL, 2016, AM J SPORT MED, V44, P1382, DOI 10.1177/0363546516629626; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; DiMasi FP, 1995, TRANSFORMATION 9 ACC; Dreyer NA, 2019, SPORTS HEALTH, V11, P440, DOI 10.1177/1941738119854759; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Gabler L. F., 2019, P 2019 BIOM ENG SOC; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Moran R, 2015, J SPORTS SCI, V3, P29, DOI [10.11648/j.ajss.20150302.11, DOI 10.11648/J.AJSS.20150302.11]; NOCSAE, 2015, STAND PERF SPEC NEWL; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Rowson, 2018, VARSITY FOOTBALL HEL; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Society of Automotive Engineers, 2014, J2111201403 SAE INT; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Versace J, 1971, REV SEVERITY INDEX; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zemper Eric D., 1994, Journal of Athletic Training, V29, P44	47	10	10	1	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2020	48	11			SI		2531	2541		10.1007/s10439-020-02627-5		OCT 2020	11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PB5UI	WOS:000575717000005	33025320				2022-02-06	
J	Lapinlampi, N; Andrade, P; Paananen, T; Hamalainen, E; Ndode-Ekane, XE; Puhakka, N; Pitkanen, A				Lapinlampi, Niina; Andrade, Pedro; Paananen, Tomi; Hamalainen, Elina; Ekolle Ndode-Ekane, Xavier; Puhakka, Noora; Pitkanen, Asla			Postinjury weight rather than cognitive or behavioral impairment predicts development of posttraumatic epilepsy after lateral fluid-percussion injury in rats	EPILEPSIA			English	Article						biomarkers; epileptogenesis; EPITARGET; ROC analysis; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MODEL; EPILEPTOGENESIS; DEPRESSION; BIOMARKERS; SEIZURES; DEFICITS; RISK; AGE	Objective To identify postinjury physiologic, behavioral, and cognitive biomarkers for posttraumatic epilepsy to enrich study populations for long-term antiepileptogenesis studies. Methods The EPITARGET cohort with behavioral follow-up and 1-month 24/7 video-electroencephalography (vEEG) monitoring included 115 adult male Sprague-Dawley rats with lateral fluid-percussion-induced traumatic brain injury (TBI), 23 sham-operated controls, and 13 naive rats. Animals underwent assessment of somatomotor performance (composite neuroscore), anxiety-like behavior (elevated plus maze, open field), spatial memory (Morris water maze), and depression-like behavior (Porsolt forced swim, sucrose preference). Impact force, postimpact apnea time, postimpact seizure-like behavior, and body weight were monitored. Results TBI rats were impaired in the composite neuroscore (P < .001) on days (D) 2-14 and in the spatial memory test (P < .001) on D35-39 post-TBI. Differences in the elevated plus-maze (D28 and D126) and in the open field (D29 and D127) between TBI rats and controls were meager. No differences were observed in the Porsolt forced swim and sucrose preference tests as compared with sham-operated controls. Epilepsy developed in 27% of rats by the end of the sixth month. None of the behavioral or cognitive outcome measures discriminated rats with or without epilepsy. The receiver-operating characteristic analysis indicated that a decrease in body weight between D0 and D4 differentiated TBI rats with epilepsy from TBI rats without epilepsy (48% sensitivity, 83% specificity, area under the curve [AUC] 0.679, confidence interval [CI] 95% 0.56-0.80,P < .01). A 16% body weight decrease during D0-D4 could be used as a biomarker to enrich the study population from 27% (observed) to 50%. Significance Single behavioral and cognitive outcome measures showed no power as prognostic/diagnostic biomarkers for posttraumatic epilepsy. A reduction in body weight during the first postinjury week showed some prognostic value for posttraumatic epileptogenesis and could serve as a subacute measure for selectively enriching the study population for long-term preclinical biomarker and therapy discovery studies of posttraumatic epileptogenesis.	[Lapinlampi, Niina; Andrade, Pedro; Paananen, Tomi; Hamalainen, Elina; Ekolle Ndode-Ekane, Xavier; Puhakka, Noora; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi	Andrade, Pedro/N-8410-2018	Andrade, Pedro/0000-0001-9118-8341; Pitkanen, Asla/0000-0002-8163-5416; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632	Sigrid Juselius FoundationSigrid Juselius Foundation; Academy of FinlandAcademy of FinlandEuropean Commission [272249, 273909, 2285733-9]; FP7-HEALTH project [602102]	Sigrid Juselius Foundation; Academy of Finland, Grant/Award Number: 272249, 273909 and 2285733-9; FP7-HEALTH project, Grant/Award Number: 602102 (EPITARGET)	Andrade P, 2019, J NEUROTRAUM, V36, P1890, DOI 10.1089/neu.2018.6107; Andrade P, 2018, J NEUROSCI METH, V307, P37, DOI 10.1016/j.jneumeth.2018.06.015; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Broer S, 2015, EPILEPSY BEHAV, V53, P98, DOI 10.1016/j.yebeh.2015.09.028; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; Casillas-Espinosa PM, 2019, EPILEPSY RES, V156, DOI 10.1016/j.eplepsyres.2019.04.011; Cutpointr TC, 2019, DETERMINE EVALUATE O; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Engel J, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2019.107735; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ferreira VMM, 1996, ADDICT BIOL, V1, P395, DOI 10.1080/1355621961000125016; Fucich EA, 2019, J NEUROTRAUM, V36, P1847, DOI 10.1089/neu.2018.5854; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hesdorffer DC, 1998, ANN NEUROL, V44, P908, DOI 10.1002/ana.410440609; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Juengst SB, 2017, EPILEPSY BEHAV, V73, P240, DOI 10.1016/j.yebeh.2017.06.001; Kalitzin S, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104488; Kanner AM, 2006, LANCET NEUROL, V5, P107, DOI 10.1016/S1474-4422(06)70331-3; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kim H, 2017, J NEUROSURG, V127, P23, DOI 10.3171/2016.7.JNS161263; Kuo JR, 2013, J NEUROTRAUM, V30, P1223, DOI 10.1089/neu.2012.2689; Lapinlampi N, 2017, EPILEPSY RES, V129, P87, DOI 10.1016/j.eplepsyres.2016.11.010; Laufs H, 2012, CURR OPIN NEUROL, V25, P194, DOI 10.1097/WCO.0b013e3283515db9; Lim SW, 2017, WORLD NEUROSURG, V100, P128, DOI 10.1016/j.wneu.2016.12.118; Manninen E, 2020, J NEUROTRAUM, V37, P2580, DOI 10.1089/neu.2019.6796; Manschot SM, 2003, BRAIN RES, V966, P274, DOI 10.1016/S0006-8993(02)04211-7; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Pascente R, 2016, NEUROBIOL DIS, V93, P146, DOI 10.1016/j.nbd.2016.05.001; Pietrelli A, 2012, NEUROSCIENCE, V202, P252, DOI 10.1016/j.neuroscience.2011.11.054; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2019, NEUROBIOL DIS, V123, P42, DOI 10.1016/j.nbd.2018.05.007; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; Pittau F, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00031; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Wang X, 2016, EPILEPSY RES, V128, P35, DOI 10.1016/j.eplepsyres.2016.10.002	46	10	10	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	SEP	2020	61	9					2035	2052		10.1111/epi.16632		AUG 2020	18	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OA2ND	WOS:000558459900001	32786029	hybrid			2022-02-06	
J	Douglas, J				Douglas, Jacinta			Loss of friendship following traumatic brain injury: A model grounded in the experience of adults with severe injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; Friends; Social participation; Social connection; Relationships	QUALITY-OF-LIFE; INCOG RECOMMENDATIONS; SOCIAL RELATIONSHIPS; HEAD-INJURY; PEOPLE; HEALTH; SELF; PERSPECTIVES; PARTICIPATION; COMMUNICATION	Relationships make important contributions to wellbeing and maintenance of self-worth. For those who sustain traumatic brain injury (TBI), life is frequently characterized by declining interpersonal relationships. The aim of this study was to understand the post-injury experience of friendship from the perspective of adults with severe TBI. Participants were 23 adults who had sustained severe TBI on average 10 years earlier; the majority was between 25 and 45 years old. The experience of friendship was explored using a convergent mixed methods design (quantitative self-report measures and in-depth interviews). Qualitative analysis of interview transcripts employed open and focussed coding to reveal themes and categories. Participants nominated on average 3.35 (SD 2.19) friends. When paid carers and family members were excluded, the mean dropped to 1.52 (SD 1.38). Exploratory correlations between number of friends and quality of life, depression and strong-tie support revealed significant associations of moderate to large effects. The post-injury experience of friendship was broadly conceptualized as "going downhill" with four overlapping phases:losing contact, being misunderstood, wanting to shareandhanging on. Participants' stories illustrated how rehabilitation can focus on friendship by supporting established relationships and facilitating access to activities that afford interpersonal encounters and opportunities to share experiences.	[Douglas, Jacinta] La Trobe Univ, Coll Sci Hlth & Engn, Living Disabil Res Ctr, Melbourne, Vic, Australia; [Douglas, Jacinta] Summer Fdn, Melbourne, Vic, Australia; [Douglas, Jacinta] NHMRC Ctr Res Excellence Traumat Brain Injury Psy, Canberra, ACT, Australia		Douglas, J (corresponding author), La Trobe Univ, Living Disabil Res Ctr, Kingsbury Dr, Bundoora, Vic 3086, Australia.	j.douglas@latrobe.edu.au		Douglas, Jacinta/0000-0003-0940-6624	La Trobe University, Summer Foundation Research Partnership	This project was supported by the La Trobe University, Summer Foundation Research Partnership.	AIHW, 2007, AIHW B, V55; Australian Bureau of Statistics (ABS), 2011, AUSTR STAND CLASS CU; Barry S. S., 2000, ADV SPEECH LANGUAGE, V2, P77, DOI DOI 10.3109/14417040008996793; Blake H, 2009, CLIN REHABIL, V23, P589, DOI 10.1177/0269215508101736; Bluff R., 2005, QUALITATIVE RES HLTH, P147; Blumer H., 1969, SYMB INTERACT; Brown K, 2013, INT J SPEECH-LANG PA, V15, P165, DOI 10.3109/17549507.2012.692814; Browne J., 2004, RES METHODS NURSING, P624; Burleson BR., 1992, S J COMMUN, V57, P260, DOI DOI 10.1080/10417949209372873; Callaway L., 2005, AUSTR OCCUPATIONAL T, V52, P257, DOI [10.1111/j.1440-1630.2005.00492, DOI 10.1111/J.1440-1630.2005.00492]; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Carlsson E, 2007, QUAL HEALTH RES, V17, P1361, DOI 10.1177/1049732307306926; Carroll J., 2004, GALLUP; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Charmaz K., 2014, BROKERAGE CLOSURE IN; Charmaz K., 2009, DEV GROUNDED THEORY, P127; Clare L, 2012, ALZ DIS ASSOC DIS, V26, P148, DOI 10.1097/WAD.0b013e318221ba23; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Cohen J., 2013, STAT POWER ANAL BEHA; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Creswell J., 2015, OXFORD HDB MULTIMETH, P39; Creswell J.W., 2011, BEST PRACTICES MIXED; Cruice M, 2006, APHASIOLOGY, V20, P1210, DOI 10.1080/02687030600790136; D'Cruz K., NEUROPSYCHOLOGICAL R; Davidson B, 2008, TOP STROKE REHABIL, V15, P325, DOI 10.1310/tsr1504-325; Degges-White S., 2015, TOXIC FRIENDSHIPS; Delle Fave A, 2013, J POSIT PSYCHOL, V8, P517, DOI 10.1080/17439760.2013.830761; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Douglas J, 2015, RETHINKING REHABILIT, DOI DOI 10.1201/B18118; Douglas J, 2015, INT J SPEECH-LANG PA, V17, P199, DOI 10.3109/17549507.2015.1016113; Douglas JM, 2017, BRAIN IMPAIR, V18, P321, DOI 10.1017/BrImp.2017.20; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Ensel W., 1986, SOCIAL SUPPORT LIFE, P129; Ford A, 2018, APHASIOLOGY, V32, P367, DOI 10.1080/02687038.2017.1413486; Fotiadou D, 2014, APHASIOLOGY, V28, P1281, DOI 10.1080/02687038.2014.928664; HADORN DC, 1995, J CLIN EPIDEMIOL, V48, P619, DOI 10.1016/0895-4356(94)00186-T; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Hoofien D, 2001, BRAIN INJURY, V15, P189; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Jennett B, 1981, CONT NEUROLOGY SERIE; Jetten J., 2012, SOCIAL CURE IDENTITY; Johnson K, 1998, BEHAV MODIF, V22, P502, DOI 10.1177/01454455980224004; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kinsella G, 1989, Int Disabil Stud, V11, P9; Knox L, 2017, DISABIL REHABIL, V39, P2250, DOI 10.1080/09638288.2016.1219925; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; Mealings M, 2017, INT J SPEECH-LANG PA, V19, P441, DOI 10.1080/17549507.2016.1221453; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Mitchell EJ, 2014, DISABIL REHABIL, V36, P1474, DOI 10.3109/09638288.2013.845259; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nichols JL, 2014, J REHABIL, V80, P21; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Northcott S, 2016, J SPEECH LANG HEAR R, V59, P772, DOI 10.1044/2016_JSLHR-L-15-0201; Northcott S, 2016, CLIN REHABIL, V30, P811, DOI 10.1177/0269215515602136; Northcott S, 2011, INT J LANG COMM DIS, V46, P524, DOI 10.1111/j.1460-6984.2011.00079.x; Nussbaum JF., 1994, INTERPERSONAL COMMUN, P209; O'Connor K., 2000, EXPLORING EXISTENTIA, P75; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Palmer S, 2016, NEUROREHABILITATION, V38, P291, DOI 10.3233/NRE-161320; Paterson J., 2002, REHABIL NURS, V27, P13, DOI DOI 10.1002/J.2048-7940.2002.TB01973.X; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Pound P, 1998, CLIN REHABIL, V12, P338, DOI 10.1191/026921598677661555; Powell JM, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020909; Pozzebon M, 2018, J SPEECH LANG HEAR R, V61, P2292, DOI 10.1044/2018_JSLHR-L-17-0492; Pozzebon M, 2016, INT PSYCHOGERIATR, V28, P537, DOI 10.1017/S1041610215002239; Public Health England (PHE), 2018, BRIEF DOC 1 INC STRO; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Sarre S, 2014, DISABIL REHABIL, V36, P716, DOI 10.3109/09638288.2013.814724; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 2017, PERSP PRAGMAT PHILO, V11, P617, DOI 10.1007/978-3-319-47489-2_23; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Tashakkori A, 2010, SAGE HDB MIXED METHO; Tashakkori A, 2009, J MIX METHOD RES, V3, P287, DOI 10.1177/1558689809346151; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate R, 2014, BRAIN IMPAIR, V15, P157, DOI 10.1017/BrImp.2014.28; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Thomas M, 2004, BRAIN INJURY, V18, P1271, DOI 10.1080/02699050410001698776; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Umberson D, 2006, J HEALTH SOC BEHAV, V47, P1, DOI 10.1177/002214650604700101; Willmott C, 2014, J HEAD TRAUMA REHAB, V29, P248, DOI 10.1097/HTR.0000000000000014; Willmott P., 1987, FRIENDSHIP NETWORKS; [No title captured], DOI DOI 10.1375/BRIM.7.2.107	106	10	10	2	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	AUG 8	2020	30	7					1277	1302		10.1080/09602011.2019.1574589			26	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MH9SO	WOS:000547060000004	30755079	hybrid			2022-02-06	
J	McKee, AC				McKee, Ann C.			The Neuropathology of Chronic Traumatic Encephalopathy: The Status of the Literature	SEMINARS IN NEUROLOGY			English	Article						neuropathology; chronic traumatic encephalopathy; neurodegenerative disease; tauopathies	AMYLOID PROTEIN DEPOSITION; NEUROFIBRILLARY TANGLES; DEMENTIA-PUGILISTICA; ALZHEIMERS-DISEASE; BRAIN; PATHOLOGY; INJURY; TAU; AFTERMATH; DIAGNOSIS	Chronic traumatic encephalopathy (CTE) is a tauopathy associated with repetitive mild head trauma, including concussion and asymptomatic subconcussive impacts. CTE was first recognized in boxers almost a century ago and has been identified more recently in contact sports athletes, military veterans exposed to blast, and victims of domestic violence. Like most neurodegenerative diseases, CTE is diagnosed conclusively by a neuropathological examination of brain tissue. CTE is characterized by the buildup of hyperphosphorylated tau (p-tau) in neurofibrillary tangles (NFTs), neurites, and, sometimes, astrocytes, surrounding small blood vessels in a patchy distribution at the sulcal depths of the cerebral cortex. In 2015, using the McKee proposed criteria for the neuropathological diagnosis of CTE, a consensus panel of expert neuropathologists confirmed CTE as a unique neurodegenerative disease with a pathognomonic lesion and published the preliminary NINDS (National Institute of Neurological Disorders and Stroke) criteria for CTE. Since that time, the NINDS criteria for CTE have been implemented and validated in multiple international publications. Using the NINDS criteria, the largest clinicopathological series of CTE to date was reported that included 177 former American football players, including 110 (99%) of 111 former National Football League players, 48 (91%) of 53 former college football players, and 3 (21%) of 14 former high school players. Studies have also shown a significant association between cumulative exposure to repetitive head trauma, as judged by the length of American football playing career, and risk for and severity of CTE. There is also a significant relationship of the length of football playing career with p-tau pathology, inflammation, white matter rarefaction, and age at death in CTE. While p-tau pathology, inflammation, white matter rarefaction, and arteriolosclerosis contribute to dementia in CTE, whether they also influence the behavioral and mood symptoms in CTE has yet to be determined. There have been several instances of aging-related tau astrogliopathy (ARTAG), a common astrocytic pathology in the elderly, misdiagnosed as CTE in the recent literature, provoking claims that CTE pathology is present in people not known to have experienced repetitive head trauma. Although ARTAG is often found in CTE, the pathognomonic lesion of CTE is a neuronal lesion consisting of NFTs and neurites, with or without p-tau immunoreactive astrocytes. Some authors consider beta -amyloid (A beta) to be a primary feature of CTE, yet the data indicate that CTE is a primary tauopathy, with A beta deposition a function of age and inheritance of the ApoEe4 allele. Some authors also question the progressive nature of CTE pathology, although there is clear evidence in most individuals that p-tau pathology increases in density and affects more brain regions with survival. This review is intended to outline the status of the evidence-based literature regarding CTE neuropathology and to address the misrepresentations and confusions that have arisen in recent reviews and a letter of correspondence.	[McKee, Ann C.] Boston Univ, Sch Med, Boston, MA 02118 USA; [McKee, Ann C.] Boston Univ, Alzheimers Dis Ctr, Boston, MA 02215 USA; [McKee, Ann C.] Boston Univ, Chron Traumat Encephalopathy Ctr, Boston, MA 02215 USA; [McKee, Ann C.] VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA		McKee, AC (corresponding author), VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA.	amckee@bu.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54 NS115266] Funding Source: Medline		Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckland ME, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0751-1; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Forrest SL, 2019, J NEUROPATH EXP NEUR, V78, P398, DOI 10.1093/jnen/nlz017; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; Goldfinger MH, 2018, ACTA NEUROPATHOL, V136, P973, DOI 10.1007/s00401-018-1926-8; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grinberg LT, 2016, J ALZHEIMERS DIS, V54, P169, DOI 10.3233/JAD-160312; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Iverson GL, 2019, J NEUROPATH EXP NEUR, V78, P615, DOI 10.1093/jnen/nlz045; Keene CD, 2018, ACTA NEUROPATHOL, V135, P303, DOI 10.1007/s00401-017-1801-z; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y; Kovacs GG, 2011, ACTA NEUROPATHOL, V122, P205, DOI 10.1007/s00401-011-0819-x; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; Thal Dietmar R, 2006, Sci Aging Knowledge Environ, V2006, pre1, DOI 10.1126/sageke.2006.6.re1; Williams DJ, 1996, PATHOLOGY, V28, P102, DOI 10.1080/00313029600169653; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509	54	10	10	3	13	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	AUG	2020	40	04					359	369		10.1055/s-0040-1713632			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NL6KK	WOS:000567521900004	32712946				2022-02-06	
J	Manning, KY; Brooks, JS; Dickey, JP; Harriss, A; Fischer, L; Jevremovic, T; Blackney, K; Barreira, C; Brown, A; Bartha, R; Doherty, T; Fraser, D; Holmes, J; Dekaban, GA; Menon, RS				Manning, Kathryn Y.; Brooks, Jeffrey S.; Dickey, James P.; Harriss, Alexandra; Fischer, Lisa; Jevremovic, Tatiana; Blackney, Kevin; Barreira, Christy; Brown, Arthur; Bartha, Robert; Doherty, Tim; Fraser, Douglas; Holmes, Jeff; Dekaban, Gregory A.; Menon, Ravi S.			Longitudinal changes of brain microstructure and function in nonconcussed female rugby players	NEUROLOGY			English	Article							COLLEGIATE FOOTBALL PLAYERS; WHITE-MATTER MICROSTRUCTURE; HEAD IMPACTS; DIFFUSIVITY MEASURES; ONE SEASON; CONTACT; CONCUSSION; INTEGRITY; INJURY; EXPOSURE	Objective To longitudinally assess brain microstructure and function in female varsity athletes participating in contact and noncontact sports. Methods Concussion-free female rugby players (n = 73) were compared to age-matched (ages 18-23) female swimmers and rowers (n = 31) during the in- and off-season. Diffusion and resting-state fMRI (rs-fMRI) measures were the primary outcomes. The Sports Concussion Assessment Tool and head impact accelerometers were used to monitor symptoms and impacts, respectively. Results We found cross-sectional (contact vs noncontact) and longitudinal (in- vs off-season) changes in white matter diffusion measures and rs-fMRI network connectivity in concussion-free contact athletes relative to noncontact athletes. In particular, mean, axial, and radial diffusivities were increased with decreased fractional anisotropy in multiple white matter tracts of contact athletes accompanied with default mode and visual network hyperconnectivity (p < 0.001). Longitudinal diffusion changes in the brainstem between the in- and off-season were observed for concussion-free contact athletes only, with progressive changes observed in a subset of athletes over multiple seasons. Axial diffusivity was significantly lower in the genu and splenium of the corpus callosum in those contact athletes with a history of concussion. Conclusions Together, these findings demonstrate longitudinal changes in the microstructure and function of the brain in otherwise healthy, asymptomatic athletes participating in contact sport. Further research to understand the long-term brain health and biological implications of these changes is required, in particular to what extent these changes reflect compensatory, reparative, or degenerative processes.	[Manning, Kathryn Y.; Bartha, Robert; Menon, Ravi S.] Western Univ, Med Biophys, London, ON, Canada; [Brooks, Jeffrey S.; Dickey, James P.] Western Univ, Sch Kinesiol, London, ON, Canada; [Blackney, Kevin] Western Univ, Microbiol & Immunol, London, ON, Canada; [Harriss, Alexandra] Western Univ, Hlth & Rehabil Sci, London, ON, Canada; [Brown, Arthur] Western Univ, Anat & Cell Biol, London, ON, Canada; [Doherty, Tim] Western Univ, Phys Med & Rehabil, London, ON, Canada; [Holmes, Jeff] Western Univ, Sch Occupat Therapy, London, ON, Canada; [Manning, Kathryn Y.; Bartha, Robert; Menon, Ravi S.] Robarts Res Inst, Ctr Funct & Metab Mapping, London, ON, Canada; [Blackney, Kevin; Barreira, Christy; Brown, Arthur; Dekaban, Gregory A.] Robarts Res Inst, Mol Med Res Labs, London, ON, Canada; [Fischer, Lisa; Jevremovic, Tatiana] Fowler Kennedy Sport Med, Primary Care Sport Med, London, ON, Canada; [Fraser, Douglas] London Hlth Sci Ctr, Paediat Crit Care Med, London, ON, Canada		Menon, RS (corresponding author), Western Univ, Med Biophys, London, ON, Canada.; Menon, RS (corresponding author), Robarts Res Inst, Ctr Funct & Metab Mapping, London, ON, Canada.	rmenon@robarts.ca	Menon, Ravi S/K-5500-2013; Dickey, James P/K-6776-2013; Bartha, Robert/K-3611-2013; Dekaban, Gregory/L-1987-2013	Menon, Ravi S/0000-0002-7916-0263; Dickey, James P/0000-0002-4101-835X; Bartha, Robert/0000-0002-7118-9096; Dekaban, Gregory/0000-0002-3087-4660	Schulich School of Medicine and Dentistry, Western University; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); Brain Canada; Canada First Research Excellence Fund; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	Funded through the Schulich School of Medicine and Dentistry (A.B. and G.A.D.), Western University; the Canadian Institutes for Health Research (R.S.M.); Brain Canada (R.S.M.); Canada First Research Excellence Fund; and the Natural Sciences and Engineering Research Council of Canada (K.Y.M.).	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; [Anonymous], 2013, Br J Sports Med, V47, P259; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Davenport EM, 2014, J NEUROTRAUM, V8, P1; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King DA, 2018, J SCI MED SPORT, V21, P139, DOI 10.1016/j.jsams.2017.10.026; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Manning KY, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2018.101627; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Schranz AL, 2018, HUM BRAIN MAPP, V39, P1489, DOI 10.1002/hbm.23919; Sexton CE, 2014, J NEUROSCI, V34, P15425, DOI 10.1523/JNEUROSCI.0203-14.2014; Shuttleworth-Edwards AB, 2008, J CLIN EXP NEUROPSYC, V30, P870, DOI 10.1080/13803390701846914; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54	36	10	10	2	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUL 28	2020	95	4					E402	E412		10.1212/WNL.0000000000009821			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OH2CV	WOS:000582378300026	32554762	Green Published, hybrid			2022-02-06	
J	Hind, K; Konerth, N; Entwistle, I; Theadom, A; Lewis, G; King, D; Chazot, P; Hume, P				Hind, Karen; Konerth, Natalie; Entwistle, Ian; Theadom, Alice; Lewis, Gwyn; King, Doug; Chazot, Paul; Hume, Patria			Cumulative Sport-Related Injuries and Longer Term Impact in Retired Male Elite- and Amateur-Level Rugby Code Athletes and Non-contact Athletes: A Retrospective Study	SPORTS MEDICINE			English	Article							RISK-FACTORS; PREVENTION PROGRAM; PROSPECTIVE COHORT; NEW-ZEALAND; UNION; LEAGUE; FOOTBALL; EPIDEMIOLOGY; MATCH; PATTERNS	Background Rugby union and rugby league are popular team contact sports, but they bring a high risk of injury. Although previous studies have reported injury occurrence across one or several seasons, none have explored the total number of injuries sustained across an entire career. As the first to do so, the aim of this study was to report on cumulative injuries and their perceived long-term impact in retired rugby code athletes compared to athletes from non-contact sports. Methods One hundred and eighty-nine former rugby code athletes (rugby unionn = 145; rugby leaguen = 44) and 65 former non-contact athletes were recruited to the UK Rugby Health Project between September 2016 and December 2018. Details on sports participation, sports injuries and concussion history, sports injury-related surgeries, and previous and current health were obtained from a validated, online self-report questionnaire. Results Former elite rugby code athletes (n = 83) reported more total injuries per player (median 39, IQR 35) than former amateur rugby code athletes (n = 106; median 23, IQR 30;p = 0.014) and non-contact sports athletes (n = 65; median 7.5, IQR 15;p < 0.001). Concussion was the most frequently reported injury for the elite and amateur rugby code groups, followed by upper/lower back and knee ligament injuries. These injuries also presented with the highest recurrence. Rugby code groups reported a higher continued impact of previous concussion, neck injuries, shoulder dislocation, ACL tears, and knee ligament injuries (p = 0.003-0.045). The reported prevalence of osteoarthritis was more than twofold greater in the elite rugby code group than in non-contact athletes (51% v 22%,p < 0.001). The prevalence of back pain and/or severe and regular joint pain was high across all groups (47-80%), particularly the elite rugby code group. The total number of joint injuries and sport injury-related surgeries was higher in those who reported current osteoarthritis and current severe and regular joint pain (p < 0.001-p = 0.028). Conclusion Across multiple injury types, past participation in rugby union and rugby league, particularly at elite level, is associated with a high cumulative injury load and a continued impact of previous injuries post-retirement. Given the high number of reported concussions (and their recurrence) and associations between previous injuries during a player's career and current musculoskeletal conditions, efforts should be prioritized to reduce the occurrence and recurrence of injuries in rugby codes at all levels of the sport. Strategies should also be developed for supporting the specific physical health needs of rugby code athletes post-retirement.	[Hind, Karen; Konerth, Natalie; Entwistle, Ian] Univ Durham, Dept Sport & Exercise Sci, 42 Old Elvet, Durham DH1 3HN, England; [Hind, Karen; Entwistle, Ian; Chazot, Paul] Univ Durham, Wolfson Res Inst Hlth & Wellbeing, Queens Campus, Stockton On Tees TS17 6BH, England; [Theadom, Alice; Hume, Patria] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Lewis, Gwyn] Auckland Univ Technol, Fac Hlth & Environm Sci, Hlth & Rehabil Res Inst, Auckland, New Zealand; [King, Doug; Hume, Patria] Auckland Univ Technol, Fac Hlth & Environm Sci, Sports Performance Res Inst New Zealand SPRINZ, Auckland, New Zealand; [Chazot, Paul] Univ Durham, Dept Biosci, Stockton Rd, Durham DH1 3LE, England		Hind, K (corresponding author), Univ Durham, Dept Sport & Exercise Sci, 42 Old Elvet, Durham DH1 3HN, England.; Hind, K (corresponding author), Univ Durham, Wolfson Res Inst Hlth & Wellbeing, Queens Campus, Stockton On Tees TS17 6BH, England.	karen.hind@durham.ac.uk	Hume, Patria/AAN-5514-2021; Hume, Patria Anne/P-1084-2017; Hind, Karen/AAE-6433-2021	Hume, Patria/0000-0003-1847-8128; Hume, Patria Anne/0000-0003-1847-8128; Entwistle, Ian/0000-0003-2686-8556; Hind, Karen/0000-0002-4546-5536	Auckland University of Technology; Wolfson Research Institute for Health and Wellbeing, Durham University	The project team received "UK Rugby Health-SRIF RCRG project" funding from Auckland University of Technology for NZ$15,000. The project team also received funding from the Wolfson Research Institute for Health and Wellbeing, Durham University, for GBP 4,800 pound.	Attwood MJ, 2018, BRIT J SPORT MED, V52, P368, DOI 10.1136/bjsports-2017-098005; Best JP, 2005, BRIT J SPORT MED, V39, P812, DOI 10.1136/bjsm.2004.016402; Beyera GK, 2019, RHEUMATOL INT, V39, P1663, DOI 10.1007/s00296-019-04430-5; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brown JC, 2016, SCAND J MED SCI SPOR, V26, P221, DOI 10.1111/sms.12414; Brown JC, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00423; Chalmers DJ, 2012, BRIT J SPORT MED, V46, P95, DOI 10.1136/bjsports-2011-090272; Chalmers DJ, 2004, J SCI MED SPORT, V7, P74, DOI 10.1016/S1440-2440(04)80046-X; Cross MJ, 2016, INT J SPORT PHYSIOL, V11, P350, DOI 10.1123/ijspp.2015-0187; Cummins C, 2017, NZ J SPORTS MED, V44, P60; Davies M, 2017, SCI REP, V7, P1; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Fayaz A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010364; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fitzpatrick AC, 2018, J SCI MED SPORT, V21, P160, DOI 10.1016/j.jsams.2017.08.012; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Gabbett TJ, 2012, J SPORT SCI, V30, P1421, DOI 10.1080/02640414.2012.710760; Gabbett TJ, 2004, SPORTS MED, V34, P849, DOI 10.2165/00007256-200434120-00004; GARRAWAY M, 1995, LANCET, V345, P1485; Hind K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097427; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; King D, 2014, INT J SPORTS SCI COA, V9, P417, DOI 10.1260/1747-9541.9.2.417; Lee AJ, 2001, BRIT J SPORT MED, V35, P38, DOI 10.1136/bjsm.35.1.38; Nicholl JP, 1995, BRIT J SPORT MED, V29, P232, DOI 10.1136/bjsm.29.4.232; Orchard JW, 2006, J SCI MED SPORT, V9, P459, DOI 10.1016/j.jsams.2006.05.001; Pearce AJ, 2018, BRAIN INJURY, V32, P498, DOI 10.1080/02699052.2018.1430376; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Quarrie KL, 2001, BRIT J SPORT MED, V35, P157, DOI 10.1136/bjsm.35.3.157; Saxon L, 1999, SPORTS MED, V28, P123, DOI 10.2165/00007256-199928020-00005; Tee JC, 2019, J SPORT SCI, V37, P1181, DOI 10.1080/02640414.2018.1547100; Viviers PL, 2018, SPORTS HEALTH, V10, P223, DOI 10.1177/1941738118757178; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Whitehouse T, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116634075; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; Willigenburg NW, 2016, AM J SPORT MED, V44, P753, DOI 10.1177/0363546515622389; World Rugby, 2017, YEAR REV GLOB PART N; Yeomans C, 2018, SPORTS MED, V48, P837, DOI 10.1007/s40279-017-0838-4	40	10	10	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	NOV	2020	50	11					2051	2061		10.1007/s40279-020-01310-y		JUL 2020	11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	OG2ZT	WOS:000548816500001	32671695	hybrid, Green Published, Green Accepted			2022-02-06	
J	Enam, SF; Kader, SR; Bodkin, N; Lyon, JG; Calhoun, M; Azrak, C; Tiwari, PM; Vanover, D; Wang, HC; Santangelo, PJ; Bellamkonda, RV				Enam, Syed Faaiz; Kader, Sajidur Rahman; Bodkin, Nicholas; Lyon, Johnathan G.; Calhoun, Mark; Azrak, Cesar; Tiwari, Pooja Munnilal; Vanover, Daryll; Wang, Haichen; Santangelo, Philip J.; Bellamkonda, Ravi Venkat			Evaluation of M2-like macrophage enrichment after diffuse traumatic brain injury through transient interleukin-4 expression from engineered mesenchymal stromal cells	JOURNAL OF NEUROINFLAMMATION			English	Article						Interleukin-4; IL-4; mRNA; Stem cell; MSC; Macrophage; M2; Traumatic brain injury; TBI; RNA-seq	CLOSED-HEAD INJURY; SPINAL-CORD; STEM-CELLS; FUNCTIONAL RECOVERY; BONE-MARROW; MICROGLIA/MACROPHAGE POLARIZATION; ALTERNATIVE ACTIVATION; M2 MACROPHAGES; NERVOUS-SYSTEM; MESSENGER-RNA	Background Appropriately modulating inflammation after traumatic brain injury (TBI) may prevent disabilities for the millions of those inflicted annually. In TBI, cellular mediators of inflammation, including macrophages and microglia, possess a range of phenotypes relevant for an immunomodulatory therapeutic approach. It is thought that early phenotypic modulation of these cells will have a cascading healing effect. In fact, an anti-inflammatory, "M2-like" macrophage phenotype after TBI has been associated with neurogenesis, axonal regeneration, and improved white matter integrity (WMI). There already exist clinical trials seeking an M2-like bias through mesenchymal stem/stromal cells (MSCs). However, MSCs do not endogenously synthesize key signals that induce robust M2-like phenotypes such as interleukin-4 (IL-4). Methods To enrich M2-like macrophages in a clinically relevant manner, we augmented MSCs with synthetic IL-4 mRNA to transiently express IL-4. These IL-4 expressing MSCs (IL-4 MSCs) were characterized for expression and functionality and then delivered in a modified mouse TBI model of closed head injury. Groups were assessed for functional deficits and MR imaging. Brain tissue was analyzed through flow cytometry, multi-plex ELISA, qPCR, histology, and RNA sequencing. Results We observed that IL-4 MSCs indeed induce a robust M2-like macrophage phenotype and promote anti-inflammatory gene expression after TBI. However, here we demonstrate that acute enrichment of M2-like macrophages did not translate to improved functional or histological outcomes, or improvements in WMI on MR imaging. To further understand whether dysfunctional pathways underlie the lack of therapeutic effect, we report transcriptomic analysis of injured and treated brains. Through this, we discovered that inflammation persists despite acute enrichment of M2-like macrophages in the brain. Conclusion The results demonstrate that MSCs can be engineered to induce a stronger M2-like macrophage response in vivo. However, they also suggest that acute enrichment of only M2-like macrophages after diffuse TBI cannot orchestrate neurogenesis, axonal regeneration, or improve WMI. Here, we also discuss our modified TBI model and methods to assess severity, behavioral studies, and propose that IL-4 expressing MSCs may also have relevance in other cavitary diseases or in improving biomaterial integration into tissues.	[Enam, Syed Faaiz; Kader, Sajidur Rahman; Bodkin, Nicholas; Lyon, Johnathan G.; Calhoun, Mark; Azrak, Cesar; Bellamkonda, Ravi Venkat] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Tiwari, Pooja Munnilal; Vanover, Daryll; Santangelo, Philip J.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Wang, Haichen] Duke Univ, Dept Neurol, Durham, NC USA		Bellamkonda, RV (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	ravi@duke.edu		Lyon, Johnathan/0000-0002-0926-231X; Enam, Syed Faaiz/0000-0002-5320-6809; Vanover, Daryll/0000-0001-8744-5923; Bodkin, Nicholas/0000-0001-5090-9616	National Institute of Neurological Disorders and Stroke (NINDS), of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079739-05]	This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS), of the National Institutes of Health (NIH), R01NS079739-05.	Ali I, 2017, EPILEPSIA, V58, P1063, DOI 10.1111/epi.13743; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Basrai HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153418; Blomster LV, 2013, EXP NEUROL, V247, P226, DOI 10.1016/j.expneurol.2013.05.002; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Brown BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00510; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Calabrese E, 2015, CEREB CORTEX, V25, P4628, DOI 10.1093/cercor/bhv121; Casella G, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0596-5; CDC, 2016, REV DIAGN TEST ZIK C, P1; CDC Injury Center, 2016, SEV TBI CONC TRAUM B; Chen J, 2016, INTERLEUKIN 4 NOVEL; CHEN X, 2018, J NEUROINFLAMM, V15, P1, DOI DOI 10.1186/S12974-018-1151-3; Conlon P J, 1989, Biotechnol Ther, V1, P31; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cox CS, 2018, PEDIATR RES, V83, P325, DOI 10.1038/pr.2017.253; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Desai A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0714-4; Desestret V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067063; Dooley D, 2016, STEM CELL REP, V7, P1099, DOI 10.1016/j.stemcr.2016.11.005; Enam SF, 2017, BIOMATERIALS, V142, P52, DOI 10.1016/j.biomaterials.2017.07.013; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Fernandez-Klett F, 2014, BRAIN PATHOL, V24, P404, DOI 10.1111/bpa.12162; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Francos-Quijorna I, 2016, GLIA, V64, P2079, DOI 10.1002/glia.23041; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246; Gao JL, 2016, CELL TRANSPLANT, V25, P1863, DOI 10.3727/096368916X691150; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Ghosh S, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5815439; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grin'kina NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161053; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hei WH, 2017, NEUROSCI LETT, V643, P111, DOI 10.1016/j.neulet.2017.02.030; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Kansagara D., 2013, COMPLICATIONS MILD T; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kyurkchiev Dobroslav, 2014, World J Stem Cells, V6, P552, DOI 10.4252/wjsc.v6.i5.552; Lee SI, 2010, J NEUROSCI RES, V88, P2409, DOI 10.1002/jnr.22411; Levy O, 2013, BLOOD, V122, pE23, DOI 10.1182/blood-2013-04-495119; Lima R, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10040083; Lin TH, 2018, CYTOTHERAPY, V20, P1028, DOI 10.1016/j.jcyt.2018.06.009; Liu XR, 2016, STROKE, V47, P498, DOI 10.1161/STROKEAHA.115.012079; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2009, NEUROBIOL AGING, V30, P920, DOI 10.1016/j.neurobiolaging.2007.09.001; Luzina IG, 2012, J LEUKOCYTE BIOL, V92, P753, DOI 10.1189/jlb.0412214; Lv JF, 2018, BRAIN RES, V1685, P91, DOI 10.1016/j.brainres.2018.01.032; Ma SF, 2015, BRAIN BEHAV IMMUN, V45, P157, DOI 10.1016/j.bbi.2014.11.007; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mokarram N, 2017, P NATL ACAD SCI USA, V114, pE5077, DOI 10.1073/pnas.1705757114; Mokarram N, 2014, ANN BIOMED ENG, V42, P338, DOI 10.1007/s10439-013-0941-0; Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050; Morganti JM, 2015, J NEUROSCI; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Oosterhof N, 2015, GLIA, V63, P719, DOI 10.1002/glia.22780; Park Chae Woon, 2009, Int J Stem Cells, V2, P59; Payne NL, 2012, CELL ADHES MIGR, V6, P179, DOI 10.4161/cam.20341; Peruzzaro ST, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1383-2; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Posel C, 2016, JOVE-J VIS EXP, V2016, P108; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Rossi C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0288-4; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P3, DOI 10.1093/ndt/gfh1092; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shi XD, 2018, CELL TISSUE RES, V372, P67, DOI 10.1007/s00441-017-2716-7; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; Song GY, 2019, J MOL NEUROSCI, V69, P324, DOI 10.1007/s12031-019-01361-5; Spittau B, 2017, NEURAL REGEN RES, V12, P1433, DOI 10.4103/1673-5374.215250; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JM, 2015, CYTOTHERAPY, V17, P775, DOI 10.1016/j.jcyt.2015.03.004; Taj SH, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1212-7; Takamiya M, 2007, J NEUROTRAUM, V24, P1833, DOI 10.1089/neu.2007.0336; Teixeira FG, 2013, CELL MOL LIFE SCI, V70, P3871, DOI 10.1007/s00018-013-1290-8; Thawer SG, 2013, J NEUROIMMUNOL, V261, P7, DOI 10.1016/j.jneuroim.2013.04.008; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Vugmeyster Yulia, 2012, World J Biol Chem, V3, P73, DOI 10.4331/wjbc.v3.i4.73; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang N, 2018, BRAIN STRUCT FUNCT, V223, P4323, DOI 10.1007/s00429-018-1750-x; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Weil ZM, 2008, PROG NEUROBIOL, V86, P48, DOI 10.1016/j.pneurobio.2008.06.001; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Willing AE, 2003, J NEUROSCI RES, V73, P296, DOI 10.1002/jnr.10659; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Xu YT, 2019, J IMMUNOL, V202, P608, DOI 10.4049/jimmunol.1800924; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang YX, 2019, NEUROCHEM RES, V44, P811, DOI 10.1007/s11064-018-02714-z; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang ZG, 2019, NAT REV NEUROL, V15, P193, DOI 10.1038/s41582-018-0126-4; Zhao XR, 2015, J NEUROSCI, V35, P11281, DOI 10.1523/JNEUROSCI.1685-15.2015	114	10	10	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JUN 20	2020	17	1							197	10.1186/s12974-020-01860-y			24	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	MD6HQ	WOS:000544073100002	32563258	Green Submitted, Green Published, gold			2022-02-06	
J	Logsdon, AF; Schindler, AG; Meabon, JS; Yagi, M; Herbert, MJ; Banks, WA; Raskind, MA; Marshall, DA; Keene, CD; Perl, DP; Peskind, ER; Cook, DG				Logsdon, Aric F.; Schindler, Abigail G.; Meabon, James S.; Yagi, Mayumi; Herbert, Melanie J.; Banks, William A.; Raskind, Murray A.; Marshall, Desiree A.; Keene, C. Dirk; Perl, Daniel P.; Peskind, Elaine R.; Cook, David G.			Nitric oxide synthase mediates cerebellar dysfunction in mice exposed to repetitive blast-induced mild traumatic brain injury	SCIENTIFIC REPORTS			English	Article							BARRIER PERMEABILITY; ENDOTHELIAL-CELLS; GENE-EXPRESSION; METHYL-ESTER; MOUSE MODEL; L-NAME; RAT; INFLAMMATION; ENCEPHALOPATHY; VETERANS	We investigated the role of nitric oxide synthase (NOS) in mediating blood-brain barrier (BBB) disruption and peripheral immune cell infiltration in the cerebellum following blast exposure. Repetitive, but not single blast exposure, induced delayed-onset BBB disruption (72hours post-blast) in cerebellum. The NOS inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) administered after blast blocked BBB disruption and prevented CD4(+) T-cell infiltration into cerebellum. L-NAME also blocked blast-induced increases in intercellular adhesion molecule-1 (ICAM-1), a molecule that plays a critical role in regulating blood-to-brain immune cell trafficking. Blocking NOS-mediated BBB dysfunction during this acute/subacute post-blast interval (24-71hours after the last blast) also prevented sensorimotor impairment on a rotarod task 30 days later, long after L-NAME cleared the body. In postmortem brains from Veterans/military Servicemembers with blast-related TBI, we found marked Purkinje cell dendritic arbor structural abnormalities, which were comparable to neuropathologic findings in the blast-exposed mice. Taken collectively, these results indicate that blast provokes delayed-onset of NOS-dependent pathogenic cascades that can later emerge as behavioral dysfunction. These results also further implicate the cerebellum as a brain region vulnerable to blast-induced mTBI.	[Logsdon, Aric F.; Schindler, Abigail G.; Yagi, Mayumi; Herbert, Melanie J.; Banks, William A.; Cook, David G.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr GRECC, Seattle, WA 98108 USA; [Logsdon, Aric F.; Banks, William A.; Cook, David G.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Meabon, James S.; Raskind, Murray A.; Peskind, Elaine R.] Vet Affairs Puget Sound Hlth Care Syst, VA Northwest Mental Illness Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Schindler, Abigail G.; Meabon, James S.; Raskind, Murray A.; Peskind, Elaine R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Marshall, Desiree A.; Keene, C. Dirk] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Perl, Daniel P.] Uniformed Serv Univ Hlth Sci, Sch Med, Ctr Neurosci & Regenerat Med, Dept Pathol, Bethesda, MD 20814 USA		Cook, DG (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr GRECC, Seattle, WA 98108 USA.; Cook, DG (corresponding author), Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA.	dgcook@u.washington.edu	Banks, William A/K-1330-2017	Banks, William A/0000-0002-0496-3619	VA Biomedical Laboratory Research and Development Service from the U.S. Department of Veterans AffairsUS Department of Veterans Affairs [I01BX002311, IK2 BX003258-01A1]; Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [B77421]; University of Washington Friends of Alzheimer's Research; VA Puget Sound Health Care System Seed GrantUS Department of Veterans Affairs; NIH National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG046619, T32AG052354]; Alzheimer's Disease Research Center [P50AG005136]; Nancy and Buster Alvord Endowment	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the VA Biomedical Laboratory Research and Development Service from the U.S. Department of Veterans Affairs I01BX002311(DGC); Veterans Affairs Rehabilitation Research and Development Service #B77421 (ERP); University of Washington Friends of Alzheimer's Research (DGC, ERP); VA Puget Sound Health Care System Seed Grant (JSM); and NIH National Institute on Aging projects R01AG046619 (WAB) and T32AG052354 (AFL); Alzheimer's Disease Research Center P50AG005136 (CDK, DAM); Nancy and Buster Alvord Endowment (CDK): VA Biomedical Laboratory Research and Development Service from the U.S. Department of Veterans Affairs IK2 BX003258-01A1 (AGS).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abutarboush R, 2019, J NEUROTRAUM, V36, P3138, DOI 10.1089/neu.2019.6423; AFHSB, 2019, DOD WORLDW NUMB TBI; Avontuur JAM, 1998, EUR J CLIN PHARMACOL, V54, P627, DOI 10.1007/s002280050525; Badea A, 2018, NEUROIMAGE-CLIN, V18, P60, DOI 10.1016/j.nicl.2018.01.007; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Banks WA, 2008, ENDOCRINOLOGY, V149, P1514, DOI 10.1210/en.2007-1091; Banks WA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0434-1; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bhowmick S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010011; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Braun M, 2017, BBA-MOL BASIS DIS, V1863, P2614, DOI 10.1016/j.bbadis.2017.05.020; Braun M, 2017, J IMMUNOL, V198, P3615, DOI 10.4049/jimmunol.1601948; Cao J, 2017, SCI REP, V7, DOI [10.1038/s41598-017-11654-75595858, DOI 10.1038/S41598-017-11654-75595858]; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Del Razo MJ, 2016, SIAM J SCI COMPUT, V38, pB347, DOI 10.1137/15M1010750; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; ENGELHARDT B, 1994, J NEUROIMMUNOL, V51, P199, DOI 10.1016/0165-5728(94)90082-5; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Gahm C, 2005, NEUROSURGERY, V57, P1272, DOI 10.1227/01.NEU.0000187317.32529.06; Gao F, 2018, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01124; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hall AA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00104; Hatakeyama T, 2006, J PHYSIOL-LONDON, V574, P275, DOI 10.1113/jphysiol.2006.108175; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Janelidze S, 2017, NEUROBIOL AGING, V51, P104, DOI 10.1016/j.neurobiolaging.2016.11.017; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Khaldi A, 2002, ANN NY ACAD SCI, V962, P53, DOI 10.1111/j.1749-6632.2002.tb04055.x; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; LEVIN VA, 1970, AM J PHYSIOL, V219, P1528, DOI 10.1152/ajplegacy.1970.219.5.1528; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Macdonald A, 2011, J TRAUMA STRESS, V24, P268, DOI 10.1002/jts.20642; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; MISHRA V, 2016, SCI REP UK, V0006; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Nelson AR, 2016, BBA-MOL BASIS DIS, V1862, P887, DOI 10.1016/j.bbadis.2015.12.016; Nonaka H, 2002, ACTA NEUROPATHOL, V104, P608, DOI 10.1007/s00401-002-0592-y; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; RAHNERWELSCH S, 1995, J CEREBR BLOOD F MET, V15, P681, DOI 10.1038/jcbfm.1995.84; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Robinson ME, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101651; Schindler AG, 2017, NEUROBIOL DIS, V106, P23, DOI 10.1016/j.nbd.2017.06.004; SHETTY AK, 2014, FRONT CELL NEUROSCI, V0008; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Steiner O, 2010, J IMMUNOL, V185, P4846, DOI 10.4049/jimmunol.0903732; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Townsend MT, 2019, ANN BIOMED ENG, V47, P2019, DOI 10.1007/s10439-018-02178-w; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; WERTHEIMER SJ, 1992, J BIOL CHEM, V267, P12030; Winer B. J., 1991, STAT PRINCIPLES EXPT, V3rd; Wong D, 2005, EUR J PHARMACOL, V514, P91, DOI 10.1016/j.ejphar.2005.03.025; Wui MZ, 2009, GLIA, V57, P1204, DOI 10.1002/glia.20842; Xaio HP, 2001, BRAIN RES, V896, P36, DOI 10.1016/S0006-8993(00)03247-9; Xu SL, 2013, AM J PHYSIOL-HEART C, V305, pH1484, DOI 10.1152/ajpheart.00382.2013; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; [No title captured]	93	10	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 10	2020	10	1							9420	10.1038/s41598-020-66113-7			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB4IW	WOS:000560478900036	32523011	Green Published, gold			2022-02-06	
J	Giacino, JT; Whyte, J; Nakase-Richardson, R; Katz, DI; Arciniegas, DB; Blum, S; Day, K; Greenwald, BD; Hammond, FM; Pape, TB; Rosenbaum, A; Seel, RT; Weintraub, A; Yablon, S; Zafonte, RD; Zasler, N				Giacino, Joseph T.; Whyte, John; Nakase-Richardson, Risa; Katz, Douglas, I; Arciniegas, David B.; Blum, Sonja; Day, Kristin; Greenwald, Brian D.; Hammond, Flora M.; Pape, Theresa Bender; Rosenbaum, Amy; Seel, Ronald T.; Weintraub, Alan; Yablon, Stuart; Zafonte, Ross D.; Zasler, Nathan			Minimum Competency Recommendations for Programs That Provide Rehabilitation Services for Persons With Disorders of Consciousness: A Position Statement of the American Congress of Rehabilitation Medicine and the National Institute on Disability, Independent Living and Rehabilitation Research Traumatic Brain Injury Model Systems	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Best practices; Brain injuries; Coma; Health services; Rehabilitation	LONG-TERM; INPATIENT REHABILITATION; VEGETATIVE STATE; POSTTRAUMATIC HYDROCEPHALUS; FUNCTIONAL RECOVERY; CLINICAL-PRACTICE; SLEEP DISRUPTION; CONTINUOUS CHAIN; CAREGIVERS; BURDEN	Persons who have disorders of consciousness (DoC) require care from multidisciplinary teams with specialized training and expertise in management of the complex needs of this clinical population. The recent promulgation of practice guidelines for patients with prolonged DoC by the American Academy of Neurology, American Congress of Rehabilitation Medicine (ACRM), and National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) represents a major advance in the development of care standards in this area of brain injury rehabilitation. Implementation of these practice guidelines requires explication of the minimum competencies of clinical programs providing services to persons who have DoC. The Brain Injury Interdisciplinary Special Interest Group of the ACRM, in collaboration with the Disorders of Consciousness Special Interest Group of the NIDILRR-Traumatic Brain Injury Model Systems convened a multidisciplinary panel of experts to address this need through the present position statement. Content area-specific workgroups reviewed relevant peer-reviewed literature and drafted recommendations which were then evaluated by the expert panel using a modified Delphi voting process. The process yielded 21 recommendations on the structure and process of essential services required for effective DoC-focused rehabilitation, organized into 4 categories: diagnostic and prognostic assessment (4 recommendations), treatment (11 recommendations), transitioning care/long-term care needs (5 recommendations), and management of ethical issues (1 recommendation). With few exceptions, these recommendations focus on infrastructure requirements and operating procedures for the provision of DoC-focused neurorehabilitation services across subacute and postacute settings. (C) 2020 by the American Congress of Rehabilitation Medicine	[Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 First Ave, Boston, MA 02129 USA; [Giacino, Joseph T.] Harvard Med Sch, Boston, MA 02115 USA; [Giacino, Joseph T.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Whyte, John] Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Elkins Pk, PA USA; [Nakase-Richardson, Risa] Univ S Florida, James A Haley Vet Hosp, Mental Hlth & Behav Sci, Def & Vet Brain Injuty Ctr, Tampa, FL 33620 USA; [Nakase-Richardson, Risa] Univ S Florida, Morsani Coll Med, Div Pulm & Sleep Med, Tampa, FL 33620 USA; [Katz, Douglas, I] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Katz, Douglas, I] Encompass Hlth Braintree Rehabil Hosp, Braintree, MA USA; [Arciniegas, David B.] Univ Colorado, Marcus Inst Brain Hlth, Anschutz Med Campus, Aurora, CO USA; [Arciniegas, David B.] Univ Colorado, Neuropsychiatty Serv, Dept Psychiat, Sch Med, Aurora, CO USA; [Blum, Sonja] NYU Langone Hlth, New York, NY USA; [Day, Kristin] Arcadia Univ, Dept Phys Therapy, Glenside, PA USA; [Greenwald, Brian D.] JFK Johnson Rehabil Inst, Edison, NJ USA; [Greenwald, Brian D.] Hackensack Meridian Hlth, Edison, NJ USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN 46202 USA; [Pape, Theresa Bender] Edward Hines Jr VA Hosp, Res Serv, Hines, IL USA; [Pape, Theresa Bender] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Rosenbaum, Amy] Pk Terrace Care Ctr, Rego Pk, NY USA; [Rosenbaum, Amy] BrainMatters Neuropsychol Serv, Plainview, NY USA; [Seel, Ronald T.] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Dept Phys Med & Rehabil, Sch Med, Richmond, VA USA; [Weintraub, Alan] Craig Hosp, Rocky Mt Reg Brain Injury Syst, Englewood, CO USA; [Weintraub, Alan] Univ Colorado, Sch Med, Dept PM&R, Aurora, CO USA; [Yablon, Stuart] Michigan State Univ, Coll Human Med, Mary Free Bed Rehabil Hosp, Grand Rapids, MI USA; [Yablon, Stuart] Michigan State Univ, Coll Human Med, Div Rehabil Med, Grand Rapids, MI USA; [Zafonte, Ross D.] Harvard Med Sch, Massachusetts Gen Hosp, Brigham & Womens Hosp, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Zasler, Nathan] Concuss Care Ctr Virginia & Tree Life Serv, Henrico, VA USA; [Zasler, Nathan] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA		Giacino, JT (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 First Ave, Boston, MA 02129 USA.	jgiacino@mgh.harvard.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Blum, Sonja/0000-0001-8877-7321	CARF International and Paradigm; Neither ACRM nor NIDILRR	This position statement was developed under the American Congress of Rehabilitation Medicine Evidence and Practice Committee (ACRM EPC), which is supported by unrestricted grants from CARF International and Paradigm. Neither CARF International nor Paradigm were involved in any phase of the development of this statement.; The recommendations and supporting text included in this article were developed through a collaboration between the ACRM and grantees of the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government. Neither ACRM nor NIDILRR provided any funding to support this work.	Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; American Academy of Family Physicians, BAS QUAL IMPR; Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bagnato S, 2016, EPILEPSY BEHAV, V56, P83, DOI 10.1016/j.yebeh.2015.12.012; Bagnato S, 2013, EPILEPSY RES, V103, P106, DOI 10.1016/j.eplepsyres.2012.09.008; Bai YL, 2012, J CLIN NEUROSCI, V19, P1376, DOI 10.1016/j.jocn.2011.10.021; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Bernat JL, 2009, PROG BRAIN RES, V177, P21, DOI 10.1016/S0079-6123(09)17703-8; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; Boly M, 2015, NEUROLOGY CONSCIOUSN, P31; Bose P, 2015, BRAIN NEUROTRAUMA MO; Cameron JI, 2016, INT J STROKE, V11, P807, DOI 10.1177/1747493016660102; Candelieri A, 2011, J NEUROTRAUM, V28, P2013, DOI 10.1089/neu.2011.1885; Chan L, 2013, ARCH PHYS MED REHAB, V94, P622, DOI 10.1016/j.apmr.2012.09.033; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cortese MD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0455-5; Covelli V, 2016, ACTA NEUROL SCAND, V134, P352, DOI 10.1111/ane.12550; Covelli V, 2014, THESCIENTIFICWORLDJO, V2014; Devlin JW, 2018, CRIT CARE MED, V46, P1532, DOI 10.1097/CCM.0000000000003259; Dobson DaVanzo & Associates LLC, ASS PA OUTC REH CAR; Dolce G, 2012, J REHABIL MED, V44, P512, DOI 10.2340/16501977-0968; Fins JJ, 2005, HASTINGS CENT REP, V35, P22, DOI 10.2307/3527759; Fins JJ, 2007, ARCH NEUROL-CHICAGO, V64, P1400, DOI 10.1001/archneur.64.10.1400; Fins JJ, 2013, ARCH PHYS MED REHAB, V94, P1934, DOI 10.1016/j.apmr.2012.12.028; Flink M, 2012, BMJ QUAL SAF, V21, P89, DOI 10.1136/bmjqs-2012-001171; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1710, DOI 10.1016/j.apmr.2018.07.002; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1699, DOI 10.1016/j.apmr.2018.07.001; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P517; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giacino JT, 2014, HDB NEUROPSYCHOLOGY, P139; Giovannetti AM, 2013, ACTA NEUROL SCAND, V127, P10, DOI 10.1111/j.1600-0404.2012.01666.x; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Goldberg Todd H, 2014, W V Med J, V110, P24; Goldsmith J, 2010, QUAL HEALTH RES, V20, P93, DOI 10.1177/1049732309355287; Gordy Stephanie, 2011, Int J Crit Illn Inj Sci, V1, P132, DOI 10.4103/2229-5151.84800; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Hill CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00227; InterQual Level of Care Criteria, 2015, INTERQUAL LEVEL CARE; Jox RJ, 2012, LANCET NEUROL, V11, P732, DOI 10.1016/S1474-4422(12)70154-0; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kotchoubey B, 2014, CURR PHARM DESIGN, V20, P4239; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Lancioni G. E., 2017, ADV NEURODEV DISORD, V1, P1, DOI [10.1007/s41252-017-0025-5, DOI 10.1007/S41252-017-0025-5]; Lanoix M, 2010, BRAIN INJURY, V24, P1336, DOI 10.3109/02699052.2010.504524; Leonardi M, 2012, BRAIN INJURY, V26, P1201, DOI 10.3109/02699052.2012.667589; Lombardi F, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001427; Lucke-Wold BP, 2015, NEUROSCI BIOBEHAV R, V55, P68, DOI 10.1016/j.neubiorev.2015.04.010; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Medicare Payment Advisory Commission, REP C MED HLTH CAR D; Mortimer D, 2019, ARCH PHYS MED REHAB, V100, P648, DOI 10.1016/j.apmr.2018.08.184; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Pagani M, 2014, J CLIN PSYCHOL MED S, V21, P214, DOI 10.1007/s10880-014-9399-y; Piccenna L, 2016, BRAIN INJURY, V30, P241, DOI 10.3109/02699052.2015.1113569; Pignat JM, 2015, CURR OPIN NEUROL, V28, P587, DOI 10.1097/WCO.0000000000000264; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; Portaccio E, 2018, ARCH PHYS MED REHAB, V99, P914, DOI 10.1016/j.apmr.2018.01.015; Rubin EB, 2011, NEUROL CLIN, V29, P1055, DOI 10.1016/j.ncl.2011.07.007; Schnakers C, 2017, CURR OPIN NEUROL, V30, P573, DOI 10.1097/WCO.0000000000000495; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; Siefferman JW, 2012, PHYS MED REH CLIN N, V23, P241, DOI 10.1016/j.pmr.2012.02.003; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Turner-Stokes L, 2017, J MED ETHICS, V43, P469, DOI 10.1136/medethics-2016-104057; Villagran M, 2010, COMMUN EDUC, V59, P220, DOI 10.1080/03634521003624031; Vogel D, 2013, ARCH PHYS MED REHAB, V94, P1891, DOI 10.1016/j.apmr.2012.11.053; Wabl R, 2019, J NEUROSURG, V131, P114, DOI 10.3171/2018.2.JNS173247; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Whyte J, 1999, ARCH PHYS MED REHAB, V80, P653, DOI 10.1016/S0003-9993(99)90168-5; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; WHYTE J, 1995, ARCH PHYS MED REHAB, V76, P804, DOI 10.1016/S0003-9993(95)80543-5; Whyte J, 2014, AM J PHYS MED REHAB, V93, P101, DOI 10.1097/PHM.0000000000000069; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Wittenberg-Lyles E, 2010, J HOSP PALLIAT NURS, V12, P282, DOI 10.1097/NJH.0b013e3181ebb45e; Wright MS, 2016, YALE J HLTH POLICY L, V16, P233; Yu T, 2013, NEUROLOGY, V80, P345, DOI 10.1212/WNL.0b013e31827f0846	99	10	10	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2020	101	6					1072	1089		10.1016/j.apmr.2020.01.013			18	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	MC1BC	WOS:000543030600016	32087109	Bronze, Green Submitted			2022-02-06	
J	Rocha, TAH; Elahi, C; da Silva, NC; Sakita, FM; Fuller, A; Mmbaga, BT; Green, EP; Haglund, MM; Staton, CA; Vissoci, JRN				Rocha, Thiago Augusto Hernandes; Elahi, Cyrus; da Silva, Nubia Cristina; Sakita, Francis M.; Fuller, Anthony; Mmbaga, Blandina T.; Green, Eric P.; Haglund, Michael M.; Staton, Catherine A.; Vissoci, Joao Ricardo Nickenig			A traumatic brain injury prognostic model to support in-hospital triage in a low-income country: a machine learning-based approach	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; predictive analytics; neurosurgery; machine learning; LMICs	SEVERE HEAD-INJURY; OUTCOME PREDICTION; MORTALITY; MODERATE; CARE	OBJECTIVE Traumatic brain injury (TBI) is a leading cause of death and disability worldwide, with a disproportionate burden of this injury on low- and middle-income countries (LMICs). Limited access to diagnostic technologies and highly skilled providers combined with high patient volumes contributes to poor outcomes in LMICs. Prognostic modeling as a clinical decision support tool, in theory, could optimize the use of existing resources and support timely treatment decisions in LMICs. The objective of this study was to develop a machine learning-based prognostic model using data from Kilimanjaro Christian Medical Centre in Moshi, Tanzania. METHODS This study is a secondary analysis of a TBI data registry including 3138 patients. The authors tested nine different machine learning techniques to identify the prognostic model with the greatest area under the receiver operating characteristic curve (AUC). Input data included demographics, vital signs, injury type, and treatment received. The outcome variable was the discharge score on the Glasgow Outcome Scale-Extended. RESULTS The AUC for the prognostic models varied from 66.2% (k-nearest neighbors) to 86.5% (Bayesian generalized linear model). An increasing Glasgow Coma Scale score, increasing pulse oximetry values, and undergoing TBI surgery were predictive of a good recovery, while injuries suffered from a motor vehicle crash and increasing age were predictive of a poor recovery. CONCLUSIONS The authors developed a TBI prognostic model with a substantial level of accuracy in a low-resource setting. Further research is needed to externally validate the model and test the algorithm as a clinical decision support tool.	[Rocha, Thiago Augusto Hernandes; Elahi, Cyrus; Fuller, Anthony; Haglund, Michael M.; Staton, Catherine A.; Vissoci, Joao Ricardo Nickenig] Duke Div Global Neurosurg & Neurol, Durham, NC USA; [Elahi, Cyrus; da Silva, Nubia Cristina; Fuller, Anthony; Mmbaga, Blandina T.; Green, Eric P.; Haglund, Michael M.; Staton, Catherine A.; Vissoci, Joao Ricardo Nickenig] Duke Univ, Global Hlth Inst, Durham, NC USA; [Sakita, Francis M.; Mmbaga, Blandina T.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Fuller, Anthony; Haglund, Michael M.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA; [Staton, Catherine A.] Duke Univ, Med Ctr, Div Emergency Med, Durham, NC USA; [Mmbaga, Blandina T.] Kilimanjaro Clin Res Inst, Moshi, Tanzania		Elahi, C (corresponding author), Duke Univ, Durham, NC 27708 USA.	cyrusweal@gmail.com	Mmbaga, Blandina Theophil/AAR-8707-2021; Rocha, Thiago/AAW-3805-2020	Mmbaga, Blandina Theophil/0000-0002-5550-1916; Rocha, Thiago/0000-0002-6262-3276; Staton, Catherine/0000-0002-6468-2894	Duke Division of Global Neurosurgery and Neurology group; Duke University Global Health Institute; KCMC	Thank you to the entire Duke Division of Global Neurosurgery and Neurology group, Duke University Global Health Institute, and KCMC for their support and guidance in shaping this manuscript.	Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dewan MC, J NEUROSURG; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hastie T, 2009, ELEMENTS STAT LEARNI; Holmes DE, 2018, MACHINE LEARNING STR; Hsu MH, 2005, STUD HEALTH TECHNOL, V116, P241; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kairalla JA, 2008, J STAT SOFTW, V28, P1; Kalpakis K, 2015, COMPUT BIOL MED, V56, P167, DOI 10.1016/j.compbiomed.2014.11.007; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Lai Y. C., 1998, Annals Academy of Medicine Singapore, V27, P326; Luo W, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5870; Mukherjee K, 2000, NEUROL INDIA, V48, P43; Murray CJL, 1996, GLOBAL BURDEN DIS CO; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Pillai SV, 2003, NEUROL INDIA, V51, P345; Ratanalert S, 2002, BRIT J NEUROSURG, V16, P487, DOI 10.1080/0268869021000030311; Raykar NP, 2015, LANCET, V385, P15, DOI 10.1016/S0140-6736(15)60810-8; Reddy C.K., 2015, HEALTHCARE DATA ANAL; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Senders JT, 2018, WORLD NEUROSURG, V109, P476, DOI 10.1016/j.wneu.2017.09.149; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; van Buuren S, 2011, J STAT SOFTW, V45, P1; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762	41	10	10	1	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2020	132	6					1961	1969		10.3171/2019.2.JNS182098			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LU6FW	WOS:000537850100034	31075779				2022-02-06	
J	Song, XJ; Li, CC; Wang, Y; Wang, DH; Liu, ZH				Song, Xinjian; Li, Chenchen; Wang, Yan; Wang, Donghua; Liu, Zhihong			A ratiometric two-photon fluorescence probe for monitoring mitochondrial HOCl produced during the traumatic brain injury process	SENSORS AND ACTUATORS B-CHEMICAL			English	Article						Fluorescence probe; Hypochlorous acid; Two-photon bioimaging; Traumatic brain injury (TBI)	HYPOCHLOROUS ACID; REACTIVE OXYGEN; OXIDATIVE STRESS; LIVING CELLS; LYSOSOME; NEUROINFLAMMATION; GENERATION	Mitochondrial hypochlorous acid (HOCl) is closely related to the redox balance in mitochondria. Abnormal HOCl levels in mitochondria can induce mitochondrial inactivation and further cause cell apoptosis. Consequently, developing a reliable method for detecting HOCl in mitochondria is essential. A mitochondria-targeting two-photon fluorescence probe (Mito-P-OCl) with zero cross-talk ratiometric emission was synthesized and applied to study the traumatic brain injury process in mice. The probe gives a considerable variation (up to 58.5-fold) in its fluorescence intensity ratio (I-595/I-453) upon reacting with HOCl for 150 s. Mito-P-OCl exhibited excellent properties such as fast response, high sensitivity with a low detection limit of 55.4 nM, high selectivity and deep tissue penetration (270 mu m). Moreover, the probe possesses the capability of monitoring endogenous HOCl in living cells and tissues using dual-emission channels and two-photon microscopy.	[Song, Xinjian; Li, Chenchen; Wang, Yan; Wang, Donghua] Hubei Minzu Univ, Sch Chem & Environm Engn, Hubei Key Lab Biol Resources Protect & Utilizat, Enshi 445000, Peoples R China; [Song, Xinjian; Liu, Zhihong] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China		Song, XJ; Liu, ZH (corresponding author), Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China.; Song, XJ; Liu, ZH (corresponding author), Hubei Minzu Univ, Sch Chem & Environm Engn, Enshi 445000, Peoples R China.	whxjsong@163.com; zhhliu@whu.edu.cn		Song, Xinjian/0000-0003-1897-3145	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [21625503, 21561011]; Natural Science Foundation of Hubei ProvinceNatural Science Foundation of Hubei Province [2016CFB400]; Open Foundation of Hubei Key Laboratory of Biological Resources Protection and Utilization [PKLHB1905]; Special Funds for "Double FirstClass" Construction in Hubei Province	This work was funded by the National Natural Science Foundation of China (Grant Nos. 21625503 and 21561011), the Natural Science Foundation of Hubei Province (Grant No. 2016CFB400), the Open Foundation of Hubei Key Laboratory of Biological Resources Protection and Utilization (PKLHB1905), and Special Funds for "Double FirstClass" Construction in Hubei Province.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Andina D, 2017, CHEM-EUR J, V23, P13549, DOI 10.1002/chem.201702458; Beija M, 2009, CHEM SOC REV, V38, P2410, DOI 10.1039/b901612k; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Chen PY, 2017, ANAL CHEM, V89, P5694, DOI 10.1021/acs.analchem.7b01103; Chen XQ, 2012, CHEM REV, V112, P1910, DOI 10.1021/cr200201z; Chen XQ, 2011, CHEM SOC REV, V40, P4783, DOI 10.1039/c1cs15037e; Chen XQ, 2008, CHEM-EUR J, V14, P4719, DOI 10.1002/chem.200701677; Choi HJ, 2019, SENSOR ACTUAT B-CHEM, V283, P810, DOI 10.1016/j.snb.2018.12.087; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Dou K, 2017, J MATER CHEM B, V5, P8389, DOI 10.1039/c7tb01900a; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Gao P, 2019, CHEM SCI, V10, P6035, DOI 10.1039/c9sc01652j; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Hammer A, 2001, LAB INVEST, V81, P543, DOI 10.1038/labinvest.3780263; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hill RL, 2018, NEUROSCIENCE, V386, P265, DOI 10.1016/j.neuroscience.2018.06.028; Hou JT, 2015, CHEM COMMUN, V51, P6781, DOI 10.1039/c5cc01217a; Hu JJ, 2017, ISR J CHEM, V57, P251, DOI 10.1002/ijch.201600113; Jiao XJ, 2019, ORG BIOMOL CHEM, V17, P108, DOI 10.1039/c8ob02583e; Kim HM, 2015, CHEM REV, V115, P5014, DOI 10.1021/cr5004425; Kim YJ, 2019, ANAL CHEM, V91, P9246, DOI 10.1021/acs.analchem.9b02137; Kolanowski JL, 2018, CHEM SOC REV, V47, P195, DOI 10.1039/c7cs00528h; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee MH, 2015, CHEM SOC REV, V44, P4185, DOI 10.1039/c4cs00280f; Li G, 2017, SENSOR ACTUAT B-CHEM, V252, P127, DOI 10.1016/j.snb.2017.05.138; Li J, 2018, SENSOR ACTUAT B-CHEM, V265, P84, DOI 10.1016/j.snb.2018.03.027; Li X, 2015, J AM CHEM SOC, V137, P12296, DOI 10.1021/jacs.5b06865; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Mao ZQ, 2018, CHEM SCI, V9, P6035, DOI 10.1039/c8sc01697f; Pak YL, 2018, ANAL CHEM, V90, P9510, DOI 10.1021/acs.analchem.8b02195; Pak YL, 2018, ANGEW CHEM INT EDIT, V57, P1567, DOI 10.1002/anie.201711188; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Prokopowicz ZM, 2010, J IMMUNOL, V184, P824, DOI 10.4049/jimmunol.0902606; Ren MG, 2018, J MATER CHEM B, V6, P1716, DOI 10.1039/c7tb03337k; Ren MG, 2016, J MATER CHEM B, V4, P4739, DOI 10.1039/c6tb01085g; Ren TB, 2018, ANGEW CHEM INT EDIT, V57, P7473, DOI 10.1002/anie.201800293; Sedgwick AC, 2018, CHEM SOC REV, V47, P8842, DOI 10.1039/c8cs00185e; Shen SL, 2017, J MATER CHEM B, V5, P289, DOI 10.1039/c6tb01992g; Shi HJ, 2019, NEUROPHARMACOLOGY, V145, P259, DOI 10.1016/j.neuropharm.2018.07.022; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Tan DH, 2017, MOL MED REP, V16, P4235, DOI 10.3892/mmr.2017.7040; Wang KN, 2019, SENSOR ACTUAT B-CHEM, V295, P215, DOI 10.1016/j.snb.2019.05.077; Xie XX, 2018, ANALYST, V143, P5736, DOI 10.1039/c8an01469h; Xu D, 2018, ANAL CHEM, V90, P8800, DOI 10.1021/acs.analchem.8b00520; Xu Q, 2015, ANGEW CHEM INT EDIT, V54, P4890, DOI 10.1002/anie.201500537; Xu W, 2016, ANGEW CHEM INT EDIT, V55, P13658, DOI 10.1002/anie.201510721; Yuan L, 2015, J AM CHEM SOC, V137, P5930, DOI 10.1021/jacs.5b00042; Zhang LJ, 2018, SENSOR ACTUAT B-CHEM, V276, P8, DOI 10.1016/j.snb.2018.08.071; Zhang YR, 2014, CHEM COMMUN, V50, P14241, DOI 10.1039/c4cc05976j; Zhou K, 2018, ANAL METHODS-UK, V10, P2546, DOI 10.1039/c8ay00607e; Zhou LY, 2014, J AM CHEM SOC, V136, P9838, DOI 10.1021/ja504015t; Zhu BC, 2018, SENSOR ACTUAT B-CHEM, V267, P589, DOI 10.1016/j.snb.2018.04.011; Zhu JL, 2019, CHEM COMMUN, V55, P6629, DOI 10.1039/c9cc03299a	56	10	10	7	63	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND		0925-4005		SENSOR ACTUAT B-CHEM	Sens. Actuator B-Chem.	MAY 15	2020	311								127895	10.1016/j.snb.2020.127895			9	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Electrochemistry; Instruments & Instrumentation	KY4RG	WOS:000522555800014					2022-02-06	
J	Zhao, W; Ji, SB				Zhao, Wei; Ji, Songbai			Incorporation of vasculature in a head injury model lowers local mechanical strains in dynamic impact	JOURNAL OF BIOMECHANICS			English	Article						Traumatic brain injury; Finite element model; Vasculature; Neuroimaging; Worcester Head Injury Model	WALL THICKNESS MEASUREMENTS; HUMAN CIRCLE; BRAIN; VALIDATION; COMPRESSIBILITY; BIOMECHANICS	Cerebral vasculature is several orders of magnitude stiffer than the brain tissue. However, only a handful of studies have investigated its potential stiffening effect on dynamic brain strains; yet, they report contradictory findings. Here, we reanalyze the cerebrovascular stiffening effect by incorporating vasculature derived from the latest neuroimaging atlases into a re-meshed Worcester Head Injury Model using an embedded element method. Regional brain strains with and without vasculature were simulated using a reconstructed, predominantly sagittal head impact. Using the two previously adopted linear or nonlinear vessel material models, we reproduced the earlier conflicting results (similar to 40% vs. similar to 1-6% in regional strain reductions). Nevertheless, with refitted non-linear material models chosen to represent the average dynamic tension behaviors of arteries and veins, respectively, inclusion of vasculature reduced regional brain strains by similar to 13-36% relative to the baselines without vasculature. Compared to the whole brain baseline response, inclusion of vasculature led to an element-wise linear regression slope of 0.8 and a Pearson correlation coefficient of 0.8. The vascular stiffening effect appears mild for the whole brain but more significant locally, which should not be ignored in head injury models. Nevertheless, more work is necessary to investigate the cerebrovascular mechanical behaviors and loading environment to allow for more biofidelic modeling of the brain in the future. (C) 2020 Elsevier Ltd. All rights reserved.	[Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA		Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA.	sji@wpi.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Ji, Songbai/0000-0002-2886-5781	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853]; Ford University Research Program	Funding is provided by the NIH Grant R01 NS092853 and the Ford University Research Program. The authors are grateful to the National Football League (NFL) Committee on Mild Traumatic Brain Injury (MTBI) and Biokinetics and Associates Ltd. for providing the reconstructed head impact data. The sponsors do not have any role in the study. The authors also thank Dr. Svein Kleiven at Kungliga Tekniska hogskolan (KTH) and Dr. Kenneth Monson at University of Utah for helpful discussions.	Abaqus, 2016, AB ONL DOC; Atsumi N, 2018, ANN BIOMED ENG, V46, P736, DOI 10.1007/s10439-018-1988-8; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bernier M, 2018, HUM BRAIN MAPP, V39, P4962, DOI 10.1002/hbm.24337; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; Fonov V., 2009, NEUROIMAGE, V47, pS102; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Harteveld AA, 2018, DATA BRIEF, V19, P6, DOI 10.1016/j.dib.2018.04.116; Harteveld AA, 2018, ATHEROSCLEROSIS, V273, P106, DOI 10.1016/j.atherosclerosis.2018.04.023; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Huss L, 2003, MUL LIN DIV, P1; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Jochimsen TH, 2007, NMR BIOMED, V20, P429, DOI 10.1002/nbm.1107; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Migueis GFJ, 2019, CLIN BIOMECH, V63, P104, DOI 10.1016/j.clinbiomech.2019.02.010; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Monson K. L. V., 2001, MECH FAILURE PROPERT; Monson KL, 2019, CLIN BIOMECH, V64, P98, DOI 10.1016/j.clinbiomech.2018.02.011; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Parnaik Yednesh, 2004, Stapp Car Crash J, V48, P259; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Unnikrishnan G, 2019, ANN BIOMED ENG, V47, P2033, DOI 10.1007/s10439-019-02277-2; Yang King H, 2006, Stapp Car Crash J, V50, P429; Yosibash Z, 2014, J MECH BEHAV BIOMED, V39, P339, DOI 10.1016/j.jmbbm.2014.07.030; Yossef OE, 2017, J MECH BEHAV BIOMED, V65, P177, DOI 10.1016/j.jmbbm.2016.08.013; Zhang L., 2002, SAE TECH PAP, DOI [10.4271/2002-22-0008, DOI 10.4271/2002-22-0008]; Zhao W, 2019, ANN BIOMED ENG, V47, P475, DOI 10.1007/s10439-018-02159-z; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5	42	10	10	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	MAY 7	2020	104								109732	10.1016/j.jbiomech.2020.109732			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	LG8GA	WOS:000528331100025	32151380	Green Accepted			2022-02-06	
J	Yeh, TC; Chien, WC; Chung, CH; Liang, CS; Chang, HA; Kao, YC; Yeh, HW; Yang, YJ; Tzeng, NS				Yeh, Ta-Chuan; Chien, Wu-Chien; Chung, Chi-Hsiang; Liang, Chih-Sung; Chang, Hsin-An; Kao, Yu-Chen; Yeh, Hui-Wen; Yang, Yun-Ju; Tzeng, Nian-Sheng			Psychiatric Disorders After Traumatic Brain Injury: A Nationwide Population-Based Cohort Study and the Effects of Rehabilitation Therapies	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Psychiatric disorders; Rehabilitation; Traumatic brain injuries	INSURANCE RESEARCH DATABASE; SEVERITY SCORE; A NATIONWIDE; FOLLOW-UP; RISK; DEPRESSION; NEUROREHABILITATION; DEMENTIA; ADULTS; ASSOCIATION	Objective: To investigate the risk of psychiatric disorders after traumatic brain injury (TBI), and to clarify whether the post-TBI rehabilitation was associated with a lower risk of developing psychiatric disorders. Design: A register-based, retrospective cohort design. Setting: Using data from the National Health Insurance Research Database of Taiwan, we established an exposed cohort with TBI and a nonexposed group without TBI matched by age and year of diagnosis between 2000 and 2015. Participants: This study included 231,894 patients with TBI and 695,682 patients without TBI (N=927,576). Interventions: Rehabilitation therapies in TBI patients. Main Outcome Measures: A multivariable Cox proportional hazards regression model was used to compare the risk of developing psychiatric disorders. Results: The incidence rate of psychiatric disorders was higher in the TBI group than the control group. Compared with the control group, the risk of psychiatric disorders in the TBI group was twofold (hazard ratio [HR] =2.072; 95% confidence interval [95% CI], 1.955-2.189; P<.001). Among the participants with TBI, 49,270 (21.25%) had received rehabilitation therapy and had a lower risk of psychiatric disorders (HR =0.691; 95% CI, 0.679-0.703; P<.001). In the subgroup analysis, the medium- to high-level intensity rehabilitation therapy was associated with lower risks of psychiatric disorder (HR =0.712 and 0.568, respectively), but there was no significant finding in the low-intensity group. Conclusions: We found that TBI was associated with a high risk for developing psychiatric disorders, and that the post-TBI rehabilitation significantly reduced the risk of psychiatric disorders in a dose-dependent manner. (C) 2020 by the American Congress of Rehabilitation Medicine.	[Yeh, Ta-Chuan; Chang, Hsin-An; Yeh, Hui-Wen; Tzeng, Nian-Sheng] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Psychiat, 325,Sect 2,Cheng Kung Rd, Taipei 11490, Taiwan; [Yeh, Ta-Chuan] Triserv Gen Hosp, Dept Psychiat, Penghu Branch, Penghu, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Liang, Chih-Sung] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Psychiat,Beitou Branch, Taipei, Taiwan; [Liang, Chih-Sung] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chang, Hsin-An; Tzeng, Nian-Sheng] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan; [Kao, Yu-Chen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Psychiatty, Song Shan Branch, Taipei, Taiwan; [Yeh, Hui-Wen] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Yeh, Hui-Wen] Triserv Gen Hosp, Natl Def Med Ctr, Sch Nursing, Dept Nursing, Taipei, Taiwan; [Yeh, Hui-Wen] Kang Ning Univ, Dept Nursing, Taipei Campus, Taipei, Taiwan; [Yang, Yun-Ju] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Surg, Taipei, Taiwan		Tzeng, NS (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Psychiat, 325,Sect 2,Cheng Kung Rd, Taipei 11490, Taiwan.	pierrens@mail.ndmctsgh.edu.tw	Yeh, Ta-Chuan/ABB-2957-2021; Tzeng, Nian-Sheng/AAU-4945-2021; Liang, Chih-Sung/V-6720-2019; Chung, Chi-Hsiang/AAY-3386-2021	Yeh, Ta-Chuan/0000-0002-1016-3634; Liang, Chih-Sung/0000-0003-1138-5586; Chang, Hsin-An/0000-0001-5572-7109	Medical Affairs Bureau, Ministry of Defense of Taiwan; Tri-Service General Hospital Research Foundation [TSGH-C107-004, TSGH-C107106, TSGH-C108-003, TSGH-C108-151]	Supported by the Medical Affairs Bureau, Ministry of Defense of Taiwan (grant no. MAB-107-084) and the Tri-Service General Hospital Research Foundation (grant nos. TSGH-C107-004, TSGH-C107106, TSGH-C108-003, and TSGH-C108-151).	Akerlund E, 2013, BRAIN INJURY, V27, P1649, DOI 10.3109/02699052.2013.830195; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bangirana P, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1246-1; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bayley PJ, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-48; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bombardier CH, 2017, J HEAD TRAUMA REHAB, V32, P343, DOI 10.1097/HTR.0000000000000288; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Chang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089867; Chang SY, 2018, J INVEST MED, V66, P1070, DOI 10.1136/jim-2018-000759; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien WC, 2017, RES DEV DISABIL, V65, P57, DOI 10.1016/j.ridd.2017.04.011; Chien WC, 2014, INT J INJ CONTROL SA, V21, P3, DOI 10.1080/17457300.2012.717084; Chu CW, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00397; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Ho CH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005269; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hsieh CY, 2019, CLIN EPIDEMIOL, V11, P349, DOI 10.2147/CLEP.S196293; Huang MF, 2018, PSYCHIAT RES, V261, P517, DOI 10.1016/j.psychres.2017.12.061; Kanchan A, 2018, INDIAN J PSYCHIAT, V60, P38, DOI 10.4103/psychiatry.IndianJPsychiatry_118_17; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Lee SY, 2019, BRAIN INJURY, V33, P1263, DOI 10.1080/02699052.2019.1641747; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Liang JA, 2011, CANCER EPIDEM BIOMAR, V20, P473, DOI 10.1158/1055-9965.EPI-10-1280; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mills AL, 2016, J OCCUP REHABIL, V26, P20, DOI 10.1007/s10926-015-9608-z; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Needham DM, 2005, J CRIT CARE, V20, P12, DOI 10.1016/j.jcrc.2004.09.007; Osborn AJ, 2018, J HEAD TRAUMA REHAB, V33, P62, DOI 10.1097/HTR.0000000000000311; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; STONER HB, 1980, J ROY SOC MED, V73, P19, DOI 10.1177/014107688007300105; Thompson JN, 2013, BRIT J NEUROSURG, V27, P24, DOI 10.3109/02688697.2012.714818; Tsai MC, 2014, J PEDIATR-US, V164, P136, DOI 10.1016/j.jpeds.2013.08.042; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Tzeng NS, 2018, NEUROTHERAPEUTICS, V15, P417, DOI 10.1007/s13311-018-0611-x; Tzeng NS, 2019, J ATTEN DISORD, V23, P995, DOI 10.1177/1087054717714057; Tzeng NS, 2017, AM J MED SCI, V353, P197, DOI 10.1016/j.amjms.2016.12.014; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wheeler S, 2016, AM J OCCUP THER, V70, P1, DOI DOI 10.5014/AJ0T.115.020677; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	55	10	10	2	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2020	101	5					822	831		10.1016/j.apmr.2019.12.005			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	MC0ZD	WOS:000543025400010	31917196				2022-02-06	
J	Chen, MH; Wylie, GR; Sandroff, BM; Dacosta-Aguayo, R; DeLuca, J; Genova, HM				Chen, Michelle H.; Wylie, Glenn R.; Sandroff, Brian M.; Dacosta-Aguayo, Rosalia; DeLuca, John; Genova, Helen M.			Neural mechanisms underlying state mental fatigue in multiple sclerosis: a pilot study	JOURNAL OF NEUROLOGY			English	Article						Multiple sclerosis; Mental fatigue; Cognitive fatigue; State fatigue; Neuroimaging; fMRI	TRAUMATIC BRAIN-INJURY; COGNITIVE FATIGUE; CORTICAL ATROPHY; PERFORMANCE; DEPRESSION; VALIDITY; SCALE	Neuroimaging underpinnings of state (in the moment, transient) mental fatigue in multiple sclerosis (MS) are not well understood. The current pilot study examined the effect of state mental fatigue on brain activation (measured using functional magnetic resonance imaging [fMRI]) during conditions of varying cognitive loads of rapid information processing in persons with MS relative to healthy controls. Nineteen persons with MS and 17 healthy controls underwent fMRI scanning while performing a modified version of the Symbol Digit Modalities Test, which consisted of high and low cognitive load conditions with comparable visual stimulation. State mental fatigue was assessed using the Visual Analog Scale of Fatigue before and after each run of the behavioral task. Results indicated that the healthy control group recruited significantly more anterior brain regions (superior and middle frontal gyri, insula, and superior temporal gyrus) to meet increased task demands during the high cognitive load condition as fatigue level increased (p < 0.05), which was accompanied by shorter response time. In contrast, the MS group did not recruit anterior areas to the same extent as the healthy control group as task demands and fatigue increased. Indeed, the MS group continued to activate more posterior brain regions (precuneus, lingual gyrus, and middle occipital gyrus) for the high cognitive load condition (p < 0.05) with no improvement in speed. In conclusion, persons with MS may allocate neural resources less efficiently than healthy controls when faced with increased task demands, which may result in increased mental fatigue. Results of the current pilot investigation warrant replication with a larger sample size.	[Chen, Michelle H.; Wylie, Glenn R.; Dacosta-Aguayo, Rosalia; DeLuca, John; Genova, Helen M.] Kessler Fdn, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA; [Chen, Michelle H.; Wylie, Glenn R.; Dacosta-Aguayo, Rosalia; DeLuca, John; Genova, Helen M.] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07102 USA; [Sandroff, Brian M.] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL USA		Genova, HM (corresponding author), Kessler Fdn, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA.; Genova, HM (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07102 USA.	hgenova@kesslerfoundation.org		Sandroff, Brian/0000-0002-2013-7632	National Multiple Sclerosis Society (NMSS)National Multiple Sclerosis Society [RG 4232A1/1]; NMSSNational Multiple Sclerosis Society [MB-1606-08779, CA1069-A-7]; Kessler Foundation	The preparation of this manuscript was supported in part by the National Multiple Sclerosis Society (NMSS) Grant RG 4232A1/1 to Helen Genova, NMSS Grant MB-1606-08779 to John DeLuca, NMSS Grant CA1069-A-7 to John DeLuca, and Kessler Foundation.	Benito-Leon J, 2007, MULT SCLER J, V13, P645, DOI 10.1177/1352458506073528; Bruce JM, 2010, NEUROPSYCHOLOGY, V24, P77, DOI 10.1037/a0015046; Bryant D, 2004, REHABIL PSYCHOL, V49, P114, DOI 10.1037/0090-5550.49.2.114; Calabrese M, 2010, MULT SCLER J, V16, P1220, DOI 10.1177/1352458510376405; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chiaravalloti ND, 2005, J CLIN EXP NEUROPSYC, V27, P33, DOI 10.1080/138033990513609; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DeLuca J, 2008, J NEUROL SCI, V270, P28, DOI 10.1016/j.jns.2008.01.018; DeLuca J, 2009, PHYS MED REH CLIN N, V20, P325, DOI 10.1016/j.pmr.2008.12.007; Dobryakova E, 2018, MULT SCLER J, V24, P1174, DOI 10.1177/1352458517717087; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Genova HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078811; Genova HM, 2009, J INT NEUROPSYCH SOC, V15, P383, DOI 10.1017/S1355617709090535; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Hanken K, 2016, MULT SCLER RELAT DIS, V6, P81, DOI 10.1016/j.msard.2016.02.005; Jameen ARM, 2019, J NEUROL SCI, V400, P52, DOI 10.1016/j.jns.2019.03.007; Khan F, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00177; Langdon DW, 2012, MULT SCLER J, V18, P891, DOI 10.1177/1352458511431076; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Multiple Sclerosis Clinical Practice Guidelines, 1998, FATIGUE MULTIPLE SCL; Parmenter BA, 2010, J INT NEUROPSYCH SOC, V16, P6, DOI 10.1017/S1355617709990750; Pellicano C, 2010, ARCH NEUROL-CHICAGO, V67, P447, DOI 10.1001/archneurol.2010.48; Penner IK, 2003, J NEUROL, V250, P461, DOI 10.1007/s00415-003-1025-0; Pravata E, 2016, MULT SCLER J, V22, P1665, DOI 10.1177/1352458515625806; Sandry J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00214; Schoonheim MM, 2017, MULT SCLER J, V23, P194, DOI 10.1177/1352458516677593; Sepulcre J, 2009, MULT SCLER J, V15, P337, DOI 10.1177/1352458508098373; Shah A, 2009, PHYS MED REH CLIN N, V20, P363, DOI 10.1016/j.pmr.2008.12.003; Talairach J., 1988, COPLANAR STEREOTAXIC; Tartaglia MC, 2008, EUR J NEUROL, V15, P413, DOI 10.1111/j.1468-1331.2008.02090.x; Wood B, 2013, MULT SCLER J, V19, P217, DOI 10.1177/1352458512450351; Wylie GR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08846-6	33	10	10	1	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	AUG	2020	267	8					2372	2382		10.1007/s00415-020-09853-w		APR 2020	11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MJ2DK	WOS:000529574900002	32350648				2022-02-06	
J	Barlow, KM; Brooks, BL; Esser, MJ; Kirton, A; Mikrogianakis, A; Zemek, RL; MacMaster, FP; Nettel-Aguirre, A; Yeates, KO; Kirk, V; Hutchison, JS; Crawford, S; Turley, B; Cameron, C; Hill, MD; Samuel, T; Buchhalter, J; Richer, L; Platt, R; Boyd, R; Dewey, D				Barlow, Karen M.; Brooks, Brian L.; Esser, Michael J.; Kirton, Adam; Mikrogianakis, Angelo; Zemek, Roger L.; MacMaster, Frank P.; Nettel-Aguirre, Alberto; Yeates, Keith Owen; Kirk, Valerie; Hutchison, James S.; Crawford, Susan; Turley, Brenda; Cameron, Candice; Hill, Michael D.; Samuel, Tina; Buchhalter, Jeffrey; Richer, Lawrence; Platt, Robert; Boyd, Roslyn; Dewey, Deborah			Efficacy of Melatonin in Children With Postconcussive Symptoms: A Randomized Clinical Trial	PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; SLEEP DISTURBANCE; ACUTE CONCUSSION; ADOLESCENTS; VALIDITY; REHABILITATION; PERFORMANCE; INVENTORY; OUTCOMES	BACKGROUND: Approximately 25% of children with concussion have persistent postconcussive symptoms (PPCS) with resultant significant impacts on quality of life. Melatonin has significant neuroprotective properties, and promising preclinical data suggest its potential to improve outcomes after traumatic brain injury. We hypothesized that treatment with melatonin would result in a greater decrease in PPCS symptoms when compared with a placebo. METHODS: We conducted a randomized, double-blind trial of 3 or 10 mg of melatonin compared with a placebo (NCT01874847). We included youth (ages 8-18 years) with PPCS at 4 to 6 weeks after mild traumatic brain injury. Those with significant medical or psychiatric histories or a previous concussion within the last 3 months were excluded. The primary outcome was change in the total youth self-reported Post-Concussion Symptom Inventory score measured after 28 days of treatment. Secondary outcomes included change in health-related quality of life, cognition, and sleep. RESULTS: Ninety-nine children (mean age: 13.8 years; SD = 2.6 years; 58% girls) were randomly assigned. Symptoms improved over time with a median Post-Concussion Symptom Inventory change score of -21 (95% confidence interval [CI]: -16 to -27). There was no significant effect of melatonin when compared with a placebo in the intention-to-treat analysis (3 mg melatonin, -2 [95% CI: -13 to 6]; 10 mg melatonin, 4 [95% CI: -7 to 14]). No significant group differences in secondary outcomes were observed. Side effects were mild and similar to the placebo. CONCLUSIONS: Children with PPCS had significant impairment in their quality of life. Seventy-eight percent demonstrated significant recovery between 1 and 3 months postinjury. This clinical trial does not support the use of melatonin for the treatment of pediatric PPCS.	[Barlow, Karen M.; Brooks, Brian L.; Esser, Michael J.; Kirton, Adam; Mikrogianakis, Angelo; MacMaster, Frank P.; Nettel-Aguirre, Alberto; Yeates, Keith Owen; Kirk, Valerie; Buchhalter, Jeffrey; Dewey, Deborah] Alberta Childrens Prov Gen Hosp, Dept Pediat, Res Inst, Calgary, AB, Canada; [Nettel-Aguirre, Alberto; Dewey, Deborah] Univ Calgary, Dept Community Hlth Sci, Cumming Sch Med, Calgary, AB, Canada; [Kirton, Adam] Univ Calgary, Cumming Sch Med, Dept Radiol, Calgary, AB, Canada; [Mikrogianakis, Angelo] Univ Calgary, Cumming Sch Med, Dept Emergency Med, Calgary, AB, Canada; [Barlow, Karen M.; Brooks, Brian L.; Esser, Michael J.; Kirton, Adam; Yeates, Keith Owen; Hill, Michael D.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [MacMaster, Frank P.] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [MacMaster, Frank P.] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.; Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Barlow, Karen M.; Boyd, Roslyn] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Brooks, Brian L.; Crawford, Susan; Turley, Brenda; Samuel, Tina] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB, Canada; [Zemek, Roger L.] Childrens Hosp Eastern Ontario, Dept Pediat, Res Inst, Ottawa, ON, Canada; [Zemek, Roger L.] Childrens Hosp Eastern Ontario, Dept Emergency Med, Res Inst, Ottawa, ON, Canada; [Zemek, Roger L.] Univ Ottawa, Ottawa, ON, Canada; [Hutchison, James S.] Hosp Sick Children, Dept Crit Care Med, Neurosci & Mental Hlth Res Program, Toronto, ON, Canada; [Cameron, Candice] Alberta Hlth Serv, Res Pharm, Foothills Med Ctr, Calgary, AB, Canada; [Richer, Lawrence] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Richer, Lawrence] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Platt, Robert] McGill Univ, Montreal, PQ, Canada; [Hutchison, James S.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Hutchison, James S.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada		Barlow, KM (corresponding author), Univ Queensland, Child Hlth Res Ctr, Level 6,62 Graham St, South Brisbane, Qld 4101, Australia.	k.barlow@uq.edu.au	Yeates, Keith/AAJ-4223-2020; Boyd, Roslyn N/A-4498-2011; Barlow, Karen/I-6492-2019; Barlow, Karen/C-1323-2014; Hill, Michael D/C-9073-2012; Nettel-Aguirre, Alberto/ABB-9412-2021; Mikrogianakis, Angelo/AAW-5929-2021; Richer, Lawrence/D-3622-2009	Boyd, Roslyn N/0000-0002-4919-5975; Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Hill, Michael D/0000-0002-6269-1543; Mikrogianakis, Angelo/0000-0002-8854-0620; Richer, Lawrence/0000-0002-6897-8668; Nettel-Aguirre, Alberto/0000-0001-6604-0652; MacMaster, Frank/0000-0002-7159-7583; Samuel, Tina/0000-0002-0516-3453; Dewey, Deborah/0000-0002-1323-5832	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [293375]; Alberta Children's Hospital Research Institute; University of Calgary	Funded by the Canadian Institutes of Health Research (grant 293375), the Alberta Children's Hospital Research Institute, and the University of Calgary.	Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Barlow KM, 2019, J NEUROTRAUM, V36, P523, DOI 10.1089/neu.2018.5752; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Camins A, 2010, EXPERT OPIN INV DRUG, V19, P587, DOI 10.1517/13543781003781898; Castelnuovo G, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00310; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hingley S, 2016, ARCH DIS CHILDHOOD-E, V101, P58, DOI 10.1136/archdischild-2014-307252; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Janusz JA, 2012, MILD TRAUMATIC BRAIN, DOI [10.1249/JSR.0b013-31819c7-87, DOI 10.1249/JSR.0B013-31819C7-87]; Jungquist Carla R, 2015, Sleep Disord, V2015, P758937, DOI 10.1155/2015/758937; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Klante G, 1997, J PINEAL RES, V23, P191, DOI 10.1111/j.1600-079X.1997.tb00354.x; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Landgraf JM, 1996, CHILD HLTH QUESTIONN; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Lequerica A, 2015, ARCH PHYS MED REHAB, V96, P1802, DOI 10.1016/j.apmr.2015.05.011; Lewis DW, 2005, HEADACHE, V45, P786, DOI 10.1111/j.1526-4610.2005.05050.x; Mahooti N, 2018, CHILD ADOL PSYCH CL, V27, P93, DOI 10.1016/j.chc.2017.08.005; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; Maldonado MD, 2012, PHYSIOL BEHAV, V105, P1099, DOI 10.1016/j.physbeh.2011.12.015; Mannix R, 2019, J NEUROTRAUM, V36, P2886, DOI 10.1089/neu.2018.6290; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mrazik M, 2016, ARCH CLIN NEUROPSYCH, V31, P297, DOI 10.1093/arclin/acw013; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Register-Mihalik JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01176; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Santini A, 2018, BRIT J CLIN PHARMACO, V84, P659, DOI 10.1111/bcp.13496; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schroder CM, 2019, J AUTISM DEV DISORD, V49, P3218, DOI 10.1007/s10803-019-04046-5; Teel EF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00672; Winkler R, 2015, J HEAD TRAUMA REHAB, V30, P324, DOI 10.1097/HTR.0000000000000114; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2017, JAMA-J AM MED ASSOC, V317, P1375, DOI 10.1001/jama.2017.1327	58	10	10	0	6	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	APR	2020	145	4							e20192812	10.1542/peds.2019-2812			12	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	LC4RD	WOS:000525310600006	32217739	Bronze			2022-02-06	
J	Hunter, LE; Freudenberg-Hua, Y; Davies, P; Kim, M; Lipton, RB; Stewart, WF; Srinivasan, P; Hu, SS; Lipton, ML				Hunter, Liane E.; Freudenberg-Hua, Yun; Davies, Peter; Kim, Mimi; Lipton, Richard B.; Stewart, Walter F.; Srinivasan, Priyanka; Hu, ShanShan; Lipton, Michael L.			Associations of Apolipoprotein E epsilon 4 Genotype and Ball Heading With Verbal Memory in Amateur Soccer Players	JAMA NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; DECLINE; ALLELE	Importance Emerging evidence suggests that long-term exposure to ball heading in soccer, the most popular sport in the world, confers risk for adverse cognitive outcomes. However, the extent to which the apolipoprotein E epsilon 4 (APOE epsilon 4) allele, a common risk factor for neurodegeneration, and ball heading are associated with cognition in soccer players remains unknown. Objective To determine whether the APOE epsilon 4 allele and 12-month ball heading exposure are associated with verbal memory in a cohort of adult amateur soccer players. Design, Settings, and Participants A total of 379 amateur soccer players were enrolled in the longitudinal Einstein Soccer Study from November 11, 2013, through January 23, 2018. Selection criteria included participation in soccer for more than 5 years and for more than 6 months per year. Of the 379 individuals enrolled in the study, 355 were genotyped. Three players were excluded for reporting extreme levels of heading. Generalized estimating equation linear regression models were employed to combine data across visits for a cross-sectional analysis of the data. Exposures At each study visit every 3 to 6 months, players completed the HeadCount 12-Month Questionnaire, a validated, computer-based questionnaire to estimate 12-month heading exposure that was categorized as low (quartiles 1 and 2), moderate (quartile 3), and high (quartile 4). Main Outcome and Measures Verbal memory was assessed at each study visit using the International Shopping List Delayed Recall task from CogState. Results A total of 352 soccer players (256 men and 96 women; median age, 23 years [interquartile range, 21-28 years]) across a total of 1204 visits were analyzed. High levels of heading were associated with worse verbal memory performance (beta = -0.59; 95% CI, -0.93 to -0.25; P = .001). There was no main association of APOE epsilon 4 with verbal memory (beta = 0.09; 95% CI, -0.24 to 0.42; P = .58). However, there was a significant association of APOE epsilon 4 and heading with performance on the ISRL task (chi(2) = 7.22; P = .03 for overall interaction). In APOE epsilon 4-positive players, poorer verbal memory associated with high vs low heading exposure was 4.1-fold greater (APOE epsilon 4 negative, beta = -0.36; 95% CI, -0.75 to 0.03; APOE epsilon 4 positive, beta = -1.49; 95% CI, -2.05 to -0.93), and poorer verbal memory associated with high vs moderate heading exposure was 8.5-fold greater (APOE epsilon 4 negative, beta = -0.13; 95% CI, -0.54 to 0.29; APOE epsilon 4 positive, beta = -1.11, 95% CI, -1.70 to -0.53) compared with that in APOE epsilon 4-negative players. Conclusions and Relevance This study suggests that the APOE epsilon 4 allele is a risk factor for worse memory performance associated with higher heading exposure in the prior year, which highlights that assessing genetic risks may ultimately play a role in promoting safer soccer play. This cross-sectional study examines whether the apolipoprotein E epsilon 4 allele and 12-month ball heading exposure are associated with verbal memory in a cohort of adult amateur soccer players. Question Are apolipoprotein E epsilon 4 status and ball heading associated with verbal memory? Findings In this cross-sectional analysis of 352 amateur soccer players, those with greater exposure to ball heading in the prior 12 months and the apolipoprotein E epsilon 4 allele demonstrated worse verbal memory than players with low exposure to ball heading. Meaning The findings from this study provide evidence to suggest that apolipoprotein E epsilon 4 is a genetic risk factor for cognitive impairment associated with the high levels of long-term ball heading.	[Hunter, Liane E.; Srinivasan, Priyanka; Hu, ShanShan; Lipton, Michael L.] Montefiore Med Ctr, Albert Einstein Coll Med, Gruss Magnet Resonance Imaging Ctr, Bronx, NY 10467 USA; [Freudenberg-Hua, Yun; Davies, Peter] Northwell Hlth, Feinstein Inst Med Res, Litwin Zucker Ctr Study Alzheimers Dis, Manhasset, NY USA; [Freudenberg-Hua, Yun] Northwell Hlth, Div Geriatr Psychiat, Glen Oaks, NY USA; [Kim, Mimi; Lipton, Richard B.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Lipton, Richard B.; Lipton, Michael L.] Montefiore Med Ctr, Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Lipton, Richard B.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Stewart, Walter F.] HINT Consulting, Orinda, CA USA; [Lipton, Michael L.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Lipton, Michael L.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA		Lipton, ML (corresponding author), Albert Einstein Coll Med, Gruss Magnet Resonance Imaging Ctr, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	michael.lipton@einsteinmed.org	Lipton, Richard Bruce/AAY-2818-2021		NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K08 AG054727] Funding Source: Medline		Albrecht MA, 2015, NEUROPSYCHOLOGIA, V75, P411, DOI 10.1016/j.neuropsychologia.2015.06.008; Allen B, 2017, NEUROLOGY, V88, pE74, DOI 10.1212/WNL.0000000000003669; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Cao JQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11654-7; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Hardin J.W., 2005, GEN ESTIMATING EQUAT; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Keene CD, 2011, CURR OPIN NEUROBIOL, V21, P920, DOI 10.1016/j.conb.2011.08.002; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Kunz M., 2007, FIFA MAGAZINE, V7, P11, DOI DOI 10.1080/13673882.2007.9680857; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lipton ML, 2018, J SCI MED SPORT, V21, P363, DOI 10.1016/j.jsams.2017.08.008; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Suri S, 2013, NEUROSCI BIOBEHAV R, V37, P2878, DOI 10.1016/j.neubiorev.2013.10.010; Teng ZP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06932-3; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8	29	10	10	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	APR	2020	77	4					419	426		10.1001/jamaneurol.2019.4828			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LH2CS	WOS:000528595700005	31985774	Bronze, Green Published			2022-02-06	
J	McGuine, T; Post, E; Pfaller, AY; Hetzel, S; Schwarz, A; Brooks, MA; Kliethermes, SA				McGuine, Timothy; Post, Eric; Pfaller, Adam Yakuro; Hetzel, Scott; Schwarz, Allison; Brooks, M. Alison; Kliethermes, Stephanie A.			Does soccer headgear reduce the incidence of sport-related concussion? A cluster, randomised controlled trial of adolescent athletes	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						soccer; high school; concussion; prevention; headgear	PROTECTIVE EQUIPMENT; EPIDEMIOLOGY	Background There have been no large randomised controlled trials to determine whether soccer headgear reduces the incidence or severity of sport-related concussion (SRC) in US high school athletes. Objective We aimed to determine whether headgear reduces the incidence or severity (days out from soccer) of SRCs in soccer players. Methods 2766 participants (67% female, age 15.61.2) (who undertook 3050 participant years) participated in this cluster randomised trial. Athletes in the headgear (HG) group wore headgear during the season, while those in the no headgear (NoHG) group did not. Staff recorded SRC and non-SRC injuries and soccer exposures. Multivariate Cox proportional hazards models were used to examine time-to-SRC between groups, while severity was compared with a Wilcoxon rank-sum test. Results 130 participants (5.3% female, 2.2% male) sustained an SRC. The incidence of SRC was not different between the HG and NoHG groups for males (HR: 2.00 (0.63-6.43) p=0.242) and females (HR: 0.86 (0.54-1.36) p=0.520). Days lost from SRC were not different (p=0.583) between the HG group (13.5 (11.0-018.8) days) and the NoHG group (13.0 (9.0-18.8) days). Conclusions Soccer headgear did not reduce the incidence or severity of SRC in high school soccer players. Trial registration number NCT02850926.	[McGuine, Timothy; Pfaller, Adam Yakuro; Schwarz, Allison; Brooks, M. Alison; Kliethermes, Stephanie A.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI USA; [Post, Eric] San Diego State Univ, Sch Exercise & Nutr Sci, San Diego, CA 92182 USA; [Hetzel, Scott] Univ Wisconsin, Biostat & Med Informat, Madison, WI USA		McGuine, T (corresponding author), Univ Wisconsin, Orthoped, Madison, WI 53705 USA.	mcguine@ortho.wisc.edu		Kliethermes, Stephanie/0000-0001-9756-7406	National Operating Committee on Standards for Athletic Equipment (NOCSAE) [04-16]	Funding for this study was provided by the National Operating Committee on Standards for Athletic Equipment (NOCSAE #04-16).	Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martini DN, 2017, AM J SPORT MED, V45, P1420, DOI 10.1177/0363546516686785; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Press JN, 2018, ANN BIOMEDICAL ENG, V2018; R Development Core Team, 2012, R LANG ENV STAT COMP; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174	19	10	10	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	APR	2020	54	7					408	413		10.1136/bjsports-2018-100238			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	LB2ZI	WOS:000524506500008	31088784	Green Published, hybrid			2022-02-06	
J	Rosenfeld, EH; Johnson, B; Wesson, DE; Shah, SR; Vogel, AM; Naik-Mathuria, B				Rosenfeld, Eric H.; Johnson, Brittany; Wesson, David E.; Shah, Sohail R.; Vogel, Adam M.; Naik-Mathuria, Bindi			Understanding non-accidental trauma in the United States: A national trauma databank study	JOURNAL OF PEDIATRIC SURGERY			English	Article						Nonaccidental trauma; NAT; NTDB	CHILD-ABUSE; HEAD-INJURY; SURGEON	Background: The purpose of this study is to characterize the epidemiology, injury patterns, outcomes and trends of non-accidental trauma (NAT) in the United States using a large national database. Methods: Children <15 years presenting after NAT were identified in the 2007-2014 National Trauma Databank research datasets. Clinical and outcome data were analyzed using descriptive statistics, chi-square and logistic regression. Results: Of 678,503 children admitted for traumatic injuries, 3% (19,149) were victims of NAT. The majority (95%) were under 5 years and 71% under 1 year old. The majority (59%) were male. The median injury severity score (ISS) was 10 (IQR:5-19). African Americans were disproportionally affected (27% vs 17% of all traumas), and the majority had public or no insurance (85%). Incidence was highest in the midwest and lowest in the northeast regions of the country, although trends varied over time. NAT resulted in 43% of trauma deaths in children <1 year and 31% of trauma deaths in children <5. Traumatic brain injury (TBI) was the most commonly encountered diagnosis (50%). Polytrauma was common, and certain injury patterns were identified. Urgent operation was required in 6%, 43% were admitted to intensive care, and 9% died. Mortality was independently associated with TB!, thoracic injury, hollow viscus injury and older age. Conclusion: Non-accidental trauma is a leading cause of trauma mortality in young children. Multiple injuries are common, requiring comprehensive evaluation and early surgical involvement. The data presented in this study could serve as a guide to target injury prevention efforts. Study type: Prognostic and Epidemiological (C) 2019 Elsevier Inc. All rights reserved.	Texas Childrens Hosp, Dept Pediat Surg, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA		Rosenfeld, EH (corresponding author), 6701 Fannin St 1210, Houston, TX 77030 USA.	erosenfe@bcm.edu; brittjohnson40@gmail.com; dewesson@texaschildrens.org; srshah2@texaschildrens.org; amvogel@texaschildrens.org; bnaik@texaschildrens.org					Al Odhayani A, 2013, CAN FAM PHYSICIAN, V59, P831; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Buckingham ET, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0342-3; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P161, DOI 10.1097/TA.0b013e3182984831; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; Farrell CA, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1616; Ince EE, 2010, CHILD ABUSE NEGLECT, V34, P403, DOI 10.1016/j.chiabu.2009.10.008; Irazuzta JE, 1997, CHILD ABUSE NEGLECT, V21, P751, DOI 10.1016/S0145-2134(97)00036-7; Larimer EL, 2013, J PEDIATR SURG, V48, P1357, DOI 10.1016/j.jpedsurg.2013.03.035; Naik-Mathuria B, 2015, PEDIATR SURG INT, V31, P605, DOI 10.1007/s00383-015-3688-x; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Rovi S, 2004, AM J PUBLIC HEALTH, V94, P586, DOI 10.2105/AJPH.94.4.586; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Shilt JGN, 2009, SKELETAL TRAUMA CHIL, P585; Stevenson J, 1999, J CHILD PSYCHOL PSYC, V40, P89, DOI 10.1017/S0021963098003345; U.S. Department of Health and Human Services, 2016, CHILD MALTREAT, V2017; Ward A, 2015, AM SURGEON, V81, P835; Yu YR, 2018, J PEDIATR SURG, V53, P1060, DOI 10.1016/j.jpedsurg.2018.02.039	19	10	10	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	APR	2020	55	4					693	697		10.1016/j.jpedsurg.2019.03.024			5	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics; Surgery	KZ3TW	WOS:000523189100019	31103270				2022-02-06	
J	Wan, FJ; Chien, WC; Chung, CH; Yang, YJ; Tzeng, NS				Wan, Fang-Jung; Chien, Wu-Chien; Chung, Chi-Hsiang; Yang, Yun-Ju; Tzeng, Nian-Sheng			Association between traumatic spinal cord injury and affective and other psychiatric disorders-A nationwide cohort study and effects of rehabilitation therapies	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Traumatic spinal cord injury; Psychiatric disorders; Cohort study; National Health Insurance Research Database; Physical therapy; Occupational therapy	INSURANCE RESEARCH DATABASE; ACUTE MYOCARDIAL-INFARCTION; POPULATION-BASED COHORT; ACUTE ISCHEMIC-STROKE; QUALITY-OF-LIFE; ERECTILE DYSFUNCTION; BRAIN-INJURY; RISK; HEALTH; VALIDATION	Background: This study aimed to investigate the association between traumatic spinal cord injury (TSCI) and the risk of affective and other psychiatric disorders, and the role of the rehabilitation therapies. Methods: In this population-based, retrospective cohort study, we used Taiwan's National Health Insurance Research Database to analyze the patients who were newly diagnosed with TSCI between 2000 and 2015 were included, with a 1:3 ratio by age, sex, and index year matched in the non-TSCI comparison group, for the risk of affective and other psychiatric disorders. Results: In total, 5375 out of 16,151 patients with TSCI developed psychiatric disorders, and 1467 out of 48,543 patients in the non-TSCI group developed psychiatric disorders (2930.88 vs 2823.29 per 100,000 persons/year). The Kaplan-Meier analysis showed that the TSCI cohort had a significantly higher risk of psychiatric disorders (log-rank, p < 0.001). Fine and Grays survival analysis revealed that the adjusted hazard ratio was 1.977 (95% CI: 1.914-2.042, p < 0.001). Rehabilitation therapies, including physical and occupational therapies, within 90 days after the injury, was associated with a lowered risk of psychiatric disorders, including anxiety, depression, and bipolar disorder, in the TSCI cohort (adjusted HR = 0.702 [95% CI: 0.661-0.746, p < 0.001]). In the subgroups with low, medium, and high intensity, rehabilitation therapies were associated with a lowered risk of psychiatric disorders. Conclusions: TSCI was associated with the risk of affective and other psychiatric disorders, and rehabilitation therapies were associated with a lowered risk of these in the TSCI cohort.	[Wan, Fang-Jung; Tzeng, Nian-Sheng] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Psychiat, Section 2,Cheng Gung Rd, Taipei 325, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Yang, Yun-Ju] Triserv Gen Hosp, Dept Neurol Surg, Sch Med, Natl Def Med Ctr, Taipei, Taiwan; [Tzeng, Nian-Sheng] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan		Tzeng, NS (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Psychiat, Section 2,Cheng Gung Rd, Taipei 325, Taiwan.	pierrens@mail.ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021; Tzeng, Nian-Sheng/AAU-4945-2021		Tri-Service General Hospital Research Foundation [TSGH-C107-004, TSGH-C107-106, TSGH-C108-003, TSGH-C108-151]; Medical Affairs Bureau, Ministry of Defense, Taiwan [MAB-107-084]	This work was supported by the Tri-Service General Hospital Research Foundation (TSGH-C107-004, TSGH-C107-106, TSGH-C108-003, and TSGH-C108-151), and the Medical Affairs Bureau, Ministry of Defense, Taiwan (MAB-107-084).	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Andresen SR, 2016, SPINAL CORD, V54, P973, DOI 10.1038/sc.2016.46; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bouchard SM, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00044; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Chao PC, 2019, COMPR PSYCHIAT, V93, P14, DOI 10.1016/j.comppsych.2019.02.002; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chinese Hospital Association, 2000, ICD 9 900 ENGL CHIN; Chiu M.L., 2018, PSYCHIAT J, V2018; Chou IC, 2013, J DEV BEHAV PEDIATR, V34, P181, DOI 10.1097/DBP.0b013e3182829f2b; Chou YC, 2012, J REHABIL MED, V44, P319, DOI 10.2340/16501977-0935; Christodoulou VN, 2019, INJURY, V50, P1847, DOI 10.1016/j.injury.2019.07.035; Chuang CH, 2018, J CLIN NURS, V27, pE1038, DOI 10.1111/jocn.14139; Dahlberg LS, 2018, NEUROSCI BIOBEHAV R, V90, P272, DOI 10.1016/j.neubiorev.2018.04.018; Foy T, 2011, J SPINAL CORD MED, V34, P162, DOI 10.1179/107902611X12971826988093; Freund P, 2019, LANCET NEUROL, V18, P1123, DOI 10.1016/S1474-4422(19)30138-3; Giardino ND, 2003, PAIN, V106, P19, DOI 10.1016/S0304-3959(03)00226-4; Gomara-Toldra N, 2014, J SPINAL CORD MED, V37, P371, DOI 10.1179/2045772314Y.0000000194; Group S.G.-B.S.T., 1997, LANCET, V349, P225; Hachem LD, 2017, J SPINAL CORD MED, V40, P665, DOI 10.1080/10790268.2017.1329076; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hou WH, 2013, J CLIN PSYCHIAT, V74, pE859, DOI 10.4088/JCP.12m08259; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Huang SW, 2017, J NEUROTRAUM, V34, P615, DOI 10.1089/neu.2016.4525; James ND, 2018, LANCET NEUROL, V17, P905, DOI 10.1016/S1474-4422(18)30287-4; January AM, 2017, J SPINAL CORD MED, V40, P560, DOI 10.1080/10790268.2017.1308109; Kreuter M, 2000, SPINAL CORD, V38, P2, DOI 10.1038/sj.sc.3100933; Kuo WY, 2019, NURS RES, V68, P383, DOI 10.1097/NNR.0000000000000371; Lam C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184253; Lee B, 1996, AM J OCCUP THER, V50, P362, DOI 10.5014/ajot.50.5.362; Li-Ting C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-380; Liang JA, 2011, CANCER EPIDEM BIOMAR, V20, P473, DOI 10.1158/1055-9965.EPI-10-1280; Lidal IB, 2007, DISABIL REHABIL, V29, P1341, DOI 10.1080/09638280701320839; Lim SW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169623; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin SL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004271; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Ministry of Justice, 2014, NAT HLTH INS REIMB R; Monden K.R., 2019, REHAB PSYCHOL; Monden KR, 2019, SPINAL CORD, V57, P1031, DOI 10.1038/s41393-019-0318-9; Moreno A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014331; Ozelie R, 2012, J SPINAL CORD MED, V35, P527, DOI 10.1179/2045772312Y.0000000062; Pakpour AH, 2016, SPINAL CORD, V54, P1053, DOI 10.1038/sc.2016.7; Pollock K, 2017, SPINAL CORD, V55, P800, DOI 10.1038/sc.2017.45; Ramer LM, 2014, LANCET NEUROL, V13, P1241, DOI 10.1016/S1474-4422(14)70144-9; Sachdeva R, 2018, NEUROLOGY, V91, P611, DOI 10.1212/WNL.0000000000006244; Shavelle RM, 2007, J SPINAL CORD MED, V30, pS48, DOI 10.1080/10790268.2007.11753969; Silvestri J, 2017, DISABIL REHABIL, V39, P82, DOI 10.3109/09638288.2016.1140829; Sung SF, 2016, INT J CARDIOL, V215, P277, DOI 10.1016/j.ijcard.2016.04.069; Sweis R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0715-4; Tetrault M., 2014, Annals of Physical and Rehabilitation Medicine, V57, P684, DOI 10.1016/j.rehab.2014.10.002; Trost Z, 2017, SPINAL CORD, V55, P898, DOI 10.1038/sc.2017.39; Tseng HP, 2015, J STROKE CEREBROVASC, V24, P1179, DOI 10.1016/j.jstrokecerebrovasdis.2015.01.010; Tseng WS, 2019, PSYCHIAT DANUB, V31, P172, DOI 10.24869/psyd.2019.172; Tzeng NS, 2019, J INVEST MED, V67, P977, DOI 10.1136/jim-2018-000910; Tzeng NS, 2019, AM J MENS HEALTH, V13, P1, DOI 10.1177/1557988319842985; Tzeng NS, 2019, J INVEST MED, V67, P312, DOI 10.1136/jim-2018-000835; Tzeng NS, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00133; Tzeng NS, 2017, J NEUROL SCI, V381, P88, DOI 10.1016/j.jns.2017.08.022; Tzeng NS, 2016, NEUROEPIDEMIOLOGY, V47, P82, DOI 10.1159/000449166; Yang CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117323; Yang YJ, 2018, AM J MENS HEALTH, V12, P913, DOI 10.1177/1557988317750970; Yeh HW, 2018, INT J CLIN PRACT, V72, DOI 10.1111/ijcp.13212; Yeh TC, 2020, ARCH PHYS MED REHAB, V101, P822, DOI 10.1016/j.apmr.2019.12.005	66	10	10	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	MAR 15	2020	265						381	388		10.1016/j.jad.2020.01.063			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	KN4QC	WOS:000514822200048	32090763				2022-02-06	
J	Yagura, K; Ohtaki, H; Tsumuraya, T; Sato, A; Miyamoto, K; Kawada, N; Suzuki, K; Nakamura, M; Kanzaki, K; Dohi, K; Izumizaki, M; Hiraizumi, Y; Honda, K				Yagura, Kazumichi; Ohtaki, Hirokazu; Tsumuraya, Tomomi; Sato, Atsushi; Miyamoto, Kazuyuki; Kawada, Naoto; Suzuki, Keisuke; Nakamura, Motoyasu; Kanzaki, Koji; Dohi, Kenji; Izumizaki, Masahiko; Hiraizumi, Yutaka; Honda, Kazuho			The enhancement of CCL2 and CCL5 by human bone marrow-derived mesenchymal stem/stromal cells might contribute to inflammatory suppression and axonal extension after spinal cord injury	PLOS ONE			English	Article							STEM-CELLS; ALTERNATIVE ACTIVATION; MACROPHAGE ACTIVATION; TRAUMATIC BRAIN; ISCHEMIA; RECOVERY; CCR2; MICE; OVEREXPRESSION; POLARIZATION	Human bone marrow-derived mesenchymal stem/stromal cells (hMSCs) have shown potential in facilitating recovery from spinal cord injury (SCI) through communicating with microglia/macrophages (MG/MF). We here focused on chemokines as a candidate for the communication. Selected MG/MFrelated chemokines were determined gene expression after SCI and further focused CCL2/CCR2 and CCL5/CCR5 to estimate role of the chemokines by hMSCs. Male C57/BL6 mice were subjected to spinal cord transection. Gene expression was assayed in the spinal cords following SCI for selected MG/MFrelated chemokines and their receptors. hMSCs (5x10(5) cells) were then transplanted into parenchyma of the spinal cord, and the expressions of the Ccl2/Ccr2 and Ccl5/Ccr5 axes, inflammation, MG/MFpolarization, and axonal regeneration were evaluated to measure the influence of the hMSCs. Finally, mouse CCL5 was injected into the spinal cords. Acute increases in gene expression after SCI were observed for most chemokines, including Ccl2; chronic increases were observed for Ccl5. CCL2(+)cells merged with NeuN+neurons. CCR2(+) immunoreactivity was principally observed in Ly-6G(+)/iNOS(+)-granulocytes on postoperative day (pod) 1, and CCL5(+) and CCR5(+) immunoreactivity overlapped with NeuN(+)-neurons and F4/ 80+MG/MF on pod 14. The hMSC transplantation enhanced Ccl2 and Ccl5 and improved locomotor activity. The hMSC implantation did not alter the number of Ly-6G(+)/CCR2(+) but decreased Il1, Elane, and Mpo on pod 3. Conversely, hMSC transplantation increased expression of Zc3h12a (encodes MCP-1-induced protein) on pod 14. Moreover, hMSC increased the Aif1, and two alternatively activated macrophage (AAM)-related genes, Arg1 and Chil3 (Ym1), as well as axonal regenerative markers, Dpysl2 and Gap43. Gene expression indicative of AAM polarization and axonal regeneration were partially recovered by CCL5 injection. These results suggest that hMSC implantation increases Ccl2 and Ccl5, improves locomotor activity, enhances MG/MF polarization to AAM, and increases the gene expression of axonal regenerative markers. These functions of hMSCs might be partially mediated by the CCL2/CCR2 and CCL5/CCR5 axes.	[Yagura, Kazumichi; Ohtaki, Hirokazu; Kawada, Naoto; Suzuki, Keisuke; Nakamura, Motoyasu; Honda, Kazuho] Showa Univ, Dept Anat, Sch Med, Shinagawa Ku, Tokyo, Japan; [Yagura, Kazumichi; Tsumuraya, Tomomi; Sato, Atsushi; Kanzaki, Koji] Showa Univ, Dept Orthoped Surg, Fujigaoka Hosp, Aoba Ku, Yokohama, Kanagawa, Japan; [Miyamoto, Kazuyuki; Suzuki, Keisuke; Nakamura, Motoyasu; Dohi, Kenji] Showa Univ, Dept Emergency & Clin Care Med, Sch Med, Shinagawa Ku, Tokyo, Japan; [Izumizaki, Masahiko] Showa Univ, Dept Physiol, Sch Med, Shinagawa Ku, Tokyo, Japan; [Hiraizumi, Yutaka] Showa Univ, Dept Orthoped Surg, Sch Med, Shinagawa Ku, Tokyo, Japan		Ohtaki, H (corresponding author), Showa Univ, Dept Anat, Sch Med, Shinagawa Ku, Tokyo, Japan.	taki@med.showa-u.ac.jp		Ohtaki, Hirokazu/0000-0003-3116-5265; dohi, kenji/0000-0002-4451-0382	KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [16H05443, 17K10943, 26861214]	YES. This work was supported by KAKENHI, as follows: 16H05443 (Hirokazu Ohtaki), 17K10943 (Yutaka Hiraizumi), and 26861214 (Atsushi Sato).	Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P1425, DOI 10.1038/jcbfm.2014.120; Cordova LA, 2017, J BIOMED MATER RES A, V105, P3069, DOI 10.1002/jbm.a.36166; Nunes AKD, 2016, EXP NEUROL, V275, P143, DOI 10.1016/j.expneurol.2015.10.013; Easton AS, 2013, INT IMMUNOPHARMACOL, V17, P1218, DOI 10.1016/j.intimp.2013.06.015; Foresti ML, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-40; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gamo K, 2008, J NEUROSCI, V28, P11980, DOI 10.1523/JNEUROSCI.2920-08.2008; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Hermann DM, 2018, J NEUROIMMUNOL, V321, P138, DOI 10.1016/j.jneuroim.2018.04.015; Hickman SE, 2010, CNS NEUROL DISORD-DR, V9, P168, DOI 10.2174/187152710791011982; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Jura J, 2012, BBA-MOL CELL RES, V1823, P1905, DOI 10.1016/j.bbamcr.2012.06.029; Kapoor N, 2015, J IMMUNOL, V194, P6011, DOI 10.4049/jimmunol.1402797; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; KIM JS, 1995, J NEUROIMMUNOL, V56, P127, DOI 10.1016/0165-5728(94)00138-E; Knoller N, 2005, J NEUROSURG-SPINE, V3, P173, DOI 10.3171/spi.2005.3.3.0173; Kwon MJ, 2015, J NEUROSCI, V35, P15934, DOI 10.1523/JNEUROSCI.1924-15.2015; Lee RH, 2012, CELL STEM CELL, V11, P825, DOI 10.1016/j.stem.2012.10.001; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li FT, 2015, INFLAMMATION, V38, P126, DOI 10.1007/s10753-014-0014-z; Liang J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-182; Liu XS, 2007, J NEUROSCI RES, V85, P2120, DOI 10.1002/jnr.21359; Ma MH, 2002, J NEUROSCI RES, V68, P691, DOI 10.1002/jnr.10269; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McBride C, 2003, CYTOTHERAPY, V5, P7, DOI 10.1080/14653240310000038; McTigue DM, 1998, J NEUROSCI RES, V53, P368, DOI 10.1002/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.CO;2-1; Murdoch C, 2000, BLOOD, V95, P3032; Neirinckx V, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0202-2; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021; Niemi JP, 2016, EXP NEUROL, V275, P25, DOI 10.1016/j.expneurol.2015.09.018; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; OWEN M, 1988, CIBA F SYMP, V136, P42, DOI 10.1002/9780470513637.ch4; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.6100313; Prockop DJ, 2017, MOL THER, V25, P1748, DOI 10.1016/j.ymthe.2017.06.004; Pylaeva E, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00629; RANSOHOFF RM, 1993, FASEB J, V7, P592, DOI 10.1096/fasebj.7.6.8472896; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Sato A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-65; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shaul ME, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1232221; Song DD, 2013, J NEUROIMMUNOL, V263, P55, DOI 10.1016/j.jneuroim.2013.07.018; Sorce S, 2010, BRIT J PHARMACOL, V160, P311, DOI 10.1111/j.1476-5381.2010.00697.x; Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC; Stewart AN, 2017, RESTOR NEUROL NEUROS, V35, P395, DOI 10.3233/RNN-160678; Sugiyama Y, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00757; Terao S, 2008, STROKE, V39, P2560, DOI 10.1161/STROKEAHA.107.513150; Tokami H, 2013, BRAIN RES, V1517, P122, DOI 10.1016/j.brainres.2013.04.022; Tsumuraya T, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0252-5; Uccelli A, 2012, MOL MED, V18, P794, DOI 10.2119/molmed.2011.00498; Wolinski P, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/727189; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570; Xu P, 2017, AM J TRANSL RES, V9, P2878; Yin Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115120; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	60	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2020	15	3							e0230080	10.1371/journal.pone.0230080			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8WI	WOS:000535278500062	32155215	gold, Green Published			2022-02-06	
J	Chesnut, RM; Temkin, N; Videtta, W; Petroni, G; Lujan, S; Pridgeon, J; Dikmen, S; Chaddock, K; Barber, J; Machamer, J; Guadagnoli, N; Hendrickson, P; Aguilera, S; Alanis, V; Quezada, MEB; Coronel, EB; Bustamante, LA; Cacciatori, AC; Carricondo, CJ; Carvajal, F; Davila, R; Dominguez, M; Melgarejo, JAF; Fillipi, MM; Godoy, DA; Gomez, DC; Gallardo, AJL; Garcia, JAG; Zerain, GL; Cuientas, LAL; Lequipe, C; Yuca, GVG; Vega, MJ; Kessler, ME; Delgado, HJL; Lora, FS; Mazzola, AM; Maldonado, RM; de Pedro, NM; Zubieta, JRM; Mendez, JCM; Mora, J; Parra, JMO; Pahnke, PB; Paranhos, J; Pinero, GR; Pilacuan, FAR; Rivera, MNM; Figueroa, RLR; Rubiano, AM; Orozco, AMS; Jimenez, JIS; Naranjo, LS; Morejon, CS; Urbina, Z				Chesnut, Randall M.; Temkin, Nancy; Videtta, Walter; Petroni, Gustavo; Lujan, Silvia; Pridgeon, Jim; Dikmen, Sureyya; Chaddock, Kelley; Barber, Jason; Machamer, Joan; Guadagnoli, Nahuel; Hendrickson, Peter; Aguilera, Sergio; Alanis, Victor; Bello Quezada, Manuel Enrique; Bautista Coronel, Ermitano; Alberto Bustamante, Luis; Cacciatori, Armando C.; Javier Carricondo, Carlos; Carvajal, Felipe; Davila, Rafael; Dominguez, Mario; Figueroa Melgarejo, Jairo Antonio; Martha Fillipi, Maria; Godoy, Daniel A.; Cristina Gomez, Delia; Lacerda Gallardo, Angel J.; Guerra Garcia, Juan Antonio; la Fuente Zerain, Gustavo; Lavadenz Cuientas, Luis Arturo; Lequipe, Cecilio; Grajales Yuca, Gerardo Vicente; Jibaja Vega, Manuel; Eduardo Kessler, Michael; Lopez Delgado, Hubiel J.; Sandi Lora, Freddy; Maria Mazzola, Ana; Merida Maldonado, Roberto; Mezquia de Pedro, Natascha; Martinez Zubieta, J. Ricardo; Mijangos Mendez, Julio C.; Mora, Jacobo; Ochoa Parra, Johnny Marcelo; Pahnke, Perla B.; Paranhos, Jorge; Pinero, Gustavo R.; Rivadeneira Pilacuan, Francisco A.; Mendez Rivera, Mario Napoleon; Romero Figueroa, Ricardo Luis; Rubiano, Andres M.; Saraguro Orozco, Alexandra Matilde; Silesky Jimenez, Juan Ignacio; Silva Naranjo, Luis; Soler Morejon, Caridad; Urbina, Zulma			Consensus-Based Management Protocol (CREVICE Protocol) for the Treatment of Severe Traumatic Brain Injury Based on Imaging and Clinical Examination for Use When Intracranial Pressure Monitoring Is Not Employed	JOURNAL OF NEUROTRAUMA			English	Article						global health; ICP monitoring; intracranial hypertension; neurocritical care; sTBI	GUIDELINES	Globally, intracranial pressure (ICP) monitoring use in severe traumatic brain injury (sTBI) is inconsistent and susceptible to resource limitations and clinical philosophies. For situations without monitoring, there is no published comprehensive management algorithm specific to identifying and treating suspected intracranial hypertension (SICH) outside of the one ad hoc Imaging and Clinical Examination (ICE) protocol in the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure (BEST:TRIP) trial. As part of an ongoing National Institutes of Health (NIH)-supported project, a consensus conference involving 43 experienced Latin American Intensivists and Neurosurgeons who routinely care for sTBI patients without ICP monitoring, refined, revised, and augmented the original BEST:TRIP algorithm. Based on BEST:TRIP trial data and pre-meeting polling, 11 issues were targeted for development. We used Delphi-based methodology to codify individual statements and the final algorithm, using a group agreement threshold of 80%. The resulting CREVICE (Consensus REVised ICE) algorithm defines SICH and addresses both general management and specific treatment. SICH treatment modalities are organized into tiers to guide treatment escalation and tapering. Treatment schedules were developed to facilitate targeted management of disease severity. A decision-support model, based on the group's combined practices, is provided to guide this process. This algorithm provides the first comprehensive management algorithm for treating sTBI patients when ICP monitoring is not available. It is intended to provide a framework to guide clinical care and direct future research toward sTBI management. Because of the dearth of relevant literature, it is explicitly consensus based, and is provided solely as a resource (a "consensus-based curbside consult") to assist in treating sTBI in general intensive care units in resource-limited environments.	[Chesnut, Randall M.; Temkin, Nancy; Pridgeon, Jim; Dikmen, Sureyya; Chaddock, Kelley; Barber, Jason; Machamer, Joan; Hendrickson, Peter] Univ Washington, Harborview Med Ctr, 325 9Th Ave, Seattle, WA 98104 USA; [Videtta, Walter] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Petroni, Gustavo; Lujan, Silvia; Guadagnoli, Nahuel] Hosp Emergencia, Dr Clemente Alvarez, Rosario, Argentina; [Aguilera, Sergio] Hosp Reg, Iquique, Chile; [Alanis, Victor] Hosp San Juan Dios, Santa Cruz, Bolivia; [Bello Quezada, Manuel Enrique] Hosp Nacl San Rafael, La Tecla, El Salvador, Argentina; [Bautista Coronel, Ermitano] Hosp Nacl Guillermo Almenara Irigoyen, Lima, Peru; [Alberto Bustamante, Luis] Hosp Delicia Concepcion Masvernat, Concordia, Entre Rios, Argentina; [Cacciatori, Armando C.] Circulo Catol Obreros Uruguay, Montevideo, Uruguay; [Javier Carricondo, Carlos] Hosp Cent, Mendoza, Argentina; [Carvajal, Felipe] Hosp Municipal Eva Peron Merlo, Merlo, Buenos Aires, Argentina; [Davila, Rafael; Mora, Jacobo] Hosp Univ Luis Razetti, Barcelona, Venezuela; [Dominguez, Mario] Hosp Univ Prov Arnaldo Milian Castro, Santa Clara, Cuba; [Figueroa Melgarejo, Jairo Antonio; Urbina, Zulma] Hosp Erasmo Meoz, Cucuta, Colombia; [Martha Fillipi, Maria] Hosp Dr Jose Maria Cullen, Santa Fe, Argentina; [Godoy, Daniel A.] Sanatorio Pasteur, Catamarca, Argentina; [Cristina Gomez, Delia] Hosp Urgencias, Cordoba, Argentina; [Lacerda Gallardo, Angel J.] Hosp Roberto Rodriguez, Moron, Ciego De Avila, Cuba; [Guerra Garcia, Juan Antonio] Hosp Mil Cent COSSMIL, La Paz, Bolivia; [la Fuente Zerain, Gustavo] Hosp Japones, Santa Cruz, Bolivia; [Lavadenz Cuientas, Luis Arturo] Hosp Clin Viedma, Cochabamba, Bolivia; [Lequipe, Cecilio] Hosp Clorazon Jesus, El Alto, Bolivia; [Grajales Yuca, Gerardo Vicente] Hosp Especialidades ISSTECH Vida Mejor, Chiapas, Mexico; [Jibaja Vega, Manuel] Hosp Eugenio Espejo, Intens Care Unit, Quito, Ecuador; [Eduardo Kessler, Michael] Hosp Arco Iris, La Paz, Bolivia; [Lopez Delgado, Hubiel J.] CEDIMAT, Crit Care Med, Neurosurg, Plaza Salud Juan, Santo Domingo, Dominican Rep; [Sandi Lora, Freddy] Hosp Obrero 1, La Paz, Bolivia; [Maria Mazzola, Ana] Hosp San Felipe, San Nicolas, Argentina; [Merida Maldonado, Roberto] Hosp San Juan Dios, Tarija, Bolivia; [Mezquia de Pedro, Natascha] Inst Hosp Clin Quirurg Docente Dr Miguel Enriquez, Havana, Cuba; [Martinez Zubieta, J. Ricardo] Hosp Espanol Mexico Cd Mexico, Mexico City, DF, Mexico; [Mijangos Mendez, Julio C.] Hosp Civil Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Ochoa Parra, Johnny Marcelo] Univ Azuay, Hosp Jose Carrasco Arteaga, IESS Cuenca, Fac Med, Cuenca, Ecuador; [Pahnke, Perla B.] Hosp Municipal Urgencias, Cordoba, Argentina; [Paranhos, Jorge] Hosp Santa Casa, Sao Joao Del Rei, Brazil; [Pinero, Gustavo R.] Lucero Hosp, Leonidas, Bahia Blanca, Buenos Aires, Argentina; [Rivadeneira Pilacuan, Francisco A.] Hosp San Vicente Paul, Ibarra, Ecuador; [Mendez Rivera, Mario Napoleon] Hosp San Juan Dios, Guatemala City, Guatemala; [Romero Figueroa, Ricardo Luis] Fdn Campbell, Barranquilla, Colombia; [Rubiano, Andres M.] El Bosque Univ, Bogota, Colombia; [Saraguro Orozco, Alexandra Matilde] Hosp Gen Docente Riobamba, Riobamba, Ecuador; [Silesky Jimenez, Juan Ignacio] Hosp CIMA San Jose, Hosp San Juan Dios, Caja Costarricense Seguro Social, San Jose, Costa Rica; [Silva Naranjo, Luis] Hosp Inst Ecuatoriano Seguridad Social, Ambato, Ecuador; [Soler Morejon, Caridad] Hermanos Ameijeiras Hosp, Havana, Cuba		Chesnut, RM (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Mailstop 359766,325 Ninth Ave, Seattle, WA 98104 USA.	chesnutr@uw.edu	RUBIANO, ANDRES M/K-6704-2012; Gallardo, Angel Jesus Lacerda/AAZ-9478-2020	RUBIANO, ANDRES M/0000-0001-8931-3254; Gallardo, Angel Jesus Lacerda/0000-0001-9171-2000; ROMERO FIGUEROA, RICARDO LUIS/0000-0002-3124-8717; Ochoa-Parra, Marcelo/0000-0003-0432-8962; Mijangos-Mendez, Julio Cesar/0000-0002-9640-3036	National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) through the Fogarty International Center [NS080648]	The conference and ongoing validation study are National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) funded through the Fogarty International Center (grant number NS080648).	Aiolfi A, 2018, J NEUROSURG, V128, P828, DOI 10.3171/2016.11.JNS162198; American College of Surgeons Committee on Trauma (2015), 2015, BEST PRACT MAN TRAUM; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2018, J NEUROTRAUM, V35, P54, DOI 10.1089/neu.2016.4472; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Espinosa-Aguilar A, 2008, J TRAUMA, V64, P1327, DOI 10.1097/TA.0b013e3181469ebe; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825	13	10	10	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2020	37	11					1291	1299		10.1089/neu.2017.5599		MAR 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT0OT	WOS:000525043400001	32013721	Bronze, Green Published			2022-02-06	
J	Gao, C; Wang, HC; Wang, T; Luo, CL; Wang, ZF; Zhang, MY; Chen, XP; Tao, LY				Gao, Cheng; Wang, Haochen; Wang, Tao; Luo, Chengliang; Wang, Zufeng; Zhang, Mingyang; Chen, Xiping; Tao, Luyang			Platelet regulates neuroinflammation and restores blood-brain barrier integrity in a mouse model of traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						mouse model; neuroinflammation; platelet CLEC-2; traumatic brain injury	ACTIVATION MOTIF ITAM; INDUCED CELL-DEATH; MICROGLIAL POLARIZATION; PODOPLANIN; AUTOPHAGY; CONTRIBUTES; MACROPHAGES; DISRUPTION; EXPRESSION; RAPAMYCIN	Neuroinflammation accompanied by microglial activation triggers multiple cell death after traumatic brain injury (TBI). The secondary injury caused by inflammation may persist for a long time. Recently, platelet C-type lectin-like 2 receptor (CLEC-2) has been shown to regulate inflammation in certain diseases. However, its possible effects on TBI remain poorly understood. Here, we aimed to investigate the role of platelet CLEC-2 in the pathological process of neuroinflammation after TBI. In this study, mice were subjected to sham or controlled cortical impact injury, and arbitrarily received recombinant platelet CLEC-2. In parallel, BV2 cells were treated with lipopolysaccharide (LPS) to mimic microglial activation after TBI. Primary endothelial cells were also subjected to LPS in order to replicate the inflammatory damage caused by TBI. We used western blot analysis, reverse transcription polymerase chain reaction (RT-PCR), and immunostaining to evaluate the role of platelet CLEC-2 in TBI. In conditional knock out platelet CLEC-2 mice, trauma worsened the integrity of the blood-brain barrier and amplified the release of inflammatory cytokines. In wild type mice subjected to controlled cortical impact injury, recombinant platelet CLEC-2 administration altered the secretion of inflammatory cytokines, reduced brain edema, and improved neurological function. In vitro, the polarization phenotype of microglia induced by LPS was transformed by recombinant platelet CLEC-2, and this conversion depended on the mammalian target of rapamycin (mTOR) pathway. Endothelial cell injury by LPS was ameliorated when microglia expressed mostly M2 phenotype markers. In conclusion, platelet CLEC-2 regulates trauma-induced neuroinflammation and restores blood-brain barrier integrity.	[Gao, Cheng; Wang, Haochen; Wang, Tao; Luo, Chengliang; Wang, Zufeng; Zhang, Mingyang; Chen, Xiping; Tao, Luyang] Soochow Univ, Sch Med, Dept Forens Med, 178 East Ganjiang Rd, Suzhou 215213, Peoples R China		Chen, XP; Tao, LY (corresponding author), Soochow Univ, Sch Med, Dept Forens Med, 178 East Ganjiang Rd, Suzhou 215213, Peoples R China.	xipingchen@suda.edu.cn; taoluyang@suda.edu.cn	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Tao, Luyang/0000-0002-6598-1730; Zhang, Mingyang/0000-0003-1612-0763	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81530062, 81871536, 81971800]	National Natural Science Foundation of China, Grant/Award Number: 81530062, 81871536 and 81971800	Asai J, 2016, AM J PATHOL, V186, P101, DOI 10.1016/j.ajpath.2015.09.007; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bierbach B, 2008, STROKE, V39, P213, DOI 10.1161/STROKEAHA.107.496620; Boulaftali Y, 2014, CIRC RES, V114, P1174, DOI 10.1161/CIRCRESAHA.114.301611; Boulaftali Y, 2013, J CLIN INVEST, V123, P908, DOI 10.1172/JCI65154; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Chen YQ, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0722-z; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Chuang WY, 2015, INT J CLIN EXP PATHO, V8, P12757; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dou Y, 2017, J NEUROCHEM, V142, P478, DOI 10.1111/jnc.14075; Eisenreich A, 2016, J HYPERTENS, V34, P323, DOI 10.1097/HJH.0000000000000799; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hazelton I, 2018, J NEUROTRAUM, V35, P639, DOI 10.1089/neu.2017.5049; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Horstman LL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-10; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kerrigan AM, 2012, J THROMB HAEMOST, V10, P484, DOI 10.1111/j.1538-7836.2011.04614.x; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Kolar K, 2015, J NEUROPATH EXP NEUR, V74, P64, DOI 10.1097/NEN.0000000000000150; Konishi H, 2017, GLIA, V65, P1927, DOI 10.1002/glia.23204; Kumar A, 2019, J PHARMACOL EXP THER, V368, P338, DOI 10.1124/jpet.118.253955; Lee RH, 2016, J THROMB HAEMOST, V14, P645, DOI 10.1111/jth.13250; Lee SW, 2018, J NEUROTRAUM, V35, P1681, DOI 10.1089/neu.2017.5530; Li DJ, 2016, FASEB J, V30, P3388, DOI 10.1096/fj.201600495R; Li FZ, 2019, J NEUROCHEM, V148, P97, DOI 10.1111/jnc.14626; Li HL, 2018, TOXICOL APPL PHARM, V340, P58, DOI 10.1016/j.taap.2017.12.019; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Lowe KL, 2015, BLOOD, V125, P3769, DOI 10.1182/blood-2014-09-603803; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Manaenko A, 2011, J NEUROSCI METH, V195, P206, DOI 10.1016/j.jneumeth.2010.12.013; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Martin GE, 2018, SHOCK, V50, P551, DOI 10.1097/SHK.0000000000001056; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Rayes J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02402-6; RISHI AK, 1995, DEV BIOL, V167, P294, DOI 10.1006/dbio.1995.1024; Shi FS, 2013, J NEUROCHEM, V124, P168, DOI 10.1111/jnc.12053; Shi YJ, 2011, J NEUROCHEM, V119, P124, DOI 10.1111/j.1471-4159.2011.07403.x; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Song Y, 2014, CELL MOL NEUROBIOL, V34, P839, DOI 10.1007/s10571-014-0060-y; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Sumi N, 2010, CELL MOL NEUROBIOL, V30, P247, DOI 10.1007/s10571-009-9446-7; Tomooka M, 2013, ACTA HISTOCHEM CYTOC, V46, P171, DOI 10.1267/ahc.13035; Veszelka S, 2007, NEUROCHEM INT, V50, P219, DOI 10.1016/j.neuint.2006.08.006; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Welser-Alves JV, 2014, METHODS MOL BIOL, V1135, P345, DOI 10.1007/978-1-4939-0320-7_28; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Yang XW, 2016, INT J IMMUNOPATH PH, V29, P54, DOI 10.1177/0394632015617065; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang S, 2016, NEUROCHEM INT, V96, P46, DOI 10.1016/j.neuint.2016.02.013; Zhong LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032195	62	10	11	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUL	2020	154	2					190	204		10.1111/jnc.14983		MAR 2020	15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	MI5PI	WOS:000517788200001	32048302	Bronze			2022-02-06	
J	Dams-O'Connor, K; Ketchum, JM; Cuthbert, JP; Corrigan, JD; Hammond, FM; Haarbauer-Krupa, J; Kowalski, RG; Miller, AC				Dams-O'Connor, Kristen; Ketchum, Jessica M.; Cuthbert, Jeffrey P.; Corrigan, John D.; Hammond, Flora M.; Haarbauer-Krupa, Juliet; Kowalski, Robert G.; Miller, A. Cate			Functional Outcome Trajectories Following Inpatient Rehabilitation for TBI in the United States: A NIDILRR TBIMS and CDC Interagency Collaboration	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						disability; independence; longitudinal data analysis; outcomes; rehabilitation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; NATIONAL INSTITUTE; HEAD-INJURY; PROGNOSTIC VALUE; RATING-SCALE; OLDER-ADULTS; DISABILITY; MODEL; PREDICTORS; HEALTH	Objective: To describe trajectories of functioning up to 5 years after traumatic brain injury (TBI) that required inpatient rehabilitation in the United States using individual growth curve models conditioned on factors associated with variability in functioning and independence over time. Design: Secondary analysis of population-weighted data from a multicenter longitudinal cohort study. Setting: Acute inpatient rehabilitation facilities. Participants: A total of 4624 individuals 16 years and older with a primary diagnosis of TBI. Main Outcome Measures: Ratings of global disability and supervision needs as reported by participants or proxy during follow-up telephone interviews at 1, 2, and 5 years postinjury. Results: Many TBI survivors experience functional improvement through 1 and 2 years postinjury, followed by a decline in functioning and decreased independence by 5 years. However, there was considerable heterogeneity in outcomes across individuals. Factors such as older age, non-White race, lower preinjury productivity, public payer source, longer length of inpatient rehabilitation stay, and lower discharge functional status were found to negatively impact trajectories of change over time. Conclusions: These findings can inform the content, timing, and target recipients of interventions designed to maximize functional independence after TBI.	[Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Ketchum, Jessica M.; Kowalski, Robert G.] Craig Hosp, Res Dept, Englewood, CO USA; [Ketchum, Jessica M.] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Cuthbert, Jeffrey P.] Swedish Med Ctr, Englewood, CO 80110 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Haarbauer-Krupa, Juliet] Ctr Dis Control & Prevent, Div Unintent Injury, Atlanta, GA USA; [Miller, A. Cate] Natl Inst Disabiliy Independent Living & Rehabil, Washington, DC USA		Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA.	kristen.dams-oconnor@mountsinai.org			US Department of Health and Human Services (HHS); Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; US Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR)US Department of Education; NIDRR [90DP0013, 90DP0084]; Traumatic Brain InjuryModel System Centers grants from NIDILRR [90DP0038, 90DPTB0009]; Indiana University/Rehabilitation Hospital of Indiana [90DP0036, 90DRTB0002]; Rocky Mountain Regional Brain Injury System [90DP0034, 90DPTB0007]; Ohio State UniversityOhio State University [90DP0040]; National Institutes ofHealth, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [K01HD074651-01A1]	This research was supported by an interagency agreement between the US Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), and the US Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR) with supplemental funding to the NIDRR-funded Traumatic Brain Injury Model Systems National Data and Statistical Center (Grant numbers 90DP0013 and 90DP0084). In 2014, NIDRR was moved from the US Department of Education to the Administration for Community Living of the US Department of Health andHuman Services, and was renamed theNational Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). This research was also supported by Traumatic Brain InjuryModel System Centers grants from NIDILRR to the Icahn School of Medicine at Mount Sinai (Grant numbers 90DP0038 and 90DPTB0009), Indiana University/Rehabilitation Hospital of Indiana (Grant number 90DP0036; 90DRTB0002), Rocky Mountain Regional Brain Injury System (Grant numbers 90DP0034 and 90DPTB0007), and Ohio State University (Grant number 90DP0040); and by a grant from theNational Institutes ofHealth, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (Grant number K01HD074651-01A1). This paper does not reflect the official policy or opinions of the CDC, NIDILRR, or HHS and does not constitute an endorsement of the individuals or their programs-by the CDC, NIDILRR, HHS, or other components of the federal government-and none should be inferred. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2010, ARCH PHYS MED REHAB, V91, P1495, DOI 10.1016/j.apmr.2010.07.010; Block CK, 2017, CLIN NEUROPSYCHOL, V31, P487, DOI 10.1080/13854046.2016.1267803; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Boake C, 2000, SUPERVISION RATING S; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Connelly J, 2006, DISABIL REHABIL, V28, P629, DOI 10.1080/09638280500276513; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; Dams-O'Connor K, 2017, J HEAD TRAUMA REHAB, V32, P147, DOI 10.1097/HTR.0000000000000263; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Forslund MV, 2017, BRAIN INJURY, V31, P329, DOI 10.1080/02699052.2016.1255778; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger CV, 2007, AM J PHYS MED REHAB, V86, P883, DOI 10.1097/PHM.0b013e318152058a; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Kolakowsky-Hayner SA, 2012, BRAIN INJURY, V26, P1328, DOI 10.3109/02699052.2012.706353; Kowalski R, J NEUROSURG; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; Lee BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018174; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Malec J, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.0000000000000465, DOI 10.1097/HTR.0000000000000465]; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P1603, DOI 10.1016/j.apmr.2012.04.003; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Masel EK, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12707; McLafferty FS, 2016, NEUROREHABILITATION, V39, P423, DOI 10.3233/NRE-161373; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Pretz CR, 2014, J HEAD TRAUMA REHAB, V29, pE65, DOI 10.1097/HTR.0000000000000025; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Roe C, 2012, J NEUROL RES, V2, P134, DOI DOI 10.4021/JNR133W; SAS Institute Inc, SAS VERS 9 4; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Stawicki Stanislaw P, 2017, Int J Crit Illn Inj Sci, V7, P23, DOI 10.4103/IJCIIS.IJCIIS_2_17; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	56	10	10	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2020	35	2			SI		127	139		10.1097/HTR.0000000000000484			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LC0HT	WOS:000525012500011	31033744	Green Accepted			2022-02-06	
J	Elkbuli, A; Zajd, S; Ehrhardt, JD; McKenney, M; Boneva, D				Elkbuli, Adel; Zajd, Sarah; Ehrhardt, John D., Jr.; McKenney, Mark; Boneva, Dessy			Aggressive Crystalloid Resuscitation Outcomes in Low-Severity Pediatric Trauma	JOURNAL OF SURGICAL RESEARCH			English	Article						Fluid resuscitation; Pediatrics; Trauma outcomes; ICU length-of-stay	HEART-ASSOCIATION GUIDELINES; CARDIOPULMONARY-RESUSCITATION; RESISTANT; VOLUME; IRAQ	Background: Trauma is the leading cause of death among children. Studies have found that insufficient intravenous (IV) fluid resuscitation contributes significantly to morbidity and mortality in pediatric trauma. While large-volume resuscitation represents a potential solution, overly aggressive fluid management may complicate hospitalizations and recovery. Through this study, we aim to evaluate the impact of aggressive fluid resuscitation on outcomes in pediatric trauma. Materials and methods: This is a retrospective review utilizing our level I trauma center registry for pediatric patients aged <16 y admitted from 2014 to 2017. Patients transferred from our center within 24 h and those who arrived from outside hospitals were excluded. Patients who received blood product transfusions were excluded. Included patients were divided into two crystalloid groups: <60 mL/kg/24 h and >= 60 mL/kg/24 h. Outcome measures included ICU length-of-stay, length-of-hospitalization, complications, and mortality rate. Results: Study sample included 320 patients (<60 mL/kg/24 h = 219; >= 60 mL/kg/24 h = 101). The >= 60 mL/kg/24 h group was younger (9.95 versus 5.27, P = 0.0001). There were no significant differences in GCS on arrival, injury severity score, Abbreviated Injury Scale, Revised Trauma Scores, traumatic brain injury, and operative intervention between groups. Outcome measures showed there was no significant difference in 30-day readmission rate, complications, or mortality. Large-volume crystalloid resuscitation was associated with longer mean ICU length-of-stay (1.5 d versus 0.8 d, P = 0.004). Conclusions: In this single-institution retrospective database analysis, large-volume crystalloid resuscitation (>= 60 mL/kg) was associated with a significant increase in ICU length-of-stay without survival benefit. More research in the form of randomized trials will help determine the optimal rate for fluid resuscitation in pediatric trauma patients while weighing potential critical care complications. (C) 2019 Elsevier Inc. All rights reserved.	[Elkbuli, Adel; Zajd, Sarah; Ehrhardt, John D., Jr.; McKenney, Mark; Boneva, Dessy] Kendall Reg Med Ctr, Dept Surg, Miami, FL 33175 USA; [McKenney, Mark; Boneva, Dessy] Univ S Florida, Tampa, FL 33620 USA		Elkbuli, A (corresponding author), Kendall Reg Med Ctr, 11750 Bird Rd, Miami, FL 33175 USA.	adel.elkbulli@hcahealthcare.com	Zajd, Sarah/AAR-1903-2020; Elkbuli, Adel/AAK-7374-2021	Elkbuli, Adel/0000-0001-7730-617X			Acker SN, 2014, J PEDIATR SURG, V49, P1852, DOI 10.1016/j.jpedsurg.2014.09.034; Al-Sharif A, 2012, INJURY, V43, P2078, DOI 10.1016/j.injury.2012.01.012; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Calkins CM, 2002, J TRAUMA, V53, P1058, DOI 10.1097/00005373-200212000-00005; Cao RN, 2019, CHINESE MED J-PEKING, V132, P963, DOI 10.1097/CM9.0000000000000177; Coons BE, 2018, J PEDIATR SURG, V53, P2202, DOI 10.1016/j.jpedsurg.2018.07.009; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; de Caen AR, 2015, CIRCULATION, V132, pS526, DOI 10.1161/CIR.0000000000000266; Edwards MJ, 2015, J TRAUMA ACUTE CARE, V78, P330, DOI 10.1097/TA.0000000000000469; Gilley M, 2018, CURR OPIN PEDIATR, V30, P338, DOI 10.1097/MOP.0000000000000617; Greene Nathaniel, 2012, Int J Crit Illn Inj Sci, V2, P135, DOI 10.4103/2229-5151.100890; Henry S., 2018, B AM COLL SURG, V103, P15; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Misir A, 2018, CURR PEDIATR REV, V14, P9, DOI 10.2174/1573396313666170815101504; National Center for Injury Prevention and Control CuW, 2017, 10 LEAD CAUS DEATH A 10 LEAD CAUS DEATH A; Raina R, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00306; Samuels M, 2016, ADV PAEDIATRIC LIFE, P115; Schauer SG, 2018, PREHOSP EMERG CARE, V22, P624, DOI 10.1080/10903127.2018.1439130; Shah SK, 2010, SURGERY, V148, P263, DOI 10.1016/j.surg.2010.03.019; Tosounidis TH, 2016, EUR J TRAUMA EMERG S, V42, P297, DOI 10.1007/s00068-015-0614-9; Tripathi A, 2015, INDIAN PEDIATR, V52, P965, DOI 10.1007/s13312-015-0754-3	21	10	10	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2020	247						350	355		10.1016/j.jss.2019.10.009			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	KM1VD	WOS:000513908200048	31676145				2022-02-06	
J	Korgaonkar, AA; Li, Y; Sekhar, D; Subramanian, D; Guevarra, J; Swietek, B; Pallottie, A; Singh, S; Kella, K; Elkabes, S; Santhakumar, V				Korgaonkar, Akshata A.; Li, Ying; Sekhar, Dipika; Subramanian, Deepak; Guevarra, Jenieve; Swietek, Bogumila; Pallottie, Alexandra; Singh, Sukwinder; Kella, Kruthi; Elkabes, Stella; Santhakumar, Vijayalakshmi			Toll-like Receptor 4 Signaling in Neurons Enhances Calcium-Permeable alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Currents and Drives Post-Traumatic Epileptogenesis	ANNALS OF NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; LONG-TERM HYPEREXCITABILITY; AMPA RECEPTOR; HEAD-INJURY; EPILEPSY; EXCITABILITY; HIPPOCAMPAL; ACTIVATION; POTENTIATION; CONTRIBUTES	Objective Traumatic brain injury is a major risk factor for acquired epilepsies, and understanding the mechanisms underlying the early pathophysiology could yield viable therapeutic targets. Growing evidence indicates a role for inflammatory signaling in modifying neuronal excitability and promoting epileptogenesis. Here we examined the effect of innate immune receptor Toll-like receptor 4 (TLR4) on excitability of the hippocampal dentate gyrus and epileptogenesis after brain injury. Methods Slice and in vivo electrophysiology and Western blots were conducted in rats subject to fluid percussion brain injury or sham injury. Results The studies identify that TLR4 signaling in neurons augments dentate granule cell calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor (CP-AMPAR) currents after brain injury. Blocking TLR4 signaling in vivo shortly after brain injury reduced dentate network excitability and seizure susceptibility. When blocking of TLR4 signaling after injury was delayed, however, this treatment failed to reduce postinjury seizure susceptibility. Furthermore, TLR4 signal blocking was less efficacious in limiting seizure susceptibility when AMPAR currents, downstream targets of TLR4 signaling, were transiently enhanced. Paradoxically, blocking TLR4 signaling augmented both network excitability and seizure susceptibility in uninjured controls. Despite the differential effect on seizure susceptibility, TLR4 antagonism suppressed cellular inflammatory responses after injury without impacting sham controls. Interpretation These findings demonstrate that independently of glia, the immune receptor TLR4 directly regulates post-traumatic neuronal excitability. Moreover, the TLR4-dependent early increase in dentate excitability is causally associated with epileptogenesis. Identification and selective targeting of the mechanisms underlying the aberrant TLR4-mediated increase in CP-AMPAR signaling after injury may prevent epileptogenesis after brain trauma.	[Korgaonkar, Akshata A.; Li, Ying; Sekhar, Dipika; Subramanian, Deepak; Guevarra, Jenieve; Swietek, Bogumila; Kella, Kruthi; Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Sekhar, Dipika; Subramanian, Deepak; Santhakumar, Vijayalakshmi] Univ Calif Riverside, Dept Mol Cell & Syst Biol, Riverside, CA 92521 USA; [Pallottie, Alexandra; Elkabes, Stella] Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ USA; [Singh, Sukwinder] Rutgers New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ USA		Korgaonkar, AA (corresponding author), Washington Univ, Sch Med, Dept Neurol, 660 South Euclid Ave,Campus Box 8111, St Louis, MO 63110 USA.	akskor@gmail.com	Subramanian, Deepak/AAB-3928-2022	Subramanian, Deepak/0000-0001-7109-6714; Santhakumar, Vijayalakshmi/0000-0001-6278-4187; Korgaonkar, Akshata/0000-0002-4687-9669	CURE Foundation [CF 259051]; New Jersey Commission on Brain Injury Research [CBIR14RG024, CBIR15FEL011]; NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS069861, R01NS097750]	This research was supported by CURE Foundation CF 259051, New Jersey Commission on Brain Injury Research CBIR14RG024 and CBIR15FEL011 (A.A.K.), and NIH National Institute of Neurological Disorders and Stroke R01 NS069861 and R01NS097750 (V.S.).	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Arai AC, 2000, MOL PHARMACOL, V58, P802, DOI 10.1124/mol.58.4.802; Balosso S, 2014, ANTIOXID REDOX SIGN, V21, P1726, DOI 10.1089/ars.2013.5349; Baudry M, 2012, NEUROBIOL DIS, V47, P210, DOI 10.1016/j.nbd.2012.04.002; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; Casillas-Espinosa PM, 2019, EPILEPSY RES, V156, DOI 10.1016/j.eplepsyres.2019.04.011; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Dedeurwaerdere S, 2012, EPILEPSIA, V53, P1113, DOI 10.1111/j.1528-1167.2012.03520.x; Diogenes A, 2011, J DENT RES, V90, P759, DOI 10.1177/0022034511400225; Dong XQ, 2011, INFLAMM RES, V60, P533, DOI 10.1007/s00011-010-0300-7; Echegoyen J, 2009, EPILEPSY RES, V85, P123, DOI 10.1016/j.eplepsyres.2009.02.019; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Fourgeaud L, 2010, P NATL ACAD SCI USA, V107, P22278, DOI 10.1073/pnas.0914064107; Frigerio F, 2018, MOL NEUROBIOL, V55, P7500, DOI 10.1007/s12035-018-0915-1; Garate I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-8; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gu XJ, 2014, CHIN J TRAUMATOL, V17, P1, DOI 10.3760/cma.j.issn.1008-1275.2014.01.001; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Hilgenberg LG, 2007, J VIS EXP, V562; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hua F, 2015, J CEREBR BLOOD F MET, V35, P536, DOI 10.1038/jcbfm.2014.240; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Jensen JB, 1998, J NEUROSCI RES, V54, P273, DOI 10.1002/(SICI)1097-4547(19981015)54:2<273::AID-JNR15>3.3.CO;2-7; Jensen JB, 2001, J NEUROSCI RES, V65, P267, DOI 10.1002/jnr.1150; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Karasawa J, 2010, NEUROCHEM INT, V57, P615, DOI 10.1016/j.neuint.2010.07.011; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Li Y, 2015, NEUROBIOL DIS, V74, P240, DOI 10.1016/j.nbd.2014.11.021; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Nasr IW, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112957; Neuberger EJ, 2019, J NEUROSCI RES, V97, P1335, DOI 10.1002/jnr.24202; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Pribiag H, 2014, NEUROPHARMACOLOGY, V78, P13, DOI 10.1016/j.neuropharm.2013.06.008; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raghupathi R, 2017, NEURAL REGEN RES, V12, P741, DOI 10.4103/1673-5374.206639; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Reis WL, 2015, ENDOCRINOLOGY; Rodgers KM, 2009, BRAIN, V132, P2478, DOI 10.1093/brain/awp177; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Saletti PG, 2019, NEUROBIOL DIS, V123, P86, DOI 10.1016/j.nbd.2018.06.017; Sansing LH, 2011, ANN NEUROL, V70, P646, DOI 10.1002/ana.22528; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Schmidt D, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0695-9; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Terrone G, 2017, CURR PHARM DESIGN, V23, P5569, DOI 10.2174/1381612823666170926113754; Vezzani A, 2015, COLD SPRING HARB PER, V6, DOI DOI 10.1101/CSHPERSPECT.A022699; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Webster KM, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112979; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; West PJ, 2014, EPILEPSIA, V55, P214, DOI 10.1111/epi.12524; Wilson NM, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00005; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Xing F, 2018, MOL PAIN, V14, DOI 10.1177/1744806918807050; Yu JD, 2016, CEREB CORTEX, V26, P4299, DOI 10.1093/cercor/bhv199	67	10	10	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	APR	2020	87	4					497	515		10.1002/ana.25698		FEB 2020	19	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU4ER	WOS:000518136500001	32031699	Green Accepted, Green Submitted			2022-02-06	
J	Kumar, R; Nedungadi, A				Kumar, Rubbel; Nedungadi, Ashish			Using Gas-Driven Shock Tubes to Produce Blast Wave Signatures	FRONTIERS IN NEUROLOGY			English	Article						primary blast injury; shock tube; blast wave; CFD; shock tube parameters	SYSTEMS	The increased incidence of improvised explosives in military conflicts has brought about an increase in the number of traumatic brain injuries (TBIs) observed. Although physical injuries are caused by shrapnel and the immediate blast, encountering the blast wave associated with improvised explosive devices (IEDs) may be the cause of traumatic brain injuries experienced by warfighters. Assessment of the effectiveness of personal protective equipment (PPE) to mitigate TBI requires understanding the interaction between blast waves and human bodies and the ability to replicate the pressure signatures caused by blast waves. Prior research has validated compression-driven shock tube designs as a laboratory method of generating representative pressure signatures, or Friedlander-shaped blast profiles; however, shock tubes can vary depending on their design parameters and not all shock tube designs generate acceptable pressure signatures. This paper presents a comprehensive numerical study of the effects of driver gas, driver (breech) length, and membrane burst pressure of a constant-area shock tube. Discrete locations in the shock tube were probed, and the blast wave evolution in time at these points was analyzed to determine the effect of location on the pressure signature. The results of these simulations are used as a basis for suggesting guidelines for obtaining desired blast profiles.	[Kumar, Rubbel; Nedungadi, Ashish] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20707 USA; [Kumar, Rubbel] Univ Maryland, Dept Aerosp Engn, College Pk, MD 20742 USA		Kumar, R (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20707 USA.; Kumar, R (corresponding author), Univ Maryland, Dept Aerosp Engn, College Pk, MD 20742 USA.	rubbel.kumar@jhuapl.edu			U.S. Army Natick Soldier Research, Development and Engineering Center	The only funds received for this work will be for the open access publication fee and they will be from the U.S. Army Natick Soldier Research, Development and Engineering Center.	Baker W.E., 1973, EXPLOSIONS AIR; BLEAKNEY W, 1949, REV SCI INSTRUM, V20, P807, DOI 10.1063/1.1741395; Chakravarthy S, 1996, AIAA ASME SAE ASEE J; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Gibbs J.W., 1898, NATURE, V59, P200; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Merkle AC, 2013, J HOPKINS APL TECH D, V31, P286; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Needham E, 2013, 29 INT S SHOCK WAV 2, V2, P849; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; SOD GA, 1978, J COMPUT PHYS, V27, P1, DOI 10.1016/0021-9991(78)90023-2; Sundaramurthy A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00253; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilbraham H., 1848, CAMBRIDGE DUBLIN MAT, V3, P198; Yu AW, 2014, PERS ARM SYST S CAMB	16	10	10	4	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 21	2020	11								90	10.3389/fneur.2020.00090			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KZ7IY	WOS:000523433000001	32153491	gold, Green Published			2022-02-06	
J	O'Connell, GC; Alder, ML; Smothers, CG; Still, CH; Webel, AR; Moore, SM				O'Connell, Grant C.; Alder, Megan L.; Smothers, Christine G.; Still, Carolyn H.; Webel, Allison R.; Moore, Shirley M.			Use of high-sensitivity digital ELISA improves the diagnostic performance of circulating brain-specific proteins for detection of traumatic brain injury during triage	NEUROLOGICAL RESEARCH			English	Article						Single molecule array; SiMoA; molecular diagnostics; concussion; biomarkers; triage	ROBUST; ASSAY; SERUM	Background: Historically, limited sensitivity associated with traditional immunoassay methods has prevented the use of brain-specific proteins as blood biomarkers of traumatic brain injury (TBI) during triage, as these proteins exhibit low circulating concentrations. Digital ELISA is a newly-developed technique that is up to 1000 times more sensitive than conventional ELISA methods. The purpose of this study was to determine whether the use of digital ELISA over conventional ELISA improves the performance of brain-specific proteins as blood biomarkers of TBI during triage. Methods: Blood was sampled from TBI patients (n = 13) at emergency department admission, as well as from neurologically normal controls (n = 72). Serum levels of two brain-specific proteins, neurofilament light chain (NfL) and Tau, were measured via digital ELISA. Estimated conventional ELISA measures were generated by adjusting values according to the lower limits of detection achievable with commercially available conventional ELISA assays, and receiver operating characteristic (ROC) analysis was used to compare the diagnostic performance of digital ELISA measures to estimated conventional ELISA measures in terms of their ability to discriminate between TBI patients and controls. Results: Used in combination, digital ELISA measures of NfL and Tau could discriminate between groups with 100% sensitivity and 91.7% specificity. Estimated conventional ELISA measures could only discriminate between groups with 7.7% sensitivity and 94.4% specificity. This difference in diagnostic performance was statistically significant when comparing areas under ROC curves. Conclusions: The use of digital ELISA over conventional ELISA methods improves the diagnostic performance of circulating brain-specific proteins for detection of TBI during triage.	[O'Connell, Grant C.; Alder, Megan L.; Smothers, Christine G.; Still, Carolyn H.; Webel, Allison R.; Moore, Shirley M.] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, 10900 Euclid Ave, Cleveland, OH 44106 USA		O'Connell, GC (corresponding author), Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, 10900 Euclid Ave, Cleveland, OH 44106 USA.	grant.oconnell@case.edu	Webel, Allison R./ABA-1972-2020; Alder, Megan/L-6112-2016	Smothers, Christine/0000-0002-8269-2375; O'Connell, Grant/0000-0002-2642-6670; Alder, Megan/0000-0002-7817-3476	National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); National Institute on Aging of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30NR015326]; Case Western Reserve University FPB School of Nursing start-up funds	Research reported in this publication was supported by the National Institute of Nursing Research and the National Institute on Aging of the National Institutes of Health under Award Number P30NR015326 issued to SMM. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported by Case Western Reserve University FPB School of Nursing start-up funds issued to GCO.	Akama K, 2019, ELECTR COMMUN JPN, V102, P43, DOI 10.1002/ecj.12137; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fuller G, 2016, EUR J EMERG MED, V23, P61, DOI 10.1097/MEJ.0000000000000327; Fuller G, 2014, EMERG MED J, V31, P914, DOI 10.1136/emermed-2013-202575; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI 10.2307/1390807; Iverson GL, 2019, J NEUROTRAUM, V36, P2400, DOI 10.1089/neu.2018.6341; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; O'Connell GC, 2018, TRANSL STROKE RES; O'Connell GC, 2019, BIOANALYSIS, V11, P2087, DOI 10.4155/bio-2019-0213; O'Connell GC, 2017, LAB MED, V48, P346, DOI 10.1093/labmed/lmx035; O'Connell GC, 2017, GENOM DATA, V14, P47, DOI 10.1016/j.gdata.2017.08.006; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Ripley B.D, 2002, MODERN APPL STAT S, DOI DOI 10.1007/978-0-387-21706-2; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Yelleswarapu V, 2019, P NATL ACAD SCI USA, V116, P4489, DOI 10.1073/pnas.1814110116	22	10	10	5	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR 2	2020	42	4					346	353		10.1080/01616412.2020.1726588		FEB 2020	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU8VV	WOS:000513614200001	32048573	Green Accepted			2022-02-06	
J	Wu, JC; He, JC; Tian, XC; Luo, YT; Zhong, JJ; Zhang, HR; Li, H; Cen, B; Jiang, T; Sun, XC				Wu, Jingchuan; He, Junchi; Tian, Xiaocui; Luo, Yuetao; Zhong, Jianjun; Zhang, Hongrong; Li, Hui; Cen, Bo; Jiang, Tao; Sun, Xiaochuan			microRNA-9-5p alleviates blood-brain barrier damage and neuroinflammation after traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						apoptosis; blood-brain barrier; microRNA-9-5p; neuroinflammation; Ptch-1; traumatic brain injury	IN-VITRO; EXPRESSION; BIOMARKERS; RNAS; PROTECTS; MIR-9; CNS	The level of microRNA-9-5p (miRNA-9-5p) in brain tissues is significantly changed after traumatic brain injury (TBI). However, the effect of miRNA-9-5p for brain function in TBI has not been elucidated. In this study, a controlled cortical impact model was used to induce TBI in Sprague-Dawley rats, and an oxygen glucose deprivation model was used to mimic the pathological state in vitro. Brain microvascular endothelial cells (BMECs) and astrocytes were extracted from immature Sprague-Dawley rats and cocultured to reconstruct blood-brain barrier (BBB) in vitro. The results show that the level of miRNA-9-5p was significantly increased in brain tissues after TBI, and up-regulation of miRNA9-5p contributed to the recovery of neurological function. Up-regulation of miRNA-9-5p with miRNA agomir may significantly alleviate apoptosis, neuroinflammation, and BBB damage in rats after TBI. Moreover, a dual luciferase reporter assay confirmed that miRNA-9-5p is a post-transcriptional modulator of Ptch-1. In in vitro experiments, the results confirmed that up-regulation of miRNA-9-5p with miRNA mimic alleviates cellular apoptosis, inflammatory response, and BBB damage mainly by inhibiting Ptch-1. In addition, we found that the activation of Hedgehog pathway was accompanied by inhibition of NF-kappa B/MMP-9 pathway in the BMECs treated with miRNA-9-5p mimic. Taken together, these results indicate that up-regulation of miRNA-9-5p alleviates BBB damage and neuroinflammatory responses by activating the Hedgehog pathway and inhibiting NF-kappa B/MMP-9 pathway, which promotes the recovery of neurological function after TBI.	[Wu, Jingchuan; Cen, Bo] Wuhan Brain Hosp, Gen Hosp YangTze River Shipping, Dept Neurosurg, Wuhan, Peoples R China; [Wu, Jingchuan; He, Junchi; Zhong, Jianjun; Zhang, Hongrong; Li, Hui; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China; [Tian, Xiaocui] Chongqing Med Univ, Chongqing Key Lab Biochem & Mol Pharmacol, Coll Pharm, Chongqing, Peoples R China; [Luo, Yuetao] Chongqing Med Univ, Dept Clin Epidemiol & Biostat, Childrens Hosp, Chongqing, Peoples R China; [Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China		Sun, XC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China.; Jiang, T (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.	zacharytaojiang@163.com; sunxch1445@qq.com	风, 张/AAR-1410-2020; JIANG, TAO/AAU-5948-2020; Wu, Jingchuan/AAV-7799-2020	JIANG, TAO/0000-0002-8529-4487; Wu, Jingchuan/0000-0002-1213-4888	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571159]; National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [81801230]; Health Commission of Wuhan Municipality scientific research Funding [WX19Q17]; Health Commission of Hubei Province scientific research project [WJ2019H364]; Capital's Funds for Health Improvement and Research [CFH2018-2-2042]	This work was supported by grants from the National Natural Science Foundation of China (NO. 81571159), National Natural Science Foundation for Youth of China (No. 81801230), Health Commission of Wuhan Municipality scientific research Funding (No. WX19Q17), Health Commission of Hubei Province scientific research project (No. WJ2019H364), and Capital's Funds for Health Improvement and Research (CFH2018-2-2042).	Amorini AM, 2016, BBA-MOL BASIS DIS, V1862, P679, DOI 10.1016/j.bbadis.2016.01.023; An Y, 2019, BMC ANESTHESIOL, V19, DOI 10.1186/s12871-019-0775-x; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Chakraborty S, 2015, AM J PHYSIOL-CELL PH, V309, pC680, DOI 10.1152/ajpcell.00122.2015; Chandran R, 2017, NEUROCHEM INT, V111, P12, DOI 10.1016/j.neuint.2017.01.015; Chen SC, 2017, BIOCHEM BIOPH RES CO, V485, P167, DOI 10.1016/j.bbrc.2017.02.043; Chen T, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01432; Cheng C, 2013, J BIOL CHEM, V288, P13748, DOI 10.1074/jbc.M112.381392; Churov A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225547; DeStefano JG, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0068-z; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; He JC, 2018, NEUROBIOL DIS, V117, P114, DOI 10.1016/j.nbd.2018.06.003; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hu YM, 2014, STEM CELLS DEV, V23, P2771, DOI 10.1089/scd.2014.0021; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Katt ME, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0092-7; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li ZK, 2020, CELL CYCLE, V19, P24, DOI 10.1080/15384101.2019.1691763; Lian YH, 2019, MED SCI MONITOR, V25, P2265, DOI 10.12659/MSM.913145; Liu N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246125; Lu D, 2016, FRONT GENET, V7, DOI [10.3389/fgene.2015.00053, 10.3389/fgene.2016.00053]; Nampoothiri SS, 2019, CELL MOL NEUROBIOL, V39, P223, DOI 10.1007/s10571-018-0642-1; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Petri R, 2014, EXP CELL RES, V321, P84, DOI 10.1016/j.yexcr.2013.09.022; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Ramirez SH, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0104-7; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sengupta D, 2018, ACS CHEM NEUROSCI, V9, P725, DOI 10.1021/acschemneuro.7b00423; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Sun TY, 2014, J HUAZHONG U SCI-MED, V34, P548, DOI 10.1007/s11596-014-1313-1; Tian XC, 2016, J NEUROCHEM, V139, P757, DOI 10.1111/jnc.13833; Topol A, 2016, CELL REP, V15, P1024, DOI 10.1016/j.celrep.2016.03.090; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wu MY, 2020, BRAIN RES, V1727, DOI 10.1016/j.brainres.2019.146553; Xu LL, 2019, STROKE VASC NEUROL, V4, P78, DOI 10.1136/svn-2018-000198; Zhang X, 2019, MED SCI MONITOR, V25, P794, DOI 10.12659/MSM.908500; Zhao YH, 2015, INT J MOL SCI, V16, P30105, DOI 10.3390/ijms161226223; Zhong JH, 2020, J CELL PHYSIOL, V235, P1090, DOI 10.1002/jcp.29023; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001	46	10	11	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUN	2020	153	6					710	726		10.1111/jnc.14963		FEB 2020	17	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	LY6NR	WOS:000512430000001	31951014	Green Published, hybrid			2022-02-06	
J	Chen, P; Tang, H; Zhang, QT; Xu, L; Zhou, W; Hu, X; Deng, YB; Zhang, LY				Chen, Peng; Tang, Hao; Zhang, Qingtao; Xu, Lei; Zhou, Wei; Hu, Xi; Deng, Yongbing; Zhang, Lianyang			Basic Fibroblast Growth Factor (bFGF) Protects the Blood-Brain Barrier by Binding of FGFR1 and Activating the ERK Signaling Pathway After Intra-Abdominal Hypertension and Traumatic Brain Injury	MEDICAL SCIENCE MONITOR			English	Article						Blood-Brain Barrier; Brain Injuries; Intra-Abdominal Hypertension; Receptor, Fibroblast Growth Factor, Type 1	ABDOMINAL COMPARTMENT SYNDROME; IN-VITRO MODEL; INTRACRANIAL-PRESSURE; DECOMPRESSIVE LAPAROTOMY; ENDOTHELIAL-CELLS; PERMEABILITY; DISRUPTION; DAMAGE; MICE; INSUFFLATION	Background: Intra-abdominal hypertension (IAH) is associated with high morbidity and mortality. IAH leads to intra-abdominal tissue damage and causes dysfunction in distal organs such as the brain. The effect of a combined injury due to IAH and traumatic brain injury (TBI) on the integrity of the blood-brain barrier (BBB) has not been investigated. Material/Methods: Intracranial pressure (ICP) monitoring, brain water content, EB permeability detection, immunofluorescence staining, real-time PCR, and Western blot analysis were used to examine the effects of IAH and TBI on the BBB in rats, and to characterize the protective effects of basic fibroblast growth factor (bFGF) on combined injury-induced BBB damage. Results: Combined injury from IAH and TBI to the BBB resulted in brain edema and increased intracranial pressure. The effects of bFGF on alleviating the rat BBB injuries were determined, indicating that bFGF regulated the expression levels of the tight junction (TJ), adhesion junction (AJ), matrix metalloproteinase (MMP), and IL-1 beta, as well as reduced BBB permeability, brain edema, and intracranial pressure. Moreover, the FGFR1 antagonist PD 173074 and the ERK antagonist PD 98059 decreased the protective effects of bFGF. Conclusions: bFGF effectively protected the BBB from damage caused by combined injury from IAH and TBI, and binding of FGFR1 and activation of the ERK signaling pathway was involved in these effects.	[Chen, Peng; Tang, Hao; Zhang, Lianyang] Army Med Univ, Daping Hosp, Trauma Ctr Peoples Liberat Army PLA, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China; [Chen, Peng; Zhang, Qingtao; Xu, Lei; Zhou, Wei; Hu, Xi; Deng, Yongbing] Chongqing Emergency Med Ctr, Dept Neurosurg, Chongqing, Peoples R China		Zhang, LY (corresponding author), Army Med Univ, Daping Hosp, Trauma Ctr Peoples Liberat Army PLA, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	dpzhangly@163.com			Foundation Program of Technology of Education Committee of Chongqing [KJQN201800122]; Program of Technology of Science and Technology Committee of Yuzhong District in Chongqing [20180131]	The study was supported by the Foundation Program of Technology of Education Committee of Chongqing (KJQN201800122) and the Program of Technology of Science and Technology Committee of Yuzhong District in Chongqing (20180131)	Bai W, 2019, SHOCK, V51, P502, DOI 10.1097/SHK.0000000000001170; Bendfeldt K, 2007, J NEUROSCI, V27, P3260, DOI 10.1523/JNEUROSCI.4033-06.2007; BURCHARD KW, 1990, CRIT CARE MED, V18, P120, DOI 10.1097/00003246-199001000-00027; Chang MT, 2014, J SURG RES, V187, P244, DOI 10.1016/j.jss.2013.09.038; Cheatham ML, 2007, INTENS CARE MED, V33, P951, DOI 10.1007/s00134-007-0592-4; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Chen P, 2019, MED SCI MONITOR, V25, P7191, DOI 10.12659/MSM.918626; De Laet IE, 2008, LANGENBECK ARCH SURG, V393, P833, DOI 10.1007/s00423-008-0347-x; Deeren DH, 2005, INTENS CARE MED, V31, P1577, DOI 10.1007/s00134-005-2802-2; Dorfman JD, 2011, NEUROCRIT CARE, V15, P516, DOI 10.1007/s12028-011-9549-0; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; Ge XT, 2019, J NEUROTRAUM, V36, P1291, DOI 10.1089/neu.2018.5728; Halverson A, 1998, SURG ENDOSC, V12, P266, DOI 10.1007/s004649900648; Halverson AL, 1999, SURG ENDOSC-ULTRAS, V13, P797, DOI 10.1007/s004649901102; Jahromi AH, 2012, J TRAUMA ACUTE CARE, V73, P1175, DOI 10.1097/TA.0b013e31825dec35; Joseph DK, 2004, J TRAUMA, V57, P687, DOI 10.1097/01.TA.0000140645.84897.F2; Kamine TH, 2016, SURG ENDOSC, V30, P4029, DOI 10.1007/s00464-015-4715-7; Kamine TH, 2014, JAMA SURG, V149, P380, DOI 10.1001/jamasurg.2013.3024; Li L, 2015, TRANSL STROKE RES, V6, P467, DOI 10.1007/s12975-015-0425-7; Li QX, 2018, WORLD NEUROSURG, V117, pE117, DOI 10.1016/j.wneu.2018.05.202; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Lin L, 2018, MOL NEUROBIOL, V55, P3131, DOI 10.1007/s12035-017-0544-0; Liu D, 2015, NEUROPEPTIDES, V49, P55, DOI 10.1016/j.npep.2014.12.003; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Malbrain MLNG, 2007, INTENS CARE MED, V33, P1869, DOI 10.1007/s00134-007-0843-4; Malbrain MLNG, 2004, INTENS CARE MED, V30, P822, DOI 10.1007/s00134-004-2169-9; Marinis A, 2010, CRIT CARE, V14, DOI 10.1186/cc8908; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Price L., 2016, FRONTIERS NEUROSCIEN; Raballo R, 2000, J NEUROSCI, V20, P5012; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reuss B, 2003, J NEUROSCI, V23, P6404; Rosas-Hernandez H, 2018, MOL NEUROBIOL, V55, P258, DOI 10.1007/s12035-017-0738-5; Scalea TM, 2007, J TRAUMA, V62, P647, DOI 10.1097/TA.0b013e31802ee542; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Wang Z, 2012, J MOL NEUROSCI, V48, P273, DOI 10.1007/s12031-012-9769-6; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Youssef AM, 2012, J TRAUMA ACUTE CARE, V72, P183, DOI 10.1097/TA.0b013e31822a3254	42	10	10	0	6	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	FEB 9	2020	26								e922009	10.12659/MSM.922009			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	KL6KT	WOS:000513530800001	32036381	Green Published			2022-02-06	
J	Shin, SS; Marsh, EB; Ali, H; Nyquist, PA; Hanley, DF; Ziai, WC				Shin, Samuel S.; Marsh, Elisabeth B.; Ali, Hasan; Nyquist, Paul A.; Hanley, Daniel F.; Ziai, Wendy C.			Comparison of Traumatic Intracranial Hemorrhage Expansion and Outcomes Among Patients on Direct Oral Anticoagulants Versus Vitamin k Antagonists	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; TBI; Direct oral anticoagulant; Novel oral anticoagulant; Rivaroxaban; Apixaban; Dabigatran; Intracerebral hemorrhage	PROTHROMBIN COMPLEX CONCENTRATE; ACTIVATED FACTOR-VII; INTRACEREBRAL HEMORRHAGE; ATRIAL-FIBRILLATION; LABORATORY MEASUREMENT; ANDEXANET ALPHA; WARFARIN; DABIGATRAN; RIVAROXABAN; REVERSAL	Background With increasing use of direct oral anticoagulants (DOACs) and availability of new reversal agents, the risk of traumatic intracranial hemorrhage (tICH) requires better understanding. We compared hemorrhage expansion rates, mortality, and morbidity following tICH in patients treated with vitamin k antagonists (VKA: warfarin) and DOACs (apixaban, rivaroxaban, dabigatran). Methods Retrospective chart review of patients from 2010 to 2017 was performed to identify patients with imaging diagnosis of acute traumatic intraparenchymal, subdural, subarachnoid, and epidural hemorrhage with preadmission use of DOACs or VKAs. We identified 39 patients on DOACs and 97 patients on VKAs. Demographic information, comorbidities, hemorrhage size, and expansion over time, as well as discharge disposition and Glasgow Outcome Scale (GOS) were collected. Primary outcome was development of new or enlargement of tICH within the first 48 h of initial CT imaging. Results Of 136 patients with mean (SD) age 78.7 (13.2) years, most common tICH subtype was subdural hematoma (N = 102/136; 75%), and most common mechanism was a fall (N = 130/136; 95.6%). Majority of patients in the DOAC group did not receive reversal agents (66.7%). Hemorrhage expansion or new hemorrhage occurred in 11.1% in DOAC group vs. 14.6% in VKA group (p = 0.77) at a median of 8 and 11 h from initial ED admission, respectively (p = 0.82). Patients in the DOAC group compared to VKA group had higher median discharge GOS (4 vs. 3 respectively, p = 0.03), higher percentage of patients with good outcome (GOS 4-5, 66.7% vs. 40.2% respectively, p = 0.005), and higher rate of discharge to home or rehabilitation (p = 0.04). Conclusions We report anticoagulation-associated tICH outcomes predominantly due to fall-related subdural hematomas. Patients on DOACs had lower tICH expansion rates although not statistically significantly different from VKA-treated patients. DOAC-treated patients had favorable outcomes versus VKA group following tICH despite low use of reversal strategies. DOAC use may be a safer alternative to VKA in patients at risk of traumatic brain hemorrhage.	[Shin, Samuel S.; Marsh, Elisabeth B.; Nyquist, Paul A.; Ziai, Wendy C.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ali, Hasan; Hanley, Daniel F.] Johns Hopkins Sch Med, Div Brain Injury Outcomes, Baltimore, MD USA; [Nyquist, Paul A.; Ziai, Wendy C.] Johns Hopkins Sch Med, Dept Neurocrit Care, Baltimore, MD 21205 USA; [Ziai, Wendy C.] Johns Hopkins Univ Hosp, Div Neurosci Crit Care, 600 N Wolfe St,Phipps 455, Baltimore, MD 21287 USA		Ziai, WC (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Ziai, WC (corresponding author), Johns Hopkins Sch Med, Dept Neurocrit Care, Baltimore, MD 21205 USA.; Ziai, WC (corresponding author), Johns Hopkins Univ Hosp, Div Neurosci Crit Care, 600 N Wolfe St,Phipps 455, Baltimore, MD 21287 USA.	weziai@jhmi.edu		Hanley, Daniel/0000-0002-9536-4258	 [5U01NS062851];  [1U01NS080824]	Dr. Hanley was awarded significant research support through grant numbers 5U01NS062851 for Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage III and for Minimally Invasive Surgery Plus r-tPA for Intracerebral Hemorrhage Evacuation (MISTIE) III 1U01NS080824. Dr. Ziai is supported by grants 5U01NS062851 and 1U01NS080824. Dr. Ziai reports personal fees from CR Bard, Inc. and Portola Pharmaceuticals, outside the submitted work.	Awad AJ, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1323; Biondi-Zoccai G, 2013, HEART LUNG VESSEL, V5, P40; Chatterjee S, 2013, JAMA NEUROL, V70, P1486, DOI 10.1001/jamaneurol.2013.4021; Connolly SJ, 2019, NEW ENGL J MED, V380, P1326, DOI 10.1056/NEJMoa1814051; Connolly SJ, 2016, NEW ENGL J MED, V375, P1131, DOI 10.1056/NEJMoa1607887; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cuker A, 2014, J AM COLL CARDIOL, V64, P1128, DOI 10.1016/j.jacc.2014.05.065; DIMINNO G, 1985, AM J MED, V79, P552, DOI 10.1016/0002-9343(85)90051-8; Edwards Gail, 2018, Trauma Case Rep, V13, P46, DOI 10.1016/j.tcr.2017.12.003; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Feeney JM, 2017, INJURY, V48, P47, DOI 10.1016/j.injury.2016.08.016; Ganetsky M, 2017, ACAD EMERG MED, V24, P1258, DOI 10.1111/acem.13217; Gehrie E, 2015, ARCH PATHOL LAB MED, V139, P687, DOI 10.5858/arpa.2013-0677-RS; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Godier A, 2012, ANESTHESIOLOGY, V116, P94, DOI 10.1097/ALN.0b013e318238c036; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hagii J, 2014, STROKE, V45, P2805, DOI 10.1161/STROKEAHA.114.006661; Hankey GJ, 2014, STROKE, V45, P1304, DOI 10.1161/STROKEAHA.113.004506; Joppa SA, 2018, J CLIN MED, V7, DOI 10.3390/jcm7020029; Klein AM, 2013, J NEUROTRAUM, V30, P1476, DOI 10.1089/neu.2012.2735; Kleinman JT, 2011, DEV MED CHILD NEUROL, V53, P281, DOI 10.1111/j.1469-8749.2010.03798.x; Kleinow ME, 2011, J MANAGE CARE PHARM, V17, P523, DOI 10.18553/jmcp.2011.17.7.523; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Kwong JSW, 2013, CARDIOVASC DRUG THER, V27, P23, DOI 10.1007/s10557-012-6426-9; Martin AC, 2013, INT J CARDIOL, V168, P4228, DOI 10.1016/j.ijcard.2013.07.152; Paiva WS, 2010, INT SURG, V95, P172; Parra MW, 2013, J NEUROSURG, V119, P760, DOI 10.3171/2013.3.JNS12503; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pollack CV, 2017, NEW ENGL J MED, V377, P431, DOI 10.1056/NEJMoa1707278; Powers AY, 2018, J CRIT CARE, V48, P243, DOI 10.1016/j.jcrc.2018.09.014; Purrucker JC, 2014, AM J EMERG MED, V32, DOI 10.1016/j.ajem.2014.01.042; Riccardi A, 2017, AM J EMERG MED, V35, P1317, DOI 10.1016/j.ajem.2017.03.072; Rogers KC, 2019, AM J MED, V132, P38, DOI 10.1016/j.amjmed.2018.06.028; Romero JM, 2013, AM J NEURORADIOL, V34, P1528, DOI 10.3174/ajnr.A3434; Sardar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077694; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Sheikh-Taha M, 2018, AM J CARDIOVASC DRUG; Siegal Deborah, 2017, Blood Adv, V1, P1827, DOI 10.1182/bloodadvances.2017007112; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; Simonsen CZ, 2014, J STROKE CEREBROVASC, V23, pE133, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.011; Stollberger C, 2013, J NEUROL SCI, V330, P16, DOI 10.1016/j.jns.2013.03.017; Takahashi H, 2016, AM J CARDIOL, V118, P222, DOI 10.1016/j.amjcard.2016.04.034; Wassef SN, 2013, NEUROSURGERY, V73, pE368, DOI 10.1227/01.neu.0000430763.95349.5f; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	44	10	10	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2020	32	2					407	418		10.1007/s12028-019-00898-y		FEB 2020	12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KV8ES	WOS:000516108300002	32034657				2022-02-06	
J	Yin, R; Zhao, SF; Qiu, CX				Yin, Rui; Zhao, Shufa; Qiu, Caixia			Brain-derived neurotrophic factor fused with a collagen-binding domain inhibits neuroinflammation and promotes neurological recovery of traumatic brain injury mice via TrkB signalling	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article						Brain-derived neurotrophic factor fused with a collagen-binding domain; inflammation; microglia; traumatic brain injury; TrkB	NF-KAPPA-B; FACTOR BDNF; NEUROPROTECTION; POLARIZATION; INFLAMMATION; PROTECTION; MICROGLIA; BDNF/TRKB; PATHWAY	Objectives As one of the vital nutrient factors in central nervous system (CNS), brain-derived neurotrophic factor (BDNF) can significantly attenuate neuron damage and promote neurogenesis. Nevertheless, little research has been conducted on regulating the effect of BDNF on the inflammatory response after traumatic brain injury (TBI). Methods In this study, we used BDNF fused with a collagen-binding domain (CBD-BDNF) to maintain a sufficient concentration of BDNF in the TBI hemisphere, and then, the regulatory effects of BDNF and CBD-BDNF on the inflammatory response of microglia were investigated both on a TBI mice model in vivo and LPS-stimulated microglia experiment in vitro. Key findings The results revealed that BDNF and CBD-BDNF had similar effects on attenuating the pro-inflammatory reactions but promoting anti-inflammatory responses of microglia induced by LPS in vitro. Furthermore, CBD-BDNF significantly improved the neurological behaviours of TBI mice and alleviated the inflammatory reaction after TBI, while BDNF had weaker effects compared with those of CBD-BDNF. Additionally, the TrkB inhibitor K252a significantly inhibited the above effects of CBD-BDNF. Conclusions In conclusion, CBD-BDNF can promote the anti-inflammatory function of microglia and neurological recovery of TBI mice through TrkB signalling.	[Yin, Rui; Zhao, Shufa; Qiu, Caixia] Huzhou Cent Hosp, Dept Neurosurg, Huzhou, Peoples R China		Qiu, CX (corresponding author), Huzhou Cent Hosp, Dept Neurol, 198 Hongqi Rd, Huzhou 313000, Zhejiang, Peoples R China.	jiaziyuan1986@126.com			Huzhou Public Welfare Applied Research Project [2017GYB02]	Huzhou Public Welfare Applied Research Project (2017GYB02).	Addi C, 2017, TISSUE ENG PART B-RE, V23, P163, DOI [10.1089/ten.TEB.2016.0280, 10.1089/ten.teb.2016.0280]; Andero R, 2014, PROG MOL BIOL TRANSL, V122, P169, DOI 10.1016/B978-0-12-420170-5.00006-4; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Barde YA, 1987, PROG BRAIN RES <D>, V71, P185; Bjorkholm C, 2016, NEUROPHARMACOLOGY, V102, P72, DOI 10.1016/j.neuropharm.2015.10.034; Choo M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00260-w; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dong H, 2016, CELL MOL NEUROBIOL, V36, P639, DOI 10.1007/s10571-015-0244-0; Guan J, 2015, TISSUE ENG PT A, V21, P62, DOI [10.1089/ten.tea.2014.0139, 10.1089/ten.TEA.2014.0139]; Han SF, 2015, BIOMATERIALS, V41, P89, DOI 10.1016/j.biomaterials.2014.11.031; Hanrahan F, 2016, NEUROINFLAMMATION; Hung TH, 2017, ONCOTARGET, V8, P103236, DOI 10.18632/oncotarget.21139; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Leon-Cabrera SA, 2017, CANCER IMMUNOL RES, V5, P385, DOI 10.1158/2326-6066.CIR-16-0168; Lin GT, 2006, J SEX MED, V3, P821, DOI 10.1111/j.1743-6109.2006.00292.x; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Mills CD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00212; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sakane T, 1997, PHARMACEUT RES, V14, P1085, DOI 10.1023/A:1012117815460; Sandhya VK, 2013, J CELL COMMUN SIGNAL, V7, P301, DOI 10.1007/s12079-013-0200-z; Shirayama Y, 2015, EUR NEUROPSYCHOPHARM, V25, P2449, DOI 10.1016/j.euroneuro.2015.09.002; Skaper SD, 2018, METHODS MOL BIOL, V1727, P1, DOI 10.1007/978-1-4939-7571-6_1; Tajbakhsh A, 2017, J CELL BIOCHEM, V118, P2502, DOI 10.1002/jcb.25943; TAPLEY P, 1992, ONCOGENE, V7, P371; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Wei PH, 2018, NICOTINE TOB RES, V20, P515, DOI 10.1093/ntr/ntx157; Wood Heather, 2018, Nat Rev Neurol, V14, P127, DOI 10.1038/nrneurol.2018.8; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Yao XL, 2019, BIOCHEM BIOPH RES CO, V509, P624, DOI 10.1016/j.bbrc.2018.11.145; Zhang JC, 2016, CURR NEUROPHARMACOL, V14, P721, DOI 10.2174/1570159X14666160119094646; Zhu JR, 2019, CELL MOL NEUROBIOL, V39, P751, DOI 10.1007/s10571-019-00675-7	35	10	10	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3573	2042-7158		J PHARM PHARMACOL	J. Pharm. Pharmacol.	APR	2020	72	4					539	550		10.1111/jphp.13233		FEB 2020	12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	KT1UA	WOS:000511602800001	32034779	Bronze			2022-02-06	
J	Cook, NE; Sapigao, RG; Silverberg, ND; Maxwell, BA; Zafonte, R; Berkner, P; Iverson, GL				Cook, Nathan E.; Sapigao, Rosemarie G.; Silverberg, Noah D.; Maxwell, Bruce A.; Zafonte, Ross; Berkner, Paul; Iverson, Grant L.			Attention-Deficit/Hyperactivity Disorder Mimics the Post-concussion Syndrome in Adolescents	FRONTIERS IN PEDIATRICS			English	Article						concussion; mild traumatic brain injury; pediatrics; assessment; symptoms	POSTCONCUSSION-LIKE SYMPTOMS; TEST-PERFORMANCE; HEAD-INJURY; CHILDREN; SCORES; TRENDS; ADHD; CARE; SEX	The objective of this study was to evaluate concussion-like symptom reporting among uninjured adolescents with Attention-deficit/hyperactivity disorder (ADHD), stratified by several cooccurring conditions, and to examine the base rate and predictors of uninjured adolescents with ADHD meeting diagnostic criteria for the International Classification of Diseases, 10th Revision (ICD-10) post-concussional syndrome (PCS). Participants in this cross-sectional, observational study, were drawn from a cohort of 48,834 adolescent student athletes from Maine (ages 13-18) with no concussion in the past 6 months who completed a preseason, baseline testing program between 2009 and 2015. The final sample included 3,031 students with ADHD, 2,146 (70.8%) boys and 885 (29.2%) girls. They were 15.2 years old on average (SD = 1.3). Concussion-like symptom reporting was more common in girls than boys. Most students with ADHD reported one or more symptoms (69.3% of boys and 81.1% of girls). The presence of an additional, co-occurring condition or comorbidity was associated with increased symptom reporting. In the absence of a recent concussion, 28.8% percent of boys and 47.1% of girls with ADHD endorsed symptoms resembling an ICD-10 diagnosis of post-concussional syndrome (PCS). Adolescents with pre-existing conditions were even more likely to endorse symptoms that resembled PCS (28-47% of boys and 45-69% of girls). Prior treatment for a psychiatric condition was the strongest independent predictor for meeting PCS criteria in boys, followed by treatment for migraines and co-occurring learning disorder. For girls, the only independent predictor was prior treatment of a psychiatric condition. In uninjured adolescent student athletes, ADHD appears to mimic the post-concussion syndrome. Adolescents with ADHD commonly endorse concussion-like symptoms in the absence of a recent concussion. Demographic characteristics (sex) and the presence of co-occurring conditions are related to symptom reporting in adolescents with ADHD. Understanding factors associated with baseline symptom reporting, such as pre-existing ADHD, is important when evaluating youth who have persistent symptoms following concussion as well as making both return to school and return to athletics decisions.	[Cook, Nathan E.; Zafonte, Ross; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Cook, Nathan E.; Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA 02114 USA; [Cook, Nathan E.; Zafonte, Ross] Spaulding Rehabil Hosp, Charlestown, MA 02129 USA; [Cook, Nathan E.; Zafonte, Ross; Iverson, Grant L.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sapigao, Rosemarie G.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Maxwell, Bruce A.] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Zafonte, Ross] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Berkner, Paul] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Berkner, Paul] Colby Coll, Dept Biol, Waterville, ME 04901 USA; [Iverson, Grant L.] Spaulding Res Inst, Boston, MA USA		Cook, NE (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Cook, NE (corresponding author), MassGen Hosp Children, Sports Concuss Program, Boston, MA 02114 USA.; Cook, NE (corresponding author), Spaulding Rehabil Hosp, Charlestown, MA 02129 USA.; Cook, NE (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	necook@mgh.harvard.edu; paul.berkner@colby.edu			Louis V. Gerstner III Research Scholar Award	NC acknowledged the support from the Louis V. Gerstner III Research Scholar Award. GI acknowledged an unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, Heinz Family Foundation, Spaulding Research Institute, and ImPACT <SUP>R</SUP> Applications, Inc.	Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Anderson LE, 2015, PEDIATRICS, V136, pE1178, DOI 10.1542/peds.2015-0807; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Balasundaram AP, 2017, PM&R, V9, P866, DOI 10.1016/j.pmrj.2017.01.004; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Bloom B, 2013, VITAL HLTH STAT; Brooks BL, 2016, APPL NEUROPSYCH-CHIL, V5, P119, DOI 10.1080/21622965.2014.1003066; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Collings LJ, 2017, BRAIN INJURY, V31, P1479, DOI 10.1080/02699052.2017.1377351; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Davis GA., 2012, MILD TRAUMATIC BRAIN, P99; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; ImPACT Applications Inc, 2011, IMM POSTC ASS COGN T; Itriyeva Khalida, 2017, Int J Adolesc Med Health, V31, DOI 10.1515/ijamh-2017-0070; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kiluk BD, 2009, J ATTEN DISORD, V12, P499, DOI 10.1177/1087054708320400; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Ludyga S, 2017, DEV COGN NEUROS-NETH, V28, P21, DOI 10.1016/j.dcn.2017.10.007; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Santa Maria MP, 2001, ARCH CLIN NEUROPSYCH, V16, P133; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Visser SN, 2015, NATL HLTH STAT REPOR, V81; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	33	10	10	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2360			FRONT PEDIATR	Front. Pediatr.	FEB 5	2020	8								2	10.3389/fped.2020.00002			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	KO8GP	WOS:000515786100001	32117823	Green Published, gold			2022-02-06	
J	Mao, X; Terpolilli, NA; Wehn, A; Cheng, SQ; Hellal, F; Liu, BY; Seker, B; Plesnila, N				Mao, Xiang; Terpolilli, Nicole A.; Wehn, Antonia; Cheng, Shiqi; Hellal, Farida; Liu, Baiyun; Seker, Burcu; Plesnila, Nikolaus			Progressive Histopathological Damage Occurring Up to One Year after Experimental Traumatic Brain Injury Is Associated with Cognitive Decline and Depression-Like Behavior	JOURNAL OF NEUROTRAUMA			English	Article						CCI; cognitive function; degeneration; head trauma; TBI	CONTROLLED CORTICAL IMPACT; TAIL SUSPENSION TEST; POSTTRAUMATIC HYDROCEPHALUS; DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY; POSTURAL INSTABILITY; SPATIAL MEMORY; RISK-FACTOR; MODERATE; DEFICITS	Increasing clinical and experimental evidence suggests that traumatic brain injury (TBI) is associated with progressive histopathological damage. The aim of the current study was to characterize the time course of motor function, memory performance, and depression-like behavior up to 1 year after experimental TBI, and to correlate these changes to histopathological outcome. Male C57BL/6N mice underwent controlled cortical impact (CCI) or sham operation, and histopathological outcome was evaluated 15 min, 24 h, 1 week, or 1, 3, 6, or 12 months thereafter (n = 12 animals per time point). Motor function, depression-like behavior, and memory function were evaluated concomitantly, and magnetic resonance imaging (MRI) was repeatedly performed. Naive mice (n = 12) served as an unhandled control group. Injury volume almost doubled within 1 year after CCI (p = 0.008) and the ipsilateral hemisphere became increasingly atrophic (p < 0.0001). Progressive tissue loss was observed in the corpus callosum (p = 0.007) and the hippocampus (p = 0.004) together with hydrocephalus formation (p < 0.0001). Motor function recovered partially after TBI, but 6 months after injury progressive depression-like behavior (p < 0.0001) and loss of memory function (p < 0.0001) were observed. The present study demonstrates that delayed histopathological damage that occurs over months after brain injury is followed by progressive depression and memory loss, changes also observed after TBI in humans. Hence, experimental TBI models in mice replicate long-term sequelae of brain injury such as post-traumatic dementia and depression.	[Mao, Xiang; Terpolilli, Nicole A.; Wehn, Antonia; Cheng, Shiqi; Hellal, Farida; Seker, Burcu; Plesnila, Nikolaus] Munich Univ Hosp, Inst Stroke & Dementia Res, Feodor Lynen Str 17, D-81377 Munich, Germany; [Terpolilli, Nicole A.] Munich Univ Hosp, Dept Neurosurg, Munich, Germany; [Mao, Xiang; Wehn, Antonia; Cheng, Shiqi; Hellal, Farida; Seker, Burcu; Plesnila, Nikolaus] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Liu, Baiyun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China		Plesnila, N (corresponding author), Munich Univ Hosp, Inst Stroke & Dementia Res, Feodor Lynen Str 17, D-81377 Munich, Germany.	nikolaus.plesnila@med.uni-muenchen.de	Terpolilli, Nicole/AAG-3598-2021; Hellal, Farida/D-1834-2015	Hellal, Farida/0000-0002-9344-1846	Friedrich Baur Foundation [60/17]; Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)Federal Ministry of Education & Research (BMBF) [01EW1502A]; China Scholarship CouncilChina Scholarship Council [201508080072]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [2016KJ12]	The study was supported by the Friedrich Baur Foundation (#60/17, NAT) and by the Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung, BMBF, grant #01EW1502A, NP). X.M. was supported by the China Scholarship Council (grant #201508080072) and the National Natural Science Foundation of China (grant #2016KJ12).	Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Arulsamy A, 2018, BEHAV BRAIN RES, V348, P127, DOI 10.1016/j.bbr.2018.04.009; Attar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080355; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bohbot VD, 2000, ANN NY ACAD SCI, V911, P355; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Buhler D, 2015, STROKE, V46, P819, DOI 10.1161/STROKEAHA.114.007703; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Curtis KA, 2012, MED J AUSTRALIA, V197, P233, DOI 10.5694/mja11.11351; Davies M, 2018, J NEUROTRAUM, V35, P790, DOI 10.1089/neu.2017.5354; Dehail P, 2007, J REHABIL MED, V39, P531, DOI 10.2340/16501977-0096; Di Saverio S, 2014, LANGENBECK ARCH SURG, V399, P109, DOI 10.1007/s00423-013-1143-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Engel DC, 2008, J NEUROTRAUM, V25, P739, DOI 10.1089/neu.2007.0480; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Ferguson S, 2017, J NEUROTRAUM, V34, P1676, DOI 10.1089/neu.2016.4636; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Ghosh M, 2015, ANN NEUROL, V78, P887, DOI 10.1002/ana.24512; Goldstein L.E., 2012, SCI TRANSL MED, p134R460; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Guillen J, 2012, J AM ASSOC LAB ANIM, V51, P311; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guyot LL, 2000, NEUROL RES, V22, P25; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MOSER E, 1993, J NEUROSCI, V13, P3916; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nagata I, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018635; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Pottker B, 2017, BRAIN STRUCT FUNCT, V222, P4005, DOI 10.1007/s00429-017-1452-9; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Reed JM, 1997, BEHAV NEUROSCI, V111, P667, DOI 10.1037/0735-7044.111.4.667; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Sargin D, 2009, GLIA, V57, P693, DOI 10.1002/glia.20797; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schulz-Heik RJ, 2017, BRAIN INJURY, V31, P1287, DOI 10.1080/02699052.2017.1307449; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Terpolilli N.A., 2009, J NEUROTRAUMA, pNeurotrauma; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Vespa P, 2017, CURR OPIN NEUROL, V30, P563, DOI 10.1097/WCO.0000000000000506; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; WHO, 2018, PROJ MORT CAUS DEATH; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	104	10	10	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2020	37	11					1331	1341		10.1089/neu.2019.6510		FEB 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LT0OT	WOS:000512114900001	31847690	Bronze			2022-02-06	
J	Clausen, AN; Clarke, E; Phillips, RD; Haswell, C; Morey, RA; Brancu, M; Beckham, JC; Calhoun, PS; Dedert, E; Elbogen, EB; Fairbank, JA; Hurley, RA; Kilts, JD; Kimbrel, NA; Kirby, A; Marx, CE; McDonald, SD; Moore, SD; Morey, RA; Naylor, JC; Rowland, J; Swinkels, C; Szabo, ST; Taber, KH; Tupler, LA; Van Voorhees, EE; Wagner, HR; Yoash-Gantz, RE				Clausen, Ashley N.; Clarke, Emily; Phillips, Rachel D.; Haswell, Courtney; Morey, Rajendra A.; Brancu, Mira; Beckham, Jean C.; Calhoun, Patrick S.; Dedert, Eric; Elbogen, Eric B.; Fairbank, John A.; Hurley, Robin A.; Kilts, Jason D.; Kimbrel, Nathan A.; Kirby, Angela; Marx, Christine E.; McDonald, Scott D.; Moore, Scott D.; Morey, Rajendra A.; Naylor, Jennifer C.; Rowland, Jared; Swinkels, Cindy; Szabo, Steven T.; Taber, Katherine H.; Tupler, Larry A.; Van Voorhees, Elizabeth E.; Wagner, H. Ryan; Yoash-Gantz, Ruth E.		VA Mid-Atlantic MIRECC Workgrp	Combat exposure, posttraumatic stress disorder, and head injuries differentially relate to alterations in cortical thickness in military Veterans	NEUROPSYCHOPHARMACOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; NORMAL OLDER-ADULTS; NEURAL SYSTEMS; PTSD; IRAQ; DEPLOYMENT; ARMY; CONNECTIVITY; AFGHANISTAN; HEALTH	Combat-exposed Veterans are at increased risk for developing psychological distress, mood disorders, and trauma and stressor-related disorders. Trauma and mood disorders have been linked to alterations in brain volume, function, and connectivity. However, far less is known about the effects of combat exposure on brain health. The present study examined the relationship between severity of combat exposure and cortical thickness. Post-9/11 Veterans (N = 337; 80% male) were assessed with structural neuroimaging and clinically for combat exposure, depressive symptoms, prior head injury, and posttraumatic stress disorder (PTSD). Vertex-wide cortical thickness was estimated using FreeSurfer autosegmentation. FreeSurfer's Qdec was used to examine relationship between combat exposure, PTSD, and prior head injuries on cortical thickness (Monte Carlo corrected for multiple comparisons, vertex-wise cluster threshold of 1.3, p < 0.01). Covariates included age, sex, education, depressive symptoms, nonmilitary trauma, alcohol use, and prior head injury. Higher combat exposure uniquely related to lower cortical thickness in the left prefrontal lobe and increased cortical thickness in the left middle and inferior temporal lobe; whereas PTSD negatively related to cortical thickness in the right fusiform. Head injuries related to increased cortical thickness in the bilateral medial prefrontal cortex. Combat exposure uniquely contributes to lower cortical thickness in regions implicated in executive functioning, attention, and memory after accounting for the effects of PTSD and prior head injury. Our results highlight the importance of examining effects of stress and trauma exposure on neural health in addition to the circumscribed effects of specific syndromal pathology.	[Clausen, Ashley N.; Clarke, Emily; Phillips, Rachel D.; Haswell, Courtney; Morey, Rajendra A.; VA Mid-Atlantic MIRECC Workgrp] Durham VAHCS, VA Midatlantic MIRECC, 508 Fulton St, Durham, NC 27705 USA; [Clausen, Ashley N.; Clarke, Emily; Phillips, Rachel D.; Haswell, Courtney; Morey, Rajendra A.] Duke Univ, Duke UNC Brain Imaging & Anal Ctr, Durham, NC 27708 USA; [Morey, Rajendra A.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Morey, Rajendra A.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA		Clausen, AN (corresponding author), Durham VAHCS, VA Midatlantic MIRECC, 508 Fulton St, Durham, NC 27705 USA.; Clausen, AN (corresponding author), Duke Univ, Duke UNC Brain Imaging & Anal Ctr, Durham, NC 27708 USA.	ashley.clausen@duke.edu	Rowland, Jared A./AAN-3030-2021; Clausen, Ashley N/W-5627-2019; Fairbank, John/F-8972-2013	Rowland, Jared A./0000-0002-3655-3411; Clausen, Ashley N/0000-0002-1773-7733; Fairbank, John/0000-0003-2604-7256; Clarke-Rubright, Emily/0000-0003-3553-2990; Phillips, Rachel/0000-0001-9958-1703	U.S. Department of Veterans Affairs (VA) Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC) core funds of the Department of Veterans Affairs Office of Mental Health ServicesUS Department of Veterans Affairs; VA Office of Research and Development [5I01CX000748-01, 5I01CX000120-02]; National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS086885-01A1]; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs; Medical Research Service of the Durham VA Health Care System; Department of Veterans Affairs Mid-Atlantic MIRECCUS Department of Veterans Affairs	This research was supported by the U.S. Department of Veterans Affairs (VA) Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC) core funds of the Department of Veterans Affairs Office of Mental Health Services. Dr. Morey also received financial support from the VA Office of Research and Development (5I01CX000748-01, 5I01CX000120-02). Additional financial support was provided by the National Institute for Neurological Disorders and Stroke (R01NS086885-01A1). Writing of this paper was supported by the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, the Medical Research Service of the Durham VA Health Care System, and the Department of Veterans Affairs Mid-Atlantic MIRECC. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States Government. The authors have no conflicts of interest to disclose, including the contributing members of the VA Mid-Atlantic MIRECC Workgroup.	Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; American Psychiatric Association, 2000, DIAGN STAT MAN 4 TEX; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Averill Lynnette A, 2017, Chronic Stress (Thousand Oaks), V1, DOI 10.1177/2470547017724714; Bartlett EA, 2018, NEUROPSYCHOPHARMACOL, V43, P2221, DOI 10.1038/s41386-018-0122-9; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Brancu M, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1570; Butler O, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.288; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chao LL, 2012, NEUROREPORT, V23, P412, DOI 10.1097/WNR.0b013e328352025e; Cheng CPW, 2018, AGING DIS, V9, P1020, DOI 10.14336/AD.2018.0125; Clausen AN, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02151; Corbo V, 2016, PSYCHIAT RES-NEUROIM, V249, P38, DOI 10.1016/j.pscychresns.2016.02.003; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Ferrier-Auerbach AG, 2010, J PSYCHIATR RES, V44, P470, DOI 10.1016/j.jpsychires.2009.10.010; First M.B., 1996, STRUCTURED CLIN INTE; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Frodl T, 2013, NEUROBIOL DIS, V52, P24, DOI 10.1016/j.nbd.2012.03.012; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hahn AM, 2015, PSYCHOL SERV, V12, P378, DOI 10.1037/ser0000060; Hendler T, 2001, CELL MOL NEUROBIOL, V21, P733, DOI 10.1023/A:1015156222101; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Ikin JF, 2010, J AFFECT DISORDERS, V125, P279, DOI 10.1016/j.jad.2009.12.005; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kim YK, 2017, BEHAV BRAIN RES, V329, P6, DOI 10.1016/j.bbr.2017.04.020; Kline A, 2010, AM J PUBLIC HEALTH, V100, P276, DOI 10.2105/AJPH.2009.162925; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Kulka R. A., 1988, CONTRACTUAL REPORT F; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; McConathy J, 2015, BIOL PSYCHIAT, V77, P685, DOI 10.1016/j.biopsych.2014.08.024; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Morey RA, 2008, PSYCHIAT RES-NEUROIM, V162, P59, DOI 10.1016/j.pscychresns.2007.07.007; Morey RA, 2009, J PSYCHIATR RES, V43, P809, DOI 10.1016/j.jpsychires.2008.10.014; Pacheco J, 2015, NEUROBIOL AGING, V36, P903, DOI 10.1016/j.neurobiolaging.2014.08.031; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Qi S, 2018, BRAIN IMAGING BEHAV, V12, P390, DOI 10.1007/s11682-017-9693-z; Riley E, 2019, NEUROPSYCHOLOGY, V33, P534, DOI 10.1037/neu0000529; Sadeh N, 2015, HUM BRAIN MAPP, V36, P3076, DOI 10.1002/hbm.22829; Sartory G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058150; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Savjani RR, 2017, J NEUROTRAUM, V34, P3107, DOI 10.1089/neu.2017.5022; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wenger J. W., 2018, RR1928A RAND ARR CTR; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Wrocklage KM, 2017, EUR NEUROPSYCHOPHARM, V27, P515, DOI 10.1016/j.euroneuro.2017.02.010	62	10	11	4	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	FEB	2020	45	3					491	498		10.1038/s41386-019-0539-9			8	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	KH7FU	WOS:000510816700007	31600766	Bronze, Green Published			2022-02-06	
J	McCurry, KL; Frueh, BC; Chiu, PH; King-Casas, B				McCurry, Katherine L.; Frueh, B. Christopher; Chiu, Pearl H.; King-Casas, Brooks			Opponent Effects of Hyperarousal and Re-experiencing on Affective Habituation in Posttraumatic Stress Disorder	BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING			English	Article						Affective neuroscience; Emotion; fMRI; Habituation; Heterogeneity; PTSD	TRAUMATIC BRAIN-INJURY; EMOTION REGULATION; FUNCTIONAL CONNECTIVITY; NEUROCIRCUITRY MODELS; AMYGDALA HABITUATION; PTSD; METAANALYSIS; RESPONSES; THREAT; SYMPTOMS	BACKGROUND: Aberrant emotion processing is a hallmark of posttraumatic stress disorder (PTSD), with neurobiological models suggesting both heightened neural reactivity and diminished habituation to aversive stimuli. However, empirical work suggests that these response patterns may be specific to subsets of those with PTSD. This study investigates the unique contributions of PTSD symptom clusters (re-experiencing, avoidance and numbing, and hyperarousal) to neural reactivity and habituation to negative stimuli in combat-exposed veterans. METHODS: Ninety-five combat-exposed veterans (46 with PTSD) and 53 community volunteers underwent functional magnetic resonance imaging while viewing emotional images. This study examined the relationship between symptom cluster severity and hemodynamic responses to negative compared with neutral images (NEG>NEU). RESULTS: Veterans exhibited comparable mean and habituation-related responses for NEG>NEU, relative to civilians. However, among veterans, habituation, but not mean response, was differentially related to PTSD symptom severity. Hyperarousal symptoms were related to decreased habituation for NEG>NEU in a network of regions, including superior and inferior frontal gyri, ventromedial prefrontal cortex, superior and middle temporal gyri, and anterior insula. In contrast, re-experiencing symptoms were associated with increased habituation in a similar network. Furthermore, re-experiencing severity was positively related to amygdalar functional connectivity with the left inferior frontal gyrus and dorsal anterior cingulate cortex for NEG>NEU. CONCLUSIONS: These results indicate that hyperarousal symptoms in combat-related PTSD are associated with decreased neural habituation to aversive stimuli. These impairments are partially mitigated in the presence of re-experiencing symptoms, such that during exposure to negative stimuli, re-experiencing symptoms are positively associated with amygdalar connectivity to prefrontal regions implicated in affective suppression.	[McCurry, Katherine L.; Chiu, Pearl H.; King-Casas, Brooks] Salem Vet Affairs Med Ctr, Salem, VA USA; [McCurry, Katherine L.; Frueh, B. Christopher; Chiu, Pearl H.; King-Casas, Brooks] Virginia Tech, Virginia Tech Carilion, Fralin Biomed Res Inst, Roanoke, VA USA; [Chiu, Pearl H.; King-Casas, Brooks] Virginia Tech Carilion, Dept Psychiat & Behav Med, Sch Med, Roanoke, VA 24016 USA; [McCurry, Katherine L.; Chiu, Pearl H.; King-Casas, Brooks] Virginia Tech, Dept Psychol, Blacksburg, VA USA; [King-Casas, Brooks] Wake Forest Univ, Sch Biomed Engn & Sci, Virginia Tech, Blacksburg, VA USA; [Frueh, B. Christopher] Univ Hawaii, Dept Psychol, Hilo, HI 96720 USA; [Frueh, B. Christopher] Univ Texas Hlth Sci Ctr Houston, Trauma & Resilience Ctr, Dept Psychiat, Houston, TX 77030 USA		Chiu, PH; King-Casas, B (corresponding author), Virginia Tech Carilion, Fralin Biomed Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA.	chiup@vtc.vt.edu; bkcasas@vtc.vt.edu		McCurry, Katherine/0000-0001-6921-7636	Department of Veterans Affairs, Office of Research and Development, Rehabilitation Research and DevelopmentUS Department of Veterans Affairs [B7760P, D2354R, D7030R]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH074468, MH115221, MH087692, MH106756]	This work was supported in part by the Department of Veterans Affairs, Office of Research and Development, Rehabilitation Research and Development Grant Nos. D2354R and D7030R (to BK-C), and National Institutes of Health Grant Nos. MH074468 (to BCF), MH115221 (to BK-C), and MH087692 and MH106756 (to PHC).; We thank Wright Williams and Matt Estey (who were supported by the Department of Veterans Affairs, Office of Research and Development, Rehabilitation Research and Development Grant No. B7760P [to WW]), and Jessica Eiseman, Kat Gardner, David Graham, LaRaun Lindsey, Robert McNamara, and April Sanders, for their research support. We also gratefully acknowledge discussions with Vanessa Brown and Nina Lauharatanahirun.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Bardeen JR, 2017, BEHAV RES THER, V99, P67, DOI 10.1016/j.brat.2017.09.003; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLANCHARD EB, 1994, BEHAV RES THER, V32, P283, DOI 10.1016/0005-7967(94)90123-6; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Brunetti M, 2010, NEUROSCIENCE, V168, P670, DOI 10.1016/j.neuroscience.2010.04.024; Bryant RA, 2008, HUM BRAIN MAPP, V29, P517, DOI 10.1002/hbm.20415; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Christley R., 2010, OPEN EPIDEMIOLOGY J, V3, P16; Cohen JE, 2013, HUM BRAIN MAPP, V34, P1344, DOI 10.1002/hbm.21516; Costanzi M, 2011, LEARN MEMORY, V18, P508, DOI 10.1101/lm.2175811; Denny BT, 2014, SOC COGN AFFECT NEUR, V9, P1660, DOI 10.1093/scan/nst160; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fani N, 2012, BIOL PSYCHOL, V90, P134, DOI 10.1016/j.biopsycho.2012.03.001; Feinstein JS, 2002, NEUROREPORT, V13, P1255, DOI 10.1097/00001756-200207190-00007; Felmingham K, 2010, J ABNORM PSYCHOL, V119, P241, DOI 10.1037/a0017551; Felmingham KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103653; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Forster GL, 2017, AMYGDALA EMOTIONS SH, P113, DOI [10.5772/67585, DOI 10.5772/67585]; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; Frewen PA, 2008, J TRAUMA STRESS, V21, P243, DOI 10.1002/jts.20320; Golub Y, 2009, BEHAV BRAIN RES, V205, P544, DOI 10.1016/j.bbr.2009.08.019; Grupe DW, 2016, PSYCHOL MED, V46, P1885, DOI 10.1017/S0033291716000374; Grupe DW, 2016, PSYCHIAT ANN, V46, P519, DOI 10.3928/00485713-20160803-01; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Herzog JI, 2017, EUR ARCH PSY CLIN N, V71, P1; Hopper JW, 2007, J TRAUMA STRESS, V20, P713, DOI 10.1002/jts.20284; Hou CL, 2007, BRAIN RES, V1144, P165, DOI 10.1016/j.brainres.2007.01.089; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; Kim MJ, 2008, J PSYCHIATR RES, V42, P268, DOI 10.1016/j.jpsychires.2007.02.003; Kimble M, 2014, J ANXIETY DISORD, V28, P241, DOI 10.1016/j.janxdis.2013.12.006; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Kurdi B, 2017, BEHAV RES METHODS, V49, P457, DOI 10.3758/s13428-016-0715-3; Landre L, 2012, J PSYCHIATR NEUROSCI, V37, P87, DOI 10.1503/jpn.100167; Lang P. J, 2008, INT AFFECTIVE PICTUR; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Lanius RA, 2007, PSYCHIAT RES-NEUROIM, V155, P45, DOI 10.1016/j.pscychresns.2006.11.006; Liberzon I, 2006, ANN NY ACAD SCI, V1071, P87, DOI 10.1196/annals.1364.009; Liberzon I, 2016, NEURON, V92, P14, DOI 10.1016/j.neuron.2016.09.039; Lissek S, 2015, INT J PSYCHOPHYSIOL, V98, P594, DOI 10.1016/j.ijpsycho.2014.11.006; Mairean C, 2017, ANXIETY STRESS COPIN, V30, P304, DOI 10.1080/10615806.2016.1263839; McCabe C, 2010, BIOL PSYCHIAT, V67, P439, DOI 10.1016/j.biopsych.2009.11.001; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; McTeague LM, 2010, BIOL PSYCHIAT, V67, P346, DOI 10.1016/j.biopsych.2009.08.023; MONTAGU JD, 1963, J PSYCHOSOM RES, V7, P199, DOI 10.1016/0022-3999(63)90004-7; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Morawetz C, 2017, NEUROSCI BIOBEHAV R, V72, P111, DOI 10.1016/j.neubiorev.2016.11.014; Moser DA, 2015, SOC COGN AFFECT NEUR, V10, P645, DOI 10.1093/scan/nsu099; Murakami H, 2015, PLOS ONE, V10; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phan KL, 2006, ARCH GEN PSYCHIAT, V63, P184, DOI 10.1001/archpsyc.63.2.184; Phan KL, 2003, NEUROPSYCHOPHARMACOL, V28, P1344, DOI 10.1038/sj.npp.1300186; Pietrzak RH, 2015, JAMA PSYCHIAT, V72, P396, DOI 10.1001/jamapsychiatry.2014.2470; Pissiota A, 2002, EUR ARCH PSY CLIN N, V252, P68, DOI 10.1007/s004060200014; Plichta MM, 2014, NEUROIMAGE, V103, P383, DOI 10.1016/j.neuroimage.2014.09.059; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; Protopopescu X, 2005, BIOL PSYCHIAT, V57, P464, DOI 10.1016/j.biopsych.2004.12.026; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Sadeh N, 2014, CLIN PSYCHOL SCI, V2, P748, DOI 10.1177/2167702614530113; Schell TL, 2004, J ABNORM PSYCHOL, V113, P189, DOI 10.1037/0021-843X.113.2.189; Schulze L, 2018, BIOL PSYCHIAT-COGN N, V4, P1; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seligowski AV, 2015, COGN BEHAV THERAPY, V44, P87, DOI 10.1080/16506073.2014.980753; Seppala EM, 2014, J TRAUMA STRESS, V27, P397, DOI 10.1002/jts.21936; Shea MT, 2010, J TRAUMA STRESS, V23, P100, DOI 10.1002/jts.20497; Shepherd L, 2014, J BEHAV THER EXP PSY, V45, P360, DOI 10.1016/j.jbtep.2014.03.002; Shipherd JC, 2005, BEHAV THER, V36, P277, DOI 10.1016/S0005-7894(05)80076-0; Siegmund A, 2007, PHYSIOL BEHAV, V90, P103, DOI 10.1016/j.physbeh.2006.08.032; Simmons AN, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-6; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Solomon Z, 2009, J CLIN PSYCHIAT, V70, P837, DOI 10.4088/JCP.08m04347; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Stein NR, 2012, BEHAV THER, V43, P790, DOI 10.1016/j.beth.2012.04.003; Stevens JS, 2017, BIOL PSYCHIAT, V81, P1023, DOI 10.1016/j.biopsych.2016.11.015; Stevens JS, 2013, J PSYCHIATR RES, V47, P1469, DOI 10.1016/j.jpsychires.2013.05.031; Tabachnick B.G., 2013, USING MULTIVARIATE S; Tuescher O, 2011, J ANXIETY DISORD, V25, P251, DOI 10.1016/j.janxdis.2010.09.010; Tursich M, 2015, ACTA PSYCHIAT SCAND, V132, P29, DOI 10.1111/acps.12387; U.S. Department of Health and Human Services, 2008, MENTAL HLTH MEDICATI; van Rooij SJH, 2015, PSYCHOL MED, V45, P575, DOI 10.1017/S0033291714001706; van Wingen GA, 2012, P NATL ACAD SCI USA, V109, P15508, DOI 10.1073/pnas.1206330109; Vythilingam M, 2007, PSYCHOL MED, V37, P1445, DOI 10.1017/S003329170700092X; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Wisco BE, 2013, COGNITION EMOTION, V27, P1314, DOI 10.1080/02699931.2013.775109; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006	92	10	10	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2451-9022	2451-9030		BIOL PSYCHIAT-COGN N	Biol. Psychiat.-Cogn. Neurosci. Neuroimag.	FEB	2020	5	2					203	212		10.1016/j.bpsc.2019.09.006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KK7GX	WOS:000512908200010	31759868	hybrid, Green Accepted, Green Published			2022-02-06	
J	Rao, CPV; Suarez, JI; Martin, RH; Bauza, C; Georgiadis, A; Calvillo, E; Hemphill, JC; Sung, G; Oddo, M; Taccone, FS; LeRoux, PD; Domeniconi, G; Camputaro, LA; Villalobos, M; Allasia, M; Goldenberg, FD; Teran, MD; Rosciani, F; Alvarez, H; Costilla, M; Videtta, W; Perez, D; Raffa, P; Seppelt, I; Rodgers, H; Paxton, J; Bhonagiri, D; Aneman, A; Jenkinson, E; Bradford, C; Finfer, S; Yarad, E; Bass, F; Hammond, N; O'Connor, A; Bird, S; Smith, R; Barge, D; Shilkin, J; Woods, W; Roberts, B; O'Leary, M; Vallance, S; Helbok, R; Beer, R; Pfaulser, B; Schiefecker, A; Almemari, A; Mukaddam, S; Taccone, FS; Wittebole, X; Berghe, C; Dujardin, MF; Renard, S; Hantson, P; Biston, P; Meyfroidt, G; da Silva, IRF; de Oliveira, J; Neto, AR; Domingues, JRS; Rodrigues, PMD; Teitelbaum, J; Chapman, M; McCredie, V; Marinoff, N; Perez, A; Kutsogiannis, DJ; Bernard, F; Kramer, A; Moretti, JI; Aguilera, S; Poch, EJ; Romero, C; Wong, GKC; Song, J; Xu, G; Mejia-Mantilla, JH; Madrinan-Navia, H; Martinez, JE; Ochoa, ME; Bautista, D; Varga, M; Gomez, M; Ciro, JD; Gil, B; Murillo, R; Hernandez, O; Ramirez-Arce, J; Breitenfeld, T; Gallardo, AJL; Delgado, HJL; Gonzalez, JRY; Hache-Marliere, M; Pinto, DB; Llano, M; Salgado, E; Jibaja, M; Wright, JC; Harvey, D; Verma, V; Hopkins, P; Chan, A; Welbourne, J; Dowling, S; Katila, A; Lasocki, S; Wartenberg, K; Hobohm, C; Poli, S; Schirotzek, I; Bosel, J; Schoenenberger, S; Francken, S; Shieber, S; Kern, A; Falla, J; Herrera, EA; Gilvaz, PC; Goyal, K; Sokhal, N; Sohal, J; Aggarwal, DG; Ray, B; Pattnaik, S; Garg, S; Dixit, S; Rawal, R; Samavedam, S; Madhusudan, M; Paul, G; Mishra, S; Shushma, P; Shukla, U; Sinha, V; Vanamoorthy, P; Vadi, S; Mokhtari, M; Rasulo, F; Pegoli, M; Bilotta, F; Nagayama, M; Kobata, H; Vosylius, S; Abdullah, JM; Granillo, JF; Mijangos-Mendez, JC; Horn, J; Muller, MCA; Kuiper, M; Abdo, WF; McArthur, C; Newby, L; Hashmi, M; Shiraz, SA; Abrego, GC; Coronel, EB; Rivera, OS; Paucar, JLC; Gomez, O; Palo, JE; Lokin, J; Misiewska-Kaczur, A; Dias, C; Amorim, P; Andre, S; Rodriguez-Vega, G; Gritsan, A; Titova, Y; Al Jabbary, A; Al Zahrani, AR; Pelunkova, L; Zraiki, H; Deeb, AM; Al Bshabshe, A; Al-Jehani, H; Al-Suwaidan, F; Svigelj, V; Ramos-Gomez, LA; Aguilar, G; Badenes, R; Pou, JAL; Zavala, E; Julian, FB; Barrachina, LG; Tegedor, BV; Tena, SA; Krauchi, OR; Tamayo, G; Sanchez, B; Gonzalezluengo, RI; Puvanendiran, S; Merlani, P; Laiwattana, D; Promsin, P; Nazliel, B; Eriksson, E; Chalela, J; Miller, DW; Guisado, R; Gordon, E; Murthy, HHK; Paulson, A; Rajajee, V; Sheehan, K; Williamson, C; Ball, R; Allan, P; Berkeley, J; Muehlschlegel, S; Carandang, R; Hall, W; Sarwal, A; Damani, R; Maldonado, N; Tan, B; Gupta, P; Lazaridis, C; Bershad, EM; Ansari, S; Martinez, J; Singares, ES; Manno, E; Provencio, JJ; Chaudhry, B; McBride, M; Dhar, R; Roberts, D; Allen, M; Schumacher, HC; Habre, W; Sheth, K; Greer, D; Kunze, K; Varelas, P; Tack, L; Porter, NS; Junker, C; Rodricks, M; Tuppeny, M; Basignani, C; Napolitano, S; Anderson, G; Donaldson, K; Davis, R; Sternberg, S; Giraldo, EA; Tran, H; Coplin, WM; Badjatia, N; Fathy, A; Reshi, RA; Bonomo, J; Seder, D; Connolyy, LS; McCrum, B; Carter, T; Treggiari, M; Dickinson, M; Rison, RA; Mirski, M; John, S; Bleck, TP; Malek, A; Trim, T; Smith, M; Athar, MK; Rincon, F; Altaweel, L; Vespa, P; Emanuel, B; Eskiogly, E; McNett, M; Sukumaran, AV; Shutter, L; Milzman, D; Glassner, S; OPhelan, K; Rosenthal, E; Hemphill, JC; Kottapally, M; Smith, WS; Ko, N; Josephson, SA; Kim, A; Singhal, NS; Ahmad, A; Meeker, M; Hirsch, KG; Nair, D; Chou, S; Santos, G; Clark, S; Feske, S; Henderson, G; Sorond, F; Vaitkevicius, H; Chung, D; Kim, J; Amatangelo, M; Kapinos, G; Torbey, M; Kahn, DE; Chang, C; Koenig, M; Gorman, M; Langdon, JR; Dissin, J; Cross, L; Peled, H; Claassen, J; Ali, A; Layon, A; Miller, A; Wilensky, EM; Kumar, M; Levine, JM; Maldonado, IL; Schneck, M; Lele, A; Sarma, AK; Yazbeck, MF; Johnston, G; Jarquin-Valdivia, AA; Johnson, L; Kuisle, L; Sajjad, R; Glickman, S; Garvin, R; Parra, A; DeFilippis, M; Fletcher, JJ; Freeman, WD; Rao, VA; Olmecah, HM; Dugan, G; Medary, IB; Hoesch, R; Brehaut, SS; Afshinnik, A; Moreda, M; Graffagnino, C; Laskowitz, DT; Naidech, A; Francis, B; Berman, M; Tesoro, E; Medow, J; Jordan, D; Aiyagari, V; Rosengart, A; De Georgia, M; Bowling, S; Sharaby, M; Nathan, B; Landry, R; Hebert, C; Hubner, KE; Karanjia, N; Hightower, B; Cummings, K; Kirkwood, J; Frank, JI; Hassan, A; Sanchez, O; Cordina, S; Mora, JE; Bui, TV				Rao, Chethan P. Venkatasubba; Suarez, Jose, I; Martin, Renee H.; Bauza, Colleen; Georgiadis, Alexandros; Calvillo, Eusebia; Hemphill, J. Claude; Sung, Gene; Oddo, Mauro; Taccone, Fabio Silvio; LeRoux, Peter D.; Domeniconi, Gustavo; Alberto Camputaro, Luis; Villalobos, Milton; Allasia, Mariela; Goldenberg, Fernando D.; Teran, Mario D.; Rosciani, Foda; Alvarez, Hector; Costilla, Marcelo; Videtta, Walter; Perez, Diego; Raffa, Pablo; Seppelt, Ian; Rodgers, Helen; Paxton, Jody; Bhonagiri, Deepak; Aneman, Anders; Jenkinson, Elizabeth; Bradford, Celia; Finfer, Simon; Yarad, Elizabeth; Bass, Francess; Hammond, Naomi; O'Connor, Anne; Bird, Simon; Smith, Roger; Barge, Deborah; Shilkin, Jane; Woods, Wpd; Roberts, Brigit; O'Leary, Michael; Vallance, Shirley; Helbok, Raimund; Beer, Ronny; Pfaulser, Bettina; Schiefecker, Alois; Almemari, Ayesha; Mukaddam, Sajid; Taccone, Fabio S.; Wittebole, Xavier; Berghe, Caroline; Dujardin, Marie-France; Renard, Suzanne; Hantson, Philippe; Biston, Patrick; Meyfroidt, Geert; Ferreira da Silva, Ivan Rocha; de Oliveira, Janaina; Reao Neto, Alvaro; Sala Domingues, Joao Roberto; de Azambuja Rodrigues, Pedro Mendes; Teitelbaum, Jeanne; Chapman, Martin; McCredie, Vicki; Marinoff, Nicole; Perez, Adic; Kutsogiannis, Demetrios Jim; Bernard, Francis; Kramer, Andreas; Moretti, Jose, I; Aguilera, Sergio; Poch, Eugenio J.; Romero, Carlos; Wong, George K. C.; Song, Jian; Xu, Guozheng; Mejia-Mantilla, Jorge H.; Madrinan-Navia, Humberto; Martinez, Jorge E.; Elena Ochoa, Maria; Bautista, Diego; Varga, Monica; Gomez, Monica; Diego Ciro, Juan; Gil, Bladimir; Murillo, Rodrigo; Hernandez, Olga; Ramirez-Arce, Jorge; Breitenfeld, Tomislav; Lacerda Gallardo, Angel J.; Lopez Delgado, Hubiel J.; Yunen Gonzalez, Jose Rafael; Hache-Marliere, Manuel; Pinto, Diego Barahona; Llano, Miguel; Salgado, Estuardo; Jibaja, Manuel; Wright, Judith C.; Harvey, Daniel; Verma, Vishwajit; Hopkins, Philip; Chan, Alexander; Welbourne, Jessie; Dowling, Susan; Katila, Ari; Lasocki, Sigismond; Wartenberg, Katja; Hobohm, Carsten; Poli, Sven; Schirotzek, Ingo; Bosel, Julian; Schoenenberger, Silvia; Francken, Susanne; Shieber, Simon; Kern, Alexander; Falla, Joel; Avalos Herrera, Edgar; Gilvaz, P. C.; Goyal, Keshav; Sokhal, Navdeep; Sohal, Jyoti; Aggarwal, Deepesh G.; Ray, Banambar; Pattnaik, Saroj; Garg, Sanchita; Dixit, Subhal; Rawal, Raj; Samavedam, Srinivas; Madhusudan, Madhu; Paul, Gunchan; Mishra, Sanghamitra; Shushma, Patil; Shukla, Urvi; Sinha, Vandana; Vanamoorthy, Ponniah; Vadi, Sonali; Mokhtari, Majid; Rasulo, Frank; Pegoli, Marianna; Bilotta, Federico; Nagayama, Masao; Kobata, Hitoshi; Vosylius, Saulius; Malin Abdullah, Jafri; Franco Granillo, Juvenal; Mijangos-Mendez, Julio Cesar; Horn, Janneke; Muller, Marcella C. A.; Kuiper, Michael; Abdo, Wilson F.; McArthur, Colin; Newby, Lynette; Hashmi, Madiha; Shiraz, Seemin Afshan; Castillo Abrego, Guadalupe; Bautista Coronel, Ermitao; Saldarriaga Rivera, Oscar; Cam Paucar, Juan Luis; Gomez, Oscar; Palo, Jose Emmanuel; Lokin, Johnny; Misiewska-Kaczur, Agnieszka; Dias, Celeste; Amorim, Pedro; Andre, Sonia; Rodriguez-Vega, Gloria; Gritsan, Alexey; Titova, Yulia; Al Jabbary, Ahmed; Al Zahrani, Amer Rashed; Pelunkova, Lucie; Zraiki, Hebaa; Deeb, Ahmad M.; Al Bshabshe, Ali; Al-Jehani, Hosam; Al-Suwaidan, Faisal; Svigelj, Viktor; Ramos-Gomez, Luis A.; Aguilar, Gerardo; Badenes, Rafael; Llopart Pou, Juan Antonio; Zavala, Elizabeth; Bernal Julian, Francisco; Galarza Barrachina, Laura; Vidal Tegedor, Barbara; Altaba Tena, Susana; Romero Krauchi, Oliva; Tamayo, Gonzalo; Sanchez, Baltasar; Gonzalezluengo, Raul-Ismael; Puvanendiran, S.; Merlani, Paolo; Laiwattana, Denchai; Promsin, Panuwat; Nazliel, Bijen; Eriksson, Evert; Chalela, Julio; Miller, David W.; Guisado, Raul; Gordon, Errol; Murthy, Harrish H. K.; Paulson, Audrey; Rajajee, Venkatakrishna; Sheehan, Kyle; Williamson, Craig; Ball, Ron; Allan, Patrick; Berkeley, Jennifer; Muehlschlegel, Susanne; Carandang, Raphael; Hall, Willey; Sarwal, Aarti; Damani, Rahul; Maldonado, Nelson; Tan, Benedict; Gupta, Pramod; Lazaridis, Christos; Bershad, Eric M.; Ansari, Safdar; Martinez, Julie; Singares, Eduardo Smith; Manno, Edward; Provencio, J. Javier; Chaudhry, Burhan; McBride, Moneen; Dhar, Raj; Roberts, Debra; Allen, Michelle; Schumacher, Hermann C.; Habre, Wassim; Sheth, Kevin; Greer, David; Kunze, Kimberley; Varelas, Panayiotis; Tack, Lauren; Porter, N. Stevenson; Junker, Christopher; Rodricks, Michael; Tuppeny, Misti; Basignani, Cherlynn; Napolitano, Sarah; Anderson, Gabriella; Donaldson, Karin; Davis, Rhonda; Sternberg, Shannon; Giraldo, Elias A.; Tran, Huy; Coplin, William M.; Badjatia, Neeraj; Fathy, Ahmed; Reshi, Rwoof A.; Bonomo, Jordan; Seder, David; Connolyy, Lauren S.; McCrum, Barbara; Carter, Teresa; Treggiari, Miriam; Dickinson, Matthew; Rison, Richard A.; Mirski, Marek; John, Sayona; Bleck, Thomas P.; Malek, Ali; Trim, Tiffany; Smith, Murline; Athar, M. Kamran; Rincon, Fred; Altaweel, Laith; Vespa, Paul; Emanuel, Benjamin; Eskiogly, Eric; McNett, Molly; Sukumaran, Anakara, V; Shutter, Lori; Milzman, Dave; Glassner, Stuart; OPhelan, Kristine; Rosenthal, Eric; Hemphill, J. C., III; Kottapally, Mohan; Smith, Wade S.; Ko, Nerissa; Josephson, Scott A.; Kim, Anthony; Singhal, Neel S.; Ahmad, Ahmad; Meeker, Michele; Hirsch, Karen G.; Nair, Deepak; Chou, Sherry; Santos, Gabriela; Clark, Sarah; Feske, Steven; Henderson, Galen; Sorond, Farzaneh; Vaitkevicius, Henrikas; Chung, David; Kim, Jennifer; Amatangelo, Mary; Kapinos, Gregory; Torbey, Michel; Kahn, D. Ethan; Chang, Cherylee; Koenig, Matthew; Gorman, Mark; Langdon, James R.; Dissin, Jonathan; Cross, Laura; Peled, Harry; Claassen, Jan; Ali, Abbas; Layon, Aj; Miller, Angela; Wilensky, Eileen Maloney; Kumar, Monisha; Levine, Joshua M.; Maldonado, Ivan L.; Schneck, Michael; Lele, Abhijit; Sarma, Anand K.; Yazbeck, Moussa F.; Johnston, Greg; Jarquin-Valdivia, Adrian A.; Johnson, Lindsey; Kuisle, Lauren; Sajjad, Rehan; Glickman, Scott; Garvin, Rachel; Parra, Augusto; DeFilippis, Michele; Fletcher, Jeffrey J.; Freeman, W. David; Rao, Vivek A.; Olmecah, Huitzilin Mauricio; Dugan, Guy; Medary, Irene B.; Hoesch, Robert; Brehaut, Scott S.; Afshinnik, Arash; Moreda, Melissa; Graffagnino, Carmelo; Laskowitz, Daniel T.; Naidech, Andrew; Francis, Brandon; Berman, Michael; Tesoro, Eljim; Medow, Joshua; Jordan, Dedrick; Aiyagari, Venkatesh; Rosengart, Axel; De Georgia, Michael; Bowling, Susana; Sharaby, Mohamed; Nathan, Barnett; Landry, Ryan; Hebert, Cullen; Hubner, Kathleen E.; Karanjia, Navaz; Hightower, Bradley; Cummings, Kathie; Kirkwood, Jennifer; Frank, Jeffrey, I; Hassan, Ameer; Sanchez, Olive; Cordina, Steve; Mora, Jacobo Elias; Tuan Van Bui		PRINCE Study Investigators	Global Survey of Outcomes of Neurocritical Care Patients: Analysis of the PRINCE Study Part 2	NEUROCRITICAL CARE			English	Article						Neurocritical care; Observational study; Outcomes; Critical care; Prospective	TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; GLASGOW COMA SCALE; LENGTH-OF-STAY; INTENSIVE-CARE; UNITED-STATES; IMPACT; NEUROSCIENCES; VALIDATION; PATTERNS	Background Neurocritical care is devoted to the care of critically ill patients with acute neurological or neurosurgical emergencies. There is limited information regarding epidemiological data, disease characteristics, variability of clinical care, and in-hospital mortality of neurocritically ill patients worldwide. We addressed these issues in the Point PRevalence In Neurocritical CarE (PRINCE) study, a prospective, cross-sectional, observational study. Methods We recruited patients from various intensive care units (ICUs) admitted on a pre-specified date, and the investigators recorded specific clinical care activities they performed on the subjects during their first 7 days of admission or discharge (whichever came first) from their ICUs and at hospital discharge. In this manuscript, we analyzed the final data set of the study that included patient admission characteristics, disease type and severity, ICU resources, ICU and hospital length of stay, and in-hospital mortality. We present descriptive statistics to summarize data from the case report form. We tested differences between geographically grouped data using parametric and nonparametric testing as appropriate. We used a multivariable logistic regression model to evaluate factors associated with in-hospital mortality. Results We analyzed data from 1545 patients admitted to 147 participating sites from 31 countries of which most were from North America (69%, N = 1063). Globally, there was variability in patient characteristics, admission diagnosis, ICU treatment team and resource allocation, and in-hospital mortality. Seventy-three percent of the participating centers were academic, and the most common admitting diagnosis was subarachnoid hemorrhage (13%). The majority of patients were male (59%), a half of whom had at least two comorbidities, and median Glasgow Coma Scale (GCS) of 13. Factors associated with in-hospital mortality included age (OR 1.03; 95% CI, 1.02 to 1.04); lower GCS (OR 1.20; 95% CI, 1.14 to 1.16 for every point reduction in GCS); pupillary reactivity (OR 1.8; 95% CI, 1.09 to 3.23 for bilateral unreactive pupils); admission source (emergency room versus direct admission [OR 2.2; 95% CI, 1.3 to 3.75]; admission from a general ward versus direct admission [OR 5.85; 95% CI, 2.75 to 12.45; and admission from another ICU versus direct admission [OR 3.34; 95% CI, 1.27 to 8.8]); and the absence of a dedicated neurocritical care unit (NCCU) (OR 1.7; 95% CI, 1.04 to 2.47). Conclusion PRINCE is the first study to evaluate care patterns of neurocritical patients worldwide. The data suggest that there is a wide variability in clinical care resources and patient characteristics. Neurological severity of illness and the absence of a dedicated NCCU are independent predictors of in-patient mortality.	[Rao, Chethan P. Venkatasubba; Georgiadis, Alexandros] Baylor Coll Med, Div Vasc Neurol & Neurocrit Care, Houston, TX 77030 USA; [Rao, Chethan P. Venkatasubba; Georgiadis, Alexandros] CHI Baylor St Lukes Med Ctr, Houston, TX USA; [Suarez, Jose, I; Calvillo, Eusebia] Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, Dept Anesthesiol & Crit Care Med, 1800 Orleans St,Zayed 3014C, Baltimore, MD 21287 USA; [Suarez, Jose, I; Calvillo, Eusebia] Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, Dept Neurol, 1800 Orleans St,Zayed 3014C, Baltimore, MD 21287 USA; [Suarez, Jose, I; Calvillo, Eusebia] Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, Dept Neurosurg, 1800 Orleans St,Zayed 3014C, Baltimore, MD 21287 USA; [Martin, Renee H.] Med Univ South Carolina, Charleston, SC 29425 USA; [Bauza, Colleen] Johns Hopkins All Childrens Hosp, Dept Hlth Informat, St Petersburg, FL USA; [Hemphill, J. Claude; Hemphill, J. C., III; Kottapally, Mohan; Smith, Wade S.; Ko, Nerissa; Josephson, Scott A.; Kim, Anthony; Singhal, Neel S.; Ahmad, Ahmad; Meeker, Michele] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Sung, Gene; Emanuel, Benjamin] Univ Southern Calif, Los Angeles, CA 90007 USA; [Oddo, Mauro] CHUV Lausanne Univ Hosp, Lausanne, Switzerland; [Taccone, Fabio Silvio] Erasme Univ Hosp, Brussels, Belgium; [Taccone, Fabio Silvio] Free Univ Brussels, Brussels, Belgium; [LeRoux, Peter D.] Main Line Hlth Care Wynnewood, Wynnewood, PA USA; [Domeniconi, Gustavo] Sanatorio Trinidad San Isidro, Gran Buenos Aires, Argentina; [Alberto Camputaro, Luis] Sanatorio San Jose, Buenos Aires, DF, Argentina; [Villalobos, Milton] Hosp Municipal San Miguel, Buenos Aires, DF, Argentina; [Allasia, Mariela] Hosp Ninos O Allasia, Santa Fe, Argentina; [Goldenberg, Fernando D.; Teran, Mario D.; Rosciani, Foda] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Alvarez, Hector] Hosp Escuela Gen San Martin, Buenos Aires, DF, Argentina; [Costilla, Marcelo; Videtta, Walter] Hosp Nacl Alejandro Posadas, Buenos Aires, DF, Argentina; [Perez, Diego] Hosp Trauma & Emergencia Dr Federico Abete, Buenos Aires, DF, Argentina; [Raffa, Pablo] Hosp Interzonal Gen Agudos, Buenos Aires, DF, Argentina; [Videtta, Walter] Hosp Eva Peron de Merlo, Buenos Aires, Aires, Argentina; [Seppelt, Ian] Nepean Hosp, Sydney, NSW, Australia; [Rodgers, Helen] Canberra Hosp, Canberra, ACT, Australia; [Paxton, Jody] Gold Coast Univ Hosp, Southport, Qld, Australia; [Bhonagiri, Deepak] Macquarie Univ Hosp, Sydney, NSW, Australia; [Aneman, Anders] Liverpool Hosp, Liverpool, Australia; [Jenkinson, Elizabeth] Royal Perth Hosp, Perth, WA, Australia; [Yarad, Elizabeth; Bass, Francess; Hammond, Naomi; O'Connor, Anne; Bird, Simon] Royal North Shore Hosp, Sydney, NSW, Australia; [Smith, Roger] St Vincents Hosp, Melbourne, Vic, Australia; [Barge, Deborah] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Shilkin, Jane; Woods, Wpd; Roberts, Brigit] Sir Charles Gairdner Hosp, Nedlands, WA, Australia; [O'Leary, Michael] Royal Prince Alfred Hosp, Camperdown, NSW, Australia; [Vallance, Shirley] Alfred Hosp, Melbourne, Vic, Australia; [Helbok, Raimund; Beer, Ronny; Pfaulser, Bettina; Schiefecker, Alois] Innsbruck Med Univ, Innsbruck, Austria; [Almemari, Ayesha] Mafraq Hosp, Manama, Bahrain; [Mukaddam, Sajid] Salmaniya Med Complex, Manama, Bahrain; [Taccone, Fabio S.] Hop Erasme, Brussels, Belgium; [Wittebole, Xavier; Berghe, Caroline; Dujardin, Marie-France; Renard, Suzanne; Hantson, Philippe] Clin Univ St Luc, Louvain, Belgium; [Biston, Patrick] CHU Charleroi, Charleroi, Belgium; [Meyfroidt, Geert] Univ Hosp, Leuven, Belgium; [Ferreira da Silva, Ivan Rocha; de Oliveira, Janaina] Hosp Copa DOr, Rio De Janeiro, Brazil; [Reao Neto, Alvaro] Inst Neurol Curitiba, Curitiba, Parana, Brazil; [Sala Domingues, Joao Roberto] Hosp Samaritano, Sao Paulo, Brazil; [de Azambuja Rodrigues, Pedro Mendes] Sao Lucas Copacabana Hosp, Rio De Janeiro, Brazil; [Teitelbaum, Jeanne] Mt Real Neurol Inst, Montreal, PQ, Canada; [Chapman, Martin; McCredie, Vicki; Marinoff, Nicole; Perez, Adic] Sunnybrook Hlth Sci Unit, Toronto, ON, Canada; [Kutsogiannis, Demetrios Jim] Univ Alberta Hosp, Edmonton, AB, Canada; [Bernard, Francis] Hop Sacre Coeur, Montreal, PQ, Canada; [Kramer, Andreas] Univ Calgary, Calgary, AB, Canada; [Moretti, Jose, I] Hosp Trabajador, Santiago, Chile; [Aguilera, Sergio] Hosp Reg Iquique, Iquique, Chile; [Poch, Eugenio J.] Inst Neurocirugia Alfonso Asenjo, Santiago, Chile; [Romero, Carlos] Hosp Clin Univ Chile, Santiago, Chile; [Wong, George K. C.] Chinese Univ Hong Kong, Hong Kong, Peoples R China; [Song, Jian; Xu, Guozheng] Wuhan Gen Hosp, Wuhan, Peoples R China; [Mejia-Mantilla, Jorge H.; Madrinan-Navia, Humberto; Martinez, Jorge E.; Elena Ochoa, Maria; Bautista, Diego; Varga, Monica; Gomez, Monica] Fdn Valle del Lili, Cali, Colombia; [Diego Ciro, Juan; Gil, Bladimir; Murillo, Rodrigo] Clin Las Amer, Medellin, Colombia; [Hernandez, Olga] Inst Neurol Colombia, Medellin, Colombia; [Ramirez-Arce, Jorge] CCSS, Surg Intens Care Unit, San Jose, Costa Rica; [Breitenfeld, Tomislav] KBC Sestre Milosrdnice, Zagreb, Croatia; [Lacerda Gallardo, Angel J.] Hosp Gen Roberto Rodriguez, Moron, Cuba; [Lopez Delgado, Hubiel J.; Yunen Gonzalez, Jose Rafael; Hache-Marliere, Manuel] CEDIMAT, Santo Domingo, Dominican Rep; [Pinto, Diego Barahona] Hosp Los Valles, Quito, Ecuador; [Llano, Miguel] Hosp Especialidades FFAA, Quito, Ecuador; [Salgado, Estuardo] Clin La Merced, Quito, Ecuador; [Jibaja, Manuel] Hosp Eugenio Espejo, Quito, Ecuador; [Wright, Judith C.] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Harvey, Daniel] Nottingham Univ Hosp, Nottingham, England; [Verma, Vishwajit] Royal London Hosp, London, England; [Hopkins, Philip; Chan, Alexander] Kings Coll Hosp London, London, England; [Welbourne, Jessie] Derriford Hosp, Plymouth, Devon, England; [Dowling, Susan] Whiston Hosp, Rainhill, Merseyside, England; [Katila, Ari] Turku Univ Hosp, Turku, Finland; [Lasocki, Sigismond] CHU Angers, Angers, France; [Wartenberg, Katja] Martin Luther Univ Halle Wittenberg, Halle, Germany; [Hobohm, Carsten] Univ Leipzig, Leipzig, Germany; [Poli, Sven] Univ Tuebigen, Tubingen, Germany; [Schirotzek, Ingo] UKGM, Giessen, Germany; [Bosel, Julian; Schoenenberger, Silvia; Francken, Susanne; Shieber, Simon; Kern, Alexander] Heidelberg Univ, Heidelberg, Germany; [Falla, Joel; Avalos Herrera, Edgar] Hosp Gen San Juan Dios, Guatemala City, Guatemala; [Gilvaz, P. C.] Jubilee Mission Med Coll, Trichur, India; [Goyal, Keshav; Sokhal, Navdeep; Sohal, Jyoti] All India Inst Med Sci, New Delhi, India; [Aggarwal, Deepesh G.] Saifee Hosp, Mumbai, Maharashtra, India; [Ray, Banambar; Pattnaik, Saroj] Apollo Hosp, Bhubaneswar, India; [Garg, Sanchita] Fortis Hosp, Mohali, India; [Dixit, Subhal] Sanjeevan Hosp, Pune, Maharashtra, India; [Rawal, Raj] Hope Neuro Care Hosp, Ahmadabad, India; [Samavedam, Srinivas; Madhusudan, Madhu] Care Hosp, Hyderabad, India; [Paul, Gunchan] Dayanand Med Coll, Pohir, India; [Mishra, Sanghamitra] IMS & Sum Hosp, Bhubaneswar, India; [Shushma, Patil] Ruby Hall Clin, Pune, Maharashtra, India; [Shukla, Urvi] Aditya Birla Mem Hosp, Pune, Maharashtra, India; [Sinha, Vandana] GNRC Hosp, Dispur, India; [Vanamoorthy, Ponniah] Global Hlth City, Chennai, Tamil Nadu, India; [Vadi, Sonali] Global Hosp, Mumbia, India; [Mokhtari, Majid] SBUMS, IHH, Tehran, Iran; [Rasulo, Frank] Spedali Civili Hosp, Brescia, Italy; [Pegoli, Marianna] Osped Bellaria IRCCS Sci Neurol, Bologna, Italy; [Bilotta, Federico] Osped Policlin Umberto I, Rome, Italy; [Nagayama, Masao] Int Univ Hlth & Welf, Atami Hosp, Atami, Japan; [Kobata, Hitoshi] Osaka Mishima Emergency Crit Care Ctr, Osaka, Japan; [Vosylius, Saulius] Vilnius Univ Hosp, Vilnius, Lithuania; [Malin Abdullah, Jafri] Univ Sains Malaysia P3Neuro, Ctr Neurosci Serv & Res, Kubang Kerian, Malaysia; [Franco Granillo, Juvenal] Ctr Med ABC, Mexico City, DF, Mexico; [Mijangos-Mendez, Julio Cesar] Hosp Civil Guadalajara, Guadalajara, Jalisco, Mexico; [Horn, Janneke] Acad Med Ctr, Amsterdam, Netherlands; [Muller, Marcella C. A.] Med Ctr Haaglanden, The Hague, Netherlands; [Kuiper, Michael] Med Ctr Leeuwarden, Leeuwarden, Netherlands; [Abdo, Wilson F.] Radboud UMC, Nijmeden, Netherlands; [McArthur, Colin; Newby, Lynette] Auckland City Hosp, Auckland, New Zealand; [Hashmi, Madiha] Aga Khan Univ, Karachi, Pakistan; [Shiraz, Seemin Afshan] Sheikh Khalifa Gen Hosp, Lahore, Pakistan; [Castillo Abrego, Guadalupe] Caja de Seguro Social Hosp, Panama City, Panama; [Bautista Coronel, Ermitao] Hosp Nacl Hipolito Unanue, Lima, Peru; [Saldarriaga Rivera, Oscar] Hosp Guillermo Almenara Irigoyen, Lima, Peru; [Cam Paucar, Juan Luis] Inst Nacl Ciencias Neurol, Lima, Peru; [Gomez, Oscar] Hosp Nacl Dos de Mayo, Lima, Peru; [Palo, Jose Emmanuel] Med City, Manila, Philippines; [Lokin, Johnny] Univ Santo Tomas Hosp, Manila, Philippines; [Misiewska-Kaczur, Agnieszka] ZPZOZ Silesian Hosp, Cieszyn, Poland; [Dias, Celeste] Hosp Sao Joao, Porto, Portugal; [Amorim, Pedro; Andre, Sonia] Hosp Santo Antonio, Porto, Portugal; [Rodriguez-Vega, Gloria] HIMA San Pablo, Caguas, PR USA; [Gritsan, Alexey] Krasnoyarsk Reg Hosp, Krasnoyarsk, Russia; [Titova, Yulia] Sklifosovsky Res Inst Emergency Med, Moscow, Russia; [Al Jabbary, Ahmed; Al Zahrani, Amer Rashed; Pelunkova, Lucie; Zraiki, Hebaa; Deeb, Ahmad M.] King Abdul Aziz Med City, Riyadh, Saudi Arabia; [Al Bshabshe, Ali] Aseer Cent Hosp, Abha, Saudi Arabia; [Al-Jehani, Hosam] King Fahad Univ Hosp, Dammam, Saudi Arabia; [Al-Suwaidan, Faisal] King Fahad Med City, Riyadh, Saudi Arabia; [Svigelj, Viktor] Univ Med Ctr, Ljubljana, Slovenia; [Ramos-Gomez, Luis A.] Hosp Gen La Palma, Santa Cruz De Tenerife, Spain; [Aguilar, Gerardo; Badenes, Rafael] Hosp Clin Univ Valencia, Valencia, Spain; [Llopart Pou, Juan Antonio] Hosp Univ Son Espases, Palma De Mallorca, Spain; [Zavala, Elizabeth] Hosp Clin Barcelona, Barcelona, Spain; [Bernal Julian, Francisco; Galarza Barrachina, Laura; Vidal Tegedor, Barbara; Altaba Tena, Susana] Hosp Gen Univ Castello, Castellon de La Plana, Spain; [Romero Krauchi, Oliva] Hosp Son Espases, Palma De Mallorca, Spain; [Tamayo, Gonzalo] Cruces Univ Hosp, Baracaldo, Spain; [Sanchez, Baltasar] Hosp Univ Mutua Terrassa, Barcelona, Spain; [Gonzalezluengo, Raul-Ismael] Complejo Hosp Leon, Leon, Spain; [Puvanendiran, S.] Gen Teaching Hosp, Kandy, Sri Lanka; [Merlani, Paolo] Osped Reg, Lugano, Switzerland; [Laiwattana, Denchai] Bangkok Hosp Trat, Bangkok, Thailand; [Promsin, Panuwat] Siriraj Hosp, Bangkok, Thailand; [Nazliel, Bijen] Gazi Univ, Fac Med, Ankara, Turkey; [Eriksson, Evert; Chalela, Julio] MUSC, Charleston, SC USA; [Miller, David W.] Univ Alabama Birmingham, Birmingham, AL USA; [Guisado, Raul] San Jose Reg Med Ctr, San Jose, CA USA; [Gordon, Errol] Mt Sinai Med Ctr, Nyc, NY USA; [Murthy, Harrish H. K.; Paulson, Audrey] Good Samaritan Hosp, San Jose, CA USA; [Rajajee, Venkatakrishna; Sheehan, Kyle; Williamson, Craig; Ball, Ron] Univ Michigan, Ann Arbor, MI 48109 USA; [Allan, Patrick] Good Samaritan Hosp, Dayton, OH USA; [Berkeley, Jennifer] Sinai Hosp Baltimore, Baltimore, MD USA; [Muehlschlegel, Susanne; Carandang, Raphael; Hall, Willey] Univ Massachusetts, Med Sch UMASS, Worcester, MA 01605 USA; [Sarwal, Aarti] Wake Forest Baptist Med Ctr, Winston Salem, NC USA; [Rao, Chethan P. Venkatasubba; Suarez, Jose, I; Georgiadis, Alexandros; Calvillo, Eusebia; Damani, Rahul; Maldonado, Nelson; Tan, Benedict; Gupta, Pramod; Lazaridis, Christos; Bershad, Eric M.] Baylor Coll Med, Houston, TX 77030 USA; [Ansari, Safdar; Martinez, Julie] Univ Utah, Salt Lake City, UT USA; [Singares, Eduardo Smith] Advocate Christ Med Ctr, Oak Lawn, IL USA; [Manno, Edward; Provencio, J. Javier; Chaudhry, Burhan; McBride, Moneen] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Dhar, Raj; Roberts, Debra; Allen, Michelle] Barnes Jewish Hosp, St Louis, MO 63110 USA; [Schumacher, Hermann C.] Lehigh Valley Hlth Network, Allentown, PA USA; [Habre, Wassim] Corzer Chester Med Ctr, Chester, PA USA; [Sheth, Kevin; Greer, David; Kunze, Kimberley] Yale Univ, Sch Med, New Haven, CT USA; [Varelas, Panayiotis; Tack, Lauren] Henry Ford Hosp, Detroit, MI 48202 USA; [Porter, N. Stevenson] Rhode Isl Hosp, Providence, RI USA; [Junker, Christopher] George Washington Univ, Washington, DC USA; [Rodricks, Michael; Tuppeny, Misti; Basignani, Cherlynn; Napolitano, Sarah; Anderson, Gabriella; Donaldson, Karin] Florida Hosp, Orlando, FL USA; [Davis, Rhonda; Sternberg, Shannon] Greenville Hlth Syst, Greenville, SC USA; [Giraldo, Elias A.] Drexel Univ, Philadelphia, PA 19104 USA; [Tran, Huy] Univ New Mexico, Albuquerque, NM 87131 USA; [Coplin, William M.] St Anthony Hosp, Denver, CO USA; [Badjatia, Neeraj] Univ Maryland, Baltimore, MD 21201 USA; [Fathy, Ahmed] Miami Valley Hosp, Dayton, OH USA; [Reshi, Rwoof A.] Univ Minnesota, Minneapolis, MN USA; [Bonomo, Jordan] Univ Cincinnati, Cincinnati, OH USA; [Seder, David; Connolyy, Lauren S.; McCrum, Barbara] Maine Med Ctr, Portland, ME 04102 USA; [Carter, Teresa] Sutter Roseville Med Ctr, Roseville, CA USA; [Treggiari, Miriam] Univ Washington, Seattle, WA 98195 USA; [Dickinson, Matthew] Centura St Anthony Hosp, Lakewood, CO USA; [Rison, Richard A.] PIH Hlth, Whittier, CA USA; [Mirski, Marek] Johns Hopkins Univ, Baltimore, MD USA; [John, Sayona; Bleck, Thomas P.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Malek, Ali; Trim, Tiffany; Smith, Murline] St Marys Hosp, W Palm Beach, FL USA; [Athar, M. Kamran; Rincon, Fred] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA; [Altaweel, Laith] Inova Fairfax, Falls Church, VA USA; [Vespa, Paul] UCLA, Med Ctr, Los Angeles, CA 90024 USA; [Eskiogly, Eric] Phys Reg Healthcare Syst, Naples, FL USA; [McNett, Molly] Metro Hlth Med Ctr, Cleveland, OH USA; [Sukumaran, Anakara, V] Houston Methodist Hosp, Houston, TX 77030 USA; [Shutter, Lori] Univ Pittsburgh UPMC, Pittsburgh, PA USA; [Milzman, Dave] Georgetown Univ, Washington, DC USA; [Glassner, Stuart] Univ Florida, Jacksonville, FL USA; [OPhelan, Kristine] Univ Miami, Miami, FL USA; [Rosenthal, Eric] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hirsch, Karen G.] Stanford Univ, Palo Alto, CA 94304 USA; [Kottapally, Mohan] San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Nair, Deepak] OSF St Francis Med Ctr, Peoria, IL USA; [Chou, Sherry; Santos, Gabriela; Clark, Sarah; Feske, Steven; Henderson, Galen; Sorond, Farzaneh; Vaitkevicius, Henrikas; Chung, David; Kim, Jennifer; Amatangelo, Mary] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Kapinos, Gregory] North Shore LIJ Hlth Syst, Long Isl City, NY USA; [Torbey, Michel] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Kahn, D. Ethan] Christiana Care Hlth Syst, Wilmington, DE USA; [Chang, Cherylee; Koenig, Matthew] Queens Med Ctr, Honolulu, HI USA; [Gorman, Mark] Fletcher Allen Hlth Care, Burlington, VT USA; [Langdon, James R.] Univ Tennessee, Med Ctr, Knoxville, TN USA; [Dissin, Jonathan] Einstein Med Ctr, Philadelphia, PA USA; [Cross, Laura; Peled, Harry] St Jude Med Ctr, Fullerton, CA USA; [Claassen, Jan] Columbia Univ, Nyc, NY USA; [Ali, Abbas; Layon, Aj; Miller, Angela] Geisinger Med Ctr, Danville, PA 17822 USA; [Wilensky, Eileen Maloney; Kumar, Monisha; Levine, Joshua M.] Univ Penn, Philadelphia, PA 19104 USA; [Maldonado, Ivan L.] Minist St Josephs Hosp, Marshfield, WI USA; [Schneck, Michael] Loyola Univ, Chicago, IL 60611 USA; [Lele, Abhijit] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Sarma, Anand K.] Virginia Commonwealth Univ Med Coll Virginia, Richmond, VA USA; [Yazbeck, Moussa F.] John Muir Hlth, Walnut Creek, CA USA; [Johnston, Greg] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA; [Jarquin-Valdivia, Adrian A.] TriStar Centennial Med Ctr, Nashville, TN USA; [Johnson, Lindsey] Halifax Hlth, Port Orange, FL USA; [Kuisle, Lauren] Swedish Med Ctr, Aurora, CO USA; [Sajjad, Rehan] Aurora St Lukes Med Ctr, Milwaukee, WI USA; [Glickman, Scott] Six Points Neurosci, Washington, DC USA; [Garvin, Rachel; Parra, Augusto] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [DeFilippis, Michele] Morristown Med Ctr, Morristown, NJ USA; [Fletcher, Jeffrey J.] Bronson Methodist Hosp, Kalamazoo, MI USA; [Freeman, W. David] Mayo Clin, Jacksonville, FL 32224 USA; [Rao, Vivek A.] Redwood City Med Ctr, Redwood City, CA USA; [Olmecah, Huitzilin Mauricio] Loma Linda Univ, Med Ctr, Loma Linda, CA USA; [Dugan, Guy] Alexian Bros Med Ctr, Elk Grove Village, IL USA; [Medary, Irene B.] Orlando Hlth, Orlando, FL USA; [Hoesch, Robert] Intermt Med Ctr, Salt Lake City, UT USA; [Brehaut, Scott S.] Faxton St Lukes Healthcare, Utica, NY USA; [Afshinnik, Arash] Ochsner Hlth Syst, New Orleans, LA USA; [Moreda, Melissa; Graffagnino, Carmelo; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Durham, NC USA; [Naidech, Andrew; Francis, Brandon; Berman, Michael] Northwestern Univ, Chicago, IL 60611 USA; [Tesoro, Eljim] Univ Illinois, Chicago, IL 60680 USA; [Medow, Joshua] Univ Wisconsin, Madison, WI USA; [Jordan, Dedrick] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Aiyagari, Venkatesh] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Rosengart, Axel] NYPH Weill Cornell Med Coll, New York, NY USA; [De Georgia, Michael] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA; [Bowling, Susana] Summa Hlth Syst, Akron, OH USA; [Sharaby, Mohamed; Nathan, Barnett] Univ Virginia Hlth Syst, Charlottesville, VA USA; [Landry, Ryan; Hebert, Cullen] Our Lady Lake RMC, Baton Rouge, LA USA; [Hubner, Kathleen E.] St Vincents Hosp, Indianapolis, IN USA; [Karanjia, Navaz] Univ Calif San Diego, La Jolla, CA 92093 USA; [Hightower, Bradley; Cummings, Kathie; Kirkwood, Jennifer] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Frank, Jeffrey, I] Univ Chicago, Chicago, IL 60637 USA; [Hassan, Ameer; Sanchez, Olive] Valley Baptist Hosp, Harlingen, TX USA; [Cordina, Steve] Univ S Alabama, Mobile, AL USA; [Mora, Jacobo Elias] Hosp Univ Luis Razetti, Puerto La Cruz, Venezuela; [Tuan Van Bui] Cho Ray Hosp, Ho Chi Minh City, Vietnam		Suarez, JI (corresponding author), Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, Dept Anesthesiol & Crit Care Med, 1800 Orleans St,Zayed 3014C, Baltimore, MD 21287 USA.; Suarez, JI (corresponding author), Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, Dept Neurol, 1800 Orleans St,Zayed 3014C, Baltimore, MD 21287 USA.; Suarez, JI (corresponding author), Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, Dept Neurosurg, 1800 Orleans St,Zayed 3014C, Baltimore, MD 21287 USA.; Suarez, JI (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	jsuarez5@jhmi.edu	Gallardo, Angel Jesus Lacerda/AAZ-9478-2020; Chang, Cherylee/ABG-2080-2020; Nazliel, Bijen/ABI-2924-2020; Helbok, Raimund/AAA-8361-2021; Wong, George Kwok Chu/L-4344-2016; Galarza, Laura/ABB-2294-2020; Badjatia, Neeraj/AAS-4855-2021; Dias, Celeste/L-9901-2014; Abdullah, J/C-2828-2011; Smith-Singares, Eduardo/I-3518-2018; Pegoli, Marianna/AAC-8822-2020; Provencio, Jose Javier/AAG-5114-2021; Wittebole, Xavier/ABC-2036-2021; Cordina, Steve/AAI-3513-2020; Kuiper, Michael/AAG-9878-2019; Kapinos, Gregory/B-5957-2011; Hemphill, Claude/AAY-5630-2021; bshabshe, ali al/AAR-1799-2020; Badenes, Rafael/K-6628-2019; Shutter, Lori A/G-2957-2013; John, Sayona/AAR-6849-2020; Rosenthal, Eric/A-2085-2017; DAMANI, RAHUL/R-7012-2018; Gritsan, Alexey/M-4261-2014	Gallardo, Angel Jesus Lacerda/0000-0001-9171-2000; Galarza, Laura/0000-0002-4658-748X; Dias, Celeste/0000-0003-0340-9808; Abdullah, J/0000-0002-0258-7410; Smith-Singares, Eduardo/0000-0002-0169-2788; Pegoli, Marianna/0000-0002-6601-3256; Provencio, Jose Javier/0000-0003-1298-1806; Kapinos, Gregory/0000-0002-1527-4552; Hemphill, Claude/0000-0003-4019-7525; bshabshe, ali al/0000-0003-0974-7226; Badenes, Rafael/0000-0001-7017-0150; John, Sayona/0000-0002-2133-7265; rocha ferreira da silva, ivan/0000-0001-8572-9631; SHUKLA, URVI/0000-0001-9001-6898; Abdo, Wilson/0000-0002-5783-8643; Rosenthal, Eric/0000-0003-3900-356X; Verma, Vishwajit/0000-0003-2428-2391; Bass, Frances/0000-0003-3826-8558; Hassan, Ameer/0000-0002-7148-7616; Goldenberg, Fernando/0000-0003-1100-6830; Amorim, Pedro/0000-0001-7466-4174; Hashmi, Madiha/0000-0002-7332-0692; Cordina, Steve/0000-0001-7931-8983; Shutter, Lori/0000-0002-1390-0628; milzman, dave/0000-0002-3917-7239; Deeb, Ahmad/0000-0002-3680-7338; Mijangos-Mendez, Julio Cesar/0000-0002-9640-3036; Finfer, Simon/0000-0002-2785-5864; Kuiper, Michael/0000-0001-6201-7332; DAMANI, RAHUL/0000-0001-7990-0965; vadi, sonali/0000-0002-7341-2407; Badjatia, Neeraj/0000-0003-1509-9034; Jordan, Dedrick/0000-0002-0706-9583; Singhal, Neel/0000-0003-1605-4444; Gritsan, Alexey/0000-0002-0500-2887; Mokhtari, Majid/0000-0001-5980-1003; Bhonagiri, Deepak/0000-0003-4376-6682			Abe T, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2126-6; Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; Bakhru RN, 2016, ANN AM THORAC SOC, V13, P1527, DOI 10.1513/AnnalsATS.201601-078OC; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bank TW, GNI PER CAP ATL METH; Cao L, 1998, ARCH INTERN MED, V158, P1154, DOI 10.1001/archinte.158.10.1154; Devlin JW, 2018, CRIT CARE MED, V46, P328, DOI 10.1097/CCM.0000000000002879; Durbin CG, 2010, RESP CARE, V55, P1056; Elias KM, 2015, CRIT CARE MED, V43, P856, DOI 10.1097/CCM.0000000000000858; Faigle R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1195-7; Gruenberg DA, 2006, AM J CRIT CARE, V15, P502; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Hua MS, 2014, AM J RESP CRIT CARE, V189, P428, DOI 10.1164/rccm.201307-1229OC; Kramer AH, 2011, NEUROCRIT CARE, V14, P329, DOI 10.1007/s12028-011-9530-y; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Markandaya M, 2012, NEUROCRIT CARE, V16, P72, DOI 10.1007/s12028-011-9628-2; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Sakr Y, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy313; Suarez JI, 2012, NEUROCRIT CARE, V16, P29, DOI 10.1007/s12028-011-9612-x; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; Suarez JI, 2019, NEUROCRIT CARE; Suarez JI, 2006, CRIT CARE MED, V34, pS232, DOI 10.1097/01.CCM.0000231881.29040.25; Varelas PN, 2004, CRIT CARE MED, V32, P2191, DOI 10.1097/01.CCM.0000146131.03578.21; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; Xian Y, 2012, AM HEART J, V163, P392, DOI 10.1016/j.ahj.2011.12.012; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	28	10	10	3	25	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2020	32	1					88	103		10.1007/s12028-019-00835-z			16	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KK6PD	WOS:000512861100004	31486027	Green Accepted			2022-02-06	
J	Fuller, GW; Tucker, R; Starling, L; Falvey, E; Douglas, M; Raftery, M				Fuller, G. W.; Tucker, R.; Starling, L.; Falvey, E.; Douglas, M.; Raftery, M.			The performance of the World Rugby Head Injury Assessment Screening Tool: a diagnostic accuracy study	SPORTS MEDICINE-OPEN			English	Article						Concussion; Screening; Rugby; Diagnostic accuracy	CONCUSSION; TESTS; SPECIFICITY; RELIABILITY; SENSITIVITY; SPORT	Background Off-field screening tools, such as the Sports Concussion Assessment Tool (SCAT), have been recommended to identify possible concussion following a head impact where the consequences are unclear. However, real-life performance, and diagnostic accuracy of constituent sub-tests, have not been well characterized. Methods A retrospective cohort study was performed in elite Rugby Union competitions between September 2015 and June 2018. The study population comprised consecutive players identified with a head impact event undergoing off-field assessments with the World Rugby Head Injury Assessment (HIA01) screening tool, an abridged version of the SCAT3. Off-field screening performance was investigated by evaluating real-life removal-from-play outcomes and determining the theoretical diagnostic accuracy of the HIA01 tool, and individual sub-tests, if player-specific baseline or normative sub-test thresholds were strictly applied. The reference standard was clinically diagnosed concussion determined by serial medical assessments. Results One thousand one hundred eighteen head impacts events requiring off-field assessments were identified, resulting in 448 concussions. Real-life removal-from-play decisions demonstrated a sensitivity of 76.8% (95% CI 72.6-80.6) and a specificity of 86.6% (95% CI 83.7-89.1) for concussion (AUROC 0.82, 95% CI 0.79-0.84). Theoretical HIA01 tool performance worsened if pre-season baseline values (sensitivity 89.6%, specificity 33.9%, AUROC 0.62, p < 0.01) or normative thresholds (sensitivity 80.4%, specificity 69.0%, AUROC 0.75, p < 0.01) were strictly applied. Symptoms and clinical signs were the HIA01 screening tool sub-tests most predictive for concussion; with immediate memory and tandem gait providing little additional diagnostic value. Conclusions These findings support expert recommendations that clinical judgement should be used in the assessment of athletes following head impact events. Substitution of the tandem gait and 5-word immediate memory sub-tests with alternative modes could potentially improve screening tool performance.	[Fuller, G. W.] Univ Sheffield, Ctr Urgent & Emergency Care Res, Sch Hlth & Related Res, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England; [Tucker, R.] Univ Cape Town, Sch Management Studies, Cape Town, South Africa; [Starling, L.] Univ Cape Town, Dept Human Biol, Cape Town, South Africa; [Falvey, E.] Univ Coll Cork, Dept Med, Cork, Ireland; [Douglas, M.; Raftery, M.] World Rugby, World Rugby House 8-10 Lower Pembroke St, Dublin 2, Ireland		Fuller, GW (corresponding author), Univ Sheffield, Ctr Urgent & Emergency Care Res, Sch Hlth & Related Res, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England.	g.fuller@sheffield.ac.uk		Falvey, Eanna/0000-0003-3961-1805; Fuller, Gordon Ward/0000-0001-8532-3500	World Rugby	The study was supported by World Rugby. World Rugby had no influence in the study design, data collection, analysis, interpretation of data, or in writing the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P338, DOI 10.1111/j.1651-2227.2006.00180.x; Altman D.G., 1990, PRACTICAL STAT MED R; [Anonymous], 2013, Br J Sports Med, V47, P259; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Courvoisier DS, 2011, J CLIN EPIDEMIOL, V64, P993, DOI 10.1016/j.jclinepi.2010.11.012; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doubilet P M, 1985, Med Decis Making, V5, P447, DOI 10.1177/0272989X8500500406; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Mallett S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3999; McCrea HJ, 2013, SPORTS HEALTH, V5, P160, DOI 10.1177/1941738112462203; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Roy JS, 2015, BRIT J SPORT MED, V49, P1316, DOI 10.1136/bjsports-2014-094148; Rutjes A W S, 2007, Health Technol Assess, V11, pix; Rutjes AWS, 2005, CLIN CHEM, V51, P1335, DOI 10.1373/clinchem.2005.048595; Schriger DL, 2017, ANN EMERG MED, V70, P338, DOI 10.1016/j.annemergmed.2016.12.004; Steyerberg, 2019, CLIN PREDICTION MODE; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Weber EJ, 2019, EMERG MED J, V36, P2, DOI 10.1136/emermed-2018-208151; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	31	10	10	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open	JAN 9	2020	6	1							2	10.1186/s40798-019-0231-y			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KM0IW	WOS:000513801800001	31919687	Green Published, gold, Green Accepted			2022-02-06	
J	He, H; Shi, XJ; Wang, JY; Wang, XJ; Wang, Q; Yu, DY; Ge, BS; Zhang, XD; Huang, F				He, Hua; Shi, Xinjian; Wang, Junying; Wang, Xiaojuan; Wang, Qian; Yu, Daoyong; Ge, Baosheng; Zhang, Xiaodong; Huang, Fang			Reactive Oxygen Species-Induced Aggregation of Nanozymes for Neuron Injury	ACS APPLIED MATERIALS & INTERFACES			English	Article						nanozyme; catalytic activity; ROS-induced aggregation; organ-targeting; traumatic brain injury	PEROXIDASE-LIKE ACTIVITY; HYDROGEN-PEROXIDE; NANOPARTICLES; BRAIN; GOLD; ENZYME; NEUROINFLAMMATION; MECHANISMS; THERAPIES; CHEMISTRY	Nanozymes show excellent enzyme activity and robust catalytic properties, but the targeting capability to disease organs is limited because of lack of specificity. Herein, we developed an ultrasmall (similar to 3 nm) organic nanozyme that can gradually aggregate under a reactive oxygen species (ROS)-rich environment via a spontaneous reaction, namely, ROS-induced aggregation. The size of nanozymes is 75 and 100 times higher than the original size under (OH)-O-center dot and H2O2 environments without losing enzyme activity. In vitro experiments confirm that nanozymes prefer to aggregate in mitochondria under ROS-rich conditions. Importantly, the nanozymes show in situ ROS-induced aggregation in the brain, similar to 9 times higher uptake than ordinary nanozymes, indicating their potential for treating ROS-related diseases in the central nervous system.	[He, Hua; Shi, Xinjian; Wang, Xiaojuan; Wang, Qian; Yu, Daoyong; Ge, Baosheng; Huang, Fang] China Univ Petr East China, State Key Lab Heavy Oil Proc, Qingdao 266580, Peoples R China; [He, Hua; Shi, Xinjian; Wang, Xiaojuan; Wang, Qian; Yu, Daoyong; Ge, Baosheng; Huang, Fang] China Univ Petr East China, Coll Chem Engn, Qingdao 266580, Peoples R China; [Wang, Junying; Zhang, Xiaodong] Tianjin Univ, Sch Sci, Dept Phys, Tianjin 300350, Peoples R China		Huang, F (corresponding author), China Univ Petr East China, State Key Lab Heavy Oil Proc, Qingdao 266580, Peoples R China.; Huang, F (corresponding author), China Univ Petr East China, Coll Chem Engn, Qingdao 266580, Peoples R China.; Zhang, XD (corresponding author), Tianjin Univ, Sch Sci, Dept Phys, Tianjin 300350, Peoples R China.	xiaodongzhang@tju.edu.cn; fhuang@upc.edu.cn	Yu, Daoyong/E-5269-2013; Nanozymes, Nanozymes/D-8197-2019; Ge, Baosheng/AAT-4788-2020; Zhang, Xiaodong/F-4665-2015	Yu, Daoyong/0000-0002-3380-1897; Ge, Baosheng/0000-0001-9906-2081; Zhang, Xiaodong/0000-0002-7212-0138; He, Hua/0000-0002-6084-1034; Wang, Xiaojuan/0000-0002-2617-6317	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [21874154, 21573289, 21673292]; Fundamental Research Funds for Central UniversitiesFundamental Research Funds for the Central Universities [18CX02126A]	This work was supported by the National Natural Science Foundation of China (21874154, 21573289, and 21673292) and the Fundamental Research Funds for Central Universities (18CX02126A).	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Astete CE, 2011, ACS NANO, V5, P9313, DOI 10.1021/nn102845t; Bitner BR, 2012, ACS NANO, V6, P8007, DOI 10.1021/nn302615f; Chang MCY, 2004, J AM CHEM SOC, V126, P15392, DOI 10.1021/ja0441716; Clond MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061819; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Fan KL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03903-8; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Gao LZ, 2007, NAT NANOTECHNOL, V2, P577, DOI 10.1038/nnano.2007.260; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; He H, 2015, J MATER CHEM B, V3, P4786, DOI 10.1039/c5tb00570a; Hou CX, 2012, ACS NANO, V6, P8692, DOI 10.1021/nn302270b; Hu YH, 2018, CHEM MATER, V30, P6431, DOI 10.1021/acs.chemmater.8b02726; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Huang YY, 2019, CHEM REV, V119, P4357, DOI 10.1021/acs.chemrev.8b00672; Huang YY, 2016, ANGEW CHEM INT EDIT, V55, P6646, DOI 10.1002/anie.201600868; Li XC, 2017, J AGR FOOD CHEM, V65, P6288, DOI 10.1021/acs.jafc.7b02247; Li YY, 2015, ANGEW CHEM INT EDIT, V54, P1832, DOI 10.1002/anie.201410398; Lin YH, 2014, ADV MATER, V26, P4200, DOI 10.1002/adma.201400238; Liu CP, 2016, SMALL, V12, P4127, DOI 10.1002/smll.201503919; Liu L, 2016, CHEM COMMUN, V52, P13912, DOI 10.1039/c6cc07896f; Liu YL, 2017, J AM CHEM SOC, V139, P856, DOI 10.1021/jacs.6b11013; Lv Y, 2019, CHEM-EUR J, V25, P954, DOI 10.1002/chem.201804419; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Moglianetti M, 2016, NANOSCALE, V8, P3739, DOI 10.1039/c5nr08358c; Mu XY, 2019, ACS NANO, V13, P1870, DOI 10.1021/acsnano.8b08045; Natalio F, 2012, NAT NANOTECHNOL, V7, P530, DOI [10.1038/NNANO.2012.91, 10.1038/nnano.2012.91]; Shen XM, 2015, J AM CHEM SOC, V137, P15882, DOI 10.1021/jacs.5b10346; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Singh N, 2017, ANGEW CHEM INT EDIT, V56, P14267, DOI 10.1002/anie.201708573; Sun HJ, 2018, ANGEW CHEM INT EDIT, V57, P9224, DOI 10.1002/anie.201712469; Sun HJ, 2014, ACS NANO, V8, P6202, DOI 10.1021/nn501640q; Sun HC, 2015, ACS NANO, V9, P5461, DOI 10.1021/acsnano.5b01311; Tao Y, 2014, CHEM COMMUN, V50, P3030, DOI 10.1039/c4cc00328d; Vernekar AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6301; Wang FM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03617-x; Wang H, 2018, NANO LETT, V18, P3344, DOI 10.1021/acs.nanolett.7b05095; Wang H, 2018, SMALL, V14, DOI 10.1002/smll.201703710; Wang S, 2012, CHEMPHYSCHEM, V13, P1199, DOI 10.1002/cphc.201100906; Wang ZZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05798-x; Wu JJX, 2019, CHEM SOC REV, V48, P1004, DOI 10.1039/c8cs00457a; Yoo D, 2017, ACS NANO, V11, P8600, DOI 10.1021/acsnano.7b03426; Zhang XD, 2016, ACS NANO, V10, P4511, DOI 10.1021/acsnano.6b00321; Zhang Y, 2018, ACS NANO, V12, P651, DOI 10.1021/acsnano.7b07746	44	10	11	13	79	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244	1944-8252		ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	JAN 8	2020	12	1					209	216		10.1021/acsami.9b17509			8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Materials Science	KC4JL	WOS:000507146100016	31840496				2022-02-06	
J	Muresanu, DF; Florian, S; Homberg, V; Matula, C; von Steinbuchel, N; Vos, PE; von Wild, K; Birle, C; Muresanu, I; Slavoaca, D; Rosu, OV; Strilciuc, S; Vester, J				Muresanu, Dafin F.; Florian, Stefan; Hoemberg, Volker; Matula, Christian; von Steinbuechel, Nicole; Vos, Pieter E.; von Wild, Klaus; Birle, Codruta; Muresanu, Ioana; Slavoaca, Dana; Rosu, Olivia Verisezan; Strilciuc, Stefan; Vester, Johannes			Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial	NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Cerebrolysin; Multidimensional approach; Wei-Lachin pooling	QUALITY-OF-LIFE; GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; CLINICAL-TRIALS; HOSPITAL ANXIETY; DOUBLE-BLIND; QOLIBRI; NEUROPROTECTION; RECOMMENDATIONS; DISABILITY	Introduction The objective of this trial was to evaluate the efficacy and safety of Cerebrolysin in treating patients after moderate to severe traumatic brain injury (TBI) as an adjunct to standard care protocols. The trial was designed to investigate the clinical effects of Cerebrolysin in the acute (neuroprotective) stage and during early and long-term recovery as part of a neurorestorative strategy. Materials and methods The study was a phase IIIb/IV single-center, prospective, randomized, double-blind, placebo-controlled clinical trial. Eligible patients with a Glasgow Coma Score (GCS) between 7 and 12 received study medication (50 ml of Cerebrolysin or physiological saline solution per day for 10 days, followed by two additional treatment cycles with 10 ml per day for 10 days) in addition to standard care. We tested ensembles of efficacy criteria for 90, 30, and 10 days after TBI with a priori ordered hypotheses using a multivariate, directional test, to reflect the global status of patients after TBI. Results The study enrolled 142 patients, of which 139 underwent formal analysis (mean age = 47.4, mean admission GCS = 10.4, and mean Baseline Prognostic Risk Score = 2.6). The primary endpoint, a multidimensional ensemble of 13 outcome scales, indicated a "small-to-medium"-sized effect in favor of Cerebrolysin, statistically significant at day 90 (MWcombined = 0.59, 95% CI 0.52 to 0.66, P = 0.0119). Safety and tolerability observations were comparable between treatment groups. Conclusion Our trial confirms previous beneficial effects of the multimodal, biological agent Cerebrolysin for overall outcome after moderate to severe TBI, as measured by a multidimensional approach. Study findings must be appraised and aggregated in conjunction with existing literature, as to improve the overall level of insight regarding therapeutic options for TBI patients. The widely used pharmacologic intervention may benefit from a large-scale observational study to map its use and to establish comparative effectiveness in real-world clinical settings.	[Muresanu, Dafin F.; Florian, Stefan; Birle, Codruta; Muresanu, Ioana; Slavoaca, Dana; Rosu, Olivia Verisezan; Strilciuc, Stefan] Iuliu Hatieganu Univ Med & Pharm, Dept Neurosci, 43 Victor Babes St, Cluj Napoca 400012, Romania; [Muresanu, Dafin F.; Birle, Codruta; Muresanu, Ioana; Slavoaca, Dana; Rosu, Olivia Verisezan; Strilciuc, Stefan] RoNeuro Inst Neurol Res & Diagnost, Cluj Napoca, Romania; [Hoemberg, Volker] SRH Gesundheitszentrum Bad Wimpfen GmbH, Dept Neurol, Bei Alten Saline 2, D-74206 Bad Wimpfen, Germany; [Matula, Christian] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [von Steinbuechel, Nicole] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Vos, Pieter E.] Slingeland Hosp, Dept Neurol, Kruisbergseweg 25, NL-7009 BL Doetinchem, Netherlands; [von Wild, Klaus] Westphalia Wilhelms Univ, Med Fac, Munster, Germany; [Vester, Johannes] Idv Data Anal & Study Planning, Dept Biometry & Clin Res, Gauting, Germany		Muresanu, DF (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Dept Neurosci, 43 Victor Babes St, Cluj Napoca 400012, Romania.; Muresanu, DF (corresponding author), RoNeuro Inst Neurol Res & Diagnost, Cluj Napoca, Romania.	dafinm@ssnn.ro	Ioana Anamaria, Muresanu/ABF-9536-2021; Strilciuc, Stefan/AAC-6253-2019; Muresanu, Fior-Dafin/AAI-8120-2021; Verisezan Rosu, Olivia/ABF-9185-2021	Strilciuc, Stefan/0000-0001-6112-0223; 			Alvarez XA, 2003, INT CLIN PSYCHOPHARM, V18, P271, DOI 10.1097/07.yic.0000085765.24936.9a; Alvarez XA, 2008, J NEURAL TRANSM, V115, P683, DOI 10.1007/s00702-008-0024-9; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bagiella E, 2009, ARCH PHYS MED REHAB, V90, pS17, DOI 10.1016/j.apmr.2009.08.133; Bauer P, 1999, STAT MED, V18, P1833, DOI 10.1002/(SICI)1097-0258(19990730)18:14<1833::AID-SIM221>3.3.CO;2-V; BAUER P, 1994, BIOMETRICS, V50, P1029, DOI 10.2307/2533441; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bretz F, 2009, STAT MED, V28, P1181, DOI 10.1002/sim.3538; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen CC, 2013, BRIT J NEUROSURG, V27, P803, DOI 10.3109/02688697.2013.793287; Cohen J., 2013, STAT POWER ANAL BEHA; Colditz G A, 1988, Int J Technol Assess Health Care, V4, P637; D'Agostino RB, 2006, STAT MED; Dimitrenko A, 2010, MULTIPLE TESTING PRO; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Dorer CL, 2018, BRAIN INJURY, V32, P1040, DOI 10.1080/02699052.2018.1469166; El Sayed I, 2018, NEUROSURG REV, V41, P427, DOI 10.1007/s10143-016-0775-y; Farzanegan GR, 2017, J CLIN NEUROSCI, V44, P143, DOI 10.1016/j.jocn.2017.06.010; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghaffarpasand F, 2019, NEUROPSYCH DIS TREAT, V15, P127, DOI 10.2147/NDT.S186865; Ghalaenovi H, 2018, BRAIN INJURY, V32, P1050, DOI 10.1080/02699052.2018.1476733; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Huang P, 2008, STAT MED, V27, P3084, DOI 10.1002/sim.3182; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Iznak EV, 2010, ZH NEVROL PSIKHIATR, V110, P27; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Khalili H, 2017, CLIN NEUROL NEUROSUR, V152, P34, DOI 10.1016/j.clineuro.2016.11.011; LACHIN JM, 1992, STAT MED, V11, P1151, DOI 10.1002/sim.4780110903; LaVange LM, 2005, STAT METHODS MED RES, V14, P281, DOI 10.1191/0962280205sm397oa; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P465, DOI 10.1076/1380-3395(200008)22:4;1-0;FT465; Lu M, 2001, STAT MED, V20, P1891, DOI 10.1002/sim.841.abs; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; MAHONEY F I, 1965, Md State Med J, V14, P61; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Muresanu D, 2003, NEUROTROPHIC FACTORS; Muresanu DF, 2015, CNS NEUROL DISORD-DR, V14, P587, DOI 10.2174/1871527314666150430162531; Muresanu Dafin F., 2009, STROKE PRACTICAL GUI, P37; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Onose G, 2009, J Med Life, V2, P350; Poon W, 2020, NEUROL SCI, V41, P281, DOI 10.1007/s10072-019-04053-5; Poon W, 2015, J NEUROTRAUM, V32, P571, DOI 10.1089/neu.2014.3558; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rollnik JD, 2011, REHABILITATION, V50, P408, DOI 10.1055/s-0031-1273728; Ruozi B, 2015, MOL NEUROBIOL, V52, P899, DOI 10.1007/s12035-015-9235-x; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Skolnick BE, 2015, NEW ENGL J MED, V372, P1767, DOI 10.1056/NEJMc1503138; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wechsler DW, ADULT INTELLIGENCE S; WEI LJ, 1984, J AM STAT ASSOC, V79, P653, DOI 10.2307/2288413; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; White T., 1996, COLOR TRAILS TEST PR; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wong GKC, 2005, ACTA NEUROCHIR SUPPL, V95, P59; Zhang YL, 2018, J NEUROSURG, V129, P1295, DOI 10.3171/2017.6.JNS171007; Zhang YL, 2019, NEUROREHAB NEURAL RE, V33, P15, DOI 10.1177/1545968318809916; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	65	10	11	0	1	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	MAY	2020	41	5					1171	1181		10.1007/s10072-019-04181-y		JAN 2020	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LI8WX	WOS:000505377400002	31897941				2022-02-06	
J	Corrales, MA; Gierczycka, D; Barker, J; Bruneau, D; Bustamante, MC; Cronin, DS				Corrales, M. A.; Gierczycka, D.; Barker, J.; Bruneau, D.; Bustamante, M. C.; Cronin, D. S.			Validation of a Football Helmet Finite Element Model and Quantification of Impact Energy Distribution	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Impact; Head injury; Anthropomorphic test device; Helmet design	STATES HIGH-SCHOOL; PROFESSIONAL FOOTBALL; BIOMECHANICS; CONCUSSIONS; KINEMATICS	Head injury in contact sports can be mitigated, in part, through the enhancement of protective helmets that may be enabled by detailed finite element models. However, many contemporary helmet FE models include simplified geometry and material properties and have limited verification and validation over a representative range of impact conditions. To address these limitations, a detailed numerical model of a modern football helmet was developed, integrated with two headforms and assessed for 60 impact conditions with excellent ratings (0.79-0.93). The strain energy of the helmet components was investigated for eight impact locations and three impact speeds. In general, the helmet shell had the highest strain energy followed by the compression shocks; however, the facemask and straps had the highest strain energy for impacts involving the facemask. The component strain energy was positively correlated with the Head Injury Criterion, while the strain energy was not strongly correlated with the Brain Injury Criterion due to the dependence on rotational kinematics. This study demonstrated the applicability of a detailed football helmet finite element model to investigate a range of impact conditions and to assess energy distribution as a function of impact location and severity as a means of future helmet optimization.	[Corrales, M. A.; Gierczycka, D.; Barker, J.; Bruneau, D.; Bustamante, M. C.; Cronin, D. S.] Univ Waterloo, Dept Mech & Mechatron Engn, 200 Univ Ave West, University, ON N2L 3G1, Canada		Cronin, DS (corresponding author), Univ Waterloo, Dept Mech & Mechatron Engn, 200 Univ Ave West, University, ON N2L 3G1, Canada.	duane.cronin@uwaterloo.ca	Corrales, Miguel A./AAG-1494-2019	Bruneau, David/0000-0002-8612-1959	Football Research, Inc. (FRI); National Football League (NFL); Biomechanical Consulting and Research, LLC (Biocore)	The research presented in this paper was made possible by a grant from Football Research, Inc. (FRI), the National Football League (NFL), and Biomechanical Consulting and Research, LLC (Biocore). The authors acknowledge the contributions of the NFLPA. The views expressed are solely those of the authors and do not represent those of FRI, the NFL, Biocore, or any of their affiliates or funding sources.	Barbat S., 2013, 21 ESV C SEOUL; Barker J. B., 2018, CONTRIBUTION ENERGY; Bustamante MC, 2019, J DYNAM BEHAV MAT, V5, P117, DOI 10.1007/s40870-019-00189-9; Darling T, 2016, COMPUT METHOD BIOMEC, V19, P1432, DOI 10.1080/10255842.2016.1149574; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Gehre C., 2009, OBJECTIVE RATING SIG; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hoshizaki T. B., 2010, 5 INT S SAF IC HOCK; Johnson KL, 2016, MATER DESIGN, V111, P108, DOI 10.1016/j.matdes.2016.08.064; Johnston JM, 2015, SPORTS ENG, V18, P11, DOI 10.1007/s12283-014-0160-4; King A. I, 2003, IS HEAD INJURY CAUSE; Kleiven S., 2015, FRONT BIOENG BIOTECH, V1, P15; Lamb L, 2009, P I MECH ENG H, V223, P1021, DOI 10.1243/09544119JEIM573; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; National Operating Committee on Standards for Athletic Equipment, 2007, STAND TEST METH EQ U; NFL, NFL SAF TECH 2; NFL, ENG ROAD MAP; NOCSAE, 2019, STAND LIN IMP TEST M; NOCSAE, 2019, STAND PERF SPEC NEWL; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; ROACHE PJ, 1994, J FLUID ENG-T ASME, V116, P405, DOI 10.1115/1.2910291; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Schap JM, 2019, ANN BIOMED ENG, V47, P512, DOI 10.1007/s10439-018-02180-2; Sproule DW, 2017, P I MECH ENG P-J SPO, V231, P317, DOI 10.1177/1754337117703019; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; van der Laan E, 2009, INT J CRASHWORTHINES, V14, P323, DOI 10.1080/13588260902774937; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Withnall, 2017, NFL LINEAR IMPACTOR; YU HY, 2017, JOVE-J VIS EXP, DOI DOI 10.3791/56288; Zhang L., 2003, EFFECTIVENESS OF THE; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	39	10	10	2	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2020	48	1					121	132		10.1007/s10439-019-02359-1			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	KI8PN	WOS:000511620300014	31549326				2022-02-06	
J	Elbogen, EB; Molloy, K; Wagner, HR; Kimbrel, NA; Beckham, JC; Van Male, L; Leinbach, J; Bradford, DW				Elbogen, Eric B.; Molloy, Kiera; Wagner, H. Ryan; Kimbrel, Nathan A.; Beckham, Jean C.; Van Male, Lynn; Leinbach, Jonathan; Bradford, Daniel W.			Psychosocial protective factors and suicidal ideation: Results from a national longitudinal study of veterans	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Suicidal ideation; Protective factors; Veterans; Psychosocial rehabilitation	TRAUMATIC BRAIN-INJURY; US MILITARY VETERANS; MENTAL-HEALTH; RISK-FACTORS; RESILIENCE SCALE; IRAQ; DEPRESSION; BEHAVIOR; PTSD; PERSONNEL	Background: This study investigates the empirical association between psychosocial protective factors and subsequent suicidal ideation in veterans. Methods: We conducted a national longitudinal survey in which participants were randomly drawn from over one million U.S. military service members who served after September 11, 2001. Data were provided by a total of 1090 veterans representative of all 50 states and all military branches in two waves of data collection one year apart (79% retention rate). Results: In chi-square analyses, psychosocial protective factors at wave 1 (employment, meeting basic needs, self-care, living stability, social support, spirituality, resilience, and self-determination) were significantly related to lower suicidal ideation at wave 2. In multivariable analyses controlling for covariates at wave 1 including suicidal ideation, the total number of protective factors endorsed at wave 1 significantly predicted reduced odds of suicidal ideation at wave 2. In multivariable analysis examining individual risk and protective factors, again controlling for covariates, results showed that money to cover basic needs and higher psychological resilience at wave 1 were associated with significantly lower odds of suicidal ideation at wave 2. Limitations: The study measured the link between psychosocial protective factors and suicidal ideation but not suicide attempts, which would be an important next step for this research. Conclusions: The results indicate that psychosocial rehabilitation and holistic approaches targeting financial well-being, homelessness, resilience, self-care, social support, spirituality, and work may offer a promising avenue in both veteran and non-veteran populations for treatment safety planning as well as suicide risk management and prevention.	[Elbogen, Eric B.; Wagner, H. Ryan; Kimbrel, Nathan A.; Beckham, Jean C.; Leinbach, Jonathan; Bradford, Daniel W.] Durham VA Hlth Care Syst, Durham, NC USA; [Elbogen, Eric B.; Wagner, H. Ryan; Kimbrel, Nathan A.; Beckham, Jean C.] Durham VA Med Ctr, VISN 6, MIRECC, Durham, NC USA; [Elbogen, Eric B.; Molloy, Kiera; Wagner, H. Ryan; Kimbrel, Nathan A.; Beckham, Jean C.; Leinbach, Jonathan; Bradford, Daniel W.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27705 USA; [Van Male, Lynn] Off Mental Hlth & Suicide Prevent, Vet Hlth Adm, Washington, DC USA; [Van Male, Lynn] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA		Elbogen, EB (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27705 USA.	eric.elbogen@duke.edu			National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH080988]; Office of Research and Development Clinical Science, Department of Veterans AffairsUS Department of Veterans Affairs; Mid-Atlantic Mental Illness Research, Education and Clinical Center	We would like to extend our sincere thanks to the participants who volunteered for this study. Preparation of this manuscript was supported by the National Institute of Mental Health (R01MH080988), the Office of Research and Development Clinical Science, Department of Veterans Affairs, and the Mid-Atlantic Mental Illness Research, Education and Clinical Center.	Agaibi CE, 2005, TRAUMA VIOLENCE ABUS, V6, P195, DOI 10.1177/1524838005277438; ANTHONY WA, 1986, SCHIZOPHRENIA BULL, V12, P542, DOI 10.1093/schbul/12.4.542; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Bradley KA, 1998, J GEN INTERN MED, V13, P379, DOI 10.1046/j.1525-1497.1998.00118.x; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Currier JM, 2016, INT J PSYCHOL RELIG, V26, P167, DOI 10.1080/10508619.2015.1019793; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Defense Manpower Data Center, 2010, FY2009 ANN DEM PROF; Dillman D.A., 2009, INTERNET MAIL MIXED, V3rd ed.; Eisen SV, 2014, AM J PREV MED, V47, P754, DOI 10.1016/j.amepre.2014.07.049; Elbogen EB, 2013, PSYCHIAT SERV, V64, P134, DOI 10.1176/appi.ps.004792011; FERRANS CE, 1992, RES NURS HEALTH, V15, P29, DOI 10.1002/nur.4770150106; Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3; Fonda JR, 2017, AM J EPIDEMIOL, V186, P220, DOI 10.1093/aje/kwx044; Franklin JC, 2017, PSYCHOL BULL, V143, P187, DOI 10.1037/bul0000084; Friedman MJ, 2015, JAMA-J AM MED ASSOC, V313, P1154, DOI 10.1001/jama.2014.15303; Gensichen J, 2010, J AFFECT DISORDERS, V125, P124, DOI 10.1016/j.jad.2009.12.008; Glynn S. M., 2009, EFFECTIVE TREATMENTS, V2, P388, DOI DOI 10.1002/PON.660; Goodwin RD, 2003, PSYCHOSOM MED, V65, P501, DOI 10.1097/01.PSY.0000041544.14277.EC; Green KT, 2014, ASSESSMENT, V21, P443, DOI 10.1177/1073191114524014; Hellmuth JC, 2012, J TRAUMA STRESS, V25, P527, DOI 10.1002/jts.21732; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Isaacs K, 2017, J PSYCHIATR RES, V84, P301, DOI 10.1016/j.jpsychires.2016.10.017; Iversen AC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-68; Jobes DA, 2005, SUICIDE LIFE-THREAT, V35, P483, DOI 10.1521/suli.2005.35.5.483; Johnson J, 2011, CLIN PSYCHOL REV, V31, P563, DOI 10.1016/j.cpr.2010.12.007; Joiner TE, 2005, J ABNORM PSYCHOL, V114, P291, DOI 10.1037/0021-843X.114.2.291; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Kaplan MS, 2007, J EPIDEMIOL COMMUN H, V61, P619, DOI 10.1136/jech.2006.054346; Kim S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162929; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; LeardMann CA, 2013, JAMA-J AM MED ASSOC, V310, P496, DOI 10.1001/jama.2013.65164; LePage J. P., 2006, PSYCHOL SERV, V3, P16, DOI DOI 10.1037/1541-1559.3.1.16; Martz E, 2009, J CLIN PSYCHOL, V65, P94, DOI 10.1002/jclp.20541; McLean CP, 2017, J AFFECT DISORDERS, V208, P392, DOI 10.1016/j.jad.2016.08.061; Nock MK, 2014, JAMA PSYCHIAT, V71, P514, DOI 10.1001/jamapsychiatry.2014.30; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Penk W, 2009, PSYCHIATR REHABIL J, V33, P297, DOI 10.2975/33.4.2010.297.307; Perkins DF, 2002, J ADOLESCENT RES, V17, P3, DOI 10.1177/0743558402171001; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Raines AM, 2017, J AFFECT DISORDERS, V222, P57, DOI 10.1016/j.jad.2017.06.035; Ro E, 2009, PSYCHOL ASSESSMENT, V21, P313, DOI 10.1037/a0016611; Rojas SM, 2014, J ANXIETY DISORD, V28, P318, DOI 10.1016/j.janxdis.2014.02.004; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Schutt RK, 2003, PSYCHIATR REHABIL J, V27, P186, DOI 10.2975/27.2003.186.189; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Sharma V, 2017, J AFFECT DISORDERS, V217, P197, DOI 10.1016/j.jad.2017.03.071; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Smith NB, 2016, J AFFECT DISORDERS, V197, P66, DOI 10.1016/j.jad.2016.02.069; Spaulding W. D., 2003, TREATMENT REHABILITA; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tsai J, 2019, J EPIDEMIOL COMMUN H, V73, P346, DOI 10.1136/jech-2018-211065; U.S. Department of Veterans Affairs Office of Mental Health and Suicide Prevention, 2018, FACTS VET SUIC AUG 2; Ursano RJ, 2018, JAMA PSYCHIAT, V75, P596, DOI 10.1001/jamapsychiatry.2018.0296; Vogt D, 2011, J ABNORM PSYCHOL, V120, P797, DOI 10.1037/a0023452; Whitley E, 1999, BRIT MED J, V319, P1034, DOI 10.1136/bmj.319.7216.1034; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Yano EM, 2012, J GEN INTERN MED, V27, P331, DOI 10.1007/s11606-011-1904-5; Yehuda R, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.57	64	10	10	0	47	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	JAN 1	2020	260						703	709		10.1016/j.jad.2019.09.062			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	JE1BQ	WOS:000490428300088	31561113	Green Accepted			2022-02-06	
J	Quintero, LM; Moore, JW; Yeager, MG; Rowsey, K; Olmi, DJ; Britton-Slater, J; Harper, ML; Zezenski, LE				Quintero, Laura M.; Moore, James W.; Yeager, M. Garrett; Rowsey, Kyle; Olmi, D. Joe; Britton-Slater, Joshua; Harper, Michaela L.; Zezenski, Lauren E.			Reducing risk of head injury in youth soccer: An extension of behavioral skills training for heading	JOURNAL OF APPLIED BEHAVIOR ANALYSIS			English	Article						behavioral skills training; concussion; social validity; sports-related applications of behavior analysis; traumatic brain injury	CHRONIC TRAUMATIC ENCEPHALOPATHY; SPORT-RELATED CONCUSSION; TACKLING SKILLS; VIDEO FEEDBACK; HIGH-SCHOOL; FOOTBALL; COLLEGIATE; STATEMENT; MEDICINE; PLAYER	Recently, concerns regarding sport-related concussions have increased within the research literature, the media, and popular culture. One potential source of soccer-related concussions involves the purposeful striking of the ball with one's head (i.e., heading). There is currently limited research on an effective teaching method to improve safe heading technique. In the current study, Behavior Skills Training (BST) was evaluated as a method to teach correct heading techniques to youth soccer players. BST increased the percentage of correct steps for each player based on a task analysis of heading. Based on social validity questionnaires administered to players and the coach, BST was rated as an acceptable form of training. After the final training session, experienced coaches rated each player as having improved from baseline to training.	[Quintero, Laura M.; Moore, James W.; Yeager, M. Garrett; Rowsey, Kyle; Olmi, D. Joe; Britton-Slater, Joshua; Harper, Michaela L.; Zezenski, Lauren E.] Univ Southern Mississippi, Hattiesburg, MS 39406 USA; [Quintero, Laura M.] Mississippi State Univ, Starkville, MS USA; [Moore, James W.; Yeager, M. Garrett] Canopy Childrens Solut, Jackson, MS 39216 USA; [Rowsey, Kyle] Northern Michigan Univ, Marquette, MI USA		Moore, JW (corresponding author), Canopy Childrens Solut, Autism Solut, 1465 Lakeland Dr, Jackson, MS 39216 USA.	james.moore@mycanopy.org					ALLISON MG, 1980, J APPL BEHAV ANAL, V13, P297, DOI 10.1901/jaba.1980.13-297; Barker LK, 2019, J ORGAN BEHAV MANAGE, V39, P145, DOI 10.1080/01608061.2019.1632240; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; BenitezSantiago A, 2016, BEHAV INTERVENT, V31, P12, DOI 10.1002/bin.1424; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Carrion TJ, 2019, J DEV PHYS DISABIL, V31, P151, DOI 10.1007/s10882-018-9630-0; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention National Center for Injury Prevention Control, 2010, HEADS ONL TRAIN COUR; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Delaney J Scott, 2005, Clin J Sport Med, V15, P216, DOI 10.1097/01.jsm.0000168077.74497.a4; Downs HE, 2015, J APPL BEHAV ANAL, V48, P930, DOI 10.1002/jaba.248; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kelley H, 2016, J APPL BEHAV ANAL, V49, P138, DOI 10.1002/jaba.272; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Luiselli JK, 2011, J APPL BEHAV ANAL, V44, P999, DOI 10.1901/jaba.2011.44-999; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moore JW, 2019, J APPL BEHAV ANAL, V52, P50, DOI 10.1002/jaba.517; National Research Council Committee on Sports-Related Concussions in Youth, 2014, SPORTS RELATED CONCU; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Quinn M, 2017, BEHAV INTERVENT, V32, P370, DOI 10.1002/bin.1492; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Stokes JV, 2010, J APPL BEHAV ANAL, V43, P509, DOI 10.1901/jaba.2010.43-509; Tai SSM, 2017, J APPL BEHAV ANAL, V50, P849, DOI 10.1002/jaba.412; United States Youth Soccer, 2018, US YOUTH SOCC POL PL	34	10	10	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8855	1938-3703		J APPL BEHAV ANAL	J. Appl. Behav. Anal.	JAN	2020	53	1					237	248		10.1002/jaba.557			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	KD8LP	WOS:000508113300016	30924148				2022-02-06	
J	Levy, D; Gruener, H; Riabinin, M; Feingold, Y; Schreiber, S; Pick, CG; Defrin, R				Levy, Dan; Gruener, Hila; Riabinin, Miri; Feingold, Yelena; Schreiber, Shaul; Pick, Chaim G.; Defrin, Ruth			Different clinical phenotypes of persistent post-traumatic headache exhibit distinct sensory profiles	CEPHALALGIA			English	Article						Post-traumatic headache; quantitative sensory testing; hyperalgesia; hypoalgesia; post-traumatic stress disorder	TRAUMATIC BRAIN-INJURY; PRESSURE PAIN THRESHOLDS; STRESS-DISORDER; MIGRAINE; STIMULATION; PREDICTORS; MECHANISM	Introduction Persistent post-traumatic headache remains a poorly understood clinical entity. Although there are currently no accepted therapies for persistent post-traumatic headache, its clinical symptoms, which primarily resemble those of migraine or tension-type headache, often serve to guide treatment. However, evidence-based justification for this treatment approach remains lacking given the paucity of knowledge regarding the characteristics of these two major persistent post-traumatic headache phenotypes and their etiology. Methods We compared clinical features and quantitative sensory testing profiles between two distinct cohorts of persistent post-traumatic headache subjects that exhibited symptoms resembling either migraine (n = 15) or tension-type headache (n = 13), as well as to headache-free subjects that had suffered traumatic brain injury (n = 19), and to healthy controls (n = 10). We aimed to determine whether the two persistent post-traumatic headache subgroups could be discriminated based on additional clinical features, distinct quantitative sensory testing profiles, or the interaction of pain severity with the level of post-traumatic stress disorder. Results Persistent post-traumatic headache subjects with migraine-like symptoms reported that bright light and focused attention aggravated their pain, while stress and nervousness were reported to aggravate the headache in subjects with tension-type headache-like symptoms. Quietness was better in alleviating migraine-like persistent post-traumatic headache, while anti-inflammatory medications provided better relief in tension-type headache-like persistent post-traumatic headache. The two persistent post-traumatic headache subgroups exhibited distinct quantitative sensory testing profiles with subjects exhibiting tension-type headache-like persistent post-traumatic headache displaying a more pronounced cephalic and extracephalic thermal hypoalgesia that was accompanied by cephalic mechanical hyperalgesia. While both persistent post-traumatic headache subgroups had high levels of post-traumatic stress disorder, there was a positive correlation with pain severity in subjects with tension-type headache-like symptoms, but a negative correlation in subjects with migraine-like symptoms. Conclusions Distinct persistent post-traumatic headache symptoms and quantitative sensory testing profiles may be linked to different etiologies, potentially involving various levels of neuropathic and inflammatory pain, and if confirmed in a larger cohort, could be used to further characterize and differentiate between persistent post-traumatic headache subgroups in studies aimed to improve treatment.	[Levy, Dan] Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, 330 Brookline Ave, Boston, MA 02215 USA; [Levy, Dan] Harvard Med Sch, Boston, MA 02115 USA; [Gruener, Hila; Defrin, Ruth] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, Tel Aviv, Israel; [Gruener, Hila; Defrin, Ruth] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Riabinin, Miri; Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Feingold, Yelena] Sheba Med Ctr, Dept Neurol, Ramat Gan, Israel; [Schreiber, Shaul] Tel Aviv Sourasky Med Ctr, Dept Psychiat, Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel		Levy, D (corresponding author), Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, 330 Brookline Ave, Boston, MA 02215 USA.	dlevy1@bidmc.harvard.edu	Levy, Dan/AAF-1871-2021; Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693; Levy, Dan/0000-0003-0630-6660	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS078263, R01NS086830, R21NS101405]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr. Levy is supported by NIH Grants R01NS078263; R01NS086830, R21NS101405.	Antonaci F, 1998, SCAND J REHABIL MED, V30, P3; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Becker WJ, 2015, HEADACHE, V55, P778, DOI 10.1111/head.12550; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bomyea J, 2016, HEADACHE, V56, P699, DOI 10.1111/head.12799; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Cappon D, 2019, CEPHALALGIA, V39, P1099, DOI 10.1177/0333102419839957; Castien RF, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0833-7; Cathcart S, 2010, CEPHALALGIA, V30, P1250, DOI 10.1177/0333102410362927; Chong CD, 2019, CEPHALALGIA, V39, P1121, DOI 10.1177/0333102418815650; Clark J, 2017, PAIN PHYSICIAN, V20, P487; Cruz-Almeida Y, 2014, PAIN MED, V15, P61, DOI 10.1111/pme.12230; de Tommaso M, 2003, PAIN, V104, P111, DOI 10.1016/S0304-3959(02)00485-2; Defrin R, 2003, PAIN, V106, P471, DOI 10.1016/j.pain.2003.09.010; Defrin R, 2001, PAIN, V89, P253, DOI 10.1016/S0304-3959(00)00369-9; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Dumkrieger G, 2019, CEPHALALGIA, V39, P1366, DOI 10.1177/0333102419847728; Finnerup NB, 2003, BRAIN, V126, P57, DOI 10.1093/brain/awg007; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Howard L, 2018, HEADACHE, V58, P1397, DOI 10.1111/head.13396; JENNETT B, 1976, LANCET, V1, P1031; Jensen R, 1998, HEADACHE, V38, P10, DOI 10.1046/j.1526-4610.1998.3801010.x; Kamins J, 2018, HEADACHE, V58, P811, DOI 10.1111/head.13312; Kelman L, 2005, HEADACHE, V45, P1038, DOI 10.1111/j.1526-4610.2005.05185.x; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kosek E, 1999, SCAND J REHABIL MED, V31, P89; LANGEMARK M, 1989, PAIN, V38, P203, DOI 10.1016/0304-3959(89)90239-X; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Mickleborough MJS, 2011, J PSYCHIATR NEUROSCI, V36, P6, DOI 10.1503/jpn.080188; Nahman-Averbuch H, 2018, PAIN, V159, P1202, DOI 10.1097/j.pain.0000000000001231; Noseda R, 2019, CEPHALALGIA, V39, P1623, DOI 10.1177/0333102418784750; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Ravn SL, 2018, PAIN, V159, P2159, DOI 10.1097/j.pain.0000000000001331; Romesser J, 2012, J REHABIL RES DEV, V49, P1127, DOI 10.1682/JRRD.2010.12.0238; Roper LS, 2017, J PAIN RES, V10, P1991, DOI 10.2147/JPR.S129808; Rosenthal JF, 2013, HEADACHE, V53, P1564, DOI 10.1111/head.12200; Saunders K, 2008, NEUROLOGY, V70, P538, DOI 10.1212/01.wnl.0000297192.84581.21; Schwedt TJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00615; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Slotty PJ, 2015, CEPHALALGIA, V35, P73, DOI 10.1177/0333102414534082; SOLOMON Z, 1993, ISRAEL J PSYCHIAT, V30, P110; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Starling AJ, 2019, P 61 ANN SCI M AM HE, P17; Stiasny-Kolster K, 2004, BRAIN, V127, P773, DOI 10.1093/brain/awh079; Vargas BB, 2012, CURR OPIN NEUROL, V25, P284, DOI 10.1097/WCO.0b013e3283535bf5; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Weissman-Fogel I, 2003, PAIN, V104, P693, DOI 10.1016/S0304-3959(03)00159-3; Zeilig G, 2013, PAIN, V154, P959, DOI 10.1016/j.pain.2013.03.012; Zeilig G, 2012, BRAIN, V135, P418, DOI 10.1093/brain/awr270	53	10	10	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	JUN	2020	40	7					675	688	0333102419896368	10.1177/0333102419896368		DEC 2019	14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU9XB	WOS:000503124200001	31847569				2022-02-06	
J	Li, ZK; Xu, RJ; Zhu, XD; Li, YF; Wang, Y; Xu, W				Li, Zhikun; Xu, Ruijun; Zhu, Xiaodong; Li, Yifan; Wang, Yi; Xu, Wei			MicroRNA-23a-3p improves traumatic brain injury through modulating the neurological apoptosis and inflammation response in mice	CELL CYCLE			English	Article						MicroRNA-23a-3p; traumatic brain injury; primary cortical neurons	NEURONAL CELL-DEATH; MAMMALIAN TARGET; STEM-CELLS; EXPRESSION; INHIBITION; PTEN; PROTECTS; AKT; NEUROPROTECTION; EPIDEMIOLOGY	Secondary brain damage plays an important role in Traumatic brain injury (TBI) and inhibition of this damage has benefit for TBI treatment. However, the pathogenesis of secondary brain damage remains largely unknown. Here, we tried to explore the influence of microRNAs (miRNAs) on neuron apoptosis and inflammatory response after TBI. Firstly, the miRNA expression profiles were analyzed in the cerebral cortex tissues from the TBI mice model (controlled cortical impact) using miRNA microarray. miR-23a-3p (miR-23a) attracted our attention as its suppressive effects on apoptosis and inflammation. The further results showed that miR-23a upregulation improved long-term neurological function, the neuron apoptosis, and inhibited neuroinflammation, whereas knockdown of miR-23a had an opposite result. Using etoposide-induced primary cortical neurons injury model, we found that miR-23a was decreased in this cell model and miR-23a overexpression-suppressed etoposide induced the activity of caspase 3 and the releases of inflammatory mediators in primary cortical neurons. Phosphatase and tensin homolog (PTEN), a well-known regulator of the AKT/mTOR pathway, was found to be a direct target of miR-23a in the primary cortical neurons. Most importantly, it was found that miR-23a overexpression reactivated the AKT/mTOR pathway in TBI mice model, as demonstrated by the upregulation of phosphorylated (p-)AKT and p-mTOR. Taken together, these data indicate that miR-23a may serve as a therapeutic target for the treatment of TBI.	[Li, Zhikun; Xu, Ruijun; Zhu, Xiaodong; Li, Yifan; Wang, Yi; Xu, Wei] Shanghai Jiao Tong Univ, TongRen Hosp, Sch Med, Dept Orthoped Surg, Shanghai, Peoples R China		Xu, W (corresponding author), Shanghai Jiao Tong Univ, TongRen Hosp, Sch Med, Dept Orthoped Surg, Shanghai, Peoples R China.	weixuwx12@163.com		Li, zhikun/0000-0002-1732-5931	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501897]; Shanghai Municipal Commission of Health and Family Planning of Science and Research Fund [20154Y0070]; Hong Kong K.C. Wong Educational Foundation	The study was supported by National Natural Science Foundation of China (81501897), Shanghai Municipal Commission of Health and Family Planning of Science and Research Fund (20154Y0070), and Hong Kong K.C. Wong Educational Foundation.	Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brogan RJ, 2017, BRAIN INJURY, V31, P581, DOI 10.1080/02699052.2017.1287956; Chen A, 2013, MOL MED REP, V8, P1011, DOI 10.3892/mmr.2013.1628; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; Chen W, 2019, J CHEM NEUROANAT, V99, P1, DOI 10.1016/j.jchemneu.2019.05.003; Chen X, 2010, NEUROL RES, V32, P1097, DOI 10.1179/016164110X12681290831162; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cuello-Carrion FD, 1999, J HISTOCHEM CYTOCHEM, V47, P837, DOI 10.1177/002215549904700614; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Ding JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063850; Dong ZH, 2019, AM J PHYSIOL-GASTR L, V316, pG539, DOI 10.1152/ajpgi.00249.2018; Eme R, 2017, BRAIN SCI, P7; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Han ZJ, 2017, ONCOL REP, V38, P3064, DOI 10.3892/or.2017.5938; Henry RJ, 2019, NEUROTHERAPEUTICS, V16, P216, DOI 10.1007/s13311-018-0665-9; Hill R, 2009, J BIOL CHEM, V284, P11755, DOI 10.1074/jbc.R800071200; Hu JZ, 2013, J NEUROTRAUM, V30, P1349, DOI 10.1089/neu.2012.2748; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Ji W, 2018, NEUROCHEM RES, V43, P1863, DOI 10.1007/s11064-018-2602-z; Kou Y, 2016, EUR REV MED PHARMACO, V20, P4286; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liang JW, 2018, DRUG DES DEV THER, V12, P845, DOI 10.2147/DDDT.S160046; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Liu R, 2019, MOL IMMUNOL, V112, P30, DOI 10.1016/j.molimm.2019.04.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2016, AM J TRANSL RES, V8, P1895; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Ma YH, 2011, BRAIN RES BULL, V86, P441, DOI 10.1016/j.brainresbull.2011.07.007; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sun LQ, 2017, ONCOTARGET, V8, P59181, DOI 10.18632/oncotarget.19469; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tian K, 2015, CANCER GENE THER, V22, P351, DOI 10.1038/cgt.2015.27; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wei HL, 2018, BIOCHEM BIOPH RES CO, V503, P467, DOI 10.1016/j.bbrc.2018.04.154; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Xu KB, 2018, CHEM-BIOL INTERACT, V286, P96, DOI 10.1016/j.cbi.2018.02.028; Xu L, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00498; Yakovlev AG, 2001, MOL MED, V7, P205, DOI 10.1007/BF03401955; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Zhang M, 2018, INT IMMUNOPHARMACOL, V65, P64, DOI 10.1016/j.intimp.2018.09.046; Zhao HP, 2014, BRAIN RES, V1592, P65, DOI 10.1016/j.brainres.2014.09.055; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	63	10	11	3	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4101	1551-4005		CELL CYCLE	Cell Cycle	JAN 2	2020	19	1					24	38		10.1080/15384101.2019.1691763		DEC 2019	15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	OM4SR	WOS:000501691400001	31818176	Bronze, Green Published			2022-02-06	
J	Siponkoski, ST; Martinez-Molina, N; Kuusela, L; Laitinen, S; Holma, M; Ahlfors, M; Jordan-Kilkki, P; Ala-Kauhaluoma, K; Melkas, S; Pekkola, J; Rodriguez-Fornells, A; Laine, M; Ylinen, A; Rantanen, P; Koskinen, S; Lipsanen, J; Sarkamo, T				Siponkoski, Sini-Tuuli; Martinez-Molina, Noelia; Kuusela, Linda; Laitinen, Sari; Holma, Milla; Ahlfors, Mirja; Jordan-Kilkki, Paeivi; Ala-Kauhaluoma, Katja; Melkas, Susanna; Pekkola, Johanna; Rodriguez-Fornells, Antoni; Laine, Matti; Ylinen, Aarne; Rantanen, Pekka; Koskinen, Sanna; Lipsanen, Jari; Sarkamo, Teppo			Music Therapy Enhances Executive Functions and Prefrontal Structural Neuroplasticity after Traumatic Brain Injury: Evidence from a Randomized Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						executive function; music therapy; traumatic brain injury; voxel-based morphometry	RHYTHMIC AUDITORY-STIMULATION; FRONTAL ASSESSMENT BATTERY; WORKING-MEMORY; COGNITIVE REHABILITATION; SPATIAL NORMALIZATION; MULTIPLE IMPUTATION; CORTICAL THICKNESS; CONGENITAL AMUSIA; CHRONIC STROKE; OUTCOME SCALE	Traumatic brain injury (TBI) causes lifelong cognitive deficits, particularly impairments of executive functioning (EF). Musical training and music-based rehabilitation have been shown to enhance cognitive functioning and neuroplasticity, but the potential rehabilitative effects of music in TBI are still largely unknown. The aim of the present crossover randomized controlled trial (RCT) was to determine the clinical efficacy of music therapy on cognitive functioning in TBI and to explore its neural basis. Using an AB/BA design, 40 patients with moderate or severe TBI were randomized to receive a 3-month neurological music therapy intervention either during the first (AB, n = 20) or second (BA, n = 20) half of a 6-month follow-up period. Neuropsychological and motor testing and magnetic resonance imaging (MRI) were performed at baseline and at the 3-month and 6-month stage. Thirty-nine subjects who participated in baseline measurement were included in an intention-to-treat analysis using multiple imputation. Results showed that general EF (as indicated by the Frontal Assessment Battery [FAB]) and set shifting improved more in the AB group than in the BA group over the first 3-month period and the effect on general EF was maintained in the 6-month follow-up. Voxel-based morphometry (VBM) analysis of the structural MRI data indicated that gray matter volume (GMV) in the right inferior frontal gyrus (IFG) increased significantly in both groups during the intervention versus control period, which also correlated with cognitive improvement in set shifting. These findings suggest that neurological music therapy enhances EF and induces fine-grained neuroanatomical changes in prefrontal areas.	[Siponkoski, Sini-Tuuli; Martinez-Molina, Noelia; Sarkamo, Teppo] Univ Helsinki, Dept Psychol & Logoped, Cognit Brain Res Unit, Haartmaninkatu 3,Room F212,POB 21, FI-00014 Helsinki, Finland; [Kuusela, Linda] Univ Helsinki, Dept Phys, Helsinki, Finland; [Koskinen, Sanna; Lipsanen, Jari] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland; [Kuusela, Linda; Pekkola, Johanna] Helsinki Univ Cent Hosp, Dept Radiol, HUS Med Imaging Ctr, Helsinki, Finland; [Kuusela, Linda; Pekkola, Johanna] Univ Helsinki, Helsinki, Finland; [Laitinen, Sari] Espoo Hosp, Espoo, Finland; [Holma, Milla] Mus Therapy Cooperat InstruMental, Helsinki, Finland; [Jordan-Kilkki, Paeivi] Dial Partner Oy, Espoo, Finland; [Ala-Kauhaluoma, Katja] Assessment & Intervent Serv, Helsinki, Finland; [Melkas, Susanna; Ylinen, Aarne] Helsinki Univ Cent Hosp, Dept Neurol, Helsinki, Finland; [Melkas, Susanna; Ylinen, Aarne] Helsinki Univ Cent Hosp, Brain Injury Outpatient Clin, Helsinki, Finland; [Rodriguez-Fornells, Antoni] Bellvitge Biomed Res Inst, Cognit & Brain Plast Grp, Barcelona, Spain; [Rodriguez-Fornells, Antoni] Univ Barcelona, Dept Cognit Dev & Educ Psychol, Barcelona, Spain; [Rodriguez-Fornells, Antoni] Catalan Inst Res & Adv Studies, Barcelona, Spain; [Laine, Matti] Abo Akad Univ, Dept Psychol, Turku, Finland; [Ylinen, Aarne] Tampere Univ Hosp, Tampere, Finland; [Rantanen, Pekka] Kanta Hame Cent Hosp, Hameenlinna, Finland		Siponkoski, ST (corresponding author), Univ Helsinki, Dept Psychol & Logoped, Cognit Brain Res Unit, Haartmaninkatu 3,Room F212,POB 21, FI-00014 Helsinki, Finland.	sini-tuuli.siponkoski@helsinki.fi		Koskinen, Sanna/0000-0002-3453-5084; Martinez-Molina, Noelia/0000-0001-7699-5540; Lipsanen, Jari Olavi/0000-0003-0746-2745; Siponkoski, Sini-Tuuli/0000-0001-8078-3620; Melkas, Susanna/0000-0003-0564-9637	Academy of FinlandAcademy of FinlandEuropean Commission [277693, 299044, 306625]; University of Helsinki [313/51/2013]; Social Insurance Institution of Finland [18/26/2013]; Yrjo Johansson Foundation [6464]; Helsinki Uusimaa Hospital district [461/13/01/00/2015, 154/13/01/2016]; Finnish Association of People with Physical Disabilities	Financial support was provided by the Academy of Finland (grants no. 277693, 299044, 306625), University of Helsinki (grant no. 313/51/2013), Social Insurance Institution of Finland (grant no. 18/26/2013), Yrjo Johansson Foundation (grant no. 6464), and the Finnish Association of People with Physical Disabilities and Helsinki Uusimaa Hospital district (grants no. 461/13/01/00/2015 and 154/13/01/2016).	Albouy P, 2013, BRAIN, V136, P1639, DOI 10.1093/brain/awt082; Amengual JL, 2014, J NEUROPHYSIOL, V112, P2251, DOI 10.1152/jn.00735.2013; Amengual JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061883; Andersen SM, 2010, NEUROIMAGE, V53, P78, DOI 10.1016/j.neuroimage.2010.06.003; [Anonymous], 1948, PURD PEGB; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baker F, 2005, BRAIN INJURY, V19, P519, DOI 10.1080/02699050400005150; Baker FA, 2017, J MUSIC THER, V54, P35, DOI 10.1093/jmt/thw018; Baker FA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00299; Beck A, 1996, BDI II BECK DEPRESSI; Beck A.T., 2005, BDI II BECK DEPRESSI; Belfi AM, 2017, NEUROPSYCHOLOGIA, V97, P29, DOI 10.1016/j.neuropsychologia.2017.01.030; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Bialystok E, 2009, J EXP PSYCHOL HUMAN, V35, P565, DOI 10.1037/a0012735; Bianco R, 2016, NEUROIMAGE, V142, P444, DOI 10.1016/j.neuroimage.2016.08.025; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bradt J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub2; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Buddenberg LA, 2000, AM J OCCUP THER, V54, P555, DOI 10.5014/ajot.54.5.555; Bugos JA, 2007, AGING MENT HEALTH, V11, P464, DOI 10.1080/13607860601086504; Burgess PW, 2017, J INT NEUROPSYCH SOC, V23, P755, DOI 10.1017/S1355617717000704; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Carpentier SM, 2016, J COGNITIVE NEUROSCI, V28, P1603, DOI 10.1162/jocn_a_00988; Cheung VKM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22144-9; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Crinion J, 2007, NEUROIMAGE, V37, P866, DOI 10.1016/j.neuroimage.2007.04.065; D'Souza AA, 2018, COGN RES, V3, DOI 10.1186/s41235-018-0095-6; de la Tremblaye PB, 2019, NEUROPHARMACOLOGY, V145, P13, DOI 10.1016/j.neuropharm.2018.02.032; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Ding Y, 2019, J NEUROSCI, V39, P8112, DOI 10.1523/JNEUROSCI.1468-18.2019; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Engel A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00083; Escoffier N, 2013, HUM BRAIN MAPP, V34, P1796, DOI 10.1002/hbm.22029; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Formisano R, 2001, Ann Ist Super Sanita, V37, P627; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Fujioka T, 2017, EUR J NEUROSCI, V46, P2339, DOI 10.1111/ejn.13693; Gaser C, 2003, J NEUROSCI, V23, P9240; GLASSMAN LR, 1991, ART PSYCHOTHER, V18, P149, DOI 10.1016/0197-4556(91)90022-3; Grau-Sanchez J, 2018, ANN NY ACAD SCI, V1423, P318, DOI 10.1111/nyas.13590; Greene CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011739; Grimm T, 2018, BRAIN INJURY, V32, P704, DOI 10.1080/02699052.2018.1451657; Guetin S., 2009, Annals of Physical and Rehabilitation Medicine, V52, P30, DOI 10.1016/j.annrmp.2008.08.009; Habibi A, 2018, ANN NY ACAD SCI, V1423, P73, DOI 10.1111/nyas.13606; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hanna-Pladdy B, 2011, NEUROPSYCHOLOGY, V25, P378, DOI 10.1037/a0021895; Hannon EE, 2007, TRENDS COGN SCI, V11, P466, DOI 10.1016/j.tics.2007.08.008; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoofien D, 2001, BRAIN INJURY, V15, P189; Huang S, 2013, NEUROIMAGE, V83, P1098, DOI 10.1016/j.neuroimage.2013.07.074; Huque MH, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0615-6; Hurt CP, 1998, J MUSIC THER, V35, P228, DOI 10.1093/jmt/35.4.228; Hutchinson S, 2003, CEREB CORTEX, V13, P943, DOI 10.1093/cercor/13.9.943; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; Hyde KL, 2011, CEREB CORTEX, V21, P292, DOI 10.1093/cercor/bhq094; IBM Corp, 2016, IBM SPSS STAT WIND; Janata P, 2001, BRAIN TOPOGR, V13, P169, DOI 10.1023/A:1007803102254; Jaschke AC, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00103; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P2234, DOI 10.1016/j.neuropsychologia.2007.02.019; Kim SJ, 2016, ANN NY ACAD SCI, V1385, P53, DOI 10.1111/nyas.13294; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Koelsch S, 2005, NEUROIMAGE, V25, P1068, DOI 10.1016/j.neuroimage.2004.12.050; Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Luo C, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/180138; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Lynch C, 2016, J MUSIC THER, V53, P279, DOI 10.1093/jmt/thw008; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Magee WL, 2002, J MUSIC THER, V39, P20, DOI 10.1093/jmt/39.1.20; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Martin N, 2012, APHASIOLOGY, V26, P462, DOI 10.1080/02687038.2011.619516; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Miller LS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00506; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moradzadeh L, 2015, COGNITIVE SCI, V39, P992, DOI 10.1111/cogs.12183; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Nakaaki S, 2007, PSYCHIAT CLIN NEUROS, V61, P78, DOI 10.1111/j.1440-1819.2007.01614.x; Oh A, 2014, BRAIN COGNITION, V86, P90, DOI 10.1016/j.bandc.2014.02.006; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Paquette S, 2017, NEUROIMAGE, V163, P177, DOI 10.1016/j.neuroimage.2017.09.017; Passingham RE, 2001, NEUROIMAGE, V14, pS125, DOI 10.1006/nimg.2001.0836; Platel H, 2003, NEUROIMAGE, V20, P244, DOI 10.1016/S1053-8119(03)00287-8; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Putkinen V, 2015, ANN NY ACAD SCI, V1337, P153, DOI 10.1111/nyas.12656; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Raglio A, 2015, WORLD J PSYCHIATR, V5, P68, DOI 10.5498/wjp.v5.i1.68; Rauschecker JP, 2015, EUR J NEUROSCI, V41, P579, DOI 10.1111/ejn.12844; Ripolles P, 2016, BRAIN IMAGING BEHAV, V10, P1289, DOI 10.1007/s11682-015-9498-x; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Roddy C, 2020, NEUROPSYCHOL REHABIL, V30, P166, DOI 10.1080/09602011.2018.1448288; Rodrigues AC, 2013, BRAIN COGNITION, V82, P229, DOI 10.1016/j.bandc.2013.04.009; Rodriguez-Fornells A, 2012, ANN NY ACAD SCI, V1252, P282, DOI 10.1111/j.1749-6632.2011.06425.x; Rojas N, 2019, APPL NEUROPSYCH-ADUL, V26, P319, DOI 10.1080/23279095.2017.1422506; Rojo N, 2011, BRAIN INJURY, V25, P787, DOI 10.3109/02699052.2011.576305; Ruiz MH, 2017, HUM BRAIN MAPP, V38, P5161, DOI 10.1002/hbm.23722; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sachs M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187254; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Sarkamo T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00245; Sarkamo T, 2012, ANN NY ACAD SCI, V1252, P266, DOI 10.1111/j.1749-6632.2011.06405.x; Schneider S, 2007, J NEUROL, V254, P1339, DOI 10.1007/s00415-006-0523-2; Schneider S, 2010, MUSIC PERCEPT, V27, P271, DOI 10.1525/MP.2010.27.4.271; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Sihvonen AJ, 2016, J NEUROSCI, V36, P8872, DOI 10.1523/JNEUROSCI.0709-16.2016; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Slevc LR, 2016, COGNITION, V152, P199, DOI 10.1016/j.cognition.2016.03.017; Soto D, 2009, P NATL ACAD SCI USA, V106, P6011, DOI 10.1073/pnas.0811681106; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Strong JV, 2019, AGING NEUROPSYCHOL C, V26, P367, DOI 10.1080/13825585.2018.1448356; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Tamplin J, 2008, NEUROREHABILITATION, V23, P207; Thaut MH, 2003, ANN NY ACAD SCI, V999, P364, DOI 10.1196/annals.1284.044; Thaut MH, 2014, BRAIN SCI, V4, P428, DOI 10.3390/brainsci4020428; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Tillmann B, 2006, NEUROIMAGE, V31, P1771, DOI 10.1016/j.neuroimage.2006.02.028; Tomaszczyk JC, 2014, NEUROPSYCHOL REV, V24, P409, DOI 10.1007/s11065-014-9273-6; Traumatic Brain Injury, 2008, CURR CAR GUID WORK G; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Ginkel JR, 2020, J PERS ASSESS, V102, P297, DOI 10.1080/00223891.2018.1530680; van Ginkel JR, 2014, MULTIVAR BEHAV RES, V49, P78, DOI 10.1080/00273171.2013.855890; Vasquez BP, 2018, NEUROREHAB NEURAL RE, V32, P191, DOI 10.1177/1545968318760727; Vik BMD, 2018, BRAIN INJURY, V32, P634, DOI 10.1080/02699052.2018.1431842; Villarreal MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075427; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D., 1997, WECHSLER MEMORY SCAL; White IR, 2012, CLIN TRIALS, V9, P396, DOI 10.1177/1740774512450098; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu MT, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00280; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172; Zatorre RJ, 1996, J COGNITIVE NEUROSCI, V8, P29, DOI 10.1162/jocn.1996.8.1.29; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zatorre RJ, 2013, P NATL ACAD SCI USA, V110, P10430, DOI 10.1073/pnas.1301228110; Zuk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099868	150	10	10	6	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2020	37	4					618	634		10.1089/neu.2019.6413		DEC 2019	17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	KI3UL	WOS:000504862200001	31642408	Green Accepted			2022-02-06	
J	Sanchis, P; Fernandez-Gayol, O; Vizueta, J; Comes, G; Canal, C; Escrig, A; Molinero, A; Giralt, M; Hidalgo, J				Sanchis, Paula; Fernandez-Gayol, Olaya; Vizueta, Joel; Comes, Gemma; Canal, Carla; Escrig, Anna; Molinero, Amalia; Giralt, Mercedes; Hidalgo, Juan			Microglial cell-derived interleukin-6 influences behavior and inflammatory response in the brain following traumatic brain injury	GLIA			English	Article						behavior; cryolesion; knockout microglial IL-6; neuroinflammation; transcriptome	ASTROCYTE-TARGETED EXPRESSION; TRANSGENIC MICE; FRACTALKINE-RECEPTOR; COGNITIVE FUNCTION; METALLOTHIONEIN-I; DEFICIENCY LEADS; GENE-EXPRESSION; BODY-WEIGHT; COLD INJURY; WILD-TYPE	Traumatic brain injury (TBI) is a major health problem with high rates of mortality and morbidity worldwide. The response of the brain to TBI is orchestrated by a number of cytokines, including interleukin-6 (IL-6). IL-6 is a major cytokine in the central nervous system and it is produced by different cells, such as neurons, glial cells, and endothelial cells. Since glial cells are one of the most important sources and targets of IL-6, we have examined the role of microglia-derived IL-6 in normal conditions and following a model of TBI, cryolesion of the somatosensorial cortex. To this end, tamoxifen-inducible microglial IL-6-deficient (Il6(Delta Mic), using Cx3cr1(CreER) model) mice and control (Il6(lox/lox)) mice were used. In normal conditions, microglial IL-6 deficiency reduced deambulation and exploratory behavior and decreased anxiety in a sex-dependent manner. The transcriptome profile following cryolesion was dramatically altered 1 day post-lesion in Il6(Delta Mic) compared with Il6(lox/lox) mice. However, the phenotype of Il6(Delta Mic) mice was less compromised in the following days, suggesting that compensatory mechanisms are at play.	[Sanchis, Paula; Fernandez-Gayol, Olaya; Comes, Gemma; Canal, Carla; Escrig, Anna; Molinero, Amalia; Giralt, Mercedes; Hidalgo, Juan] Univ Autonoma Barcelona, Fac Biosci, Inst Neurosci, Barcelona, Spain; [Sanchis, Paula; Fernandez-Gayol, Olaya; Comes, Gemma; Canal, Carla; Escrig, Anna; Molinero, Amalia; Giralt, Mercedes; Hidalgo, Juan] Univ Autonoma Barcelona, Fac Biosci, Dept Cellular Biol Physiol & Immunol, Barcelona, Spain; [Vizueta, Joel] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Estadist, Barcelona, Spain; [Vizueta, Joel] Univ Barcelona, Fac Biol, Inst Recerca Biodiversitat IRBio, Barcelona, Spain		Hidalgo, J (corresponding author), Univ Autonoma Barcelona, Fac Biosci, Dept Cellular Biol Physiol & Immunol, Anim Physiol Unit, E-08193 Barcelona, Spain.	juan.hidalgo@uab.es	Hidalgo, Juan/C-9082-2011; Sanchis, Paula/K-2853-2017; Sanchis, Paula/AAR-7500-2020; Vizueta, Joel/A-8412-2018; Fernandez Gayol, Olaya/E-5635-2014	Hidalgo, Juan/0000-0003-0921-1122; Sanchis, Paula/0000-0002-2729-4622; Vizueta, Joel/0000-0003-0139-3013; Fernandez Gayol, Olaya/0000-0002-7649-3126; COMES, GEMMA/0000-0002-4074-7665	European Regional Development FundEuropean Commission [RTI2018-101105-B-I00, SAF2014-56546-R]; Fundacio la Marato de TV3 [20142210]; Ministerio de Economia y CompetitividadSpanish Government [RTI2018-101105-B-I00, SAF2014-56546-R]	European Regional Development Fund, Grant/Award Numbers: RTI2018-101105-B-I00, SAF2014-56546-R; Fundacio la Marato de TV3, Grant/Award Number: 20142210; Ministerio de Economia y Competitividad, Grant/Award Numbers: RTI2018-101105-B-I00, SAF2014-56546-R	Adamson SE, 2016, J CLIN INVEST, V126, P1311, DOI 10.1172/JCI79590; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Andersson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070699; Armario A, 1998, J NEUROIMMUNOL, V92, P160, DOI 10.1016/S0165-5728(98)00199-4; Baier PC, 2009, BEHAV BRAIN RES, V200, P192, DOI 10.1016/j.bbr.2009.01.013; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; BOISSIER J R, 1962, Therapie, V17, P1225; Braida D, 2004, BEHAV BRAIN RES, V153, P423, DOI 10.1016/j.bbr.2003.12.018; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; Butterweck V, 2003, BEHAV BRAIN RES, V144, P49, DOI 10.1016/S0166-4328(03)00059-7; Campbell IL, 1998, BRAIN RES REV, V26, P327, DOI 10.1016/S0165-0173(97)00038-6; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Chhor V, 2017, BRAIN BEHAV IMMUN, V63, P197, DOI 10.1016/j.bbi.2016.11.001; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Degrandi D, 2009, J INTERF CYTOK RES, V29, P643, DOI 10.1089/jir.2008.0013.cxn; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Erta M, 2015, HORM BEHAV, V73, P64, DOI 10.1016/j.yhbeh.2015.06.016; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Fattori E, 1995, EUR J NEUROSCI, V7, P2441, DOI 10.1111/j.1460-9568.1995.tb01042.x; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Fee D, 2000, CYTOKINE, V12, P655, DOI 10.1006/cyto.1999.0599; Fernandez-Gayol O, 2019, NEUROENDOCRINOLOGY, V109, P113, DOI 10.1159/000496845; Fonseca JE, 2009, AUTOIMMUN REV, V8, P538, DOI 10.1016/j.autrev.2009.01.012; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; GADIENT RA, 1994, NEUROSCI LETT, V182, P243, DOI 10.1016/0304-3940(94)90807-9; Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45; Giralt M, 2002, NEUROBIOL DIS, V9, P319, DOI 10.1006/nbdi.2002.0480; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Graber DJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0298-4; Guzman C, 2010, OPEN NEUROENDOCRINOL, V3, P152; Haimon Z, 2018, NAT IMMUNOL, V19, P636, DOI 10.1038/s41590-018-0110-6; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Heit C, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-22; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; LEE SC, 1993, J IMMUNOL, V150, P2659; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Liu X, 2017, INT IMMUNOPHARMACOL, V48, P76, DOI 10.1016/j.intimp.2017.04.012; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Morgan K, 1997, INT J BIOCHEM CELL B, V29, P1501, DOI 10.1016/S1357-2725(97)00118-0; Morita-Fujimura Y, 2000, J CEREBR BLOOD F MET, V20, P130, DOI 10.1097/00004647-200001000-00017; Moritz KE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09715-y; Muppala S, 2015, ARTERIOSCL THROM VAS, V35, P1975, DOI 10.1161/ATVBAHA.115.305912; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Navia B, 2014, ACTA PHYSIOL, V211, P585, DOI 10.1111/apha.12328; NISHIMURA N, 1992, J HISTOCHEM CYTOCHEM, V40, P309, DOI 10.1177/40.2.1552172; Norris GT, 2019, J EXP MED, V216, P60, DOI 10.1084/jem.20180199; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Penkowa M, 1999, GLIA, V25, P343; Penkowa M, 1999, J NEUROSCI, V19, P2535; Penkowa M, 2006, J NEUROSCI RES, V84, P1452, DOI 10.1002/jnr.21043; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; Quintana A, 2008, DEV NEUROBIOL, V68, P195, DOI 10.1002/dneu.20584; Quintana A, 2007, NEUROIMMUNOMODULAT, V14, P139, DOI 10.1159/000110637; Quintana A, 2013, BRAIN BEHAV IMMUN, V27, P162, DOI 10.1016/j.bbi.2012.10.011; Quintana A, 2009, J IMMUNOL, V183, P2079, DOI 10.4049/jimmunol.0900242; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schober A, 2001, J COMP NEUROL, V439, P32, DOI 10.1002/cne.1333; Senaris RM, 2011, J NEUROENDOCRINOL, V23, P675, DOI 10.1111/j.1365-2826.2011.02158.x; Son YM, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-33; Song AJ, 2018, TRENDS GENET, V34, P333, DOI 10.1016/j.tig.2017.12.008; St-Gelais F, 2006, J PSYCHIATR NEUROSCI, V31, P229; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236; Vazquez MJ, 2008, ENDOCRINOLOGY, V149, P4534, DOI 10.1210/en.2007-1708; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wieghofer P, 2015, GLIA, V63, P1, DOI 10.1002/glia.22727; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32987; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	90	10	11	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	MAY	2020	68	5					999	1016		10.1002/glia.23758		DEC 2019	18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KT2MS	WOS:000500370400001	31799746				2022-02-06	
J	Belluscio, V; Bergamini, E; Tramontano, M; Bustos, AO; Allevi, G; Formisano, R; Vannozzi, G; Buzzi, MG				Belluscio, Valeria; Bergamini, Elena; Tramontano, Marco; Orejel Bustos, Amaranta; Allevi, Giulia; Formisano, Rita; Vannozzi, Giuseppe; Buzzi, Maria Gabriella			Gait Quality Assessment in Survivors from Severe Traumatic Brain Injury: An Instrumented Approach Based on Inertial Sensors	SENSORS			English	Article						wearables; inertial sensors; traumatic brain injury; dynamic balance; gait disorders; gait patterns; head injury; gait symmetry; gait smoothness; acceleration	FUKUDA STEPPING TEST; BALANCE ASSESSMENT; DYNAMIC BALANCE; RELIABILITY; WALKING; SCALE; HEAD; PERFORMANCE; IMPAIRMENT; STABILITY	Despite existing evidence that gait disorders are a common consequence of severe traumatic brain injury (sTBI), the literature describing gait instability in sTBI survivors is scant. Thus, the present study aims at quantifying gait patterns in sTBI through wearable inertial sensors and investigating the association of sensor-based gait quality indices with the scores of commonly administered clinical scales. Twenty healthy adults (control group, CG) and 20 people who suffered from a sTBI were recruited. The Berg balance scale, community balance and mobility scale, and dynamic gait index (DGI) were administered to sTBI participants, who were further divided into two subgroups, severe and very severe, according to their score in the DGI. Participants performed the 10 m walk, the Figure-of-8 walk, and the Fukuda stepping tests, while wearing five inertial sensors. Significant differences were found among the three groups, discriminating not only between CG and sTBI, but also for walking ability levels. Several indices displayed a significant correlation with clinical scales scores, especially in the 10 m walking and Figure-of-8 walk tests. Results show that the use of wearable sensors allows the obtainment of quantitative information about a patient's gait disorders and discrimination between different levels of walking abilities, supporting the rehabilitative staff in designing tailored therapeutic interventions.	[Belluscio, Valeria; Bergamini, Elena; Tramontano, Marco; Orejel Bustos, Amaranta; Vannozzi, Giuseppe] Univ Rome Foro Italico, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Dept Movement Human & Hlth Sci, Pzza Lauro Bosis 15, I-00135 Rome, Italy; [Belluscio, Valeria; Tramontano, Marco; Allevi, Giulia; Formisano, Rita; Buzzi, Maria Gabriella] IRCSS Fdn Santa Lucia, Via Ardeatina 306, I-00179 Rome, Italy		Vannozzi, G (corresponding author), Univ Rome Foro Italico, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Dept Movement Human & Hlth Sci, Pzza Lauro Bosis 15, I-00135 Rome, Italy.	v.belluscio@studenti.uniroma4.it; elena.bergamini@uniroma4.it; m.tramontano@hsantalucia.it; a.orejelbustos@studenti.uniroma4.it; giulia.allevi@gmail.com; r.formisano@hsantalucia.it; giuseppe.vannozzi@uniroma4.it; mg.buzzi@hsantalucia.it	Vannozzi, Giuseppe/G-9897-2013; TRAMONTANO, MARCO/K-4373-2018; Orejel, Amaranta/AAF-9463-2021; Bergamini, Elena/AAC-1555-2019	Vannozzi, Giuseppe/0000-0002-2359-6076; TRAMONTANO, MARCO/0000-0001-6034-0638; Orejel, Amaranta/0000-0002-0884-3315; Bergamini, Elena/0000-0002-9055-3981; Buzzi, Maria Gabriella/0000-0003-1307-8707; Formisano, Rita/0000-0002-2516-0540			Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Baker K, 2007, ARCH PHYS MED REHAB, V88, P1593, DOI 10.1016/j.apmr.2007.07.026; Balasubramanian S, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0090-9; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Belluscio V, 2019, HUM MOVEMENT SCI, V63, P53, DOI 10.1016/j.humov.2018.11.010; Belluscio V, 2018, GAIT POSTURE, V60, P203, DOI 10.1016/j.gaitpost.2017.12.010; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; Bergamini E, 2017, J BIOMECH, V61, P208, DOI 10.1016/j.jbiomech.2017.07.034; Bergamini E, 2014, SENSORS-BASEL, V14, P18625, DOI 10.3390/s141018625; Bivona U, 2019, BRAIN INJURY, V33, P1245, DOI 10.1080/02699052.2019.1641225; Bivona U, 2015, RESTOR NEUROL NEUROS, V33, P335, DOI 10.3233/RNN-140484; Boonstra AM, 2008, INT J REHABIL RES, V31, P165, DOI 10.1097/MRR.0b013e3282fc0f93; Buckley C, 2019, GAIT POSTURE, V71, P289, DOI 10.1016/j.gaitpost.2018.06.166; Buckley C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/865873; Chen G, 2005, GAIT POSTURE, V22, P51, DOI 10.1016/j.gaitpost.2004.06.009; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Cohen J., 1992, CURR DIR PSYCHOL SCI, V1, P98, DOI [DOI 10.2307/20182143, DOI 10.1111/1467-8721.EP10768783]; Di Russo F, 2005, J NEUROTRAUM, V22, P297; Doi T, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-7; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Esser P, 2011, GAIT POSTURE, V34, P558, DOI 10.1016/j.gaitpost.2011.06.018; Fang X, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.170818; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Foley JA, 2010, BRAIN INJURY, V24, P851, DOI 10.3109/02699051003789278; Formisano R., 1987, NEW TRENDS CLIN NEUR, V1, P115; Formisano R, 2014, J HEAD TRAUMA REHAB, V29, P387, DOI 10.1097/HTR.0000000000000027; Formisano R, 2011, FUNCT NEUROL, V26, P15; Galna B, 2014, GAIT POSTURE, V39, P1062, DOI 10.1016/j.gaitpost.2014.01.008; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Haggard P, 2000, J NEUROL NEUROSUR PS, V69, P479, DOI 10.1136/jnnp.69.4.479; Herman T, 2009, GAIT POSTURE, V29, P237, DOI 10.1016/j.gaitpost.2008.08.013; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Iosa M, 2018, APPL BIONICS BIOMECH, V2018, DOI [10.1155/2018/5405680, 10.1155/2018/5105680]; Iosa M, 2012, J REHABIL RES DEV, V49, P439, DOI 10.1682/JRRD.2011.03.0057; Iosa M, 2012, RES DEV DISABIL, V33, P129, DOI 10.1016/j.ridd.2011.08.031; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lehmann J., 1990, ARCH PHYS MED REHAB, V93, P2012; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mazza C, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-30; Menz HB, 2003, GAIT POSTURE, V18, P35, DOI 10.1016/S0966-6362(02)00159-5; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Paquet N, 2014, J REHABIL RES DEV, V51, P1013, DOI 10.1682/JRRD.2013.09.0206; Pasciuto I, 2017, J BIOMECH, V53, P84, DOI 10.1016/j.jbiomech.2017.01.005; Patterson KK, 2008, ARCH PHYS MED REHAB, V89, P304, DOI 10.1016/j.apmr.2007.08.142; Peppe A, 1998, ELECTROEN CLIN NEURO, V106, P374, DOI 10.1016/S0013-4694(97)00075-8; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Popescu C, 2015, J Med Life, V8, P272; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Schlachetzki JCM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183989; Shany T, 2012, Z GERONTOL GERIATR, V45, P694, DOI 10.1007/s00391-012-0407-2; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Summa A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151792; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tramontano M, 2017, EUR J PHYS REHAB MED, V53, P7, DOI 10.23736/S1973-9087.16.04203-9; Turcato AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197264; van Hedel HJ, 2005, ARCH PHYS MED REHAB, V86, P190, DOI 10.1016/j.apmr.2004.02.010; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Wong SST, 2013, DISABIL REHABIL, V35, P1896, DOI 10.3109/09638288.2013.766274; Zhang YB, 2011, J INT MED RES, V39, P1432, DOI 10.1177/147323001103900431	68	10	10	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	DEC	2019	19	23							5315	10.3390/s19235315			14	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Chemistry; Engineering; Instruments & Instrumentation	KD1BI	WOS:000507606200258	31816843	Green Published, gold			2022-02-06	
J	Berberian, M; Walker, MS; Kaimal, G				Berberian, Marygrace; Walker, Melissa S.; Kaimal, Girija			'Master My Demons': art therapy montage paintings by active-duty military service members with traumatic brain injury and post-traumatic stress	MEDICAL HUMANITIES			English	Article							COMBAT VETERANS; PTSD; CARE; TBI	This study involved a thematic analysis of montage paintings and of related clinical records of 240 active-duty military service members collected during their art therapy treatment for traumatic brain injury and underlying psychological health concerns, including post-traumatic stress, at the National Intrepid Center of Excellence, Walter Reed National Military Medical Center, Bethesda, Maryland, USA. Congruent with other research findings, the qualitative analyses of this study suggest that the group art therapy experiences fostered improvement in interpersonal relatedness, hopefulness and gratification for the service members in treatment, aiding in externalisation, progressive exposure and construction of a trauma narrative imperative for recovery. The mixed media nature of the montage painting supported the expression of a range of postcombat symptoms. Results from this study highlighted the complexity of military culture, necessitating a broader scope of analyses for how art therapy helps service members express and communicate their challenges to care providers, peers and family as well as regulate emotion in the short and long term.	[Berberian, Marygrace; Kaimal, Girija] Drexel Univ, Coll Nursing & Hlth Profess, Creat Arts Therapies, Philadelphia, PA 19104 USA; [Berberian, Marygrace] NYU, Art & Arts Profess, New York, NY USA; [Walker, Melissa S.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence NICoE, Bethesda, MD USA		Kaimal, G (corresponding author), Drexel Univ, Coll Nursing & Hlth Profess, Philadelphia, PA 19034 USA.	gk27@drexel.edu		Kaimal, Girija/0000-0002-7316-0473; Berberian, Marygrace/0000-0001-6642-3426	National Endowment for the Arts, Creative Forces: NEA Military Healing Arts Network	This research was supported through funding from the National Endowment for the Arts, Creative Forces: NEA Military Healing Arts Network.	[Anonymous], 2018, DEDOOSE COMPUTER SOF; Avrahami Dalia, 2005, J Trauma Dissociation, V6, P5, DOI 10.1300/J229v06n04_02; Brailey K, 2007, J TRAUMA STRESS, V20, P495, DOI 10.1002/jts.20234; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brunswick M., 2014, BEAT MILITARY AFFAIR, p3B; Collie K, 2006, ART THER, V23, P157, DOI 10.1080/07421656.2006.10129335; Deci E.L., 1985, INTRINSIC MOTIVATION; Defense & Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBI; Department of Veterans Affairs, 2013, VHA HDB; Doorly, 2013, TRUTH ART RECLAIMING; Ellis A., 2009, PERSONALITY THEORIES; Gantt L, 2007, ART PSYCHOTHER, V34, P69, DOI 10.1016/j.aip.2006.09.007; Gantt L, 2009, ART PSYCHOTHER, V36, P148, DOI 10.1016/j.aip.2008.12.005; GOLUB D, 1985, ART PSYCHOTHER, V12, P285, DOI 10.1016/0197-4556(85)90041-3; GORELICK K, 1989, ART PSYCHOTHER, V16, P149, DOI 10.1016/0197-4556(89)90017-8; Harris DA, 2009, ART PSYCHOTHER, V36, P94, DOI 10.1016/j.aip.2009.01.006; Herman J.L., 1992, TRAUMA RECOVERY AFTE; Hinz, 2016, ART THERAPY TRAUMA N, P42; Howie P., 2017, ART THERAPY MILITARY, P64; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; Jones J, 2017, INT J ART THERAPY, V17, P1; Kopytin A, 2013, ART THER, V30, P20, DOI 10.1080/07421656.2013.757758; Lande RG, 2010, ART PSYCHOTHER, V37, P42, DOI 10.1016/j.aip.2009.09.007; LANGER R, 2011, WAR LIT ARTS INT J H, V23, P50; Lobban J., 2014, INT J ART THER, V19, P3, DOI [https://doi.org/10.1080/17454832.2012.725547, DOI 10.1080/17454832.2012.725547]; Nanda U, 2010, ENVIRON BEHAV, V42, P376, DOI 10.1177/0013916510361874; National Endowment for the Arts, 2015, CREAT ARTS THER US T; Naumburg M., 1987, DYNAMICALLY ORIENTED; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Pew Research Center, 2011, MIL CIV GAP WAR SACR; Rademaker AR, 2009, MIL PSYCHOL, V21, P482, DOI 10.1080/08995600903206420; Raffaelli T, 2016, ART THER, V33, P21, DOI 10.1080/07421656.2016.1127115; Ramirez J, 2016, J MIL VETERANS HEALT, V24, P40; Sandmire DA, 2012, ART THER, V29, P68, DOI 10.1080/07421656.2012.683748; Scholten J, 2016, PROF CASE MANAG, V21, P266, DOI 10.1097/NCM.0000000000000165; Scotti V., 2017, HDB ARTS BASED RES, P355; Shin LM, 1997, ANN NY ACAD SCI, V821, P521, DOI 10.1111/j.1749-6632.1997.tb48320.x; Shu IW, 2014, J AFFECT DISORDERS, V155, P234, DOI 10.1016/j.jad.2013.06.057; Smith A., 2016, INT J ART THERAP, V21, P66, DOI DOI 10.1080/17454832.2016.1170055; Smith RT, 2014, SOC MENT HEALTH, V4, P147, DOI 10.1177/2156869313512212; Spoont MR, 2014, PSYCHIAT SERV, V65, P654, DOI 10.1176/appi.ps.201200324; Steger MF., 2012, INTEGRATED APPROACH, P171, DOI DOI 10.1037/13746-008; Strauss E, 1998, CLIN ORTHOP RELAT R, P2; Tripp T., 2016, ART THERAPY TRAUMA N, P173; U.S. Government Accountability Office, 2011, 1212 GAO; van der Kolk B, 2000, Dialogues Clin Neurosci, V2, P7; van der Kolk B.A., 2014, BODY KEEPS SCORE BRA; van der Kolk BA, 2002, EMDR AS AN INTEGRATIVE PSYCHOTHERAPY APPROACH, P57, DOI 10.1037/10512-003; VERLON A, 1968, LEONARDO, V1, P383, DOI 10.2307/1571987; Walker M., 2011, ART THERAPY SUPPORTI; Walker M., 2017, ART THERAPY MILITARY, P111; Walker MS, 2017, INT J QUAL STUD HEAL, V12, DOI 10.1080/17482631.2016.1267317; Walker MS, 2016, ART PSYCHOTHER, V49, P10, DOI 10.1016/j.aip.2016.05.015; Waller D., 2015, GROUP INTERACTIVE AR, VSecond	54	10	10	2	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1468-215X	1473-4265		MED HUMANIT	Med. Humanit.	DEC	2019	45	4					353	360		10.1136/medhum-2018-011493			8	Humanities, Multidisciplinary	Arts &amp; Humanities Citation Index (A&amp;HCI)	Arts & Humanities - Other Topics	KS3QN	WOS:000518227100003	30077986	Green Published, hybrid			2022-02-06	
J	Fuller, GW; Cross, MJ; Stokes, KA; Kemp, SPT				Fuller, Gordon Ward; Cross, Matthew J.; Stokes, Keith A.; Kemp, Simon P. T.			King-Devick concussion test performs poorly as a screening tool in elite rugby union players: a prospective cohort study of two screening tests versus a clinical reference standard	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							RELIABILITY; SENSITIVITY; AGREEMENT	Background The King-Devick (KD) test is an objective clinical test of eye movements that has been used to screen for concussion. We characterised the accuracy of the KD test and the World Rugby Head Injury Assessment (HIA-1) screening tools as methods of off-field evaluation for concussion after a suspicious head impact event. Methods A prospective cohort study was performed in elite English rugby union competitions between September 2016 and May 2017. The study population comprised consecutive players identified with a head impact event with the potential to result in concussion. The KD test was administered off-field, alongside the World Rugby HIA-1 screening tool, and the results were compared with the preseason baseline. Accuracy was measured against a reference standard of confirmed concussion, based on the clinical judgement of the team doctor after serial assessments. Results 145 head injury events requiring off-field medical room screening assessments were included in the primary analysis. The KD test demonstrated a sensitivity of 60% (95% CI 49.0 to 70) and a specificity of 39% (95% CI 26 to 54) in identifying players subsequently diagnosed with concussion. Area under the receiver operating characteristic curve for prolonged KD test times was 0.51 (95% CI 0.41 to 0.61). The World Rugby HIA-1 off-field screening tool sensitivity did not differ significantly from the KD test (sensitivity 75%, 95% CI 66 to 83, P=0.08), but specificity was significantly higher (91%, 95% CI 82 to 97, P<0.001). Although combining the KD test and the World Rugby HIA-1 multimodal screening assessment achieved a significantly higher sensitivity of 93% (95% CI 86% to 97%), there was a significantly lower specificity of 33% (95% CI 21% to 48%), compared with the HIA-1 test alone. Conclusions The KD test demonstrated limited accuracy as a stand-alone remove-from-play sideline screening test for concussion. As expected with the addition of any parallel test, combination of the KD test with the HIA-1 off-field screening tool provided improved sensitivity in identifying concussion, but at the expense of markedly lower specificity. These results suggest that it is unlikely that the KD test will be incorporated into multimodal off-field screening assessments for concussion at the present time.	[Fuller, Gordon Ward] Univ Sheffield, Ctr Urgent & Emergency Care Res, Sheffield, S Yorkshire, England; [Cross, Matthew J.; Kemp, Simon P. T.] Rugby Football Union, London, England; [Cross, Matthew J.; Stokes, Keith A.] Univ Bath, Dept Hlth, Bath, Avon, England		Fuller, GW (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Emergency Med Res Sheffield Grp, Sheffield S1 4DA, S Yorkshire, England.	g.fuller@sheffield.ac.uk	; Stokes, Keith/C-2605-2009	Fuller, Gordon Ward/0000-0001-8532-3500; Stokes, Keith/0000-0002-5049-2838; Kemp, Simon/0000-0002-3250-2713	Rugby Football Union; King-Devick Technologies	The study was funded by the Rugby Football Union and supported by King-Devick Technologies.	Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Buderer NMF, 1996, ACAD EMERG MED, V3, P895, DOI 10.1111/j.1553-2712.1996.tb03538.x; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Galetta K., 2015, CONCUSSION, V1; Genders TSS, 2012, RADIOLOGY, V265, P910, DOI 10.1148/radiol.12120509; Helmy A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5748; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Molloy JH, 2017, J SCI MED SPORT, V20, P708, DOI 10.1016/j.jsams.2017.02.002; Patricios J, 2017, BR J SPORTS MED, V51; Pepe M S, 2000, Biostatistics, V1, P123; Raynowska J, 2016, NEUROLOGY, V86; Technologies K-D, 2017, KING DEV TEST SEC KI; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	24	10	10	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	DEC	2019	53	24					1526	1532		10.1136/bjsports-2017-098560			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JX6FI	WOS:000503828000007	29563095	Green Accepted			2022-02-06	
J	Guinn, AS; Ports, KA; Ford, DC; Breiding, M; Merrick, MT				Guinn, Angie S.; Ports, Katie A.; Ford, Derek C.; Breiding, Matt; Merrick, Melissa T.			Associations between adverse childhood experiences and acquired brain injury, including traumatic brain injuries, among adults: 2014 BRFSS North Carolina	INJURY PREVENTION			English	Article						adverse childhood experiences; acquired brain injury; traumatic brain injury	RISK; ABUSE; CHILDREN; VIOLENCE; HEALTH; STATES	Adverse childhood experiences (ACEs) can negatively affect lifelong health and opportunity. Acquired brain injury (ABI), which includes traumatic brain injury (TBI) as well as other causes of brain injury, is a health condition that affects millions annually. The present study uses data from the 2014 North Carolina Behavioral Risk Factor Surveillance System to examine the relationship between ACEs and ABI. The study sample included 3454 participants who completed questions on both ABI and ACEs. Multivariable logistic regression models were used to determine the relationship between ACEs and ABI as well as ACEs and TBI. Sexual abuse, emotional abuse, physical abuse, household mental illness and household substance abuse were significantly associated with ABI after adjusting for age, race/ethnicity, gender and employment. Compared with those reporting no ACEs, individuals reporting three ACEs had 2.55 times the odds of having experienced an ABI; individuals reporting four or more ACEs had 3.51 times the odds of having experienced an ABI. Examining TBI separately, those who experienced sexual abuse, physical abuse, household mental illness and had incarcerated household members in childhood had greater odds of reported TBI, after adjusting for age, race/ethnicity, gender and income. Respondents reporting three ACEs (AOR=4.16, 95% CI (1.47 to 11.76)) and four or more ACEs (AOR=3.39, 95% CI (1.45 to 7.90)) had significantly greater odds of reporting TBI than respondents with zero ACEs. Prevention of early adversity may reduce the incidence of ABI; however, additional research is required to elucidate the potential pathways from ACEs to ABI, and vice versa.	[Guinn, Angie S.; Ports, Katie A.; Ford, Derek C.; Merrick, Melissa T.] Ctr Dis Control & Prevent, Div Violence Prevent, Atlanta, GA 30341 USA; [Breiding, Matt] Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Atlanta, GA USA		Guinn, AS (corresponding author), Ctr Dis Control & Prevent, Div Violence Prevent, Atlanta, GA 30341 USA.	lsj8@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Alosco ML, 2017, BRAIN INJURY, V31, P1116, DOI 10.1080/02699052.2017.1294709; American Association for Public Opinion Research, 2016, STAND DEF FIN DISP C; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; Brewer-Smyth K, 2016, HEALTH CARE WOMEN IN, V37, P802, DOI 10.1080/07399332.2016.1140768; Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021; Centers for Disease Control and Prevention, 2018, C MAN TRAUM BRAIN IN; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Coronado VG, 2011, HEMPHILL JD, P1997; Cronholm PF, 2015, AM J PREV MED, V49, P354, DOI 10.1016/j.amepre.2015.02.001; Cunningham TJ, 2014, INT J CHRONIC OBSTR, V9, P1033, DOI 10.2147/COPD.S68226; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finkelhor D, 2015, JAMA PEDIATR, V169, P746, DOI 10.1001/jamapediatrics.2015.0676; Finkelstein E., 2006, INCIDENCE EC BURDEN; Ford ES, 2011, PREV MED, V53, P188, DOI 10.1016/j.ypmed.2011.06.015; Fortson B.L., 2016, PREVENTING CHILD ABU; Gilbert LK, 2015, AM J PREV MED, V48, P345, DOI 10.1016/j.amepre.2014.09.006; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4; Ma ZC, 2019, DISABIL REHABIL, V41, P1360, DOI 10.1080/09638288.2018.1424957; Merrick M, 2011, ADVERSE CHILDHOOD EX; Merrick MT, 2017, CHILD ABUSE NEGLECT, V69, P10, DOI 10.1016/j.chiabu.2017.03.016; Metzler M, 2017, CHILD YOUTH SERV REV, V72, P141, DOI 10.1016/j.childyouth.2016.10.021; National Center for Injury Prevention and Control, 2014, ESS CHILDH STEPS CRE; National Scientific Council on the Developing Child, 3 NAT SCI COUNC DEV; North Carolina State Center for Health Statistics, 2015, TECHN NOT 2014; North Carolina State Center for Health Statistics Division of Public Health, 2014, N CAR BEH RISK FACT; Ports KA, 2017, AM J PREV MED, V53, P400, DOI 10.1016/j.amepre.2017.03.015; Ports KA, 2016, CHILD ABUSE NEGLECT, V51, P313, DOI 10.1016/j.chiabu.2015.08.017; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; SAS Institute, 2015, BAS SAS 9 4 PROC GUI; Schneeberger A. R., 2012, J AGGRESS MALTREAT T, V21, P570, DOI DOI 10.1080/10926771.2012.678468; Shonkoff JP, 2016, JAMA PEDIATR, V170, P1003, DOI 10.1001/jamapediatrics.2016.1559; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Song MJ, 2018, J HEAD TRAUMA REHAB, V33, P185, DOI 10.1097/HTR.0000000000000310; Strine TW, 2012, AM J HEALTH BEHAV, V36, P408, DOI 10.5993/AJHB.36.3.11; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; Whitfield CL, 2003, J INTERPERS VIOLENCE, V18, P166, DOI 10.1177/0886260502238733	40	10	10	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	DEC	2019	25	6					514	520		10.1136/injuryprev-2018-042927			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	JW1IY	WOS:000502813500007	30317219	Green Accepted, Bronze			2022-02-06	
J	Lee, S; Hwang, H; Yamal, JM; Goodman, JC; Aisiku, IP; Gopinath, S; Robertson, CS				Lee, Sungho; Hwang, Hyunsoo; Yamal, Jose-Miguel; Goodman, J. Clay; Aisiku, Imoigele P.; Gopinath, Shankar; Robertson, Claudia S.			IMPACT probability of poor outcome and plasma cytokine concentrations are associated with multiple organ dysfunction syndrome following traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; multiple organ dysfunction syndrome; cytokines; critical care; prognosis; sepsis	RESPIRATORY-DISTRESS-SYNDROME; EXTRACRANIAL COMPLICATIONS; CEREBROSPINAL-FLUID; INTERLEUKIN-8; SCORE; PNEUMONIA; MORTALITY; FAILURE; SEPSIS	OBJECTIVE Traumatic brain injury (TBI) is a major cause of morbidity and mortality. Multiple organ dysfunction syndrome (MODS) occurs frequently after TBI and independently worsens outcome. The present study aimed to identify potential admission characteristics associated with post-TBI MODS. METHODS The authors performed a secondary analysis of a recent randomized clinical trial studying the effects of erythropoietin and blood transfusion threshold on neurological recovery after TBI. Admission clinical, demographic, laboratory, and imaging parameters were used in a multivariable Cox regression analysis to identify independent risk factors for MODS following TBI, defined as maximum total Sequential Organ Failure Assessment (SOFA) score > 7 within 10 days of TBI. RESULTS Two hundred patients were initially recruited and 166 were included in the final analysis. Respiratory dysfunction was the most common nonneurological organ system dysfunction, occurring in 62% of the patients. International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) probability of poor outcome at admission was significantly associated with MODS following TBI (odds ratio [OR] 8.88, 95% confidence interval [CI] 1.94-42.68, p < 0.05). However, more commonly used measures of TBI severity, such as the Glasgow Coma Scale, Injury Severity Scale, and Marshall classification, were not associated with post-TBI MODS. In addition, initial plasma concentrations of interleukin (IL)-6, IL-8, and IL-10 were significantly associated with the development of MODS (OR 1.47, 95% CI 1.20-1.80, p < 0.001 for IL-6; OR 1.26, 95% CI 1.01-1.58, p = 0.042 for IL-8; OR 1.77, 95% CI 1.24-2.53, p = 0.002 for IL-10) as well as individual organ dysfunction (SOFA component score >= 1). Finally, MODS following TBI was significantly associated with mortality (OR 5.95, 95% CI 2.18-19.14, p = 0.001), and SOFA score was significantly associated with poor outcome at 6 months (Glasgow Outcome Scale score < 4) when analyzed as a continuous variable (OR 1.21, 95% CI 1.06-1.40, p = 0.006). CONCLUSIONS Admission IMPACT probability of poor outcome and initial plasma concentrations of IL-6, IL-8, and IL-10 were associated with MODS following TBI.	[Lee, Sungho; Gopinath, Shankar; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Goodman, J. Clay] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Hwang, Hyunsoo; Yamal, Jose-Miguel] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA; [Aisiku, Imoigele P.] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA		Robertson, CS (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	claudiar@bcm.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660]; Cytometry and Cell Sorting Core at Baylor College of Medicine; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AI036211, CA125123, RR024574]	This study was supported by the National Institute of Neurological Disorders and Stroke (grant no. P01-NS38660) and the Cytometry and Cell Sorting Core at Baylor College of Medicine, with funding from the NIH (grant nos. AI036211, CA125123, and RR024574).	Aisiku IP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1470-7; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; CHOLLETMARTIN S, 1993, INFECT IMMUN, V61, P4553, DOI 10.1128/IAI.61.11.4553-4559.1993; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Elmer J, 2013, CRIT CARE MED, V41, P1992, DOI 10.1097/CCM.0b013e31828a3f4d; Gopcevic A, 2007, TOHOKU J EXP MED, V211, P387, DOI 10.1620/tjem.211.387; Hastie T, 2009, ELEMENTS STAT LEARNI, V2nd, DOI 10.1007/978-0-387-84858-7; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Liesz A, 2015, J NEUROSCI, V35, P583, DOI 10.1523/JNEUROSCI.2439-14.2015; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PINSKY MR, 1993, CHEST, V103, P565, DOI 10.1378/chest.103.2.565; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Scranton RA, 2015, J CLIN MED, V4, P1463, DOI 10.3390/jcm4071463; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Weber DJ, 2014, SCI TRANSL MED, V6, P252; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Woratyla S P, 1995, Conn Med, V59, P643; Yousefzadeh-Chabok S, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.18357; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	40	10	11	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2019	131	6					1931	1937		10.3171/2018.8.JNS18676			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JS4CC	WOS:000500253800030	30641838				2022-02-06	
J	Miki, K; Abe, H; Morishita, T; Hayashi, S; Yagi, K; Arima, H; Inoue, T				Miki, Koichi; Abe, Hiroshi; Morishita, Takashi; Hayashi, Shuji; Yagi, Kenji; Arima, Hisatomi; Inoue, Tooru			Double-crescent sign as a predictor of chronic subdural hematoma recurrence following burr-hole surgery	JOURNAL OF NEUROSURGERY			English	Article						chronic subdural hematoma; recurrence; hygroma; double-crescent sign; traumatic brain injury	RISK-FACTORS; COMPLICATIONS; REOPERATION; OUTCOMES; SYSTEM; VOLUME	OBJECTIVE Subdural hygroma has been reported as a causative factor in the development of a chronic subdural hematoma (CSDH) following a head trauma and/or neurosurgical procedure. In some CSDH cases, the presence of a 2-layered space delineated by the same or similar density of CSF surrounded by a superficial, residual hematoma is seen on CT imaging after evacuation of the hematoma. The aims of the present study were to test the hypothesis that the double-crescent sign (DCS), a unique imaging finding described here, is associated with the postoperative recurrence of CSDH, and to investigate other factors that are related to CSDH recurrence. METHODS The authors retrospectively analyzed data from 278 consecutive patients who underwent single burr-hole surgery for CSDH between April 2012 and March 2017. The DCS was defined as a postoperative CT finding, characterized by the following 2 layers: a superficial layer demonstrating residual hematoma after evacuation of the CSDH, and a deep layer between the brain's surface and the residual hematoma, depicted as a low-density space. Correlation of the recurrence of CSDH with the DCS was evaluated by multivariate logistic regression modeling. The authors also investigated other classic predictive factors including age, sex, past history of head injury, hematoma laterality, anticoagulant and antiplatelet therapy administration, preoperative hematoma volume, postoperative residual hematoma volume, and postoperative brain reexpansion rate. RESULTS A total of 277 patients (320 hemispheres) were reviewed. Fifty (18.1%) of the 277 patients experienced recurrence of CSDH within 3 months of surgery. CSDH recurred within 3 months of surgery in 32 of the 104 hemispheres with a positive DCS. Multivariate logistic analyses revealed that the presence of the DCS (OR 3.36, 95% CI 1.72-6.57, p < 0.001), large postoperative residual hematoma volume (OR 2.88, 95% CI 1.24-6.71, p = 0.014), anticoagulant therapy (OR 3.03, 95% CI 1.02-9.01, p = 0.046), and bilateral hematoma (OR 3.57, 95% CI 1.79-7.13, p < 0.001) were significant, independent predictors of CSDH recurrence. CONCLUSIONS In this study, the authors report that detection of the DCS within 7 days of surgery is an independent predictive factor for CSDH recurrence. They therefore advocate that clinicians should carefully monitor patients for postoperative DCS and subsequent CSDH recurrence.	[Miki, Koichi; Abe, Hiroshi; Morishita, Takashi; Yagi, Kenji; Inoue, Tooru] Fukuoka Univ, Fukuoka Univ Hosp, Fac Med, Dept Neurosurg, Fukuoka, Fukuoka, Japan; [Miki, Koichi; Abe, Hiroshi; Morishita, Takashi; Yagi, Kenji; Arima, Hisatomi; Inoue, Tooru] Fukuoka Univ, Sch Med, Fukuoka, Fukuoka, Japan; [Hayashi, Shuji] Hakujyuji Hosp, Dept Neurosurg, Fukuoka, Fukuoka, Japan; [Arima, Hisatomi] Fukuoka Univ, Fukuoka Univ Hosp, Fac Med, Dept Prevent Med & Publ Hlth, Fukuoka, Fukuoka, Japan		Abe, H (corresponding author), Fukuoka Univ, Fukuoka, Fukuoka, Japan.	roabe1972@gmail.com			Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; St. Luke Life Science Institute; Nakatomi Foundation; Takeda Science FoundationTakeda Science Foundation (TSF); Uehara Memorial FoundationUehara Memorial Foundation; Central Research Institute of Fukuoka University; AOSpine; Clinical Research Promotion Foundation Japan; Japan Agency for Medical Research and DevelopmentJapan Agency for Medical Research and Development (AMED)	Dr. Morishita received grant support from the Japan Society for the Promotion of Science, St. Luke Life Science Institute, Nakatomi Foundation, Takeda Science Foundation, Uehara Memorial Foundation, and Central Research Institute of Fukuoka University. Dr. Yagi received grant support from the Japan Society for the Promotion of Science and AOSpine. Dr. Inoue received grant support from the Clinical Research Promotion Foundation Japan and Japan Agency for Medical Research and Development.	Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Bartek J, 2017, WORLD NEUROSURG, V106, P609, DOI 10.1016/j.wneu.2017.07.044; Chari A, 2016, J NEUROTRAUM, V33, P1569, DOI 10.1089/neu.2015.4248; DIERCKX RA, 1989, ACTA NEUROL BELG, V89, P352; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Ivamoto HS, 2016, WORLD NEUROSURG, V86, P399, DOI 10.1016/j.wneu.2015.10.025; Jack A, 2015, CAN J NEUROL SCI, V42, P34, DOI 10.1017/cjn.2014.122; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Lee KS, 2000, J KOREAN MED SCI, V15, P560, DOI 10.3346/jkms.2000.15.5.560; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; Leroy HA, 2015, J CLIN NEUROSCI, V22, P1895, DOI 10.1016/j.jocn.2015.03.064; Liu WM, 2014, J NEUROSURG, V121, P665, DOI 10.3171/2014.5.JNS132715; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; Motiei-Langroudi R, 2018, J NEUROSURG, V129, P1143, DOI 10.3171/2017.6.JNS17130; NABESHIMA S, 1975, J COMP NEUROL, V164, P127, DOI 10.1002/cne.901640202; Nakaguchi H, 2000, J NEUROSURG, V93, P791, DOI 10.3171/jns.2000.93.5.0791; Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256; Nayil K, 2012, WORLD NEUROSURG, V77, P103, DOI 10.1016/j.wneu.2011.06.012; NOMURA S, 1994, J NEUROSURG, V81, P910, DOI 10.3171/jns.1994.81.6.0910; Park J, 2016, J NEUROSURG, V124, P310, DOI 10.3171/2015.1.JNS14309; Park SH, 2008, J CLIN NEUROSCI, V15, P868, DOI 10.1016/j.jocn.2007.08.003; Schwarz F, 2015, CLIN NEUROL NEUROSUR, V138, P66, DOI 10.1016/j.clineuro.2015.08.002; Stanisic M, 2017, NEUROSURGERY, V81, P752, DOI 10.1093/neuros/nyx090; Stavrinou P, 2017, WORLD NEUROSURG, V99, P465, DOI 10.1016/j.wneu.2016.12.058; Sucu HK, 2005, STROKE, V36, P998, DOI 10.1161/01.STR.0000162714.46038.0f; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17	26	10	10	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2019	131	6					1905	1911		10.3171/2018.8.JNS18805			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JS4CC	WOS:000500253800027	30611142				2022-02-06	
J	Whiteside, DM; Hunt, I; Choate, A; Caraher, K; Basso, MR				Whiteside, Douglas M.; Hunt, Isaac; Choate, Alyssa; Caraher, Kristen; Basso, Michael R.			Stratified performance on the Test of Memory Malingering (TOMM) is associated with differential responding on the Personality Assessment Inventory (PAI)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Performance validity test; Personality Assessment Inventory; symptom validity; Test of Memory Malingering; non-credible performance	TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY; BELIEFS; SCALES	Introduction: This study evaluated symptom endorsement patterns in participants at various stratified performance levels on the Test of Memory Malingering (TOMM). It was hypothesized that the lowest stratum (chance performance and below) would have the most pathological (i.e., elevated item endorsement) responding on the Personality Assessment Inventory (PAI) validity and clinical scales. This study was primarily a replication of previous work with emphasis on the PAI scales and consideration of varying degrees of performance on TOMM Trial 2. Methods: Participants were 760 (54% female, 85.4% Caucasian, mean age = 42.01 (SD = 15.89), mean education = 13.55 (SD = 2.35)) consecutively referred neuropsychological outpatients who completed the TOMM and PAI. Participants were placed in one of 5 stratified TOMM Trial 2 performance level groups (High Pass, Low Pass, High Fail, Low Fail, and Chance). No significant differences were found between the demographic variables except for referral source, which was overrepresented in the Chance group relative to the other groups. Results: Due to the highly skewed nature of TOMM Trial 2, Spearman rank order correlations were calculated for the 5 stratified levels of TOMM performance and all the main PAI scales. The NIM, SOM, DEP, ANX, SCZ and SUI scales had significant correlations, so a series of One-way ANOVAs were calculated to examine these scales at different TOMM stratified performance levels. Results indicated that the Chance group had the highest level of responding on all scales, with NIM, SOM, DEP, SCZ and SUI having mean elevations above the clinical cutoff (T = 70). Conclusions: Results were consistent with previous pass-fail PVT research, but extended earlier research to provide evidence that Chance performance group had more pathological PAI responding. The results provide preliminary evidence to support the notion that patients who fail PVTs at different levels do not have the same characteristics.	[Whiteside, Douglas M.] Univ Minnesota, Dept Rehabil Med, Neuropsychol Lab, Minneapolis, MN 55455 USA; [Hunt, Isaac] St Marys Hosp, Dept Neurol, Essentia Hlth, Duluth, MN USA; [Choate, Alyssa; Caraher, Kristen] Univ Iowa Hosp & Clin, Dept Psychiat, Iowa City, IA 52242 USA; [Basso, Michael R.] Mayo Clin, Dept Psychiat & Psychol, Rochester, NY USA		Whiteside, DM (corresponding author), Univ Minnesota, Neuropsychol Lab, MMC 390,420 Delaware St SE, Minneapolis, MN 55455 USA.	whit3055@umn.edu	Whiteside, Douglas/AAK-6396-2020; Basso, Michael/S-9587-2019	Caraher, Kristen/0000-0003-2590-3022; Basso, Michael/0000-0002-0217-662X; Whiteside, Douglas/0000-0002-8454-4413			American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI [DOI 10.1176/APPI.BOOKS.9780890423349, 10.1176/appi.books.9780890423349]; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Binder LM, 2018, CLIN NEUROPSYCHOL, V32, P132, DOI 10.1080/13854046.2017.1337931; Busse M, 2014, CLIN NEUROPSYCHOL, V28, P237, DOI 10.1080/13854046.2013.876100; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen J., 2013, STAT POWER ANAL BEHA; Field A., 2017, DISCOVERING STAT USI, V5th; Gaasedelen OJ, 2019, CLIN NEUROPSYCHOL, V33, P1467, DOI 10.1080/13854046.2019.1612947; Gaasedelen OJ, 2017, CLIN NEUROPSYCHOL, V31, P844, DOI 10.1080/13854046.2017.1312700; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Green P., 2003, WORD MEMORY TEST WIN; Green P., 1996, WORD MEMORY TEST USE; Haggerty KA, 2007, CLIN NEUROPSYCHOL, V21, P917, DOI 10.1080/13854040600899724; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Keiski MA, 2015, ASSESSMENT, V22, P233, DOI 10.1177/1073191114539380; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2017, CLIN NEUROPSYCHOL, V31, P1387, DOI 10.1080/13854046.2017.1364423; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Morey L.C., 2007, PERSONALITY ASSESSME; Persinger VC, 2018, CLIN NEUROPSYCHOL, V32, P1039, DOI 10.1080/13854046.2017.1419507; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Sumanti M, 2006, CLIN NEUROPSYCHOL, V20, P754, DOI 10.1080/13854040500428467; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Whiteside D, 2010, CLIN NEUROPSYCHOL, V24, P315, DOI 10.1080/13854040903482822; Whiteside DM, 2012, J CLIN EXP NEUROPSYC, V34, P172, DOI 10.1080/13803395.2011.630648; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169	33	10	10	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB 7	2020	42	2					131	141		10.1080/13803395.2019.1695749		NOV 2019	11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	KH7CJ	WOS:000498782200001	31771455				2022-02-06	
J	Saber, M; Giordano, KR; Hur, Y; Ortiz, JB; Morrison, H; Godbout, JP; Murphy, SM; Lifshitz, J; Rowe, RK				Saber, Maha; Giordano, Katherine R.; Hur, Yerin; Ortiz, John B.; Morrison, Helena; Godbout, Jonathan P.; Murphy, Sean M.; Lifshitz, Jonathan; Rowe, Rachel K.			Acute peripheral inflammation and post-traumatic sleep differ between sexes after experimental diffuse brain injury	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						concussion; cytokine; microglia; midline fluid percussion; mouse; neuroinflammation; post-traumatic sleep; sex differences	GENDER-DIFFERENCES; BAYESIAN METHODS; R PACKAGE; CYTOKINES; METAANALYSIS; RESPONSES; MODERATE; STRESS; MODELS; DISTURBANCES	Identifying differential responses between sexes following traumatic brain injury (TBI) can elucidate the mechanisms behind disease pathology. Peripheral and central inflammation in the pathophysiology of TBI can increase sleep in male rodents, but this remains untested in females. We hypothesized that diffuse TBI would increase inflammation and sleep in males more so than in females. Diffuse TBI was induced in C57BL/6J mice and serial blood samples were collected (baseline, 1, 5, 7 days post-injury [DPI]) to quantify peripheral immune cell populations and sleep regulatory cytokines. Brains and spleens were harvested at 7DPI to quantify central and peripheral immune cells, respectively. Mixed-effects regression models were used for data analysis. Female TBI mice had 77%-124% higher IL-6 levels than male TBI mice at 1 and 5DPI, whereas IL-1 beta and TNF-alpha levels were similar between sexes at all timepoints. Despite baseline sex differences in blood-measured Ly6C(high) monocytes (females had 40% more than males), TBI reduced monocytes by 67% in TBI mice at 1DPI. Male TBI mice had 31%-33% more blood-measured and 31% more spleen-measured Ly6G(+) neutrophils than female TBI mice at 1 and 5DPI, and 7DPI, respectively. Compared with sham, TBI increased sleep in both sexes during the first light and dark cycles. Male TBI mice slept 11%-17% more than female TBI mice, depending on the cycle. Thus, sex and TBI interactions may alter the peripheral inflammation profile and sleep patterns, which might explain discrepancies in disease progression based on sex.	[Saber, Maha; Giordano, Katherine R.; Hur, Yerin; Ortiz, John B.; Lifshitz, Jonathan; Rowe, Rachel K.] Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AL USA; [Saber, Maha; Giordano, Katherine R.; Hur, Yerin; Ortiz, John B.; Murphy, Sean M.; Lifshitz, Jonathan; Rowe, Rachel K.] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA; [Morrison, Helena] Univ Arizona, Coll Nursing, Tucson, AZ 85721 USA; [Godbout, Jonathan P.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Godbout, Jonathan P.] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA; [Godbout, Jonathan P.] Ohio State Univ, Inst Behav Med Res, Columbus, OH 43210 USA; [Lifshitz, Jonathan; Rowe, Rachel K.] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ USA		Rowe, RK (corresponding author), Univ Arizona, Coll Med Phoenix, Translat Neurotrauma Res Program, ABC 1 Bldg,425 N 5th St, Phoenix, AZ 85004 USA.	rkro222@email.arizona.edu	Murphy, Sean/AAM-4692-2021	Murphy, Sean/0000-0002-9404-8878; Rowe, Rachel/0000-0002-9034-3159; Saber, Maha/0000-0001-6120-3993	Phoenix Children's hospital Mission support; Foundation for the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 AG044402]; UACC/ARL Cytometry Core Facilities (Cancer Center Support) [CCSG-CA 023074]	Phoenix Children's hospital Mission support; Foundation for the National Institutes of Health, Grant/Award Number: T32 AG044402; UACC/ARL Cytometry Core Facilities (Cancer Center Support), Grant/Award Number: CCSG-CA 023074	Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Burkner PC, 2018, R J, V10, P395; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Burkner P, 2019, ESTIMATING MULTIVARI; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Clinton JM, 2011, J CLIN SLEEP MED, V7, pS38, DOI 10.5664/JCSM.1360; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Davis CJ, 2012, SLEEP MED CLIN, V7, P517, DOI 10.1016/j.jsmc.2012.06.006; Denker SP, 2007, J NEUROCHEM, V100, P893, DOI 10.1111/j.1471-4159.2006.04162.x; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Figueroa-Zuniga JI, 2013, COMPUT STAT DATA AN, V61, P137, DOI 10.1016/j.csda.2012.12.002; Gabry J., 2019, BAYESPLOT PLOTTING B; Gabry J, 2019, J R STAT SOC A STAT, V182, P389, DOI 10.1111/rssa.12378; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Gelman A., 2013, BAYESIAN DATA ANAL, P157; Gelman A., 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gelman A, 2019, AM STAT, V73, P307, DOI 10.1080/00031305.2018.1549100; Gelman A, 2015, J EDUC BEHAV STAT, V40, P530, DOI 10.3102/1076998615606113; Gelman A, 2011, CH CRC HANDB MOD STA, P163; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Halli S., 1992, ADV TECHNIQUES POPUL, P172; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Harrison JL, 2014, EXP BRAIN RES, V232, P2709, DOI 10.1007/s00221-014-3948-3; Hart R. A., 1999, ANN M MIDW POL SCI A, P1; HARWELL MR, 1992, J EDUC STAT, V17, P315, DOI 10.3102/10769986017004315; Hilbe, 2011, NEGATIVE BINOMIAL RE; Hilbe JM, 2014, MODELING COUNT DATA, P1; Hill J., 2006, DATA ANAL USING REGR; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Hunger M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-144; Ji Y, 2005, BIOINFORMATICS, V21, P2118, DOI 10.1093/bioinformatics/bti318; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Koehl M, 2006, SLEEP, V29, P1224, DOI 10.1093/sleep/29.9.1224; Kohman RA, 2010, BRAIN BEHAV IMMUN, V24, P486, DOI 10.1016/j.bbi.2009.12.004; Krishnan V, 2006, CURR OPIN PULM MED, V12, P383, DOI 10.1097/01.mcp.0000245705.69440.6a; Krueger AM, 2017, CRIT REV IMMUNOL, V37, P291, DOI 10.1615/CritRevImmunol.v37.i2-6.70; KRUEGER J M, 1989, Journal of Rheumatology, V16, P52; Krueger James M, 2011, Handb Clin Neurol, V98, P229, DOI 10.1016/B978-0-444-52006-7.00015-0; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; KRUEGER JM, 1995, INT ARCH ALLERGY IMM, V106, P97, DOI 10.1159/000236827; KRUEGER JM, 1995, ADV NEUROIMMUNOL, V5, P171, DOI 10.1016/0960-5428(95)00007-O; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Kruschke JK, 2018, PSYCHON B REV, V25, P178, DOI 10.3758/s13423-016-1221-4; Kruschke JK, 2012, ORGAN RES METHODS, V15, P722, DOI 10.1177/1094428112457829; LANCEL M, 1995, AM J PHYSIOL-REG I, V268, pR1310, DOI 10.1152/ajpregu.1995.268.5.R1310; Lewandowski D, 2009, J MULTIVARIATE ANAL, V100, P1989, DOI 10.1016/j.jmva.2009.04.008; Lix LM, 1996, REV EDUC RES, V66, P579, DOI 10.3102/00346543066004579; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; McLachlan GJ., 2000, WILEY SER PROB STAT, DOI 10.1002/0471721182; McNeish D, 2016, STRUCT EQU MODELING, V23, P750, DOI 10.1080/10705511.2016.1186549; Medic G, 2017, NAT SCI SLEEP, V9, P151, DOI 10.2147/NSS.S134864; Mong JA, 2011, J NEUROSCI, V31, P16107, DOI 10.1523/JNEUROSCI.4175-11.2011; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Mullington J, 2000, AM J PHYSIOL-REG I, V278, pR947, DOI 10.1152/ajpregu.2000.278.4.R947; Mullington JM, 2010, BEST PRACT RES CL EN, V24, P775, DOI 10.1016/j.beem.2010.08.014; Nalborczyk L, 2019, J SPEECH LANG HEAR R, V62, P1225, DOI 10.1044/2018_JSLHR-S-18-0006; Paul KN, 2006, SLEEP, V29, P1211, DOI 10.1093/sleep/29.9.1211; Paul KN, 2009, NEUROSCI LETT, V463, P239, DOI 10.1016/j.neulet.2009.07.081; Perperoglou A, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0666-3; Pitsillides CM, 2011, CYTOM PART A, V79A, P758, DOI 10.1002/cyto.a.21125; Polo-Kantola P, 1998, AM J OBSTET GYNECOL, V178, P1002, DOI 10.1016/S0002-9378(98)70539-3; R Core Team, 2019, R LANG ENV STAT COMP; Rangaraju S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00405; Rasouli J, 2011, Einstein J Biol Med, V27, P74; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Rohleder N, 2012, ANN NY ACAD SCI, V1261, P88, DOI 10.1111/j.1749-6632.2012.06634.x; Rowe RK, 2019, J NEUROTRAUM, V36, P1318, DOI 10.1089/neu.2018.5980; Rowe RK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1200-y; Rowe RK, 2018, J NEUROSURG-PEDIATR, V22, P22, DOI 10.3171/2018.1.PEDS17449; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; SHOHAM S, 1987, AM J PHYSIOL, V253, pR142, DOI 10.1152/ajpregu.1987.253.1.R142; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Thomasy HE, 2019, J NEUROTRAUM, V36, P802, DOI 10.1089/neu.2018.5810; Truettner JS, 2017, J CEREBR BLOOD F MET, V37, P2952, DOI 10.1177/0271678X16680003; Twisk J, 2018, CONT CLIN TRIAL COMM, V10, P80, DOI 10.1016/j.conctc.2018.03.008; van de Schoot R, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.25216; van de Schoot R, 2014, CHILD DEV, V85, P842, DOI 10.1111/cdev.12169; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Viola-Saltzman M, 2016, NEUROPSYCH DIS TREAT, V12, P339, DOI 10.2147/NDT.S69105; WEIGLE WO, 1989, HOSP PRACT, V24, P112; West B.T., 2014, LINEAR MIXED MODELS; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Wu L., 2009, MIXED EFFECTS MODELS	110	10	11	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JUL	2020	52	1			SI		2791	2814		10.1111/ejn.14611		NOV 2019	24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NE3FC	WOS:000498723100001	31677290	Green Accepted			2022-02-06	
J	Zhang, ZJ; Zheng, XX; Zhang, XY; Zhang, Y; Huang, BY; Luo, T				Zhang, Zhi-jing; Zheng, Xin-xun; Zhang, Xin-yun; Zhang, Yi; Huang, Bao-yi; Luo, Tao			Aging alters Hv1-mediated microglial polarization and enhances neuroinflammation after peripheral surgery	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						aging; Hv1; microglial polarization; neuroinflammation	POSTOPERATIVE COGNITIVE DYSFUNCTION; TRAUMATIC BRAIN-INJURY; AGED MICE; MICROGLIA/MACROPHAGE POLARIZATION; MACROPHAGE SUBSETS; M2 POLARIZATION; EXPRESSION; DAMAGE; IMPAIRMENT; ISOFLURANE	Perioperative neurocognitive disorders have been widely recognized as common adverse events after surgical intervention. Aging is one of the most important independent risk factors for worsened cognitive outcome, and this deterioration is linked to exacerbated microglia-mediated neuroinflammation in the aged brain. Under pathological stimulation, microglia are capable of polarizing toward proinflammatory M1 and anti-inflammatory M2 phenotypes. In the present study, we examined how aging affects microglial responses and neuroinflammation following peripheral surgery. Adult (2-3 months) and aged (18 months old) male C57/BL6 mice were subjected to tibial fracture or sham surgery. Aged mice exhibited higher level of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) in the hippocampus. The expression of synaptic protein synaptophysin (SYP) was also markedly reduced in the aged brain after the surgery. Both adult and aged mice showed significant increases in M1 microglial polarization (CD16/32). In contrast, tibial fracture surgery induced a decreased M2 microglial polarization (CD206, Ym1/2, Arg1) in aged brain but enhanced M2 microglial polarization in adult brain. Aged mice have upregulated voltage-gated proton channel (Hv1) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunit expression compared with adult mice. The percentage of CD16/32-positive M1 microglia colabeling with Hv1 was higher in aged mice after tibial fracture surgery. Thus, Hv1/NADPH oxidase upregulation in the aged brain may shift the dynamic equilibrium of microglial activation toward M1 polarization and exaggerate postoperative neuroinflammatory responses after peripheral surgical intervention.	[Zhang, Zhi-jing; Zheng, Xin-xun; Zhang, Xin-yun; Zhang, Yi; Huang, Bao-yi; Luo, Tao] Peking Univ, Dept Anesthesiol, Shenzhen Hosp, 1120 Lianhua Rd Shenzhen, Shenzhen 518036, Guangdong, Peoples R China; [Zhang, Zhi-jing; Zhang, Xin-yun; Huang, Bao-yi] Shantou Univ, Med Coll, Shantou, Peoples R China; [Zhang, Yi] Anhui Med Univ, Hefei, Anhui, Peoples R China		Luo, T (corresponding author), Peking Univ, Dept Anesthesiol, Shenzhen Hosp, 1120 Lianhua Rd Shenzhen, Shenzhen 518036, Guangdong, Peoples R China.	luotao_wh@yahoo.com		Luo, Tao/0000-0002-5592-8899	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271205]; Foundation of Shenzhen Science and Technology Innovation [201703073000395]	This study was supported by the National Natural Science Foundation of China (grant no. 81271205) and Foundation of Shenzhen Science and Technology Innovation (grant no. 201703073000395).	Androsova G, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00112; Cao XZ, 2010, PROG NEURO-PSYCHOPH, V34, P1426, DOI 10.1016/j.pnpbp.2010.07.027; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; David S, 2015, NEUROSCIENCE, V307, P311, DOI 10.1016/j.neuroscience.2015.08.064; Fenn AM, 2012, BRAIN BEHAV IMMUN, V26, P766, DOI 10.1016/j.bbi.2011.10.003; Harry LE, 2008, J ORTHOP RES, V26, P1238, DOI 10.1002/jor.20649; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Kawai T, 2017, J NEUROCHEM, V142, P686, DOI 10.1111/jnc.14106; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Labandeira-Garcia JL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00129; Li XM, 2014, ANESTHESIOLOGY, V121, P79, DOI 10.1097/ALN.0000000000000191; Liu XR, 2016, STROKE, V47, P498, DOI 10.1161/STROKEAHA.115.012079; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Newman S, 2007, ANESTHESIOLOGY, V106, P572, DOI 10.1097/00000542-200703000-00023; Njie EG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.008; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Suenaga J, 2015, EXP NEUROL, V272, P109, DOI 10.1016/j.expneurol.2015.03.021; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Tian DS, 2016, J NEUROCHEM, V139, P96, DOI 10.1111/jnc.13751; Tian XS, 2015, CNS NEUROSCI THER, V21, P398, DOI 10.1111/cns.12368; von Leden RE, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0933-3; Wang M, 2019, CNS NEUROSCI THER, V25, P1126, DOI 10.1111/cns.13208; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; Wynne AM, 2009, INTEGR COMP BIOL, V49, P254, DOI 10.1093/icb/icp009; Xiao JY, 2018, CNS NEUROSCI THER, V24, P917, DOI 10.1111/cns.12832; Yu Y, 2018, BIOCHEM BIOPH RES CO, V498, P1, DOI 10.1016/j.bbrc.2017.06.197; Zhang B, 2016, NEUROBIOL AGING, V47, P157, DOI 10.1016/j.neurobiolaging.2016.07.029; Zhang B, 2015, EXP NEUROL, V273, P83, DOI 10.1016/j.expneurol.2015.08.001; Zhang J, 2014, NEUROSCIENCE, V261, P1, DOI 10.1016/j.neuroscience.2013.12.034; Zuo CL, 2018, CNS NEUROSCI THER, V24, P212, DOI 10.1111/cns.12794	36	10	10	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	MAR	2020	26	3					374	384		10.1111/cns.13271		NOV 2019	11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	KR5AW	WOS:000498766600001	31774629	Green Published, gold			2022-02-06	
J	Wu, SJ; Zhao, W; Rowson, B; Rowson, S; Ji, SB				Wu, Shaoju; Zhao, Wei; Rowson, Bethany; Rowson, Steven; Ji, Songbai			A network-based response feature matrix as a brain injury metric	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Concussion; Brain structural network; Traumatic brain injury; Support vector machine; Worcester head injury model	FINITE-ELEMENT MODELS; HEAD KINEMATICS; AXONAL STRAIN; FOOTBALL; CONCUSSION; PREDICTION; CONSTRUCTION; VALIDATION; IMPACTS; SYSTEM	Conventional brain injury metrics are scalars that treat the whole head/brain as a single unit but do not characterize the distribution of brain responses. Here, we establish a network-based "response feature matrix" to characterize the magnitude and distribution of impact-induced brain strains. The network nodes and edges encode injury risks to the gray matter regions and their white matter interconnections, respectively. The utility of the metric is illustrated in injury prediction using three independent, real-world datasets: two reconstructed impact datasets from the National Football League (NFL) and Virginia Tech, respectively, and measured concussive and non-injury impacts from Stanford University. Injury predictions with leave-one-out cross-validation are conducted using the two reconstructed datasets separately, and then by combining all datasets into one. Using support vector machine, the network-based injury predictor consistently outperforms four baseline scalar metrics including peak maximum principal strain of the whole brain (MPS), peak linear/rotational acceleration, and peak rotational velocity across all five selected performance measures (e.g., maximized accuracy of 0.887 vs. 0.774 and 0.849 for MPS and rotational acceleration with corresponding positive predictive values of 0.938, 0.772, and 0.800, respectively, using the reconstructed NFL dataset). With sufficient training data, real-world injury prediction is similar to leave-one-out in-sample evaluation, suggesting the potential advantage of the network-based injury metric over conventional scalar metrics. The network-based response feature matrix significantly extends scalar metrics by sampling the brain strains more completely, which may serve as a useful framework potentially allowing for other applications such as characterizing injury patterns or facilitating targeted multi-scale modeling in the future.	[Wu, Shaoju; Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA; [Rowson, Bethany; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, 100 Inst Rd, Worcester, MA 01609 USA		Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA.; Ji, SB (corresponding author), Worcester Polytech Inst, Dept Mech Engn, 100 Inst Rd, Worcester, MA 01609 USA.	sji@wpi.edu	Rowson, Steven/B-1270-2012; WU, SHAOJU/S-1930-2019; Lang, Steven/AAE-8102-2021	Rowson, Steven/0000-0002-3227-0596; Lang, Steven/0000-0003-1669-9146; Ji, Songbai/0000-0002-2886-5781	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092853] Funding Source: NIH RePORTER	Funding is provided by the NIH Grant R01 NS092853. The authors are grateful to Dr. David B. Camarillo at Stanford University for data sharing. They also thank Dr. Zheyang Wu at Worcester Polytechnic Institute for help on statistical analysis.	Agoston Denes V, 2017, Concussion, V2, pCNC45, DOI 10.2217/cnc-2016-0013; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Cai YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197992; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2011, MULTISCALE MECH TRAU; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; FORNITO A., 2016, FUNDAMENTALS BRAIN N; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hastie T., 2008, ELEMENTS STAT LEARNI, VSecond; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hira Zena M., 2015, Advances in Bioinformatics, V2015, P198363, DOI 10.1155/2015/198363; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Khvostikov A., 2018, ARXIV180105968; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Kuo C, 2018, BIOMECH MODEL MECHAN, V17, P235, DOI 10.1007/s10237-017-0957-8; Leemans A., 2009, P INT SOC MAG RESON; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Mohammadipour A, 2017, J BIOMECH, V65, P61, DOI 10.1016/j.jbiomech.2017.09.029; Montanino A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00643; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NRC I, 2014, SPORTS RELATED CONCU; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Qi SL, 2015, J NEUROSCI METH, V253, P170, DOI 10.1016/j.jneumeth.2015.06.016; Rathore S, 2017, NEUROIMAGE, V155, P530, DOI 10.1016/j.neuroimage.2017.03.057; Rowson B, 2016, EVALUATION APPL BRAI; Rowson S, 2019, ANN BIOMED ENG, V47, P2048, DOI 10.1007/s10439-019-02329-7; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Sanchez EJ, 2017, J NEUROTRAUM, V34, P2410, DOI 10.1089/neu.2016.4681; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Simundic Ana-Maria, 2009, EJIFCC, V19, P203; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Takahashi Y., 2015, 2015011439 SAE, DOI DOI 10.4271/2015-01-1439; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Versace J., 1971, REV SEVERITY INDEX; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W., 2019, IRCOBI, P619; Zhao W, 2019, ANN BIOMED ENG, V47, P475, DOI 10.1007/s10439-018-02159-z; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; ZHOU Z, 2018, STAPP CAR CRASH J, V62, P1; Zhu F, 2016, J NEUROTRAUM, V33, P859, DOI 10.1089/neu.2015.4007	78	10	10	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	JUN	2020	19	3					927	942		10.1007/s10237-019-01261-y		NOV 2019	16	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	LK5AX	WOS:000499756200002	31760600	Green Accepted			2022-02-06	
J	Wu, SJ; Zhao, W; Ghazi, K; Ji, SB				Wu, Shaoju; Zhao, Wei; Ghazi, Kianoosh; Ji, Songbai			Convolutional neural network for efficient estimation of regional brain strains	SCIENTIFIC REPORTS			English	Article							INJURY; FOOTBALL; SPORTS; IMPACTS; CONCUSSION; RESPONSES	Head injury models are important tools to study concussion biomechanics but are impractical for real-world use because they are too slow. Here, we develop a convolutional neural network (CNN) to estimate regional brain strains instantly and accurately by conceptualizing head rotational velocity profiles as two-dimensional images for input. We use two impact datasets with augmentation to investigate the CNN prediction performances with a variety of training-testing configurations. Three strain measures are considered, including maximum principal strain (MPS) of the whole brain, MPS of the corpus callosum, and fiber strain of the corpus callosum. The CNN is further tested using an independent impact dataset (N = 314) measured in American football. Based on 2592 training samples, it achieves a testing R-2 of 0.916 and root mean squared error (RMSE) of 0.014 for MPS of the whole brain. Combining all impact-strain response data available (N = 3069), the CNN achieves an R-2 of 0.966 and RMSE of 0.013 in a 10-fold cross-validation. This technique may enable a clinical diagnostic capability to a sophisticated head injury model, such as facilitating head impact sensors in concussion detection via a mobile device. In addition, it may transform current acceleration-based injury studies into focusing on regional brain strains. The trained CNN is publicly available along with associated code and examples at https://github.com/Jilab-biomechanics/CNN-brain-strains. They will be updated as needed in the future.	[Wu, Shaoju; Zhao, Wei; Ghazi, Kianoosh; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA		Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.; Ji, SB (corresponding author), Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA.	sji@wpi.edu	WU, SHAOJU/S-1930-2019		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853]; Ford University Research Program	Funding is provided by the NIH Grant R01 NS092853 and the Ford University Research Program. The authors are grateful to the National Football League (NFL) Committee on Mild Traumatic Brain Injury (MTBI) and Biokinetics and Associates Ltd. for providing the reconstructed head impact data. They also thank Dr. David Camarillo at Stanford University and Dr. Adam Bartsch at Prevent Biometrics for sharing head impact data. The Titan X Pascal GPU used in this work was donated by the NVIDIA Corporation.	Abderezaei J, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.014058; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Bouckaert G, 2010, PUB SECTOR ORGAN, P3; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CDC, 2015, C TRAUM BRAIN INJ US, DOI [10.1161/HYPERTENSIONAHA.111.186106, DOI 10.1161/HYPERTENSIONAHA.111.186106]; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Franklyn Melanie, 2005, Stapp Car Crash J, V49, P1; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Glorot X., 2011, P 14 INT C ART INT S, P315; Graham R., 2014, JAMA, V311; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hannink J, 2017, IEEE J BIOMED HEALTH, V21, P85, DOI 10.1109/JBHI.2016.2636456; Hastie T., 2008, ELEMENTS STAT LEARNI, VSecond; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; King A. I., 2003, P IRCOBI C; King A. I., 2003, IRCOBI C LISB PORT; Kingma D.P., 2015, P 3 INT C LEARN REPR, DOI DOI 10.1145/1830483.1830503; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Krizhevsky A., 2012, ADV NEURAL INFORM PR, P1097, DOI DOI 10.1145/3065386; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Lusch B, 2018, BRAIN COGNITION, V123, P154, DOI 10.1016/j.bandc.2018.02.012; Mihalik JP, 2017, MED SCI SPORT EXER, V49, P247, DOI 10.1249/MSS.0000000000001089; Nair V., 2010, P 27 INT C MACH LEAR; Peden M., 2004, WORLD REPORT ROAD TR; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Prechelt L, 1998, LECT NOTES COMPUT SC, V1524, P55; Rane L, 2019, ANN BIOMED ENG, V47, P778, DOI 10.1007/s10439-018-02190-0; Ren Shaoqing, 2017, IEEE Trans Pattern Anal Mach Intell, V39, P1137, DOI 10.1109/TPAMI.2016.2577031; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Roy S, 2018, I S BIOMED IMAGING, P158, DOI 10.1109/ISBI.2018.8363545; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Takhounts EG, 2008, STAPP CAR C, V52, P1; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Voulodimos A, 2018, COMPUT INTEL NEUROSC, V2018, DOI 10.1155/2018/7068349; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yamashita R, 2018, INSIGHTS IMAGING, V9, P611, DOI 10.1007/s13244-018-0639-9; Yang King H, 2006, Stapp Car Crash J, V50, P429; Zhao W., 2019, IRCOBI, P619; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhao W, 2017, ANN BIOMED ENG, V45, P2437, DOI 10.1007/s10439-017-1888-3; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7	54	10	10	2	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	NOV 22	2019	9								17326	10.1038/s41598-019-53551-1			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP1UG	WOS:000498056500002	31758002	Green Published, gold			2022-02-06	
J	Remedios, SW; Roy, S; Bermudez, C; Patel, MB; Butman, JA; Landman, BA; Pham, DL				Remedios, Samuel W.; Roy, Snehashis; Bermudez, Camilo; Patel, Mayur B.; Butman, John A.; Landman, Bennett A.; Pham, Dzung L.			Distributed deep learning across multisite datasets for generalized CT hemorrhage segmentation	MEDICAL PHYSICS			English	Article						computed tomography (CT); deep learning; distributed; hemorrhage; image segmentation; lesion; multisite; neural network; traumatic brain injury	HUMAN BRAIN; VARIABILITY; DICOM	Purpose As deep neural networks achieve more success in the wide field of computer vision, greater emphasis is being placed on the generalizations of these models for production deployment. With sufficiently large training datasets, models can typically avoid overfitting their data; however, for medical imaging it is often difficult to obtain enough data from a single site. Sharing data between institutions is also frequently nonviable or prohibited due to security measures and research compliance constraints, enforced to guard protected health information (PHI) and patient anonymity. Methods In this paper, we implement cyclic weight transfer with independent datasets from multiple geographically disparate sites without compromising PHI. We compare results between single-site learning (SSL) and multisite learning (MSL) models on testing data drawn from each of the training sites as well as two other institutions. Results The MSL model attains an average dice similarity coefficient (DSC) of 0.690 on the holdout institution datasets with a volume correlation of 0.914, respectively corresponding to a 7% and 5% statistically significant improvement over the average of both SSL models, which attained an average DSC of 0.646 and average correlation of 0.871. Conclusions We show that a neural network can be efficiently trained on data from two physically remote sites without consolidating patient data to a single location. The resulting network improves model generalization and achieves higher average DSCs on external datasets than neural networks trained on data from a single source.	[Remedios, Samuel W.; Roy, Snehashis; Pham, Dzung L.] Henry M Jackson Fdn Adv Mil Med, Ctr Neurosci & Regenerat Med, Bethesda, MD 20892 USA; [Remedios, Samuel W.; Butman, John A.; Pham, Dzung L.] NIH, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Remedios, Samuel W.] Middle Tennessee State Univ, Dept Comp Sci, Murfreesboro, TN 37132 USA; [Remedios, Samuel W.; Landman, Bennett A.] Vanderbilt Univ, Dept Elect Engn, Nashville, TN 37235 USA; [Bermudez, Camilo; Landman, Bennett A.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Patel, Mayur B.] Crit Illness Brain Dysfunct & Survivorship CIBS C, Sect Surg Sci, Dept Surg, Div Trauma Emergency Gen Surg & Surg Crit Care, Nashville, TN 37212 USA; [Landman, Bennett A.] Vanderbilt Univ, Dept Comp Sci, Nashville, TN 37235 USA		Remedios, SW (corresponding author), Henry M Jackson Fdn Adv Mil Med, Ctr Neurosci & Regenerat Med, Bethesda, MD 20892 USA.; Remedios, SW (corresponding author), NIH, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA.; Remedios, SW (corresponding author), Middle Tennessee State Univ, Dept Comp Sci, Murfreesboro, TN 37132 USA.; Remedios, SW (corresponding author), Vanderbilt Univ, Dept Elect Engn, Nashville, TN 37235 USA.	samuel.remedios@nih.gov	Landman, Bennett A/A-2343-2009; Pham, Dzung/AAR-8263-2020	Landman, Bennett A/0000-0001-5733-2127; Roy, Snehashis/0000-0002-7997-3993	National Institutes of Health (NIH) Clinical CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG-1507-05243]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01EB017230-01A1, R01GM120484, R01AG058639]; NSFNational Science Foundation (NSF) [1452485]; VICTR CTSA award from NCATS/NIH [ULTR000445]; Vanderbilt University Medical Center institutional funding; Patient-Centered Outcomes Research Institute (PCORI)Patient-Centered Outcomes Research Institute - PCORI [CDRN-1306-04869]; Advanced Computing Center for Research and Education (ACCRE) at the Vanderbilt University, Nashville, TN; ViSE/VICTR [VR3029]; NVIDIA	Support for this work included funding from the Intramural Research Program of the National Institutes of Health (NIH) Clinical Center and the Department of Defense in the Center for Neuroscience and Regenerative Medicine, the National Multiple Sclerosis Society RG-1507-05243 (Pham), and NIH grants 1R01EB017230-01A1 (Landman) and R01GM120484 and R01AG058639 (Patel), as well as NSF 1452485 (Landman). The VUMC dataset was obtained from ImageVU, a research resource supported by the VICTR CTSA award (ULTR000445 from NCATS/NIH), Vanderbilt University Medical Center institutional funding and Patient-Centered Outcomes Research Institute (PCORI; contract CDRN-1306-04869). This work received support from the Advanced Computing Center for Research and Education (ACCRE) at the Vanderbilt University, Nashville, TN, as well as in part by ViSE/VICTR VR3029. We also extend gratitude to NVIDIA for their support by means of the NVIDIA hardware grant.	Abadi M, 2016, CCS'16: PROCEEDINGS OF THE 2016 ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P308, DOI 10.1145/2976749.2978318; Andreasen NC, 1996, J COMPUT ASSIST TOMO, V20, P98, DOI 10.1097/00004728-199601000-00018; [Anonymous], 1996, PUBLIC LAW, V104, P191, DOI [10.4135/9781452234243.n359, DOI 10.4135/9781452234243.N359]; [Anonymous], 2003, NIH DATA SHARING POL; BESAG J, 1986, J R STAT SOC B, V48, P259; Birnbaum BA, 2007, RADIOLOGY, V242, P109, DOI 10.1148/radiol.2421052066; Chang K, 2018, J AM MED INFORM ASSN, V25, P945, DOI 10.1093/jamia/ocy017; Chang PD, 2018, AM J NEURORADIOL, V39, P1609, DOI 10.3174/ajnr.A5742; Cheng JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24454; Cootes TF, 2001, PROC SPIE, V4322, P236, DOI 10.1117/12.431093; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Brebisson Alexandre, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P20, DOI 10.1109/CVPRW.2015.7301312; Fetzer DT, 2008, ACAD RADIOL, V15, P390, DOI 10.1016/j.acra.2007.11.008; FUNAHASHI K, 1989, NEURAL NETWORKS, V2, P183, DOI 10.1016/0893-6080(89)90003-8; GILES CL, 1987, APPL OPTICS, V26, P4972, DOI 10.1364/AO.26.004972; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Halevy A, 2009, IEEE INTELL SYST, V24, P8, DOI 10.1109/MIS.2009.36; Huang ZH, 2018, IET IMAGE PROCESS, V12, P254, DOI 10.1049/iet-ipr.2017.0518; Huang ZH, 2018, BIOMED SIGNAL PROCES, V40, P131, DOI 10.1016/j.bspc.2017.09.019; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Kim J, 2013, REAL TIM SYST SYMP P, P246, DOI 10.1109/RTSS.2013.32; Kingma D.P., 2015, P 3 INT C LEARN REPR, DOI DOI 10.1145/1830483.1830503; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kirkpatricka J, 2017, P NATL ACAD SCI USA, V114, P3521, DOI 10.1073/pnas.1611835114; Konecny J., 2016, P NIPS WORKSH PRIV M; Konecny J., 2016, FEDERATED OPTIMIZATI; Kooi T, 2017, MED IMAGE ANAL, V35, P303, DOI 10.1016/j.media.2016.07.007; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Li XR, 2016, J NEUROSCI METH, V264, P47, DOI 10.1016/j.jneumeth.2016.03.001; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Luxton DD, 2012, TELEMED E-HEALTH, V18, P284, DOI 10.1089/tmj.2011.0180; Mackin D, 2015, INVEST RADIOL, V50, P757, DOI 10.1097/RLI.0000000000000180; McClure Patrick, 2018, Adv Neural Inf Process Syst, V31, P4093; Milletari F, 2016, INT CONF 3D VISION, P565, DOI 10.1109/3DV.2016.79; Muschelli J, 2017, NEUROIMAGE-CLIN, V14, P379, DOI 10.1016/j.nicl.2017.02.007; Muschelli J, 2015, NEUROIMAGE, V114, P379, DOI 10.1016/j.neuroimage.2015.03.074; Nguyen C. V., 2017, ARXIV171010628; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Prasoon A, 2013, LECT NOTES COMPUT SC, V8150, P246, DOI 10.1007/978-3-642-40763-5_31; Remedios S, 2019, MED IMAGING 2018 IMA, V10949; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Roy S, 2018, I S BIOMED IMAGING, P158, DOI 10.1109/ISBI.2018.8363545; Schlegl T, 2017, LECT NOTES COMPUT SC, V10265, P146, DOI 10.1007/978-3-319-59050-9_12; Shamir RR, 2018, BIORXIV306977; Simonyan K., 2014, ARXIV, DOI DOI 10.1109/CVPR.2015.7298594; Sudre H, 2018, ARXIV181209046; Thompson LA, 2011, J MED INTERNET RES, V13, P3, DOI 10.2196/jmir.1590; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Yahiaoui AFZ, 2016, 2016 INTERNATIONAL SYMPOSIUM ON SIGNAL, IMAGE, VIDEO AND COMMUNICATIONS (ISIVC), P13, DOI 10.1109/ISIVC.2016.7893954; Yosinski J, 2014, ADV NEUR IN, V27; Zenke F, 2017, PR MACH LEARN RES, V70; Zhang SS, 2013, INT CONF ACOUST SPEE, P6660, DOI 10.1109/ICASSP.2013.6638950	53	10	10	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0094-2405	2473-4209		MED PHYS	Med. Phys.	JAN	2020	47	1					89	98		10.1002/mp.13880		NOV 2019	10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	KD1IM	WOS:000497164000001	31660621	Bronze, Green Accepted			2022-02-06	
J	Zheng, F; Zhou, YT; Feng, DD; Li, PF; Tang, T; Luo, JK; Wang, Y				Zheng, Fei; Zhou, Yan-Tao; Feng, Dan-Dan; Li, Peng-Fei; Tang, Tao; Luo, Jie-Kun; Wang, Yang			Metabolomics analysis of the hippocampus in a rat model of traumatic brain injury during the acute phase	BRAIN AND BEHAVIOR			English	Article						acute traumatic brain injury; hippocampus; metabolomics; protein database analysis	LONG-TERM POTENTIATION; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; NITRIC-OXIDE; ACID; POLYAMINE; MECHANISMS; DISEASE; MEMORY	Background Traumatic brain injury (TBI) has increased in rank among traumatic injuries worldwide. Traumatic brain injury is a serious obstacle given that its complex pathology represents a long-term process. Recently, systems biology strategies such as metabolomics to investigate the multifactorial nature of TBI have facilitated attempts to find biomarkers and probe molecular pathways for its diagnosis and therapy. Methods This study included a group of 20 rats with controlled cortical impact and a group of 20 sham rats. We utilized mNSS tests to investigate neurological metabolic impairments on day 1 and day 3. Furthermore, we applied metabolomics and bioinformatics to determine the metabolic perturbation caused by TBI during the acute period in the hippocampus tissue of controlled cortical impact (CCI) rats. Notably, TBI-protein-metabolite subnetworks identified from a database were assessed for associations between metabolites and TBI by the dysregulation of related enzymes and transporters. Results Our results identified 7 and 8 biomarkers on day 1 and day 3, respectively. Additionally, related pathway disorders showed effects on arginine and proline metabolism as well as taurine and hypotaurine metabolism on day 3 in acute TBI. Furthermore, according to metabolite-protein database searches, 25 metabolite-protein pairs were established as causally associated with TBI. Further, bioinformation indicated that these TBI-associated proteins mainly take part in 5 '-nucleotidase activity and carboxylic acid transmembrane transport. In addition, interweaved networks were constructed to show that the development of TBI might be affected by metabolite-related proteins and their protein pathways. Conclusion The overall results show that acute TBI is susceptible to metabolic disorders, and the joint metabolite-protein network analysis provides a favorable prediction of TBI pathogenesis mechanisms in the brain. The signatures in the hippocampus might be promising for the development of biomarkers and pathways relevant to acute TBI and could further guide testable predictions of the underlying mechanism of TBI.	[Zheng, Fei; Zhou, Yan-Tao] Hunan Univ, Coll Elect & Informat Engn, Changsha, Peoples R China; [Feng, Dan-Dan; Li, Peng-Fei; Tang, Tao; Luo, Jie-Kun; Wang, Yang] Cent South Univ, Lab Ethnopharmacol, Inst Integrated Tradit Chinese & Western Med, Xiangya Hosp, Changsha, Peoples R China		Wang, Y (corresponding author), Cent South Univ, Lab Ethnopharmacol, Inst Integrated Tradit Chinese & Western Med, Xiangya Hosp, Changsha, Peoples R China.	wangyang_xy87@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81973665, 81673719, 61472126]; Hunan Provincial Natural Science Foundation of ChinaNatural Science Foundation of Hunan Province [2019JJ30042]	This work was supported by the National Natural Science Foundation of China (Nos. 81973665, 81673719, and 61472126) and Hunan Provincial Natural Science Foundation of China (No. 2019JJ30042).	Abreu-Villaca Y, 2011, BEHAV BRAIN RES, V221, P367, DOI 10.1016/j.bbr.2009.12.049; Abu-Asab MS, 2011, OMICS, V15, P105, DOI 10.1089/omi.2010.0023; Al-Majed AA, 2006, CLIN EXP PHARMACOL P, V33, P725, DOI 10.1111/j.1440-1681.2006.04425.x; Albright CD, 1999, DEV BRAIN RES, V113, P13, DOI 10.1016/S0165-3806(98)00183-7; Andreasson KI, 2016, J NEUROCHEM, V138, P653, DOI 10.1111/jnc.13667; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Bae S, 2020, BRAIN IMAGING BEHAV, V14, P1850, DOI 10.1007/s11682-019-00127-2; Beale DJ, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1449-2; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Bentz K, 2010, CELL PHYSIOL BIOCHEM, V26, P821, DOI 10.1159/000323991; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; Castillo L, 1996, P NATL ACAD SCI USA, V93, P11460, DOI 10.1073/pnas.93.21.11460; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Cho CR, 2006, CURR OPIN CHEM BIOL, V10, P294, DOI 10.1016/j.cbpa.2006.06.025; Choi Hyungwon, 2012, Frontiers in Genetics, V2, P105, DOI [10.3389/fgene.2011.00018, 10.3389/fgene.2011.00105]; Cisek K, 2016, NEPHROL DIAL TRANSPL, V31, P2003, DOI 10.1093/ndt/gfv364; COFFMAN JD, 1960, CIRC RES, V8, P649; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cortese GP, 2017, BEHAV BRAIN RES, V322, P269, DOI 10.1016/j.bbr.2016.08.027; Darrah SD, 2013, EPILEPSY RES, V103, P180, DOI 10.1016/j.eplepsyres.2012.07.006; Fei Z., 2017, PLOS ONE, V12; Frenguelli BG, 2019, NEUROCHEM RES, V44, P661, DOI 10.1007/s11064-017-2386-6; Graham SF, 2018, J PROTEOME RES, V17, P2460, DOI 10.1021/acs.jproteome.8b00224; Gui YX, 2015, ONCOTARGET, V6, P37043, DOI 10.18632/oncotarget.6158; Hillmer RA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004786; Jackson EK, 2017, J NEUROCHEM, V141, P676, DOI 10.1111/jnc.14018; Jaworski T, 2011, AM J PATHOL, V179, P2001, DOI 10.1016/j.ajpath.2011.06.025; Jeter CB, 2012, J NEUROTRAUM, V29, P119, DOI 10.1089/neu.2011.2029; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Leonardi R, 2007, P NATL ACAD SCI USA, V104, P1494, DOI 10.1073/pnas.0607621104; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Liao WT, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01950; LONGO LD, 1993, P NATL ACAD SCI USA, V90, P692, DOI 10.1073/pnas.90.2.692; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; McGuire JL, 2019, MOL NEUROBIOL, V56, P2908, DOI 10.1007/s12035-018-1276-5; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menon V, 2016, PROG BRAIN RES, V227, P159, DOI 10.1016/bs.pbr.2016.04.026; Menzie J, 2013, BRAIN SCI, V3, P877, DOI 10.3390/brainsci3020877; Obeid R, 2013, NUTRIENTS, V5, P3481, DOI 10.3390/nu5093481; PAULSON DJ, 1986, CARDIOVASC RES, V20, P536, DOI 10.1093/cvr/20.7.536; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; Roberts LD, 2013, CELL METAB, V18, P43, DOI 10.1016/j.cmet.2013.05.009; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Sarkar B, 2017, INT J EXP PATHOL, V98, P52, DOI 10.1111/iep.12222; Stipanuk MH, 2011, AMINO ACIDS, V41, P91, DOI 10.1007/s00726-010-0518-2; Szarka N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133223; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; VANSTEEG H, 1989, NUCLEIC ACIDS RES, V17, P8855, DOI 10.1093/nar/17.21.8855; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; WATSON BD, 1993, PROG BRAIN RES, V96, P69; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Wu JF, 2014, CELL CYCLE, V13, P2446, DOI 10.4161/cc.29420; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yang YX, 2019, NEUROIMMUNOMODULAT, V26, P43, DOI 10.1159/000495465; Yao JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009508; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zampieri Mattia, 2017, Current Opinion in Systems Biology, V6, P28, DOI 10.1016/j.coisb.2017.08.007; Zeisel SH, 2006, NUTR REV, V64, P197, DOI [10.1301/nr.2006.janr.197-203, 10.1111/j.1753-4887.2006.tb00202.x]; Zhang AH, 2012, APPL BIOCHEM BIOTECH, V168, P1718, DOI 10.1007/s12010-012-9891-5; Zhang C, 2014, BRAIN RES, V1555, P1, DOI 10.1016/j.brainres.2014.01.051; Zhou J, 2017, ONCOTARGET, V8, P72069, DOI 10.18632/oncotarget.18895	67	10	10	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	FEB	2020	10	2							e01520	10.1002/brb3.1520		NOV 2019	17	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	KM7TF	WOS:000505666600001	31908160	Green Published, gold			2022-02-06	
J	Zhu, BY; Eom, J; Hunt, RF				Zhu, Bingyao; Eom, Jisu; Hunt, Robert F.			Transplanted interneurons improve memory precision after traumatic brain injury	NATURE COMMUNICATIONS			English	Article							CONTROLLED CORTICAL IMPACT; POSTTRAUMATIC EPILEPSY; CELL TRANSPLANTATION; DENTATE GYRUS; ADULT; NEURONS; INHIBITION; HIPPOCAMPUS; REESTABLISHMENT; PRECURSORS	Repair of the traumatically injured brain has been envisioned for decades, but regenerating new neurons at the site of brain injury has been challenging. We show GABAergic progenitors, derived from the embryonic medial ganglionic eminence, migrate long distances following transplantation into the hippocampus of adult mice with traumatic brain injury, functionally integrate as mature inhibitory interneurons and restore post-traumatic decreases in synaptic inhibition. Grafted animals had improvements in memory precision that were reversed by chemogenetic silencing of the transplanted neurons and a long-lasting reduction in spontaneous seizures. Our results reveal a striking ability of transplanted interneurons for incorporating into injured brain circuits, and this approach is a powerful therapeutic strategy for correcting post-traumatic memory and seizure disorders.	[Zhu, Bingyao; Eom, Jisu; Hunt, Robert F.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Hunt, Robert F.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; [Hunt, Robert F.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA		Hunt, RF (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.; Hunt, RF (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA.; Hunt, RF (corresponding author), Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA.	robert.hunt@uci.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS096012]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096012] Funding Source: NIH RePORTER	This work was supported by funding from the National Institutes of Health grant R01-NS096012. We thank Young Kim for training with the confocal microscope.	Adams B, 2002, BEHAV BRAIN RES, V133, P351, DOI 10.1016/S0166-4328(02)00020-7; Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Becerra GD, 2007, BEHAV BRAIN RES, V179, P118, DOI 10.1016/j.bbr.2007.01.024; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Butler CR, 2016, EXP NEUROL, V280, P30, DOI 10.1016/j.expneurol.2016.03.022; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Cardin JA, 2018, TRENDS NEUROSCI, V41, P689, DOI 10.1016/j.tins.2018.07.015; Casalia ML, 2017, ANN NEUROL, V82, P530, DOI 10.1002/ana.25021; Chang J, 2015, EXP NEUROL, V273, P225, DOI 10.1016/j.expneurol.2015.08.020; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cox CS, 2018, PEDIATR RES, V83, P325, DOI 10.1038/pr.2017.253; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Falkner S, 2016, NATURE, V539, P248, DOI 10.1038/nature20113; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Frankowski JC, 2019, NEUROBIOL DIS, V129, P208, DOI 10.1016/j.nbd.2018.07.022; Gaillard A, 2007, NAT NEUROSCI, V10, P1294, DOI 10.1038/nn1970; Grade S, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0033-0; Guo NN, 2018, NAT MED, V24, P438, DOI 10.1038/nm.4491; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Howard MA, 2016, J NEUROPHYSIOL, V116, P472, DOI 10.1152/jn.00321.2016; Hsieh JY, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0359-16.2017; Hunt RF, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022376; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Kim H, 2012, TRENDS BIOTECHNOL, V30, P55, DOI 10.1016/j.tibtech.2011.07.002; Kim YJ, 2018, NEURON, V100, P1180, DOI 10.1016/j.neuron.2018.09.049; Larimer P, 2016, CELL REP, V16, P1391, DOI 10.1016/j.celrep.2016.06.071; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Martinez-Losa M, 2018, NEURON, V98, P75, DOI 10.1016/j.neuron.2018.02.029; Michelsen KA, 2015, NEURON, V85, P982, DOI 10.1016/j.neuron.2015.02.001; Nasser M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00895; Nichols J, 2018, J PHYSIOL-LONDON, V596, P1277, DOI 10.1113/JP275393; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Pelkey KA, 2017, PHYSIOL REV, V97, P1619, DOI 10.1152/physrev.00007.2017; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Santos M, 2013, J NEUROSCI, V33, P15259, DOI 10.1523/JNEUROSCI.2161-13.2013; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Siwani S, 2018, NEURON, V99, P404, DOI 10.1016/j.neuron.2018.06.022; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Sun D, 2011, J NEUROTRAUM, V28, P961, DOI 10.1089/neu.2010.1697; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Szonyi A, 2019, SCIENCE, V364, P752, DOI 10.1126/science.aaw0445; Thome A, 2016, MOL PSYCHIATR, V21, P1257, DOI 10.1038/mp.2015.160; Tong LM, 2014, J NEUROSCI, V34, P9506, DOI 10.1523/JNEUROSCI.0693-14.2014; Toth Z, 1997, J NEUROSCI, V17, P8106; Valentinuzzi VS, 1998, LEARN MEMORY, V5, P391; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Yassa MA, 2011, HIPPOCAMPUS, V21, P968, DOI 10.1002/hipo.20808; Zhu H, 2016, GENESIS, V54, P439, DOI 10.1002/dvg.22949	67	10	10	2	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV 14	2019	10								5156	10.1038/s41467-019-13170-w			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JM7SP	WOS:000496409800004	31727894	Green Published, gold			2022-02-06	
J	Desai, A; Chen, HZ; Kim, HY				Desai, Abhishek; Chen, Huazhen; Kim, Hee-Yong			Multiple Mild Traumatic Brain Injuries Lead to Visual Dysfunction in a Mouse Model	JOURNAL OF NEUROTRAUMA			English	Article						behavior; CHIMERA; repeated TBI; VEP; visual acuity	IMPAIRMENT; DEFICITS; DAMAGE; MICE; VULNERABILITY; PERFORMANCE; BLAST	Visual dysfunction is a common occurrence after traumatic brain injury (TBI). We investigated in this study effects of single or multiple mild TBI on visual function in mice using a closed head injury model that permits unconstrained head movement after impact. Adult mice were briefly anesthetized with isoflurane and given one or three mild TBI with the closed head injury by mechanically engineered rotational acceleration (CHIMERA) device with an interinjury interval of 24 h. Mice were then tested in the Morris water maze, visual cliff, and open field tests from day 19 to day 32 and for visual evoked potential at 5 weeks after the last injury and euthanized. Mice with multiple TBI showed impaired performance in the visible platform water maze test and had increased errors in the visual cliff test. Further, there was a graded difference in visual evoked potential, with the single injury mice showing modest reduction in N1 amplitude whereas the multiple injuries produced significant reduction compared to sham and single injury groups. The optic tract of the injured mice showed increases in glial cell immunostaining. The increase in glial fibrillary acid protein immunostaining reached statistical significance for both injured groups whereas the ionized calcium binding adaptor molecule 1 immunostaining was only significantly increased in the optic tract of repeatedly injured mice. These results indicate that multiple injuries using CHIMERA may result in visual deficits, which can affect certain behavioral performances. The change in vision may be a useful marker when monitoring repeated TBI outcome and screening for protective agents from TBI.	[Desai, Abhishek; Chen, Huazhen; Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, 5625 Fishers Lane, Rockville, MD 20852 USA; [Chen, Huazhen] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Desai, A; Kim, HY (corresponding author), NIAAA, Lab Mol Signaling, NIH, 5625 Fishers Lane, Rockville, MD 20852 USA.	abhishek.desai@nih.gov; hykim@nih.gov			Intramural Program of NIAAA, NIH; Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense	This study is supported by Intramural Program of NIAAA, NIH, and the Department of Defense in the Center for Neuroscience and Regenerative Medicine.	Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; FOX MW, 1965, ANIM BEHAV, V13, P232, DOI 10.1016/0003-3472(65)90040-0; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gerlai R, 2002, NEUROPHARMACOLOGY, V43, P235, DOI 10.1016/S0028-3908(02)00078-3; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Haar CV, 2019, EXP NEUROL, V317, P87, DOI 10.1016/j.expneurol.2019.02.012; Hulse P, 2010, NEUROREHABILITATION, V27, P269, DOI 10.3233/NRE-2010-0608; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lucke-Wold BP, 2015, TRANSL RES, V166, P509, DOI 10.1016/j.trsl.2015.08.005; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Philip SS, 2014, CLIN EXP OPTOM, V97, P196, DOI 10.1111/cxo.12155; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Satz JS, 2009, J NEUROSCI, V29, P13136, DOI 10.1523/JNEUROSCI.0474-09.2009; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Van't Veer A, 2013, NEUROPSYCHOPHARMACOL, V38, P1585, DOI 10.1038/npp.2013.58; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Vonder Haar C, 2014, J NEUROTRAUM, V31, P1711, DOI 10.1089/neu.2014.3459; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yin T.C., 2016, ENEURO, P3	38	10	10	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					286	294		10.1089/neu.2019.6602		NOV 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000495444800001	31530220	Green Published			2022-02-06	
J	Marincowitz, C; Lecky, FE; Allgar, V; Hutchinson, P; Elbeltagi, H; Johnson, F; Quinn, E; Tarantino, S; Townend, W; Kolias, AG; Sheldon, TA				Marincowitz, Carl; Lecky, Fiona E.; Allgar, Victoria; Hutchinson, Peter; Elbeltagi, Hadir; Johnson, Faye; Quinn, Eimhear; Tarantino, Silvia; Townend, Will; Kolias, Angelos G.; Sheldon, Trevor A.			Development of a Clinical Decision Rule for the Early Safe Discharge of Patients with Mild Traumatic Brain Injury and Findings on Computed Tomography Brain Scan: A Retrospective Cohort Study	JOURNAL OF NEUROTRAUMA			English	Article						intracranial hemorrhage; mild traumatic brain injury; minor head injury; prognostic modeling	PREDICTION; VALIDATION; MODEL; RISK	International guidelines recommend routine hospital admission for all patients with mild traumatic brain injury (TBI) who have injuries on computed tomography (CT) brain scan. Only a small proportion of these patients require neurosurgical or critical care intervention. We aimed to develop an accurate clinical decision rule to identify low-risk patients safe for discharge from the emergency department (ED) and facilitate earlier referral of those requiring intervention. A retrospective cohort study of case notes of patients admitted with initial Glasgow Coma Scale 13-15 and injuries identified by CT was completed. Data on a primary outcome measure of clinically important deterioration (indicating need for hospital admission) and secondary outcome of neurosurgery, intensive care unit admission, or intubation (indicating need for neurosurgical admission) were collected. Multi-variable logistic regression was used to derive models and a risk score predicting deterioration using routinely reported clinical and radiological candidate variables identified in a systematic review. We compared the performance of this new risk score with the Brain Injury Guideline (BIG) criteria, derived in the United States. A total of 1699 patients were included from three English major trauma centers. A total of 27.7% (95% confidence interval [CI], 25.5-29.9) met the primary and 13.1% (95% CI, 11.6-14.8) met the secondary outcomes of deterioration. The derived clinical decision rule suggests that patients with simple skull fractures or intracranial bleeding <5 mm in diameter who are fully conscious could be safely discharged from the ED. The decision rule achieved a sensitivity of 99.5% (95% CI, 98.1-99.9) and specificity of 7.4% (95% CI, 6.0-9.1) to the primary outcome. The BIG criteria achieved the same sensitivity, but lower specificity (5%). Our empirical models showed good predictive performance and outperformed the BIG criteria. This would potentially allow ED discharge of 1 in 20 patients currently admitted for observation. However, prospective external validation and economic evaluation are required.	[Marincowitz, Carl] Univ Hull, Hull York Med Sch, Allam Med Bldg, Kingston Upon Hull HU6 7RX, N Humberside, England; [Lecky, Fiona E.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Allgar, Victoria] Univ York, Hull York Med Sch, John Hughlings Jackson Bldg, Heslington, England; [Hutchinson, Peter; Tarantino, Silvia; Kolias, Angelos G.] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Hutchinson, Peter; Tarantino, Silvia; Kolias, Angelos G.] Univ Cambridge, Cambridge, England; [Hutchinson, Peter; Tarantino, Silvia; Kolias, Angelos G.] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Elbeltagi, Hadir; Quinn, Eimhear] Salford Royal NHS Fdn Trust, Salford Royal Hosp, Emergency Dept, Salford, Lancs, England; [Johnson, Faye] Salford Royal NHS Fdn Trust, Salford Royal Hosp, Acute Res Delivery Team, Salford, Lancs, England; [Townend, Will] Hull Univ Teaching Hosp NHS Trust, Emergency Dept, Kingston Upon Hull, N Humberside, England; [Sheldon, Trevor A.] Univ York, Alcuin Res Resource Ctr, Dept Hlth Sci, Heslington, England		Marincowitz, C (corresponding author), Univ Hull, Hull York Med Sch, Allam Med Bldg, Kingston Upon Hull HU6 7RX, N Humberside, England.	Carl.Marincowitz@hyms.ac.uk	Sheldon, Trevor/AAK-7088-2021	Sheldon, Trevor/0000-0002-7479-5913; Marincowitz, Carl/0000-0003-3043-7564; Allgar, Victoria/0000-0002-5228-2623; Kolias, Angelos/0000-0003-3992-0587	National Institute for Health Research Doctoral Fellowship [DRF-2016-09-086]; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); National Institute for Health Research (NIHR) Global Health Research Group on NeurotraumaNational Institute for Health Research (NIHR); NIHRNational Institute for Health Research (NIHR) [16/137/105]; European Union Framework 7 Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (EC) [602150]; NHS Trusts "Trauma Audit and Research Network"	Carl Marincowitz is funded by a National Institute for Health Research Doctoral Fellowship (DRF-2016-09-086). This study presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.; Dr. Kolias is supported by the National Institute for Health Research (NIHR) Global Health Research Group on Neurotrauma. The Group was commissioned by the NIHR using Official Development Assistance funding (project 16/137/105). The views expressed in this article are those of the authors and are not necessarily those of the UK National Health Service, NIHR, or the UK Department of Health.; Professor Lecky is supported by the European Union Framework 7 Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (EC grant 602150) and NHS Trusts "Trauma Audit and Research Network: www.tarn.ac.uk.''	Battle CE, 2014, CRIT CARE, V18, DOI 10.1186/cc13873; Bouamra O, 2015, EMERG MED J, V32, P933, DOI 10.1136/emermed-2015-205176; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Eddings W, 2012, STATA J, V12, P353, DOI 10.1177/1536867X1201200301; Gregorevic KJ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0292-4; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heymans MW, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-33; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Kreitzer N, 2014, ACAD EMERG MED, V21, P1084, DOI 10.1111/acem.12479; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Marincowitz C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-028912; Marincowitz Carl, 2018, Diagn Progn Res, V2, P6, DOI 10.1186/s41512-018-0027-4; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Morris TP, 2015, STAT MED, V34, P3298, DOI 10.1002/sim.6553; Morris TP, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-75; [National Institute for Health and Care Excellence (NICE) National Clinical Guidance Centre], 2014, CG 176 HEAD INJ TRIA; Olivecrona M, 2016, J NEUROTRAUM, V33, pA34; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rufibach K, 2010, J CLIN EPIDEMIOL, V63, P938, DOI 10.1016/j.jclinepi.2009.11.009; Schaller B, 2010, EMERG MED J, V27, P537, DOI 10.1136/emj.2009.073031; Schomaker M, 2018, STAT MED, V37, P2252, DOI 10.1002/sim.7654; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Wahl S, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0239-7; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wintermark M, 2018, J NEUROTRAUM, V35, P2665, DOI 10.1089/neu.2017.5311; Wood AM, 2008, STAT MED, V27, P3227, DOI 10.1002/sim.3177	34	10	10	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					324	333		10.1089/neu.2019.6652		NOV 2019	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000495445200001	31588845	Green Published, Green Accepted, hybrid, Green Submitted			2022-02-06	
J	Luo, ML; Pan, L; Wang, L; Wang, HY; Li, S; Long, ZY; Zeng, L; Liu, Y				Luo, Mei-ling; Pan, Lu; Wang, Li; Wang, Hai-yan; Li, Sen; Long, Zai-yun; Zeng, Lin; Liu, Yuan			Transplantation of NSCs Promotes the Recovery of Cognitive Functions by Regulating Neurotransmitters in Rats with Traumatic Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						Neural stem cells; Rats; Transplantation; Behavior; Traumatic brain injury		Transplantation of neural stem cells (NSCs) may be a potential strategy for traumatic brain injury treatment (TBI) due to their intrinsic advantages, such as cell replacement, secretion of neurotrophins and formation of functional synapses with host. However the underlying effects of transplanted NSCs on host micro-environment still need to be further elucidated. In this manuscript the effects of NSCs on release of neurotransmitter, survival of hippocampal neurons, reactivity of astrocytes and recovery of cognitive function after TBI were observed. The NSCs were isolated from cortex of neonatal Sprague-Dawley rat and then transplanted into injured brain regions caused by free-weight drop. The proliferation of astrocytes around injured sites were examined by GFAP immunofluorescent staining on 3, 7, 14 days after injury. The survival of neurons at CA1 regions of hippocampus toward contused regions was observed by HE staining on 3 and 14 days post-injury. The content of glutamic acid (Glu) and GABA in hippocampal tissues was examined on 1, 3, 7, 14, 28 days after injury by ELISA. On third day post-injury, hippocampal-dependent spatial memory was measured for 5 days without intermittent. NSCs in culture have the ability to proliferate and differentiate into different phenotypes of neural cells. After transplantation of NSCs, the proliferation of astrocytes around injured site was significantly inhibited compared to the injured group. At the same time the survival of neurons in hippocampal CA1 region were much more than those in injured group on 14 days post-injury. Meanwhile, the cognitive functions in NSC transplanted group was remarkably improved compared with injured group (p < 0.05). Furthermore, NSCs transplantation dramatically inhibited the release of Glu and maintained the content of GABA in injured hippocampal tissues on 1, 3, 7, 14, 28 days post-injury, which was of difference in statistics (p < 0.05). NSCs transplantation can effectively alleviate the formation of glial scar, enhance the survival of hippocampal neurons and improve cognitive function defects in rats with TBI. The underlying mechanism may be related to their effects on inhibiting the release of Glu and maintaining the content of GABA, so as to down-regulate excitotoxicity of neurotransmitter and improve the micro-environment in injured sites.	[Luo, Mei-ling; Pan, Lu; Wang, Li; Wang, Hai-yan; Li, Sen; Long, Zai-yun; Zeng, Lin; Liu, Yuan] Army Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Daping Hosp, Res Inst Surg, Chongqing 400042, Peoples R China		Liu, Y (corresponding author), Army Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Daping Hosp, Res Inst Surg, Chongqing 400042, Peoples R China.	yliu312@sina.com			Qinnian Peiyu project of Military [16QNP105]; national natural scientific fund of ChinaNational Natural Science Foundation of China (NSFC) [81772066]	Funding was provided by Qinnian Peiyu project of Military (Grant No. 16QNP105) and national natural scientific fund of China (Grant No. 81772066).	Andrea SV, 2014, ALZHEIMERS DEMENTI S, V10, P174; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Braun SMG, 2015, CELL REP, V11, P1679, DOI 10.1016/j.celrep.2015.05.024; Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043; Cho DY, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1011-1; Fortress AM, 2016, NEUROSCIENTIST, V22, P278, DOI 10.1177/1073858415574728; Gao J, 2014, MED SCI MONITOR, V20, P499, DOI 10.12659/MSM.890589; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Kaj B, 2012, NEURON, V76, P888; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Le W, 2014, BRAIN RES, V1575, P87, DOI 10.1016/j.brainres.2014.05.038; Liu YX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061031, 10.1371/journal.pone.0072930, 10.1371/journal.pone.0082678, 10.1371/journal.pone.0079417, 10.1371/journal.pone.0055221, 10.1371/journal.pone.0080097, 10.1371/journal.pone.0075318]; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Patel K, 2016, BRAIN RES, V1640, P104, DOI 10.1016/j.brainres.2016.01.055; Ruggieri M, 2014, PROG NEUROBIOL, V114, P15, DOI 10.1016/j.pneurobio.2013.11.001; Saeb S, 2018, IRAN J MED SCI, V43, P523; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Thompson LH, 2015, NEUROBIOL DIS, V79, P28, DOI 10.1016/j.nbd.2015.04.003; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Wang L, 2017, AM J TRANSL RES, V9, P3411; Wang YC, 2014, CYTOTHERAPY, V16, P1000, DOI 10.1016/j.jcyt.2013.12.009	24	10	11	2	7	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	DEC	2019	44	12					2765	2775		10.1007/s11064-019-02897-z		NOV 2019	11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	KJ8LT	WOS:000495066100001	31701381				2022-02-06	
J	Miller, HA; Magsam, AW; Tarudji, AW; Romanova, S; Weber, L; Gee, CC; Madsen, GL; Bronich, TK; Kievit, FM				Miller, Hunter A.; Magsam, Alexander W.; Tarudji, Aria W.; Romanova, Svetlana; Weber, Laura; Gee, Connor C.; Madsen, Gary L.; Bronich, Tatiana K.; Kievit, Forrest M.			Evaluating differential nanoparticle accumulation and retention kinetics in a mouse model of traumatic brain injury via K-trans mapping with MRI	SCIENTIFIC REPORTS			English	Article							DCE-MRI; ENHANCED PERMEABILITY; BARRIER BREAKDOWN; BIODISTRIBUTION; TRACER; INHOMOGENEITY; PARAMETERS; DELIVERY; MODERATE; IMPACT	Traumatic brain injury (TBI) is a leading cause of injury-related death worldwide, yet there are no approved neuroprotective therapies that improve neurological outcome post-injury. Transient opening of the blood-brain barrier following injury provides an opportunity for passive accumulation of intravenously administered nanoparticles through an enhanced permeation and retention-like effect. However, a thorough understanding of physicochemical properties that promote optimal uptake and retention kinetics in TBI is still needed. In this study, we present a robust method for magnetic resonance imaging of nanoparticle uptake and retention kinetics following intravenous injection in a controlled cortical impact mouse model of TBI. Three contrast-enhancing nanoparticles with different hydrodynamic sizes and relaxivity properties were compared. Accumulation and retention were monitored by modelling the permeability coefficient, K-trans, for each nanoparticle within the reproducible mouse model. Quantification of K-trans for different nanoparticles allowed for non-invasive, multi-time point assessment of both accumulation and retention kinetics in the injured tissue. Using this method, we found that 80 nm poly(lactic-co-glycolic acid) nanoparticles had maximal K-trans in a TBI when injected 3 hours post-injury, showing significantly higher accumulation kinetics than the small molecule, Gd-DTPA. This robust method will enable optimization of administration time and nanoparticle physicochemical properties to achieve maximum delivery.	[Miller, Hunter A.; Magsam, Alexander W.; Tarudji, Aria W.; Gee, Connor C.; Kievit, Forrest M.] Univ Nebraska, Dept Biol Syst Engn, 200 LW Chase Hall, Lincoln, NE 68583 USA; [Romanova, Svetlana; Bronich, Tatiana K.] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Durham Res Ctr 1, Room 1036, Omaha, NE 68189 USA; [Weber, Laura; Madsen, Gary L.] ProTransit Nanotherapy, 16514L St, Omaha, NE 68135 USA		Kievit, FM (corresponding author), Univ Nebraska, Dept Biol Syst Engn, 200 LW Chase Hall, Lincoln, NE 68583 USA.	fkievit2@unl.edu		Gee, Connor/0000-0002-5205-7557; Kievit, Forrest/0000-0002-9847-783X	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103480]; Nebraska Settlement Biomedical Research Development Funds; Institute of Agriculture and Natural Resources (IANR) Agricultural Research District (ARD) Undergraduate Research Program at UNL; UNL UCARE program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103480, P30GM127200] Funding Source: NIH RePORTER	FK acknowledges support from an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (P20GM103480) and the Nebraska Settlement Biomedical Research Development Funds. AM acknowledges support from the Institute of Agriculture and Natural Resources (IANR) Agricultural Research District (ARD) Undergraduate Research Program at UNL. CG acknowledges support from the UNL UCARE program.	Alam MI, 2010, EUR J PHARM SCI, V40, P385, DOI 10.1016/j.ejps.2010.05.003; Aminmansour Bahram, 2014, Adv Biomed Res, V3, P35, DOI 10.4103/2277-9175.125031; Arami H, 2015, CHEM SOC REV, V44, P8576, DOI 10.1039/c5cs00541h; Barnes SR, 2016, MAGN RESON MED, V75, P1967, DOI 10.1002/mrm.25793; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bharadwaj VN, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700668; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Boyd BJ, 2015, J DRUG TARGET, V23, P847, DOI 10.3109/1061186X.2015.1034280; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Cohen MS, 2000, HUM BRAIN MAPP, V10, P204, DOI 10.1002/1097-0193(200008)10:4<204::AID-HBM60>3.0.CO;2-2; Cunningham CH, 2006, MAGN RESON MED, V55, P1326, DOI 10.1002/mrm.20896; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; Desale SS, 2015, J CONTROL RELEASE, V220, P651, DOI 10.1016/j.jconrel.2015.09.007; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Soares DCF, 2015, PARTICUL SCI TECHNOL, V33, P331, DOI 10.1080/02726351.2014.970306; Greish K, 2010, METHODS MOL BIOL, V624, P25, DOI 10.1007/978-1-60761-609-2_3; Hedaya M.A., 2012, BASIC PHARMACOKINETI; Heye AK, 2016, NEUROIMAGE, V125, P446, DOI 10.1016/j.neuroimage.2015.10.018; Hubbard WB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28848-2; Ingrisch M, 2013, J PHARMACOKINET PHAR, V40, P281, DOI 10.1007/s10928-013-9315-3; KETY SS, 1951, PHARMACOL REV, V3, P1; Kim SM, 2013, CLIN PHYSIOL FUNCT I, V33, P150, DOI 10.1111/cpf.12010; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114173; Lipka J, 2010, BIOMATERIALS, V31, P6574, DOI 10.1016/j.biomaterials.2010.05.009; Lu LY, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00207; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Montagne A, 2018, NAT MED, V24, P326, DOI 10.1038/nm.4482; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Nance E, 2016, BIOMATERIALS, V101, P96, DOI 10.1016/j.biomaterials.2016.05.044; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Perry JL, 2012, NANO LETT, V12, P5304, DOI 10.1021/nl302638g; Rajic Z, 2012, FREE RADICAL BIO MED, V52, P1828, DOI 10.1016/j.freeradbiomed.2012.02.006; Rose VL, 1999, AM FAM PHYSICIAN, V59, P1051; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Simpson NE, 1999, MAGN RESON MED, V42, P42, DOI 10.1002/(SICI)1522-2594(199907)42:1<42::AID-MRM8>3.0.CO;2-Z; Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004; Singhal A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.362; Song SK, 2011, NEUROBIOL AGING, V32, P2183, DOI 10.1016/j.neurobiolaging.2009.12.017; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sung KH, 2013, J MAGN RESON IMAGING, V38, P454, DOI 10.1002/jmri.23996; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu J., 2016, ADV FUNCT MAT, V26; Xu JL, 2016, ADV FUNCT MATER, V26, P4124, DOI 10.1002/adfm.201504416; Yankeelov TE, 2005, MAGN RESON IMAGING, V23, P519, DOI 10.1016/j.mri.2005.02.013; Yoo D, 2017, ACS NANO, V11, P8600, DOI 10.1021/acsnano.7b03426	50	10	11	2	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 6	2019	9								16099	10.1038/s41598-019-52622-7			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JK1VX	WOS:000494636300021	31695100	gold, Green Published			2022-02-06	
J	Biesterveld, B; Williams, AM; Pai, MP; Dennahy, IS; Graham, NJ; Chtraklin, K; Siddiqui, AZ; O'Connell, RL; Bhatti, UF; Liu, BL; Russo, RM; Li, YQ; Alam, HB				Biesterveld, Ben E.; Williams, Aaron M.; Pai, Manjunath P.; Dennahy, Isabel S.; Graham, Nathan J.; Chtraklin, Kiril; Siddiqui, Ali Z.; O'Connell, Rachel L.; Bhatti, Umar F.; Liu, Baoling; Russo, Rachel M.; Li, Yongqing; Alam, Hasan B.			Dose optimization of valproic acid in a lethal model of traumatic brain injury, hemorrhage, and multiple trauma in swine	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	49th Annual Meeting of the Western-Trauma-Association	MAR 03-09, 2019	Snowmass, CO	Western Trauma Assoc		Valproic acid; histone deacetylase inhibitor; trauma; shock; traumatic brain injury	HISTONE DEACETYLASE INHIBITION; PROSURVIVAL PHENOTYPE; RODENT MODEL; LESION SIZE; SALINE; SHOCK	BACKGROUND Trauma is a leading cause of death, and traumatic brain injury is one of the hallmark injuries of current military conflicts. Valproic acid (VPA) administration in high doses (300-400 mg/kg) improves survival in lethal trauma models, but effectiveness of lower doses on survival is unknown. This information is essential for properly designing the upcoming clinical trials. We, therefore, performed the current study to determine the lowest dose at which VPA administration improves survival in a model of lethal injuries. METHODS Swine were subjected to traumatic brain injury (10-mm cortical impact), 40% blood volume hemorrhage, and multiple trauma (femur fracture, rectus crush, and Grade V liver laceration). After 1 hour of shock, animals were randomized (n = 6/group) to four groups: normal saline (NS) resuscitation; or NS with VPA doses of 150 mg/kg (VPA 150) or 100 mg/kg (VPA 100) administered over 3 hours or 100 mg/kg over 2 hours (VPA 100 over 2 hours). Three hours after shock, packed red blood cells were given, and animals were monitored for another 4 hours. Survival was assessed using Kaplan-Meier and log-rank test. RESULTS Without resuscitation, all of the injured animals died within 5 hours. Similar survival rates were observed in the NS (17%) and VPA 100 (0%) resuscitation groups. Survival rates in the 100-mg/kg VPA groups were significantly (p < 0.05) better when it was given over 2 hours (67%) compared to 3 hours (0%). 83% of the animals in the VPA 150 group survived, which was significantly higher than the NS and VPA 100 over 3 hours groups (p < 0.05). CONCLUSION A single dose of VPA (150 mg/kg) significantly improves survival in an otherwise lethal model of multiple injuries. This is a much lower dose than previously shown to have a survival benefit and matches the dose that is tolerated by healthy human subjects with minimal adverse effects.	[Biesterveld, Ben E.; Williams, Aaron M.; Dennahy, Isabel S.; Graham, Nathan J.; Chtraklin, Kiril; Siddiqui, Ali Z.; O'Connell, Rachel L.; Bhatti, Umar F.; Liu, Baoling; Russo, Rachel M.; Li, Yongqing; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Pai, Manjunath P.] Univ Michigan, Dept Clin Pharm, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Biesterveld, Ben/AAM-1087-2021		NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32 GM130010] Funding Source: Medline		Alam HB, 2011, J TRAUMA, V70, P636, DOI 10.1097/TA.0b013e31820d0dcc; Alam HB, 2009, J TRAUMA, V67, P856, DOI 10.1097/TA.0b013e3181b5ae75; Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Causey MW, 2013, J SURG RES, V184, P533, DOI 10.1016/j.jss.2013.03.087; Chang PP, 2019, J AM COLL SURGEONS, V228, P265, DOI 10.1016/j.jamcollsurg.2018.12.026; Control CfD, 2017, 9 CONTR CFD; Georgoff PE, 2018, CLIN PHARMACOKINET, V57, P209, DOI 10.1007/s40262-017-0553-1; Georgoff PE, 2016, J TRAUMA ACUTE CARE, V81, P1020, DOI 10.1097/TA.0000000000001249; Gonzales E, 2006, SHOCK, V25, P395, DOI 10.1097/01.shk.0000209522.28120.c8; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Hu Sen, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P471; Hwabejire JO, 2014, J SURG RES, V186, P363, DOI 10.1016/j.jss.2013.09.016; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jepsen CH, 2014, J TRAUMA ACUTE CARE, V77, P292, DOI 10.1097/TA.0000000000000333; Kim K, 2012, RESUSCITATION, V83, P243, DOI 10.1016/j.resuscitation.2011.07.029; Li YQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/523481; Liu ZC, 2014, SHOCK, V41, P104, DOI 10.1097/SHK.0000000000000074; Liu ZC, 2013, J TRAUMA ACUTE CARE, V74, P991, DOI 10.1097/TA.0b013e31828583e3; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nikolian VC, 2019, J TRAUMA ACUTE CARE, V86, P232, DOI 10.1097/TA.0000000000002119; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Shults C, 2008, J TRAUMA, V64, P629, DOI 10.1097/TA.0b013e3181650ff3; Williams AM, 2019, J TRAUMA ACUTE CARE, V87, P393, DOI 10.1097/TA.0000000000002281	26	10	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2019	87	5					1133	1139		10.1097/TA.0000000000002460			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	JZ1YN	WOS:000504900200028	31389922				2022-02-06	
J	Champagne, AA; Distefano, V; Boulanger, MM; Magee, B; Coverdale, NS; Gallucci, D; Guskiewicz, K; Cook, DJ				Champagne, Allen A.; Distefano, Vincent; Boulanger, Marie-Michelle; Magee, Blaire; Coverdale, Nicole S.; Gallucci, Daniel; Guskiewicz, Kevin; Cook, Douglas J.			Data-informed Intervention Improves Football Technique and Reduces Head Impacts	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						BEHAVIOR MODIFICATION; SPORT SAFETY; FOOTBALL; COACHING; INJURY PREVENTION; SUBCONCUSSIVE IMPACTS	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL; CONCUSSION; PLAYERS; INJURY; MECHANISMS; EXPOSURE; SEASON	Introduction Although sport participation is a key contributor to the physical and mental health of children and youth, exposure to subconcussive head impacts in football has raised concerns about safety for athletes. Purpose To demonstrate the efficacy of incorporating targeted football drills into a team's practice routine with the goal of improving players' technique and reduce exposure to subconcussive head impacts. Methods Seventy high school football players (age, 16.4 +/- 1.1 yr) were tested PRE season using a sport-specific functional assessment. Results from the testing were used to inform the design of a prepractice intervention aimed at improving tackling and blocking techniques while reducing exposure to head impacts. The assessment included drills which evaluated the players' ability to safely tackle, and block while simulating game-like situations. Testing was repeated at MID season (internal control) without an intervention, and again at POST season (experimental), after introduction of the prepractice intervention between these timepoints, administered twice weekly. All testing sessions were recorded, and subsequently reviewed by trained graders based on selected criteria defined by football coaches. A subset of 19 participants wore in-helmet accelerometers to assess the effectiveness of the intervention in decreasing head impacts during practice. Results Significant improvements in blocking and tackling techniques were observed after the introduction of the intervention (P < 0.0001). Participating athletes also showed better techniques when evaluated in new game-like situations, postseason, providing evidence for proper acquisition and generalizability of these safer habits. Finally, frequency of head impacts (>15g) per practice was significantly reduced by similar to 30% after 1 month of training. Conclusion Our results suggest that data-informed methods can be used to improve coaching practices and promote safer play, which can have a positive public health impact moving forward.	[Champagne, Allen A.; Magee, Blaire; Coverdale, Nicole S.; Cook, Douglas J.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Distefano, Vincent; Boulanger, Marie-Michelle] McGill Connect Lab, Sch Appl Child Psychol, Montreal, PQ, Canada; [Guskiewicz, Kevin] Univ N Carolina, Matthew Gfeller Sport Related TBI Res Ctr, Chapel Hill, NC 27515 USA; [Cook, Douglas J.] Queens Univ, Dept Surg, Room 232,18 Stuart St, Kingston, ON K7L 3N6, Canada		Cook, DJ (corresponding author), Queens Univ, Dept Surg, Room 232,18 Stuart St, Kingston, ON K7L 3N6, Canada.	dj.cook@queensu.ca			Southeastern Ontario Academic Medical Organization (SEAMO)	The authors declare no conflict of interest. Funding from the Southeastern Ontario Academic Medical Organization (SEAMO) helped making this project possible.	Abernethy B, 2005, APPL COGNITIVE PSYCH, V19, P705, DOI 10.1002/acp.1102; Asken BM, 2018, ANN BIOMED ENG; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Feghhi I, 2011, PROCD SOC BEHV, V30, DOI 10.1016/j.sbspro.2011.10.425; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guadagnoli M, 2002, J SPORT SCI, V20, P615, DOI 10.1080/026404102320183176; Houston SM, 2014, CURR TOP BEHAV NEURO, V16, P3, DOI 10.1007/7854_2013_265; Kerr HA, 2018, INT J SPORTS SCI COA, V13, P3, DOI 10.1177/1747954117711867; Liebermann DG, 2002, J SPORT SCI, V20, P755, DOI 10.1080/026404102320675611; Love S, 2015, AM J SPORT MED, V43, P1260, DOI 10.1177/0363546514535187; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Myer GD, 2011, PHYSICIAN SPORTSMED, V39, P74, DOI [10.3810/psm.2011.02.1864, 10.3810/psm.2011.02.1854]; Russell K, 2017, CAN J NEUROL SCI, V44, P225, DOI 10.1017/cjn.2016.423; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Swartz EE, 2015, J ATHL TRAINING, V51, P6; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Tucker R, 2017, BRIT J SPORT MED, V51, pA702; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, P2018; Wulf G., 2004, SKILL ACQUISITION SP, P121	35	10	10	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	NOV	2019	51	11					2366	2374		10.1249/MSS.0000000000002046			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JE5JJ	WOS:000490728400022	31269008	hybrid, Green Published			2022-02-06	
J	Purkayastha, S; Adair, H; Woodruff, A; Ryan, LJ; Williams, B; James, E; Bell, KR				Purkayastha, Sushmita; Adair, Heather; Woodruff, Amanda; Ryan, Laurence J.; Williams, Benjamin; James, Eric; Bell, Kathleen R.			Balance Testing Following Concussion: Postural Sway versus Complexity Index	PM&R			English	Article							COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; MULTISCALE ENTROPY; CONTROL DEFICITS; RECOVERY; DYNAMICS; RISK	Background Although postural control deficits are common following a concussion, the current clinical assessments for postural control tend to resolve within 3 to 10 days after injury. There is a lack of sensitive tools to examine subtle changes in postural control during the recovery phase following sports-related concussion. Only a limited number of studies have examined nonlinear dynamics of postural control; no study has examined this metric longitudinally during the recovery phase following a sports-related concussion. Objective To examine sway and complexity index of postural control in collegiate athletes during day 3, day 21, and day 90 following a concussion and compare them with noninjured controls. Design Prospective longitudinal case-control study. Setting University cerebrovascular research laboratory. Participants Thirty-one male and female collegiate athletes on day 3 following a concussion. Twenty-eight athletes returned on day 21, and 21 completed assessments on day 90. Twenty-nine sports-matched noninjured controls. Methods Center of pressure (COP) measurements obtained during 60-second quiet standing on a force plate system with either eyes opened or closed. Postural sway was estimated as range and variability of COP in the anteroposterior (AP) and mediolateral planes. Main Outcome Measurements Complexity index of AP COP utilizing multiscale entropy analysis. Results Postural sway measured as AP range (P = .03) and variability (P = .04) during quiet standing with eyes closed were higher on day 3 compared to the controls. Postural sway in the concussed group was comparable to the noninjured controls by day 21 postinjury. However, postural control dynamics utilizing complexity index was lower on day 3 (P < .001) and persisted on day 21 (P < .006) and day 90 (P < .02), despite resolution of abnormal postural sway 21 days postinjury. Conclusion Complexity index utilizing nonlinear dynamics might be a more sensitive objective biomarker for examining postural control following a concussion, with implications for return-to-play and interventions. Future studies with a larger sample size are needed to validate this finding.	[Purkayastha, Sushmita; Woodruff, Amanda; Ryan, Laurence J.] Southern Methodist Univ, Simmons Sch Educ & Human Dev, Dept Appl Physiol & Wellness, Dallas, TX 75205 USA; [Purkayastha, Sushmita; Adair, Heather; James, Eric; Bell, Kathleen R.] Univ Texas Southwestern Med Ctr, Dept Phys Med & Rehabil, Dallas, TX 75205 USA; [Williams, Benjamin] Southern Methodist Univ, Dept Stat Sci, Dallas, TX 75205 USA		Purkayastha, S (corresponding author), Southern Methodist Univ, Simmons Sch Educ & Human Dev, Dept Appl Physiol & Wellness, Dallas, TX 75205 USA.	spurkayastha@smu.edu		Bell, Kathleen/0000-0002-0928-2046; Williams, Benjamin/0000-0001-8474-5066	Texas Institute for Brain Injury and Repair at University of Texas Southwestern Medical Center, Dallas, Texas; University Research Council Grant at Southern Methodist University, Dallas, Texas	This work was supported by the Pilot Grant 2016 from the Texas Institute for Brain Injury and Repair at University of Texas Southwestern Medical Center, Dallas, Texas, and the University Research Council Grant at Southern Methodist University, Dallas, Texas.	[Anonymous], 2016, DIAGNOSIS MANAGEMENT; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Busa MA, 2016, J SPORT HEALTH SCI, V5, P44, DOI 10.1016/j.jshs.2016.01.018; Catarino A, 2011, CLIN NEUROPHYSIOL, V122, P2375, DOI 10.1016/j.clinph.2011.05.004; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Duarte M, 2008, EXP BRAIN RES, V191, P265, DOI 10.1007/s00221-008-1521-7; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2002, ORTHOP PHYS THER CLI, V11, P143; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Kang HG, 2009, J GERONTOL A-BIOL, V64, P1304, DOI 10.1093/gerona/glp113; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Manor B, 2010, NEUROLOGY, V74, P458, DOI 10.1212/WNL.0b013e3181cef647; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Raikes AC, 2017, THESIS, V5803; SOAMES RW, 1982, EUR J APPL PHYSIOL O, V49, P169, DOI 10.1007/BF02334065; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Takakusaki K, 2017, ADV ROBOTICS, V31, P2, DOI 10.1080/01691864.2016.1252690; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wu SD, 2013, PHYSICA A, V392, P5865, DOI 10.1016/j.physa.2013.07.075	33	10	10	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	NOV	2019	11	11					1184	1192		10.1002/pmrj.12129			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	JI5SQ	WOS:000493527900005	30729729				2022-02-06	
J	Wu, K; Huang, DD; Zhu, C; Kasanga, EA; Zhang, Y; Yu, EX; Zhang, HL; Ni, ZH; Ye, S; Zhang, CL; Hu, JN; Zhuge, QC; Yang, JJ				Wu, Ke; Huang, Dongdong; Zhu, Can; Kasanga, Ella A.; Zhang, Ying; Yu, Enxing; Zhang, Hengli; Ni, Zhihui; Ye, Sheng; Zhang, Chunli; Hu, Jiangnan; Zhuge, Qichuan; Yang, Jianjing			NT3(P75-2) gene-modified bone mesenchymal stem cells improve neurological function recovery in mouse TBI model	STEM CELL RESEARCH & THERAPY			English	Article						Traumatic brain injury; NT3(P75-2); Bone marrow-derived mesenchymal stem cells; Neurological function; P75 signal pathway	TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; NERVE GROWTH-FACTOR; NEUROTROPHIN; STROKE; TRANSPLANTATION; RECEPTOR; MECHANISMS; P75(NTR); SURVIVAL	Background The attainment of extensive neurological function recovery remains the key challenge for the treatment of traumatic brain injury (TBI). Transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) has been shown to improve neurological function recovery after TBI. However, the survival of BMSCs after transplantation in early-stage TBI is limited, and much is unknown about the mechanisms mediating this neurological function recovery. Secretion of neurotrophic factors, including neurotrophin 3 (NT3), is one of the critical factors mediating BMSC neurological function recovery. Gene mutation of NT3 (NT3(P75-2)) has been shown to enhance the biological function of NT3 via the reduction of the activation of the P75 signal pathway. Thus, we investigated whether NT3(P75-2) gene-modified BMSCs could enhance the survival of BMSCs and further improve neurological function recovery after TBI. Methods The ability of NT3(P75-2) induction to improve cell growth rate of NSC-34 and PC12 cells in vitro was first determined. BMSCs were then infected with three different lentiviruses (green fluorescent protein (GFP), GFP-NT3, or GFP-NT3(P75-2)), which stably express GFP, GFP-NT3, or GFP-NT3(P75-2). At 24 h post-TBI induction in mice, GFP-labeled BMSCs were locally transplanted into the lesion site. Immunofluorescence and histopathology were performed at 1, 3, and/or 7 days after transplantation to evaluate the survival of BMSCs as well as the lesion volume. A modified neurological severity scoring system and the rotarod test were chosen to evaluate the functional recovery of the mice. Cell growth rate, glial activation, and signaling pathway analyses were performed to determine the potential mechanisms of NT3(P75-2) in functional recovery after TBI. Results Overall, NT3(P75-2) improved cell growth rate of NSC-34 and PC12 cells in vitro. In addition, NT3(P75-2) significantly improved the survival of transplanted BMSCs and neurological function recovery after TBI. Overexpression of NT3(P75-2) led to a significant reduction in the activation of glial cells, brain water content, and brain lesion volume after TBI. This was associated with a reduced activation of the p75 neurotrophin receptor (P75NTR) and the c-Jun N-terminal kinase (JNK) signal pathway due to the low affinity of NT3(P75-2) for the receptor. Conclusions Taken together, our results demonstrate that administration of NT3(P75-2) gene-modified BMSCs dramatically improves neurological function recovery after TBI by increasing the survival of BMSCs and ameliorating the inflammatory environment, providing a new promising treatment strategy for TBI.	[Wu, Ke; Huang, Dongdong; Zhu, Can; Zhang, Ying; Yu, Enxing; Zhang, Hengli; Ni, Zhihui; Ye, Sheng; Hu, Jiangnan; Zhuge, Qichuan; Yang, Jianjing] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou 325000, Peoples R China; [Kasanga, Ella A.; Hu, Jiangnan; Yang, Jianjing] Univ North Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Zhang, Chunli] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA		Hu, JN; Zhuge, QC; Yang, JJ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou 325000, Peoples R China.	hu.jiangnan@hotmail.com; zhugeqichuan@vip.163.com; yangjianjing2@163.com	Hu, John/AAL-6376-2021; Hu, Jiangnan/ABD-5635-2021; Hu, Jiangnan/ABB-1329-2021	Hu, Jiangnan/0000-0002-0112-7578	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771262]; Zhejiang Health Science and Technology Project [2016RCA022]; Zhejiang Key Research and Development Project [2017C03027]; American Heart AssociationAmerican Heart Association [19PRE34380114]	The work was supported by the National Natural Science Foundation of China (No. 81771262), Zhejiang Health Science and Technology Project (2016RCA022), Zhejiang Key Research and Development Project (2017C03027), and American Heart Association Predoctoral Fellowship for Jiangnan Hu (19PRE34380114).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; Blondy S, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1385-8; Borlongan CV, 2011, PROG NEUROBIOL, V95, P213, DOI 10.1016/j.pneurobio.2011.08.005; Chen CH, 2019, CEREB CORTEX, V29, P54, DOI 10.1093/cercor/bhx303; Daviaud N, 2015, STEM CELL TRANSL MED, V4, P670, DOI 10.5966/sctm.2014-0139; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Dedoni S, 2017, MOL NEUROBIOL, V54, P1825, DOI 10.1007/s12035-016-9789-2; Ding J, 2011, J NEUROSCI RES, V89, P222, DOI 10.1002/jnr.22535; Duricki DA, 2019, ANN NEUROL, V85, P32, DOI 10.1002/ana.25386; Elshaer SL, 2019, DIABETOLOGIA, V62, P1488, DOI 10.1007/s00125-019-4885-2; Endersby R, 2011, CANCER RES, V71, P4106, DOI 10.1158/0008-5472.CAN-10-3597; Enomoto M, 2013, EXP NEUROL, V248, P170, DOI 10.1016/j.expneurol.2013.06.013; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Feng Y, 2017, MOL MED REP, V16, P654, DOI 10.3892/mmr.2017.6619; Gao C, 2017, MOL NEUROBIOL, V54, P8348, DOI 10.1007/s12035-016-0318-0; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; He WM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38750-0; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Hickman FE, 2018, J NEUROSCI, V38, P5606, DOI 10.1523/JNEUROSCI.0788-16.2018; Hu JN, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1210-4; Islam MM, 2015, STEM CELL REP, V5, P805, DOI 10.1016/j.stemcr.2015.09.015; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kathe C, 2016, ELIFE, V5; Keefe KM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030548; Kim H, 2017, J NEUROSURG, V127, P23, DOI 10.3171/2016.7.JNS161263; Kusano K, 2010, BIOCHEM BIOPH RES CO, V393, P812, DOI 10.1016/j.bbrc.2010.02.088; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Lu Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-44; Lv BK, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00080; Lv BK, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00283; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; Malerba F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136425; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Ren CH, 2018, AGING DIS, V9, P869, DOI 10.14336/AD.2017.1106; Ren CH, 2018, EXP NEUROL, V304, P30, DOI 10.1016/j.expneurol.2018.02.013; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Sakata H, 2012, J NEUROSCI, V32, P3462, DOI 10.1523/JNEUROSCI.5686-11.2012; Sarkar C, 2020, AUTOPHAGY, V16, P466, DOI 10.1080/15548627.2019.1628538; Scott ALM, 2010, BRAIN, V133, P421, DOI 10.1093/brain/awp316; Shen Q, 2016, CELL PHYSIOL BIOCHEM, V38, P748, DOI 10.1159/000443031; Shi KB, 2019, CELL MOL IMMUNOL, V16, P523, DOI 10.1038/s41423-019-0213-5; Smith DK, 2016, STEM CELL REP, V7, P955, DOI 10.1016/j.stemcr.2016.09.013; Sung KJ, 2018, J NEUROSCI, V38, P3394, DOI 10.1523/JNEUROSCI.1686-17.2018; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teng KK, 2010, DEV NEUROBIOL, V70, P350, DOI 10.1002/dneu.20768; Ultsch MH, 1999, J MOL BIOL, V290, P149, DOI 10.1006/jmbi.1999.2816; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Wu P, 2019, INT J NANOMED, V14, P4059, DOI 10.2147/IJN.S202353; Xiong Y, 2012, ANN NY ACAD SCI, V1270, P51, DOI 10.1111/j.1749-6632.2012.06683.x; Xu XL, 2017, AGING DIS, V8, P590, DOI 10.14336/AD.2017.0430; Xu XL, 2017, AGING DIS, V8, P486, DOI 10.14336/AD.2017.0507; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Xu Z, 2019, ACS CHEM NEUROSCI, V10, P412, DOI 10.1021/acschemneuro.8b00298; Yan FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037948; Yang JJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00061; Zong XM, 2017, BRAIN RES, V1676, P9, DOI 10.1016/j.brainres.2017.08.006	61	10	10	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1757-6512		STEM CELL RES THER	Stem Cell Res. Ther.	OCT 24	2019	10	1							311	10.1186/s13287-019-1428-1			16	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	JH6HW	WOS:000492870100001	31651375	Green Published, gold			2022-02-06	
J	Nalder, E; Hartman, L; Hunt, A; King, G				Nalder, Emily; Hartman, Laura; Hunt, Anne; King, Gillian			Traumatic brain injury resiliency model: a conceptual model to guide rehabilitation research and practice	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; resiliency; participation; adaptation	SELF-REGULATION; COMMUNITY INTEGRATION; EXECUTIVE FUNCTION; ADAPTATION PROCESS; LIFE SATISFACTION; INDIVIDUALS; EXPERIENCES; TRANSITION; ADJUSTMENT; IDENTITY	There is a growing trend in traumatic brain injury (TBI) rehabilitation, and research, to focus on the processes of adaptation following the injury. Resiliency is an umbrella term describing the range of personal protective factors, environmental supports and resources, as well as self-regulatory processes, engaged in response to adversity. An affective, cognitive, and behavioural self-regulatory process model of resiliency in the workplace was adapted to suit the TBI context. Through a narrative review of the literature pertaining to brain injury rehabilitation, participation, and resilience, we substantiated the model, and explained how resiliency can frame research on life experiences following the injury. TBI represents a cascading adversity as the injury and subsequent life experiences (e.g., job loss) shape adaptation. Resiliency is shaped by: personal characteristics (e.g., hope, social functioning, self-awareness, memory, spirituality, coping, and self-efficacy), environmental resources/supports (e.g., services and social support), and self-regulatory processes that lead to the resiliency-related outcomes, which we suggest involve re-engaging in activities, adapting participation, and reconstructing identity. This conceptual model outlines and defines the factors and processes operating and contributing to resiliency following TBI. Recommendations for future research are outlined.	[Nalder, Emily; Hartman, Laura; Hunt, Anne; King, Gillian] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Nalder, Emily; Hartman, Laura; Hunt, Anne; King, Gillian] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Nalder, Emily] March Dimes Canada, Toronto, ON, Canada; [Hartman, Laura; Hunt, Anne; King, Gillian] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Hartman, Laura; Hunt, Anne; King, Gillian] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada		Nalder, E (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada.; Nalder, E (corresponding author), Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada.; Nalder, E (corresponding author), Univ Toronto, Rehabil Sci Bldg,160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	emily.nalder@utoronto.ca		Hartman, Laura/0000-0001-7246-7863	Social Sciences and Humanities Research CouncilSocial Sciences and Humanities Research Council of Canada (SSHRC)	Whilst this manuscript was in preparation we received funding through the Social Sciences and Humanities Research Council, for a partnership development grant, to further our work on resiliency in the context of TBI. However, the funding source had no input into the design or conduct of the study.	Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Brands I, 2015, CLIN REHABIL, V29, P611, DOI 10.1177/0269215514549484; Brands IMH, 2012, CLIN REHABIL, V26, P840, DOI 10.1177/0269215511432018; BRANDTSTADTER J, 1990, PSYCHOL AGING, V5, P58, DOI 10.1037/0882-7974.5.1.58; Carver C. S., 2004, HDB SELF REGULATION, P3; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; DeFina P, 2009, CLIN NEUROPSYCHOL, V23, P1391, DOI 10.1080/13854040903058978; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Haggstrom A, 2008, J REHABIL MED, V40, P89, DOI 10.2340/16501977-0138; Hanks RA, 2016, REHABIL PSYCHOL, V61, P269, DOI 10.1037/rep0000069; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; Hunt AW, 2013, NEUROPSYCHOL REHABIL, V23, P914, DOI 10.1080/09602011.2013.835739; Jaglal SB, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-409; Kendall E, 2008, SOC SCI MED, V67, P1217, DOI 10.1016/j.socscimed.2008.05.033; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; King G, 2003, QUAL HEALTH RES, V13, P184, DOI 10.1177/1049732302239598; King GA, 2004, AM J ORTHOPSYCHIAT, V74, P72, DOI 10.1037/0002-9432.74.1.72; King G, 2018, DISABIL REHABIL, V40, P1829, DOI 10.1080/09638288.2017.1309583; King GA, 2010, NEW HORIZ MANAG, P361; Kitter B, 2015, BRAIN INJURY, V29, P1082, DOI 10.3109/02699052.2015.1018323; Koller K, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020198; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Krpan KM, 2013, NEUROREHABILITATION, V32, P721, DOI 10.3233/NRE-130897; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Martin R, 2015, DISABIL REHABIL, V37, P1234, DOI 10.3109/09638288.2014.961653; Masten AS., 2009, EDUC CAN, V49; McColl MA, 2000, DISABIL REHABIL, V22, P555, DOI 10.1080/096382800416805; McCubbin M., 1993, FAMILIES HLTH ILLNES, P21, DOI 10.4135/9781452274720.n8; McLarnon MJW, 2013, J PERS PSYCHOL, V12, P63, DOI 10.1027/1866-5888/a000084; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nalder E, 2013, BRAIN INJURY, V27, P1294, DOI 10.3109/02699052.2013.823560; Nalder E, 2012, BRAIN INJURY, V26, P1381, DOI 10.3109/02699052.2012.676225; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Pangallo A, 2015, PSYCHOL ASSESSMENT, V27, P1, DOI 10.1037/pas0000024; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; Rothstein MG, 2016, IND ORGAN PSYCHOL-US, V9, P416, DOI 10.1017/iop.2016.32; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, P125, DOI 10.1097/HTR.0000000000000207; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Southwick SM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25338; SPINA S, 2005, BRAIN IMPAIR, V6, P33, DOI DOI 10.1375/BRIM.6.1.33.65478; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Thomas EJ, 2014, QUAL HEALTH RES, V24, P1033, DOI 10.1177/1049732314542809; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Ungar M, 2011, AM J ORTHOPSYCHIAT, V81, P1, DOI 10.1111/j.1939-0025.2010.01067.x; Waldron-Perrine B, 2011, REHABIL PSYCHOL, V56, P107, DOI 10.1037/a0023552; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164	58	10	10	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	OCT 23	2019	41	22					2708	2717		10.1080/09638288.2018.1474495			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	JC2RM	WOS:000489124200014	29890867				2022-02-06	
J	Sirois, K; Tousignant, B; Boucher, N; Achim, AM; Beauchamp, MH; Bedell, G; Massicotte, E; Vera-Estay, E; Jackson, PL				Sirois, K.; Tousignant, B.; Boucher, N.; Achim, A. M.; Beauchamp, M. H.; Bedell, G.; Massicotte, E.; Vera-Estay, E.; Jackson, P. L.			The contribution of social cognition in predicting social participation following moderate and severe TBI in youth	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; TBI; Adolescence; Social participation; Social cognition	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; FUNCTIONAL OUTCOMES; EMOTION RECOGNITION; EXECUTIVE FUNCTIONS; ADOLESCENT SCALE; CHILDREN; CHILDHOOD; MIND; REHABILITATION	Youth with moderate or severe traumatic brain injury (TBI) are at risk for reduced social participation after the injury, and the contribution of social cognition to these changes in functioning has been little studied. This study aimed to examine social participation and to measure the contribution of social and non-social cognitive functions to social participation impairment in youth (ages 12-21) who sustained moderate or severe TBI. Youth with TBI (n = 23) were compared to typically developing (TD) controls on self- and parent-rated social participation questionnaires. Direct testing of social cognition (mentalising, social knowledge, emotion recognition) and higher order cognitive abilities (intellectual abilities, attention and executive functions) was also conducted. Significant differences were found between the TBI participants and TD controls on social participation measures. Mentalising and problem-solving abilities revealed to be significant correlates of social participation as reported by youth with brain-injury and their parents. Overall, these results corroborate previous findings by showing that social participation is significantly reduced after TBI, and further shows that mentalising, which is not always considered during rehabilitation, is an important contributing factor. In addition to executive function measures, social cognition should therefore be systematically included in assessment following youth TBI for intervention and prevention purposes.	[Sirois, K.; Tousignant, B.; Massicotte, E.; Jackson, P. L.] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada; [Sirois, K.; Tousignant, B.; Boucher, N.; Massicotte, E.; Jackson, P. L.] Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada; [Sirois, K.] Ctr Integre Univ Sante & Serv Soc Capitale Natl, Site Inst Readaptat Deficience Phys Quebec IRDPQ, Quebec City, PQ, Canada; [Tousignant, B.; Achim, A. M.; Massicotte, E.; Jackson, P. L.] Ctr Rech CERVO, Quebec City, PQ, Canada; [Achim, A. M.] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Beauchamp, M. H.; Vera-Estay, E.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, M. H.] Ctr Rech Hop Ste Justine, Montreal, PQ, Canada; [Bedell, G.] Tufts Univ, Dept Occupat Therapy, Medford, MA 02155 USA		Sirois, K (corresponding author), Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada.; Sirois, K (corresponding author), Univ Laval, Pavillon Felix Antoine Savard, Ecole Psychol, 2325,Rue Bibliotheques, Quebec City, PQ G1V 0A6, Canada.; Sirois, K (corresponding author), Ctr Integre Univ Sante & Serv Soc Capitale Natl, Site IRDPQ, Quebec City, PQ, Canada.	katia.sirois@psy.ulaval.ca		Tousignant, Beatrice/0000-0003-1328-0139; Bedell, Gary/0000-0002-9555-8861; Jackson, Philip/0000-0001-8991-3217	Fonds de recherche du Quebec-Sante (FRQS) -Reseau Provincial de Recherche en Adaptation-Readaptation (REPAR) [11-12-#6]	This research was supported by Fonds de recherche du Quebec-Sante (FRQS) -Reseau Provincial de Recherche en Adaptation-Readaptation (REPAR) under grant number [11-12-#6] to K. Sirois.	Achim AM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00823; Achim AM, 2013, PSYCHOL ASSESSMENT, V25, P117, DOI 10.1037/a0029137; Achim AM, 2012, PSYCHIAT RES, V196, P207, DOI 10.1016/j.psychres.2011.10.011; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BARONCOHEN S, 1989, J CHILD PSYCHOL PSYC, V30, P931, DOI 10.1111/j.1469-7610.1989.tb00296.x; Bates ME, 2004, J INT NEUROPSYCH SOC, V10, P392, DOI 10.1017/S135561770410307X; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bedell G., 2006, BRAIN INJ PROF, V3, P14; Bedell G. M., 2012, DEV SOCIAL NEUROSCIE, P184; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Bogan AM, 1997, BRAIN INJURY, V11, P431; Brunet-Gouet E, 2011, PSYCHIAT RES, V190, P23, DOI 10.1016/j.psychres.2010.11.029; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cohen J., 2013, STAT POWER ANAL BEHA; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; Delis DC., 2001, DELIS KAPLAN EXECUTI; DeMatteo CA, 2008, ARCH PHYS MED REHAB, V89, P1803, DOI 10.1016/j.apmr.2008.02.025; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Ekman P., 1976, PICTURES FACIAL AFFE; Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002; Fougeyrollas P., 2014, OPEN J THERAPY REHAB, V2, DOI [10.4236/ojtr.2014.24021, DOI 10.4236/OJTR.2014.24021]; Fougeyrollas P., 1997, MEASURE LIFE HABITS; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Golos A, 2016, NEUROREHABILITATION, V38, P311, DOI 10.3233/NRE-161322; Green L, 2013, BRAIN INJURY, V27, P872, DOI 10.3109/02699052.2013.775506; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P1211, DOI 10.1093/schbul/sbm145; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Henry JD, 2015, CURR OPIN PSYCHIATR, V28, P133, DOI 10.1097/YCO.0000000000000139; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Katia S., 2014, OPEN J THERAPY REHAB, V2, P11, DOI [10.4236/ojtr.2014.21009, DOI 10.4236/OJTR.2014.21009]; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P528, DOI 10.1017/S1355617713000039; McDougall J, 2013, CHILD CARE HLTH DEV, V39, P512, DOI 10.1111/cch.12050; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rosenberg H, 2018, J NEUROPSYCHOL, V12, P145, DOI 10.1111/jnp.12109; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Ross KA, 2011, BRAIN INJURY, V25, P1206, DOI 10.3109/02699052.2011.609519; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Shultz EL, 2016, NEUROPSYCHOLOGY, V30, P830, DOI 10.1037/neu0000288; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Tousignant B, 2018, NEUROPSYCHOL REHABIL, V28, P429, DOI 10.1080/09602011.2016.1158114; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Zarrett Nicole, 2006, New Dir Youth Dev, P13	77	10	10	3	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	OCT 21	2019	29	9					1383	1398		10.1080/09602011.2017.1413987			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	IT5UV	WOS:000482933600004	29254438				2022-02-06	
J	Lucas-Ruiz, F; Galindo-Romero, C; Salinas-Navarro, M; Gonzalez-Riquelme, MJ; Vidal-Sanz, M; Barriuso, MA				Lucas-Ruiz, Fernando; Galindo-Romero, Caridad; Salinas-Navarro, Manuel; Josefa Gonzalez-Riquelme, Maria; Vidal-Sanz, Manuel; Agudo Barriuso, Marta			Systemic and Intravitreal Antagonism of the TNFR1 Signaling Pathway Delays Axotomy-Induced Retinal Ganglion Cell Loss	FRONTIERS IN NEUROSCIENCE			English	Article						optic nerve crush; retinal ganglion cells; R7050; BDNF; combinatory therapy; neuroprotection	OPTIC-NERVE TRANSECTION; NECROSIS-FACTOR-ALPHA; NEUROTROPHIC FACTOR; LONG-TERM; IN-VIVO; BRAIN; SURVIVAL; DEATH; INJURY; CRUSH	Here, we have blocked the signaling pathway of tumor necrosis factor a (TNF alpha) in a mouse model of traumatic neuropathy using a small cell permeable molecule (R7050) that inhibits TNF alpha/TNF receptor 1 (TNFR1) complex internalization. Adult pigmented mice were subjected to intraorbital optic nerve crush (ONC). Animals received daily intraperitoneal injections of R7050, and/or a single intravitreal administration the day of the surgery. Some animals received a combinatorial treatment with R7050 (systemic or local) and a single intravitreal injection of brain derived neurotrophic factor (BDNF). As controls, untreated animals were used. Retinas were analyzed for RGC survival 5 and 14 days after the lesion i.e., during the quick and slow phase of axotomy-induced RGC death. qPCR analyses were done to verify that Tnfr1 and TNF alpha were up-regulated after ONC. At 5 days post-lesion, R7050 intravitreal or systemic treatment neuroprotected RGCs as much as BDNF alone. At 14 days, RGC rescue by systemic or intravitreal administration of R7050 was similar. At this time point, intravitreal treatment with BDNF was significantly better than intravitreal R7050. Combinatory treatment was not better than BDNF alone, although at both time points, the mean number of surviving RGCs was higher. In conclusion, antagonism of the extrinsic pathway of apoptosis rescues axotomized RGCs as it does the activation of survival pathways by BDNF. However, manipulation of both pathways at the same time, does not improve RGC survival.	[Lucas-Ruiz, Fernando; Galindo-Romero, Caridad; Salinas-Navarro, Manuel; Josefa Gonzalez-Riquelme, Maria; Vidal-Sanz, Manuel; Agudo Barriuso, Marta] Inst Murciano Invest Biosanitaria Virgen de la Ar, Grp Oftalmol Expt, Murcia, Spain; [Lucas-Ruiz, Fernando; Galindo-Romero, Caridad; Salinas-Navarro, Manuel; Josefa Gonzalez-Riquelme, Maria; Vidal-Sanz, Manuel; Agudo Barriuso, Marta] Univ Murcia, Fac Med, Dept Oftalmol, Murcia, Spain		Barriuso, MA (corresponding author), Inst Murciano Invest Biosanitaria Virgen de la Ar, Grp Oftalmol Expt, Murcia, Spain.; Barriuso, MA (corresponding author), Univ Murcia, Fac Med, Dept Oftalmol, Murcia, Spain.	martabar@um.es	Agudo-Barriuso, Marta/B-7100-2016; GALINDO-ROMERO, CARIDAD/AAF-8324-2021	Agudo-Barriuso, Marta/0000-0002-8566-9277; GALINDO-ROMERO, CARIDAD/0000-0001-9469-9868; Lucas Ruiz, Fernando/0000-0002-8799-6909	Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional Una manera de hacer Europa [PI16/00031, SAF2015-67643-P, RD16/0008/0026, RD16/0008/0016]; Fundacion Seneca, Agencia de Ciencia y Tecnologia Region de Murcia [19881/GERM/15]	This study was supported the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional Una manera de hacer Europa (PI16/00031, SAF2015-67643-P, RD16/0008/0026, and RD16/0008/0016), and by the Fundacion Seneca, Agencia de Ciencia y Tecnologia Region de Murcia (19881/GERM/15).	Agudo M, 2009, INVEST OPHTH VIS SCI, V50, P424, DOI 10.1167/iovs.08-2404; Agudo M, 2008, MOL VIS, V14, P1050; Agudo-Barriuso M, 2013, INVEST OPHTH VIS SCI, V54, P4249, DOI 10.1167/iovs.12-11451; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Cheng X, 2010, J ALZHEIMERS DIS, V19, P621, DOI 10.3233/JAD-2010-1253; De Groef L, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/108617; Di Pierdomenico J, 2018, INVEST OPHTH VIS SCI, V59, P4392, DOI 10.1167/iovs.18-24621; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; Feng L, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0331-16.2016; Feng L, 2016, INVEST OPHTH VIS SCI, V57, P3793, DOI 10.1167/iovs.16-19825; Galindo-Romero C, 2013, EXP EYE RES, V108, P84, DOI 10.1016/j.exer.2012.12.010; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; Galindo-Romero C, 2013, INVEST OPHTH VIS SCI, V54, P974, DOI 10.1167/iovs.12-11207; Galvao J, 2014, FASEB J, V28, P1317, DOI 10.1096/fj.13-235440; Gururaja TL, 2007, CHEM BIOL, V14, P1105, DOI 10.1016/j.chembiol.2007.08.012; Harvey AR, 2007, NEURODEGENER DIS, V4, P300, DOI 10.1159/000101886; Isenmann S, 1998, EUR J NEUROSCI, V10, P2751, DOI 10.1046/j.1460-9568.1998.00325.x; King MD, 2013, NEUROSCI LETT, V542, P92, DOI 10.1016/j.neulet.2013.02.051; Kitaoka Y, 2006, INVEST OPHTH VIS SCI, V47, P1448, DOI 10.1167/iovs.05-0299; Klocker N, 2000, J NEUROSCI, V20, P6962, DOI 10.1523/JNEUROSCI.20-18-06962.2000; Kyung H, 2015, BRAIN RES, V1609, P21, DOI 10.1016/j.brainres.2015.03.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorz C, 2009, FRONT BIOSCI-LANDMRK, V14, P583, DOI [10.2741/3265, 10.2741/3264]; Malik JMI, 2005, MOL THER, V11, P373, DOI 10.1016/j.ymthe.2004.11.014; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; Muller LPD, 2007, J COMP NEUROL, V505, P177, DOI 10.1002/cne.21487; Nadal-Nicolas FM, 2015, INVEST OPHTH VIS SCI, V56, P6095, DOI 10.1167/iovs.15-17195; Nakazawa T, 2002, INVEST OPHTH VIS SCI, V43, P3319; Nickells RW, 2008, PROG BRAIN RES, V173, P423, DOI 10.1016/S0079-6123(08)01129-1; Osborne A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1041-8; Park J, 2019, CYTOTHERAPY, V21, P671, DOI 10.1016/j.jcyt.2019.04.054; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; Pernet V, 2006, BRAIN, V129, P1014, DOI 10.1093/brain/awl015; Roh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040065; Sanchez-Migallon MC, 2018, EXP EYE RES, V170, P40, DOI 10.1016/j.exer.2018.02.010; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; Sanchez-Migallon MC, 2016, INVEST OPHTH VIS SCI, V57, P81, DOI 10.1167/iovs.15-17841; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Tezel G, 2004, BRAIN RES, V996, P202, DOI 10.1016/j.brainres.2003.10.029; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Tse BC, 2018, INVEST OPHTH VIS SCI, V59, P2905, DOI 10.1167/iovs.18-24431; Valiente-Soriano FJ, 2015, INVEST OPHTH VIS SCI, V56, P1924, DOI 10.1167/iovs.15-16454; Vargas JLC, 2015, J NEUROSCI, V35, P12088, DOI 10.1523/JNEUROSCI.1273-15.2015; Vidal-Sanz M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00235; Wei X, 2019, J NEUROSCI RES, V97, P70, DOI 10.1002/jnr.24256; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.0.CO;2-3	49	10	10	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	OCT 15	2019	13								1096	10.3389/fnins.2019.01096			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JO4YK	WOS:000497585800001	31680831	Green Published, gold			2022-02-06	
J	Dudley, M; Menzies, O; Elder, H; Nathan, L; Garrett, N; Wilson, D				Dudley, Margaret; Menzies, Oliver; Elder, Hinemoa; Nathan, Lisa; Garrett, Nick; Wilson, Denise			Mate wareware: Understanding 'dementia' from a M(a)over-barori perspective	NEW ZEALAND MEDICAL JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; NEW-ZEALAND; RACIAL-DISCRIMINATION; MAORI CHILDREN; ADOLESCENTS; EXPERIENCES	AIM: To investigate M (a) over bar ori (Indigenous people of Aotearoa New Zealand) understandings of dementia, its causes, and ways to manage a wh (a) over bar nau (extended family) member with dementia. METHOD: We undertook kaupapa M (a) over bar ori research (M (a) over bar ori informed research) with 223 kaum (a) over bar tua (M (a) over bar ori elders) who participated in 17 focus groups across seven study regions throughout Aotearoa New Zealand and eight wh (a) over bar nau from the Waikato region. We audio recorded all interviews, transcribed them and then coded and categorised the data into themes. RESULTS: Mate wareware (becoming forgetful and unwell) ('dementia') affects the wairua (spiritual dimension) of M (a) over bar ori. The findings elucidate M (a) over bar ori understandings of the causes of mate wareware, and the role of aroha (love, compassion) and manaakitanga (hospitality, kindness, generosity, support, caring) involved in caregiving for wh (a) over bar nau living with mate wareware. Participants perceived cultural activities acted as protective factors that optimised a person's functioning within their wh (a) over bar nau and community. CONCLUSION: wh (a) over bar nau are crucial for the care of a kaum (a) over bar tua with mate wareware, along with promoting healthy wairua for all. wh (a) over bar nau urgently need information to assist with their knowledge building and empowerment to meet the needs of a member affected by mate wareware. This requires collaborative healthcare practice and practitioners accessing the necessary matauranga M (a) over bar ori (M (a) over bar ori knowledge) to provide culturally appropriate and comprehensive care for wh (a) over bar nau.	[Dudley, Margaret; Elder, Hinemoa] Univ Auckland, Auckland, New Zealand; [Menzies, Oliver] Auckland Dist Hlth Board, Auckland, New Zealand; [Nathan, Lisa] Univ Waikato, Hamilton, New Zealand; [Garrett, Nick; Wilson, Denise] Auckland Univ Technol, Auckland, New Zealand		Dudley, M (corresponding author), Univ Auckland, Sch Psychol, Symonds St, Auckland 1010, New Zealand.	m.dudley@auckland.ac.nz	Wilson, Denise/ABG-4979-2020	Wilson, Denise/0000-0001-9942-3561	Health Research Council [16/089]	This study was funded by the Health Research Council (16/089).	Alzheimer's New Zealand, 2017, DEM EC IMP REP 2016; [Anonymous], 2017, UPD DEM EC IMP REP 2; Barnes HM, 2017, QUAL RES, V17, P313, DOI 10.1177/1468794117696031; Baxter J, 2006, AUST NZ J PSYCHIAT, V40, P914, DOI 10.1111/j.1440-1614.2006.01911.x; Boulton A, 2011, EVALUATION J AUSTRAL, V11, P5; Cormack D, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0735-y; Cullum S, 2018, INT J GERIATR PSYCH, V33, P1098, DOI 10.1002/gps.4898; Dudley M, 2014, NEW ZEAL J PSYCHOL, V43, P14; Durie M, 2006, NZ TREASURY GUEST LE, V1; Elder H, 2013, BRAIN IMPAIR, V14, P415, DOI 10.1017/BrImp.2013.29; Elder H, 2013, BRAIN IMPAIR, V14, P406, DOI 10.1017/BrImp.2013.28; Gifford H., 2014, NURS PRAX NZ, V30, P35; Harris R, 2012, AM J PUBLIC HEALTH, V102, P1012, DOI 10.2105/AJPH.2011.300626; Harris R, 2012, SOC SCI MED, V74, P408, DOI 10.1016/j.socscimed.2011.11.004; Ministry of Health, 2015, TAT KAH MAOR HLTH CH, V3rd; Pitama S, 2007, NEW ZEAL J PSYCHOL, V36, P118	16	10	10	0	3	NEW ZEALAND MEDICAL ASSOC	CHRISTCHURCH	C/O BRENNAN EDWARDES, DEPT SURGERY, CHRISTCHURCH HOSPITAL, PO BOX 4345, CHRISTCHURCH, 00000, NEW ZEALAND	0028-8446	1175-8716		NEW ZEAL MED J	N. Z. Med. J.	OCT 4	2019	132	1503					66	74					9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	JC0ME	WOS:000488972300007	31581183				2022-02-06	
J	Balalla, SK; Medvedev, ON; Siegert, RJ; Krageloh, CU				Balalla, Shivanthi K.; Medvedev, Oleg N.; Siegert, Richard J.; Krageloh, Christian U.			Validation of the WHOQOL-BREF and Shorter Versions Using Rasch Analysis in Traumatic Brain Injury and Orthopedic Populations	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							QUALITY-OF-LIFE; QOL 8-ITEM INDEX; PSYCHOMETRIC PROPERTIES; RESPONSE BURDEN; SHORT-FORM; OUTCOMES; QUESTIONNAIRE; VALIDITY; MODEL; RELIABILITY	Objective: To use Rasch analysis to validate the World Health Organization Quality of Life-BREF (WHOQOL-BREF) and existing short versions in individuals with traumatic brain injury and orthopedic injuries, with comparisons to a general population group. Design: The Partial Credit Rasch model was applied to evaluate the WHOQOL-BREF as well as shortened versions using a cross-sectional study design. Setting: Regional hospital, and national electoral sample in New Zealand. Participants: Individuals with traumatic brain injury (n=74), individuals with orthopedic injuries (n =114), general population (n =140). Interventions: None. Main Outcome Measure: WHOQOL-BREF. Results: The WHOQOL-BREF met expectations of the unidimensional Rasch model and demonstrated good reliability (person separation index [PSI] =0.82) when domain items were combined into physical-psychological, social, and environmental superitems. Analysis of shorter versions, the EUROHIS-QOL-8 and World Health Organization Quality of Life-5 (WHOQOL-5), indicated overall acceptable fit to the Rasch model and evidence of unidimensionality. The EUROHIS-QOL-8 showed good reliability (PSI= 0.81); however, reliability of the WHOQOL-5 (PSI= 0.68) was below acceptable standards for group comparisons, in addition to demonstrating poor person-item targeting. Conclusions: The WHOQOL-BREF and the 8-item EUROHIS-QOL-8 version are both reliable and valid in the assessment of quality of life in both injury and general populations. Ordinal-interval conversion tables published for these validated scales as well as for the WHOQOL-5 can be used to improve precision of assessment. The transformation of ordinal scale scores into an interval measure of health-related quality of life also permits the calculation of a single summary score for the WHOQOL-BREF, which will be useful in a wide range of clinical and research contexts. Further validation work of the WHOQOL-5 is needed to ascertain its psychometric properties. (C) 2019 by the American Congress of Rehabilitation Medicine	[Balalla, Shivanthi K.; Siegert, Richard J.; Krageloh, Christian U.] Auckland Univ Technol, Sch Publ Hlth & Psychosocial Studies, 90 Akoranga Dr, Auckland, New Zealand; [Medvedev, Oleg N.] Univ Waikato, Sch Psychol, Hamilton, New Zealand		Balalla, SK (corresponding author), Auckland Univ Technol, Sch Publ Hlth & Psychosocial Studies, 90 Akoranga Dr, Auckland, New Zealand.	sbalalla@aut.ac.nz	Krageloh, Christian/AAF-7879-2020; Medvedev, Oleg N./AAO-8339-2020	Krageloh, Christian/0000-0002-7298-0736; Medvedev, Oleg N./0000-0002-2167-5002; Balalla, Shivanthi/0000-0001-5320-753X			Andrich D, 1985, TEST DESIGN DEV PSYC; Andrich D, 2015, EDUC PSYCHOL MEAS, V75, P185, DOI 10.1177/0013164414534258; BAHLOULI E, 2016, ANN PHYS REHABIL MED, V0059, pE 136; Bhandari M, 2008, CAN J SURG, V51, P15; Bond A, 2015, RES HANDB IMPACT ASS, P3; Butcher JL, 1996, J TRAUMA, V41, P4, DOI 10.1097/00005373-199607000-00002; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CASSIDY JD, 2014, ARCH PHYS MED REHAB, V95, P132; Castellan N. J, 1988, NONPARAMETRIC STAT B; Chang KC, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0148-6; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Christensen KB, 2017, APPL PSYCH MEAS, V41, P178, DOI 10.1177/0146621616677520; Cook KF, 2017, MIL MED, V182, pE1851, DOI 10.7205/MILMED-D-16-00285; da Rocha NS, 2012, VALUE HEALTH, V15, P449, DOI 10.1016/j.jval.2011.11.035; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Gennarelli TA., 2008, ABBREVIATED INJURY S; Geyh S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-94; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Jang Y, 2004, ARCH PHYS MED REHAB, V85, P1890, DOI 10.1016/j.apmr.2004.02.032; Kahan M, 2018, BRAIN IMPAIR, V19, P153, DOI 10.1017/Brimp.2018.7; KERSTEN P, 2011, NZ J PHYSIOTHERAPY, V39, P92; Khoury S, 2018, PROG NEURO-PSYCHOPH, V87, P224, DOI 10.1016/j.pnpbp.2017.06.007; Krageloh CU, 2015, AUST NZ J PUBL HEAL, V39, P384, DOI 10.1111/1753-6405.12350; Krageloh CU, 2013, QUAL LIFE RES, V22, P1451, DOI 10.1007/s11136-012-0265-9; Krageloh CU, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166065; Kruithof N, 2018, INJURY, V49, P1796, DOI 10.1016/j.injury.2018.08.016; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Leung YY, 2014, J RHEUMATOL, V41, P159, DOI 10.3899/jrheum.130814; Liang WM, 2009, QUAL LIFE RES, V18, P605, DOI 10.1007/s11136-009-9471-5; Lin CY, 2019, J FORMOS MED ASSOC, V118, P215, DOI 10.1016/j.jfma.2018.03.018; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Luo G., 2010, RUMM2030; MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Medvedev O., 2018, J HLTH PSYCHOL, pprint; Nilsson AL, 2011, J REHABIL MED, V43, P884, DOI 10.2340/16501977-0871; Paredes T, 2010, PSYCHOL HEALTH MED, V15, P420, DOI 10.1080/13548506.2010.482139; Pires AC, 2018, REV BRAS PSIQUIATR, V40, P249, DOI 10.1590/1516-4446-2017-2297; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Rocha NS, 2012, MED DECIS MAKING, V32, P41, DOI 10.1177/0272989X11415112; Rolstad S, 2011, VALUE HEALTH, V14, P1101, DOI 10.1016/j.jval.2011.06.003; Schmidt S, 2006, EUR J PUBLIC HEALTH, V16, P420, DOI 10.1093/eurpub/cki155; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Snell DL, 2016, QUAL LIFE RES, V25, P51, DOI 10.1007/s11136-015-1044-1; Tennant A, 2004, VALUE HEALTH, V7, pS22, DOI 10.1111/j.1524-4733.2004.7s106.x; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Van Esch L, 2011, INT J CLIN HLTH PSYC, V11, P5; Wang WC, 2006, QUAL LIFE RES, V15, P607, DOI 10.1007/s11136-005-4365-7; Yao G, 2002, J FORMOS MED ASSOC, V101, P342; [No title captured]; [No title captured]	51	10	10	1	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2019	100	10					1853	1862		10.1016/j.apmr.2019.05.029			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	JF3QL	WOS:000491302000007	31229529				2022-02-06	
J	Cassilo, D; Sanderson, J				Cassilo, David; Sanderson, Jimmy			From Social Isolation to Becoming an Advocate: Exploring Athletes' Grief Discourse About Lived Concussion Experiences in Online Forums	COMMUNICATION & SPORT			English	Article						athletes and concussions; grief; online forums; online support groups; sport and health	MEDIATED SUPPORT GROUPS; TRAUMATIC BRAIN-INJURY; IDENTITY; PARENTS; SPORT; YOUTH; RISK; LIFE; EPIDEMIOLOGY; VALIDATION	Athletes who sustain concussions endure a variety of physical, mental, emotional, and social isolation effects as they rehabilitate. Accordingly, concussion recovery can induce grieving processes as athletes navigate the loss of athletic participation, social networks, and daily routine disruption. This research sought to gain a richer understanding of athletes' lived experiences with concussions through grief discourse shared in online narratives. Through an analysis of athletes' experiences shared via 58 blog posts on three concussion websites, the data reveal how athletes frame the losses that concussions bring into their lives, the subsequent feelings and expressions that result, along with how they eventually cope. The information disclosed in these online spaces can benefit parents, friends, coaches, and others to better understand concussion recovery, thereby enhancing their supportive communication and behaviors towards athletes as they rehabilitate from concussions.	[Cassilo, David] Kent State Univ, Kent, OH 44242 USA; [Sanderson, Jimmy] Texas Tech Univ, POB 43011,2500 Broadway, Lubbock, TX 79409 USA		Sanderson, J (corresponding author), Texas Tech Univ, POB 43011,2500 Broadway, Lubbock, TX 79409 USA.	jimmy.sanderson@ttu.edu					Albrecht TL, 2003, LEA COMMUN SER, P263; Anderson E., 2017, SPORT THEORY SOCIAL, V2nd ed; Arntson P., 1987, COMMUNICATING SOCIAL, P148; Averill J. R., 2006, HDB BEREAVEMENT THEO, P77; Barak A, 2006, COUNS PSYCHOTHER RES, V6, P186, DOI 10.1080/14733140600848203; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; BREWER BW, 1993, J PERS, V61, P343, DOI 10.1111/j.1467-6494.1993.tb00284.x; BREWER BW, 1993, INT J SPORT PSYCHOL, V24, P237; Bruinsma SM, 2015, J PALLIAT MED, V18, P438, DOI 10.1089/jpm.2014.0366; Cho JY, 2014, QUAL REP, V19, DOI 10.7838/jsebs.2014.19.1.001; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Cohen H., 2017, WESTERM J COMMUN, V82, P238; Colon GAT, 2017, QUAL HEALTH RES, V27, P1077, DOI 10.1177/1049732316669339; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Crabtree B. F., 1999, DOING QUALITATIVE RE; Currier JM, 2006, DEATH STUD, V30, P403, DOI 10.1080/07481180600614351; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Guise J, 2010, J HEALTH PSYCHOL, V15, P426, DOI 10.1177/1359105309350515; Hilliard RC, 2017, J SPORT REHABIL, V26, P208, DOI 10.1123/jsr.2015-0134; HOCHSCHILD AR, 1979, AM J SOCIOL, V85, P551, DOI 10.1086/227049; Hochschild AR., 1983, MANAGED HEART COMMER; Holland JM, 2010, INT J STRESS MANAGE, V17, P325, DOI 10.1037/a0020892; Horton A., 2002, MED SCI SPORTS EXERC, V34, P99; Hughes R., 1991, CONT ISSUES SOCIOLOG, P307; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Jakoby NR, 2012, DEATH STUD, V36, P679, DOI 10.1080/07481187.2011.584013; Keating DM, 2013, J RELIG HEALTH, V52, P1014, DOI 10.1007/s10943-012-9577-x; Kim J, 2017, PSYCHIATRY, V80, P1, DOI 10.1080/00332747.2016.1213560; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Letourneau N, 2012, J PEDIATR NURS, V27, P65, DOI 10.1016/j.pedn.2010.07.007; McAlearney AS, 2015, HEALTH SERV RES, V50, P462, DOI 10.1111/1475-6773.12227; McCrory P, 2017, BRIT J SPORT MED, V51, P1557, DOI 10.1136/bjsports-2017-098065; McKiernan A, 2017, CYBERPSYCH BEH SOC N, V20, P78, DOI 10.1089/cyber.2016.0450; Messing JT, 2015, CHILD FAM SOC WORK, V20, P30, DOI 10.1111/cfs.12051; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Neimeyer RA, 2014, DEATH STUD, V38, P485, DOI 10.1080/07481187.2014.913454; Nixon H. L. II, 1996, Journal of Sport and Social Issues, V20, P33, DOI 10.1177/019372396020001004; Owens C, 2012, HLTH EXPECTATIONS, V18, P81; Penman EL, 2014, DEATH STUD, V38, P510, DOI 10.1080/07481187.2013.873839; Podlog L, 2005, J SPORT REHABIL, V14, P20, DOI 10.1123/jsr.14.1.20; Podlog L, 2013, J ATHL TRAINING, V48, P372, DOI 10.4085/1062-6050-48.2.20; Preidt R., 2017, WHICH HIGH SCH SPORT; Rains SA, 2009, HUM COMMUN RES, V35, P309, DOI 10.1111/j.1468-2958.2009.01353.x; Rapaport L., 2018, FEWER US HIGH SCH AT; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Rossetto KR, 2015, WESTERN J COMM, V79, P533, DOI 10.1080/10570314.2015.1079332; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Shaw BR, 2006, HEALTH COMMUN, V19, P133, DOI 10.1207/s15327027hc1902_5; Steinfeldt M, 2012, J APPL SPORT PSYCHOL, V24, P115, DOI 10.1080/10413200.2011.603405; Stephan Y, 2007, J APPL SPORT PSYCHOL, V19, P67, DOI 10.1080/10413200600944090; Tanis M, 2008, J HEALTH COMMUN, V13, P698, DOI 10.1080/10810730802415316; Toller P, 2011, SOUTH COMMUN J, V76, P17, DOI 10.1080/10417940903159393; Tzivian L, 2014, DEATH STUD, V38, P109, DOI 10.1080/07481187.2012.738764; Varga MA, 2014, DEATH STUD, V38, P443, DOI 10.1080/07481187.2013.780112; Walther Joseph B, 2002, Ethics Inf Technol, V4, P205, DOI 10.1023/A:1021368426115; Weinberg R, 2013, J CLIN SPORT PSYCHOL, V7, P41, DOI 10.1123/jcsp.7.1.41; Wiechman S. A., 1997, Journal of Sport Behavior, V20, P199; Wilder SE, 2016, COMMUN STUD, V67, P111, DOI 10.1080/10510974.2015.1119171; Worthen-Chaudhari L, 2017, BRAIN INJURY, V31, P1279, DOI 10.1080/02699052.2017.1332388; Young, 2004, SPORTING BODIES DAMA, P59	69	10	10	0	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport	OCT	2019	7	5					678	696		10.1177/2167479518790039			19	Communication; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Communication; Social Sciences - Other Topics	IT5XK	WOS:000482941700007					2022-02-06	
J	Rivera-Lara, L; Geocadin, R; Zorrilla-Vaca, A; Healy, RJ; Radzik, BR; Palmisano, C; Mirski, M; White, MA; Suarez, J; Brown, C; Hogue, CW; Ziai, W				Rivera-Lara, Lucia; Geocadin, Romergryko; Zorrilla-Vaca, Andres; Healy, Ryan J.; Radzik, Batya R.; Palmisano, Caitlin; Mirski, Marek; White, Mirinda Anderson; Suarez, Jose; Brown, Charles; Hogue, Charles W.; Ziai, Wendy			Optimizing Mean Arterial Pressure in Acutely Comatose Patients Using Cerebral Autoregulation Multimodal Monitoring With Near-Infrared Spectroscopy*	CRITICAL CARE MEDICINE			English	Article						cerebral autoregulation; multimodal monitoring; cerebral oximetry index; near-infrared spectroscopy; optimal arterial blood pressure	TRAUMATIC BRAIN-INJURY; PERFUSION-PRESSURE; BLOOD-FLOW; PIAL-ARTERIES; CIRCULATION; VALIDATION; REACTIVITY; DELIRIUM	Objectives: This study investigated whether comatose patients with greater duration and magnitude of clinically observed mean arterial pressure outside optimal mean arterial blood pressure have worse outcomes than those with mean arterial blood pressure closer to optimal mean arterial blood pressure calculated by bedside multimodal cerebral autoregulation monitoring using near-infrared spectroscopy. Design: Prospective observational study. Setting: Neurocritical Care Unit of the Johns Hopkins Hospital. Subjects: Acutely comatose patients secondary to brain injury. Interventions: None. Measurements and Main Results: The cerebral oximetry index was continuously monitored with near-infrared spectroscopy for up to 3 days. Optimal mean arterial blood pressure was defined as that mean arterial blood pressure at the lowest cerebral oximetry index (nadir index) for each 24-hour period of monitoring. Kaplan-Meier analysis and proportional hazard regression models were used to determine if survival at 3 months was associated with a shorter duration of mean arterial blood pressure outside optimal mean arterial blood pressure and the absolute difference between clinically observed mean arterial blood pressure and optimal mean arterial blood pressure. A total 91 comatose patients were enrolled in the study. The most common etiology was intracerebral hemorrhage. Optimal mean arterial blood pressure could be calculated in 89 patients (97%), and the median optimal mean arterial blood pressure was 89.7 mm Hg (84.6-100 mm Hg). In multivariate proportional hazard analysis, duration outside optimal mean arterial blood pressure of greater than 80% of monitoring time (adjusted hazard ratio, 2.13; 95% CI, 1.04-4.41; p = 0.04) and absolute difference between clinically observed mean arterial blood pressure and optimal mean arterial blood pressure of more than 10 mm Hg (adjusted hazard ratio, 2.44; 95% CI, 1.21-4.92; p = 0.013) were independently associated with mortality at 3 months, after adjusting for brain herniation, admission Glasgow Coma Scale, duration on vasopressors and midline shift at septum. Conclusions: Comatose neurocritically ill adults with an absolute difference between clinically observed mean arterial blood pressure and optimal mean arterial blood pressure greater than 10 mm Hg and duration outside optimal mean arterial blood pressure greater than 80% had increased mortality at 3 months. Noninvasive near-infrared spectroscopy-based bedside calculation of optimal mean arterial blood pressure is feasible and might be a promising tool for cerebral autoregulation oriented-therapy in neurocritical care patients.	[Rivera-Lara, Lucia; Geocadin, Romergryko; Mirski, Marek; Suarez, Jose; Brown, Charles; Ziai, Wendy] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Rivera-Lara, Lucia; Geocadin, Romergryko; Zorrilla-Vaca, Andres; Healy, Ryan J.; Radzik, Batya R.; Palmisano, Caitlin; Mirski, Marek; White, Mirinda Anderson; Suarez, Jose; Brown, Charles; Ziai, Wendy] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Zorrilla-Vaca, Andres] Univ Valle, Sch Med, Dept Anesthesiol, Cali, Colombia; [Hogue, Charles W.] Northwestern Univ Feinberg, Sch Med, Dept Anesthesiol, Chicago, IL USA		Rivera-Lara, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Rivera-Lara, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	lriver14@jhmi.edu	Vaca, Andres Zorrilla/I-9274-2014; Rivera-Lara, Lucia/AAX-8233-2020	Vaca, Andres Zorrilla/0000-0001-8140-8486; Rivera-Lara, Lucia/0000-0002-9053-2283	American Academy of Neurology/American Brain Foundation	Supported, in part, by grant from the American Academy of Neurology/American Brain Foundation.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2010, STROKE, V41, P1957, DOI 10.1161/STROKEAHA.109.575167; Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159; Bruno A, 2011, STROKE, V42, P2276, DOI 10.1161/STROKEAHA.111.613273; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Diedler J, 2014, CRIT CARE, V18, DOI 10.1186/cc13796; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Fog M, 1937, ARCH NEURO PSYCHIATR, V37, P351, DOI 10.1001/archneurpsyc.1937.02260140137007; Fog M, 1939, ARCH NEURO PSYCHIATR, V41, P260, DOI 10.1001/archneurpsyc.1939.02270140046003; Hori D, 2014, BRIT J ANAESTH, V113, P1009, DOI 10.1093/bja/aeu319; Hori D, 2016, J CARDIOTHOR VASC AN, V30, P606, DOI 10.1053/j.jvca.2016.01.012; Hori D, 2016, INTERACT CARDIOV TH, V22, P445, DOI 10.1093/icvts/ivv371; Hori D, 2015, ANN THORAC SURG, V100, P487, DOI 10.1016/j.athoracsur.2015.03.036; Hughes CG, 2012, CURR OPIN CRIT CARE, V18, P518, DOI 10.1097/MCC.0b013e328357effa; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Lang EW, 2016, ACTA NEUROCHIR SUPPL, V122, P221, DOI 10.1007/978-3-319-22533-3_44; Lee JK, 2017, DEV NEUROSCI-BASEL, V39, P248, DOI 10.1159/000452833; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Mailhot T, 2016, J CRIT CARE, V34, P17, DOI 10.1016/j.jcrc.2016.02.024; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Rivera-Lara L, 2016, IMPACT DURATION CERE; Rivera-Lara L, 2019, J NEUROSURG ANESTHES; Rivera-Lara L, 2017, NEUROCRIT CARE, V27, P362, DOI 10.1007/s12028-017-0421-8; Rivera-Lara L, 2017, ANESTHESIOLOGY, V126, P1187, DOI 10.1097/ALN.0000000000001625; Rivera-Lara L, 2017, CRIT CARE MED, V45, P695, DOI 10.1097/CCM.0000000000002251; Rivera-Lara L, 2016, CRIT CARE MED, V44; Stevens RD, 2006, CRIT CARE MED, V34, P31, DOI 10.1097/01.CCM.0000194534.42661.9F; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165	29	10	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2019	47	10					1409	1415		10.1097/CCM.0000000000003908			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KF4PW	WOS:000509227100026	31356469				2022-02-06	
J	Schellenberg, M; Benjamin, E; Bardes, JM; Inaba, K; Demetriades, D				Schellenberg, Morgan; Benjamin, Elizabeth; Bardes, James M.; Inaba, Kenji; Demetriades, Demetrios			Undertriaged trauma patients: Who are we missing?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	90th Annual Meeting of the Pacific-Coast-Surgical-Association	FEB 15-18, 2019	Tucson, AZ	Pacific Coast Surg Assoc		Undertriage; trauma team activation; trauma team activation criteria; severe injury	TEAM ACTIVATION	BACKGROUND: Trauma team activation (TTA) criteria, set by the American College of Surgeons Committee on Trauma, are used to identify patients prehospital who are at highest risk for severe injury and mobilize the optimal resources. Patients are undertriaged if they are severely injured (Injury Severity Score, >= 16) but do not meet TTA criteria. This study examined the epidemiology and injury patterns of undertriaged patients and potential clinical effects. METHODS: All patients presenting to our Level I trauma center (June 1, 2017 to May 31, 2018) were screened for inclusion using modified TTA criteria (mTTA), that is, age over 70 years added to the standard American College of Surgeons Committee on Trauma TTA criteria. Demographics, injury/clinical data, and outcomes of undertriaged patients were analyzed. Undertriaged patients were further subcategorized as "high-risk" if they expired or required emergent intervention. RESULTS: 233 undertriaged patients were identified from 1423 routine trauma consults (16%). Mean Injury Severity Score was 20 (range, 16-43). Most undertriage occurred following blunt trauma (n = 224, 96%), especially motor vehicle collisions (n = 66, 28%) and auto versus pedestrian collisions (n = 57, 24%). Thirty-two (14%) patients were identified as high-risk undertriaged patients: 16 (50%) required emergency surgery (mainly craniectomy; n = 10, 63%), 5 (16%) required angioembolization, and 14 patients (44%) died. In this high-risk group, the cause of death was almost exclusively traumatic brain injury (TBI) (n = 13, 93%). Of the patients who died of TBI, the majority had a depressed Glasgow Coma Scale score on presentation to the ED (<11) (n = 10, 77%) despite not meeting field criteria for TTA. CONCLUSION: Using mTTA criteria, undertriage rates are relatively low, particularly after penetrating trauma. However, there is a high-risk population that is not captured, among whom mortality and need for emergent intervention are high. Most undertriage deaths are secondary to severe TBI. Despite not qualifying for highest-level activation, patients with head trauma and Glasgow Coma Scale score less than 11 on admission are at high-risk for adverse outcomes and additional resource mobilization should be considered. (Copyright (C) 2019 Walters Kluwer Health, Inc. All rights reserved.)	[Schellenberg, Morgan; Benjamin, Elizabeth; Bardes, James M.; Inaba, Kenji; Demetriades, Demetrios] Univ Southern Calif, Div Trauma & Surg Crit Care, LAC USC Med Ctr, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA		Schellenberg, M (corresponding author), Univ Southern Calif, Div Trauma & Surg Crit Care, LAC USC Med Ctr, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA.	morgan.schellenberg@med.usc.edu	INABA, KENJI/AAC-8532-2020; Benjamin, Elizabeth/AAD-2457-2020	Bardes, James/0000-0002-9361-6263			American College of Surgeons Committee on Trauma (ACS COT), 2014, RESOURCES OPTIMAL CA; Benjamin ER, 2018, J EMERG MED, V55, P278, DOI 10.1016/j.jemermed.2018.02.001; Davis JW, 2017, J TRAUMA ACUTE CARE, V83, P1173, DOI 10.1097/TA.0000000000001623; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Jammula S, 2018, J TRAUMA ACUTE CARE, V85, P752, DOI 10.1097/TA.0000000000002002; Roden-Foreman JW, 2018, J TRAUMA ACUTE CARE, V84, P718, DOI 10.1097/TA.0000000000001814; Roden-Foreman JW, 2017, J TRAUMA NURS, V24, P150, DOI 10.1097/JTN.0000000000000283; Rogers A, 2013, EUR J TRAUMA EMERG S, V39, P599, DOI 10.1007/s00068-013-0289-z; Tignanelli CJ, 2018, J TRAUMA ACUTE CARE, V84, P287, DOI 10.1097/TA.0000000000001745	9	10	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2019	87	4					865	869		10.1097/TA.0000000000002393			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	KB9MX	WOS:000506812600017	31205217				2022-02-06	
J	Singh, SK; Dwivedi, H; Gunjan, S; Chauhan, BS; Pandey, SK; Tripathi, R				Singh, Sunil Kumar; Dwivedi, Hemlata; Gunjan, Sarika; Chauhan, Bhavana Singh; Pandey, Swaroop Kumar; Tripathi, Renu			Potential role of arteether on N-methyl-D-aspartate (NMDA) receptor expression in experimental cerebral malaria mice and extension of their survival	PARASITOLOGY			English	Article						Arteether; cerebral malaria; glutamate; NMDA receptor; Plasmodium berghei ANKA	REGIONAL EXPRESSION; CEREBROSPINAL-FLUID; QUINOLINIC ACID; RAT-BRAIN; GLUTAMATE; CHILDREN; SUBUNIT; CLONING; NR3B; IMPAIRMENT	Cerebral malaria (CM) is the severe neurological complication causing acute non-traumatic encephalopathy in tropical countries. The mechanisms underlying the fatal cerebral complications are still not fully understood. Glutamate, a major excitatory neurotransmitter in the central nervous system of the mammalian brain, plays a key role in the development of neuronal cells, motor function, synaptic plasticity, learning and memory processes under normal physiological conditions. The subtypes of ionotropic glutamate receptor are N-methyl-D-aspartate receptors (NMDARs) which are involved in cellular mechanisms of learning and memory, synaptic plasticity and also mediate excitotoxic neuronal injury. In the present study, we found that glutamate level in synaptosomes, as well as expression of NMDAR, was elevated during the extreme condition of CM in C57BL6 mice. Arteether at 50 mg kg(-1) x 1, 25 mg kg(-1) x 2, days decreased the NMDAR expression and increased the overall survival of the experimental CM mice.	[Singh, Sunil Kumar; Dwivedi, Hemlata; Gunjan, Sarika; Chauhan, Bhavana Singh; Pandey, Swaroop Kumar; Tripathi, Renu] CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow 226031, Uttar Pradesh, India		Tripathi, R (corresponding author), CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow 226031, Uttar Pradesh, India.	renu1113@rediffmail.com	Pandey, Swaroop Kumar/ABG-3026-2020; Pandey, Swaroop/ABD-1052-2020; Singh, Sunil/AAA-1630-2022	Pandey, Swaroop/0000-0002-4207-9453; Singh, Sunil/0000-0001-7639-9212	CSIRCouncil of Scientific & Industrial Research (CSIR) - India [GAP0147]; ICMRIndian Council of Medical Research (ICMR); UGCUniversity Grants Commission, India	This work is supported by grants provided under CSIR-Network project 'New approaches towards understanding of Disease dynamics and to accelerate drug discovery (UNDO)' and ` Evaluation of rescue treatment for cerebral malaria in vitro/in vivo model (GAP0147)' to RT. SKS is thankful to ICMR, HD and SG and SKP to CSIR and BSC to UGC for Senior Research Fellowship.	AFOLABI BB, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004391.PUB2; Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; [Anonymous], 2008, NATURE, V456, P732; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; BREWSTER DR, 1990, LANCET, V336, P1039, DOI 10.1016/0140-6736(90)92498-7; Brightman M, 1989, IMPLICATIONS BLOOD B, P53; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; Clark CJ, 2005, INFECT IMMUN, V73, P5249, DOI 10.1128/IAI.73.8.5249-5251.2005; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.ne.13.030190.001021; de Miranda AS, 2017, MOL NEUROBIOL, V54, P7063, DOI 10.1007/s12035-016-0226-3; Dobbie M, 2000, AM J TROP MED HYG, V62, P284, DOI 10.4269/ajtmh.2000.62.284; Domingues AMD, 2011, J NEUROCHEM, V117, P449, DOI 10.1111/j.1471-4159.2011.07212.x; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P105; ISHII T, 1993, J BIOL CHEM, V268, P2836; John CC, 2010, EXPERT REV ANTI-INFE, V8, P997, DOI 10.1586/ERI.10.90; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Matsuda K, 2002, MOL BRAIN RES, V100, P43, DOI 10.1016/S0169-328X(02)00173-0; MCGOVERN S, 1973, FEBS LETT, V31, P193, DOI 10.1016/0014-5793(73)80101-2; McIntosh H M, 2000, Cochrane Database Syst Rev, pCD000527, DOI 10.1002/14651858.CD000527; Medana IM, 2002, J INFECT DIS, V185, P650, DOI 10.1086/339009; Miranda AS, 2010, BRAZ J MED BIOL RES, V43, P1173, DOI 10.1590/S0100-879X2010007500130; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; Nunes JJ, 2017, NEOPLASIA, V19, P333, DOI 10.1016/j.neo.2017.02.002; Oluwayemi IO, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.88.1897; OSUNTOKUN B O, 1983, African Journal of Medicine and Medical Sciences, V12, P165; Parekh SB, 2006, INT J PARASITOL, V36, P1409, DOI 10.1016/j.ijpara.2006.07.004; Petrenko AB, 2003, ANESTH ANALG, V97, P1108, DOI 10.1213/01.ANE.0000081061.12235.55; Planche T, 2002, QJM-INT J MED, V95, P89, DOI 10.1093/qjmed/95.2.89; Rae C, 2004, FASEB J, V18, P499, DOI 10.1096/fj.03-0543com; SCHWARCZ R, 1983, NEUROSCI LETT, V38, P85, DOI 10.1016/0304-3940(83)90115-5; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Stafstrom CE, 2003, EPILEPSY RES, V53, P129, DOI 10.1016/S0920-1211(02)00258-9; Stone TW, 2001, PROG NEUROBIOL, V64, P185, DOI 10.1016/S0301-0082(00)00032-0; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Sykova E, 1992, ROLE ASTROCYTES IONI; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; WALZ W, 1992, NEUROSCI LETT, V135, P243, DOI 10.1016/0304-3940(92)90446-E; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; WHO, 1998, WHO INF CONS CLIN NE; WHO, 2015, GUID TREATM MAL; World Health Organization, 2019, WORLD MALARIA REPORT	52	10	10	0	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0031-1820	1469-8161		PARASITOLOGY	Parasitology	OCT	2019	146	12					1571	1577	PII S0031182019000878	10.1017/S0031182019000878			7	Parasitology	Science Citation Index Expanded (SCI-EXPANDED)	Parasitology	IW3XI	WOS:000484914600009	31244453				2022-02-06	
J	Gravesteijn, BY; Sewalt, CA; Ercole, A; Lecky, F; Menon, D; Steyerberg, EW; Maas, AIR; Lingsma, HF; Klimek, M				Gravesteijn, B. Y.; Sewalt, C. A.; Ercole, A.; Lecky, F.; Menon, D.; Steyerberg, E. W.; Maas, A. I. R.; Lingsma, H. F.; Klimek, M.		CENTER-TBI Collaborators	Variation in the practice of tracheal intubation in Europe after traumatic brain injury: a prospective cohort study	ANAESTHESIA			English	Article						Europe; guideline; practice variation; tracheal intubation; traumatic brain injury	RAPID-SEQUENCE INTUBATION; ENDOTRACHEAL INTUBATION; HEAD-INJURY; HYPOTENSION; IMPACT; EPIDEMIOLOGY; LARYNGOSCOPY; PRESSURE; HYPOXIA	Traumatic brain injury patients frequently undergo tracheal intubation. We aimed to assess current intubation practice in Europe and identify variation in practice. We analysed data from patients with traumatic brain injury included in the prospective cohort study collaborative European neurotrauma effectiveness research in traumatic brain injury (CENTER-TBI) in 45 centres in 16 European countries. We included patients who were transported to hospital by emergency medical services. We used mixed-effects multinomial regression to quantify the effects on pre-hospital or in-hospital tracheal intubation of the following: patient characteristics; injury characteristics; centre; and trauma system characteristics. A total of 3843 patients were included. Of these, 1322 (34%) had their tracheas intubated; 839 (22%) pre-hospital and 483 (13%) in-hospital. The fit of the model with only patient characteristics predicting intubation was good (Nagelkerke R2 64%). The probability of tracheal intubation increased with the following: younger age; lower pre-hospital or emergency department GCS; higher abbreviated injury scale scores (head and neck, thorax and chest, face or abdomen abbreviated injury score); and one or more unreactive pupils. The adjusted median odds ratio for intubation between two randomly chosen centres was 3.1 (95%CI 2.1-4.3) for pre-hospital intubation, and 2.7 (95%CI 1.9-3.5) for in-hospital intubation. Furthermore, the presence of an anaesthetist was independently associated with more pre-hospital intubation (OR 2.9, 95%CI 1.3-6.6), in contrast to the presence of ambulance personnel who are allowed to intubate (OR 0.5, 95%CI 0.3-0.8). In conclusion, patient and injury characteristics are key drivers of tracheal intubation. Between-centre differences were also substantial. Further studies are needed to improve the evidence base supporting recommendations for tracheal intubation.	[Gravesteijn, B. Y.] Erasmus Univ, Dept Anesthesiol, Med Ctr, Rotterdam, Netherlands; [Gravesteijn, B. Y.; Sewalt, C. A.; Lingsma, H. F.] Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands; [Klimek, M.] Erasmus Univ, Dept Anesthesiol, Med Ctr, Residency Training, Rotterdam, Netherlands; [Ercole, A.] Univ Cambridge, Anaesthesia & Intens Care, Dept Anaesthesiol, Cambridge, England; [Lecky, F.] Univ Sheffield, Fac Med Dent & Hlth, Emergency Med Res Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Menon, D.] Univ Cambridge, Dept Anaesthesia, Cambridge, England; [Steyerberg, E. W.] Leiden Univ, Med Ctr, Dept Biostat, Leiden, Netherlands; [Maas, A. I. R.] Univ Hosp Antwerp, Dept Neurosurg, Antwerp, Belgium		Gravesteijn, BY (corresponding author), Erasmus Univ, Dept Anesthesiol, Med Ctr, Rotterdam, Netherlands.; Gravesteijn, BY (corresponding author), Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands.	b.gravesteijn@erasmusmc.nl	Posti, Jussi P./Y-2908-2019; Gravesteijn, Benjamin/AAN-9524-2020; Cooper, D. James/G-7961-2013; Maas, Andrew IR/C-5584-2013; Klimek, Markus/N-7047-2019; Lagares, Alfonso/B-2969-2011; Sahuquillo, Juan/B-3577-2008; Ercole, Ari/B-6288-2009; Castano-Leon, Ana M/ABF-6322-2020; Gomez, Pedro/E-2411-2014; Raj, Rahul/K-7693-2012	Posti, Jussi P./0000-0002-5925-5193; Cooper, D. James/0000-0002-5872-9051; Maas, Andrew IR/0000-0003-1612-1264; Klimek, Markus/0000-0002-0122-9929; Lagares, Alfonso/0000-0003-3996-0554; Sahuquillo, Juan/0000-0003-0713-5875; Ercole, Ari/0000-0001-8350-8093; Castano-Leon, Ana M/0000-0002-7918-5049; Gravesteijn, Benjamin/0000-0001-8096-5803; Caccioppola, Alessio/0000-0003-1936-3111; Sakowitz, Oliver/0000-0003-3248-6335; Andelic, Nada/0000-0002-3719-4406; Kondziella, Daniel/0000-0001-5562-9808; Radoi, Andreea/0000-0002-0677-3544; Della Corte, Francesco/0000-0003-1736-2318; Kolias, Angelos/0000-0003-3992-0587; Zeiler, Frederick/0000-0003-1737-0510; Coles, Jonathan/0000-0003-4013-679X; Gomez, Pedro/0000-0002-4185-5238; Donoghue, Emma/0000-0002-2745-9108; Blaabjerg, Morten/0000-0001-6007-1861; Newcombe, Virginia/0000-0001-6044-9035; Rossi, Sandra/0000-0002-9963-8121; Raj, Rahul/0000-0003-4243-9591	European Union7th Framework Program (EC grant) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	We thank G. de Jonge, Biomedical Information Specialist, from the Erasmus MC library, for her help with the literature search. This work was supported by the European Union 7th Framework Program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), the OneMind (USA) and the Integra LifeSciences Corporation (USA). The funders had no role in the study design, enrolment, collection of data, writing or publication decisions.	Atkinson JLD, 2000, MAYO CLIN PROC, V75, P37, DOI 10.4065/75.1.37; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; BOIDIN MP, 1985, BRIT J ANAESTH, V57, P306, DOI 10.1093/bja/57.3.306; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Buis ML, 2016, RESUSCITATION, V99, P63, DOI 10.1016/j.resuscitation.2015.11.005; BURNEY RG, 1975, ANESTH ANALG, V54, P687; Buuren, 2018, FLEXIBLE IMPUTATION; Carney N., 2016, GUIDELINES MANAGEMEN, V4th; Cnossen MC, 2019, J NEUROTRAUM, V36, P176, DOI 10.1089/neu.2018.5712; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Dinsmore J, 2013, BJA EDUC, V13, P189, DOI 10.1093/bjaceaccp/mkt010; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Green RS, 2017, J TRAUMA ACUTE CARE, V83, P569, DOI 10.1097/TA.0000000000001561; Hoffmann M, 2017, J NEUROSURG ANESTH, V29, P161, DOI 10.1097/ANA.0000000000000275; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Li BY, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-77; Little R., 1991, J EDUC STAT, V16, P150; Lockey DJ, 1999, ANAESTHESIA, V54, P1097, DOI 10.1046/j.1365-2044.1999.00754.x; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; MOULTON C, 1991, BRIT MED J, V303, P1240, DOI 10.1136/bmj.303.6812.1240; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Shafi S, 2005, J TRAUMA, V59, P1140, DOI 10.1097/01.ta.0000196434.88182.77; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Van Essen TA, 2016, J NEUROTRAUM, V33, pA20; von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x; vonsElm E, 2007, BMJ-BRIT MED J, V335, P806	37	10	10	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	JAN	2020	75	1					45	53		10.1111/anae.14838		SEP 2019	9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	JS2VW	WOS:000486462000001	31520421	Green Published, Green Accepted, Green Submitted, hybrid			2022-02-06	
J	Bohr, AD; Boardman, JD; McQueen, MB				Bohr, Adam D.; Boardman, Jason D.; McQueen, Matthew B.			Association of Adolescent Sport Participation With Cognition and Depressive Symptoms in Early Adulthood	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						football (American); statistics; head injuries; concussion; epidemiology	HIGH-SCHOOL FOOTBALL; RECURRENT CONCUSSION; LEAGUE PLAYERS; IMPACT; RISK; MORTALITY; INJURY	Background: Recent studies have associated sport-related concussion with depression and impaired cognitive ability later in life in former professional football players. However, population studies with two 1950s-era cohorts did not find an association between high school football participation and impaired cognition or depressive symptoms in late adulthood. Purpose/Hypothesis: This study assessed whether actual/intended participation in contact sports during adolescence had an adverse effect on participants' cognition or depressive symptoms in early adulthood. We hypothesized that there would not be an association. Study Design: Cohort study; Level of evidence, 2. Methods: This study used a subsample (n = 10,951) from the National Longitudinal Study of Adolescent to Adult Health (Add Health), a nationally (United States) representative prospective cohort study following participants through 4 waves of data collection from 1994 through 2008. Participants were categorized as actual/intended participation in no sports, noncontact sports only, and contact sports. We constructed 6 multivariate and logistic regression models predicting word recall, number recall, modified Center for Epidemiologic Studies Depression Scale, depression diagnosis, suicide ideation, and suicide attempts at wave IV as a function of sport participation during wave I. Sport participation was treated as a factor with the referent category noncontact sports. This analysis was repeated on a males-only sample (n = 5008). In the males-only analysis, participants were classified as actual/intended participation in no sports, noncontact sports, contact sports other than American football, and American football. The referent category remained noncontact sports. Results: Intention to participate in contact sports was not significantly associated with any of the outcomes in the full-sample analysis. Intention to participate in football was significantly associated with a reduced odds of depression diagnosis in adulthood (odds ratio, 0.70; P = .02) when compared with noncontact sports participation in the males-only sample. Football was not significantly associated with impaired cognitive ability, increased depressive symptoms, or increased suicide ideation. Conclusion: Actual/intended participation in contact sports during adolescence did not adversely affect Add Health participants' cognition or depressive symptoms in young adulthood.	[Bohr, Adam D.; Boardman, Jason D.; McQueen, Matthew B.] Univ Colorado, Boulder, CO 80309 USA; [Bohr, Adam D.; McQueen, Matthew B.] Univ Colorado, Dept Integrat Physiol, 354 UCB, Boulder, CO 80309 USA; [Boardman, Jason D.] Univ Colorado, Dept Sociol, Boulder, CO 80309 USA; [Boardman, Jason D.] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA		Bohr, AD (corresponding author), Univ Colorado, Dept Integrat Physiol, 354 UCB, Boulder, CO 80309 USA.	adam.bohr@colorado.edu			University of Colorado Boulder Libraries Open Access Fund [P01HD31921]; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P2CHD066613, P01HD031921] Funding Source: NIH RePORTER	The authors thank the University of Colorado Boulder Libraries Open Access Fund for its financial support in publishing this article. This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill and funded by grant P01HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth).No direct support was received from grant P01-HD31921 for this analysis.	Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Bachynski KE, 2016, NEW ENGL J MED, V374, P405, DOI 10.1056/NEJMp1513993; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Child Trends Data Bank, PART SCH ATHL; Chung J, 2018, STAR TRIBUNE; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Harris K. M. C.T, 2009, NATL LONGITUDINAL ST; Harris KM, 2013, TWIN RES HUM GENET, V16, P391, DOI 10.1017/thg.2012.137; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Jones SAV, 2014, BRIT J SPORT MED, V48, P159, DOI 10.1136/bjsports-2013-092758; Kahn NF, 2018, J SEX RES, V55, P99, DOI 10.1080/00224499.2016.1247149; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Lawrence EM, 2017, J HEALTH SOC BEHAV, V58, P291, DOI 10.1177/0022146517715671; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mays D, 2010, AM J PREV MED, V38, P491, DOI 10.1016/j.amepre.2010.01.023; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Miles SH, 2016, AM J BIOETHICS, V16, P6, DOI 10.1080/15265161.2016.1128751; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Perreira KM, 2005, SOC FORCES, V83, P1567, DOI 10.1353/sof.2005.0077; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Putnick DL, 2016, DEV REV, V41, P71, DOI 10.1016/j.dr.2016.06.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RStudio Team, 2016, RSTUDIO INT DEV R; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350	38	10	10	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	SEP	2019	7	9							2325967119868658	10.1177/2325967119868658			11	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	JA6EC	WOS:000487934000001	31598525	Green Published, gold			2022-02-06	
J	Hostetter, TA; Hoffmire, CA; Forster, JE; Adams, RS; Stearns-Yoder, KA; Brenner, LA				Hostetter, Trisha A.; Hoffmire, Claire A.; Forster, Jeri E.; Adams, Rachel Sayko; Stearns-Yoder, Kelly A.; Brenner, Lisa A.			Suicide and Traumatic Brain Injury Among Individuals Seeking Veterans Health Administration Services Between Fiscal Years 2006 and 2015	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						firearms; suicide; traumatic brain injury; veterans; Veterans Health Administration	RISK; TBI; ASSOCIATION; RELIABILITY; VALIDITY	Objective: Examine associations between traumatic brain injury (TBI) and (1) suicide and (2) suicide method among individuals receiving Veterans Health Administration (VHA) care. Setting: VHA, Fiscal Years 2006-2015. Participants: Veterans with a TBI diagnosis during/prior to the study window (n = 215 610), compared with a 20% random sample of those without TBI (n = 1 187 639). Design: Retrospective, cohort study. Cox proportional hazards models were fit accounting for time-dependent measures, chronic conditions, and demographics for those with TBI compared with those without. Additional models evaluated the impact of TBI severity on the association between TBI and suicide, and method. Main Outcome Measures: Death by and method of suicide. Results: The hazard of suicide was 2.19 times higher for those with TBI than for those without TBI (95% CI = 2.02-2.37), and was still significant after accounting for covariates (hazard ratio [HR] = 1.71; 95% confidence interval [CI] = 1.56-1.87). Considering severity, mild TBI compared with no TBI was significantly associated with an elevated hazard of suicide, after adjusting for covariates (HR = 1.62; 95% CI = 1.47-1.78). There was also a significant difference in death by suicide between moderate/severe TBI when compared with no TBI, after adjusting for covariates (HR = 2.45; 95% CI = 2.02-2.97). Moderate/severe TBI was significantly associated with an increase in the odds of suicide by firearm among decedents (odds ratio = 2.39; 95% CI = 1.48-3.87). Conclusion: Traumatic brain injury is associated with an elevated risk for suicide. Particular concern is warranted for those with moderate/severe TBI. Lethal means safety should be explored as an intervention.	[Hostetter, Trisha A.; Hoffmire, Claire A.; Forster, Jeri E.; Adams, Rachel Sayko; Stearns-Yoder, Kelly A.; Brenner, Lisa A.] VHA Rocky Mt Mental Illness Res Educ & Clin Ctr, 1700 North Wheeling St, Aurora, CO 80045 USA; [Adams, Rachel Sayko] Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, Waltham, MA USA; [Hoffmire, Claire A.; Forster, Jeri E.; Stearns-Yoder, Kelly A.; Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Dept Phys Med & Rehabil, Aurora, CO USA; [Stearns-Yoder, Kelly A.; Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Marcus Inst Brain Hlth, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Dept Neurol, Aurora, CO USA		Brenner, LA (corresponding author), VHA Rocky Mt Mental Illness Res Educ & Clin Ctr, 1700 North Wheeling St, Aurora, CO 80045 USA.	lisa.brenner@va.gov	Adams, Rachel/AAH-4653-2020; Brenner, Lisa A./AAG-2442-2019		VHA Rocky Mountain Mental Illness Research Education and Clinical Center	This project was supported by the VHA Rocky Mountain Mental Illness Research Education and Clinical Center. Dr. Brenner consults for a professional sports league.	Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Ahmedani BK, 2017, AM J PREV MED, V53, P308, DOI 10.1016/j.amepre.2017.04.001; [Anonymous], 2018, VA NAT SUIC DAT REP; Bahraini N, 2013, J HEAD TRAUMA REHAB, V28, P223, DOI 10.1097/HTR.0b013e318291dab7; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Boggs JM, 2018, PSYCHIAT SERV, V69, P677, DOI 10.1176/appi.ps.201700237; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brenner LA, 2018, HLTH SERV RES DE SPR; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Centers for Disease Control and Prevention, 2018, SUIC RAT RIS US; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eliasen A, 2018, J NEUROL, V265, P1303, DOI 10.1007/s00415-018-8837-4; Gonsoulin M, 2015, ARE ALL MEMBERS MY C; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kessler RC, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1575; Lee DJ, 2018, DEPRESS ANXIETY, V35, P609, DOI 10.1002/da.22736; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; McCarthy JF, 2015, AM J PUBLIC HEALTH, V105, P1935, DOI 10.2105/AJPH.2015.302737; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Office of the Surgeon General, 2012, 2012 NAT STRAT SUIC; Research Prioritization Task Force National Action Alliance for Suicide Prevention, 2014, PRIOR RES AG SUIC PR PRIORITIZED RES AGEN; Russell LM, 2013, AM J PUBLIC HEALTH, V103, pS211, DOI 10.2105/AJPH.2013.301485; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; United States Department of Veterans Affairs Office of Mental Health and Suicide Prevention, 2016, SUIC VET OTH AM 2001; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; World Health Organization, 1977, INT STAT CLASS DIS R	37	10	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		E1	E9		10.1097/HTR.0000000000000489			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100001	31369450	Bronze			2022-02-06	
J	Jones, KF; Simpson, G; Briggs, L; Dorsett, P; Anderson, M				Jones, Kate Fiona; Simpson, Grahame; Briggs, Lynne; Dorsett, Pat; Anderson, Malcolm			A study of whether individual and dyadic relations between spirituality and resilience contribute to psychological adjustment among individuals with spinal cord injuries and their family members	CLINICAL REHABILITATION			English	Article						Spinal cord injuries; family; spirituality; resilience; a model of adjustment	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; SUPPORTING RELATIVES; SATISFACTION; CAREGIVERS; DEPRESSION; SCALE	Objective: To test a model of spiritual well-being and resilience among individuals with spinal cord injuries and their family members. Design: Prospective cross-sectional observational data were analyzed by structural equation modelling. Setting: Inpatient and community services at one rehabilitation hospital. Subjects: Individual with spinal cord injury (n = 50) and family member (n = 50) dyads. Interventions: Standard rehabilitation, both inpatient and community. Main measure(s): Functional assessment of chronic illness therapy - spiritual well-being scale - expanded, Connor-Davidson resilience scale, positive and negative affect scale, depression anxiety and stress scale-21, satisfaction with life scale. Results: Median time post-injury was 8.95 months (IQR (interquartile range) = 14.15). Individuals with spinal cord injury and family members reported high scores for both spiritual well-being (66.06 +/- 14.89; 68.42 +/- 13.75) and resilience (76.68 +/- 13.88; 76.64 +/- 11.75), respectively. Analysis found the model had acceptable fit (e.g. chi-square goodness of fit statistic = 38.789; P = .263). For individuals with spinal cord injury, spiritual well-being was positively associated with resilience which, in turn, was associated with increasing positive affect and satisfaction with life. Among family members, spiritual well-being was positively associated with resilience. Resilience was then associated with lowered levels of depression and mediated the impact of depression on satisfaction with life. Limited evidence was found for mutual dyadic links, with the only significant pathway finding that resilience in the individual with spinal cord injury was associated with increased satisfaction with life among family members. Conclusion: Increased spirituality and resilience make a significant contribution (both independently and in combination) to positive psychological outcomes for both individuals with spinal cord injury and their family members.	[Jones, Kate Fiona] Royal Rehab, POB 6, Ryde, NSW 1680, Australia; [Jones, Kate Fiona; Simpson, Grahame] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Liverpool, NSW, Australia; [Simpson, Grahame; Briggs, Lynne; Dorsett, Pat] Griffith Univ, Sch Human Serv & Social Work, Nathan, Qld, Australia; [Briggs, Lynne; Dorsett, Pat] Griffith Univ, Menzies Hlth Inst Queensland, Hopkins Ctr Res Rehabil & Resilience, Nathan, Qld, Australia; [Anderson, Malcolm] Avondale Coll Higher Educ, Wahroonga, NSW, Australia		Jones, KF (corresponding author), Royal Rehab, POB 6, Ryde, NSW 1680, Australia.	kate.jones@royalrehab.com.au	briggs, lynne/K-5581-2019; Jones, Kate/AAV-7641-2021	Briggs, Lynne/0000-0002-0219-3323; Simpson, Grahame/0000-0001-8156-9060; Jones, Kate/0000-0002-5964-3479	Community of Christ	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The manuscript was partially written as part of a larger project researching spirituality and spinal cord injury rehabilitation funded by a grant from the Community of Christ.	Anderson M, 2017, BRAIN INJURY, V31, P815; Arbuckle J. L, 2016, AMOS 24 0 USERS GUID; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; BOLLEN KA, 1990, PSYCHOL BULL, V107, P256, DOI 10.1037/0033-2909.107.2.256; Bredle JM, 2011, RELIGIONS, V2, P77, DOI 10.3390/rel2010077; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Canda E.R, 2009, SPIRITUAL DIVERSITY; Chan RCK, 2000, DISABIL REHABIL, V22, P764, DOI 10.1080/09638280050200269; Charlifue SB, 2016, SPINAL CORD, V54, P732, DOI 10.1038/sc.2016.25; Chevalier Z, 2009, SPINAL CORD, V47, P778, DOI 10.1038/sc.2009.60; Cohn MA, 2009, EMOTION, V9, P361, DOI 10.1037/a0015952; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Corrigan JD, 2013, J HEAD TRAUMA REHAB, V28, P489, DOI 10.1097/HTR.0000000000000004; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dowler R, 2001, J Spinal Cord Med, V24, P87; Elliott TR, 2014, J CONSULT CLIN PSYCH, V82, P1072, DOI 10.1037/a0037593; Feigin R, 1998, MARRIAGE FAM REV, V27, P71, DOI 10.1300/J002v27n01_06; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Ho R., 2014, HDB UNIVARIATE MULTI, V2nd ed.; Hooper D., 2008, EJBRM, V6, P53, DOI [10.21427/D7CF7R, DOI 10.21427/D7CF7R]; Hui SKA, 2007, REHABIL PSYCHOL, V52, P113, DOI 10.1037/0090-5550.52.1.113; Iacobucci D, 2010, J CONSUM PSYCHOL, V20, P90, DOI 10.1016/j.jcps.2009.09.003; IBM Corp, 2016, IBM SPSS STAT WIND V; Jones K, 2016, DISABIL REHABIL, V38, P921, DOI 10.3109/09638288.2015.1066884; Jones KF, 2018, BRAIN INJURY, V32, P1612, DOI 10.1080/02699052.2018.1511066; Jones KF, 2018, REHABIL PSYCHOL, V63, P521, DOI 10.1037/rep0000229; Jones Kate Fiona, 2018, Spinal Cord Ser Cases, V4, P54, DOI 10.1038/s41394-018-0078-3; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Lefebvre H., 2006, ILLNESS CRISIS LOSS, V14, P337, DOI DOI 10.1177/105413730601400403; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Meredith P, 2012, J RELIG HEALTH, V51, P879, DOI 10.1007/s10943-010-9399-7; Middleton JW, 2014, ARCH PHYS MED REHAB, V95, P1312, DOI 10.1016/j.apmr.2014.03.017; Newman R, 2005, PROF PSYCHOL-RES PR, V36, P227, DOI 10.1037/0735-7028.36.3.227; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Schonherr MC, 2005, SPINAL CORD, V43, P241, DOI 10.1038/sj.sc.3101683; Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961; Smith WB, 2012, OXFORD HDB PSYCHOL S, P437; Wagnild G M, 1993, J Nurs Meas, V1, P165; Watson D., 1994, PANAS X MANUAL POSIT; White B, 2010, REHABIL PSYCHOL, V55, P23, DOI 10.1037/a0018451; Wilson CS, 2017, DISABIL REHABIL, V39, P491, DOI 10.3109/09638288.2016.1152600; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8	45	10	10	3	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	SEP	2019	33	9					1503	1514		10.1177/0269215519845034			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	IU8FT	WOS:000483818100009	31056938				2022-02-06	
J	Standring, OJ; Friedberg, J; Tripodis, Y; Chua, AS; Cherry, JD; Alvarez, VE; Huber, BR; Xia, WM; Mez, J; Alosco, ML; Nicks, R; Mahar, I; Pothast, MJ; Gardner, HM; Meng, GY; Palmisano, JN; Martin, BM; Dwyer, B; Kowall, NW; Cantu, RC; Goldstein, LE; Katz, DI; Stern, RA; McKee, AC; Stein, TD				Standring, Oliver J.; Friedberg, Jacob; Tripodis, Yorghos; Chua, Alicia S.; Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand R.; Xia, Weiming; Mez, Jesse; Alosco, Michael L.; Nicks, Raymond; Mahar, Ian; Pothast, Morgan J.; Gardner, Hannah M.; Meng, Gaoyuan; Palmisano, Joseph N.; Martin, Brett M.; Dwyer, Brigid; Kowall, Neil W.; Cantu, Robert C.; Goldstein, Lee E.; Katz, Douglas I.; Stern, Robert A.; McKee, Ann C.; Stein, Thor D.			Contact sport participation and chronic traumatic encephalopathy are associated with altered severity and distribution of cerebral amyloid angiopathy	ACTA NEUROPATHOLOGICA			English	Article						Chronic traumatic encephalopathy; Alzheimer's disease; Cerebral amyloid angiopathy; Repetitive head impacts; Mild traumatic brain injury; American football	BRAIN-INJURY; ALZHEIMERS-DISEASE; TOPOGRAPHICAL DISTRIBUTION; PERIVASCULAR DRAINAGE; PATHOLOGY; FOOTBALL; HEMORRHAGES; DYSFUNCTION; DEMENTIA; LOCATION	Cerebral amyloid angiopathy (CAA) consists of beta-amyloid deposition in the walls of the cerebrovasculature and is commonly associated with Alzheimer's disease (AD). However, the association of CAA with repetitive head impacts (RHI) and with chronic traumatic encephalopathy (CTE) is unknown. We evaluated the relationship between RHI from contact sport participation, CTE, and CAA within a group of deceased contact sport athletes (n = 357), a community-based cohort (n = 209), and an AD cohort from Boston University AD Center (n = 241). Unsupervised hierarchal cluster analysis demonstrated a unique cluster (n = 11) with increased CAA in the leptomeningeal vessels compared to the intracortical vessels (p < 0.001) comprised of participants with significantly greater frequencies of CTE (7/11) and history of RHI. Overall, participants with CTE (n = 251) had more prevalent (p < 0.001) and severe (p = 0.010) CAA within the frontal leptomeningeal vessels compared to intracortical vessels. Compared to those with AD, participants with CTE had more severe CAA in frontal than parietal lobes (p < 0.001) and more severe CAA in leptomeningeal than intracortical vessels (p = 0.002). The overall frequency of CAA in participants with CTE was low, and there was no significant association between contact sport participation and the presence of CAA. However, in those with CAA, a history of contact sports was associated with increased CAA severity in the frontal leptomeningeal vessels (OR = 4.01, 95% CI 2.52-6.38, p < 0.001) adjusting for AD, APOE epsilon 4 status, and age. Participants with CAA had increased levels of sulcal tau pathology and decreased levels of the synaptic marker PSD-95 (p's < 0.05), and CAA was a predictor of dementia (OR = 1.75, 95% CI 1.02-2.99, p = 0.043) adjusting for age, sex, and comorbid pathology. Overall, contact sport participation and CTE were associated with more severe frontal and leptomeningeal CAA, and CAA was independently associated with worse pathological and clinical outcomes.	[Standring, Oliver J.; Friedberg, Jacob; Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand R.; Mez, Jesse; Alosco, Michael L.; Nicks, Raymond; Mahar, Ian; Pothast, Morgan J.; Palmisano, Joseph N.; Martin, Brett M.; Kowall, Neil W.; Cantu, Robert C.; Goldstein, Lee E.; Stern, Robert A.; McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Standring, Oliver J.; Friedberg, Jacob; Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand R.; Pothast, Morgan J.; Gardner, Hannah M.; Meng, Gaoyuan; Kowall, Neil W.; McKee, Ann C.; Stein, Thor D.] VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA; [Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand R.; Mez, Jesse; Alosco, Michael L.; Mahar, Ian; Dwyer, Brigid; Kowall, Neil W.; Katz, Douglas I.; Stern, Robert A.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Tripodis, Yorghos; Chua, Alicia S.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Alvarez, Victor E.; Xia, Weiming; Nicks, Raymond; Pothast, Morgan J.; Meng, Gaoyuan; McKee, Ann C.; Stein, Thor D.] Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA; [Palmisano, Joseph N.; Martin, Brett M.] Boston Univ, Sch Publ Hlth, Biostat & Epidemiol Data Analyt Ctr, Boston, MA USA; [Dwyer, Brigid; Katz, Douglas I.] Braintree Rehabil Hosp, Braintree, MA 02118 USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Cantu, Robert C.] Concuss Legacy Fdn, Boston, MA 02115 USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA 01742 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Psychiat, Dept Ophthalmol, Boston, MA USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Dept Biomed Elect & Comp Engn, Boston, MA 02215 USA; [Goldstein, Lee E.; McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA		Stein, TD (corresponding author), Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA.; Stein, TD (corresponding author), VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA.; Stein, TD (corresponding author), Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA.; Stein, TD (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA.	tdstein@bu.edu	Lang, Steven/AAE-8102-2021; , Bob/ABA-8507-2020; Dwyer, Brigid/AAI-6199-2020; Chua, Alicia/AAA-3628-2019	Lang, Steven/0000-0003-1669-9146; Dwyer, Brigid/0000-0002-6446-8054; Tripodis, Yorghos/0000-0003-2190-7608	Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award [I01-CX001038]; Veterans Affairs Biorepository [BX002466]; Alzheimer's AssociationAlzheimer's Association [NIRG-305779, NIRG-362697, AARF-17-529888]; National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG054156, R56AG057768, R01AG057768, K23AG046377, R01AG016495, R01AG033040, K23NS102399]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659, F32NS096803, R01NS017950]; National Institute of Aging Boston University AD Center [P30AG13846, 0572063345-5]; Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01-CX001135]; National Heart, Lung, and Blood Institute, Framingham Heart Study [N01-HC-25195, HHSN268201500001I]; Concussion Legacy Foundation; Fonds de Recherche du Quebec -Sante (FRQS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS017950, U01NS086659, K23NS102399, F32NS096803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG057768, P30AG013846, RF1AG057902, R01AG033040, R01AG061028, R56AG057768, RF1AG054156, R01AG062348, K23AG046377, R01AG016495] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX002170, I01CX001038, I01CX001135, I01BX002466] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award (I01-CX001038); Veterans Affairs Biorepository (BX002466); Alzheimer's Association (NIRG-305779, NIRG-362697, AARF-17-529888); National Institute of Aging (RF1AG054156, R56AG057768, R01AG057768, K23AG046377, R01AG016495, R01AG033040, K23NS102399); National Institute of Neurological Disorders and Stroke (U01NS086659, F32NS096803, R01NS017950); National Institute of Aging Boston University AD Center (P30AG13846; supplement 0572063345-5); Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and Department of Veterans Affairs CENC Award I01-CX001135; National Heart, Lung, and Blood Institute, Framingham Heart Study (N01-HC-25195, HHSN268201500001I); Concussion Legacy Foundation. IM receives funding as a Fonds de Recherche du Quebec -Sante (FRQS) postdoctoral scholar. This work was also supported by unrestricted gifts from the Andlinger Foundation and WWE. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We gratefully acknowledge the use of resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA), the outreach and recruitment contributions of Dr. Christopher Nowinski from the Concussion Legacy Foundation, and all the individuals whose participation and contributions made this work possible.	Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Attems J, 2005, ACTA NEUROPATHOL, V110, P222, DOI 10.1007/s00401-005-1064-y; Attems J, 2011, NEUROPATH APPL NEURO, V37, P75, DOI 10.1111/j.1365-2990.2010.01137.x; Attems J, 2008, J NEUROL, V255, P70, DOI 10.1007/s00415-008-0674-4; Attems J, 2007, J NEUROL SCI, V257, P49, DOI 10.1016/j.jns.2007.01.013; Biffi A, 2011, J CLIN NEUROL, V7, P1, DOI 10.3988/jcn.2011.7.1.1; Boyle PA, 2015, NEUROLOGY, V85, P1930, DOI 10.1212/WNL.0000000000002175; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Charidimou A, 2017, BRAIN, V140, P1829, DOI 10.1093/brain/awx047; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; Cherry JD, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0619-9; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cordonnier C, 2010, BRAIN, V133, P3281, DOI 10.1093/brain/awq246; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Diem AK, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00018; Farell M, 2019, CLIN NEUROPATHOL, V38, P51, DOI 10.5414/NP301130; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hawkes CA, 2014, BRAIN PATHOL, V24, P396, DOI 10.1111/bpa.12159; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hecht M, 2018, ACTA NEUROPATHOL, V135, P681, DOI 10.1007/s00401-018-1834-y; ITOH Y, 1993, J NEUROL SCI, V116, P135, DOI 10.1016/0022-510X(93)90317-R; Keage HAD, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-3; Kumar-Singh S, 2008, GENES BRAIN BEHAV, V7, P67, DOI 10.1111/j.1601-183X.2007.00380.x; Lauer A, 2016, NEUROLOGY, V87, P1488; Leclercq PD, 2005, J NEUROL NEUROSUR PS, V76, P229, DOI 10.1136/jnnp.2003.025528; Mamourian AC, 2000, AM J NEURORADIOL, V21, P105; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Merlini M, 2016, ACTA NEUROPATHOL, V131, P737, DOI 10.1007/s00401-016-1560-2; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; O'Donnell HC, 2000, NEW ENGL J MED, V342, P240, DOI 10.1056/NEJM200001273420403; Pfeifer LA, 2002, NEUROLOGY, V58, P1629, DOI 10.1212/WNL.58.11.1629; Rannikmae K, 2014, J NEUROL NEUROSUR PS, V85, P300, DOI 10.1136/jnnp-2013-306485; Richard E, 2010, J NEUROPATH EXP NEUR, V69, P1158, DOI 10.1097/NEN.0b013e3181fab558; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Shin HK, 2007, BRAIN, V130, P2310, DOI 10.1093/brain/awm156; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Thal DR, 2010, ACTA NEUROPATHOL, V120, P169, DOI 10.1007/s00401-010-0707-9; Tian J, 2004, NEUROPATH APPL NEURO, V30, P46, DOI 10.1046/j.0305-1846.2003.00510.x; Tian J, 2003, NEUROSCI LETT, V352, P137, DOI 10.1016/j.neulet.2003.08.048; VINTERS HV, 1983, STROKE, V14, P924, DOI 10.1161/01.STR.14.6.924; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; Viswanathan A, 2008, STROKE, V39, P1988, DOI 10.1161/STROKEAHA.107.509091; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Walt GS, 2018, J NEUROPATH EXP NEUR, V77, P1091, DOI 10.1093/jnen/nly092; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Xiong L, 2018, J CEREBR BLOOD F MET, V38, P241, DOI 10.1177/0271678X17700435	62	10	10	1	20	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	SEP	2019	138	3			SI		401	413		10.1007/s00401-019-02031-x			13	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	IQ2SB	WOS:000480599000005	31183671	Green Accepted			2022-02-06	
J	Verdugo, MA; Fernandez, M; Gomez, LE; Amor, AM; Aza, A				Verdugo, Miguel A.; Fernandez, Maria; Gomez, Laura E.; Amor, Antonio M.; Aza, Alba			Predictive factors of quality of life in acquired brain injury	INTERNATIONAL JOURNAL OF CLINICAL AND HEALTH PSYCHOLOGY			English	Article						Quality of life; acquired brain injury; CAVIDACE scale; predictors; descriptive survey study	MODERATE; POPULATION; OUTCOMES; MILD	Background/Objective: The sequelae and the disability and dependence that follow an acquired brain injury (ABI) may result in a significant reduction in the quality of life (QoL) of those affected. The objective was to assess the QoL of a sample of Spanish patients with an ABI and analyze the influence of certain sociodemographic and injury-related variables on their QoL. Method: The sample comprised 421 adults (60% male; M-age = 53.12; SD = 14.87). Professionals and relatives assessed the patients' QoL through the CAVIDACE scale, an ABI-specific tool based on the eight-domain QoL model. Results: Univariate analyses showed statistically significant differences in the QoL scores in several sociodemographic (age, civil status, education level, prior employment status, type of home, level of supports, toss of legal capacity, recognized dependence, and degree of dependence) and injury-related (time since the injury, location of the injury, and presence of post-traumatic amnesia) variables. The multiple linear regression showed that loss of legal capacity, time since the injury, prior employment status, location of the injury, and degree of dependence were significant QoL predictors. Conclusions: These findings provide knowledge for the development of programs aimed at reducing the negative impact of ABI on QoL. (C) 2019 Asociacion Espanola de Psicologia Conductual. Published by Elsevier Espana, S.L.U.	[Verdugo, Miguel A.; Fernandez, Maria; Amor, Antonio M.; Aza, Alba] Univ Salamanca, Fac Psicol, Avda Merced 109-131, Salamanca 37005, Spain; [Gomez, Laura E.] Univ Oviedo, Fac Psicol, Oviedo, Spain; [Verdugo, Miguel A.; Fernandez, Maria; Gomez, Laura E.; Amor, Antonio M.; Aza, Alba] Univ Salamanca, Inst Integrac Comunidad INICO, Salamanca, Spain		Fernandez, M (corresponding author), Univ Salamanca, Fac Psicol, Avda Merced 109-131, Salamanca 37005, Spain.	mariafernandez@usal.es	Aza, Alba/M-1265-2017; Fernandez, Maria/H-2632-2018; Gomez, Laura E/B-5013-2011; Hernandez, Alba Aza/AAB-1909-2021; Amor Gonzalez, Antonio Manuel/A-5595-2019	Aza, Alba/0000-0002-1460-1195; Fernandez, Maria/0000-0002-3398-6086; Gomez, Laura E/0000-0002-0776-1836; Hernandez, Alba Aza/0000-0002-1460-1195; Amor Gonzalez, Antonio Manuel/0000-0001-7757-1299	Spanish Ministry of Economy and Competitiveness [MINECO/FEDER, UE]Spanish Government [PSI2015-65193-P]; Spanish Ministry of Economy and CompetitivenessSpanish Government [BES-2013-065113, BES-2016-078252]; Ministry of Education, Culture and Sport [FPU13/03897]	We gratefully acknowledge the funding and support of the Spanish Ministry of Economy and Competitiveness (Grant PSI2015-65193-P [MINECO/FEDER, UE]) and the fellowships provided to Maria Fernandez, Alba Aza, and Antonio M. Amor (BES-2013-065113, BES-2016-078252, and FPU13/03897 - Spanish Ministry of Economy and Competitiveness and Ministry of Education, Culture and Sport, respectively). We would also like to thank the people with brain injury, their relatives, the professionals and the organizations for completing the questionnaires and for their support on this project.	Vieira RDA, 2013, REV LAT-AM ENFERM, V21, P868, DOI 10.1590/S0104-11692013000400006; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Alcedo MA, 2017, INT J CLIN HLTH PSYC, V17, P38, DOI 10.1016/j.ijchp.2016.07.002; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Castellanos-Pinedo F, 2012, REV NEUROLOGIA, V54, P357, DOI 10.33588/rn.5406.2011714; Claes C, 2012, RES DEV DISABIL, V33, P96, DOI 10.1016/j.ridd.2011.08.024; Cohen J., 2013, STAT POWER ANAL BEHA; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fernandez M, 2019, QUAL LIFE RES, V28, P801, DOI 10.1007/s11136-018-2047-5; Fernandez M, 2018, SOC INDIC RES, V137, P813, DOI 10.1007/s11205-017-1612-6; Finck C, 2018, INT J CLIN HLTH PSYC, V18, P27, DOI 10.1016/j.ijchp.2017.11.002; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Gomez L. E., 2016, CROSS CULTURAL QUALI, P71; Gomez LE, 2013, EVAL PROGRAM PLANN, V40, P17, DOI 10.1016/j.evalprogplan.2013.05.001; Gonzalez E, 2016, SIGLO CERO, V47, P7, DOI [10.14201/scero2016473727, DOI 10.14201/SCERO2016473727]; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Man DWK, 2010, APPL RES QUAL LIFE, V5, P27, DOI 10.1007/s11482-009-9090-x; Materne M, 2018, BRAIN INJURY, V32, P1731, DOI 10.1080/02699052.2018.1517224; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Quezada M.Y., 2015, PERSONAS CON DANO CE; Schalock RL, 2018, INT J CHILD YOUTH FA, V9, P188, DOI 10.18357/ijcyfs94201818647; Schalock RL, 2018, J POLICY PRACT INTEL, V15, P176, DOI 10.1111/jppi.12250; Schalock R.L., 2002, HDB QUALITY LIFE HUM; Schalock R.L., 2018, SIGLO CERO, V49, P21, DOI [10.14201/scero20184912133, DOI 10.14201/SCERO20184912133, DOI 10.14201/scero20184912133]; Schalock R. L., 2007, SIGLOCERO, V38, P21; Schalock RL, 2016, AJIDD-AM J INTELLECT, V121, P1, DOI 10.1352/1944-7558-121.1.1; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Sharma A, 2015, INDIAN J NEUROTRAUM, V12, P2, DOI 10.1055/s-0035-1554948; Simoes C, 2016, J INTELL DISABIL RES, V60, P378, DOI 10.1111/jir.12256; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thompson JR, 2018, INTELLECT DEV DISAB, V56, P396, DOI 10.1352/1934-9556-56.6.396; Verdugo M. A, 2018, MANUAL APLICACION CO; Verdugo MA, 2015, INT J CLIN HLTH PSYC, V15, P149, DOI 10.1016/j.ijchp.2015.03.001; Winter L, 2016, DISABIL REHABIL, V38, P1280, DOI 10.3109/09638288.2015.1077531	41	10	10	2	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1697-2600	1576-7329		INT J CLIN HLTH PSYC	Int. J. Clin. Health Psychol.	SEP	2019	19	3					189	197		10.1016/j.ijchp.2019.06.004			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	IU3CW	WOS:000483457900003	31516497	gold, Green Published			2022-02-06	
J	Shan, HY; Qiu, JP; Chang, P; Chu, Y; Gao, C; Wang, HC; Chen, G; Luo, CL; Wang, T; Chen, XP; Zhang, MY; Tao, LY				Shan, Haiyan; Qiu, Jianping; Chang, Pan; Chu, Yang; Gao, Cheng; Wang, Haocheng; Chen, Guang; Luo, Chengliang; Wang, Tao; Chen, Xiping; Zhang, Mingyang; Tao, Luyang			Exogenous Hydrogen Sulfide Offers Neuroprotection on Intracerebral Hemorrhage Injury Through Modulating Endogenous H2S Metabolism in Mice	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						hydrogen sulfide; intracerebral hemorrhage; autophagic cell death; apoptosis; mice	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; PLASMALEMMA PERMEABILITY; CELL-DEATH; AUTOPHAGY; MECHANISM; APOPTOSIS; RECOVERY; THERAPY; DAMAGE	Hydrogen sulfide (H2S), an important endogenous signaling molecule, has a significant neuroprotective role in the central nervous system. In this study, we examined the protective effects of exogenous H2S against intracerebral hemorrhage (ICH), as well as its underlying mechanisms. We investigated the effects of exogenous H2S on ICH using Western blotting, injury volume, measurement of brain edema, propidium iodide (PI) staining, and behavior assessment, respectively. We found that endogenous H2S production was downregulated in the brain after ICH, which is caused by the decrease in cystathionine beta-synthase (CBS) as the predominant cerebral H2S-generating enzyme in the brain. Treatment with sodium hydrosulfide (NaHS; an H2S producer) could restore the H2S production and the expression of CBS. NaHS could also attenuate brain edema, injury volume, and neurological deficits in the Morris water maze test after ICH. Western blotting results indicated that H2S pretreatment reversed the increase in caspase 3 cleavage and the decrease in Bcl-2, suppressed the activation of autophagy marker (LC3II and Beclin-1), and maintained the p62 level in injured striatum post-ICH. However, H2S could not restore brain CBS expression and H2S content, reduce brain edema, and improve motor performance and memory function after ICH through modulating autophagy and apoptosis when pretreated with the CBS inhibitor aminooxyacetic acid (AOAA). We also found that AOAA reduced the endogenous H2S production through inhibiting the enzyme activity of CBS rather than modulating the expression of CBS protein level. These present results indicate that H2S may possess potential therapeutic value in the treatment of brain injury after ICH, and the protective effect of exogenous H2S against ICH may be not a direct action but an indirect effect through inducing endogenous H2S metabolism responses.	[Shan, Haiyan; Chu, Yang; Gao, Cheng; Wang, Haocheng; Chen, Guang; Luo, Chengliang; Wang, Tao; Chen, Xiping; Zhang, Mingyang; Tao, Luyang] Soochow Univ, Inst Forens Sci, Suzhou, Peoples R China; [Shan, Haiyan; Qiu, Jianping] Nanjing Med Univ, Affiliated Suzhou Hosp, Dept Obstet & Gynecol, Suzhou, Peoples R China; [Chang, Pan] Xian Med Coll, Affiliated Hosp 2, Cent Lab, Xian, Shaanxi, Peoples R China; [Zhang, Mingyang] Soochow Univ, Sch Pharm, Suzhou, Peoples R China		Zhang, MY; Tao, LY (corresponding author), Soochow Univ, Inst Forens Sci, Suzhou, Peoples R China.; Zhang, MY (corresponding author), Soochow Univ, Sch Pharm, Suzhou, Peoples R China.	mingyangzhang@suda.edu.cn; taoluyang@suda.edu.cn	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601306, 81301039, 81530062]; China Post-doctoral Science FoundationChina Postdoctoral Science Foundation [2015M570476]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Talent Youth Medical Program [QNRC2016245]; Shanghai Key Lab of Forensic Medicine [KF1801]; Suzhou Science and Technology Development Project [SYS2018082]; Fifth Batch of Gusu District Health Talent Training Project [GSWS2019060]	This work was supported by the National Natural Science Foundation of China (Nos. 81601306, 81301039, and 81530062), the China Post-doctoral Science Foundation Funded Project (No. 2015M570476), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Jiangsu Talent Youth Medical Program (QNRC2016245), the Shanghai Key Lab of Forensic Medicine (KF1801), the Suzhou Science and Technology Development Project (SYS2018082), and the Fifth Batch of Gusu District Health Talent Training Project (GSWS2019060).	Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bierbach B, 2008, STROKE, V39, P213, DOI 10.1161/STROKEAHA.107.496620; Bobinger T, 2018, CURR NEUROPHARMACOL, V16, P1267, DOI 10.2174/1570159X15666170602112851; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Gao Y, 2017, MOL NEUROBIOL, V54, P3879, DOI 10.1007/s12035-016-9947-6; Garcia PY, 2013, J STROKE CEREBROVASC, V22, P80, DOI 10.1016/j.jstrokecerebrovasdis.2011.06.013; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Gopalakrishnan Priya, 2019, Pathophysiology, V26, P1, DOI 10.1016/j.pathophys.2018.10.005; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI 10.1089/ARS.2008.2132; Kamat PK, 2015, METHOD ENZYMOL, V555, P207, DOI 10.1016/bs.mie.2014.11.025; Kim B, 2011, THESCIENTIFICWORLDJO, V11, P992, DOI 10.1100/tsw.2011.95; Kim JY, 2017, J STROKE, V19, P28, DOI 10.5853/jos.2016.01935; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Lin X, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3706047; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Olson KR, 2008, AM J PHYSIOL-REG I, V295, pR669, DOI 10.1152/ajpregu.00807.2007; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Paul BD, 2018, BIOCHEM PHARMACOL, V149, P101, DOI 10.1016/j.bcp.2017.11.019; Qureshi AI, 2003, NEUROSURGERY, V52, P1041, DOI 10.1227/01.NEU.0000057694.96978.BC; Rodriguez C, 2017, CELL DEATH DIFFER, V24, P144, DOI 10.1038/cdd.2016.109; Salihu AT, 2016, REV NEUROSCIENCE, V27, P317, DOI 10.1515/revneuro-2015-0046; Selim M, 2020, J NEUROSCI RES, V98, P212, DOI 10.1002/jnr.24372; Shen X, 2016, NEUROCHEM INT, V96, P100, DOI 10.1016/j.neuint.2016.03.004; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Tovar-y-Romo LB, 2016, J NEUROCHEM, V136, P13, DOI 10.1111/jnc.13362; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wang T, 2013, BEHAV BRAIN RES, V247, P132, DOI 10.1016/j.bbr.2013.03.023; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Zhang JY, 2017, MED GAS RES, V7, P113, DOI 10.4103/2045-9912.208517; Zhang MY, 2017, CELL MOL NEUROBIOL, V37, P291, DOI 10.1007/s10571-016-0369-9; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Zhao HL, 2018, AMINO ACIDS, V50, P439, DOI 10.1007/s00726-017-2529-8; Zhao HL, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0940-4; Zhu XX, 2012, STROKE, V43, P524, DOI 10.1161/STROKEAHA.111.635672; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609	38	10	11	5	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	AUG 7	2019	13								349	10.3389/fncel.2019.00349			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IO2XZ	WOS:000479246400001	31440142	gold, Green Published			2022-02-06	
J	Falcucci, RM; Wertz, R; Green, JL; Meucci, O; Salvino, J; Fontana, ACK				Falcucci, Romulo Martelli; Wertz, Ryan; Green, Jennifer Leigh; Meucci, Olimpia; Salvino, Joseph; Fontana, Andreia Cristina Karklin			Novel Positive Allosteric Modulators of Glutamate Transport Have Neuroprotective Properties in an in Vitro Excitotoxic Model	ACS CHEMICAL NEUROSCIENCE			English	Article						EAAT2; glutamate transporter; glutamate uptake; transport enhancement; EAAT2 activators; glutamate excitotoxicity	TRAUMATIC BRAIN-INJURY; REGIONAL CEREBRAL EDEMA; AMINO-ACID TRANSPORTERS; SPINAL-CORD; CELL-DEATH; CLAVULANIC ACID; NEUROBEHAVIORAL FUNCTION; EXTRACELLULAR GLUTAMATE; MOLECULAR-MECHANISMS; HIPPOCAMPAL-NEURONS	Dysfunction of excitatory amino acid transporters (EAATs) has been implicated in the pathogenesis of various neurological disorders, such as stroke, brain trauma, epilepsy, and several neurodegenerative disorders. EAAT2 is the main transporter subtype responsible for glutamate clearance in the brain, and plays a key role in regulating neurotransmission and preventing excitotoxicity. Therefore, compounds that increase the activity of EAAT2 have therapeutic potential for neuroprotection. In previous studies, we used virtual screening approaches to identify novel positive allosteric modulators (PAMs) of EAAT2. These compounds were shown to selectively increase the activity of EAAT2 and increase V-max of transport, without changing substrate affinity. In this work, our major effort was to investigate whether increasing the activity of EAAT2 by allosteric modulation would translate to neuroprotection in in vitro primary culture models of excitotoxicity. To investigate potential neuroprotective effects of one EAAT2 PAM, GT949, we subjected cultures to acute and prolonged excitotoxic insults by exogenous application of glutamate, or oxidative stress by application of hydrogen peroxide. GT949 administration did not result in neuroprotection in the oxidative stress model, likely due to damage of the glutamate transporters. However, GT949 displayed neuroprotective properties after acute and prolonged glutamate-mediated excitotoxicity. We propose that this compound prevents excess glutamate signaling by increasing the rate of glutamate clearance by EAAT2, thereby preventing excitotoxic damage and cell death. This novel class of compounds is therefore an innovative approach for neuroprotection with potential for translation in in vivo animal models of excitotoxicity.	[Falcucci, Romulo Martelli; Wertz, Ryan; Green, Jennifer Leigh; Meucci, Olimpia; Fontana, Andreia Cristina Karklin] Drexel Univ, Dept Pharmacol & Physiol, Coll Med, Philadelphia, PA 19102 USA; [Salvino, Joseph] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA		Fontana, ACK (corresponding author), Drexel Univ, Dept Pharmacol & Physiol, Coll Med, Philadelphia, PA 19102 USA.	acm83@drexel.edu	Mortensen, Andreia/AAR-2177-2020	Mortensen, Andreia/0000-0002-4791-8746	Drexel University's startup funds; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA15014, DA32444]; Pennsylvania Department of Health; CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [15149399]; CNPQConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [15149399]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA015014, R01DA032444, R37DA015014] Funding Source: NIH RePORTER	This work was supported by Drexel University's startup funds to A.C.K.F. and NIH grants to O.M. (DA15014 and DA32444). This project is also funded, in part, under a grant with the Pennsylvania Department of Health to J.M.S. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. We would also like to acknowledge the Brazilian Scientific mobility program sponsored by CAPES & CNPQ for providing financial support to R.M.F. (Grant ID 15149399).	Ahn Jee-Yin, 2014, Exp Neurobiol, V23, P200, DOI 10.5607/en.2014.23.3.200; Akyuz N, 2013, NATURE, V502, P114, DOI 10.1038/nature12265; Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; AMATO A, 1994, J PHYSIOL-LONDON, V479, P371, DOI 10.1113/jphysiol.1994.sp020302; Aronica E, 2003, EUR J NEUROSCI, V17, P2106, DOI 10.1046/j.1460-9568.2003.02657.x; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Azbill RD, 2000, BRAIN RES, V871, P175, DOI 10.1016/S0006-8993(00)02430-6; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Barker-Haliski M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022863; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Berry JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061177; Boston-Howes W, 2006, J BIOL CHEM, V281, P14076, DOI 10.1074/jbc.M600653200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Bunch L, 2009, EXPERT OPIN THER TAR, V13, P719, DOI 10.1517/14728220902926127; Burbassi S, 2010, EUR J NEUROSCI, V32, P1278, DOI 10.1111/j.1460-9568.2010.07402.x; Carrier RL, 2006, J NEUROSCI METH, V154, P239, DOI 10.1016/j.jneumeth.2005.12.030; Chao XD, 2010, NEUROCHEM RES, V35, P1224, DOI 10.1007/s11064-010-0178-3; Chen Shih-Heng, 2013, Methods Mol Biol, V1041, P231, DOI 10.1007/978-1-62703-520-0_21; Cheney JA, 2000, J NEUROTRAUM, V17, P83, DOI 10.1089/neu.2000.17.83; Chernova T, 2007, J NEUROSCI, V27, P8475, DOI 10.1523/JNEUROSCI.0792-07.2007; CHOI DW, 1987, J NEUROSCI, V7, P357; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Cook A, 2010, J BIOL CHEM, V285, P10563, DOI 10.1074/jbc.M109.035477; Cook DR, 2011, J NEUROCHEM, V118, P1113, DOI 10.1111/j.1471-4159.2011.07383.x; COUTINHONETTO J, 1981, EPILEPSIA, V22, P289, DOI 10.1111/j.1528-1157.1981.tb04112.x; Cristina A, 2007, MOL PHARMACOL, V72, P1228, DOI 10.1124/mol.107.037127; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dunlop J, 2003, J NEUROSCI, V23, P1688; Dunlop J, 2006, CURR OPIN PHARMACOL, V6, P103, DOI 10.1016/j.coph.2005.09.004; Estrada-Sanchez AM, 2012, BASAL GANGLIA, V2, P57, DOI 10.1016/j.baga.2012.04.029; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feeney CJ, 2008, BRAIN RES, V1198, P1, DOI 10.1016/j.brainres.2007.12.049; Fontana ACK, 2003, BRIT J PHARMACOL, V139, P1297, DOI 10.1038/sj.bjp.0705352; Frizzo ME, 2005, CELL MOL NEUROBIOL, V25, P913, DOI 10.1007/s10571-005-4939-5; Frizzo MES, 2001, NEUROREPORT, V12, P879, DOI 10.1097/00001756-200103260-00051; Ganel R, 2006, NEUROBIOL DIS, V21, P556, DOI 10.1016/j.nbd.2005.08.014; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Guillet B, 2002, NEUROCHEM INT, V40, P661, DOI 10.1016/S0197-0186(01)00110-3; Gunawan S, 2012, TETRAHEDRON, V68, P5606, DOI 10.1016/j.tet.2012.04.068; Hajhashemi V, 2014, RES PHARM SCI, V9, P315; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; HARDY J, 1987, NEUROSCI LETT, V73, P77, DOI 10.1016/0304-3940(87)90034-6; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; Huang YHH, 2004, J NEUROSCI, V24, P4551, DOI 10.1523/JNEUROSCI.5217-03.2004; Huh Y, 2010, DRUG DEVELOP RES, V71, P351, DOI 10.1002/ddr.20378; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jabs R, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01488.x; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jones KA, 2019, MOL CELL NEUROSCI, V98, P19, DOI 10.1016/j.mcn.2019.05.001; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Kim J, 2016, AMINO ACIDS, V48, P689, DOI 10.1007/s00726-015-2117-8; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; Kis B, 2004, NEUROREPORT, V15, P345, DOI 10.1097/00001756-200402090-00027; Kong QM, 2014, J CLIN INVEST, V124, P1255, DOI 10.1172/JCI66163; Kortagere S, 2018, ACS CHEM NEUROSCI, V9, P522, DOI 10.1021/acschemneuro.7b00308; Kovalevich J, 2012, FUTURE VIROL, V7, P687, DOI 10.2217/FVL.12.57; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039382; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lauriat TL, 2007, MOL PSYCHIATR, V12, P1065, DOI 10.1038/sj.mp.4002065; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Lee Y, 2004, NEUROCHEM INT, V44, P107, DOI 10.1016/S0197-0186(03)00112-8; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; Li Y, 2011, NEUROPHARMACOLOGY, V60, P1168, DOI 10.1016/j.neuropharm.2010.10.016; Lin CLG, 2012, FUTURE MED CHEM, V4, P1689, DOI [10.4155/fmc.12.122, 10.4155/FMC.12.122]; Lipski J, 2007, NEUROSCIENCE, V146, P617, DOI 10.1016/j.neuroscience.2007.02.003; LOUZADAJUNIOR P, 1992, J NEUROCHEM, V59, P358, DOI 10.1111/j.1471-4159.1992.tb08912.x; Luebke JI, 2010, BRAIN STRUCT FUNCT, V214, P181, DOI 10.1007/s00429-010-0244-2; Maas AIR, 2000, CNS DRUGS, V13, P139, DOI 10.2165/00023210-200013020-00007; Maeda S, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-65; Magou GC, 2015, BRAIN RES, V1624, P525, DOI 10.1016/j.brainres.2015.07.056; Maleki A, 2015, RSC ADV, V5, P60938, DOI 10.1039/c5ra11531k; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Massieu L, 1998, Neurobiology (Bp), V6, P99; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; MCENTEE WJ, 1993, PSYCHOPHARMACOLOGY, V111, P391, DOI 10.1007/BF02253527; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; Miralles VJ, 2001, BRAIN RES, V922, P21, DOI 10.1016/S0006-8993(01)03124-9; Monnerie H, 2003, J NEUROSCI RES, V74, P688, DOI 10.1002/jnr.10797; Mortensen OV, 2015, J NEUROCHEM, V133, P199, DOI 10.1111/jnc.13047; Mu XJ, 2000, J NEUROTRAUM, V17, P773, DOI 10.1089/neu.2000.17.773; Nakajima Y, 2016, J TOXICOL SCI, V41, P311, DOI 10.2131/jts.41.311; Nederkoorn PJ, 2011, INT J STROKE, V6, P159, DOI 10.1111/j.1747-4949.2010.00555.x; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; Nicolai J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.10; NILSSON E, 1990, NEUROBIOL AGING, V11, P425, DOI 10.1016/0197-4580(90)90009-O; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Niquet J, 2003, P NATL ACAD SCI USA, V100, P2825, DOI 10.1073/pnas.0530113100; Nishida A, 2004, BIOL PHARM BULL, V27, P817, DOI 10.1248/bpb.27.817; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; O'Donnell LA, 2006, J NEUROSCI, V26, P981, DOI 10.1523/JNEUROSCI.4617-05.2006; O'Neill KM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00285; Odaka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099271; Okiyama K, 1998, BRAIN RES, V792, P291, DOI 10.1016/S0006-8993(98)00158-9; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; [潘向东 PAN Xingdong], 2011, [浙江大学学报. 医学版, Journal of Zhejiang University. Medical Sciences], V40, P522; Patel RAG, 2017, PROG CARDIOVASC DIS, V59, P542, DOI 10.1016/j.pcad.2017.04.005; Patil P, 2015, BIOORGAN MED CHEM, V23, P2699, DOI 10.1016/j.bmc.2014.12.021; Peng S, 2011, MOL BIOL REP, V38, P453, DOI 10.1007/s11033-010-0128-9; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Plachez C, 2000, J NEUROSCI RES, V59, P587; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Potter MC, 2013, J NEUROIMMUNE PHARM, V8, P594, DOI 10.1007/s11481-013-9442-z; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramli NNN, 2015, NEURAL REGEN RES, V10, P1221, DOI 10.4103/1673-5374.162748; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sabri F, 2003, BRAIN PATHOL, V13, P84, DOI 10.1111/j.1750-3639.2003.tb00009.x; Salim S, 2017, J PHARMACOL EXP THER, V360, P201, DOI 10.1124/jpet.116.237503; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Scofield MD, 2014, NEUROSCIENTIST, V20, P610, DOI 10.1177/1073858413520347; Seal RP, 1999, ANNU REV PHARMACOL, V39, P431, DOI 10.1146/annurev.pharmtox.39.1.431; Sengupta R, 2009, J NEUROSCI, V29, P2534, DOI 10.1523/JNEUROSCI.5865-08.2009; Shahlaie K, 2010, J NEUROTRAUM, V27, P175, DOI 10.1089/neu.2009.1003; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shimada F, 1999, EUR J PHARMACOL, V386, P263, DOI 10.1016/S0014-2999(99)00735-9; Shimizu S, 2011, JOVE-J VIS EXP, DOI 10.3791/3257; SHOLL DA, 1953, J ANAT, V87, P387; SISK DR, 1985, GRAEF ARCH CLIN EXP, V223, P250, DOI 10.1007/BF02153655; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Suchak SK, 2003, J NEUROCHEM, V84, P522, DOI 10.1046/j.1471-4159.2003.01553.x; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Takahashi K, 2015, J EXP MED, V212, P319, DOI 10.1084/jem.20140413; Takeda K, 2002, GENES CELLS, V7, P1099, DOI 10.1046/j.1365-2443.2002.00591.x; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Trotti D, 2001, J BIOL CHEM, V276, P576, DOI 10.1074/jbc.M003779200; Vandenberg RJ, 2013, PHYSIOL REV, V93, P1621, DOI 10.1152/physrev.00007.2013; Velly LJ, 2003, ANESTHESIOLOGY, V99, P368, DOI 10.1097/00000542-200308000-00018; Vergassola M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00324; Verma R, 2010, EUR J PHARMACOL, V638, P65, DOI 10.1016/j.ejphar.2010.04.021; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vetiska S., 2014, HDB NEUROTOXICITY, P1381; Vishnoi S, 2016, J ENVIRON PATHOL TOX, V35, P365, DOI 10.1615/JEnvironPatholToxicolOncol.2016016399; von Bartheld CS, 2016, J COMP NEUROL, V524, P3865, DOI 10.1002/cne.24040; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Wang Y, 2007, J NEUROCHEM, V103, P439, DOI 10.1111/j.1471-4159.2007.04746.x; Wang YM, 1997, BRAIN RES, V772, P45, DOI 10.1016/S0006-8993(97)00837-8; Wei J, 2012, J TRAUMA ACUTE CARE, V73, P654, DOI 10.1097/TA.0b013e31825133c0; WEILER IJ, 1995, BEHAV BRAIN RES, V66, P1, DOI 10.1016/0166-4328(94)00116-W; White MG, 2011, NEUROSCI RES, V70, P220, DOI 10.1016/j.neures.2011.01.013; Xie NC, 2016, NEUROCHEM RES, V41, P1335, DOI 10.1007/s11064-016-1835-y; Xing XC, 2011, BIOORG MED CHEM LETT, V21, P5774, DOI 10.1016/j.bmcl.2011.08.009; Yamamoto T, 1999, ACT NEUR S, V75, P17; Yao HH, 2005, J NEUROCHEM, V92, P948, DOI 10.1111/j.1471-4159.2004.02937.x; Yatomi Y, 2013, NEUROSCIENCE, V244, P113, DOI 10.1016/j.neuroscience.2013.04.018; Ye ZC, 1999, GLIA, V25, P270, DOI 10.1002/(SICI)1098-1136(19990201)25:3<270::AID-GLIA7>3.0.CO;2-V; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhao T, 2013, ORG LETT, V15, P639, DOI 10.1021/ol303348m; Zhong ZQ, 2015, MOL MED REP, V12, P7985, DOI 10.3892/mmr.2015.4437; Zhou F, 2006, J NEUROSCI RES, V84, P268, DOI 10.1002/jnr.20897; Zhou Yun, 2013, Front Endocrinol (Lausanne), V4, P165, DOI 10.3389/fendo.2013.00165	173	10	10	1	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	AUG	2019	10	8					3437	3453		10.1021/acschemneuro.9b00061			33	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	IT0OS	WOS:000482546100018	31257852	Green Accepted			2022-02-06	
J	Joodaki, H; Bailey, A; Lessley, D; Funk, J; Sherwood, C; Crandall, J				Joodaki, Hamed; Bailey, Ann; Lessley, David; Funk, James; Sherwood, Chris; Crandall, Jeff			Relative Motion Between the Helmet and the Head in Football Impact Test	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL FOOTBALL; PROFESSIONAL FOOTBALL; CONCUSSION; SYSTEM; ACCELERATION; PERFORMANCE; KINEMATICS; DEVICE	Approximately 1.6-3.8 million sports-related traumatic brain injuries occur each year in the U.S. Researchers track the head motion using a variety of techniques to study the head injury biomechanics. To understand how helmets provide head protection, quantification of the relative motion between the head and the helmet is necessary. The purpose of this study was to compare helmet and head kinematics and quantify the relative motion of helmet with respect to head during experimental representations of on-field American football impact scenarios. Seven helmet-to-helmet impact configurations were simulated by propelling helmeted crash test dummies into each other. Head and helmet kinematics were measured with instrumentation and an optical motion capture system. The analysis of results, from 10 ms prior to the helmet contact to 20 ms after the loss of helmet contact, showed that the helmets translated 12-41mm and rotated up to 37 deg with respect to the head. The peak resultant linear acceleration of the helmet was about 2-5 times higher than the head. The peak resultant angular velocity of the helmet ranged from 37% less to 71% more than the head, depending on the impact conditions. The results of this study demonstrate that the kinematics of the head and the helmet are noticeably different and that the helmet rotates significantly with respect to the head during impacts. Therefore, capturing the helmet kinematics using a video motion tracking methodology is not sufficient to study the biomechanics of the head. Head motion must be measured independently of the helmet.	[Joodaki, Hamed; Crandall, Jeff] Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA; [Bailey, Ann; Lessley, David; Funk, James; Sherwood, Chris] Biocore LLC, 1621 Quail Run, Charlottesville, VA 22911 USA		Joodaki, H (corresponding author), Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	hj2vq@virginia.edu; ABailey@biocorellc.com; djl6j@virginia.edu; JFunk@biocorellc.com; CSherwood@biocorellc.com; jrc2h@virginia.edu			Football Research, Inc. [153124-101-GI14678-31365, 10.13039/100006425]	Football Research, Inc. (Grant No. 153124-101-GI14678-31365; Funder ID: 10.13039/100006425).	Abreu M. A., 2016, SPORT J, P1; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bailey A., 2018, SPORTS BIOMECH; Beard DA, 2003, BIOPHYS J, V85, P2973, DOI 10.1016/S0006-3495(03)74717-1; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Colello RJ, 2018, J NEUROTRAUM, V35, P1213, DOI 10.1089/neu.2017.5446; Collins CL, 2016, AM J SPORT MED, V44, P1382, DOI 10.1177/0363546516629626; Dibb Alan T, 2006, Stapp Car Crash J, V50, P567; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Funk JR, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039673; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; Greenhill DA, 2016, SPORTS HEALTH, V8, P238, DOI 10.1177/1941738116639027; Halldin P., 2013, U. S. Patent, Patent No. [No. 8,578,520, 8578520]; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Holbourn AHS, 1943, LANCET, V2, P438; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Jadischke R, 2012, FOOTBALL HELMET FITM; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kang YS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005427; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lessley D, 2014, INT J AUTOMOT ENG, V5, P1; Lessley D., 2011, J BIOSENS BIOELECTRO, VS1, P1; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NEWMAN JA, 1993, ACCIDENTAL INJURY BI, P292; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Piziali R., 1998, 980362 SAE; Roetenberg D., 2009, 1 XSENS MOT TECHN BV; Rowson S., 2007, 35 INT WORKSH INJ BI, P85; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; *SAE, 1995, SURF VEH REC PRACT 1; Takhounts E.G., 2013, 2013220010 SAE; Takhounts EG, 2008, STAPP CAR C, V52, P1; Trotta A, 2018, ANN BIOMED ENG, V46, P831, DOI 10.1007/s10439-018-2003-0; UNTERHARNSCHEIDT F, 1969, ACTA NEUROPATHOL, V12, P200, DOI 10.1007/BF00692508; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4	44	10	10	0	7	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	AUG	2019	141	8							081006	10.1115/1.4043038			16	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	IF4QA	WOS:000473065000006	30835289				2022-02-06	
J	Marcolini, E; Stretz, C; DeWitt, KM				Marcolini, Evie; Stretz, Christoph; DeWitt, Kyle M.			Intracranial Hemorrhage and Intracranial Hypertension	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Intracerebral hemorrhage; Subarachnoid hemorrhage; Traumatic brain injury; Blood pressure; Anticoagulation; Intracranial hypertension; Herniation; ICP monitoring	TRAUMATIC BRAIN-INJURY; PROTHROMBIN COMPLEX CONCENTRATE; SYSTOLIC BLOOD-PRESSURE; INTRACEREBRAL HEMORRHAGE; PLATELET TRANSFUSION; ADULT PATIENTS; ACUTE STROKE; MANAGEMENT; THERAPY; HYPOTENSION	Central nervous system hemorrhage has multiple pathophysiologic etiologies, including intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and traumatic brain injury (TBI). Given the nuances intrinsic to each of these etiologies and pathophysiologic processes, optimal blood pressure varies significantly and depends on type of hemorrhage and individual characteristics. This article reviews the most current evidence regarding blood pressure targets and provides guidance on reversal of anticoagulation for TBI, ICH, and SAH. It also describes the assessment, optimal therapeutic targets, and interventions to treat intracranial hypertension that can result from TBI, ICH, or SAH.	[Marcolini, Evie] Univ Vermont, Coll Med, Div Emergency Med, Dept Surg, 111 Colchester Ave, Burlington, VT 05401 USA; [Marcolini, Evie] Univ Vermont, Coll Med, Dept Neurol, Div Neurocrit Care, 111 Colchester Ave, Burlington, VT 05401 USA; [Stretz, Christoph] Yale Sch Med, Div Vasc Neurol, 15 York St,LLCI Bldg Suite 1004, New Haven, CT 06510 USA; [DeWitt, Kyle M.] Univ Vermont, Med Ctr, Dept Pharm, 111 Colchester Ave,Mailstop 272 BA1, Burlington, VT 05401 USA		Marcolini, E (corresponding author), 111 Colchester Ave, Burlington, VT 05401 USA.	emarcolini@gmail.com	Stretz, Christoph/AAJ-7323-2021				Alfotih GTA, 2014, NEUROL NEUROCHIR POL, V48, P346, DOI 10.1016/j.pjnns.2014.08.002; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; [Anonymous], 2017, NEUROLCU BOOK; Ansell JE, 2014, NEW ENGL J MED, V371, P2141, DOI 10.1056/NEJMc1411800; Arima H, 2015, NEUROLOGY, V84, P464, DOI 10.1212/WNL.0000000000001205; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Berger K, 2019, J INTENSIVE CARE MED; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Billoir P, 2019, ANN PHARMACOTHER, V53, P341, DOI 10.1177/1060028018811657; Boulouis G, 2017, J NEUROL NEUROSUR PS, V88, P339, DOI 10.1136/jnnp-2016-315346; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Britt RB, 2018, CLIN APPL THROMB-HEM, V24, P5, DOI 10.1177/1076029616674825; Buletko AB, 2018, NEUROLOGY, V91, pE1058, DOI 10.1212/WNL.0000000000006156; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Bullock MR, 1996, J NEUROTRAUM, V13, P711; Butcher KS, 2013, STROKE, V44, P620, DOI 10.1161/STROKEAHA.111.000188; Butcher KS, 2004, STROKE, V35, P1879, DOI 10.1161/01.STR.0000131807.54742.1a; Cadena R, 2017, NEUROCRIT CARE, V27, pS82, DOI 10.1007/s12028-017-0454-z; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cervera A, 2012, J NEUROL, V259, P212, DOI 10.1007/s00415-011-6153-3; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Connolly SJ, 2016, NEW ENGL J MED, V375, P1131, DOI 10.1056/NEJMoa1607887; Cuker A, 2014, J AM COLL CARDIOL, V64, P1128, DOI 10.1016/j.jacc.2014.05.065; Cushing H, 1901, B J HOPKINS HOSP, V12; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; FRANKE CL, 1990, STROKE, V21, P726, DOI 10.1161/01.STR.21.5.726; Freeman W David, 2015, Continuum (Minneap Minn), V21, P1299, DOI 10.1212/CON.0000000000000235; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Fuller G, 2014, INJURY, V45, P612, DOI 10.1016/j.injury.2013.09.008; Hall ST, 2018, J THROMB THROMBOLYS, V46, P50, DOI 10.1007/s11239-018-1653-y; HEFFNER JE, 1983, ARCH INTERN MED, V143, P765, DOI 10.1001/archinte.143.4.765; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Kapapa T, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/298767; Keegan J, 2015, HOSP NEUROLOGY BOOK, P339; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Lip GYH, 2018, CHEST, V154, P1121, DOI 10.1016/j.chest.2018.07.040; Lu GM, 2017, BLOOD, V130; Mayer SA, 2016, MERRITTS NEUROLOGY, P933; Monro A., 1783, OBSERVATIONS STRUCTU; Naidech AM, 2014, STROKE, V45, P2451, DOI 10.1161/STROKEAHA.114.006061; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Olivot JM, 2010, STROKE, V41, P2681, DOI 10.1161/STROKEAHA.110.590638; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Pollack CV, 2017, NEW ENGL J MED, V377, P431, DOI 10.1056/NEJMoa1707278; Qureshi AI, 2007, AM J EMERG MED, V25, P32, DOI 10.1016/j.ajem.2006.07.008; Qureshi AI, 2016, NEW ENGL J MED, V375, P1033, DOI 10.1056/NEJMoa1603460; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Roberts RJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8145; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Rose JC, 2006, NEUROCRIT CARE, V4, P98, DOI 10.1007/s12028-006-0001-9; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Schiele F, 2013, BLOOD, V121, P3554, DOI 10.1182/blood-2012-11-468207; Scott R, 2018, J EMERG MED, V54, P861, DOI 10.1016/j.jemermed.2018.01.030; Shi LG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13111-x; Shibahashi K, 2018, WORLD NEUROSURG, V120, pE667, DOI 10.1016/j.wneu.2018.08.142; Smith MN, 2019, J THROMB THROMBOLYSI; Solanki C, 2016, ACTA NEUROCHIR, V158, P1037, DOI 10.1007/s00701-016-2784-6; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Tang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099536; Tomaselli GF, 2017, J AM COLL CARDIOL, V70, P3042, DOI 10.1016/j.jacc.2017.09.1085; Vanassche T, 2014, THROMB HAEMOSTASIS, V112, P918, DOI 10.1160/TH14-04-0346; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Zhang YH, 2008, J HYPERTENS, V26, P1446, DOI 10.1097/HJH.0b013e328300a24a	68	10	11	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	AUG	2019	37	3					529	+		10.1016/j.emc.2019.04.001			18	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	IN9TF	WOS:000479020600013	31262419				2022-02-06	
J	Sanuki, R; Tanaka, T; Suzuki, F; Ibaraki, K; Takano, T				Sanuki, Rikako; Tanaka, Tomoya; Suzuki, Fumiko; Ibaraki, Kimihide; Takano, Toshiyuki			Normal aging hyperactivates innate immunity and reduces the medical efficacy of minocycline in brain injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Aging; Brain injury; Neurodegeneration; Innate immunity; Minocycline	LIFE-SPAN; DROSOPHILA; AGE; MODEL; PERFORMANCE	Symptoms of many neurodegenerative diseases appear later in human life. However, young animal models for penetrating traumatic brain injury (pTBI) have been used to study neurodegenerative diseases and evaluate the efficacy of neuroprotective medicines. Possibly because of this discordance, effective neuroprotective drugs have still not been developed. For patients suffering from pTBI, aging is known to be a significant prognostic factor of mortality. In this study, we aimed to establish a model of aged pTBI animals using Drosophila melanogaster. We successfully generated aged pTBI flies as a new pTBI model showing increased neurodegeneration and higher mortality. To elucidate the mechanism of increased vulnerability in aged pTBI animals, we analyzed the GenBank-deposited transcriptome data of young and aged flies, demonstrating the importance of innate immunity genes for higher mortality in aged pTBI models. We found that in the context of pTBI, normal aging strongly activated the expression of antimicrobial peptide genes and upregulated the nuclear factor-kappa B gene in the immune deficiency pathway, but not the Toll pathway. Moreover, we found that minocycline increased the survival of young pTBI flies, but not aged pTBI flies. These results suggested that immune system activation under neurodegenerative conditions was involved in normal aging, thereby inhibiting the medicinal efficacy of neuroprotective drugs effective for young flies in aged flies.	[Sanuki, Rikako; Tanaka, Tomoya; Suzuki, Fumiko; Ibaraki, Kimihide; Takano, Toshiyuki] Kyoto Inst Technol, Dept Appl Biol, Ukyo Ku, Saga Campus,Saga Ippongi Cho, Kyoto 6168354, Japan; [Sanuki, Rikako; Takano, Toshiyuki] Kyoto Inst Technol, Dept Drosophila Genom & Genet Resources, Ctr Adv Insect Res Promot, Ukyo Ku, Saga Ippongi Cho, Kyoto 6168354, Japan		Sanuki, R (corresponding author), Saga Ippongi Cho,Ukyo Ku, Kyoto 6168354, Japan.	sanuki@kit.ac.jp	Sanuki, Rikako/AAV-7143-2021	Sanuki, Rikako/0000-0001-9862-9840	Leading Initiative for Excellent Young Researchers (LEADER) by MEXT, Japan; Japan Society for the Promotion of Science (JSPS) KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [18K06485]; JSPS Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers [S2802]	This work was supported by the Leading Initiative for Excellent Young Researchers (LEADER) initiated by MEXT, Japan, the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant No. 18K06485), JSPS Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (Grant No. S2802).	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Badinloo M, 2018, ARCH INSECT BIOCHEM, V98, DOI 10.1002/arch.21464; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Cao Y., 2013, P NATL ACAD SCI US; Carlock C, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.142; Cernak I, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00209; Charm S. I, 2016, MOL NEUROBIOL; Edamakanti C. R., 2018, J CLIN INVEST; Fan Y, 2010, CELL DEATH DIFFER, V17, P534, DOI 10.1038/cdd.2009.185; Faust K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-109; Fernandez-Hernandez I, 2013, CELL REP, V3, P1857, DOI 10.1016/j.celrep.2013.05.034; Gressot L. V., 2014, J NEUROSURG, P1; Grimm A., 2014, BBA; Gutierrez-Gonzalez R, 2008, CLIN NEUROL NEUROSUR, V110, P207, DOI 10.1016/j.clineuro.2007.09.014; Hada B, 2013, J GERONTOL A-BIOL, V68, P226, DOI 10.1093/gerona/gls156; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hoane MR, 2004, BEHAV BRAIN RES, V153, P189, DOI 10.1016/j.bbr.2003.11.012; Karelina K., 2018, BRAIN BEHAV IMMUNITY; Katzenberger R. J., 2013, P NATL ACAD SCI US; Katzenberger RJ, 2016, G3-GENES GENOM GENET, V6, P4151, DOI 10.1534/g3.116.036194; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Kounatidis I, 2017, CELL REP, V19, P836, DOI 10.1016/j.celrep.2017.04.007; Lee GJ, 2017, ONCOTARGET, V8, P87878, DOI 10.18632/oncotarget.21224; Lee HG, 2009, AM J PATHOL, V174, P891, DOI 10.2353/ajpath.2009.080583; Lee R. J., 2014, J NEUROCHEM; Lindberg BG, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006936; Liu S, 2013, NEURAL REGEN RES, V8, P2800, DOI 10.3969/j.issn.1673-5374.2013.30.002; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Meyer SN, 2014, SCIENCE, V346, P1199, DOI 10.1126/science.1258236; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Qiu S, 2017, COMP BIOCHEM PHYS A, V206, P17, DOI 10.1016/j.cbpa.2017.01.003; Raj K, 2017, MODELS J MOL NEUROSC; Sanuki R., 2015, CELL REP; Sekiya M, 2017, DEV CELL, V41, P652, DOI 10.1016/j.devcel.2017.05.019; Senoo-Matsuda N, 2007, P NATL ACAD SCI USA, V104, P18543, DOI 10.1073/pnas.0709021104; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Siller SS, 2011, DIS MODEL MECH, V4, P673, DOI 10.1242/dmm.008045; Singh M. D., 2013, NEUROBIOL DIS; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Skolnick B. E., 2014, N ENGL J MED; Temple N, 2015, J MED RADIAT SCI, V62, P122, DOI 10.1002/jmrs.101; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wright D. W., 2014, N ENGL J MED; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-7; Zaidman-Remy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017231	49	10	10	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	AUG	2019	80						427	438		10.1016/j.bbi.2019.04.023			12	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	IM6LX	WOS:000478105500042	30986429				2022-02-06	
J	Stukas, S; Higgins, V; Frndova, H; Gill, J; Hubara, E; Guerguerian, AM; Boutis, K; Beauchamp, M; Farrell, C; Babl, FE; Delzoppo, C; Greenham, M; Wilkinson, AA; Crichton, A; Anderson, V; Adeli, K; Hutchison, J; Wellington, C				Stukas, Sophie; Higgins, Victoria; Frndova, Helena; Gill, Jasmine; Hubara, Evyatar; Guerguerian, Anne-Marie; Boutis, Kathy; Beauchamp, Miriam; Farrell, Catherine; Babl, Franz E.; Delzoppo, Carmel; Greenham, Mardee; Wilkinson, Amy A.; Crichton, Alison; Anderson, Vicki; Adeli, Khosrow; Hutchison, Jamie; Wellington, Cheryl		Serum Biomarkers Quality Life Chil; Natl Biobank Database Patients Tra; Canadian Critical Care Translation; Canadian Traumatic Brain Injury Re	Characterisation of serum total tau following paediatric traumatic brain injury: a case-control study	LANCET CHILD & ADOLESCENT HEALTH			English	Article							CHILDREN; PROTEIN; BIOMARKERS; BLOOD	Background Traumatic brain injury (TBI) is a major health problem in children. Blood-based biomarkers interpreted by use of normative values might improve the accuracy of diagnosis. Ultrasensitive assays can quantify serum concentrations of the neuronal microtubule-associated protein tau, which is increased in adult brains following TBI. We aimed to determine if serum total tau correlates with TBI diagnosis, severity, and radiological findings on CT scans in children younger than 18 years. Methods In this case-control study, we included venous blood samples from healthy control children in the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) biobank. For TBI cases, we recruited children (aged 0-17 years) who presented to the emergency department within 24 h of a TBI in three tertiary-care paediatric hospitals (Toronto, Vancouver, and Melbourne). Children were eligible if they required hospital observation for a minimum of 4 h or admission to the intensive care unit, and were excluded if they had had hospital treatment for a previous TBI, had birth trauma, or their parents could not speak English or French and therefore could not readily give consent. All available control samples were used and a case-control match was therefore not done. Venous and arterial blood samples were collected from patients with TBI within 28 h of injury (day 1). We used an ultrasensitive single-molecule immunoassay to measure serum total tau in blood samples. We first generated reference intervals of serum total tau from the control group, and used these normative data to interpret injury-associated changes in serum total tau in children with TBI. Concentrations of serum tau were measured in all CALIPER participants and patients with TBI, and no participants were excluded before analysis. Findings We included samples from 416 control participants from the CALIPER cohort. Median total tau concentrations did not differ between sexes (p=0.12), but three significant reference intervals based on age groups were identified (1-3 years [0.88-19.2 pg/mL], 4-15 years [0.93-5.31 pg/mL], and 16-19 years [0.79-4.20 pg/mL]). Blood samples were obtained from 158 patients with TBI recruited between April 30, 2011, and June 28, 2013. Serum total tau on day 1 of TBI was negatively associated with Glasgow Coma Scale (GCS) score (r(s)=-0.42, 95% CI -0.55 to -0.28, p<0.0001). Median total tau was 2.86 pg/mL (IQR 1.52-4.83) in patients with GCS score 13-15 points (n=114), 7.08 pg/mL (3.75-41.1) in those with GCS score 9-12 points (n=13), and 8.48 pg/mL (2.53-70.6) in those with GCS score 3-8 points (n=31). Notably, participants who had GCS scores of 15 points had median total tau concentrations (2.57 pg/mL [1.50-4.61]) indistinguishable from those of control participants (2.46 pg/mL [1.77-3.42]), whereas those with GCS score 13-14 points had elevated total tau (6.41 pg/mL [2.97-42.5]). Serum total tau was not strongly associated with CT findings in patients with mild TBI. Interpretation Serum total tau might help to differentiate between patients with mild TBI (GCS 13-14 vs GCS 15), but larger studies are needed to validate these results before this biomarker can be used for diagnosis and prognosis. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Stukas, Sophie; Gill, Jasmine; Wellington, Cheryl] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Stukas, Sophie; Gill, Jasmine; Wellington, Cheryl] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Higgins, Victoria; Adeli, Khosrow] Univ Toronto, Canadian Lab Initiat Paediat Reference Intervals, Dept Pediat Lab Med, Fac Med, Toronto, ON, Canada; [Higgins, Victoria; Adeli, Khosrow] Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, Toronto, ON, Canada; [Guerguerian, Anne-Marie; Hutchison, Jamie] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Guerguerian, Anne-Marie; Hutchison, Jamie] Univ Toronto, Interdept Div Crit Ore, Toronto, ON, Canada; [Frndova, Helena; Hubara, Evyatar; Guerguerian, Anne-Marie; Hutchison, Jamie] Hosp Sick Children, Dept Crit Care Med, Toronto, ON, Canada; [Guerguerian, Anne-Marie; Wilkinson, Amy A.; Hutchison, Jamie] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Boutis, Kathy] Hosp Sick Children, Div Paediat Emergency Med, Dept Paediat, Toronto, ON, Canada; [Beauchamp, Miriam] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam] St Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Farrell, Catherine] St Justine Hosp, Div Paediat Intens Care, Dept Paediat, Montreal, PQ, Canada; [Babl, Franz E.; Delzoppo, Carmel; Greenham, Mardee; Crichton, Alison; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Babl, Franz E.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Babl, Franz E.; Delzoppo, Carmel; Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia; [Wilkinson, Amy A.] Toronto Western Hosp, Krembil Res Inst, Toronto, ON, Canada; [Crichton, Alison] Monash Univ, Dept Pediat, Melbourne, Vic, Australia		Wellington, C (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V6T 1Z3, Canada.	wcheryl@mail.ubc.ca	Greenham, Mardee/AAR-1711-2020		Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Ontario Neurotrauma Foundation; Victoria Neurotrauma Foundation	Canadian Institutes of Health Research, Ontario Neurotrauma Foundation, and Victoria Neurotrauma Foundation	Adeli K, 2017, CRIT REV CL LAB SCI, V54, P358, DOI 10.1080/10408363.2017.1379945; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Gardner RC, 2018, J NEUROTRAUM, V35, P2341, DOI 10.1089/neu.2018.5694; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Guzel A, 2010, AM J EMERG MED, V28, P399, DOI 10.1016/j.ajem.2008.12.025; Henny J, 2016, CLIN CHEM LAB MED, V54, P1893, DOI 10.1515/cclm-2016-0793; Keenan HT, 2019, J NEUROTRAUM, V36, P282, DOI 10.1089/neu.2018.5687; Keshavan Ashvini, 2018, Alzheimers Dement (Amst), V10, P448, DOI 10.1016/j.dadm.2018.06.001; Lugones M, 2018, NEUROSCI BIOBEHAV R, V87, P206, DOI 10.1016/j.neubiorev.2018.02.006; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Portela LVC, 2002, CLIN CHEM, V48, P950; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Zetterberg H, 2018, J ALZHEIMERS DIS, V64, pS271, DOI 10.3233/JAD-179926	28	10	10	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2352-4642			LANCET CHILD ADOLESC	Lancet Child. Adolesc. Health	AUG	2019	3	8					558	567		10.1016/S2352-4642(19)30194-4			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	IH7YN	WOS:000474720600021	31231066				2022-02-06	
J	Vonder Haar, C; Ferland, JMN; Kaur, S; Riparip, LK; Rosi, S; Winstanley, CA				Vonder Haar, Cole; Ferland, Jacqueline-Marie N.; Kaur, Sukhbir; Riparip, Lara-Kirstie; Rosi, Susanna; Winstanley, Catharine A.			Cocaine self-administration is increased after frontal traumatic brain injury and associated with neuroinflammation	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						brain injury; cytokine; dopamine; psychostimulant; rat	COGNITIVE DYSFUNCTION; DOPAMINE TRANSPORTER; RECEPTOR-BINDING; DECISION-MAKING; WHITE-MATTER; DEFICITS; INFLAMMATION; IMPULSIVITY; EXPRESSION; DISCRIMINATION	Traumatic brain injury (TBI) has been linked to the development of numerous psychiatric diseases, including substance use disorder. However, it can be difficult to ascertain from clinical data whether the TBI is cause or consequence of increased addiction vulnerability. Surprisingly few studies have taken advantage of animal models to investigate the causal nature of this relationship. In terms of a plausible neurobiological mechanism through which TBI could magnify the risk of substance dependence, numerous studies indicate that TBI can cause widespread disruption to monoaminergic signaling in striatal regions, and also increases neuroinflammation. In the current study, male Long-Evans rats received either a mild or severe TBI centered over the frontal cortex via controlled cortical impact, and were subsequently trained to self-administer cocaine over 10 6-hour sessions. At the end of the study, markers of striatal dopaminergic function, and levels of inflammatory cytokine levels in the frontal lobes, were assessed via western blot and multiplex ELISA, respectively. There was significantly higher cocaine intake in a subset of animals with either mild or severe TBI. However, many animals within both TBI groups failed to acquire self-administration. Principal components analysis suggested that both dopaminergic and neuroinflammatory proteins were associated with overall cocaine intake, yet only an inflammatory component was associated with acquisition of self-administration, suggesting neuroinflammation may make a more substantial contribution to the likelihood of drug-taking. Should neuroinflammation play a causal role in mediating TBI-induced addiction risk, anti-inflammatory therapy may reduce the likelihood of substance abuse in TBI populations.	[Vonder Haar, Cole] West Virginia Univ, Dept Psychol, Injury & Recovery Lab, POB 6040,53 Campus Dr, Morgantown, WV 26505 USA; [Vonder Haar, Cole; Ferland, Jacqueline-Marie N.; Kaur, Sukhbir; Winstanley, Catharine A.] Univ British Columbia, Lab Mol & Behav Neurosci, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; [Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, Dept Phys Therapy Rehabil Sci, San Francisco, CA 94143 USA; [Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, Dept Neurol Surg, San Francisco, CA 94143 USA		Vonder Haar, C (corresponding author), West Virginia Univ, Dept Psychol, Injury & Recovery Lab, POB 6040,53 Campus Dr, Morgantown, WV 26505 USA.; Vonder Haar, C; Winstanley, CA (corresponding author), Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada.	cole.vonderhaar@mail.wvu.edu; cwinstanley@psych.ubc.ca		Ferland, Jacqueline-Marie/0000-0002-1140-2422; Vonder Haar, Cole/0000-0001-7949-2068	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [PJT-148631]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS087458]; (CIHR) postdoctoral fellowshipCanadian Institutes of Health Research (CIHR); WVU startup funds	We would like to thank the Anthony Phillips laboratory at UBC for generously providing additional self-administration chambers and expert advice for this project. Funding for this project was provided by operating grants from the Canadian Institutes of Health Research (CIHR; PJT-148631) awarded to CAW, and the National Institute of Neurological Disorders and Stroke (R21NS087458) awarded to SR. CV was supported by a (CIHR) postdoctoral fellowship, and WVU startup funds. In the past 3years, CAW has received salary support from the CIHR New Investigator Award program and the Michael Smith Foundation for Health Research.	Anderson GD, 2015, AAPS J, V17, P1255, DOI 10.1208/s12248-015-9792-y; [Anonymous], 2015, OV DEATH RAT; [Anonymous], 2017, INJ PREV CONTR TRAUM; Ashok AH, 2017, JAMA PSYCHIAT, V74, P511, DOI 10.1001/jamapsychiatry.2017.0135; Bajo M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00049; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Beers SR, 2005, J HEAD TRAUMA REHAB, V20, P450, DOI 10.1097/00001199-200509000-00006; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brown KT, 2018, BRAIN BEHAV IMMUN, V67, P130, DOI 10.1016/j.bbi.2017.08.012; Calu DJ, 2007, LEARN MEMORY, V14, P325, DOI 10.1101/lm.534807; Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration, 2015, BEH HLTH TRENDS US R; Chen YH, 2015, CELL TRANSPLANT, V24, P2113, DOI 10.3727/096368914X683584; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dhillon NK, 2008, J NEUROIMMUNE PHARM, V3, P52, DOI 10.1007/s11481-007-9091-1; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Felger JC, 2013, NEUROPSYCHOPHARMACOL, V38, P2179, DOI 10.1038/npp.2013.115; Ferland JMN, 2017, ADDICT BIOL, V22, P991, DOI 10.1111/adb.12388; Fox HC, 2012, HUM PSYCHOPHARM CLIN, V27, P156, DOI 10.1002/hup.1251; Goldsmith DR, 2016, MOL PSYCHIATR, V21, P1696, DOI 10.1038/mp.2016.3; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Hasbi A, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00924; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karelina K, 2017, EXP NEUROL, V297, P110, DOI 10.1016/j.expneurol.2017.08.003; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; LI COR, 2016, W BLOT NORM HDB; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Ma LS, 2015, DRUG ALCOHOL DEPEN, V151, P128, DOI 10.1016/j.drugalcdep.2015.03.015; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; Martin-Garcia E, 2014, NEUROPSYCHOPHARMACOL, V39, P2317, DOI 10.1038/npp.2014.66; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; Merkel SF, 2017, CELL TRANSPLANT, V26, P1178, DOI 10.1177/0963689717714341; Merkel SF, 2017, J NEUROTRAUM, V34, P165, DOI 10.1089/neu.2015.4275; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Moore RJ, 1998, SYNAPSE, V28, P1; Moreno-Lopez L, 2017, EUR NEUROPSYCHOPHARM, V27, P159, DOI 10.1016/j.euroneuro.2016.12.002; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Northcutt AL, 2015, MOL PSYCHIATR, V20, P1525, DOI 10.1038/mp.2014.177; O'Neill B, 2013, GENES BRAIN BEHAV, V12, P34, DOI 10.1111/j.1601-183X.2012.00872.x; Perez MF, 2010, SYNAPSE, V64, P742, DOI 10.1002/syn.20788; Perry JL, 2005, PSYCHOPHARMACOLOGY, V178, P193, DOI 10.1007/s00213-004-1994-4; Petrulli JR, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.18; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; Ramesh D, 2015, AM J ADDICTION, V24, P341, DOI 10.1111/ajad.12192; Ramoa CP, 2014, BIOL PSYCHIAT, V76, P8, DOI 10.1016/j.biopsych.2013.09.028; Ray LA, 2014, INT REV NEUROBIOL, V118, P381, DOI 10.1016/B978-0-12-801284-0.00012-9; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Rodrigues LCM, 2014, ACTA NEUROPSYCHIATR, V26, P334, DOI 10.1017/neu.2014.24; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Sakano E, 2014, BRAZ J OTORHINOLAR, V80, P1, DOI [10.1002/0471142700.nc0909s57, 10.5935/1808-8694.20140001]; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Tortorelli LS, 2015, BEHAV BRAIN RES, V287, P226, DOI 10.1016/j.bbr.2015.03.054; Treble-Barna A, 2017, J NEUROTRAUM, V34, P1919, DOI 10.1089/neu.2016.4840; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Viviani B, 2003, J NEUROSCI, V23, P8692; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Vonder Haar C, 2016, J NEUROTRAUM, V33, P1892, DOI 10.1089/neu.2015.4276; Vonder Haar C, 2014, J NEUROTRAUM, V31, P1711, DOI 10.1089/neu.2014.3459; Vonder Haar C, 2014, J NEUROTRAUM, V31, P961, DOI 10.1089/neu.2013.3119; Vonder Haar C, 2014, BRAIN INJURY, V28, P235, DOI 10.3109/02699052.2013.860473; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Winstanley CA, 2009, CEREB CORTEX, V19, P435, DOI 10.1093/cercor/bhn094; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	75	10	10	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	AUG	2019	50	3			SI		2134	2145		10.1111/ejn.14123			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IY1UN	WOS:000486177300013	30118561	Green Accepted			2022-02-06	
J	Yuan, WS; Ibanez, CF; Lin, Z				Yuan, Wensu; Ibanez, Carlos F.; Lin, Zhi			Death domain of p75 neurotrophin receptor: a structural perspective on an intracellular signalling hub	BIOLOGICAL REVIEWS			English	Article						death domain; p75(NTR); signalling; structural mechanism; cytosolic interactors	NERVE GROWTH-FACTOR; NF-KAPPA-B; ADAPTER PROTEIN TRADD; CELL-DEATH; HIPPOCAMPAL-NEURONS; FUNCTIONAL INTERACTION; NUCLEAR TRANSLOCATION; CALMODULIN-BINDING; MOLECULAR-CLONING; CRYSTAL-STRUCTURE	The death domain (DD) is a globular protein motif with a signature feature of an all-helical Greek-key motif. It is a primary mediator of a variety of biological activities, including apoptosis, cell survival and cytoskeletal changes, which are related to many neurodegenerative diseases, neurotrauma, and cancers. DDs exist in a wide range of signalling proteins including p75 neurotrophin receptor (p75(NTR)), a member of the tumour necrosis factor receptor superfamily. The specific signalling mediated by p75(NTR) in a given cell depends on the type of ligand engaging the extracellular domain and the recruitment of cytosolic interactors to the intracellular domain, especially the DD, of the receptor. In solution, the p75(NTR)-DDs mainly form a symmetric non-covalent homodimer. In response to extracellular signals, conformational changes in the p75(NTR) extracellular domain (ECD) propagate to the p75(NTR)-DD through the disulfide-bonded transmembrane domain (TMD) and destabilize the p75(NTR)-DD homodimer, leading to protomer separation and exposure of binding sites on the DD surface. In this review, we focus on recent advances in the study of the structural mechanism of p75(NTR)-DD signalling through recruitment of diverse intracellular interactors for the regulation and control of diverse functional outputs.	[Yuan, Wensu; Lin, Zhi] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China; [Ibanez, Carlos F.; Lin, Zhi] Natl Univ Singapore, Dept Physiol, Singapore 117456, Singapore; [Ibanez, Carlos F.; Lin, Zhi] Natl Univ Singapore, Life Sci Inst, Singapore 117456, Singapore; [Ibanez, Carlos F.] Karolinska Inst, Dept Cell & Mol Biol, S-17165 Stockholm, Sweden		Lin, Z (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.; Lin, Z (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore 117456, Singapore.; Lin, Z (corresponding author), Natl Univ Singapore, Life Sci Inst, Singapore 117456, Singapore.	linzhi@linzhi.net	LIN, ZHI/B-1254-2016	LIN, ZHI/0000-0002-8902-4935	Natural Science Foundation of Tianjin CityNatural Science Foundation of Tianjin [17JCYBJC24200]; European Research CouncilEuropean Research Council (ERC)European Commission [ERC-2013-AdG-339237]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2016-01538]; Swedish Cancer SocietySwedish Cancer Society [CAN 2015/304]; Ministry of Education of SingaporeMinistry of Education, Singapore [MOE2014-T2-1-120, MOE2018-T2-1-129]; National Medical Research Council of SingaporeNational Medical Research Council, Singapore [CBRG13nov12, CBRG15may004]; Tianjin University	This work was supported in part by grants from Tianjin University and Natural Science Foundation of Tianjin City (17JCYBJC24200) (to Z.L.) and European Research Council (ERC-2013-AdG-339237), Swedish Research Council (2016-01538), Swedish Cancer Society (CAN 2015/304), Ministry of Education of Singapore (MOE2014-T2-1-120 and MOE2018-T2-1-129), and National Medical Research Council of Singapore (CBRG13nov12 and CBRG15may004) (to C.F.I.).	Ahn EY, 2004, J BIOL CHEM, V279, P5661, DOI 10.1074/jbc.M311040200; Bai D, 2003, BIOCHEM BIOPH RES CO, V309, P552, DOI 10.1016/j.bbrc.2003.08.033; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; Bender LM, 2005, CELL DEATH DIFFER, V12, P473, DOI 10.1038/sj.cdd.4401578; Benzel I, 2001, GENE, V281, P19, DOI 10.1016/S0378-1119(01)00730-2; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bredesen DE, 1997, TRENDS NEUROSCI, V20, P287, DOI 10.1016/S0166-2236(96)01049-1; Bronfman FC, 2007, J NEUROCHEM, V103, P91, DOI 10.1111/j.1471-4159.2007.04781.x; Cabral KMS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137916; Cao P, 2014, ACTA CRYSTALLOGR D, V70, P1604, DOI 10.1107/S1399004714006919; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; Chang XX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16390-6; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; Charalampopoulos I, 2012, CELL REP, V2, P1563, DOI 10.1016/j.celrep.2012.11.009; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; Coulson EJ, 2004, PROG BRAIN RES, V146, P41, DOI 10.1016/S0079-6123(03)46003-2; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Demir IE, 2016, BBA-REV CANCER, V1866, P37, DOI 10.1016/j.bbcan.2016.05.003; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Egea J, 2000, MOL CELL BIOL, V20, P1931, DOI 10.1128/MCB.20.6.1931-1946.2000; Egea J, 2001, J CELL BIOL, V154, P585, DOI 10.1083/jcb.200101023; El Yazidi-Belkoura I, 2003, J BIOL CHEM, V278, P16952, DOI 10.1074/jbc.M300631200; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; Fernandez EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117206; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Forsyth PA, 2014, J BIOL CHEM, V289, P8067, DOI 10.1074/jbc.M113.513762; Frankowski H, 2002, NEUROMOL MED, V1, P153; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; FRIEDMAN WJ, 1991, DEV BRAIN RES, V63, P43, DOI 10.1016/0165-3806(91)90065-Q; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Gehler S, 2004, J NEUROSCI, V24, P4363, DOI 10.1523/JNEUROSCI.0404-04.2004; Gentry JJ, 2004, J BIOL CHEM, V279, P16646, DOI 10.1074/jbc.M309209200; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; Gowrishankar K, 2004, J CELL SCI, V117, P4099, DOI 10.1242/jcs.01263; Ho R, 2011, CANCER LETT, V305, P76, DOI 10.1016/j.canlet.2011.02.029; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; HUTCHINSON EG, 1993, PROTEIN ENG, V6, P233, DOI 10.1093/protein/6.3.233; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kendall SE, 2003, DEV BRAIN RES, V144, P151, DOI 10.1016/S0165-3806(03)00166-4; Khursigara G, 2001, J NEUROSCI, V21, P5854, DOI 10.1523/JNEUROSCI.21-16-05854.2001; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Kisiswa L, 2018, CELL REP, V24, P1013, DOI 10.1016/j.celrep.2018.06.098; Kohl A, 2004, CR BIOL, V327, P1077, DOI 10.1016/j.crvi.2004.08.006; Krygier S, 2002, INT J CANCER, V98, P1, DOI 10.1002/ijc.10160; Lauri A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2456062; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Lim R, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12664; Lin Z, 2015, ELIFE, V4, DOI 10.7554/eLife.11692; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; MARANO N, 1987, J NEUROCHEM, V48, P225, DOI 10.1111/j.1471-4159.1987.tb13151.x; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Mi ZP, 2009, J NEUROCHEM, V110, P295, DOI 10.1111/j.1471-4159.2009.06137.x; Mineev KS, 2015, BIOPHYS J, V109, P772, DOI 10.1016/j.bpj.2015.07.009; MOBLEY WC, 1989, NEURON, V3, P655, DOI 10.1016/0896-6273(89)90276-6; Molloy Niamh H, 2011, Cancers (Basel), V3, P510, DOI 10.3390/cancers3010510; Muka J, 2003, VITAM HORM, V66, P385, DOI 10.1016/S0083-6729(03)01011-2; Mukai J, 2002, J BIOL CHEM, V277, P13973, DOI 10.1074/jbc.M106342200; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Nadezhdin KD, 2016, J BIOL CHEM, V291, P12346, DOI 10.1074/jbc.M116.723585; Nichols A, 1998, APOPTOSIS, V3, P289, DOI 10.1023/A:1009617426753; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Papoff G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116251; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park HH, 2011, APOPTOSIS, V16, P209, DOI 10.1007/s10495-010-0571-z; Park HH, 2009, MOL MED REP, V2, P539, DOI 10.3892/mmr_00000133; Park YH, 2014, BIOCHEM BIOPH RES CO, V443, P1155, DOI 10.1016/j.bbrc.2013.12.068; Perrone L, 2005, BIOCHEM J, V385, P233, DOI 10.1042/BJ20041155; Pobezinskaya YL, 2012, CELL CYCLE, V11, P871, DOI 10.4161/cc.11.5.19300; Pobezinskaya YL, 2011, J IMMUNOL, V186, P5212, DOI 10.4049/jimmunol.1002374; Qu QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057839; Rabizadeh S, 2003, CYTOKINE GROWTH F R, V14, P225, DOI 10.1016/S1359-6101(03)00018-2; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; Reed JC, 2004, SCI STKE, V2004, pr, DOI DOI 10.1126/STKE.2392004RE9; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Salemi LM, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170081; Salemi LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117655; Sano H, 2001, LARYNGOSCOPE, V111, P535, DOI 10.1097/00005537-200103000-00027; Sborgi L, 2015, P NATL ACAD SCI USA, V112, P13237, DOI 10.1073/pnas.1507579112; Selimovic D, 2012, J CELL MOL MED, V16, P349, DOI 10.1111/j.1582-4934.2011.01304.x; Steward A, 2009, J MOL BIOL, V389, P425, DOI 10.1016/j.jmb.2009.04.004; Sung TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069286; Suresh B, 2012, DRUG DISCOV TODAY, V17, P379, DOI 10.1016/j.drudis.2011.10.030; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; Tanaka K, 2016, J NEUROSCI, V36, P5587, DOI 10.1523/JNEUROSCI.4536-15.2016; Tong XJ, 2003, INT J ONCOL, V22, P1357; Torshin IY, 2002, PROTEIN ENG, V15, P359, DOI 10.1093/protein/15.5.359; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; Tsao DHH, 2000, MOL CELL, V5, P1051, DOI 10.1016/S1097-2765(00)80270-1; Verbeke S, 2010, CELL SIGNAL, V22, P1864, DOI 10.1016/j.cellsig.2010.07.014; Vicario A, 2015, J CELL SCI, V128, P1507, DOI 10.1242/jcs.161745; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Vilar M, 2017, VITAM HORM, V104, P57, DOI 10.1016/bs.vh.2016.10.007; Vilar M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001918; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Wang JJL, 2000, J MOL NEUROSCI, V15, P19, DOI 10.1385/JMN:15:1:19; Wang X, 2001, J BIOL CHEM, V276, P33812, DOI 10.1074/jbc.M010548200; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wiese S, 1999, EUR J NEUROSCI, V11, P1668, DOI 10.1046/j.1460-9568.1999.00585.x; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Wu LP, 2017, BIOCHEM BIOPH RES CO, V483, P810, DOI 10.1016/j.bbrc.2016.12.104; Wu XJ, 2005, J BIOL CHEM, V280, P29964, DOI 10.1074/jbc.M500710200; WYATT S, 1990, NEURON, V4, P421, DOI 10.1016/0896-6273(90)90054-J; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Xu ZY, 2017, POULTRY SCI, V96, P1438, DOI 10.3382/ps/pew496; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yang Jie, 2015, Zhonghua Nan Ke Xue, V21, P982; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004; Yi JS, 2003, NEUROSCI LETT, V347, P126, DOI 10.1016/S0304-3940(03)00656-6; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zhang N, 2017, BIOMOL NMR ASSIGN, V11, P281, DOI 10.1007/s12104-017-9763-6; Zhang N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07348-9; Zhu GQ, 2017, J IMMUNOL, V198, P1104, DOI 10.4049/jimmunol.1600403	128	10	11	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-7931	1469-185X		BIOL REV	Biol. Rev.	AUG	2019	94	4					1282	1293		10.1111/brv.12502			12	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	IG8BF	WOS:000474020700005	30762293				2022-02-06	
J	Guillot, X; Tordi, N; Laheurte, C; Pazart, L; Prati, C; Saas, P; Wendling, D				Guillot, X.; Tordi, N.; Laheurte, C.; Pazart, L.; Prati, C.; Saas, P.; Wendling, D.			Local ice cryotherapy decreases synovial interleukin 6, interleukin 1 beta, vascular endothelial growth factor, prostaglandin-E2, and nuclear factor kappa B p65 in human knee arthritis: a controlled study	ARTHRITIS RESEARCH & THERAPY			English	Article						Local cryotherapy; Knee arthritis; Cytokines; PG-E2; NF-kB	WHOLE-BODY CRYOTHERAPY; INFLAMMATORY RHEUMATIC-DISEASES; TRAUMATIC BRAIN-INJURY; HYPOTHERMIA; TEMPERATURE; IL-6; ACTIVATION; SECRETION; TNF	BackgroundThe aim of this study was to assess the anti-inflammatory effects of local cryotherapy in human non-septic knee arthritis.MethodsIn the phase I of the study, patients were randomized to receive either ice (30min; N=16) or cold CO2 (2min; N=16) applied twice during 1day at an 8-h interval on the arthritic knee. In phase II, 16 other ice-treated arthritic knees according to the same protocol were compared to the contralateral non-treated arthritic knees (N=16). The synovial fluid was analyzed just before the first cold application, then 24h later. IL-6, IL-1 beta, TNF-alpha, IL-17A, VEGF, NF-kB-p65 protein, and PG-E2 levels were measured in the synovial fluid and compared before/after the two cold applications.ResultsForty-seven patients were included (17 gouts, 11 calcium pyrophosphate deposition diseases, 13 rheumatoid arthritides, 6 spondyloarthritides). Local ice cryotherapy significantly reduced the IL-6, IL-1 beta, VEGF, NF-kB-p65, and PG-E2 synovial levels, especially in the microcrystal-induced arthritis subgroup, while only phosphorylated NF-kB-p65 significantly decreased in rheumatoid arthritis and spondyloarthritis patients. Cold CO2 only reduced the synovial VEGF levels. In the phase II of the study, the synovial PG-E2 was significantly reduced in ice-treated knees, while it significantly increased in the corresponding contralateral non-treated arthritic knees, with a significant inter-class effect size (mean difference -1329 [-2232; -426] pg/mL; N=12).ConclusionsThese results suggest that local ice cryotherapy reduces IL-6, IL-1 beta, and VEGF synovial protein levels, mainly in microcrystal-induced arthritis, and potentially through NF-kB and PG-E2-dependent mechanisms.Trial registrationClinicaltrials.gov, NCT03850392-registered February 20, 2019-retrospectively registered	[Guillot, X.] Felix Guyon Univ Hosp, Dept Rheumatol, St Denis, Reunion, France; [Guillot, X.; Tordi, N.; Prati, C.] Bourgogne Franche Comte Univ, FHU INCREASE, PEPITE EA4267, Besancon, France; [Guillot, X.; Prati, C.; Wendling, D.] Besancon Univ Hosp, Dept Rheumatol, Besancon, France; [Laheurte, C.; Saas, P.] Besancon Univ Hosp, INSERM, Biomonitoring Platform, U1098,EFS, Besancon, France; [Pazart, L.] Besancon Univ Hosp, INSERM, Ctr CIT 808, CIC IT, Besancon, France; [Wendling, D.] Bourgogne Franche Comte Univ, EA 4266, Besancon, France		Guillot, X (corresponding author), Felix Guyon Univ Hosp, Dept Rheumatol, St Denis, Reunion, France.; Guillot, X (corresponding author), Bourgogne Franche Comte Univ, FHU INCREASE, PEPITE EA4267, Besancon, France.	xavier.guillot@chu-reunion.fr	Saas, Philippe/M-9605-2019; Tordi, Nicolas/K-2137-2017	Saas, Philippe/0000-0002-8857-9939; PRATI, clement/0000-0003-4682-4489; Laheurte, Caroline/0000-0002-1364-4556; GUILLOT, Xavier/0000-0002-1217-7351; Tordi, Nicolas/0000-0002-8459-9465	GIRCI Est II [2014 - 21324]	This work was supported by GIRCI Est II ("Young scientist" grant -2014 21324 euros). Not applicable.	Anderson GD, 1996, J CLIN INVEST, V97, P2672, DOI 10.1172/JCI118717; Banfi G, 2010, SPORTS MED, V40, P509, DOI 10.2165/11531940-000000000-00000; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettoni L, 2013, CLIN RHEUMATOL, V32, P1337, DOI 10.1007/s10067-013-2280-9; Cholewka A, 2017, J THERM ANAL CALORIM, V127, P1155, DOI 10.1007/s10973-016-5453-3; Coassin M, 2010, BRIT J OPHTHALMOL, V94, P1678, DOI 10.1136/bjo.2009.168864; Diestel A, 2008, CRYOBIOLOGY, V57, P216, DOI 10.1016/j.cryobiol.2008.08.005; Fiocco U, 2013, JOINT BONE SPINE, V80, P165, DOI 10.1016/j.jbspin.2012.06.016; Guillot X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178668; Guillot X, 2017, JOINT BONE SPINE, V84, P477, DOI 10.1016/j.jbspin.2016.09.004; Guillot X, 2014, EXPERT REV CLIN IMMU, V10, P281, DOI 10.1586/1744666X.2014.870036; HARRIS ED, 1974, NEW ENGL J MED, V290, P1, DOI 10.1056/NEJM197401032900101; Jastrzabek R, 2013, RHEUMATOL INT, V33, P2053, DOI 10.1007/s00296-013-2692-5; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Lange U, 2008, MED KLIN, V103, P383, DOI 10.1007/s00063-008-1056-5; Lubkowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046352; Mourot L, 2007, ARCH PHYS MED REHAB, V88, P1339, DOI 10.1016/j.apmr.2007.06.771; OOSTERVELD FGJ, 1994, ARTHRITIS RHEUM, V37, P1578, DOI 10.1002/art.1780371104; Schlesinger N, 2002, J RHEUMATOL, V29, P331; Stanek A, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/8592532; Stanek A, 2010, POL J ENVIRON STUD, V19, P167; Straburzynska-Lupa A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2157496; Straub RH, 2009, ANN RHEUM DIS, V68, P572, DOI 10.1136/ard.2008.089458; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Webster CM, 2009, NEUROBIOL DIS, V33, P301, DOI 10.1016/j.nbd.2008.11.001; Welch V, 2001, COCHRANE DB SYST REV; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016	28	10	11	2	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1478-6354	1478-6362		ARTHRITIS RES THER	Arthritis Res. Ther.	JUL 30	2019	21								180	10.1186/s13075-019-1965-0			11	Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Rheumatology	IM3XQ	WOS:000477929700001	31362785	Green Published, gold			2022-02-06	
J	Yoshizaki, S; Kijima, K; Hara, M; Saito, T; Tamaru, T; Tanaka, M; Konno, D; Nakashima, Y; Okada, S				Yoshizaki, Shingo; Kijima, Ken; Hara, Masamitsu; Saito, Takeyuki; Tamaru, Tetsuya; Tanaka, Masatake; Konno, Dai-jiro; Nakashima, Yasuharu; Okada, Seiji			Tranexamic acid reduces heme cytotoxicity via the TLR4/TNF axis and ameliorates functional recovery after spinal cord injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Spinal cord injury; Tranexamic acid; Heme; Toll-like receptor 4; Demyelination; Hyperfibrinolysis	TRAUMATIC BRAIN-INJURY; PLASMINOGEN-ACTIVATOR; SCAR FORMATION; IN-VITRO; T-PA; FIBRINOLYSIS; HEMORRHAGE; COAGULATION; APROTININ; NECROSIS	BackgroundSpinal cord injury (SCI) is a catastrophic trauma accompanied by intralesional bleeding and neuroinflammation. Recently, there is increasing interest in tranexamic acid (TXA), an anti-fibrinolytic drug, which can reduce the bleeding volume after physical trauma. However, the efficacy of TXA on the pathology of SCI remains unknown.MethodsAfter producing a contusion SCI at the thoracic level of mice, TXA was intraperitoneally administered and the bleeding volume in the lesion area was quantified. Tissue damage was evaluated by immunohistochemical and gene expression analyses. Since heme is one of the degraded products of red blood cells (RBCs) and damage-associated molecular pattern molecules (DAMPs), we examined the influence of heme on the pathology of SCI. Functional recovery was assessed using the open field motor score, a foot print analysis, a grid walk test, and a novel kinematic analysis system. Statistical analyses were performed using Wilcoxon's rank-sum test, Dunnett's test, and an ANOVA with the Tukey-Kramer post-hoc test.ResultsAfter SCI, the intralesional bleeding volume was correlated with the heme content and the demyelinated area at the lesion site, which were significantly reduced by the administration of TXA. In the injured spinal cord, toll-like receptor 4 (TLR4), which is a DAMP receptor, was predominantly expressed in microglial cells. Heme stimulation increased TLR4 and tumor necrosis factor (TNF) expression levels in primary microglial cells in a dose-dependent manner. Similarly to the in vitro experiments, the injection of non-lysed RBCs had little pathological influence on the spinal cord, whereas the injection of lysed RBCs or heme solution significantly upregulated the TLR4 and TNF expression in microglial cells. In TXA-treated SCI mice, the decreased expressions of TLR4 and TNF were observed at the lesion sites, accompanied by a significant reduction in the number of apoptotic cells and better functional recovery in comparison to saline-treated control mice.ConclusionThe administration of TXA ameliorated the intralesional cytotoxicity both by reducing the intralesional bleeding volume and preventing heme induction of the TLR4/TNF axis in the SCI lesion. Our findings suggest that TXA treatment may be a therapeutic option for acute-phase SCI.	[Yoshizaki, Shingo; Kijima, Ken; Hara, Masamitsu; Saito, Takeyuki; Tamaru, Tetsuya; Nakashima, Yasuharu; Okada, Seiji] Kyushu Univ, Dept Orthoped Surg, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan; [Yoshizaki, Shingo; Kijima, Ken; Tamaru, Tetsuya; Tanaka, Masatake; Konno, Dai-jiro; Okada, Seiji] Kyushu Univ, Dept Immunol & Neurosci, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan		Okada, S (corresponding author), Kyushu Univ, Dept Orthoped Surg, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.; Okada, S (corresponding author), Kyushu Univ, Dept Immunol & Neurosci, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	seokada@ortho.med.kyushu-u.ac.jp		Tamaru, Tetsuya/0000-0002-0917-5128	General Insurance Association of Japan [19H03771]; AMEDJapan Agency for Medical Research and Development (AMED) [19gm6210003h0002]	This work was supported by the General Insurance Association of Japan (SY), a Grant-in-Aid for Scientific Research (B) (19H03771) (SO) and AMED (19gm6210003h0002) (SO). The funders had no role in the study design, data collection, data analysis, interpretation, and writing of the report.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Aruoma OI, 1998, J AM OIL CHEM SOC, V75, P199, DOI 10.1007/s11746-998-0032-9; Asakura H, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-20; Barrachina B, 2016, ANESTH ANALG, V122, P986, DOI 10.1213/ANE.0000000000001159; BURNEY RE, 1993, ARCH SURG-CHICAGO, V128, P596; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; del Zoppo GJ, 2013, SEMIN THROMB HEMOST, V39, P856, DOI 10.1055/s-0033-1357490; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Dietrich W, 2008, ANESTH ANALG, V107, P1469, DOI 10.1213/ane.0b013e318182252b; Ducloy-Bouthors AS, 2011, CRIT CARE, V15, DOI 10.1186/cc10143; Dunn CJ, 1999, DRUGS, V57, P1005, DOI 10.2165/00003495-199957060-00017; Dutra FF, 2014, P NATL ACAD SCI USA, V111, pE4110, DOI 10.1073/pnas.1405023111; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Fernandez AZ, 2001, ATHEROSCLEROSIS, V158, P103, DOI 10.1016/S0021-9150(01)00422-1; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; FOO D, 1982, NEUROSURGERY, V11, P25, DOI 10.1227/00006123-198207010-00006; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; Fredriksson L, 2017, SEMIN THROMB HEMOST, V43, P154, DOI 10.1055/s-0036-1586229; Gall LS, 2018, CURR OPIN ANESTHESIO, V31, P227, DOI 10.1097/ACO.0000000000000561; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Gayet-Ageron A, 2018, LANCET, V391, P125, DOI 10.1016/S0140-6736(17)32455-8; Godier A, 2017, J CLIN PATHOL, V70, P154, DOI 10.1136/jclinpath-2016-203854; Gruen RL, 2011, LANCET, V377, P1052, DOI 10.1016/S0140-6736(11)60396-6; Han DX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0236-8; Hansen AR, 1998, PEDIATR NEUROL, V18, P15, DOI 10.1016/S0887-8994(97)00127-6; Hara M, 2017, NAT MED, V23, P818, DOI 10.1038/nm.4354; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Hooda J, 2014, NUTRIENTS, V6, P1080, DOI 10.3390/nu6031080; Huber D, 2002, BLOOD, V99, P3637, DOI 10.1182/blood.V99.10.3637; Inukai T, 2009, SPINE, V34, P2848, DOI 10.1097/BRS.0b013e3181b0d078; Kappler S, 2017, HEMATOL ONCOL CLIN N, V31, P1081, DOI 10.1016/j.hoc.2017.08.010; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Kobayakawa K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009430; Kubota K, 2012, SPINE, V37, P1448, DOI 10.1097/BRS.0b013e31824ffda5; Kumamaru H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-116; Lammertse D, 2007, J SPINAL CORD MED, V30, P205, DOI 10.1080/10790268.2007.11753928; Lemarchant S, 2012, NEUROPHARMACOLOGY, V62, P749, DOI 10.1016/j.neuropharm.2011.10.020; Levy JH, 2010, LANCET, V376, P3, DOI 10.1016/S0140-6736(10)60939-7; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Lin WP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0521-y; Lin Z, 2016, SEIZURE-EUR J EPILEP, V36, P70, DOI 10.1016/j.seizure.2016.02.011; Mahmood A, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2073-6; MARKUS G, 1979, J BIOL CHEM, V254, P1211; Masuda T, 2012, CELL REP, V1, P334, DOI 10.1016/j.celrep.2012.02.014; McCormack PL, 2012, DRUGS, V72, P585, DOI 10.2165/11209070-000000000-00000; MCGUIRE PG, 1990, NEURON, V4, P633, DOI 10.1016/0896-6273(90)90121-U; Medcalf RL, 2015, BLOOD, V125, P2457, DOI 10.1182/blood-2015-02-629808; Mendonca R, 2016, INFLAMM RES, V65, P665, DOI 10.1007/s00011-016-0955-9; MOONEN G, 1982, NATURE, V298, P753, DOI 10.1038/298753a0; Moore HB, 2015, SHOCK, V43, P39, DOI 10.1097/SHK.0000000000000245; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Neilipovitz DT, 2004, EUR SPINE J, V13, pS62, DOI 10.1007/s00586-004-0716-2; OKAMOTO SHOSUKE, 1962, KEIO JOUR MED, V11, P105; Pajoohesh-Ganji A, 2010, NEUROSCI RES, V67, P117, DOI 10.1016/j.neures.2010.02.009; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Saiwai H, 2013, J NEUROCHEM, V125, P74, DOI 10.1111/jnc.12135; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; Samson AL, 2009, BLOOD, V114, P1937, DOI 10.1182/blood-2009-02-203448; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Soares MP, 2016, CURR OPIN IMMUNOL, V38, P94, DOI 10.1016/j.coi.2015.11.006; Taketani S, 2005, TOHOKU J EXP MED, V205, P297, DOI 10.1620/tjem.205.297; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tengborn L, 2015, THROMB RES, V135, P231, DOI 10.1016/j.thromres.2014.11.012; Watts G, 2016, LANCET, V387, P2286, DOI 10.1016/S0140-6736(16)30697-3; Yokota K, 2017, AM J PATHOL, V187, P639, DOI 10.1016/j.ajpath.2016.11.010; Ziai WC, 2012, STROKE, V43, P1234, DOI 10.1161/STROKEAHA.111.641050; ZLOKOVIC BV, 1995, NEUROSURGERY, V37, P955, DOI 10.1227/00006123-199511000-00015; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	71	10	11	2	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JUL 29	2019	16								160	10.1186/s12974-019-1536-y			15	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	IM3MI	WOS:000477896900001	31358003	Green Published, gold			2022-02-06	
J	Shao, XY; You, R; Hui, TH; Fang, C; Gong, Z; Yan, ZS; Chang, RCC; Shenoy, VB; Lin, Y				Shao, Xueying; You, Ran; Hui, Tsz Hin; Fang, Chao; Gong, Ze; Yan, Zishen; Chang, Raymond Chuen Chung; Shenoy, Vivek B.; Lin, Yuan			Tension- and Adhesion-Regulated Retraction of Injured Axons	BIOPHYSICAL JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; MYOSIN-II ACTIVITY; CELL-ADHESION; GROWTH CONE; NEURITE OUTGROWTH; AMYLOID-BETA; FORCE; MICROTUBULES; REGENERATION; DYNAMICS	Damage-induced retraction of axons during traumatic brain injury is believed to play a key role in the disintegration of the neural network and to eventually lead to severe symptoms such as permanent memory loss and emotional disturbances. However, fundamental questions such as how axon retraction progresses and what physical factors govern this process still remain unclear. Here, we report a combined experimental and modeling study to address these questions. Specifically, a sharp atomic force microscope probe was used to transect axons and trigger their retraction in a precisely controlled manner. Interestingly, we showed that the retracting motion of a well-developed axon can be arrested by strong cell-substrate attachment. However, axon retraction was found to be retriggered if a second transection was conducted, albeit with a lower shrinking amplitude. Furthermore, disruption of the actin cytoskeleton or cell-substrate adhesion significantly altered the retracting dynamics of injured axons. Finally, a mathematical model was developed to explain the observed injury response of neural cells in which the retracting motion was assumed to be driven by the pre-tension in the axon and progress against neuron-substrate adhesion as well as the viscous resistance of the cell. Using realistic parameters, model predictions were found to be in good agreement with our observations under a variety of experimental conditions. By revealing the essential physics behind traumatic axon retraction, findings here could provide insights on the development of treatment strategies for axonal injury as well as its possible interplay with other neurodegenerative diseases.	[Shao, Xueying; Hui, Tsz Hin; Fang, Chao; Yan, Zishen; Lin, Yuan] Univ Hong Kong, Dept Mech Engn, Hong Kong, Peoples R China; [Shao, Xueying; Hui, Tsz Hin; Fang, Chao; Yan, Zishen; Lin, Yuan] HKU Shenzhen Inst Res & Innovat, Shenzhen, Guangdong, Peoples R China; [You, Ran; Chang, Raymond Chuen Chung] Univ Hong Kong, Sch Biomed Sci, LKS Fac Med, Lab Neurodegenerat Dis, Hong Kong, Peoples R China; [Gong, Ze; Shenoy, Vivek B.] Univ Penn, Ctr Engn Mechanobiol, Philadelphia, PA 19104 USA; [Gong, Ze; Shenoy, Vivek B.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA		Lin, Y (corresponding author), Univ Hong Kong, Dept Mech Engn, Hong Kong, Peoples R China.; Lin, Y (corresponding author), HKU Shenzhen Inst Res & Innovat, Shenzhen, Guangdong, Peoples R China.; Shenoy, VB (corresponding author), Univ Penn, Ctr Engn Mechanobiol, Philadelphia, PA 19104 USA.; Shenoy, VB (corresponding author), Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.	vshenoy@seas.upenn.edu; ylin@hku.hk	Gong, Ze/V-1194-2019; Shenoy, Vivek/ABD-5075-2021	Gong, Ze/0000-0003-0172-0563; 	Research Grants Council of the Hong Kong Special Administration RegionHong Kong Research Grants Council [HKU 17205114, HKU 17211215, HKU 17257016]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11572273, 11872325]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-EB021293]; Allen Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB021293] Funding Source: NIH RePORTER	This work was supported by grants from the Research Grants Council (Project Nos. HKU 17205114, HKU 17211215, HKU 17257016) of the Hong Kong Special Administration Region and the National Natural Science Foundation of China (Project Nos. 11572273, 11872325). V.B.S. acknowledges support from the National Institutes of Health through award R01-EB021293 and the Allen Foundation.	Ahmad FJ, 2000, NAT CELL BIOL, V2, P276, DOI 10.1038/35010544; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; Blanquie O, 2018, CURR OPIN NEUROBIOL, V51, P60, DOI 10.1016/j.conb.2018.02.024; Blizzard CA, 2007, EUR J NEUROSCI, V26, P1100, DOI 10.1111/j.1460-9568.2007.05750.x; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; Cao X, 2017, P NATL ACAD SCI USA, V114, pE4549, DOI 10.1073/pnas.1620486114; Cengiz N, 2012, J NEUROTRAUM, V29, P2465, DOI 10.1089/neu.2009.0947; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; de Rooij R, 2018, BIOPHYS J, V114, P201, DOI 10.1016/j.bpj.2017.11.010; Difato F, 2011, SCI REP-UK, V1, DOI 10.1038/srep00183; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Fanti Z, 2008, IEEE ENG MED BIO, P1196, DOI 10.1109/IEMBS.2008.4649377; Fisher TE, 1999, TRENDS BIOCHEM SCI, V24, P379, DOI 10.1016/S0968-0004(99)01453-X; Franze K, 2009, BIOPHYS J, V97, P1883, DOI 10.1016/j.bpj.2009.07.033; Gallo G, 2004, EXP NEUROL, V189, P112, DOI 10.1016/j.expneurol.2004.05.019; Gallo G, 2002, J CELL BIOL, V158, P1219, DOI 10.1083/jcb.200204140; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Ganguly A, 2015, J CELL BIOL, V210, P401, DOI 10.1083/jcb.201506110; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Gong Z, 2019, SOFT MATTER, V15, P166, DOI 10.1039/c8sm01747f; Gong Z, 2016, J APPL PHYS, V119, DOI 10.1063/1.4952704; GRAHAM DI, 1992, J CLIN PATHOL, V45, P840, DOI 10.1136/jcp.45.9.840; Grevesse T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09475; He Y, 2002, J NEUROSCI, V22, P5982; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Kunik D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026832; LAMOUREUX P, 1989, NATURE, V340, P156, DOI 10.1038/340159a0; Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307; Li XJ, 2018, BIOPHYS J, V115, P554, DOI 10.1016/j.bpj.2018.06.014; Magdesian MH, 2012, BIOPHYS J, V103, P405, DOI 10.1016/j.bpj.2012.07.003; Maruthamuthu V, 2009, BIOPHYS J, V96, P3005, DOI 10.1016/j.bpj.2008.12.3936; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Miller KE, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00447; Mutalik SP, 2018, BIOPHYS J, V115, P713, DOI 10.1016/j.bpj.2018.07.007; Neukomm LJ, 2014, TRENDS CELL BIOL, V24, P515, DOI 10.1016/j.tcb.2014.04.003; O'Toole M, 2008, BIOPHYS J, V94, P2610, DOI 10.1529/biophysj.107.117424; O'Toole M, 2015, BIOPHYS J, V108, P1027, DOI 10.1016/j.bpj.2015.01.021; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; Postuma RB, 2000, J NEUROCHEM, V74, P1122; Recho P, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.032410; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; THEODOROPOULOS PA, 1994, BIOCHEM PHARMACOL, V47, P1875, DOI 10.1016/0006-2952(94)90318-2; Tofangchi A, 2016, BIOPHYS J, V111, P1519, DOI 10.1016/j.bpj.2016.08.024; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; WESSELLS NK, 1978, EXP CELL RES, V117, P335, DOI 10.1016/0014-4827(78)90147-7; Wieland JA, 2005, J BIOL CHEM, V280, P41037, DOI 10.1074/jbc.M503975200; YAMADA KM, 1971, J CELL BIOL, V49, P614, DOI 10.1083/jcb.49.3.614; YAWO H, 1983, SCIENCE, V222, P1351, DOI 10.1126/science.6658457	61	10	10	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	JUL 23	2019	117	2					193	202		10.1016/j.bpj.2019.06.011			10	Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics	IK6PE	WOS:000476709900002	31278003	Green Published, Bronze			2022-02-06	
J	Imran, A; Xiao, L; Ahmad, W; Anwar, H; Rasul, A; Imran, M; Aziz, N; Razzaq, A; Arshad, MU; Shabbir, A; de Aguilar, JLG; Sun, T; Hussain, G				Imran, Ali; Xiao, Lei; Ahmad, Waseem; Anwar, Haseeb; Rasul, Azhar; Imran, Muhammad; Aziz, Nimra; Razzaq, Aroona; Arshad, Muhammad Umair; Shabbir, Asghar; de Aguilar, Jose-Luis Gonzalez; Sun, Tao; Hussain, Ghulam			Foeniculum vulgare (Fennel) promotes functional recovery and ameliorates oxidative stress following a lesion to the sciatic nerve in mouse model	JOURNAL OF FOOD BIOCHEMISTRY			English	Article						Foeniculum vulgare; functional recovery; nerve regeneration; oxidative stress; peripheral nerve injury	REGENERATION; INJURY; EXTRACT; MEMORY; FRUIT	Peripheral nerve injury is one of the major health concerns of the present era which can lead to the long-lasting disability and even demise. Currently, no effective and side effect free remedy exists and exploration of effective therapeutic strategies to regain functional outcome is a need of hour. In the present study, we used BALB/c mice (N = 14 age, 10-12 weeks & weight 32-34 g) that were divided into two groups: Normal chow (n = 7) and Fennel chow (n = 7) group. Here, we have explored the role of crude Foeniculum vulgare mill seeds in promoting functional recovery following a mechanical insult to the sciatic nerve by an oral administration of a crude dose of 500 mg/kg BW. The recovery of both sensory and motor functions was significantly (p > .05) accelerated in the treatment group, assessed by behavioral analyses alongside total antioxidant capacity increase. Conclusively, F. vulgare can be a potential therapeutic candidate for accelerating functional recovery after peripheral nerve injury. Practical applications The outcomes of study have vital practical application both for scientists and consumers. The therapeutic role of phytochemicals on functional recovery has not been explored yet. This study will help figure out plant based regimen as booster for brain health and intervention against traumatic nerve injuries. Moreover, it may also attract the food and pharmaceutical industries to formulate cost effective therapeutic products. Likewise, it can prove instrumental for scientists for advance research on this aspect with more mechanistic targets.	[Imran, Ali; Arshad, Muhammad Umair] Govt Coll Univ, Inst Home & Food Sci, Faisalabad, Pakistan; [Xiao, Lei; Sun, Tao] Huaqiao Univ, Ctr Precis Med, Sch Med, Xiamen, Fujian, Peoples R China; [Xiao, Lei; Sun, Tao] Huaqiao Univ, Sch Biomed Sci, Xiamen, Fujian, Peoples R China; [Ahmad, Waseem; Anwar, Haseeb; Aziz, Nimra; Razzaq, Aroona; Hussain, Ghulam] Govt Coll Univ, Dept Physiol, NGL, Fac Life Sci, Faisalabad 38000, Pakistan; [Rasul, Azhar] Govt Coll Univ, Fac Life Sci, Dept Zool, Faisalabad, Pakistan; [Imran, Muhammad] Univ Lahore, Univ Inst Diet & Nutr Sci, Fac Allied Hlth Sci, Lahore, Pakistan; [Shabbir, Asghar] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [de Aguilar, Jose-Luis Gonzalez] Univ Strasbourg, UMR S 1118, Strasbourg, France; [de Aguilar, Jose-Luis Gonzalez] INSERM, Mecanismes Cent & Peripher Neurodegenerescence, Strasbourg, France		Hussain, G (corresponding author), Govt Coll Univ, Dept Physiol, NGL, Fac Life Sci, Faisalabad 38000, Pakistan.	gh_azer@hotmail.com	Hussain, Ghulam/Y-9776-2019; Imran, Ali/J-1316-2019; Shabbir, Asghar/AAA-3171-2022; Rasul, Azhar/AAF-5253-2021; Arshad, Muhammad U/D-4269-2011; HUSSAIN, Ghulam/S-7609-2016	Hussain, Ghulam/0000-0001-9090-7789; Rasul, Azhar/0000-0001-9669-7364; Arshad, Muhammad U/0000-0003-1032-6250; HUSSAIN, Ghulam/0000-0001-9090-7789	Higher Education Commission of PakistanHigher Education Commission of Pakistan [7612/Punjab/NRPU/R D/HEC/2017]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471152, 31771141, 81701132]	This work was supported by the Higher Education Commission of Pakistan (7612/Punjab/NRPU/R& D/HEC/2017) and the National Natural Science Foundation of China (81471152, 31771141, and 81701132).	ALBERTPULEO M, 1980, J ETHNOPHARMACOL, V2, P337, DOI 10.1016/S0378-8741(80)81015-4; Aziz N, 2019, PAK J PHARM SCI, V32, P785; Benga A, 2017, INDIAN J PLAST SURG, V50, P5, DOI 10.4103/ijps.IJPS_14_17; Bhatti S, 2018, DRUG CHEM TOXICOL, V41, P399, DOI 10.1080/01480545.2018.1459669; Bowtell J, 2019, SPORTS MED, V49, pS3, DOI 10.1007/s40279-018-0998-x; Choi EM, 2004, FITOTERAPIA, V75, P557, DOI 10.1016/j.fitote.2004.05.005; Elfar JC, 2008, J BONE JOINT SURG AM, V90A, P1644, DOI 10.2106/JBJS.G.00557; Gerhke SA, 2015, NEURAL REGEN RES, V10, P1063, DOI 10.4103/1673-5374.160082; Halter B, 2010, FREE RADICAL BIO MED, V48, P915, DOI 10.1016/j.freeradbiomed.2010.01.014; Hoke A., 2009, J EXPT NEUROLOGY, V223, P1, DOI [10.1016/j.expneurol.2009.12.001, DOI 10.1016/J.EXPNEUROL.2009.12.001]; Hussain G, 2019, MOLECULES, V24, DOI 10.3390/molecules24122213; Hussain G, 2018, MOLECULES, V23, DOI 10.3390/molecules23040814; Hussain G, 2018, INT J BIOL SCI, V14, P341, DOI 10.7150/ijbs.23247; Hussain G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064525; Joshi H, 2006, J MED FOOD, V9, P413, DOI 10.1089/jmf.2006.9.413; Kooti W., 2015, J HERBMED PHARM, V4, P1; Koppula S, 2013, TROP J PHARM RES, V12, P553, DOI 10.4314/tjpr.v12i4.17; Lee JY, 2018, BBA-MOL BASIS DIS, V1864, P2472, DOI 10.1016/j.bbadis.2018.04.006; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Ma JX, 2016, NEUROSCI LETT, V610, P139, DOI 10.1016/j.neulet.2015.11.005; Menendez L, 2002, J NEUROSCI METH, V113, P91, DOI 10.1016/S0165-0270(01)00483-6; Mhaidat NM, 2015, INT J PHARMACOL, V11, P72, DOI 10.3923/ijp.2015.72.75; Moimas S, 2013, GENE THER, V20, P1014, DOI 10.1038/gt.2013.26; Oktay M, 2013, LEBENSON WISS TECHNO, V36, P263; Rubio CP, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0792-7; Plastaras CT, 2014, ORTHOP CLIN N AM, V45, P55, DOI 10.1016/j.ocl.2013.09.005; Rather MA, 2016, ARAB J CHEM, V9, pS1574, DOI 10.1016/j.arabjc.2012.04.011; Richner M, 2014, MOL NEUROBIOL, V50, P945, DOI 10.1007/s12035-014-8706-9; Uriarte Pueyo I, 2009, PHARMACOGN MAG, V5, P287; Wu R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170003; Yang IJ, 2015, IMMUNOPHARM IMMUNOT, V37, P308, DOI 10.3109/08923973.2015.1038751; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61	32	10	10	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-8884	1745-4514		J FOOD BIOCHEM	J. Food Biochem.	SEP	2019	43	9							e12983	10.1111/jfbc.12983		JUL 2019	9	Biochemistry & Molecular Biology; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Food Science & Technology	IY2QK	WOS:000477105700001	31489666				2022-02-06	
J	Lee, SY; Amatya, B; Judson, R; Truesdale, M; Reinhardt, JD; Uddin, T; Xiong, XH; Khan, F				Lee, Su Yi; Amatya, Bhasker; Judson, Rodney; Truesdale, Melinda; Reinhardt, Jan D.; Uddin, Taslim; Xiong, Xiang-Hu; Khan, Fary			Clinical practice guidelines for rehabilitation in traumatic brain injury: a critical appraisal	BRAIN INJURY			English	Article						Traumatic brain injury; rehabilitation; clinical practice guidelines; critical appraisal	EPIDEMIOLOGY	This review aim to provide an overview of recommendations and quality of existing clinical practice guidelines (CPGs) for the management of traumatic brain injury (TBI) from the rehabilitation perspective. Comprehensive literature search, including health databases, CPG clearinghouse/developer websites, and grey literature using Internet search engines up to September 2017. All TBI CPGs published in the last decade were selected if their scope included management of TBI, systematic methods for evidence search, clear defined recommendations, and supporting evidence for rehabilitation interventions. Three authors independently critically appraised the quality of included CPGs using the Appraisal of Guidelines, Research, and Evaluation II (AGREE II) Instrument. Four of 13 potential CPGs met the inclusion criteria. Despite variation in scope, target population, size, and guideline development processes, all four CPGs assessed were good quality (AGREE score of 5-7/7). Key rehabilitation recommendations included education, physical rehabilitation, integrated computer-based management, repetitive task-specific practice in daily living activities, safe equipment usage, cognitive/behavioral feedback, compensatory memory/visual strategies, swallowing/communication, and psychological input for TBI survivors. In conclusion, although rehabilitation is an integral component in TBI management, many published CPGs do not include rehabilitation. These CPGs, however, recommend comprehensive, flexible coordinated multidisciplinary care and appropriate follow-up, education, and support for patients with TBI (and carers).	[Lee, Su Yi; Amatya, Bhasker; Khan, Fary] Royal Melbourne Hosp, Dept Rehabil, Parkville, Vic, Australia; [Lee, Su Yi; Amatya, Bhasker; Khan, Fary] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Lee, Su Yi; Amatya, Bhasker; Reinhardt, Jan D.; Uddin, Taslim; Khan, Fary] Int Soc Phys & Rehabil Med, Disaster Rehabil Comm, Geneva, Switzerland; [Lee, Su Yi; Amatya, Bhasker; Xiong, Xiang-Hu; Khan, Fary] Royal Melbourne Hosp, Australian Rehabil Res Ctr, Parkville, Vic, Australia; [Judson, Rodney] Royal Melbourne Hosp, Trauma Serv, Parkville, Vic, Australia; [Truesdale, Melinda] Royal Melbourne Hosp, Emergency Serv, Parkville, Vic, Australia; [Reinhardt, Jan D.] Sichuan Univ, Inst Disaster Management & Reconstruct, Dept Disaster Hlth Sci, Chengdu, Sichuan, Peoples R China; [Reinhardt, Jan D.] Hong Kong Polytech Univ, Chengdu, Sichuan, Peoples R China; [Reinhardt, Jan D.] Swiss Parapleg Res, Nottwil, Switzerland; [Reinhardt, Jan D.] Univ Lucerne, Dept Hlth Sci, Luzern, Switzerland; [Uddin, Taslim] Bangabandhu Sheikh Mujib Med Univ BSMMU, Fac Med, Dept Phys Med & Rehabil, Dhaka, Bangladesh; [Xiong, Xiang-Hu] Brain Injury Rehab Laura Fergusson Trust, Christchurch, New Zealand		Lee, SY (corresponding author), Royal Melbourne Hosp, Dept Rehabil Med, 34-54 Poplar Rd Parkville, Melbourne, Vic 3052, Australia.	leesuyi121@gmail.com	Amatya, Bhasker/E-1062-2017; Uddin, Taslim/L-7816-2016; Uddin, Taslim/AAC-4850-2022	Amatya, Bhasker/0000-0003-4793-1104; Uddin, Taslim/0000-0002-2884-9212; Uddin, Taslim/0000-0002-2884-9212	Department of Rehabilitation Medicine, Royal Melbourne Hospital, Royal Park Campus, Melbourne, Australia	This review was supported by internal resources of the Department of Rehabilitation Medicine, Royal Melbourne Hospital, Royal Park Campus, Melbourne, Australia, and no external funding was available. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.	Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carney N., 2016, GUIDELINES MANAGEMEN, V4th; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cincinnati Children's Hospital Medical Center Best evidence statement (BESt), 2012, COORD OUTP REH CAR P, DOI [10.1094/PDIS-11-11-0999-PDN, DOI 10.1094/PDIS-11-11-0999-PDN]; Department of Labor and Employment, 2013, TRAUM BRAIN INJ MED; Harris SR, 2012, CANCER S, V118, P2012, DOI [10.1002/cncr.26523, DOI 10.1002/CNCR.26523]; Hoffmann-Esser W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174831; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Iosifidis P, 2016, PALGR GLOB MED POL, P1, DOI 10.1057/978-1-137-41030-6; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kochanek P, 2012, PLANT DIS, V96, DOI [10.1094/PDIS-11-11-0999-PDN, DOI 10.1094/PDIS-11-11-0999-PDN]; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; McMilla A G, 2013, BRAIN INJURY REHABIL; National Institute for Health and Care Excellence, 2016, MAJ TRAUM ASS IN MAN; National institute of health and care excellence, 2014, HEAD INJURY; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Reed D, 2011, ADULT TRAUMA CLIN PR; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Siering U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082915; SIGN, 2009, EARL MAN PAT HEAD IN; Sun MF, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/519032; Tuck D, 2014, TRAUMATIC BRAIN INJU; Vos P, 2012, PLANT DIS, V96, DOI [10.1094/PDIS-11-11-0999-PDN, DOI 10.1094/PDIS-11-11-0999-PDN]; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	27	10	10	2	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2019	33	10					1263	1271		10.1080/02699052.2019.1641747		JUL 2019	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM5YC	WOS:000476299900001	31314607				2022-02-06	
J	Kuceyeski, AF; Jamison, KW; Owen, JP; Raj, A; Mukherjee, P				Kuceyeski, Amy F.; Jamison, Keith W.; Owen, Julia P.; Raj, Ashish; Mukherjee, Pratik			Longitudinal increases in structural connectome segregation and functional connectome integration are associated with better recovery after mild TBI	HUMAN BRAIN MAPPING			English	Article						connectome; diffusion MRI; imaging methodology; resting state connectivity; tractography; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CONNECTIVITY; DIFFUSION; STATE; CONSCIOUSNESS; DYSFUNCTION; NETWORKS; STRESS; MODELS; LEVEL	Traumatic brain injury damages white matter pathways that connect brain regions, disrupting transmission of electrochemical signals and causing cognitive and emotional dysfunction. Connectome-level mechanisms for how the brain compensates for injury have not been fully characterized. Here, we collected serial MRI-based structural and functional connectome metrics and neuropsychological scores in 26 mild traumatic brain injury subjects (29.4 +/- 8.0 years, 20 males) at 1 and 6 months postinjury. We quantified the relationship between functional and structural connectomes using network diffusion (ND) model propagation time, a measure that can be interpreted as how much of the structural connectome is being utilized for the spread of functional activation, as captured via the functional connectome. Overall cognition showed significant improvement from 1 to 6 months (t(25) = -2.15, p = .04). None of the structural or functional global connectome metrics was significantly different between 1 and 6 months, or when compared to 34 age- and gender-matched controls (28.6 +/- 8.8 years, 25 males). We predicted longitudinal changes in overall cognition from changes in global connectome measures using a partial least squares regression model (cross-validated R-2 = .27). We observe that increased ND model propagation time, increased structural connectome segregation, and increased functional connectome integration were related to better cognitive recovery. We interpret these findings as suggesting two connectome-based postinjury recovery mechanisms: one of neuroplasticity that increases functional connectome integration and one of remote white matter degeneration that increases structural connectome segregation. We hypothesize that our inherently multimodal measure of ND model propagation time captures the interplay between these two mechanisms.	[Kuceyeski, Amy F.; Jamison, Keith W.] Weill Cornell Med, Dept Radiol, 515 E 71st St, New York, NY 10065 USA; [Kuceyeski, Amy F.] Weill Cornell Med, Brain & Mind Res Inst, New York, NY 10065 USA; [Owen, Julia P.; Raj, Ashish; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Mukherjee, Pratik] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA		Kuceyeski, AF (corresponding author), Weill Cornell Med, Dept Radiol, 515 E 71st St, New York, NY 10065 USA.	amk2012@med.cornell.edu		Jamison, Keith/0000-0001-7139-6661; Kuceyeski, Amy/0000-0002-5050-8342	Anna-Maria and Stephen Kellen Foundation; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01 EB022717]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS060776, R01 NS102646-01A1, R01NS092802, R21 NS104634-01]; GE HealthcareGeneral ElectricGE Healthcare; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB022717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092802, R21NS104634, R01NS102646] Funding Source: NIH RePORTER	Anna-Maria and Stephen Kellen Foundation, Grant/Award Number: Junior Faculty Fellowship; National Institute of Biomedical Imaging and Bioengineering, Grant/Award Number: R01 EB022717; National Institute of Neurological Disorders and Stroke, Grant/Award Numbers: R01 NS060776, R01 NS102646-01A1, R01NS092802, R21 NS104634-01; GE Healthcare	Abdelnour F, 2018, NEUROIMAGE, V172, P728, DOI 10.1016/j.neuroimage.2018.02.016; Abdelnour F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004564; Abdelnour F, 2014, NEUROIMAGE, V90, P335, DOI 10.1016/j.neuroimage.2013.12.039; Ashman TA, 2006, MT SINAI J MED, V73, P999; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Cauda F, 2018, BRAIN, V141, P3211, DOI 10.1093/brain/awy252; Cazalis Fabienne, 2011, Front Neurol, V1, P158, DOI 10.3389/fneur.2010.00158; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chu Shu-Hsien, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P2740, DOI 10.1109/EMBC.2018.8512852; Chu SH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23051-9; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Das TK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/237898; Deco G, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00068; Demertzi A, 2014, CORTEX, V52, P35, DOI 10.1016/j.cortex.2013.11.005; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Falcon MI, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0158-15.2016; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Galan RF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002148; Goni J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058070; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kuceyeski A, 2016, NEUROIMAGE-CLIN, V11, P635, DOI 10.1016/j.nicl.2016.04.006; Kuceyeski A, 2011, NEUROIMAGE, V58, P109, DOI 10.1016/j.neuroimage.2011.05.087; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Messe A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003530; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Palacios E., 2018, BIORXIV345629; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scheibel RS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00352; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Seguin C, 2018, P NATL ACAD SCI USA, V115, P6297, DOI 10.1073/pnas.1801351115; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Soddu A, 2011, FUNCT NEUROL, V26, P37; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; van der Horn HJ, 2017, J NEUROTRAUM, V34, P1035, DOI 10.1089/neu.2016.4659; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Woolrich MW, 2013, NEUROIMAGE, V80, P330, DOI 10.1016/j.neuroimage.2013.03.059; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	79	10	10	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	OCT 15	2019	40	15					4441	4456		10.1002/hbm.24713		JUL 2019	16	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	RB6YY	WOS:000474863300001	31294921	Green Accepted, Green Submitted, Green Published			2022-02-06	
J	Warmath, D; Winterstein, AP				Warmath, Dee; Winterstein, Andrew P.			Reporting Skill: The Missing Ingredient in Concussion Reporting Intention Assessment	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; reporting; skill; training	SELF-EFFICACY; EDUCATION; KNOWLEDGE; SPORT; PLAYERS	Background: Extant literature suggests that a substantial portion of athletes may not report a possible concussion and that concussion knowledge is insufficient to predict concussion reporting behavior. One area that has not been explored is reporting skill; that is, mastery of the actions required to report a concussion. This study evaluated the relationship between reporting skill and reporting intention, introducing a measure of the reporting skill construct. Hypotheses: Reporting intentions will be more closely associated with reporting skill than with concussion/symptom knowledge. The relationship between concussion (or symptom) knowledge and reporting intentions will differ by level of reporting skill. Study Design: Repeated cross-sectional study. Methods: A set of items was administered to young adults aged 18 to 24 years from the Survey Sampling International panel. Exploratory/confirmatory factor analyses were conducted on 2 waves of data to develop the scale (n = 899). Hypotheses were tested using structural equation modeling on the responses from the third wave of participants (n = 406). Results: Knowing the actions to take in reporting was more important than having knowledge of concussions or concussion symptoms. Reporting skill, not concussion or concussion symptom knowledge, was associated with higher intentions to report symptoms. Among those with higher levels of reporting skill, concussion symptom knowledge (but not general concussion knowledge) was associated with higher intentions to report symptoms. Conclusion: Reporting skill is an important and, until now, missing ingredient in the concussion literature and practice.	[Warmath, Dee] Univ Georgia, Coll Family & Consumer Sci, Dept Financial Planning Housing & Consumer Econ, Dawson Hall Room 307,305 Sanford Dr, Athens, GA 30602 USA; [Winterstein, Andrew P.] Univ Wisconsin, Sch Educ, Dept Kinesiol, Madison, WI USA		Warmath, D (corresponding author), Univ Georgia, Coll Family & Consumer Sci, Dept Financial Planning Housing & Consumer Econ, Dawson Hall Room 307,305 Sanford Dr, Athens, GA 30602 USA.	warmath@uga.edu	Warmath, Dee/AAK-5148-2021	Warmath, Dee/0000-0001-8301-1386	National Collegiate Athletic Association; Department of DefenseUnited States Department of Defense	The following authors declared potential conflicts of interest: D.W. and A.P.W. report grants from NCAA Mind Matters Challenge. This study was supported by the National Collegiate Athletic Association and Department of Defense through a Mind Matters Challenge Grant.	Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; ARNETT JJ, 1995, J MARRIAGE FAM, V57, P617, DOI 10.2307/353917; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bagozzi RP., 1988, J ACAD MARKET SCI, V16, P74, DOI DOI 10.1007/BF02723327; BANDURA A, 1993, EDUC PSYCHOL, V28, P117, DOI 10.1207/s15326985ep2802_3; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Baugh CM, 2019, J NEUROTRAUM, V36, P2065, DOI 10.1089/neu.2018.6161; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Bergman ME, 2002, J APPL PSYCHOL, V87, P230, DOI 10.1037//0021-9010.87.2.230; BLOOM BS, 1956, TAXONOMY ED OBJECTIV, V1, DOI DOI 10.1007/S40279-013-0084-3; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Carroll-Alfano M, 2017, J ATHL TRAINING, V52, P689, DOI 10.4085/1062-6050-52.3.08; *CDCP, HEADS YOUTH SPORTS, DOI DOI 10.1016/J.GAITPOST.2011.09.104; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; *CONS FIN PROT BUR, 2018, MEAS FIN SKILL GUID, DOI DOI 10.1136/BJSM.2007.044677; *CONS FIN PROT BUR, 2015, FIN WELL BEING GOAL, DOI DOI 10.1136/BJSPORTS-2012-090953; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; FANG Z, 1999, J RES CHILDHOOD ED, V13, P175, DOI DOI 10.1080/02568549909594738; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; HARROW AJ, 1972, TAXONOMY PSYCHOMOTOR, DOI DOI 10.1007/S11136-010-9606-8; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jonker L, 2010, J SPORT SCI, V28, P901, DOI 10.1080/02640411003797157; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Keenan J. P., 1990, J BUSINESS PSYCHOL, V5, P223, DOI DOI 10.1007/BF01014334; KRATHWOHL DR, 1964, TAXONOMY ED OBJECTIV, V2, DOI DOI 10.2519/JOSPT.2016.6280; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; *NAT COLL ATHL ASS, CONC ED RES; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; SCHNEIDER W, 1998, HDB CHILD PSYCHOL, V0002, P00467; Shin S, 2015, NURS EDUC TODAY, V35, P176, DOI 10.1016/j.nedt.2014.09.009; Zelazo PD, 1998, CURR DIR PSYCHOL SCI, V7, P121, DOI 10.1111/1467-8721.ep10774761	44	10	10	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	SEP	2019	11	5					416	424	1941738119856609	10.1177/1941738119856609		JUL 2019	9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	IT6GH	WOS:000476459100001	31268836	Green Published			2022-02-06	
J	Baskota, SU; Lopez, OL; Greenamyre, JT; Kofler, J				Baskota, Swikrity Upadhyay; Lopez, Oscar L.; Greenamyre, J. Timothy; Kofler, Julia			Spectrum of tau pathologies in Huntington's disease	LABORATORY INVESTIGATION			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; AMYOTROPHIC-LATERAL-SCLEROSIS; ALZHEIMERS ASSOCIATION GUIDELINES; FRONTOTEMPORAL LOBAR DEGENERATION; NEUROPATHOLOGIC ASSESSMENT; INTRANUCLEAR INCLUSIONS; NATIONAL INSTITUTE; FUS; PROTEIN; FUS/TLS	Huntington's disease (HD) is an autosomal dominant disorder caused by a trinucleotide expansion in the huntingtin gene. Recently, a new role for tau has been implicated in the pathogenesis of HD, whereas others have argued that postmortem tau pathology findings are attributable to concurrent Alzheimer's disease pathology. The frequency of other well-defined common age-related tau pathologies in HD has not been examined in detail. In this single center, retrospective analysis, we screened seven cases of Huntington's disease (5 females, 2 males, age at death: 47-73 years) for neuronal and glial tau pathology using phospho-tau immunohistochemistry. All seven cases showed presence of neuronal tau pathology. Five cases met diagnostic criteria for primary age-related tauopathy (PART), with three cases classified as definite PART and two cases as possible PART, all with a Braak stage of I. One case was diagnosed with low level of Alzheimer's disease neuropathologic change. In the youngest case, rare perivascular aggregates of tau-positive neurons, astrocytes and processes were identified at sulcal depths, meeting current neuropathological criteria for stage 1 chronic traumatic encephalopathy (CTE). Although the patient had no history of playing contact sports, he experienced several falls, but no definitive concussions during his disease course. Three of the PART cases and the CTE-like case showed additional evidence of aging-related tau astrogliopathy. None of the cases showed significant tau pathology in the striatum. In conclusion, while we found evidence for tau hyperphosphorylation and aggregation in all seven of our HD cases, the tau pathology was readily classifiable into known diagnostic entities and most likely represents non-specific age- or perhaps trauma-related changes. As the tau pathology was very mild in all cases and not unexpected for a population of this age range, it does not appear that the underlying HD may have promoted or accelerated tau accumulation.	[Baskota, Swikrity Upadhyay; Kofler, Julia] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Lopez, Oscar L.; Greenamyre, J. Timothy] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Lopez, Oscar L.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Greenamyre, J. Timothy] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA USA		Kofler, J (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	koflerjk@upmc.edu	Kofler, Julia/AAJ-8032-2021	Greenamyre, J. Timothy/0000-0003-3468-7878	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIA P50 AG005133]; University of Pittsburgh Brain Institute; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005133] Funding Source: NIH RePORTER	The authors would like to acknowledge the excellent technical assistance of Jonette Werley, Mark Stauffer, and Kelly Ann Puglisi with immunohistochemical stains. The authors would also like to thank Peter Davies and Manuela Neumann for providing antibodies used in this project. This study was supported by the National Institute of Health grant NIA P50 AG005133 and the University of Pittsburgh Brain Institute.	[Anonymous], 1997, Neurobiol Aging, V18, pS1; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blum D, 2015, HUM MOL GENET, V24, P76, DOI 10.1093/hmg/ddu421; Braak H, 2014, ACTA NEUROPATHOL, V128, P767, DOI 10.1007/s00401-014-1356-1; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Charles V, 2000, NEUROSCI LETT, V289, P29, DOI 10.1016/S0304-3940(00)01247-7; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Davis MY, 2014, J HUNTINGTONS DIS, V3, P209, DOI 10.3233/JHD-140111; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Fernandez-Nogales M, 2014, NAT MED, V20, P881, DOI 10.1038/nm.3617; Fujioka Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02388; Gratuze M, 2016, BRAIN, V139, P1014, DOI 10.1093/brain/aww021; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Ishigaki S, 2017, CELL REP, V18, P1118, DOI 10.1016/j.celrep.2017.01.013; Ishigaki S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00529; Jellinger KA, 1998, J NEURAL TRANSM, V105, P787, DOI 10.1007/s007020050095; Kim SD, 2014, CURR OPIN NEUROL, V27, P477, DOI 10.1097/WCO.0000000000000116; Kino Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35236; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Kovacs GG, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0552-y; Kovacs GG, 2017, BRAIN PATHOL, V27, P675, DOI 10.1111/bpa.12536; Kovacs GG, 2017, J NEUROPATH EXP NEUR, V76, P270, DOI 10.1093/jnen/nlx007; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Neumann M, 2009, ACTA NEUROPATHOL, V118, P605, DOI 10.1007/s00401-009-0581-5; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Orozco D, 2012, EMBO REP, V13, P759, DOI 10.1038/embor.2012.90; Ray P, 2011, J MOL NEUROSCI, V45, P453, DOI 10.1007/s12031-011-9634-z; Rogelj B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00603; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; St-Amour I, 2018, ACTA NEUROPATHOL, V135, P249, DOI 10.1007/s00401-017-1786-7; Sturrock A, 2010, J GERIATR PSYCH NEUR, V23, P243, DOI 10.1177/0891988710383573; Tada M, 2012, ACTA NEUROPATHOL, V124, P749, DOI 10.1007/s00401-012-1005-5; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vonsattel Jean Paul G, 2008, Handb Clin Neurol, V89, P599, DOI 10.1016/S0072-9752(07)01256-0; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Vuono R, 2015, BRAIN, V138, P1907, DOI 10.1093/brain/awv107; Woulfe J, 2010, BRAIN PATHOL, V20, P589, DOI 10.1111/j.1750-3639.2009.00337.x	50	10	10	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	JUL	2019	99	7					1068	1077		10.1038/s41374-018-0166-9			10	Medicine, Research & Experimental; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pathology	IG3XK	WOS:000473738500014	30573872				2022-02-06	
J	Healy, RJ; Zorrilla-Vaca, A; Ziai, W; Mirski, MA; Hogue, CW; Geocadin, R; Radzik, B; Palmisano, C; Rivera-Lara, L				Healy, Ryan J.; Zorrilla-Vaca, Andres; Ziai, Wendy; Mirski, Marek A.; Hogue, Charles W.; Geocadin, Romergryko; Radzik, Batya; Palmisano, Caitlin; Rivera-Lara, Lucia			Glasgow Coma Scale Score Fluctuations are Inversely Associated With a NIRS-based Index of Cerebral Autoregulation in Acutely Comatose Patients	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						Glasgow Coma Scale; near-infrared spectroscopy; cerebral autoregulation; multimodal monitoring	TRAUMATIC BRAIN-INJURY; NEAR-INFRARED SPECTROSCOPY; SUBARACHNOID HEMORRHAGE; CARDIOPULMONARY BYPASS; OUTCOME PREDICTION; PERFUSION-PRESSURE; PROGNOSTIC VALUE; MOTOR SCORE; MORTALITY; SEVERITY	Background: The Glasgow Coma Scale (GCS) is an essential coma scale in critical care for determining the neurological status of patients and for estimating their long-term prognosis. Similarly, cerebral autoregulation (CA) monitoring has shown to be an accurate technique for predicting clinical outcomes. However, little is known about the relationship between CA measurements and GCS scores among neurological critically ill patients. This study aimed to explore the association between noninvasive CA multimodal monitoring measurements and GCS scores. Methods: Acutely comatose patients with a variety of neurological injuries admitted to a neurocritical care unit were monitored using near-infrared spectroscopy-based multimodal monitoring for up to 72 hours. Regional cerebral oxygen saturation (rScO(2)), cerebral oximetry index (COx), GCS, and GCS motor data were measured hourly. COx was calculated as a Pearson correlation coefficient between low-frequency changes in rScO(2) and mean arterial pressure. Mixed random effects models with random intercept was used to determine the relationship between hourly near-infrared spectroscopy-based measurements and GCS or GCS motor scores. Results: A total of 871 observations (h) were analyzed from 57 patients with a variety of neurological conditions. Mean age was 58.7 +/- 14.2 years and the male to female ratio was 1:1.3. After adjusting for hemoglobin and partial pressure of carbon dioxide in arterial blood, COx was inversely associated with GCS (beta=-1.12, 95% confidence interval [CI], -1.94 to -0.31, P=0.007) and GCS motor score (beta=-1.06, 95% CI, -2.10 to -0.04, P=0.04). In contrast rScO(2) was not associated with GCS (beta=-0.002, 95% CI, -0.01 to 0.01, P=0.76) or GCS motor score (beta=-0.001, 95% CI, -0.01 to 0.01, P=0.84). Conclusions: This study showed that fluctuations in GCS scores are inversely associated with fluctuations in COx; as COx increases (impaired autoregulation), more severe neurological impairment is observed. However, the difference in COx between high and low GCS is small and warrants further studies investigating this association. CA multimodal monitoring with COx may have the potential to be used as a surrogate of neurological status when the neurological examination is not reliable (ie, sedation and paralytic drug administration).	[Healy, Ryan J.; Zorrilla-Vaca, Andres; Ziai, Wendy; Geocadin, Romergryko; Rivera-Lara, Lucia] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Healy, Ryan J.; Ziai, Wendy; Mirski, Marek A.; Geocadin, Romergryko; Rivera-Lara, Lucia] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Hogue, Charles W.] Northwestern Univ Feinberg, Sch Med, Dept Anesthesiol, Chicago, IL USA; [Zorrilla-Vaca, Andres] Univ Valle, Sch Med, Fac Hlth, Cali, Colombia; [Radzik, Batya; Palmisano, Caitlin] Johns Hopkins Univ Hosp, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA		Healy, RJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.; Healy, RJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	ryanhealy@comcast.net	Vaca, Andres Zorrilla/I-9274-2014; Rivera-Lara, Lucia/AAX-8233-2020	Vaca, Andres Zorrilla/0000-0001-8140-8486; Rivera-Lara, Lucia/0000-0002-9053-2283	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL092259] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL092259] Funding Source: Medline		BRODERSE.P, 1974, REV EEG NEUROPHYSIOL, V4, P329, DOI 10.1016/S0370-4475(74)80019-5; Budohoski KP, 2013, J CEREBR BLOOD F MET, V33, P449, DOI 10.1038/jcbfm.2012.189; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Demet G, 2000, J Postgrad Med, V46, P70; DERR RF, 1973, J NEUROCHEM, V21, P1555, DOI 10.1111/j.1471-4159.1973.tb06039.x; DONEGAN JH, 1985, AM J PHYSIOL, V249, pH421, DOI 10.1152/ajpheart.1985.249.2.H421; Dunham CM, 2004, J TRAUMA, V56, P482, DOI 10.1097/01.TA.0000114537.52540.95; Dunham CM, 2002, J TRAUMA, V52, P40, DOI 10.1097/00005373-200201000-00009; Eggers KM, 2018, INT J CARDIOL, V257, P300, DOI 10.1016/j.ijcard.2017.10.095; Fischer J, 2001, Crit Care Nurs Q, V23, P52; Handschu R, 2005, J NEUROL, V252, P1249, DOI 10.1007/s00415-005-0853-5; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hori D, 2014, BRIT J ANAESTH, V113, P1009, DOI 10.1093/bja/aeu319; Hori D, 2015, ANN THORAC SURG, V100, P487, DOI 10.1016/j.athoracsur.2015.03.036; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Lewis SB, 1996, CRIT CARE MED, V24, P1334, DOI 10.1097/00003246-199608000-00011; Lidon-Moyano C, 2017, CANCER EPIDEMIOL, V51, P87, DOI 10.1016/j.canep.2017.10.011; Livingston BM, 2000, CRIT CARE MED, V28, P389, DOI 10.1097/00003246-200002000-00017; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Navarrete-Navarro P, 2003, INTENS CARE MED, V29, P1237, DOI 10.1007/s00134-003-1755-6; Neuhaus JM, 2013, STAT MED, V32, P2419, DOI 10.1002/sim.5682; Neuhaus JM, 2011, CAN J STAT, V39, P488; Ono M, 2012, BRIT J ANAESTH, V109, P391, DOI 10.1093/bja/aes148; Ono M, 2014, J THORAC CARDIOV SUR, V147, P483, DOI 10.1016/j.jtcvs.2013.07.069; Rasulo FA, 2012, J NEUROSURG ANESTH, V24, P3, DOI 10.1097/ANA.0b013e318224030a; Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038; Rivera-Lara L, 2017, NEUROCRIT CARE, V27, P362, DOI 10.1007/s12028-017-0421-8; Rivera-Lara L, 2017, CRIT CARE MED, V45, P695, DOI 10.1097/CCM.0000000000002251; Scheeren TWL, 2012, J CLIN MONIT COMPUT, V26, P279, DOI 10.1007/s10877-012-9348-y; Schmidt B, 2016, J CLIN MONIT COMPUT, V30, P367, DOI 10.1007/s10877-015-9726-3; Sen AN, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031409; Shah FA, 2017, CURR OPIN CRIT CARE, V23, P45, DOI 10.1097/MCC.0000000000000382; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; Starke RM, 2009, J CLIN NEUROSCI, V16, P26, DOI 10.1016/j.jocn.2008.02.010; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Summors AC, 1999, ANESTH ANALG, V88, P341, DOI 10.1097/00000539-199902000-00022; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Weigl W, 2016, J CEREBR BLOOD F MET, V36, P1825, DOI 10.1177/0271678X16667953	40	10	10	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2019	31	3					306	310		10.1097/ANA.0000000000000513			5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	ID4TM	WOS:000471669200008	29782388	Green Accepted			2022-02-06	
J	Hou, WS; Rhodes, CS; Jiang, L; Roys, S; Zhuo, JC; JaJa, J; Gullapalli, RP				Hou, Wenshuai; Rhodes, Chandler Sours; Jiang, Li; Roys, Steven; Zhuo, Jiachen; JaJa, Joseph; Gullapalli, Rao P.			Dynamic Functional Network Analysis in Mild Traumatic Brain Injury	BRAIN CONNECTIVITY			English	Article						dynamic functional connectivity; graph theory; mild traumatic brain injury; postconcussive syndrome	CONNECTIVITY; FMRI; PERFUSION; CLASSIFICATION; DISRUPTION; REGRESSION; DEFICITS; ISSUES	Mild traumatic brain injury (mTBI) is one of the most common neurological disorders for which a subset of patients develops persistent postconcussive symptoms. Previous studies discovered abnormalities and disruptions in the brain functional networks of mTBI patients principally using static functional connectivity measures which assume that neural communication across the brain is static during resting state conditions. In this study, we examine the differences in dynamic neural communication between mTBI and control participants through the application of a combination of dynamic functional analysis and graph theoretic algorithms. Resting state functional magnetic resonance imaging data was obtained on 47 mTBI patients at the acute stage of injury and 30 demographically matched healthy control participants. Results show unique alterations in both the static and dynamic functional connectivity at the acute stage in mTBI patients who suffer persistent symptoms (>= 6 months after injury). In addition, mTBI patients with postconcussion syndrome demonstrated a unique allocation of time in various brain states compared to both control participants and mTBI patients with favorable outcomes. These findings suggest that global damage to the overall communication across the brain in the acute stage may contribute to chronic mTBI symptoms. Dynamic functional analysis is a powerful tool that provides insights into the brain states and the innovative analysis methodology utilized may hold the potential to delineate patients predisposed to poor outcomes upon early presentation following injury.	[Hou, Wenshuai; JaJa, Joseph] UMIACS, Dept Elect & Comp Engn, College Pk, MD USA; [Rhodes, Chandler Sours; Jiang, Li; Roys, Steven; Zhuo, Jiachen; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 South Greene St, Baltimore, MD 21201 USA		Gullapalli, RP (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 South Greene St, Baltimore, MD 21201 USA.; JaJa, J (corresponding author), Univ Maryland, Dept Elect & Comp Engn, UMIACS, 3433 AV Williams Bldg, College Pk, MD 20742 USA.	josephj@umd.edu; rgullapalli@umm.edu			University of Maryland/Mpowering the State through the Center for Health-related Informatics and Bioimaging (CHIB); Department of DefenseUnited States Department of Defense [W81XWH-08-1-0725, W81XWH-12-1-0098]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS105503]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS105503] Funding Source: NIH RePORTER	We gratefully acknowledge funding provided by The University of Maryland/Mpowering the State through the Center for Health-related Informatics and Bioimaging (CHIB) to R.P.G. and J.J. Support for this work was in part provided by the Department of Defense (W81XWH-08-1-0725, W81XWH-12-1-0098) and National Institutes of Health (1R01NS105503).	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Cherkassky BV, 1996, MATH PROGRAM, V73, P129, DOI 10.1007/BF02592101; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damaraju E, 2014, NEUROIMAGE-CLIN, V5, P298, DOI 10.1016/j.nicl.2014.07.003; Ding H, 2008, PROC VLDB ENDOW, V1, P1542; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Faul M, 2010, TRAUMATIC BRAIN INJU; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gilbert N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197419; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Hyvarinen A, 1999, ISCAS '99: PROCEEDINGS OF THE 1999 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOL 5, P57, DOI 10.1109/ISCAS.1999.777510; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Isometsa E, 2014, CAN J PSYCHIAT, V59, P120, DOI 10.1177/070674371405900303; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LEHMANN D, 1990, MACHINERY OF THE MIND, P209; Leonardi N, 2015, NEUROIMAGE, V104, P430, DOI 10.1016/j.neuroimage.2014.09.007; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Minati L, 2014, MED ENG PHYS, V36, P1212, DOI 10.1016/j.medengphy.2014.06.012; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pettie S, 2002, J ACM, V49, P16, DOI 10.1145/505241.505243; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Ryali S, 2012, NEUROIMAGE, V59, P3852, DOI 10.1016/j.neuroimage.2011.11.054; Ryali S, 2010, NEUROIMAGE, V51, P752, DOI 10.1016/j.neuroimage.2010.02.040; Sair HI, 2016, HUM BRAIN MAPP, V37, P913, DOI 10.1002/hbm.23075; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sours C, 2015, BRAIN CONNECT, V5, P442, DOI 10.1089/brain.2014.0333; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; SPM8, 2009, STAT PARAMETRIC MAPP; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Talairach J., 1988, COPLANAR STEREOTAXIC; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; The World Health Organization, 2010, INT CLASS DIS; Tie YM, 2014, HUM BRAIN MAPP, V35, P1018, DOI 10.1002/hbm.22231; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Varoquaux G, 2010, NEUROIMAGE, V51, P288, DOI 10.1016/j.neuroimage.2010.02.010; Varoquaux G, 2010, I S BIOMED IMAGING, P1177, DOI 10.1109/ISBI.2010.5490204; Vergara VM, 2018, NEUROIMAGE-CLIN, V19, P30, DOI 10.1016/j.nicl.2018.03.017; Vergara VM, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.809; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zalesky A, 2015, NEUROIMAGE, V114, P466, DOI 10.1016/j.neuroimage.2015.03.047; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	57	10	10	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	JUL 1	2019	9	6					475	487		10.1089/brain.2018.0629			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IL0VR	WOS:000477018800003	30982332	Green Published			2022-02-06	
J	Kane, MS; Sonne, C; Zhu, SY; Malhotra, A; Van Haren, K; Messacar, K; Glaser, CA				Kane, Miranda S.; Sonne, Chris; Zhu, Shiyun; Malhotra, Amit; Van Haren, Keith; Messacar, Kevin; Glaser, Carol A.			Incidence, Risk Factors and Outcomes Among Children With Acute Flaccid Myelitis: A Population-based Cohort Study in a California Health Network Between 2011 and 2016	PEDIATRIC INFECTIOUS DISEASE JOURNAL			English	Article						AFM; Paralysis; risk factors; incidence	CLINICAL-FEATURES; ATOPIC-DERMATITIS; ENCEPHALITIS; PARALYSIS; TRAUMA; JAPAN	Background: Acute flaccid myelitis (AFM) is defined as an acute onset of limb weakness with longitudinal spinal gray matter lesions. Reporting bias and misdiagnosis confound epidemiologic studies of AFM. We mitigated these confounders by using a large data set to assess AFM incidence, risk factors and outcomes in a fixed population. Methods: A retrospective cohort study was conducted within Kaiser Permanente Northern California population among children 1-18 years. Cases met radiographic and clinical criteria for AFM and were confirmed by two clinicians. Clinical and demographic data were assessed. Results: A total of 28 patients met study criteria for AFM between January 1, 2011 and December 31, 2016, an overall rate of 1.46 per 100,000 person-years. Incidence increased from 0.30 to 1.43 cases/per 100,000 person-years between 2011 and 2016, respectively. Median age was 9 years. Risk factors included male sex, Asian ancestry and history of asthma, atopic dermatitis or head injury. Risk factors associated with poliomyelitis were absent. Prodromal illness was common; enterovirus was the most common pathogen detected (n = 5). Among the 27 patients with 12-month follow-up, most demonstrated some improvement, 11 (41.0%) had full recovery, but several had significant deficits with one death reported after the study period. Conclusions: We employed a closed-population study to generate AFM incidence, risk and outcome data. Our findings support previous reports of male sex and atopy as risk factors. Interval increase in incidence, predisposing Asian ancestry and history of head injury were unique findings to this study. Overall prognosis was better than prior reports, but recovery was incomplete in several patients.	[Kane, Miranda S.] Kaiser Permanente Oakland Med Ctr, Dept Pediat Hosp Med, 3600 Broadway Ave, Oakland, CA 94611 USA; [Kane, Miranda S.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Sonne, Chris] Kaiser Permanente Oakland Med Ctr, Dept Radiol, Oakland, CA USA; [Sonne, Chris] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Zhu, Shiyun] Kaiser Permanente, Div Res, Biostat Consulting Unit, Oakland, CA USA; [Malhotra, Amit] Kaiser Permanente Oakland Med Ctr, Dept Pediat Specialty, Oakland, CA USA; [Van Haren, Keith] Stanford Univ, Dept Neurol, Sch Med, Palo Alto, CA 94304 USA; [Messacar, Kevin] Univ Colorado, Childrens Hosp Colorado, Dept Pediat, Sect Hosp Med, Aurora, CO USA; [Messacar, Kevin] Univ Colorado, Childrens Hosp Colorado, Dept Pediat, Infect Dis Sect, Aurora, CO USA; [Glaser, Carol A.] Kaiser Permanente Oakland Med Ctr, Dept Pediat Infect Dis, Oakland, CA USA		Kane, MS (corresponding author), Kaiser Permanente Oakland Med Ctr, Dept Pediat Hosp Med, 3600 Broadway Ave, Oakland, CA 94611 USA.; Kane, MS (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	Miranda.d.savani@kp.org		Van Haren, Keith/0000-0002-0233-9361; Messacar, Kevin/0000-0001-5830-3491			Ayscue P, 2014, MMWR-MORBID MORTAL W, V63, P903; Battles HT, 2017, SOC SCI HIST, V41, P305, DOI 10.1017/ssh.2017.1; Chong PF, 2018, CLIN INFECT DIS, V66, P653, DOI 10.1093/cid/cix860; Cohen HA, 1998, INFECTION, V26, P247, DOI 10.1007/BF02962374; Crider T, 2018, CLIN NEUROL NEUROSUR, V170, P159, DOI 10.1016/j.clineuro.2018.05.019; Goldacre MJ, 2006, J NEUROL NEUROSUR PS, V77, P351, DOI 10.1136/jnnp.2005.077693; Granerod J, 2016, CLIN RADIOL, V71, P1050, DOI 10.1016/j.crad.2016.03.015; Hu Y, 2015, PEDIATR INFECT DIS J, V34, P718, DOI 10.1097/INF.0000000000000711; Knoester M, 2019, PEDIATR INFECT DIS J, V38, P16, DOI 10.1097/INF.0000000000002188; Koebnick Corinna, 2012, Perm J, V16, P37; Koelman DLH, 2017, EUR J NEUROL, V24, P391, DOI 10.1111/ene.13220; Langer-Gould A, 2011, NEUROLOGY, V77, P1143, DOI 10.1212/WNL.0b013e31822facdd; Li K, 2016, EXP DERMATOL, V25, P816, DOI 10.1111/exd.13063; Lunny CA, 2014, J NEUROL SCI, V336, P13, DOI 10.1016/j.jns.2013.08.011; Martin JA, 2017, NEUROLOGY, V89, P129, DOI 10.1212/WNL.0000000000004081; Marx A, 2000, EPIDEMIOL REV, V22, P298, DOI 10.1093/oxfordjournals.epirev.a018041; Mawdsley SE, 2014, LANCET, V384, P300, DOI 10.1016/S0140-6736(14)61251-4; Messacar K, 2018, LANCET INFECT DIS, V18, pE239, DOI 10.1016/S1473-3099(18)30094-X; Messacar K, 2016, ANN NEUROL, V80, P326, DOI 10.1002/ana.24730; Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0; Miller L, 2017, 2014 RESULTS NATIONW, V63, P737; Montgomery S, 2017, ANN NEUROL, V82, P554, DOI 10.1002/ana.25036; Nathanson N, 2010, AM J EPIDEMIOL, V172, P1213, DOI 10.1093/aje/kwq320; Noda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015; Pandit L, 2015, MULT SCLER J, V21, P845, DOI 10.1177/1352458515572406; Peach ANNM, 1953, FURTHER INVESTIGATIO, P7; RUSSELL W R, 1949, Br Med J, V1, P465; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Sun SY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0103-4; Teoh HL, 2016, JAMA NEUROL, V73, P300, DOI 10.1001/jamaneurol.2015.4388; Van Haren K, 2015, JAMA-J AM MED ASSOC, V314, P2663, DOI 10.1001/jama.2015.17275; Wong M, 2000, ARCH PEDIAT ADOL MED, V154, P827, DOI 10.1001/archpedi.154.8.827; Zhang T, 2018, AM J NEURORADIOL, V39, P824, DOI 10.3174/ajnr.A5593	33	10	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0891-3668	1532-0987		PEDIATR INFECT DIS J	Pediatr. Infect. Dis. J.	JUL	2019	38	7					667	672		10.1097/INF.0000000000002276			6	Immunology; Infectious Diseases; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases; Pediatrics	IE2GT	WOS:000472203300015	30985511				2022-02-06	
J	McIntosh, AS; Willmott, C; Patton, DA; Mitra, B; Brennan, JH; Dimech-Betancourt, B; Howard, TS; Rosenfeld, JV				McIntosh, Andrew S.; Willmott, Catherine; Patton, Declan A.; Mitra, Biswadev; Brennan, James H.; Dimech-Betancourt, Bleydy; Howard, Teresa S.; Rosenfeld, Jeffrey V.			An assessment of the utility and functionality of wearable head impact sensors in Australian Football	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Head impact biomechanics; Wearable sensors; Australian Football; Concussion; Sports injury	LABORATORY EVALUATION; RUGBY; ACCURACY; TEAM	Objectives: To assess the utility and functionality of the X-Patch (R) as a measurement tool to study head impact exposure in Australian Football. Accuracy, precision, reliability and validity were examined. Designs: Laboratory tests and prospective observational study. Methods: Laboratory tests on X-Patch (R) were undertaken using an instrumented Hybrid III head and neck and linear impactor. Differences between X-Patch (R) and reference data were analysed. Australian Football players wore the X-Patch (R) devices and games were video-recorded. Video recordings were analysed qualitatively for head impact events and these were correlated with X-Patch (R) head acceleration events. Wearability of the X-Patch (R) was assessed using the Comfort Rating Scale for Wearable Computers. Results: Laboratory head impacts, performed at multiple impact sites and velocities, identified significant correlations between headform-measured and device-measured kinematic parameters (p < 0.05 for all). On average, the X_Patch (R) -recorded peak linear acceleration (PLA) was 17% greater than the reference PLA, 28% less for peak rotational acceleration (PRA) and 101% greater for the Head Injury Criterion (HIC). For video analysis, 118 head acceleration events (HAE) were included with PLA >= 30 g across 53 players. Video recordings of X-Patch (R) -measured HAEs (PLA >= 30 g) determined that 31.4% were direct head impacts, 9.3% were indirect impacts, 44.1% were unknown or unclear and 15.3% were neither direct nor indirect head impacts. The X-Patch (R) system was deemed wearable by 95-100% of respondents. Conclusions: This study reinforces evidence that use of the current X-Patch (R) devices should be limited to research only and in conjunction with video analysis. (C) 2019 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[McIntosh, Andrew S.] Monash Univ, MUARC, Melbourne, Vic, Australia; [McIntosh, Andrew S.; Patton, Declan A.] Federat Univ Australia, Ballarat, Vic, Australia; [Willmott, Catherine; Dimech-Betancourt, Bleydy] Monash Univ, Monash Inst Cognit & Clin Neurosci, Sch Psychol Sci, Melbourne, Vic, Australia; [Willmott, Catherine; Dimech-Betancourt, Bleydy] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Mitra, Biswadev; Brennan, James H.; Howard, Teresa S.] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Mitra, Biswadev] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Howard, Teresa S.; Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic, Australia		McIntosh, AS (corresponding author), Monash Univ, Monash Univ Accid Res Ctr, Level 1,Bldg 70,Clayton Campus,21 Alliance Lane, Clayton, Vic 3800, Australia.	as.mcintosh@bigpond.com	Mitra, Biswadev/AAC-3724-2019; Willmott, Catherine/AAA-5105-2019	Mitra, Biswadev/0000-0002-0508-2450; Willmott, Catherine/0000-0001-8517-9035	Monash University Faculty of Medicine, Nursing & Health Sciences StrategicMonash University [Grant-SGS15-196]	This study was supported by a Monash University Faculty of Medicine, Nursing & Health Sciences Strategic Grant-SGS15-196. The X2 Biosystems X-Patch devices were purchased on a commercial basis. The authors wish to thank the staff and players at Melbourne High School Old Boys and Eastern Devils football clubs for their willing participation and genuine interest in the study findings. We also acknowledge the assistance of: Nicole Stefanac, Karen Richardson & Ebony Lindor in data collection and coding.	Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; King D, 2017, INT J SPORTS SCI COA, V12, P359, DOI 10.1177/1747954117710512; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Knight JF, 2005, HUM FACTORS, V47, P77, DOI 10.1518/0018720053653875; Mcintosh A.S., 2014, CONCUSSIONS ATHLETIC, P167, DOI [DOI 10.1007/978-1-4939-0295-8_9, 10.1007/978-1-4939-0295-8_9]; McIntosh A S, 2010, P 37 STAPP CAR CRASH; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1108, DOI 10.1136/bjsports-2015-095094; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2012, P I MECH ENG P-J SPO, V226, P193, DOI 10.1177/1754337111431024; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; SAE International, 2014, INSTR IMP TEST 1; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	24	10	10	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JUL	2019	22	7					784	789		10.1016/j.jsams.2019.02.004			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	IM1ZL	WOS:000477790300009	31000457				2022-02-06	
J	Schneider, KJ				Schneider, Kathryn J.			Concussion - Part I: The need for a multifaceted assessment	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article							TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; CERVICAL FLEXOR MUSCLES; DYNAMIC VISUAL-ACUITY; FLEXION-ROTATION TEST; KING-DEVICK TEST; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; POSTURAL STABILITY; NECK PAIN	Introduction: Concussion is among the most commonly occurring sport and recreation injuries in today's society. An understanding of the heterogenous nature of concussion will assist in directing a multifaceted and comprehensive interdisciplinary assessment following injury. Purpose: The purpose of this masterclass article is to summarize the current state of the evidence in the area of concussion, describe typical symptom presentations and assessment techniques that may assist in directing appropriate management following concussion. Implications: A comprehensive assessment including a thoughtful differential diagnosis will assist the clinician to direct care appropriately and efficiently in individuals who have suffered a concussion.	[Schneider, Kathryn J.] Univ Calgary, Alberta Childrens Hosp Res Inst, Sport Injury Prevent Res Ctr, Fac Kinesiol,Hotchkiss Brain Inst, KNB3300D,2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada		Schneider, KJ (corresponding author), Univ Calgary, Alberta Childrens Hosp Res Inst, Sport Injury Prevent Res Ctr, Fac Kinesiol,Hotchkiss Brain Inst, KNB3300D,2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kjschnei@ucalgary.ca		Schneider, Kathryn/0000-0002-5951-5899			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Armstrong B, 2008, SPORTS MED, V38, P101, DOI 10.2165/00007256-200838020-00002; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Balatsouras DG, 2007, INT J PEDIATR OTORHI, V71, P487, DOI 10.1016/j.ijporl.2006.11.024; Balatsouras DG, 2017, ANN OTO RHINOL LARYN, V126, P54, DOI 10.1177/0003489416674961; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Black A. M., 2017, BJSM BR J SEX MED, V51, pe201; BOGDUK N, 1986, J NEUROL NEUROSUR PS, V49, P775, DOI 10.1136/jnnp.49.7.775; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Chen XQ, 2013, MANUAL THER, V18, P562, DOI 10.1016/j.math.2013.05.015; Choi JH, 2017, STROKE, V48, P556, DOI 10.1161/STROKEAHA.116.015507; Cohen H., 2010, ACTA OTO-LARYNGOL, P1; Daley M, 2009, SLEEP MED, V10, P427, DOI 10.1016/j.sleep.2008.04.005; Dannenbaum E, 2009, OTOL NEUROTOL, V30, P368, DOI 10.1097/MAO.0b013e31819bda35; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Edmondston S, 2011, MANUAL THER, V16, P332, DOI 10.1016/j.math.2010.12.005; Edmondston SJ, 2008, J MANIP PHYSIOL THER, V31, P348, DOI 10.1016/j.jmpt.2008.04.010; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Ellis MJ, 2019, J HEAD TRAUMA REHAB, V34, P103, DOI 10.1097/HTR.0000000000000411; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Falla DL, 2004, SPINE, V29, P2108, DOI 10.1097/01.brs.0000141170.89317.0e; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Foundation O. O. N., 2018, GUID CONC MTBI PERS; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Grandner Michael A, 2006, Sleep Biol Rhythms, V4, P129, DOI 10.1111/j.1479-8425.2006.00207.x; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hall T, 2004, MANUAL THER, V9, P197, DOI 10.1016/j.math.2004.04.004; Herdman SJ, 1998, AM J OTOL, V19, P790; Herdman SJ, 2007, VESTIBULAR REHABILIT; Heyer GL, 2016, CEPHALALGIA, V36, P309, DOI 10.1177/0333102415590240; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; Hillier S, 2007, COCHRANE DB SYST REV, V17; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hong TP, 2014, BRAIN INJURY, V28, P839; Hynes L. M., 2006, BRAIN INJ, V20; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jull G, 1999, CEPHALALGIA, V19, P179, DOI 10.1046/j.1468-2982.1999.1903179.x; Jull G, 2007, PAIN, V129, P28, DOI 10.1016/j.pain.2006.09.030; JULL G, 1988, MED J AUSTRALIA, V148, P233, DOI 10.5694/j.1326-5377.1988.tb99431.x; Jull GA, 2008, J MANIP PHYSIOL THER, V31, P525, DOI 10.1016/j.jmpt.2008.08.003; Kattah JC, 2009, STROKE, V40, P3504, DOI 10.1161/STROKEAHA.109.551234; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; L'Heureux-Lebeau B, 2014, OTOL NEUROTOL, V35, P1858, DOI 10.1097/MAO.0000000000000506; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laukkanen H, 2017, OPTOMETRY VISION SCI, V94, P43, DOI 10.1097/OPX.0000000000000940; Leddy J. J., 2013, USE GRADED EXERCISE, V12; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lluch E, 2015, J MANIP PHYSIOL THER, V38, P587, DOI 10.1016/j.jmpt.2015.08.004; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; MacGregor K., 2017, BJSM BR J SEX MED, V51, pE126; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Manaseer TS, 2020, CLIN J SPORT MED, V30, pS11, DOI 10.1097/JSM.0000000000000537; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Merwick A., 2014, BMJ-BRIT MED J, P1; Metcalfe S, 2006, J MAN MANIP THER, V14, P152, DOI 10.1179/106698106790835687; Mollayeva T, 2016, SLEEP MED, V20, P157, DOI 10.1016/j.sleep.2015.09.008; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Necajauskaite Olga, 2005, Medicina (Kaunas), V41, P100; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Oddsdottir GL, 2012, MANUAL THER, V17, P60, DOI 10.1016/j.math.2011.08.009; Ogince M, 2007, MANUAL THER, V12, P256, DOI 10.1016/j.math.2006.06.016; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Olson LE, 2006, J MANIP PHYSIOL THER, V29, P134, DOI 10.1016/j.jmpt.2005.12.009; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P263, DOI 10.1016/j.pediatrneurol.2014.10.013; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Reid S, 2007, MAN THER, V13, P357; Reid SA, 2005, MANUAL THER, V10, P4, DOI 10.1016/j.math.2004.03.006; Reid SA, 2017, MUSCULOSKEL SCI PRAC, V30, P42, DOI 10.1016/j.msksp.2017.03.008; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Robinson KE, 2014, J PEDIATR PSYCHOL, V39, P846, DOI 10.1093/jpepsy/jsu031; Saxena Anudeep, 2015, J Pain Palliat Care Pharmacother, V29, P16, DOI 10.3109/15360288.2014.997853; Schneider GM, 2014, ARCH PHYS MED REHAB, V95, P1695, DOI 10.1016/j.apmr.2014.02.026; Schneider GM, 2013, ARCH PHYS MED REHAB, V94, P1628, DOI 10.1016/j.apmr.2013.02.015; Schneider K, 2018, CJSM EPUB; Schneider K., 2017, BJSM BR J SEX MED, V51, pE132; Schneider K. J., 2017, BJSM BR J SEX MED, V51, pE124; Schneider KJ, 2018, J ORTHOP SPORT PHYS, V48, P974, DOI 10.2519/jospt.2018.8258; Schneider KJ, 2016, J ORTHOP SPORT PHYS, V46, P613, DOI 10.2519/jospt.2016.0607; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schubert MC, 2004, PHYS THER, V84, P151, DOI 10.1093/ptj/84.2.151; Schubert MC, 2004, PHYS THER, V84, P373, DOI 10.1093/ptj/84.4.373; Seidman DH, 2015, J NEUROL SCI, V356, P97, DOI 10.1016/j.jns.2015.06.021; Sharma I., 2018, CJSM, V28, pE71; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Tjell C, 1998, AM J OTOL, V19, P76; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2008, ARCH PHYS MED REHAB, V89, P522, DOI 10.1016/j.apmr.2007.11.002; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Treleaven J, 2016, MANUAL THER, V22, P122, DOI 10.1016/j.math.2015.10.017; van Leeuwen RB, 2017, ACTA NEUROL BELG, V117, P241, DOI 10.1007/s13760-016-0694-2; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wiseman-Hakes C., 2009, CRIT REV PHYS REHABI, V21, P317, DOI [10.1615/CritRevPhysRehabilMed.v21.i3-4.70, DOI 10.1615/CRITREVPHYSREHABILMED.V21.I3-4.70]; Woodhouse A, 2010, EXP BRAIN RES, V201, P261, DOI 10.1007/s00221-009-2033-9; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Zasler ND, 2015, BRAIN INJURY, V29, P207, DOI 10.3109/02699052.2014.965213; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	157	10	10	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	JUL	2019	42						140	150		10.1016/j.msksp.2019.05.007			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	IC2BJ	WOS:000470764100020	31133539				2022-02-06	
J	Suskauer, SJ; Yeates, KO; Sarmiento, K; Benzel, EC; Breiding, MJ; Broomand, C; Haarbauer-Krupa, J; Turner, M; Weissman, B; Lumba-Brown, A				Suskauer, Stacy J.; Yeates, Keith Owen; Sarmiento, Kelly; Benzel, Edward C.; Breiding, Matthew J.; Broomand, Catherine; Haarbauer-Krupa, Juliet; Turner, Michael; Weissman, Barbara; Lumba-Brown, Angela			Strengthening the Evidence Base: Recommendations for Future Research Identified Through the Development of CDC's Pediatric Mild TBI Guideline	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						child; concussion; guideline; mild traumatic brain injury; pediatrics; study design	TRAUMATIC BRAIN-INJURY; COMMON DATA ELEMENTS; CHILDREN; CONCUSSION; SYMPTOMS; EPIDEMIOLOGY	Objective: The recently published Centers for Disease Control and Prevention evidence-based guideline on pediatric mild traumatic brain injury (mTBI) was developed following an extensive review of the scientific literature. Through this review, experts identified limitations in existing pediatric mTBI research related to study setting and generalizability, mechanism of injury and age of cohorts studied, choice of control groups, confounding, measurement issues, reporting of results, and specific study design considerations. This report summarizes those limitations and provides a framework for optimizing the future quality of research conduct and reporting. Results: Specific recommendations are provided related to diagnostic accuracy, population screening, prognostic accuracy, and therapeutic interventions. Conclusion: Incorporation of the recommended approaches will increase the yield of eligible research for inclusion in future systematic reviews and guidelines for pediatric mTBI.	[Suskauer, Stacy J.] Kennedy Krieger Inst, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Yeates, Keith Owen] Univ Calgary, Calgary, AB, Canada; [Sarmiento, Kelly; Breiding, Matthew J.; Haarbauer-Krupa, Juliet] Ctr Dis Control & Prevent, Atlanta, GA USA; [Benzel, Edward C.] Cleveland Clin, Cleveland, OH 44106 USA; [Turner, Michael] Goodman Campbell Brain & Spine, Indianapolis, IN USA; [Weissman, Barbara] Emory Univ, Sch Med, Atlanta, GA USA; [Lumba-Brown, Angela] Stanford Univ, Sch Med, Stanford, CA 94305 USA		Suskauer, SJ (corresponding author), 707 North Broadway, Baltimore, MD 21205 USA.	suskauer@kennedykrieger.org	Yeates, Keith/AAJ-4223-2020		Orthopedic Research and Education Foundation [12-205]; DODUnited States Department of Defense; Department of DefenseUnited States Department of Defense; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Medtronic CorporationMedtronic; NICO corporation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Research Institute at Nationwide Children's Hospital in Columbus, Ohio	The findings and conclusions in this article are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Dr Benzel discloses 2012 Spine Prospective Clinical Research Grant #12-205, "Anatomical Differences and Protective Helmet Design in American Football," which he received from the Orthopedic Research and Education Foundation, and his work with Prevent Biometrics, where he was awarded DOD and US Department of Transportation grants focusing on concussion dosimetry and behavioral deficits. Dr Lumba-Brown reports receiving a grant from the Department of Defense. Dr Suskauer reports receiving funding from the National Institute of Child Health and Human Development. Dr Turner discloses 2 sources of corporate financial support from Medtronic Corporation and NICO corporation. Dr Yeates discloses his role as the President of the International Neuropsychological Society, his research grant support from NIH and the Canadian Institutes of Health Research, and his research support from the Research Institute at Nationwide Children's Hospital in Columbus, Ohio. Drs Benzel, Broomand, Lumba-Brown, Suskauer, Turner, and Yeates report that they did not receive grants for this submitted work and were on the expert work group that helped form the basis for the CDC guideline. Ms Sarmiento was the designated federal official for CDC Pediatric Mild TBI Workgroup.	American Academy of Neurology, 2011, CLIN PRACTICE GUIDEL; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN; Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moons KGM, 2015, ADV ANAT PATHOL, V22, P303, DOI 10.1097/PAP.0000000000000072; Risen SR, 2017, PM&R, V9, P874, DOI 10.1016/j.pmrj.2016.12.005; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	25	10	10	2	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2019	34	4					215	223		10.1097/HTR.0000000000000455			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IQ4XH	WOS:000480754400010	30608306	Green Accepted			2022-02-06	
J	Zeiler, FA; Ercole, A; Cabeleira, M; Beqiri, E; Zoerle, T; Carbonara, M; Stocchetti, N; Menon, DK; Smielewski, P; Czosnyka, M; Anke, A; Beer, R; Bellander, BM; Buki, A; Chevallard, G; Chieregato, A; Citerio, G; Czeiter, E; Depreitere, B; Eapen, G; Frisvold, S; Helbok, R; Jankowski, S; Kondziella, D; Koskinen, LO; Meyfroidt, G; Moeller, K; Nelson, D; Piippo-Karjalainen, A; Radoi, A; Ragauskas, A; Raj, R; Rhodes, J; Rocka, S; Rossaint, R; Sahuquillo, J; Sakowitz, O; Stevanovic, A; Sundstrom, N; Takala, R; Tamosuitis, T; Tenovuo, O; Vajkoczy, P; Vargiolu, A; Vilcinis, R; Wolf, S; Younsi, A				Zeiler, Frederick A.; Ercole, Ari; Cabeleira, Manuel; Beqiri, Erta; Zoerle, Tommaso; Carbonara, Marco; Stocchetti, Nino; Menon, David K.; Smielewski, Peter; Czosnyka, Marek; Anke, Audny; Beer, Ronny; Bellander, Bo-Michael; Buki, Andras; Chevallard, Giorgio; Chieregato, Arturo; Citerio, Giuseppe; Czeiter, Endre; Depreitere, Bart; Eapen, George; Frisvold, Shirin; Helbok, Raimund; Jankowski, Stefan; Kondziella, Daniel; Koskinen, Lars-Owe; Meyfroidt, Geert; Moeller, Kirsten; Nelson, David; Piippo-Karjalainen, Anna; Radoi, Andreea; Ragauskas, Arminas; Raj, Rahul; Rhodes, Jonathan; Rocka, Saulius; Rossaint, Rolf; Sahuquillo, Juan; Sakowitz, Oliver; Stevanovic, Ana; Sundstrom, Nina; Takala, Riikka; Tamosuitis, Tomas; Tenovuo, Olli; Vajkoczy, Peter; Vargiolu, Alessia; Vilcinis, Rimantas; Wolf, Stefan; Younsi, Alexander		CTR-TBI High Resolution ICU	Compensatory-reserve-weighted intracranial pressure versus intracranial pressure for outcome association in adult traumatic brain injury: a CENTER-TBI validation study	ACTA NEUROCHIRURGICA			English	Article						Compensatory reserve; Intracranial pressure; Outcome; Weighted ICP	MANAGEMENT	BackgroundCompensatory-reserve-weighted intracranial pressure (wICP) has recently been suggested as a supplementary measure of intracranial pressure (ICP) in adult traumatic brain injury (TBI), with a single-center study suggesting an association with mortality at 6months. No multi-center studies exist to validate this relationship. The goal was to compare wICP to ICP for association with outcome in a multi-center TBI cohort.MethodsUsing the Collaborative European Neuro Trauma Effectiveness Research in TBI (CENTER-TBI) high-resolution intensive care unit (ICU) cohort, we derived ICP and wICP (calculated as wICP=(1-RAP)xICP; where RAP is the compensatory reserve index derived from the moving correlation between pulse amplitude of ICP and ICP). Various univariate logistic regression models were created comparing ICP and wICP to dichotomized outcome at 6 to 12months, based on Glasgow Outcome ScoreExtended (GOSE) (alive/deadGOSE 2/GOSE=1; favorable/unfavorableGOSE 5 to 8/GOSE 1 to 4, respectively). Models were compared using area under the receiver operating curves (AUC) and p values.ResultswICP displayed higher AUC compared to ICP on univariate regression for alive/dead outcome compared to mean ICP (AUC 0.712, 95% CI 0.615-0.810, p=0.0002, and AUC 0.642, 95% CI 0.538-746, p<0.0001, respectively; no significant difference on Delong's test), and for favorable/unfavorable outcome (AUC 0.627, 95% CI 0.548-0.705, p=0.015, and AUC 0.495, 95% CI 0.413-0.577, p=0.059; significantly different using Delong's test p=0.002), with lower wICP values associated with improved outcomes (p<0.05 for both). These relationships on univariate analysis held true even when comparing the wICP models with those containing both ICP and RAP integrated area under the curve over time (p<0.05 for all via Delong's test).ConclusionsCompensatory-reserve-weighted ICP displays superior outcome association for both alive/dead and favorable/unfavorable dichotomized outcomes in adult TBI, through univariate analysis. Lower wICP is associated with better global outcomes. The results of this study provide multi-center validation of those seen in a previous single-center study.	[Zeiler, Frederick A.; Ercole, Ari; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada; [Zeiler, Frederick A.; Cabeleira, Manuel; Beqiri, Erta; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Beqiri, Erta; Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Zoerle, Tommaso; Carbonara, Marco; Stocchetti, Nino] Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Anke, Audny] Univ Hosp Northern Norway, Dept Phys Med & Rehabil, Tromso, Norway; [Beer, Ronny; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Innsbruck, Austria; [Bellander, Bo-Michael; Nelson, David] Karolinska Univ Hosp, Dept Neurosurg & Anesthesia & Intens Care Med, Stockholm, Sweden; [Buki, Andras; Czeiter, Endre] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] Univ Pecs, MTA PTE Clin Neurosci MR Res Grp, Hungarian Brain Res Program, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] Univ Pecs, Janos Szentagothai Res Ctr, Hungarian Brain Res Program, Pecs, Hungary; [Chevallard, Giorgio; Chieregato, Arturo] Osped Niguarda Ca Granda, NeuroIntens Care, Milan, Italy; [Citerio, Giuseppe; Vargiolu, Alessia] ASST Monza, Dept Anesthesia & Intens Care, NeuroIntens Care Unit, Monza, Italy; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Depreitere, Bart] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium; [Frisvold, Shirin] Univ Hosp Northern Norway, Dept Anesthesiol & Intens Care, Tromso, Norway; [Jankowski, Stefan] Sheffield Teaching Hosp NHS Fdn Trust, Neurointens Care, Sheffield, S Yorkshire, England; [Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Neurol, Copenhagen, Denmark; [Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Clin Neurophysiol, Copenhagen, Denmark; [Kondziella, Daniel; Moeller, Kirsten] Reg Hovedstaden Rigshosp, Dept Neuroanesthesiol, Copenhagen, Denmark; [Koskinen, Lars-Owe] Umea Univ Hosp, Dept Clin Neurosci, Neurosurg, Umea, Sweden; [Meyfroidt, Geert] Univ Hosp Leuven, Intens Care Med, Leuven, Belgium; [Piippo-Karjalainen, Anna; Raj, Rahul] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Radoi, Andreea; Sahuquillo, Juan] Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Ragauskas, Arminas; Rocka, Saulius] Kaunas Univ Technol, Dept Neurosurg, Vilnius, Lithuania; [Ragauskas, Arminas; Rocka, Saulius] Vilnius Univ, Vilnius, Lithuania; [Rhodes, Jonathan] NHS Lothian, Dept Anaesthesia Crit Care & Pain Med, Edinburgh, Midlothian, Scotland; [Rhodes, Jonathan] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Rossaint, Rolf; Stevanovic, Ana] Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany; [Sakowitz, Oliver] Klinikum Ludwigsburg, Klin Neurochirurg, Ludwigsburg, Germany; [Sakowitz, Oliver; Younsi, Alexander] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany; [Sundstrom, Nina] Umea Univ Hosp, Dept Radiat Sci, Biomed Engn, Umea, Sweden; [Takala, Riikka] Turku Univ, Cent Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Takala, Riikka; Tenovuo, Olli] Univ Turku, Turku, Finland; [Tamosuitis, Tomas] Kaunas Univ Hlth Sci, Neurointens Care Unit, Kaunas, Lithuania; [Tenovuo, Olli] Turku Univ, Cent Hosp, Rehabil & Brain Trauma, Turku, Finland; [Vajkoczy, Peter] Charite Univ Med Berlin, Neurol Neurochirurg & Psychiat, Berlin, Germany; [Vilcinis, Rimantas] Kaunas Univ Hlth Sci, Dept Neurosurg, Kaunas, Lithuania; [Wolf, Stefan] Charite Univ Med Berlin, Interdisciplinary Neuro Intens Care Unit, Berlin, Germany		Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada.; Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab, Cambridge, England.	umzeiler@myumanitoba.ca; ae105@cam.ac.uk; mc916@cam.ac.uk; erta.beqiri@gmail.com; tommaso.zoerle@policlinico.mi.it; marco.carbonara@gmail.com; nino.stocchetti@policlinico.mi.it; dkm13@cam.ac.uk; ps10011@cam.ac.uk; mc141@medschl.cam.ac.uk	Depreitere, Bart/AAA-9846-2020; Koskinen, Lars-Owe/AAQ-8957-2020; Carbonara, Marco/N-3793-2015; Sahuquillo, Juan/B-3577-2008; Raj, Rahul/K-7693-2012; Helbok, Raimund/AAA-8361-2021; Ercole, Ari/B-6288-2009; Younsi, Alexander/AAW-7869-2020; Moller, Kirsten/A-4751-2009	Depreitere, Bart/0000-0002-7458-0648; Carbonara, Marco/0000-0002-1431-8322; Sahuquillo, Juan/0000-0003-0713-5875; Raj, Rahul/0000-0003-4243-9591; Ercole, Ari/0000-0001-8350-8093; Younsi, Alexander/0000-0002-8218-9243; Kondziella, Daniel/0000-0001-5562-9808; Zoerle, Tommaso/0000-0001-8713-8085; Sakowitz, Oliver/0000-0003-3248-6335; Radoi, Andreea/0000-0002-0677-3544; Zeiler, Frederick/0000-0003-1737-0510; Moller, Kirsten/0000-0003-3058-1072; Nelson, David/0000-0003-2530-8207	European Union 7th Framework program (EC grant) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); National Institute for Health Research (NIHR, UK)National Institute for Health Research (NIHR); Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust; NIHR Clinical Research network; Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada -Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Thorlakson Chair in Surgical Research Establishment Fund; University of Manitoba Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship Award	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA).; DKM was also supported by funding from the National Institute for Health Research (NIHR, UK) through a Senior Investigator award and the Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust. The study also received additional support from the NIHR Clinical Research network. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care, UK.; FAZ has received salary support for dedicated research time, during which part of this project was completed. Such salary support came from the Cambridge Commonwealth Trust Scholarship, the University of Manitoba Clinician Investigator Program, and the Royal College of Surgeons of Canada -Harry S. Morton Travelling Fellowship in Surgery. FAZ receives research support from the University of Manitoba Thorlakson Chair in Surgical Research Establishment Fund, the University of Manitoba Research Investment Fund (RIF), and the University of Manitoba Rudy Falk Clinician-Scientist Professorship Award.; PS and MC receive part of licensing fees for the software ICM+ (Cambridge Enterprise Ltd., UK) used for data collection and analysis in this study.	Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Calviello L, 2018, NEUROCRIT CARE, V28, P212, DOI 10.1007/s12028-017-0475-7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 2005, ACT NEUR S, V95, P341; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zeiler FA, 2018, ACTA NEUROCHIR, V160, P2277, DOI 10.1007/s00701-018-3681-y	12	10	10	2	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2019	161	7					1275	1284		10.1007/s00701-019-03915-3			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ID9JZ	WOS:000472004700002	31053909	Green Published, Green Submitted, hybrid			2022-02-06	
J	Zhang, CY; Ren, XM; Li, HB; Wei, W; Wang, KX; Li, YM; Hu, JL; Li, X				Zhang, C-Y; Ren, X-M; Li, H-B; Wei, W.; Wang, K-X; Li, Y-M; Hu, J-L; Li, X.			Simvastatin alleviates inflammation and oxidative stress in rats with cerebral hemorrhage through Nrf2-ARE signaling pathway	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Cerebral hemorrhage; Inflammatory response; Oxidative stress; Simvastatin	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; ANGIOGENESIS	OBJECTIVE: To investigate the regulatory effects of simvastatin on the inflammation and oxidative stress in rats with cerebral hemorrhage through the nuclear factor E2-related factor 2-antioxidant response element (Nrf2-ARE) signaling pathway. MATERIALS AND METHODS: A total of 120 healthy male rats weighing 280-300 g and 7-8 weeks old were selected to establish the traumatic brain injury (TBI) model. Rats were divided into group A (trauma operation, n=30), group B (no treatment, n=30), group C (drug administration after trauma operation, n=30), and group D (no trauma operation, drug administration, n=30). Cerebral edema content in brain tissues was measured by calculating the dry and wet weight. Neurological dysfunction was scored using the Garcia method. Positive levels of the Toll-like receptor 4 (TLR4) and interleukin-1 beta (IL-1 beta) were qualitatively analyzed via immunohistochemistry. Protein levels of TLR4 and IL-1 beta were quantitatively analyzed via Western blotting. Moreover, the brain injury volume and neuronal apoptosis were evaluated via Nissl staining and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining, respectively. At 48 h after injury, activities of superoxide dismutase (SOD), reduced glutathione (GSH), and oxidized glutathione (GSSG) in brain tissues were detected, and levels of malondialdehyde (MDA) and nitric oxide (NO) were detected using the enzyme activity assay kits. Finally, relative levels of the Nrf2-ARE signaling pathway and its downstream molecules heme oxygenase-1 (HO-1) and NAD (P) H dehydrogenase, quinone 1 (NQO1) were detected via reverse Transcription-Polymerase Chain Reaction (RT-PCR) and Western blotting. RESULTS: Compared with those in group B, cerebral edema content in brain tissues significantly increased (p<0.05), the neurological dysfunction score significantly declined (p<0.05), and protein levels of TLR4 and IL-1 beta were significantly upregulated in group A (p<0.05). In group C, relative levels of TLR4 and IL-1 beta were down-regulated, cerebral edema content decreased, and the neurological dysfunction score significantly increased (p<0.05). After 48 h, activities of SOD, reduced GSH and GSSG and levels of MDA and NO all increased, and levels of MDA and NO declined in group C (p<0.05). Western blotting and RT-PCR showed that simvastatin could increase the transcriptional level of Nrf2. After simvastatin intervention, expression levels of downstream molecules HO-1 and NQO1 were upregulated. CONCLUSIONS: Simvastatin alleviates TLR4-mediated inflammatory injury, promotes neurological recovery and resists oxidative stress through the Nrf2-ARE signaling pathway, thus exerting a neuroprotective effect in TBI.	[Zhang, C-Y; Li, Y-M; Hu, J-L] Jiamusi Univ, Dept Emergency, Affiliated Hosp 1, Jiamusi, Peoples R China; [Ren, X-M; Wang, K-X; Li, X.] Jiamusi Univ, Dept Neurol, Affiliated Hosp 1, Jiamusi, Peoples R China; [Li, H-B] Jiamusi Univ, Dept Neurosurg, Affiliated Hosp 1, Jiamusi, Peoples R China; [Wei, W.] Jiamusi Univ, Dept Stomatol, Affiliated Hosp 1, Jiamusi, Peoples R China		Li, X (corresponding author), Jiamusi Univ, Dept Neurol, Affiliated Hosp 1, Jiamusi, Peoples R China.	15694548231@163.com			project Tlasmid pVAX1-Mediated Adrenomedullin Gene Therapy for Cerebral Vasospasm Following Subarachnoid Hemorrhage in Rats' [2016-KYYWIF-0579]	This study was supported by the project Tlasmid pVAX1-Mediated Adrenomedullin Gene Therapy for Cerebral Vasospasm Following Subarachnoid Hemorrhage in Rats' (2016-KYYWIF-0579).	Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen L, 2018, EUR REV MED PHARMACO, V22, P2421, DOI 10.26355/eurrev_201804_14835; Chen XS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.261; Hamanaka Junya, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P107; Huang J, 2014, MOL MED, V20, P448, DOI 10.2119/molmed.2014.00103; Kang K, 2012, NEUROL RES, V34, P447, DOI 10.1179/1743132812Y.0000000015; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lei C, 2013, NEUROSCIENCE, V228, P190, DOI 10.1016/j.neuroscience.2012.10.023; Leonarduzzi G, 2010, PHARMACOL THERAPEUT, V128, P336, DOI 10.1016/j.pharmthera.2010.08.003; Liew HK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-13; Liu HC, 2012, BRAIN RES, V1474, P73, DOI 10.1016/j.brainres.2012.07.028; Miao Xingyu, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P970; Okatani Y, 2000, J PINEAL RES, V28, P89, DOI 10.1034/j.1600-079X.2001.280204.x; Povlishock J T, 1992, Hum Cell, V5, P345; van Muiswinkel FL, 2005, CNS NEUROL DISORD-DR, V4, P267, DOI 10.2174/1568007054038238; Venetsanou K, 2007, EUR CYTOKINE NETW, V18, P206, DOI 10.1684/ecn.2007.0112; Vera S, 2015, ANN MED, V47, P289, DOI 10.3109/07853890.2015.1029967	20	10	12	1	9	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	JUL	2019	23	14					6321	6329					9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	IN3HD	WOS:000478567100039	31364139				2022-02-06	
J	Dyhrfort, P; Shen, QJ; Clausen, F; Thulin, M; Enblad, P; Kamali-Moghaddam, M; Lewen, A; Hillered, L				Dyhrfort, Philip; Shen, Qiujin; Clausen, Fredrik; Thulin, Mans; Enblad, Per; Kamali-Moghaddam, Masood; Lewen, Anders; Hillered, Lars			Monitoring of Protein Biomarkers of Inflammation in Human Traumatic Brain Injury Using Microdialysis and Proximity Extension Assay Technology in Neurointensive Care	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; inflammation; microdialysis; molecular tools; neurointensive care; proteomics; traumatic brain injury	INTRACEREBRAL MICRODIALYSIS; CEREBROSPINAL-FLUID; CYTOKINES; HEMORRHAGE; EXPRESSION; CHEMOKINES	Traumatic brain injury (TBI) is followed by secondary injury mechanisms strongly involving neuroinflammation. To monitor the complex inflammatory cascade in human TBI, we used cerebral microdialysis (MD) and multiplex proximity extension assay (PEA) technology and simultaneously measured levels of 92 protein biomarkers of inflammation in MD samples every three hours for five days in 10 patients with severe TBI under neurointensive care. One mu L MD samples were incubated with paired oligonucleotide-conjugated antibodies binding to each protein, allowing quantification by real-time quantitative polymerase chain reaction. Sixty-nine proteins were suitable for statistical analysis. We found five different patterns with either early (<48 h; e.g., CCL20, IL6, LIF, CCL3), mid (48-96 h; e.g., CCL19, CXCL5, CXCL10, MMP1), late (>96 h; e.g., CD40, MCP2, MCP3), biphasic peaks (e.g., CXCL1, CXCL5, IL8) or stable (e.g., CCL4, DNER, VEGFA)/low trends. High protein levels were observed for e.g., CXCL1, CXCL10, MCP1, MCP2, IL8, while e.g., CCL28 and MCP4 were detected at low levels. Several proteins (CCL8, -19, -20, -23, CXCL1, -5, -6, -9, -11, CST5, DNER, Flt3L, and SIRT2) have not been studied previously in human TBI. Cross-correlation analysis revealed that LIF and CXCL5 may play a central role in the inflammatory cascade. This study provides a unique data set with individual temporal trends for potential inflammatory biomarkers in patients with TBI. We conclude that the combination of MD and PEA is a powerful tool to map the complex inflammatory cascade in the injured human brain. The technique offers new possibilities of protein profiling of complex secondary injury pathways.	[Dyhrfort, Philip; Clausen, Fredrik; Enblad, Per; Lewen, Anders; Hillered, Lars] Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden; [Shen, Qiujin; Kamali-Moghaddam, Masood] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Thulin, Mans] Uppsala Univ, Dept Stat, Uppsala, Sweden; [Thulin, Mans] Univ Edinburgh, Sch Math, Edinburgh, Midlothian, Scotland; [Thulin, Mans] Univ Edinburgh, Maxwell Inst Math Sci, Edinburgh, Midlothian, Scotland		Clausen, F (corresponding author), Uppsala Univ, Dept Neurosci, SE-75185 Uppsala, Sweden.	Fredrik.clausen@neuro.uu.se		Clausen, Fredrik/0000-0003-3592-4417	Uppsala University Hospital; Centre of Excellence Neurotrauma; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Vinnova FoundationVinnova; Uppsala Berzelii Technology Centre for Neurodiagnostics; Marie Curie ITN (GastricGlycoExplorer); Selander Foundation; Uppsala County Council (Region Uppsala)	The authors are sincerely grateful to the nurses and staff of the NIC unit for running the bedside microdialysis and to Inger Stahl Myllyaho for excellent technical assistance. The study was supported financially by Uppsala University Hospital, Uppsala County Council (Region Uppsala), the Centre of Excellence Neurotrauma, the Swedish Research Council, the Vinnova Foundation, the Uppsala Berzelii Technology Centre for Neurodiagnostics, Marie Curie ITN (GastricGlycoExplorer) and the Selander Foundation.	Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Dahlin AP, 2010, ANAL CHEM, V82, P4376, DOI 10.1021/ac1007706; Darmanis S, 2016, CELL REP, V14, P380, DOI 10.1016/j.celrep.2015.12.021; Darmanis S, 2010, MOL CELL PROTEOMICS, V9, P327, DOI 10.1074/mcp.M900248-MCP200; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Guilfoyle MR, 2015, J NEUROTRAUM, V32, P1553, DOI 10.1089/neu.2014.3764; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helsel D.R., 2011, STAT CENSORED ENV DA, V2; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Hill LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04722-5; Hillered L, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00245; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104754; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; Landegren U, 2012, ANAL CHEM, V84, P1824, DOI 10.1021/ac2032222; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maciejewski-Lenoir D, 1999, J IMMUNOL, V163, P1628; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mellergard P, 2008, NEUROSURGERY, V62, P151, DOI 10.1227/01.NEU.0000311072.33615.3A; Mellergard P, 2011, NEUROSURGERY, V68, P12, DOI 10.1227/NEU.0b013e3181ef2a40; Michlmayr D, 2014, J VIROL, V88, P9553, DOI 10.1128/JVI.03421-13; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Nepusz T, 2006, INTERJOURNAL COMPLEX; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Pepe G, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1011-6; Pittaluga A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01079; Puntambekar SS, 2018, BRAIN BEHAV IMMUN, V71, P9, DOI 10.1016/j.bbi.2018.03.033; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Roberts DJ, 2013, J NEUROTRAUM, V30, P1717, DOI 10.1089/neu.2012.2841; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Shore PM, 2004, NEUROSURGERY, V54, P605, DOI 10.1227/01.NEU.0000108642.88724.DB; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Simats A, 2018, J INTERN MED, V283, P461, DOI 10.1111/joim.12738; Team R. C, 2016, R LANG ENV STAT COMP; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zeiler FA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00331	48	10	10	3	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2019	36	20					2872	2885		10.1089/neu.2018.6320		JUN 2019	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JC0JD	WOS:000472621900001	31017044	hybrid, Green Submitted, Green Published			2022-02-06	
J	Barthelemy, EJ; Spaggiari, R; Corley, J; Lepard, JR; Staffa, SJ; Iv, V; Servadei, F; Park, KB				Barthelemy, Ernest J.; Spaggiari, Riccardo; Corley, Jacquelyn; Lepard, Jacob R.; Staffa, Steven J.; Iv, Vycheth; Servadei, Franco; Park, Kee B.			Injury-to-Admission Delay Beyond 4 Hours Is Associated with Worsening Outcomes for Traumatic Brain Injury in Cambodia	WORLD NEUROSURGERY			English	Article						Global health; Global neurosurgery; Global surgery; LMIC; Prehospital care; Sustainable development; TBI	HEMATOMA	BACKGROUND: In Cambodia, the most common victims of traumatic brain injury (TBI) are men 20-30 years of age involved in motor vehicle collision. Secondary injury sustained by these patients occurs during the time period between initial insult and hospital admission. Strengthening prehospital systems for TBI in low- and middle-income countries (LMICs) such as Cambodia is therefore a key element of the development agenda for universal health equity. We report a retrospective analysis of the relationship between prehospital delays and TBI outcomes among patients from a large government hospital in Cambodia. METHODS: Data were collected from 3476 patients with TBI admitted to a major government hospital in Phnom Penh, Cambodia, from June 2013 to June 2018. Patients with missing data or those admitted >8 hours postinjury were excluded. Statistical analyses examined associations between injury-to-admission delay (IAD) and outcomes such as Glasgow Outcome Scale (GOS) score and length of stay (LOS). RESULTS: A total of 2125 patients with TBI (76.85% men) were included. The median age was 27 years (interquartile range, 22-37 years). Injury severity at presentation included 1406 mild (66%), 464 moderate (22%), and 240 severe cases (11%). No Glasgow Coma Scale (GCS) data were available for 15 patients (1%). We found an inverse relationship between IAD and GOS score, most evidently for mild and moderate TBI (n = 1870; 88%). Regression analysis revealed a marked decrease in GOS score at the IAD >4-hour threshold. Each 30-minute delay in IAD was correlated with >2-hour increase in LOS for mild (P < 0.001) and moderate TBI (P < 0.001). CONCLUSIONS: In a retrospective cohort of >2000 patients with TBI from Cambodia, we found that increasing IAD was associated with worsening outcome, especially beyond the 4-hour threshold. These data should inform development of prehospital guidelines for TBI care in LMICs.	[Barthelemy, Ernest J.; Corley, Jacquelyn; Lepard, Jacob R.; Park, Kee B.] Harvard Med Sch, Global Neurosurg Initiat, Program Global Surg & Social Change, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Barthelemy, Ernest J.] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA; [Spaggiari, Riccardo; Servadei, Franco] Humanitas Univ & Res Hosp, Milan, Italy; [Corley, Jacquelyn] Duke Dept Neurosurg, Durham, NC USA; [Lepard, Jacob R.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA; [Barthelemy, Ernest J.; Corley, Jacquelyn] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA USA; [Lepard, Jacob R.] Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Staffa, Steven J.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [Iv, Vycheth] Preah Kossamak Hosp, Dept Neurosurg, Phnom Penh, Cambodia		Barthelemy, EJ (corresponding author), Harvard Med Sch, Global Neurosurg Initiat, Program Global Surg & Social Change, Dept Global Hlth & Social Med, Boston, MA 02115 USA.; Barthelemy, EJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA.; Barthelemy, EJ (corresponding author), Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA USA.	globalneurosurgeon@gmail.com		Spaggiari, Riccardo/0000-0001-6069-7514	UAB Women's Leadership Council	This research was conducted while J. R. Lepard was a Wilson Family Clinical Scholar supported by the UAB Women's Leadership Council.	Barthelemy EJ, 2018, WORLD NEUROSURG, V120, P143, DOI 10.1016/j.wneu.2018.08.070; Barthelemy EJ, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.10.012; Fatigba HO, 2013, WORLD NEUROSURG, V80, P246, DOI 10.1016/j.wneu.2011.09.016; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Goldstein LN, 2017, AFR J EMERG MED, V7, P100, DOI 10.1016/j.afjem.2017.04.012; Griswold D, 2016, WORLD NEUROSURG, V93, P474, DOI 10.1016/j.wneu.2016.06.044; Gutowski P, 2018, WORLD NEUROSURG, V118, pE166, DOI 10.1016/j.wneu.2018.06.147; Henry GL, 2010, NEUROLOGIC EMERGENCI; Hilmer Louise Vera, 2018, Asian J Neurosurg, V13, P23, DOI 10.4103/ajns.AJNS_342_16; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kang Jiin, 2015, Korean J Neurotrauma, V11, P112, DOI 10.13004/kjnt.2015.11.2.112; Kobusingye O., 2014, AFR J TRAUMA, V3, P3, DOI DOI 10.4103/1597-1112.139448; Kulkarni AP, 2013, INDIAN J CRIT CARE M, V17, P292, DOI 10.4103/0972-5229.120321; Mason A, 2005, E ASIAN EC DEV 2 DEM; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; Peeters S, 2017, WORLD NEUROSURG, V97, P580, DOI 10.1016/j.wneu.2016.09.127; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; United Nations, TRANSF OUR WORLD 203; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; *WHO, 2005, PREH TRAUM CAR SYST; World Health Organization (WHO) and Cambodian Ministry of Health, 2012, CAMB HLTH SERV DEL P	25	10	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2019	126						E232	E240		10.1016/j.wneu.2019.02.019			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IA0BU	WOS:000469222400029	30825623				2022-02-06	
J	Bustamante, MC; Bruneau, D; Barker, JB; Gierczycka, D; Coralles, MA; Cronin, DS				Bustamante, M. C.; Bruneau, D.; Barker, J. B.; Gierczycka, D.; Coralles, M. A.; Cronin, D. S.			Component-Level Finite Element Model and Validation for a Modern American Football Helmet	JOURNAL OF DYNAMIC BEHAVIOR OF MATERIALS			English	Article						Material characterization; Football helmet; Finite element modelling; Mechanical testing; Thermoplastic urethane	STRESS-STRAIN BEHAVIOR; STATES HIGH-SCHOOL; IMPACT ATTENUATION; HEAD; POLYURETHANE; DEFORMATION; POLYCARBONATE; EPIDEMIOLOGY; PERFORMANCE; CONCUSSIONS	Epidemiological data and measurement of biomechanical data collected through physical experiments have contributed to the understanding of potential head injury risk in contact sports such as football. Further improvement of protective helmets requires repeatable conditions and detailed parametric studies that may be addressed in part using the Finite Element (FE) method. However, such an approach requires thorough experimentation and validation of the helmet materials and subcomponents, which previous studies do not fully address, prior to implementing these subcomponents in a full helmet model. Development of a modern football helmet FE model requires a bottom-up approach, focusing on material testing, constitutive models and subcomponent-level validation, which has not been fully addressed in the literature to date. Material samples were extracted from a modern football helmet including the helmet shell, energy-absorbing structures, comfort foam, and strap system. The subcomponents were tested across a range of quasi-static and high deformation rates relevant to football impact scenarios. FE models of the subcomponents were developed and validated, focusing on verification of material behaviour, representative loading conditions, and mesh convergence to achieve realistic responses and increase computational efficiency. Evaluation of the FE models comparing experimental with simulated responses, yielded good to excellent CORrelation and Analysis (CORA) ratings of 0.954-0.985, 0.931, 0.937-0.974, and 0.847-0.958 for the helmet shell, facemask, energy-absorbing structures, and comfort pads, respectively. The resulting validated subcomponent-level models provide an important foundation for integration into a full helmet model to ultimately optimize performance and reduce head injury.	[Bustamante, M. C.; Bruneau, D.; Barker, J. B.; Gierczycka, D.; Coralles, M. A.; Cronin, D. S.] Univ Waterloo, Dept Mech Engn, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada		Cronin, DS (corresponding author), Univ Waterloo, Dept Mech Engn, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.	dscronin@mecheng1.uwaterloo.ca	Corrales, Miguel A./AAG-1494-2019	Bruneau, David/0000-0002-8612-1959	Football Research, Inc.; Football Research, Inc. (FRI.)	The research presented in this paper was made possible by a Grant from Football Research, Inc. (FRI.) The views expressed are solely those of the authors and do not represent those of FRI or any of its affiliates or funding sources.	Barker JB, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036464; Chang FS, 1998, J ENG MATER-T ASME, V120, P212, DOI 10.1115/1.2812345; Cronin D., 2018, USER MANUAL FINITE E; Cronin DS, 2016, POLYM TEST, V53, P40, DOI 10.1016/j.polymertesting.2016.04.018; Darling T, 2016, COMPUT METHOD BIOMEC, V19, P1432, DOI 10.1080/10255842.2016.1149574; Davallo M., 2012, ADV APPL SCI RES, V3, P1900; DuBois P, 2003, 4 EUR LS DYNA US C U, P31; Gehre C, 2009, ENHANC SAF VEH; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giudice JS, 2018, USER MANUAL FINITE E; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hibbeler R., 2016, MECH MAT, V10; Jankowski M, 2010, FME TRANS, V38, P121; Johnston JM, 2015, SPORTS ENG, V18, P11, DOI 10.1007/s12283-014-0160-4; Krzeminski DE, 2016, POLYM TEST, V55, P190, DOI 10.1016/j.polymertesting.2016.08.019; Lamb L, 2009, AM SOC TEST MATER, V1516, P117, DOI 10.1520/JAI101884; Lamb L, 2009, P I MECH ENG H, V223, P1021, DOI 10.1243/09544119JEIM573; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lu J, 1999, INT J SOLIDS STRUCT, V36, P391, DOI 10.1016/S0020-7683(98)00004-3; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mates S, 2018, DYNAMIC BEHAV MAT, P67; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Moss WC, 2011, IMPACT RESPONSE US A; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Qi HJ, 2005, MECH MATER, V37, P817, DOI 10.1016/j.mechmat.2004.08.001; ROACHE PJ, 1994, J FLUID ENG-T ASME, V116, P405, DOI 10.1115/1.2910291; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Salisbury C., 2015, J DYN BEHAV MAT, V1, P237, DOI DOI 10.1007/S40870-015-0026-2; Salisbury C, 2015, J DYNAM BEHAV MAT, V1, P249; Sarva SS, 2007, POLYMER, V48, P2208, DOI 10.1016/j.polymer.2007.02.058; Semyon M, 2014, CONCUSSIONS ATHLETIC; Serifi E, 2003, 4 EUR LSDYNA US C, P59; Shah QH, 2008, INT J IMPACT ENG, V35, P1244, DOI 10.1016/j.ijimpeng.2007.07.012; TAN LB, 2012, INT J IMPACT ENG, V50, P99, DOI DOI 10.1016/j.ijimpeng.2012.06.003; Thunert, 2012, CORA RELEASE 3 6 USE; Trimino L.F., 2016, J DYNAM BEHAV MAT, V2, DOI [10.1007/s40870-016-0045-7, DOI 10.1007/S40870-016-0045-7]; Tsukinovsky D, 1997, J PHYS IV, V7, P335, DOI 10.1051/jp4:1997359; Uhlemann J, 2015, STEEL CONSTR-DES RES, V8, P222, DOI 10.1002/stco.201510030; Vavalle NA, 2015, ANN BIOMED ENG, V43, P2163, DOI 10.1007/s10439-015-1286-7; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Whyte T, 2016, INT J CRASHWORTHINES, V21, P555, DOI 10.1080/13588265.2016.1199007; Yi J, 2005, STRAIN RATE DEPENDEN, P889; Yin ZN, 2012, APPL MATH MECH-ENGL, V33, P455, DOI 10.1007/s10483-012-1563-x	43	10	10	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2199-7446	2199-7454		J DYNAM BEHAV MAT	J. Dyn. Behav. Mater.	JUN	2019	5	2					117	131		10.1007/s40870-019-00189-9			15	Materials Science, Multidisciplinary; Mechanics; Materials Science, Characterization & Testing	Emerging Sources Citation Index (ESCI)	Materials Science; Mechanics	NZ5HR	WOS:000577131300001					2022-02-06	
J	Collins, JM; King, AE; Woodhouse, A; Kirkcaldie, MTK; Vickers, JC				Collins, Jessica M.; King, Anna E.; Woodhouse, Adele; Kirkcaldie, Matthew T. K.; Vickers, James C.			Age Moderates the Effects of Traumatic Brain Injury on Beta-Amyloid Plaque Load in APP/PS1 Mice	JOURNAL OF NEUROTRAUMA			English	Article						Alzheimer's disease; beta-amyloid; brain Injury; APP; PS1	CONTROLLED CORTICAL IMPACT; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; MICROGLIAL CELLS; COGNITIVE IMPAIRMENT; DIFFUSE PLAQUES; HEAD TRAUMA; RISK-FACTOR; DEPOSITION	Traumatic brain injury (TBI) has been identified as a risk factor for Alzheimer's disease (AD). However, how such neural damage contributes to AD pathology remains unclear; specifically, the relationship between the timing of a TBI relative to aging and the onset of AD pathology is not known. In this study, we have examined the effect of TBI on subsequent beta-amyloid (A beta) deposition in APP/PS1 (APP(SWE)/PSEN1dE9) transgenic mice either before (3 months of age) or after the onset (6 months of age) of plaque pathology. Lateral fluid percussion injury (LFPI), a model of diffuse brain injury, was induced in APP/PS1 and C57Bl/6 wild-type (WT) littermates. LFPI caused a significant increase in both total (p < 0.001) and fibrillar (p < 0.001) A beta plaque load in the cortex of 3-month-old APP/PS1 mice compared to sham-treated mice at 30 days post-injury. However, in the cortex of 6-month-old mice at 30 days post-injury, LFPI caused a significant decrease in total (p < 0.01), but not fibrillar (p > 0.05), A beta plaque load compared to sham-treated mice. No A beta plaques were present in any WT mice across these conditions. Glial fibrillary acidic protein immunolabeling of astrocytes and ionized calcium-binding adapter molecule 1 immunolabeling of microglial/macrophages was not significantly different (p < 0.05) in injured animals compared to sham mice, or APP/PS1 mice compared to WT mice. The current data indicate that TBI may have differential effects on A beta plaque deposition depending on the age and the stage of amyloidosis at the time of injury.	[Collins, Jessica M.; King, Anna E.; Woodhouse, Adele; Kirkcaldie, Matthew T. K.; Vickers, James C.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Private Bag 143, Hobart, Tas 7001, Australia		Collins, JM (corresponding author), Univ Tasmania, Wicking Dementia Res & Educ Ctr, Private Bag 143, Hobart, Tas 7001, Australia.	Jessica.Collins@utas.edu.au	Kirkcaldie, Matthew TK/J-4418-2012; Vickers, James/J-7464-2014	Kirkcaldie, Matthew TK/0000-0003-3285-0168; Vickers, James/0000-0001-5671-4879; Collins, Jessica/0000-0002-1938-2470	Jo and JR Wicking Trust (Equity Trustees)	The technical assistance of Graeme McCormack and Justin Dittman is gratefully acknowledged. Funding was provided by Jo and JR Wicking Trust (Equity Trustees).	Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; Abu Hamdeh S, 2018, BRAIN PATHOL, V28, P451, DOI 10.1111/bpa.12532; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Collins JM, 2015, EXP NEUROL, V267, P219, DOI 10.1016/j.expneurol.2015.02.034; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Dickson TC, 2001, NEUROSCIENCE, V105, P99, DOI 10.1016/S0306-4522(01)00169-5; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Funato H, 1998, AM J PATHOL, V152, P983; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Graham LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21568; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lou DD, 2018, MOL NEUROBIOL, V55, P4928, DOI 10.1007/s12035-017-0687-z; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Masumura M, 2000, J NEUROTRAUM, V17, P123, DOI 10.1089/neu.2000.17.123; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Miszczuk D, 2016, MOL NEUROBIOL, V53, P7010, DOI 10.1007/s12035-015-9578-3; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; O'Mara AR, 2017, J OPEN RES SOFT, V5, P31; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Pierce JES, 1996, J NEUROSCI, V16, P1083; PIKE CJ, 1995, EXP NEUROL, V132, P172, DOI 10.1016/0014-4886(95)90022-5; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; SELKOE DJ, 1989, ANNU REV NEUROSCI, V12, P463, DOI 10.1146/annurev.ne.12.030189.002335; Shishido H, 2016, NEUROSCI LETT, V629, P62, DOI 10.1016/j.neulet.2016.06.066; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Wegiel J, 2000, ACTA NEUROPATHOL, V100, P356, DOI 10.1007/s004010000199; Woodhouse A, 2006, NEUROBIOL DIS, V22, P323, DOI 10.1016/j.nbd.2005.11.010; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Youmans KL, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-8	77	10	10	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1876	1889		10.1089/neu.2018.5982			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600018	30623730				2022-02-06	
J	Shehadeh, M; Palzur, E; Apel, L; Soustiel, JF				Shehadeh, Mona; Palzur, Eilam; Apel, Liat; Soustiel, Jean Francois			Reduction of Traumatic Brain Damage by Tspo Ligand Etifoxine	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						mitochondria; traumatic brain injury; mitochondrial permeability transition pore; translocator protein; etifoxine	PERIPHERAL BENZODIAZEPINE-RECEPTOR; CELL-CYCLE ARREST; PERMEABILITY TRANSITION; MITOCHONDRIAL-MEMBRANE; INDUCE APOPTOSIS; BINDING-SITES; RAT MODEL; PK11195; PROLIFERATION; DERIVATIVES	Experimental studies have shown that ligands of the 18 kDa translocator protein can reduce neuronal damage induced by traumatic brain injury by protecting mitochondria and preventing metabolic crisis. Etifoxine, an anxiolytic drug and 18 kDa translocator protein ligand, has shown beneficial effects in the models of peripheral nerve neuropathy. The present study investigates the potential effect of etifoxine as a neuroprotective agent in traumatic brain injury (TBI). For this purpose, the effect of etifoxine on lesion volume and modified neurological severity score at 4 weeks was tested in Sprague-Dawley adult male rats submitted to cortical impact contusion. Effects of etifoxine treatment on neuronal survival and apoptosis were also assessed by immune stains in the perilesional area. Etifoxine induced a significant reduction in the lesion volume compared to nontreated animals in a dose-dependent fashion with a similar effect on neurological outcome at four weeks that correlated with enhanced neuron survival and reduced apoptotic activity. These results are consistent with the neuroprotective effect of etifoxine in TBI that may justify further translational research.	[Shehadeh, Mona; Palzur, Eilam; Soustiel, Jean Francois] Galilee Med Ctr, Eliachar Res Lab, POB 21, IL-2210001 Nahariyya, Israel; [Apel, Liat] Galilee Med Ctr, Inst Pathol, POB 21, IL-2210001 Nahariyya, Israel; [Apel, Liat; Soustiel, Jean Francois] Bar Ilan Univ, Azrieli Fac Med Galilee, IL-13100 Safed, Israel; [Soustiel, Jean Francois] Galilee Med Ctr, Dept Neurosurg, POB 21, IL-2210001 Nahariyya, Israel		Soustiel, JF (corresponding author), Galilee Med Ctr, Eliachar Res Lab, POB 21, IL-2210001 Nahariyya, Israel.; Soustiel, JF (corresponding author), Bar Ilan Univ, Azrieli Fac Med Galilee, IL-13100 Safed, Israel.; Soustiel, JF (corresponding author), Galilee Med Ctr, Dept Neurosurg, POB 21, IL-2210001 Nahariyya, Israel.	monas@gmc.gov.il; eilamp@gmc.gov.il; Liata@gmc.gov.il; JeanS@gmc.gov.il		Shehadeh, Mona/0000-0001-6075-6676; Palzur, Eilam/0000-0003-2032-2974	Galilee Clinical Bio Research Center	This study was funded by a grant of the Galilee Clinical Bio Research Center.	Aouad M, 2014, EUR J PAIN, V18, P258, DOI 10.1002/j.1532-2149.2013.00367.x; Aouad M, 2014, PAIN, V155, P403, DOI 10.1016/j.pain.2013.11.003; Aouad M, 2009, PAIN, V147, P54, DOI 10.1016/j.pain.2009.08.001; Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; Banker DE, 2002, LEUKEMIA RES, V26, P91, DOI 10.1016/S0145-2126(01)00112-6; Batra S, 1998, INT J ONCOL, V12, P1295; Bono F, 1999, BIOCHEM BIOPH RES CO, V265, P457, DOI 10.1006/bbrc.1999.1683; Campiani G, 1996, J MED CHEM, V39, P3435, DOI 10.1021/jm960251b; Campiani G, 1997, J MED CHEM, V40, P3670, DOI 10.1021/jm970376w; Carmel I, 1999, BIOCHEM PHARMACOL, V58, P273, DOI 10.1016/S0006-2952(99)00093-3; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; Decaudin D, 2002, CANCER RES, V62, P1388; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; Fennell DA, 2001, BRIT J CANCER, V84, P1397, DOI 10.1054/bjoc.2001.1788; Ganau M, 2018, MINERVA ANESTESIOL, V84, P632, DOI 10.23736/S0375-9393.18.12294-2; Ganau Mario, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5010019; Girard C, 2012, J NEUROENDOCRINOL, V24, P71, DOI 10.1111/j.1365-2826.2011.02215.x; Girard C, 2008, P NATL ACAD SCI USA, V105, P20505, DOI 10.1073/pnas.0811201106; Girard P, 2009, CLIN EXP PHARMACOL P, V36, P655, DOI 10.1111/j.1440-1681.2008.05127.x; Gonzalez-Polo RA, 2005, ONCOGENE, V24, P7503, DOI 10.1038/sj.onc.1208907; Hardwick M, 1999, CANCER RES, V59, P831; Hirsch T, 1998, EXP CELL RES, V241, P426, DOI 10.1006/excr.1998.4084; Jorda EG, 2005, APOPTOSIS, V10, P91, DOI 10.1007/s10495-005-6064-9; KATZ Y, 1990, ONCOLOGY, V47, P139; KINNALLY KW, 1993, P NATL ACAD SCI USA, V90, P1374, DOI 10.1073/pnas.90.4.1374; KOZIKOWSKI AP, 1993, J MED CHEM, V36, P2908, DOI 10.1021/jm00072a010; LEFUR G, 1983, LIFE SCI, V33, P449, DOI 10.1016/0024-3205(83)90794-4; Maaser K, 2001, BRIT J CANCER, V85, P1771, DOI 10.1054/bjoc.2001.2181; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; MESTRE M, 1985, LIFE SCI, V36, P391, DOI 10.1016/0024-3205(85)90126-2; Nakamoto Y, 1996, BRAIN RES, V717, P91, DOI 10.1016/0006-8993(96)00033-9; Okuyama S, 1999, LIFE SCI, V64, P1455, DOI 10.1016/S0024-3205(99)00079-X; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Selleri S, 2001, BIOORGAN MED CHEM, V9, P2661, DOI 10.1016/S0968-0896(01)00192-4; Shiotani T, 2000, BRAIN RES, V859, P255, DOI 10.1016/S0006-8993(00)01971-5; Simon-O'Brien E, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0687-3; Soustiel JF, 2011, PHARM RES-DORDR, V28, P2945, DOI 10.1007/s11095-011-0463-0; Soustiel JF, 2008, EXP NEUROL, V214, P201, DOI 10.1016/j.expneurol.2008.08.008; Stein DJ, 2015, ADV THER, V32, P57, DOI 10.1007/s12325-015-0176-6; Sutter AP, 2004, J HEPATOL, V41, P799, DOI 10.1016/j.jhep.2004.07.015; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; SZABO I, 1991, J BIOL CHEM, V266, P3376; Taliani S, 2007, J MED CHEM, V50, P404, DOI 10.1021/jm061137o; Trapani G, 1997, J MED CHEM, V40, P3109, DOI 10.1021/jm970112+; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Venturini I, 1998, LIFE SCI, V63, P1269, DOI 10.1016/S0024-3205(98)00388-9; Verleye M, 2005, PHARMACOL BIOCHEM BE, V82, P712, DOI 10.1016/j.pbb.2005.11.013; Vlodavsky E, 2007, J NEURO-ONCOL, V81, P1, DOI 10.1007/s11060-006-9199-9; Zhou X, 2014, MUSCLE NERVE, V50, P235, DOI 10.1002/mus.24131; Zhou X, 2013, MOL MED REP, V8, P75, DOI 10.3892/mmr.2013.1474	52	10	10	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUN 1	2019	20	11							2639	10.3390/ijms20112639			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	IE8OX	WOS:000472634100033	31146356	gold, Green Published, Green Submitted			2022-02-06	
J	Zhu, ZM; Jiang, CK; Jiang, H				Zhu, Zhongmeng; Jiang, Chengkai; Jiang, Han			A visco-hyperelastic model of brain tissue incorporating both tension/compression asymmetry and volume compressibility	ACTA MECHANICA			English	Article							LARGE-STRAIN; MECHANICAL CHARACTERIZATION; MATTER; SHEAR; BEHAVIOR; WHITE; VISCOELASTICITY; INDENTATION	The understanding of the mechanical behavior of the brain tissue is essential to prevent the occurrence of potential brain damage, such as traumatic brain injury. Recent experimental results showed that brain tissue exhibits significant tension/compression asymmetry. Due to the migration and diffusion of interstitial fluid, brain tissue also shows a moderate volume compressibility during loading. These mechanical characteristics have a strong impact on the deformation response of brain tissue. In this paper, a visco-hyperelastic constitutive model incorporating both tension/compression asymmetry and volume compressibility is proposed to describe the mechanical behavior of brain tissue under various loading modes. An Ogden-type model with the addition of a viscoelastic part is used to characterize the tension/compression asymmetry as well as the viscoelastic properties. Poisson's ratio was introduced as a phenomenological index to represent the total volume change as well as the compressibility/recoverability. The mechanical responses of brain tissue under uniaxial tension, unconfined compression, stress relaxation, and cyclic compression were reproduced with a good capture of the tension/compression asymmetry, volume compressibility, significant viscoelastic properties, and cyclic hysteresis behaviors. The good agreement with the experimental data implies that the proposed model has a strong capability to describe the complex mechanical performance of brain tissue under a variety of loading conditions.	[Zhu, Zhongmeng; Jiang, Chengkai; Jiang, Han] Southwest Jiaotong Univ, Sch Mech & Engn, Appl Mech & Struct Safety Key Lab Sichuan Prov, Chengdu 610031, Sichuan, Peoples R China		Jiang, H (corresponding author), Southwest Jiaotong Univ, Sch Mech & Engn, Appl Mech & Struct Safety Key Lab Sichuan Prov, Chengdu 610031, Sichuan, Peoples R China.	jianghan@home.swjtu.edu.cn	Jiang, Han/G-7061-2011; Jiang, Chengkai/A-3702-2013	Jiang, Han/0000-0003-2582-3014; 	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11472231, 11872322]; Doctoral Innovation Fund Program of Southwest Jiaotong University [D-CX201835]	This work was supported by the National Natural Science Foundation of China (Grant No. 11472231, 11872322) and partially supported by Doctoral Innovation Fund Program of Southwest Jiaotong University (Grant No. D-CX201835).	Abdulhafez M., 2018, ASME 2018 13 INT MAN; Ames N. M, 2003, THESIS; Anand L, 2006, INT J PLASTICITY, V22, P1123, DOI 10.1016/j.ijplas.2005.07.006; Balakrishnan A, 2007, THESIS; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Budday S, 2017, J MECH BEHAV BIOMED, V74, P463, DOI 10.1016/j.jmbbm.2017.07.014; Budday S, 2017, ACTA BIOMATER, V60, P315, DOI 10.1016/j.actbio.2017.06.024; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; Destrade M, 2015, INT J NONLIN MECH, V75, P54, DOI 10.1016/j.ijnonlinmec.2015.02.014; Feng Y, 2017, J MECH BEHAV BIOMED, V65, P490, DOI 10.1016/j.jmbbm.2016.09.020; Grandjean AC, 2007, J AM COLL NUTR, V26, p549S, DOI 10.1080/07315724.2007.10719657; Gu LX, 2012, COMPOS PART B-ENG, V43, P3160, DOI 10.1016/j.compositesb.2012.04.014; Haslach HW, 2014, J MECH BEHAV BIOMED, V29, P138, DOI 10.1016/j.jmbbm.2013.08.027; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hu YH, 2012, ACTA MECH SOLIDA SIN, V25, P441, DOI 10.1016/S0894-9166(12)60039-1; Jenson D, 2015, COMPOS STRUCT, V121, P211, DOI 10.1016/j.compstruct.2014.08.028; Kaczmarek M, 1997, B MATH BIOL, V59, P295; Kleiven S., 2007, SAE TECHNICAL PAPER; Kyriacou SK, 2002, BIOMECH MODEL MECHAN, V1, P151, DOI 10.1007/s10237-002-0013-0; Labus KM, 2016, J MECH PHYS SOLIDS, V96, P591, DOI 10.1016/j.jmps.2016.08.010; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; Li G, 2016, J MECH BEHAV BIOMED, V57, P224, DOI 10.1016/j.jmbbm.2015.12.002; Lodish H., 2008, MOL CELL BIOL; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Mihai LA, 2017, J MECH PHYS SOLIDS, V106, P60, DOI 10.1016/j.jmps.2017.05.015; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Moran R, 2014, J BIOMECH, V47, P3762, DOI 10.1016/j.jbiomech.2014.09.030; Nolan DR, 2014, J MECH BEHAV BIOMED, V39, P48, DOI 10.1016/j.jmbbm.2014.06.016; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Pogoda K, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/075002; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Samadidooki A, 2018, THESIS; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Voyiadjis GZ, 2018, J MECH BEHAV BIOMED, V83, P63, DOI 10.1016/j.jmbbm.2018.04.011; WANG Q, 1946, PRC, V30, P20, DOI DOI 10.1007/S10409-014-0015-Z; Wang RZ, 2019, J MECH BEHAV BIOMED, V89, P1, DOI 10.1016/j.jmbbm.2018.08.043; Yoon JW, 2010, SOFT MATTER, V6, P6004, DOI 10.1039/c0sm00434k; Zhang W, 2016, J BIOMECH, V49, P3990, DOI 10.1016/j.jbiomech.2016.10.032	52	10	10	3	8	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-5970	1619-6937		ACTA MECH	Acta Mech.	JUN	2019	230	6					2125	2135		10.1007/s00707-019-02383-1			11	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	HY7CK	WOS:000468288700011					2022-02-06	
J	Lamm, AG; Goldstein, R; Giacino, JT; Niewczyk, P; Schneider, JC; Zafonte, R				Lamm, Adam G.; Goldstein, Richard; Giacino, Joseph T.; Niewczyk, Paulette; Schneider, Jeffrey C.; Zafonte, Ross			Changes in Patient Demographics and Outcomes in the Inpatient Rehabilitation Facility Traumatic Brain Injury Population from 2002 to 2016: Implications for Patient Care and Clinical Trials	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; geriatric brain injury; outcome measures; rehabilitation; traumatic brain injury (TBI)	SKILLED NURSING FACILITY; PLACEBO-CONTROLLED TRIAL; RISK; AMANTADINE; TRENDS	Initial studies examining patient demographics and outcomes in traumatic brain injury (TBI) suggest a trend toward increasing patient age and decreasing rehabilitation length of stay, but such studies have not been repeated since the passage of healthcare reform legislation, most notably the Affordable Care Act. This study utilized the Uniform Data System for Medical RehabilitationA (R) (UDSMR) for patients admitted to medical rehabilitation facilities after sustaining a TBI from January 1, 2002 through December 31, 2016. Trends for demographic and medical data were evaluated. In total, 233,843 patients from 1290 facilities were included; mean patient age increased from 54.1 to 64.8 years, rehabilitation length of stay decreased from 19 to 14.5 days, and mean admission Functional Independence MeasureA (R) (FIM) decreased from 56.9 to 54.5. Sex and racial distribution remained relatively stable across all years, as did discharge FIM. There was an increase in Medicare patients from 40.7% to 62.1%, a concomitant decrease in commercially insured patients from 29.2% to 15.4%, and a decrease in unreimbursed patients from 7.2% to 2.6% over the course of the study. Based on these data, medical rehabilitation facilities appear to be admitting an older TBI patient population that is less functional on admission and discharging them after shorter rehabilitation lengths of stay. Similar discharge functional status, despite shorter rehabilitation lengths of stay and an older population may suggest a change in the typical mechanism of injury. Many current TBI patients would fail to meet inclusion criteria for post-acute clinical trials in TBI because of their age, and treatments based on such trials may not be generalizable, which has significant implications on both research and clinical care realms within brain injury rehabilitation.	[Lamm, Adam G.; Goldstein, Richard; Giacino, Joseph T.; Schneider, Jeffrey C.; Zafonte, Ross] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 First Ave, Charlestown, MA 02129 USA; [Giacino, Joseph T.; Zafonte, Ross] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Niewczyk, Paulette] Uniform Data Syst Med Rehabil, Amherst, NY USA; [Zafonte, Ross] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA		Zafonte, R (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 First Ave, Charlestown, MA 02129 USA.	rzafonte@mgh.harvard.edu	Giacino, Joseph/AAF-1952-2021; Schneider, Jeffrey/AAO-2126-2020	Giacino, Joseph/0000-0002-7916-9698; 	National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), Administration for Community Living [90DP0039, 90DP0036]; TBI Model Systems [TBIMS-90DPTB0011-01-00]; TBI [W81XWH-11-2-0210]	Dr. Zafonte and Giacino's contributions were partially supported by awards from the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), Administration for Community Living (Award Nos. 90DP0039, Spaulding-Harvard TBI Model System; 90DP0036). The contents of this article do not necessarily represent the policy of the U.S. Department of Health and Human Services, and endorsement by the federal government should not be assumed. Additionally, Dr. Zafonte and Dr. Giacino are involved with the TBI Model Systems, grant number TBIMS-90DPTB0011-01-00; as well as a clinical trial involving the use of huperzine in TBI, grant number W81XWH-11-2-0210.	Band GPH, 2002, BRAIN COGNITION, V49, P259, DOI 10.1006/brcg.2001.1499; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; *CLIN GOV, 2018, TRAUMATIC BRAIN INJU, DOI DOI 10.1089/NEU.2005.370; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; *CTR MED MED SERV, 2018, INP REH FAC PAT ASS, DOI DOI 10.1186/S13054-015-0835-7; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.1089/NEU.2006.0119; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Glahn DC, 2013, P NATL ACAD SCI USA, V110, P19006, DOI 10.1073/pnas.1313735110; Granger CV, 2007, ARCH PHYS MED REHAB, V88, P265, DOI 10.1016/j.apmr.2006.12.033; Hammond FM, 2017, J HEAD TRAUMA REHAB, V32, P308, DOI 10.1097/HTR.0000000000000342; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; HOWDEN LM, 2010, 2010 CENSUS BRIEFS, DOI DOI 10.3109/02699052.2010.491494; *INS I HIGHW SAF, 2018, FAT FACTS 2016 YEARL, DOI DOI 10.3109/02688697.2016.1139048; King BJ, 2013, J AM GERIATR SOC, V61, P1095, DOI 10.1111/jgs.12328; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; McDonald NC, 2017, AM J PREV MED, V52, P598, DOI 10.1016/j.amepre.2016.12.012; Morrison CN, 2018, AM J EPIDEMIOL, V187, P224, DOI 10.1093/aje/kwx233; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Robert-Ebadi H, 2010, PHARMACEUTICALS, V3, P3543, DOI 10.3390/ph3123543; Rolston JD, 2014, J NEUROSURG, V120, P736, DOI 10.3171/2013.10.JNS122419; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Runge J W, 1993, Emerg Med Clin North Am, V11, P241; Shim G, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.766; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tjia J, 2009, J GEN INTERN MED, V24, P630, DOI 10.1007/s11606-009-0948-2; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0	31	10	10	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2019	36	17					2513	2520		10.1089/neu.2018.6014		MAY 2019	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IW9BT	WOS:000469463500001	30887892				2022-02-06	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Evaluating Cerebrovascular Reactivity during the Early Symptomatic Phase of Sport Concussion	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; cerebral blood flow; cerebrovascular reactivity; concussion; fMRI	CEREBRAL-BLOOD-FLOW; DEFAULT-MODE NETWORK; BOLD; CO2; PATHOPHYSIOLOGY; IMPAIRMENT; HYPOCAPNIA; DYNAMICS; FOOTBALL	Cerebrovascular reactivity (CVR) indexes the ability of blood vessels to respond to vasoactive stimuli and may be a sensitive biomarker of concussion. However, alterations in whole-brain CVR remain poorly understood during the early symptomatic phase of injury. In this study, CVR was assessed using blood-oxygenation-level dependent functional magnetic resonance imaging (BOLD fMRI) combined with a respiratory challenge paradigm; resting cerebral blood flow (CBF) was also evaluated using arterial spin labeling (ASL). Imaging data were collected for 77 university-level athletes, including 56 athletic uninjured controls and 21 concussed athletes scanned in the early symptomatic phase of injury (<= 7 days post-injury). The normal response to respiratory challenge was assessed in the athletic control group, in which a robust whole-brain response was observed. The concussed athletes were then compared to a matched subset of controls. Concussion was associated with greater reductions in BOLD activity during the early phase of the respiratory task, localized primarily in frontal and pre-frontal areas, whereas no significant effects on resting global CBF were observed. In addition, greater symptom severity was associated with greater reductions in BOLD response, with effects distributed throughout the brain. This study establishes fMRI with respiratory challenge as a robust method for assessing acute concussion-related alterations in CVR. Moreover, it highlights the importance of examining neurovascular response to physiological stressors after a concussion.	[Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, 209 Victoria St, Toronto, ON M5B 1M8, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada		Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, 209 Victoria St, Toronto, ON M5B 1M8, Canada.	nchurchill.research@gmail.com			CIHRCanadian Institutes of Health Research (CIHR) [RN294001-367456] Funding Source: Medline		Borogovac A, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/818456; Bright MG, 2013, NEUROIMAGE, V83, P559, DOI 10.1016/j.neuroimage.2013.07.007; Bright MG, 2009, NEUROIMAGE, V48, P166, DOI 10.1016/j.neuroimage.2009.05.026; Chan ST, 2015, BRAIN INJURY, V29, P403, DOI 10.3109/02699052.2014.974209; Churchill NW, 2018, NEUROIMAGE-CLIN, V18, P518, DOI 10.1016/j.nicl.2018.02.011; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Cohen ER, 2002, J CEREBR BLOOD F MET, V22, P1042, DOI 10.1097/00004647-200209000-00002; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Golestani AM, 2016, NEUROIMAGE, V138, P147, DOI 10.1016/j.neuroimage.2016.05.025; Graham D.I., 2002, GREENFIELDS NEUROPAT; Guskiewicz KM, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P65, DOI 10.1007/0-387-32565-4_4; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hall EL, 2011, NEUROIMAGE, V58, P1034, DOI 10.1016/j.neuroimage.2011.06.073; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; HUDAK ML, 1986, AM J PHYSIOL, V251, pH63, DOI 10.1152/ajpheart.1986.251.1.H63; Kastrup A, 2001, MAGN RESON IMAGING, V19, P13, DOI 10.1016/S0730-725X(01)00227-2; KETY S S, 1956, J Chronic Dis, V3, P478, DOI 10.1016/0021-9681(56)90146-1; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Mark CI, 2010, MAGN RESON MED, V64, P749, DOI 10.1002/mrm.22405; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Mikulis DJ, 2005, J NEUROSURG, V103, P347, DOI 10.3171/jns.2005.103.2.0347; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Regan RE, 2014, BRAIN BEHAV, V4, P775, DOI 10.1002/brb3.275; Scouten A, 2008, NEUROIMAGE, V43, P250, DOI 10.1016/j.neuroimage.2008.03.052; Selim M, 2008, CLIN AUTON RES, V18, P331, DOI 10.1007/s10286-008-0490-z; Sobczyk O, 2015, J CEREBR BLOOD F MET, V35, P213, DOI 10.1038/jcbfm.2014.184; Spano VR, 2013, RADIOLOGY, V266, P592, DOI 10.1148/radiol.12112795; Stefanovic B, 2006, NEUROIMAGE, V30, P726, DOI 10.1016/j.neuroimage.2005.10.038; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Urback AL, 2017, NEUROSCI BIOBEHAV R, V79, P27, DOI 10.1016/j.neubiorev.2017.05.003; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125	48	10	10	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1518	1525		10.1089/neu.2018.6024			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900003	30451069				2022-02-06	
J	Row, J; Chan, L; Damiano, D; Shenouda, C; Collins, J; Zampieri, C				Row, Jessica; Chan, Leighton; Damiano, Diane; Shenouda, Christian; Collins, John; Zampieri, Cris			Balance Assessment in Traumatic Brain Injury: A Comparison of the Sensory Organization and Limits of Stability Tests	JOURNAL OF NEUROTRAUMA			English	Article						balance; limits of stability; posture; sensory organization; symptoms; TBI	VESTIBULAR REHABILITATION; POSTURAL STABILITY; HEAD-INJURY; DIZZINESS; DISORDERS; VERTIGO; DEFICITS; FALLERS	Balance problems are common after a traumatic brain injury (TBI). Symptoms of dizziness, unsteadiness, or imbalance have been most frequently attributed to sensory organization problems involving the use of visual, proprioceptive, and/or vestibular information for postural control. These problems can be assessed with the Sensory Organization Test (SOT). However, as head trauma can affect any brain region, areas responsible for voluntary control of movements involved in dynamic balance tasks, such as the motor cortex and its projections, could also be compromised, which would likely affect one's limits of stability. The Limits of Stability (LOS) balance test has received little attention in TBI. In the present study, we compared the prevalence of SOT versus LOS abnormalities in a cohort of 48 patients, the majority classified as having mild or moderate chronic TBI. Compared with a normative database provided by the balance testing manufacturer, a larger portion of our cohort presented abnormalities in the LOS test. Dizziness Handicap Inventory (DHI) results indicated mild disability, with the five activities most frequently endorsed as problematic being: looking up, performing quick head movements, performing ambitious such as sports or dancing activities, feeling frustrated, and performing strenuous house/yard work. Although regression analysis revealed that both tests significantly predicted subjective scores on the DHI, more LOS than SOT testing variables were important predictors of DHI results indicating disability. These results suggest that the LOS test is an informative tool that should be included in any objective balance evaluations that screen TBI patients with balance complaints.	[Row, Jessica; Chan, Leighton; Damiano, Diane; Collins, John; Zampieri, Cris] NIH, Rehabil Med Dept, Clin Ctr, Bldg 10,CRC MSC 1604,10 Ctr Dr, Bethesda, MD 20892 USA; [Shenouda, Christian] US FDA, Div Neurol & Phys Med Devices, Silver Spring, MD USA; [Collins, John] Coll Hlth & Human Serv, Dept Rehabil Sci, Fairfax, VA USA		Zampieri, C (corresponding author), NIH, Rehabil Med Dept, Clin Ctr, Bldg 10,CRC MSC 1604,10 Ctr Dr, Bethesda, MD 20892 USA.	zampierigallac@cc.nih.gov		Collins, John/0000-0002-3863-0329	Intramural Research Program of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [10-CC-0118]; Center for Neuroscience and Regenerative Medicine (CNRM)United States Department of Defense	This research was supported by the Intramural Research Program of the National Institutes of Health (Protocol #10-CC-0118), and by the Center for Neuroscience and Regenerative Medicine (CNRM). We thank Andre van der Merwe, at the Center for Neuroscience and Regenerative Medicine, for coordinating this project.	Academy of Neurologic Physical Therapy and APTA Task Force on TBI, 2013, TBI EDGE OUTC MEAS R; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; BERMAN JM, 1978, J OTOLARYNGOL, V7, P237; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Chien CW, 2007, ARCH PHYS MED REHAB, V88, P374, DOI 10.1016/j.apmr.2006.11.019; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark S, 2001, ARCH PHYS MED REHAB, V82, P468, DOI 10.1053/apmr.2001.21859; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Faraldo-Garcia A, 2016, ACTA OTO-LARYNGOL, V136, P1125, DOI 10.1080/00016489.2016.1201591; Faraldo-Garcia A, 2016, AURIS NASUS LARYNX, V43, P149, DOI 10.1016/j.anl.2015.07.001; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Ganesan M, 2012, GAIT POSTURE, V35, P625, DOI 10.1016/j.gaitpost.2011.12.012; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Herdman SJ, 2014, VESTIBULAR REHABILIT; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jacobson GP, 1977, HDB BALANCE FUNCTION; Jessop RT, 2006, NEUROREHAB NEURAL RE, V20, P459, DOI 10.1177/1545968306287107; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kleffelgaard I, 2016, PHYS THER, V96, P839, DOI 10.2522/ptj.20150095; Kolev OI, 2016, FUNCT NEUROL, V31, P75; Management of Concussion/m TBIWG, 2009, J REHABIL RES DEV, V46, pCP1; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Newton R, 1989, Brain Inj, V3, P335, DOI 10.3109/02699058909004558; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Shumway-Cook A, 1990, J HEAD TRAUMA REHAB, V5, P51, DOI DOI 10.1097/00001199-199012000-00007; Tuohimaa P, 1978, Acta Otolaryngol Suppl, V359, P3; Umphred D.A., 2000, NEUROLOGICAL REHABIL; Vereeck L, 2007, OTOL NEUROTOL, V28, P87, DOI 10.1097/01.mao.0000247821.98398.0d	37	10	10	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2019	36	16					2435	2442		10.1089/neu.2018.5755		MAY 2019	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IN3NH	WOS:000468181300001	30909842	Green Published			2022-02-06	
J	Adams, RS; Larson, MJ; Meerwijk, EL; Williams, TV; Harris, AHS				Adams, Rachel Sayko; Larson, Mary Jo; Meerwijk, Esther L.; Williams, Thomas, V; Harris, Alex H. S.			Postdeployment Polytrauma Diagnoses Among Soldiers and Veterans Using the Veterans Health Affairs Polytrauma System of Care and Receipt of Opioids, Nonpharmacologic, and Mental Health Treatments	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						chronic pain; mental health; military; nonpharmacologic; opioids; polytrauma; posttraumatic stress disorder; traumatic brain injury; Veterans Health Administration	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; INTEGRATIVE MEDICINE THERAPIES; CHRONIC BACK-PAIN; CLINICAL-TRIAD; ACTIVE-DUTY; US VETERANS; COMBAT; IRAQ	Objectives: To determine the proportion of Army soldiers who utilized care in the Veterans Health Administration (VHA) Polytrauma System of Care (PSC) within the postdeployment year and to describe prevalence of polytrauma diagnoses, and receipt of opioids, nonpharmacologic treatments (NPTs), and mental health treatments in the VHA during the year following first PSC utilization. Setting: VHA's 4-tiered integrated PSC network of specialized rehabilitation services for military members and veterans with polytrauma. Participants: Soldiers and veterans who used the PSC during the postdeployment year after an Afghanistan or Iraq deployment ending in fiscal years 2008-2011. Design: Population-based cohort study. Main Measures: Prevalence of polytrauma diagnoses (ie, traumatic brain injury [TBI], posttraumatic stress disorder [PTSD], and chronic pain [CP]), VHA utilization rates of opioid prescriptions, NPT, and specialty mental health treatment within 1 year of PSC utilization. Results: In total, 2.6% of the sample (n = 16 590) used the PSC during the postdeployment year. Among PSC users, CP (76.5%), PTSD (53.1%), and TBI (48.6%) were common and more frequently found together than in isolation; 26.6% filled an opioid prescription, 35.5% received at least 1 NPT, and 83.8% received specialty mental health treatment in the VHA within 1 year of PSC utilization. Conclusion: CP was the most common polytrauma condition among PSC users, highlighting the importance of incorporating interdisciplinary pain management approaches within the PSC, with an effort to reduce reliance on long-term opioid therapy and improve rehabilitation.	[Adams, Rachel Sayko; Larson, Mary Jo] Brandeis Univ, Inst Behav Hlth, Heller Sch Social Policy & Management, 415 South St,Mailstop 035, Waltham, MA 02453 USA; [Meerwijk, Esther L.; Harris, Alex H. S.] VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat, Palo Alto, CA USA; [Williams, Thomas, V] Univ Chicago, NORC, Bethesda, MD USA		Adams, RS (corresponding author), Brandeis Univ, Inst Behav Hlth, Heller Sch Social Policy & Management, 415 South St,Mailstop 035, Waltham, MA 02453 USA.	radams@brandeis.edu	Adams, Rachel/AAH-4653-2020		National Center for Complementary and Integrative Health [R01 AT008404]; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01 DA030150]; VA HSRD Service [RCS14-232]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AT008404] Funding Source: NIH RePORTER	This study was funded by the National Center for Complementary and Integrative Health (R01 AT008404), with support to develop the study cohort from the National Institute on Drug Abuse (R01 DA030150) and the VA HSR&D Service (RCS14-232). The authors acknowledge Cheng Chen, MS, for Veterans Health Administration (VHA) programming support; Micaela Cornis-Pop, PhD, for review of their manuscript and guidance on interpreting VHA data related to the Polytrauma System of Care; Sharon Reif, PhD, for leadership developing analytic pain measures; AXIOM Resource Management for assisting with the specifications of complementary and integrative health modalities; Mark R. Bauer, MD, for clinical consultation; and Kennell and Associates, Inc, for compiling the data files used in these analyses. Chester Buckenmaier III, MD, of the Uniformed Services University is the Department of Defense (DoD) data sponsor. The Defense Health Agency's Privacy and Civil Liberties Office provided access to DoD data.	Adams RS, 2017, J NEUROTRAUM, V34, P1457, DOI 10.1089/neu.2016.4693; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; [Anonymous], 2011, JORNAL CACAU, V6, P5; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Corrigan JD, 2019, ADDICT BEHAV, V90, P143, DOI 10.1016/j.addbeh.2018.10.030; Crawford C, 2014, PAIN MED, V15, pS86, DOI 10.1111/pme.12407; Delgado R, 2014, PAIN MED, V15, pS9, DOI 10.1111/pme.12412; Department of Defense, 2014, INT MED MIL HLTH SYS; Department of Veteran Affairs and Department of Defense, 2017, VA DOD CLIN PRACT GU; Department of Veterans Affairs, 2013, POL SYST CAR; Department of Veterans Affairs Office of Inspector General, 2014, HEALTHC INSP VA PATT; Department of Veterans Affairs Veterans Health Administration, 2011, COMPLEMENTARY ALTERN; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Harris AHS, 2014, MIL MED, V179, P1090, DOI 10.7205/MILMED-D-13-00521; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; International Association for the Study of Pain (IASP), 2002, CLASSIFICATION CHRON; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; Khullar D, 2016, JAMA-J AM MED ASSOC, V315, P2521, DOI 10.1001/jama.2016.4641; Krebs EE, 2018, JAMA-J AM MED ASSOC, V319, P872, DOI 10.1001/jama.2018.0899; Larson MJ, 2018, J ALTERN COMPLEM MED, V24, P666, DOI 10.1089/acm.2017.0290; Larson MJ, 2013, SUBST USE MISUSE, V48, P863, DOI 10.3109/10826084.2013.794840; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Office of The Army Surgeon General, 2010, PAIN MAN TASK FORC F; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Pietrzak RH, 2011, J PSYCHIATR RES, V45, P1579, DOI 10.1016/j.jpsychires.2011.07.010; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Reif S, 2018, MIL MED, V183, pE330, DOI 10.1093/milmed/usx200; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scholten J, 2017, J HEAD TRAUMA REHAB, V32, P219, DOI 10.1097/HTR.0000000000000333; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Skopp Nancy A, 2012, MSMR, V19, P7; US Department of Veterans Affairs, 2016, POL TBI SYST CAR; Vanneman ME, 2018, MED CARE, V56, P855, DOI 10.1097/MLR.0000000000000977; Vanneman ME, 2017, PSYCHIAT SERV, V68, P803, DOI 10.1176/appi.ps.201600259; Vogt DS, 2008, J TRAUMA STRESS, V21, P66, DOI 10.1002/jts.20306	47	10	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2019	34	3			SI		167	175		10.1097/HTR.0000000000000481			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IH1KG	WOS:000474249100013	31058759	Green Accepted			2022-02-06	
J	Bree, D; Levy, D				Bree, Dara; Levy, Dan			Intact mast cell content during mild head injury is required for development of latent pain sensitization: implications for mechanisms underlying post-traumatic headache	PAIN			English	Article						Post-traumatic headache; Concussion; CGRP; Mast cells; Latent sensitization; Cranial meninges	TRAUMATIC BRAIN-INJURY; GENE-RELATED PEPTIDE; MENINGEAL NOCICEPTORS; MIGRAINE PAIN; NITRIC-OXIDE; SUBSTANCE-P; ACTIVATION; MODULATION; HISTAMINE; RATS	Post-traumatic headache (PTH) is one of the most common, debilitating, and difficult symptoms to manage after a traumatic head injury. Although the mechanisms underlying PTH remain elusive, recent studies in rodent models suggest the potential involvement of calcitonin gene-related peptide (CGRP), a mediator of neurogenic inflammation, and the ensuing activation of meningeal mast cells (MCs), proalgesic resident immune cells that can lead to the activation of the headache pain pathway. Here, we investigated the relative contribution of MCs to the development of PTH-like pain behaviors in a model of mild closed-head injury (mCHI) in male rats. We initially tested the relative contribution of peripheral CGRP signaling to the activation of meningeal MCs after mCHI using a blocking anti-CGRP monoclonal antibody. We then used a prophylactic MC granule depletion approach to address the hypotheses that intact meningeal MC granule content is necessary for the development of PTH-related pain-like behaviors. The data suggest that after mCHI, ongoing activation of meningeal MCs is not mediated by peripheral CGRP signaling and does not contribute to the development of the mCHI-evoked cephalic mechanical pain hypersensitivity. Our data, however, also reveal that the development of latent sensitization, manifested as persistent hypersensitivity upon the recovery from mCHI-evoked acute cranial hyperalgesia to the headache trigger glyceryl trinitrate requires intact MC content during and immediately after mCHI. Collectively, our data implicate the acute activation of meningeal MCs as mediator of chronic pain hypersensitivity after a concussion or mCHI. Targeting MCs may be explored for early prophylactic treatment of PTH.	Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA; Harvard Med Sch, Boston, MA 02215 USA		Levy, D (corresponding author), Dept Anesthesia Crit Care & Pain Med, 330 Brookline Ave DA 717, Boston, MA 02215 USA.	dlevy1@bidmc.harvard.edu	Levy, Dan/AAF-1871-2021		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS086830, NS078263, NS101405]; Teva PharmaceuticalsTeva Pharmaceutical Industries; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS101405, R01NS086830, R01NS078263] Funding Source: NIH RePORTER	The authors thank Dr Claire (Xinling) Xu (Center for Anesthesia Research Excellence, Beth Israel Medical Deaconess Medical Center, Boston) for advice on the statistical analyses. The study was funded by NIH grants NS086830, NS078263, NS101405 to D. Levy, and in part by Teva Pharmaceuticals, through a grant to D. Levy.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Dina OA, 2008, NEUROSCIENCE, V152, P521, DOI 10.1016/j.neuroscience.2008.01.006; Edelmayer RM, 2012, PAIN, V153, P1949, DOI 10.1016/j.pain.2012.06.012; FELDBERG W, 1953, J PHYSIOL-LONDON, V120, P550, DOI 10.1113/jphysiol.1953.sp004917; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; JAFFERY G, 1994, INT ARCH ALLERGY IMM, V105, P274, DOI 10.1159/000236769; Joseph EK, 2010, NEUROSCIENCE, V169, P431, DOI 10.1016/j.neuroscience.2010.04.082; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kilkenny C, 2012, VET CLIN PATH, V41, P27, DOI 10.1111/j.1939-165X.2012.00418.x; Kopruszinski CM, 2017, CEPHALALGIA, V37, P560, DOI 10.1177/0333102416650702; Levy D, 2007, PAIN, V130, P166, DOI 10.1016/j.pain.2007.03.012; Levy D, 2019, CEPHALALGIA, V39, P1606, DOI 10.1177/0333102418771350; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Levy D, 2012, BRAIN BEHAV IMMUN, V26, P311, DOI 10.1016/j.bbi.2011.09.016; Levy D, 2010, HEADACHE, V50, P909, DOI 10.1111/j.1526-4610.2010.01670.x; Levy D, 2009, CURR PAIN HEADACHE R, V13, P237, DOI 10.1007/s11916-009-0040-y; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lopes DM, 2017, PAIN, V158, P1314, DOI 10.1097/j.pain.0000000000000917; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Messlinger K, 2000, BRIT J PHARMACOL, V129, P1397, DOI 10.1038/sj.bjp.0703220; Messlinger K, 2009, EXP BRAIN RES, V196, P179, DOI 10.1007/s00221-009-1756-y; Mills C, 2012, J PAIN, V13, P519, DOI 10.1016/j.jpain.2012.02.009; Moye LS, 2018, CEPHALALGIA, V1; Noseda R, 2013, PAIN, V154, pS44, DOI 10.1016/j.pain.2013.07.021; Olesen J, 2009, LANCET NEUROL, V8, P679, DOI 10.1016/S1474-4422(09)70090-0; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Ottosson A, 1997, CEPHALALGIA, V17, P166, DOI 10.1046/j.1468-2982.1997.1703166.x; Parada CA, 2003, EUR J NEUROSCI, V17, P1847, DOI 10.1046/j.1460-9568.2003.02626.x; Pedersen SH, 2015, CEPHALALGIA, V35, P1287, DOI 10.1177/0333102415574846; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Reuter U, 2001, BRAIN, V124, P2490, DOI 10.1093/brain/124.12.2490; REYNIERREBUFFEL AM, 1994, AM J PHYSIOL-REG I, V267, pR1421, DOI 10.1152/ajpregu.1994.267.5.R1421; Russo AF, 2015, ANNU REV PHARMACOL, V55, P533, DOI 10.1146/annurev-pharmtox-010814-124701; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397; Tillu DV, 2015, PAIN, V156, P859, DOI 10.1097/j.pain.0000000000000125; Tyburski AL, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0726-1; Vargas BB, 2012, CURR OPIN NEUROL, V25, P284, DOI 10.1097/WCO.0b013e3283535bf5; VOS BP, 1994, J NEUROSCI, V14, P2708; Yan J, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-6; Zhang XC, 2008, CEPHALALGIA, V28, P276, DOI 10.1111/j.1468-2982.2007.01523.x; Zhang XC, 2007, J PHARMACOL EXP THER, V322, P806, DOI 10.1124/jpet.107.123745; Zhang XC, 2013, ANN NEUROL, V73, P741, DOI 10.1002/ana.23873; Zhao J, 2014, PAIN, V155, P1392, DOI 10.1016/j.pain.2014.04.019	51	10	10	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	MAY	2019	160	5					1050	1058		10.1097/j.pain.0000000000001481			9	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	IQ4ZM	WOS:000480760500008	30624345	Green Submitted, Green Accepted			2022-02-06	
J	Gomez, AD; Knutsen, AK; Xing, FX; Lu, YC; Chan, D; Pham, DL; Bayly, P; Prince, JL				Gomez, Arnold D.; Knutsen, Andrew K.; Xing, Fangxu; Lu, Yuan-Chiao; Chan, Deva; Pham, Dzung L.; Bayly, Philip; Prince, Jerry L.			3-D Measurements of Acceleration-Induced Brain Deformation via Harmonic Phase Analysis and Finite-Element Models	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Tagged MRI; harmonic phase analysis; finite strain; finite element method; brain biomechanics	MOTION ESTIMATION; TAGGED MRI; REGISTRATION; DISPLACEMENT; INJURY; VALIDATION; VENTRICLE; FRAMEWORK; TRACKING; STRAIN	Objective: To obtain dense spatiotemporal measurements of brain deformation from two distinct but complementary head motion experiments: linear and rotational accelerations. Methods: This study introduces a strategy for integrating harmonic phase analysis of tagged magnetic resonance imaging (MRI) and finite-element models to extract mechanically representative deformation measurements. The method was calibrated using simulated as well as experimental data, demonstrated in a phantom including data with image artifacts, and used to measure brain deformation in human volunteers undergoing rotational and linear acceleration. Results: Evaluation methods yielded a displacement error of 1.1 mm compared to human observers and strain errors between 0.1 +/- 0.2% (mean +/- std. dev.) for linear acceleration and 0.7 +/- 0.3% for rotational acceleration. This study also demonstrates an approach that can reduce error by 86% in the presence of corrupted data. Analysis of results shows consistency with 2-D motion estimation, agreement with external sensors, and the expected physical behavior of the brain. Conclusion: Mechanical regularization is useful for obtaining dense spatiotemporal measurements of in vivo brain deformation under different loading regimes. Significance: The measurements suggest that the brain's 3-D response to mild accelerations includes distinct patterns observable using practical MRI resolutions. This type of measurement can provide validation data for computer models for the study of traumatic brain injury.	[Gomez, Arnold D.; Prince, Jerry L.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Knutsen, Andrew K.; Lu, Yuan-Chiao; Chan, Deva; Pham, Dzung L.] Henry M Jackson Fdn, Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Xing, Fangxu] Harvard Med Sch, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Bayly, Philip] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO USA		Gomez, AD (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA.	adgomez@jhu.edu	Chan, Deva/F-1496-2010; Pham, Dzung/AAR-8263-2020	Chan, Deva/0000-0003-1508-1045; Gomez, Arnold/0000-0002-5564-2233; Xing, Fangxu/0000-0002-0517-0952	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS055951, PA12-149]; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke under Grant R01-NS055951, supplement PA12-149, and in part by the Center for Neuroscience and Regenerative Medicine.	Aletras AH, 1999, J MAGN RESON, V137, P247, DOI 10.1006/jmre.1998.1676; Bathe K.-J., 1996, FINITE ELEMENT PROCE; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bonet J, 1997, NONLINEAR CONTINUUM; Cabezas M, 2011, COMPUT METH PROG BIO, V104, pE158, DOI 10.1016/j.cmpb.2011.07.015; Chan YL, 2001, IEEE T IMAGE PROCESS, V10, P1223, DOI 10.1109/83.935038; Chung SH, 2011, MAGN RESON MED, V65, P949, DOI 10.1002/mrm.22785; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Gomez Arnold David, 2017, Comput Biomech Med Algorithms Models Appl (2017), V2017, P81, DOI 10.1007/978-3-319-54481-6_7; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Guo HQ, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007177; Haber I, 2000, MED IMAGE ANAL, V4, P335, DOI 10.1016/S1361-8415(00)00028-1; HORN BKP, 1981, P SOC PHOTO-OPT INST, V281, P319; Ibrahim ESH, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-36; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Kim M, 2012, IEEE T IMAGE PROCESS, V21, P1823, DOI 10.1109/TIP.2011.2170698; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Kumaresan S, 1996, MED BIOL ENG COMPUT, V34, P27, DOI 10.1007/BF02637019; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Le Besnerais G, 2006, IEEE T IMAGE PROCESS, V15, P3201, DOI 10.1109/TIP.2006.877485; Ledesma-Carbayo MJ, 2008, MAGN RESON MED, V59, P181, DOI 10.1002/mrm.21444; Liu XF, 2010, IEEE T MED IMAGING, V29, P1560, DOI 10.1109/TMI.2010.2045509; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas SA, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005694; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Moerman KM, 2012, MED PHYS, V39, P1793, DOI 10.1118/1.3685579; Monea AG, 2012, J NEUROTRAUM, V29, P2305, DOI 10.1089/neu.2011.2271; Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836; Osman NF, 2001, MAGNET RESON MED, V46, P324, DOI 10.1002/mrm.1195; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; Oubel E, 2012, MED IMAGE ANAL, V16, P339, DOI 10.1016/j.media.2011.09.001; Perperidis D, 2005, MED IMAGE ANAL, V9, P441, DOI 10.1016/j.media.2005.05.004; Phatak NS, 2009, MED IMAGE ANAL, V13, P354, DOI 10.1016/j.media.2008.07.004; Puso MA, 2006, INT J NUMER METH ENG, V67, P841, DOI 10.1002/nme.1651; RABBITT RD, 1995, P SOC PHOTO-OPT INS, V2573, P252, DOI 10.1117/12.216419; Ramsey J. A., 2017, P SOC PHOTO-OPT INS, V10137; RIVLIN RS, 1948, PHILOS TR R SOC S-A, V241, P379, DOI 10.1098/rsta.1948.0024; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Spencer AJM., 1985, CONTINUUM MECH; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; Tobon-Gomez C, 2013, MED IMAGE ANAL, V17, P632, DOI 10.1016/j.media.2013.03.008; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; Veress AI, 2008, ANN BIOMED ENG, V36, P1104, DOI 10.1007/s10439-008-9497-9; Weiss JA, 2006, MECHANICS OF BIOLOGICAL TISSUE, P489, DOI 10.1007/3-540-31184-X_35; Xing FX, 2017, IEEE T MED IMAGING, V36, P2116, DOI 10.1109/TMI.2017.2723021; Xu C, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-19; Zagorchev L, 2006, IEEE T IMAGE PROCESS, V15, P529, DOI 10.1109/TIP.2005.863114; ZERHOUNI EA, 1988, RADIOLOGY, V169, P59, DOI 10.1148/radiology.169.1.3420283; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149; Zhong XD, 2009, MED PHYS, V36, P3413, DOI 10.1118/1.3157109; Zhou HH, 2007, J MAGN RESON IMAGING, V25, P175, DOI 10.1002/jmri.20783; 2010, IEEE T MED IMAGING, V29, P1114, DOI DOI 10.1109/TMI.2009.2037955; 2007, IEEE T MED IMAGING, V26, P15, DOI DOI 10.1109/TMI.2006.884215; 2012, IEEE T MED IMAGING, V31, P326, DOI DOI 10.1109/TMI.2011.2168825; 2013, IEEE T MED IMAGING, V32, P1153, DOI DOI 10.1109/TMI.2013.2265603; 2015, P SOC PHOTO-OPT INS, V9413; 2012, BIOMECH MODEL MECHAN, V11, P245, DOI DOI 10.1007/S10237-011-0307-1; 1998, IEEE T MED IMAG, V17, P463	62	10	10	1	12	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	MAY	2019	66	5					1456	1467		10.1109/TBME.2018.2874591			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	HV5LE	WOS:000466024600026	30296208	Green Accepted			2022-02-06	
J	Lynall, RC; Blackburn, JT; Guskiewicz, KM; Marshall, SW; Plummer, P; Mihalik, JP				Lynall, Robert C.; Blackburn, J. Troy; Guskiewicz, Kevin M.; Marshall, Stephen W.; Plummer, Prudence; Mihalik, Jason P.			Functional balance assessment in recreational college-aged individuals with a concussion history	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Gait; Tandem gait; Functional movement; Movement assessment; Dynamic balance	FOOTBALL PLAYERS; GAIT STABILITY; INJURY; RISK; TASK; ADOLESCENTS; RECOVERY; MOBILITY; SPORT	Objectives: Despite evidence for increased musculoskeletal injury after concussion recovery, there is a lack of dynamic balance assessments that could inform management and research into this increased injury risk post-concussion. Our purpose was to identify tandem gait dynamic balance deficits in recreational athletes with a concussion history within the past 18-months compared to matched controls. Design: Cross-sectional, laboratory study. Methods: Fifteen participants with a concussion history (age: 19.7 +/- 0.9 years; 9 females; median time since concussion 126 days, range 28-432 days), and 15 matched controls (19.7 +/- 1.6 years; 9 females) with no recent concussion history participated. We measured center-of-pressure (COP) outcomes (velocity, path length, speed, dual-task cost) under 4 tandem gait conditions: (1) tandem gait, (2) tandem gait, eyes closed, (3) tandem gait, eyes open, cognitive distraction, and (4) tandem gait, eyes closed, cognitive distraction. Results: The concussion history group demonstrated slower tandem gait velocity compared to the control group (4.0 cm/s difference), thus velocity was used as a covariate when analyzing COP path length and speed. The concussion history group (23.5%) demonstrated greater COP speed dual-task cost than the control group (16.3%) during the eyes closed dual-task condition. No other comparisons were statistically significant. Conclusions: There may be subtle dynamic balance differences during tandem gait that are detectable after return-to-activity following concussion, but the clinical significance of these findings is unclear. Longitudinal investigations should identify acute movement deficits in varying visual and cognitive scenarios after concussion in comparison with recovery on traditional concussion assessment tools while also recording musculoskeletal injury outcomes. (C) 2018 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Lynall, Robert C.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA; [Lynall, Robert C.; Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Lynall, Robert C.; Blackburn, J. Troy; Guskiewicz, Kevin M.; Plummer, Prudence; Mihalik, Jason P.] Univ N Carolina, Dept Allied Hlth Sci, Human Movement Sci Curriculum, Chapel Hill, NC 27515 USA; [Blackburn, J. Troy] Univ N Carolina, Dept Exercise & Sport Sci, Neuromuscular Res Lab, Chapel Hill, NC 27515 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Plummer, Prudence] Univ N Carolina, Dept Allied Hlth Sci, Div Phys Therapy, Chapel Hill, NC 27515 USA		Lynall, RC (corresponding author), Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA.; Lynall, RC (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA.; Lynall, RC (corresponding author), Univ N Carolina, Dept Allied Hlth Sci, Human Movement Sci Curriculum, Chapel Hill, NC 27515 USA.	rlynall@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640	University of North Carolina at Chapel Hill Junior Faculty Development Award	This study was funded by The University of North Carolina at Chapel Hill Junior Faculty Development Award (PI Mihalik).	Beakey M, 2018, CLIN J SPORT MED; BROOKS LR, 1967, Q J EXP PSYCHOL, V19, P289, DOI 10.1080/14640746708400105; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Conway FN, 2018, CLIN J SPORT MED; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2017, J ATHL TRAINING, V52, P518, DOI 10.4085/1062-6050-52.2.03; Lynall RC, 2017, GAIT POSTURE, V52, P308, DOI 10.1016/j.gaitpost.2016.12.023; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Plummer P, 2013, ARCH PHYS MED REHAB, V94, P2565, DOI 10.1016/j.apmr.2013.08.002; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Rogers JM, 2015, BRAIN INJURY, V29, P343, DOI 10.3109/02699052.2014.976273; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	30	10	10	2	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2019	22	5					503	508		10.1016/j.jsams.2018.10.012			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HY6RB	WOS:000468256300003	30446238				2022-02-06	
J	Olsen, M; Vik, A; Nilsen, TIL; Uleberg, O; Moen, KG; Fredriksli, O; Lien, E; Finnanger, TG; Skandsen, T				Olsen, Mari; Vik, Anne; Nilsen, Torn Ivan Lund; Uleberg, Oddvar; Moen, Kent Goran; Fredriksli, Oddrun; Lien, Espen; Finnanger, Torun Gangaune; Skandsen, Toril			Incidence and mortality of moderate and severe traumatic brain injury in children: A ten year population-based cohort study in Norway	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						Head injury; Head trauma; Traumatic brain injury; Paediatric head injury; Paediatric traumatic brain injury; Paediatric; Incidence; Mortality; Epidemiology; Epidemiological study; Population; Child; Children	HEAD-INJURIES; EPIDEMIOLOGY; TRENDS; PREVENTION; COUNTY; IMPACT; CARE	Objective: In this study we wanted to estimate population-based rates of incidence and mortality of moderate and severe traumatic brain injury (TBI) in children in one specific region in Norway. Methods: In the region there are seven acute care hospitals (ACHs) in addition to a Level 1 trauma centre. Of 702 869 inhabitants (2014), 145 395 were children aged 0-16 years. Data were collected during ten years (2004-2014). All children aged 0-16 years with moderate (Glasgow Coma Scale [GCS] score 9-13) or severe (GCS score <= 8) TBI admitted to the Level 1 trauma centre were prospectively included. Children treated outside the Level 1 trauma centre were retrospectively included from the ACHs. Children who died from TBI pre-hospitally were included from the National Cause of Death Registry. Poisson regression was used to estimate incidence rate ratios (with a 95% confidence interval) comparing age, sex, and time periods. Results: A total of 71 children with moderate or severe TBI were identified. Crude incidence rates were 2.4 (95% CI 1.7-3.3) for moderate and 2.5 (95% CI 1.8-3.4) for severe TBI per 100 000 person-years (py). Mortality rate from TBI was 1.2 (95% CI 0.7-1-9) per 100 000 py, and 88% were prehospital deaths. Conclusion: The incidence rates and mortality of moderate and severe TBI were low compared to international reports. Most likely explained by successful national prevention of TBI. (C) 2019 The Authors. Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.	[Olsen, Mari; Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olays Hosp, Clin Phys Med & Rehabil, Trondheim, Norway; [Olsen, Mari; Vik, Anne; Moen, Kent Goran; Fredriksli, Oddrun; Skandsen, Toril] Norwegian Univ Sci & Technol, NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Vik, Anne; Fredriksli, Oddrun] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Neurosurg, Trondheim, Norway; [Nilsen, Torn Ivan Lund] Norwegian Univ Sci & Technol, NTNU, Dept Publ Hlth & Nursing, Trondheim, Norway; [Nilsen, Torn Ivan Lund] Trondheim Reg & Univ Hosp, St Olays Hosp, Clin Anaesthesia & Intens Care, Trondheim, Norway; [Uleberg, Oddvar] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Emergency Med & Prehosp Serv, Trondheim, Norway; [Uleberg, Oddvar] Norwegian Air Ambulance Fdn, Dept Res & Dev, NO-0103 Oslo, Norway; [Moen, Kent Goran] Nord Trondelag Hosp Trust, Dept Radiol, Levanger, Norway; [Lien, Espen; Finnanger, Torun Gangaune] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Pediat, Trondheim, Norway		Olsen, M (corresponding author), NTNU, Fac Med & Hlth Sci, N-7491 Trondheim, Norway.	mari.olsen@ntnu.no; ann.vik@ntnu.no; tom.nilsen@ntnu.no; Oddvar.Uleberg@stolav.no; kent.g.moen@ntnu.no; oddrun.fredriksli@ntnu.no; espen.lien@stolav.no; Torun.Gangaune.Finnanger@stolav.no; toril.skandsen@ntnu.no	Skandsen, Toril/P-6767-2014	Skandsen, Toril/0000-0001-5495-9338			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Ahmad OB., GPE DISCUSSION PAPER, V31; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Halldorsson Jonas G, 2007, Neuropsychiatr Dis Treat, V3, P935; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingri Myklestad KA, 2014, ACCIDENTS INJURIES N, P2; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Alvarez JML, 2011, MED INTENSIVA, V35, P331, DOI 10.1016/j.medin.2011.02.001; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2014, J NEUROTRAUM, V31, P1046, DOI 10.1089/neu.2013.3200; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Statistics Norway, POP SEX ON YEAR AG G; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Uleberg O, 2017, ACTA ANAESTH SCAND, V61, P346, DOI 10.1111/aas.12856; van Pelt ED, 2011, EUR J PAEDIATR NEURO, V15, P519, DOI 10.1016/j.ejpn.2011.05.005; Ventsel G, 2008, NEUROEPIDEMIOLOGY, V30, P20, DOI 10.1159/000113302; Williamson LM, 2002, J EPIDEMIOL COMMUN H, V56, P285, DOI 10.1136/jech.56.4.285	30	10	10	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	MAY	2019	23	3					500	506		10.1016/j.ejpn.2019.01.009			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	IE7XL	WOS:000472588200021	30879962	hybrid, Green Published			2022-02-06	
J	Ondruschka, B; Woydt, L; Bernhard, M; Franke, H; Kirsten, H; Loffler, S; Pohlers, D; Hammer, N; Dressler, J				Ondruschka, Benjamin; Woydt, Lina; Bernhard, Michael; Franke, Heike; Kirsten, Holger; Loeffler, Sabine; Pohlers, Dirk; Hammer, Niels; Dressler, Jan			Post-mortem in situ stability of serum markers of cerebral damage and acute phase response	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Acute phase response; Intra-individual stability; Post-mortem biochemistry; Serum; Thanatochemistry; Traumatic brain injury	C-REACTIVE PROTEIN; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; NEUROTROPHIC FACTOR; CHEMISTRY UPDATE; DIAGNOSIS; PROCALCITONIN; BLOOD; HEMOLYSIS; STORAGE	The aim of the given study was to test the in situ stability of biochemical markers of cerebral damage and acute phase response in the early post-mortem interval to assess their usability for forensic pathology. A monocentric, prospective study investigated post-mortem femoral venous blood samples at four time points obtained within 48 h post-mortem starting at the death of 20 deceased, using commercial immunoassays for the ten parameters: S100 calcium-binding protein B (S100B), glial fibrillary acidic protein (GFAP), neuron-specific enolase (NSE), brain-derived neurotrophic factor (BDNF), interleukin-6 (IL-6), C-reactive protein (CRP), procalcitonin (PCT), ferritin, soluble tumor necrosis factor receptor type 1 (sTNFR1), and lactate dehydrogenase (LDH). Significant changes in serum levels were observed only later than 2 h after death for all markers. Inter-laboratory comparability was high, and intra-assay precision was sufficient for most markers. Most of the biomarker levels depended on the severity of hemolysis and lipemia but were robust against freeze-thaw cycles. Serum levels increased with longer post-mortem intervals for S100B, NSE, ferritin, sTNFR1, and LDH (for all p < 0.001) but decreased over this period for CRP (p = 0.089) and PCT (p < 0.001). Largely unchanged median values were found for GFAP (p = 0.139), BDNF (p = 0.106), and IL-6 (p = 0.094). Serum levels of CRP (p = 0.059) and LDH (p = 0.109) did not differ significantly between the final ante-mortem (resuscitation) and the first post-mortem sample (moment of death). Collecting the post-mortem blood sample as soon as possible will reduce the influence of post-mortem blood changes. Serum GFAP for detection of cerebral damage as well as serum IL-6 and CRP as proof of acute phase response seemed to be preferable due to their in situ stability in the first 2 days after death.	[Ondruschka, Benjamin; Woydt, Lina; Dressler, Jan] Univ Leipzig, Med Fac, Inst Legal Med, Johannisallee 28, D-04103 Leipzig, Germany; [Bernhard, Michael] Heinrich Heine Univ Duesseldorf, Emergency Dept, Dusseldorf, Germany; [Franke, Heike] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Leipzig, Germany; [Kirsten, Holger] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Kirsten, Holger] Univ Leipzig, LIFE Ctr Leipzig Interdisciplinary Res Cluster Ge, Leipzig, Germany; [Loeffler, Sabine] Univ Leipzig, Inst Anat, Leipzig, Germany; [Pohlers, Dirk] Klinikum Chemnitz, Ctr Diagnost GmbH, Chemnitz, Germany; [Hammer, Niels] Univ Otago, Dept Anat, Dunedin, New Zealand; [Hammer, Niels] Univ Hosp Leipzig, Dept Orthoped & Trauma Surg, Leipzig, Germany; [Hammer, Niels] Fraunhofer Inst Machine Tools & Forming Technol, Dresden, Germany		Ondruschka, B (corresponding author), Univ Leipzig, Med Fac, Inst Legal Med, Johannisallee 28, D-04103 Leipzig, Germany.	benjamin.ondruschka@medizin.uni-leipzig.de	Kirsten, Holger/AAP-7250-2020	Kirsten, Holger/0000-0002-3126-7950			Astrup BS, 2007, FORENSIC SCI INT, V172, P49, DOI 10.1016/j.forsciint.2006.10.021; Beaudeux JL, 2000, CLIN CHEM, V46, P989; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bode-Janisch S, 2013, FORENSIC SCI INT, V226, P266, DOI 10.1016/j.forsciint.2013.01.041; Chirica VI, 2017, ROM J LEG MED, V25, P146, DOI 10.4323/rjlm.2017.146; COE JI, 1993, AM J FOREN MED PATH, V14, P91, DOI 10.1097/00000433-199306000-00001; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Flanagan R. J., 2017, ARAB J FOR SCI FOR M, V1, P540; Fujita MQ, 2002, FORENSIC SCI INT, V130, P160, DOI 10.1016/S0379-0738(02)00381-X; Goede A, 2015, RECHTSMEDIZIN, V25, P261, DOI 10.1007/s00194-015-0040-7; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Hess C, 2017, DRUG TEST ANAL, V9, P1506, DOI 10.1002/dta.2133; Ishikawa T, 2008, FORENSIC SCI INT, V179, P135, DOI 10.1016/j.forsciint.2008.04.021; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Li Dong-Ri, 2006, Legal Medicine, V8, P71, DOI 10.1016/j.legalmed.2005.07.004; Li Dong-Ri, 2006, Legal Medicine, V8, P78, DOI 10.1016/j.legalmed.2005.09.002; Luna A, 2009, Leg Med (Tokyo), V11 Suppl 1, pS27, DOI 10.1016/j.legalmed.2009.02.040; Madea B, 2007, FORENSIC SCI INT, V165, P165, DOI 10.1016/j.forsciint.2006.05.023; Maeda Hitoshi, 2009, Leg Med (Tokyo), V11 Suppl 1, pS46, DOI 10.1016/j.legalmed.2009.01.048; Maeda H, 2008, FORENSIC SCI MED PAT, V4, P175, DOI 10.1007/s12024-008-9029-9; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Meisner M, 1997, EUR J CLIN CHEM CLIN, V35, P597; Mimasaka S, 2007, INJURY, V38, P1047, DOI 10.1016/j.injury.2007.02.045; Missler U, 1999, CLIN CHEM, V45, P138; Ondruschka B, 2018, J NEUROTRAUM, V35, P2044, DOI 10.1089/neu.2017.5441; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; OSUNA E, 1992, FORENSIC SCI INT, V52, P193, DOI 10.1016/0379-0738(92)90107-8; Palmiere C, 2014, CROAT MED J, V55, P103, DOI 10.3325/cmj.2014.55.103; Palmiere C, 2013, J INFECTION, V67, P545, DOI 10.1016/j.jinf.2013.08.020; Palmiere C, 2012, INT J LEGAL MED, V126, P187, DOI 10.1007/s00414-011-0625-y; Raabe A, 2003, CLIN CHEM LAB MED, V41, P700, DOI 10.1515/CCLM.2003.106; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Ramsthaler F, 2008, FORENSIC SCI INT, V178, P139, DOI 10.1016/j.forsciint.2008.03.010; RiliBak, 2015, J LAB MED, V39, P26, DOI DOI 10.1515/LABMED-2014-0046; Schmidt S, 2015, INT J LEGAL MED, V129, P117, DOI 10.1007/s00414-014-1057-2; Schrag B, 2012, INT J LEGAL MED, V126, P505, DOI 10.1007/s00414-011-0596-z; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Tsokos M, 2001, INT J LEGAL MED, V114, P237, DOI 10.1007/s004140000177; Tsokos M, 2001, FORENSIC SCI INT, V119, P47, DOI 10.1016/S0379-0738(00)00391-1; Tsokos M, 2007, FORENSIC SCI INT, V165, P155, DOI 10.1016/j.forsciint.2006.05.015; Uhlin-Hansen L, 2001, FORENSIC SCI INT, V124, P32, DOI 10.1016/S0379-0738(01)00558-8; Verfaillie CJ, 2010, CLIN CHEM LAB MED, V48, P891, DOI 10.1515/CCLM.2010.159; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	46	10	11	1	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	MAY	2019	133	3					871	881		10.1007/s00414-018-1925-2			11	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	HT8XL	WOS:000464848100027	30167776	Green Published			2022-02-06	
J	Ratliff, WA; Mervis, RF; Citron, BA; Schwartz, B; Rubovitch, V; Schreiber, S; Pick, CG				Ratliff, Whitney A.; Mervis, Ronald F.; Citron, Bruce A.; Schwartz, Brian; Rubovitch, Vardit; Schreiber, Shaul; Pick, Chaim G.			Mild blast-related TBI in a mouse model alters amygdalar neurostructure and circuitry	EXPERIMENTAL NEUROLOGY			English	Article						Blast-related traumatic brain injury; Post-traumatic stress disorder; Basulateral amygdala; Golgi stain	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; FEAR EXTINCTION; HIPPOCAMPAL; PREVENTION; MORPHOLOGY; PATTERNS; SPINES; PTSD	Traumatic brain injury (TBI) continues to be a signature injury of our modern conflicts. Due in part to increased use of improvised explosive devices (IEDs), we have seen blast trauma make up a significant portion of This sustained by deployed troops and civilians. In addition to the physical injury, TBI is also a common comorbidity with post-traumatic stress disorder (PTSD). Previous research suggests that PTSD is often associated with increased signaling within the amygdala, leading to feelings of fear and hyperarousal. In our study, we utilized a mouse model of mild blast-related TBI (bTBI) to investigate how TBI induces changes within the amygdala, which may provide favorable conditions for the development of PTSD. To do this, we performed Golgi staining on the stellate neurons of the basolateral amygdala and quantified dendritic amount, distribution, and complexity. We found increases in dendritic branching and in the density of dendritic spines in injured mice. Increases in spine density appears to be primarily due to increases in memory associated mushroom type dendritic spines. These changes observed in our bTBI model that are consistent with chronic stress models, suggesting an important connection between the physical changes induced by TBI and the neurological symptoms of PTSD.	[Ratliff, Whitney A.; Citron, Bruce A.] Bay Pines VA Healthcare Syst, Res & Dev, 151,Bldg 22 Rm 123,10000 Bay Pines Blvd, Bay Pines, FL 33744 USA; [Ratliff, Whitney A.; Citron, Bruce A.] USF Coll Med, Dept Mol Med, 12901 Bruce B Downs Blvd,MDC 7, Tampa, FL 33612 USA; [Mervis, Ronald F.] NeuroStruct Analyt Inc, Columbus, OH USA; [Mervis, Ronald F.] Univ South Florida Morsani, Ctr Aging & Brain Repair, Coll Med, Dept Neurosurg & Brain Repair, 2 Tampa Gen Circle, Tampa, FL 33606 USA; [Citron, Bruce A.] VA New Jersey Hlth Care Syst, Res & Dev, Mailstop 15,Bldg 16,Rm 16-176,385 Tremont Ave, E Orange, NJ 07018 USA; [Citron, Bruce A.] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, 185 South Orange Ave, Newark, NJ 07101 USA; [Schwartz, Brian; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Sourasky Med Ctr, Dept Psychiat, IL-64239 Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Sackler Fac Med, Dept Psychiat, IL-64239 Tel Aviv, Israel; [Schreiber, Shaul; Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, IL-69978 Tel Aviv, Israel		Ratliff, WA (corresponding author), 10000 Bay Pines Blvd, Bay Pines, FL 33744 USA.	whitney.ratliff@va.gov	Schreiber, Shaul/E-5821-2010; Ratliff, Whitney/L-3556-2016	Schreiber, Shaul/0000-0002-2189-0693; Ratliff, Whitney/0000-0002-5461-7802	Ani and Regine Aprijaskis Fund; Dr. Miriam and Sheldon G. Adelson Chair; Center for the Biology of Addictive Diseases; Department of Veterans AffairsUS Department of Veterans Affairs; Bay Pines Foundation; Veterans Bio-Medical Research Institute; Veterans AffairsUS Department of Veterans Affairs [I01RX001520] Funding Source: NIH RePORTER	This research was supported in part by the Ani and Regine Aprijaskis Fund; and in part by the Dr. Miriam and Sheldon G. Adelson Chair and Center for the Biology of Addictive Diseases. This study was also supported by the Department of Veterans Affairs, The Bay Pines Foundation, and The Veterans Bio-Medical Research Institute.	Admon R, 2013, HUM BRAIN MAPP, V34, P2808, DOI 10.1002/hbm.22100; Admon R, 2009, P NATL ACAD SCI USA, V106, P14120, DOI 10.1073/pnas.0903183106; Ahmed-Leitao F, 2016, PSYCHIAT RES-NEUROIM, V256, P33, DOI 10.1016/j.pscychresns.2016.09.008; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Andreasen N. C, 2014, AM J PSYCHIAT, V161, P1321; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Chauveau F, 2012, NEUROPSYCHOPHARMACOL, V37, P1588, DOI 10.1038/npp.2012.3; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI, P1; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jackson CE, 2016, J TRAUMA STRESS, V29, P309, DOI 10.1002/jts.22110; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Koyama Y, 2013, J NEUROSCI METH, V218, P103, DOI 10.1016/j.jneumeth.2013.05.004; Lau T, 2017, MOL PSYCHIATR, V22, P227, DOI 10.1038/mp.2016.68; Maroun M, 2013, EUR J NEUROSCI, V38, P2611, DOI 10.1111/ejn.12259; Masel BE, 2012, J NEUROTRAUM, V29, P2143, DOI 10.1089/neu.2011.2258; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Pitman RK, 2001, J CLIN PSYCHIAT, V62, P47; Qiao H, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8056370; Qin M, 2011, NEUROSCIENCE, V194, P282, DOI 10.1016/j.neuroscience.2011.06.047; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Ronzoni G, 2016, PSYCHONEUROENDOCRINO, V70, P1, DOI 10.1016/j.psyneuen.2016.04.018; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sajja VSSS, 2015, SHOCK, V44, P71, DOI 10.1097/SHK.0000000000000311; Sartory G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058150; Saykally JN, 2018, J NEUROTRAUM, V35, P139, DOI 10.1089/neu.2017.5070; Seedat S, 2004, J AFFECT DISORDERS, V80, P45, DOI 10.1016/S0165-0327(03)00047-8; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; VanElzakker MB, 2014, NEUROBIOL LEARN MEM, V113, P3, DOI 10.1016/j.nlm.2013.11.014; Vyas A, 2002, J NEUROSCI, V22, P6810; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960	39	10	10	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2019	315						9	14		10.1016/j.expneurol.2019.01.020			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HQ0RG	WOS:000462102100002	30711646	Green Accepted			2022-02-06	
J	Southard, RN; Bardo, DME; Temkit, MH; Thorkelson, MA; Augustyn, RA; Martinot, CA				Southard, R. N.; Bardo, D. M. E.; Temkit, M. H.; Thorkelson, M. A.; Augustyn, R. A.; Martinot, C. A.			Comparison of Iterative Model Reconstruction versus Filtered Back-Projection in Pediatric Emergency Head CT: Dose, Image Quality, and Image-Reconstruction Times	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							COMPUTED-TOMOGRAPHY; REDUCTION; PROTOCOLS; HYBRID	BACKGROUND AND PURPOSE: Noncontrast CT of the head is the initial imaging test for traumatic brain injury, stroke, or suspected nonaccidental trauma. Low-dose head CT protocols using filtered back-projection are susceptible to increased noise and decreased image quality. Iterative reconstruction noise suppression allows the use of lower-dose techniques with maintained image quality. We review our experience with children undergoing emergency head CT examinations reconstructed using knowledge-based iterative model reconstruction versus standard filtered back-projection, comparing reconstruction times, radiation dose, and objective and subjective image quality. MATERIALS AND METHODS: This was a retrospective study comparing 173 children scanned using standard age-based noncontrast head CT protocols reconstructed with filtered back-projection with 190 children scanned using low-dose protocols reconstructed with iterative model reconstruction. ROIs placed on the frontal white matter and thalamus yielded signal-to-noise and contrast-to-noise ratios. Volume CT dose index and study reconstruction times were recorded. Random subgroups of patients were selected for subjective image-quality review. RESULTS: The volume CT dose index was significantly reduced in studies reconstructed with iterative model reconstruction compared with filtered back-projection, (mean, 24.4 3.1 mGy versus 31.1 +/- 6.0 mGy, P < .001), while the SNR and contrast-to-noise ratios improved 2-fold (P < .001). Radiologists graded iterative model reconstruction images as superior to filtered back-projection images for gray-white matter differentiation and anatomic detail (P < .001). The average reconstruction time of the filtered back-projection studies was 101 seconds, and with iterative model reconstruction, it was 147 seconds (P < .001), without a practical effect on work flow. CONCLUSIONS: In children referred for emergency noncontrast head CT, optimized low-dose protocols with iterative model reconstruction allowed us to significantly reduce the relative dose, on average, 22% compared with filtered back-projection, with significantly improved objective and subjective image quality.	[Southard, R. N.; Bardo, D. M. E.; Thorkelson, M. A.; Augustyn, R. A.; Martinot, C. A.] Phoenix Childrens Hosp, Dept Med Imaging, Phoenix, AZ USA; [Temkit, M. H.] Phoenix Childrens Hosp, Dept Clin Res, Phoenix, AZ USA		Southard, RN (corresponding author), Phoenix Childrens Hosp, Dept Med Imaging, Clin Operat, 1919 East Thomas Rd,Main Tower Radiol, Phoenix, AZ 85016 USA.; Southard, RN (corresponding author), Phoenix Childrens Hosp, Dept Med Imaging, CT & Cardiac Imaging, 1919 East Thomas Rd,Main Tower Radiol, Phoenix, AZ 85016 USA.	rsouthard@phoenixchildrens.com		Thorkelson, Marrit/0000-0002-6110-0131; Martinot, Carlos/0000-0001-5386-9306; Southard, Richard/0000-0002-1273-8091; Augustyn, Robyn/0000-0002-0750-3642			Bodelle B, 2014, AM J NEURORADIOL, V35, P445, DOI 10.3174/ajnr.A3801; Cheng BC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30300-4; Coakley FV, 2011, AM J ROENTGENOL, V196, P619, DOI 10.2214/AJR.10.5043; den Harder AM, 2015, AM J ROENTGENOL, V204, P645, DOI 10.2214/AJR.14.12590; Harris MA, 2017, J MED IMAGING RADIAT, V48, P259, DOI 10.1016/j.jmir.2017.04.002; Ho C, 2014, CLIN IMAG, V38, P231, DOI 10.1016/j.clinimag.2013.12.009; Kilic K, 2013, J COMPUT ASSIST TOMO, V37, P377, DOI 10.1097/RCT.0b013e31828426de; Kim HG, 2017, EUR RADIOL, V27, P3609, DOI 10.1007/s00330-017-4733-z; Korn A, 2012, AM J NEURORADIOL, V33, P218, DOI 10.3174/ajnr.A2749; Liu XY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009412; Mahesh Mahadevappa, 2011, Pediatr Radiol, V41 Suppl 2, P493, DOI 10.1007/s00247-011-2169-1; McKnight CD, 2014, PEDIATR RADIOL, V44, P997, DOI 10.1007/s00247-014-2943-y; Mirro AE, 2016, AM J NEURORADIOL, V37, P1199, DOI 10.3174/ajnr.A4754; Notohamiprodjo S, 2015, EUR RADIOL, V25, P140, DOI 10.1007/s00330-014-3374-8; Ono S, 2016, J NEURORADIOLOGY, V43, P31, DOI 10.1016/j.neurad.2015.07.005; Padole A, 2015, AM J ROENTGENOL, V204, pW384, DOI 10.2214/AJR.14.13241; Ren QG, 2012, EUR J RADIOL, V81, P2597, DOI 10.1016/j.ejrad.2011.12.041; Ryan ME, 2014, J AM COLL RADIOL, V11, P939, DOI 10.1016/j.jacr.2014.07.017; Seibert JA, 2014, PEDIATR RADIOL, V44, P431, DOI 10.1007/s00247-014-3102-1; Singh S, 2012, RADIOLOGY, V263, P537, DOI 10.1148/radiol.12110268; Smith AB, 2007, AM J NEURORADIOL, V28, P1628, DOI 10.3174/ajnr.A0814; Smith EA, 2014, RADIOLOGY, V270, P526, DOI 10.1148/radiol.13130362; Thomas AK, 2018, J COMPUT ASSIST TOMO, V42, P475, DOI 10.1097/RCT.0000000000000690; Vorona GA, 2013, AM J NEURORADIOL, V34, P205, DOI 10.3174/ajnr.A3122; Willemink MJ, 2013, INSIGHTS IMAGING, V4, P391, DOI 10.1007/s13244-013-0226-z	25	10	10	6	10	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAY	2019	40	5					866	871		10.3174/ajnr.A6034			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	HY4TD	WOS:000468119900024	30975652	hybrid, Green Published			2022-02-06	
J	Stelmashook, EV; Isaev, NK; Genrikhs, EE; Novikova, SV				Stelmashook, Elena, V; Isaev, Nickolay K.; Genrikhs, Elisaveta E.; Novikova, Svetlana, V			Mitochondria-Targeted Antioxidants as Potential Therapy for the Treatment of Traumatic Brain Injury	ANTIOXIDANTS			English	Article						mitochondria-targeted antioxidant; traumatic brain injury; mitochondria	INDUCED NEUROLOGICAL DEFICIT; BETA-INDUCED IMPAIRMENT; LONG-TERM POTENTIATION; PLASTOQUINONE DERIVATIVES; INTERRUPT EXECUTION; OXIDATIVE STRESS; CARDIOLIPIN; SENESCENCE; PROTECTION; TOOLS	The aim of this article is to review the publications describing the use of mitochondria-targeted antioxidant therapy after traumatic brain injury (TBI). Recent works demonstrated that mitochondria-targeted antioxidants are very effective in reducing the negative effects associated with the development of secondary damage caused by TBI. Using various animal models of TBI, mitochondria-targeted antioxidants were shown to prevent cardiolipin oxidation in the brain and neuronal death, as well as to markedly reduce behavioral deficits and cortical lesion volume, brain water content, and DNA damage. In the future, not only a more detailed study of the mechanisms of action of various types of such antioxidants needs to be conducted, but also their therapeutic values and toxicological properties are to be determined. Moreover, the optimal therapeutic effect needs to be achieved in the shortest time possible from the onset of damage to the nervous tissue, since secondary brain damage in humans can develop for a long time, days and even months, depending on the severity of the damage.	[Stelmashook, Elena, V; Isaev, Nickolay K.; Genrikhs, Elisaveta E.; Novikova, Svetlana, V] Res Ctr Neurol, Moscow 125367, Russia; [Isaev, Nickolay K.] Moscow MV Lomonosov State Univ, NA Belozersky Inst Physicochem Biol, Biol Fac, Moscow 119991, Russia		Stelmashook, EV (corresponding author), Res Ctr Neurol, Moscow 125367, Russia.	estelmash@mail.ru; nisaev61@mail.ru; genrikhs@neurology.ru; novikova.s.v@neurology.ru	Genrikhs, Elizaveta E/C-3854-2012; Stelmashook, Elena V/B-4442-2012; Isaev, Nikolay K/B-4194-2012	Genrikhs, Elizaveta/0000-0002-3203-0250	Russian Science FoundationRussian Science Foundation (RSF) [16-15-10108]	This work was financially supported by the Russian Science Foundation projects No. 16-15-10108.	Antonenko YN, 2008, J MEMBRANE BIOL, V222, P141, DOI 10.1007/s00232-008-9108-6; Antonenko YN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1273, DOI 10.1134/S0006297908120018; Bakeeva LE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1288, DOI 10.1134/S000629790812002X; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Calkins MJ, 2012, PHARMACEUTICALS-BASE, V5, P1103, DOI 10.3390/ph5101103; Chelombitko MA, 2017, B EXP BIOL MED+, V162, P730, DOI 10.1007/s10517-017-3699-9; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Cho J, 2007, CORONARY ARTERY DIS, V18, P215, DOI 10.1097/01.mca.0000236285.71683.b6; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Genrikhs EE, 2019, BRAIN RES BULL, V148, P100, DOI 10.1016/j.brainresbull.2019.03.011; Genrikhs EE, 2015, J DRUG TARGET, V23, P347, DOI 10.3109/1061186X.2014.997736; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Isaev NK, 2012, BIOCHEMISTRY-MOSCOW+, V77, P996, DOI 10.1134/S0006297912090052; Isaev NK, 2016, REV NEUROSCIENCE, V27, P849, DOI 10.1515/revneuro-2016-0036; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Jourdan C, 2018, AM J PHYS MED REHAB, V97, P323, DOI 10.1097/PHM.0000000000000848; Kapay NA, 2013, J ALZHEIMERS DIS, V36, P377, DOI 10.3233/JAD-122428; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; LIBERMAN EA, 1969, NATURE, V222, P1076, DOI 10.1038/2221076a0; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Ma T, 2011, J NEUROSCI, V31, P5589, DOI 10.1523/JNEUROSCI.6566-10.2011; Nie XD, 2019, MOL MED REP, V19, P1139, DOI 10.3892/mmr.2018.9706; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956; Pointer CB, 2017, CELL MOL NEUROBIOL, V37, P1161, DOI 10.1007/s10571-016-0458-9; Shen QH, 2016, WORLDV EVID-BASED NU, V13, P380, DOI 10.1111/wvn.12167; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Silachev DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051553; Singh A, 2019, MOLECULES, V24, DOI 10.3390/molecules24081583; Skulachev MV, 2011, CURR DRUG TARGETS, V12, P800; Skulachev VP, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1385, DOI 10.1134/S0006297907120139; Stefanova NA, 2014, J ALZHEIMERS DIS, V38, P681, DOI 10.3233/JAD-131034; Szarka N, 2018, J NEUROTRAUM, V35, P930, DOI 10.1089/neu.2017.5056; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yao X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139416; Zhou J, 2018, AM J TRANSL RES, V10, P1887; Zhou ZW, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.827; Zhu YH, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4783602	43	10	11	1	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3921		ANTIOXIDANTS-BASEL	Antioxidants	MAY	2019	8	5							124	10.3390/antiox8050124			7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology	IC5PO	WOS:000471020500014	31071926	Green Published, gold, Green Submitted			2022-02-06	
J	Singh, R; Mason, S; Lecky, F; Dawson, J				Singh, Rajiv; Mason, Suzanne; Lecky, Fiona; Dawson, Jeremy			Comparison of early and late depression after TBI; (the SHEFBIT study)	BRAIN INJURY			English	Article						TBI; depression; outcome; follow-up; cohort; rehabilitation	TRAUMATIC BRAIN-INJURY; PSYCHIATRIC-DISORDERS; HOSPITAL ANXIETY; HEAD-INJURY; SCALE; CLASSIFICATION; SYMPTOMS; PREVALENCE; COMPLAINTS; MODERATE	Objective: Evaluate the prevalence and risk factors for depression at 1 year after traumatic brain injury (TBI) and contrast against those at 10 weeks. Methods: Prospective TBI admissions over 2 years to an emergency department were recruited to form a representative TBI population. Depression was recorded at 10 weeks and 1 year by HADS (Hospital Anxiety and Depression Scale) with score>8. Demographic and injury features were analyzed for association with depression. Results: A total of 774 individuals were recruited of whom 690 attended 1-year follow-up; 38 had died. Only 6% of the cohort was lost to follow-up. The prevalence of depression at 10 weeks was 56.3% [95% CI 52.8-59.8] and at 1 year 41.2% [95% CI 37.6-44.9] A multivariable analysis identified the independent predictors of 1 year depression as an abnormal CT scan, past psychiatric history, alcohol intoxication, and female gender. TBI severity, age, etiology, and medical comorbidity were not significant. By contrast at 10weeks, increasing severity and CT findings were highly significant. Conclusions: Depression at 1 year post-TBI remains high but injury features are less predictive than early after injury. It is likely that pre-injury personality and coping mechanisms are more important in determining long term outcome. The predictors identified may allow targeting of vulnerable sub-populations.	[Singh, Rajiv] Sheffield Teaching Hosp, Dept Rehabil Med, Osborn Neurorehabil Unit, Sheffield S5 7AU, S Yorkshire, England; [Singh, Rajiv; Mason, Suzanne; Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res ScHARR, Emergency Med Res Sheffield EMRiS, Fac Med Dent & Hlth, Sheffield, S Yorkshire, England; [Dawson, Jeremy] Univ Sheffield, Sch Management, Inst Work Psychol, Sheffield, S Yorkshire, England		Singh, R (corresponding author), Sheffield Teaching Hosp, Dept Rehabil Med, Osborn Neurorehabil Unit, Sheffield S5 7AU, S Yorkshire, England.	rajiv.singh@sth.nhs.uk		singh, rajiv/0000-0002-3173-9591			Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chandola T, 2000, J PUBLIC HEALTH MED, V22, P182, DOI 10.1093/pubmed/22.2.182; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Dyer JR, 2016, J HEAD TRAUMA REHAB, V31, P225, DOI 10.1097/HTR.0000000000000177; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Guillamondegui OD, 2011, AHRQ PUBLICATION; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Jorge R, 2002, NEUROREHABILITATION, V17, P311; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	10	10	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2019	33	5					584	591		10.1080/02699052.2019.1566837			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HR1NT	WOS:000462901200005	30663421	Green Accepted			2022-02-06	
J	Okamoto, RJ; Romano, AJ; Johnson, CL; Bayly, PV				Okamoto, Ruth J.; Romano, Anthony J.; Johnson, Curtis L.; Bayly, Philip, V			Insights Into Traumatic Brain Injury From MRI of Harmonic Brain Motion	JOURNAL OF EXPERIMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; MR elastography; brain-skull interface; brain mechanics; chronic traumatic encephalopathy	MAGNETIC-RESONANCE ELASTOGRAPHY; DEFORMATION; ENCEPHALOPATHY	Measurements of dynamic deformation of the human brain. induced by external harmonic vibration of the skull, were analyzed to illuminate the mechanics of mild traumatic brain injury (TBI). Shear wave propagation velocity vector fields were obtained to illustrate the role of the skull and stiff internal membranes in transmitting motion to the brain. Relative motion between the cerebrum and cerebellum was quantified to assess the vulnerability of connecting structures. Mechanical deformation was quantified throughout the brain to investigate spatial patterns of strain and axonal stretch. Strain magnitude was generally attenuated as shear waves propagated into interior structures of the brain: this attenuation was greater at higher frequencies. Analysis of shear wave propagation direction indicates that the stiff membranes (falx and tentorium) greatly affect brain deformation during imposed skull motion as they serve as sites for both initiation and reflection of shear waves. Relative motion between the cerebellum and cerebrum was small in comparison with the overall motion of both structures. which suggests that such relative motion might play only a minor role in TBI mechanics. Strain magnitudes and the amount of axonal stretch near the bases of sulci were similar to those in other areas of the cortex. and local strain concentrations at the gray-white matter boundary were not observed. We tentatively conclude that observed differences in neuropathological response in these areas might be due to heterogeneity in the response to mechanical deformation rather than heterogeneity of the deformation itself.	[Okamoto, Ruth J.; Bayly, Philip, V] Washington Univ, Dept Mech Engn & Mat Sci, Campus Box 1186,1 Brookings Dr, St Louis, MO 63130 USA; [Romano, Anthony J.] US Naval Res Lab, Acoust Div, Washington, DC USA; [Johnson, Curtis L.] Univ Delaware, Dept Biomed Engn, Newark, DE USA		Bayly, PV (corresponding author), Washington Univ, Dept Mech Engn & Mat Sci, Campus Box 1186,1 Brookings Dr, St Louis, MO 63130 USA.	pvb@wustl.edu	Johnson, Curtis/U-8372-2019	Bayly, Philip/0000-0003-4303-0704; Johnson, Curtis/0000-0002-7760-131X; Okamoto, Ruth/0000-0002-3085-3878	 [NIH R01-NS055951];  [ONR N0001417P7002];  [NSF CMMI-1727412]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the following grants: NIH R01-NS055951, ONR N0001417P7002, and NSF CMMI-1727412.	Arani A, 2015, NEUROIMAGE, V111, P59, DOI 10.1016/j.neuroimage.2015.02.016; Badachhape AA, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036146; Bayly PV, 2018, J MAGN RESON, V291, P73, DOI 10.1016/j.jmr.2018.01.004; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bower A. F., 2010, APPL MECH SOLIDS; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Gomez AD, 2019, IEEE T BIO-MED ENG, V66, P1456, DOI 10.1109/TBME.2018.2874591; Hiscox LV, 2016, PHYS MED BIOL, V61, pR401, DOI 10.1088/0031-9155/61/24/R401; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; Johnson CL, 2014, MAGN RESON MED, V71, P477, DOI 10.1002/mrm.25065; Johnson CL, 2013, NEUROIMAGE, V79, P145, DOI 10.1016/j.neuroimage.2013.04.089; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Kornguth S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120164; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McGarry MDJ, 2011, PHYS MED BIOL, V56, pN153, DOI 10.1088/0031-9155/56/13/N02; McGrath DM, 2016, MAGN RESON MED, V76, P645, DOI 10.1002/mrm.25881; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Pierpaoli C, 2009, ISMRM 18 ANN M EXH A; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Shiee N, 2010, NEUROIMAGE, V49, P1524, DOI 10.1016/j.neuroimage.2009.09.005; Strang G., 1986, INTRO APPL MATH; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yin ZY, 2018, MAGN RESON MED, V80, P2573, DOI 10.1002/mrm.27347; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034; 2006, J HEAD TRAUMA REHABI, V21, P375; 2017, J MAGN RESON IMAGING, V46, P1007, DOI DOI 10.1002/JMRI.25623	34	10	10	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-0695			J EXP NEUROSCI	J. Exp. Neurosci.	APR 7	2019	13								1179069519840444	10.1177/1179069519840444			10	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HV4PS	WOS:000465968800001	31001064	gold, Green Published			2022-02-06	
J	Chen, JC; Li, LM; Gao, JQ				Chen, Jia-Chen; Li, Li-Ming; Gao, Jian-Qing			Biomaterials for local drug delivery in central nervous system	INTERNATIONAL JOURNAL OF PHARMACEUTICS			English	Article						Central nervous system; Biomaterials; Local drug delivery system	SPINAL-CORD-INJURY; SUPERPARAMAGNETIC IRON-OXIDE; TRAUMATIC BRAIN-INJURY; PROMOTE AXON REGROWTH; HEPARIN-POLOXAMER; FUNCTIONAL RECOVERY; CONTROLLED-RELEASE; TARGETED DELIVERY; MALIGNANT GLIOMA; GROWTH-FACTOR	The central nervous system (CNS) is a vital part of human body which coordinate the actions by transmitting signals. Because of the existence of the blood-brain barrier and the blood-spinal cord barrier, diseases in CNS can hardly be directly intervened by non-invasive methods. While systemic delivery usually requires extravagant drug dosage and leads into toxicity in unexpected tissues, local drug delivery in CNS tissues provides a solution for the problems of physiological barriers and systematic side effects. Biomaterials are applied in local drug delivery system (LDDS) for CNS disease therapy with aims of tuning the drug release property and improving bioavailability, solubility, stability and safety of pharmaceutics. The indispensable importance and distinct physiological structure of cerebrospinal area bring about challenges to biomaterials in LDDS. Thus, properties of drug delivery systems are necessitated with prudently concern. In this review, the development of LDDS utilizing biomaterials will be presented, including sustained release, local parameter-responsible release, and regional cell-selective active targeting release. Studies on biomaterials employed as pharmaceuticals will give rise to a more efficacious method and the better understanding of LDDS design in CNS.	[Chen, Jia-Chen; Li, Li-Ming; Gao, Jian-Qing] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmaceut, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Li-Ming; Gao, Jian-Qing] Zhejiang Univ, Dr Li Dak Sum & Yip Yio Chin Ctr Stem Cell & Rege, Hangzhou 310058, Zhejiang, Peoples R China		Li, LM; Gao, JQ (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmaceut, Hangzhou 310058, Zhejiang, Peoples R China.	limingli@zju.edu.cn; gaojianqing@zju.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81620108028, 81473143, 81803451]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2018M632493]	This work was financially supported by the National Natural Science Foundation of China (81620108028, 81473143, and 81803451), and China Postdoctoral Science Foundation (2018M632493).	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Acarregui A, 2014, ACTA BIOMATER, V10, P4206, DOI 10.1016/j.actbio.2014.06.038; AHMAD MB, 1994, POLYM INT, V33, P273, DOI 10.1002/pi.1994.210330306; Alali AS, 2015, VALUE HEALTH, V18, P721, DOI 10.1016/j.jval.2015.04.012; Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o; Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514; Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Buonerba C, 2011, CRIT REV ONCOL HEMAT, V80, P54, DOI 10.1016/j.critrevonc.2010.09.001; Calzolari A, 2010, TRANSL ONCOL, V3, P123, DOI 10.1593/tlo.09274; Chaichana KL, 2015, THER DELIV, V6, P353, DOI [10.4155/tde.14.114, 10.4155/TDE.14.114]; Chen EM, 2018, BIOMATERIALS, V178, P193, DOI 10.1016/j.biomaterials.2018.06.024; Chen X, 2018, NEURAL REGEN RES, V13, P1231, DOI 10.4103/1673-5374.235061; Cheng Y, 2014, ADV DRUG DELIVER REV, V66, P42, DOI 10.1016/j.addr.2013.09.006; Chew SA, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201600766; Chu DS, 2015, BIOMATER SCI-UK, V3, P41, DOI [10.1039/c4bm00259h, 10.1039/C4BM00259H]; Chu DSH, 2013, BIOMATERIALS, V34, P9632, DOI 10.1016/j.biomaterials.2013.08.045; Colello RJ, 2016, J TISSUE ENG REGEN M, V10, P656, DOI 10.1002/term.1805; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Cui Y, 2015, MOL PHARMACEUT, V12, P1279, DOI 10.1021/mp500815b; Dagdeviren C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan2742; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006; Donaghue IE, 2015, ACTA BIOMATER, V25, P35, DOI 10.1016/j.actbio.2015.08.002; Dong GC, 2015, MAT SCI ENG C-MATER, V49, P691, DOI 10.1016/j.msec.2015.01.030; Dutta D, 2015, J MATER CHEM B, V3, P7963, DOI 10.1039/c5tb00935a; Freitas RA, 2005, DM-DIS MON, V51, P325, DOI 10.1016/j.disamonth.2005.08.003; Fuhrmann T, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201601130; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Garg T, 2014, EXPERT OPIN DRUG DEL, V11, P767, DOI 10.1517/17425247.2014.891014; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Geissler SA, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aaa55c; GhoshMitra S, 2012, ADV DRUG DELIVER REV, V64, P110, DOI 10.1016/j.addr.2011.12.013; GREIG NH, 1987, CANCER TREAT REV, V14, P1, DOI 10.1016/0305-7372(87)90048-X; Guasti L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-35; Gwak SJ, 2016, ACTA BIOMATER, V35, P98, DOI 10.1016/j.actbio.2016.02.013; Gwak SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147389; Gwak SJ, 2015, J BIOMED MATER RES A, V103, P3474, DOI 10.1002/jbm.a.35489; Hezi-Yamit A, 2009, J BIOMED MATER RES A, V90A, P133, DOI 10.1002/jbm.a.32057; HSU C Y, 1990, Journal of Neurotrauma, V7, P115, DOI 10.1089/neu.1990.7.115; Huang F, 2016, NEUROREPORT, V27, P116, DOI 10.1097/WNR.0000000000000507; Huang LJ, 2017, PROG NEUROBIOL, V157, P29, DOI 10.1016/j.pneurobio.2017.07.003; HUEBERS HA, 1987, PHYSIOL REV, V67, P520, DOI 10.1152/physrev.1987.67.2.520; Jiang LY, 2013, BIOMATERIALS, V34, P7418, DOI 10.1016/j.biomaterials.2013.05.078; Johnson CD, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aac4de; Jordan J., 2007, Current Drug Delivery, V4, P225; Kheirkhah P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29736-5; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Kraus RL, 2005, J NEUROCHEM, V94, P819, DOI 10.1111/j.1471-4159.2005.03219.x; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; Ladet SG, 2011, BIOMATERIALS, V32, P5354, DOI 10.1016/j.biomaterials.2011.04.012; Lam FC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04315-4; Lan L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173814; LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876; Lee JH, 2007, NAT MED, V13, P95, DOI 10.20659/jfp.13.1_95; Lee JY, 2014, J KOR ASSOC ORAL MAX, V40, P3, DOI 10.5125/jkaoms.2014.40.1.3; Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031; Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573; Leprince L, 2010, J MATER SCI-MATER M, V21, P925, DOI 10.1007/s10856-010-4008-6; LEVIN VA, 1980, J MED CHEM, V23, P682, DOI 10.1021/jm00180a022; Li H, 2014, ANN BIOMED ENG, V42, P1456, DOI 10.1007/s10439-013-0925-0; Li HG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034566; Li LM, 2018, CURR GENE THER, V18, P29, DOI 10.2174/1566523218666180413150023; Li LM, 2017, ACS APPL MATER INTER, V9, P3330, DOI 10.1021/acsami.6b12829; Li W, 2015, BIOMATERIALS, V65, P76, DOI 10.1016/j.biomaterials.2015.06.041; Liu DF, 2018, ADV MATER, V30, DOI 10.1002/adma.201706032; Liu GD, 2013, CANCER BIOTHER RADIO, V28, P691, DOI 10.1089/cbr.2013.1480; Liu S., 2018, FRONT CELL NEUROSCI, V11; Liu T, 2012, TISSUE ENG PT A, V18, P1057, DOI [10.1089/ten.TEA.2011.0430, 10.1089/ten.tea.2011.0430]; Locatelli E, 2014, NANOMEDICINE-UK, V9, P839, DOI [10.2217/NNM.14.1, 10.2217/nnm.14.1]; LOEFFLER DA, 1995, J NEUROCHEM, V65, P710; Lowry N, 2012, BIOMATERIALS, V33, P2892, DOI 10.1016/j.biomaterials.2011.12.048; Lu Y, 2009, BIOMATERIALS, V30, P4143, DOI 10.1016/j.biomaterials.2009.04.030; Lueshen E, 2014, NANOMEDICINE-UK, V9, P1155, DOI [10.2217/NNM.13.69, 10.2217/nnm.13.69]; Luo R. C., 2013, INT C OPT MEMS UNPUB; Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8; Mellott AJ, 2013, ANN BIOMED ENG, V41, P446, DOI 10.1007/s10439-012-0678-1; Misra A, 2003, J PHARM PHARM SCI, V6, P252; Montembault A, 2006, BIOCHIMIE, V88, P551, DOI 10.1016/j.biochi.2006.03.002; Mu QX, 2015, ADV HEALTHC MATER, V4, P1236, DOI 10.1002/adhm.201500034; Mugge L, 2018, NEUROSURG REV; Nawrotek K, 2017, J BIOMED MATER RES A, V105, P2004, DOI 10.1002/jbm.a.36067; Nikodemova M, 2007, J BIOL CHEM, V282, P15208, DOI 10.1074/jbc.M611907200; Pardridge WM, 2015, CLIN PHARMACOL THER, V97, P347, DOI 10.1002/cpt.18; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Patel SJ, 2005, NEUROSURGERY, V56, P1243, DOI 10.1227/01.NEU.0000159649.71890.30; Pedron S, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700529; PEPPAS NA, 1985, J BIOMED MATER RES, V19, P397, DOI 10.1002/jbm.820190405; Pires LR, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-017-5967-7; Qian T, 2005, SPINAL CORD, V43, P199, DOI 10.1038/sj.sc.3101681; Rafalowska J, 2014, FOLIA NEUROPATHOL, V52, P407, DOI 10.5114/fn.2014.47841; Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P; Ren H, 2014, BIOMATERIALS, V35, P6585, DOI 10.1016/j.biomaterials.2014.04.042; Roman JA, 2016, ADV HEALTHC MATER, V5, P2628, DOI 10.1002/adhm.201600415; Rudolfson N., 2018, J NEUROSURG, V1; Sawyer Andrew J, 2006, Yale J Biol Med, V79, P141; Segal Malcolm B., 1996, PHYSL CSF BLOOD BRAI; Sellers DL, 2014, BIOMATERIALS, V35, P8895, DOI 10.1016/j.biomaterials.2014.06.051; Serwer LP, 2012, ADV DRUG DELIVER REV, V64, P590, DOI 10.1016/j.addr.2012.01.004; SHAPIRO WR, 1992, J NEUROSURG, V76, P772, DOI 10.3171/jns.1992.76.5.0772; Tan EYM, 2007, PHARM RES-DORDR, V24, P2297, DOI 10.1007/s11095-007-9454-6; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tiwari SK, 2014, ACS NANO, V8, P76, DOI 10.1021/nn405077y; Tuladhar A, 2015, J CONTROL RELEASE, V215, P1, DOI 10.1016/j.jconrel.2015.07.023; Turabee MH, 2019, CARBOHYD POLYM, V203, P302, DOI 10.1016/j.carbpol.2018.09.065; Turkoglu OF, 2010, BRIT J NEUROSURG, V24, P578, DOI 10.3109/02688697.2010.487126; Venugopal I, 2017, NANOMEDICINE-UK, V12, P865, DOI 10.2217/nnm-2016-0418; Wang H, 2016, SMALL, V12, P6388, DOI 10.1002/smll.201602263; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; Wang QQ, 2017, ACS APPL MATER INTER, V9, P6725, DOI 10.1021/acsami.6b13155; Wang Y, 2018, NEURAL PROCESS LETT, V48, P1323, DOI 10.1007/s11063-017-9759-3; Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; Wang ZC, 2017, BIOMATERIALS, V112, P62, DOI 10.1016/j.biomaterials.2016.10.002; Wei XL, 2014, ACTA PHARM SIN B, V4, P193, DOI 10.1016/j.apsb.2014.03.001; Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Wen YJ, 2016, CELL TISSUE RES, V364, P17, DOI 10.1007/s00441-015-2298-1; Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/S1522851702000236; Whittle IR, 1999, BRIT J NEUROSURG, V13, P132, DOI 10.1080/02688699943871; Winblad B, 2007, NEUROLOGY, V69, pS14, DOI 10.1212/01.wnl.0000281847.17519.e0; XU H, 2016, SCI REP UK, V0006; Xu HL, 2018, INT J NANOMED, V13, P681, DOI 10.2147/IJN.S152246; Yamane K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19316-y; Yao L, 2013, GENE THER, V20, P1149, DOI 10.1038/gt.2013.42; Young W., 1991, NEW ENGL J MED, V322, P1207; Yu SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep33428; Zaviskova K, 2018, J BIOMED MATER RES A, V106, P1129, DOI 10.1002/jbm.a.36311; Zhang ZL, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046015; Zhao YZ, 2017, J BIOMED MATER RES A, V105, P2816, DOI 10.1002/jbm.a.36134; Zhao YZ, 2016, ACTA BIOMATER, V29, P71, DOI 10.1016/j.actbio.2015.10.014; Zhou L., 2018, ACS NANO; Ziemba AM, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00245; Zuidema JM, 2011, ACTA BIOMATER, V7, P1634, DOI 10.1016/j.actbio.2010.11.039	137	10	10	8	35	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5173	1873-3476		INT J PHARMACEUT	Int. J. Pharm.	APR 5	2019	560						92	100		10.1016/j.ijpharm.2019.01.071			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HP0AH	WOS:000461326800010	30742988				2022-02-06	
J	Bodapati, AS; Combs, HL; Pastorek, NJ; Miller, B; Troyanskaya, M; Romesser, J; Sim, A; Linck, J				Bodapati, Anjuli S.; Combs, Hannah L.; Pastorek, Nicholas J.; Miller, Brian; Troyanskaya, Maya; Romesser, Jennifer; Sim, Anita; Linck, John			Detection of symptom over-reporting on the Neurobehavioral Symptom Inventory in OEF/OIF/OND veterans with history of mild TBI	CLINICAL NEUROPSYCHOLOGIST			English	Article						NSI Validity-10; symptom validity testing; symptom exaggeration; mild TBI; veterans	TRAUMATIC BRAIN-INJURY; PERSISTENT POSTCONCUSSIVE SYMPTOMS; VALIDITY SCALES; CLINICAL UTILITY; SERVICE MEMBERS; BASE RATES; STRESS; EXAGGERATION; COMPLAINTS; SENSITIVITY	Objective: As part of routine care at Veterans Affairs facilities, veterans with a service-related traumatic brain injury (TBI) are administered a self-report post-concussive symptom measure, the Neurobehavioral Symptom Inventory (NSI). Interpreting the NSI can be problematic given that over-reporting on self-report measures is often found in both civilian and military patient populations. This study investigates embedded scales on the NSI that identify possible and probable symptom exaggeration. Method: 183 veterans with a history of mild TBI were administered the Minnesota Multiphasic Personality Inventory, 2nd edition, Restructured Form (MMPI-2-RF) and the NSI. The participants were divided into symptom validity testing pass and fail groups based on their performance on the MMPI-2-RF symptom validity scales. Cut scores on the NSI Total and Validity-10 scores were then established and applied to two additional veteran populations. Results: Sensitivity and specificity values were derived for all NSI Total and Validity-10 values. Optimal cut scores were determined based on specificity levels of >= 95%. The NSI Total cut score was >= 57 for possible and >= 67 for probable symptom exaggeration and the Validity-10 cut score was >= 22 for possible and >= 27 for probable symptom exaggeration, with sensitivity ranging from 27 to 43%. Applying these cut scores to a broader clinical and research sample resulted in lower rates of suspected exaggeration. Conclusions: Both the NSI Total and Validity-10 cut scores consistently identified potential symptom exaggeration across three mild TBI samples. Clinicians and researchers who use the NSI are encouraged to utilize either embedded validity measure in their practice.	[Bodapati, Anjuli S.; Pastorek, Nicholas J.; Miller, Brian; Troyanskaya, Maya] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Bodapati, Anjuli S.; Combs, Hannah L.; Pastorek, Nicholas J.; Miller, Brian] Baylor Coll Med, Houston, TX 77030 USA; [Romesser, Jennifer] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Sim, Anita] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Linck, John] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA		Pastorek, NJ (corresponding author), Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA.; Pastorek, NJ (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	Nicholas.Pastorek@va.gov		Pastorek, Nicholas/0000-0002-9290-380X	A Longitudinal Study of Chronic TBI in OEF/OIF/OND Veterans and Service Members [O1062-I]	This work was supported by A Longitudinal Study of Chronic TBI in OEF/OIF/OND Veterans and Service Members [grant number O1062-I].	Akobeng AK, 2007, ACTA PAEDIATR, V96, P338, DOI 10.1111/j.1651-2227.2006.00180.x; Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Defense & Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBI; Freeman T, 2008, PSYCHIAT RES, V158, P374, DOI 10.1016/j.psychres.2007.04.002; Frueh BC, 2003, PSYCHIATR SERV, V54, P84, DOI 10.1176/appi.ps.54.1.84; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Harrison AG, 2010, APPL NEUROPSYCHOL, V17, P135, DOI 10.1080/09084281003715642; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jurick SM, 2016, J REHABIL RES DEV, V53, P571, DOI 10.1682/JRRD.2015.05.0094; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; McCrea M., 2008, MILD TRAUMATIC BRAIN; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morey, 1991, PERSONALITY ASSESSME; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Sullivan K., 2007, J FORENSIC NEUROPSYC, V4, P49, DOI DOI 10.1300/J151V04N04_04; Tellegen, 2008, MINNESOTA MULTIPHASI; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tolin DF, 2010, PSYCHOL ASSESSMENT, V22, P729, DOI 10.1037/a0020973; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e	35	10	10	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	APR 3	2019	33	3					539	556		10.1080/13854046.2018.1482003			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	HU3FG	WOS:000465157200006	29865932				2022-02-06	
J	Mollayeva, T; Sutton, M; Chan, V; Colantonio, A; Jana, S; Escobar, M				Mollayeva, Tatyana; Sutton, Mitchell; Chan, Vincy; Colantonio, Angela; Jana, Sayantee; Escobar, Michael			Data mining to understand health status preceding traumatic brain injury	SCIENTIFIC REPORTS			English	Article							FALSE DISCOVERY RATE; RISK-FACTORS; OLDER; FALLS; EPIDEMIOLOGY; CONSEQUENCES; ASSOCIATION; COHORT; ADULTS; CARE	The use of precision medicine is poised to increase in complex injuries such as traumatic brain injury (TBI), whose multifaceted comorbidities and personal circumstances create significant challenges in the domains of surveillance, management, and environmental mapping. Population-wide health administrative data remains a rather unexplored, but accessible data source for identifying clinical associations and environmental patterns that could lead to a better understanding of TBIs. However, the amount of data structured and coded by the International Classification of Disease poses a challenge to its successful interpretation. The emerging field of data mining can be instrumental in helping to meet the daunting challenges faced by the TBI community. The report outlines novel areas for data mining relevant to TBI, and offers insight into how the above approach can be applied to solve pressing healthcare problems. Future work should focus on confirmatory analyses, which subsequently can guide precision medicine and preventive frameworks.	[Mollayeva, Tatyana; Chan, Vincy; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Sutton, Mitchell; Colantonio, Angela; Jana, Sayantee; Escobar, Michael] Univ Toronto, Dana Lana Sch Publ Hlth, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Fac Med, Rehabil Sci Inst, Toronto, ON, Canada		Escobar, M (corresponding author), Univ Toronto, Dana Lana Sch Publ Hlth, Toronto, ON, Canada.	m.escobar@utoronto.ca	Chan, Vincy/AAA-7813-2020; , Mollayeva/A-4522-2018	Escobar, Michael/0000-0001-9055-4709; Chan, Vincy/0000-0002-6884-044X; Colantonio, Angela/0000-0003-2094-4765; Mollayeva, Tatyana/0000-0002-2787-1848	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R21HD089106]; Canadian Institutes of Health Research (CIHR) Chair in Gender, Work and Health [CGW-126580]; Alzheimer's AssociationAlzheimer's Association [AARF-16-442937]; Canada's Strategy for Patient-Oriented Research (SPOR); Ontario SPOR Support Unit; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Government of Ontario; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD089106] Funding Source: NIH RePORTER	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R21HD089106. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. AC was funded by the Canadian Institutes of Health Research (CIHR) Chair in Gender, Work and Health (CGW-126580). TM was supported by the postdoctoral research grant from the Alzheimer's Association (AARF-16-442937). The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript. This study made use of de-identified data from the ICES Data Repository, which is managed by the Institute for Clinical Evaluative Sciences with support from its funders and partners: Canada's Strategy for Patient-Oriented Research (SPOR), the Ontario SPOR Support Unit, the Canadian Institutes of Health Research and the Government of Ontario. Parts of this material are based on data and information compiled and provided by the Canadian Institute for Health Information (CIHI). The opinions, results and conclusions reported are those of the authors. No endorsement by ICES or any of its funders or partners, nor CIHI, is intended or should be inferred.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Benjamini Y, 2001, ANN STAT, V29, P1165; Breen JM, 2018, FORENSIC SCI MED PAT, V14, P4, DOI 10.1007/s12024-017-9934-x; Brenner LA, 2009, BRAIN INJURY, V23, P991, DOI 10.3109/02699050903379362; Chan DC, 2012, ARCH GERONTOL GERIAT, V54, P168, DOI 10.1016/j.archger.2011.02.005; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Cobb AN, 2018, SURGERY, V164, P640, DOI 10.1016/j.surg.2018.06.022; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Estape Estela S, 2016, Intell Inf Manag, V8, P9; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Gal M, 2012, EUR J EMERG MED, V19, P146, DOI 10.1097/MEJ.0b013e32834ada2e; Gonzalez-Chica DA, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0806-6; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/978-0-387-84858-7_7, DOI 10.1007/978-0-387-84858-7_7]; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Hwang HF, 2015, J HEAD TRAUMA REHAB, V30, pE9, DOI 10.1097/HTR.0000000000000093; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Institute for Clinical Evaluation Sciences, PRIV COD PROT PERS H; Islam MS, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6020054; Jonsdottir GM, 2017, ACTA ANAESTH SCAND, V61, P408, DOI 10.1111/aas.12869; Karakurt G, 2017, J FAM VIOLENCE, V32, P79, DOI 10.1007/s10896-016-9872-5; Karjalainen K, 2012, ACCIDENT ANAL PREV, V45, P731, DOI 10.1016/j.aap.2011.09.044; Karwat ID, 2009, ANN AGR ENV MED, V16, P23; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Lasry O, 2018, EPIDEMIOLOGY, V29, P876, DOI [10.1097/ede.0000000000000888, 10.1097/EDE.0000000000000888]; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahler B, 2018, NEUROLOGY, V90, pE779, DOI 10.1212/WNL.0000000000005035; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; MOUSSA MAA, 1985, COMPUT PROG BIOMED, V19, P239, DOI 10.1016/0010-468X(85)90017-0; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Quaglio G, 2017, LANCET NEUROL, V16, P951, DOI 10.1016/S1474-4422(17)30370-8; Ristevski B, 2018, J INTEGR BIOINFORMAT, V15, DOI 10.1515/jib-2017-0030; Roche KE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26310-x; Sabatti C, 2003, GENETICS, V164, P829; Scott-Parker B, 2015, INJURY PREV, V21, P131, DOI 10.1136/injuryprev-2015-041568; Seppala L. J, 2018, J AM MED DIR ASSOC, V19; Shah ND, 2018, JAMA-J AM MED ASSOC, V320, P27, DOI 10.1001/jama.2018.5602; Short D, 1999, JEMS, V24, P68; Stawicki Stanislaw P, 2015, J Emerg Trauma Shock, V8, P224, DOI 10.4103/0974-2700.161658; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tollefsen MH, 2018, WORLD NEUROSURG, V114, pE209, DOI 10.1016/j.wneu.2018.02.167; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; Walker RL, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-149; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wolff ML, 2012, J AM GERIATR SOC, V60, P987, DOI 10.1111/j.1532-5415.2012.03913.x; Yang Y, 2017, J HEAD TRAUMA REHAB, V32, P168, DOI 10.1097/HTR.0000000000000257; Yokomoto-Umakoshi M, 2017, ENDOCR J, V64, P727, DOI 10.1507/endocrj.EJ17-0011; You N, 2018, BIOMETRICS, V74, P814, DOI 10.1111/biom.12843	54	10	10	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 3	2019	9								5574	10.1038/s41598-019-41916-5			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR5HU	WOS:000463178500035	30944376	Green Published, gold			2022-02-06	
J	Moussavi, Z; Suleiman, A; Rutherford, G; Pouya, OR; Dastgheib, Z; Zhang, WJ; Salter, J; Wang, XK; Mansouri, B; Lithgow, B				Moussavi, Zahra; Suleiman, Abdelbaset; Rutherford, Grant; Pouya, Omid Ranjbar; Dastgheib, Zeinab; Zhang, Weijia; Salter, Jennifer; Wang, Xikui; Mansouri, Behzad; Lithgow, Brian			A Pilot Randomised Double-Blind Study of the Tolerability and efficacy of repetitive Transcranial Magnetic Stimulation on Persistent Post-Concussion Syndrome	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; DORSOLATERAL PREFRONTAL CORTEX; ALZHEIMERS-DISEASE; HEAD-INJURY; POSTCONCUSSION SYMPTOMS; EXECUTIVE FUNCTIONS; CONSTRUCT-VALIDITY; DEPRESSION; IMPACT; QUESTIONNAIRE	This study investigates the effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on persistent post-concussion syndrome (PCS). The study design was a randomized (coin toss), placebo controlled, and double-blind study. Thirty-seven participants with PCS were assessed for eligibility; 22 were randomised and 18 completed the study requirements. Half the participants with PCS were given an Active rTMS intervention and the other half given Sham rTMS over 3 weeks. Follow ups were at the end of treatment and at 30 and 60 days. The primary outcome measure was the Rivermead Post-Concussion Symptoms Questionnaire (RPQ3 & RPQ13). The results indicate participants with more recent injuries (<12 month), who received Active rTMS, showed significant improvements compared to those of: 1) the same subgroup who received Sham, and 2) those with a longer duration of injury (>14 months) who received Active rTMS. This improvement predominantly manifested in RPQ13 in the follow up periods 1 and 2 months after the intervention (RPQ13 change (mean +/- SD): at 1 month, Active = -21.8 +/- 6.6, Sham = -2.2 +/- 9.8; at 2 months, Active = -21.2 +/- 5.3, Sham = -5.4 +/- 13.7). No improvement was found in the subgroup with longer duration injuries. The results support rTMS as a tolerable and potentially effective treatment option for individuals with a recent (<1 year) concussion.	[Moussavi, Zahra; Suleiman, Abdelbaset; Rutherford, Grant; Pouya, Omid Ranjbar; Dastgheib, Zeinab; Mansouri, Behzad; Lithgow, Brian] Univ Manitoba, Biomed Engn, Winnipeg, MB, Canada; [Moussavi, Zahra; Salter, Jennifer; Lithgow, Brian] Riverview Hlth Ctr, Winnipeg, MB, Canada; [Zhang, Weijia; Wang, Xikui] Univ Manitoba, Stat Dept, Winnipeg, MB, Canada; [Mansouri, Behzad] Univ Manitoba, Neurol Dept, Winnipeg, MB, Canada; [Lithgow, Brian] Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia		Moussavi, Z (corresponding author), Univ Manitoba, Biomed Engn, Winnipeg, MB, Canada.; Moussavi, Z (corresponding author), Riverview Hlth Ctr, Winnipeg, MB, Canada.	Zahra.Moussavi@umanitoba.ca	Pouya, Omid/AAH-2419-2021	Rutherford, Grant/0000-0002-1511-9675	MITACS; Manitoba Public Insurance (MPI)	This study was supported by MITACS in partnership with Manitoba Public Insurance (MPI). The study was registered on Clinicaltrials.gov on 27/04/2015; Registration ID: NCT02426749. The study protocol can be accessed through clinicaltrials.gov. MITACS (IT04908) in partnership with Manitoba Public Insurance (MPI). The author B.L has less than 0.5% in the supporting company NEURAL DIAGNOSTICS Pty. Ltd.	Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Allen L, 2012, TOP STROKE REHABIL, V19, P523, DOI 10.1310/tsr1906-523; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderkova L, 2014, J NEUROL SCI, V339, P15, DOI 10.1016/j.jns.2014.01.037; [Anonymous], 2009, REPORT ACCESS EC VIC, V31; BARKER AT, 1991, J CLIN NEUROPHYSIOL, V8, P26, DOI 10.1097/00004691-199101000-00005; Bentwich J, 2011, J NEURAL TRANSM, V118, P463, DOI 10.1007/s00702-010-0578-1; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Blakley B, 2019, J MED BIOL ENG, V39, P213, DOI 10.1007/s40846-018-0398-6; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Cavinato M, 2012, CLIN NEUROPHYSIOL, V123, P1893, DOI 10.1016/j.clinph.2012.02.066; Cha YH, 2013, OTOL NEUROTOL, V34, P175, DOI 10.1097/MAO.0b013e318278bf7c; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Devi G, 2014, AM J ALZHEIMERS DIS, V29, P248, DOI 10.1177/1533317513517047; Dietrich W. D., 2016, BRADLEYS NEUROLOGY C, V2, P850; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; GALINOWSKI A, 1995, INT CLIN PSYCHOPHARM, V10, P157, DOI 10.1097/00004850-199510030-00004; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hamilton M., 2000, HAMILTON RATING SCAL; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kisilevski V, 2001, Int Tinnitus J, V7, P118; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Leung A, 2018, NEUROMODULATION, V21, P390, DOI 10.1111/ner.12615; Leung A, 2016, NEUROMODULATION, V19, P133, DOI 10.1111/ner.12364; Lithgow B, 2012, ANN BIOMED ENG, V40, P1835, DOI 10.1007/s10439-012-0526-3; Lithgow BJ, 2019, EUR ARCH PSY CLIN N, V269, P761, DOI 10.1007/s00406-018-0935-x; Lithgow BJ, 2015, WORLD J BIOL PSYCHIA, V16, P334, DOI 10.3109/15622975.2015.1014410; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lyoo IK, 2011, ARCH GEN PSYCHIAT, V68, P701, DOI 10.1001/archgenpsychiatry.2011.70; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maeda F., 2000, EXPT BRAIN RES, V133; Mailer JJ, 2015, ARCH NEUROSCI, V2, DOI 10.5812/archneurosci.19257; Martin JLR, 2003, BRIT J PSYCHIAT, V182, P480, DOI 10.1192/bjp.182.6.480; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; McCrory P., 2017, BRIT J SPORTS MED; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Montgomery SA, 2000, HDB PSYCHIAT MEASURE, P531; Muller MJ, 2003, J AFFECT DISORDERS, V77, P255, DOI 10.1016/S0165-0327(02)00120-9; Organisation W. H., 1993, ICD 10 CLASS MENT DI; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Rabey JM, 2013, J NEURAL TRANSM, V120, P813, DOI 10.1007/s00702-012-0902-z; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rutherford Grant, 2013, Neurosci J, V2013, P679389, DOI 10.1155/2013/679389; Rutherford G, 2015, J EXP NEUROSCI, V9, P43, DOI 10.4137/JEN.S24004; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shoushtarian M., 2008, THESIS; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Suleiman A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32808-1; Suleiman A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15487-2; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Xia XY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00182; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	72	10	10	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 2	2019	9								5498	10.1038/s41598-019-41923-6			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR2TL	WOS:000462990000040	30940870	Green Published, gold			2022-02-06	
J	Avraham, JB; Bhandari, M; Frangos, SG; Levine, DA; Tunik, MG; DiMaggio, CJ				Avraham, Jacob B.; Bhandari, Misha; Frangos, Spiros G.; Levine, Deborah A.; Tunik, Michael G.; DiMaggio, Charles J.			Epidemiology of paediatric trauma presenting to US emergency departments: 2006-2012	INJURY PREVENTION			English	Article							UNITED-STATES; BRAIN-INJURY; VISITS; CARE; PATTERNS; OUTCOMES; TRENDS; RACE	Background Traumatic injury is the leading cause of paediatric morbidity and mortality in the USA. We present updated national data on emergency department (ED) discharges for traumatic injury for a recent 7-year period. Methods We conducted a descriptive epidemiological analysis of the Nationwide Emergency Department Sample Survey, the largest and most comprehensive database in the USA, for 2006-2012. Among children and adolescents, we tracked changes in injury mechanism and severity, cost of care, injury intent and the role of trauma centres. Results There was an 8.3% (95% CI 7.7 to 8.9) decrease in the annual number of ED visits for traumatic injury in children and adolescents over the study period, from 8 557 904 (SE=5861) in 2006 to 7 846 912 (SE=5191) in 2012. The case-fatality rate was 0.04% for all injuries and 3.2% for severely injured children. Children and adolescents with high-mortality injury mechanisms were more than three times more likely to be treated at a level 1 trauma centre (OR=3.5, 95% CI 3.3 to 3.7), but were more no more likely to die (OR=0.96, 95% CI 0.93 to 1.00). Traumatic brain injury diagnoses increased 22.2% (95% CI 20.6 to 23.9) during the study period. Intentional assault accounted for 3% (SE=0.1) of all child and adolescent ED injury discharges and 7.2% (SE=0.3) of discharges among 15-19 year-olds. There was an 11.3% (95% CI 10.0 to 12.6) decline in motor vehicle injuries from 2009 to 2012. The total cost of care was $23 billion (SE=0.01), a 78% increase from 2006 to 2012. Conclusions This analysis presents a recent portrait of paediatric trauma across the USA. These analyses indicate the important role and value of trauma centre care for injured children and adolescents, and that the most common causes and mechanisms of injury are preventable.	[Avraham, Jacob B.; Bhandari, Misha] NYU, Dept Surg, Sch Med, New York, NY 10016 USA; [Bhandari, Misha] Univ Hosp Columbia & Cornell, Dept Emergency Med, New York Presbyterian, New York, NY USA; [Frangos, Spiros G.; DiMaggio, Charles J.] NYU, Bellevue Hosp Ctr, Dept Surg, Div Acute Care & Trauma Surg,Sch Med, New York, NY 10016 USA; [Levine, Deborah A.; Tunik, Michael G.] NYU, Bellevue Hosp Ctr, Dept Pediat, Sch Med, New York, NY 10016 USA; [Levine, Deborah A.; Tunik, Michael G.] NYU, Bellevue Hosp Ctr, Sch Med, Ronald O Perelman Dept Emergency Med, New York, NY 10016 USA; [DiMaggio, Charles J.] NYU, Sch Med, Populat Hlth, New York, NY USA		DiMaggio, CJ (corresponding author), NYU, Bellevue Hosp Ctr, Dept Surg, Div Acute Care & Trauma Surg,Sch Med, New York, NY 10016 USA.	Charles.DiMaggio@nyumc.org		DiMaggio, Charles/0000-0003-2356-6659; Frangos, Spiros/0000-0003-2860-8969; Tunik, Michael/0000-0002-2368-5933	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1 R01 HD087460]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD087460] Funding Source: NIH RePORTER	The study was funded by the National Institute of Child Health and Human Development (to CJD) (Grant 1 R01 HD087460). The study funder had no role in the study design, analysis, drafting of the manuscript, or decision to submit the study for publication.	American College of Surgeons, 1990, RESOURCES OPTIMAL CA; Amini Rachid, 2011, J Emerg Trauma Shock, V4, P12, DOI 10.4103/0974-2700.76824; [Anonymous], 2015, INTRO HCUP NATIONWID; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Bartolomeos KK, JOINT M INT COLL EFF; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Borse N, 2009, FAM COMMUNITY HEALTH, V32, P189, DOI 10.1097/01.FCH.0000347986.44810.59; Centers for Disease Control and Prevention, 1999, WEB BAS INJ STAT QUE; Centers for Disease Control Prevention, 2012, NAT ACT PLAN CHILD I; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; DiMaggio C, 2016, INJURY, V47, P1393, DOI 10.1016/j.injury.2016.04.002; DiMaggio C, 2013, BRAIN INJURY, V27, P1238, DOI 10.3109/02699052.2013.809552; DiMaggio CJ, WALL SPACAD EMERG ME; Gausche-Hill M, 2015, JAMA PEDIATR, V169, P527, DOI 10.1001/jamapediatrics.2015.138; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Haider AH, 2011, J PEDIATR SURG, V46, P1557, DOI 10.1016/j.jpedsurg.2011.04.055; HealthIT. gov, BEN EL MED REC; Hirshon JM, 2009, ACAD EMERG MED, V16, P1103, DOI 10.1111/j.1553-2712.2009.00554.x; Hsia RY, 2008, ANN EMERG MED, V51, P265, DOI 10.1016/j.annemergmed.2007.08.009; Kalesan B, 2016, ANN EPIDEMIOL, V26, P1, DOI 10.1016/j.annepidem.2015.10.009; Kalesan B, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005628; Kenefake ME, 2013, EMERG MED CLIN N AM, V31, P627, DOI 10.1016/j.emc.2013.04.004; LeMier M, 2001, Inj Prev, V7, P334, DOI 10.1136/ip.7.4.334; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Odetola FO, 2015, INT J INJ CONTROL SA, V22, P260, DOI 10.1080/17457300.2014.925937; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Schappert SM, 2012, NATL HLTH STAT REPOR, V47; Segui-Gomez M, 2003, J PEDIATR SURG, V38, P1162, DOI 10.1016/S0022-3468(03)00262-8; Segui-Gomez M, 2012, INJURY SEVERITY SCAL, P281; Short SS, 2013, J SURG RES, V184, P383, DOI 10.1016/j.jss.2013.03.042; Smith NA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0346; Srinivasan S, 2014, ARCH DIS CHILD, V99, P331, DOI 10.1136/archdischild-2013-304642; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Stylianos S, 2008, SEMIN PEDIATR SURG, V17, P110, DOI 10.1053/j.sempedsurg.2008.02.006; Wesson DE, 2012, TEX HEART I J, V39, P871; WHO, 2013, DEF KEY TERMS; Winthrop AL, 2005, J TRAUMA, V58, P468, DOI 10.1097/01.TA.0000153940.23471.B7	42	10	10	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	APR	2019	25	2					136	143		10.1136/injuryprev-2017-042435			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	IC6OL	WOS:000471091300013	29056586				2022-02-06	
J	Carlozzi, NE; Kallen, MA; Ianni, PA; Hahn, EA; French, LM; Lange, RT; Brickell, TA; Hanks, R; Sander, AM				Carlozzi, Noelle E.; Kallen, Michael A.; Ianni, Phillip A.; Hahn, Elizabeth A.; French, Louis M.; Lange, Rael T.; Brickell, Tracey A.; Hanks, Robin; Sander, Angelle M.			The Development of a New Computer-Adaptive Test to Evaluate Strain in Caregivers of Individuals With TBI: TBI-CareQOL Caregiver Strain	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Caregiver; Health-related quality of life; Military family; Patient reported outcome; Rehabilitation; Traumatic brain injury; Veterans	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; BLUNT HEAD-INJURY; FAMILY NEEDS; PSYCHOLOGICAL DISTRESS; ITEM BANKS; REHABILITATION; OUTCOMES; BURDEN; HEALTH	Objective: To develop a new measure of caregiver strain for use in caregivers of individuals with traumatic brain injury (TBI), Traumatic Brain Injury Caregiver Quality of Life (TBI-CareQOL) Caregiver Strain. Design: Qualitative data, literature reviews, and cross-sectional survey study. Setting: Three TBI Model Systems rehabilitation hospitals, an academic medical center, and a military medical treatment facility. Participants: Caregivers (N=560) of civilians (n=344) or service members/veterans (SMVs) with TBI (n=216). Interventions: Not applicable. Main outcome measure: TBI-CareQOL Caregiver Strain Item Bank. Results: Exploratory and confirmatory factor analyses, a graded response model (GRM) and differential item functioning supported the retention of 33 items in the final measure. GRM calibration data was used to inform the selection of a 6-item static short form, and to program the TBI-CareQOL Caregiver Strain computer-adaptive test (CAT). CAT simulation analyses indicated a 0.97 correlation between the CAT scores and the full item-bank. Three-week test-retest reliability was strong (r=0.83). Conclusions: The new TBI-CareQOL Caregiver Strain CAT and corresponding 6-item short form were developed using established rigorous measurement development standards; this is the first self-reported measure developed to evaluate caregiver strain in caregivers of individuals with TBI. (C) 2018 by the American Congress of Rehabilitation Medicine	[Carlozzi, Noelle E.; Ianni, Phillip A.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Kallen, Michael A.; Hahn, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [French, Louis M.; Lange, Rael T.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [French, Louis M.; Lange, Rael T.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [French, Louis M.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Hanks, Robin] Rehabilitat Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433, UL1TR002240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658] Funding Source: NIH RePORTER	Supported by the National Institutes of Health (NIH), National Institute of Nursing Research (R01NR013658), the National Center for Advancing Translational Sciences (UL1TR000433), and the Defense and Veterans Brain Injury Center (DVBIC). We thank the investigators, coordinators, and research associates/assistants who worked on this study, the study participants, and organizations who supported recruitment efforts. The University of Michigan Research Team would also like to thank the Hearts of Valor and the Brain Injury Association of Michigan for assistance with community outreach for recruitment efforts at this site.	Bailey EK, 2017, J HEAD TRAUMA REHAB, V32, P245, DOI 10.1097/HTR.0000000000000317; Bastawrous M, 2013, INT J NURS STUD, V50, P431, DOI 10.1016/j.ijnurstu.2012.10.005; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Brooks D N, 1979, Int Rehabil Med, V1, P160; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; CLAUSER BE, 1994, J EDUC MEAS, V31, P88; Cook KF, 2007, QUAL LIFE RES, V16, P121, DOI 10.1007/s11136-007-9177-5; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Crane PK, 2006, MED CARE, V44, pS115, DOI 10.1097/01.mlr.0000245183.28384.ed; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS1, DOI 10.1016/j.apmr.2017.04.013; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; DVBIC, 2015, DOD WORLDW NUMB TBI; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; GEORGE LK, 1986, GERONTOLOGIST, V26, P253, DOI 10.1093/geront/26.3.253; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Grandhi R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120160; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hatcher L, 1994, STEP BY STEP APPROAC, P325; Howrey BT, 2017, ARCH PHYS MED REHAB, V98, P1606, DOI 10.1016/j.apmr.2017.03.009; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Lu, 2003, J MED SCI, V23, P73, DOI DOI 10.6136/JMS; Malec JF, 2006, BRAIN INJURY, V20, P227, DOI 10.1080/02699050500488124; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; McDonald R, 1999, TEST THEORY UNIFIED; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; MONTGOMERY RJV, 1985, FAM RELAT, V34, P19, DOI 10.2307/583753; Murphy L, 2006, BRAIN INJURY, V20, P1119, DOI 10.1080/02699050600664335; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Samejima F, 1996, HDB MODERN ITEM RESP, P85; Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Sashika H, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005968; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Smith A M, 1998, Rehabil Nurs, V23, P252; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	80	10	10	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4		1			S13	S21		10.1016/j.apmr.2018.05.033			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FV	WOS:000462951900002	29966647	Green Accepted			2022-02-06	
J	Carlozzi, NE; Kallen, MA; Ianni, PA; Sander, AM; Hahn, EA; Lange, RT; Brickell, TA; French, LM; Miner, JA; Hanks, R				Carlozzi, Noelle E.; Kallen, Michael A.; Ianni, Phillip A.; Sander, Angelle M.; Hahn, Elizabeth A.; Lange, Rael T.; Brickell, Tracey A.; French, Louis M.; Miner, Jennifer A.; Hanks, Robin			The Development of Two New Computer Adaptive Tests To Evaluate Feelings of Loss in Caregivers of Individuals With Traumatic Brain Injury: TBI-CareQOL Feelings of Loss-Self and Feelings of Loss-Person With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Caregiver; Health-related quality of life; Patient reported outcome; Psychometrics; Rehabilitation; Traumatic brain injury; Veterans	ITEM RESPONSE THEORY; QUALITY-OF-LIFE; ALZHEIMERS-DISEASE; SOCIAL SUPPORT; OUTCOMES; FAMILY; REHABILITATION; HEALTH; MODEL; EXPERIENCE	Objective: To develop new patient-reported outcome (PRO) measures to better understand feelings of loss in caregivers of individuals with traumatic brain injury (TBI). Design: Cross-sectional survey study. Setting: Three TBI Model Systems rehabilitation hospitals, an academic medical center, and a military medical treatment facility. Participants: Caregivers (N=560) of civilians with TBI (n=344) or service members/veterans (SMVs) with TBI (n=216). Interventions: Not applicable. Main outcome measures: Traumatic Brain Injury Caregiver Quality of Life (TBI-CareQOL) Feelings of Loss-Self and TBI-CareQOL Feelings of Loss-Person with Traumatic Brain Injury item banks. Results: While the initial exploratory and confirmatory factor analyses of the feelings of loss item pool (98 items) potentially supported a unidimensional set of items, further analysis indicated 2 different factors: Feelings of Loss-Self (43 items) and Feelings of Loss-Person with TBI (20 items). For Feelings of Loss-Self, an additional 13 items were deleted due to item-response theory-based item misfit; the remaining 30 items had good overall model fit (comparative fit index [CFI]=0.96, Tucker-Lewis index [TLI]=.96, root mean squared error of approximation [RMSEA]=.10). For Feelings of Loss-Other, 1 additional item was deleted due to an associated high correlated error modification index value; the final 19 items evidenced good overall model fit (CFI=0.97, TLI=.97, RMSEA=.095). The final item banks were developed to be administered as either a Computer Adaptive Test (CAT) or a short-form (SF). Clinical experts approved the content of the 6-item SFs of the 2 measures (3-week test-retest was r=.87 for Feelings of Loss-Self and r=.85 for Feelings of Loss-Person with TBI). Conclusions: The findings from this study resulted in the development of 2 new PROs to assess feelings of loss in caregivers of individuals with TBI; TBI-CareQOL Feelings of Loss-Self and TBI-CareQOL Feelings of Loss-Person with TBI. Good psychometric properties were established and an SF was developed for ease of use in clinical situations. Additional research is needed to determine concurrent and predictive validity of these measures in the psychological treatment of those caring for persons with TBI. (C) 201 8 by the American Congress of Rehabilitation Medicine	[Carlozzi, Noelle E.; Ianni, Phillip A.; Miner, Jennifer A.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Kallen, Michael A.; Hahn, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Hanks, Robin] Rehabil Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604; Hanks, Robin/0000-0002-3432-4789	National Institutes of Health, National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01 NR013658]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002240, UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Institute of Nursing Research (grant no. R01 NR013658), the National Center for Advancing Translational Sciences (grant no. UL1TR000433), and the Defense and Veterans Brain Injury Center.	Beeson RA, 2003, ARCH PSYCHIAT NURS, V17, P135, DOI 10.1016/S0883-9417(03)00057-8; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bjorge H, 2016, DEMENTIA LONDON; Boss P, 2002, J CLIN PSYCHOL, V58, P1351, DOI 10.1002/jclp.10083; Boss P., 1999, AMBIGUOUS LOSS; Cappelleri JC, 2014, CLIN THER, V36, P648, DOI 10.1016/j.clinthera.2014.04.006; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Choi SW, 2011, J STAT SOFTW, V39, P1; Choi SW, 2009, APPL PSYCH MEAS, V33, P644, DOI 10.1177/0146621608329892; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Crane PK, 2006, MED CARE, V44, pS115, DOI 10.1097/01.mlr.0000245183.28384.ed; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Doser K, 2016, BRAIN INJURY, V30, P334, DOI 10.3109/02699052.2015.1114143; DVBIC, 2015, DOD WORLDW NUMB TBI; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Frank Jacquelyn B, 2007, Am J Alzheimers Dis Other Demen, V22, P516, DOI 10.1177/1533317507307787; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Hatcher L, 1994, STEP BY STEP APPROAC, P325; Hogsnes Linda, 2016, Open Nurs J, V10, P122, DOI 10.2174/1874434601610010122; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hutchinson K, 2016, DEMENTIA-LONDON, V15, P609, DOI 10.1177/1471301214532111; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Karger CR, 2018, AGING MENT HEALTH, V22, P316, DOI 10.1080/13607863.2016.1261797; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Loos C, 1997, DEATH STUD, V21, P501; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Massimo L, 2013, GERIATR NURS, V34, P302, DOI 10.1016/j.gerinurse.2013.05.001; McDonald R, 1999, TEST THEORY UNIFIED; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; Meuser TM, 2001, GERONTOLOGIST, V41, P658, DOI 10.1093/geront/41.5.658; Moriarty H, 2016, PM&R, V8, P495, DOI 10.1016/j.pmrj.2015.10.008; Muthen L.K., 2011, MPLUS USERS GUIDE, V6th ed.; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Samejima F, 1996, HDB MODERN ITEM RESP, P85; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Sanders S, 2003, SOC WORK HEALTH CARE, V37, P35, DOI 10.1300/J010v37n03_03; Sanders S, 2008, DEATH STUD, V32, P495, DOI 10.1080/07481180802138845; Smith A M, 1998, Rehabil Nurs, V23, P252; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Thurman D, 2007, BRAIN INJURY MED PRI, P373; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x	59	10	10	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4		1			S31	S42		10.1016/j.apmr.2018.05.026			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FV	WOS:000462951900004	29958904	Green Accepted			2022-02-06	
J	Carlson, KF; Gilbert, TA; O'Neil, ME; Zaugg, TL; Manning, CA; Kaelin, C; Thielman, EJ; Reavis, KM; Henry, JA				Carlson, Kathleen F.; Gilbert, Tess A.; O'Neil, Maya E.; Zaugg, Tara L.; Manning, Candice A.; Kaelin, Christine; Thielman, Emily J.; Reavis, Kelly M.; Henry, James A.			Health Care Utilization and Mental Health Diagnoses Among Veterans With Tinnitus	AMERICAN JOURNAL OF AUDIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; SKILLS EDUCATION; HEARING-LOSS; CHRONIC PAIN; PREVALENCE; AFGHANISTAN; THERAPY; IRAQ; ACCEPTANCE	Purpose: Tinnitus is prevalent among military Veterans and may frequently co-occur with mental health disorders. This study examined health care utilization and mental health diagnoses among Veterans with and without tinnitus who receive Department of Veterans Affairs (VA) health care. Method: We randomly sampled 10% of VA health care users for a 5-year period between 2011 and 2016. Tinnitus and other diagnoses were identified using International Classification of Diseases diagnosis codes; Veterans assigned 1 or more inpatient codes or 2 or more outpatient codes were considered to have the respective diagnosis. We examined demographics, military service, clinical characteristics, and health care utilization of Veterans with and without tinnitus diagnoses. Bivariable and multivariable logistic regression was used to estimate associations between tinnitus and mental health diagnoses of interest. Results: Among 617,534 eligible Veterans, 3.8% met criteria for tinnitus diagnosis. Prevalence of tinnitus was associated with sex, age, race, marital status, and VA service connection status; additionally, hearing loss and traumatic brain injury were frequently codiagnosed with tinnitus. Veterans with tinnitus had higher annual health care utilization than those without. While controlling for potential confounders, tinnitus diagnoses were associated with mental health diagnoses, including anxiety, depression, and substance use disorders. Conclusion: Findings suggest that Veterans who are diagnosed with tinnitus have more health care utilization and are more frequently diagnosed with mental health disorders than Veterans who are not diagnosed with tinnitus. This suggests a need for coordinated tinnitus and mental health care services for Veterans in the VA system of care.	[Carlson, Kathleen F.; O'Neil, Maya E.; Zaugg, Tara L.; Manning, Candice A.; Kaelin, Christine; Thielman, Emily J.; Reavis, Kelly M.; Henry, James A.] VA Portland Hlth Care Syst, VA Rehabil Res & Dev Serv, Natl Ctr Rehabil Auditory Res, Portland, OR 97239 USA; [Carlson, Kathleen F.; Gilbert, Tess A.; O'Neil, Maya E.] VA Portland Hlth Care Syst, VA Hlth Serv Res & Dev Serv Ctr Innovat, Ctr Improve Vet Involvement Care, Portland, OR 97239 USA; [Carlson, Kathleen F.; Gilbert, Tess A.; Reavis, Kelly M.] Oregon Hlth & Sci Univ, OHSU PSU Sch Publ Hlth, Portland, OR 97201 USA; [O'Neil, Maya E.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [O'Neil, Maya E.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Manning, Candice A.; Henry, James A.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA		Carlson, KF (corresponding author), VA Portland Hlth Care Syst, VA Rehabil Res & Dev Serv, Natl Ctr Rehabil Auditory Res, Portland, OR 97239 USA.; Carlson, KF (corresponding author), VA Portland Hlth Care Syst, VA Hlth Serv Res & Dev Serv Ctr Innovat, Ctr Improve Vet Involvement Care, Portland, OR 97239 USA.; Carlson, KF (corresponding author), Oregon Hlth & Sci Univ, OHSU PSU Sch Publ Hlth, Portland, OR 97201 USA.	kathleen.carlson@va.gov	Reavis, Kelly/AAU-3893-2021		Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [SPiRE 121 RX002216-01, C9427S, C9230C]; Veterans AffairsUS Department of Veterans Affairs [I21RX002216] Funding Source: NIH RePORTER	This research was supported by Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service Grants SPiRE 121 RX002216-01, awarded to K. F. Carlson; C9427S, awarded to J. A. Henry; and C9230C, awarded to M. P. Feeney. The contents of this article do not necessarily represent the views of the Department of Veterans Affairs or the U.S. Government.	Bhatt JM, 2016, JAMA OTOLARYNGOL, V142, P959, DOI 10.1001/jamaoto.2016.1700; Carlson KF, 2018, ARCH PHYS MED REHAB, V99, pS4, DOI 10.1016/j.apmr.2017.06.027; COLES RRA, 2000, TINNITUS HDB, P399; Edmonds CM, 2017, AM J AUDIOL, V26, P242, DOI 10.1044/2017_AJA-16-0085; Ehde DM, 2014, AM PSYCHOL, V69, P153, DOI 10.1037/a0035747; Fagelson Marc A, 2007, Am J Audiol, V16, P107, DOI 10.1044/1059-0889(2007/015); Folmer RL, 2011, J REHABIL RES DEV, V48, P503, DOI 10.1682/JRRD.2010.07.0138; Goldstein E, 2015, OTOLARYNG HEAD NECK, V152, P518, DOI 10.1177/0194599814566179; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Groenewold Matthew R., 2011, Morbidity and Mortality Weekly Report, V60, P955; Henry JA, 2017, J SPEECH LANG HEAR R, V60, P1378, DOI 10.1044/2016_JSLHR-H-16-0126; Hesser H, 2012, J CONSULT CLIN PSYCH, V80, P649, DOI 10.1037/a0027021; Holmes S, 2009, J CLIN NURS, V18, P2927, DOI 10.1111/j.1365-2702.2009.02909.x; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Maes IHL, 2013, EAR HEARING, V34, P508, DOI 10.1097/AUD.0b013e31827d113a; Martinez-Devesa P, 2010, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD005233.PUB2; McCormack A, 2016, HEARING RES, V337, P70, DOI 10.1016/j.heares.2016.05.009; Moring J. C., 2017, INT J BEHAVAVIOARAL, V25, P312; Myers PJ, 2014, J REHABIL RES DEV, V51, P609, DOI 10.1682/JRRD.2013.08.0189; Nuttal AL, 2004, TINNITUS THEORY MANA, P52; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Office of the Secretary HHS, 2009, FED REGISTER, V74, P3328; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pattyn T, 2016, HEARING RES, V333, P255, DOI 10.1016/j.heares.2015.08.014; Schmidt Caroline J, 2017, Fed Pract, V34, P6; Snow J, 2004, TINNITUS THEORY MANA, P16; Swan AA, 2017, HEARING RES, V349, P4, DOI 10.1016/j.heares.2017.01.013; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Theodoroff SM, 2015, EPIDEMIOL REV, V37, P71, DOI 10.1093/epirev/mxu005; Trevis KJ, 2018, CLIN PSYCHOL REV, V60, P62, DOI 10.1016/j.cpr.2017.12.006; Trivedi RB, 2015, AM J PUBLIC HEALTH, V105, P2564, DOI 10.2105/AJPH.2015.302836; Trotrer MI, 2008, J LARYNGOL OTOL, V122, P1052, DOI 10.1017/S002221510800203X; Tunkel DE, 2014, OTOLARYNG HEAD NECK, V151, pS1, DOI 10.1177/0194599814545325; Tyler R.S., 2000, TINNITUS HDB, P1; U.S. Centers for Disease Control and Prevention National Center for Health Statistics, 2017, INT CLASS DIS 10 REV; U.S. Department of Veterans Affairs, 2017, VBA ANN BEN REP FISC; U.S. Department of Veterans Affairs Veterans Benefits Administration, 2017, VET COMP BEN RAT TAB; US Centers for Medicare & Medicaid Services, 2016, 2017 ICD 10 CM GEMS; US Department of Veterans Affairs, 2014, CORP DAT WAR CDW; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002; Vowles KE, 2008, J CONSULT CLIN PSYCH, V76, P397, DOI 10.1037/0022-006X.76.3.397; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016; Zirke N, 2013, QUAL LIFE RES, V22, P2095, DOI 10.1007/s11136-012-0338-9	44	10	10	0	2	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1059-0889	1558-9137		AM J AUDIOL	Am. J. Audiol.	APR	2019	28	1		S	SI		181	190		10.1044/2018_AJA-TTR17-18-0042			10	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology	HV6VP	WOS:000466121200005	31022360				2022-02-06	
J	Esnault, P; Roubin, J; Cardinale, M; D'Aranda, E; Montcriol, A; Cungi, PJ; Goutorbe, P; Joubert, C; Dagain, A; Meaudre, E				Esnault, Pierre; Roubin, Johanna; Cardinale, Mickael; D'Aranda, Erwan; Montcriol, Ambroise; Cungi, Pierre-Julien; Goutorbe, Philippe; Joubert, Christophe; Dagain, Arnaud; Meaudre, Eric			Spontaneous Hyperventilation in Severe Traumatic Brain Injury: Incidence and Association with Poor Neurological Outcome	NEUROCRITICAL CARE			English	Article						Severe traumatic brain injury; Spontaneous hyperventilation; Hypocapnia; Respiratory alkalosis; Glasgow Outcome Scale	CEREBRAL-BLOOD-FLOW; HEAD-INJURY; PROLONGED HYPERVENTILATION; CARBON-DIOXIDE; HYPOCAPNIA; MANAGEMENT; ISCHEMIA	BackgroundHypocapnia induces cerebral vasoconstriction leading to a decrease in cerebral blood flow, which might precipitate cerebral ischemia. Hypocapnia can be intentional to treat intracranial hypertension or unintentional due to a spontaneous hyperventilation (SHV). SHV is frequent after subarachnoid hemorrhage. However, it is understudied in patients with severe traumatic brain injury (TBI). The objective of this study was to describe the incidence and consequences on outcome of SHV after severe TBI.MethodsWe conducted a retrospective, observational study including all intubated TBI patients admitted in the trauma center and still comatose 24h after the withdrawal of sedation. SHV was defined by the presence of at least one arterial blood gas (ABG) with both PaCO2<35mmHg and pH>7.45. Patient characteristics and outcome were extracted from a prospective registry of all intubated TBI admitted in the intensive care unit. ABG results were retrieved from patient files. A multivariable logistic regression model was developed to determine factors independently associated with unfavorable outcome (defined as a Glasgow Outcome Scale between 1 and 3) at 6-month follow-up.ResultsDuring 7years, 110 patients fully respecting inclusion criteria were included. The overall incidence of SHV was 69.1% (95% CI [59.9-77]). Patients with SHV were more severely injured (median head AIS score (5 [4-5] vs. 4 [4-5]; p=0.016)) and exhibited an elevated morbidity during their stay. The proportion of patients with an unfavorable functional neurologic outcome was significantly higher in patients with SHV: 40 (52.6%) versus 6 (17.6%), p=0.0006. After adjusting for confounders, SHV remains an independent factor associated with unfavorable outcome at the 6-month follow-up (OR 4.1; 95% CI [1.2-14.4]).ConclusionsSHV is common in patients with a persistent coma after a severe TBI (overall rate: 69%) and was independently associated with unfavorable outcome at 6-month follow-up.	[Esnault, Pierre; Roubin, Johanna; Cardinale, Mickael; D'Aranda, Erwan; Montcriol, Ambroise; Cungi, Pierre-Julien; Goutorbe, Philippe; Meaudre, Eric] St Anne Mil Hosp, Intens Care Unit, Toulon, France; [Joubert, Christophe; Dagain, Arnaud] St Anne Mil Hosp, Dept Neurosurg, Toulon, France; [Dagain, Arnaud; Meaudre, Eric] Ecole Val De Grace, French Mil Hlth Serv Acad Unit, Paris, France		Esnault, P (corresponding author), St Anne Mil Hosp, Intens Care Unit, Toulon, France.	pierre.esnault@gmail.com	Esnault, Pierre/AAN-5792-2020; Joubert, Christophe/AAU-4807-2020				ALBERTI E, 1975, BRIT J ANAESTH, V47, P941, DOI 10.1093/bja/47.9.941; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carrera E, 2010, J NEUROL NEUROSUR PS, V81, P793, DOI 10.1136/jnnp.2009.174425; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Gaviani P, 2005, NEUROLOGY, V64, P166, DOI 10.1212/01.WNL.0000148579.80486.F1; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Godoy DA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00250; Graham EM, 1996, NEUROSCI LETT, V218, P29, DOI 10.1016/0304-3940(96)13114-1; Haberthur C, 1999, INTENS CARE MED, V25, P514, DOI 10.1007/s001340050890; Huttunen J, 1999, EXP BRAIN RES, V125, P248, DOI 10.1007/s002210050680; Ito H, 2005, J CEREBR BLOOD F MET, V25, P852, DOI 10.1038/sj.jcbfm.9600076; JENNETT B, 1975, LANCET, V1, P480; KONTOS HA, 1977, STROKE, V8, P358, DOI 10.1161/01.STR.8.3.358; LEITCH AG, 1979, NEUROSURGERY, V5, P701, DOI 10.1227/00006123-197912000-00011; MADDEN JA, 1993, PHARMACOL THERAPEUT, V59, P229, DOI 10.1016/0163-7258(93)90045-F; Marehbian J, 2017, NEUROCRIT CARE, V30, P1; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Moller K, 2000, CLIN PHYSIOL, V20, P399, DOI 10.1046/j.1365-2281.2000.00276.x; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; MYKITA S, 1986, J NEUROCHEM, V47, P223; Neumann JO, 2008, INTENS CARE MED, V34, P1676, DOI 10.1007/s00134-008-1123-7; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; Roberts BW, 2015, RESUSCITATION, V27, P1; Solaiman O, 2013, J NEUROSURG ANESTH, V25, P254, DOI 10.1097/ANA.0b013e3182806465; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Williamson CA, 2015, NEUROCRIT CARE, V23, P330, DOI 10.1007/s12028-015-0138-5	35	10	11	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2019	30	2					405	413		10.1007/s12028-018-0639-0			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HP0UB	WOS:000461380900024	30386962	Bronze			2022-02-06	
J	Gauthier, JM; Bierhals, AJ; Liu, JX; Balsara, KR; Frederiksen, C; Gremminger, E; Hachem, RR; Witt, CA; Trulock, EP; Byers, DE; Yusen, RD; Aguilar, PR; Marklin, G; Nava, RG; Kozower, BD; Pasque, MK; Meyers, BF; Patterson, GA; Kreisel, D; Puri, V				Gauthier, Jason M.; Bierhals, Andrew J.; Liu, Jingxia; Balsara, Keki R.; Frederiksen, Christine; Gremminger, Emily; Hachem, Ramsey R.; Witt, Chad A.; Trulock, Elbert P.; Byers, Derek E.; Yusen, Roger D.; Aguilar, Patrick R.; Marklin, Gary; Nava, Ruben G.; Kozower, Benjamin D.; Pasque, Michael K.; Meyers, Bryan F.; Patterson, G. Alexander; Kreisel, Daniel; Puri, Varun			Chest computed tomography imaging improves potential lung donor assessment	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article; Proceedings Paper	98th Annual Meeting of the American-Association-for-Thoracic-Surgery	APR 28-MAY 01, 2018	San Diego, CA	Amer Assoc Thorac Surg		lung transplantation; organ allocation; surgery; lung diseases	SIZE MISMATCH; TRANSPLANTATION; SURVIVAL; CRITERIA	Objective: Chest computed tomography (CT) imaging is being increasingly used for potential lung donor assessment. However, the efficacy of CT imaging in this setting remains unknown. We hypothesize that chest CT imaging independently affects the decision-making process in donor lung utilization. Methods: We conducted a retrospective cohort study of all adult donation after brain death donors managed through our local organ procurement organization from June 2011 to November 2016. An experienced thoracic radiologist independently reviewed donor chest CTand chest x-ray images in a blinded, standardized manner to determine the presence of structural lung disease (eg, emphysema, interstitial lung disease [ILD]) and acute abnormalities (eg, traumatic lung injury [TLI]). Distinct models of lung utilization were fit to groups with initial partial pressure of oxygen (iPaO(2)) <= 300 mm Hg (suboptimal) and iPaO(2) > 300 mm Hg (optimal). Results: The organ procurement organization managed 753 donors during the study period, with a lung utilization rate ([lung donors/all organ donors] x 100) of 36.5% (275 of 753). Four hundred forty-five (59.1%) donors received chest CT imaging, revealing emphysema (13.7%), ILD (2.5%), and TLI (7.2%). In univariate analysis, findings of TLI (odds ratio [OR], 2.23; 95% confidence interval [CI], 1.08-4.61) were positively associated with lung utilization, whereas findings of emphysema (OR, 0.18; CI, 0.08-0.40) were negatively associated with utilization. In multivariate analysis, CT findings of emphysema (OR, 0.21; CI 0.08-0.54) remained negatively associated with utilization. No potential donors with CT findings of ILD became lung donors. After controlling for chest x-ray findings, chest CT imaging findings of structural lung disease remained negatively associated with utilization (P = .0001). Lung utilization rate in the suboptimal and optimal iPaO(2) populations was 35.1% and 41.4%, respectively, and CT findings of emphysema had a significant association with nonutilization in both groups. Conclusions: In the evaluation of potential lung donors, chest CT imaging findings of structural lung disease, such as emphysema and ILD, have a significant negative association with lung utilization. Our findings suggest that chest CT imaging might be an important adjunct to conventional lung donor assessment criteria.	[Gauthier, Jason M.; Frederiksen, Christine; Gremminger, Emily; Nava, Ruben G.; Kozower, Benjamin D.; Pasque, Michael K.; Meyers, Bryan F.; Patterson, G. Alexander; Kreisel, Daniel; Puri, Varun] Washington Univ, Sch Med, Div Cardiothorac Surg, Campus Box 8234,660 South Euclid Ave, St Louis, MO 63110 USA; [Liu, Jingxia] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA; [Bierhals, Andrew J.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Diagnost Radiol, St Louis, MO USA; [Hachem, Ramsey R.; Witt, Chad A.; Trulock, Elbert P.; Byers, Derek E.; Yusen, Roger D.; Aguilar, Patrick R.] Washington Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; [Marklin, Gary] Washington Univ, Sch Med, Mid Amer Transplant, St Louis, MO USA; [Kreisel, Daniel] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Balsara, Keki R.] Vanderbilt Univ, Sch Med, Dept Cardiac Surg, Nashville, TN USA		Puri, V (corresponding author), Washington Univ, Sch Med, Div Cardiothorac Surg, Campus Box 8234,660 South Euclid Ave, St Louis, MO 63110 USA.	varunpuri@wustl.edu	Bierhals, Andrew/W-2061-2019	Liu, Jingxia/0000-0002-9434-7907; Bierhals, Andrew/0000-0002-8894-1504	U.S. National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HL007776]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 DC011311, K07 CA178120, R01 HL094601, 1P01AI116501, R01 HL131961]; U.S. Department of Veterans AffairsUS Department of Veterans Affairs [1I01BX002730]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [K07CA178120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL094601, R01HL131961, T32HL007776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [P01AI116501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC011311] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002730] Funding Source: NIH RePORTER	J.M.G. is supported by the U.S. National Institutes of Health (NIH) T32 HL007776, V.P. is supported by NIH K07 CA178120, D.K. is supported by the U.S. Department of Veterans Affairs 1I01BX002730, NIH R01 HL094601, and NIH 1P01AI116501. A.J.B. is supported by NIH R01 HL131961 and NIH R01 DC011311.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aigner C, 2005, EUR J CARDIO-THORAC, V27, P757, DOI 10.1016/j.ejcts.2005.01.024; Bonser RS, 2012, LANCET, V380, P747, DOI 10.1016/S0140-6736(12)60160-3; Chang SH, 2018, ANN THORAC SURG, V105, P1531, DOI 10.1016/j.athoracsur.2017.12.009; Eberlein M, 2015, J HEART LUNG TRANSPL, V34, P233, DOI 10.1016/j.healun.2014.09.030; Eberlein Michael, 2013, Ann Am Thorac Soc, V10, P418, DOI 10.1513/AnnalsATS.201301-008OC; Eberlein M, 2012, CHEST, V141, P451, DOI 10.1378/chest.11-0767; KAZEROONI EA, 1995, AM J ROENTGENOL, V165, P1343, DOI 10.2214/ajr.165.6.7484560; Konheim JA, 2016, J THORAC CARDIOV SUR, V151, P1163, DOI 10.1016/j.jtcvs.2015.10.051; Lardinois D, 2005, EUR J CARDIO-THORAC, V27, P762, DOI 10.1016/j.ejcts.2005.01.019; Lindemann J, 2018, AM J TRANSPLANT; Miniati M, 2008, EUR RESPIR J, V31, P509, DOI 10.1183/09031936.00095607; Mulligan MJ, 2016, J THORAC CARDIOV SUR, V152, P891, DOI 10.1016/j.jtcvs.2016.03.096; Pierre AF, 2002, J THORAC CARDIOV SUR, V123, P421, DOI 10.1067/mtc.2002.120345; Self WH, 2013, AM J EMERG MED, V31, P401, DOI 10.1016/j.ajem.2012.08.041; Sommer W, 2013, J HEART LUNG TRANSPL, V32, P1065, DOI 10.1016/j.healun.2013.06.021; Stockburger, 2004, RADIOL MANAGE, V26, P24; Stockburger Wayne T, 2004, Radiol Manage, V26, P20; SUNDARESAN S, 1995, J THORAC CARDIOV SUR, V109, P1075, DOI 10.1016/S0022-5223(95)70190-7; THURLBECK WM, 1978, AM J ROENTGENOL, V130, P429, DOI 10.2214/ajr.130.3.429; Trupka A, 1997, J TRAUMA, V43, P405, DOI 10.1097/00005373-199709000-00003; Valapour M, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14129; Van Raemdonck Dirk, 2009, Proc Am Thorac Soc, V6, P28, DOI 10.1513/pats.200808-098GO; Yusen RD, 2016, J HEART LUNG TRANSPL, V35, P1170, DOI 10.1016/j.healun.2016.09.001	24	10	10	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	APR	2019	157	4					1711	+		10.1016/j.jtcvs.2018.11.038			9	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cardiovascular System & Cardiology; Respiratory System; Surgery	HP5KZ	WOS:000461717300126	30772037	Green Accepted, Bronze			2022-02-06	
J	Graves, JM; Mackelprang, JL; Moore, M; Abshire, DA; Rivara, FP; Jimenez, N; Fuentes, M; Vavilala, MS				Graves, Janessa M.; Mackelprang, Jessica L.; Moore, Megan; Abshire, Demetrius A.; Rivara, Frederick P.; Jimenez, Nathalia; Fuentes, Molly; Vavilala, Monica S.			Rural-urban disparities in health care costs and health service utilization following pediatric mild traumatic brain injury	HEALTH SERVICES RESEARCH			English	Article						health care costs; health service utilization; pediatrics; rehabilitation; rural health	UNITED-STATES; MEDICAL-CARE; CHILDREN; CONCUSSION; ACCESS; TELEMEDICINE; ADOLESCENTS	Objectives To compare health care costs and service utilization associated with mild traumatic brain injury (mTBI) in rural and urban commercially insured children. Data Source MarketScan Commercial Claims and Encounters Data, 2007-2011. Study Design We compared health care costs and outpatient encounters for physical/occupational therapy, speech therapy, and psychiatry/psychology encounters 180 days after mTBI among rural versus urban children (<18 years). Principal Findings A total of 387 846 children had mTBI, with 13 percent residing in rural areas. Adjusted mean total health care costs in the 180 days after mTBI were $2778 (95% CI: 2660-2897) among rural children, compared to $2499 (95% CI: 2471-2528) among urban children (adjusted cost ratio 1.11, 95% CI 1.06-1.16). Rural-urban differences in utilization for specific services were also found. Conclusions Total health care costs were higher for rural compared to urban children despite lower utilization of certain services. Differences in health service utilization may exacerbate geographic disparities in adverse outcomes associated with mTBI.	[Graves, Janessa M.] Washington State Univ, Coll Nursing, Hlth Sci Campus, Spokane, WA 99210 USA; [Mackelprang, Jessica L.] Swinburne Univ Technol, Sch Hlth Sci, Dept Psychol Sci, Melbourne, Vic, Australia; [Moore, Megan] Univ Washington, Sch Social Work, HIPRC, Seattle, WA 98195 USA; [Abshire, Demetrius A.] Univ South Carolina, Coll Nursing, Columbia, SC 29208 USA; [Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Sch Med, Dept Pediat, HIPRC, Seattle, WA 98195 USA; [Jimenez, Nathalia] Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, HIPRC,Seattle Childrens Res Inst, Seattle, WA USA; [Fuentes, Molly] Univ Washington, Sch Med, Dept Rehabil Med, HIPRC,Seattle Childrens Res Inst, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, HIPRC, Seattle, WA USA		Graves, JM (corresponding author), Washington State Univ, Coll Nursing, Hlth Sci Campus, Spokane, WA 99210 USA.	janessa.graves@wsu.edu	Graves, Janessa M./J-2596-2019; Mackelprang, Jessica L./AAT-4283-2021	Graves, Janessa M./0000-0002-7659-2634; Mackelprang, Jessica L./0000-0001-9135-7811; Jimenez, Nathalia/0000-0002-6785-8330	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD07843]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS072308-06]; Health Equity Research Center, Washington State University; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078453, T32HD057822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, Grant/Award Number: K23 HD07843; National Institute of Neurological Disorders and Stroke, Grant/Award Number: R01 NS072308-06; Health Equity Research Center, Washington State University; National Center for Advancing Translational Sciences, Grant/Award Number: KL2TR000421	Aday L A, 1974, Health Serv Res, V9, P208; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Anderson TJ, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1053-3; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barnighausen T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-86; Carlson, 2015, INJ EPIDEMIOL, V2, P32, DOI DOI 10.1186/s40621-015-0063-2; Chan V, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0631-2; Charlson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112479; Clark DE, 2010, ICDPIC STATA MODULE; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Cummings JR, 2016, ADM POLICY MENT HLTH, V43, P717, DOI 10.1007/s10488-015-0685-2; Danielson E, TRUVEN HLTH ANAL WHI; Dismuke CE, 2015, GLOB J HLTH SCI, V7, P43213; Duncan AB, 2014, J CLIN CHILD ADOLESC, V43, P115, DOI 10.1080/15374416.2013.836452; Faul M, 2010, TRAUMATIC BRAIN INJU; Fontanella CA, 2015, JAMA PEDIATR, V169, P466, DOI 10.1001/jamapediatrics.2014.3561; Fortney JC, 2015, INT REV PSYCHIATR, V27, P525, DOI 10.3109/09540261.2015.1085838; Friedberg MW, 2016, EVALUATION POLICY OP; Fuentes MM, 2017, ARCH PHYS MED REHAB, V98, P1763, DOI 10.1016/j.apmr.2016.12.013; Garrido MM, 2014, HEALTH SERV RES, V49, P1701, DOI 10.1111/1475-6773.12182; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Greene NH, 2015, INJURY PREV, V21, P325, DOI 10.1136/injuryprev-2014-041524; Hagan JF, 2017, BRIGHT FUTURES GUIDE, V4th; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Inagami S, 2016, J RURAL HEALTH, V32, P219, DOI 10.1111/jrh.12148; Jameson JP, 2007, CLIN PSYCHOL-SCI PR, V14, P283, DOI 10.1111/j.1468-2850.2007.00089.x; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Keenan HT, 2013, J HEAD TRAUMA REHAB, V28, P426, DOI 10.1097/HTR.0b013e31825935b8; Kim K, 2012, INJURY PREV, V18, P264, DOI 10.1136/injuryprev-2011-040306; Kim PT, 2017, SEMIN PEDIATR SURG, V26, P47, DOI 10.1053/j.sempedsurg.2017.01.008; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; McManus BM, 2016, ACAD PEDIATR, V16, P358, DOI 10.1016/j.acap.2015.10.010; Mihaylova B, 2011, HEALTH ECON, V20, P897, DOI 10.1002/hec.1653; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Sanchez AI, 2012, J HEAD TRAUMA REHAB, V27, P159, DOI 10.1097/HTR.0b013e3182074c41; Seibert P, 2014, BRAIN INJURY, V28, P818; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vargas BB, 2015, TELENEUROLOGY PRACTI, P159; Vedom J, 2011, ESPACES-POPUL-SOC, P63, DOI 10.4000/eps.4345; Xierali IM, 2013, J AM BOARD FAM MED, V26, P114, DOI 10.3122/jabfm.2013.02.120219	52	10	10	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-9124	1475-6773		HEALTH SERV RES	Health Serv. Res.	APR	2019	54	2					337	345		10.1111/1475-6773.13096			9	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	HO1GT	WOS:000460654200004	30507042	Green Published			2022-02-06	
J	Howell, DR; Taylor, JA; Tan, CO; Orr, R; Meehan, WP				Howell, David R.; Taylor, J. Andrew; Tan, Can Ozan; Orr, Rhonda; Meehan, William P., III			The Role of Aerobic Exercise in Reducing Persistent Sport-related Concussion Symptoms	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						AEROBIC EXERCISE; CONCUSSION; SYMPTOM; POSTCONCUSSION SYNDROME; REHABILITATION	POSTCONCUSSION SYNDROME; ACTIVE REHABILITATION; ADOLESCENTS; CHILDREN; RECOVERY; SAFETY; RISK	Aerobic exercise has received increasing attention in the scientific literature as a component of management for individuals who sustain a concussion. Because exercise training has been reported to reduce symptoms and improve function for those experiencing persistent postconcussion symptoms, it represents a potentially useful and clinically pragmatic rehabilitation technique. However, the specific exercise parameters that best facilitate recovery from concussion remain poorly defined and unclear. This review will provide a summary of the current understanding of the role of subsymptom exercise to improve outcomes after a concussion and will describe the exercise parameters that appear to be important. The latter will take into account the three pillars of exercise dose-frequency, duration, and intensity-to examine what is currently known. In addition, we identify important gaps in our knowledge of exercise as a treatment for those who develop persistent symptoms of concussion.	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, 13123 East 16th Ave,Box 060, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Howell, David R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Taylor, J. Andrew; Tan, Can Ozan] Spaulding Hosp Cambridge, Cardiovasc Res Lab, Cambridge, MA USA; [Taylor, J. Andrew; Tan, Can Ozan] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Orr, Rhonda] Univ Sydney, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW, Australia; [Meehan, William P., III] Boston Childrens Hosp, Dept Orthoped, Div Sports Med, Sport Concuss Clin, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA 02115 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, 13123 East 16th Ave,Box 060, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu	Taylor, J. Andrew/N-7097-2013; Tan, Can Ozan/E-2598-2016; Orr, Rhonda/C-1817-2008	Tan, Can Ozan/0000-0001-9673-9907; Taylor, J Andrew/0000-0003-2802-4330	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS106444]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS106444] Funding Source: NIH RePORTER	This work was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (grant no. R03HD094560) and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (grant no. R03NS106444).	Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Chan C, 2018, ARCH PHYS MED REHAB, V99, P242, DOI 10.1016/j.apmr.2017.09.108; Chrisman SPD, 2017, NEUROREHABILITATION, V40, P493, DOI 10.3233/NRE-161436; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Giza CC, 2018, JAMA NEUROL, V75, P399, DOI 10.1001/jamaneurol.2018.0006; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Howell DR, 2018, AM J SPORTS MED; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McArdle W., 2014, EXERCISE PHYSL NUTR; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Micay R, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000404; Moore Brian M, 2016, J Allied Health, V45, pe59; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Steindel SJ, 2010, J AM MED INFORM ASSN, V17, P274, DOI 10.1136/jamia.2009.001230; World Health Organization, WHAT IS MOD INT VIG; Yuan WH, 2017, J HEAD TRAUMA REHAB, V32, P378, DOI 10.1097/HTR.0000000000000318; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	34	10	11	20	27	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	APR	2019	51	4					647	652		10.1249/MSS.0000000000001829			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	HP1TF	WOS:000461449700006	30376513	Green Accepted, Bronze			2022-02-06	
J	Lan, YL; Wang, X; Zou, YJ; Xing, JS; Lou, JC; Zou, S; Ma, BB; Ding, Y; Zhang, B				Lan, Yu-Long; Wang, Xun; Zou, Yu-Jie; Xing, Jin-Shan; Lou, Jia-Cheng; Zou, Shuang; Ma, Bin-Bin; Ding, Yan; Zhang, Bo			Bazedoxifene protects cerebral autoregulation after traumatic brain injury and attenuates impairments in blood-brain barrier damage: involvement of anti-inflammatory pathways by blocking MAPK signaling	INFLAMMATION RESEARCH			English	Article						Bazedoxifene; Traumatic brain injury; Inflammation; Neuroprotection	ESTROGEN-RECEPTOR MODULATOR; NF-KAPPA-B; EDEMA; GENDER; KINASE; ACID; PROGESTERONE; SENSORIMOTOR; EXPRESSION; BREAKDOWN	ObjectiveTraumatic brain injury (TBI) is a significant cause of death and long-term deficits in motor and cognitive functions for which there are currently no effective chemotherapeutic drugs. Bazedoxifene (BZA) is a third-generation selective estrogen receptor modulator (SERM) and has been investigated as a treatment for postmenopausal osteoporosis. It is generally safe and well tolerated, with favorable endometrial and breast safety profiles. Recent findings have shown that SERMs may have therapeutic benefits; however, the role of BZA in the treatment of TBI and its molecular and cellular mechanisms remain poorly understood. The aim of the present study was to examine the neuroprotective effects of BZA on early TBI in rats and to explore the underlying mechanisms of these effects.Materials and methodsTBI was induced using a modified weight-drop method. Neurological deficits were evaluated according to the neurological severity score (NSS). Morris water maze and open-field behavioral tests were used to test cognitive functions. Brain edema was measured by brain water content, and impairments in the blood-brain barrier (BBB) were evaluated by expression analysis of tight junction-associated proteins, such as occludin and zonula occludens-1 (ZO-1). Neuronal injury was assessed by hematoxylin and eosin (H&E) staining. LC-MS/MS analysis was performed to determine the ability of BZA to cross the BBB.ResultsOur results indicated that BZA attenuated the impaired cognitive functions and the increased BBB permeability of rats subjected to TBI through activation of inflammatory cascades. In vivo experiments further revealed that BZA provided this neuroprotection by suppressing TBI-induced activation of the MAPK/NF-B signaling pathway. Thus, mechanically, the anti-inflammatory effects of BZA in TBI may be partially mediated by blocking the MAPK signaling pathway.ConclusionsThese findings suggest that BZA might attenuate neurological deficits and BBB damage to protect against TBI by blocking the MAPK/NF-B signaling pathway.	[Lan, Yu-Long; Wang, Xun; Xing, Jin-Shan; Lou, Jia-Cheng; Ma, Bin-Bin; Zhang, Bo] Dalian Med Univ, Affiliated Hosp 2, Dept Neurosurg, Dalian, Peoples R China; [Lan, Yu-Long; Wang, Xun; Xing, Jin-Shan; Lou, Jia-Cheng; Ma, Bin-Bin; Zhang, Bo] Shenzhen Peoples Hosp, Dept Neurosurg, Shenzhen, Peoples R China; [Lan, Yu-Long] Dalian Med Univ, Dept Pharm, Dalian 116044, Peoples R China; [Lan, Yu-Long; Zou, Shuang] Dalian Med Univ, Dept Physiol, Dalian 116044, Peoples R China; [Zou, Yu-Jie] Dalian Med Univ, Affiliated Hosp 1, Dept Nursing, Dalian 116023, Peoples R China; [Ding, Yan] Harvard Med Sch, Childrens Hosp Boston, Dept Pediat, Boston, MA 02115 USA		Zhang, B (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dept Neurosurg, Dalian, Peoples R China.	zhangbodlykdx@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372714, 81672480]; Liaoning Provincial Natural Science Foundation of China [201602244]; Distinguished Professor Project of Liaoning Province; Special Grant for Translational Medicine, Dalian Medical University [2015002]; Basic research projects in colleges and universities of Liaoning Province [LQ2017033]	This work is supported by grants from National Natural Science Foundation of China (nos. 81372714, 81672480), Liaoning Provincial Natural Science Foundation of China (no. 201602244), Distinguished Professor Project of Liaoning Province, Special Grant for Translational Medicine, Dalian Medical University (no. 2015002), Basic research projects in colleges and universities of Liaoning Province (no. LQ2017033).	Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Archer DF, 2009, MENOPAUSE, V16, P1109, DOI 10.1097/gme.0b013e3181a818db; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Chakrabarti M, 2014, BRAIN RES BULL, V109, P22, DOI 10.1016/j.brainresbull.2014.09.004; Chen T, 2011, NEUROSCIENCE, V183, P203, DOI 10.1016/j.neuroscience.2011.03.038; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chung TW, 2004, FASEB J, V18, P1670, DOI 10.1096/fj.04-2126com; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Drean A, 2016, EXPERT REV NEUROTHER, V16, P1285, DOI 10.1080/14737175.2016.1202761; Garcia-Rivera D, 2011, CANCER LETT, V305, P21, DOI 10.1016/j.canlet.2011.02.011; Gatti D, 2013, EXPERT OPIN DRUG MET, V9, P883, DOI 10.1517/17425255.2013.794221; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Kanis JA, 2009, BONE, V44, P1049, DOI 10.1016/j.bone.2009.02.014; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim HN, 2014, CANCER LETT, V351, P41, DOI 10.1016/j.canlet.2014.03.037; Komm BS, 2005, ENDOCRINOLOGY, V146, P3999, DOI 10.1210/en.2005-0030; Komm BS, 2001, ANN NY ACAD SCI, V949, P317; Li HX, 2016, BRAIN RES, V1642, P70, DOI 10.1016/j.brainres.2016.03.031; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Lim SW, 2018, WORLD NEUROSURG, V112, pE278, DOI 10.1016/j.wneu.2018.01.036; Lin JH, 2008, CURR DRUG METAB, V9, P46, DOI 10.2174/138920008783331077; Moretti R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00040; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Nadler Y, 2008, GLIA, V56, P552, DOI 10.1002/glia.20638; Olga NK, 2006, BEHAV BRAIN RES, V170, P233, DOI 10.1016/j.bbr.2006.02.026; Palacios S, 2010, MATURITAS, V67, P101, DOI 10.1016/j.maturitas.2010.06.019; Raghava Narayan, 2017, Neurosci Neuroecon, V6, P15, DOI 10.2147/NAN.S105134; Rahman Arshad, 2011, Proc Am Thorac Soc, V8, P497, DOI 10.1513/pats.201101-009MW; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Ray SK, 2016, NEURAL REGEN RES, V11, P1418, DOI 10.4103/1673-5374.191212; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Shelly W, 2008, OBSTET GYNECOL SURV, V63, P163, DOI 10.1097/OGX.0b013e31816400d7; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Suzuki T, 2003, EXP NEUROL, V184, P1017, DOI 10.1016/S0014-4886(03)00389-3; Tsai YT, 2014, J SURG RES, V189, P106, DOI 10.1016/j.jss.2014.02.009; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wen JF, 2014, EXP THER MED, V8, P881, DOI 10.3892/etm.2014.1818; Xie NC, 2010, NEUROSCI LETT, V482, P51, DOI 10.1016/j.neulet.2010.07.004; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061; Zhao YZ, 2015, NEURAL REGEN RES, V10, P1076, DOI 10.4103/1673-5374.160097	55	10	10	0	14	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	APR	2019	68	4					311	323		10.1007/s00011-019-01217-z			13	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	HP0DH	WOS:000461335200006	30706110				2022-02-06	
J	Nicholson, SE; Burmeister, DM; Johnson, TR; Zou, Y; Lai, Z; Scroggins, S; DeRosa, M; Jonas, RB; Merrill, DR; Zhu, C; Newton, LM; Stewart, RM; Schwacha, MG; Jenkins, DH; Eastridge, BJ				Nicholson, Susannah E.; Burmeister, David M.; Johnson, Taylor R.; Zou, Yi; Lai, Zhao; Scroggins, Shannon; DeRosa, Mark; Jonas, Rachelle B.; Merrill, Daniel R.; Zhu, Caroline; Newton, Larry M.; Stewart, Ronald M.; Schwacha, Martin G.; Jenkins, Donald H.; Eastridge, Brian J.			A prospective study in severely injured patients reveals an altered gut microbiome is associated with transfusion volume	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	77th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery / 4th World Trauma Congress	SEP 26-29, 2018	San Diego, CA	Amer Assoc Surg Trauma		Trauma; injury; gut microbiome; dysbiosis; transfusion	INTESTINAL ISCHEMIA; BRAIN-INJURY; DYSBIOSIS; FAILURE; HEALTH	BACKGROUND: Traumatic injury can lead to a compromised intestinal epithelial barrier and inflammation. While alterations in the gut microbiome of critically injured patients may influence clinical outcomes, the impact of trauma on gut microbial composition is unknown. Our objective was to determine if the gut microbiome is altered in severely injured patients and begin to characterize changes in the gut microbiome due to time and therapeutic intervention. METHODS: We conducted a prospective, observational study in adult patients (n = 72) sustaining severe injury admitted to a Level I Trauma Center. Healthy volunteers (n = 13) were also examined. Fecal specimens were collected on admission to the emergency department and at 3, 7, 10, and 13 days (+/- 2 days) following injury. Microbial DNA was isolated for 16s rRNA sequencing, and a and ss diversities were estimated, according to taxonomic classification against the Greengenes database. RESULTS: The gut microbiome of trauma patients was altered on admission (i.e., within 30 minutes following injury) compared to healthy volunteers. Patients with an unchanged gut microbiome on admission were transfused more RBCs than those with an altered gut microbiome (p < 0.001). Although the gut microbiome started to return to a ss-diversity profile similar to that of healthy volunteers over time, it remained different from healthy controls. Alternatively, a diversity initially increased postinjury, but subsequently decreased during the hospitalization. Injured patients on admission had a decreased abundance of traditionally beneficial microbial phyla (e.g., Firmicutes) with a concomitant decrease in opportunistic phyla (e.g., Proteobacteria) compared to healthy controls (p < 0.05). Large amounts of blood products and RBCs were both associated with higher a diversity (p < 0.001) and a ss diversity clustering closer to healthy controls. CONCLUSION: The human gut microbiome changes early after trauma and may be aided by early massive transfusion. Ultimately, the gut microbiome of trauma patients may provide valuable diagnostic and therapeutic insight for the improvement of outcomes postinjury.	[Nicholson, Susannah E.; Johnson, Taylor R.; Scroggins, Shannon; DeRosa, Mark; Jonas, Rachelle B.; Merrill, Daniel R.; Zhu, Caroline; Newton, Larry M.; Stewart, Ronald M.; Schwacha, Martin G.; Jenkins, Donald H.; Eastridge, Brian J.] UT Hlth San Antonio, Dept Surg, San Antonio, TX USA; [Zou, Yi; Lai, Zhao] UT Hlth San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX USA; [Lai, Zhao] UT Hlth San Antonio, Dept Mol Med, San Antonio, TX USA; [Burmeister, David M.] US Army, Inst Surg Res, San Antonio, TX USA		Nicholson, SE (corresponding author), UT Hlth San Antonio, Dept Surg, Div Trauma & Emergency Surg, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	nicholsons@uthscsa.edu	Scroggins, Shannon/AAY-5909-2020; Nicholson, Susannah/AAI-2757-2021	Sayyadioskoie, Shannon/0000-0002-2542-8877	National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR001118]; University of Texas Health San Antonio Military Health Institute; Bob Kelso Endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001120, KL2TR001118] Funding Source: NIH RePORTER	The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant KL2 TR001118. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Department of the Army and the Department of Defense. Support was also received by the University of Texas Health San Antonio Military Health Institute and the Bob Kelso Endowment awarded to the University of Texas Health San Antonio Department of Surgery. We would like to thank the following individuals for their support: Basil A. Pruitt, Jr., Dawn Garcia and Korri S. Weldon for 16S sequencing sample processing and data generation, Yidong Chen, PhD for bioinformatics support.	Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Budding AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101344; Caricilli Andrea Moro, 2014, World J Gastrointest Pathophysiol, V5, P18, DOI 10.4291/wjgp.v5.i1.18; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Dickson RP, 2016, LANCET RESP MED, V4, P59, DOI 10.1016/S2213-2600(15)00427-0; DuPont AW, 2011, NAT REV GASTRO HEPAT, V8, P523, DOI 10.1038/nrgastro.2011.133; Earley ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129996; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grootjans J, 2010, AM J PATHOL, V176, P2283, DOI 10.2353/ajpath.2010.091069; Hammer AM, 2016, SHOCK, V45, P73, DOI 10.1097/SHK.0000000000000483; Hayakawa M, 2011, DIGEST DIS SCI, V56, P2361, DOI 10.1007/s10620-011-1649-3; Hormann N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113080; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Howard B.M, 2017, OPEN, V2, pe108, DOI 10.1136/tsaco-2017-000108; Huang GT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01237; Hugon P, 2015, LANCET INFECT DIS, V15, P1211, DOI 10.1016/S1473-3099(15)00293-5; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Krezalek MA, 2016, SHOCK, V45, P475, DOI 10.1097/SHK.0000000000000534; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Lerner A, 2013, ANTIMICROB AGENTS CH, V57, P1474, DOI 10.1128/AAC.01275-12; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; MCDONALD D, 2016, J VIS, V1, DOI DOI 10.1128/MSPHERE.00199-16; McGhan LJ, 2012, INJURY, V43, P129, DOI 10.1016/j.injury.2011.05.032; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; Moore FA, 1999, AM J SURG, V178, P449, DOI 10.1016/S0002-9610(99)00231-7; Moore FA, 1996, J TRAUMA, V40, P510; Nicholson SE, 2018, AM J SURG; Nicholson SE, 2018, SHOCK; Papia G, 1999, J TRAUMA, V47, P923, DOI 10.1097/00005373-199911000-00018; Pham TAN, 2014, CURR OPIN MICROBIOL, V17, P67, DOI 10.1016/j.mib.2013.12.002; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Shimizu Kentaro, 2015, Burns, V41, pe28, DOI 10.1016/j.burns.2014.10.019; Shimizu K, 2011, DIGEST DIS SCI, V56, P1171, DOI 10.1007/s10620-010-1418-8; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Waligora-Dupriet AJ, 2018, NUTRITION, V45, P104, DOI 10.1016/j.nut.2017.06.026; Wang F, 2013, SHOCK, V39, P96, DOI 10.1097/SHK.0b013e318279265f; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042027; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zaborin A, 2014, MBIO, V5, DOI 10.1128/mBio.01361-14; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113	51	10	10	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2019	86	4					573	582		10.1097/TA.0000000000002201			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	HR5QD	WOS:000463201000003	30633104	Green Accepted			2022-02-06	
J	Scarponi, F; Zampolini, M; Zucchella, C; Bargellesi, S; Fassio, C; Pistoia, F; Bartolo, M; Antenucci, R; Bozzini, E; Cassio, A; Gruppi, MP; Raggi, R; Beatrici, M; Macchetta, C; Cocchini, L; Benedetti, A; Bianconi, F; Bramanti, P; Marino, S; Corallo, F; Brambilla, M; Carboncini, MC; Spina, V; Cervigni, G; Cimenti, F; Previaio, C; Semerjian, M; Colombari, M; De Cicco, D; De Tanti, A; Iardella, L; Diverio, M; Grifoni, C; Carl, V; Pasqualone, E; Estraneo, A; Formisano, R; Ciurli, MP; Galardi, M; Santangelo, A; Giorgini, T; Biasutti, E; Iaia, V; Intiso, D; Lamberti, G; Antoniono, E; Lanfranchi, M; Lavezzi, S; Chiavaroli, R; Lucca, LF; Maggioni, G; Mancuso, M; Canova, S; Mandala, G; Melizza, G; Montis, A; Pilia, F; Mule, C; Navarro, J; Lanzillotti, C; Perin, C; Petrozzino, S; Schierano, G; Battistini, A; Premoselli, S; Salvi, P; Simonini, M; Sara, M; Pardo, M; Serafini, P; Fortuna, R; Sergio, MA; Volanti, P				Scarponi, Federico; Zampolini, Mauro; Zucchella, Chiara; Bargellesi, Stefano; Fassio, Chiara; Pistoia, Francesca; Bartolo, Michelangelo; Antenucci, Roberto; Bozzini, Emilia; Cassio, Anna; Gruppi, Maria P.; Raggi, Rossella; Beatrici, Maurizio; Macchetta, Claudia; Cocchini, Lorella; Benedetti, Adonella; Bianconi, Fortunato; Bramanti, Placido; Marino, Silvia; Corallo, Francesco; Brambilla, Massimo; Carboncini, Maria C.; Spina, Vincenzo; Cervigni, Giuliana; Cimenti, Fabio; Previaio, Chiara; Semerjian, Monica; Colombari, Mauro; De Cicco, Domenico; De Tanti, Antonio; Iardella, Laura; Diverio, Manuela; Grifoni, Camilla; Carl, Valentina; Pasqualone, Eugenia; Estraneo, Anna; Formisano, Rita; Ciurli, Maria P.; Galardi, Massimo; Santangelo, Antonin; Giorgini, Tullio; Biasutti, Emanuele; Iaia, Vincenzo; Intiso, Domenico; Lamberti, Gianfranco; Antoniono, Elena; Lanfranchi, Maurizio; Lavezzi, Susanna; Chiavaroli, Roberta; Lucca, Lucia F.; Maggioni, Giorgio; Mancuso, Mauro; Canova, Stefania; Mandala, Giorgio; Melizza, Gianni; Montis, Andrea; Pilia, Felicita; Mule, Chiara; Navarro, Jorge; Lanzillotti, Crocifissa; Perin, Cecilia; Petrozzino, Salvatore; Schierano, Gabriella; Battistini, Alberto; Premoselli, Silvia; Salvi, Piero; Simonini, Marcello; Sara, Marco; Pardo, Moira; Serafini, Paolo; Fortuna, Rossella; Sergio, Maria A.; Volanti, Paolo		CIRCLE Comorbidita Ingresso Riabil	Identifying clinical complexity in patients affected by severe acquired brain injury in neurorehabilitation: a cross sectional survey	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injuries; Comorbidity; Rehabilitation; Patient admission	PAROXYSMAL SYMPATHETIC HYPERACTIVITY; PRESSURE ULCERS; EARLY REHABILITATION; CARE-UNIT; HETEROTOPIC OSSIFICATION; CARDIAC-ARREST; DISORDERS; ASSOCIATION; COMORBIDITIES; PREVENTION	BACKGROUND: Literature shows that occurrence of comorbidities in people with severe acquired brain injury (sABI) is a common problem in rehabilitation stay. Consequently, patients could require an increase of interventions for diagnosis and treatment of clinical conditions, with a reduction of the rehabilitative take in charge for both clinical and organizational aspects. AIM: The first aim was to evaluate the rate of clinical conditions of sABI patients at admission in rehabilitation and the types of rehabilitative interventions performed in the first week; second objective was to explore the impact of clinical conditions on real rehabilitative take in charge. DESIGN: Cross sectional study. SETTING: Inpatient rehabilitation centers. POPULATION: The study included data from 586 sABI patients. METHODS: Collected data regarded anamnestic information, functional status assessed by means of Glasgow Outcome Scale, Levels of cognitive functioning, Early Rehabilitation Barthel Index, comorbidities at admission and type of rehabilitative interventions carried out in first week of rehabilitation stay. Spearman correlation coefficients were applied to detect possible correlations between the number of treatments in first week and clinical variables; through a multiple regression analysis the effect of patient's characteristics on rehabilitative take in charge was explored. RESULTS : Data from the sABI patients: mean age 55.1 +/- 17.1 years; etiology of sABI was vascular in 315 patients (53.8%), anoxic in 83 (14.2%), neoplastic in 17 (2.9%), infectious in 15 (2.6%), traumatic in 150 (25.6%); 6 subjects (1%) presented a mixed etiology. Need of cardiorespiratory monitoring, pressure sores, infections or presence of multi drug resistant bacteria were the most frequent comorbidities. Passive mobilization, sitting positioning, arousal/awareness stimulation, evaluation and management of dysphagia were the interventions most frequently carried out in the first week. The regression analysis showed that severe neurological and clinical conditions, acute organ failure, cardio-respiratory instability and paroxysmal sympathetic hyperactivity significantly limit access to rehabilitative sessions. CONCLUSIONS: In sABI patients clinical comorbidities requiring elevated care assistance are frequent at admission in rehabilitation from acute wards and may interfere with rehabilitative take in charge. CLINICAL REHABILITATION IMPACT : The knowledge of clinical complexity of sABI patients may improve their care pathways, promoting early and appropriate transition from acute care to rehabilitation settings.	[Scarponi, Federico; Zampolini, Mauro] San Giovanni Battista Hosp, Dept Rehabil, Perugia, Italy; [Zucchella, Chiara] Univ Hosp Verona, Unit Neurol, Verona, Italy; [Bargellesi, Stefano] Ca Foncello Hosp, Severe Brain Injuries Rehabil Unit, Unit Phys Med & Rehabil, Treviso, Italy; [Fassio, Chiara] IRCSS Maugeri Fdn, Unit Rehabil, Pavia, Italy; [Pistoia, Francesca] Univ Laquila, Neurol Inst, Dept Biotechnol & Appl Clin Sci, Laquila, Italy; [Bartolo, Michelangelo] HABILITA, Dept Rehabil, Unit Neurorehabil, Bergamo, Italy		Scarponi, F (corresponding author), San Giovanni Battista Hosp, Dept Rehabil, Brain Injury Unit, Via Arcamone 1, I-06034 Perugia, Italy.	federico.scarponi@uslumbria2.it	Marino, Silvia/T-5118-2019; Bramanti, Placido/K-5117-2016; Antenucci, Roberto/AAA-8195-2020; Fassio, Chiara/AAB-8759-2020; Maggioni, Giorgio/K-3148-2016; Pistoia, Francesca/AAC-1027-2019; mandala, giorgio/AAC-1842-2019; Bianconi, Fortunato/L-7359-2019; Sara, Marco/AAB-3651-2019; Intiso, Domenico/H-2414-2016; Lucca, Lucia Francesca/AAB-8558-2022; Scarponi, Federico/K-5714-2018	Marino, Silvia/0000-0002-1088-6808; Antenucci, Roberto/0000-0002-7205-8995; Fassio, Chiara/0000-0001-7909-609X; Maggioni, Giorgio/0000-0002-9246-7008; mandala, giorgio/0000-0002-4384-8672; Bianconi, Fortunato/0000-0002-3132-0061; Intiso, Domenico/0000-0002-6564-5956; Scarponi, Federico/0000-0001-9683-8104			Almangour W, 2016, ANN PHYS REHABIL MED, V59, P263, DOI 10.1016/j.rehab.2016.03.009; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Bargellesi S, 2018, CLIN REHABIL, V32, P255, DOI 10.1177/0269215517723161; Bartolo M, 2016, EUR J PHYS REHAB MED, V52, P90; Baumgarten M, 2006, J GERONTOL A-BIOL, V61, P749, DOI 10.1093/gerona/61.7.749; Bergstrom N, 1996, J AM GERIATR SOC, V44, P22, DOI 10.1111/j.1532-5415.1996.tb05633.x; Chraa M, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.37.3226; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Dhandapani M, 2014, J CLIN NURS, V23, P1114, DOI 10.1111/jocn.12396; Dubb R, 2016, ANN AM THORAC SOC, V13, P724, DOI 10.1513/AnnalsATS.201509-586CME; EVANS RL, 1991, SOC SCI MED, V33, P801, DOI 10.1016/0277-9536(91)90384-O; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Hagen C, 1979, LEVELS COGNITIVE FUN; INMAN KJ, 1993, JAMA-J AM MED ASSOC, V269, P1139; Intiso D, 2017, EUR J PHYS REHAB MED, V53, P910, DOI 10.23736/S1973-9087.17.04595-6; Intiso D, 2017, EUR J PHYS REHAB MED, V53, P268, DOI 10.23736/S1973-9087.16.04288-X; JENNETT B, 1975, LANCET, V1, P480; Johns RH, 2010, POSTGRAD MED J, V86, P541, DOI 10.1136/pgmj.2010.100206; Laxe S, 2013, BRAIN INJURY, V27, P1383, DOI 10.3109/02699052.2013.823648; Li Y, 2011, JAMA-J AM MED ASSOC, V306, P179, DOI 10.1001/jama.2011.942; Luther MS, 2008, CLIN REHABIL, V22, P1034, DOI 10.1177/0269215508092821; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Lyder CH, 2003, JAMA-J AM MED ASSOC, V289, P223, DOI 10.1001/jama.289.2.223; Lyder CH, 2012, J AM GERIATR SOC, V60, P1603, DOI 10.1111/j.1532-5415.2012.04106.x; Mathew MJ, 2016, ACTA NEUROCHIR, V158, P2047, DOI 10.1007/s00701-016-2934-x; Maulden SA, 2005, ARCH PHYS MED REHAB, V86, pS34, DOI 10.1016/j.apmr.2005.08.119; Meyer Kimberly S, 2014, Surg Neurol Int, V5, pS490, DOI 10.4103/2152-7806.144632; Montalcini T, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0660-4; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; Paci M, 2017, CAN J NEUROL SCI, V44, P518, DOI 10.1017/cjn.2017.43; Petzold T, 2014, BRIT J DERMATOL, V170, P1285, DOI 10.1111/bjd.12915; Pfeifer R, 2013, RESUSCITATION, V84, P1375, DOI 10.1016/j.resuscitation.2013.05.016; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; Riberholt CG, 2013, DAN MED J, V60; Rollnik JD, 2011, REHABILITATION, V50, P408, DOI 10.1055/s-0031-1273728; Sandroni C, 2013, RESUSCITATION, V84, P1324, DOI 10.1016/j.resuscitation.2013.06.020; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Taricco M, 2006, Eura Medicophys, V42, P73; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; VanGilder C, 2017, J WOUND OSTOMY CONT, V44, P20, DOI 10.1097/WON.0000000000000292; Verma R, 2015, INDIAN J CRIT CARE M, V19, P34, DOI 10.4103/0972-5229.148638; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Zampolini M, 2013, EUR J PHYS REHAB MED, V49, P365; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358; Zhang Y, 2011, J CLIN NEUROPHYSIOL, V28, P497, DOI 10.1097/WNP.0b013e318231c852	50	10	10	2	10	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	APR	2019	55	2					191	198		10.23736/S1973-9087.18.05342-X			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	HX5QP	WOS:000467458000008	30543265				2022-02-06	
J	Sutton, M; Chan, V; Escobar, M; Mollayeva, T; Hu, Z; Colantonio, A				Sutton, Mitchell; Chan, Vincy; Escobar, Michael; Mollayeva, Tatyana; Hu, Zheng; Colantonio, Angela			Neck Injury Comorbidity in Concussion-Related Emergency Department Visits: A Population-Based Study of Sex Differences Across the Life Span	JOURNAL OF WOMENS HEALTH			English	Article						concussion; neck injury; sex; motor vehicle; sports	WHIPLASH-ASSOCIATED DISORDERS; TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; UNITED-STATES; PUBLIC-HEALTH; EPIDEMIOLOGY; SYMPTOMS; STRENGTH; SPORTS; TRENDS	Background: The cervical spine region can be especially vulnerable to concurrent injury in concussion, with research suggesting that females may be at greater risk due to their weaker and anatomically distinct necks. The main objective of our research was to study sex differences in the rate of neck injury comorbidity across the life span among patients with a concussion diagnosis in the emergency department (ED) setting, by cause of injury (motor vehicle collisions [MVC] and sports). Materials and Methods: All patients with a first concussion-related ED visit between fiscal years 2002/2003 and 2011/2012 (inclusive) in Ontario were identified in population-based health administrative data using the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Canada (ICD-10-CA) codes. Age-dependent odds ratios of comorbid neck injury for sex were estimated using polynomial multivariable logistic regression models, adjusting for sociodemographic characteristics. Results: Females with a concussion had significantly higher odds of sustaining a comorbid neck injury between the ages of 5-49 years for all concussion-related ED visits, 15-49 years for MVC-related concussion ED visits, and 10-39 years for sports-related concussion ED visits, holding all other covariates in the model constant. Conclusions: These results support the consideration of increased screening for comorbid neck injuries, particularly for females, to allow for early intervention. Furthermore, the increased risk of comorbid neck injury in females with a concussion-related ED visit was age-dependent, with the interaction between sex and age following a nonlinear trend. As such, future studies on concussions should consider linear and nonlinear sex and age interactions.	[Sutton, Mitchell; Chan, Vincy; Mollayeva, Tatyana; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Sutton, Mitchell; Escobar, Michael; Hu, Zheng] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mollayeva, Tatyana] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Colantonio, Angela] Inst Clin & Evaluat Sci, Toronto, ON, Canada		Colantonio, A (corresponding author), Univ Toronto, Rehabil Sci Bldg,500 Univ Ave,Suite 160, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	Chan, Vincy/AAA-7813-2020; , Mollayeva/A-4522-2018	Chan, Vincy/0000-0002-6884-044X; Escobar, Michael/0000-0001-9055-4709; Colantonio, Angela/0000-0003-2094-4765	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD089106] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD089106] Funding Source: NIH RePORTER		Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; [Anonymous], 2017, EMERGENCY AMBULATORY; [Anonymous], 2018, SAS 9 3; [Anonymous], 2017, ICD INJURY MATRICES; Barker-Collo S, 2016, NEUROEPIDEMIOLOGY, V47, P46, DOI 10.1159/000448403; Catenaccio E, 2017, PM&R, V9, P884, DOI 10.1016/j.pmrj.2017.01.005; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Clemenson, 2001, RURAL SMALL TOWN CAN; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Faelker T, 2000, Inj Prev, V6, P203, DOI 10.1136/ip.6.3.203; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fujii Tomoko, 2013, J Emerg Trauma Shock, V6, P252, DOI 10.4103/0974-2700.120365; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Glazier RH., 2012, COMP PRIMARY CARE MO; Hasler RM, 2012, J TRAUMA ACUTE CARE, V72, P975, DOI 10.1097/TA.0b013e31823f5e8e; Hecht JS, 2004, J HEAD TRAUMA REHAB, V19, P58, DOI 10.1097/00001199-200401000-00006; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kleinbaum DG, 1998, APPL REGRESSION ANAL, V3rd; Kmet L, 2006, ACCIDENT ANAL PREV, V38, P122, DOI 10.1016/j.aap.2005.07.007; Langelier DM, 2017, PHYS THER SPORT, V25, P84, DOI 10.1016/j.ptsp.2017.01.003; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leslie O, 2013, CLIN J SPORT MED, V23, P331, DOI 10.1097/JSM.0b013e318295bbb1; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mallinson AI, 1998, AM J OTOL, V19, P814; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McClune T, 2002, EMERG MED J, V19, P499, DOI 10.1136/emj.19.6.499; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Ministry of Transportation, 2017, OFF MIN TRANSP MTO D; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Proctor MR, 2000, CLIN SPORT MED, V19, P693, DOI 10.1016/S0278-5919(05)70233-7; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Quinlan KP, 2004, ACCIDENT ANAL PREV, V36, P21, DOI 10.1016/S0001-4575(02)00110-0; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Social Determinants of Health, 2016, PUBL HLTH AG CAN; Springer KW, 2011, J HEALTH SOC BEHAV, V52, P212, DOI 10.1177/0022146510393972; Statistics Canada, 2013, SPORT PART 2010 RES; Statistics Canada, 2017, POP YEAR PROV TERR P; Stemper BD, 2016, J ORTHOP SPORT PHYS, V46, P834, DOI 10.2519/jospt.2016.6846; Suzanne Fegan CB, 2013, RECOMMENDED ICD 10 C; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Treleaven J, 2011, SPINE, V36, pS211, DOI 10.1097/BRS.0b013e3182387f78; Treleaven J, 2011, MANUAL THER, V16, P252, DOI 10.1016/j.math.2010.11.002; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; Walton DM, 2009, J ORTHOP SPORT PHYS, V39, P334, DOI 10.2519/jospt.2009.2765; Weisberg S ., 1985, APPL LINEAR REGRESSI, V2nd; Williams DR, 2008, AM J PUBLIC HEALTH, V98, pS150, DOI 10.2105/AJPH.98.Supplement_1.S150; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	58	10	10	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-9996	1931-843X		J WOMENS HEALTH	J. Womens Health	APR 1	2019	28	4					473	482		10.1089/jwh.2018.7282			10	Public, Environmental & Occupational Health; Medicine, General & Internal; Obstetrics & Gynecology; Women's Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine; Obstetrics & Gynecology; Women's Studies	HS6VU	WOS:000464010200008	30592685	Green Published, hybrid			2022-02-06	
J	Wei, F; Song, J; Zhang, C; Lin, J; Xue, R; Shan, LD; Gong, S; Zhang, GX; Qin, ZH; Xu, GY; Wang, LH				Wei, Fang; Song, Jian; Zhang, Cui; Lin, Jun; Xue, Rong; Shan, Li-Dong; Gong, Shan; Zhang, Guo-Xing; Qin, Zheng-Hong; Xu, Guang-Yin; Wang, Lin-Hui			Chronic stress impairs the aquaporin-4-mediated glymphatic transport through glucocorticoid signaling	PSYCHOPHARMACOLOGY			English	Article						Glymphatic system; Chronic stress; Aquaporin-4; Cerebrospinal fluid; Glucocorticoid receptor	CHRONIC MILD STRESS; TERMINAL HUNTINGTIN FRAGMENT; FIBRILLARY ACIDIC PROTEIN; AMYLOID-BETA; ALZHEIMERS-DISEASE; TAU PATHOLOGY; PREFRONTAL CORTEX; MOUSE MODEL; PSYCHOLOGICAL DISTRESS; PARKINSONS-DISEASE	BackgroundThe glymphatic system has recently been proposed to function as a brain-wide macroscopic system for the clearance of potentially harmful molecules, such as amyloid beta (e.g., A), from the brain parenchyma. Previous literatures have established that the glymphatic function is dramatically suppressed by aging, traumatic brain injury, and some diseases. However, the effect of chronic stress on the glymphatic function and its underlying mechanism remains largely unknown.MethodsAdult mice were randomly divided into four groups: chronic unpredictable mild stress (CUMS)-treated group, CUMS simultaneously treated with mifepristone (MFP) group, dexamethasone (DEX)-treated group, and control group. Stress response was observed by assessing the change of body weight, plasma corticosterone level, and behavior tests. The level of A42 in cerebral tissue was assessed by ELISA. The glymphatic function was determined by using fluorescence tracer injection. The expression and localization of aquaporin-4 (AQP4) were evaluated by immunohistochemistry and western blot. The transcription level of AQP4 and anchoring molecules was evaluated by real-time PCR.FindingsCompared with control group, CUMS-treated mice exhibited the impairment of global glymphatic function especially in the anterior brain. This change was accompanied by the decreased expression and polarization of AQP4, reduced transcription of AQP4, agrin, laminin, and dystroglycan in the anterior cortex. Similarly, the glucocorticoid receptor (GR) agonist DEX exposure could reduce the glymphatic function and AQP4 expression. Moreover, the GR antagonist MFP treatment could significantly rescue the glymphatic function and reverse the expression and polarization of AQP4 impaired by CUMS.ConclusionChronic stress could impair the AQP4-mediated glymphatic transport in the brain through glucocorticoid signaling. Our results also suggest that GR antagonist could be beneficial to rescue the glymphatic function suppressed by chronic stress.	[Wei, Fang; Song, Jian; Zhang, Cui; Xue, Rong; Shan, Li-Dong; Gong, Shan; Zhang, Guo-Xing; Wang, Lin-Hui] Soochow Univ, Dept Physiol & Neurobiol, Coll Med, 199 Ren Ai Rd, Suzhou 215123, Peoples R China; [Lin, Jun] Soochow Univ, Dept Orthopaed, Affiliated Hosp 1, 188 Shi Zi St, Suzhou 215006, Peoples R China; [Qin, Zheng-Hong] Soochow Univ, Dept Pharmacol, Sch Pharm, Suzhou 215123, Peoples R China; [Qin, Zheng-Hong] Soochow Univ, Lab Aging & Nervous Dis, Sch Pharm, Suzhou 215123, Peoples R China; [Xu, Guang-Yin] Soochow Univ, Inst Neurosci, 199 Ren Ai Rd, Suzhou 215123, Peoples R China		Wang, LH (corresponding author), Soochow Univ, Dept Physiol & Neurobiol, Coll Med, 199 Ren Ai Rd, Suzhou 215123, Peoples R China.	wanglinhui@suda.edu.cn		Lin, Jun/0000-0002-8094-5826	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31871167]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2016M601882]; Postdoctoral Science Foundation of Jiangsu Province, ChinaChina Postdoctoral Science Foundation [1601083C]; Suzhou Science and Technology Research Project [SYS201669]; Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by the National Natural Science Foundation of China (31871167), China Postdoctoral Science Foundation (No. 2016M601882), Postdoctoral Science Foundation of Jiangsu Province, China (No. 1601083C), Suzhou Science and Technology Research Project (No. SYS201669), and Priority Academic Program Development of Jiangsu Higher Education Institutions.	Achariyar TM, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0138-8; Baglietto-Vargas D, 2013, BIOL PSYCHIAT, V74, P357, DOI 10.1016/j.biopsych.2012.12.003; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Banasr M, 2007, BIOL PSYCHIAT, V62, P496, DOI 10.1016/j.biopsych.2007.02.006; Benveniste H, 2017, NEUROSCIENTIST; Bernard R, 2011, MOL PSYCHIATR, V16, P634, DOI 10.1038/mp.2010.44; Camassa LMA, 2015, GLIA, V63, P2073, DOI 10.1002/glia.22878; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Conrad CD, 1999, NEUROBIOL LEARN MEM, V72, P39, DOI 10.1006/nlme.1998.3898; Csernansky JG, 2006, AM J PSYCHIAT, V163, P2164, DOI 10.1176/appi.ajp.163.12.2164; Cuadrado-Tejedor M, 2012, J ALZHEIMERS DIS, V28, P567, DOI 10.3233/JAD-2011-110572; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DeBattista C, 2006, BIOL PSYCHIAT, V60, P1343, DOI 10.1016/j.biopsych.2006.05.034; Djamshidian A, 2014, J NEUROL NEUROSUR PS, V85, P879, DOI 10.1136/jnnp-2013-305911; Dong LR, 2017, CELL PHYSIOL BIOCHEM, V42, P1098, DOI 10.1159/000478764; Dong L, 2015, PSYCHOPHARMACOLOGY, V232, P2827, DOI 10.1007/s00213-015-3921-2; Eilert-Olsen M, 2012, GLIA, V60, P432, DOI 10.1002/glia.22277; Enger R, 2012, GLIA, V60, P2018, DOI 10.1002/glia.22416; Frigeri A, 2001, FASEB J, V15, P90, DOI 10.1096/fj.00-0260com; Gaberel T, 2014, STROKE, V45, P3092, DOI 10.1161/STROKEAHA.114.006617; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; He XF, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00144; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jeong YH, 2006, FASEB J, V20, P729, DOI 10.1096/fj.05-4265fje; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Joshi YB, 2013, AGING CELL, V12, P706, DOI 10.1111/acel.12096; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kulstad JJ, 2005, J NEUROPATH EXP NEUR, V64, P139, DOI 10.1093/jnen/64.2.139; Landfield PW, 2007, CURR ALZHEIMER RES, V4, P205, DOI 10.2174/156720507780362083; Lee BK, 2008, AM J PSYCHIAT, V165, P1456, DOI 10.1176/appi.ajp.2008.07091532; Lee HD, 2015, J NEUROSCI, V35, P11034, DOI 10.1523/JNEUROSCI.1625-15.2015; Lien CF, 2012, J BIOL CHEM, V287, P41374, DOI 10.1074/jbc.M112.400044; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Lundgaard I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20424-y; Lundgaard I, 2017, J CEREBR BLOOD F MET, V37, P2112, DOI 10.1177/0271678X16661202; Lundgaard I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7807; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; Medina A, 2016, J PSYCHIATR RES, V72, P15, DOI 10.1016/j.jpsychires.2015.10.010; Mejia S, 2003, INT PSYCHOGERIATR, V15, P337, DOI 10.1017/S1041610203009591; Miguel-Hidalgo JJ, 2000, BIOL PSYCHIAT, V48, P861, DOI 10.1016/S0006-3223(00)00999-9; Mo C, 2014, NEUROBIOL DIS, V71, P81, DOI 10.1016/j.nbd.2014.07.008; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Nielsen S, 1997, J NEUROSCI, V17, P171; Nishioka R, 2016, EXP NEUROL, V277, P150, DOI 10.1016/j.expneurol.2015.12.016; Noell S, 2011, EUR J NEUROSCI, V33, P2179, DOI 10.1111/j.1460-9568.2011.07688.x; Ostadhadi S, 2016, BIOMED PHARMACOTHER, V81, P295, DOI 10.1016/j.biopha.2016.04.026; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; Prenderville JA, 2015, TRENDS NEUROSCI, V38, P13, DOI 10.1016/j.tins.2014.11.001; Rajkowska G, 2013, CURR DRUG TARGETS, V14, P1225; Rajkowska G, 2013, BIOL PSYCHIAT, V73, P613, DOI 10.1016/j.biopsych.2012.09.024; Rauch SM, 2011, J NEUROPATH EXP NEUR, V70, P1124, DOI 10.1097/NEN.0b013e31823b0b12; Ren HX, 2017, FASEB J, V31, P282, DOI 10.1096/fj.201600896; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Ron NP, 2005, REPROD FERT DEVELOP, V17, P535, DOI 10.1071/RD03044; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; Satz JS, 2010, J NEUROSCI, V30, P14560, DOI 10.1523/JNEUROSCI.3247-10.2010; Si XH, 2004, NEUROPSYCHOPHARMACOL, V29, P2088, DOI 10.1038/sj.npp.1300525; Smith AD, 2002, PHYSIOL BEHAV, V77, P527, DOI 10.1016/S0031-9384(02)00939-3; Srivareerat M, 2009, BIOL PSYCHIAT, V65, P918, DOI 10.1016/j.biopsych.2008.08.021; Thrane VR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02582; Unemura K, 2012, J PHARMACOL SCI, V119, P30, DOI 10.1254/jphs.12047FP; Verheggen ICM, 2018, NEUROSCI BIOBEHAV R, V90, P26, DOI 10.1016/j.neubiorev.2018.03.028; Wang LH, 2012, BRAIN RES, V1449, P69, DOI 10.1016/j.brainres.2012.01.077; Wang LH, 2012, ACTA BIOCH BIOPH SIN, V44, P249, DOI 10.1093/abbs/gmr125; Wei F, 2017, LIFE SCI, V182, P29, DOI 10.1016/j.lfs.2017.05.028; Wilson RS, 2006, NEUROEPIDEMIOLOGY, V27, P143, DOI 10.1159/000095761; Wilson RS, 2003, NEUROLOGY, V61, P1479, DOI 10.1212/01.WNL.0000096167.56734.59; Wu LM, 2007, NEUROPSYCHOPHARMACOL, V32, P2500, DOI 10.1038/sj.npp.1301386; Wu QM, 2016, EXP NEUROL, V285, P61, DOI 10.1016/j.expneurol.2016.09.004; Wulsin AC, 2010, PSYCHONEUROENDOCRINO, V35, P1100, DOI 10.1016/j.psyneuen.2010.01.011; Xia MS, 2017, PSYCHOPHARMACOLOGY, V234, P365, DOI 10.1007/s00213-016-4473-9; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zhang C, 2018, LIFE SCI, V201, P150, DOI 10.1016/j.lfs.2018.03.057; Zhang JZ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00395; Zhang XQ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00388	84	10	10	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	APR	2019	236	4					1367	1384		10.1007/s00213-018-5147-6			18	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	IF3LG	WOS:000472981400022	30607477				2022-02-06	
J	Yang, MC; Wang, XX; Fan, YS; Chen, YQ; Sun, DD; Xu, X; Wang, JH; Gu, G; Peng, RL; Shen, TY; Liu, XL; Li, FJ; Wang, Y; Wang, D; Rong, HT; Han, ZY; Gao, XL; Li, QF; Fan, KY; Yuan, YH; Zhang, JN				Yang, Mengchen; Wang, Xiaoxue; Fan, Yueshan; Chen, Yaqing; Sun, Dongdong; Xu, Xin; Wang, Jianhao; Gu, Gang; Peng, Ruilong; Shen, Tianyu; Liu, Xilei; Li, Fanjian; Wang, Yi; Wang, Dong; Rong, Hongtao; Han, Zhenying; Gao, Xiangliang; Li, Qifeng; Fan, Keyuan; Yuan, Yuhua; Zhang, Jianning			Semaphorin 3A Contributes to Secondary Blood-Brain Barrier Damage After Traumatic Brain Injury	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						traumatic brain injury; blood-brain barrier; Semaphorin 3A; miRNA-30b-5p; oxygen-glucose deprivation	OXYGEN-GLUCOSE DEPRIVATION; CONTROLLED CORTICAL IMPACT; IN-VITRO; MURINE MODEL; EXPRESSION; CELLS; PERMEABILITY; RECOVERY; PROLIFERATION; INFLAMMATION	Semaphorin 3A (SEMA3A) is a member of the Semaphorins family, a class of membrane-associated protein that participates in the construction of nerve networks. SEMA3A has been reported to affect vascular permeability previously, but its influence in traumatic brain injury (TBI) is still unknown. To investigate the effects of SEMA3A, we used a mouse TBI model with a controlled cortical impact (CCI) device and a blood-brain barrier (BBB) injury model in vitro with oxygen-glucose deprivation (OGD). We tested post-TBI changes in SEMA3A, and its related receptors (Nrp-1 and plexin-A1) expression and distribution through western blotting and double-immunofluorescence staining, respectively. Neurological outcomes were evaluated by modified neurological severity scores (mNSSs) and beam-walking test. We examined BBB damage through Evans Blue dye extravasation, brain water content, and western blotting for VE-cadherin and p-VE-cadherin in vivo, and we examined the endothelial cell barrier through hopping probe ion conductance microscopy (HPICM), transwell leakage, and western blotting for VE-cadherin and p-VE-cadherin in vitro. Changes in miR-30b-5p were assessed by RT-PCR. Finally, the neuroprotective function of miR-30b-5p is measured by brain water content, mNSSs and beam-walking test. SEMA3A expression varied following TBI and peaked on the third day which expressed approximate fourfold increase compared with sham group, with the protein concentrated at the lesion boundary. SEMA3A contributed to neurological function deficits and secondary BBB damage in vivo. Our results demonstrated that SEMA3A level following OGD injury almost doubled than control group, and the negative effects of OGD injury can be improved by blocking SEMA3A expression. Furthermore, the expression of miR-30b-5p decreased approximate 40% at the third day and 60% at the seventh day post-CCI. OGD injury also exhibited an effect to approximately decrease 50% of miR-30b-5p expression. Additionally, the expression of SEMA3A post-TBI is regulated by miR-30b-5p, and miR-30b-5p could improve neurological outcomes post-TBI efficiently. Our results demonstrate that SEMA3A is a significant factor in secondary BBB damage after TBI and can be abolished by miR-30b-5p, which represents a potential therapeutic target.	[Yang, Mengchen; Fan, Yueshan; Sun, Dongdong; Xu, Xin; Wang, Jianhao; Gu, Gang; Peng, Ruilong; Liu, Xilei; Li, Fanjian; Wang, Yi; Wang, Dong; Rong, Hongtao; Han, Zhenying; Gao, Xiangliang; Li, Qifeng; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Yang, Mengchen; Fan, Yueshan; Sun, Dongdong; Xu, Xin; Wang, Jianhao; Gu, Gang; Peng, Ruilong; Liu, Xilei; Li, Fanjian; Wang, Yi; Wang, Dong; Rong, Hongtao; Han, Zhenying; Gao, Xiangliang; Li, Qifeng; Zhang, Jianning] Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China; [Yang, Mengchen; Wang, Xiaoxue; Fan, Yueshan; Chen, Yaqing; Sun, Dongdong; Xu, Xin; Wang, Jianhao; Gu, Gang; Peng, Ruilong; Shen, Tianyu; Liu, Xilei; Li, Fanjian; Gao, Xiangliang; Li, Qifeng; Yuan, Yuhua; Zhang, Jianning] Tianjin Med Univ, Tianjin, Peoples R China; [Wang, Xiaoxue; Chen, Yaqing; Yuan, Yuhua] Tianjin Med Univ, Gen Hosp, Dept Clin Lab Diagnost, Tianjin, Peoples R China; [Shen, Tianyu] Tianjin Med Univ, Hosp 2, Tianjin, Peoples R China; [Fan, Keyuan] Tianjin Chest Hosp, Tianjin, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.; Zhang, JN (corresponding author), Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China.; Yuan, YH; Zhang, JN (corresponding author), Tianjin Med Univ, Tianjin, Peoples R China.; Yuan, YH (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Clin Lab Diagnost, Tianjin, Peoples R China.	yyhxxx39@sina.com; jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81700403, 81501057, 81671380, 81502173, 81501069, 81330029, 81720108015]; Tianjin Municipal Science and Technology Commission [16PTSYJC00180, 15ZXLCSY00060, 15ZXJZSY00040]; Tianjin Natural Science FoundationNatural Science Foundation of Tianjin [17JCZDJC35900]; Tianjin Medical University General Hospital Funding [ZYYFY201616]; Tianjin Research Program of Application Foundation and Advanced Technology [15JCQNJC11300]; Science and Technology Development Fund of Tianjin Education Commission for Higher Education [2016YD02]; National Key R&D Program of China [2017YFC1104004]; Technology Program Fund of Tianjin Health and Family Planning Commission for the Key Field of Traditional Chinese Medicine [2018001]	This research was supported by grants from the National Natural Science Foundation of China (Grant Nos. 81700403, 81501057, 81671380, 81502173, 81501069, 81330029, and 81720108015), Tianjin Municipal Science and Technology Commission (Grant Nos. 16PTSYJC00180, 15ZXLCSY00060, and 15ZXJZSY00040), Tianjin Natural Science Foundation (Grant No. 17JCZDJC35900), the Tianjin Medical University General Hospital Funding (Grant No. ZYYFY201616), the Tianjin Research Program of Application Foundation and Advanced Technology (Grant No. 15JCQNJC11300), the Science and Technology Development Fund of Tianjin Education Commission for Higher Education (Grant No. 2016YD02), National Key R&D Program of China (Grant No. 2017YFC1104004), the Technology Program Fund of Tianjin Health and Family Planning Commission for the Key Field of Traditional Chinese Medicine (Grant No. 2018001).	Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Alluri H, 2018, METHODS MOL BIOL, V1717, P37, DOI 10.1007/978-1-4939-7526-6_4; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Baudet ML, 2012, NAT NEUROSCI, V15, P29, DOI 10.1038/nn.2979; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; Beckmann A, 2019, NEUROSCIENCE, V397, P67, DOI 10.1016/j.neuroscience.2018.11.043; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Chen CH, 2009, NEUROBIOL DIS, V33, P509, DOI 10.1016/j.nbd.2008.12.010; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen XW, 2013, J MEMBRANE BIOL, V246, P7, DOI 10.1007/s00232-012-9495-6; Cheng CW, 2012, BREAST CANCER RES TR, V134, P1081, DOI 10.1007/s10549-012-2034-4; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Cope EC, 2012, NUTR REV, V70, P410, DOI 10.1111/j.1753-4887.2012.00486.x; Costa C, 2015, MULT SCLER J, V21, P1632, DOI 10.1177/1352458515599848; Duh EJ, 2011, BLOOD, V117, P5785, DOI 10.1182/blood-2011-03-343228; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Forster C, 2005, J PHYSIOL-LONDON, V565, P475, DOI 10.1113/jphysiol.2005.084038; Fu XD, 2018, CLIN EXP PHARMACOL P, V45, P68, DOI 10.1111/1440-1681.12856; Gaur P, 2009, CLIN CANCER RES, V15, P6763, DOI 10.1158/1078-0432.CCR-09-1810; Ge XT, 2019, J NEUROTRAUM, V36, P1291, DOI 10.1089/neu.2018.5728; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Goncalves A, 2012, DIABETES OBES METAB, V14, P454, DOI 10.1111/j.1463-1326.2011.01548.x; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Gu D, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2093940; Gutierrez-Franco A, 2016, CLIN IMMUNOL, V163, P22, DOI 10.1016/j.clim.2015.12.005; Han F, 2015, BRAIN RES, V1611, P65, DOI 10.1016/j.brainres.2015.03.014; Hou ST, 2015, SCI REP-UK, V5, DOI 10.1038/srep07890; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Ishiguro M, 2011, CURR NEUROVASC RES, V8, P86, DOI 10.2174/156720211795495385; Jiang L, 2017, NEURAL REGEN RES, V12, P90, DOI 10.4103/1673-5374.198990; Joyal JS, 2011, BLOOD, V117, P6024, DOI 10.1182/blood-2010-10-311589; Khalili H, 2017, WORLD NEUROSURG, V103, P88, DOI 10.1016/j.wneu.2017.02.060; Le Guelte A, 2012, J CELL SCI, V125, P4137, DOI 10.1242/jcs.108282; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Li YC, 2017, APPL IMMUNOHISTO M M, V25, P251, DOI 10.1097/PAI.0000000000000296; Li ZJ, 2018, ONCOL RES, V26, P219, DOI 10.3727/096504017X14944585873659; Liu Qing Yan, 2014, Am J Neurodegener Dis, V3, P33; Liu XD, 2019, IN VITRO CELL DEV-AN, V55, P189, DOI 10.1007/s11626-019-00318-7; Luo D, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/5302049; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rezaeepoor M, 2018, CELL J, V20, P113, DOI 10.22074/cellj.2018.4842; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Salvador E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00323; Sayeed I, 2019, EXP NEUROL, V312, P63, DOI 10.1016/j.expneurol.2018.11.005; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; Shen YQ, 2015, ANTIOXID REDOX SIGN, V22, P224, DOI 10.1089/ars.2014.5909; Singh SV, 2017, BIOCHEM BIOPH RES CO, V491, P946, DOI 10.1016/j.bbrc.2017.07.140; Sun DD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00193; Sun TT, 2016, CELL PROLIFERAT, V49, P270, DOI 10.1111/cpr.12261; Takamatsu H, 2010, CELL MOL IMMUNOL, V7, P83, DOI 10.1038/cmi.2009.111; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Villain G, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156232; Wood H, 2018, NAT REV NEUROL, V14, pP254, DOI 10.1038/nrneurol.2018.29; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yang K, 2018, BONE, V114, P40, DOI 10.1016/j.bone.2018.06.003; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Zhang R, 2017, TUMOR BIOL, V39, P1, DOI 10.1177/1010428317703984; Zhong ZP, 2014, MOL MED REP, V10, P2575, DOI 10.3892/mmr.2014.2494; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	74	10	10	2	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	MAR 26	2019	13								117	10.3389/fncel.2019.00117			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ8BQ	WOS:000462649200001	30971898	gold, Green Published			2022-02-06	
J	Huijben, JA; Wiegers, EJA; Keizer, NF; Maas, AIR; Menon, D; Ercole, A; Citerio, G; Lecky, F; Wilson, L; Cnossen, MC; Polinder, S; Steyerberg, EW; Jagt, MD; Lingsma, HF; Aries, M; Badenes, R; Beishuizen, A; Bilotta, F; Chieregato, A; Cingolani, E; Cnossen, M; Coburn, M; Coles, JP; Delargy, M; Depreitere, B; Flaatten, H; Golyk, V; Grauwmeijer, E; Haitsma, I; Helbok, R; Hoedemaekers, C; Jacobs, B; Jellema, K; Koskinen, LOD; Maegele, M; Delgado, MCM; Moller, K; Moreno, R; Nelson, D; Oldenbeuving, AW; Payen, JF; Pejakovic, J; Ribbbers, GM; Rossaint, R; Schoonman, GG; Steiner, LA; Stocchetti, N; Silvio, F; Takala, R; Tenovuo, O; Valeinis, E; van den Bergh, WM; van Essen, T; van Leeuwen, N; Verhofstad, MHJ; Vos, PE				Huijben, Jilske A.; Wiegers, Eveline J. A.; de Keizer, Nicolette F.; Maas, Andrew I. R.; Menon, David; Ercole, Ari; Citerio, Giuseppe; Lecky, Fiona; Wilson, Lindsay; Cnossen, Maryse C.; Polinder, Suzanne; Steyerberg, Ewout W.; van der Jagt, Mathieu; Lingsma, Hester F.; Aries, Marcel; Badenes, Rafael; Beishuizen, Albertus; Bilotta, Federico; Chieregato, Arturo; Cingolani, Emiliano; Cnossen, Maryse; Coburn, Mark; Coles, Jonathan P.; Delargy, Mark; Depreitere, Bart; Flaatten, Hans; Golyk, Volodymyr; Grauwmeijer, Erik; Haitsma, Iain; Helbok, Raimund; Hoedemaekers, Cornelia; Jacobs, Bram; Jellema, Korne; Koskinen, Lars-Owe D.; Maegele, Marc; Martin Delgado, Maria Cruz; Moller, Kirsten; Moreno, Rui; Nelson, David; Oldenbeuving, Annemarie W.; Payen, Jean-Francois; Pejakovic, Jasmina; Ribbbers, Gerard M.; Rossaint, Rolf; Schoonman, Guus Geurt; Steiner, Luzius A.; Stocchetti, Nino; Silvio, Fabio; Takala, Riikka; Tenovuo, Olli; Valeinis, Eglis; van den Bergh, Walter M.; van Essen, Thomas; van Leeuwen, Nikki; Verhofstad, Michael H. J.; Vos, Pieter E.		Delphi Panel	Development of a quality indicator set to measure and improve quality of ICU care for patients with traumatic brain injury	CRITICAL CARE			English	Article						Quality indicators; Benchmarking; Traumatic brain injury; Intensive care unit; Trauma registry; Quality of care	NEUROTRAUMA EFFECTIVENESS RESEARCH; OF-CARE; HOSPITAL-CARE; MANAGEMENT; ADHERENCE; VALIDITY; BENCHMARKING; GUIDELINES; CHILDREN; OUTCOMES	BackgroundWe aimed to develop a set of quality indicators for patients with traumatic brain injury (TBI) in intensive care units (ICUs) across Europe and to explore barriers and facilitators for implementation of these quality indicators.MethodsA preliminary list of 66 quality indicators was developed, based on current guidelines, existing practice variation, and clinical expertise in TBI management at the ICU. Eight TBI experts of the Advisory Committee preselected the quality indicators during a first Delphi round. A larger Europe-wide expert panel was recruited for the next two Delphi rounds. Quality indicator definitions were evaluated on four criteria: validity (better performance on the indicator reflects better processes of care and leads to better patient outcome), feasibility (data are available or easy to obtain), discriminability (variability in clinical practice), and actionability (professionals can act based on the indicator). Experts scored indicators on a 5-point Likert scale delivered by an electronic survey tool.ResultsThe expert panel consisted of 50 experts from 18 countries across Europe, mostly intensivists (N=24, 48%) and neurosurgeons (N=7, 14%). Experts agreed on a final set of 42 indicators to assess quality of ICU care: 17 structure indicators, 16 process indicators, and 9 outcome indicators. Experts are motivated to implement this finally proposed set (N=49, 98%) and indicated routine measurement in registries (N=41, 82%), benchmarking (N=42, 84%), and quality improvement programs (N=41, 82%) as future steps. Administrative burden was indicated as the most important barrier for implementation of the indicator set (N=48, 98%).ConclusionsThis Delphi consensus study gives insight in which quality indicators have the potential to improve quality of TBI care at European ICUs. The proposed quality indicator set is recommended to be used across Europe for registry purposes to gain insight in current ICU practices and outcomes of patients with TBI. This indicator set may become an important tool to support benchmarking and quality improvement programs for patients with TBI in the future.	[Huijben, Jilske A.; Wiegers, Eveline J. A.; Cnossen, Maryse C.; Polinder, Suzanne; Steyerberg, Ewout W.; Lingsma, Hester F.] Erasmus MC Univ, Med Ctr Rotterdam, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; [de Keizer, Nicolette F.] Univ Amsterdam, Acad Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Med Informat, Amsterdam, Netherlands; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Menon, David; Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] ASST, San Gerardo Hosp, Dept Emergency & Intens Care, Neurointens Care, Monza, Italy; [Lecky, Fiona] Univ Sheffield, Ctr Urgent & Emergency Care Res, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling, Scotland; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [van der Jagt, Mathieu] Erasmus MC Univ, Med Ctr, Dept Intens Care Adults, Rotterdam, Netherlands; [Aries, Marcel] Univ Maastricht, Maastricht Univ Med Ctr, Dept Intens Care, Maastricht, Netherlands; [Badenes, Rafael] Univ Valencia, Dept Anesthesiol, Valencia, Spain; [Badenes, Rafael] Univ Valencia, Surg Trauma Intens Care Hosp Clin, Valencia, Spain; [Beishuizen, Albertus] Medisch Spectrum Twente, Intens Care Ctr, Enschede, Netherlands; [Bilotta, Federico] Univ Roma La Sapienza, Policlin Umberto 1, Dept Anesthesiol Crit Care & Pain Med, Rome, Italy; [Chieregato, Arturo] Osped Niguarda Ca Granda, Neurorianimaz, Milan, Italy; [Cingolani, Emiliano] UOSD Shock & Trauma Azienda Osped San Camillo For, I-8700152 Rome, Italy; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] ASST Monza, San Gerardo Hosp, Neurointens Care, Monza, Italy; [Cnossen, Maryse] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Ctr Med Decis Sci, Rotterdam, Netherlands; [Coburn, Mark] Univ Hosp RWTH Aachen, Dept Anesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany; [Coles, Jonathan P.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 0QQ, England; [Delargy, Mark] Royal Coll Surgeons Ireland, Dublin, Ireland; [Depreitere, Bart] Univ Hosp Leuven, Neurosurg, Leuven, Belgium; [Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Hills Rd, Cambridge CB2 0QQ, England; [Flaatten, Hans] Univ Bergen, Dept Clin Med, Bergen, Norway; [Golyk, Volodymyr] Natl Acad Postgrad Med Educ, Neurol, Kiev, Ukraine; [Grauwmeijer, Erik] Rijndam Rehabil Ctr, Rotterdam, Netherlands; [Grauwmeijer, Erik] Erasmus MC, Dept Rehabil, Rotterdam, Netherlands; [Haitsma, Iain] Erasmus MC, Dept Neurosurg, Gravendijkwal 230,Kamer H-703, NL-3015 CE Rotterdam, Netherlands; [Haitsma, Iain] Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurocrit Care Unit, Anichstr 35, A-6020 Innsbruck, Austria; [Hoedemaekers, Cornelia] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care, POB 9101, NL-6500 HB Nijmegen 707, Netherlands; [Jacobs, Bram] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Jellema, Korne] Haaglanden Med Ctr, Dept Neurol, The Hague, Netherlands; [Koskinen, Lars-Owe D.] Neurosurg Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Maegele, Marc] UWH, IFOM, CMMC, Dept Traumatol & Orthoped Surg, Cologne, Germany; [Martin Delgado, Maria Cruz] Hosp Univ Torrejon, Intens Care Unit, Madrid, Spain; [Menon, David] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Moller, Kirsten] Univ Copenhagen, Rigshosp, Neurosci Ctr, Dept Neuroanaesthesiol, Copenhagen, Denmark; [Moreno, Rui] UCIPNC Hosp Sao Jose, Centro Hosp Lisboa Cent Nova, Med Sch, Lisbon, Portugal; [Nelson, David] Karolinska Inst, Sect Anaesthesia & Intens Care, Dept Physiol & Pharmacol, S-17173 Stockholm, Sweden; [Oldenbeuving, Annemarie W.] Elisabeth TweeSteden Hosp ETZ, Dept Intens Care, Tilburg, Netherlands; [Payen, Jean-Francois] Grenoble Alpes Univ Hosp, F-38000 Grenoble, France; [Polinder, Suzanne] Univ Med Ctr Rotterdam, Erasmus MC, Ctr Med Decis Sci, Dept Publ Hlth, Rotterdam, Netherlands; [Pejakovic, Jasmina] Clin Ctr Vojvodina, Clin Anesthesiol & Intens Care Med, Novi Sad, Serbia; [Ribbbers, Gerard M.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Rehabil Med Rijndam Rehabil, Rotterdam, Netherlands; [Rossaint, Rolf] Rhein Westfal TH Aachen, Med Fac, Dept Anaesthesiol, Aachen, Germany; [Schoonman, Guus Geurt] Elisabeth Tweesteden Hosp Tilburg, Tilburg, Netherlands; [Steiner, Luzius A.] Univ Basel, Univ Basel Hosp, Dept Clin Res, Anesthesiol, Basel, Switzerland; [Stocchetti, Nino] Milan Univ, Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Pol, Dept Physiopathol & Transplantat, Via F Sforza 35, I-20122 Milan, Italy; [Silvio, Fabio] Hop ErasmeDot Intens Care, Route Lennik, B-8081070 Brussels, Belgium; [Takala, Riikka] Turku Univ Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Tenovuo, Olli] Turku Univ Hosp, Turku, Finland; [Tenovuo, Olli] Univ Turku, Turku, Finland; [Valeinis, Eglis] Univ Hosp Riga, Neurosurg ClinicPauls Stradins Clin, Riga, Latvia; [van den Bergh, Walter M.] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands; [van der Jagt, Mathieu] Univ Med Ctr Rotterdam, Erasmus Med Ctr Rotterdam, Dept Intens Care, Rotterdam, Netherlands; [van der Jagt, Mathieu] Univ Med Ctr Rotterdam, Erasmus Med Ctr Rotterdam, Erasmus MC Stroke Ctr, Rotterdam, Netherlands; [van Essen, Thomas] Leiden Univ, Med Ctr, Neurosurg Cooperat Holland, Dept Neurosurg, Leiden, Netherlands; [van Essen, Thomas] Med Ctr Haaglanden, Leiden, Netherlands; [van Leeuwen, Nikki] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Verhofstad, Michael H. J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Surg, TRUE, Rotterdam, Netherlands; [Vos, Pieter E.] Slingeland Hosp Doetinchem, Dept Neurol, Doetinchem, Netherlands; [Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling, Scotland		Huijben, JA (corresponding author), Erasmus MC Univ, Med Ctr Rotterdam, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands.	a.huijben@erasmusmc.nl	Citerio, Giuseppe/B-1839-2015; Badenes, Rafael/K-6628-2019; Wilson, Lindsay/A-3659-2009; Ercole, Ari/B-6288-2009; Maas, Andrew IR/C-5584-2013; Flaatten, Hans/AAG-7030-2020; Depreitere, Bart/AAA-9846-2020; Golyk, Volodymyr A./M-4610-2015; Helbok, Raimund/AAA-8361-2021; Koskinen, Lars-Owe/AAQ-8957-2020; Wilson, Lindsay/O-8883-2019; Moller, Kirsten/A-4751-2009; van der Jagt, Mathieu/G-1905-2017	Citerio, Giuseppe/0000-0002-5374-3161; Badenes, Rafael/0000-0001-7017-0150; Wilson, Lindsay/0000-0003-4113-2328; Ercole, Ari/0000-0001-8350-8093; Maas, Andrew IR/0000-0003-1612-1264; Flaatten, Hans/0000-0001-9186-3482; Depreitere, Bart/0000-0002-7458-0648; Golyk, Volodymyr A./0000-0001-5106-6382; Wilson, Lindsay/0000-0003-4113-2328; Moller, Kirsten/0000-0003-3058-1072; Nelson, David/0000-0003-2530-8207; Van Essen, Thomas/0000-0003-4657-5283; van der Jagt, Mathieu/0000-0003-2566-8325; Huijben, Jilske (Antonia)/0000-0002-2892-5406	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [602150]; National Institute for Health Research (NIHR), UK, through an NIHR Senior Investigator AwardNational Institute for Health Research (NIHR); Cambridge NIHR Biomedical Research CentreNational Institute for Health Research (NIHR)	European Commission FP7 Framework Program 602150. The study was part of the CENTER-TBI project, a large collaborative project with the support of the European Commission 7th Framework program (602150). The funder had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. DKM was supported by the National Institute for Health Research (NIHR), UK, through an NIHR Senior Investigator Award and the Cambridge NIHR Biomedical Research Centre.	American Thoracic Society; Infectious Diseases Society of America, 2005, AM J RESP CRIT CARE; Anema HA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-212; [Anonymous], 2016, LIMESURVEY USER MANU; Barber CE, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0843-7; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Darling G, 2014, ANN THORAC SURG, V98, P183, DOI 10.1016/j.athoracsur.2014.03.001; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Fischer C, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1778-7; Fischer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112282; Fitch K, 2001, RANDUCLA APPROPRIATE; Gooiker GA, 2013, J SURG ONCOL, V108, P465, DOI 10.1002/jso.23420; Gude WT, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0594-8; Haider AH, 2014, WORLD J SURG, V38, P1882, DOI 10.1007/s00268-014-2629-5; Howard G, 2018, JAMA NEUROL, V75, P1331, DOI 10.1001/jamaneurol.2018.2101; Huijben JA, 2018, J NEUROTRAUM, V35, P323, DOI 10.1089/neu.2017.5194; Huijben JA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2000-6; Kallen MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207991; Kimberlin CL, 2008, AM J HEALTH-SYST PH, V65, P2276, DOI 10.2146/ajhp070364; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mant J, 2001, INT J QUAL HEALTH C, V13, P475, DOI 10.1093/intqhc/13.6.475; O'Reilly GM, 2012, INJURY, V43, P1148, DOI 10.1016/j.injury.2012.03.003; Odgaard L, 2018, J NEUROSCI NURS, V50, P149, DOI 10.1097/JNN.0000000000000365; Olij BF, 2017, INJURY, V48, P2017, DOI 10.1016/j.injury.2017.06.022; Patwardhan M, 2007, J EVAL CLIN PRACT, V13, P831, DOI 10.1111/j.1365-2753.2006.00762.x; Peabody JW, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1293; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; R Core Team, 2018, R LANG ENV STAT COMP; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Rietjens JAC, 2017, LANCET ONCOL, V18, pE543, DOI 10.1016/S1470-2045(17)30582-X; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Roos-Blom MJ, 2019, J CRIT CARE, V49, P136, DOI 10.1016/j.jcrc.2018.10.027; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Saherwala AA, 2018, CRIT CARE NURSE, V38, pE11, DOI 10.4037/ccn2018691; Salluh JIF, 2017, INTENS CARE MED, V43, P1703, DOI 10.1007/s00134-017-4760-x; Singer M, 2016, JAMA; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Tarapore PE, 2016, J NEUROTRAUM, V33, P2026, DOI 10.1089/neu.2015.4114; van Zanten ARH, 2014, CRIT CARE MED, V42, P1890, DOI 10.1097/CCM.0000000000000297; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	46	10	13	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	MAR 22	2019	23								95	10.1186/s13054-019-2377-x			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ2CX	WOS:000462208200002	30902117	Green Published, Green Accepted, gold			2022-02-06	
J	Chandran, A; Elmi, A; Young, H; DiPietro, L				Chandran, Avinash; Elmi, Angelo; Young, Heather; DiPietro, Loretta			Determinants of concussion diagnosis, symptomology, and resolution time in US high school soccer players	RESEARCH IN SPORTS MEDICINE			English	Article						Concussion; Soccer; Surveillance	INJURY SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY; SEX-DIFFERENCES; SPORTS; STATEMENT; PROGRAM; MENS; AGE	Determinants of concussion diagnosis, symptomology, and other sequelae have not been examined in high school soccer players. Using a sample of soccer-related head/neck injuries from the NATION Surveillance Program, we evaluated potential determinants (sex, injury history, injury mechanism, setting) of concussion characteristics. A total of 378 head/neck injuries were recorded, and 189 (50.0%) injuries from this sample, resulted in a concussion diagnosis. Odds of concussion diagnosis were 84% higher among female players compared with their male counterparts, and over two-fold higher in game settings compared with practice settings. We also observed several significant symptom dependencies, such as higher odds of difficulty concentrating (OR = 5.84, 95% CI = [2.99, 11.42]) given concurrent light sensitivity. Furthermore, we identified injury mechanism as a determinant of concussion symptom resolution time. Our results suggest that determinants of soccer-related concussions and their sequelae are multifactorial, and extend the existing literature with the potential to inform clinical practice.	[Chandran, Avinash; DiPietro, Loretta] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Exercise & Nutr Sci, Washington, DC USA; [Chandran, Avinash] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related TBI Res Ctr, Chapel Hill, NC 27515 USA; [Elmi, Angelo; Young, Heather] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst, Sch Publ Hlth, Washington, DC USA		Chandran, A (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related TBI Res Ctr, Chapel Hill, NC 27515 USA.	avinashc@email.unc.edu		Young, Heather/0000-0002-0225-4894	National Athletic Trainers' Association Research and Education Foundation; Central Indiana Corporate Partnership Foundation; BioCrossroads	This study would not be possible without the assistance of the many high school athletic trainers who participated in the NATION-SP. This project was funded by the National Athletic Trainers' Association Research and Education Foundation, and the Central Indiana Corporate Partnership Foundation in cooperation with BioCrossroads. The content of this report is solely the responsibility of the authors and does not reflect the views of the sponsors. All actions pertaining to the study analysis were performed at The George Washington University. The authors declare that they have no competing interests.	Agel J, 2007, J ATHL TRAINING, V42, P270; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; CDC, 2013, FACTS CONC BRAIN INJ, DOI [10.1037/e572562009-001, DOI 10.1037/E572562009-001]; Chandran Avinash, 2017, Inj Epidemiol, V4, P28, DOI 10.1186/s40621-017-0127-6; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dick R, 2007, J ATHL TRAINING, V42, P278; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; FIFA, 2007, FIFA COMMUNICATIONS, V31, P1; Fitzmaurice GM, 2011, APPL LONGITUDINAL AN, V2nd; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hunter LE, 2018, RES SPORTS MED, V26, P390, DOI 10.1080/15438627.2018.1492396; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Junge Astrid, 2004, Sports Med, V34, P929, DOI 10.2165/00007256-200434130-00004; Kakavelakis KN, 2003, SCAND J MED SCI SPOR, V13, P175, DOI 10.1034/j.1600-0838.2003.00294.x; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Le Gall F, 2006, AM J SPORT MED, V34, P928, DOI 10.1177/0363546505283271; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; LINDENFELD TN, 1994, AM J SPORT MED, V22, P364, DOI 10.1177/036354659402200312; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Roos KG, 2017, BRIT J SPORT MED, V51, P1029, DOI 10.1136/bjsports-2015-095718; Walden M, 2011, KNEE SURG SPORT TR A, V19, P3, DOI 10.1007/s00167-010-1172-7; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	32	10	10	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	JAN 2	2020	28	1					42	54		10.1080/15438627.2019.1590834		MAR 2019	13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KE9PZ	WOS:000463406500001	30892095	hybrid			2022-02-06	
J	Aman, M; Forssblad, M; Larsen, K				Aman, Malin; Forssblad, Magnus; Larsen, Karin			National injury prevention measures in team sports should focus on knee, head, and severe upper limb injuries	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Sport; Accidents; Prevention; Nationwide; Medical impairment; Severe injuries; Insurance; Football; Handball; Soccer; Floorball; Ice hockey	ELITE HANDBALL; ICE HOCKEY; FOOTBALL; MENS; EPIDEMIOLOGY; FLOORBALL; PLAYERS; IMPACT; 7-YEAR; YOUTH	PurposeTo examine acute injuries in licensed floorball, football, handball, and ice hockey players in all ages nationwide in Sweden, and to identify the most common and severe injuries in each body location and recommend injury prevention measures.MethodsUsing national sport insurance data from years 2006-2015 was the incidence and proportion of acute injuries, and injuries leading to permanent medical impairment (PMI), calculated in the four team sports. The most common injury type and injured body part was identified, with a particular focus of the severe injuries. Comparison between sexes was made.ResultsIn total, there were 92,162 registered injuries in all sports together. Knee injuries were most common, and also had the highest incidence of PMI, in all ball sports and in female ice hockey players. In male ice hockey, the most common injury was a dental and face injury, and PMI injuries were mostly in the shoulder. The most severe PMI injuries were rare and most often a face/eye injury in male floorball and ice hockey, a concussion in female ice hockey, and a knee injury in female floorball, and in both sexes in football and handball.ConclusionsTo achieve the greatest impact in reducing the adverse effects of acute sport injuries nationwide in Sweden, preventive measures should focus on knee injuries in all the investigated team sports. The severe head/face and upper limb injuries also need attention. Protective equipment, neuromuscular training programs, rules enforcements, and fair-play interventions may reduce the incidence of injuries.	[Aman, Malin] Swedish Sch Sport & Hlth Sci, GIH, Lidingovagen 1,Box 5626, S-11486 Stockholm, Sweden; [Forssblad, Magnus] Karolinska Inst, Stockholm Sports Trauma Res Ctr, Box 5605, S-11486 Stockholm, Sweden; [Larsen, Karin] Umea Univ, Dept Surg & Perioperat Sci, Clin Physiol, S-90185 Umea, Sweden		Aman, M (corresponding author), Swedish Sch Sport & Hlth Sci, GIH, Lidingovagen 1,Box 5626, S-11486 Stockholm, Sweden.	malin.aman@gih.se; magnus.forssblad@ki.se; karin.larsen@umu.se		Aman, Malin/0000-0002-6483-1394			Agel J, 2010, CAN J SURG, V53, P319; Aman M, 2018, SCAND J MED SCI SPOR, V28, P1147, DOI 10.1111/sms.12956; Aman M, 2016, SCAND J MED SCI SPOR, V26, P451, DOI 10.1111/sms.12462; Aman M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005056; Beaudouin F, 2017, BR J SPORTS MED; Bergman L, 2017, DENT TRAUMATOL, V33, P199, DOI 10.1111/edt.12323; Bro T, 2017, SCAND J MED SCI SPOR, V27, P430, DOI 10.1111/sms.12653; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Faude O, 2013, SPORTS MED, V43, P819, DOI 10.1007/s40279-013-0061-x; Forssblad M, 2005, SCAND J MED SCI SPOR, V15, P43, DOI 10.1111/j.1600-0838.2004.00392.x; Fuller CW, 2006, CLIN J SPORT MED, V16, P97, DOI 10.1097/00042752-200603000-00003; Giroto N, 2017, SCAND J MED SCI SPOR, V27, P195, DOI 10.1111/sms.12636; Hagglund M, 2009, SCAND J MED SCI SPOR, V19, P819, DOI 10.1111/j.1600-0838.2008.00861.x; Karcher C, 2014, SPORTS MED, V44, P797, DOI 10.1007/s40279-014-0164-z; Langevoort G, 2007, SCAND J MED SCI SPOR, V17, P400, DOI 10.1111/j.1600-0838.2006.00587.x; MacCormick L, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518181; Moller M, 2012, BRIT J SPORT MED, V46, P531, DOI 10.1136/bjsports-2012-091022; Myklebust G, 1998, SCAND J MED SCI SPOR, V8, P149, DOI 10.1111/j.1600-0838.1998.tb00185.x; Myklebust G, 2003, CLIN J SPORT MED, V13, P71, DOI 10.1097/00042752-200303000-00002; Olsen OE, 2005, BRIT MED J, V330, P449, DOI 10.1136/bmj.38330.632801.8F; Pasanen K, 2008, BMJ-BRIT MED J, V337, P96; Pasanen K, 2018, J SCI MED SPORT, V21, P268, DOI 10.1016/j.jsams.2017.06.021; Roos KG, 2017, BRIT J SPORT MED, V51, P1029, DOI 10.1136/bjsports-2015-095718; Tervo T, 2014, OPEN ACCESS J SPORTS, V5, P249, DOI 10.2147/OAJSM.S60490; The National Board of Health and Welfare; Ellen Lundqvist. AT, 2011, SKAD SOM FOR LAK AK; Tirabassi J, 2016, AM J SPORT MED, V44, P2925, DOI 10.1177/0363546516644604; Tuominen M, 2015, BRIT J SPORT MED, V49, P30, DOI 10.1136/bjsports-2014-093688; vanMechelen W, 1997, SPORTS MED, V24, P176, DOI 10.2165/00007256-199724030-00006; Walden M, 2016, BRIT J SPORT MED, V50, P744, DOI 10.1136/bjsports-2015-095952; Walden M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3042; Walden M, 2011, KNEE SURG SPORT TR A, V19, P3, DOI 10.1007/s00167-010-1172-7; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19	32	10	10	1	20	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	MAR	2019	27	3					1000	1008		10.1007/s00167-018-5225-7			9	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	HO8ZY	WOS:000461251400042	30413861	Green Published, hybrid			2022-02-06	
J	Moscato, EL; Miley, AE; LeBlond, EI; King, JA; Raj, SP; Narad, ME; Platt, A; Thompson, AN; Baum, KT; Salloum, R; Wade, SL				Moscato, Emily L.; Miley, Aimee E.; LeBlond, Elizabeth, I; King, Jessica A.; Raj, Stacey P.; Narad, Megan E.; Platt, Amber; Thompson, Aimee N.; Baum, Katherine T.; Salloum, Ralph; Wade, Shari L.			Feasibility and Acceptability of an Online Problem-Solving Therapy Intervention for Adolescent and Young Adult Brain Tumor Survivors	CLINICAL PRACTICE IN PEDIATRIC PSYCHOLOGY			English	Article						pediatric brain tumor survivors; oncology; Internet interventions; problem solving		Objective: To describe the preliminary feasibility and acceptability of a web-based, problem-solving intervention for adolescent and young adult pediatric brain tumor survivors. Methods: With feedback from survivors and stakeholders, we created "A Survivor's Journey" by modifying an existing problem-solving intervention for traumatic brain injury. Survivors (ages 13-25) were recruited from a pediatric survivorship clinic and were eligible if they had self or caregiver-reported psychosocial difficulties. A Survivor's Journey has four core sessions (i.e., introduction, problem-solving, positive thinking, memory) and up to seven supplemental sessions. Each session involved web content and videoconferencing with a doctoral-level therapist. We analyzed postintervention data related to feasibility (i.e., enrollment and completion rates), as well as survivor's ratings of satisfaction and usability of the intervention. Results: Nineteen survivors (M-age = 17.57), half of eligible participants, agreed to participate, and 95% of those enrolled completed at least the core sessions. Overall, survivors rated the intervention favorably on usability and satisfaction. Survivors who had borderline to impaired IQ or who were treated with cranial radiation reported higher satisfaction, suggesting that the intervention is appealing even for high-risk groups. Conclusions: Online problem-solving therapy could be a promising therapeutic approach for survivors of pediatric brain tumor, given the relatively high satisfaction and usability ratings. However, improving enrollment and examining treatment efficacy should be addressed in future work.	[Moscato, Emily L.; Miley, Aimee E.; LeBlond, Elizabeth, I; King, Jessica A.; Raj, Stacey P.; Narad, Megan E.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Moscato, Emily L.; LeBlond, Elizabeth, I] Univ Cincinnati, Dept Psychol, Cincinnati, OH USA; [Raj, Stacey P.] Xavier Univ, Sch Psychol, Cincinnati, OH 45207 USA; [Platt, Amber; Thompson, Aimee N.; Baum, Katherine T.; Salloum, Ralph] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA		Moscato, EL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	emily.moscato@cchmc.org					Brier MJ, 2015, HEALTH PSYCHOL, V34, P130, DOI 10.1037/hea0000119; Brooke J., 1996, USABILITY EVALUATION, P189; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; D'Agostino NM, 2011, CANCER-AM CANCER SOC, V117, P2329, DOI 10.1002/cncr.26043; De Ruiter MA, 2013, DEV MED CHILD NEUROL, V55, P408, DOI 10.1111/dmcn.12020; DZurilla TJ, 2010, HDB COGNITIVE BEHAV, P197, DOI 10.1891/0889-8391.2.4.283a; Galan S, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12558; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Gurney JG, 2009, J CLIN ONCOL, V27, P2390, DOI 10.1200/JCO.2008.21.1458; Hommel KA, 2013, EUR J GASTROEN HEPAT, V25, P469, DOI 10.1097/MEG.0b013e32835c2a1b; Nezu AM, 2003, J CONSULT CLIN PSYCH, V71, P1036, DOI 10.1037/0022-006X.71.6.1036; Ostrom Q. T., 2016, NEURO-ONCOLOGY, V18, P75; Palermo TM, 2009, PAIN, V146, P205, DOI 10.1016/j.pain.2009.07.034; Palmer SL, 2003, NEUROPSYCHOLOGY, V17, P548, DOI 10.1037/0894-4105.17.4.548; Patel SK, 2009, J PEDIAT HEMATOL ONC, V31, P670, DOI 10.1097/MPH.0b013e3181b25a1d; Poggi G, 2009, DISABIL REHABIL, V31, P1066, DOI 10.1080/09638280802509546; Raj SP, 2018, J ADOLESC YOUNG ADUL, V7, P187, DOI 10.1089/jayao.2017.0084; Ris MD, 2001, J CLIN ONCOL, V19, P3470, DOI 10.1200/JCO.2001.19.15.3470; Santacroce SJ, 2010, J PEDIATR ONCOL NURS, V27, P10, DOI 10.1177/1043454209340325; Seitz DCM, 2014, SUPPORT CARE CANCER, V22, P2075, DOI 10.1007/s00520-014-2193-4; Shah SS, 2015, CHILD NERV SYST, V31, P653, DOI 10.1007/s00381-015-2669-7; Stinson J, 2009, J PEDIATR PSYCHOL, V34, P495, DOI 10.1093/jpepsy/jsn115; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2014, WECHSLER ADULT INTEL, Vfourth; Wolfe KR, 2012, DEV NEUROPSYCHOL, V37, P153, DOI 10.1080/87565641.2011.632462; Wu YP, 2014, J PEDIATR PSYCHOL, V39, P612, DOI 10.1093/jpepsy/jsu022; Zebrack B, 2012, J CLIN ONCOL, V30, P1221, DOI 10.1200/JCO.2011.39.5467; Zeltzer LK, 2009, J CLIN ONCOL, V27, P2396, DOI 10.1200/JCO.2008.21.1433	33	10	10	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	2169-4826	2169-4834		CLIN PRACT PEDIAT PS	Clin. Pract. Pediatr. Psychol.	MAR	2019	7	1			SI		68	78		10.1037/cpp0000265			11	Psychology, Clinical; Psychology, Developmental	Emerging Sources Citation Index (ESCI)	Psychology	VJ9VH	WOS:000648728100007					2022-02-06	
J	Sanchez, E; El-Khatib, H; Arbour, C; Bedetti, C; Blais, H; Marcotte, K; Baril, AA; Descoteaux, M; Gilbert, D; Carrier, J; Gosselin, N				Sanchez, Erlan; El-Khatib, Hejar; Arbour, Caroline; Bedetti, Christophe; Blais, Helene; Marcotte, Karine; Baril, Andree-Ann; Descoteaux, Maxime; Gilbert, Danielle; Carrier, Julie; Gosselin, Nadia			Brain white matter damage and its association with neuronal synchrony during sleep	BRAIN			English	Article						white matter; sleep; NREM sleep; traumatic brain injury	SLOW WAVES; WAKE DISTURBANCES; CORTICAL SYNCHRONIZATION; COGNITIVE FATIGUE; INJURY; HOMEOSTASIS; INTEGRITY; SEVERITY; OSCILLATIONS; MODULATION	The restorative function of sleep partly relies on its ability to deeply synchronize cerebral networks to create large slow oscillations observable with EEG. However, whether a brain can properly synchronize and produce a restorative sleep when it undergoes massive and widespread white matter damage is unknown. Here, we answer this question by testing 23 patients with various levels of white matter damage secondary to moderate to severe traumatic brain injuries (ages 18-56; 17 males, six females, 11-39 months post-injury) and compared them to 27 healthy subjects of similar age and sex. We used MRI and diffusion tensor imaging metrics (e.g. fractional anisotropy as well as mean, axial and radial diffusivities) to characterize voxel-wise white matter damage. We measured the following slow wave characteristics for all slow waves detected in N2 and N3 sleep stages: peak-to-peak amplitude, negative-to-positive slope, negative and positive phase durations, oscillation frequency, and slow wave density. Correlation analyses were performed in traumatic brain injury and control participants separately, with age as a covariate. Contrary to our hypotheses, we found that greater white matter damage mainly over the frontal and temporal brain regions was strongly correlated with a pattern of higher neuronal synchrony characterized by slow waves of larger amplitudes and steeper negative-to-positive slopes during non-rapid eye movement sleep. The same pattern of associations with white matter damage was also observed with markers of high homeostatic sleep pressure. More specifically, higher white matter damage was associated with higher slow-wave activity power, as well as with more severe complaints of cognitive fatigue. These associations between white matter damage and sleep were found only in our traumatic brain injured participants, with no such correlation in controls. Our results suggest that, contrary to previous observations in healthy controls, white matter damage does not prevent the expected high cerebral synchrony during sleep. Moreover, our observations challenge the current line of hypotheses that white matter microstructure deterioration reduces cerebral synchrony during sleep. Our results showed that the relationship between white matter and the brain's ability to synchronize during sleep is neither linear nor simple.	[Sanchez, Erlan; El-Khatib, Hejar; Arbour, Caroline; Bedetti, Christophe; Blais, Helene; Marcotte, Karine; Baril, Andree-Ann; Gilbert, Danielle; Carrier, Julie; Gosselin, Nadia] Hop Sacre Coeur Montreal, Res Ctr, Montreal, PQ, Canada; [Sanchez, Erlan] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [El-Khatib, Hejar; Carrier, Julie; Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Arbour, Caroline] Univ Montreal, Fac Nursing, Montreal, PQ, Canada; [Bedetti, Christophe] Inst Univ Geriatrie Montreal, Res Ctr, Montreal, PQ, Canada; [Marcotte, Karine] Univ Montreal, Sch Speech Therapy & Audiol, Montreal, PQ, Canada; [Baril, Andree-Ann] Univ Montreal, Dept Psychiat, Montreal, PQ, Canada; [Descoteaux, Maxime] Univ Sherbrooke, Dept Informat, Sherbrooke, PQ, Canada		Gosselin, N (corresponding author), Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, 5400 Boul Gouin Ouest,Local J-5135, Montreal, PQ H4J 1C5, Canada.	nadia.gosselin@umontreal.ca	Lang, Steven/AAE-8102-2021; Marcotte, Karine/AAM-7378-2021	Lang, Steven/0000-0003-1669-9146; Marcotte, Karine/0000-0002-3275-1154; Carrier, Julie/0000-0001-5311-2370	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP 115172]; Fonds de Recherche Sante-Quebec (FRQS) [34851]; CIHRCanadian Institutes of Health Research (CIHR); FRQS	This study was funded by government granting agencies by grants to N.G. as a principal investigator: Canadian Institutes of Health Research (CIHR MOP 115172) and Fonds de Recherche Sante-Quebec (FRQS #34851). E.S. and A.A.B. received scholarships from the CIHR and FRQS. N.G. received a salary award from the FRQS. J.C. received a salary award from the CIHR. M.D. holds a Universite de Sherbrooke Research Chair in Neuroinformatics.	AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Avramescu S, 2009, J NEUROTRAUM, V26, P799, DOI 10.1089/neu.2008.0739; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bersagliere A, 2010, J SLEEP RES, V19, P228, DOI 10.1111/j.1365-2869.2009.00775.x; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Buchmann A, 2011, J SLEEP RES, V20, P506, DOI 10.1111/j.1365-2869.2011.00916.x; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carrier J, 2011, EUR J NEUROSCI, V33, P758, DOI 10.1111/j.1460-9568.2010.07543.x; Chauvette S, 2011, J NEUROSCI, V31, P14998, DOI 10.1523/JNEUROSCI.2339-11.2011; Clark AL, 2017, BRAIN IMAGING BEHAV, V11, P1548, DOI 10.1007/s11682-016-9594-6; Crunelli V, 2015, CURR OPIN NEUROBIOL, V31, P72, DOI 10.1016/j.conb.2014.09.001; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dube J, 2015, J NEUROSCI, V35, P7795, DOI 10.1523/JNEUROSCI.3956-14.2015; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lemieux M, 2014, J NEUROSCI, V34, P5689, DOI 10.1523/JNEUROSCI.1156-13.2014; Mander BA, 2015, NAT NEUROSCI, V18, P1051, DOI 10.1038/nn.4035; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morawska MM, 2016, J NEUROSCI, V36, P3422, DOI 10.1523/JNEUROSCI.3274-15.2016; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nardone R, 2011, J NEUROTRAUM, V28, P1165, DOI 10.1089/neu.2010.1748; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Palacios EM, 2013, J NEUROTRAUM, V30, P1991, DOI 10.1089/neu.2012.2836; Peters A, 2002, PROG BRAIN RES, V136, P455; Piantoni G, 2013, J NEUROSCI, V33, P227, DOI 10.1523/JNEUROSCI.2030-12.2013; Pitkonen M, 2012, BRAIN RES, V1445, P103, DOI 10.1016/j.brainres.2012.01.043; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rodriguez AV, 2016, J NEUROSCI, V36, P12436, DOI 10.1523/JNEUROSCI.1614-16.2016; Sanchez-Vives MV, 2017, NEURON, V94, P993, DOI 10.1016/j.neuron.2017.05.015; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schonberger M, 2017, NEUROPSYCHOL REHABIL, V27, P1056, DOI 10.1080/09602011.2016.1154875; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; TEASDALE G, 1974, LANCET, V2, P81; Timofeev I, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00154; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Vyazovskiy VV, 2007, SLEEP, V30, P1631, DOI 10.1093/sleep/30.12.1631; Vyazovskiy VV, 2011, PROG BRAIN RES, V193, P17, DOI 10.1016/B978-0-444-53839-0.00002-8; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yap QJ, 2013, J NEURAL TRANSM, V120, P1369, DOI 10.1007/s00702-013-0971-7	64	10	10	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	MAR	2019	142		3				674	687		10.1093/brain/awy348			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK4PB	WOS:000512724900022	30698667	Green Published, Green Submitted, Bronze			2022-02-06	
J	Streifer, M; Brown, AM; Porfido, T; Anderson, EZ; Buckman, JF; Esopenko, C				Streifer, Michael; Brown, Allison M.; Porfido, Tara; Anderson, Ellen Zambo; Buckman, Jennifer F.; Esopenko, Carrie			The Potential Role of the Cervical Spine in Sports-Related Concussion: Clinical Perspectives and Considerations for Risk Reduction	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						head injury; mild traumatic brain injury; neck	COLLEGIATE FOOTBALL PLAYERS; NECK FLEXOR ENDURANCE; HIGH-SCHOOL; SEX-DIFFERENCES; HEAD ACCELERATION; MUSCLE ACTIVATION; GENDER-DIFFERENCES; NORMATIVE DATA; JOINT LAXITY; STRENGTH	Sports-related concussion (SRC) occurs due to biomechanical forces to the head or neck that can result in pathophysiological changes in the brain. The musculature of the cervical spine has been identified as one potential factor in reducing SRC risk as well as for underlying sex differences in SRC rates. Recent research has demonstrated that linear and rotational head acceleration, as well as the magnitude of force upon impact, is influenced by cervical spine biomechanics. Increased neck strength and girth are associated with reduced linear and rotational head acceleration during impact. Past work has also shown that overall neck strength and girth are reduced in athletes with SRC. Additionally, differences in cervical spine biomechanics are hypothesized as a critical factor underlying sex differences in SRC rates. Specifically, compared to males, females tend to have less neck strength and girth, which are associated with increased linear and rotational head acceleration. Although our ability to detect SRC has greatly improved, our ability to prevent SRC from occurring and decrease the severity of clinical outcomes postinjury is limited. However, we suggest, along with others, that cervical spine biomechanics may be a modifiable factor in reducing SRC risk. In this commentary, we review the role of the cervical spine in reducing SRC risk, and how this risk differs by sex. We discuss clinical considerations for the examination of the cervical spine and the potential clinical relevance for SRC prevention. Additionally, we provide suggestions for future research examining cervical spine properties as modifiable factors in reducing SRC risk.	[Streifer, Michael; Brown, Allison M.; Porfido, Tara; Anderson, Ellen Zambo; Esopenko, Carrie] Rutgers State Univ, Sch Hlth Profess, Dept Rehabil & Movement Sci, 65 Bergen St, Newark, NJ 07107 USA; [Porfido, Tara] Rutgers State Univ, Sch Grad Studies, Biomed Sci, Newark, NJ USA; [Anderson, Ellen Zambo; Esopenko, Carrie] Rutgers State Univ, Sch Hlth Profess, Dept Hlth Informat, Newark, NJ USA; [Buckman, Jennifer F.] Rutgers State Univ, Dept Kinesiol & Hlth, New Brunswick, NJ USA		Esopenko, C (corresponding author), Rutgers State Univ, Sch Hlth Profess, Dept Rehabil & Movement Sci, 65 Bergen St, Newark, NJ 07107 USA.	carrie.esopenko@rutgers.edu		Esopenko, Carrie/0000-0001-8607-5633; Porfido, Tara/0000-0003-0953-3594; Zambo Anderson, Ellen/0000-0001-8434-7391	NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K02 AA025123] Funding Source: Medline		Blouin JS, 2003, EXP BRAIN RES, V150, P458, DOI 10.1007/s00221-003-1466-9; Bokaee F, 2016, CRANIO, V34, P286, DOI 10.1080/08869634.2016.1169616; Borisut S, 2013, J PHYS THER SCI, V25, P1157, DOI 10.1589/jpts.25.1157; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Brody LT, 2011, THERAPEUTIC EXERCISE; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Catenaccio E, 2017, PM&R, V9, P884, DOI 10.1016/j.pmrj.2017.01.005; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2013, TRANSL STROKE RES, V4, P420, DOI 10.1007/s12975-012-0228-z; Davis-Hayes C, 2017, J AM ACAD ORTHOP SUR, V25, P818, DOI 10.5435/JAAOS-D-17-00276; de Araujo FX, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019486; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Domenech MA, 2011, PM&R, V3, P105, DOI 10.1016/j.pmrj.2010.10.023; Dvir Z, 2008, J MANIP PHYSIOL THER, V31, P518, DOI 10.1016/j.jmpt.2008.08.008; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Falla D, 2007, PHYS THER, V87, P408, DOI 10.2522/ptj.20060009; Ghaderi F, 2017, J BACK MUSCULOSKELET, V30, P211, DOI 10.3233/BMR-160735; Grimmer K, 1994, Aust J Physiother, V40, P251, DOI 10.1016/S0004-9514(14)60461-X; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Harris KD, 2005, PHYS THER, V85, P1349, DOI 10.1093/ptj/85.12.1349; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; Hislop H.J., 2007, DANIELS WORTHINGHAMS; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; Jarman NF, 2017, PM&R, V9, P969, DOI 10.1016/j.pmrj.2017.02.002; Jin X, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037399; Jull GA, 2008, J MANIP PHYSIOL THER, V31, P525, DOI 10.1016/j.jmpt.2008.08.003; Juul T, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-339; Kelly M, 2013, MANUAL THER, V18, P83, DOI 10.1016/j.math.2012.04.008; Kendall FP, 2005, MUSCLES TESTING FUNC, DOI [10.1589/jpts.28.269, DOI 10.1589/JPTS.28.269]; Kim JY, 2016, J PHYS THER SCI, V28, P269, DOI 10.1589/jpts.28.269; Kim MS, 2015, J PHYS THER SCI, V27, P3425, DOI 10.1589/jpts.27.3425; Krave U, 2011, J NEUROTRAUM, V28, P57, DOI 10.1089/neu.2010.1431; Lee J, 2018, BIO-MED MATER ENG, V29, P289, DOI 10.3233/BME-181728; Lee KJ, 2015, J PHYS THER SCI, V27, P977, DOI 10.1589/jpts.27.977; Lee MY, 2014, J PHYS THER SCI, V26, P1741, DOI 10.1589/jpts.26.1741; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miguel R, 2017, J MANIP PHYSIOL THER, V40, P1, DOI 10.1016/j.jmpt.2016.10.005; Neidecker JM, 2017, J AM OSTEOPATH ASSOC, V117, P635, DOI 10.7556/jaoa.2017.120; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; O'Leary S, 2017, J APPL BIOMECH, V33, P166, DOI 10.1123/jab.2016-0168; Peolsson A, 2001, Physiother Res Int, V6, P15, DOI 10.1002/pri.210; Pollard CD, 2006, CLIN BIOMECH, V21, P1060, DOI 10.1016/j.clinbiomech.2006.07.002; Quatman CE, 2008, J SCI MED SPORT, V11, P257, DOI 10.1016/j.jsams.2007.05.005; Ruivo RM, 2014, BRAZ J PHYS THER, V18, P364, DOI 10.1590/bjpt-rbf.2014.0027; Salahzadeh Z, 2014, J BACK MUSCULOSKELET, V27, P131, DOI 10.3233/BMR-130426; Salo PK, 2006, J ORTHOP SPORT PHYS, V36, P495, DOI 10.2519/jospt.2006.2122; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Sebastian D, 2015, J BODYW MOV THER, V19, P213, DOI 10.1016/j.jbmt.2014.04.014; Shultz SJ, 2005, J SPORT MED PHYS FIT, V45, P594; Siegmund GP, 2007, J BIOMECH ENG-T ASME, V129, P66, DOI 10.1115/1.2401185; Stemper BD, 2008, SPINE, V33, pE44, DOI 10.1097/BRS.0b013e318160462a; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Stemper Brian D, 2009, Biomed Sci Instrum, V45, P149; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Valkeinen H, 2002, EUR J APPL PHYSIOL, V88, P247, DOI 10.1007/s00421-002-0709-y; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; Versteegh T, 2015, PHYSIOTHER CAN, V67, P58, DOI 10.3138/ptc.2013-66; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Vibert N, 2001, J PHYSIOL-LONDON, V532, P851, DOI 10.1111/j.1469-7793.2001.0851e.x; Yip CHT, 2008, MANUAL THER, V13, P148, DOI 10.1016/j.math.2006.11.002	72	10	10	0	6	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	MAR	2019	49	3					202	208		10.2519/jospt.2019.8582			7	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	HQ2JR	WOS:000462227500011	30645949	Green Accepted			2022-02-06	
J	Vaughn, MG; Salas-Wright, CP; John, R; Holzer, KJ; Qian, ZM; Veeh, C				Vaughn, Michael G.; Salas-Wright, Christopher P.; John, Rachel; Holzer, Katherine J.; Qian, Zhengmin; Veeh, Christopher			Traumatic Brain Injury and Psychiatric Co-Morbidity in the United States	PSYCHIATRIC QUARTERLY			English	Article						Traumatic brain injury; TBI; Violence; Substance use; Mental health	ECONOMIC BURDEN; MENTAL-HEALTH; SUBSTANCE USE; DISORDERS; PREVALENCE; SEQUELAE; SUICIDE; RISK	The objective of the present study was to provide a nationally representative psychiatric epidemiologic investigation of traumatic brain injury (TBI) and its co-morbid conditions. Data from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC-III) collected between 2012 and 2013 was used. Results indicated that TBI was significantly associated with any lifetime mental health (AOR = 2.32, 95% CI = 1.65-3.70), substance use disorder (AOR = 1.57-1.01-2.42), and violent (AOR = 1.65, 95% CI = 1.03-2.65) and nonviolent (AOR = 1.84, 95% CI = 1.25-2.70) criminal behaviors. In our study, TBI was highly comorbid with psychiatric disorders and especially antisocial behaviors, both violent and non-violent.	[Vaughn, Michael G.; Holzer, Katherine J.] St Louis Univ, Coll Publ Hlth & Social Justice, Sch Social Work, Tegeler Hall,3550 Lindell Blvd, St Louis, MO 63103 USA; [Salas-Wright, Christopher P.; John, Rachel] Boston Univ, Sch Social Work, Boston, MA 02215 USA; [Qian, Zhengmin] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Epidemiol & Biostat, St Louis, MO 63103 USA; [Veeh, Christopher] Univ Iowa, Sch Social Work, Iowa City, IA 52242 USA		Vaughn, MG (corresponding author), St Louis Univ, Coll Publ Hlth & Social Justice, Sch Social Work, Tegeler Hall,3550 Lindell Blvd, St Louis, MO 63103 USA.	mvaughn9@slu.edu	Vaughn, Michael/W-2694-2019		National Institute on Drug Abuse at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R25 DA030310];  [1KL2TR001411]	This research was supported in part by grant number R25 DA030310 from the National Institute on Drug Abuse at the National Institutes of Health and by the National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI Grant Number 1KL2TR001411. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Adams RS, 2017, J NEUROTRAUM, V34, P1457, DOI 10.1089/neu.2016.4693; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brenner LA, 2017, BRAIN INJURY, V31, P1731, DOI 10.1080/02699052.2017.1376758; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Gooch CL, 2017, ANN NEUROL, V81, P479, DOI 10.1002/ana.24897; Grant BF, 2015, DRUG ALCOHOL DEPEN, V148, P27, DOI 10.1016/j.drugalcdep.2014.11.026; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Kennedy E, 2017, J HEAD TRAUMA REHAB, V32, P425, DOI 10.1097/HTR.0000000000000289; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; Marin JR, 2017, BRAIN INJURY, V31, P24, DOI 10.1080/02699052.2016.1217351; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McHugo GJ, 2017, J HEAD TRAUMA REHAB, V32, pE65, DOI 10.1097/HTR.0000000000000249; Moreno JA, 2018, NEUROPSYCHOL REHABIL, V28, P34, DOI 10.1080/09602011.2015.1136222; Mosti C, 2018, J NEUROPSYCH CLIN N, V30, P220, DOI 10.1176/appi.neuropsych.17070141; National Institute on Alcohol Abuse and Alcoholism, NAT EP SURV ALC REL; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Scofield DE, 2017, J NEUROTRAUM, V34, P3249, DOI 10.1089/neu.2017.5101; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Vaughn MG, 2014, J CRIM JUST, V42, P483, DOI 10.1016/j.jcrimjus.2014.09.004; Vaughn MG, 2014, YOUTH VIOLENCE JUV J, V12, P3, DOI 10.1177/1541204013478973; Vaughn MG, 2011, J CRIM JUST, V39, P75, DOI 10.1016/j.jcrimjus.2010.12.001; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wojtowicz Magdalena, 2017, Focus (Am Psychiatr Publ), V15, P384, DOI 10.1176/appi.focus.20170028	30	10	10	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-2720	1573-6709		PSYCHIAT QUART	Psychiatr. Q.	MAR	2019	90	1					151	158		10.1007/s11126-018-9617-0			8	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	HQ2EM	WOS:000462212900013	30465326				2022-02-06	
J	Wang, B; Han, SS				Wang, Bo; Han, Shuangshuang			Modified Exosomes Reduce Apoptosis and Ameliorate Neural Deficits Induced by Traumatic Brain Injury	ASAIO JOURNAL			English	Article						traumatic brain injury; apoptosis; exosome; gene therapy	BCL-2; GENE; DELIVERY; THERAPY; BAX; OVEREXPRESSION; MITOCHONDRIA; VECTORS; SIRNA; DNA	Apoptosis contributes to the pathogenesis of traumatic brain injury (TBI). Engineered exosomes incorporated with therapeutic nuclear acids have been explored for gene therapy for human diseases. The current study sought to investigate the effect of modified exosome-containing plasmids expressing B-cell lymphoma-2 (Bcl-2) and Bcl-2-associated X-protein (Bax) short hairpin RNA (shRNA) on apoptosis and neural functions after TBI. C57BL/6J mice were subjected to controlled cortical impact injury and were treated with the modified exosomes. The results showed that modified exosomes attenuated the decrease of myeloid cell leukemia-1 (Mcl-1), X-linked inhibitor of apoptosis protein (XIAP), and Survivin protein levels in the brain and reduced Cytochrome c release from mitochondria to cytosol after TBI. They also attenuated the impairments of miniature excitatory postsynaptic current (mEPSC) and long-term potentiation (LTP) in the hippocampus of TBI mice and improved the motor and cognitive behaviors after TBI. These results suggested that the modified exosomes might reduce apoptosis and ameliorate neural and functional deficits in mouse models of TBI.	[Wang, Bo] Cangzhou Cent Hosp, Emergency Dept, 16 Xinhua West Rd, Cangzhou 061001, Hebei, Peoples R China; [Han, Shuangshuang] Cangzhou Med Coll, Cangzhou, Hebei, Peoples R China		Wang, B (corresponding author), Cangzhou Cent Hosp, Emergency Dept, 16 Xinhua West Rd, Cangzhou 061001, Hebei, Peoples R China.	wangbo6292@126.com					Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Barile L, 2017, PHARMACOL THERAPEUT, V174, P63, DOI 10.1016/j.pharmthera.2017.02.020; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Gillardon F, 1996, MOL BRAIN RES, V40, P254, DOI 10.1016/0169-328X(96)00059-9; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Jiang XC, 2017, INT J PHARMACEUT, V521, P167, DOI 10.1016/j.ijpharm.2017.02.038; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lawrence MS, 1996, J NEUROSCI, V16, P486; Marcus ME, 2013, PHARMACEUTICALS-BASE, V6, P659, DOI 10.3390/ph6050659; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Seow Y, 2009, MOL THER, V17, pS7; Shen F, 2007, NEUROSURG REV, V30, P291, DOI 10.1007/s10143-007-0094-4; Srivastava A, 2016, J BIOMED NANOTECHNOL, V12, P1159, DOI 10.1166/jbn.2016.2205; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Yang Xiao-feng, 2006, Chin J Traumatol, V9, P276	21	10	10	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1058-2916	1538-943X		ASAIO J	Asaio J.	MAR-APR	2019	65	3					285	292		10.1097/MAT.0000000000000810			8	Engineering, Biomedical; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Transplantation	HN6KN	WOS:000460295000015	29762232	Bronze			2022-02-06	
J	Murdaugh, DL; King, TZ; O'toole, K				Murdaugh, Donna L.; King, Tricia Z.; O'toole, Kathleen			The efficacy of a pilot pediatric cognitive remediation summer program to prepare for transition of care	CHILD NEUROPSYCHOLOGY			English	Article						Cognitive remediation; pediatric; transition of care; adaptive functioning; executive functioning	TRAUMATIC BRAIN-INJURY; HEALTH-CARE; CHILDHOOD-CANCER; PARENTING PRACTICES; ADULT CARE; CHILDREN; REHABILITATION; ADOLESCENTS; ATTENTION; SURVIVORS	This study assessed the efficacy of a time-sensitive cognitive remediation summer program (CRSP) that provided patients and their families with tools to help mitigate neurocognitive deficits and promote independence to foster precursor transition of medical care skills. A total of 38 participants (aged 9-15) were included in one of the CRSPs offered yearly from 2013 to 2016. A longitudinal design was employed and at each evaluation time point, one week before start of the CRSP (pre-testing) and within three weeks after the end of the program (post-testing)), participants were administered measures of executive functioning in addition to parent ratings of behavior, executive functioning, and adaptive skills (Year 1-Year 4). In Year 4, additional measures were collected, including parenting style and parent engagement and involvement in the program. Results from Year 1 to Year 4 (n = 35) demonstrated that participants in the CRSP showed significant improvement on neuropsychological testing in sustained and selective attention, planning, and cognitive flexibility. Robust changes in parent ratings of adaptive functioning from pre- to post-treatment were also found. Specific to Year 4 (n = 13), results revealed that participants showed improvement in levels of independence with at least one of the individualized goals focused on during the program. This study provided a systematic method to gauge the levels of instruction necessary to reach goals, a crucial tool in skill-teaching. Overall, our study provides evidence for the efficacy of the CRSP and validates a feasible intervention that can be integrated into standard of care for pediatric medical populations.	[Murdaugh, Donna L.; O'toole, Kathleen] Childrens Healthcare Atlanta, Dept Neuropsychol, Atlanta, GA USA; [King, Tricia Z.] Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA; [King, Tricia Z.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA		O'toole, K (corresponding author), Childrens Healthcare Atlanta, 1547 Clifton Rd NE,Suite 200, Atlanta, GA 30322 USA.	Kathleen.O'Toole@choa.org		King, Tricia/0000-0003-1363-9914; Murdaugh, Donna/0000-0001-8550-8353; O'Toole, Kathleen/0000-0002-3013-7230			Adamson AM, 2012, CLIN NEUROPSYCHOL, V26, P59, DOI 10.1080/13854046.2011.639313; Annunziato RA, 2014, PEDIATR TRANSPLANT, V18, P794, DOI 10.1111/petr.12359; Antshel K. M., 2012, FOCUS, V10, P334, DOI DOI 10.1176/appi.focus.10.3.334; Baumrind D., 1991, ENCY ADOLESCENCE, P746; BOLL T, 1993, CHILDRENS CATEGORY T; Borlot F, 2014, EPILEPSIA, V55, P1659, DOI 10.1111/epi.12752; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Davis AM, 2014, PEDIATRICS, V134, P900, DOI 10.1542/peds.2014-1909; Delis DC., 2001, DELIS KAPLAN EXECUTI; Doll C., 2013, INT J BASIC APPL SCI, V2, P131; Farina E, 2015, EPILEPSY RES, V109, P210, DOI 10.1016/j.eplepsyres.2014.10.017; Felsenstein S, 2015, ARTHRIT CARE RES, V67, P1521, DOI 10.1002/acr.22611; Fredericks EM, 2010, PEDIATR TRANSPLANT, V14, P944, DOI 10.1111/j.1399-3046.2010.01349.x; Freed GL, 2006, J PEDIATR-US, V148, P824, DOI 10.1016/j.jpeds.2006.02.010; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gioia GA IP, 2000, BEHAV RATING INVENTO; Granek L, 2012, J CANCER SURVIV, V6, P260, DOI 10.1007/s11764-012-0223-0; Hardy KK, 2011, J PEDIATR ONCOL NURS, V28, P27, DOI 10.1177/1043454210377178; Harrison P, 2003, ADAPTIVE BEHAV ASSES, V2; Hobson WL, 2011, PEDIATRICS, V128, P1, DOI 10.1542/peds.2011-0662; Hume K, 2009, J AUTISM DEV DISORD, V39, P1329, DOI 10.1007/s10803-009-0751-2; Isquith P. K., 2010, TASKS EXECUTIVE CONT; Krasny-Pacini A, 2014, J HEAD TRAUMA REHAB, V29, pE49, DOI 10.1097/HTR.0000000000000015; Langenbahn DM, 2013, ARCH PHYS MED REHAB, V94, P271, DOI 10.1016/j.apmr.2012.09.011; Lawson EF, 2011, PEDIATR RHEUMATOL, V9, DOI 10.1186/1546-0096-9-35; Limond J, 2014, CLIN NEUROPSYCHOL, V28, P181, DOI 10.1080/13854046.2013.873083; Mahan JD, 2017, PEDIATR REV, V38, P305, DOI 10.1542/pir.2016-0074; Mariano MA, 2015, SCHIZOPHR RES, V166, P283, DOI 10.1016/j.schres.2015.05.030; Mazur-Mosiewicz A, 2015, EPILEPSIA, V56, P735, DOI 10.1111/epi.12963; McDonagh JE, 2006, BMJ-BRIT MED J, V332, P435, DOI 10.1136/bmj.332.7539.435; Moore IM, 2012, PEDIATR BLOOD CANCER, V59, P278, DOI 10.1002/pbc.23354; Morales V. A., 2016, GRADUATED GUIDANCE E; Olson K, 2016, CHILD NEUROPSYCHOL, V22, P509, DOI 10.1080/09297049.2015.1049941; Reiss J, 2002, PEDIATRICS, V110, P1307; Reiss JG, 2005, PEDIATRICS, V115, P112, DOI 10.1542/peds.2004-1321; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; Sharma N, 2014, ACAD PEDIATR, V14, P120, DOI 10.1016/j.acap.2013.11.007; Sohlberg M. M., 2003, J MED SPEECH-LANG PA, V11; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Spera C, 2005, EDUC PSYCHOL REV, V17, P120, DOI 10.1007/s10648-005-3950-1; Tarazi RA, 2007, REHABIL PSYCHOL, V52, P196, DOI 10.1037/0090-5550.52.2.196; Thiele EA, 2014, EPILEPSIA, V55, P29, DOI 10.1111/epi.12722; Treble-Barna A, 2016, J HEAD TRAUMA REHAB, V31, P407, DOI 10.1097/HTR.0000000000000200; van't Hooft I, 2010, NEUROREHABILITATION, V26, P105, DOI 10.3233/NRE-2010-0541; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2014, WECHSLER INTELLIGENC, V5th	48	10	10	1	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	FEB 17	2019	25	2					131	151		10.1080/09297049.2017.1391949			21	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HD7WV	WOS:000452765400001	29063818				2022-02-06	
J	Lapadatu, I; Morris, R				Lapadatu, Irina; Morris, Reg			The relationship between stroke survivors' perceived identity and mood, self-esteem and quality of life	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Stroke; identity; self-esteem; mood; quality of life	TRAUMATIC BRAIN-INJURY; DEPRESSIVE SYMPTOMS; DISCREPANCY THEORY; BARTHEL INDEX; REHABILITATION; PERFORMANCE; DISABILITY; EXPERIENCE; STABILITY; ASSOCIATION	Objectives: To examine change in identity after stroke and to elucidate its relationship with mood and quality of life. To test Higgins' theory of the impact of identity (self-discrepancy) on anxiety and depression. To examine the role of self-esteem in mediating the relationship between identity and outcomes. Method: Sixty-five community-living first-time stroke survivors, mean age 61.58 and time since stroke 5.60 years, were recruited from stroke charities. A cross-sectional study used the Head Injury Semantic Differential Scale, the Hospital Anxiety and Depression Scale, the Rosenberg Self-Esteem Scale, the Stroke-Specific Quality of Life Questionnaire (adapted) and the Barthel Index. Results: Identity was rated more negatively after stroke than before (t(64) = 6.46, p < .00). Greater discrepancy in identity was associated with anxiety (r = .38, p < .00), depression (r = .59, p < .00), self-esteem (r = -.48, p < .00) and quality of life (r = -.54, p < .00). Overall positivity of identity after stroke predicted outcomes even better than discrepancy. The association between discrepancy and mood and quality of life was mediated by self-esteem (beta = .30, p < .01; beta = -.24, p < .01, respectively). Specific types of discrepancy defined by Higgins did not show differential relationships with anxiety and depression as predicted. Conclusions: Identity changes after stroke and identity and self-esteem are associated with important outcomes for stroke survivors.	[Lapadatu, Irina; Morris, Reg] Cardiff Univ, Sch Psychol, Clin Psychol, Cardiff, S Glam, Wales; [Lapadatu, Irina; Morris, Reg] Cardiff & Vale Univ Hlth Board, Cardiff, S Glam, Wales		Morris, R (corresponding author), Cardiff Univ, Clin Psychol, Tower Bldg,70 Pk Pl, Cardiff CF10 3AT, S Glam, Wales.	morrisr@cardiff.ac.uk		Morris, Reg/0000-0002-8250-9315			Alford, 1999, SCI FDN COGNITIVE TH; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Ayerbe L, 2013, STROKE, V44, P1105, DOI 10.1161/STROKEAHA.111.679340; Ben-Yishay Y, 2008, NEUROPSYCHOL REHABIL, V18, P513, DOI 10.1080/09602010802141525; Brands IMH, 2012, CLIN REHABIL, V26, P840, DOI 10.1177/0269215511432018; BROWN JD, 1995, J PERS SOC PSYCHOL, V68, P712, DOI 10.1037/0022-3514.68.4.712; Burton CAC, 2013, INT J STROKE, V8, P545, DOI 10.1111/j.1747-4949.2012.00906.x; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Clarke P, 2005, J APPL GERONTOL, V24, P319, DOI 10.1177/0733464805277976; Cloute K, 2008, NEUROPSYCHOL REHABIL, V18, P651, DOI 10.1080/09602010701306989; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Dancey CP, 2004, STAT MATHS PSYCHOL U; Ebrahim S., 1994, CLIN REHABIL, V8, P233, DOI [10.1177/026921559400800308, DOI 10.1177/026921559400800308]; Ellis-Hill CS, 2000, CLIN REHABIL, V14, P279, DOI 10.1191/026921500671231410; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Fairbrother N, 1998, COGNITIVE THER RES, V22, P279, DOI 10.1023/A:1018796810260; FLEMING JS, 1984, J PERS SOC PSYCHOL, V46, P404, DOI 10.1037/0022-3514.46.2.404; Gracey F., 2015, NEURODISABILITY PSYC, V3, P154; Green J, 2001, DISABIL REHABIL, V23, P670, DOI 10.1080/09638280110045382; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; HAVLICEK LL, 1977, PSYCHOL BULL, V84, P373, DOI 10.1037/0033-2909.84.2.373; Hayes, 2018, INTRO MEDIATION MODE; HEIDRICH SM, 1994, HEALTH PSYCHOL, V13, P346, DOI 10.1037/0278-6133.13.4.346; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; HIGGINS ET, 1986, J PERS SOC PSYCHOL, V51, P5, DOI 10.1037/0022-3514.51.1.5; HIGGINS ET, 1985, SOC COGNITION, V3, P51, DOI 10.1521/soco.1985.3.1.51; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Judge TA, 2001, J APPL PSYCHOL, V86, P80, DOI 10.1037/0021-9010.86.1.80; Keppel CC, 2000, NEUROPSYCHOL REHABIL, V10, P15, DOI 10.1080/096020100389273; Kindermans HPJ, 2011, PAIN, V152, P403, DOI 10.1016/j.pain.2010.11.009; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; Levack WMM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004630; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; LEWINSOHN PM, 1975, J ABNORM PSYCHOL, V84, P729, DOI 10.1037/0021-843X.84.6.729; Li L, 1998, J SOC PSYCHOL, V138, P13, DOI 10.1080/00224549809600349; MAHONEY F I, 1965, Md State Med J, V14, P61; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Morley D, 2012, EUR J NEUROL, V19, P927, DOI 10.1111/j.1468-1331.2011.03592.x; MORRIS SD, 2004, J COGN REHABIL, V22, P15; Mukherjee D, 2006, TOP STROKE REHABIL, V13, P26, DOI 10.1310/tsr1304-26; Murray CD, 2004, DISABIL REHABIL, V26, P808, DOI 10.1080/09638280410001696746; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Pallesen H, 2014, DISABIL REHABIL, V36, P232, DOI 10.3109/09638288.2013.788217; Phillips AG, 2010, PERS INDIV DIFFER, V49, P148, DOI 10.1016/j.paid.2010.03.010; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; Prigatano G., 2008, TXB CLIN NEUROPSYCHO, P985; Rosenberg M., 1979, CONCEIVING SELF; Rosenberg M., 1965, SOC ADOLESCENT SELF; Roth EJ, 2007, TOP STROKE REHABIL, V14, P48, DOI 10.1310/tsr1401-48; Sagen U, 2009, J PSYCHOSOM RES, V67, P325, DOI 10.1016/j.jpsychores.2009.03.007; SANDELANDS LE, 1988, J APPL PSYCHOL, V73, P208, DOI 10.1037/0021-9010.73.2.208; Schroevers MJ, 2003, SOC SCI MED, V57, P375, DOI 10.1016/S0277-9536(02)00366-0; SCOTT L, 1993, J ABNORM PSYCHOL, V102, P282, DOI 10.1037/0021-843X.102.2.282; Tangney JP, 1998, J PERS SOC PSYCHOL, V75, P256, DOI 10.1037/0022-3514.75.1.256; Trzesniewski KH, 2003, J PERS SOC PSYCHOL, V84, P205, DOI 10.1037//0022-3514.84.1.205; Turner A, 2012, STROKE, V43, P1000, DOI 10.1161/STROKEAHA.111.643296; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Vickery CD, 2008, REHABIL PSYCHOL, V53, P171, DOI 10.1037/0090-5550.53.2.171; Vickery CD, 2006, CLIN REHABIL, V20, P1075, DOI 10.1177/0269215506071269; Waschull SB, 1996, PERS SOC PSYCHOL B, V22, P4, DOI 10.1177/0146167296221001; Williams LS, 1999, STROKE, V30, P1362, DOI 10.1161/01.STR.30.7.1362; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	68	10	10	2	24	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	FEB 7	2019	29	2					199	213		10.1080/09602011.2016.1272468			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HE7RF	WOS:000453636700002	28075218	Green Submitted			2022-02-06	
J	Raskin, SA; Smith, MP; Mills, G; Pedro, C; Zamroziewicz, M				Raskin, Sarah A.; Smith, Michael P.; Mills, Ginger; Pedro, Consuelo; Zamroziewicz, Marta			Prospective memory intervention using visual imagery in individuals with brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; cognitive rehabilitation; prospective memory	PAGING SYSTEM; PSYCHOMETRIC PROPERTIES; ASSISTIVE TECHNOLOGY; ELECTRONIC MEMORY; REHABILITATION; PEOPLE; ADULTS; AID; TRIAL; PERFORMANCE	Prospective memory deficits are common after brain injury and can create impediments to independent living. Most approaches to management of such deficits are compensatory, such as the use of notebooks or electronic devices. While these can be effective, a restorative approach, in theory, could lead to greater generalisation of treatment. In the current study a metacognitive technique, using visual imagery, was employed under conditions of rote repetition and spaced retrieval. Treatment was provided in an AB-BA crossover design with A as the active treatment and B as a no-treatment attention control to 20 individuals with brain injury. A group of 20 healthy participants served to control for effects of re-testing. Individuals with brain injury demonstrated improvement on the main outcome measure of prospective memory, the Memory for Intentions Screening Test, only after the active treatment condition. In addition, some generalisation of treatment was measured in daily life. Moreover, treatment gains were maintained for one year after treatment was completed.	[Raskin, Sarah A.] Trinity Coll, Dept Psychol, 300 Summit St, Hartford, CT 06106 USA; [Raskin, Sarah A.; Smith, Michael P.; Pedro, Consuelo] Trinity Coll, Neurosci Program, 300 Summit St, Hartford, CT 06106 USA; [Mills, Ginger] Univ Hartford, Grad Inst Profess Psychol, Hartford, CT USA; [Zamroziewicz, Marta] Univ Illinois, Decis Lab, Urbana, IL 61801 USA		Raskin, SA (corresponding author), Trinity Coll, Dept Psychol, 300 Summit St, Hartford, CT 06106 USA.; Raskin, SA (corresponding author), Trinity Coll, Neurosci Program, 300 Summit St, Hartford, CT 06106 USA.	sarah.raskin@trincoll.edu	Raskin, Sarah/T-1420-2019	Raskin, Sarah/0000-0002-4310-4278			Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Costa A, 2012, NEUROL SCI, V33, P965, DOI 10.1007/s10072-012-0935-y; Einstein, 2008, PROSPECTIVE MEMORY C, P283; Emslie H, 2007, NEUROPSYCHOL REHABIL, V17, P567, DOI 10.1080/09602010701381933; Evald L, 2015, NEUROPSYCHOL REHABIL, V25, P283, DOI 10.1080/09602011.2014.970557; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fish JE, 2015, NEUROPSYCHOL REHABIL, V25, P159, DOI 10.1080/09602011.2014.921204; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gillette Y, 2008, PSYCHOL SCHOOLS, V45, P665, DOI 10.1002/pits.20316; Gonzales A, 2016, INFORM COMMUN SOC, V19, P234, DOI 10.1080/1369118X.2015.1050438; Grilli MD, 2011, NEUROPSYCHOL REHABIL, V21, P847, DOI 10.1080/09602011.2011.627263; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Guynn MJ, 2003, INT J PSYCHOL, V38, P245, DOI 10.1080/00207590344000178; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Hollingshead A. B, 1975, 4 FACTOR INDEX UNPUB; Huang J, 2014, NEUROPSYCHOL REHABIL, V24, P61, DOI 10.1080/09602011.2013.854723; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kinsella GJ, 2007, NEUROPSYCHOL REHABIL, V17, P688, DOI 10.1080/09602010600892824; Kirsch NL, 2004, REHABIL PSYCHOL, V49, P200, DOI 10.1037/0090-5550.49.3.200; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Kolb B., 2011, NEUROPLASTICITY REHA, P13; Kurtz MM, 2001, NEUROREHAB NEURAL RE, V15, P75, DOI 10.1177/154596830101500110; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; McKerracher G, 2005, NEUROPSYCHOL REHABIL, V15, P115, DOI 10.1080/09602010443000056; Morris DM, 1997, NEUROREHABILITATION, V9, P29, DOI 10.3233/NRE-1997-9104; National Institutes of Health Consensus Development Panel on Rehabilitation of Persons with Traumatic Brain Injury, 1998, CENS C REH PERS TRAU; Bryen DN, 2007, INTELLECT DEV DISAB, V45, P1, DOI 10.1352/1934-9556(2007)45[1:CPUBAW]2.0.CO;2; Neulinger K, 2016, AGING NEUROPSYCHOL C, V23, P171, DOI 10.1080/13825585.2015.1069252; Newman L, 2017, INFORM SYST J, V27, P559, DOI 10.1111/isj.12106; O'Connell ME, 2003, NEUROREHABILITATION, V18, P9; Pearson J, 2011, PSYCHOL SCI, V22, P1535, DOI 10.1177/0956797611417134; Pereira A, 2012, CONSCIOUS COGN, V21, P1257, DOI 10.1016/j.concog.2012.04.012; Potvin MJ, 2011, NEUROPSYCHOL REHABIL, V21, P899, DOI 10.1080/09602011.2011.630882; Raskin, 2010, MEMORY INTENTIONS SC; Raskin S, 2004, J INT NEUROPSYCHO S1, V10, P110, DOI DOI 10.1017/S1355617704040019; Raskin S., 2011, REHABIL PSYCHOL, V22, P42; Raskin SA, 1996, J HEAD TRAUMA REHAB, V11, P32, DOI 10.1097/00001199-199606000-00007; Raskin SA, 2009, BRAIN IMPAIR, V10, P76, DOI 10.1375/brim.10.1.76; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; Scherer MJ, 2015, NEUROREHABILITATION, V37, P315, DOI 10.3233/NRE-151264; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Shum D, 2011, J REHABIL MED, V43, P216, DOI 10.2340/16501977-0647; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; SOHLBERG M M, 1992, Brain Injury, V6, P139, DOI 10.3109/02699059209029652; Sohlberg M. M., 2006, REV NEUROPSICOLOGIA, V1, P14; Sohlberg M. M., 2005, REHABILITATION TRAUM, P47; Sohlberg MM, 1996, J HEAD TRAUMA REHAB, V11, P65, DOI 10.1097/00001199-199604000-00007; SOHLBERG MM, 2001, COGNITIVE REHABILIAT; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Stock S, 2013, INCLUSION, V1, P103, DOI DOI 10.1352/2326-6988-01.02.103; TEASDALE G, 1974, LANCET, V2, P81; Thone-Otto AIT, 2003, INT J PSYCHOL, V38, P236, DOI 10.1080/00207590344000169; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 2003, NEUROREHABILITATION, V18, P3; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Yasuda K, 2002, NEUROPSYCHOL REHABIL, V12, P155, DOI 10.1080/09602010143000239	67	10	10	1	23	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	FEB 7	2019	29	2					289	304		10.1080/09602011.2017.1294082			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HE7RF	WOS:000453636700007	28285571				2022-02-06	
J	Goubert, E; Altvater, M; Rovira, MN; Khalilov, I; Mazzarino, M; Sebastiani, A; Schaefer, MKE; Rivera, C; Pellegrino, C				Goubert, Emmanuelle; Altvater, Marc; Rovira, Marie-Noelle; Khalilov, Ilgam; Mazzarino, Morgane; Sebastiani, Anne; Schaefer, Michael K. E.; Rivera, Claudio; Pellegrino, Christophe			Bumetanide Prevents Brain Trauma-Induced Depressive-Like Behavior	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						psychiatric disease; depression; potassium chloride cotransporter 2 (KCC2); bumetanide; neurogenesis; interneuron cell death	NEURAL STEM-CELL; ADULT HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; DIURETIC BUMETANIDE; COTRANSPORTER KCC2; DOWN-REGULATION; GRANULE CELLS; UP-REGULATION; INJURY; INHIBITION	Brain trauma triggers a cascade of deleterious events leading to enhanced incidence of drug resistant epilepsies, depression, and cognitive dysfunctions. The underlying mechanisms leading to these alterations are poorly understood and treatment that attenuates those sequels are not available. Using controlled-cortical impact as an experimental model of brain trauma in adult mice, we found a strong suppressive effect of the sodium-potassium-chloride importer (NKCC1) specific antagonist bumetanide on the appearance of depressive-like behavior. We demonstrate that this alteration in behavior is associated with an impairment of post-traumatic secondary neurogenesis within the dentate gyrus of the hippocampus. The mechanism mediating the effect of bumetanide involves early transient changes in the expression of chloride regulatory proteins and qualitative changes in GABA(A) mediated transmission from hyperpolarizing to depolarizing after brain trauma. This work opens new perspectives in the early treatment of human post-traumatic induced depression. Our results strongly suggest that bumetanide might constitute an efficient prophylactic treatment to reduce neurological and psychiatric consequences of brain trauma.	[Goubert, Emmanuelle; Rovira, Marie-Noelle; Khalilov, Ilgam; Mazzarino, Morgane; Rivera, Claudio; Pellegrino, Christophe] Aix Marseille Univ, Inst Mediterranean Neurobiol, INSERM, Marseille, France; [Altvater, Marc; Sebastiani, Anne; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany; [Altvater, Marc; Sebastiani, Anne; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Translat Neurosci, Mainz, Germany; [Khalilov, Ilgam] Kazan Fed Univ, Lab Neurobiol, Kazan, Russia; [Rivera, Claudio] Univ Helsinki, Neurosci Ctr, Helsinki, Finland		Rivera, C; Pellegrino, C (corresponding author), Aix Marseille Univ, Inst Mediterranean Neurobiol, INSERM, Marseille, France.; Rivera, C (corresponding author), Univ Helsinki, Neurosci Ctr, Helsinki, Finland.	claudio.rivera@helsinki.fi; christophe.pellegrino@inserm.fr	Khalilov, Ilgam/B-5267-2015; Rivera, Claudio/ABE-2499-2021; Pellegrino, Christophe/P-5266-2016	Khalilov, Ilgam/0000-0002-9468-4778; Rivera, Claudio/0000-0003-2462-6561; Pellegrino, Christophe/0000-0002-0669-4918	French National Agency for Research, ANR through CR and EG [ANR-Traumep-13-BSV4-0012-01]; Eranet Neuron III program through Acrobat grant; Akademy of Finland [AK1308265]; "fondation des gueules cassees" through EG; FRC grant "espoir en tete 2015"; Ministry of Education and Research of Russian Federation [6.2313.2017/4.6, Top-100]; DAAD research mobility grant	This work was supported by the French National Agency for Research, ANR through CR and EG ANR-Traumep-13-BSV4-0012-01, the Eranet Neuron III program through Acrobat grant to CR, the Akademy of Finland (AK1308265) to CR and by the "fondation des gueules cassees" through EG, part of the behavioral unit has been funded by an FRC grant "espoir en tete 2015" to Y. Ben-Ari. The Ministry of Education and Research of Russian Federation (6.2313.2017/4.6 and Top-100 to IK). This research article was also available at BioRxiv website, please visit http://biorxiv.org/cgi/content/short/443739v1. DAAD research mobility grant to MA and MS in the funding sources.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Aldenkamp AR, 2005, ACTA NEUROL SCAND, V112, P19, DOI 10.1111/j.1600-0404.2005.00523.x; Alvarez DD, 2016, SCIENCE, V354, P459, DOI 10.1126/science.aaf2156; Amini-Khoei H, 2017, PROG NEURO-PSYCHOPH, V76, P169, DOI 10.1016/j.pnpbp.2017.02.022; Anacker C, 2017, NAT REV NEUROSCI, V18, P335, DOI 10.1038/nrn.2017.45; Anderson GD, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00129; Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; Belousov AB, 2012, NEUROSCI LETT, V524, P16, DOI 10.1016/j.neulet.2012.06.065; Ben-Ari Y, 2017, TRENDS NEUROSCI, V40, P536, DOI 10.1016/j.tins.2017.07.001; Berglund K, 2006, BRAIN CELL BIOL, V35, P207, DOI 10.1007/s11068-008-9019-6; Boldrini M, 2013, NEUROPSYCHOPHARMACOL, V38, P1068, DOI 10.1038/npp.2013.5; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Brandon NJ, 2015, NAT NEUROSCI, V18, P1537, DOI 10.1038/nn.4144; Butler CR, 2016, EXP NEUROL, V280, P30, DOI 10.1016/j.expneurol.2016.03.022; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chell JM, 2012, CELL STEM CELL, V11, P282, DOI 10.1016/j.stem.2012.08.009; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; Damier P, 2016, CLIN NEUROPHARMACOL, V39, P57, DOI 10.1097/WNF.0000000000000114; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drexel M, 2011, NEUROSCIENCE, V189, P316, DOI 10.1016/j.neuroscience.2011.05.021; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Egeland M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.68; Fan QY, 2016, CNS NEUROSCI THER, V22, P700, DOI 10.1111/cns.12567; Fenton AA, 2015, BIOL PSYCHIAT, V77, P1079, DOI 10.1016/j.biopsych.2015.03.013; Ferguson S, 2017, J NEUROTRAUM, V34, P1676, DOI 10.1089/neu.2016.4636; Gabbay V, 2012, ARCH GEN PSYCHIAT, V69, P139, DOI 10.1001/archgenpsychiatry.2011.131; Gagnon M, 2013, NAT MED, V19, P1524, DOI 10.1038/nm.3356; Garcia-Pardo MP, 2017, BEHAV BRAIN RES, V319, P63, DOI 10.1016/j.bbr.2016.11.012; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hsieh LT, 2014, NEURON, V81, P1165, DOI 10.1016/j.neuron.2014.01.015; Hu DF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13860-9; Hu JJ, 2017, BRAIN RES BULL, V130, P188, DOI 10.1016/j.brainresbull.2017.01.022; Hui H, 2016, NEUROCHEM INT, V94, P23, DOI 10.1016/j.neuint.2016.02.002; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Jefferys JGR, 2010, SEIZURE-EUR J EPILEP, V19, P638, DOI 10.1016/j.seizure.2010.10.026; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Kandratavicius L, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0081-2; Kelley MR, 2016, NEUROPHARMACOLOGY, V108, P103, DOI 10.1016/j.neuropharm.2016.04.029; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Khodaie B, 2015, BEHAV BRAIN RES, V278, P55, DOI 10.1016/j.bbr.2014.09.034; Khundakar A, 2011, INT PSYCHOGERIATR, V23, P644, DOI 10.1017/S1041610210001444; Kourdougli N, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00413; Kvajo M, 2011, P NATL ACAD SCI USA, V108, pE1349, DOI 10.1073/pnas.1114113108; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee HHC, 2011, NAT NEUROSCI, V14, P736, DOI 10.1038/nn.2806; Lemonnier E, 2016, CLIN NEUROPHARMACOL, V39, P115, DOI 10.1097/WNF.0000000000000136; Lemonnier E, 2013, ACTA PAEDIATR, V102, pe288, DOI 10.1111/apa.12235; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; Luscher B, 2011, MOL PSYCHIATR, V16, P383, DOI 10.1038/mp.2010.120; Luscher Bernhard, 2015, Adv Pharmacol, V73, P97, DOI 10.1016/bs.apha.2014.11.003; Marrocco J, 2014, J NEUROSCI, V34, P2015, DOI 10.1523/JNEUROSCI.4131-13.2014; Medina I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00027; Merali Z, 2004, J NEUROSCI, V24, P1478, DOI 10.1523/JNEUROSCI.4734-03.2004; Meyer Kimberly, 2008, J Trauma Nurs, V15, P185, DOI 10.1097/01.JTN.0000343324.55087.de; Mombereau C, 2005, NEUROREPORT, V16, P307, DOI 10.1097/00001756-200502280-00021; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Moss J, 2013, BIOESSAYS, V35, P28, DOI 10.1002/bies.201200136; Ostroumov A, 2016, NEURON, V92, P493, DOI 10.1016/j.neuron.2016.09.029; Pallud J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008065; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pehrson AL, 2015, DRUG DES DEV THER, V9, P603, DOI 10.2147/DDDT.S62912; Pellegrino C, 2011, J PHYSIOL-LONDON, V589, P2475, DOI 10.1113/jphysiol.2010.203703; Peng ZC, 2013, J NEUROSCI, V33, P14392, DOI 10.1523/JNEUROSCI.2045-13.2013; Perez-Dominguez M, 2018, REV NEUROSCIENCE, V29, P1, DOI 10.1515/revneuro-2017-0024; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Petit AC, 2014, PROG NEURO-PSYCHOPH, V54, P76, DOI 10.1016/j.pnpbp.2014.04.013; Poleszak E, 2006, PHARMACOL REP, V58, P746; Puskarjov M, 2014, EMBO REP, V15, P723, DOI 10.1002/embr.201438749; Ren Z, 2015, NEUROPHARMACOLOGY, V88, P171, DOI 10.1016/j.neuropharm.2014.07.019; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Roddy DW, 2019, BIOL PSYCHIAT, V85, P487, DOI 10.1016/j.biopsych.2018.08.021; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Samuels BA, 2015, NAT NEUROSCI, V18, P1606, DOI 10.1038/nn.4116; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Savitz J, 2010, NEUROIMAGE, V49, P2966, DOI 10.1016/j.neuroimage.2009.11.025; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Scharfman HE, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00112; Scharfman HE, 2009, EPILEPSY RES, V85, P150, DOI 10.1016/j.eplepsyres.2009.03.006; Schuhmacher A, 2013, INT J NEUROPSYCHOPH, V16, P83, DOI 10.1017/S1461145712000223; Shiri Z, 2015, ANN NEUROL, V77, P541, DOI 10.1002/ana.24342; Shulga A, 2013, NEUROSCIENCE, V239, P241, DOI 10.1016/j.neuroscience.2012.12.007; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; Smiley JF, 2016, J CHEM NEUROANAT, V76, P108, DOI 10.1016/j.jchemneu.2015.10.008; Solmaz I, 2009, TURK NEUROSURG, V19, P216; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Sun L, 2012, EUR J NEUROSCI, V35, P661, DOI 10.1111/j.1460-9568.2012.08007.x; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Tao WW, 2016, BEHAV BRAIN RES, V308, P177, DOI 10.1016/j.bbr.2016.04.039; Toda T, 2018, CELL TISSUE RES, V373, P693, DOI 10.1007/s00441-017-2735-4; Todkar K, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00056; Tollner K, 2014, ANN NEUROL, V75, P550, DOI 10.1002/ana.24124; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Ullah G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004414; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Wang CB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26526; WINKELMANN A, 2015, CELL DEATH DIS, V6; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Xu WS, 2016, NEURAL REGEN RES, V11, P745, DOI 10.4103/1673-5374.182700; Zeuthen T, 2010, J MEMBRANE BIOL, V234, P57, DOI 10.1007/s00232-009-9216-y; Zhang J, 2017, NEUROCHEM INT, V111, P23, DOI 10.1016/j.neuint.2017.05.020; Zhang W, 2009, J NEUROSCI, V29, P7846, DOI 10.1523/JNEUROSCI.6199-08.2009; ZHAO J, 2015, SCI REP UK, V5; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113	127	10	9	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	FEB 5	2019	12								12	10.3389/fnmol.2019.00012			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK3SH	WOS:000457837600001	30804751	Green Published, Green Submitted, gold			2022-02-06	
J	Hale, AT; Stonko, DP; Lim, J; Guillamondegui, OD; Shannon, CN; Patel, MB				Hale, Andrew T.; Stonko, David P.; Lim, Jaims; Guillamondegui, Oscar D.; Shannon, Chevis N.; Patel, Mayur B.			Using an artificial neural network to predict traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						TBI; pediatrics; machine learning; artificial intelligence; trauma	BLUNT HEAD TRAUMA; COMPUTED-TOMOGRAPHY; BIG DATA; CHILDREN; PREVALENCE; VALIDATION; PECARN; RULES; SCORE; CONSCIOUSNESS	OBJECTIVE Pediatric traumatic brain injury (TBI) is common, but not all injuries require hospitalization. A computational tool for ruling in patients who will have a clinically relevant TBI (CRTBI) would be valuable, providing an evidencebased way to safely discharge children who are at low risk for a CRTBI. The authors hypothesized that an artificial neural network (ANN) trained on clinical and radiologist-interpreted imaging metrics could provide a tool for identifying patients likely to suffer from a CRTBI. METHODS The authors used the prospectively collected, publicly available, multicenter Pediatric Emergency Care Applied Research Network (PECARN) TBI data set. All patients under the age of 18 years with TBI and admission head CT imaging data were included. The authors constructed an ANN using clinical and radiologist-interpreted imaging metrics in order to predict a CRTBI, as previously defined by PECARN: 1) neurosurgical procedure, 2) intubation > 24 hours as direct result of the head trauma, 3) hospitalization >= 48 hours and evidence of TBI on a CT scan, or 4) death due to TBI. RESULTS Among 12,902 patients included in this study, 480 were diagnosed with CRTBI. The authors' ANN had a sensitivity of 99.73% with precision of 98.19%, accuracy of 97.98%, negative predictive value of 91.23%, false-negative rate of 0.0027%, and specificity for CRTBI of 60.47%. The area under the receiver operating characteristic curve was 0.9907. CONCLUSIONS The authors are the first to utilize artificial intelligence to predict a CRTBI in a clinically meaningful manner, using radiologist-interpreted CT information, in order to identify pediatric patients likely to suffer from a CRTBI. This proof-of-concept study lays the groundwork for future studies incorporating iterations of this algorithm directly into the electronic medical record for real-time, data-driven predictive assistance to physicians.	[Hale, Andrew T.] Vanderbilt Univ, Sch Med, Med Scientist Training Program, Nashville, TN 37212 USA; [Hale, Andrew T.; Stonko, David P.; Lim, Jaims; Guillamondegui, Oscar D.; Shannon, Chevis N.; Patel, Mayur B.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Stonko, David P.; Guillamondegui, Oscar D.] Johns Hopkins Univ, Sch Med, Johns Hopkins Med Inst, Baltimore, MD USA; [Patel, Mayur B.] Vanderbilt Univ, Dept Surg, Div Trauma Emergency Gen Surg & Surg Crit Care, Sect Surg Sci,Med Ctr, Nashville, TN 37240 USA; [Patel, Mayur B.] Vanderbilt Univ, Dept Hearing & Speech Sci, Div Trauma Emergency Gen Surg & Surg Crit Care, Sect Surg Sci,Med Ctr, Nashville, TN 37240 USA; [Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Ctr Hlth Serv Res, Vanderbilt Brain Inst, Nashville, TN USA; [Patel, Mayur B.] Tennessee Valley Hlth Care Syst, Geriatr Res Educ & Clin Ctr Serv, Surg Serv, Dept Vet Affairs Med Ctr, Nashville, TN USA; [Guillamondegui, Oscar D.; Shannon, Chevis N.; Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN USA; [Guillamondegui, Oscar D.; Shannon, Chevis N.; Patel, Mayur B.] Vanderbilt Univ, Div Pediat Neurosurg, Monroe Carell Jr Childrens Hosp, 221 Kirkland Hall, Nashville, TN 37235 USA; [Shannon, Chevis N.] Vanderbilt Univ, Surg Outcomes Ctr Kids, Monroe Carell Jr Childrens Hosp, Nashville, TN USA		Hale, AT (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	andrew.hale@vanderbilt.edu		Hale, Andrew/0000-0003-3182-2966; Stonko, David/0000-0002-2804-2857	Vanderbilt University School of Medicine Medical Scientist Training Program [5T32GM007347]; Vanderbilt Clinical and Translational Science Award (NIH/NCAT) [UL1RR024975]; R01 (NIH/NIGMS) [GM120484]; Vanderbilt Faculty Scholars Award	A.T.H. receives salary and tuition support through the Vanderbilt University School of Medicine Medical Scientist Training Program (5T32GM007347). This project is supported by the Vanderbilt Clinical and Translational Science Award (UL1RR024975, NIH/NCAT; to M.B.P.). M.B.P. is funded by R01 (GM120484, NIH/NIGMS) and a Vanderbilt Faculty Scholars Award.	Ahmed FE, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-29; Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Badawy MK, 2017, ACAD EMERG MED, V24, P595, DOI 10.1111/acem.13168; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Beam AL, 2016, JAMA-J AM MED ASSOC, V316, P2368, DOI 10.1001/jama.2016.17217; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Chong SL, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0015-0; Darcy AM, 2016, JAMA-J AM MED ASSOC, V315, P551, DOI 10.1001/jama.2015.18421; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gholipour C, 2015, J CLIN DIAGN RES, V9, pOC19, DOI 10.7860/JCDR/2015/9467.5828; Glass T, 2015, AM J EMERG MED, V33, P1458, DOI 10.1016/j.ajem.2015.06.069; Greenberg JK, 2017, JAMA PEDIATR, V171, P342, DOI 10.1001/jamapediatrics.2016.4520; Ide K, 2017, ACAD EMERG MED, V24, P308, DOI 10.1111/acem.13129; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kreif N, 2015, HEALTH ECON, V24, P1213, DOI 10.1002/hec.3189; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Magana JN, 2017, ACAD EMERG MED, V24, P382, DOI 10.1111/acem.13155; Marcin JP, 2018, HEALTH SERV RES, V53, P1316, DOI 10.1111/1475-6773.12800; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Nakhjavan-Shahraki B, 2017, EUR J TRAUMA EMERG S, V43, P755, DOI 10.1007/s00068-017-0811-9; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Nigrovic LE, 2013, ANN EMERG MED, V61, P389, DOI 10.1016/j.annemergmed.2012.08.030; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Penny W, 1996, MED DECIS MAKING, V16, P386, DOI 10.1177/0272989X9601600409; Pourahmad S, 2016, METHOD INFORM MED, V55, P440, DOI 10.3414/ME15-01-0080; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Rughani AI, 2010, J NEUROSURG, V113, P585, DOI 10.3171/2009.11.JNS09857; Segal ME, 2006, J HEAD TRAUMA REHAB, V21, P298, DOI 10.1097/00001199-200607000-00003; Senders JT, 2018, NEUROSURGERY, V83, P181, DOI 10.1093/neuros/nyx384; Senders JT, 2018, ACTA NEUROCHIR, V160, P29, DOI 10.1007/s00701-017-3385-8; Senders JT, 2018, WORLD NEUROSURG, V109, P476, DOI 10.1016/j.wneu.2017.09.149; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Walczak S, 2005, IEEE T INF TECHNOL B, V9, P468, DOI 10.1109/TITB.2005.847510; Zou Jinming, 2008, V458, P15	41	10	11	1	19	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	FEB	2019	23	2					219	226		10.3171/2018.8.PEDS18370			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	HO6BY	WOS:000461014800014	30485240	Bronze			2022-02-06	
J	Harvin, JA; Podbielski, JM; Vincent, LE; Liang, MK; Kao, LS; Wade, CE; Holcomb, JB				Harvin, John A.; Podbielski, Jeanette M.; Vincent, Laura E.; Liang, Mike K.; Kao, Lillian S.; Wade, Charles E.; Holcomb, John B.			Impact of Social Media on Community Consultation in Exception From Informed Consent Clinical Trials	JOURNAL OF SURGICAL RESEARCH			English	Article						Trauma; Exception from informed consent; Emergency research; Informed consent; Community consultation	PUBLIC DISCLOSURE; BLOOD	Background: Exception from informed consent (EFIC) allows clinician scientists to perform much needed emergency research. Obtaining this exception, however, requires many meetings with community groups for consultation, which can make the process time-consuming and expensive. We aim to determine the impact of using social media in lieu of some community meetings in an effort to obtain an EFIC. Materials and methods: An economic analysis of four randomized clinical trials was performed. Costs were conservatively estimated using personnel costs, social media costs, and adjusted to 2016 US dollars. People were considered reached if they attended a community meeting or were directed to the study website by social media and spent >1 min. Results: The Early Whole Blood study required 14 meetings, reached 272 people, and cost $8260 ($30/person reached). The Pragmatic, Randomized Optimal Platelet and Plasma Ratios study required 14 meetings, reached 260 people, and cost $7479 overall ($29/person reached). The Prehospital Tranexamic Acid Use for Traumatic Brain Injury study required 12 meetings, reached 198 people, and cost $6340 ($32/person reached). Only the damage control laparotomy trial utilized social media in lieu of some community meetings. The damage control laparotomy trial required six meetings at which 137 people were reached. The $1000 social media campaign reached 229 people. The cost was $3977 overall and $11/ person reached. Conclusions: Including a social media campaign during the EFIC process increased the number of potential patients reached and reduced total and per person costs reached costs. Obtaining an EFIC for future emergency clinical trials may be facilitated by the inclusion of a social media campaign. (C) 2018 Elsevier Inc. All rights reserved.	[Harvin, John A.; Podbielski, Jeanette M.; Vincent, Laura E.; Liang, Mike K.; Kao, Lillian S.; Wade, Charles E.; Holcomb, John B.] Univ Texas Houston, McGovern Med Sch, 6431 Fannin St,MSB 4-264, Houston, TX 77030 USA		Harvin, JA (corresponding author), Univ Texas Houston, McGovern Med Sch, 6431 Fannin St,MSB 4-264, Houston, TX 77030 USA.	john.harvin@uth.tmc.edu		holcomb, john/0000-0001-8312-9157	KL2 grant from the Center for Clinical and Translational Sciences - National Institutes of Health Clinical and Translational Award from the National Center for Advancing Translational Sciences [UL1 TR000371, KL2 TR000370]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000371] Funding Source: NIH RePORTER	Dr. Harvin is supported by a KL2 grant from the Center for Clinical and Translational Sciences, which is funded by National Institutes of Health Clinical and Translational Award UL1 TR000371 and KL2 TR000370 from the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.	[Anonymous], 2016, NATL TRAUMA CARE SYS; Chen DW, 2014, J SURG RES, V190, P478, DOI 10.1016/j.jss.2014.04.028; Cotton BA, 2013, ANN SURG, V258, P527, DOI 10.1097/SLA.0b013e3182a4ffa0; Hamilton EC, 2017, J PEDIAT SURG; Harvin John A, 2017, Trauma Surg Acute Care Open, V2, pe000083, DOI 10.1136/tsaco-2017-000083; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holsti M, 2015, CLIN TRIALS, V12, P67, DOI 10.1177/1740774514555586; Pew Research Center, SOC MED FACT SHEET; Stephens SW, 2016, J TRAUMA ACUTE CARE, V80, P1005, DOI 10.1097/TA.0000000000001042; Stephens SW, 2013, CIRCULATION, V128, P267, DOI 10.1161/CIRCULATIONAHA.113.002390; UT Health Committee for the Protection of Human Subjects, QUAL IMPR PROJ	11	10	10	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2019	234						65	71		10.1016/j.jss.2018.09.007			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	HD5BL	WOS:000452542500012	30527501	Green Accepted, Bronze			2022-02-06	
J	Hipskind, SG; Grover, FL; Fort, TR; Helffenstein, D; Burke, TJ; Quint, SA; Bussiere, G; Stone, M; Hurtado, T				Hipskind, S. Gregory; Grover, Fred L., Jr.; Fort, T. Richard; Helffenstein, Dennis; Burke, Thomas J.; Quint, Shane A.; Bussiere, Garrett; Stone, Michael; Hurtado, Timothy			Pulsed Transcranial Red/Near-Infrared Light Therapy Using Light-Emitting Diodes Improves Cerebral Blood Flow and Cognitive Function in Veterans with Chronic Traumatic Brain Injury: A Case Series	PHOTOBIOMODULATION PHOTOMEDICINE AND LASER SURGERY			English	Article						photobiomodulation; transcranial; traumatic brain injury; quantitative; SPECT imaging; LED; cognitive function	LEVEL LASER THERAPY; TECHNETIUM-99M-HMPAO SPECT; NITRIC-OXIDE; MILD; HEAD; PHOTOBIOMODULATION; PERFORMANCE; RADIATION	Objective: This study explored the outcome of applying red/near-infrared light therapy using light-emitting diodes (LEDs) pulsed with three different frequencies transcranially to treat traumatic brain injury (TBI) in Veterans. Background: Photobiomodulation therapy (PBMT) using LEDs has been shown to have positive effects on TBI in humans and animal models. Materials and methods: Twelve symptomatic military Veterans diagnosed with chronic TBI > 18 months posttrauma received pulsed transcranial PBMT (tPBMT) using two neoprene therapy pads containing 220 infrared and 180 red LEDs, generating a power output of 3.3Wand an average power density of 6.4 mW/cm(2) for 20 min, thrice per week over 6 weeks. Outcome measures included standardized neuropsychological test scores and qualitative and quantitative single photon emission computed tomography (SPECT) measures of regional cerebral blood flow (rCBF). Results: Pulsed tPBMT significantly improved neuropsychological scores in 6 of 15 subscales (40.0%; p < 0.05; two tailed). SPECT analysis showed increase in rCBF in 8 of 12 (66.7%) study participants. Quantitative SPECT analysis revealed a significant increase in rCBF in this subgroup of study participants and a significant difference between pre-treatment and post-treatment gamma ray counts per cubic centimeter [t = 3.77, df = 7, p = 0.007, 95% confidence interval (95,543.21-21,931.82)]. This is the first study to report quantitative SPECT analysis of rCBF in regions of interest following pulsed tPBMT with LEDs in TBI. Conclusions: Pulsed tPBMT using LEDs shows promise in improving cognitive function and rCBF several years after TBI. Larger, controlled studies are indicated.	[Hipskind, S. Gregory] Brain Injury Consulting LLC, Dept Brain Res, Addison, TX USA; [Hipskind, S. Gregory] InLight Med, Med Advisory Dept, Addison, TX USA; [Grover, Fred L., Jr.] Revolutionary MD, Dept Med Res, Denver, CO USA; [Fort, T. Richard; Quint, Shane A.; Bussiere, Garrett] CereScan Corp, Dept Imaging Res, Littleton, CO USA; [Helffenstein, Dennis] Colorado Neuropsychol Associates, Testing Dept, Englewood, CO USA; [Burke, Thomas J.] Univ Colorado, Sch Med, Dept Physiol, Aurora, CO USA; [Stone, Michael] Vet Adm Hosp, Dept Radiol, Las Vegas, NV USA; [Hurtado, Timothy] Penrose St Francis Hlth Serv, Emergency Dept, Colorado Springs, CO USA		Hipskind, SG (corresponding author), Brain Injury Consulting LLC, 16200 Addison Rd,Suite 105, Addison, TX 75001 USA.	hippiedoc47@gmail.com			Tug McGraw Foundation of Yountville, CA	This research was supported by a grant from the Tug McGraw Foundation of Yountville, CA. The authors thank Dr. Fred Grover, Jr. and Dr. Terry Smith for their professional care and treatment of the Veterans who participated in this study. They also thank Alicia Novak and the Colorado Neurological Institute for their study coordination and record keeping, Mary Beth Lehto, PhD, for her help with statistics and with the article, and Jody Mittiga, ND, ANP, for her help with the article and submission.	Abu-Judeh H H, 2000, Nucl Med Rev Cent East Eur, V3, P5; Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Bigler ED, 2015, NEUROPATHOLOGY MILD; Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73; Delis D.C., 2000, CALIFORNIA VERBAL LE; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferraresi C, 2015, J BIOPHOTONICS, V8, P740, DOI 10.1002/jbio.201400087; Gliner JA, 2009, RESEARCH METHODS IN APPLIED SETTTINGS: AN INTEGRATED APPROACH TO DESIGN AND ANALYSIS, 2ND EDITION, P1; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hamblin MR, 2016, VIRULENCE, V7, P836, DOI 10.1080/21505594.2016.1201348; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Hashmi JT, 2010, LASER SURG MED, V42, P450, DOI 10.1002/lsm.20950; Henderson Theodore A, 2015, Adv Mind Body Med, V29, P27; ICHISE M, 1994, J NUCL MED, V35, P217; JACOBS A, 1994, J NUCL MED, V35, P942; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Jonsson C, 2000, NUCL MED COMMUN, V21, P9, DOI 10.1097/00006231-200001000-00004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kemp J, 2012, SUICIDE DATA REPORT, P1; Lapchak PA, 2012, EXPERT REV MED DEVIC, V9, P71, DOI 10.1586/ERD.11.64; LESSER IM, 1993, SCHIZOPHRENIA BULL, V19, P773, DOI 10.1093/schbul/19.4.773; Lewis R., 1995, DIGIT VIGILANCE TEST; Lohr NL, 2013, J MOL CELL CARDIOL, V62, P36, DOI 10.1016/j.yjmcc.2013.05.007; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Mena FM, 1993, CLIN NUCL MED, V18, P924; NAESER MA, 2010, SPIE NEWSROOM, V7552; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron U, 2007, PHOTOMED LASER SURG, V25, P180, DOI 10.1089/pho.2007.2064; Quirk BJ, 2012, PHOTOMED LASER SURG, V30, P523, DOI 10.1089/pho.2012.3261; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Romero K, 2015, PSYCHIAT RES-NEUROIM, V231, P15, DOI 10.1016/j.pscychresns.2014.11.003; RUBIN RT, 1995, BIOL PSYCHIAT, V38, P429, DOI 10.1016/0006-3223(94)00305-M; Saltmarche AE, 2017, PHOTOMED LASER SURG, V35, P432, DOI 10.1089/pho.2016.4227; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; WAN S, 1981, PHOTOCHEM PHOTOBIOL, V34, P679, DOI 10.1111/j.1751-1097.1981.tb09424.x; Wechsler D., 2008, WECHSLER ADULT INTEL; Wong SBC, 2006, PROG BRAIN RES, V157, P173, DOI 10.1016/S0079-6123(06)57011-6; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Young AER, 2000, BRIT J ANAESTH, V84, P38, DOI 10.1093/oxfordjournals.bja.a013379	46	10	11	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2578-5478		PHOTOBIOMODULATION P	Photobiomodulation Photomed. Laser Surg.	FEB	2019	37	2					77	84		10.1089/photob.2018.4489			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JD0SY	WOS:000489687800004	31050928	Green Published			2022-02-06	
J	Hoffer, ME; Levin, BE; Snapp, H; Buskirk, J; Balaban, C				Hoffer, Michael E.; Levin, Bonnie E.; Snapp, Hillary; Buskirk, James; Balaban, Carey			Acute findings in an acquired neurosensory dysfunction	LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY			English	Article						Vestibular disorder; Cuba exposure; cognitive disorder; brain injury	TRAUMATIC BRAIN-INJURY; WAVE EMISSION; EXPOSURE; COLLAPSE; ANXIETY	Background In the Autumn of 2016, diplomatic personnel residing in Havana began to present with symptoms of dizziness, ear pain, and tinnitus that emerged after perception of high frequency noise and/or a pressure sensation. Understanding the acute symptoms of this disorder is important for better defining the disorder and developing optimal diagnostic, preventive, and treatment algorithms. Objectives To define the presenting symptoms in a cohort of patients in the acute time period after perceiving a noise/pressure exposure in Havana. Design/Settings/Participants Review of 25 symptomatic individuals who reported a localized sensation of noise/pressure and 10 asymptomatic individuals (roommates of those affected) who did not experience the sound/pressure. Results Immediately after the exposure, the majority of individuals reported intense ear pain in one or both ears and experienced tinnitus. All of the individuals noticed unsteadiness and features of cognitive impairment. On presentation to our center, dizziness (92%) and cognitive complaints (56%) were the most common symptoms. Formal testing revealed that 100% of individuals had an otolithic abnormality and evidence of cognitive dysfunction. Conclusion and Relevance This study focuses on the acute presentation of a phenomenon in which symptoms emerge after perception of a localized noise/pressure and in which the acute symptomology includes the universal nature of vestibular injuries and select cognitive deficits. The findings presented in this acute group of patients begin to provide a better picture of the initial injury pattern seen after this exposure and may allow for more accurate diagnosis of this disorder in futu	[Hoffer, Michael E.; Snapp, Hillary; Buskirk, James] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Hoffer, Michael E.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Levin, Bonnie E.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Balaban, Carey] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Balaban, Carey] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA USA; [Balaban, Carey] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA		Hoffer, ME (corresponding author), Univ Miami, Otolaryngol & Neurol Surg, 1120 NW 14th St,5th Floor, Miami, FL 33136 USA.	michael.hoffer@miami.edu	Balaban, Carey/O-6586-2019; Buskirk, James/ABF-8288-2020; Balaban, Carey/I-3467-2017	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844			Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Akhatov I, 2001, PHYS FLUIDS, V13, P2805, DOI 10.1063/1.1401810; Apfel R. E., 1981, METHODS EXPT PHYS, V19, DOI 10.1016/S0076-695X(08)60338-5; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Balaban CD, 2017, AUTON NEUROSCI-BASIC, V202, P5, DOI 10.1016/j.autneu.2016.07.003; Balaban CD, 2001, J ANXIETY DISORD, V15, P53, DOI 10.1016/S0887-6185(00)00042-6; Brujan EA, 2005, PHYS MED BIOL, V50, P4797, DOI 10.1088/0031-9155/50/20/004; Brujan EA, 2006, J FLUID MECH, V558, P281, DOI 10.1017/S0022112006000115; CHOU C-K, 1975, Journal of Microwave Power, V10, P361; Coelho CM, 2015, NEUROSCI BIOBEHAV R, V48, P148, DOI 10.1016/j.neubiorev.2014.10.023; Curthoys IS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00117; Fassnidge C, 2017, CONSCIOUS COGN, V49, P15, DOI 10.1016/j.concog.2016.12.009; Health Canada, 1991, GUID SAF US ULTR 2; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Julien J, 2017, BRAIN INJURY, V17, P1; LAUTERBORN W, 1975, J FLUID MECH, V72, P391, DOI 10.1017/S0022112075003448; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lucas S, 2017, NEUROL CLIN, V35, P501, DOI 10.1016/j.ncl.2017.03.012; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mercier E, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017848; Patel M, 2016, OTOL NEUROTOL, V37, P179, DOI 10.1097/MAO.0000000000000949; Rowley DA, 2017, BRAIN INJURY, V31, P1564, DOI 10.1080/02699052.2017.1341645; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Swanson RL, 2018, JAMA-J AM MED ASSOC, V319, P1125, DOI 10.1001/jama.2018.1742; Tal D, 2015, J NEUROPHYSIOL, V114, P1521, DOI 10.1152/jn.00466.2015; TYAZHELOV VV, 1979, RADIO SCI, V14, P259, DOI 10.1029/RS014i06Sp00259; Wackym PA, 2016, OTOL NEUROTOL, V37, P70, DOI 10.1097/MAO.0000000000000928	29	10	10	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2378-8038			LARYNGOSCOPE INVEST	Laryngoscope Investig. Otol.	FEB	2019	4	1					124	131		10.1002/lio2.231			8	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	HM2ZC	WOS:000459339700019	30828629	Green Published, gold			2022-02-06	
J	Joo, H; Bae, J; Lee, JS; Bang, Y; Lee, BJ; Park, JW; Lee, K; Cho, JH; Bu, Y				Joo, Hyejin; Bae, Jinhyun; Lee, Jun-Seon; Bang, Yumi; Lee, Beom-Joon; Park, Jae-Woo; Lee, Kyungjin; Cho, Jae-Heung; Bu, Youngmin			Icariin Improves Functional Behavior in a Mouse Model of Traumatic Brain Injury and Promotes Synaptic Plasticity Markers	PLANTA MEDICA			English	Article						icariin; Epimedii Herba; traumatic brain injury; synaptic plasticity; functional recovery; Berberidaceae	OXIDATIVE STRESS; RECOVERY; REHABILITATION; INFLAMMATION; HIPPOCAMPUS; DEFICITS; IMPACT; MOTOR; MICE	Epimedii Herba (EH) has been used in traditional Asian medicine to treat hemiplegia following stroke. Icariin, its major active component, is used as a quality-control marker and for its various pharmacological effects. We hypothesized that icariin would show protective effects following traumatic brain injury (TBI). The TBI mouse model was induced using a controlled cortical impact method. Body weight, brain damage, motor function, and cognitive function were evaluated. Synaptogenesis markers were analyzed to investigate potential mechanisms of action. The animals were divided into six groups: sham, control, minocycline-treated group, and icariin-treated (3, 10, and 30mg/kg, p.o.) groups. The icariin 30mg/kg-treated group regained body weight at 7 and 8d post TBI. Icariin 30mg/kg- and 10mg/kg-treated groups showed enhanced sensory-motor function at 8d post TBI in rotarod and balance beam tests. Icariin-treated groups showed increased recognition index in the novel object recognition test at all doses and increased spontaneous alternation in the Y-maze test at 30mg/kg. Icariin upregulated brain-derived neurotrophic factor, synaptophysin and postsynaptic density protein 95 expressions. However, no protective effects against brain damage or neuronal death were observed. The current results provide a basis for using icariin following TBI and suggest that it could be a candidate for the development of therapeutic agents for functional recovery after TBI.	[Joo, Hyejin] Kyung Hee Univ, Grad Sch, Dept Sci Korean Med, Seoul, South Korea; [Joo, Hyejin; Bae, Jinhyun; Lee, Jun-Seon; Bang, Yumi; Lee, Kyungjin; Bu, Youngmin] Kyung Hee Univ, Dept Herbal Pharmacol, Coll Korean Med, 26 Kyungheedae Ro, Seoul 02447, South Korea; [Lee, Beom-Joon; Park, Jae-Woo] Kyung Hee Univ, Dept Internal Med, Coll Korean Med, Seoul, South Korea; [Cho, Jae-Heung] Kyung Hee Univ, Dept Korean Rehabil Med, Seoul, South Korea		Bu, Y (corresponding author), Kyung Hee Univ, Dept Herbal Pharmacol, Coll Korean Med, 26 Kyungheedae Ro, Seoul 02447, South Korea.	ymbu@khu.ac.kr	Park, Jae-Woo/AAH-9097-2020	Park, Jae-Woo/0000-0002-1862-7317; Lee, Beom-Joon/0000-0003-4205-1175	Basic Science Research Program of the National Research Foundation of Korea (NRF) - ministry of Science ICT [2016R1A2B4012546]	This research was supported by a grant of Basic Science Research Program (2016R1A2B4012546) of the National Research Foundation of Korea (NRF) funded by the ministry of Science & ICT [42].	Aadal L, 2015, J NEUROSCI NURS, V47, P85, DOI 10.1097/JNN.0000000000000121; AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Cho JH, 2017, PHYTOTHER RES, V31, P838, DOI 10.1002/ptr.5807; Choi W, 2017, EVID-BASED COMPL ALT, V2017; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Curzon P., 2009, METHODS BEHAV ANAL N; Denes Z, 2004, DISABIL REHABIL, V26, P1163, DOI 10.1080/09638280412331270380; Ding J, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12802; Dolenec P, 2015, J NEUROPATH EXP NEUR, V74, P512, DOI 10.1097/NEN.0000000000000194; Fozouni N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076343; George P., 2004, MOUSE BRAIN STEREOTA; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Heo J, 1610, JAPBYEONGPYEON DONGU; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Indran IR, 2016, PHARMACOL THERAPEUT, V162, P188, DOI 10.1016/j.pharmthera.2016.01.015; Kooda K, 2015, CRIT CARE MED S1, V43, P289, DOI DOI 10.1097/01.CCM.0000474980.38145.7B; Kwon D, 2012, BONCHOHAK; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; Ministry of Food and Drug Safety, 2017, KOR HERB PHARM; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; Pandit V, 2018, J TRAUMA ACUTE CARE, V85, P48, DOI 10.1097/TA.0000000000001835; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rice RA, 2017, GLIA, V65, P931, DOI 10.1002/glia.23135; Rice RA, 2015, J NEUROSCI, V35, P9977, DOI 10.1523/JNEUROSCI.0336-15.2015; Rossini PM, 2003, LANCET NEUROL, V2, P493, DOI 10.1016/S1474-4422(03)00485-X; Sherman S. M., 2005, EXPLORING THALAMUS I; Soler JE, 2018, HIPPOCAMPUS, V28, P189, DOI 10.1002/hipo.22822; State Pharmacopoeia Commission, 2015, PHARMACOPOEIA PEOPLE; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Wu B, 2012, J ETHNOPHARMACOL, V142, P746, DOI 10.1016/j.jep.2012.05.056; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang ZG, 2018, CHIN J INTEGR MED, V24, P366, DOI 10.1007/s11655-018-2823-z	41	10	10	1	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	FEB	2019	85	3					231	238		10.1055/a-0753-0400			8	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	HM9GJ	WOS:000459790700007	30300905				2022-02-06	
J	Koola, MM				Koola, Maju Mathew			Antipsychotic-minocycline-acetylcysteine combination for positive, cognitive, and negative symptoms of schizophrenia	ASIAN JOURNAL OF PSYCHIATRY			English	Article						Minocycline; NAC; Schizophrenia; Traumatic brain injury	N-ACETYL-CYSTEINE; MISMATCH NEGATIVITY; KYNURENIC ACID; PHARMACOLOGY; METAANALYSIS; PSYCHOSIS; AGONIST; TRIAL	Preclinical evidence shows that the minocycline and N-acetylcysteine (NAC) combination synergistically improved cognition. Meta-analyses of randomized controlled trials (RCTs) with minocycline and NAC have shown some efficacy signal for positive, cognitive, and negative symptoms of schizophrenia. Hence, the combination may be more effective than either medication alone. The objective of this article is to highlight the potential role of the minocycline-NAC combination for the treatment of schizophrenia. The antipsychotic-minocycline-NAC combination is promising and has the potential to concurrently treat positive, cognitive, and primary negative symptoms. RCTs are warranted with the minocycline-NAC combination to address the unmet clinical need in schizophrenia.	[Koola, Maju Mathew] George Washington Univ, Sch Med & Hlth Sci, Dept Psychiat & Behav Sci, 2300 I St NW, Washington, DC 20037 USA		Koola, MM (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Psychiat & Behav Sci, 2300 I St NW, Washington, DC 20037 USA.	mkoola@gwu.edu					Bahrami Z, 2018, CYTOKINE, V107, P125, DOI 10.1016/j.cyto.2017.12.013; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Collis MG, 2006, NAT REV DRUG DISCOV, V5, P377, DOI 10.1038/nrd2036; Deakin B, 2018, LANCET PSYCHIAT, V5, P885, DOI 10.1016/S2215-0366(18)30345-6; Fawcett JA, 2015, PRIM CARE COMPANION, V17; Flis Marta, 2016, Pol Merkur Lekarski, V41, P160; Freedman R, 2008, AM J PSYCHIAT, V165, P1040, DOI 10.1176/appi.ajp.2008.07071135; Geerts H, 2006, J CLIN PHARMACOL, V46, p8S, DOI 10.1177/0091270006288734; Ghaderi A., EUR J CLIN PHARM; Girgis RR, 2019, J PSYCHIATR RES, V108, P57, DOI 10.1016/j.jpsychires.2018.07.006; Gmiro V. E., 2000, Eksperimental'naya i Klinicheskaya Farmakologiya, V63, P7; Haber M, 2018, J CEREBR BLOOD F MET, V38, P1312, DOI 10.1177/0271678X17718106; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Haroon Ebrahim, 2017, Mod Trends Pharmacopsychiatry, V31, P37, DOI 10.1159/000470805; Keshavan MS, 2017, PROG NEUROBIOL, V152, P3, DOI 10.1016/j.pneurobio.2016.07.004; Koola Maju Mathew, 2018, Mol Neuropsychiatry, V4, P134, DOI 10.1159/000494495; Koola MM, 2016, PSYCHIAT ANN, V46, P429, DOI 10.3928/00485713-20160624-01; Koola MM, SCHIZOPHR RES; Lavoie S, 2008, NEUROPSYCHOPHARMACOL, V33, P2187, DOI 10.1038/sj.npp.1301624; Perez VB, 2017, NEUROPSYCHOPHARMACOL, V42, P2206, DOI 10.1038/npp.2017.25; Perl A, 2015, METABOLOMICS, V11, P1157, DOI 10.1007/s11306-015-0772-0; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Preskorn SH, 2014, J PSYCHIATR PRACT, V20, P12, DOI 10.1097/01.pra.0000442935.15833.c5; Retsa C, 2018, SCHIZOPHR RES, V191, P80, DOI 10.1016/j.schres.2017.07.008; Sangobowale M. A., J NEUROTRAUMA; Sangobowale M, 2018, NEUROSCI LETT, V682, P16, DOI 10.1016/j.neulet.2018.06.010; Shiina A, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-27; Shim JC, 2012, NEUROPSYCHOPHARMACOL, V37, P660, DOI 10.1038/npp.2011.238; Solmi M, 2017, CNS SPECTRUMS, V22, P415, DOI 10.1017/S1092852916000638; Thiebes S, 2017, J PSYCHIATR NEUROSCI, V42, P273, DOI 10.1503/jpn.160187; Weiser M, SCHIZOPHR RES; Xiang YQ, 2017, EUR NEUROPSYCHOPHARM, V27, P8, DOI 10.1016/j.euroneuro.2016.11.012; Yang YS, 2017, CLIN PHARMACOL THER, V101, P191, DOI 10.1002/cpt.529; Youn T, 2003, SCHIZOPHR RES, V59, P253, DOI 10.1016/S0920-9964(02)00154-8	34	10	10	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1876-2018	1876-2026		ASIAN J PSYCHIATR	Asian J. Psychiatr.	FEB	2019	40						100	102		10.1016/j.ajp.2019.02.007			3	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	HQ7YX	WOS:000462641100027	30776665				2022-02-06	
J	Muceli, S; Bergmeister, KD; Hoffmann, KP; Aman, M; Vukajlija, I; Aszmann, OC; Farina, D				Muceli, Silvia; Bergmeister, Konstantin D.; Hoffmann, Klaus-Peter; Aman, Martin; Vukajlija, Ivan; Aszmann, Oskar C.; Farina, Dario			Decoding motor neuron activity from epimysial thin-film electrode recordings following targeted muscle reinnervation	JOURNAL OF NEURAL ENGINEERING			English	Article						targeted muscle reinnervation; motor neuron; man-machine interface; prostheses; EMG; epimysial electrode	NERVE INJURY; SURFACE; DRIVE; SIGNALS; MODEL	Objective. Surface electromyography (EMG) is currently used as a control signal for active prostheses in amputees who underwent targeted muscle reinnervation (TMR) surgery. Recent research has shown that it is possible to access the spiking activity of spinal motor neurons from multi-channel surface EMG. In this study, we propose the use of multi-channel epimysial EMG electrodes as an interface for decoding motor neurons activity following TMR. Approach. We tested multi-channel epimysial electrodes (48 detection sites) built with thin-film technology in an animal model of TMR. Eight animals were tested 12 weeks after reinnervation of the biceps brachii lateral head by the ulnar nerve. We identified the position of the innervation zone and the muscle fiber conduction velocity of motor units decoded from the multi-channel epimysial recordings. Moreover, we characterized the pick-up volume by the distribution of the motor unit action potential amplitude over the epimysium surface. Main results. The electrodes provided high quality signals with average signal-to-noise ratio >30 dB across 95 identified motor units. The motor unit action potential amplitude decreased with increasing distance of the electrode from the muscle fibers (P << 0.001). The decrease was more pronounced for bipolar compared to monopolar derivations. The average muscle fiber conduction velocity was 2.46 +/- 0.83 m s(-1). Most of the neuromuscular junctions were close to the region where the nerve was neurotized, as observed from the EMG recordings and imaging data. Significance. These results show that epimysial electrodes can be used for selective recordings of motor unit activities with a pick-up volume that included the entire muscle in the rat hindlimb. Epimysial electrodes can thus be used for detecting motor unit activity in muscles with specific fascicular territories associated to different functions following TMR surgery.	[Muceli, Silvia; Vukajlija, Ivan; Farina, Dario] Imperial Coll London, Dept Bioengn, London, England; [Bergmeister, Konstantin D.; Aman, Martin; Aszmann, Oskar C.] Med Univ Vienna, Christian Doppler Lab Restorat Extrem Funct, Vienna, Austria; [Hoffmann, Klaus-Peter] Fraunhofer Inst Biomed Engn, Dept Med Engn & Neuroprosthet, St Ingbert, Germany; [Aszmann, Oskar C.] Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Vienna, Austria; [Farina, Dario] Imperial Coll Sci, Dept Bioengn, Technol & Med, London SW7 2AZ, England		Farina, D (corresponding author), Imperial Coll London, Dept Bioengn, London, England.; Farina, D (corresponding author), Imperial Coll Sci, Dept Bioengn, Technol & Med, London SW7 2AZ, England.	d.farina@imperial.ac.uk	Muceli, Silvia/AAC-9127-2021; Bergmeister, Konstantin/AAO-9835-2021; Farina, Dario/AAB-2648-2019	Muceli, Silvia/0000-0002-0310-1021; 	H2020-ICT Project EXTEND [779982]; ERC Advanced Grant DEMOVE [267888]; ERC PoC INTERSPINE [737570]; Christian Doppler Research Association; Austrian Council for Research and Technology Development; Austrian Federal Ministry of Science, Research and Economy	This study was financed by the H2020-ICT Project EXTEND (No. 779982), the ERC Advanced Grant DEMOVE (No. 267888), the ERC PoC INTERSPINE (737570) and the Christian Doppler Research Association, Austrian Council for Research and Technology Development, Austrian Federal Ministry of Science, Research and Economy. None of the funding agencies were involved in the collection, analyses, and interpretation of data or writing and publication of this article.	Bergmeister KD, 2016, EUR SURG, V48, P334, DOI 10.1007/s10353-016-0386-4; Bergmeister K D, PERIPHERAL NER UNPUB; Bergmeister KD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00421; DIMITROV G V, 1974, Electromyography and Clinical Neurophysiology, V14, P423; Farina D, 2004, METHOD INFORM MED, V43, P30; Farina D, 2001, MED BIOL ENG COMPUT, V39, P225, DOI 10.1007/BF02344807; Farina D, 2008, J APPL PHYSIOL, V104, P821, DOI 10.1152/japplphysiol.00788.2007; Farina D, 2017, J NEUROSCI, V37, P11285, DOI 10.1523/JNEUROSCI.1179-17.2017; Farina D, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0025; Farina D, 2016, P IEEE, V104, P353, DOI 10.1109/JPROC.2015.2498665; Glaser V, 2013, IEEE T NEUR SYS REH, V21, P949, DOI 10.1109/TNSRE.2013.2247631; HOFFER JA, 1980, ANN BIOMED ENG, V8, P351, DOI 10.1007/BF02363438; Holobar A, 2007, IEEE T SIGNAL PROCES, V55, P4487, DOI 10.1109/TSP.2007.896108; Huang H, 2008, IEEE T NEUR SYS REH, V16, P37, DOI 10.1109/TNSRE.2007.910282; Kapelner T, 2018, IEEE T NEUR SYS REH, V26, P244, DOI 10.1109/TNSRE.2017.2766360; Kemp SWP, 2013, J PERIPHER NERV SYST, V18, P220, DOI 10.1111/jns5.12035; KUIKEN TA, 1995, BRAIN RES, V676, P113, DOI 10.1016/0006-8993(95)00102-V; Kuiken TA, 2007, LANCET, V369, P371, DOI 10.1016/S0140-6736(07)60193-7; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Kung TA, 2014, PLAST RECONSTR SURG, V133, P1380, DOI 10.1097/PRS.0000000000000168; KUPA EJ, 1995, J APPL PHYSIOL, V79, P23, DOI 10.1152/jappl.1995.79.1.23; MASUDA T, 1983, ELECTROEN CLIN NEURO, V55, P594, DOI 10.1016/0013-4694(83)90171-2; McGill KC, 2005, J NEUROSCI METH, V149, P121, DOI 10.1016/j.jneumeth.2005.05.015; Merletti R, 2003, J ELECTROMYOGR KINES, V13, P37, DOI 10.1016/S1050-6411(02)00082-2; Miller LA, 2008, IEEE T NEUR SYS REH, V16, P46, DOI 10.1109/TNSRE.2007.911817; Moore AM, 2012, J NEUROSCI METH, V204, P19, DOI 10.1016/j.jneumeth.2011.10.011; Muceli S, 2015, J PHYSIOL-LONDON, V593, P3789, DOI 10.1113/JP270902; Negro F, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026027; Ortiz-Catalan M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008933; Roeleveld K, 1997, ACTA PHYSIOL SCAND, V161, P465, DOI 10.1046/j.1365-201X.1997.00247.x; Vujaklija I, 2017, BIOSYST BIOROBOT, V15, P1359, DOI 10.1007/978-3-319-46669-9_222	31	10	10	0	11	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	FEB	2019	16	1							016010	10.1088/1741-2552/aaed85			9	Engineering, Biomedical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	HE1QI	WOS:000453047500001	30524045	hybrid			2022-02-06	
J	Raikes, AC; Satterfield, BC; Killgore, WDS				Raikes, Adam C.; Satterfield, Brieann C.; Killgore, William D. S.			Evidence of actigraphic and subjective sleep disruption following mild traumatic brain injury	SLEEP MEDICINE			English	Article						Actigraphy; Daytime sleepiness; Sleep disruption; Mild traumatic brain injury; Sleep onset latency; Sleep efficiency; Sleep quality	SPORT-RELATED CONCUSSION; PROLONGED RECOVERY; DAYTIME SLEEPINESS; HIGH-SCHOOL; SYMPTOMS; INSOMNIA; TRAJECTORIES; DISORDERS; QUALITY; TEAM	Objective/background: Mild traumatic brain injuries (mTBI) are frequently associated with long-term, self-reported sleep disruption. Objective corroboration of these self-reports is sparse and limited by small sample sizes. The purpose of this study was to report on actigraphically-measured sleep outcomes in individuals with and without a history of recent mTBI in two U.S. cities (Boston, MA and Tucson, AZ). Patients/methods: Fifty-eight individuals with a recent (within 18 months) mTBI and 35 individuals with no prior mTBI history were recruited for one of four studies across two sites. Participants completed a minimum of one week of actigraphy. Additionally, mTBI participants self-reported daytime sleepiness, sleep disruption, and functional sleep-related outcomes. Results: In Boston, mTBI participants obtained less average sleep with shorter sleep onset latencies (SOL) than healthy individuals. In Tucson, mTBI participants had greater SOL and less night-to-night SOL variability compared to healthy individuals. Across mTBI participants, SOL was shorter and night-to-night SOL variability was greater in Boston than Tucson. Sleep efficiency (SE) variability was greater in Tucson than Boston across both groups. Only SOL variability was significantly associated with daytime sleepiness (r = 0.274) in the mTBI group after controlling for location. Conclusion: Sleep quality, SOL and SE variability, are likely affected by mTBIs. Between-group differences in each site existed but went in opposite directions. These findings suggest the possibility of multiple, rather than a singular, profiles of sleep disruption following mTBI. Precision medicine models are warranted to determine whether multiple sleep disruption profiles do indeed exist following mTBI and the predisposing conditions that contribute to an individual's experience of sleep disruption. (c) 2018 Elsevier B.V. All rights reserved.	[Raikes, Adam C.; Satterfield, Brieann C.; Killgore, William D. S.] Univ Arizona, Coll Med, Dept Psychiat, Social Cognit & Affect Neurosci Lab, Tucson, AZ 85724 USA; [Killgore, William D. S.] Harvard Med Sch, Dept Psychiat, McLean Hosp, Belmont, MA USA		Raikes, AC (corresponding author), Univ Arizona, Dept Psychiat, POB 245002, Tucson, AZ 85724 USA.	raikes.research@gmail.com	Satterfield, Brieann/AAC-1475-2022; Raikes, Adam/M-2600-2019	Raikes, Adam/0000-0002-1609-6727	US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-1-0056, W81XWH-14-1-0571, W81XWH-17-C-008, D12AP00241]	This research was supported by multiple grants from the US Army Medical Research and Materiel Command (USAMRMC) to Dr. William D. S. Killgore, including W81XWH-11-1-0056, W81XWH-14-1-0571, W81XWH-17-C-008, and D12AP00241. The content, opinions, interpretations, conclusions, and recommendations are solely the responsibility of the authors and do not necessarily represent the views of Partners Healthcare, the University of Arizona College of Medicine, the Department of Defense, or the U.S. Army Medical Research and Materiel Command.	Allan AC, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000222; [Anonymous], 2016, VA DOD CLIN PRACTICE; Arbour C, 2015, SLEEP MED, V16, P534, DOI 10.1016/j.sleep.2014.12.002; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bajaj S, 2018, HUM BRAIN MAPP, V39, P1886, DOI 10.1002/hbm.23951; Bajaj S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00616; Berger I, 2017, GLOBAL PEDIAT HLTH, V4, DOI [10.1177/2333794X17745973.2333794X17745973, DOI 10.1177/2333794X17745973.2333794X17745973]; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chiu HY, 2014, INT J NURS STUD, V51, P892, DOI 10.1016/j.ijnurstu.2013.10.020; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Cui J, 2015, NEUROIMAGE, V106, P123, DOI 10.1016/j.neuroimage.2014.11.035; Dregan A, 2011, INT PSYCHOGERIATR, V23, P1413, DOI 10.1017/S1041610211000664; Farrell-Carnahan L, 2015, BRAIN INJURY, V29, P1400, DOI 10.3109/02699052.2015.1063161; Faul M, 2010, TRAUMATIC BRAIN INJU; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Hashizaki M, 2018, CHRONOBIOL INT, V35, P933, DOI 10.1080/07420528.2018.1443118; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Johns M, 1997, SLEEP, V20, P844, DOI 10.1093/sleep/20.10.844; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kantermann T, 2007, CURR BIOL, V17, P1996, DOI 10.1016/j.cub.2007.10.025; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kerr Z, 2016, BRAIN INJURY, V30, P504; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; Mani Arash, 2015, Bull Emerg Trauma, V3, P93; Mantua J, 2018, SLEEP MED REV, V41, P61, DOI 10.1016/j.smrv.2018.01.004; Mantua J, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx062; Mantua J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00328; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Modarres Mo H., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P59, DOI 10.1016/j.nbscr.2016.06.001; Mollayeva T, 2017, SLEEP MED, V34, P179, DOI 10.1016/j.sleep.2017.02.021; Mollayeva T, 2016, SLEEP MED, V20, P157, DOI 10.1016/j.sleep.2015.09.008; Mollayeva T, 2016, SLEEP MED, V19, P153, DOI 10.1016/j.sleep.2015.05.014; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Okonkwo D, 2016, J NEUROTRAUM, V33, pA38; Omachi TA, 2011, ARTHRIT CARE RES, V63, pS287, DOI 10.1002/acr.20544; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Soldatos CR, 2005, SLEEP MED, V6, P5, DOI 10.1016/j.sleep.2004.10.006; Stein E, 2017, BRAIN INJURY, V31, P1736, DOI 10.1080/02699052.2017.1380843; Sufrinko AM, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000387; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; The Centers for Disease Control and Prevention, 2016, BAS INF TRAUM BRAIN; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; Weaver TE, 1997, SLEEP, V20, P835; Wickham H, 2016, TIDYR EASILY TIDY DA; Wickham H., 2015, dplyr: A Grammar of Data Manipulation; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Zhang D, 2018, RSQ R SQUARED RELATE	69	10	10	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	FEB	2019	54						62	69		10.1016/j.sleep.2018.09.018			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HL5WB	WOS:000458800800010	30529779				2022-02-06	
J	Zhao, W; Ji, SB				Zhao, Wei; Ji, Songbai			Mesh Convergence Behavior and the Effect of Element Integration of a HumanHead Injury Model	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Finite element model; Mesh convergence; Element integration; Worcester head injury model	BRAIN-INJURY; STRAIN; HEAD; DEFORMATION; VALIDATION; TRAUMA; IMPACT; ATLAS	Numerous head injury models exist that vary in mesh density by orders of magnitude. A careful study of the mesh convergence behavior is necessary, especially in terms of strain most relevant to brain injury. To this end, as well as to investigate the effect of element integration scheme on simulated strains, we re-meshed the Worcester Head Injury Model at five mesh densities (similar to 7.2-1000k high-quality hexahedral elements of the brain). Results from explicit dynamic simulations of three cadaveric impacts and an in vivo head rotation were compared. First, scalar metrics of the whole brain only considering magnitude were used, including peak maximum principal strain and population-based median strain. They were further extended to deep white matter regions and the entire brain elements, respectively, to form two response vectors to account for both magnitude and distribution. Using benchmark enhanced full-integration elements (C3D8I), a minimum of 202.8k brain elements werenecessary to converge for response vectors of the deep white matterregions. This model was further used to simulate with reduced integration (C3D8R). We found that hourglass energy higher than the commonrule of thumb (e.g., up to 44.38% vs.<10% of internal energy) was necessary to maintain comparable strain relative to C3D8I. Based on these results, it is recommended that a humanhead injury model should have a minimum number of 202.8k elements, oran average element size of no larger than 1.8mm, for the brain. C3D8R formulation with relax stiffness hourglass control using a high scaling factor is also recommended to achieve sufficient accuracy without substantial computational cost.	[Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA		Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA.	sji@wpi.edu		Ji, Songbai/0000-0002-2886-5781	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853, R21 NS088781]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088781, R01NS092853] Funding Source: NIH RePORTER	Funding is provided by the NIH Grants R01 NS092853 and R21 NS088781.	Abaqus, 2016, AB ONL DOC AB 2016; Atsumi N., 2016, INT J VEH SAF, V9, P1, DOI [10.1504/ijvs.2016.077145, DOI 10.1504/IJVS.2016.077145]; BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Cai YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197992; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; King A. I, 2003, IS HEAD INJURY CAUSE; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Krueger R, 2011, NF1676L11493 NASA; Langer P, 2017, J COMPUT ACOUST, V25, DOI 10.1142/S0218396X17500254; Laurent H, 2010, FINITE ELEM ANAL DES, V46, P751, DOI 10.1016/j.finel.2010.04.004; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2013, COMPUT METHOD BIOMEC, V16, P271, DOI 10.1080/10255842.2011.617005; Mao HJ, 2011, J NEUROTRAUM, V28, P2263, DOI 10.1089/neu.2010.1600; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Post A, 2012, P I MECH ENG P-J SPO, V226, P200, DOI 10.1177/1754337112449420; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Ruan JS, 1993, SAE TECHNICAL PAPERS, DOI [10. 4271/933114, DOI 10.4271/933114]; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Ward C. C, 1975, STAPP CAR CRASH C P, DOI [10. 4271/751163., DOI 10.4271/751163]; Yanaoka T, 2015, 2015011439 SAE, DOI [10. 4271/2015-01-1439, DOI 10.4271/2015-01-1439.C0PYRIGHT]; Yang KH, 2011, STUD MECHANOBIOL TIS, V3, P69, DOI 10.1007/8415_2010_62; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhao W, 2018, J NEUROTRAUM, V2018, P5; Zhao W, 2015, IRCOBI C LYON FRANC, P208; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhao W, 2017, ANN BIOMED ENG, V45, P2437, DOI 10.1007/s10439-017-1888-3; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239	45	10	10	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	FEB	2019	47	2					475	486		10.1007/s10439-018-02159-z			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	HI3XA	WOS:000456383600012	30377900	Green Accepted			2022-02-06	
J	Schroeder, RW; Martin, PK; Walling, A				Schroeder, Ryan W.; Martin, Phillip K.; Walling, Anne			Neuropsychological Evaluations in Adults	AMERICAN FAMILY PHYSICIAN			English	Article							TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CLINICAL-NEUROPSYCHOLOGY; DIFFERENTIAL-DIAGNOSIS; NATIONAL ACADEMY; AMERICAN-ACADEMY; TOTAL SCORE; FOLLOW-UP; DEMENTIA	Neuropsychologists provide detailed assessments of cognitive and emotional functioning that often cannot be obtained through other diagnostic means. They use standardized assessment tools and integrate the findings with other data to determine whether cognitive decline has occurred, to differentiate neurologic from psychiatric conditions, to identify neurocognitive etiologies, and to determine the relationship between neurologic factors and difficulties in daily functioning. Family physicians should consider referring patients when there are questions about diagnostic decision making or planning of individualized management strategies for patients with mild cognitive impairment, dementia, traumatic brain injury, and other clinical conditions that affect cognitive functioning. Neuropsychological testing can differentiate Alzheimer dementia from nondementia with nearly 90% accuracy. The addition of neuropsychological testing to injury severity variables (e.g., posttraumatic amnesia) increases predicted accuracy in functional outcomes. A neuropsychological evaluation can be helpful in addressing concerns about functional capacities (e.g., ability to drive or live independently) and in determining a patient's capacity to make decisions about health care or finances. Most patients who underwent neuropsychological evaluation and their significant others reported that they found the evaluation helpful in understanding and coping with cognitive problems. (Copyright (C) 2019 American Academy of Family Physicians.)	[Schroeder, Ryan W.; Martin, Phillip K.; Walling, Anne] Univ Kansas, Sch Med, 1010 N Kansas St, Wichita, KS 67214 USA		Schroeder, RW (corresponding author), Univ Kansas, Sch Med, 1010 N Kansas St, Wichita, KS 67214 USA.	rschroeder2@kumc.edu					American Bar Association & American Psychological Association, 2008, ASS OLD AD DIM CAP H; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 1996, NEUROLOGY, V47, P592; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; BENNETTLEVY J, 1994, CLIN NEUROPSYCHOL, V8, P219, DOI 10.1080/13854049408401559; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Braun M, 2011, COGN BEHAV NEUROL, V24, P107, DOI 10.1097/WNN.0b013e3182351289; Centers for Disease Control and Prevention, UPD MILD TRAUM BRAIN; Chandler MJ, 2005, NEUROLOGY, V65, P102, DOI 10.1212/01.wnl.0000167607.63000.38; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Fields JA, 2010, CLIN NEUROPSYCHOL, V24, P1167, DOI 10.1080/13854046.2010.514865; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Gurnani AS, 2017, NEUROPSYCHOL REV, V27, P1, DOI 10.1007/s11065-016-9334-0; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Hentschel F, 2005, INT J GERIATR PSYCH, V20, P645, DOI 10.1002/gps.1333; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Michels TC, 2010, AM FAM PHYSICIAN, V82, P495; Moafmashhadi P, 2013, J GERIATR PSYCH NEUR, V26, P19, DOI 10.1177/0891988712473802; Ramirez-Gomez L, 2017, DEMENT GERIATR COGN, V44, P1, DOI 10.1159/000477344; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Roebuck-Spencer TM, 2017, ARCH CLIN NEUROPSYCH, V32, P491, DOI 10.1093/arclin/acx021; Sandry J, 2016, ARCH PHYS MED REHAB, V97, P1026, DOI 10.1016/j.apmr.2015.10.109; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Sorbi S, 2012, EUR J NEUROL, V19, P1159, DOI 10.1111/j.1468-1331.2012.03784.x; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Swainson R, 2001, DEMENT GERIATR COGN, V12, P265, DOI 10.1159/000051269; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Talacchi A, 2011, J NEURO-ONCOL, V103, P541, DOI 10.1007/s11060-010-0417-0; Temple RO, 2006, ARCH CLIN NEUROPSYCH, V21, P371, DOI 10.1016/j.acn.2006.05.002; Torrent C, 2007, ACTA PSYCHIAT SCAND, V116, P453, DOI 10.1111/j.1600-0447.2007.01072.x; U.S. Dept. of Veterans Affairs; U.S. Dept. of Defense, 2016, VA DOD CLIN PRACT GU; Visser PJ, 1999, J NEUROL, V246, P477, DOI 10.1007/s004150050387; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wahlin TBR, 2007, NEUROPSYCHOLOGY, V21, P31, DOI 10.1037/0894-4105.21.1.31; WARRINGTON EK, 1986, NEUROPSYCHOLOGIA, V24, P223, DOI 10.1016/0028-3932(86)90055-2; Watt S, 2018, CLIN NEUROPSYCHOL, V32, P368, DOI 10.1080/13854046.2017.1414885; Wechsler D., 2009, WMS 4 TECHNICAL INTE; Weissberger GH, 2017, NEUROPSYCHOL REV, V27, P354, DOI 10.1007/s11065-017-9360-6; Westervelt HJ, 2007, CLIN NEUROPSYCHOL, V21, P263, DOI 10.1080/13854040500519745; Wolfsgruber S, 2014, AM J GERIAT PSYCHIAT, V22, P1017, DOI 10.1016/j.jagp.2012.08.021; World Health Organization, 1993, ICD 10 CLASS MENT BE	47	10	10	0	3	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X	1532-0650		AM FAM PHYSICIAN	Am. Fam. Physician	JAN 15	2019	99	2					101	108					8	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HI3MR	WOS:000456354800011	30633479				2022-02-06	
J	Combs, PR; Ford, CB; Campbell, KR; Carneiro, KA; Mihalik, JP; Gfeller, M				Combs, Patricia R.; Ford, Cassie B.; Campbell, Kody R.; Carneiro, Kevin A.; Mihalik, Jason P.; Gfeller, Matthew			Influence of Self-reported Fatigue and Sex on Baseline Concussion Assessment Scores	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						neurocognition; postural control; postinjury; college athlete; mild traumatic brain injury	RECURRENT CONCUSSION; SINGLE-ITEM; NEUROCOGNITIVE PERFORMANCE; STANDARDIZED ASSESSMENT; COGNITIVE IMPAIRMENT; BRAIN-INJURY; SPORT; SYMPTOMS; GENDER; DEPRESSION	Background: Baseline concussion assessments are advocated to provide an objective preinjury point of comparison for determining the extent of postconcussion neurological deficits and to assist with return-to-activity decision making. Many factors, including testing environment, proctor availability, and testing group size, can influence test accuracy and validity; however, it is unknown how self-reported fatigue affects test scores. Purpose: To investigate the influence of self-reported fatigue and patient sex on baseline concussion assessment scores. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Participants included 494 healthy Division I college student-athletes (221 women, 273 men; mean +/- SD age, 20.0 +/- 1.3 years). During preseason baseline testing, participants were asked to rate their fatigue on a scale from 0 to 100 based on how they normally feel and function each day (0, completely exhausted; 100, completely awake and alert). Each participant then completed a multimodal baseline concussion assessment, including a graded symptom checklist (number of symptoms endorsed and total symptom severity score), Standardized Assessment of Concussion (SAC), Balance Error Scoring System (BESS), and CNS Vital Signs computerized neurocognitive testing. Multiple linear regressions tested whether self-reported fatigue and sex predicted baseline concussion examination scores. Results: Athletes with higher self-reported fatigue levels (ss = -0.014, P < .01) and female athletes (ss = -0.216, P < .01) reported more total symptoms. Being male (ss = 0.856, P < .01) increased the likelihood of endorsing zero symptoms versus any symptoms by a factor of 2.40. Women also had significantly higher SAC scores (ss = 0.569, P < .001), BESS scores (ss = -2.747, P < .001), and CNS Vital Signs summary scores (ss = 4.506, P < .001). SAC, BESS, and CNS Vital Signs scores were not predicted by fatigue level (P > .05). Conclusion: Female athletes and fatigued athletes endorsed more symptoms and higher symptom severity at baseline. Using total symptom endorsement and total symptom severity scores as part of the postinjury management is a common practice. The current data suggest that levels of reported exhaustion can influence concussion assessment scores meant to represent a healthy baseline and likely would interfere with postinjury assessment scores.	[Combs, Patricia R.; Ford, Cassie B.; Campbell, Kody R.; Carneiro, Kevin A.; Mihalik, Jason P.; Gfeller, Matthew] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Combs, Patricia R.; Ford, Cassie B.; Campbell, Kody R.; Carneiro, Kevin A.; Mihalik, Jason P.; Gfeller, Matthew] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Combs, Patricia R.; Campbell, Kody R.; Mihalik, Jason P.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC 27515 USA; [Carneiro, Kevin A.; Mihalik, Jason P.] Univ N Carolina, Dept Neurosurg, Chapel Hill, NC 27515 USA		Mihalik, JP (corresponding author), 2201 Stallings Evans Sports Med Complex, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu		Campbell, Kody/0000-0002-4534-5497; Roby, Patricia/0000-0003-0166-4274			Ahsberg E, 2000, SCAND J PSYCHOL, V41, P231, DOI 10.1111/1467-9450.00192; Altemus M, 2006, HORM BEHAV, V50, P534, DOI 10.1016/j.yhbeh.2006.06.031; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Iverson GL, 2014, APPL NEUROPSYCH-ADUL, V21, P36, DOI 10.1080/09084282.2012.721149; Kelman L, 2005, HEADACHE, V45, P904, DOI 10.1111/j.1526-4610.2005.05159.x; Kim HJ, 2017, INT J NURS STUD, V65, P35, DOI 10.1016/j.ijnurstu.2016.10.012; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leeder J, 2012, J SPORT SCI, V30, P541, DOI 10.1080/02640414.2012.660188; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Patrician PA, 2004, NURS RES, V53, P347, DOI 10.1097/00006199-200409000-00011; Pederson EL, 2007, J COUNS PSYCHOL, V54, P373, DOI 10.1037/0022-0167.54.4.373; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Sargent C, 2014, CHRONOBIOL INT, V31, P1160, DOI 10.3109/07420528.2014.957306; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Van Hooff MLM, 2007, J OCCUP HEALTH, V49, P224, DOI 10.1539/joh.49.224; VanWijk CMTG, 1997, SOC SCI MED, V45, P231, DOI 10.1016/S0277-9536(96)00340-1; VERBRUGGE L M, 1980, Journal of Behavioral Medicine, V3, P327, DOI 10.1007/BF00845289; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	40	10	10	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	JAN 3	2019	7	1							2325967118817515	10.1177/2325967118817515			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	HH1IM	WOS:000455472900001	30643836	gold, Green Published			2022-02-06	
J	Chen, G; Zhao, XN; Yu, G; Jian, HR; Li, Y; Xu, GM				Chen, Gang; Zhao, Xuening; Yu, Gang; Jian, Huirong; Li, Yun; Xu, Guangming			Otolith dysfunction in recurrent benign paroxysmal positional vertigo after mild traumatic brain injury	ACTA OTO-LARYNGOLOGICA			English	Article						Benign paroxysmal positional vertigo; vestibular evoked myogenic potential; traumatic brain injury; recurrence	EVOKED MYOGENIC POTENTIALS	Background: The pathogenesis of recurrence of traumatic benign paroxysmal positional vertigo (BPPV) is poorly understood by far. Objectives: To evaluate the value of secondary otolith dysfunction using vestibular evoked myogenic potential (VEMP) test in the pathogenesis of recurrence of BPPV after mild traumatic brain injury (mTBI). Material and methods: We reviewed 42 patients with BPPV after mTBI. According to recurrence, patients were divided into two groups. Both cervical VEMP (cVEMP) and ocular VEMP (oVEMP) tests were performed on all of them. Results: We detected abnormal cVEMP responses in four (26.7%) patients in the recurrent BPPV group after mTBI and five (18.5%) patients in the non-recurrent BPPV group after mTBI, and there was no significant difference between both groups. We detected abnormal oVMEP responses in nine (60.0%) patients in the recurrent BPPV group after mTBI and six (22.2%) patients in the non-recurrent BPPV group after mTBI, and there was a significant difference between both groups. Conclusions and significance: Our study shows that oVEMP abnormalities in recurrent BPPV group after mTBI are significantly higher than those in non- recurrent BPPV group after mTBI. Therefore, we can conclude that secondary utricular dysfunction may be a potential pathogenesis of recurrence of traumatic BPPV.	[Chen, Gang; Zhao, Xuening; Yu, Gang; Jian, Huirong; Li, Yun] Shandong Univ, Shandong Prov Hosp, Dept Otolaryngol Head & Neck Surg, Jinan, Shandong, Peoples R China; [Xu, Guangming] Shandong Univ, Shandong Prov Hosp, Dept Neurosurg, 324 Jingwu Rd, Jinan 250021, Shandong, Peoples R China		Xu, GM (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Neurosurg, 324 Jingwu Rd, Jinan 250021, Shandong, Peoples R China.	gmxu163@163.com			Key Technologies R & D Program of Shandong Province of China [2011GSF11844]	This work was supported by the Key Technologies R & D Program of Shandong Province of China under Grant No. 2011GSF11844.	Ahn SK, 2011, J TRAUMA, V70, P442, DOI 10.1097/TA.0b013e3181d0c3d9; Akin FW, 2004, J REHABIL RES DEV, V41, P473, DOI 10.1682/JRRD.2003.04.0060; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Brandt T, 2006, ACTA OTO-LARYNGOL, V126, P160, DOI 10.1080/00016480500280140; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; Lee JD, 2013, ACTA OTO-LARYNGOL, V133, P150, DOI 10.3109/00016489.2012.723823; Lee JD, 2011, EUR ARCH OTO-RHINO-L, V268, P1427, DOI 10.1007/s00405-010-1426-5; Lee SK, 2008, ACTA OTO-LARYNGOL, V128, P66, DOI 10.1080/00016480701387108; Liu HJ, 2012, ACTA OTO-LARYNGOL, V132, P803, DOI 10.3109/00016489.2012.657359; Murofushi T, 2011, ACTA OTO-LARYNGOL, V131, P945, DOI 10.3109/00016489.2011.580003; Pisani V, 2015, INT J AUDIOL, V54, P329, DOI 10.3109/14992027.2014.989454; Rosengren SM, 2010, CLIN NEUROPHYSIOL, V121, P636, DOI 10.1016/j.clinph.2009.10.016; SCHUKNECHT HF, 1969, ANN OTO RHINOL LARYN, V78, P253, DOI 10.1177/000348946907800205; Seo T, 2013, NEUROSCI LETT, V550, P12, DOI 10.1016/j.neulet.2013.06.041; Su HC, 2004, OTOL NEUROTOL, V25, P977, DOI 10.1097/00129492-200411000-00019; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; Xu H, 2016, J OTOLARYNGOL-HEAD N, V45, DOI 10.1186/s40463-016-0125-7; Yang CJ, 2017, ACTA OTO-LARYNGOL, V137, P29, DOI 10.1080/00016489.2016.1217043; Yang WS, 2008, OTOL NEUROTOL, V29, P1162, DOI 10.1097/MAO.0b013e31818a0881	20	10	10	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	JAN 2	2019	139	1					18	21		10.1080/00016489.2018.1562214			4	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	HO0XN	WOS:000460629200004	30714506				2022-02-06	
J	Deng, HS; Yue, JK; Winkler, EA; Dhall, SS; Manley, GT; Tarapore, PE				Deng, Hansen; Yue, John K.; Winkler, Ethan A.; Dhall, Sanjay S.; Manley, Geoffrey T.; Tarapore, Phiroz E.			Adult Firearm-Related Traumatic Brain Injury in United States Trauma Centers	JOURNAL OF NEUROTRAUMA			English	Article						firearm epidemiology; gunshot wound to the head; penetrating brain injury; traumatic brain injury	CIVILIAN GUNSHOT WOUNDS; HEAD TRAUMA; LEVEL-I; MORTALITY; OUTCOMES; PREDICTORS; CARE; HOMICIDE; IMPACT; DEMOGRAPHICS	Civilian firearm injury is an important public health concern in the United States. Gunshot wounds to the head (GSWH) remain in need of update and systematic characterization. We identify predictors of prolonged hospital length of stay (HLOS), intensive care unit length of stay (ICU LOS), medical complications, mortality, and discharge disposition from a population-based sample using the National Sample Program (NSP) of the National Trauma Data Bank (NTDB), years 2003-2012. Statistical significance was assessed at < 0.001 to correct for multiple comparisons. In total, 8148 adult GSWH patients were included extrapolating to 32,439 national incidents. Age was 36.6 +/- 16.4 years and 64.4% were severe traumatic brain injury (TBI; Glasgow Coma Scale [GCS] score 3-8). Assault (49.2%), handgun (50.3%), and residential injury (43.2%) were of highest incidence. HLOS and ICU LOS were 7.7 +/- 14.2 and 5.7 +/- 13.4 days, respectively. Overall mortality was 54.6%; suicide/self-injury was associated with the highest mortality rate (71.6%). GCS, Injury Severity Score, and hypotension were significant predictors for outcomes overall. Medicare/Medicaid patients had longer HLOS compared to private/commercial insured (mean increase, 4.4 days; 95% confidence interval [2.6-6.3]). Compared to the Midwest, the South had longer HLOS (mean increase, 3.7 days; [2.0-5.4]) and higher odds of complications (odds ratio [OR], 1.7 [1.4-2.0]); the West had lower odds of complications (OR, 0.6; [0.5-0.7]). Versus handgun, shotgun (OR, 0.3; [0.2-0.4]) and hunting rifle (OR, 0.5; [0.4-0.8]) resulted in lower mortality. Patients with government/other insurance had higher odds of discharging home compared to private/commercially insured (OR, 1.7; [1.3-2.3]). In comparison to level I trauma centers, level II trauma centers had lower odds of discharge to home (OR, 0.7; [0.5-0.8]). Our results support hypotension, injury severity, injury intent, firearm type, and U.S. geographical location as important prognostic variables in firearm-related TBI. Improved understanding of civilian GSWH is critical to promoting increased awareness of firearm injuries as a public health concern and reducing its debilitating injury burden to patients, families, and healthcare systems.	[Deng, Hansen; Yue, John K.; Winkler, Ethan A.; Dhall, Sanjay S.; Manley, Geoffrey T.; Tarapore, Phiroz E.] Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94143 USA; [Deng, Hansen; Yue, John K.; Winkler, Ethan A.; Dhall, Sanjay S.; Manley, Geoffrey T.; Tarapore, Phiroz E.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA		Tarapore, PE (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94143 USA.	phiroz.tarapore@ucsf.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Ambrosi PB, 2012, NEUROSURG REV, V35, P429, DOI 10.1007/s10143-012-0377-2; American College of Surgeons, DAT ADM YEAR 2012 US; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; [Anonymous], 2001, J TRAUMA S, V51, pS3; BAIGELMAN W, 1981, NEUROSURGERY, V9, P729, DOI 10.1227/00006123-198112000-00021; Baker S, 2012, INJURY RES THEORIES; BAZZOLI GJ, 1995, JAMA-J AM MED ASSOC, V273, P395; Bekelis K, 2015, ANN SURG, V261, P579, DOI 10.1097/SLA.0000000000000672; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; BENZEL EC, 1991, NEUROSURGERY, V29, P67, DOI 10.1227/00006123-199107000-00011; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Bizhan Aarabi, 2015, Handb Clin Neurol, V127, P181, DOI 10.1016/B978-0-444-52892-6.00012-X; Blissitt Patricia A, 2006, Crit Care Nurs Clin North Am, V18, P321, DOI 10.1016/j.ccell.2006.05.006; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carr BG, 2008, J TRAUMA, V64, P197, DOI 10.1097/TA.0b013e318061b628; Centers for Disease Control and Prevention, 2000, JAMA-J AM MED ASSOC, V283, P47, DOI [10.1001/jama.283.1.47, DOI 10.1001/JAMA.283.1.47]; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P1029; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Cook PJ, 1999, JAMA-J AM MED ASSOC, V282, P447, DOI 10.1001/jama.282.5.447; Cooper K. D, 1983, NEUROEPIDEMIOLOGY, V2, P79, DOI [10.1159/000110513, DOI 10.1159/000110513]; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Esposito DP, 2009, NEUROSURG QUART, V19, P249, DOI 10.1097/WNQ.0b013e3181bd1d53; FACKLER ML, 1984, J TRAUMA, V24, P35, DOI 10.1097/00005373-198401000-00005; Faul M, 2010, TRAUMATIC BRAIN INJU; Fowler KA, 2015, PREV MED, V79, P5, DOI 10.1016/j.ypmed.2015.06.002; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Hadley J, 2007, JAMA-J AM MED ASSOC, V297, P1073, DOI 10.1001/jama.297.10.1073; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; Harbrecht BG, 2004, J AM COLL SURGEONS, V198, P232, DOI 10.1016/j.jamcollsurg.2003.10.007; Hargarten SW, 1996, JAMA-J AM MED ASSOC, V275, P42, DOI 10.1001/jama.275.1.42; Hemenway D, 2000, J TRAUMA, V49, P985, DOI 10.1097/00005373-200012000-00001; HOLLERMAN JJ, 1990, AM J ROENTGENOL, V155, P685, DOI 10.2214/ajr.155.4.2119095; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; Jandial R, 2008, NEUROSURGERY, V62, P472, DOI 10.1227/01.neu.0000316015.05550.7a; Kaplan MS, 1998, SOC SCI MED, V46, P1227, DOI 10.1016/S0277-9536(97)10051-X; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KAUFMAN HH, 1993, NEUROSURGERY, V32, P962, DOI 10.1227/00006123-199306000-00013; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; KILLIAS M, 1993, CAN MED ASSOC J, V148, P1721; Kim KA, 2005, NEUROSURGERY, V57, P737, DOI [10.1227/01.NEU.0000175727.76530.94, 10.1227/01.NEU.0000164174.07281.F9]; Laskowitz D., 2015, TRANSLATIONAL RES TR; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2003, JAMA-J AM MED ASSOC, V289, P1515, DOI 10.1001/jama.289.12.1515; Majidi S, 2013, AM J EMERG MED, V31, P1215, DOI 10.1016/j.ajem.2013.05.026; MAX W, 1993, HEALTH AFFAIR, V12, P171, DOI 10.1377/hlthaff.12.4.171; McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757; Miller TR, 1997, ACCIDENT ANAL PREV, V29, P329, DOI 10.1016/S0001-4575(97)00007-9; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; ORDOG GJ, 1988, J TRAUMA, V28, P624, DOI 10.1097/00005373-198805000-00011; Panczak R, 2013, FORENSIC SCI INT, V233, P28, DOI 10.1016/j.forsciint.2013.08.017; Peek-Asa Corinne, 2017, Inj Epidemiol, V4, P20, DOI 10.1186/s40621-017-0120-0; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; Reddy AK, 2014, JAMA OPHTHALMOL, V132, P730, DOI 10.1001/jamaophthalmol.2013.8201; Reedy DC, 2003, INJ PREV, V9, P151, DOI 10.1136/ip.9.2.151; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; RISH BL, 1980, J NEUROSURG, V53, P772, DOI 10.3171/jns.1980.53.6.0772; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schoenfeld AJ, 2013, SPINE J, V13, P1766, DOI 10.1016/j.spinee.2013.03.024; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; SORLIE PD, 1994, ARCH INTERN MED, V154, P2409, DOI 10.1001/archinte.154.21.2409; STONE JL, 1995, J TRAUMA, V38, P851, DOI 10.1097/00005373-199506000-00002; Swan K G, 1985, Surg Annu, V17, P163; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vincent J.M., 2015, GUNSHOT WOUNDS PRACT; Vyrostek S.B., 2001, PSYCEXTRA DATASET; WELCH WP, 1993, NEW ENGL J MED, V328, P621, DOI 10.1056/NEJM199303043280906; Winkler EA, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15613; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612; Zafonte RD, 2001, NEUROL RES, V23, P219, DOI 10.1179/016164101101198370; Zehtabchi S, 2011, ACAD EMERG MED, V18, P637, DOI 10.1111/j.1553-2712.2011.01083.x; Zhao T., 2016, J TRAUMA ACUTE CARE	87	10	10	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					322	337		10.1089/neu.2017.5591			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800015	29855212				2022-02-06	
J	Kumar, MA; Cao, WJ; Pham, HP; Raju, D; Nawalinski, K; Maloney-Wilensky, E; Schuster, J; Zheng, XL				Kumar, Monisha A.; Cao, Wenjing; Pham, Huy P.; Raju, Dheeraj; Nawalinski, Kelsey; Maloney-Wilensky, Eileen; Schuster, James; Zheng, X. Long			Relative Deficiency of Plasma A Disintegrin and Metalloprotease with Thrombospondin Type 1 Repeats 13 Activity and Elevation of Human Neutrophil Peptides in Patients with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						ADAMTS13; coagulopathy; inflammation; traumatic brain injury; von Willebrand factor	VON-WILLEBRAND-FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; ADAMTS13 ACTIVITY; INTRAVASCULAR COAGULATION; PLASMINOGEN-ACTIVATOR; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE; INFLAMMATION; VWF; CELLS	Traumatic microvascular injury (tMVI) is a universal endophenotype of traumatic brain injury (TBI) that is responsible for significant neurological morbidity and mortality. The mechanism underlying tMVI is not fully understood. The present study aims to determine plasma levels of von Willebrand factor (VWF), a disintegrin and metalloprotease with thrombospondin type 1 repeats (ADAMTS) 13 activity, and human neutrophil peptides (HNP) 1-3 and to correlate these biomarkers with functional outcomes after moderate-severe TBI. Thirty-one consecutive TBI patients (Glasgow Coma Scale [GCS] range, 3-12) were enrolled into the study between February 2010 and November 2014. Blood samples were collected on 0, 1, 2, 3, and 5 days after admission and analyzed for plasma levels of VWF antigen (VWFAg), collagen-binding activity (VWFAc), ADAMTS13 activity, and HNP1-3 proteins. Mean values of plasma VWFAg, VWFAc, and HNP1-3 were significantly increased in TBI patients compared to those in healthy controls (n=30). Conversely, mean plasma values of ADAMTS13 activity in TBI patients were significantly decreased during the first 2 days after admission. This resulted in a dramatic reduction in the ratio of ADAMTS13 activity to VWFAg or ADAMTS13 to VWFAc in all 5 post-TBI days. Cluster analysis demonstrated that high median plasma levels of VWFAg and HNP1-3 were observed in the cluster with a high mortality rate. These results demonstrate that a relative deficiency of plasma ADAMTS13 activity, resulting from activation of neutrophils and endothelium, may contribute to the formation of microvascular thrombosis and mortality after moderate-severe TBI.	[Kumar, Monisha A.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nawalinski, Kelsey; Maloney-Wilensky, Eileen; Schuster, James] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kumar, Monisha A.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cao, Wenjing; Zheng, X. Long] Univ Alabama Birmingham, Dept Pathol, Div Lab Med, WP230K,619 19th St South, Birmingham, AL 35249 USA; [Pham, Huy P.] USC, Keck Sch Med, Dept Pathol, Los Angeles, CA USA; [Raju, Dheeraj] Univ Alabama Birmingham, Dept Acute Chron & Continuing Care, Birmingham, AL USA		Zheng, XL (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Lab Med, WP230K,619 19th St South, Birmingham, AL 35249 USA.	xzheng@uabmc.edu	Zheng, X. Long/ABD-7362-2021	Raju, Dheeraj/0000-0002-6571-3410	National Heart, Lung, and Blood Institute (NHLBI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01-HL126724, R01-HL115187]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL126724] Funding Source: NIH RePORTER	The study was, in part, supported by grants from National Heart, Lung, and Blood Institute (NHLBI) R01-HL126724 and R01HL115187 (to X.L.Z.).	Andersson HM, 2012, BLOOD, V119, P1555, DOI 10.1182/blood-2011-09-380618; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Aref S, 2013, HEMATOLOGY, V18, P237, DOI 10.1179/1607845412Y.0000000070; Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Boudreau RM, 2017, J SURG RES, V215, P47, DOI 10.1016/j.jss.2017.03.031; Braun M, 2017, BBA-MOL BASIS DIS, V1863, P2614, DOI 10.1016/j.bbadis.2017.05.020; Cao WJ, 2008, J THROMB HAEMOST, V6, P1233, DOI 10.1111/j.1538-7836.2008.02989.x; Cao WJ, 2016, HAEMATOLOGICA, V101, P1319, DOI 10.3324/haematol.2016.149021; Chauhan AK, 2006, J EXP MED, V203, P767, DOI 10.1084/jem.20051732; Chauhan AK, 2008, J EXP MED, V205, P2065, DOI 10.1084/jem.20080130; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Denorme F, 2016, BLOOD, V127, P2337, DOI 10.1182/blood-2015-08-662650; Everitt B, 2004, STAT METHODS MED RES, V13, P343, DOI 10.1191/0962280204sm371ed; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Gerritsen HE, 1999, THROMB HAEMOSTASIS, V82, P1386; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Higazi AAR, 1996, J BIOL CHEM, V271, P17650, DOI 10.1074/jbc.271.30.17650; Horii M, 2008, HEART VESSELS, V23, P301, DOI 10.1007/s00380-008-1053-x; Horn M, 2012, J THROMB HAEMOST, V10, P647, DOI 10.1111/j.1538-7836.2012.04640.x; Hosler GA, 2003, ARCH PATHOL LAB MED, V127, P834; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; Khan MM, 2012, J THROMB HAEMOST, V10, P1665, DOI 10.1111/j.1538-7836.2012.04822.x; Kumar M, 2017, THROMB HAEMOSTASIS, V117, P691, DOI 10.1160/TH16-11-0834; Lafuente JV, 1999, J NEUROTRAUM, V16, P425, DOI 10.1089/neu.1999.16.425; Lowenberg EC, 2010, THROMB HAEMOSTASIS, V103, P181, DOI 10.1160/TH09-04-0223; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Lu RN, 2015, J THROMB HAEMOST, V13, P1064, DOI 10.1111/jth.12901; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; Morel O, 2008, PLATELETS, V19, P9, DOI 10.1080/09537100701817232; Nakano T, 2015, BRAIN RES, V1624, P330, DOI 10.1016/j.brainres.2015.07.027; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Pillai VG, 2016, BLOOD, V128, P110, DOI 10.1182/blood-2015-12-688747; RICE WG, 1987, BLOOD, V70, P757; Sabatier F, 2002, BLOOD, V99, P3962, DOI 10.1182/blood.V99.11.3962; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Sonneveld MAH, 2015, BLOOD, V126, P2739, DOI [10.1182/blood-2015-05643338, 10.1182/blood-2015-05-643338]; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; WAGNER DD, 1991, MAYO CLIN PROC, V66, P621, DOI 10.1016/S0025-6196(12)60522-9; Wang LX, 2013, ANN NEUROL, V73, P189, DOI 10.1002/ana.23762; Zhao BQ, 2009, BLOOD, V114, P3329, DOI 10.1182/blood-2009-03-213264; Zheng XL, 2013, J THROMB HAEMOST, V11, P11, DOI 10.1111/jth.12221; Zheng XL, 2008, ANNU REV PATHOL-MECH, V3, P249, DOI 10.1146/annurev.pathmechdis.3.121806.154311; Zheng XL, 2015, ANNU REV MED, V66, P211, DOI 10.1146/annurev-med-061813-013241	49	10	10	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					222	229		10.1089/neu.2018.5696			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800005	29848170	Green Published			2022-02-06	
J	Lininger, MR; Wayment, HA; Craig, DI; Huffman, AH; Lane, TS				Lininger, Monica R.; Wayment, Heidi A.; Craig, Debbie, I; Huffman, Ann Hergatt; Lane, Taylor S.			Improving Concussion-Reporting Behavior in National Collegiate Athletic Association Division I Football Players: Evidence for the Applicability of the Socioecological Model for Athletic Trainers	JOURNAL OF ATHLETIC TRAINING			English	Article						theories; mild traumatic brain injuries; head trauma	ICE HOCKEY; KNOWLEDGE; EDUCATION; IMPACT; ATTITUDES; NORMS; DISCLOSURE; SYMPTOMS; COACH; LAW	Context: Few researchers have examined the views of important stakeholders in football student-athletes' spheres of influence and whether their views map well in a systems approach to understanding concussion-reporting behavior (CRB). Objective: To examine the extent to which stakeholders' beliefs about what influences football players' CRBs reflect system-level influences that go beyond individual-level factors. Design: Qualitative study. Setting: Four National Collegiate Athletic Association Division I university athletic programs. Patients or Other Participants: A total of 26 individuals (athletic directors = 5, athletic trainers [ATs] = 10, football coaches = 11). Data Collection and Analysis: Semistructured interviews with stakeholders were transcribed and analyzed using the socioecological model according to the Miles and Huberman coding methods. Results: Stakeholders largely identified individual-level factors (attitudes), followed by exosystem-level factors (university policies and support for ATs), with fewer microsystem- and mesosystem-level factors (coach influence and communication between coaches and ATs, respectively) and almost no macrosystem-level factors (media influence, cultural norms about aggression and toughness in football). Conclusions: Promising evidence indicates growing stakeholder awareness of the importance of exosystem-level factors (eg, medical personnel and CRB policies) in influencing CRB rates. However, frontline stakeholders and policy makers may benefit from practices that bridge these influences (eg, coach involvement and communication), allowing for a more integrated approach to influence student-athletes' willingness to improve their CRBs.	[Lininger, Monica R.] No Arizona Univ, Dept Phys Therapy & Athlet Training, POB 15094, Flagstaff, AZ 86011 USA; [Wayment, Heidi A.; Huffman, Ann Hergatt; Lane, Taylor S.] No Arizona Univ, Dept Psychol Sci, Flagstaff, AZ 86011 USA; [Craig, Debbie, I] No Arizona Univ, Athlet Training Program, Flagstaff, AZ 86011 USA		Lininger, MR (corresponding author), No Arizona Univ, Dept Phys Therapy & Athlet Training, POB 15094, Flagstaff, AZ 86011 USA.	monica.lininger@nau.edu		Lane, Taylor Scarlett/0000-0001-9387-5700	NCAA; US Department of DefenseUnited States Department of Defense	We thank the Research Grand Challenge: Changing Attitudes about Concussion in Young and Emerging Adults, which was sponsored by the NCAA and the US Department of Defense, for funding this research. The views expressed in this article do not necessarily represent the official policy or position of the NCAA or the US Department of Defense. We thank graduate assistants Patrick Doyle, MS; Keragan Cavolo, BS; and Emilee Jung, BA, for all their work in support of this research.	Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Carroll-Alfano M, 2017, J ATHL TRAINING, V52, P689, DOI 10.4085/1062-6050-52.3.08; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Faure CE, 2011, SPORT J, V14; Flaherty MR, 2016, J PEDIATR-US, V178, P268, DOI 10.1016/j.jpeds.2016.08.025; Furness Z, 2016, POP COMMUN, V14, P49, DOI 10.1080/15405702.2015.1084628; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lininger M, 2017, ATHLETIC TRAIN SPORT, V9, P71, DOI DOI 10.3928/19425864-20161116-01; Mackenzie B, 2015, PEDIATR EMERG CARE, V31, P25, DOI 10.1097/PEC.0000000000000325; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; National Collegiate Athletic Association Academic and Membership Affairs Staff, 2016, 2016 2017 NCAA DIV 1; Onate JA., 2009, ATHLETIC TRAINING SP, V1, DOI [DOI 10.3928/19425864-20090427-07, 10.3928/19425864-20090427-07]; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sanderson J, 2016, COMMUN SPORT, V4, P3, DOI 10.1177/2167479514536982; Sefton T., 2003, EVALUATION, P73; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Wallace LM, 2014, HEALTH PSYCHOL REV, V8, P8, DOI 10.1080/17437199.2013.775629	38	10	10	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2019	54	1					21	29		10.4085/1062-6050-47-18			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	HO1BA	WOS:000460639000004	30721092	Green Published, gold			2022-02-06	
J	Mac Donald, CL; Barber, J; Patterson, J; Johnson, AM; Dikmen, S; Fann, JR; Temkin, N				Mac Donald, Christine L.; Barber, Jason; Patterson, Jana; Johnson, Ann M.; Dikmen, Sureyya; Fann, Jesse R.; Temkin, Nancy			Association Between 5-Year Clinical Outcome in Patients With Nonmedically Evacuated Mild Blast Traumatic Brain Injury and Clinical Measures Collected Within 7 Days Postinjury in Combat	JAMA NETWORK OPEN			English	Article							QUALITY-OF-LIFE; HEAD-INJURY; SCALE; SYMPTOMS; HEALTH; RELIABILITY; SENSITIVITY; QOLIBRI	IMPORTANCE Although previous work has examined clinical outcomes in combat-deployed veterans, questions remain regarding how symptoms evolve or resolve following mild blast traumatic brain injury (TBI) treated in theater and their association with long-term outcomes. OBJECTIVE To characterize 5-year outcome in patients with nonmedically evacuated blast concussion compared with combat-deployed controls and understand what clinical measures collected acutely in theater are associated with 5-year outcome. DESIGN, SETTING, AND PARTICIPANTS A prospective, longitudinal cohort study including 45 service members with mild blast TBI within 7 days of injury (mean 4 days) and 45 combat deployed nonconcussed controls was carried out. Enrollment occurred in Afghanistan at the point of injury with evaluation of 5-year outcome in the United States. The enrollment occurred from March to September 2012 with 5-year follow up completed from April 2017 to May 2018. Data analysis was completed from June to July 2018. EXPOSURES Concussive blast TBI. All patients were treated in theater, and none required medical evacuation. MAIN OUTCOMES AND MEASURES Clinical measures collected in theater included measures for concussion symptoms, posttraumatic stress disorder (PTSD) symptoms, depression symptoms, balance performance, combat exposure intensity, cognitive performance, and demographics. Five-year outcome evaluation included measures for global disability, neurobehavioral impairment, PTSD symptoms, depression symptoms, and 10 domains of cognitive function. Forward selection multivariate regression was used to determine predictors of 5-year outcome for global disability, neurobehavior impairment, PTSD, and cognitive function. RESULTS Nonmedically evacuated patients with concussive blast injury (n = 45; 44 men, mean [SD] age, 31 [5] years) fared poorly at 5-year follow-up compared with combat-deployed controls (n = 45; 35 men; mean [SD] age, 34 [7] years) on global disability, neurobehavioral impairment, and psychiatric symptoms, whereas cognitive changes were unremarkable. Acute predictors of 5-year outcome consistently identified TBI diagnosis with contribution from acute concussion and mental health symptoms and select measures of cognitive performance depending on the model for 5-year global disability (area under the curve following bootstrap validation [AUC(BV)] = 0.79), neurobehavioral impairment (correlation following bootstrap validation [R-BV] = 0.60), PTSD severity (R-BV = 0.36), or cognitive performance (R-BV = 0.34). CONCLUSIONS AND RELEVANCE Service members with concussive blast injuries fared poorly at 5-year outcome. The results support a more focused acute screening of mental health following TBI diagnosis as strong indicators of poor long-term outcome. This extends prior work examining outcome in patients with concussive blast injury to the larger nonmedically evacuated population.	[Mac Donald, Christine L.; Barber, Jason; Patterson, Jana; Temkin, Nancy] Univ Washington, Dept Neurol Surg, 352 9th Ave,Box 359924, Seattle, WA 98195 USA; [Johnson, Ann M.] Washington Univ, Ctr Clin Studies, St Louis, MO USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA		Mac Donald, CL (corresponding author), Univ Washington, Dept Neurol Surg, 352 9th Ave,Box 359924, Seattle, WA 98195 USA.	cmacd@uw.edu			NIH RO1 grant from NINDS [1R01NS091618-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091618] Funding Source: NIH RePORTER	Support for this study was provided an NIH RO1 grant from NINDS awarded to Dr Mac Donald (1R01NS091618-01). Any opinions, findings, conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the US Government, Department of Defense, NIH or the US Department of Veterans Affairs, and no official endorsement should be inferred.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Cook PA, 2018, J NEUROTRAUM, V35, P991, DOI 10.1089/neu.2017.5141; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Martinson SJ, 2019, B ENTOMOL RES, V109, P141, DOI [10.1017/S0007485318000184, 10.1080/02699052.2018.1492741]; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; McCauley SR, 2010, J NEUROTRAUM, V27, P991, DOI 10.1089/neu.2009.1195; McDonald JH., 2014, HDB BIOL STAT; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Polusny MA, 2011, PSYCHOL MED, V41, P687, DOI 10.1017/S0033291710002047; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tombough T., 1996, TEST MEMORY MALINGER; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Walker WC, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000251; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; 1996, STAT MED, V15, P361, DOI DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-41089/NEU.2013.2984; 2013, J INT NEUROPSYCH SOC, V19, P1, DOI DOI 10.1017/S1355617712000902; 2008, AM J EPIDEMIOL, V167, P1446, DOI DOI 10.1093/AJE/KWN068; 2010, J NEUROTRAUM, V27, P975, DOI DOI 10.1089/NEU.2009.1193; 1987, J NEUROL NEUROSUR PS, V50, P183, DOI DOI 10.1136/JNNP.50.2.183; 1971, AM J PSYCHIAT, V127, P1653, DOI DOI 10.1176/AJP.127.12.1653; 2017, JAMA NEUROL, V74, P821, DOI DOI 10.1001/JAMANEUROL.2017.0143; 1995, J NEUROL, V242, P587, DOI DOI 10.1007/BF00868811; 1999, NEUROLOGY, V53, P988, DOI DOI 10.1212/WNL.53.5.988; 2007, GEN HOSP PSYCHIAT, V29, P294, DOI DOI 10.1016/J.GENHOSPPSYCH.2007.03.004; 2017, ARCH PHYS MED REHAB, V98, P1646, DOI DOI 10.1016/J.APMR.2017.03.022; 2012, PSYCHOSOM MED, V74, P249, DOI DOI 10.1097/PSY.0B013E318244C604; 2003, QUAL LIFE RES, V12, P963, DOI DOI 10.1023/A:1026119331193; 1998, J NEUROTRAUM, V15, P573, DOI DOI 10.1089/NEU.1998.15.573; 2014, J NEUROTRAUM, V31, P425, DOI DOI 10.1089/NEU.2013.2952; 2013, J NEUROTRAUM, V30, P680, DOI DOI 10.1089/NEU.2012.2506; 2018, J TRAUMA STRESS, V31, P114, DOI DOI 10.1002/JTS.22259; 2007, PEDIATRICS, V119, P749, DOI DOI 10.1542/PEDS.2006-1186; 1983, PSYCHOL MED, V13, P595, DOI DOI 10.1017/S0033291700048017; 2001, DEPRESS ANXIETY, V13, P132, DOI DOI 10.1002/DA.1029; 2001, J ATHL TRAIN, V36, P263; 2011, ARCH GEN PSYCHIAT, V68, P79, DOI DOI 10.1001/ARCHGENPSYCHIATRY.2010.172; 2015, AM J PSYCHIAT, V172, P1101, DOI DOI 10.1176/APPI.AJP.2015.14121572; 1982, BIOMETRICS, V38, P715; 2008, J NEUROSURG, V108, P950, DOI DOI 10.3171/JNS/2008/108/5/0950; 2001, SLEEP MED, V2, P297, DOI DOI 10.1016/S1389-9457(00)00065-4; 2014, J NEUROTRAUM, V31, P1899, DOI DOI 10.1089/NEU.2014.3455; 2018, BRAIN INJURY, V32, P1245, DOI DOI 10.1080/02699052.2018.1494854	66	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	JAN	2019	2	1							e186676	10.1001/jamanetworkopen.2018.6676			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU6WO	WOS:000465422700040	30646193	gold, Green Published			2022-02-06	
J	Michetti, CP; Fakhry, SM; Brasel, K; Martin, ND; Teicher, EJ; Newcomb, A				Michetti, Christopher P.; Fakhry, Samir M.; Brasel, Karen; Martin, Niels D.; Teicher, Erik J.; Newcomb, Anna		TRIPP Study Grp	Trauma ICU Prevalence Project: the diversity of surgical critical care	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						surgical critical care; prevalence study; trauma intensive care unit; ICU mortality; critical care diagnoses		Background Surgical critical care is crucial to the care of trauma and surgical patients. This study was designed to provide a contemporary assessment of patient types, injuries, and conditions in intensive care units (ICU) caring for trauma patients. Methods This was a multicenter prevalence study of the American Association for the Surgery of Trauma; data were collected on all patients present in participating centers' trauma ICU (TICU) on November 2, 2017 and April 10, 2018. Results Forty-nine centers submitted data on 1416 patients. Median age was 58 years (IQR 41-70). Patient types included trauma (n=665, 46.9%), non-trauma surgical (n=536, 37.8%), medical (n=204, 14.4% overall), or unspecified (n=11). Surgical intensivists managed 73.1% of patients. Of ICU-specific diagnoses, 57% were pulmonary related. Multiple high-intensity diagnoses were represented (septic shock, 10.2%; multiple organ failure, 5.58%; adult respiratory distress syndrome, 4.38%). Hemorrhagic shock was seen in 11.6% of trauma patients and 6.55% of all patients. The most common traumatic injuries were rib fractures (41.6%), brain (38.8%), hemothorax/pneumothorax (30.8%), and facial fractures (23.7%). Forty-four percent were on mechanical ventilation, and 17.6% had a tracheostomy. One-third (33%) had an infection, and over half (54.3%) were on antibiotics. Operations were performed in 70.2%, with 23.7% having abdominal surgery. At 30 days, 5.4% were still in the ICU. Median ICU length of stay was 9 days (IQR 4-20). 30-day mortality was 11.2%. Conclusions Patient acuity in TICUs in the USA is very high, as is the breadth of pathology and the interventions provided. Non-trauma patients constitute a significant proportion of TICU care. Further assessment of the global predictors of outcome is needed to inform the education, research, clinical practice, and staffing of surgical critical care providers. Level of evidence IV, prospective observational study.	[Michetti, Christopher P.; Teicher, Erik J.; Newcomb, Anna] Inova Fairfax Med Campus, Surg, Falls Church, VA USA; [Fakhry, Samir M.] Reston Hosp Ctr, Surg, Reston, VA USA; [Brasel, Karen] Oregon Hlth & Sci Univ, Surg, Portland, OR 97201 USA; [Martin, Niels D.] Univ Penn, Surg, Philadelphia, PA 19104 USA		Michetti, CP (corresponding author), Inova Fairfax Med Campus, Dept Surg, Falls Church, VA 22042 USA.	Christopher.Michetti@inova.org	Agrawal, Vaidehi/B-8282-2019; Martin, Niels/AAQ-8152-2021; /O-3005-2018	Agrawal, Vaidehi/0000-0002-1958-630X; Martin, Niels/0000-0002-2157-0825; West, Michaela A/0000-0002-6598-4114; Campion, Eric/0000-0002-4563-7748; Ferrari-Light, Dana/0000-0002-7658-5442; Michetti, Christopher/0000-0002-3744-0603; /0000-0001-9617-001X			Alam HB, 2010, J TRAUMA, V69, P471, DOI 10.1097/TA.0b013e3181e93159; Bukur M, 2015, J TRAUMA ACUTE CARE, V78, P920, DOI 10.1097/TA.0000000000000613; Committee on Trauma American College of Surgeons, 2014, RESOURCES OPTIMAL CA; Davies PE, 2018, AM J INFECT CONTROL, V46, P758, DOI 10.1016/j.ajic.2017.11.032; De Waele J, 2014, BMC INFECT DIS, V14, DOI [10.1186/1471-2334-14-420, 10.1186/1471-2334-14-193]; Duane Therese M, 2008, J Emerg Trauma Shock, V1, P74, DOI 10.4103/0974-2700.43183; Jurkovich GJ, 2017, CURR PROB SURG, V54, P364, DOI 10.1067/j.cpsurg.2017.05.001; Klein AL, 2014, J TRAUMA ACUTE CARE, V77, P964, DOI 10.1097/TA.0000000000000460; Leonard KL, 2016, SURG INFECT, V17, P363, DOI 10.1089/sur.2014.076; Lilly CM, 2011, CHEST, V140, P1232, DOI 10.1378/chest.11-0718; Lombardo S, 2017, J TRAUMA ACUTE CARE, V82, P489, DOI 10.1097/TA.0000000000001361; Lott JP, 2009, AM J RESP CRIT CARE, V179, P676, DOI 10.1164/rccm.200808-1281OC; Michetti CP, 2012, J TRAUMA ACUTE CARE, V72, P1165, DOI 10.1097/TA.0b013e31824d10fa; Napolitano LM, 2010, J TRAUMA, V69, P1619, DOI 10.1097/TA.0b013e3182011089; Nates JL, 2016, CRIT CARE MED, V44, P1553, DOI 10.1097/CCM.0000000000001856; The American Board of Surgery, 1937, PROM SURG EXC PROM SURG EXC	16	10	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open	JAN	2019	4	1							e000288	10.1136/tsaco-2018-000288			6	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	VK2XU	WOS:000672553800033	30899799	Green Published, gold			2022-02-06	
J	Nemeth, JM; Mengo, C; Kulow, E; Brown, A; Ramirez, R				Nemeth, Julianna M.; Mengo, Cecilia; Kulow, Emily; Brown, Alexandra; Ramirez, Rachel			Provider Perceptions and Domestic Violence (DV) Survivor Experiences of Traumatic and Anoxic-Hypoxic Brain injury: Implications for DV Advocacy Service Provision	JOURNAL OF AGGRESSION MALTREATMENT & TRAUMA			English	Article						Domestic violence; intimate partner violence; traumatic brain injury; anoxic-hypoxic brain injury; strangulation; intervention services; disability; accessibility	INTIMATE PARTNER VIOLENCE; STRANGULATION; PROFESSIONALS	Domestic violence (DV) survivors are susceptible to traumatic and anoxic-hypoxic brain injury, collectively referred to as brain injury (BI). This study characterized: 1) provider perception of the impact of BI on DV survivors' experiences with advocacy services and 2) survivors' reported exposures that can lead to BI. Data were collected at five advocacy organizations in 2017: 11 focus groups were conducted with service providers (n = 45 staff & 17 administrators) and interview administered surveys were completed with survivors (n = 49). Our findings indicate a discrepancy between providers' perception of the potential impact of BI on survivors' presentation and ability to access services, and survivors' pervasive exposure to incidents that can cause BI. Over 81% of survivors reported having been hit in the head or been made to have their head hit another object at least once, and over 83% of survivors reported ever having been strangled. Raising organizational capacity to serve DV survivors with BI is necessary. Intervention suggestions are provided.	[Nemeth, Julianna M.; Brown, Alexandra] Ohio State Univ, Coll Publ Hlth, Div Hlth Behav & Hlth Promot, Columbus, OH 43210 USA; [Mengo, Cecilia] Ohio State Univ, Coll Social Work, Columbus, OH 43210 USA; [Kulow, Emily; Brown, Alexandra; Ramirez, Rachel] Ohio Domest Violence Network, Columbus, OH USA		Nemeth, JM (corresponding author), Ohio State Univ, Coll Publ Hlth, 300C Cunz Hall,1841 Neil Ave, Columbus, OH 43210 USA.	nemeth.37@osu.edu		Nemeth, Julianna/0000-0002-1247-3337	Office for Victims of Crime, Office of Justice Programs, U.S. Department of Justice [2016-VX-GX-K012]	This project was supported under grant 2016-VX-GX-K012, awarded to the Ohio Domestic Violence Network by the Office for Victims of Crime, Office of Justice Programs, U.S. Department of Justice.	Bay E, 2009, CURR TREAT OPTION NE, V11, P377, DOI 10.1007/s11940-009-0042-4; Black M C., 2011, NATL INTIMATE PARTNE; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1041; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Foushee JP, 2017, RADIOL TECHNOL, V89, P83; Hunnicutt G, 2017, J FAM VIOLENCE, V32, P471, DOI 10.1007/s10896-016-9854-7; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Krueger RA, 2015, FOCUS GROUPS PRACTIC, V5th; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Mcquown C, 2016, AM J EMERG MED, V34, P1281, DOI 10.1016/j.ajem.2016.04.029; Mechanic MB, 2008, VIOLENCE AGAINST WOM, V14, P1148, DOI 10.1177/1077801208323792; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; O'Donnell C., 1970, DOMESTIC VIOLENCE PO; Padgett, 2017, QUALITATIVE METHODS; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Pritchard AJ, 2017, TRAUMA VIOLENCE ABUS, V18, P407, DOI 10.1177/1524838015622439; SCHUYLER M, 1976, SOC WORK, V21, P488; Synapse, 2018, TRAUM BRAIN INJ TBI; Synapse, 2018, AN HYP BRAIN INJ FAC; Taliaferro E, 2001, J EMERG MED, V21, P293, DOI 10.1016/S0736-4679(01)00397-3; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797	21	10	10	1	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1092-6771	1545-083X		J AGGRESS MALTREAT T	J. Aggress. Maltreatment Trauma		2019	28	6			SI		744	763		10.1080/10926771.2019.1591562			20	Psychology, Clinical; Criminology & Penology; Family Studies; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies; Psychiatry	IM2YW	WOS:000477859700007					2022-02-06	
J	Pijet, B; Stefaniuk, M; Kaczmarek, L				Pijet, Barbara; Stefaniuk, Marzena; Kaczmarek, Leszek			MMP-9 Contributes to Dendritic Spine Remodeling Following Traumatic Brain Injury	NEURAL PLASTICITY			English	Article								Traumatic brain injury (TBI) occurs when a blow to the head causes brain damage. Apart from physical trauma, it causes a wide range of cognitive, behavioral, and emotional deficits including impairments in learning and memory. On neuronal level, TBI may lead to circuitry remodeling and in effect imbalance between excitatory and inhibitory neurotransmissions. Such change in brain homeostasis may often lead to brain disorders. The basic units of neuronal connectivity are dendritic spines that are tiny protrusions forming synapses between two cells in a network. Spines are dynamic structures that undergo morphological transformation throughout life. Their shape is strictly related to an on/off state of synapse and the strength of synaptic transmission. Matrix metalloproteinase-9 (MMP-9) is an extrasynaptically operating enzyme that plays a role in spine remodeling and has been reported to be activated upon TBI. The aim of the present study was to evaluate the influence of MMP-9 on dendritic spine density and morphology following controlled cortical impact (CCI) as animal model of TBI. We examined spine density and dendritic spine shape in the cerebral cortex and the hippocampus. CCI caused a marked decrease in spine density as well as spine shrinkage in the cerebral cortex ipsilateral to the injury, when compared to sham animals and contralateral side both 1 day and 1 week after the insult. Decreased spine density was also observed in the dentate gyrus of the hippocampus; however, in contrast to the cerebral cortex, spines in the DG became more filopodia-like. In mice lacking MMP-9, no effects of TBI on spine density and morphology were observed.	[Pijet, Barbara; Stefaniuk, Marzena; Kaczmarek, Leszek] Polish Acad Sci, Nencki Inst Expt Biol, BRAINCITY, Lab Neurobiol, Pasteura 3, PL-02093 Warsaw, Poland		Pijet, B; Kaczmarek, L (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, BRAINCITY, Lab Neurobiol, Pasteura 3, PL-02093 Warsaw, Poland.	b.pijet@nencki.gov.pl; l.kaczmarek@nencki.gov.pl	Pijet-Binkiewicz, Barbara/B-6559-2019; Kaczmarek, Leszek/B-6171-2008	Pijet-Binkiewicz, Barbara/0000-0002-9268-5208; Kaczmarek, Leszek/0000-0002-7207-3490; Stefaniuk, Marzena/0000-0003-4725-8909	National Center of Research and Development (NCBiR) [NEURON/09/13, PBS/A8/36/2015]; Foundation for Polish Science BRAINCITYFoundation for Polish Science [MAB/2018/10]; European Union under the European Regional Development Fund	The study was supported by a grant from the National Center of Research and Development (NCBiR) grants: ERA-NET Neuron grant (NEURON/09/13) and (PBS/A8/36/2015) and the Foundation for Polish Science BRAINCITY MAB/2018/10. The BRAINCITY project is carried out within the International Research Agendas programme of the Foundation for Polish Science cofinanced by the European Union under the European Regional Development Fund.	Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Chen JR, 2010, NEUROSCIENCE, V167, P414, DOI 10.1016/j.neuroscience.2010.02.028; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Dziembowska M, 2012, INT J BIOCHEM CELL B, V44, P709, DOI 10.1016/j.biocel.2012.01.023; ERTURK A, 2002, THE JOURNAL OF NEURO, V36, P9962, DOI DOI 10.1523/JNEUROSCI.1898-15.2016; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Ferrer-Ferrer M, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00040; Frankowski H, 2012, METHODS MOL BIOL, V814, P221, DOI 10.1007/978-1-61779-452-0_15; GAO X, 2000, GAO X, V6, DOI DOI 10.1371/JOURNAL.PONE.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; GRAY EG, 1959, J ANAT, V93, P420; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Huntley GW, 2012, NAT REV NEUROSCI, V13, P743, DOI 10.1038/nrn3320; Jarero-Basulto JJ, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010017; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Lepeta K, 2015, SCHIZOPHRENIA BULL, V41, P1003, DOI 10.1093/schbul/sbv036; Magnowska M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27757; McCann RF, 2017, BIOL PSYCHIAT, V82, pE11, DOI 10.1016/j.biopsych.2017.05.020; Michaluk P, 2011, J CELL SCI, V124, P3369, DOI 10.1242/jcs.090852; MILLER MW, 1986, DEV BRAIN RES, V25, P271, DOI 10.1016/0165-3806(86)90217-8; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nagaoka A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26651; Neuhofer D, 2018, NEUROBIOL LEARN MEM, V154, P97, DOI 10.1016/j.nlm.2018.02.007; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Opdenakker G, 1997, Verh K Acad Geneeskd Belg, V59, P489; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Phillips LL, 2014, NEURAL REGEN RES, V9, P362, DOI 10.4103/1673-5374.128237; Pijet B, 2018, MOL NEUROBIOL, V55, P9294, DOI 10.1007/s12035-018-1061-5; Pitkanen A, 2014, PROG BRAIN RES, V214, P229, DOI 10.1016/B978-0-444-63486-3.00011-6; Reeves TM, 2003, J NEUROSCI, V23, P10182; Reinhard SM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00280; Ruszczycki B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-213; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Sutula TP, 2007, PROG BRAIN RES, V163, P541, DOI 10.1016/S0079-6123(07)63029-5; Szepesi Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098274; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; TIAN L, 2002, JOURNAL OF CELL BIOL, V178, P687, DOI DOI 10.1083/JCB.200612097; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vandooren J, 2014, PROG BRAIN RES, V214, P193, DOI 10.1016/B978-0-444-63486-3.00009-8; Verslegers M, 2013, PROG NEUROBIOL, V105, P60, DOI 10.1016/j.pneurobio.2013.03.004; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; WANG X, 2002, PROCEEDINGS OF THE N, V105, P19520, DOI DOI 10.1073/PNAS.0807248105; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; WILCZYNSKI G, 2002, JOURNAL OF CELL BIOL, V180, P1021, DOI DOI 10.1083/JCB.200708213; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wosiski-Kuhn M, 2012, SYNAPSE, V66, P661, DOI 10.1002/syn.21545; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024; Zhang YL, 2017, J NEUROSURG, V126, P782, DOI 10.3171/2016.3.JNS152699; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z	64	10	10	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.		2019	2019								3259295	10.1155/2019/3259295			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HZ0GD	WOS:000468518000001	31198417	Green Published, gold			2022-02-06	
J	Ruiter, KI; Boshra, R; Doughty, M; Noseworthy, M; Connolly, JF				Ruiter, Kyle, I; Boshra, Rober; Doughty, Mitchell; Noseworthy, Michael; Connolly, John F.			Disruption of function: Neurophysiological markers of cognitive deficits in retired football players	CLINICAL NEUROPHYSIOLOGY			English	Article						Concussion; mTBI; Event-related potentials; EEG; Behavioral assessment; Football	EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; RECURRENT CONCUSSION; CEREBRAL CONCUSSION; P3 AMPLITUDE; NOVELTY P3; DEPRESSION; MISMATCH; HISTORY	Objective: Recent studies demonstrate that sports-related concussions can have negative consequences on long-term brain health. The goal of the present study was to determine whether retired Canadian Football League (CFL) athletes with a history of concussions exhibit alterations in neurocognitive functioning, along with changes in physical, social, and psychological health. Methods: Our study compared nineteen retired CFL athletes' concussion histories to eighteen healthy age-matched controls with no history of concussion. Self-report inventories were used to assess depression, memory, attention, and general health. Neurophysiological markers of cognitive function were evaluated with event-related brain potentials (ERPs) as measured in two protocols: (1) A Mismatch Negativity (MMN) protocol for assessing the automatic early attentional brain mechanism; and, (2) a P300 auditory oddball task for assessing consciously controlled attention. Results: Relative to controls, CFL players exhibited: response delays and reduced amplitudes in neurophysiological responses; overall decreases in cognitive function; and poorer scores on self-reports of physical, social, and psychological health; reflecting problems in all three categories. Conclusion: Our findings demonstrate that multiple concussions sustained over several years can lead to altered cognitive and psychosocial function. Significance: Neurophysiological markers of conscious and pre-conscious attention provide an objective assessment for evaluating long-term cognitive consequences of concussion. (C) 2018 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.	[Ruiter, Kyle, I; Connolly, John F.] McMaster Univ, Dept Linguist & Languages, Togo Salmon Hall 513,1280 Main St, West Hamilton, ON L8S 4M2, Canada; [Ruiter, Kyle, I; Boshra, Rober; Noseworthy, Michael; Connolly, John F.] McMaster Univ, ARiEAL Res Ctr, LR Wilson Hall,1280 Main St, West Hamilton, ON L8S 4M2, Canada; [Boshra, Rober; Doughty, Mitchell; Noseworthy, Michael; Connolly, John F.] McMaster Univ, Sch Biomed Engn, ETB-406,1280 Main St, West Hamilton, ON L8S 4K1, Canada; [Boshra, Rober; Connolly, John F.] Vector Inst, MaRS Ctr, Toronto, ON, Canada; [Connolly, John F.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada		Ruiter, KI; Connolly, JF (corresponding author), McMaster Univ, Dept Linguist & Languages, Togo Salmon Hall 513,1280 Main St, West Hamilton, ON L8S 4M2, Canada.	ruiterki@mcmaster.ca; boshrar@rocmaster.ca; doughtmw@mcmaster.ca; nosewor@mcmaster.ca; jconnol@mcmaster.ca	Boshra, Rober/AAE-6466-2019; Doughty, Mitchell/AAC-7722-2022	Boshra, Rober/0000-0003-2925-199X; Doughty, Mitchell/0000-0001-7617-307X; Connolly, John/0000-0001-8869-5369; Ruiter, Kyle/0000-0002-7815-5980	Hamilton Spectator; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Senator William McMaster Chair in Cognitive Neuroscience of Language; Ontario Ministry of Research and InnovationMinistry of Research and Innovation, Ontario	The authors gratefully acknowledge the participants for their time and support of this project as well as Mr. Steve Buist and The Hamilton Spectator newspaper for their support. This work was supported by The Hamilton Spectator, Canada Foundation for Innovation (JFC), Senator William McMaster Chair in Cognitive Neuroscience of Language (JFC), and the Ontario Ministry of Research and Innovation (RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Finally, the authors would like to thank the reviewers whose comments and suggestions significantly improved this manuscript.	Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; BARR RE, 1978, INT J BIOMED COMPUT, V9, P465, DOI 10.1016/0020-7101(78)90053-3; Barth JT, 2001, J ATHL TRAINING, V36, P253; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; Blain-Moraes S, 2016, NORMAL BRAIN RESPONS, DOI [10.3389/fnhum.2016.00248, DOI 10.3389/FNHUM.2016.00248]; Brannan SK, 2005, J PSYCHIATR RES, V39, P43, DOI 10.1016/j.jpsychires.2004.04.011; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; BUTLER RA, 1968, J ACOUST SOC AM, V44, P945, DOI 10.1121/1.1911233; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dick BD, 2003, CLIN NEUROPHYSIOL, V114, P1497, DOI 10.1016/S1388-2457(03)00133-0; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Frishkoff G, 2011, STAND GENOMIC SCI, V5, P211, DOI 10.4056/sigs.2025347; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Girden E. R., 1992, ANOVA REPEATED MEASU; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heil M, 2000, J PSYCHOPHYSIOL, V14, P218, DOI 10.1027//0269-8803.14.4.218; Iverson GL, 2003, U BRIT COLUMBIA RIVE; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Kaipio ML, 2001, NEUROREPORT, V12, P1517, DOI 10.1097/00001756-200105250-00043; Kayser J, 2000, INT J PSYCHOPHYSIOL, V36, P211, DOI 10.1016/S0167-8760(00)00078-7; KEIDEL WD, 1965, J ACOUST SOC AM, V38, P191, DOI 10.1121/1.1909629; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; KEWMAN DG, 1991, INT J PSYCHIAT MED, V21, P253, DOI 10.2190/FRYK-TMGA-AULW-BM5G; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kopjar B, 1996, Inj Prev, V2, P135, DOI 10.1136/ip.2.2.135; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Light GA, 2007, J COGNITIVE NEUROSCI, V19, P1624, DOI 10.1162/jocn.2007.19.10.1624; Lim CL, 1999, PSYCHOPHYSIOLOGY, V36, P543; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maxwell S., 2004, DESIGNING EXPT ANAL; McCrory P, 2009, S AFR J SPORTS MED, V21; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Morlet D, 2014, BRAIN TOPOGR, V27, P467, DOI 10.1007/s10548-013-0335-5; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Naatanen R., 1983, TUTORIALS ERP RES, VVolume 10, P119, DOI DOI 10.1016/S0166-4115(08)62036-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Patel Salil H, 2005, Int J Med Sci, V2, P147; Pelosi L, 2000, CLIN NEUROPHYSIOL, V111, P1531, DOI 10.1016/S1388-2457(00)00354-0; POLICH J, 1983, PSYCHOPHYSIOLOGY, V20, P665, DOI 10.1111/j.1469-8986.1983.tb00936.x; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Reinvang I, 1999, NEUROPSYCHOL REV, V9, P231, DOI 10.1023/A:1021638723486; Seminowicz DA, 2007, PAIN, V130, P8, DOI 10.1016/j.pain.2007.03.036; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; SPRENG M, 1980, SCAND AUDIOL, P299; Sumich AL, 2006, J AFFECT DISORDERS, V92, P171, DOI 10.1016/j.jad.2006.01.006; Tavakoli P, 2018, CONSCIOUS COGN, V58, P60, DOI 10.1016/j.concog.2017.10.012; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Todd J, 2008, BIOL PSYCHIAT, V63, P58, DOI 10.1016/j.biopsych.2007.02.016; Veldhuijzen DS, 2006, PSYCHOPHARMACOLOGY, V183, P462, DOI 10.1007/s00213-005-0204-3; Xu C, 2012, COMP EFFECT DULOXETI; Yang WH, 2011, NEUROSCI LETT, V487, P372, DOI 10.1016/j.neulet.2010.10.059; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	81	10	11	5	21	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	JAN	2019	130	1					111	121		10.1016/j.clinph.2018.10.013			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HF3NJ	WOS:000454141500015	30522024				2022-02-06	
J	Santhanam, P; Wilson, SH; Oakes, TR; Weaver, LK				Santhanam, Priya; Wilson, Steffanie H.; Oakes, Terrence R.; Weaver, Lindell K.			Accelerated age-related cortical thinning in mild traumatic brain injury	BRAIN AND BEHAVIOR			English	Article						aging; cortical thinning; mild traumatic brain injury	HUMAN CEREBRAL-CORTEX; POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSIVE SYMPTOMS; GEOMETRICALLY ACCURATE; HYPERBARIC-OXYGEN; SERVICE MEMBERS; THICKNESS; ATROPHY; SEGMENTATION; TBI	Introduction: Mild traumatic brain injury (mTBI) can result in many structural abnormalities in the cerebral cortex. While thinning of the cortex has been shown in mTBI patients, there is high regional variability in reported findings. High-resolution imaging can elucidate otherwise unnoticed changes in cortical measures following injury. This study examined age-related patterns of cortical thickness in U.S. active duty service members and veterans with a history of mTBI (n = 66) as compared to a normative population (n = 67). Methods: Using a fully automated cortical parcellation methodology, cortical thickness measures were extracted from 31 bilateral cortical regions for all participants. Results: The effect of diagnosis and age on cortical thickness (group x age interaction) was found to be significant (p < 0.05) for many regions, including bilateral parietal and left frontal and temporal cortices. Findings held for a male-only subset, and there was no effect of time since injury in any regions. Conclusions: The presence of mTBI appeared to accelerate age-related cortical thinning across the cortex in our study population.	[Santhanam, Priya] Lovelace Biomed Res, Albuquerque, NM USA; [Wilson, Steffanie H.] Emmes Corp, Rockville, MD 20850 USA; [Oakes, Terrence R.] Univ Wisconsin, Madison Sch Med & Publ Hlth, Madison, WI USA; [Weaver, Lindell K.] Intermt Med Ctr, Div Hyperbar Med, Murray, UT USA; [Weaver, Lindell K.] Intermt LDS Hosp, Salt Lake City, UT USA; [Weaver, Lindell K.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA		Santhanam, P (corresponding author), Emmes Corp, Rockville, MD 20850 USA.	psanthanam@lrri.org			US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-15-D-0039-0003]	US Army Medical Research and Material Command, Grant/Award Number: W81XWH-15-D-0039-0003	Affairs Department of Defense & Department of Veterans, 2009, VA DOD CLIN PRACT GU; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bigler E, 2015, NEUROPSYCHOL REV, V25, P224, DOI 10.1007/s11065-015-9290-0; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Coffey CE, 1998, ARCH NEUROL-CHICAGO, V55, P169, DOI 10.1001/archneur.55.2.169; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DVBIC  Defense and Veterans Brain Injury Center, 2015, DOD NUMB TRAUM BRAIN; Espeseth T, 2008, NEUROBIOL AGING, V29, P329, DOI 10.1016/j.neurobiolaging.2006.10.030; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Hutton C, 2008, NEUROIMAGE, V40, P1701, DOI 10.1016/j.neuroimage.2008.01.027; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; King JB, 2016, NEUROIMAGE-CLIN, V11, P81, DOI 10.1016/j.nicl.2016.01.003; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Van Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weaver LK, 2018, UNDERSEA HYPERBAR M, V45, P129; Weaver LK, 2016, UNDERSEA HYPERBAR M, V43, P491; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028	50	10	11	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	JAN	2019	9	1							e01161	10.1002/brb3.1161			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	HM7CY	WOS:000459636100009	30488646	Green Published, gold			2022-02-06	
J	Tolmacheva, A; Savolainen, S; Kirveskari, E; Brandstack, N; Makela, JP; Shulga, A				Tolmacheva, Aleksandra; Savolainen, Sarianna; Kirveskari, Erika; Brandstack, Nina; Makela, Jyrki P.; Shulga, Anastasia			Paired associative stimulation improves hand function after non-traumatic spinal cord injury: A case series	CLINICAL NEUROPHYSIOLOGY PRACTICE			English	Article						TMS; Rehabilitation; Plasticity; Spinal Cord; Paired Associative Stimulation; Spinal cord injury	MOTOR CORTEX; PLASTICITY; PRIORITIES; INDUCTION; RECOVERY; BRAIN	Objectives: Long-term paired associative stimulation (PAS) is a non-invasive combination of transcranial magnetic stimulation and peripheral nerve stimulation and leads to improved hand motor function in individuals with incomplete traumatic tetraplegia. Spinal cord injuries (SCIs) can also be induced by neurological diseases. We tested a similar long-term PAS approach in patients with non-traumatic neurological SCI. Methods: In this case series, five patients with non-traumatic tetraplegia received PAS to the weaker upper limb 3 to 5 times per week for 6 weeks. Patients were evaluated by manual muscle testing (MMT) before and immediately after the therapy and at the 1- and 6-month follow-ups. Patients were also evaluated for spasticity, hand mechanical and digital dynamometry, pinch test and Box and Block test. Results: MMT values of all patients improved at all post-PAS evaluations. The mean +/- standard error MMT increase was 1.44 +/- 0.37 points (p = 0.043) immediately after PAS, 1.57 +/- 0.4 points (p = 0.043) at the 1-month follow-up and 1.71 +/- 0.47 points (p = 0.043) at the 6-month follow-up. The pinch test, digital dynamometry and Box and Block test results also improved in all patients. Conclusions: Long-term PAS may be a safe and effective treatment for improving hand function in patients with non-traumatic tetraplegia. Significance: This is the first report demonstrating the therapeutic potential of PAS for neurological SCI. (C) 2019 International Federation of Clinical Neurophysiology. Published by Elsevier B.V.	[Tolmacheva, Aleksandra; Savolainen, Sarianna; Kirveskari, Erika; Makela, Jyrki P.; Shulga, Anastasia] Univ Helsinki, HUS Med Imaging Ctr, BioMag Lab, Helsinki, Finland; [Tolmacheva, Aleksandra; Savolainen, Sarianna; Kirveskari, Erika; Brandstack, Nina; Makela, Jyrki P.; Shulga, Anastasia] Helsinki Univ Hosp, Helsinki, Finland; [Savolainen, Sarianna] Validia Rehabil Ctr, Helsinki, Finland; [Kirveskari, Erika] Helsinki Univ Hosp, HUS Med Imaging Ctr, Clin Neurophysiol, Clin Neurosci, Helsinki, Finland; [Kirveskari, Erika] Univ Helsinki, Helsinki, Finland; [Brandstack, Nina] Univ Helsinki, HUS Med Imaging Ctr, Radiol, Radiology, Finland; [Shulga, Anastasia] Helsinki Univ Hosp, Neurol, Clin Neurosci, Helsinki, Finland		Shulga, A (corresponding author), BioMag Lab, POB 340, Helsinki 00029, Finland.	anastasia.shulga@helsinki.fi		Shulga, Anastasia/0000-0003-0262-3570	Academy of FinlandAcademy of FinlandEuropean Commission [307951]; Maire Taponen Foundation; University of Helsinki	This work was supported by the Academy of Finland (AS, 307951), governmental subsidiary funds (AS), the Maire Taponen Foundation (AS) and the University of Helsinki (AT). The study sponsors had no role in the collection, analysis and interpretation of data or in the writing of the manuscript. We thank David Monter-Danger for excellent technical assistance (MRI).	Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Boddington LJ, 2017, BRAIN STIMUL, V10, P214, DOI 10.1016/j.brs.2017.01.006; Di Lazzaro V, 2008, BRAIN STIMUL, V1, P345, DOI 10.1016/j.brs.2008.07.004; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Hallett M., 2008, OXFORD HDB TRANSCRAN; Hislop H.J., 2014, DANIELS WORTHINGHAMS, V9; Rodionov A., 2019, SPINAL CORD SE UNPUB; Scivoletto G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00141; Sharp KG, 2017, J NEUROTRAUM, V34, P623, DOI 10.1089/neu.2016.4503; Shulga Anastasia, 2016, Spinal Cord Ser Cases, V2, P16016, DOI 10.1038/scsandc.2016.16; Shulga A, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00470; Shulga A, 2015, J NEUROSCI METH, V242, P112, DOI 10.1016/j.jneumeth.2015.01.012; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Suppa A, 2017, CLIN NEUROPHYSIOL, V128, P2140, DOI 10.1016/j.clinph.2017.08.003; Tolmacheva A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40474-0; Tolmacheva A, 2017, J NEUROTRAUM, V34, P2668, DOI 10.1089/neu.2017.4996; van Middendorp J, 2014, LANCET NEUROL, V13, P1167, DOI 10.1016/S1474-4422(14)70253-4; Wagner FB, 2018, NATURE, V563, P65, DOI 10.1038/s41586-018-0649-2; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844	20	10	10	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2467-981X			CLIN NEUROPHYS PRACT	Clin. Neurophys. Pract.		2019	4						178	183		10.1016/j.cnp.2019.07.002			6	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	JQ0LB	WOS:000498645400028	31886442	Green Published, gold			2022-02-06	
J	Wu, P; Zhao, HT; Gou, XC; Wu, XW; Zhang, SQ; Deng, G; Chen, QX				Wu, Peng; Zhao, Haitian; Gou, Xingchun; Wu, Xingwang; Zhang, Shenqi; Deng, Gang; Chen, Qianxue			Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury	INTERNATIONAL JOURNAL OF NANOMEDICINE			English	Article						traumatic brain injury; Nanoparticle; Tat-NR2B9c; CAQK; CCAQK	SYSTEM	Background and purpose: Traumatic brain injury (TBI) is a major disease without effective treatment. Recently, Tat-NR2B9c peptide emerged as a promising neuroprotective agent, but limited in clinical translation by it low brain penetrability. We synthesized Tat-NR2B9c loaded self-assembled activatable protein nanoparticles, termed TN-APNPs, and demonstrated that TN-APNPs enhanced the delivery of Tat-NR2B9c to the brain lesion in stroke. Herein we developed a novel approach to further engineering TN-APNPs for targeted delivery of Tat-NR2B9c to the injured brain with enhanced efficiency through conjugation of CAQK or CCAQK, a short peptide. Methods: Short peptide-conjugated TN-APNPs were synthesized by conjugated with CAQK or CCAQK via a click condensation reaction with CBT, then analyzed by dynamic light scattering, transmission electron microscopy and thrombin responsive assay. Characterization of short peptide-conjugated TN-APNPs were investigated by using cell excitotoxicity assay and transwell blood-brain-barrier model in vitro, and pharmacokinetics, IVIS imaging system and confocal analysis in TBI-bearing mice. Evaluation of therapeutic effects were analyzed by H&E staining, Elevated Plus Maze analysis and Rotarod test. Results: CAQK-conjugated TN-APNPs (C-TN-APNPs) and CCAQK-conjugated TN-APNPs (CC-TN-APNPs) were spherical in morphology and 30 nm in diameter. In vitro studies revealed that TN-APNPs, C-TN-APNPs and CC-TN-APNPs were responsive to thrombin cleavage, reduced the cytotoxicity of Tat-NR2B9c, and increased BBB permeability of Tat-NR2B9c. CC-TN-APNPs demonstrated the better circulation time, better targeting ability and penetrating efficiency to the injured brain, and better therapeutic benefits in vivo studies. Conclusion: This study demonstrated CC-TN-APNPs as a promising therapeutic for clinical management of TBI.	[Wu, Peng; Zhang, Shenqi; Deng, Gang; Chen, Qianxue] Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan 430060, Hubei, Peoples R China; [Zhao, Haitian] Harbin Inst Technol, Sch Chem & Chem Engn, Harbin 150001, Heilongjiang, Peoples R China; [Gou, Xingchun] Xian Med Univ, Shaanxi Key Lab Brain Disorders, Xian 710021, Shaanxi, Peoples R China; [Gou, Xingchun] Xian Med Univ, Inst Basic & Translat Med, Xian 710021, Shaanxi, Peoples R China; [Wu, Xingwang] Anhui Med Univ, Affiliated Hosp 1, Dept Radiol, Hefei 230020, Anhui, Peoples R China		Chen, QX (corresponding author), Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan 430060, Hubei, Peoples R China.	chenqx666@whu.edu.cn	wu, peng/S-7027-2019	wu, peng/0000-0002-7580-7314; Chen, Qianxue/0000-0002-9413-1030; Zhang, Shenqi/0000-0003-2939-6312	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81572489, 81372683, 81502175]; Projects of International Cooperation and Exchanges Natural Science Foundation of Shannxi Province of China [2018KW-038]	This work was supported by National Natural Science Foundation of China (No. 81572489, 81372683, and 81502175) and Projects of International Cooperation and Exchanges Natural Science Foundation of Shannxi Province of China (no. 2018KW-038).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Bharadwaj VN, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700668; Chatard M, 2017, CELL PHYSIOL BIOCHEM, V42, P1592, DOI 10.1159/000479399; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cook DJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003824; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Czupalla CJ, 2014, METHODS MOL BIOL, V1135, P415, DOI 10.1007/978-1-4939-0320-7_34; Fasano S, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.029.2009; Haberny KA, 2002, TOXICOL SCI, V68, P9, DOI 10.1093/toxsci/68.1.9; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Leea AS, 2008, P NATL ACAD SCI USA, V105, P17163, DOI 10.1073/pnas.0807749105; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mann AP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11980; Papadopoulou LC, 2013, PHARMACEUTICALS, V6, P32, DOI 10.3390/ph6010032; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Yu Xi, 2018, Adv Mater, V30, pe1803888, DOI 10.1002/adma.201803888; Zheng Z, 2017, CHEM SCI, V8, P214, DOI 10.1039/c6sc01461e	22	10	11	9	22	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2013			INT J NANOMED	Int. J. Nanomed.		2019	14						4059	4069		10.2147/IJN.S202353			11	Nanoscience & Nanotechnology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Pharmacology & Pharmacy	IC0UQ	WOS:000470675900004	31213815	Green Published, Green Submitted, gold			2022-02-06	
J	Yang, B; Li, B; Xu, CH; Hu, SJ; Dai, M; Xia, JY; Luo, P; Shi, XT; Zhao, ZQ; Dong, XZ; Fei, Z; Fu, F				Yang, Bin; Li, Bing; Xu, Canhua; Hu, Shijie; Dai, Meng; Xia, Junying; Luo, Peng; Shi, Xuetao; Zhao, Zhanqi; Dong, Xiuzhen; Fei, Zhou; Fu, Feng			Comparison of electrical impedance tomography and intracranial pressure during dehydration treatment of cerebral edema	NEUROIMAGE-CLINICAL			English	Article						Cerebral edema; Intracranial pressure; Dehydration treatment; Electrical impedance tomography	SEVERE HEAD-INJURY; HYPEROSMOLAR THERAPY; BRAIN EDEMA; MANNITOL; BIOIMPEDANCE; HEMORRHAGE; MODEL	Cerebral edema after brain injury can lead to brain damage and death if diagnosis and treatment are delayed. This study investigates the feasibility of employing electrical impedance tomography (EIT) as a non-invasive imaging tool for monitoring the development of cerebral edema, in which impedance imaging of the brain related to brain water content is compared with intracranial pressure (ICP). We enrolled forty patients with cerebral hemorrhage who underwent lateral external ventricular drain with intraventricular ICP and EIT monitoring for 3 h after initiation of dehydration treatment. The average reconstructed impedance value (ARV) calculated from EIT images was compared with ICP. Dehydration effects induced changes in ARV and ICP showed a close negative correlation in all patients, and the mean correlation reached R-2 = 0.78 +/- 0.16 (p < .001). A regression equation (R-2 = 0.62, p < .001) was formulated from the total of measurement data. The 95% limits of agreement were - 6.13 to 6.13 mmHg. Adaptive clustering and variance analysis of normalized changes in ARV and ICP showed 92.5% similarity and no statistically significant differences (p > .05). Moreover, the sensitivity, specificity and area under the curve of changes in ICP > 10 mmHg were 0.65, 0.73 and 0.70 respectively. The findings show that EIT can monitor changes in brain water content associated with cerebral edema, which could provide a real-time and non-invasive imaging tool for early identification of cerebral edema and the evaluation of mannitol dehydration.	[Yang, Bin; Xu, Canhua; Dai, Meng; Xia, Junying; Shi, Xuetao; Zhao, Zhanqi; Dong, Xiuzhen; Fu, Feng] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Shaanxi, Peoples R China; [Li, Bing; Hu, Shijie; Luo, Peng; Fei, Zhou] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Zhao, Zhanqi] Furtwangen Univ, Inst Tech Med, D-78054 Villingen Schwenningen, Germany		Fu, F (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Shaanxi, Peoples R China.; Fei, Z (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.	feizhou@fmmu.edu.cn; fengfu@fmmu.edu.cn		Fu, Feng/0000-0002-4286-5227; Luo, Peng/0000-0003-0746-939X; Zhao, Zhanqi/0000-0002-1279-2207; Yang, Bin/0000-0001-9687-5968	State Key Program of National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51837011]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61771475, 31771073]; Shaanxi Province Natural Science Research Project [2014JM2-6092]; Military Logistics Major Research Plan of China [AWS14C006]	This work was supported by the State Key Program of National Natural Science Foundation of China [51837011]; the National Natural Science Foundation of China [61771475] and [31771073]; the Shaanxi Province Natural Science Research Project [2014JM2-6092]; the Military Logistics Major Research Plan of China [AWS14C006].	Aristovich KY, 2016, NEUROIMAGE, V124, P204, DOI 10.1016/j.neuroimage.2015.08.071; Bagshaw AP, 2003, NEUROIMAGE, V20, P752, DOI 10.1016/S1053-8119(03)00301-X; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bilotta F, 2012, NEUROCRIT CARE, V16, P280, DOI 10.1007/s12028-011-9652-2; Brown B. H., 2003, Journal of Medical Engineering & Technology, V27, P97, DOI 10.1080/0309190021000059687; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2016, NEUROSURGERY, DOI [DOI 10.1227/NEU.0000000000001432, 10.1227/NEU.0000000000001432, 10.1227/neu.0000000000001432]; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Frerichs I, 2017, THORAX, V72, P83, DOI 10.1136/thoraxjnl-2016-208357; Fu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113202; Gilad O, 2009, NEUROIMAGE, V47, P514, DOI 10.1016/j.neuroimage.2009.04.085; Hannan S, 2018, NEUROIMAGE-CLIN, V20, P674, DOI 10.1016/j.nicl.2018.09.004; Harting MT, 2010, J SURG RES, V159, P557, DOI 10.1016/j.jss.2008.10.014; HARTWELL RC, 1993, NEUROSURGERY, V32, P444, DOI 10.1227/00006123-199303000-00017; HOLDER D, 2005, ELECT IMPEDANCE TOMO; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; Li G, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030537; Lingwood BE, 2002, BRAIN RES, V945, P97, DOI 10.1016/S0006-8993(02)02744-0; Malaeb SN, 2018, PEDIATR RES, V83, P484, DOI 10.1038/pr.2017.264; Manwaring PK, 2013, ANESTH ANALG, V117, P866, DOI 10.1213/ANE.0b013e318290c7b7; Marko NF, 2012, CRIT CARE, V16, DOI 10.1186/cc11182; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Oh T, 2011, MED BIOL ENG COMPUT, V49, P593, DOI 10.1007/s11517-011-0761-z; Reinert M, 2007, NEUROL RES, V29, P455, DOI 10.1179/016164107X164175; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Shi XT, 2018, IEEE SENS J, V18, P5974, DOI 10.1109/JSEN.2018.2836336; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; Tang T, 2016, PHYSIOL MEAS, V37, P751, DOI 10.1088/0967-3334/37/6/751; Torre-Healy A, 2012, NEUROCRIT CARE, V17, P117, DOI 10.1007/s12028-011-9649-x; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; VANNUCCI RC, 1993, SEMIN PERINATOL, V17, P330; Videen TO, 2001, NEUROLOGY, V57, P2120, DOI 10.1212/WNL.57.11.2120; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Xu C, 2015, 16 INT C BIOM APPL E, P90; Xu CH, 2011, PHYSIOL MEAS, V32, P585, DOI 10.1088/0967-3334/32/5/007; Yang B., 2013, 5 INT C DIG IM PROC; You WD, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0199-9; Zeng HK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-153; Zhang G, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-016-0294-7	41	10	12	2	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	23								101909	10.1016/j.nicl.2019.101909			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IX6OV	WOS:000485804400101	31284231	Green Published, gold			2022-02-06	
J	Yang, YX; Ye, YQ; Chen, C; Kong, CG; Su, XH; Zhang, X; Bai, W; He, XS				Yang, Yongxiang; Ye, Yuqin; Chen, Chen; Kong, Chuiguang; Su, Xinhong; Zhang, Xin; Bai, Wei; He, Xiaosheng			Acute Traumatic Brain Injury Induces CD4(+) and CD8(+) T Cell Functional Impairment by Upregulating the Expression of PD-1 via the Activated Sympathetic Nervous System	NEUROIMMUNOMODULATION			English	Article						Traumatic brain injury; T cell dysfunction; Programmed cell death-1; Sympathetic nervous system; Norepinephrine	HEAD-INJURY; ORGAN DYSFUNCTION; MECHANISMS; COMPLICATIONS; RECEPTOR; CATECHOLAMINES; RESTORATION; RESPONSES; BLOCKADE; IMMUNITY	Objective: Traumatic brain injury (TBI) induces immunosuppression in the acute phase, and the activation of the sympathetic nervous system (SNS) might play a role in this process, but the mechanism involved is unknown. Herein, we explored the impact of acute (a) TBI on the peripheral immune system and its correlation with the SNS and the T cell exhaustion marker, PD-1 (programmed cell death-1). Methods: Flow cytometry (FCM) was performed to analyze the expression of T cell markers and intracellular cytokines, interferon-. and tumor necrosis factor-a, and the T cell exhaustion marker, PD-1, in the peripheral blood mononuclear cells (PBMCs) of TBI rats. Enzyme-linked immunosorbent assay (ELISA) was performed to analyze the concentration of norepinephrine (NE) in the serum. Propranolol was administrated to block the SNS in vivo and NE stimulation was used to imitate the activation of the SNS in vitro. Results: We found that the concentration of NE was significantly elevated after TBI, and the dysfunction of CD4(+) and CD8(+) T cells was reversed by the SNS blocker propranolol in vivo and imitated by the SNS neurotransmitter NE in vitro. The expression of PD-1 on CD4(+) and CD8(+) T cells was upregulated after aTBI, which was reversed by propranolol administration in vivo and imitated by NE stimulation in vitro. Furthermore, the PD-1 blocker reversed the dysfunction of CD4(+) and CD8(+) T cells in vitro. Conclusion: Our findings demonstrated that aTBI activated the SNS, and further upregulated the expression of PD-1 on CD4(+) and CD8(+) T cells, which, in turn, impaired their function and contributed to immunosuppression. (c) 2019 S. Karger AG, Basel	[Yang, Yongxiang; Ye, Yuqin; Kong, Chuiguang; Su, Xinhong; Zhang, Xin; Bai, Wei; He, Xiaosheng] Fourth Mil Med Univ, Airforce Mil Med Univ, Xijing Hosp, Dept Neurosurg, 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China; [Yang, Yongxiang] PLA 422nd Hosp, Dept Neurosurg, Zhanjiang, Peoples R China; [Ye, Yuqin] Hunan Normal Univ, Affiliated Hosp 2, PLA 163rd Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China; [Chen, Chen] Fourth Mil Med Univ, Airforce Mil Med Univ, Inst Psychol, Xian, Shaanxi, Peoples R China		He, XS (corresponding author), Fourth Mil Med Univ, Airforce Mil Med Univ, Xijing Hosp, Dept Neurosurg, 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.	hexiaos@fmmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471264]; Science and Technology Development Fund of Airforce Military Medical University (Fourth Military Medical University) [2016XC178, 2016XC210]	This work was supported by grants from the National Natural Science Foundation of China (81471264 to X.H.), Science and Technology Development Fund of Airforce Military Medical University (Fourth Military Medical University) (2016XC178 and 2016XC210 to X.H.).	Bai RJ, 2017, NEUROCHEM RES, V42, P2892, DOI 10.1007/s11064-017-2310-0; Bai RJ, 2017, MED SCI MONITOR, V23, P1707, DOI 10.12659/MSM.901124; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bellinger DL, 2014, AUTON NEUROSCI-BASIC, V182, P15, DOI 10.1016/j.autneu.2014.01.006; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chavan SS, 2017, IMMUNITY, V46, P927, DOI 10.1016/j.immuni.2017.06.008; Chavez-Galan L, 2009, CELL MOL IMMUNOL, V6, P15, DOI 10.1038/cmi.2009.3; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Gholami MD, 2017, CELL IMMUNOL, V322, P1, DOI 10.1016/j.cellimm.2017.10.002; Goding SR, 2013, J IMMUNOL, V190, P4899, DOI 10.4049/jimmunol.1300271; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; HOYT DB, 1990, J TRAUMA, V30, P759, DOI 10.1097/00005373-199007000-00001; Inoue T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00945; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kemp CD, 2008, AM SURGEON, V74, P866; Lages CS, 2010, AGING CELL, V9, P785, DOI 10.1111/j.1474-9726.2010.00611.x; LaJevic MD, 2011, IMMUNOLOGY, V132, P197, DOI 10.1111/j.1365-2567.2010.03354.x; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Loftus TJ, 2016, SHOCK, V46, P341, DOI 10.1097/SHK.0000000000000636; Lorton D, 2015, INT J MOL SCI, V16, P5635, DOI 10.3390/ijms16035635; Lunde IG, 1985, J APPL PHYSIOL, V111, P1278; Mathieu M, 2013, IMMUNOL CELL BIOL, V91, P82, DOI 10.1038/icb.2012.53; Mrakovcic-Sutic I, 2010, SCAND J IMMUNOL, V72, P57, DOI 10.1111/j.1365-3083.2010.02407.x; Nakai A, 2014, J EXP MED, V211, P2583, DOI 10.1084/jem.20141132; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Oberbeck R, 2002, SHOCK, V18, P331, DOI 10.1097/00024382-200210000-00007; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Pasquariello KZ, 2018, BEHAV BRAIN RES, V339, P278, DOI 10.1016/j.bbr.2017.10.037; PAULEUGENE N, 1993, MOL IMMUNOL, V30, P157, DOI 10.1016/0161-5890(93)90087-R; Penna A, 2007, HEPATOLOGY, V45, P588, DOI 10.1002/hep.21541; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; QUATTROCCHI KB, 1992, J NEUROSURG, V77, P694, DOI 10.3171/jns.1992.77.5.0694; Sanders VM, 1997, J IMMUNOL, V158, P4200; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Scott BNV, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-68; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Slifka MK, 2000, IMMUNITY, V12, P451, DOI 10.1016/S1074-7613(00)80197-1; Smrcka M, 2005, Bratisl Lek Listy, V106, P144; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Trabold B, 2010, SURGERY, V147, P562, DOI 10.1016/j.surg.2009.10.028; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tsutsui Yukako, 2017, Anesth Prog, V64, P221, DOI 10.2344/anpr-64-04-09; Tzeng HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039179; vanderPoll T, 1996, J CLIN INVEST, V97, P713, DOI 10.1172/JCI118469; Wang JW, 2017, ANN CLIN LAB SCI, V47, P10; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	57	10	10	1	7	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2019	26	1					43	57		10.1159/000495465			15	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	HO5RA	WOS:000460984200005	30695785				2022-02-06	
J	Zhao, SL; Li, G; Gu, SS; Ren, J; Chen, JB; Xu, L; Chen, MS; Yang, J; Leung, KW; Sun, J				Zhao, Shuanglin; Li, Gen; Gu, Shanshan; Ren, Jian; Chen, Jingbo; Xu, Lin; Chen, Mingsheng; Yang, Jun; Leung, Kwok Wa; Sun, Jian			An Experimental Study of Relationship Between Magnetic Induction Phase Shift and Brain Parenchyma Volume With Brain Edema in Traumatic Brain injury	IEEE ACCESS			English	Article						Cerebral edema; magnetic induction; intracranial pressure; brain water content	SPECTROSCOPY; PRESSURE; SYSTEM	As a very common secondary disease after traumatic brain injury (TBI), brain edema can lead to increased intracranial water content and elevated intracranial pressure (ICP), which makes the patient suffer a less favorable prognosis outcome such as hemiplegia, aphasia, dysgnosia, and even death. Its real-time monitoring is of great significance for improving the therapeutic condition of TBI and reducing the mortality and disability rate. Magnetic induction phase shift (MIPS) has the advantages of non-invasive, non-contact, strong penetration, and real-time bedside monitoring. In this work, 34 rabbits divided into the experimental group (n = 26) and control group (n = 8) were used to carry out 24-h MIPS monitoring in brain edema. Meanwhile, ICP and brain water content (BWC) were chosen as references. The MIPS of rabbits in the experimental group decreased continuously in 24 h, while the ICP and BWC increased. Furthermore, MIPS detection sensitivity became lower and lower within the development of brain edema. The weights of ICP and BWC estimated by MIPS in three different stages were calculated to get the index of brain edema severity (BESI), which can evaluate the severity of brain edema. The BESI of rabbits in the experimental group increased over time, ranging from 0 to 1. The 0 represents normal, and the 1 represents severe brain edema. The first stage of BESI changed from 0 to 0.43, the second stage from 0.43 to 0.917, and the third stage from 0.917 to 1. The BESI of rabbits in the control group did not increase obviously within time. There were significant differences among them. Through the comparative experimental study of MIPS, ICP, and BWC on rabbits with brain edema, a more effective and direct parameter was found, which can promote the application value of MIPS in the real-time bedside monitoring of brain edema.	[Zhao, Shuanglin; Chen, Jingbo; Xu, Lin; Chen, Mingsheng; Yang, Jun; Sun, Jian] Army Med Univ, Coll Biomed Engn, Chongqing 400030, Peoples R China; [Li, Gen] Chongqing Univ Technol, Sch Pharm & Bioengn, Chongqing 400020, Peoples R China; [Gu, Shanshan] Southwest Hosp, Dept Clin Psychol, Chongqing 400028, Peoples R China; [Ren, Jian; Leung, Kwok Wa; Sun, Jian] City Univ Hong Kong, Dept Elect Engn, Hong Kong, Peoples R China		Sun, J (corresponding author), Army Med Univ, Coll Biomed Engn, Chongqing 400030, Peoples R China.; Leung, KW; Sun, J (corresponding author), City Univ Hong Kong, Dept Elect Engn, Hong Kong, Peoples R China.	1306542011@qq.com; 30067982@qq.com	Ren, Jian/AAY-2409-2020	Ren, Jian/0000-0001-9899-5963; Gen, Li/0000-0002-4183-4242; SUN, Jian/0000-0002-4868-5905	Brain Science Collaborative Innovation Center, Army Medical University; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51607181]; Hong Kong Scholars Program [XJ2017026]	This work was supported in part by the Brain Science Collaborative Innovation Center, Army Medical University, in part by the National Natural Science Foundation of China under Grant 51607181, and in part by the Hong Kong Scholars Program under Grant XJ2017026.	AVEZAAT CJJ, 1986, ACTA NEUROCHIR, V79, P13, DOI 10.1007/BF01403461; Bigdeli MR, 2007, BRAIN RES, V1152, P228, DOI 10.1016/j.brainres.2007.03.068; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Che ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186761; Chen M, 2017, APPL SCI, V7, P1, DOI DOI 10.1145/3183624.3183627; Corrigan F, 2017, J NEUROTRAUM, V34, P971, DOI 10.1089/neu.2016.4589; Flores O, 2008, IEEE ENG MED BIO, P678, DOI 10.1109/IEMBS.2008.4649243; Gonzalez CA, 2009, PHYSIOL MEAS, V30, P809, DOI 10.1088/0967-3334/30/8/006; Gonzalez CA, 2006, PHYSIOL MEAS, V27, P829, DOI 10.1088/0967-3334/27/9/006; Gonzalez CA, 2006, PHYSIOL MEAS, V27, P539, DOI 10.1088/0967-3334/27/6/007; Griffiths H, 2001, MEAS SCI TECHNOL, V12, P1126, DOI 10.1088/0957-0233/12/8/319; Griffiths H, 1999, ANN NY ACAD SCI, V873, P335, DOI 10.1111/j.1749-6632.1999.tb09481.x; Jee MJ, 2007, PUBL ASTRON SOC PAC, V119, P1403, DOI 10.1086/524849; Jin G, 2011, COMMUNICATION SYSTEM, V4, P361, DOI [10.1007/978-3-642-21762-3_47, DOI 10.1007/978-3-642-21762-3_]; Jin G, 2014, BIOSENS BIOELECTRON, V52, P374, DOI 10.1016/j.bios.2013.09.019; Lambert C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00462; Larsson H. B. W., 2010, J MAGN RESON IMAGING, V27, P754; Lauzier F, 2014, CRIT CARE MED, V42, P712, DOI 10.1097/CCM.0000000000000046; Li G, 2017, NANOSCI NANOTECH LET, V9, P1470, DOI 10.1166/nnl.2017.2493; Li G, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030537; Luan WF, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9020303; Pan W. C., 2017, PLOS ONE, V10; Rolland WB, 2013, EXP NEUROL, V241, P45, DOI 10.1016/j.expneurol.2012.12.009; Scharfetter H, 2003, IEEE T BIO-MED ENG, V50, P870, DOI 10.1109/TBME.2003.813533; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Shah NJ, 2011, METHODS MOL BIOL, V711, P29, DOI 10.1007/978-1-61737-992-5_3; Thiex Ruth, 2007, Neurosurg Focus, V22, pE6; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Trepte CJC, 2016, CRIT CARE, V20, DOI 10.1186/s13054-015-1173-5; Tucker B, 2017, J EMERG MED, V53, P18, DOI 10.1016/j.jemermed.2017.02.010; Yan QG, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0354-7; Zakaria Z, 2012, SENSORS-BASEL, V12, P7126, DOI 10.3390/s120607126	33	10	10	3	8	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2019	7						20974	20983		10.1109/ACCESS.2019.2897609			10	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	HN9UZ	WOS:000460547000001		gold			2022-02-06	
J	Rowe, RK; Harrison, JL; Morrison, HW; Subbian, V; Murphy, SM; Lifshitz, J				Rowe, Rachel K.; Harrison, Jordan L.; Morrison, Helena W.; Subbian, Vignesh; Murphy, Sean M.; Lifshitz, Jonathan			Acute Post-Traumatic Sleep May Define Vulnerability to a Second Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						concussion; inflammation; pathology; repetitive TBI; sleep	PREDICT PROTRACTED RECOVERY; SPORT-RELATED CONCUSSION; NEUROPSYCHIATRIC SEQUELAE; PERSONALIZED MEDICINE; MOUSE MODEL; REM-SLEEP; OREXIN-A; PATHOPHYSIOLOGY; DISTURBANCE; INCREASES	Chronic neurological impairments can manifest from repetitive traumatic brain injury (rTBI), particularly when subsequent injuries occur before the initial injury completely heals. Herein, we apply post-traumatic sleep as a physiological biomarker of vulnerability, hypothesizing that a second TBI during post-traumatic sleep worsens neurological and histological outcomes compared to one TBI or a second TBI after post-traumatic sleep subsides. Mice received sham or diffuse TBI by midline fluid percussion injury; brain-injured mice received one TBI or rTBIs at 3- or 9-h intervals. Over 40 h post-injury, injured mice slept more than shams. Functional assessments indicated lower latencies on rotarod and increased Neurological Severity Scores for mice with rTBIs within 3 h. Anxiety-like behaviors in the open field task were increased for mice with rTBIs at 3 h. Based on pixel density of silver accumulation, neuropathology was greater at 28 days post-injury (DPI) in rTBI groups than sham and single TBI. Cortical microglia morphology was quantified and mice receiving rTBI were de-ramified at 14 DPI compared to shams and mice receiving a single TBI, suggesting robust microglial response in rTBI groups. Orexin-A-positive cells were sustained in the lateral hypothalamus with no loss detected, indicating that loss of wake-promoting neurons did not contribute to post-traumatic sleep. Thus, duration of post-traumatic sleep is a period of vulnerability that results in exacerbated injury from rTBI. Monitoring individual post-traumatic sleep is a potential clinical tool for personalized TBI management, where regular sleep patterns may inform rehabilitative strategies and return-to-activity guidelines.	[Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, 425 N 5th St ABC1 Bldg,3rd Floor, Phoenix, AZ 85004 USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ USA; [Harrison, Jordan L.] Univ Arizona, Dept Basic Med Sci, Coll Med Phoenix, Phoenix, AZ USA; [Morrison, Helena W.] Univ Arizona, Coll Nursing, Tucson, AZ 85721 USA; [Subbian, Vignesh] Univ Arizona, Coll Engn, Tucson, AZ USA; [Murphy, Sean M.] Univ Kentucky, Dept Forestry & Nat Resources, Lexington, KY USA		Lifshitz, J (corresponding author), Univ Arizona, Dept Child Hlth, Coll Med Phoenix, 425 N 5th St ABC1 Bldg,3rd Floor, Phoenix, AZ 85004 USA.	jlifshitz@email.arizona.edu	Morrison, Helena/P-5297-2019; Murphy, Sean/AAM-4692-2021	Murphy, Sean/0000-0002-9404-8878; Rowe, Rachel/0000-0002-9034-3159; Subbian, Vignesh/0000-0001-9974-8382	National Institute of Neurological Disorders and Stroke of the NIH [R21 NS072611, RO1 NS-065052]; PCH Mission Support Funds; Diane and Bruce Halle Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31 NS-090921]; Science Foundation Arizona Bisgrove Scholarship	Research reported in this article was supported, in part, by National Institute of Neurological Disorders and Stroke of the NIH under award numbers R21 NS072611 and RO1 NS-065052 and PCH Mission Support Funds. The generosity of the Diane and Bruce Halle Foundation supported J.L.H. during the conduct of these studies, as well as NIH F31 NS-090921. R.K.R. was supported by a Science Foundation Arizona Bisgrove Scholarship during the conduct of these studies. The authors thank Anthony Romero for his contribution to behavior scoring. The authors also thank Cody Zurhellen for optimizing the Orexin-A staining. J.L. is a member of the University of Arizona Bio5 Institute.	Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Arciniegas, 2000, Curr Treat Options Neurol, V2, P169; Bai RJ, 2017, NEUROCHEM RES, V42, P2892, DOI 10.1007/s11064-017-2310-0; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Billiard M, 2013, SLEEP MED, V14, P462, DOI 10.1016/j.sleep.2013.01.009; Borniger JC, 2018, NEUROSCIENCE, V375, P74, DOI 10.1016/j.neuroscience.2018.01.064; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; DEOLMOS JS, 1971, BRAIN RES, V33, P523, DOI 10.1016/0006-8993(71)90130-2; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Donohue KD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-14; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Eugene Andy R, 2015, MEDtube Sci, V3, P35; Falcon MI, 2016, CURR OPIN NEUROL, V29, P429, DOI 10.1097/WCO.0000000000000344; Gregory E, 2017, CONTEMP CLIN TRIALS, V52, P95, DOI 10.1016/j.cct.2016.11.005; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Harrison JL, 2014, EXP BRAIN RES, V232, P2709, DOI 10.1007/s00221-014-3948-3; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Inutsuka Ayumu, 2013, Front Endocrinol (Lausanne), V4, P18, DOI 10.3389/fendo.2013.00018; Iverson GL, 2016, PHYS MED REH CLIN N, V27, P429, DOI 10.1016/j.pmr.2015.12.002; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; List Mark, 2014, S D Med, V67, P370; Lucke-Wold BP, 2015, NEUROSCI BIOBEHAV R, V55, P68, DOI 10.1016/j.neubiorev.2015.04.010; Mang GM, 2014, SLEEP, V37, P1383, DOI 10.5665/sleep.3936; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; McShane BB, 2010, J NEUROSCI METH, V193, P321, DOI 10.1016/j.jneumeth.2010.08.024; Merritt VC, 2018, NEUROPSYCHOLOGIA, V119, P340, DOI 10.1016/j.neuropsychologia.2018.08.026; Mikics E, 2008, PHYSIOL BEHAV, V94, P341, DOI 10.1016/j.physbeh.2008.01.023; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Murdaugh DL, 2018, ARCH PHYS MED REHAB, V99, P960, DOI 10.1016/j.apmr.2018.01.005; Nagai T, 2012, J PHARMACOL SCI, V120, P213, DOI 10.1254/jphs.12142FP; Pasinetti GM, 2010, PSYCHIAT CLIN N AM, V33, P905, DOI 10.1016/j.psc.2010.09.003; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Piper DC, 2000, EUR J NEUROSCI, V12, P726, DOI 10.1046/j.1460-9568.2000.00919.x; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; PORSOLT RD, 1979, BIOMEDICINE, V30, P139; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; R Core Team, 2018, STATS PACK LANG ENV; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Rowe RK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1200-y; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; Taylor AN, 2018, J NEUROTRAUM, V35, P630, DOI 10.1089/neu.2017.5238; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Thomasy HE, 2019, J NEUROTRAUM, V36, P802, DOI 10.1089/neu.2018.5810; Toman E, 2016, J ROY ARMY MED CORPS, V162, P103, DOI 10.1136/jramc-2015-000517; Tyburski AL, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0726-1; van Buuren S, 2011, J STAT SOFTW, V45, P1; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Zhang Z., 2018, PRACTICAL STAT POWER; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	89	10	10	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2019	36	8					1318	1334		10.1089/neu.2018.5980		DEC 2018	17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HS4DK	WOS:000453800300001	30398389	Green Published			2022-02-06	
J	Hadanny, A; Bechor, Y; Catalogna, M; Daphna-Tekoah, S; Sigal, T; Cohenpour, M; Lev-Wiesel, R; Efrati, S				Hadanny, Amir; Bechor, Yair; Catalogna, Merav; Daphna-Tekoah, Shir; Sigal, Tal; Cohenpour, Mehrzad; Lev-Wiesel, Rachel; Efrati, Shai			Hyperbaric Oxygen Therapy Can Induce Neuroplasticity and Significant Clinical Improvement in Patients Suffering From Fibromyalgia With a History of Childhood Sexual Abuse-Randomized Controlled Trial	FRONTIERS IN PSYCHOLOGY			English	Article						fibromyalgia; childhood sexual abuse; FMS; CSA; PTSD; post trauma; hyperbaric oxygen; HBOT	POSTTRAUMATIC-STRESS-DISORDER; FORM HEALTH SURVEY; POST-CONCUSSION SYNDROME; CEREBRAL-BLOOD-FLOW; ADULT SURVIVORS; PSYCHOLOGICAL TREATMENTS; DIFFUSION-TENSOR; SURVEY SF-36; BRAIN; ABNORMALITIES	Background: Fibromyalgia syndrome (FMS), a condition considered to represent a prototype of central sensitization syndrome, can be induced by different triggers including childhood sexual abuse (CSA). Recent studies have demonstrated hyperbaric oxygen therapy (HBOT) can induce neuroplasticity and improve clinical outcome of FMS. The aim of the current study was to evaluate the effect of HBOT on patients suffering from FMS with a history of CSA. Materials and methods: A prospective randomized clinical trial conducted between July 2015 and November 2017 included women with a history of CSA who fulfilled fibromyalgia diagnosis criteria for at least 5 years prior to inclusion. Included participants (N = 30) were randomly assigned to treatment group, treated with 60 HBOT sessions and a control/crossover group received psychotherapy. After the control period, the control/crossover group was crossed to HBOT. Clinical outcomes were assessed using FMS questioners, post-traumatic stress disorder (PTSD) questioners and quality of life questioners. Objective outcome were assessed using brain function and structure imaging. Findings: Following HBOT, there was a significant improvement in all FMS questionnaires (widespread pain index, Fibromyalgia symptoms severity scale, Fibromyalgia functional impairment), most domains of quality of life, PTSD symptoms and psychological distress. The same significant improvements were demonstrated in the control following crossover to HBOT. Following HBOT, brain SPECT imaging demonstrated significant increase in brain activity in the prefrontal cortex, orbital frontal cortex, and subgenual area (p < 0.05). Brain microstructure improvement was seen by MRI-DTI in the anterior thalamic radiation (p = 0.0001), left Insula (p = 0.001), and the right Thalamus (p = 0.001). Conclusion: HBOT induced significant clinical improvement that correlates with improved brain functionality and brain microstructure in CSA related FMS patients.	[Hadanny, Amir; Bechor, Yair; Catalogna, Merav; Efrati, Shai] Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, Zerifin, Israel; [Hadanny, Amir] Bar Ilan Univ, Galilee Fac Med, Ramat Gan, Israel; [Hadanny, Amir; Sigal, Tal; Cohenpour, Mehrzad; Efrati, Shai] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Daphna-Tekoah, Shir; Lev-Wiesel, Rachel] Univ Haifa, Emili Sagol CAT Res Ctr, Haifa, Israel; [Daphna-Tekoah, Shir] Ashkelon Acad Coll, Fac Social Work, Ashqelon, Israel; [Daphna-Tekoah, Shir] Kaplan Med Ctr, Social Work Serv, Rehovot, Israel; [Sigal, Tal] Assaf Harofeh Med Ctr, Radiol Dept, Zerifin, Israel; [Cohenpour, Mehrzad] Assaf Harofeh Med Ctr, Nucl Med Inst, Zerifin, Israel; [Efrati, Shai] Assaf Harofeh Med Ctr, Res & Dev Unit, Zerifin, Israel; [Efrati, Shai] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel		Hadanny, A; Efrati, S (corresponding author), Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, Zerifin, Israel.; Hadanny, A (corresponding author), Bar Ilan Univ, Galilee Fac Med, Ramat Gan, Israel.; Hadanny, A; Efrati, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Efrati, S (corresponding author), Assaf Harofeh Med Ctr, Res & Dev Unit, Zerifin, Israel.; Efrati, S (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.	amir.had@gmail.com; efratishai@outlook.com					Ablin JN, 2016, CLIN EXP RHEUMATOL, V34, pS3; Amano T, 2016, SCI REP-UK, V6, DOI 10.1038/srep34610; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Benedetti F, 2014, PSYCHOL MED, V44, P3069, DOI 10.1017/S0033291714000506; Berthoz S, 2002, BRAIN, V125, P1696, DOI 10.1093/brain/awf190; Bisson JI, 2007, BRIT J PSYCHIAT, V190, P97, DOI 10.1192/bjp.bp.106.021402; Boussi-Gross R, 2015, NEUROPSYCHOLOGY, V29, P610, DOI 10.1037/neu0000149; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Buskila D, 1996, J RHEUMATOL, V23, P903; Buskila D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2720; Callahan KL, 2004, INT J GROUP PSYCHOTH, V54, P491, DOI 10.1521/ijgp.54.4.491.42770; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Clauw DJ, 2011, MAYO CLIN PROC, V86, P907, DOI 10.4065/mcp.2011.0206; Conversano C, 2018, CLIN EXP RHEUMATOL; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Efrati S, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00848; Efrati S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127012; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Ehring T, 2014, CLIN PSYCHOL REV, V34, P645, DOI 10.1016/j.cpr.2014.10.004; FINK LA, 1995, AM J PSYCHIAT, V152, P1329, DOI 10.1176/ajp.152.9.1329; Floresco SB, 2003, J NEUROSCI, V23, P3930; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; Frodl T, 2010, J PSYCHIATR RES, V44, P799, DOI 10.1016/j.jpsychires.2010.01.006; Goldberg RT, 1999, DISABIL REHABIL, V21, P23, DOI 10.1080/096382899298061; Goldenberg DL, 2008, J CLIN PSYCHIAT, V69, P30; Guedj E, 2008, J NUCL MED, V49, P1798, DOI 10.2967/jnumed.108.053264; Guedj E, 2007, EUR J NUCL MED MOL I, V34, P130, DOI 10.1007/s00259-006-0174-7; Hadanny A, 2015, RESTOR NEUROL NEUROS, V33, P471, DOI 10.3233/RNN-150517; Hadanny A, 2016, EXPERT REV NEUROTHER, V16, P875, DOI 10.1080/14737175.2016.1205487; Hadanny A, 2016, EXPERT REV NEUROTHER, V16, P359, DOI 10.1586/14737175.2016.1157018; Hadanny A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1034-2; Hauser W, 2013, PAIN, V154, P1216, DOI 10.1016/j.pain.2013.03.034; Imbierowicz K, 2003, EUR J PAIN, V7, P113, DOI 10.1016/S1090-3801(02)00072-1; Irish L, 2010, J PEDIATR PSYCHOL, V35, P450, DOI 10.1093/jpepsy/jsp118; Jensen KB, 2009, PAIN, V144, P95, DOI 10.1016/j.pain.2009.03.018; Kim SJ, 2007, ACTA PSYCHIAT SCAND, V116, P145, DOI 10.1111/j.1600-0447.2006.00952.x; Lanius RA, 2003, BIOL PSYCHIAT, V53, P204, DOI 10.1016/S0006-3223(02)01466-X; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Lei D, 2015, SCI REP-UK, V5, DOI 10.1038/srep08933; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Linnman C, 2009, EUR J PAIN, V13, P65, DOI 10.1016/j.ejpain.2008.03.001; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; Martsolf Donna S, 2005, Issues Ment Health Nurs, V26, P801, DOI 10.1080/01612840500184012; Matthey A, 2013, PAIN PHYSICIAN, V16, pE553; McBeth J, 1999, ARTHRITIS RHEUM, V42, P1397, DOI 10.1002/1529-0131(199907)42:7<1397::AID-ANR13>3.0.CO;2-7; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Monkul ES, 2012, HUM BRAIN MAPP, V33, P272, DOI 10.1002/hbm.21212; Niida Richi, 2017, Brain Nerve, V69, P417, DOI 10.11477/mf.1416200759; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Recklitis CJ, 2006, PSYCHOL ASSESSMENT, V18, P22, DOI 10.1037/1040-3590.18.1.22; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Russo J, 1998, MED CARE, V36, P752, DOI 10.1097/00005650-199805000-00015; Sancassiani F, 2017, INT REV PSYCHIATR, V29, P473, DOI 10.1080/09540261.2017.1320982; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; SAPOLSKY RM, 1985, BRAIN RES, V359, P300, DOI 10.1016/0006-8993(85)91440-4; Sarzi-Puttini P, 2011, BEST PRACT RES CL RH, V25, P133, DOI 10.1016/j.berh.2011.04.001; Schmidt-Wilcke T, 2011, NAT REV RHEUMATOL, V7, P518, DOI 10.1038/nrrheum.2011.98; Schnurr Paula P, 2004, Adv Mind Body Med, V20, P18; SELIGMAN MEP, 1995, AM PSYCHOL, V50, P965, DOI 10.1037/0003-066X.50.12.965; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tal S, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00508; Tal S, 2015, RESTOR NEUROL NEUROS, V33, P943, DOI 10.3233/RNN-150585; TAYLOR ML, 1995, ARTHRITIS RHEUM, V38, P229, DOI 10.1002/art.1780380211; Tomoda A, 2009, NEUROIMAGE, V47, pT66, DOI 10.1016/j.neuroimage.2009.03.005; Treadway M. T., 2009, PLOS ONE, V4; Walker EA, 1997, PSYCHOSOM MED, V59, P565, DOI 10.1097/00006842-199711000-00002; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Yakov Gologorsky M, 2011, ESSENTIAL NEUROMODUL, P47, DOI [10.1016/C2009-0-61346-5, DOI 10.1016/C2009-0-61346-5]; Yen Chen-Tung, 2013, Acta Anaesthesiol Taiwan, V51, P73, DOI 10.1016/j.aat.2013.06.011; Yildiz S, 2004, J INT MED RES, V32, P263; Zhang YX, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004083	76	10	10	1	15	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	DEC 17	2018	9								2495	10.3389/fpsyg.2018.02495			13	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	HE4ZT	WOS:000453379800001	30618929	gold, Green Published			2022-02-06	
J	Swan, AA; Amuan, ME; Morissette, SB; Finley, EP; Eapen, BC; Jaramillo, CA; Pugh, MJ				Swan, Alicia A.; Amuan, Megan E.; Morissette, Sandra B.; Finley, Erin P.; Eapen, Blessen C.; Jaramillo, Carlos A.; Pugh, Mary Jo			Long-term physical and mental health outcomes associated with traumatic brain injury severity in post-9/11 veterans: A retrospective cohort study	BRAIN INJURY			English	Article						Comorbidity; mental health; stress disorders; health status; self report	POSTTRAUMATIC-STRESS-DISORDER; DEPRESSIVE SYMPTOMS; CLINICAL IMPORTANCE; CHRONIC PAIN; DISABILITY; IRAQ; TRAJECTORIES; PERSISTENT; PTSD; TBI	Objectives: To examine long-term outcomes of self-reported physical and mental health among Post-9/11 Veterans stratified by traumatic brain injury (TBI) severity, we hypothesized that more severe TBI would be associated with significantly poorer outcomes. Methods: A prospective longitudinal survey of physical and mental health status was conducted with a national cohort of Post-9/11 Veterans. We then used generalized linear models (GLM) to assess the unique contribution of TBI severity on long-term outcomes after controlling for socio-demographic characteristics, comorbidity phenotypes, and deployment experiences. Results: TBI of any severity was associated with significantly poorer outcomes relative to the No TBI group. However, the manifestation of these outcomes identified in our study differed meaningfully by TBI severity level. Conclusions: Veterans with any TBI exposure experience poorer long-term outcomes than those with no TBI even when covariates are considered. In particular, measures of somatization, PTSD symptom distress, and depression indicate pervasive and long-term health concerns among individuals with TBI. Additional research is required to fully explicate what appear to be complex relationships among TBI severity, physical and mental well-being, combat exposures, and socioeconomic resources in this population.	[Swan, Alicia A.; Eapen, Blessen C.; Jaramillo, Carlos A.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Amuan, Megan E.] Edith Nourse Rogers VA Med Ctr, Ctr Hlth Care Org & Implementat Res, Bedford, MA USA; [Morissette, Sandra B.; Finley, Erin P.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, IDEAS 2 0 Ctr Innovat, Salt Lake City, UT 84148 USA; [Pugh, Mary Jo] Univ Utah, Sch Med, Dept Med, Div Epidemiol, Salt Lake City, UT 84112 USA		Pugh, MJ (corresponding author), VA Salt Lake City Hlth Care Syst, IDEAS 2 0 Ctr Innovat, Salt Lake City, UT 84148 USA.; Pugh, MJ (corresponding author), Univ Utah, Sch Med, Dept Med, Div Epidemiol, Salt Lake City, UT 84112 USA.	maryjo.pugh@hsc.utah.edu	Swan, Alicia A/O-3536-2018	Swan, Alicia A/0000-0003-2412-0499	Health Services Research and Development [DHI 09-237, IK6 HX002608-01]	This work was supported by the Health Services Research and Development [grant number DHI 09-237], [grant number IK6 HX002608-01].	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Azouvi P, 2016, BRAIN INJURY, V30, P1665, DOI 10.1080/02699052.2016.1201593; Bjorgvinsson T, 2013, ASSESSMENT, V20, P429, DOI 10.1177/1073191113481998; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Braden JB, 2008, PSYCHIAT SERV, V59, P878, DOI 10.1176/ps.2008.59.8.878; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; CUNNY KA, 1991, PSYCHOL REP, V69, P127, DOI 10.2466/PR0.69.5.127-130; Darnall BD, 2005, ARCH PHYS MED REHAB, V86, P650, DOI 10.1016/j.apmr.2004.10.028; Davern M, 2010, HEALTH SERV RES, V45, P1324, DOI 10.1111/j.1475-6773.2010.01128.x; Department of Defense, 2015, POSTD HLTH ASS PDHA; Department of Veterans Affairs, VA DOD CLIN PRACT GU; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; DILLMAN DA, 1991, ANNU REV SOCIOL, V17, P225, DOI 10.1146/annurev.so.17.080191.001301; Dillman DA., 2014, INTERNET PHONE MAIL, V4th; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Jaramillo CA, 2015, BRAIN IMAGING BEHAV, V9, P445, DOI 10.1007/s11682-015-9402-8; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kilbourne AM, 2002, J GEN INTERN MED, V17, P512, DOI 10.1046/j.1525-1497.2002.10803.x; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McGarity S, 2017, J HEAD TRAUMA REHAB, V32, P34, DOI 10.1097/HTR.0000000000000242; Military Health System [Internet], SURV CAS DEF 13 0 NE; PTSD . National Center for PTSD, PTSD CHECKL DSM 5 PC; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Sayer NA, 2014, PSYCHIAT SERV, V65, P663, DOI 10.1176/appi.ps.201300017; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Schulz-Heik RJ, 2016, BRAIN INJURY, V30, P271, DOI 10.3109/02699052.2015.1113567; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Tran J, 2017, J HEAD TRAUMA REHAB, V32, P264, DOI 10.1097/HTR.0000000000000296; Wilson J, 2009, AM J EPIDEMIOL, V169, P1362, DOI 10.1093/aje/kwp044; Witthoft M, 2013, INT J BEHAV MED, V20, P172, DOI 10.1007/s12529-012-9237-2; Wortmann JH, 2016, PSYCHOL ASSESSMENT, V28, P1392, DOI 10.1037/pas0000260	37	10	10	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1637	1650		10.1080/02699052.2018.1518539			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600005	30273517				2022-02-06	
J	Tran, S; Kenny, B; Power, E; Tate, R; McDonald, S; Heard, R; Togher, L				Tran, Sarah; Kenny, Belinda; Power, Emma; Tate, Robyn; McDonald, Skye; Heard, Rob; Togher, Leanne			Cognitive-communication and psychosocial functioning 12 months after severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; cognitive-communication; psychosocial functioning; speech pathology assessment; community rehabilitation	OF-THE-LITERATURE; REHABILITATION; DEFICITS; PARTICIPATION; EMPLOYMENT; STABILITY; OUTCOMES; ABILITY; ADULTS; SKILLS	Objective: Cognitive-communication deficits after severe Traumatic Brain Injury (TBI) may contribute to poor psychosocial functioning, however, the possible nature of this relationship remains unclear and warrants investigation. The current study explored the variance and correlations of a measure of cognitive-communication with a measure of psychosocial outcome in adults 12 months following TBI. Method: 36 adults with severe TBI evaluated at 12 months post-injury. Cognitive-communication skills were evaluated with the Functional Assessment of Verbal Reasoning and Executive Strategies (FAVRES), Sydney Psychosocial Reintegration Scale-2 (SPRS-2) Form A - Informant version assessed psychosocial functioning. Multiple regression analyses were used to investigate association between cognitive-communication and psychosocial outcomes. Results: Two measures of cognitive-communication assessment (Accuracy and Rationale of the FAVRES) contributed significantly to total psychosocial outcome (SPRS-2). Multiple regression analyses revealed these variables accounted for 29.1% of the variance. Cognitive-communication variables accounted for 24.0% and 28.6% of the Work/Leisure and Relationship domains of the SPRS-2. Conclusion: Cognitive-communication ability was significantly related to psychosocial functioning at 12 months post-TBI. Findings suggested continued speech pathology involvement in the post-acute stages of recovery may improve social, vocational and overall psychosocial functioning. The FAVRES is a promising cognitive-communication assessment for identification of treatable factors impacting psychosocial outcomes.	[Tran, Sarah; Kenny, Belinda; Power, Emma; Togher, Leanne] Univ Sydney, Speech Pathol, Fac Hlth Sci, Sydney, NSW, Australia; [Tate, Robyn] Univ Sydney, Rehabil Studies Unit, Northern Clin Sch, Sydney, NSW, Australia; [McDonald, Skye] Univ NSW, Sch Psychol, Sydney, NSW, Australia; [Heard, Rob] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia		Tran, S (corresponding author), Univ Sydney, Speech Pathol, Sydney, NSW, Australia.	sarah.tran1995@gmail.com	Togher, Leanne/AAC-7083-2019; McDonald, Skye/G-4118-2014; Power, Emma/A-9263-2015	McDonald, Skye/0000-0003-0723-6094; Power, Emma/0000-0002-2638-0406; Togher, Leanne/0000-0002-4518-6748			Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Athanasou J. A., 2003, AUSTR J CAREER DEV, V12, P58, DOI DOI 10.1177/103841620301200108; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cohen L. H., 1988, LIFE EVENTS PSYCHOL; Collie A, 2010, INJURY PREV, V16, pA25, DOI 10.1136/ip.2010.029215.92; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Corp I., 2013, IBM SPSS STAT WIND V; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Docking K, 1999, BRAIN INJURY, V13, P953; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Ferstl EC, 2005, J CLIN EXP NEUROPSYC, V27, P367, DOI 10.1080/13803390490515784; Fleming J, 2014, SYDNEY PSYCHOSOCIAL; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Golper LC, 2001, ACAD NEUROL COMMUN D, P1; Gong JJ, 2000, CONTROL CLIN TRIALS, V21, P313, DOI 10.1016/S0197-2456(00)00049-0; Harrell FE Jr, 2017, REGRESSION MODELING; Hoofien D, 2001, BRAIN INJURY, V15, P189; Isaki E, 2000, BRAIN INJURY, V14, P441; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Larkins Brigette, 2007, Seminars in Speech and Language, V28, P334, DOI 10.1055/s-2007-986530; Lexell J, 2016, BRAIN INJURY, V30, P969, DOI 10.3109/02699052.2016.1148196; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; MacDonald S., 2005, FUNCTIONAL ASSESSMEN; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; McDonald S., 2013, SOCIAL COMMUNICATION; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Mueller JA, 2013, J SPEECH LANG HEAR R, V56, P1051, DOI 10.1044/1092-4388(2012/12-0147); Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Organization WH, 2001, INT CLASS FUNCT DIS; Penn C, 2000, NEUROGENIC COMMUNICA, P103; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Shordone RJ, 1999, ECOLOGICAL VALIDITY; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Tabish S, 2015, EMERGEN MED, V5, P10, DOI DOI 10.4172; Tate R, 2012, AUST PSYCHOL, V47, P20, DOI 10.1111/j.1742-9544.2011.00060.x; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; TEASDALE G, 1974, LANCET, V2, P81; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M, 2005, BEHAV SOCIAL INTERVE, P256; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	60	10	10	2	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1700	1711		10.1080/02699052.2018.1537006			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600012	30346807				2022-02-06	
J	Wang, WJ; Shen, MY; Sun, K; Wang, YP; Wang, XD; Jin, XD; Xu, JJ; Ding, LS; Sun, XY				Wang, Weijie; Shen, Mingyang; Sun, Kun; Wang, Yanping; Wang, Xiaodong; Jin, Xiaodong; Xu, Jingjing; Ding, Lianshu; Sun, Xiaoyang			Aminoguanidine reverses cognitive deficits and activation of cAMP/CREB/BDNF pathway in mouse hippocampus after traumatic brain injury (TBI)	BRAIN INJURY			English	Article						Traumatic brain injury (TBI); aminoguanidine; cAMP/CREB/BDNF pathway; brain-derived neurotrophic factor (BDNF); postsynaptic proteins; learning and memory	LONG-TERM POTENTIATION; INHIBITOR AMINOGUANIDINE; MEMORY IMPAIRMENT; OXIDATIVE STRESS; CREB ACTIVATION; INOS EXPRESSION; PROTEIN-KINASE; HEAD-INJURY; MODEL; INVOLVEMENT	Primary Objective: We aim to study the effects of chronic aminoguanidine (AG) administration on learning and memory impairment after TBI and explore the potential mechanism involved in this process. Research Design: Male C57BL/6J mice were divided into 6 groups: Control, TBI + Veh, TBI+ AG (50, 100, 200 and 400 mg/kg, i.p.). Methods and Procedures: Then, we measured cyclicadenosine 3MODIFIER LETTER PRIME, 5MODIFIER LETTER PRIME-monophosphate (cAMP) content, phosphorylated form of cAMP-response element binding protein (p-CREB) level, iNOS, brain-derived neurotrophic factor (BDNF) and postsynaptic density-93/95 (PSD-93/95) expression in hippocampus. The learning and memory abilities were assessed using Morris water maze and step-down test. Main Outcomes and Results: The results demonstrate that TBI induced down-regulation of BDNF, loss of PSD-93/95, learning and memory deficits with down-regulation of cAMP content and p-CREB/CREB ratio. Administration of AG (200 and 400 mg/kg) reversed TBI induced down-regulation of BDNF and PSD-93/95, up-regulated the cAMP content and p-CREB/CREB ratio, which resulted in improvement of learning and memory ability. Conclusions: We suspect that AG (200 and 400 mg/kg) might reverse TBI-induced selective loss of postsynaptic proteins and learning and memory deficits with the activation of cAMP/CREB/BDNF signalling pathway.	[Wang, Weijie; Shen, Mingyang; Sun, Kun; Wang, Yanping; Wang, Xiaodong; Jin, Xiaodong; Xu, Jingjing; Ding, Lianshu; Sun, Xiaoyang] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Neurosurg, Huaian 223300, Jiangsu, Peoples R China		Sun, XY (corresponding author), Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Neurosurg, Huaian 223300, Jiangsu, Peoples R China.	xiaoyangsunhayy@163.com			Key Research and Development Plan Projects (Social Development) in Huai'an city of Jiangsu Province [HAS2015018]; Natural Science Research Program in Huai'an city of Jiangsu Province [HAB201726]	This project was supported by Key Research and Development Plan Projects (Social Development) in Huai'an city of Jiangsu Province (No. HAS2015018) for Lianshu Ding and the Natural Science Research Program in Huai'an city of Jiangsu Province (HAB201726) for Weijie Wang.	Alipour M, 2016, CAN J PHYSIOL PHARM, V94, P669, DOI 10.1139/cjpp-2015-0357; Anaeigoudari A, 2016, LIFE SCI, V158, P22, DOI 10.1016/j.lfs.2016.06.019; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Bell KFS, 2013, J NEUROCHEM, V126, P274, DOI 10.1111/jnc.12176; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Butler RN, 2004, J GERONTOL A-BIOL, V59, P560; Chang SY, 2013, J CELL BIOCHEM, V114, P844, DOI 10.1002/jcb.24425; Chen CC, 1999, J BIOL CHEM, V274, P31559, DOI 10.1074/jbc.274.44.31559; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Diaz A, 2014, NEUROPEPTIDES, V48, P153, DOI 10.1016/j.npep.2014.03.002; Du AJ, 2013, INT J OPHTHALMOL-CHI, V6, P436, DOI 10.3980/j.issn.2222-3959.2013.04.05; Firouzjaei MA, 2014, CELL MOL NEUROBIOL, V34, P343, DOI 10.1007/s10571-013-0018-5; HARRIS HB, 1976, SOUTHERN MED J, V69, P1511, DOI 10.1097/00007611-197611000-00034; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hosseini M, 2011, ACTA PHYSIOL HUNG, V98, P421, DOI 10.1556/APhysiol.98.2011.4.5; Hsieh CY, 2015, CHINESE J PHYSIOL, V58, P19, DOI 10.4077/CJP.2015.BAC248; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Lee D, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00161; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Liu P, 2013, BRAIN RES, V1522, P67, DOI 10.1016/j.brainres.2013.05.032; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lueptow LM, 2016, PSYCHOPHARMACOLOGY, V233, P447, DOI 10.1007/s00213-015-4129-1; Ma Q, 2015, J ALZHEIMERS DIS, V43, P1413, DOI 10.3233/JAD-140216; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mojtahedzadeh M, 2014, J RES MED SCI, V19, P867; Mori K, 2001, BEHAV BRAIN RES, V120, P159, DOI 10.1016/S0166-4328(00)00371-5; Panagiotopoulos S, 1998, ATHEROSCLEROSIS, V136, P125, DOI 10.1016/S0021-9150(97)00192-5; Perez EJ, 2016, NEUROBIOL DIS, V94, P73, DOI 10.1016/j.nbd.2016.06.007; Qian Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140974; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Schimchowitsch S, 2006, J PHYSIOL-PARIS, V99, P221, DOI 10.1016/j.jphysparis.2005.12.015; Sun M, 2010, NEUROCHEM INT, V56, P634, DOI 10.1016/j.neuint.2010.01.009; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Vaillancourt VA, 2001, J MED CHEM, V44, P1231, DOI 10.1021/jm000094n; Vakili A, 2008, PAK J PHARM SCI, V21, P24; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Wang Y, 2016, PARKINSONISM RELAT D, V29, P66, DOI 10.1016/j.parkreldis.2016.05.023; Williams CM, 2008, FREE RADICAL BIO MED, V45, P295, DOI 10.1016/j.freeradbiomed.2008.04.008; Wu W, 2013, BEHAV BRAIN RES, V253, P212, DOI 10.1016/j.bbr.2013.07.052; Xiang L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050256; Xing RZ, 2016, ONCOTARGET, V7, P27855, DOI 10.18632/oncotarget.8428; Xue WD, 2016, SCI REP-UK, V6, DOI 10.1038/srep26331; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; Yao ZH, 2014, CURR NEUROVASC RES, V11, P156, DOI 10.2174/1567202611666140408115111; Yuruker V, 2015, METAB BRAIN DIS, V30, P223, DOI 10.1007/s11011-014-9623-3; Zhong L, 2016, J CELL MOL MED, V20, P1920, DOI 10.1111/jcmm.12884	51	10	11	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1858	1865		10.1080/02699052.2018.1537513			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600032	30346862				2022-02-06	
J	Foreman, B; Ngwenya, LB; Stoddard, E; Hinzman, JM; Andaluz, N; Hartings, JA				Foreman, Brandon; Ngwenya, Laura B.; Stoddard, Erica; Hinzman, Jason M.; Andaluz, Norberto; Hartings, Jed A.			Safety and Reliability of Bedside, Single Burr Hole Technique for Intracranial Multimodality Monitoring in Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Neurocritical care; Multimodality monitoring; Neuromonitoring; Intracranial pressure; Traumatic brain injury; PbtO2	HEMORRHAGIC COMPLICATIONS; SPREADING DEPOLARIZATION; VENTRICULOSTOMY PLACEMENT	BackgroundWe aimed to provide a systematic description of our 2-year experience using a standardized bedside, single burr hole approach to intracranial multimodality monitoring (MMM) in patients with severe traumatic brain injury (sTBI), focusing on safety and probe reliability. MethodsWe performed this observational cohort study at a university-affiliated, Level I trauma center with dedicated 20-bed neuroscience intensive care unit. We included 43 consecutive sTBI patients who required MMM to guide clinical care based on institutional protocol and had a four-lumen bolt placed to measure intracranial pressure, brain tissue oxygen, regional cerebral blood flow, brain temperature, and intracranial electroencephalography. ResultssTBI patients were aged 41.617.5years (mean +/- SD) and 84% were men. MMM devices were placed at a median of 12.5h (interquartile range [IQR] 9.0-21.4h) after injury and in non-dominant frontal lobe in 72.1% of cases. Monitoring was conducted for a median of 97.1h (IQR 46.9-124.6h) per patient. While minor hemorrhage, pneumocephalus, or small bone chips were common, only one (2.4%) patient experienced significant hemorrhage related to device placement. Radiographically, device malpositioning was noted in 13.9% of patients. Inadvertent device discontinuation occurred for at least one device in 58% of patients and was significantly associated with the frequency of travel for procedures or imaging. Devices remained in place for>80% of the total monitoring period and generated usable data>50% of that time.Conclusions A standardized, bedside single burr hole approach to MMM was safe. Despite some probe-specific recording limitations, MMM provided real-time measurements of intracranial pressure, oxygenation, regional cerebral blood flow, brain temperature, and function.	[Foreman, Brandon; Ngwenya, Laura B.] Univ Cincinnati, Med Ctr, Dept Neurol & Rehabil Med, 231 Albert Sabin Way, Cincinnati, OH 45208 USA; [Ngwenya, Laura B.; Hinzman, Jason M.; Andaluz, Norberto; Hartings, Jed A.] Univ Cincinnati, Med Ctr, Dept Neurosurg, Cincinnati, OH 45267 USA; [Ngwenya, Laura B.] Univ Cincinnati, Gardner Neurosci Inst, Neurotrauma Ctr, Cincinnati, OH USA; [Stoddard, Erica] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Foreman, B (corresponding author), Univ Cincinnati, Med Ctr, Dept Neurol & Rehabil Med, 231 Albert Sabin Way, Cincinnati, OH 45208 USA.	foremabo@ucmail.uc.edu		Foreman, Brandon/0000-0002-5418-674X; Ngwenya, Laura/0000-0001-7103-971X	Office of the Assistant Secretary of Defense for Health Affairs through Defense Medical Research and Development Program [W81XWH-16-2-0020]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Mayfield Education and Research Foundation	This work was supported in part by the Office of the Assistant Secretary of Defense for Health Affairs, through the Defense Medical Research and Development Program under Award No. W81XWH-16-2-0020. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. Funding was also provided by National Institute of Neurological Disorders and Stroke and Mayfield Education and Research Foundation.	Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bauer DF, 2011, NEUROSURGERY, V69, P255, DOI 10.1227/NEU.0b013e31821a45ba; Bekar A, 2009, J CLIN NEUROSCI, V16, P236, DOI 10.1016/j.jocn.2008.02.008; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Gardner PA, 2009, J NEUROSURG, V110, P1021, DOI 10.3171/2008.9.JNS17661; Hartings JA, 2017, CURR OPIN CRIT CARE, V23, P94, DOI 10.1097/MCC.0000000000000395; Hawryluk GWJ, 2016, J NEUROSURG, V125, P1217, DOI 10.3171/2015.7.JNS15809; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Jeffcote T, 2014, NEUROCRIT CARE, V20, P21, DOI 10.1007/s12028-013-9938-7; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Koskinen LOD, 2013, ACTA NEUROCHIR, V155, P2141, DOI 10.1007/s00701-013-1856-0; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Li CY, 2017, J CEREBR BLOOD F MET, V37, P1634, DOI 10.1177/0271678X16667131; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Ngwenya LB, 2016, RESP CARE, V61, P1232, DOI 10.4187/respcare.04962; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Patil V, 2013, ACTA NEUROCHIR, V155, P1773, DOI 10.1007/s00701-013-1769-y; Poca MA, 2002, J NEUROTRAUM, V19, P439, DOI 10.1089/08977150252932398; Shen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168901; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Wolf Stefan, 2012, Acta Neurochir Suppl, V114, P161, DOI 10.1007/978-3-7091-0956-4_30; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460	32	10	10	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2018	29	3					469	480		10.1007/s12028-018-0551-7			12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HD4SH	WOS:000452517800019	29949001				2022-02-06	
J	Liu, S; Lu, C; Liu, Y; Zhou, XY; Sun, L; Gu, Q; Shen, GY; Guo, AS				Liu, Su; Lu, Chun; Liu, Ying; Zhou, Xiaoyun; Sun, Li; Gu, Qi; Shen, Guangyu; Guo, Aisong			Hyperbaric Oxygen Alleviates the Inflammatory Response Induced by LPS Through Inhibition of NF-B/MAPKs-CCL2/CXCL1 Signaling Pathway in Cultured Astrocytes	INFLAMMATION			English	Article						hyperbaric oxygen; astrocytes; CCL2; CXCL1; LPS	TRAUMATIC BRAIN-INJURY; SPINAL-CORD; THERAPY; NEUROINFLAMMATION; IMMEDIATE; APOPTOSIS; ALPHA; EDEMA; PAIN	The purpose of this study was to investigate the inhibition neuroinflammation mechanisms of hyperbaric oxygen therapy (HBOT). Primary astrocytes were incubated with lipopolysaccharide (LPS) after which they underwent HBOT and separate administration of inflammatory cytokine inhibitors. The respective expression of inflammatory factors was then detected. Results showed that LPS significantly induced increases in the expression levels of chemokine (C-X-C motif) ligand 1 (CXCL1), chemokine C-C motif ligand 2 (CCL2), phospho-nuclear factor-kappa B (p-NF-B), phospho-c-Jun N-terminal kinase (p-JNK), phospho-extracellular signal-regulated kinase (p-ERK), and phospho-p38 (p-p38) in cultured astrocytes and peaked at 3h. HBOT downregulated the expression of some inflammation mediators including CXCL1 and CCL2. Furthermore, HBOT inhibited the expression of some up-stream regulators of inflammation mediators including p-NF-B, p-JNK, p-p38 (at 3 and 6h), and p-ERK (3h). Inhibitors of NF-B, ERK, and JNK (BAY117082, PD98059, and SP600125) significantly suppressed the expression of CXCL1 and CCL2 that were induced by LPS for 3h. However, the p38 inhibitor, SB203580, had no obvious effect on expression levels of CXCL1 and CCL2. In conclusion, we found that HBOT inhibits neuroinflammation via regulation of the LPS-induced NF-B/mitogen-activated protein kinases (MAPKs, JNK, and ERK) -CCL2/CXCL1 signaling pathways.	[Liu, Su; Zhou, Xiaoyun; Sun, Li; Gu, Qi; Shen, Guangyu; Guo, Aisong] Nantong Univ, Dept Rehabil Med, Affiliated Hosp, Nantong, Peoples R China; [Lu, Chun] Nantong Univ, Sch Med, Nantong, Peoples R China; [Liu, Ying] Nantong Univ, Dept Pathol, Affiliated Hosp, Nantong, Peoples R China		Guo, AS (corresponding author), Nantong Univ, Dept Rehabil Med, Affiliated Hosp, Nantong, Peoples R China.	lsjane@126.com			the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81702223] Funding Source: Medline; the Science and Technology Planning Project of Nantong [MS22016044] Funding Source: Medline		Baratz-Goldstein R, 2017, MOL CELL NEUROSCI, V83, P74, DOI 10.1016/j.mcn.2017.06.004; Berman JW, 1996, J IMMUNOL, V156, P3017; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Chistyakov DV, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010113; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Choi SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097093; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Geng FY, 2016, NEUROIMMUNOMODULAT, V23, P122, DOI 10.1159/000445689; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Hui J, 2013, J PAIN, V14, P747, DOI 10.1016/j.jpain.2013.02.003; Liu H, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6352159; Liu S, 2015, EXP BRAIN RES, V233, P3359, DOI 10.1007/s00221-015-4405-7; Liu S, 2013, NEURAL REGEN RES, V8, P3334, DOI 10.3969/j.issn.1673-5374.2013.35.008; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Lu Y, 2014, PAIN, V155, P2618, DOI 10.1016/j.pain.2014.09.027; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; Marshall JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02744-7; Meng XE, 2016, MED SCI MONITOR, V22, P284, DOI 10.12659/MSM.894148; Merkel SF, 2017, CELL TRANSPLANT, V26, P1178, DOI 10.1177/0963689717714341; Moriyama M, 2018, NEUROCHEM RES, V43, P363, DOI 10.1007/s11064-017-2431-5; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Sun WF, 2014, INFLAMM RES, V63, P287, DOI 10.1007/s00011-013-0699-8; Vargas-Caraveo A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13302-6; Wee HY, 2015, J SURG RES, V197, P382, DOI 10.1016/j.jss.2015.04.052; Wu FJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0316-6; Yang T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10201-8; Yang YK, 2017, NEUROREPORT, V28, P1232, DOI 10.1097/WNR.0000000000000901; Zhang YM, 2014, NEUROCHEM RES, V39, P950, DOI 10.1007/s11064-014-1292-4	32	10	12	2	12	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0360-3997	1573-2576		INFLAMMATION	Inflammation	DEC	2018	41	6					2003	2011		10.1007/s10753-018-0843-2			9	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	HC0BK	WOS:000451459800001	30073566				2022-02-06	
J	Rowe, BH; Eliyahu, L; Lowes, J; Gaudet, LA; Beach, J; Mrazik, M; Cummings, G; Voaklander, D				Rowe, Brian H.; Eliyahu, Leeor; Lowes, Justin; Gaudet, Lindsay A.; Beach, Jeremy; Mrazik, Martin; Cummings, Garnet; Voaklander, Donald			Concussion diagnoses among adults presenting to three Canadian emergency departments: Missed opportunities	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	Annual Scientific Meeting of the Canadian-Association-of-Emergency-Physicians (CAEP)	JUN 03-07, 2017	Whistler, CANADA	Canadian Assoc Emergency Phys		Emergency department; Concussion; Diagnostic error	MEDICAL-EDUCATION; INJURY; HEAD; PHYSICIANS; STATEMENT; SPORT; RISK	Objectives: Patients with concussion commonly present to the emergency department (ED) for assessment. Misdiagnosis of concussion has been documented in children and likely impacts treatment and discharge instructions. This study aimed to examine diagnosis of concussion in a general adult population. Methods: Patients N17 years old presenting meeting the World Health Organization's definition of concussion were recruited in one academic (Hospital 1) and two community (Hospitals 2 and 3) EDs in a Canadian city. A physician questionnaire and patient interviews documented recommendations given by emergency physicians. Bi-variable comparisons are reported using chi-square tests, t-tests orMann-Whitney tests, as appropriate. Multivariate analyses were performed using logistic regression methods. Results: Overall, the study enrolled 250 patients. The median age was 35 (IQR: 23 to 49) and 52% were female. A variety of concussion causes were documented. Forty-one (16%) patients were not diagnosed with a concussion despitemeeting criteria. Concussion diagnosiswas less likelywith a longer ED length of stay (OR=0.71; 95% CI: 0.60 to 0.83), presenting to the non-academic centers (Hospital 2: OR=0.21, 95% CI: 0.08 to 0.58; Hospital 3: OR =0.07, 95% CI: 0.02 to 0.24), or involvement in a motor vehicle collision (OR =0.11; 95% CI: 0.03 to 0.46). Conclusion: One in six patients with concussion signs and symptoms were misdiagnosed in the ED. Misdiagnosis was related to injury mechanism, length of stay, and enrolment site. Closer examination of institutional factors is needed to identify effective strategies to promote accurate diagnosis of concussion. (c) 2018 Elsevier Inc. All rights reserved.	[Rowe, Brian H.; Eliyahu, Leeor; Beach, Jeremy; Voaklander, Donald] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Rowe, Brian H.; Lowes, Justin; Gaudet, Lindsay A.; Cummings, Garnet] Univ Alberta, Fac Med & Dent, Dept Emergency Med, Edmonton, AB, Canada; [Eliyahu, Leeor] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Beach, Jeremy] Univ Alberta, Fac Med & Dent, Div Prevent Med, Edmonton, AB, Canada; [Beach, Jeremy] Coll Phys & Surg Alberta, Edmonton, AB, Canada; [Mrazik, Martin] Univ Alberta, Dept Educ Psychol, Fac Educ, Edmonton, AB, Canada		Rowe, BH (corresponding author), Univ Alberta, Dept Emergency Med, 1G1-43 Walter C Mackenzie Ctr,8440-112 St NW, Edmonton, AB T6G 2B7, Canada.	brian.rowe@ualberta.ca			Workers Compensation Board of Alberta; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [CBI 127054]; Frederick Banting and Charles Best Canada Graduate Scholarship from the CIHR [GSM 123187]; Health Quality Council of Alberta (HQCA) Studentship; Walter H. Johns Graduate Fellowship from the University of Alberta; Emergency Medicine Research Group (EMeRG) at the University of Alberta; Tier I Canada Research Chair in Evidence-based Emergency Medicine from the CIHR through the Government of Canada (Ottawa, ON) [1222864]	This study was co-funded by the Workers Compensation Board of Alberta and the Canadian Institutes of Health Research (CIHR; CBI 127054). Ms. Eliyahu was supported by a Frederick Banting and Charles Best Canada Graduate Scholarship from the CIHR (GSM 123187), The Health Quality Council of Alberta (HQCA) Studentship and the Walter H. Johns Graduate Fellowship from the University of Alberta. Mr. Lowes and Ms. Gaudet are supported by the Emergency Medicine Research Group (EMeRG) at the University of Alberta. Dr. Rowe is supported by a Tier I Canada Research Chair in Evidence-based Emergency Medicine from the CIHR through the Government of Canada (Ottawa, ON; 1222864). The funders had no direct role in the study or interpretation of the results.	Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Binstadt ES, 2007, ANN EMERG MED, V49, P495, DOI 10.1016/j.annemergmed.2006.08.023; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bullard MJ, 2008, CAN J EMERG MED, V10, P136; Burke MJ, 2012, CAN J NEUROL SCI, V39, P763, DOI 10.1017/S0317167100015584; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; De Maio VJ, 2014, PEDIATR EMERG CARE, V30, P20, DOI 10.1097/PEC.0000000000000058; Donaworth MA, 2016, PHYSICIAN SPORTSMED, V44, P1, DOI 10.1080/00913847.2016.1135039; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hobbs JG, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15617; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Megyesi JF, 2012, CAN J NEUROL SCI, V39, P698, DOI 10.1017/S0317167100015511; Patrick Sean P, 2017, AEM Educ Train, V1, P346, DOI 10.1002/aet2.10053; Pines JM, 2006, ACAD EMERG MED, V13, P90, DOI 10.1197/j.aem.2005.07.028; Royal College of Physicians and Surgeons of Canada, 2017, OBJ TRAIN SPEC EM ME; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Sinclair D, 2017, CAN J EMERG MED, V19, pS1, DOI 10.1017/cem.2017.372; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	27	10	10	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	DEC	2018	36	12					2144	2151		10.1016/j.ajem.2018.03.040			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	HB4MM	WOS:000451027100002	29636295				2022-02-06	
J	Verma, SK; Kumari, P; Ansari, SN; Ansari, MO; Deori, D; Mobin, SM				Verma, Sanjay K.; Kumari, Pratibha; Ansari, Shagufi Naz; Ansari, Mohd Ovais; Deori, Dondinath; Mobin, Shaikh M.			A novel mesoionic carbene based highly fluorescent Pd( II) complex as an endoplasmic reticulum tracker in live cells	DALTON TRANSACTIONS			English	Article							HETEROCYCLIC CARBENES; PALLADIUM(II) COMPLEX; LIGANDS; TARGET; DEATH; PROBE	A recent study advocates that endoplasmic reticulum (ER) dysfunction may be linked to critical neurotrauma and advanced tauopathy. In this regard, targeting the ER warrants urgent attention towards the therapeutic treatment of neurotrauma-related neurodegeneration. Herein, we report the synthesis of a new N-heterocyclic mesoionic carbene based highly fluorescent square-planar Pd(ii) complex 1, with a high quantum yield (0.737). Probe 1 is a non-toxic probe for selectively labeling the endoplasmic reticulum in live cells.	[Verma, Sanjay K.; Ansari, Shagufi Naz; Ansari, Mohd Ovais; Deori, Dondinath; Mobin, Shaikh M.] Discipline Chem, Indore, Madhya Pradesh, India; [Kumari, Pratibha; Mobin, Shaikh M.] Discipline Biosci & Biomed Engn, Indore, Madhya Pradesh, India; [Mobin, Shaikh M.] Indian Inst Technol Indore, Discipline Met Engn & Mat Sci, Khandwa Rd, Indore 453552, Madhya Pradesh, India		Mobin, SM (corresponding author), Discipline Chem, Indore, Madhya Pradesh, India.; Mobin, SM (corresponding author), Discipline Biosci & Biomed Engn, Indore, Madhya Pradesh, India.; Mobin, SM (corresponding author), Indian Inst Technol Indore, Discipline Met Engn & Mat Sci, Khandwa Rd, Indore 453552, Madhya Pradesh, India.	xray@iiti.ac.in	, Mobin/D-1273-2014; SHAIKH, MOBIN M/E-9381-2013	, Mobin/0000-0003-1940-3822; Kumari, Pratibha/0000-0002-2179-102X	SERBDepartment of Science & Technology (India)Science Engineering Research Board (SERB), India; MHRD, New Delhi; SERB-DST, New Delhi, Government of India [EMR/2016/001113]; IIT Indore	The authors are grateful to the Sophisticated Instrumentation Centre (SIC), IIT Indore for providing characterization facilities. SKV is grateful to the SERB for providing National Post-Doctoral Fellowship; PK and SNA are thankful to the MHRD, New Delhi for fellowship; and MOA is thankful to IIT Indore for his internship. DND is thankful to IIT Indore. SMM is thankful to the SERB-DST (Project No. EMR/2016/001113), New Delhi, Government of India and IIT Indore for financial support. This work is dedicated to Professor Dr Dietmar Stalke on his 60<SUP>th</SUP> birthday.	Adams CJ, 2007, DALTON T, P4446, DOI 10.1039/b709252k; Banerjee S, 2014, CHEM COMMUN, V50, P5590, DOI 10.1039/c4cc02093f; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Chen X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09004; Cummings SD, 1996, J AM CHEM SOC, V118, P1949, DOI 10.1021/ja951345y; Deshaies RJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0094-0; Divsalar A, 2010, J PHYS CHEM B, V114, P3639, DOI 10.1021/jp909143b; Eryazici I, 2008, CHEM REV, V108, P1834, DOI 10.1021/cr0781059; Fulmer GR, 2010, ORGANOMETALLICS, V29, P2176, DOI 10.1021/om100106e; Hahn FE, 2008, ANGEW CHEM INT EDIT, V47, P3122, DOI 10.1002/anie.200703883; Han Y, 2010, CHEM-EUR J, V16, P771, DOI 10.1002/chem.200902737; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Herrmann WA, 2002, ANGEW CHEM INT EDIT, V41, P1290, DOI 10.1002/1521-3773(20020415)41:8<1290::AID-ANIE1290>3.0.CO;2-Y; Huang SP, 2015, BIOSENS BIOELECTRON, V71, P313, DOI 10.1016/j.bios.2015.04.056; Janes M.S., 2005, MICROSC MICROANAL, V11, P246; Khan H, 2011, EUR J MED CHEM, V46, P4071, DOI 10.1016/j.ejmech.2011.06.007; Kim HR, 2016, CHEM COMMUN, V52, P7134, DOI 10.1039/c6cc02330d; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kumari P, 2018, CHEM COMMUN, V54, P539, DOI 10.1039/c7cc07812a; Maity R, 2015, DALTON T, V44, P46, DOI 10.1039/c4dt03239j; Maity R, 2013, CHEM COMMUN, V49, P1011, DOI 10.1039/c2cc37446c; McDonald L, 2016, J MATER CHEM B, V4, P7902, DOI 10.1039/c6tb02456d; Meinig JM, 2015, ANGEW CHEM INT EDIT, V54, P9696, DOI 10.1002/anie.201504156; Mukherjee S, 2011, INORG CHIM ACTA, V373, P40, DOI 10.1016/j.ica.2011.03.048; Nadeem S, 2010, INORG CHIM ACTA, V363, P3261, DOI 10.1016/j.ica.2010.06.015; Pugh D, 2007, COORDIN CHEM REV, V251, P610, DOI 10.1016/j.ccr.2006.08.001; Radloff C, 2009, DALTON T, P9392, DOI 10.1039/b916651c; Radloff C, 2009, DALTON T, P7215, DOI 10.1039/b907896g; Rit A, 2010, J AM CHEM SOC, V132, P4572, DOI 10.1021/ja101490d; Ruiz J, 2008, INORG CHEM, V47, P4490, DOI 10.1021/ic701873b; Saini AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep34807; Segarra C, 2014, ORGANOMETALLICS, V33, P5077, DOI 10.1021/om500729b; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Stevenson J, 2016, ANNU REV NUTR, V36, P511, DOI 10.1146/annurev-nutr-071715-051030; Tavassoli M, 2016, ACS SUSTAIN CHEM ENG, V4, P1454, DOI 10.1021/acssuschemeng.5b01432; Valentini A, 2009, J MED CHEM, V52, P484, DOI 10.1021/jm801276a; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Zhang DY, 2017, ACS APPL MATER INTER, V9, P6761, DOI 10.1021/acsami.6b13808; Zou TT, 2013, CHEM COMMUN, V49, P5423, DOI 10.1039/c3cc40953h	39	10	10	3	24	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.	NOV 28	2018	47	44								10.1039/c8dt02778a			6	Chemistry, Inorganic & Nuclear	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	HA4DK	WOS:000450208000002	30207353				2022-02-06	
J	Liu, XY; Meng, FX; Gao, J; Zhang, L; Zhou, Z; Pan, G; Luo, BY				Liu, Xiaoyan; Meng, Fanxia; Gao, Jian; Zhang, Li; Zhou, Zhen; Pan, Gang; Luo, Benyan			Behavioral and Resting State Functional Connectivity Effects of High Frequency rTMS on Disorders of Consciousness: A Sham-Controlled Study	FRONTIERS IN NEUROLOGY			English	Article						default mode network (DMN); disorders of consciousness (DOC); functional connectivity; minimally conscious state (MCS); resting state; transcranial magnetic stimulation	TRANSCRANIAL MAGNETIC STIMULATION; TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; INTERNAL AWARENESS; VEGETATIVE STATE; DAMAGED PATIENTS; MRI; LEVEL; MODULATION; RECOVERY	Objectives: A combined approach of behavioral characteristics and network properties was applied to explore the effect of repetitive transcranial magnetic stimulation (rTMS) on disorders of consciousness (DOC) and to observe changes in brain network connections before and after the stimulation. Methods: A total of 7 DOC patients and 11 healthy controls were enrolled. The study was designed as a randomized, sham-controlled study. All DOC patients were given 20 Hz rTMS real and sham stimuli to the left M1 region, with each stimulus lasting for 5 consecutive working days and the interval between two stimuli being 1 week. Coma Recovery Scale-Revised (CRS-R) and resting state functional MRI data before and after stimuli were collected. The functional connection (FC) of the default mode network and the frontoparietal network were chosen as the central target to compare differences in network connections between the DOC group and the normal control group. For DOC patients, changes in behavior and brain function before and after real and sham stimuli were also assessed as a group and individually. Results: (1). The overall analyses showed no significant changes of CRS-R scores or brain FC following real or sham rTMS stimuli in the DOC patients. However, real rTMS stimuli tended to enhance the FC of nodes in left lateral parietal cortex (LPC), left inferior temporal cortex (ITC) and right dorsolateral prefrontal cortex (DLPFC). (2). The individual analyses showed one minimally conscious state (MCS) patient presented with a obviously increased CRS-R score following real rTMS stimuli, and a visibly enhanced connectivity was observed in the nodes of left LPC, left ITC and right DLPFC of this patient. Conclusion: Our findings did not provide sufficient evidence of therapeutic effect of 20 Hz rTMS over the left M1 in DOC. However, MCS patients shortly after brain injury may possibly benefit from rTMS. Reconstruction of the left LPC, the left ITC and the right DLPFC may be the brain networking foundation of improvements in consciousness from rTMS.	[Liu, Xiaoyan; Meng, Fanxia; Luo, Benyan] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Neurol, Hangzhou, Zhejiang, Peoples R China; [Gao, Jian] Hangzhou Hosp Zhejiang CAPR, Dept Rehabil, Hangzhou, Zhejiang, Peoples R China; [Zhang, Li] Zhejiang Prov Peoples Hosp, Dept Rehabil Med, Hangzhou, Zhejiang, Peoples R China; [Zhou, Zhen; Pan, Gang] Zhejiang Univ, Dept Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China		Luo, BY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Neurol, Hangzhou, Zhejiang, Peoples R China.; Pan, G (corresponding author), Zhejiang Univ, Dept Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China.	gpan@zju.edu.cn; luobenyan@zju.edu.cn	Pan, Gang/B-5978-2013	Pan, Gang/0000-0002-4049-6181	Science and Technology Plan of Zhejiang Province [2017C03011]; Medical Science and Technology Project [2016152769]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801056]	This work was supported by the Science and Technology Plan of Zhejiang Province (2017C03011), the Medical Science and Technology Project co-founded by Zhejiang Province and the Ministry of Health of China (2016152769), and the National Natural Science Foundation of China (81801056).	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bisenius S, 2015, NEUROIMAGE, V122, P177, DOI 10.1016/j.neuroimage.2015.07.070; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Cincotta M, 2015, CORTEX, V71, P368, DOI 10.1016/j.cortex.2015.07.027; Clauss R, 2004, NEW ENGL J MED, V351, P511, DOI 10.1056/NEJM200407293510522; Demertzi A, 2011, PROG BRAIN RES, V193, P309, DOI 10.1016/B978-0-444-53839-0.00020-X; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Fridman EA, 2010, BRAIN INJURY, V24, P636, DOI 10.3109/02699051003610433; Ge RY, 2017, J AFFECT DISORDERS, V218, P75, DOI 10.1016/j.jad.2017.04.060; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gorsler A, 2003, CLIN NEUROPHYSIOL, V114, P1800, DOI 10.1016/S1388-2457(03)00157-3; He JH, 2014, NMR BIOMED, V27, P880, DOI 10.1002/nbm.3130; Koenig MA, 2014, NEUROCRIT CARE, V20, P348, DOI 10.1007/s12028-014-9953-3; Liu CY, 2015, SLEEP MED, V16, P785, DOI 10.1016/j.sleep.2014.12.029; Liu XY, 2017, J CLIN NEUROSCI, V42, P160, DOI 10.1016/j.jocn.2017.04.015; Manganotti P, 2013, BRAIN STIMUL, V6, P913, DOI 10.1016/j.brs.2013.06.006; Naro A, 2015, RESTOR NEUROL NEUROS, V33, P159, DOI 10.3233/RNN-140448; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; Qin PM, 2015, ANN NEUROL, V78, P594, DOI 10.1002/ana.24479; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rugg MD, 2018, CORTEX, V107, P238, DOI 10.1016/j.cortex.2017.07.012; Schiff ND, 2012, ANN NY ACAD SCI, V1265, P56, DOI 10.1111/j.1749-6632.2012.06712.x; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Thibaut A, 2012, J REHABIL MED, V44, P487, DOI 10.2340/16501977-0940; Tomaiuolo F, 2016, J INT NEUROPSYCH SOC, V22, P620, DOI 10.1017/S1355617716000485; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Tsai YH, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00956; Van Overwalle F, 2015, HUM BRAIN MAPP, V36, P5137, DOI 10.1002/hbm.23002; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Wu XH, 2015, J NEUROSCI, V35, P12932, DOI 10.1523/JNEUROSCI.0415-15.2015; Xia XY, 2017, NEUROREPORT, V28, P1022, DOI 10.1097/WNR.0000000000000886; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4	38	10	12	4	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 21	2018	9								982	10.3389/fneur.2018.00982			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB3DQ	WOS:000450929400001	30519211	Green Published, gold			2022-02-06	
J	Santhanam, P; Teslovich, T; Wilson, SH; Yeh, PH; Oakes, TR; Weaver, LK				Santhanam, Priya; Teslovich, Theresa; Wilson, Steffanie H.; Yeh, Ping-Hong; Oakes, Terrence R.; Weaver, Lindell K.			Decreases in White Matter Integrity of Ventro-Limbic Pathway Linked to Post-Traumatic Stress Disorder in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; limbic system; post-traumatic stress disorder; traumatic brain injury	UNCINATE FASCICULUS; AXONAL INJURY; MILITARY; MEMORY; STATE; ABNORMALITIES; SYMPTOMS; TIME; SEGMENTATION; RELIABILITY	Post-traumatic stress disorder (PTSD) is commonly observed in military service members with mild traumatic brain injury (mTBI); however, the relationship between mTBI and PTSD is complex and not well understood. The present study aims to elucidate a link between the degree of alteration in limbic system-related white matter tracts and PTSD symptoms in an mTBI population. Diffusion-tensor imaging (DTI) with probabilistic tractography of the fronto-limbic pathways revealed decreased white matter integrity in the uncinate fasciculus in those with co-morbid mTBI and PTSD (n = 34), relative to those with only mTBI (n = 35). Additionally, fractional anisotropy (FA) and radial diffusivity (RD) measures in the bilateral uncinate fasciculus correlated with Post-Traumatic Stress Disorder Checklist Civilian version (PCL-C) scores, and primarily within the avoidance and re-experiencing domains. Findings from this study suggest the degree of traumatic injury within the limbic system could be directly related to post-traumatic stress and post-concussive symptoms, with disrupted white matter leading to significant PTSD outcomes.	[Santhanam, Priya] Lovelace Resp Res Inst, Albuquerque, NM USA; [Teslovich, Theresa] Excentium Inc, Falls Church, VA USA; [Yeh, Ping-Hong] Northtide, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Wilson, Steffanie H.] Emmes Corp, 401 N Washington St,Suite 700, Rockville, MD 20850 USA; [Oakes, Terrence R.] Univ Wisconsin, Dept Radiol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Weaver, Lindell K.] IntermtMed Ctr, Div Hyperbar Med, Intmed, Murray, UT USA; [Weaver, Lindell K.] Intermt LDS Hosp, Salt Lake City, UT USA; [Weaver, Lindell K.] Univ Utah, Dept Med, Sch Med, Salt Lake City, UT 84112 USA		Santhanam, P (corresponding author), Emmes Corp, 401 N Washington St,Suite 700, Rockville, MD 20850 USA.	psanthanam@lrri.org			U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-15-D-0039-0003]	This work is supported by the U.S. Army Medical Research and Materiel Command under Contract No. W81XWH-15-D-0039-0003. The views, opinions, and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy, or decision unless so designated by other documentation. In the conduct of research where humans are the subjects, the investigator(s) adhered to the policies regarding the protection of human subjects as prescribed by the Code of Federal Regulations (CFR) Title 45, Volume 1, Part 46; Title 32, Chapter 1, Part 219; and Title 21, Chapter 1, Part 50 (Protection of Human Subjects).	Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Catani M, 2013, NEUROSCI BIOBEHAV R, V37, P1724, DOI 10.1016/j.neubiorev.2013.07.001; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Defense and Veterans Brain Injury Center, 2015, DOD NUMB TRAUM BRAIN; Department of Defense & Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Diehl B, 2008, EPILEPSIA, V49, P1409, DOI 10.1111/j.1528-1167.2008.01596.x; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; DVBIC Defense and Veterans Brain Injury Center, 2016, RES REV MILD TRAUM B; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Feldman HM, 2010, J DEV BEHAV PEDIATR, V31, P346, DOI 10.1097/DBP.0b013e3181dcaa8b; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fujie S, 2008, DEMENT GERIATR COGN, V26, P432, DOI 10.1159/000165381; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lopez KC, 2017, J NEUROTRAUM, V34, P16, DOI 10.1089/neu.2015.4323; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McCrea Simon M, 2008, Neuropsychiatr Dis Treat, V4, P1129; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Singh S, 2016, J BIOSCIENCES, V41, P419, DOI 10.1007/s12038-016-9631-z; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sorg SF, 2016, J HEAD TRAUMA REHAB, V31, P297, DOI 10.1097/HTR.0000000000000189; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Weaver LK, 2016, UNDERSEA HYPERBAR M, V43, P491; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023	60	10	10	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1093	1098		10.1089/neu.2017.5541		NOV 2018	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR6CG	WOS:000450806400001	30039740				2022-02-06	
J	Clark, AL; Merritt, VC; Bigler, ED; Bangen, KJ; Werhane, M; Sorg, SF; Bondi, MW; Schiehser, DM; Delano-Wood, L				Clark, Alexandra L.; Merritt, Victoria C.; Bigler, Erin D.; Bangen, Katherine J.; Werhane, Madeleine; Sorg, Scott F.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa			Blast-Exposed Veterans With Mild Traumatic Brain Injury Show Greater Frontal Cortical Thinning and Poorer Executive Functioning	FRONTIERS IN NEUROLOGY			English	Article						cortical thickness; cortical thinning; mTBI; head injury; blast; blast TBI; blast exposure; subconcussive blast exposure	MILITARY SERVICE-MEMBERS; POSTTRAUMATIC-STRESS-DISORDER; HUMAN CEREBRAL-CORTEX; LOW-LEVEL BLAST; IRAQI FREEDOM; THICKNESS; SOLDIERS; MODEL; CONNECTIVITY; PERFORMANCE	Objective: Blast exposure (BE) and mild traumatic brain injury (mTBI) have been independently linked to pathological brain changes. However, the combined effects of BE and mTBI on brain structure have yet to be characterized. Therefore, we investigated whether regional differences in cortical thickness exist between mTBI Veterans with and without BE while on deployment. We also examined whether cortical thickness (CT) and cognitive performance differed among mTBI Veterans with low vs. high levels of cumulative BE. Methods: 80 Veterans with mTBI underwent neuroimaging and completed neuropsychological testing and self-report symptom rating scales. Analyses of covariance (ANCOVA) were used to compare blast-exposed Veterans (mTBI+BE, n = 51) to those without BE (mTBI-BE, n = 29) on CT of frontal and temporal a priori regions of interest (ROIs). Next, multiple regression analyses were used to examine whether CT and performance on an executive functions composite differed among mTBI Veterans with low (mTBI+BE Low, n = 22) vs. high (mTBI+BE High, n = 26) levels of cumulative BE. Results: Adjusting for age, numer of TBIs, and PTSD symptoms, the mTBI+BE group showed significant cortical thinning in frontal regions (i.e., left orbitofrontal cortex [p = 0.045], left middle frontal gyrus [p = 0.023], and right inferior frontal gyrus [p = 0.034]) compared to the mTBI-BE group. No significant group differences in CT were observed for temporal regions (p's > 0.05). Multiple regression analyses revealed a significant cumulative BE x CT interaction for the left orbitofrontal cortex (p = 0.001) and left middle frontal gyrus (p = 0.020); reduced CT was associated with worse cognitive performance in the mTBI+BE High group but not the mTBI+BE Low group. Conclusions: Findings show that Veterans with mTBI and BE may be at risk for cortical thinning post-deployment. Moreover, our results demonstrate that reductions in CT are associated with worse executive functioning among Veterans with high levels of cumulative BE. Future longitudinal studies are needed to determine whether BE exacerbates mTBI-related cortical thinning or independently negatively influences gray matter structure.	[Clark, Alexandra L.; Werhane, Madeleine] Univ Calif San Diego, SDSU, Joint Doctoral Program Clin Psychol, San Diego, CA USA; [Clark, Alexandra L.; Merritt, Victoria C.; Bangen, Katherine J.; Werhane, Madeleine; Sorg, Scott F.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Bigler, Erin D.] Brigham & Young Univ, Dept Psychol, San Diego, CA USA; [Bigler, Erin D.] Brigham & Young Univ, Neurosci Ctr, San Diego, CA USA; [Bangen, Katherine J.; Sorg, Scott F.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA; [Schiehser, Dawn M.; Delano-Wood, Lisa] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA		Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst, San Diego, CA 92161 USA.; Delano-Wood, L (corresponding author), Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA.; Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA.	ldelano@ucsd.edu		Merritt, Victoria/0000-0001-5683-4168	Veterans Affairs grants [829-MR-NB-25860, CDA-2-065-10S]; Department of DefenseUnited States Department of Defense [W81XWH-10-2-0169]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS09870]; VA Clinical Science R&D Career Development Award [CX001508-02]; Veterans AffairsUS Department of Veterans Affairs [IK2CX001508] Funding Source: NIH RePORTER	This work was supported Veterans Affairs grants awarded to Drs. Delano-Wood (829-MR-NB-25860) and Schiehser (CDA-2-065-10S). This work was further supported by grants awarded by the Department of Defense (W81XWH-10-2-0169) to Dr. Delano-Wood and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (F31NS09870) to Ms. Clark. During preparation of this manuscript, Dr. Sorg received salary support from a VA Clinical Science R&D Career Development Award (CX001508-02).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; American Psychatric Association, 2000, DIAGN STAT MAN MENT; Averill Lynnette A, 2017, Chronic Stress (Thousand Oaks), V1, DOI 10.1177/2470547017724714; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; COHEN H, 1946, ARCH PATHOL, V42, P12; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delis DC., 2001, DELIS KAPLAN EXECUTI; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Grande LJ, 2018, J INT NEUROPSYCH SOC, V24, P466, DOI 10.1017/S1355617717001242; Greer N, 2016, PREVALENCE EPIDEMIOL, P1; Hayes JP, 2012, NEUROCASE, V18, P258, DOI 10.1080/13554794.2011.588181; Heaton R.K., 1981, WISCONSIN CARD SORTI; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Kamnaksh A., 2014, TRANSL PROTEOM, V3, P22, DOI [10.1016/j.trprot.2013.11.001, DOI 10.1016/J.TRPROT.2013.11.001]; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Mu WY, 2017, J HEAD TRAUMA REHAB, V32, P55, DOI 10.1097/HTR.0000000000000213; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Savjani RR, 2017, J NEUROTRAUM, V34, P3107, DOI 10.1089/neu.2017.5022; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Stricker NH, 2017, J CLIN EXP NEUROPSYC, V39, P768, DOI 10.1080/13803395.2016.1264575; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; The Management of Concussion/ mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Tombaugh, 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wrocklage KM, 2017, EUR NEUROPSYCHOPHARM, V27, P515, DOI 10.1016/j.euroneuro.2017.02.010; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	61	10	12	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 9	2018	9								873	10.3389/fneur.2018.00873			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GZ7JQ	WOS:000449655500001	30473678	Green Published, gold			2022-02-06	
J	Bosco, FM; Parola, A; Angeleri, R; Galetto, V; Zettin, M; Gabbatore, I				Bosco, F. M.; Parola, A.; Angeleri, R.; Galetto, V.; Zettin, M.; Gabbatore, I.			Improvement of Communication Skills after Traumatic Brain Injury: The Efficacy of the Cognitive Pragmatic Treatment Program using the Communicative Activities of Daily Living	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Rehabilitation; Traumatic brain injury; Pragmatics; Functional communication; Language; Theory of mind; Executive functions	CLOSED-HEAD-INJURY; FRONTAL-LOBE; LANGUAGE-SKILLS; SEX-DIFFERENCES; MIND; ADULTS; DISCOURSE; IMPAIRMENT; ABILITIES; CHILDREN	Objective: The pragmatic impairment often characterizing individuals after a traumatic brain injury (TBI) significantly limits their independence, preventing social participation. Rehabilitation programs aim to improve the impaired capacities to help participants communicate effectively, increasing their self-perceived life quality. The aim of this study was to verify the effectiveness of the Cognitive Pragmatic Treatment (CPT) in improving communication abilities after TBI, thus enabling better management of communication activities in daily living. Method: Nineteen individuals with TBI in a post-acute phase completed the CPT, a group-based training program designed to improve pragmatic abilities. Pre- and post-training, participants were administered the Communication Activities of Daily Living (CADL-2), and the equivalent forms of the Assessment Battery for Communication (ABaCo). Results: Comparison of pre- and post-training performance showed an overall improvement in pragmatic abilities. Post-training, participants scored higher in communication skills on both the CADL-2 and ABaCo, with such scores remaining constant at a 3-month follow-up assessment. Conclusions: This study showed that the CPT was effective in improving the participants' communicative abilities. The possibility that the benefits of the CPT may generalize to everyday communicative interactions is discussed.	[Bosco, F. M.; Parola, A.; Gabbatore, I.] Univ Turin, Dept Psychol, Turin, Italy; [Bosco, F. M.] Inst Neurosci Turin, Turin, Italy; [Angeleri, R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Galetto, V.; Zettin, M.] Ctr Puzzle, Turin, Italy; [Gabbatore, I.] Univ Oulu, Res Unit Logoped, Child Language Res Ctr, Oulu, Finland		Parola, A (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.	alparola@unito.it	Gabbatore, Ilaria/AAC-1925-2019; bosco, francesca marina/B-6746-2013; Parola, alberto/AAK-3748-2020	Gabbatore, Ilaria/0000-0002-9724-8066; bosco, francesca marina/0000-0001-6101-8587; PAROLA, ALBERTO/0000-0002-6039-0907	MIUR PRIN (Progetti di Ricerca di Rilevante Interesse Nazionale) 2017, project 'The Interpretative Brain: Understanding and Promoting Pragmatic Abilities across Lifespan and in Mental Illness'Ministry of Education, Universities and Research (MIUR) [201577HA9M]	The research was funded by MIUR PRIN (Progetti di Ricerca di Rilevante Interesse Nazionale) 2017, project 'The Interpretative Brain: Understanding and Promoting Pragmatic Abilities across Lifespan and in Mental Illness,' project code 201577HA9M.	Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R, 2016, MINERVA PSICH, V57, P93; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; ATEN JL, 1982, J SPEECH HEAR DISORD, V47, P93, DOI 10.1044/jshd.4701.93; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bellon ML, 2006, BRAIN INJURY, V20, P1069, DOI 10.1080/02699050600909813; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; Bosco FM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00021; Bosco FM, 2017, APPL PSYCHOLINGUIST, V38, P57, DOI 10.1017/S0142716416000047; Bosco FM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00166; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Bosco FM, 2013, J CHILD LANG, V40, P741, DOI 10.1017/S0305000913000081; Bosco FM, 2012, J COMMUN DISORD, V45, P290, DOI 10.1016/j.jcomdis.2012.03.002; Bosco FM, 2012, J COMMUN DISORD, V45, P181, DOI 10.1016/j.jcomdis.2012.01.005; Braun C M, 1989, Brain Inj, V3, P5, DOI 10.3109/02699058909008068; Brizio A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01011; Brookshire R. H., 1997, DISCOURSE COMPREHENS; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; Carlomagno S, 2001, ARCH PHYS MED REHAB, V82, P1073, DOI 10.1053/apmr.2001.25155; Carotenuto A, 2018, ARCH CLIN NEUROPSYCH, V33, P194, DOI 10.1093/arclin/acx061; Channon S, 2007, NEUROPSYCHOLOGIA, V45, P1725, DOI 10.1016/j.neuropsychologia.2006.12.021; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Cherney LR, 2008, AM J SPEECH-LANG PAT, V17, P19, DOI 10.1044/1058-0360(2008/003); Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cruice M, 2003, APHASIOLOGY, V17, P333, DOI 10.1080/02687030244000707; Cummings L, 2017, PERSP PRAGMAT PHILO, V11, P587, DOI 10.1007/978-3-319-47489-2_22; Cummings L, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01286; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dardier V, 2011, J COMMUN DISORD, V44, P359, DOI 10.1016/j.jcomdis.2011.02.001; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); EKMAN P, 1976, ENVIRON PSYCH NONVER, V1, P56, DOI 10.1007/BF01115465; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Finch E, 2016, ARCH PHYS MED REHAB, V97, P1352, DOI [10.1016/j.apmr.2015.11.005, 10.1016/j.apmr.20.15.11.005]; Gabbatore I, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1612078; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Godbout L, 1995, NEUROPSYCHOLOGIA, V33, P1671, DOI 10.1016/0028-3932(95)00047-X; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Holland A., 1999, COMMUNICATION ACTIVI; Hopper T, 2002, APHASIOLOGY, V16, P745, DOI 10.1080/02687030244000059; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Huber W., 1983, AACHENER APHASIE TES; Ilie G, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-016-0385-3; Joanette Y., 2012, DISCOURSE ABILITY BR; Kanade T., 2000, Proceedings Fourth IEEE International Conference on Automatic Face and Gesture Recognition (Cat. No. PR00580), P46, DOI 10.1109/AFGR.2000.840611; Kertesz A., 1982, W APHASIA BATTERY TE; Kirsch NL, 2004, J HEAD TRAUMA REHAB, V19, P366, DOI 10.1097/00001199-200409000-00002; Levinson Stephen., 1983, PRAGMATICS; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; Marini A, 2017, J NEUROLINGUIST, V44, P91, DOI 10.1016/j.jneuroling.2017.03.005; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marquardt TP, 2001, APHASIOLOGY, V15, P1091, DOI 10.1080/02687040143000429; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Matsumoto D., 1988, JAPANESE CAUCASIAN F; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S., 2000, COMMUNICATION DISORD; McDonald S., 2015, J NEUROPSYCHOL, V11, P291; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; Murphy A, 2015, APHASIOLOGY, V29, P151, DOI 10.1080/02687038.2014.959411; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nudo RJ, 2011, J COMMUN DISORD, V44, P515, DOI 10.1016/j.jcomdis.2011.04.004; Parola A, 2016, J NEUROLINGUIST, V39, P10, DOI 10.1016/j.jneuroling.2015.12.003; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Prigatano G. P., 1987, COMMUNITY REENTRY HE, P1; Raven J. C., 1947, PROGR MATRICES TEST; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Rowley DA, 2017, BRAIN INJURY, V31, P1564, DOI 10.1080/02699052.2017.1341645; Sacco K, 2008, J COGN SCI, V9, P111; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00048; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; Spinnler H, 1987, ITAL J NEUROL SCI S8, V6, P1; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Tirassa M, 2006, CONSCIOUS COGN, V15, P197, DOI 10.1016/j.concog.2005.06.005; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Tu LV, 2011, BRAIN INJURY, V25, P560, DOI 10.3109/02699052.2011.571655; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Zhang L., 2001, STAPP CAR CRASH J, V45, P394	103	10	10	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2018	33	7					875	888		10.1093/arclin/acy041			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	HG9KC	WOS:000455325500007	29800139	Bronze, Green Submitted			2022-02-06	
J	Chang, HK; Hsu, JW; Wu, JC; Huang, KL; Chang, HC; Bai, YM; Chen, TJ; Chen, MH				Chang, Hsuan-Kan; Hsu, Ju-Wei; Wu, Jau-Ching; Huang, Kai-Lin; Chang, Huang-Chou; Bai, Ya-Mei; Chen, Tzeng-Ji; Chen, Mu-Hong			Traumatic Brain Injury in Early Childhood and Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder: A Nationwide Longitudinal Study	JOURNAL OF CLINICAL PSYCHIATRY			English	Article							DEFICIT HYPERACTIVITY DISORDER; PSYCHIATRIC-DISORDERS; PRESCHOOL-CHILDREN; YOUNG-ADULTS; ADOLESCENTS; BIRTH; ASSOCIATION; PREVALENCE; MANAGEMENT; DIAGNOSIS	Objective: Early childhood (< 3 years of age) is a critical period for neurodevelopment. This study investigated the correlation between early childhood traumatic brain injury (TBI) and subsequent risk of attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and developmental delay (DD) by analyzing a national-scale cohort. Methods: Data from the National Health Insurance Research Database, which comprises health care information from > 99% of the Taiwanese population, were analyzed. Children with TBI in their early childhood were enrolled from 1998-2008, and the incidence of subsequent ADHD, ASD, or DD (according to ICD-9 criteria) was assessed and compared with controls without TBI. Patients' age, number of TBI events, and TBI severity were investigated for the risk of ADHD, ASD, or DD. Results: A total of 7,801 and 31,204 children were enrolled in the TBI and control cohorts, respectively. The TBI cohort exhibited a higher incidence of subsequent ADHD, ASD, or DD than the controls (all P <.001). Diagnoses of ADHD, ASD, or DD in the TBI cohort were made at a younger age compared with the controls. Cox regression demonstrated the highest hazard ratios (HRs) of ADHD, ASD, or DD with repeated TBI events, severe TBI, and TBI events before 1 year of age, with the exception that the HR of ASD did not significantly increase after repeated TBI (rho =.335). In addition, cumulative HRs (> 10 years) of ADHD, ASD, or DD were increased after TBI (all P <.001). Conclusions: Data from this study suggest that the incidence of ADHD, ASD, and DD significantly increased after TBI events in early childhood (< 3 years of age). The risk factors include severe TBI, repeated TBI events, and TBI at a younger age. The long-term follow-up demonstrated an increased cumulative risk of ADHD, ASD, and DD after TBI.	[Chang, Hsuan-Kan; Wu, Jau-Ching] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan; [Chang, Hsuan-Kan; Wu, Jau-Ching] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Hsu, Ju-Wei; Huang, Kai-Lin; Bai, Ya-Mei; Chen, Mu-Hong] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Hsu, Ju-Wei; Huang, Kai-Lin; Bai, Ya-Mei; Chen, Mu-Hong] Natl Yang Ming Univ, Dept Psychiat, Coll Med, Taipei, Taiwan; [Wu, Jau-Ching] Natl Yang Ming Univ, Inst Pharmacol, Taipei, Taiwan; [Chang, Huang-Chou] Fu Jen Catholic Univ, Dept Surg, New Taipei, Taiwan; [Chang, Huang-Chou] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan		Chen, MH (corresponding author), Dept Psychiat, 201 Shih Pai Rd,Sec 2, Taipei 11217, Taiwan.	kremer7119@gmail.com	Wu, Jau-Ching/AAU-4009-2021; Chen, TJ/AAH-8430-2021	Wu, Jau-Ching/0000-0002-6996-3409; 	Taipei Veterans General HospitalTaipei Veterans General Hospital [V103E10-001, V104E10-002, V105E10-001-MY2-1, V105A-049, V106B-020, V107B-010, V107C-181]	The study was supported by grants from Taipei Veterans General Hospital (V103E10-001, V104E10-002, V105E10-001-MY2-1, V105A-049, V106B-020, V107B-010, V107C-181).	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Andruszkow H, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-26; Antshel KM, 2009, PSYCHOL MED, V39, P1325, DOI 10.1017/S0033291708004959; Arienta C, 1997, SURG NEUROL, V48, P213, DOI 10.1016/S0090-3019(97)00019-0; Autism and Developmental Disabilities Monitoring Network Surveillance Year, 2006, MMWR SURVEILL SUMM, V58, P1; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Breau LM, 2015, J CHILD NEUROL, V30, P588, DOI 10.1177/0883073814528282; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Chasle V, 2016, CHILD NERV SYST, V32, P2357, DOI 10.1007/s00381-016-3230-z; Chaste Pauline, 2012, Dialogues Clin Neurosci, V14, P281; Chen MH, 2016, DIABETES CARE, V39, P788, DOI 10.2337/dc15-1807; Chen MH, 2015, BRIT J PSYCHIAT, V206, P302, DOI 10.1192/bjp.bp.113.143610; Christakou A, 2013, MOL PSYCHIATR, V18, P236, DOI 10.1038/mp.2011.185; Cianchetti Carlo, 2017, Clin Pract Epidemiol Ment Health, V13, P20, DOI 10.2174/1745017901713010020; Dennis M, 1999, J AUTISM DEV DISORD, V29, P5, DOI 10.1023/A:1025962431132; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Ertan C, 2012, EMERG MED J, V29, P911, DOI 10.1136/emermed-2011-200298; Ewing-Cobbs L, 2013, J INT NEUROPSYCH SOC, V19, P497, DOI 10.1017/S1355617713000210; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Korkmaz B, 2011, PEDIATR RES, V69, p101R, DOI 10.1203/PDR.0b013e318212c177; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Landa RJ, 2008, NAT CLIN PRACT NEURO, V4, P138, DOI 10.1038/ncpneuro0731; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Li CT, 2012, BRIT J PSYCHIAT, V200, P45, DOI 10.1192/bjp.bp.110.086983; Liu CY, 2006, J HEALTHC MANAG, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Marion DW, 2006, NEUROSURGERY, V58, P655; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1997, BRAIN INJURY, V11, P699; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Pierrat V, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3448; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Singh R, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8781725; Sucksdorff M, 2015, PEDIATRICS, V136, pE599, DOI 10.1542/peds.2015-1043; Tandon M, 2009, J CHILD ADOL PSYCHOP, V19, P137, DOI 10.1089/cap.2008.048; Troiani V, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00241; Wang SSH, 2014, NEURON, V83, P518, DOI 10.1016/j.neuron.2014.07.016; Wang YP, 2014, AM J PSYCHIAT, V171, P54, DOI 10.1176/appi.ajp.2013.12111467; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Yang LY, 2016, PEDIATR RES, V80, P356, DOI 10.1038/pr.2016.85; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Young Margaret B., 2012, Morbidity and Mortality Weekly Report, V61, P1	57	10	10	2	9	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	NOV-DEC	2018	79	6							17m11857	10.4088/JCP.17m11857			7	Psychology, Clinical; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	HI0GX	WOS:000456121200012	30403445				2022-02-06	
J	Driver, S; Reynolds, M; Woolsey, A; Callender, L; Prajapati, PK; Bennett, M; Kramer, K				Driver, Simon; Reynolds, Megan; Woolsey, Anne; Callender, Librada; Prajapati, Purvi K.; Bennett, Monica; Kramer, Kaye			Impact of a Community-Based Healthy Lifestyle Program on Individuals With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						behavior; dietary; exercise; physical activity; weight loss	DIABETES-PREVENTION-PROGRAM; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; WEIGHT-GAIN; LIVING PARTNERSHIPS; ADULT PATIENTS; PUBLIC-HEALTH; HIGH-RISK; NUTRITION; INTERVENTION	Objectives: To examine adherence with and effect of an evidence-based healthy lifestyle intervention modified for individuals with traumatic brain injury (TBI). Design: Pre-/postintervention without control. Setting: Community. Participants: Eighteen individuals with TBI: primarily male (61%), white (67%), with private insurance (50%). Mean age was 45.6 12.3 years, weight 210 42.6 lb, and body mass index 31.8 4.6 (obese category) at baseline. Interventions: The primary goal of the Diabetes Prevention Program Group Lifestyle Balance program is 5% to 7% weight loss through increased physical activity and improved dietary behaviors. Main Outcome Measure(s): Adherence (ie, session attendance and self-monitoring of dietary behaviors), physiologic changes (ie, weight loss, blood pressure; waist and arm circumference; and lipid profile), and quality of life (ie, self-reported health, quality of life, and step count). Results: Average participant attendance (85% over 12 months) and self-monitoring (90% over 6 months) were high. Significant decreases were observed in diastolic blood pressure and waist and arm circumference from baseline through 12 months and from baseline to 3 months only for weight and total cholesterol. No significant changes were observed in self-reported health, quality of life, or step count. Conclusions: Participants demonstrated high adherence with the program, suggesting that individuals with TBI are able to successfully engage in the program and achieve significant weight loss and changes in key physiologic outcomes.	[Driver, Simon; Reynolds, Megan; Woolsey, Anne; Callender, Librada] Baylor Inst Rehabil, Phys Med & Rehabil, Dallas, TX 75246 USA; [Prajapati, Purvi K.; Bennett, Monica] Baylor Scott & White Hlth, Ctr Clin Effectiveness, Dallas, TX USA; [Kramer, Kaye] Innovat Wellness Solut LLC, Pittsburgh, PA USA		Driver, S (corresponding author), Baylor Inst Rehabil, Phys Med & Rehabil, Dallas, TX 75246 USA.	sjdriver@bir-rehab.com		driver, simon/0000-0003-2356-432X			Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Amundson HA, 2009, DIABETES EDUCATOR, V35, P209, DOI 10.1177/0145721709333269; [Anonymous], 2011, CLIN PRACTICE GUIDEL; BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Becker H., 1993, HLTH VALUES J HLTH B, V17, P42; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Centers for Disease Control and Prevention, ASS YOUR WEIGH; Centers for Disease Control and Prevention, TBI GET FACTS; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Costello LAS, 2014, INJURY, V45, P1834, DOI 10.1016/j.injury.2014.06.004; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; Davis-Smith M, 2007, J NATL MED ASSOC, V99, P440; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Dodani S, 2010, DIABETES EDUCATOR, V36, P465, DOI 10.1177/0145721710366756; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Driver S, 2018, J HEAD TRAUMA REHAB, V33, pE36, DOI 10.1097/HTR.0000000000000327; Driver S, 2017, BRAIN INJURY, V31, P1612, DOI 10.1080/02699052.2017.1346286; Drum CE, 2009, AM J HEALTH PROMOT, V24, P93, DOI 10.4278/ajhp.090303-CIT-94; Duraski SA, 2014, REHABIL NURS, V39, P140, DOI 10.1002/rnj.138; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Guercio J, 1999, BRAIN INJURY, V13, P729; Hamilton M, 2016, BRAIN INJURY, V30, P819, DOI 10.3109/02699052.2016.1146962; Hamilton M, 2015, BRAIN INJURY, V29, P1572, DOI 10.3109/02699052.2015.1075145; Harrison MB, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-49; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hinnant L, 2015, EVALUATION HLTH CARE; Hochbaum G., 1952, HLTH BELIEF MODEL; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS245, DOI 10.1016/j.apmr.2014.06.024; Iqbal SK, VETERANS RAND 12 ITE; Jones D, 2001, J Ambul Care Manage, V24, P68; Jones TM, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-39; Jourdan C, 2012, DEV MED CHILD NEUROL, V54, P624, DOI 10.1111/j.1469-8749.2012.04291.x; Juengst SB, 2015, BRAIN INJURY, V29, P1351, DOI 10.3109/02699052.2015.1045031; Katula JA, 2013, AM J PREV MED, V44, pS324, DOI 10.1016/j.amepre.2012.12.015; Katula JA, 2011, DIABETES CARE, V34, P1451, DOI 10.2337/dc10-2115; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kramer M, 2012, J DIABETES METAB S, VS2, P6; Kramer MK, 2015, J OCCUP ENVIRON MED, V57, P284, DOI 10.1097/JOM.0000000000000350; Kramer MK, 2011, DIABETES EDUCATOR, V37, P659, DOI 10.1177/0145721711411930; Kramer MK, 2010, DIABETES RES CLIN PR, V90, pE60, DOI 10.1016/j.diabres.2010.08.013; Kramer MK, 2009, AM J PREV MED, V37, P505, DOI 10.1016/j.amepre.2009.07.020; Lee H, 2014, BRIT J SPORT MED, V49, P499; Lee IM, 2010, JAMA-J AM MED ASSOC, V303, P1173, DOI 10.1001/jama.2010.312; Lorig K., 1996, OUTCOME MEASURES HLT; Luxton DD, 2011, TELEMED E-HEALTH, V17, P50, DOI 10.1089/tmj.2010.0091; Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987; Masel B., 2014, UNDERSTANDING TRAUMA, P28; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McDermott S., 2007, PRIM HEALTH CARE RES, V8, P36, DOI [DOI 10.1017/S1463423607000059, 10.1017/S1463423607000059]; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; National Institutes of HealthNational Institute of Neurological Disorders and Stroke, TRAUM BRAIN INJ HOP; Palmer-McLean K, 2003, ACSMS EXERCISE MANAG, P238; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; Poirier P, 2006, CIRCULATION, V113, P898, DOI [10.1161/CIRCULATIONAHA.106.171016, 10.1161/01.ATV.0000216787.85457.f3]; Rimmer JH, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0100-5; Rimmer JH, 2008, AM J LIFESTYLE MED, V2, P409, DOI 10.1177/1559827608317397; Schippers M, 2017, OBES REV, V18, P450, DOI 10.1111/obr.12492; Seidel MC, 2008, DIABETES CARE, V31, P684, DOI 10.2337/dc07-1869; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Vadheim LM, 2010, J RURAL HEALTH, V26, P266, DOI 10.1111/j.1748-0361.2010.00288.x; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Wing RR, 2004, OBES RES, V12, P1426; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002	68	10	10	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					E49	E58		10.1097/HTR.0000000000000372			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600006	29385008				2022-02-06	
J	Eslaminejad, A; Hosseini-Farid, M; Ziejewski, M; Karami, G				Eslaminejad, A.; Hosseini-Farid, M.; Ziejewski, M.; Karami, G.			Brain tissue constitutive material models and the finite element analysis of blast-induced traumatic brain injury	SCIENTIA IRANICA			English	Article						Blast traumatic brain injury; Finite element modelling; Brain tissue constitutive model; Viscoelastic; Hyperviscoelastic		Traumatic Brain Injury (TBI) often occurs due to assaulting loads such as blast on the human head. Finite Elements (FEs) can approximately simulate blast interactions with the human head. An important parameter in the FE modelling procedures is the accuracy of constitutive formulation of the brain tissue. This paper focuses on implementation of three brain tissue constitutive relations to measure and compare the dynamic behaviour of the brain under identical blast loads. For the geometry, a simple spherical head model is employed to monitor the brain tissue response and examine the uncertainties in FE brain tissue constitutive modelling. The brain tissue is constitutively modelled as hyperelastic, viscoelastic, and hyperviscoelastic material types. Intracranial Pressures (ICP), strains, and shear stresses as the dynamic parameters are measured with time. These biomechanical parameters can be compared against the injury thresholds. Our analyses show that although the results of ICPs and strains are close for the three models, shear stresses are considerably different. The study will further provide a new insight into selecting a proper constitutive model of the brain tissue under dynamic conditions. (C) 2018 Sharif University of Technology. All rights reserved.	[Eslaminejad, A.; Hosseini-Farid, M.; Ziejewski, M.; Karami, G.] North Dakota State Univ, Dept Mech Engn, Fargo, ND 58108 USA		Karami, G (corresponding author), North Dakota State Univ, Dept Mech Engn, Fargo, ND 58108 USA.	g.karami@ndsu.edu	Farid, Mohammad H./AAC-1370-2020	Farid, Mohammad H./0000-0001-9342-8644			[Anonymous], 2007, LS DYNA LS DYNA KEYW; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chafi MS, 2011, INT J APPL MECH, V3, P803, DOI 10.1142/S175882511100124X; Cotton RT, 2016, COMPUT METHOD BIOMEC, V19, P101, DOI 10.1080/10255842.2014.994118; Eslaminejad A., 2016, ASME 2016 INT MECH E; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Hoseini-Farid M., 2017, ASME INT MECH ENG C; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Nyein M.K., 2010, P NATL ACAD SCI; Sarvghad-Moghaddam H., 2016, ASME 2016 INT MECH E; Sarvghad-Moghaddam H., 2016, INT J NUMERICAL METH, V33; Sarvghad-Moghaddam H., 2015, THESIS; Sarvghad-Moghaddam H., 2014, ASME INT MECH ENG C; Sarvghad-Moghaddam H, 2015, J HEAD TRAUMA REHAB, V30, pE66; Sarvghad-Moghaddam H, 2015, COMPUT METHOD BIOMEC, V18, P1846, DOI 10.1080/10255842.2014.977878; Tse KM., 2015, AM J ENG TECHNOLOGY, V1, P28; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	19	10	10	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1026-3098			SCI IRAN	Sci. Iran.	NOV-DEC	2018	25	6			SI		3141	3150		10.24200/sci.2018.20888			10	Engineering, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	HF5FG	WOS:000454257400004		gold			2022-02-06	
J	Frassanito, P; Massimi, L; Tamburrini, G; Bianchi, F; Nataloni, A; Canella, V; Caldarelli, M				Frassanito, Paolo; Massimi, Luca; Tamburrini, Gianpiero; Bianchi, Federico; Nataloni, Angelo; Canella, Valentina; Caldarelli, Massimo			Custom-made hydroxyapatite for cranial repair in a specific pediatric age group (7-13years old): a multicenter post-marketing surveillance study	CHILDS NERVOUS SYSTEM			English	Article						Cranioplasty; Custombone; Decompressive craniectomy; Precision medicine	TRAUMATIC BRAIN-INJURY; BONE FLAP RESORPTION; DECOMPRESSIVE CRANIECTOMY; CLINICAL ARTICLE; CRANIOPLASTY; CHILDREN; RECONSTRUCTION; DEFECT	Background CustomBone Service (CBS) is a patient-specific, biocompatible, and osteoconductive device made of porous hydroxyapatite, indicated for cranial reconstruction in adults and children. Adult literature data report a failure rate of about 8%. The aim of this Post-Marketing Surveillance study is to verify the hypothesis that CBS in children aged 7-13 years old shows a failure rate not superior to adults. Materials and methods Inclusion criteria were age at implantation ranging 7-13 years old, with at least 1 year elapsed from the date of surgery. The degree of satisfaction of surgeons and patients was assessed. Results Data about 76 implants in 67 patients (M:F = 41: 26) were obtained from 28 centers across 7 European countries. The mean age at surgery was 10.03 +/- 1.72 years, with age stratification almost equally distributed. Fifty-nine subjects received one CBS, 7 subjects two and one subject received three CBS. Main etiologies were trauma (60.5%), malformation (11.8%), bone tumor (10.5%), and cerebral tumor (7.9%). Main indications to CBS were decompression (47.4%), autologous bone resorption (18.4%), tumor resection (11.8%), malformation (9.2%), comminuted fracture (5.3%), and other materials rejection (5.3%). Main implantation sites were fronto-parieto-temporal (26.3%), parietal (23.7%), frontal (11.8%), fronto-temporal (10.5%), and parieto-temporal (7.9%). CBS was chosen as first line of treatment in 63.1% of the cases. Mean follow-up was about 36 months. Eleven adverse events (14.5%) were reported in nine devices. Five CBS required explantation (three cases of infection, one fracture, and one mobilization). Failure rate was 6.58%, which is statistically not superior to the explantation rate recorded in adults (two-sided 95%, CI 2.2-14.7%). Satisfaction of surgeons and patients was of about 95%. Conclusion CBS is a safe and effective solution for cranial repair in pediatric patients. In particular, over the age of 7, CBS shows a rate of failure as low as in adults.	[Frassanito, Paolo] Fdn Policlin Univ A Gemelli, Pediat Neurosurg, IRCSS, Largo Agostino Gemelli 8, I-00168 Rome, Italy; [Massimi, Luca; Tamburrini, Gianpiero; Bianchi, Federico; Caldarelli, Massimo] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, IRCSS, Pediat Neurosurg, Rome, Italy; [Nataloni, Angelo; Canella, Valentina] Fin Ceram, Faenza, Italy		Frassanito, P (corresponding author), Fdn Policlin Univ A Gemelli, Pediat Neurosurg, IRCSS, Largo Agostino Gemelli 8, I-00168 Rome, Italy.	paolo.frassanito@gmail.com	FRASSANITO, Paolo/K-4099-2018	FRASSANITO, Paolo/0000-0003-0071-3126			Beuriat PA, 2016, NEUROCHIRURGIE, V62, P25, DOI 10.1016/j.neuchi.2016.04.003; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Faenza F-C, DATA FILE PENDING PU; Frassanito P, 2017, CHILD NERV SYST, V33, P1759, DOI 10.1007/s00381-017-3541-8; Frassanito P, 2015, ACTA NEUROCHIR, V157, P115, DOI 10.1007/s00701-014-2254-y; Frassanito P, 2014, J NEUROSURG-PEDIATR, V13, P243, DOI 10.3171/2013.6.PEDS13312; Frassanito P, 2012, ACTA NEUROCHIR, V154, P927, DOI 10.1007/s00701-011-1253-5; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Hardy H, 2012, NEUROCHIRURGIE, V58, P25, DOI 10.1016/j.neuchi.2011.09.006; Iaccarino C, 2016, J NEUROSURG SCI; Iaccarino C, 2015, J ORAL MAXIL SURG, V73, P2375, DOI 10.1016/j.joms.2015.07.008; Jaberi J, 2013, J ORAL MAXIL SURG, V71, pE81, DOI 10.1016/j.joms.2012.09.023; Josan VA, 2005, CHILD NERV SYST, V21, P200, DOI 10.1007/s00381-004-1068-2; Kabbani H, 2004, AM FAM PHYSICIAN, V69, P2863; Lam S, 2015, CRANIOMAX TRAUM REC, V8, P159, DOI 10.1055/s-0034-1395880; Lee SC, 2009, J CLIN NEUROSCI, V16, P56, DOI 10.1016/j.jocn.2008.04.001; Lindner Dirk, 2017, J Neurosurg, V126, P175, DOI 10.3171/2015.10.JNS151245; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Morice A, 2017, J NEUROSURG-PEDIATR, V19, P51, DOI 10.3171/2016.8.PEDS1653; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014; Stefini Roberto, 2013, Surg Neurol Int, V4, P12, DOI 10.4103/2152-7806.106290; Wehrli LA, 2012, EUR J PEDIATR SURG, V22, P479, DOI 10.1055/s-0032-1313349; Zaccaria L, 2017, CHILD NERV SYST, V33, P343, DOI 10.1007/s00381-016-3327-4	24	10	10	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	NOV	2018	34	11					2283	2289		10.1007/s00381-018-3905-8			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	GW9YU	WOS:000447365700023	29987377				2022-02-06	
J	Hebert, JR; Forster, JE; Stearns-Yoder, KA; Penzenik, ME; Brenner, LA				Hebert, Jeffrey R.; Forster, Jeri E.; Stearns-Yoder, Kelly A.; Penzenik, Molly E.; Brenner, Lisa A.			Persistent Symptoms and Objectively Measured Balance Performance Among OEF/OIF Veterans With Remote Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						balance; depression; dizziness; fatigue; posttraumatic stress disorder (PTSD); posturography; traumatic brain injury (TBI)	SENSORY ORGANIZATION TEST; ERROR SCORING SYSTEM; VESTIBULAR REHABILITATION; DYNAMIC POSTUROGRAPHY; SERVICE MEMBERS; COMMUNITY BALANCE; MOBILITY SCALE; HEAD-INJURY; SENSITIVITY; DISORDERS	Objective: To investigate linear relationships between dizziness, fatigue, and depression and posttraumatic stress disorder (PTSD) and objectively measured balance performance in Veterans with remote mild traumatic brain injury (mTBI). Setting: Academic laboratory; Veterans Affairs Medical Center. Participants: Thirty Veterans (28 men) who served in Iraq/Afghanistan and whose most recent mTBI was sustained more than 6 months prior to enrollment. Design: Cross-sectional, observational trial. Main Measures: The Computerized Dynamic Posturography-Sensory Organization Test (CDP-SOT) and the Community Balance and Mobility (CB&M) scale measured balance. Dizziness (Dizziness Handicap Inventory), fatigue (Modified Fatigue Impact Scale), depression-related symptoms (Beck Depression Inventory-II), and PTSD-related symptoms (PTSD Checklist 5) were also measured. Results: Objectively measured balance, CDP-SOT composite, was impaired (mean score of 67.9). CDP-SOT scores correlated with dizziness (r = -0.53; P = .002), fatigue (r = -0.38; P = .03), depression (r = -0.55; P = .001), and PTSD symptoms (r = -0.53; P = .002). Dizziness, time since most recent mTBI, and PTSD symptoms and depression combined explained significant variability in CDP-SOT scores (R-2 = 0.46; P = .003), as did fatigue depression and PTSD symptoms (R-2 = 0.33; P = .01). Conclusions: Impaired balance was identified among the cohort. Findings suggest that dizziness, fatigue, depression and PTSD, and time since most recent mTBI may influence balance performance. Additional research is needed to identify the potentially interrelated natural histories of these co-occurring symptoms.	[Hebert, Jeffrey R.; Forster, Jeri E.; Stearns-Yoder, Kelly A.; Penzenik, Molly E.; Brenner, Lisa A.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Hebert, Jeffrey R.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA; [Hebert, Jeffrey R.; Stearns-Yoder, Kelly A.; Brenner, Lisa A.] Marcus Inst Brain Hlth, Anschutz Med Campus, Aurora, CO USA; [Hebert, Jeffrey R.; Forster, Jeri E.; Stearns-Yoder, Kelly A.; Penzenik, Molly E.; Brenner, Lisa A.] VHA Rocky Mt Mental Illness Res Educ & Clin Ctr M, Denver, CO USA		Hebert, JR (corresponding author), Univ Colorado, Sch Med, Dept Phys Med & Rehabil, 12631 East 17th Ave,Mail Stop F493, Aurora, CO 80045 USA.; Hebert, JR (corresponding author), Univ Colorado, Sch Med, Dept Neurol, 12631 East 17th Ave,Mail Stop F493, Aurora, CO 80045 USA.	Jeffrey.Hebert@ucdenver.edu	Brenner, Lisa A./AAG-2442-2019		University of Colorado School of Medicine, Department of Physical Medicine and Rehabilitation; Rocky Mountain MIRECC; Department of Veterans AffairsUS Department of Veterans Affairs	The study was funded in part by an intramural Pilot Grant from the University of Colorado School of Medicine, Department of Physical Medicine and Rehabilitation. Additional support was provided by the Rocky Mountain MIRECC. This work was supported, in part, by the Department of Veterans Affairs but does not necessarily represent the views of the Department of Veterans Affairs or the US Government.	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Aligene K, 2013, NEUROREHABILITATION, V32, P543, DOI 10.3233/NRE-130876; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; [Anonymous], 1995, GAIT POSTURE; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bergman K, 2013, J NEUROSCI NURS, V45, P124, DOI 10.1097/JNN.0b013e31828a418b; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; BROWN JJ, 1990, NEUROL CLIN, V8, P209, DOI 10.1016/S0733-8619(18)30351-7; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; COHEN H, 1989, AM J OCCUP THER, V43, P331, DOI 10.5014/ajot.43.5.331; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; First M., 1995, STRUCTURED CLIN INTE, V9, P92; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Giladi N, 2005, J NEUROL, V252, P300, DOI 10.1007/s00415-005-0641-2; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Haber YO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168803; HAMID MA, 1991, ACTA OTO-LARYNGOL, P596; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; Herdman SJ, 2007, VESTIBULAR REHABILIT; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer ME, 2015, NEUROL CLIN, V33, P661, DOI 10.1016/j.ncl.2015.04.004; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Kansagara D., 2013, COMPLICATIONS MILD T; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; KESHNER EA, 1989, AM J OCCUP THER, V43, P320, DOI 10.5014/ajot.43.5.320; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kleffelgaard I, 2016, PHYS THER, V96, P839, DOI 10.2522/ptj.20150095; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larres DT, 2016, MIL MED, V181, P23, DOI 10.7205/MILMED-D-15-00152; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; Pan T, 2015, GAIT POSTURE, V42, P550, DOI 10.1016/j.gaitpost.2015.08.012; Pape MM, 2016, J HEAD TRAUMA REHAB, V31, P339, DOI 10.1097/HTR.0000000000000179; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Riechers Ronald G 2nd, 2010, Continuum (Minneap Minn), V16, P128, DOI 10.1212/01.CON.0000391456.60793.33; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, P116, DOI 10.1097/HTR.0000000000000019; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shumway-Cook A, 2001, MOTOR CONTROL THEORY, V2; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; VOORHEES RL, 1990, OTOLARYNG HEAD NECK, V103, P96, DOI 10.1177/019459989010300114; Wares JR, 2015, J REHABIL RES DEV, V52, P591, DOI 10.1682/JRRD.2014.08.0197; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Zgaljardic DJ, 2014, BRAIN INJURY, V28, P389, DOI 10.3109/02699052.2014.884242	63	10	10	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					403	411		10.1097/HTR.0000000000000385			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600016	29385020				2022-02-06	
J	Mao, YL; Black, AMB; Milbourn, HR; Krakonja, S; Nesbit, M; Bartlett, CA; Fehily, B; Takechi, R; Yates, NJ; Fitzgerald, M				Mao, Yilin; Black, Anna M. B.; Milbourn, Hannah R.; Krakonja, Samra; Nesbit, Michael; Bartlett, Carole A.; Fehily, Brooke; Takechi, Ryu; Yates, Nathanael J.; Fitzgerald, Melinda			The Effects of a Combination of Ion Channel Inhibitors in Female Rats Following Repeated Mild Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						neurotrauma; repeated mild traumatic brain injury; ion channel inhibitors; oxidative stress; node of Ranvier	BRILLIANT-BLUE-G; AMPA RECEPTOR ANTAGONIST; REGIONAL CEREBRAL EDEMA; OPTIC-NERVE TRANSECTION; GANGLION-CELL DEATH; CLOSED-HEAD INJURY; OXIDATIVE STRESS; SECONDARY DEGENERATION; MOUSE MODEL; SUPEROXIDE-DISMUTASE	Following mild traumatic brain injury (mTBI), the ionic homeostasis of the central nervous system (CNS) becomes imbalanced. Excess Ca2+ influx into cells triggers molecular cascades, which result in detrimental effects. The authors assessed the effects of a combination of ion channel inhibitors (ICI) following repeated mTBI (rmTBI). Adult female rats were subjected to two rmTBI weight-drop injuries 24 h apart, sham procedures (sham), or no procedures (normal). Lomerizine, which inhibits voltage-gated calcium channels, was administered orally twice daily, whereas YM872 and Brilliant Blue G, inhibiting alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and P2X(7) receptors, respectively, were delivered intraperitoneally every 48 h post-injury. Vehicle treatment controls were included for rmTBI, sham, and normal groups. At 11 days following rmTBI, there was a significant increase in the time taken to cross the 3 cm beam, as a sub-analysis of neurological severity score (NSS) assessments, compared with the normal control (p < 0.05), and a significant decrease in learning-associated improvement in rmTBI in Morris water maze (MWM) trials relative to the sham (p < 0.05). ICI-treated rmTBI animals were not different to sham, normal controls, or rmTBI treated with vehicle in all neurological severity score and Morris water maze assessments (p > 0.05). rmTBI resulted in increases in microglial cell density, antioxidant responses (manganese-dependent superoxide dismutase (MnSOD) immunoreactivity), and alterations to node of Ranvier structure. ICI treatment decreased microglial density, MnSOD immunoreactivity, and abnormalities of the node of Ranvier compared with vehicle controls (p < 0.01). The authors' findings demonstrate the beneficial effects of the combinatorial ICI treatment on day 11 post-rmTBI, suggesting an attractive therapeutic strategy against the damage induced by excess Ca2+ following rmTBI.	[Mao, Yilin; Black, Anna M. B.; Nesbit, Michael; Takechi, Ryu; Fitzgerald, Melinda] Curtin Univ, Fac Hlth Sci, Curtin Hlth Innovat Res Inst, Kent St, Bentley, WA 6102, Australia; [Mao, Yilin; Black, Anna M. B.; Fitzgerald, Melinda] Perron Inst Neurol & Translat Sci, Sarich Neurosci Res Inst Bldg,8 Verdun St, Nedlands, WA 6009, Australia; [Black, Anna M. B.; Milbourn, Hannah R.; Krakonja, Samra; Bartlett, Carole A.; Fehily, Brooke; Yates, Nathanael J.; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, 35 Stirling Hwy, Crawley, WA 6009, Australia; [Fehily, Brooke; Yates, Nathanael J.] Univ Western Australia, Sch Human Sci, 35 Stirling Hwy, Crawley, WA 6009, Australia		Fitzgerald, M (corresponding author), Curtin Univ, Fac Hlth Sci, Curtin Hlth Innovat Res Inst, Kent St, Bentley, WA 6102, Australia.; Fitzgerald, M (corresponding author), Perron Inst Neurol & Translat Sci, Sarich Neurosci Res Inst Bldg,8 Verdun St, Nedlands, WA 6009, Australia.; Fitzgerald, M (corresponding author), Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, 35 Stirling Hwy, Crawley, WA 6009, Australia.	yilin.mao@curtin.edu.au; ab2458@bath.ac.uk; hannah.milbourn@bath.edu; 21161317@student.uwa.edu.au; michael.nesbit@curtin.edu.au; carole.bartlett@uwa.edu.au; brooke.fehily@uwa.edu.au; r.takechi@curtin.edu.au; nathanael.yates@uwa.edu.au; lindy.fitzgerald@curtin.edu.au	Takechi, Ryu/T-9970-2019; Takechi, Ryusuke/D-3692-2012; Yates, Nathanael J/K-8358-2018; Fitzgerald, Melinda/C-4235-2011	Takechi, Ryu/0000-0001-6359-3382; Takechi, Ryusuke/0000-0001-6359-3382; Yates, Nathanael J/0000-0003-2742-6952; Fitzgerald, Melinda/0000-0002-4823-8179; Milbourn, Hannah/0000-0003-4479-8635; Mao, Yilin/0000-0002-3573-6486	National Health and Medical Research Council, AustraliaNational Health and Medical Research Council of Australia [APP1087114]	This research was funded by the National Health and Medical Research Council, Australia, grant number APP1087114.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Arbeloa J, 2012, NEUROBIOL DIS, V45, P954, DOI 10.1016/j.nbd.2011.12.014; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Atsumi T, 2003, ACT NEUR S, V86, P305; Aucoin JS, 2005, NEUROSCIENCE, V132, P73, DOI 10.1016/j.neuroscience.2004.11.047; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Beattie MS, 2010, EUR J NEUROSCI, V32, P290, DOI 10.1111/j.1460-9568.2010.07343.x; BICKLER PE, 1994, BRAIN RES, V665, P269, DOI 10.1016/0006-8993(94)91347-1; Burgos M, 2007, GLIA, V55, P1437, DOI 10.1002/glia.20555; Chakraborti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040844; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chen H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29430-6; Chen H, 2016, CLIN EXP PHARMACOL P, V43, P1107, DOI 10.1111/1440-1681.12650; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chung YH, 2001, NEUROSCI LETT, V302, P93, DOI 10.1016/S0304-3940(01)01683-4; Corniola R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049367; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; de Lores Arnaiz Georgina Rodriguez, 2014, Int J Biomed Sci, V10, P85; Doig RLO, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0380-1; Doig RLO, 2016, NEUROSCIENCE, V339, P450, DOI 10.1016/j.neuroscience.2016.10.005; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Dupree JL, 1998, J NEUROSCI, V18, P1642; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Facchinetti F, 1998, CELL MOL NEUROBIOL, V18, P667, DOI 10.1023/A:1020221919154; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fu Y, 2007, J NEUROSCI RES, V85, P2870, DOI 10.1002/jnr.21403; Furukawa T, 2003, J NEUROTRAUM, V20, P269, DOI 10.1089/089771503321532851; Gerace E, 2015, CNS NEUROL DISORD-DR, V14, P636, DOI 10.2174/1871527314666150430162841; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Gurkoff GG, 2017, NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION, P179, DOI 10.1016/B978-0-12-802686-1.00011-0; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hamilton J, 2018, J BIOL CHEM, V293, P15652, DOI 10.1074/jbc.RA118.002926; Hinkley LBN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039804; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Karim MD, 2006, CURR EYE RES, V31, P273, DOI 10.1080/02713680500536647; Keller JN, 1998, J NEUROSCI, V18, P687; Khorchid A, 2002, NAT STRUCT BIOL, V9, P239, DOI 10.1038/nsb0402-239; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Le Feuvre R, 2002, EUR J PHARMACOL, V447, P261, DOI 10.1016/S0014-2999(02)01848-4; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Milbourn HR, 2017, DISCOV MED, V23, P361; Miyauchi T, 2014, J NEUROTRAUM, V31, P773, DOI 10.1089/neu.2013.3181; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Ohno N, 2011, J NEUROSCI, V31, P7249, DOI 10.1523/JNEUROSCI.0095-11.2011; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Remy M, 2008, BRIT J OPHTHALMOL, V92, P1142, DOI 10.1136/bjo.2008.138164; Ridderstrom M, 2014, NEUROREPORT, V25, P1405, DOI 10.1097/WNR.0000000000000286; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Savigni DL, 2013, NEUROPHARMACOLOGY, V75, P380, DOI 10.1016/j.neuropharm.2013.07.034; Selwyn RG, 2016, J NEUROTRAUM, V33, P1479, DOI 10.1089/neu.2015.4129; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stanika RI, 2012, J NEUROSCI, V32, P6642, DOI 10.1523/JNEUROSCI.6008-11.2012; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Takahashi M, 1998, J PHARMACOL EXP THER, V287, P559; Tamaki Y, 2003, INVEST OPHTH VIS SCI, V44, P4864, DOI 10.1167/iovs.02-1173; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Wang YC, 2015, MOL MED REP, V12, P2149, DOI 10.3892/mmr.2015.3607; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Yates NJ, 2017, EXP BRAIN RES, V235, P2133, DOI 10.1007/s00221-017-4958-8; Yates NJ, 2017, NEURAL REGEN RES, V12, P307, DOI 10.4103/1673-5374.200814; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zou YN, 2012, P NATL ACAD SCI USA, V109, P21522, DOI 10.1073/pnas.1216913110	96	10	10	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	NOV	2018	19	11							3408	10.3390/ijms19113408			18	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	HC0ZM	WOS:000451528500124	30384417	gold, Green Published, Green Submitted			2022-02-06	
J	Martin, GE; Xia, B; Kim, Y; Johnson, MD; Veile, R; Friend, LA; Makley, AT; Caldwell, CC; Goodman, MD				Martin, Grace E.; Xia, Brent; Kim, Young; Johnson, Mark D.; Veile, Rosalie; Friend, Lou Ann; Makley, Amy T.; Caldwell, Charles C.; Goodman, Michael D.			PLATELET FUNCTION CHANGES IN A TIME-DEPENDENT MANNER FOLLOWING TRAUMATIC BRAIN INJURY IN A MURINE MODEL	SHOCK			English	Article						Hypercoagulability; impedance aggregometry; platelet aggregation; thromboelastometry; traumatic brain injury	VENOUS THROMBOEMBOLISM; HYPERCOAGULABILITY; COAGULATION; DYSFUNCTION; COAGULOPATHY; THROMBOSIS; IMPACT; THROMBOELASTOGRAPHY; MICROPARTICLES	Traumatic brain injury (TBI) results in systemic changes in coagulation and inflammation that contribute to post-traumatic morbidity and mortality. The potential interaction of platelets and pro-inflammatory cytokines in the modulation of coagulation, microthrombosis, and venous thromboembolic events after moderate TBI has not been determined. Using a murine model, we hypothesized that the degree of platelet-induced coagulation varies depending on the platelet aggregation agonist platelet-induced coagulation changes in a time-dependent manner following TBI, and changes in platelet-induced coagulation are mirrored by changes in the levels of circulating pro-inflammatory cytokines. An established weight-drop model was used to induce TBI in anesthetized mice. Blood samples were collected at intervals after injury for measurements of platelet count, serum fibrinogen, pro-inflammatory cytokines, and determination of soluble Pselectin levels. Thromboelastometry was used to evaluate changes in hemostasis. Platelet function was determined using whole blood impedance aggregometry. Ten minutes following TBI, adenosine diphosphate-induced platelet aggregation decreased as measured by platelet aggregometry. Despite no changes in platelet counts and serum fibrinogen, platelet aggregation, pro-inflammatory cytokines, and soluble P-selectin were increased at 6 h after TBI. Rotation thromboelastometry demonstrated increased maximal clot firmness at 6 h. Platelet function and coagulability returned to baseline levels 24 h following head injury. Our data demonstrate that after TBI, acute platelet dysfunction occurs followed by rebound platelet hyperaggregation. Alterations in post-TBI platelet aggregation are reflected in whole blood thromboelastometry and are temporally associated with the systemic pro-inflammatory response.	Univ Cincinnati, Div Res, Cincinnati, OH USA; Univ Cincinnati, Dept Surg, Inst Mil Med, 231 Bethesda Ave, Cincinnati, OH 45267 USA		Goodman, MD (corresponding author), 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA.	michael.goodman@uc.edu		Kim, Young/0000-0001-8763-8813; Caldwell, Charles/0000-0003-1692-4550			Branco BC, 2014, SHOCK, V41, P200, DOI 10.1097/SHK.0000000000000109; Brill JB, 2017, J TRAUMA ACUTE CARE, V83, P413, DOI 10.1097/TA.0000000000001618; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Cotton BA, 2012, J TRAUMA ACUTE CARE, V72, P1470, DOI 10.1097/TA.0b013e31824d56ad; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hsieh T, 2016, AM J PATHOL, V186, P3236, DOI 10.1016/j.ajpath.2016.08.014; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Kashuk JL, 2009, SURGERY, V146, P764, DOI 10.1016/j.surg.2009.06.054; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Luddington RJ, 2005, CLIN LAB HAEMATOL, V27, P81, DOI 10.1111/j.1365-2257.2005.00681.x; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; Midura EF, 2016, SHOCK, V45, P82, DOI 10.1097/SHK.0000000000000460; Midura EF, 2015, J SURG RES, V197, P25, DOI 10.1016/j.jss.2015.02.064; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Olufajo OA, 2016, J TRAUMA ACUTE CARE, V81, P71, DOI 10.1097/TA.0000000000001046; Park MS, 2009, J TRAUMA, V67, P266, DOI 10.1097/TA.0b013e3181ae6f1c; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Ploplis VA, 2014, J NEUROTRAUM, V31, P1672, DOI 10.1089/neu.2013.3302; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Schreiber MA, 2005, J TRAUMA, V58, P475, DOI 10.1097/01.TA.0000153938.77777.26; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Tikk A, 1979, Acta Neurochir Suppl (Wien), V28, P96; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V77, P238, DOI 10.1097/TA.0000000000000294; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075	32	10	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	NOV	2018	50	5					551	556		10.1097/SHK.0000000000001056			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	HF2AD	WOS:000454036000009	29140832				2022-02-06	
J	Mata-Mbemba, D; Mugikura, S; Nakagawa, A; Murata, T; Ishii, K; Kushimoto, S; Tominaga, T; Takahashi, S; Takase, K				Mata-Mbemba, Daddy; Mugikura, Shunji; Nakagawa, Atsuhiro; Murata, Takaki; Ishii, Kiyoshi; Kushimoto, Shigeki; Tominaga, Teiji; Takahashi, Shoki; Takase, Kei			Traumatic midline subarachnoid hemorrhage on initial computed tomography as a marker of severe diffuse axonal injury	JOURNAL OF NEUROSURGERY			English	Article						diffuse axonal injury; traumatic subarachnoid hemorrhage; traumatic brain injury; computed tomography; early outcome; long-term outcome; trauma	BRAIN-INJURY; HEAD-INJURY; INTRAVENTRICULAR HEMORRHAGE; CLASSIFICATION; DIAGNOSIS; PROGNOSIS; IMPACT	OBJECTIVE The objective of this study was to test the hypothesis that midline (interhemispheric or perimesencephalic) traumatic subarachnoid hemorrhage (tSAH) on initial CT may implicate the same shearing mechanism that underlies severe diffuse axonal injury (DAI). METHODS The authors enrolled 270 consecutive patients (mean age [+/- SD] 43 +/- 23.3 years) with a history of head trauma who had undergone initial CT within 24 hours and brain MRI within 30 days. Six initial CT findings, including intraventricular hemorrhage (IVH) and tSAH, were used as candidate predictors of DAI. The presence of tSAH was determined at the cerebral convexities, sylvian fissures, sylvian vallecula, cerebellar folia, interhemispheric fissure, and perimesencephalic cisterns. Following MRI, patients were divided into negative and positive DAI groups, and were assigned to a DAI stage: 1) stage 0, negative DAI; 2) stage 1, DAI in lobar white matter or cerebellum; 3) stage 2, DAI involving the corpus callosum; and 4) stage 3, DAI involving the brainstem. Glasgow Outcome Scale-Extended (GOSE) scores were obtained in 232 patients. RESULTS Of 270 patients, 77 (28.5%) had DAI; tSAH and IVH were independently associated with DAI (p < 0.05). Of tSAH locations, midline tSAH was independently associated with both overall DAI and DAI stage 2 or 3 (severe DAI; p < 0.05). The midline tSAH on initial CT had sensitivity of 60.8%, specificity of 81.7%, and positive and negative predictive values of 43.7% and 89.9%, respectively, for severe DAI. When adjusted for admission Glasgow Coma Score, the midline tSAH independently predicted poor GOSE score at both hospital discharge and after 6 months. CONCLUSIONS Midline tSAH could implicate the same shearing mechanism that underlies severe DAI, for which midline tSAH on initial CT is a probable surrogate.	[Mata-Mbemba, Daddy; Mugikura, Shunji; Murata, Takaki; Takahashi, Shoki; Takase, Kei] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi, Japan; [Mata-Mbemba, Daddy; Nakagawa, Atsuhiro; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi, Japan; [Kushimoto, Shigeki] Tohoku Univ, Grad Sch Med, Div Emergency & Crit Care Med, Sendai, Miyagi, Japan; [Ishii, Kiyoshi] Sendai Kousei Hosp, Dept Radiol, Sendai, Miyagi, Japan		Mugikura, S (corresponding author), Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan.	mugi@rad.med.tohoku.ac.jp	Mata-Mbemba, Daddy/AAP-3184-2020				ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Beretta L, 2010, J NEUROTRAUM, V27, P509, DOI 10.1089/neu.2009.1054; Calvi MR, 2011, J TRAUMA, V70, P1582, DOI 10.1097/01.ta.0000399125.48597.7f; Gean AD, 1995, IMAGING HEAD TRAUMA, P427; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Holbourn AHS, 1943, LANCET, V2, P438; JAYAKUMAR PN, 1990, ACTA NEUROCHIR, V106, P48, DOI 10.1007/BF01809332; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; Lin TK, 2012, J TRAUMA ACUTE CARE, V73, P131, DOI 10.1097/TA.0b013e31824aff74; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Matsukawa H, 2012, J NEUROSURG, V117, P334, DOI 10.3171/2012.5.JNS112318; Matsukawa H, 2011, ACTA NEUROCHIR, V153, P1687, DOI 10.1007/s00701-011-1002-9; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Novikov I, 2010, STAT MED, V29, P97, DOI 10.1002/sim.3728; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zwahlen RA, 2007, J CRANIO MAXILL SURG, V35, P142, DOI 10.1016/j.jcms.2007.01.006	27	10	11	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2018	129	5					1317	1324		10.3171/2017.6.JNS17466			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HE4XT	WOS:000453373600027	29303451	Bronze			2022-02-06	
J	Ostergaard, JR				Ostergaard, John R.			Paroxysmal sympathetic hyperactivity in Juvenile neuronal ceroid lipofuscinosis (Batten disease)	AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL			English	Article						Batten disease; Non epileptic seizure; Neuronal ceroid lipofuscinosis, Paroxysmal; sympathetic hyperactivity	TRAUMATIC BRAIN-INJURY; HEART-RATE-VARIABILITY; DIENCEPHALIC SEIZURES; DYSAUTONOMIA; MANAGEMENT; DIAGNOSIS; SYMPTOMS; CHILDREN; JNCL	Paroxysmal sympathetic hyperactivity (PSH) is a clinical syndrome of agitation and involuntary motor activity that particularly occurs in patients with severe acquired brain injury. The aim of the present study is to substantiate the assertion that paroxysmal non-epileptic attacks resembling PSH also occur in patients with Juvenile Neuronal Ceroid Lipofuscinosis (JNCL, Batten disease), which is the most common neurodegenerative disease in children. The paper describes a case series of five patients with JNCL which during a period of fifteen years have been followed clinically and by consecutive investigations of the autonomic nervous system using heart rate variability (HRV) investigations. Following adolescence a significant autonomic imbalance with very low parasympathetic activity and an unchanged high sympathetic excitatory activity was documented. In addition, episodes of anxiety and agitation combined with involuntary movements were reported. Beyond the frightened facial expression and involuntary increased motor activity, excessive sweating, increased body temperature, high heart and respiratory rates were reported, and typically, the episodes occurred to stimuli that were either non-nociceptive or only minimally nociceptive. Thus, from a clinical point of view the non-epileptic paroxysmal condition with anxious behavior, agitation and motor hyperactivity seen in patients with JNCL fits to the clinical description of PSH which normally occurs following acutely acquired brain injury, and as the neuropathological basis in JNCL for development of PSH is similar to what is seen in patients with traumatic brain injuries, it seems reasonable to propose that PSH also occurs following adolescence in patients with JNCL.	[Ostergaard, John R.] Aarhus Univ Hosp, Dept Pediat & Adolescents Med, Ctr Rare Dis, Palle Juul Jensens Blvd 99, Aarhus N, Denmark		Ostergaard, JR (corresponding author), Aarhus Univ Hosp, Dept Pediat & Adolescents Med, Ctr Rare Dis, Palle Juul Jensens Blvd 99, Aarhus N, Denmark.	johnoest@rm.dk					Aberg L, 2000, NEUROLOGY, V54, P1069, DOI 10.1212/WNL.54.5.1069; Aberg LE, 2000, EPILEPSIA, V41, P1296, DOI 10.1111/j.1528-1157.2000.tb04608.x; Augustine EF, 2015, DEV MED CHILD NEUROL, V57, P366, DOI 10.1111/dmcn.12634; Autti T, 1996, NEURORADIOLOGY, V38, P476; Backman M L, 2001, Eur J Paediatr Neurol, V5 Suppl A, P163, DOI 10.1053/ejpn.2000.0455; Backman ML, 2005, J INTELL DISABIL RES, V49, P25, DOI 10.1111/j.1365-2788.2005.00659.x; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; Bozorg S, 2009, SURV OPHTHALMOL, V54, P463, DOI 10.1016/j.survophthal.2009.04.007; BRUUN I, 1991, ACTA NEUROL SCAND, V83, P1; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Collins J, 2006, BRIT J OPHTHALMOL, V90, P1119, DOI 10.1136/bjo.2006.091637; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; Hinson HE, 2013, CLIN AUTON RES, V23, P109, DOI 10.1007/s10286-012-0184-4; HOFMAN IL, 1993, J INHERIT METAB DIS, V16, P249, DOI 10.1007/BF00710256; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Kim SW, 2017, ANN REHABIL MED-ARM, V41, P951, DOI 10.5535/arm.2017.41.6.951; Kirkham FJ, 2011, EUR J PAEDIATR NEURO, V15, P390, DOI 10.1016/j.ejpn.2011.04.005; Kirveskari E, 2000, PEDIATR NEUROL, V22, P347, DOI 10.1016/S0887-8994(00)00138-7; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Kristensson K., 1963, ACTA NEUROPATHOL, V4, P421; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Munroe PB, 1997, AM J HUM GENET, V61, P310, DOI 10.1086/514846; Nielsen AK, 2013, EUR J PAEDIATR NEURO, V17, P265, DOI 10.1016/j.ejpn.2012.10.011; Ostergaard JR, 2011, NEUROLOGY, V76, P1245, DOI 10.1212/WNL.0b013e31821435bd; Ostergaard JR, 2016, DEGENER NEUROL NEURO, V6, P73, DOI 10.2147/DNND.S111967; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; SORENSEN JB, 1979, ACTA PSYCHIAT SCAND, V59, P449; Williams RE, 2006, BBA-MOL BASIS DIS, V1762, P865, DOI 10.1016/j.bbadis.2006.07.001	33	10	10	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-0702	1872-7484		AUTON NEUROSCI-BASIC	Auton. Neurosci-Basic Clin.	NOV	2018	214						15	18		10.1016/j.autneu.2018.07.003			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU9YY	WOS:000445714400003	30072301				2022-02-06	
J	Reger, MA; Tucker, RP; Carter, SP; Ammerman, BA				Reger, Mark A.; Tucker, Raymond P.; Carter, Sarah P.; Ammerman, Brooke A.			Military Deployments and Suicide: A Critical Examination	PERSPECTIVES ON PSYCHOLOGICAL SCIENCE			English	Article						suicide; deployment; combat; military	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; INTERPERSONAL-PSYCHOLOGICAL THEORY; COMBAT EXPOSURE; US MILITARY; ACTIVE-DUTY; VIETNAM VETERANS; FREEDOM VETERANS; ENDURING FREEDOM; SERVICE MEMBERS	Deployment to a combat zone is a fundamental mission for most military forces, but prior research suggests that there is a complex and nuanced association between deployment and related risk factors for suicide. Deployment and combat experiences vary greatly among military personnel and can affect a variety of protective and risk factors for suicide. This article offers a critical examination of the association among modern U.S. military deployments, suicide attempts, and death while considering the context of a prominent theory of suicide. Although previous work has demonstrated that deployment is not associated with suicide overall in this population, there is growing evidence that risk may be elevated shortly after deployment, and for some subgroups. Specific aspects of combat exposure, including the experience of killing or witnessing death in combat, may be important contributing factors. An analysis of the literature illustrates that deployment-related risk factors for suicide are complex. The limitations of the literature are discussed, and future directions are suggested.	[Reger, Mark A.; Carter, Sarah P.; Ammerman, Brooke A.] VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [Reger, Mark A.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Tucker, Raymond P.] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA		Carter, SP (corresponding author), VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA.	sarah.bricker-carter@va.gov	Tucker, Raymond/AAJ-8458-2021; Carter, Sarah/K-8205-2018; Bricker-Carter, Sarah/K-8205-2018	Carter, Sarah/0000-0003-4598-7091; Bricker-Carter, Sarah/0000-0003-1371-0020			Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Anestis MD, 2019, SUICIDE LIFE-THREAT, V49, P210, DOI 10.1111/sltb.12425; Armed Forces Health Surveillance Center (AFHSC), 2012, MSMR, V19, P7; Baiocchi D., 2013, MEASURING ARMY DEPLO; Besteman C., 2018, US NEWS; Blue Ribbon Work Group on Suicide Prevention in the Veteran Population, 2008, REP BLUE RIBB WORK G; Brenner L.A., 2008, J MENTAL HEALTH COUN, V30, P211, DOI [10.17744/mehc.30.3.n6418tm72231j606, DOI 10.17744/MEHC.30.3.N6418TM72231J606]; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brent DA, 2003, AM BEHAV SCI, V46, P1192, DOI 10.1177/0002764202250662; Bryan A.O., 2014, TRAUMATOLOGY, V20, P154, DOI [10.1037/h0099852, DOI 10.1037/H0099852]; Bryan CJ, 2016, CLIN PSYCHOL SCI, V4, P376, DOI 10.1177/2167702615595000; Bryan CJ, 2015, SUICIDE LIFE-THREAT, V45, P633, DOI 10.1111/sltb.12163; Bryan CJ, 2013, J AFFECT DISORDERS, V150, P1226, DOI 10.1016/j.jad.2013.05.087; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, J AFFECT DISORDERS, V148, P37, DOI 10.1016/j.jad.2012.11.044; Bryan CJ, 2011, SUICIDE LIFE-THREAT, V41, P126, DOI 10.1111/j.1943-278X.2011.00023.x; Bryan CJ, 2010, PERS INDIV DIFFER, V48, P347, DOI 10.1016/j.paid.2009.10.023; Bullman TA, 1996, AM J PUBLIC HEALTH, V86, P662, DOI 10.2105/AJPH.86.5.662; CARD JJ, 1974, OMEGA-J DEATH DYING, V5, P37, DOI 10.2190/K59M-Y0KN-PAKV-JFUV; Carter S, 2011, J TRAUMA STRESS, V24, P352, DOI 10.1002/jts.20649; Carter SP, 2016, J FAM ISSUES, V37, P2309, DOI 10.1177/0192513X14567956; Chappelle W, 2012, PREVALENCE HIGH EMOT; Chappelle W, 2014, J ANXIETY DISORD, V28, P480, DOI 10.1016/j.janxdis.2014.05.003; Chu C, 2017, PSYCHOL BULL, V143, P1313, DOI 10.1037/bul0000123; DeBruyne N. F, 2017, AM WAR MILITARY OPER; Department of Defense Task Force on the Prevention of Suicide by Members of the Armed Forces, 2010, CHALL PROM STRENGTH; FARBEROW NL, 1990, J NERV MENT DIS, V178, P32, DOI 10.1097/00005053-199001000-00006; Fonda JR, 2017, AM J EPIDEMIOL, V186, P220, DOI 10.1093/aje/kwx044; Fontana A, 1999, J TRAUMA STRESS, V12, P111, DOI 10.1023/A:1024750417154; FONTANA A, 1992, J NERV MENT DIS, V180, P748, DOI 10.1097/00005053-199212000-00002; Griffith J, 2017, MIL PSYCHOL, V29, P202, DOI 10.1037/mil0000163; Griffith J, 2013, ARMED FORCES SOC, V39, P628, DOI 10.1177/0095327X12471333; Hamza CA, 2012, CLIN PSYCHOL REV, V32, P482, DOI 10.1016/j.cpr.2012.05.003; HENDIN H, 1991, AM J PSYCHIAT, V148, P586; Hinojosa R, 2011, J REHABIL RES DEV, V48, P1145, DOI 10.1682/JRRD.2010.08.0151; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kang HK, 2015, ANN EPIDEMIOL, V25, P96, DOI 10.1016/j.annepidem.2014.11.020; Kang HK, 2009, ANN EPIDEMIOL, V19, P757, DOI 10.1016/j.annepidem.2009.05.004; Kazan D, 2016, J AFFECT DISORDERS, V190, P585, DOI 10.1016/j.jad.2015.11.003; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; Kessler RC, 2015, PSYCHOL MED, V45, P3293, DOI 10.1017/S0033291715001294; Khazem LR, 2015, DEATH STUD, V39, P641, DOI 10.1080/07481187.2015.1047061; Klonsky ED, 2015, INT J COGN THER, V8, P114, DOI 10.1521/ijct.2015.8.2.114; LeardMann CA, 2013, JAMA-J AM MED ASSOC, V310, P496, DOI 10.1001/jama.2013.65164; Maguen S, 2012, DEPRESS ANXIETY, V29, P918, DOI 10.1002/da.21954; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; McLean CP, 2017, J AFFECT DISORDERS, V208, P392, DOI 10.1016/j.jad.2016.08.061; Meadows S. O., 2016, RR1388 RAND CORP; Michalek JE, 1998, AM J EPIDEMIOL, V148, P786, DOI 10.1093/oxfordjournals.aje.a009699; Mitchell MM, 2012, SUICIDE LIFE-THREAT, V42, P486, DOI 10.1111/j.1943-278X.2012.00106.x; Monteith LL, 2013, SUICIDE LIFE-THREAT, V43, P418, DOI 10.1111/sltb.12027; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Niederkrotenthaler T, 2014, AM J PREV MED, V47, pS235, DOI 10.1016/j.amepre.2014.06.010; O'Connor RC, 2011, CRISIS, V32, P295, DOI 10.1027/0227-5910/a000120; Oexle N, 2017, EPIDEMIOL PSYCH SCI, V26, P53, DOI 10.1017/S2045796015001018; Phillips CJ, 2017, AM J EPIDEMIOL, V186, P668, DOI 10.1093/aje/kwx117; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Price J., 2015, NUMBER 22 IS THERE F; Ramchand R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0575-z; Reger MA, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17l11790; Reger MA, 2017, SUICIDE LIFE-THREAT, V47, P242, DOI 10.1111/sltb.12282; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Sareen J, 2017, CAN J PSYCHIAT, V62, P795, DOI 10.1177/0706743717699174; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Selby EA, 2010, CLIN PSYCHOL REV, V30, P298, DOI 10.1016/j.cpr.2009.12.004; Shen YC, 2016, LANCET PSYCHIAT, V3, P1039, DOI 10.1016/S2215-0366(16)30304-2; Shulkin D. J, 2016, PREVENTING VETERAN S; Smith AR, 2012, PSYCHIAT RES, V197, P60, DOI 10.1016/j.psychres.2012.01.010; Somers D., 2013, I AM SORRY IT HAS CO; Spicer RS, 2000, AM J PUBLIC HEALTH, V90, P1885, DOI 10.2105/AJPH.90.12.1885; Stack S, 2003, J EPIDEMIOL COMMUN H, V57, P238, DOI 10.1136/jech.57.4.238; Sternke LM, 2011, WOMEN HEALTH ISS, V21, pS160, DOI 10.1016/j.whi.2011.04.020; Stravynski A, 2001, SUICIDE LIFE-THREAT, V31, P32, DOI 10.1521/suli.31.1.32.21312; Thoresen S, 2008, J NERV MENT DIS, V196, P814, DOI 10.1097/NMD.0b013e31818b6a92; TROUT DL, 1980, SUICIDE LIFE-THREAT, V10, P10; Ursano RJ, 2016, JAMA PSYCHIAT, V73, P741, DOI 10.1001/jamapsychiatry.2016.0600; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Van Winkle EP, 2011, J TRAUMA STRESS, V24, P107, DOI 10.1002/jts.20614; Walsh CG, 2017, CLIN PSYCHOL SCI, V5, P457, DOI 10.1177/2167702617691560; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314; Wilson ALG, 2010, ANN EPIDEMIOL, V20, P939, DOI 10.1016/j.annepidem.2010.08.007	81	10	11	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1745-6916	1745-6924		PERSPECT PSYCHOL SCI	Perspect. Psychol. Sci.	NOV	2018	13	6					688	699		10.1177/1745691618785366			12	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	HA5PO	WOS:000450327400003	30286298				2022-02-06	
J	Robinson, BD; Isbell, CL; Shaji, CA; Kurek, S; Regner, JL; Tharakan, B				Robinson, Bobby Darnell; Isbell, Claire Larson; Shaji, Chinchusha Anasooya; Kurek, Stanley, Jr.; Regner, Justin L.; Tharakan, Binu			Quetiapine protects the blood-brain barrier in traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	48th Annual Meeting of the Western-Trauma-Association (WTA)	FEB 15-MAR 03, 2018	Whistler, CANADA	Western Trauma Assoc		Traumatic brain injury; quetiapine; microvascular hyperpermeability	HYPERPERMEABILITY; DYSFUNCTION; UPDATE; MODEL; BETA	BACKGROUND The integrity of the blood-brain barrier (BBB) is paramount in limiting vasogenic edema following traumatic brain injury (TBI). The purpose of this study was to ascertain if quetiapine, an atypical antipsychotic commonly used in trauma/critical care for delirium, protects the BBB and attenuates hyperpermeability in TBI. METHODS The effect of quetiapine on hyperpermeability was examined through molecular modeling, cellular models in vitro and small animal models in vivo. Molecular docking was performed with AutoDock Vina to matrix metalloproteinase-9. Rat brain microvascular endothelial cells (BMECs) were pretreated with quetiapine (20 M; 1 hour) followed by an inflammatory activator (20 g/mL chitosan; 2 hours) and compared to controls. Immunofluorescence localization for tight junction proteins zonula occludens-1 and adherens junction protein -catenin was performed. Human BMECs were grown as a monolayer and pretreated with quetiapine (20 M; 1 hour) followed by chitosan (20 g/mL; 2 hours), and transendothelial electrical resistance was measured. C57BL/6 mice (n = 5/group) underwent mild to moderate TBI (controlled cortical impactor) or sham craniotomy. The treatment group was given 10 mg/kg quetiapine intravenously 10 minutes after TBI. The difference in fluorescence intensity between intravascular and interstitium (I) represented BBB hyperpermeability. A matrix metalloproteinase-9 activity assay was performed in brain tissue from animals in the experimental groups ex vivo. RESULTS In silico studies showed quetiapine thermodynamically favorable binding to MMP-9. Junctional localization of zonula occludens-1 and -catenin showed retained integrity in quetiapine-treated cells as compared with the chitosan group in rat BMECs. Quetiapine attenuated monolayer permeability compared with chitosan group (p < 0.05) in human BMECs. In the animal studies, there was a significant decrease in BBB hyperpermeability and MMP-9 activity when compared between the TBI and TBI plus quetiapine groups (p < 0.05). CONCLUSION Quetiapine treatment may have novel anti-inflammatory properties to provide protection to the BBB by preserving tight junction integrity. LEVEL OF EVIDENCE level IV.	Scott & White Med Ctr, Dept Surg, Temple, TX USA; Texas A&M Univ, Hlth Sci Ctr, Coll Med, Temple, TX 76504 USA		Tharakan, B (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Surg, 702 SW HK Dodgen Loop, Temple, TX 76504 USA.; Tharakan, B (corresponding author), Baylor Scott & White Hlth, 702 SW HK Dodgen Loop, Temple, TX 76504 USA.	Binu.Tharakan@BSWHealth.org					Alluri H, 2018, METHODS MOL BIOL, V1717, P37, DOI 10.1007/978-1-4939-7526-6_4; Alluri H, 2016, J BIOL CHEM, V291, P26958, DOI 10.1074/jbc.M116.735365; Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bueter CL, 2011, J BIOL CHEM, V286, P35447, DOI 10.1074/jbc.M111.274936; Davanzo JR, 2017, SURG CLIN N AM, V97, P1237, DOI 10.1016/j.suc.2017.08.001; DeVane CL, 2001, CLIN PHARMACOKINET, V40, P509, DOI 10.2165/00003088-200140070-00003; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Engelhardt B, 2014, CELL TISSUE RES, V355, P687, DOI 10.1007/s00441-014-1811-2; Fradera Xavier, 2017, Curr Protoc Chem Biol, V9, P196, DOI 10.1002/cpch.27; Garver DL, 2000, J CLIN PSYCHIAT, V61, P31; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Hasturk AE, 2015, ULUS TRAVMA ACIL CER, V21, P1, DOI 10.5505/tjtes.2015.57894; Hawkins WA, 2018, J CRIT CARE, V44, P289, DOI 10.1016/j.jcrc.2017.11.032; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Merkel SF, 2017, CELL TRANSPLANT, V26, P1178, DOI 10.1177/0963689717714341; Mortezaee K, 2017, J CELL PHYSL; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Narala A, 2013, J PHARMACEUTICS, V2013, DOI 10.1155/2013/265741; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Rigor RR, 2012, AM J PHYSIOL-CELL PH, V302, pC1513, DOI 10.1152/ajpcell.00371.2011; Robinson BD, 2018, METHODS MOL BIOL, V1717, P237, DOI 10.1007/978-1-4939-7526-6_19; Roomi MW, 2017, ONCOL REP, V37, P1842, DOI 10.3892/or.2017.5368; Rudra DS, 2013, J PINEAL RES, V54, P398, DOI 10.1111/jpi.12034; Sawant DA, 2013, J SURG RES, V184, P628, DOI 10.1016/j.jss.2013.04.079; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Stagg HW, 2013, J TRAUMA ACUTE CARE, V75, P1040, DOI 10.1097/TA.0b013e3182aa9c79; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; Vandooren J, 2014, PROG BRAIN RES, V214, P193, DOI 10.1016/B978-0-444-63486-3.00009-8; Weeks JJ, 2018, BEHAV BRAIN RES, V340, P159, DOI 10.1016/j.bbr.2016.09.049; Wiggins-Dohlvik K, 2016, SHOCK, V45, P626, DOI 10.1097/SHK.0000000000000556; Wiggins-Dohlvik K, 2016, AM J SURG, V211, P197, DOI 10.1016/j.amjsurg.2015.08.016	38	10	11	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2018	85	5					968	976		10.1097/TA.0000000000002011			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GZ0NG	WOS:000449060100021	29985239				2022-02-06	
J	Studerus-Germann, AM; Gautschi, OP; Bontempi, P; Thiran, JP; Daducci, A; Romascano, D; von Ow, D; Hildebrandt, G; von Hessling, A; Engel, DC				Studerus-Germann, Aline M.; Gautschi, Oliver P.; Bontempi, Pietro; Thiran, Jean-Philippe; Daducci, Alessandro; Romascano, David; von Ow, Dieter; Hildebrandt, Gerhard; von Hessling, Alexander; Engel, Doortje C.			Central nervous system microbleeds in the acute phase are associated with structural integrity by DTI one year after mild traumatic brain injury: A longitudinal study	NEUROLOGIA I NEUROCHIRURGIA POLSKA			English	Article						Mild traumatic brain injury; Diffusion tensor imaging; Susceptibility-weighted imaging; Diffuse axonal injury; Cognitive assessment	OUTCOME PREDICTION; TASK-FORCE	Introduction: Several imaging modalities are under investigation to unravel the pathophysiological mystery of delayed performance deficits in patients after mild traumatic brain injury (mTBI). Although both imaging and neuropsychological studies have been conducted, only few data on longitudinal correlations of diffusion tensor imaging (DTI), susceptibility weighted imaging (SWI) and extensive neuropsychological testing exist. Methods: MRI with T1- and T2-weighted, SWI and DTI sequences at baseline and 12 months of 30 mTBI patients were compared with 20 healthy controls. Multiparametric assessment included neuropsychological testing of cognitive performance and post-concussion syndrome (PCS) at baseline, 3 and 12 months post-injury. Data analysis encompassed assessment of cerebral microbleeds (Mb) in SWI, tract-based spatial statistics (TBSS) and voxel-based morphometry (VBM) of DTI (VBM-DTI). Imaging markers were correlated with neuropsychological testing to evaluate sensitivity to cognitive performance and post-concussive symptoms. Results: Patients with Mb in SWI in the acute phase showed worse performance in several cognitive tests at baseline and in the follow-ups during the chronic phase and higher symptom severity in the post concussion symptom scale (PCSS) at twelve months post-injury. In the acute phase there was no statistical difference in structural integrity as measured with DTI between mTBI patients and healthy controls. At twelve months post-injury, loss of structural integrity in mTBI patients was found in nearly all DTI indices compared to healthy controls. Conclusions: Presence of Mb detected by SWI was associated with worse cognitive outcome and persistent PCS in mTBI patients, while DTI did not prove to predict neuropsychological outcome in the acute phase. (C) 2018 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.	[Studerus-Germann, Aline M.] Cantonal Hosp, Dept Neurol, Div Neuropsychol, St Gallen, Switzerland; [Studerus-Germann, Aline M.] Univ Zurich, Dept Psychopathol & Clin Intervent, Zurich, Switzerland; [Gautschi, Oliver P.; Hildebrandt, Gerhard; Engel, Doortje C.] Cantonal Hosp St Gallen, Dept Neurosurg, St Gallen, Switzerland; [Gautschi, Oliver P.] Univ Geneva, Geneva Univ Med Ctr, Fac Med, Dept Neurosurg, Geneva, Switzerland; [Bontempi, Pietro] Univ Verona, Dept Biotechnol, Verona, Italy; [Thiran, Jean-Philippe; Daducci, Alessandro; Romascano, David] Ecole Polytech Fed Lausanne, Signal Proc Lab LTS5, Lausanne, Switzerland; [von Ow, Dieter] Cantonal Hosp St Gallen, Emergency Dept, St Gallen, Switzerland; [von Hessling, Alexander] Cantonal Hosp St Gallen, Dept Radiol & Nucl Med, St Gallen, Switzerland; [von Hessling, Alexander] Cantonal Hosp Lucerne, Dept Radiol & Nucl Med, Luzern, Switzerland; [Engel, Doortje C.] Univ Hosp Tubingen, Dept Neurosurg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany		Engel, DC (corresponding author), Univ Hosp Tubingen, Dept Neurosurg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	doortjeengel@gmail.com	Bontempi, Pietro/AAU-5022-2021	Bontempi, Pietro/0000-0002-7720-8243	Department of Neurosurgery, Cantonal Hospital St. Gallen; commission of the Clinical Trials Unit of the Cantonal Hospital St. Gallen	The study was funded by three independent private foundations (see Acknowledgements), the commission of the Clinical Trials Unit of the Cantonal Hospital St. Gallen and the Department of Neurosurgery, Cantonal Hospital St. Gallen.	Akoudad S., 2014, STROKE; Andersson J., 2007, SD; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barrio-Arranz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137905; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Carroll LJ, 2004, J REHABIL MED, P165, DOI [10.1080/01960410023859, DOI 10.1080/01960410023859]; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Fujiwara S, 2014, NEUROIMAGE; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gu YX, 2009, STROKE, V40, P2241, DOI 10.1161/STROKEAHA.108.539536; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Huang Y-L, 2015, NEUROLOGY, DOI [10.1212/WNL0000000000001237, DOI 10.1212/WNL0000000000001237]; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kim BJ, 2015, J STROKE, V17, P101, DOI 10.5853/jos.2015.17.2.101; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, DOI [10.1089/neu.2008.0461r10.1089, DOI 10.1089/NEU.2008.0461R10.1089]; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Liu GB, 2015, ACTA RADIOL, V56, P1256, DOI 10.1177/0284185114552883; Mayer A.R., 2010, NEUROLOGY; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sbordone RJ, LIMITATIONS NEUROPSY; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stokum JA, 2015, BRAIN INJ; Studerus-Germann AM, 2017, INT J NEUROSCI, V127, P900, DOI 10.1080/00207454.2017.1278589; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Toth A., 2015, BRAIN NEUROTRAUMA MO; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; von Wild KRH, 2008, ACTA NEUROCHIR S; Wilde EA, 2012, NEUROREHABILITATION, V31, P227, DOI 10.3233/NRE-2012-0793; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	48	10	10	1	3	ELSEVIER URBAN & PARTNER SP Z O O	WROCLAW	UL MIGDALOWA 4, LOK 59, WROCLAW, 02-796, POLAND	0028-3843			NEUROL NEUROCHIR POL	Neurol. Neurochir. Pol.	NOV-DEC	2018	52	6					710	719		10.1016/j.pjnns.2018.08.011			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE1IQ	WOS:000453024400012	30245171				2022-02-06	
J	Woodworth, DC; Holly, LT; Salamon, N; Ellingson, BM				Woodworth, Davis C.; Holly, Langston T.; Salamon, Noriko; Ellingson, Benjamin M.			Resting-State Functional Magnetic Resonance Imaging Connectivity of the Brain Is Associated with Altered Sensorimotor Function in Patients with Cervical Spondylosis	WORLD NEUROSURGERY			English	Article						Brain; Cervical spondylosis; Degenerative cervical myelopathy; Functional MRI	SPINAL-CORD-INJURY; CORTICAL REORGANIZATION; CORTICOSPINAL TRACT; MYELOPATHY; PATTERNS; RECOVERY; CORTEX; LEVEL	OBJECTIVE: To determine the relationship between functional connectivity (FC) using resting-state functional magnetic resonance imaging (MRI) and neurological impairment in patients with cervical spondylosis and healthy controls. METHODS: A total of 24 patients with cervical spondylosis with or without myelopathy and 17 neurologically intact, healthy volunteer subjects were prospectively enrolled in a cross-sectional study involving observational MRI and evaluation of neurological function using the modified Japanese Orthopedic Association (mJOA) score. Seed-to-seed connectivity and seed-to-voxel connectivity on functional MRI data were performed using a general linear model of connectivity with respect to age and mJOA score. RESULTS: Increased FC was observed with increasing neurological impairment in patients with cervical stenosis within sensorimotor areas, including precentral gyrus, postcentral gyrus, and supplemental motor regions, using both seed-to-seed and seed-to-voxel analyses. The anterior cingulate showed increasing connectivity with the supplemental motor area, thalamus, and cerebellum with increasing neurological function. Similarly, the thalamus, cerebellum, and putamen presented with increasing connectivity to both the bilateral precuneus and the posterior cingulate with an increasing mJOA score. CONCLUSIONS: Patients with cervical spondylosis exhibiting neurological impairment experience changes in brain connectivity similar to that of patients with chronic traumatic spinal cord injury. These results suggest an increase in FC within sensorimotor regions with increasing neurological impairment and decreased connectivity between the cerebellum, putamen, and thalamus to the anterior and posterior cingulate and frontal lobe regions.	[Woodworth, Davis C.; Salamon, Noriko; Ellingson, Benjamin M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Woodworth, Davis C.; Ellingson, Benjamin M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Phys & Biol Med, Los Angeles, CA 90095 USA; [Holly, Langston T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Ellingson, Benjamin M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA		Ellingson, BM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA.; Ellingson, BM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Phys & Biol Med, Los Angeles, CA 90095 USA.; Ellingson, BM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	bellingson@mednet.ucla.edu	Woodworth, Davis/L-9364-2019	Ellingson, Benjamin/0000-0002-2764-6640; Woodworth, Davis/0000-0002-6256-857X	National Institutes of Health, National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R21NS065419-01A1, 1R01NS078494-01A1, 2R01NS078494-06]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078494, R21NS065419] Funding Source: NIH RePORTER	Funding was received from the National Institutes of Health, National Institute of Neurological Disorders and Stroke (grant 1R21NS065419-01A1 to L.T.H. and N.S.; grant 1R01NS078494-01A1 to L.T.H., N.S., and B.M.E.; and grant 2R01NS078494-06 to L.T.H., N.S., and B.M.E.).	Astolfi L, 2007, BRAIN TOPOGR, V19, P107, DOI 10.1007/s10548-007-0018-1; Fallani FD, 2007, BRAIN TOPOGR, V19, P125, DOI 10.1007/s10548-007-0019-0; Dobkin BH, 2000, PROG BRAIN RES, V128, P99; Dong Y, 2008, J NEUROSURG-SPINE, V9, P538, DOI 10.3171/SPI.2008.10.0831; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Grillner S., 2013, FUNDAMENTAL NEUROSCI, P599; Higo N, 2009, J COMP NEUROL, V516, P493, DOI 10.1002/cne.22121; Holly LT, 2007, J NEUROSURG-SPINE, V6, P544, DOI 10.3171/spi.2007.6.6.5; Hou JM, 2014, NEUROSCIENCE, V277, P446, DOI 10.1016/j.neuroscience.2014.07.045; Hou JM, 2016, HUM BRAIN MAPP, V37, P2195, DOI 10.1002/hbm.23163; Hrabalek L, 2014, Rozhl Chir, V93, P530; Kalsi-Ryan S, 2013, NEUROSCIENTIST, V19, P409, DOI 10.1177/1073858412467377; Kaushal M, 2017, J NEUROTRAUM, V34, P1278, DOI 10.1089/neu.2016.4649; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Min YS, 2015, J NEUROTRAUM, V32, P1422, DOI 10.1089/neu.2014.3661; Min YS, 2015, ANN REHABIL MED-ARM, V39, P374, DOI 10.5535/arm.2015.39.3.374; Moxon KA, 2014, NEUROSCIENCE, V283, P78, DOI 10.1016/j.neuroscience.2014.06.056; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Nolte J., 2009, HUMAN BRAIN INTRO IT; Oni-Orisan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150351; Roelcke U, 1997, J NEUROL NEUROSUR PS, V62, P61, DOI 10.1136/jnnp.62.1.61; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Schmidlin E, 2004, BRAIN RES, V1017, P172, DOI 10.1016/j.brainres.2004.05.036; Tracy JA, 2010, NEUROLOGIST, V16, P176, DOI 10.1097/NRL.0b013e3181da3a29; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Woodworth DC, 2019, NEUROSURGERY, V84, P588, DOI 10.1093/neuros/nyy066; Wu CWW, 2011, BRAIN CONNECT, V1, P401, DOI 10.1089/brain.2011.0018; Yonenobu K, 2001, SPINE, V26, P1890, DOI 10.1097/00007632-200109010-00014	29	10	11	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2018	119						E740	E749		10.1016/j.wneu.2018.07.257			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GX7IO	WOS:000447941300091	30092474	Green Accepted			2022-02-06	
J	Nasser, M; Ballout, N; Mantash, S; Bejjani, F; Najdi, F; Ramadan, N; Soueid, J; Zibara, K; Kobeissy, F				Nasser, Mohammad; Ballout, Nissrine; Mantash, Sarah; Bejjani, Fabienne; Najdi, Farah; Ramadan, Naify; Soueid, Jihane; Zibara, Kazem; Kobeissy, Firas			Transplantation of Embryonic Neural Stem Cells and Differentiated Cells in a Controlled Cortical Impact (CCI) Model of Adult Mouse Somatosensory Cortex	FRONTIERS IN NEUROLOGY			English	Article						TBI; NSC; neurosphere; astrocyte; neuron; lesion; transplantation; cortex	TRAUMATIC BRAIN-INJURY; WHITE-MATTER; NEUROGENESIS; NEURONS; NEUROINFLAMMATION; OPPORTUNITIES; INFLAMMATION; MICROGLIA; RESPONSES; ISCHEMIA	Traumatic brain injury (TBI) is a major cause of death worldwide. Depending on the severity of the injury, TBI can reflect a broad range of consequences such as speech impairment, memory disturbances, and premature death. In this study, embryonic neural stern cells (ENSC) were isolated from E14 mouse embryos and cultured to produce neurospheres which were induced to generate differentiated cells (DC). As a cell replacement treatment option, we aimed to transplant ENSC or DC into the adult injured C576L/6 mouse cortex controlled cortical impact (CCI) model, 7 days post-trauma, in comparison to saline injection (control). The effect of grafted cells on neuroinflammation and neurogenesis was investigated at 1 and 4 weeks post-transplantation. Results showed that microglia were activated following mild CCI, but not enhanced after engraftment of ENSC or DC. Indeed, ipsilateral lesioned somatosensory area expressed high levels of lba-1+ microglia within the different groups after 1 and 4 weeks. On the other hand, treatment with ENSC or DC demonstrated a significant reduction in astrogliosis. The levels of GFAP expressing astrocytes started decreasing early (1 week) in the ENSC group and then were similarly low at 4 weeks in both ENSC and DC. Moreover, neurogenesis was significantly enhanced in ENSC and DC groups. Indeed, a significant increase in the number of DCX expressing progenitor cells was observed at 1 week in the ENSC group, and in DC and ENSC groups at 4 weeks. Furthermore, the number of mature neuronal cells (NeuN+) significantly increased in DC group at 4 weeks whereas they decreased in ENSC group at 1 week. Therefore, injection of ENSC or DC post-CCI caused decreased astrogliosis and suggested an increased neurogenesis via inducing neural progenitor proliferation and expression rather than neuronal maturation. Thus, ENSC may play a role in replacing lost cells and brain repair following TBI by improving neurogenesis and reducing neuroinflammation, reflecting an optimal environment for transplanted and newly born cells.	[Nasser, Mohammad; Zibara, Kazem] Lebanese Univ, Biol Dept, Fac Sci 1, Beirut, Lebanon; [Nasser, Mohammad; Ballout, Nissrine; Mantash, Sarah; Bejjani, Fabienne; Najdi, Farah; Ramadan, Naify; Zibara, Kazem] Lebanese Univ, ER045, PRASE, DSST, Beirut, Lebanon; [Ramadan, Naify; Soueid, Jihane; Kobeissy, Firas] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon		Zibara, K (corresponding author), Lebanese Univ, Biol Dept, Fac Sci 1, Beirut, Lebanon.; Zibara, K (corresponding author), Lebanese Univ, ER045, PRASE, DSST, Beirut, Lebanon.; Kobeissy, F (corresponding author), Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon.	kzibara@ul.edu.lb; firasko@gmail.com	Kobeissy, Firas/E-7042-2017; BALLOUT, Nissrine/ABG-2754-2020	Kobeissy, Firas/0000-0002-5008-6944; Zibara, Kazem/0000-0002-9887-072X; Nasser, Mohamad/0000-0002-1338-2437	AUB-MPP grant Dual Neurotherapeutic Effects of Docosahexaenoic Acid (DHA); Neonatal Neural Stem Cell transplantation Post-Traumatic Brain Injury; Lebanese University (LU); American University of Beirut; Lebanese University; L-NCSR; Arachidonic Acid (AA)	This work was supported by the AUB-MPP grant Dual Neurotherapeutic Effects of Docosahexaenoic Acid (DHA) and Arachidonic Acid (AA) with Neonatal Neural Stem Cell transplantation Post-Traumatic Brain Injury. PI: Firas Kobeissy, PhD. It is also supported by a grant from Lebanese University (LU) to Mohammad Nasser inn addition to grants from the American University of Beirut (FK), the Lebanese University (MN, KZ), and the L-NCSR (FK, KZ).	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Babaee A, 2015, IRAN J BASIC MED SCI, V18, P867; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Ballout N, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00055; Bergstrom T, 2012, UPSALA J MED SCI, V117, P132, DOI 10.3109/03009734.2012.665096; Biran V, 2006, EXP NEUROL, V199, P103, DOI 10.1016/j.expneurol.2006.01.037; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Darling WG, 2011, J INTEGR NEUROSCI, V10, P353, DOI 10.1142/S0219635211002737; Desai AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085237; Dobrowolski S., 2013, AM J NEUROSCIENCE, V4, P13, DOI DOI 10.3844/AMJNSP.2013.13.24; Falkner S, 2016, NATURE, V539, P248, DOI 10.1038/nature20113; Gaillard A, 2007, NAT NEUROSCI, V10, P1294, DOI 10.1038/nn1970; Gaspard N, 2011, DEV MED CHILD NEUROL, V53, P13, DOI 10.1111/j.1469-8749.2010.03827.x; Gazalah H, 2016, METHODS MOL BIOL, V1462, P689, DOI 10.1007/978-1-4939-3816-2_38; Ghazale H, 2018, BEHAV BRAIN RES, V340, P1, DOI 10.1016/j.bbr.2017.11.007; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Hassani Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050444; Hentze H, 2007, TRENDS BIOTECHNOL, V25, P24, DOI 10.1016/j.tibtech.2006.10.010; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Jagnoor J, 2014, AUST FAM PHYSICIAN, V43, P758; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lafrenaye AD, 2016, NEURAL REGEN RES, V11, P538, DOI 10.4103/1673-5374.180726; Lam PK, 2013, J CLIN NEUROSCI, V20, P300, DOI 10.1016/j.jocn.2012.03.028; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mirza MA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0251-6; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NICHOLS JE, 2013, STEM CELL RES THER, V4; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Opara J A, 2014, J Med Life, V7, P124; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Otero L, 2011, CYTOTHERAPY, V13, P562, DOI 10.3109/14653249.2010.544720; Perez-Pinzon Miguel A, 1996, CNS Drug Rev, V2, P257; Peron S, 2017, J NEUROSCI, V37, P1820, DOI 10.1523/JNEUROSCI.2936-16.2017; Reis C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6392592; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Singec I, 2007, CELL STEM CELL, V1, P355, DOI 10.1016/j.stem.2007.09.012; Skardelly M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00318; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sun D, 2011, J NEUROTRAUM, V28, P961, DOI 10.1089/neu.2010.1697; Vexler ZS, 2009, DEV NEUROSCI-BASEL, V31, P378, DOI 10.1159/000232556; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Watanabe S, 2001, STROKE, V32, P2615, DOI 10.1161/hs1101.097384; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zeiger W, 2018, NEUROLOGY, V90; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	75	10	11	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 24	2018	9								895	10.3389/fneur.2018.00895			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GX9HQ	WOS:000448112500001	30405520	Green Published, gold			2022-02-06	
J	Brickell, TA; French, LM; Lippa, SM; Lange, RT				Brickell, Tracey A.; French, Louis M.; Lippa, Sara M.; Lange, Rael T.			Burden among caregivers of service members and veterans following traumatic brain injury	BRAIN INJURY			English	Article						Caregiver; burden; service member veteran; traumatic brain injury; polytrauma; post-traumatic stress	POSTTRAUMATIC-STRESS-DISORDER; OIF/OEF VETERANS; POLYTRAUMA; APPRAISAL; SYMPTOMS; HEALTH; PERSISTENT; FAMILIES; PAIN; CARE	Objectives: To determine the (a) health status and caregiving appraisal and (b) influence of perceived burden on health and appraisal in a sample of caregivers helping service member/veterans (SMVs) following a traumatic brain injury (TBI). Methods: Participants were caregivers (N = 283, female = 96.1%, 86.2% = spouse/partner) of SMVs who sustained a mild-severe or penetrating TBI. Participants completed the Caregiver Appraisal Scale (CAS) and the SF-36v2 Health Survey (SF-36v2). Participants were divided into three burden groups: high, neutral, and low. Results: Almost half the sample (48.8%) reported negative feelings on the CAS Perceived Burden scale. A substantial proportion had lower scores than a normative sample on four SF-36v2 physical health scales (35.1-64.5%) and four mental health scales (70.7-79.8%). A significant main effect was found across caregiver burden groups on three CAS scales (p = 0.010 to p < 0.001), two SF-36v2 component scores (all ps < 0.001), and eight SF-36v2 scales (p = 0.001 to p < 0.001). Caregivers with high perceived burden reported significantly worse scores, except CAS Caregiving Ideology. All CAS and SF-36v2 scales were significant predictors of CAS Perceived Burden scores (all ps< 0.001), with the SF-36v2 Social Functioning scale accounting for the most variance (32.6%). Conclusions: Health care and social services are needed for caregivers who help SMVs to foster resilience, wellness, and growth.	[Brickell, Tracey A.; French, Louis M.; Lippa, Sara M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Res Div, Bethesda, MD 20889 USA; [Brickell, Tracey A.; French, Louis M.; Lippa, Sara M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada		Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 51,Room 1502B,4954 N Palmer Rd, Bethesda, MD 20889 USA.	tbrickell@dvbic.org	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This work was supported by the Defense and Veterans Brain Injury Center.	Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brickell TA, 2018, J HEAD TRAUMA REHAB, V33, P133, DOI 10.1097/HTR.0000000000000384; Chopin S. M, 2012, ROLE POSITIVE EMOTIO; Cozza SJ, 2011, RISK AND RESILIENCE IN U S MILITARY FAMILIES, P259, DOI 10.1007/978-1-4419-7064-0_13; Folkman S., 1984, STRESS; French L. M., 2012, NEUROPSYCHOLOGICAL A, P127; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Griffin JM, 2014, MILITARY DEPLOYMENT; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Hyatt K, 2014, MIL MED, V179, P849, DOI 10.7205/MILMED-D-13-00526; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; National Alliance for Caregiving, 2010, CAR VET SERV HOM; Ramchand R., 2014, HIDDEN HEROES AM MIL; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Turner-Bowker, 2007, USERS MANUAL SF 36V2; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; Ware J.E., 1994, SF 36 PHYS MENTAL SU	30	10	11	2	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2018	32	12					1541	1548		10.1080/02699052.2018.1503328			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GX0EO	WOS:000447382800013	30148407				2022-02-06	
J	Cariou, A; Payen, JF; Asehnoune, K; Audibert, G; Botte, A; Brissaud, O; Debaty, G; Deltour, S; Deye, N; Engrand, N; Francony, G; Legriel, S; Levy, B; Meyer, P; Orban, JC; Renolleau, S; Vigue, B; de Saint Blanquat, L; Mathien, C; Velly, L				Cariou, Alain; Payen, Jean-Francois; Asehnoune, Karim; Audibert, Gerard; Botte, Astrid; Brissaud, Olivier; Debaty, Guillaume; Deltour, Sandrine; Deye, Nicolas; Engrand, Nicolas; Francony, Gilles; Legriel, Stephane; Levy, Bruno; Meyer, Philippe; Orban, Jean-Christophe; Renolleau, Sylvain; Vigue, Bernard; de Saint Blanquat, Laure; Mathien, Cyrille; Velly, Lionel		SRLF; SFAR; ANARLF; GFRUP; SFMU; SFNV	Targeted temperature management in the ICU: Guidelines from a French expert panel	ANAESTHESIA CRITICAL CARE & PAIN MEDICINE			English	Article						Intensive care unit; Guidelines; Targeted temperature management	HOSPITAL CARDIAC-ARREST; TRAUMATIC BRAIN-INJURY; MILD THERAPEUTIC HYPOTHERMIA; RANDOMIZED CLINICAL-TRIAL; CRITICALLY-ILL PATIENTS; ACUTE ISCHEMIC-STROKE; INTENSIVE-CARE-UNIT; POST HOC ANALYSIS; LENGTH-OF-STAY; INTRACRANIAL HYPERTENSION	Over the recent period, the use of induced hypothermia has gained an increasing interest for critically ill patients, in particular in brain-injured patients. The term "targeted temperature management" (TTM) has now emerged as the most appropriate when referring to interventions used to reach and maintain a specific level temperature for each individual. TTM may be used to prevent fever, to maintain normothermia, or to lower core temperature. This treatment is widely used in intensive care units, mostly as a primary neuroprotective method. Indications are, however, associated with variable levels of evidence based on inhomogeneous or even contradictory literature. Our aim was to conduct a systematic analysis of the published data in order to provide guidelines. We present herein recommendations for the use of TTM in adult and paediatric critically ill patients developed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) method. These guidelines were conducted by a group of experts from the French Intensive Care Society (Societe de reanimation de langue francaise [SRLF]) and the French Society of Anesthesia and Intensive Care Medicine (Societe francaise d'anesthesie reanimation [SFAR]) with the participation of the French Emergency Medicine Association (Societe francaise de medecine d'urgence [SFMU]), the French Group for Pediatric Intensive Care and Emergencies (Groupe francophone de reanimation et urgences pediatriques [GFRUP]), the French National Association of Neuro-Anesthesiology and Critical Care (Association rationale de neuro-anesthesie reanimation francaise [ANARLF]), and the French Neurovascular Society (Societe francaise neurovasculaire [SFNV]). Fifteen experts and two coordinators agreed to consider questions concerning TTM and its practical implementation in five clinical situations: cardiac arrest, traumatic brain injury, stroke, other brain injuries, and shock. This resulted in 30 recommendations: 3 recommendations were strong (Grade 1), 13 were weak (Grade 2), and 14 were experts' opinions. After two rounds of rating and various amendments, a strong agreement from voting participants was obtained for all 30 (100%) recommendations, which are exposed in the present article. (C) 2017 The Author(s). Published by Elsevier Masson SAS on behalf of Societe francaise d'anesthesie et de reanimation (Sfar).	[Cariou, Alain; Francony, Gilles] Paris Descartes Univ, Cochin Univ Hosp, AP HP, Med Intens Care Unit, 27 Rue Faubourg St Jacques, F-75014 Paris, France; [Payen, Jean-Francois] CHU Grenoble Alpes, Hop Michallon, Pole Anesthesie Reanimat, F-38000 Grenoble, France; [Mathien, Cyrille] Ctr Hosp Mulhouse, Serv Reanimat Med, Mulhouse, France; [de Saint Blanquat, Laure] Hop Necker Enfants Malad, AP HP, Reanimat Pediat Polyvalente, Paris, France; [Velly, Lionel] Hop la Timone, AP HM, Serv Anesthesie Reanimat, Marseille, France; [Deye, Nicolas] Hop Lariboisiere, AP HP, Paris, France; [Legriel, Stephane] Ctr Hosp Versailles, Le Chesnay, France; [Levy, Bruno] CHU Nancy, Hop Cent, Nancy, France; [Audibert, Gerard] CHU Nancy, Nancy, France; [Engrand, Nicolas] Fdn Adolphe De Rothschild, Paris, France; [Orban, Jean-Christophe] CHU Nice, Hop Pasteur 2, Nice, France; [Vigue, Bernard] Anesthesie Reanimat, Le Kremlin Bicetre, France; [Debaty, Guillaume] CHU Grenoble, La Tronche, France; [Asehnoune, Karim] CHU Nantes, Hop Hotel Dieu, Nantes, France; [Botte, Astrid] CHRU Lille, Hop Jeanne de Flandre, Lille, France; [Brissaud, Olivier] CHU Bordeaux, Bordeaux, France; [Meyer, Philippe] Hop Necker Enfants Malad, AP HP, Paris, France; [Renolleau, Sylvain] Hop Armand Trousseau, AP HP, Paris, France; [Deltour, Sandrine] Hop La Pitie Salpetriere, AP HP, Paris, France		Cariou, A (corresponding author), Paris Descartes Univ, Cochin Univ Hosp, AP HP, Med Intens Care Unit, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	alain.cariou@aphp.fr	Debaty, Guillaume/M-2810-2013; Meyer, Philippe/ABE-4242-2020	Debaty, Guillaume/0000-0003-2879-0326; Meyer, Philippe/0000-0002-3829-6631	Societe de reanimation de langue francaise (SRLF); Societe francaise d'anesthesie et de reanimation (SFAR)	This work was financially supported by the Societe de reanimation de langue francaise (SRLF) and the Societe francaise d'anesthesie et de reanimation (SFAR).	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Akula VP, 2015, J PEDIATR-US, V166, P856, DOI 10.1016/j.jpeds.2014.12.061; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Annborn M, 2014, INTENS CARE MED, V40, P1210, DOI 10.1007/s00134-014-3375-8; Arrich J, 2007, CRIT CARE MED, V35, P1041, DOI 10.1097/01.CCM.0000259383.48324.35; Arrich J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub3; Arrich J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub2; Atkins DL, 2006, PEDIATRICS, V117, pE989; Badjatia N, 2010, NEUROSURGERY, V66, P696, DOI 10.1227/01.NEU.0000367618.42794.AA; Bao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090956; Bennett AE, 2014, CLIN NEUROL NEUROSUR, V126, P103, DOI 10.1016/j.clineuro.2014.08.032; Benson DW, 1958, ANESTH ANALG, V38, P423; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bernard SA, 2012, CRIT CARE MED, V40, P747, DOI 10.1097/CCM.0b013e3182377038; Bernard SA, 2010, CIRCULATION, V122, P737, DOI 10.1161/CIRCULATIONAHA.109.906859; Bi M, 2011, CLIN NEUROL NEUROSUR, V113, P768, DOI 10.1016/j.clineuro.2011.08.010; Bouwes A, 2012, RESUSCITATION, V83, P996, DOI 10.1016/j.resuscitation.2012.04.006; Broessner G, 2009, STROKE, V40, pE657, DOI 10.1161/STROKEAHA.109.557652; Busch M, 2006, ACTA ANAESTH SCAND, V50, P1277, DOI 10.1111/j.1399-6576.2006.01147.x; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Castren M, 2010, CIRCULATION, V122, P729, DOI 10.1161/CIRCULATIONAHA.109.931691; Cheung Ka Wai, 2006, CJEM, V8, P329; Chi OZ, 2001, ANESTHESIOLOGY, V95, P933, DOI 10.1097/00000542-200110000-00023; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Corry JJ, 2008, NEUROCRIT CARE, V9, P189, DOI 10.1007/s12028-008-9092-9; Craig JV, 2000, BRIT MED J, V320, P1174, DOI 10.1136/bmj.320.7243.1174; Craig JV, 2002, LANCET, V360, P603, DOI 10.1016/S0140-6736(02)09783-0; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Cuthbertson BH, 2004, ANAESTHESIA, V59, P908, DOI 10.1111/j.1365-2044.2004.03748.x; de Caen AR, 2010, RESUSCITATION, V81, pE213, DOI 10.1016/j.resuscitation.2010.08.028; De Georgia MA, 2004, NEUROLOGY, V63, P312, DOI 10.1212/01.WNL.0000129840.66938.75; de Jonge RCJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-232; Debaty G, 2014, INTENS CARE MED, V40, P1832, DOI 10.1007/s00134-014-3519-x; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; den Hertog HM, 2009, LANCET NEUROL, V8, P434, DOI 10.1016/S1474-4422(09)70051-1; Deye N, 2015, CIRCULATION, V132, P182, DOI 10.1161/CIRCULATIONAHA.114.012805; Dippel DWJ, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-2; Dippel DWJ, 2001, STROKE, V32, P1607, DOI 10.1161/01.STR.32.7.1607; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Dumas F, 2011, CIRCULATION, V123, P877, DOI 10.1161/CIRCULATIONAHA.110.987347; Els T, 2006, CEREBROVASC DIS, V21, P79, DOI 10.1159/000090007; Fernandes D, 2014, J CRIT CARE, V29, P347, DOI 10.1016/j.jcrc.2013.12.001; Fernandez A, 2007, NEUROLOGY, V68, P1013, DOI 10.1212/01.wnl.0000258543.45879.f5; Ferreira IA, 2009, NETH HEART J, V17, P378, DOI 10.1007/BF03086288; Feuchtl A., 2007, Intensivmedizin und Notfallmedizin, V44, P37, DOI 10.1007/s00390-007-0740-7; Fink EL, 2012, PEDIATR CRIT CARE ME, V13, P80, DOI 10.1097/PCC.0b013e3181fe27c7; Fink EL, 2010, PEDIATR CRIT CARE ME, V11, P66, DOI 10.1097/PCC.0b013e3181c58237; Flemming Kerstin, 2006, Ger Med Sci, V4, pDoc04; Fujita Nobuya, 2003, No To Shinkei, V55, P407; Gasser S, 2003, J NEUROSURG ANESTH, V15, P240, DOI 10.1097/00008506-200307000-00012; Gebhardt K, 2013, RESUSCITATION, V84, P1062, DOI 10.1016/j.resuscitation.2013.03.038; Gillies MA, 2010, RESUSCITATION, V81, P1117, DOI 10.1016/j.resuscitation.2010.05.001; Grasner JT, 2011, CRIT CARE, V15, DOI 10.1186/cc10035; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Guilliams K, 2013, EPILEPSIA, V54, P1586, DOI 10.1111/epi.12331; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Hachimi-Idrissi S, 2001, RESUSCITATION, V51, P275, DOI 10.1016/S0300-9572(01)00412-9; HAUPT MT, 1991, CRIT CARE MED, V19, P1339, DOI 10.1097/00003246-199111000-00006; Hemmen TM, 2010, STROKE, V41, P2265, DOI 10.1161/STROKEAHA.110.592295; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Horburger D, 2012, CRIT CARE MED, V40, P2315, DOI 10.1097/CCM.0b013e31825333cf; Holzer M, 2002, NEW ENGL J MED, V346, P549; Holzer M, 2006, STROKE, V37, P1792, DOI 10.1161/01.STR.0000227265.52763.16; Hovdenes J, 2007, ACTA ANAESTH SCAND, V51, P137, DOI 10.1111/j.1399-6576.2006.01209.x; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hutchison JS, 2010, DEV NEUROSCI-BASEL, V32, P406, DOI 10.1159/000323260; Inamasu J, 2002, CHILD NERV SYST, V18, P175, DOI 10.1007/s003810100506; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Jiang W, 1999, EPILEPSIA, V40, P5, DOI 10.1111/j.1528-1157.1999.tb01982.x; Karnatovskaia LV, 2014, NEUROCRIT CARE, V21, P451, DOI 10.1007/s12028-014-9989-4; Kasner SE, 2002, STROKE, V33, P130, DOI 10.1161/hs0102.101477; Kawano G, 2011, ARCH DIS CHILD, V96, P936, DOI 10.1136/adc.2009.180554; Kim F, 2007, CIRCULATION, V115, P3064, DOI 10.1161/CIRCULATIONAHA.106.655480; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; Kim YM, 2012, RESUSCITATION, V83, P188, DOI 10.1016/j.resuscitation.2011.07.031; Knapik P, 2012, RESUSCITATION, V83, P208, DOI 10.1016/j.resuscitation.2011.09.001; Kollmar R, 2012, INT J STROKE, V7, P168, DOI 10.1111/j.1747-4949.2011.00707.x; Kollmar R, 2010, STROKE, V41, P1684, DOI 10.1161/STROKEAHA.110.587758; Kory P, 2012, NEUROCRIT CARE, V16, P406, DOI 10.1007/s12028-011-9664-y; Kowski AB, 2012, BRAIN RES, V1446, P119, DOI 10.1016/j.brainres.2012.01.022; Krizanac D, 2013, RESUSCITATION, V84, P805, DOI 10.1016/j.resuscitation.2012.11.022; Kutlesa M, 2014, CLIN NEUROL NEUROSUR, V123, P181, DOI 10.1016/j.clineuro.2014.05.018; Kutlesa M, 2012, WIEN KLIN WOCHENSCHR, V124, P855, DOI 10.1007/s00508-012-0302-2; Kutlesa M, 2011, NEUROCRIT CARE, V15, P151, DOI 10.1007/s12028-010-9500-9; Launey Y, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0689-4; Laurent I, 2005, J AM COLL CARDIOL, V46, P432, DOI 10.1016/j.jacc.2005.04.039; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Lefrant JY, 2003, INTENS CARE MED, V29, P414, DOI 10.1007/s00134-002-1619-5; Legriel S, 2016, NEW ENGL J MED, V375, P2457, DOI 10.1056/NEJMoa1608193; Leira R, 2004, NEUROLOGY, V63, P461, DOI 10.1212/01.WNL.0000133204.81153.AC; Lemiale V, 2008, RESUSCITATION, V76, P17, DOI 10.1016/j.resuscitation.2007.06.028; Lepur D, 2011, J INFECTION, V62, P172, DOI 10.1016/j.jinf.2010.10.001; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Lin JJ, 2012, PEDIATR NEUROL, V47, P448, DOI 10.1016/j.pediatrneurol.2012.08.013; Liu YH, 2015, EXP THER MED, V9, P464, DOI 10.3892/etm.2014.2130; LIU Z, 1993, BRAIN RES, V631, P51, DOI 10.1016/0006-8993(93)91185-U; Lopez-de-Sa E, 2012, CIRCULATION, V126, P2826, DOI 10.1161/CIRCULATIONAHA.112.136408; Lord AS, 2014, NEUROCRIT CARE, V21, P200, DOI 10.1007/s12028-013-9948-5; Lundbye JB, 2012, RESUSCITATION, V83, P202, DOI 10.1016/j.resuscitation.2011.08.005; LUNDGREN J, 1994, EXP BRAIN RES, V99, P43; Lyden P, 2016, STROKE, V47, P2888, DOI 10.1161/STROKEAHA.116.014200; Maconochie IK, 2015, RESUSCITATION, V95, P223, DOI 10.1016/j.resuscitation.2015.07.028; Mader TJ, 2014, THER HYPOTHERMIA TEM, V4, P21, DOI 10.1089/ther.2013.0018; Maeda T, 1999, BRAIN RES, V818, P228, DOI 10.1016/S0006-8993(98)01269-4; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Maznyczka AM, 2015, HEART, V101, P1265, DOI 10.1136/heartjnl-2014-307411; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Mongardon N, 2011, CRIT CARE MED, V39, P1359, DOI 10.1097/CCM.0b013e3182120b56; Moran JL, 2007, CRIT CARE MED, V35, P155, DOI 10.1097/01.CCM.0000250318.31453.CB; Morris PE, 2010, CRIT CARE, V14, DOI 10.1186/cc9089; Mourvillier B, 2013, JAMA-J AM MED ASSOC, V310, P2174, DOI 10.1001/jama.2013.280506; Munakata M, 2000, BRAIN DEV-JPN, V22, P373, DOI 10.1016/S0387-7604(00)00169-8; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Nielsen N, 2009, ACTA ANAESTH SCAND, V53, P926, DOI 10.1111/j.1399-6576.2009.02021.x; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nielsen N, 2011, INT J CARDIOL, V151, P333, DOI 10.1016/j.ijcard.2010.06.008; Ntaios G, 2015, INT J STROKE, V10, P941, DOI 10.1111/ijs.12579; Nunnally ME, 2011, CRIT CARE MED, V39, P1113, DOI 10.1097/CCM.0b013e318206bab2; Ohtsuki Noriyuki, 2000, No To Hattatsu, V32, P318; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Ovesen C, 2013, ACTA NEUROL SCAND, V127, P399, DOI 10.1111/ane.12059; Perbet S, 2011, AM J RESP CRIT CARE, V184, P1048, DOI 10.1164/rccm.201102-0331OC; Pfeifer R, 2011, RESUSCITATION, V82, P1168, DOI 10.1016/j.resuscitation.2011.05.024; Piironen K, 2014, STROKE, V45, P486, DOI 10.1161/STROKEAHA.113.003180; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2004, INTENS CARE MED, V30, P1860, DOI 10.1007/s00134-004-2383-5; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; Rana M, 2011, INT J CARDIOL, V152, P321, DOI 10.1016/j.ijcard.2010.07.026; Ren GP, 2015, CHINESE MED J-PEKING, V128, P1679, DOI 10.4103/0366-6999.158378; Rittenberger JC, 2008, RESUSCITATION, V79, P198, DOI 10.1016/j.resuscitation.2008.08.014; Robinson JL, 1998, J PEDIATR-US, V133, P553, DOI 10.1016/S0022-3476(98)70067-8; ROCHE N, 1994, INTENS CARE MED, V20, P593, DOI 10.1007/BF01705730; ROMANO MJ, 1993, CRIT CARE MED, V21, P1181, DOI 10.1097/00003246-199308000-00018; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; ROSOMOFF HL, 1961, SOUTH MED J, V54, P498, DOI 10.1097/00007611-196105000-00006; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Sagalyn E, 2009, CRIT CARE MED, V37, pS223, DOI 10.1097/CCM.0b013e3181aa5c7c; Sakurai Takeo, 2007, Rinsho Shinkeigaku, V47, P639; Saxena M, 2015, INTENS CARE MED, V41, P823, DOI 10.1007/s00134-015-3676-6; Schmidt-Schweda S, 2013, RESUSCITATION, V84, P319, DOI 10.1016/j.resuscitation.2012.09.034; Schmitt FC, 2006, NEUROBIOL DIS, V23, P689, DOI 10.1016/j.nbd.2006.05.008; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; Seule MA, 2009, NEUROSURGERY, V64, P86, DOI 10.1227/01.NEU.0000336312.32773.A0; Shein SL, 2012, THER HYPOTHERMIA TEM, V2, P144, DOI 10.1089/ther.2012.0013; Shin J, 2013, RESUSCITATION, V84, P810, DOI 10.1016/j.resuscitation.2012.12.023; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; Skulec R, 2008, ACTA ANAESTH SCAND, V52, P188, DOI 10.1111/j.1399-6576.2007.01510.x; Staykov D, 2013, NEUROCRIT CARE, V18, P178, DOI 10.1007/s12028-012-9762-5; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Storm C, 2012, EMERG MED J, V29, P100, DOI 10.1136/emj.2010.105171; Stretti F, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0552-7; Suffoletto B, 2009, RESUSCITATION, V80, P1365, DOI 10.1016/j.resuscitation.2009.08.020; Testori C, 2011, RESUSCITATION, V82, P1162, DOI 10.1016/j.resuscitation.2011.05.022; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Vaahersalo J, 2013, INTENS CARE MED, V39, P826, DOI 10.1007/s00134-013-2868-1; van der Worp HB, 2014, INT J STROKE, V9, P642, DOI 10.1111/ijs.12294; Vargas M, 2015, RESUSCITATION, V91, P8, DOI 10.1016/j.resuscitation.2015.02.038; Vargas WS, 2012, PEDIATR NEUROL, V46, P387, DOI 10.1016/j.pediatrneurol.2012.03.001; Wagner I, 2011, MINERVA ANESTESIOL, V77, P371; Walters JH, 2011, RESUSCITATION, V82, P508, DOI 10.1016/j.resuscitation.2011.01.021; Wang CJ, 2013, AM J EMERG MED, V31, P319, DOI 10.1016/j.ajem.2012.08.024; Wang XP, 2013, WORLD J EMERG MED, V4, P260, DOI [10.5847/wjem.j.1920-8642.2013.04.003, 10.5847/wjem.j.issn.1920-8642.2013.04.003]; Wang Y, 2011, CNS NEUROSCI THER, V17, P271, DOI 10.1111/j.1755-5949.2010.00168.x; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Xiao GG, 2013, EMERG MED J, V30, P91, DOI 10.1136/emermed-2012-201120; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; Yokota S, 2000, PEDIATR INT, V42, P197, DOI 10.1046/j.1442-200x.2000.01204.x; Young P, 2015, NEW ENGL J MED, V373, P2215, DOI 10.1056/NEJMoa1508375; Yu LF, 2011, NEUROPATHOLOGY, V31, P144, DOI 10.1111/j.1440-1789.2010.01155.x; Zhang BF, 2015, WORLD NEUROSURG, V83, P567, DOI 10.1016/j.wneu.2014.12.010; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4; Zhou YF, 2012, FRONT BIOSCI-LANDMRK, V17, P1882, DOI 10.2741/4025; Zobel C, 2012, CRIT CARE MED, V40, P1715, DOI 10.1097/CCM.0b013e318246b820	190	10	11	0	4	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	2352-5568			ANAESTH CRIT CARE PA	Anaesth. Crit. Care Pain Med.	OCT	2018	37	5					481	491		10.1016/j.accpm.2017.06.003			11	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	GU0DT	WOS:000444919200021	28688998	hybrid			2022-02-06	
J	Cui, SS; Zhao, LK; Wang, YM; Dong, Q; Ma, JX; Wang, Y; Zhao, WJ; Ma, XL				Cui, Shuangshuang; Zhao, Likun; Wang, Yumin; Dong, Qiang; Ma, Jianxiong; Wang, Ying; Zhao, Wenjun; Ma, Xinlong			Using Naive Bayes Classifier to predict osteonecrosis of the femoral head with cannulated screw fixation	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Naive Bayes classifier; Osteonecrosis of femoral head; Spatial displacements; Predict	TOTAL HIP-REPLACEMENT; INTERNAL-FIXATION; NECK FRACTURES; AVASCULAR NECROSIS; ADULTS; FEMUR; RISK	Predictive models permitting personalized prognostication for patients with cannulated screw fixation for the femoral neck fracture before operation are lacking. The objective of this study was to train, test, and cross-validate a Naive Bayes Classifier to predict the occurrence of postoperative osteonecrosis of cannulated screw fixation before the patient underwent the operation. The data for the classifier model were obtained from a ambispective cohort of 120 patients who had undergone closed reduction and cannulated screw fixation from January 2011 to June 2013. Three spatial displaced parameters of femoral neck: displacement of centre of femoral head, displacement of deepest of femoral head foveae and rotational displacement were measured from preoperative CT scans using a 3-dimensional software. The Naive Bayes Classifier was modelled with age, gender, side of fractures, mechanism of injury, preoperative traction, Pauwels angle and the three spatial parameters. After modelling, the ten-fold cross-validation method was used in this study to validate its performance. The ten-fold cross-validation method uses the whole dataset to be trained and tested by the given algorithm. Two of the three spatial parameters of femoral neck (displacement of center of femoral head and rotational displacement) were included successfully in the final Naive Bayes Classifier. The Classifier achieved good performance of the accuracy (74.4%), sensitivity (74.2%), specificity (75%), positive predictive value (92%), negative predictive value (42.9%) and AUC (0.746). We showed that the Naive Bayes Classifier have the potential utility to be used to predict the osteonecrosis of femoral head within 5 years after surgery. Although this study population was restricted to patients treated with cannulated screws fixation, Bayesian-derived models may be developed for application to patients with other surgical procedures at risk of osteonecrosis. (C) 2018 Published by Elsevier Ltd.	[Cui, Shuangshuang; Zhao, Likun; Ma, Jianxiong; Wang, Ying; Zhao, Wenjun; Ma, Xinlong] Tianjin Hosp, Inst Orthopaed, Tianjin 300050, Peoples R China; [Wang, Yumin; Dong, Qiang; Ma, Xinlong] Tianjin Hosp, Dept Traumat Orthopaed, Tianjin 300211, Peoples R China		Ma, XL (corresponding author), Tianjin Hosp, Dept Traumat Orthopaed, Tianjin 300211, Peoples R China.	maxinlong8686@sina.com			Tianjin Health Bureau Science and Technology Foundation [2012KY23, 2012KY25, 2014KG122]	This work was supported by Tianjin Health Bureau Science and Technology Foundation (NO. 2012KY23; NO. 2012KY25; NO. 2014KG122).	ALBERTS KA, 1990, CLIN ORTHOP RELAT R, P221; BARNES R, 1976, J BONE JOINT SURG BR, V58, P2, DOI 10.1302/0301-620X.58B1.1270491; Bengio Y, 2004, J MACH LEARN RES, V5, P1089; Blomfeldt R, 2005, J BONE JOINT SURG AM, V87A, P1680, DOI 10.2106/JBJS.D.02655; Cho MR, 2007, J ORTHOP TRAUMA, V21, P158, DOI 10.1097/BOT.0b013e31803773ae; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Du CL, 2013, ORTHOPEDICS, V36, P820, DOI 10.3928/01477447-20130523-31; Dumortier A, 2016, COMPUT METH PROG BIO, V137, P203, DOI 10.1016/j.cmpb.2016.09.016; Evgenia Dimitriadou, MISC FUNCTIONS DEPT, P1; Frihagen F, 2007, BMJ-BRIT MED J, V335, P1251, DOI 10.1136/bmj.39399.456551.25; GARDEN R S, 1971, Journal of Bone and Joint Surgery British Volume, V53, P183; Geng H., 2015, BIOCH RES INT, V2015, P1, DOI DOI 10.3109/07435800.2013.879166; Hirata T, 2001, CLIN ORTHOP RELAT R, P294; Huang KY, 2000, J BONE MINER METAB, V18, P89, DOI 10.1007/s007740050017; Johansson T, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.K.00244; Judea Pearl, 2014, PROBABILISTIC REASON; Kamano M, 1998, CLIN ORTHOP RELAT R, P179; Kessler R. C., 2016, MOL PSYCHIATR, V22, P544; Ly Thuan V, 2008, J BONE JOINT SURG AM, V90, P2254; Manal Alghamdi, 2017, PLOS ONE, V12; Mao Yu-jiang, 2005, Zhonghua Yi Xue Za Zhi, V85, P3256; Miranda E, 2016, HEALTHC INFORM RES, V22, P196, DOI 10.4258/hir.2016.22.3.196; Nikolopoulos KE, 2003, INJURY, V34, P525, DOI 10.1016/S0020-1383(02)00367-4; Poole David L, 2010, ARTIFICIAL INTELLIGE; Popelka O, 2015, ACTA CHIR ORTHOP TR, V82, P282; PROTZMAN RR, 1976, J BONE JOINT SURG AM, V58, P689, DOI 10.2106/00004623-197658050-00020; Slobogean GP, 2017, J AM ACAD ORTHOP SUR, V25, P297, DOI 10.5435/JAAOS-D-15-00661; Sugamoto K, 1998, CLIN ORTHOP RELAT R, P138; Testi D, 2001, MED BIOL ENG COMPUT, V39, P633, DOI 10.1007/BF02345434; Thorngren KG, 2002, INJURY, V33, pS1; Tidermark J, 2003, J BONE JOINT SURG BR, V85B, P380, DOI 10.1302/0301-620X.85B3.13609; Upadhyay A, 2004, J BONE JOINT SURG BR, V86B, P1035, DOI 10.1302/0301-620X.86B7.15047; Wang Chen, 2015, MEDICINE, V94; Wang C, 2014, EXP THER MED, V8, P700, DOI 10.3892/etm.2014.1811; Wang T, 2014, ORTHOPEDICS, V37, pE1117, DOI 10.3928/01477447-20141124-60; Xia WB, 2012, J BONE MINER RES, V27, P125, DOI 10.1002/jbmr.519; Xu B, 2017, Zhonghua Yi Xue Za Zhi, V97, P1650, DOI 10.3760/cma.j.issn.0376-2491.2017.21.012; Yan L, 1999, BONE, V24, P151, DOI 10.1016/S8756-3282(98)00168-9; Zhang L, 2000, J BONE MINER METAB, V18, P84, DOI 10.1007/s007740050016	39	10	11	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	OCT	2018	49	10					1865	1870		10.1016/j.injury.2018.07.025			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	GU0AB	WOS:000444908500021	30097310				2022-02-06	
J	Howell, DR; Brilliant, AN; Storey, EP; Podolak, OE; Meehan, WP; Master, CL				Howell, David R.; Brilliant, Anna N.; Storey, Eileen P.; Podolak, Olivia E.; Meehan, William P., III; Master, Christina L.			Objective Eye Tracking Deficits Following Concussion for Youth Seen in a Sports Medicine Setting	JOURNAL OF CHILD NEUROLOGY			English	Article						pediatric; adolescent; mild traumatic brain injury; eye tracking; vision	ADOLESCENTS; RECOVERY; SYMPTOMS; CHILDREN; AMNESIA	Quantification of visual deficits may help to identify dysfunction following concussion. We evaluated eye-tracking measurements among adolescents within 10 days of concussion and healthy control participants. Patients who reported to 2 tertiary care sport concussion clinics within 10 days of concussion completed an objective eye tracking assessment. Seventy-nine participants completed the study, 44 with concussion (mean age = 14.1 +/- 2.2 years, 39% female) and 35 controls (mean age = 14.3 +/- 2.4 years, 57% female). Right eye skew along the bottom of the screen was significantly higher for the concussion group compared to controls (median = 0.022 [interquartile range = -0.263, 0.482] vs 0.377 [interquartile range = -0.574, -0.031]; P = .002), but not the left eye. Among the variables investigated, right eye skew was altered for adolescents with a concussion. Visual function is an important component in the postconcussion evaluation, and identifying deficits soon after injury may allow for earlier specialist referral and intervention.	[Howell, David R.] Childrens Hosp Colorado, Ctr Sports Med, Aurora, CO USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Howell, David R.; Brilliant, Anna N.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Brilliant, Anna N.; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Dept Orthopaed, Boston, MA USA; [Storey, Eileen P.; Podolak, Olivia E.; Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Div Orthoped, Philadelphia, PA 19104 USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat & Orthopaed Surg, Boston, MA USA; [Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA		Howell, DR (corresponding author), Univ Colorado, Dept Orthoped, Ctr Sports Med, Childrens Hosp Colorado,Sch Med, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu		Howell, David/0000-0002-2955-0191; Master, Christina/0000-0002-6717-4270			Brodsky MC, 2003, BRIT J OPHTHALMOL, V87, P1440, DOI 10.1136/bjo.87.12.1440; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Danchaivijitr C, 2004, J NEUROL NEUROSUR PS, V75, P24, DOI 10.1136/jnnp.2004.053413; Ehrenstein WH, 2005, GRAEF ARCH CLIN EXP, V243, P926, DOI 10.1007/s00417-005-1128-7; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Howell DR, 2020, CLIN J SPORT MED, V30, P444, DOI 10.1097/JSM.0000000000000630; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2017, CLIN J SPORT MED, V27, P444, DOI 10.1097/JSM.0000000000000374; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Howell DR, 2016, J PEDIATR ORTHOP B, V25, P310, DOI 10.1097/BPB.0000000000000275; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Le Floch A, 1865, P BIOL SCI, V284, P2017; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Register-Mihalik JK, 2015, CLIN J SPORT MED, V25, P502, DOI 10.1097/JSM.0000000000000161; Rombouts SARB, 1996, NEUROSCI LETT, V221, P1, DOI 10.1016/S0304-3940(96)13260-2; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Samadani U, 2015, CONCUSSION, V1, P1; Samadani U, 2017, BRIT J SPORT MED, V51, pA5, DOI DOI 10.1136/bjsports-2016-097270.12; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Scheiman MM, 2017, OPTOMETRY VISION SCI, V94, P74, DOI 10.1097/OPX.0000000000000936; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324	30	10	10	2	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	OCT	2018	33	12					794	800		10.1177/0883073818789320			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	GU0WZ	WOS:000444976000008	30088436				2022-02-06	
J	Jozefowicz-Korczynska, M; Pajor, A; Skora, W				Jozefowicz-Korczynska, Magdalena; Pajor, Anna; Skora, Wojciech			Benign paroxysmal positional vertigo in patients after mild traumatic brain injury	ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						rehabilitation; benign paroxysmal positional vertigo; mild traumatic brain injury	POSTTRAUMATIC VERTIGO; HEAD-INJURY; MANAGEMENT; DIZZINESS; EPIDEMIOLOGY; DIAGNOSIS; ACADEMY	Background. Post-traumatic vertigo, dizziness and balance disorders following head trauma range from 15% to 78% in the general population. Benign paroxysmal positional vertigo (BPPV) is the most common vestibular disorder in such patients. Objectives. The aim of the study was to assess the occurrence of BPPV in patients with mild traumatic brain injury (MTBI) and determine the outcome of treatment. Material and methods. A group of 179 patients, with a mean age of 45.2 years, complaining of vertigo//dizziness and balance instability after MTBI, was enrolled into the study. All these patients were diagnosed and treated in the Department of Otolaryngology (Medical University of Lodz, Poland) between the years 2012 and 2014. Anamnesis and otoneurological examination were conducted in each patient. The diagnosis was based on the medical history, the Dix-Hallpike test or the rollover test. The treatment comprised the Epley, barbecue and particle repositioning (RM) maneuvers. Results. Nineteen patients (10.6%) complained about attacks of vertigo elicited by positional changes. The diagnosis of BPPV was confirmed in 9 (47.4%) patients: 8 cases with a positive Dix-Hallpike test and 1 with the roll test. In 10 cases, a high probability of BPPV was diagnosed based on the medical history. Eight patients were treated by a single Epley maneuver and 1 patient by the barbecue roll. In 4 (44.4%) patients, the maneuvers were repeated. On the follow-up examination, the patients were not found to have vertigo. Conclusions. Benign paroxysmal positional vertigo should be diagnosed and treated successfully in patients after head trauma.	[Jozefowicz-Korczynska, Magdalena; Pajor, Anna] Med Univ Lodz, Dept Otolaryngol, Lodz, Poland; [Skora, Wojciech] Stanislaw Rybicki Mem Reg Hosp, Otolaryngol Dept, Skierniewice, Poland		Jozefowicz-Korczynska, M (corresponding author), Med Univ Lodz, Dept Otolaryngol, Lodz, Poland.	magdalena.jozefowicz-korczynska@umed.lodz.pl	Jozefowicz-Korczynska, Magdalena/R-4573-2019; Jozefowicz-Korczynska, Magdalena/S-9432-2016	Pajor, Anna/0000-0002-1740-4269; Jozefowicz-Korczynska, Magdalena/0000-0003-0066-1856	Medical University of Lodz [503/2-036-02/503-21-002]	A grant from the Medical University of Lodz (No. 503/2-036-02/503-21-002).	BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Bhattacharyya N, 2008, OTOLARYNG HEAD NECK, V139, pS47, DOI 10.1016/j.otohns.2008.08.022; Brandt T., 2000, VERTIGO ITS MULTISEN, P343; CASSIDY JD, 2014, ARCH PHYS MED REHAB, V95, P132; Cohen HS, 2004, ORL J OTO-RHINO-LARY, V66, P11, DOI 10.1159/000077227; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; EPLEY JM, 1992, OTOLARYNG HEAD NECK, V107, P399, DOI 10.1177/019459989210700310; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Fife TD, 2008, NEUROLOGY, V70, P2067, DOI 10.1212/01.wnl.0000313378.77444.ac; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Helminski JO, 2010, PHYS THER, V90, P663, DOI 10.2522/ptj.20090071; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Katsarkas A, 1999, ACTA OTO-LARYNGOL, V119, P745, DOI 10.1080/00016489950180360; Kim JS, 2014, NEW ENGL J MED, V370, P1138, DOI 10.1056/NEJMcp1309481; Liu HJ, 2012, ACTA OTO-LARYNGOL, V132, P803, DOI 10.3109/00016489.2012.657359; Liu Y, 2016, LARYNGOSCOPE, V126, P951, DOI 10.1002/lary.25688; Marzo SJ, 2004, LARYNGOSCOPE, V114, P1720, DOI 10.1097/00005537-200410000-00008; Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600; Nguyen-Huynh AT, 2012, OTOLARYNG CLIN N AM, V45, P925, DOI 10.1016/j.otc.2012.06.001; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Steenerson RL, 2005, LARYNGOSCOPE, V115, P226, DOI 10.1097/01.mlg.0000154723.55044.b5; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; von Brevern M, 2015, J VESTIBUL RES-EQUIL, V25, P105, DOI 10.3233/VES-150553	30	10	11	1	6	WROCLAW MEDICAL UNIV	WROCLAW	UL K MARCINKOWSKIEGO 2-6, WROCLAW, 50-368, POLAND	1899-5276	2451-2680		ADV CLIN EXP MED	Adv. Clin. Exp. Med.	OCT	2018	27	10					1355	1359		10.17219/acem/69708			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GX3YQ	WOS:000447663800004	30058780	gold			2022-02-06	
J	Moore, RD; Kay, JJ; Ellemberg, D				Moore, R. Davis; Kay, Jacob J.; Ellemberg, Dave			The long-term outcomes of sport-related concussion in pediatric populations	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Concussion; TBI; Children; Sports; Functional outcomes	TRAUMATIC BRAIN-INJURY; SELF-REPORTED CONCUSSIONS; TEST-RETEST RELIABILITY; DEFAULT MODE NETWORK; CEREBRAL-BLOOD-FLOW; HIGH-SCHOOL; NEUROCOGNITIVE OUTCOMES; PERSISTENT INFLUENCE; SEX-DIFFERENCES; NEUROPHYSIOLOGICAL ASSESSMENT	Although the field of concussion research is rapidly growing, the majority of research has focused on injured adults, with children being an often-neglected population. Traumatic brain injury is a leading cause of death and disability in children, with over 1.5 million cases being treated in North America annually. Approximately 75% of these injuries are classified as a concussion. Further, children are disproportionately affected by sports-related injuries, with 65% of all pediatric concussions occurring during sport and recreation. Therefore, understanding the outcomes of pediatric sportrelated concussion is of great importance, particularly given the vulnerability of the developing brain. The purpose of this review is to provide an up-to-date understanding of the outcomes of pediatric sport-related concussion from a data-driven perspective, focusing heavily on experimental studies.	[Moore, R. Davis; Kay, Jacob J.] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC USA; [Moore, R. Davis] Univ South Carolina, Inst Mind & Brain, Columbia, SC USA; [Ellemberg, Dave] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Ellemberg, Dave] Univ Montreal, Ctr Res Neuropsychol & Cognit, Montreal, PQ, Canada		Moore, RD (corresponding author), Arnold Sch Publ Hlth, Concuss & Hlth Neurosci Lab, 921 Assembly St, Columbia, SC 29208 USA.	Moorerd3@mailbox.sc.edu		Kay, Jacob/0000-0002-8032-4296			Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Bigler E. D, 2018, INT J PSYCHOPHYSIOL; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catroppa C., 2016, NEW FRONTIERS PEDIAT; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Dalecki Marc, 2016, Concussion, V1, pCNC14, DOI 10.2217/cnc-2016-0001; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DeMatteo C, 2015, DISABIL REHABIL, V37, P1107, DOI 10.3109/09638288.2014.952452; DeMatteo C, 2015, CLIN PEDIATR, V54, P152, DOI 10.1177/0009922814558256; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Feldman HM, 2010, J DEV BEHAV PEDIATR, V31, P346, DOI 10.1097/DBP.0b013e3181dcaa8b; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gioia GA IP, 2000, BEHAV RATING INVENTO; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2016, MED SCI SPORT EXER, V48, P814, DOI 10.1249/01.mss.0000487442.08546.82; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Hurtubise Johanna, 2016, Concussion, V1, pCNC17, DOI 10.2217/cnc-2016-0006; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Lax ID, 2015, BRAIN INJURY, V29, P1409, DOI 10.3109/02699052.2015.1043344; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Little CE, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0195-9; Luck S. J., 2012, INTRO EVENT RELATED; Madura SA, 2016, BRAIN INJURY, V30, P908, DOI 10.3109/02699052.2016.1146958; Mainwaring L, 2012, J CLIN SPORT PSYCHOL, V6, P247, DOI 10.1123/jcsp.6.3.247; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Master C. L, 2017, BRIT J SPORT MED, V51, pA15; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDevitt J, 2014, ORTHOP J SPORTS ME S, V2; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Moser RS, 2015, BRAIN INJURY, V29, P58, DOI 10.3109/02699052.2014.964771; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parks AC, 2015, INT J PSYCHOPHYSIOL, V98, P426, DOI 10.1016/j.ijpsycho.2015.08.006; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pontifex MB, 2012, RES Q EXERCISE SPORT, V83, P553; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Saluja RS, 2015, J NEUROTRAUM, V32, P712, DOI 10.1089/neu.2014.3470; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Sicard V, 2019, CLIN J SPORT MED, V29, P62, DOI 10.1097/JSM.0000000000000492; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Slobounov S, 2011, J NEUROTRAUM, V29, P756; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tanveer S, 2017, PEDIATR NEUROL, V70, P44, DOI 10.1016/j.pediatrneurol.2017.02.001; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Van Beek L, 2015, BRAIN INJURY, V29, P1701, DOI 10.3109/02699052.2015.1075172; Van Beek L, 2015, DEV MED CHILD NEUROL, V57, P1042, DOI 10.1111/dmcn.12858; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	152	10	10	1	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		14	24		10.1016/j.ijpsycho.2018.04.003			11	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000004	29705573				2022-02-06	
J	Murray, NG; Grimes, KE; Shiflett, ED; Munkasy, BA; D'Amico, NR; Mormile, ME; Powell, DW; Buckley, TA				Murray, Nicholas G.; Grimes, Katelyn E.; Shiflett, Eric D.; Munkasy, Barry A.; D'Amico, Nathan R.; Mormile, Megan E.; Powell, Douglas W.; Buckley, Thomas A.			Repetitive head impacts do not affect postural control following a competitive athletic season	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Subconcussive; Repetitive head impacts; Concussion; Postural control	HIGH-SCHOOL FOOTBALL; SUBCONCUSSIVE IMPACTS; RECURRENT CONCUSSION; CEREBRAL CONCUSSION; COLLEGIATE; BALANCE; ASSOCIATION; MANAGEMENT; RECOVERY; IMPAIRMENT	Evidence suggests that Repetitive Head Impacts (RHI) directly influence the brain over the course of a single contact collision season yet do not significantly impact a player's performance on the standard clinical concussion assessment battery. The purpose of this study was to investigate changes in static postural control after a season of RHI in Division I football athletes using more sensitive measures of postural control as compared to a non-head contact sports. Fourteen Division I football players (CON) (age = 20.4 +/- 1.12 years) and fourteen non-contact athletes (NON) (2 male, 11 female; age = 19.85 +/- 1.21 years) completed a single trial of two minutes of eyes open quiet upright stance on a force platform (1000 Hz) prior to athletic participation (PRE) and at the end of the athletic season (POST). All CON athletes wore helmets outfitted with Head Impact Telemetry (HIT) sensors and total number of RHI and linear accelerations forces of each RHI were recorded. Center of pressure root mean square (RMS), peak excursion velocity (PEV), and sample entropy (SampEn) in the anteroposterior (AP) and mediolateral (ML) directions were calculated. CON group experienced 649.5 +/- 496.8 mean number of impacts, 27.1 +/- 3.0 mean linear accelerations, with approximate to 1% of total player impacts exceeded 98 g over the course of the season. There were no significant interactions for group x time RMS in the AP (p = 0.434) and ML (p = 0.114) directions, PEV in the AP (p = 0.262) and ML (p = 0.977) directions, and SampEn in the AP (p = 0.499) and ML (p = 0.984) directions. In addition, no significant interactions for group were observed for RMS in the AP (p = 0.105) and ML (p = 0.272) directions, PEV in the AP (p = 0.081) and ML (p = 0.143) directions, and SampEn in the AP (p = 0.583) and ML (p = 0.129) directions. These results suggest that over the course of a single competitive season, RHI do not negatively impact postural control even when measured with sensitive non-linear metrics.	[Murray, Nicholas G.; Grimes, Katelyn E.; Shiflett, Eric D.; Munkasy, Barry A.; Mormile, Megan E.] Georgia Southern Univ, Coll Hlth & Human Serv, Sch Hlth & Kinesiol, POB 8073, Statesboro, GA 30458 USA; [D'Amico, Nathan R.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Powell, Douglas W.] Univ Memphis, Sch Hlth Studies, 106 Elma Roane Fieldhouse, Memphis, TN 28152 USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, 540 Coll Ave, Newark, DE 19716 USA; [Buckley, Thomas A.] Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, 540 Coll Ave, Newark, DE 19716 USA		Murray, NG (corresponding author), Georgia Southern Univ, Sch Hlth & Kinesiol, POB 8076, Statesboro, GA 30460 USA.	nmurray@georgiasouthern.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Murray, Nicholas/0000-0003-3288-2995			[Anonymous], 1995, GAIT POSTURE; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; BAZARIAN J, 2014, PLOS ONE, V0009, P00001; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley T. M, 2015, NEUROLOGY, V84; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Cassidy D., 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097699, DOI 10.1136/BJSPORTS-2017-097699]; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chiari L, 2000, GAIT POSTURE, V12, P225, DOI 10.1016/S0966-6362(00)00086-2; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; HOLM S, 1979, SCAND J STAT, V6, P65; Howell D. R, 2016, CLIN J SPORT MED; Iqbal K, 2011, IEEE ENG MED BIO, P7837, DOI 10.1109/IEMBS.2011.6091931; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee L. A, 2016, NON TRADITIONAL REF, P1; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Munkasy B. A, 2017, CLIN J SPORT MED; Murray N. G, 2014, EVALUATION STATIC DY; Murray N. G, 2014, J ATHL TRAINING, V49, P1; Nauman EA., 2014, ATHL TRAIN SPORTS HL, V6, P119; Oldham J, 2016, NEUROLOGY, V86, P300; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Powell DW, 2015, HUM MOVEMENT SCI, V44, P73, DOI 10.1016/j.humov.2015.08.013; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Reed-Jones RJ, 2014, SEMIN SPEECH LANG, V35, P186, DOI 10.1055/s-0034-1384680; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Williams DSB, 2016, J SPORT HEALTH SCI, V5, P70, DOI 10.1016/j.jshs.2016.01.010; Wilson MJ, 2015, SOUTH MED J, V108, P559, DOI 10.14423/SMJ.0000000000000342; Zheng BW, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019510, 10.1371/journal.pone.0019976]	59	10	10	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		81	86		10.1016/j.ijpsycho.2017.09.018			6	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000011	28982552				2022-02-06	
J	Di Battista, AP; Moes, KA; Shiu, MY; Hutchison, MG; Churchill, N; Thomas, SG; Rhind, SG				Di Battista, Alex P.; Moes, Katherine A.; Shiu, Maria Y.; Hutchison, Michael G.; Churchill, Nathan; Thomas, Scott G.; Rhind, Shawn G.			High-Intensity Interval Training Is Associated With Alterations in Blood Biomarkers Related to Brain Injury	FRONTIERS IN PHYSIOLOGY			English	Article						tau; PRDX-6; S100B; sport concussion; military medicine; MTBI	NEURON-SPECIFIC ENOLASE; MARATHON RUNNERS; OXIDATIVE STRESS; EXERCISE; TROPONIN; BARRIER; PEROXIREDOXIN; CONCUSSION; INCREASES; PLASMA	Purpose: Blood biomarkers are a useful tool to study concussion. However, their interpretation is complicated by a number of potential biological confounds, including exercise. This is particularly relevant in military and athletic settings where injury commonly occurs during physical exertion. The impact of high-intensity interval training (HIIT) on putative brain injury biomarkers remains under-examined. The purpose of this study was to observe the effects of HIIT on a panel of blood biomarkers associated with brain injury. Methods: Eleven healthy, recreationally active males (median age = 29.0, interquartile range = 26.0-31.5) performed HIIT on a bicycle ergometer (8-12 x 60-s intervals at 100% of peak power output, interspersed by 75-s recovery at 50 W) three times/week for 2 weeks. Peripheral blood samples were collected before and immediately after HIIT during the first and last training sessions. Plasma concentrations of s100 calcium-binding protein beta (S100B), glial fibrillary acidic protein (GFAP), neuron-specific enolase (NSE), brain-derived neurotrophic factor (BDNF), neurogranin (NRGN), peroxiredoxin (PRDX)-6, creatine kinase-BB isoenzyme (CKBB), visinin-like protein (VILIP)-1, von Willebrand factor (vWF), monocyte chemoattractant protein (MCP)-1, matrix metalloproteinase (MMP)-9, and total tau (T-tau) were quantitated by high-sensitivity MULTI-SPOT (R) immunoassay, on the MesoScale Diagnostics electrochemiluminescence detection platform. Differences in biomarker concentrations in response to HIIT were evaluated by partial least squares discriminant analysis (PLSDA) within a repeated-measures bootstrapped framework. Results: Ten of 12 biomarkers were increased pre-to-post HIIT; VILIP-1 remained unchanged, and GFAP was not statistically evaluated due to insufficient detectability. After 2 weeks of HIIT, T-tau was no longer significantly elevated pre-to-post HIIT, and significant attenuation was noted in the acute responses of NRGN, PRDX6, MMP-9, and vWF. In addition, compared to session 1, session 6 pre-exercise concentrations of NSE and VILIP-1 were significantly lower and higher, respectively. Conclusion: Blood biomarkers commonly associated with brain injury are significantly elevated in response to a single bout of HIIT. After a 2-week, six-session training protocol, this response was attenuated for some, but not all markers. While biomarkers continue to provide promise to concussion research, future studies are necessary to disentangle the common biological sequelae to both exercise and brain injury.	[Di Battista, Alex P.; Moes, Katherine A.; Shiu, Maria Y.; Rhind, Shawn G.] Toronto Res Ctr, Def Res & Dev Canada, Toronto, ON, Canada; [Di Battista, Alex P.; Hutchison, Michael G.; Thomas, Scott G.; Rhind, Shawn G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Hutchison, Michael G.; Churchill, Nathan] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Neurosci Program, Toronto, ON, Canada		Di Battista, AP (corresponding author), Toronto Res Ctr, Def Res & Dev Canada, Toronto, ON, Canada.; Di Battista, AP (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.	dibattista.alex@gmail.com	Thomas, Scott G/G-4522-2012	Thomas, Scott G/0000-0002-5564-4271	Defence Research and Development Canada (DRDC) Technology Investment Fund	This study was funded by a Defence Research and Development Canada (DRDC) Technology Investment Fund.	Stocchero CMA, 2014, APPL PHYSIOL NUTR ME, V39, P340, DOI 10.1139/apnm-2013-0308; Bessa AL, 2016, J STRENGTH COND RES, V30, P311, DOI 10.1519/JSC.0b013e31828f1ee9; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Bloomer RJ, 2008, GENDER MED, V5, P218, DOI 10.1016/j.genm.2008.07.002; Brinkmann C, 2012, EUR J APPL PHYSIOL, V112, P2277, DOI 10.1007/s00421-011-2203-x; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Bruunsgaard H, 2005, J LEUKOCYTE BIOL, V78, P819, DOI 10.1189/jlb.0505247; Buonora JE, 2015, J NEUROTRAUM, V32, P1805, DOI 10.1089/neu.2014.3736; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cook MD, 2013, J HUM HYPERTENS, V27, P388, DOI 10.1038/jhh.2012.48; Debad JD, 2004, MG ELEC CH, P359; Di Battista AP, 2018, BRAIN INJURY, V32, P575, DOI 10.1080/02699052.2018.1432892; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Dietrich MO, 2003, CAN J APPL PHYSIOL, V28, P710, DOI 10.1139/h03-054; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Dorneles GP, 2016, CYTOKINE, V77, P1, DOI 10.1016/j.cyto.2015.10.003; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Febbraio MA, 2007, J APPL PHYSIOL, V103, P376, DOI 10.1152/japplphysiol.00414.2007; Fu Qi, 2013, Handb Clin Neurol, V117, P147, DOI 10.1016/B978-0-444-53491-0.00013-4; Garber BG, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010780; Garber BG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0325-5; Gibala MJ, 2015, J STRENGTH COND RES, V29, pS40, DOI 10.1519/JSC.0000000000001119; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; He XF, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00144; Hermann TS, 2011, AM J TRANSPLANT, V11, P536, DOI 10.1111/j.1600-6143.2010.03403.x; Inkabi S.E., 2017, SCI J LIFE SCI, V1, P31; Isgro MA, 2015, ADV EXP MED BIOL, V867, P125, DOI 10.1007/978-94-017-7215-0_9; Kaspar F, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5474837; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Kilianski J, 2017, J CLIN NEUROSCI, V45, P100, DOI 10.1016/j.jocn.2017.07.021; Kim HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137567; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Koh Y, 2017, J EXERC REHABIL, V13, P472, DOI 10.12965/jer.1735066.533; Kyrolainen H, 2018, J SCI MED SPORT, V21, P1131, DOI 10.1016/j.jsams.2017.11.019; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; Leggate M, 2010, CELL STRESS CHAPERON, V15, P827, DOI 10.1007/s12192-010-0192-z; Liang KY, 2010, ANN NEUROL, V68, P311, DOI 10.1002/ana.22096; Lindbloom EJ, 1999, AM HEART J, V138, P798, DOI 10.1016/S0002-8703(99)70199-7; LUBKE U, 1994, AM J PATHOL, V145, P175; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marquez CMS, 2015, J APPL PHYSIOL, V119, P1363, DOI 10.1152/japplphysiol.00126.2015; Muley T, 2003, CLIN CHEM LAB MED, V41, P95, DOI 10.1515/CCLM.2003.017; Neumann JT, 2016, HEART, V102, P1251, DOI 10.1136/heartjnl-2016-309484; Nielsen AA, 2009, GENE, V442, P55, DOI 10.1016/j.gene.2009.04.003; Nierwinska K, 2008, J HUM KINET, V19, P83, DOI 10.2478/v10078-008-0006-x; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; Pickering JW, 2016, HEART, V102, P1270, DOI 10.1136/heartjnl-2015-308505; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rakobowchuk M, 2012, EXP PHYSIOL, V97, P375, DOI 10.1113/expphysiol.2011.062836; Reihmane D, 2012, SCAND J IMMUNOL, V76, P188, DOI 10.1111/j.1365-3083.2012.02720.x; Reihmane D, 2013, EUR J APPL PHYSIOL, V113, P851, DOI 10.1007/s00421-012-2491-9; Riuzzi F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12880-9; Roh HT, 2017, INT J SPORT NUTR EXE, V27, P239, DOI 10.1123/ijsnem.2016-0009; Saenz AJ, 2006, AM J CLIN PATHOL, V126, P185, DOI 10.1309/D7QU-F0HJ-MCYY-YY5A; Shahim P, 2015, BRAIN INJURY, V29, P872, DOI 10.3109/02699052.2015.1018324; SHARMA HS, 1991, NEUROSCI RES, V10, P211; Shave R, 2010, J AM COLL CARDIOL, V56, P169, DOI 10.1016/j.jacc.2010.03.037; Souza-Silva Ana Angelica, 2016, Temperature (Austin), V3, P167, DOI 10.1080/23328940.2015.1132101; TSUNG SH, 1976, CLIN CHEM, V22, P173; Turner JE, 2013, FREE RADICAL RES, V47, P821, DOI 10.3109/10715762.2013.828836; Vasikaran SD, 2012, CLIN BIOCHEM, V45, P513, DOI 10.1016/j.clinbiochem.2012.01.011; von Holstein-Rathlou S, 2018, NEUROSCI LETT, V662, P253, DOI 10.1016/j.neulet.2017.10.035; Wadley AJ, 2015, FREE RADICAL RES, V49, P290, DOI 10.3109/10715762.2014.1000890; Wahl P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096024; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Watson P, 2005, AM J PHYSIOL-REG I, V288, pR1689, DOI 10.1152/ajpregu.00676.2004; Woods JA, 2009, IMMUNOL ALLERGY CLIN, V29, P381, DOI 10.1016/j.iac.2009.02.011; Zwetsloot KA, 2014, J INFLAMM RES, V7, P9, DOI 10.2147/JIR.S54721	73	10	11	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	SEP 28	2018	9								1367	10.3389/fphys.2018.01367			10	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	GV2OS	WOS:000445931100001	30323770	Green Published, gold			2022-02-06	
J	Medvedev, ON; Theadom, A; Barker-Collo, S; Feigin, V				Medvedev, Oleg N.; Theadom, Alice; Barker-Collo, Suzanne; Feigin, Valery		BIONIC Res Grp	Distinguishing between enduring and dynamic concussion symptoms: applying Generalisability Theory to the Rivermead Post Concussion Symptoms Questionnaire (RPQ)	PEERJ			English	Article						Rivermead Post Concussion Symptoms Questionnaire; Trait; Generalisability Theory; Measurement; Psychometrics; State	TRAUMATIC-BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; BASE RATES; RELIABILITY	Background. The Rivermead Post Concussion Symptoms Questionnaire (RPQ) is a widely-used, 16-item measure of concussion symptoms yet its ability to assess change in the symptom experience over time has come under criticism. We applied Generalisability theory to differentiate between dynamic and enduring aspects of post-concussion symptoms and to examine sources of measurement error in the RPQ. Materials and Methods. Generalisability theory was applied using the longitudinal design with persons as the object of measurement. Patients with a traumatic brain injury (n = 145; aged >= 16 years) were assessed at three time occasions (1, 6 and 12 months post-injury) using the RPQ. Results. The RPQ showed overall strong generalisability of scores (G = .98) across persons and occasions with a minor proportion of variance attributed to the dynamic aspect of symptoms reflected by interaction between person and occasion. Items measuring concentration, fatigue, restlessness and irritability reflected more dynamic patterns compared to more enduring patterns of sensitivity to noise, impatience, nausea and sleep disturbance. Conclusion. The RPQ demonstrated strong reliability in assessing enduring post-concussion symptoms but its ability to assess dynamic symptoms is limited. Clinicians should exercise caution in use of the RPQ to track dynamic symptom change over time. Further investigation is necessary to enhance the RPQ's ability to assess dynamic symptoms and to address measurement error associated with individual items.	[Medvedev, Oleg N.] Auckland Univ Technol, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand; [Medvedev, Oleg N.] Univ Auckland, Sch Med, Auckland, New Zealand; [Theadom, Alice; Feigin, Valery] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand		Medvedev, ON (corresponding author), Auckland Univ Technol, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand.; Medvedev, ON (corresponding author), Univ Auckland, Sch Med, Auckland, New Zealand.	oleg.medvedev@aut.ac.nz	Feigin, Valery/AAF-2313-2019; Medvedev, Oleg N./AAO-8339-2020	Medvedev, Oleg N./0000-0002-2167-5002; Feigin, Valery L./0000-0002-6372-1740	New Zealand Health Research Council project [09/063A, 11/192]	This study was funded by the New Zealand Health Research Council project grants 09/063A and 11/192. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arterberry BJ, 2014, PERS INDIV DIFFER, V69, P98, DOI 10.1016/j.paid.2014.05.015; Barker-Collo S, 2016, JSM BURNS TRAUMA, V1, P1006; Bloch R, 2012, MED TEACH, V34, P960, DOI 10.3109/0142159X.2012.703791; Brennan R.L., 2001, GEN THEORY; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CRONBACH LJ, 1963, BRIT J STATIST PSYCH, V16, P137, DOI 10.1111/j.2044-8317.1963.tb00206.x; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Gardinet J, 2009, APPL GENERALIZABILIT; Geiser C, 2015, PSYCHOL METHODS, V20, P165, DOI 10.1037/met0000026; Hamaker EL, 2007, J RES PERS, V41, P295, DOI 10.1016/j.jrp.2006.04.003; Jacobs JP., 2017, SURG PATIENT CARE IM, P277, DOI [10.1007/978-3-319-44010-1_18, DOI 10.1007/978-3-319-44010-1_18]; Kenny DA, 2001, TRAIT STATE MODELS L; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Medvedev ON, 2017, MINDFULNESS, V8, P995, DOI 10.1007/s12671-016-0676-8; Paterson J, 2018, J AFFECT DISORDERS, V227, P698, DOI 10.1016/j.jad.2017.11.075; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; SHAVELSON RJ, 1989, AM PSYCHOL, V44, P922, DOI 10.1037/0003-066X.44.6.922; Spielberger C.D., 1970, TEST MANUAL STATE TR; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; Swiss Society for Research in Education Working Group, 2006, EDUG US GUID; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3	28	10	10	0	2	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	SEP 28	2018	6								e5676	10.7717/peerj.5676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GW5CX	WOS:000446948300015	30280043	Green Published, gold			2022-02-06	
J	Osier, ND; Conley, YP; Okonkwo, DO; Puccio, AM				Osier, Nicole D.; Conley, Yvette P.; Okonkwo, David O.; Puccio, Ava M.			Variation in Candidate Traumatic Brain Injury Biomarker Genes Are Associated with Gross Neurological Outcomes after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; genes; genotype; neurological outcomes; TBI	C-TERMINAL HYDROLASE-L1; S100B GENE; PROGNOSTIC BIOMARKER; SERUM CONCENTRATIONS; PREDICTORS; MODELS; MARKER	Diagnostic and prognostic biomarkers of traumatic brain injury (TBI) are actively being pursued; potential candidates include glial fibrillary acid protein (GFAP), S100 calcium-binding protein B (S100B), and ubiquitin C-terminal hydrolase L1 (UCHL1), two of which the United States Food and Drug Administration (FDA) recently approved for marketing of blood tests for adult concussion. The relationship between biomarker-encoding genes and TBI outcomes remains unknown. This pilot study explores variation in 18 single nucleotide polymorphisms (SNPs) in biomarker-encoding genes as predictors of neurological outcome in a population of adults with severe TBI. Participants (n=305) were assessed using the Glasgow Outcome Scale (GOS) at 3, 6, 12, and 24 months post-injury. Multivariate logistical regression was used to calculate the odds ratio (OR) and determine the odds of having a lower score on the GOS (=1-2 vs. 3-5) based on variant allele presence, while controlling for confounders. Possession of the variant allele of one S100B SNP (rs1051169) was associated with higher scores on the GOS at 3 months (OR=0.39; p=0.04), 6 months (OR=0.34; p=0.02), 12 months (OR=0.32; p=0.02), and 24 months (OR=0.30; p=0.02) post-severe TBI. The relationship among these polymorphisms, protein levels, and biomarker utility, merits examination. These findings represent a novel contribution to the evidence that can inform future studies aimed at enhancing interpretation of biomarker data, identifying novel biomarkers, and ultimately harnessing this information to improve clinical outcomes and personalize care.	[Osier, Nicole D.; Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Osier, Nicole D.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Okonkwo, David O.; Puccio, Ava M.] Univ Pittsburgh, Dept Neurol Surg, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA; [Osier, Nicole D.] Univ Texas Austin, Sch Nursing, Div Holist Adult Hlth, Austin, TX 78712 USA; [Osier, Nicole D.] Univ Texas Austin, Dell Med Sch Dept Neurol, Austin, TX 78712 USA		Puccio, AM (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA.	puccioam@upmc.edu	Osier, Nicole/Q-7913-2017	Osier, Nicole/0000-0002-2903-6774; Conley, Yvette/0000-0002-1784-6067	National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R00NR013176, F31NR014957, R01NR013342, T32NR009759]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR009759] Funding Source: NIH RePORTER	Funds in support of this study were provided by the National Institute of Nursing Research (R00NR013176, F31NR014957, R01NR013342, and T32NR009759).	Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Guo Y, 2013, NEUROSCI LETT, V555, P134, DOI 10.1016/j.neulet.2013.09.037; Hohoff C, 2010, AM J MED GENET B, V153B, P291, DOI 10.1002/ajmg.b.30950; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kenny EE, 2011, HUM MOL GENET, V20, P827, DOI 10.1093/hmg/ddq510; Kiiski H, 2016, J NEUROL SCI, V361, P144, DOI 10.1016/j.jns.2015.12.046; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Lee JY, 2015, J KOREAN NEUROSURG S, V58, P93, DOI 10.3340/jkns.2015.58.2.93; Liu JX, 2005, BIOCHEM BIOPH RES CO, V328, P335, DOI 10.1016/j.bbrc.2004.12.175; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mondello Stefania, 2015, Handb Clin Neurol, V127, P245, DOI 10.1016/B978-0-444-52892-6.00016-7; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; NIH FDA Joint Biomarker Team (2017), 2017, BIOM GUID REF MAT; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Osier ND, 2017, J NEUROTRAUM, V34, P86, DOI 10.1089/neu.2015.4343; Pinelis V G, 2015, Zh Nevrol Psikhiatr Im S S Korsakova, V115, P66, DOI 10.17116/jnevro20151158166-72; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; Shibata N, 2012, DEMENT GERIATR COGN, V33, P250, DOI 10.1159/000339357; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zhai JG, 2012, SCHIZOPHR RES, V134, P89, DOI 10.1016/j.schres.2011.09.029; Zhai JG, 2011, BEHAV BRAIN RES, V217, P363, DOI 10.1016/j.bbr.2010.11.004; Zhang B, 2015, INT J CLIN EXP MED, V8, P19172	33	10	10	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2018	35	22					2684	2690		10.1089/neu.2017.5268		SEP 2018	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GZ0MO	WOS:000444696000001	29969943	Green Published			2022-02-06	
J	Shin, N; Kim, HG; Shin, HJ; Kim, S; Kwon, HH; Baek, H; Yi, MH; Zhang, EJ; Kim, JJ; Hong, J; Lee, SY; Lee, W; Triantafillu, UL; Kim, CS; Kim, Y; Kim, DW				Shin, Nara; Kim, Hyeong-geug; Shin, Hyo Jung; Kim, Sena; Kwon, Hyeok Hee; Baek, Hyunjung; Yi, Min-Hee; Zhang, Enji; Kim, Jwa-Jin; Hong, Jinpyo; Lee, Sun Yeul; Lee, Wonhyung; Triantafillu, Ursula L.; Kim, Cuk-Seong; Kim, Yonghyun; Kim, Dong Woon			Uncoupled Endothelial Nitric Oxide Synthase Enhances p-Tau in Chronic Traumatic Encephalopathy Mouse Model	ANTIOXIDANTS & REDOX SIGNALING			English	Article						chronic traumatic encephalopathy (CTE); repetitive mild traumatic brain injury (rmTBI); inducible nitric oxide synthase (iNOS); hypoxia; astrocytic tangles (ATs)	BRAIN-INJURY; OXIDATIVE STRESS; KAPPA-B; ALZHEIMER-DISEASE; HEME OXYGENASE-1; CALCIUM INFLUX; ASTROCYTES; EXPRESSION; MICE; TETRAHYDROBIOPTERIN	Aims: Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease thought to be caused by repetitive traumatic brain injury (TBI) and subconcussive injuries. While hyperphosphorylation of tau (p-Tau), which is attributed to astrocytic tangles (ATs) and neurofibrillary tangles, is known to be involved in CTE, there are limited neuropathological or molecular data. By utilizing repetitive mild TBI (rmTBI) mouse models, our aim was to examine the pathological changes of CTE-associated structures, specifically the ATs. Results: Our rmTBI mouse models showed symptoms of depressive behavior and memory deficit, alongside an increased p-Tau expression in their neurons and astrocytes in both the hippocampus and cortex. rmTBI induced oxidative stress in endothelial cells and nitric oxide (NO) generation in astrocytes, which were mediated by hypoxia and increased hypoxia-inducible factor 1-alpha (HIF1 alpha). There was also correlated decreased regional cerebral tissue perfusion units, mild activation of astrocytes and NFB phosphorylation, increased expression of inducible nitric oxide synthase (iNOS), increased endothelial nitric oxide synthase (eNOS) uncoupling with decreased tetrahydrobiopterin, and increased expression of nitrotyrosine, NADPH oxidase 2 (Nox2)/nuclear factor (erythroid-derived 2) factor 2 (Nrf2) signaling proteins. Combined, these effects induced peroxynitrite formation and hyperphosphorylation of tau in the hippocampus and cortex toward the formation of ATs. Innovation: Our model features molecular pathogenesis events of CTE with clinically relevant latency periods. In particular, this is the first demonstration of an increased astrocytic iNOS expression in an in vivo model. Conclusion: We propose a novel mechanism of uncoupled eNOS and NO contribution to Tau phosphorylation and AT formation in rmTBI brain, toward an increased molecular understanding of the pathophysiology of human CTE. Antioxid. Redox Signal. 00, 000-000.	[Shin, Nara; Shin, Hyo Jung; Kim, Sena; Kwon, Hyeok Hee; Baek, Hyunjung; Zhang, Enji; Kim, Jwa-Jin; Hong, Jinpyo; Kim, Dong Woon] Chungnam Natl Univ, Sch Med, Brain Res Inst, Dept Anat, Daejeon 301747, South Korea; [Shin, Nara; Shin, Hyo Jung; Kwon, Hyeok Hee; Baek, Hyunjung; Kim, Cuk-Seong; Kim, Dong Woon] Chungnam Natl Univ, Sch Med, Dept Med Sci, Daejeon 301747, South Korea; [Kim, Cuk-Seong] Chungnam Natl Univ, Sch Med, Dept Physiol, Daejeon 301747, South Korea; [Shin, Nara; Lee, Sun Yeul; Lee, Wonhyung] Chungnam Natl Univ Hosp, Dept Anesthesia & Pain Med, Daejeon, South Korea; [Kim, Hyeong-geug] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Yi, Min-Hee] Mayo Clin, Dept Neurol, Rochester, MN USA; [Zhang, Enji] Yanbian Univ Hosp, Dept Anesthesia Med, Yanbian, Peoples R China; [Kim, Jwa-Jin] LES Corp Inc, Daejeon, South Korea; [Triantafillu, Ursula L.; Kim, Yonghyun] Univ Alabama, Dept Chem & Biol Engn, Tuscaloosa, AL 35487 USA		Kim, DW (corresponding author), Chungnam Natl Univ, Sch Med, Brain Res Inst, Dept Anat, Daejeon 301747, South Korea.; Kim, CS (corresponding author), Chungnam Natl Univ, Sch Med, Dept Med Sci, Daejeon 301747, South Korea.; Kim, CS (corresponding author), Chungnam Natl Univ, Sch Med, Dept Physiol, Daejeon 301747, South Korea.; Kim, Y (corresponding author), Univ Alabama, Dept Chem & Biol Engn, Tuscaloosa, AL 35487 USA.; Kim, DW (corresponding author), Chungnam Natl Univ, Sch Med, Brain Res Inst, Dept Med Sci, Daejeon 301747, South Korea.	cskim@cnu.ac.kr; ykim@eng.ua.edu; visnu528@cnu.ac.kr	Kim, Yonghyun/A-7234-2008; kim, dong woon/W-8254-2018	Kim, Yonghyun/0000-0001-6344-1258; Lee, Sun Yeul/0000-0002-6124-5138; kim, dong woon/0000-0001-7691-1394; Kim, Cuk-Seong/0000-0001-7647-6089	Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2016M3C7A1905074, 2014R1A6A 1029617, 2017R1A1A1A05001310]; Korea government (MSIP) [2016R1A2B4009409]; Business for Academic-Industrial Cooperation establishments funded Korea Small and Medium Business Administration in 2016 [C0395291]; U.S. National Science FoundationNational Science Foundation (NSF) [1614360]	This research was supported by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2016M3C7A1905074, 2014R1A6A 1029617, 2017R1A1A1A05001310), by the Korea government (MSIP) (2016R1A2B4009409), and by Business for Academic-Industrial Cooperation establishments funded Korea Small and Medium Business Administration in 2016 (Grant No. C0395291). U.L.T. was supported by the U.S. National Science Foundation (Grant No. 1614360).	Abdel-Raheem IT, 2016, PAK J PHARM SCI, V29, P685; Amitai Y, 2010, GLIA, V58, P1775, DOI 10.1002/glia.21057; Baek H, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0958-7; Bak DH, 2015, SCI REP-UK, V5, DOI 10.1038/srep15465; Bak SU, 2017, BMB REP, V50, P103, DOI 10.5483/BMBRep.2017.50.2.220; Beharka AA, 2002, FREE RADICAL BIO MED, V32, P503, DOI 10.1016/S0891-5849(01)00817-6; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cai SJ, 2005, CARDIOVASC RES, V65, P823, DOI 10.1016/j.cardiores.2004.10.040; Candelario-Jalil E, 2001, J APPL TOXICOL, V21, P403, DOI 10.1002/jat.768; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; COSENTINO F, 1995, CIRCULATION, V91, P139, DOI 10.1161/01.CIR.91.1.139; Cosentino F, 1998, J CLIN INVEST, V101, P1530, DOI 10.1172/JCI650; Crowley JJ, 2004, PHARMACOL BIOCHEM BE, V78, P269, DOI 10.1016/j.pbb.2004.03.014; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fiege B, 2004, MOL GENET METAB, V81, P45, DOI 10.1016/j.ymgme.2003.09.014; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guo GW, 2006, ANTIOXID REDOX SIGN, V8, P911, DOI 10.1089/ars.2006.8.911; Hayashi I, 2007, MUTAT RES-GEN TOX EN, V631, P55, DOI 10.1016/j.mrgentox.2007.04.006; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; HERBERT V, 1994, STEM CELLS, V12, P289, DOI 10.1002/stem.5530120305; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Huan WP, 2012, J MOL HISTOL, V43, P527, DOI 10.1007/s10735-012-9411-5; Huang WJ, 2016, BIOMED REP, V4, P519, DOI 10.3892/br.2016.630; Jazwa A, 2015, VASC PHARMACOL, V71, P127, DOI 10.1016/j.vph.2015.02.011; Kambayashi Y, 2009, J CLIN BIOCHEM NUTR, V44, P46, DOI 10.3164/jcbn.08-162; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Karbach S, 2014, CURR PHARM DESIGN, V20, P3579, DOI 10.2174/13816128113196660748; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kossmann S, 2014, J BIOL CHEM, V289, P27540, DOI 10.1074/jbc.M114.604231; Lace G, 2012, DEMENT GERIATR COGN, V34, P15, DOI 10.1159/000341581; Li HG, 2014, ATHEROSCLEROSIS, V237, P208, DOI 10.1016/j.atherosclerosis.2014.09.001; Li NZ, 2003, J NEUROSCI, V23, P10302; Lopez-Gonzalez I, 2013, BRAIN PATHOL, V23, P144, DOI 10.1111/j.1750-3639.2012.00627.x; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Niranjan A, 2014, CONCUSSION, VVii; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ozaki M, 2002, J CLIN INVEST, V110, P331, DOI 10.1172/JCI200215215; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Portbury SD, 2015, J ALZHEIMERS DIS, V46, P297, DOI 10.3233/JAD-143048; Rath G, 2012, ARTERIOSCL THROM VAS, V32, P2241, DOI 10.1161/ATVBAHA.112.252783; Sabri M, 2011, J CEREBR BLOOD F MET, V31, P190, DOI 10.1038/jcbfm.2010.76; Saez TE, 2004, IN VIVO, V18, P275; Saha RN, 2006, NEUROCHEM INT, V49, P154, DOI 10.1016/j.neuint.2006.04.007; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Verhaar MC, 2004, HEART, V90, P494, DOI 10.1136/hrt.2003.029405; WHEELER CR, 1990, ANAL BIOCHEM, V184, P193, DOI 10.1016/0003-2697(90)90668-Y; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; Yi MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34901; Yi MH, 2013, CELL MOL NEUROBIOL, V33, P223, DOI 10.1007/s10571-012-9889-0; Zetterberg H, 2016, JAMA NEUROL, V73, P60, DOI 10.1001/jamaneurol.2015.3037; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	75	10	10	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1523-0864	1557-7716		ANTIOXID REDOX SIGN	Antioxid. Redox Signal.	MAY 1	2019	30	13					1601	1620		10.1089/ars.2017.7280		SEP 2018	20	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	HP6MP	WOS:000444050500001	30070145				2022-02-06	
J	Hekierski, H; Pastor, P; Curvello, V; Armstead, WM				Hekierski, Hugh; Pastor, Philip; Curvello, Victor; Armstead, William M.			Inhaled Nitric Oxide Protects Cerebral Autoregulation and Reduces Hippocampal Neuronal Cell Necrosis after Traumatic Brain Injury in Newborn and Juvenile Pigs	JOURNAL OF NEUROTRAUMA			English	Article						age; brain injury; cerebral autoregulation; histopathology; nitric oxide; sex	TRANSIENT HYPEREMIC RESPONSE; NITROUS-OXIDE; BLOOD-FLOW; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; DOPAMINE; CHILDREN; AGE; PHENYLEPHRINE; HEMODYNAMICS	Traumatic brain injury (TBI) contributes to morbidity in children, and boys are disproportionately represented. Cerebral blood flow (CBF) is reduced and autoregulation is impaired after TBI, contributing to poor outcome. Cerebral perfusion pressure (CPP) is often normalized by use of vasoactive agents to increase mean arterial pressure (MAP). In prior studies of male and female newborn and juvenile pigs, we observed that phenylephrine, norepinephrine, epinephrine, and dopamine demonstrated different sex- and age-dependent abilities to prevent impairment of cerebral autoregulation and limit histopathology after TBI, despite equivalent CPP values. This observation complicated treatment choice. Alternatively, administration of a cerebral vasodilator may improve cerebral hemodynamics after TBI by increasing CBF. In prior studies, intravenous sodium nitroprusside, a nitric oxide (NO) releaser, elevated CBF after TBI but failed to prevent impairment of cerebral autoregulation due to a confounding decrease in MAP, which lowered CPP. We presently test the hypothesis that inhaled NO (iNO) will protect cerebral autoregulation and prevent hippocampal histopathology after TBI. Results show that iNO administered at 30min or 2h after TBI protected cerebral autoregulation and prevented neuronal cell necrosis in CA1 and CA3 hippocampus equivalently in male and female newborn and juvenile pigs without change in MAP. Protection lasted for at least 2h after iNO administration was stopped. Papaverine-induced dilation was unchanged by TBI and iNO. These data indicate that iNO offers the opportunity to have a single therapeutic that uniformly protects autoregulation and limits hippocampal neuronal cell necrosis across both ages and sexes.	[Hekierski, Hugh; Pastor, Philip; Curvello, Victor; Armstead, William M.] Univ Penn, Dept Anesthesiol, Philadelphia, PA 19104 USA; [Hekierski, Hugh; Pastor, Philip; Curvello, Victor; Armstead, William M.] Univ Penn, Dept Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu			Mallinckrodt Pharmaceuticals	This investigator-initiated research was funded by Mallinckrodt Pharmaceuticals.	Armstead WM, 2017, J NEUROTRAUM, V34, P1666, DOI 10.1089/neu.2016.4770; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Armstead WM, 2016, PEDIATR CRIT CARE ME, V17, pe130, DOI 10.1097/PCC.0000000000000603; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, BRAIN RES, V1330, P142, DOI 10.1016/j.brainres.2010.03.024; ARMSTEAD WM, 1989, J PHARMACOL EXP THER, V251, P1012; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; Bedford NM, 1999, ANESTH ANALG, V89, P170; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Curvello V, 2017, BRAIN RES, V1670, P118, DOI 10.1016/j.brainres.2017.06.010; Dobbing J., 1981, SCI F PAEDIATRICS, P744; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Girling KJ, 1999, ANESTH ANALG, V89, P175, DOI 10.1097/00000539-199907000-00031; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Ishikawa S, 2009, ANESTH ANALG, V108, P1631, DOI 10.1213/ane.0b013e31819d94e3; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS24, DOI 10.1097/PCC.0b013e31823f4450; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Newacheck PW, 2004, PEDIATRICS, V114, P79, DOI 10.1542/peds.114.1.79; Sharma D, 2010, J NEUROSURG ANESTH, V22, P132, DOI 10.1097/ANA.0b013e3181c9fbf1; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2012, CIRC RES, V110, P727, DOI 10.1161/CIRCRESAHA.111.253419; Tibble RK, 2001, ANESTH ANALG, V93, P171; Vavilala MS, 2001, ANESTH ANALG, V93, P351, DOI 10.1097/00000539-200108000-00023; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Zhu CL, 2013, TRANSL STROKE RES, V4, P201, DOI 10.1007/s12975-012-0217-2	32	10	10	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2019	36	4					630	638		10.1089/neu.2018.5824		SEP 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4MQ	WOS:000444037700001	30051755				2022-02-06	
J	Andrade, P; Paananen, T; Ciszek, R; Lapinlampi, N; Pitkanen, A				Andrade, Pedro; Paananen, Tomi; Ciszek, Robert; Lapinlampi, Niina; Pitkanen, Asia			Algorithm for automatic detection of spontaneous seizures in rats with post-traumatic epilepsy	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Electroencephalogram; Epileptogenesis; Fourier transformation; Lateral fluid-percussion; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; ELECTRICAL-STIMULATION; MODEL; EPILEPTOGENESIS; WAVE	Background: Labor intensive electroencephalogram (EEG) analysis is a major bottleneck to identifying anti-epileptogenic treatments in experimental models of post-traumatic epilepsy. We aimed to develop an algorithm for automated seizure detection in experimental post-traumatic epilepsy. New method: Continuous (24/7) 1-month-long video-EEG monitoring with three epidural screw electrodes was started 154 d after lateral fluid-percussion induced traumatic brain injury (TBI; n = 97) or sham-injury (n = 29) in adult male Sprague-Dawley rats. First, an experienced researcher screened a total of 90,720 h of digitized recordings on a computer screen to annotate the occurrence of spontaneous seizures. The same files were then analyzed using an algorithm in Spike2 (ver.9), which searching for temporally linked power peaks (14-42 Hz) in all three EEG channels, and then positive events were marked as a probable seizures. Finally, an experienced researcher confirmed all seizure candidates visually on the computer screen. Results: Visual analysis identified 197 seizures in 29 rats. Automatic detection identified 4346 seizure candidates in 109 rats, of which 202 in the same 29 rats were true positives, resulting in a false positive rate of 0.046/h or 1.10/d. The algorithm demonstrated 5% specificity and 100% sensitivity. The algorithm analyzed 1-month 3-channel EEG in 7 cohorts in 2 h, whereas analysis by an experienced technician took similar to 500 h. Comparison with Existing Methods: The algorithm had 100% sensitivity. It performed slightly better and was substantially faster than investigator-performed visual analysis. Conclusions: We present a novel seizure detection algorithm for automated detection of seizures in a rat model of post-traumatic epilepsy.	[Andrade, Pedro; Paananen, Tomi; Ciszek, Robert; Lapinlampi, Niina; Pitkanen, Asia] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi	Andrade, Pedro/N-8410-2018	Andrade, Pedro/0000-0001-9118-8341; Lapinlampi, Niina/0000-0003-3210-6312; Pitkanen, Asla/0000-0002-8163-5416	Academy of FinlandAcademy of FinlandEuropean Commission; European UnionEuropean Commission [602102]	We thank Mr. Jarmo Hartikainen for his excellent technical assistance. This study was supported by the Academy of Finland (A.P.) and the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 602102 (EPITARGET)(A.P.).	Andrade P, 2017, J NEUROTRAUM, V34, P1482, DOI 10.1089/neu.2016.4675; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P1; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Baulac M, 2015, EPILEPSIA, V56, P1687, DOI 10.1111/epi.13201; Bergstrom RA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01483; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Kelley Melinda S, 2009, Epilepsia, V50, P579, DOI 10.1111/j.1528-1167.2008.01813.x; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Lapinlampi N, 2017, EPILEPSY RES, V129, P87, DOI 10.1016/j.eplepsyres.2016.11.010; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Park YS, 2012, IEEE ENG MED BIO, P4688, DOI 10.1109/EMBC.2012.6347013; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ramgopal S, 2014, EPILEPSY BEHAV, V37, P291, DOI 10.1016/j.yebeh.2014.06.023; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; White AM, 2006, J NEUROSCI METH, V152, P255, DOI 10.1016/j.jneumeth.2005.09.014; Yang XF, 2001, ANN NEUROL, V49, P721, DOI 10.1002/ana.1021	26	10	10	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 1	2018	307						37	45		10.1016/j.jneumeth.2018.06.015			9	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GQ8ZN	WOS:000442055800006	29936072				2022-02-06	
J	Baker, JG; Leddy, JJ; Hinds, AL; Haider, MN; Shucard, J; Sharma, T; Hernandez, S; Durinka, J; Zivadinov, R; Willer, BS				Baker, John G.; Leddy, John J.; Hinds, Andrea L.; Haider, Mohammad N.; Shucard, Jennifer; Sharma, Tania; Hernandez, Sergio; Durinka, Joel; Zivadinov, Robert; Willer, Barry S.			An Exploratory Study of Mild Cognitive Impairment of Retired Professional Contact Sport Athletes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						athletics; cerebral concussion; cognitive reserve; mild cognitive impairment; neuropsychology tests; risk factors	CHRONIC TRAUMATIC ENCEPHALOPATHY; VERBAL FLUENCY; FOOTBALL; AGE; RISK; ASSOCIATION; CONCUSSION; EXPOSURE; EXERCISE; COLLEGE	Objective: To test the hypothesis that mild cognitive impairment (MCI) rates are higher among retired professional contact sport athletes than in noncontact athlete controls and compare history of contact sports with other MCI risk factors. Setting: University Concussion Management Clinic. Participants: Twenty-one retired National Football League and National Hockey League players and 21 aged-matched noncontact athlete controls. Designs: Case-control. Main Measures: Comprehensive criteria were used to assess MCI based on the following: Wisconsin Card Sorting Test, Delis-Kaplan Executive Function System; Trail Making Parts A and B; Wechsler Adult Intelligence Scale-Third Edition subtests; Neuropsychological Assessment Battery Memory Module List Learning, Story Learning, and Naming subtests; and Controlled Oral Word Association Test. The Wide Range Achievement Test was used as a proxy measure for IQ. Atherosclerotic cardiovascular disease risk factors were self-reported and blood cholesterol was measured. Depression was measured by the Beck Depression Inventory-II (BDI). Results: Eight contact sport athletes (38%) and 3 noncontact athletes (14%) met MCI criteria (P = .083). Contact sport athletes' scores were significantly worse on Letter Fluency and List B Immediate Recall. Contact athletes were more obese, had more vascular risk factors, and had higher scores on the BDI than controls. Conclusion: Athletes with a history of playing professional contact sports had more vascular risk factors and higher depression scores. MCI rates were somewhat higher, though not significant.	[Baker, John G.; Leddy, John J.; Haider, Mohammad N.; Shucard, Jennifer; Sharma, Tania] SUNY Buffalo, Sch Med & Biomed Sci, UBMD Dept Orthopaed & Sports Med, Buffalo, NY USA; [Baker, John G.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Nucl Med, Buffalo, NY USA; [Hinds, Andrea L.; Hernandez, Sergio; Willer, Barry S.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA; [Zivadinov, Robert] SUNY Buffalo, Sch Med & Biomed Sci, Dept Neurol, Buffalo, NY USA; [Durinka, Joel] SUNY Buffalo, Sch Med & Biomed Sci, Dept Internal Med, Buffalo, NY USA		Baker, JG (corresponding author), SUNY Buffalo, UBMD Orthopaed & Sports Med, 160 Farber Hall, Buffalo, NY 14214 USA.	jgbaker@buffalo.edu	Zivadinov, Robert/Q-2054-2019	Zivadinov, Robert/0000-0002-7799-1485	National Institutes ofHealth (NIH), (National Center for Advancing Translational Sciences) award [UL1TR001412]; Robert Rich Family Foundation; Ralph and Mary Wilson Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412] Funding Source: NIH RePORTER	The authors thank the following organizations for financial support: The National Institutes ofHealth (NIH), (National Center for Advancing Translational Sciences) award number UL1TR001412; the Robert Rich Family Foundation; and the Ralph and Mary Wilson Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or any other funding source. The authors also thank the research team at Boston University, in particular Dr Robert Stern, for their willingness to share their protocol for evaluation of neurocognitive performance.	Alosco ML, 2017, J NEUROPSYCH CLIN N, V29, P6, DOI 10.1176/appi.neuropsych.16030043; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Busse A, 2006, NEUROLOGY, V67, P2176, DOI 10.1212/01.wnl.0000249117.23318.e1; Clark LR, 2013, J INT NEUROPSYCH SOC, V19, P635, DOI 10.1017/S1355617713000313; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis DC., 2001, DELIS KAPLAN EXECUTI; Elwood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081877; Ganguli M, 2013, NEUROLOGY, V80, P2112, DOI 10.1212/WNL.0b013e318295d776; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Geda YE, 2014, AM J PSYCHIAT, V171, P572, DOI 10.1176/appi.ajp.2014.13060821; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Gordon B, 2014, CURR SPORT MED REP, V13, P253, DOI 10.1249/JSR.0000000000000073; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Jak AJ, 2009, AM J GERIAT PSYCHIAT, V17, P368, DOI 10.1097/JGP.0b013e31819431d5; Jonnalagadda Satya S, 2004, Curr Sports Med Rep, V3, P198, DOI 10.1249/00149619-200408000-00005; Karr JE, 2014, J CLIN EXP NEUROPSYC, V36, P15, DOI 10.1080/13803395.2013.863833; Knopman DS, 2014, MAYO CLIN P; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Lopez Oscar L, 2013, Continuum (Minneap Minn), V19, P411, DOI 10.1212/01.CON.0000429175.29601.97; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Riley DO, 2015, BRAIN INJURY, V29, P154, DOI 10.3109/02699052.2014.965215; Rodriguez-Aranda C, 2006, DEV NEUROPSYCHOL, V30, P697, DOI 10.1207/s15326942dn3002_3; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern RA, 2003, NAB NEUROPSYCHOLOGIC; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Wechsler, 1997, WECHSLER ADULT INTEL; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000421; Willeumier K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.67	46	10	10	4	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					E16	E23		10.1097/HTR.0000000000000420			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500003	30080798	Green Accepted			2022-02-06	
J	Durish, CL; Yeates, KO; Brooks, BL				Durish, Christianne Laliberte; Yeates, Keith Owen; Brooks, Brian L.			Psychological Resilience as a Predictor of Persistent Post-Concussive Symptoms in Children With Single and Multiple Concussion	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Mild traumatic brain injury; Pediatric; Adolescent; Hardiness; Outcomes; Concussion	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; PAST CONCUSSIONS; MILD; OUTCOMES; SLEEP; YOUTH	Objectives: To evaluate the relationship of psychological resilience to persistent post-concussive symptoms (PCS) in children with a history of single or multiple concussions, as well as orthopedic injury (OI). Methods: Participants (N = 75) were children, ages 8-18 years, who sustained a single concussion (n = 24), multiple concussions (n = 25), or an OI (n = 26), recruited from a tertiary care children's hospital. All participants sustained injuries at least 6 months before recruitment, with an average time since injury of 32.9 months. Self-reported psychological resilience was measured using the Connor-Davidson Resilience Scale, and both self- and parent-reported PCS were measured using the Post-Concussion Symptom Inventory. Hierarchical regression analyses examined psychological resilience as a predictor of PCS, both as a main effect and as a moderator of group differences. Results: Multiple concussions and low psychological resilience were both significant predictors of persistent PCS. Resilience was not a significant moderator of group differences in PCS. Conclusions: Sustaining multiple concussions may increase a child's risk of persistent PCS; however, high psychological resilience may serve as a protective factor, regardless of the number or type of injuries sustained. These findings provide support for developing and testing interventions aimed at increasing psychological resilience as a potential means of improving outcomes for children suffering from persistent PCS after concussion.	[Durish, Christianne Laliberte; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada		Durish, CL (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	christianne.lalibert@ucalgary.ca	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	Shaikh Family Research Award; Alberta Children's Hospital Research Institute; Ronald and Irene Ward Chair in Pediatric Brain Injury; Alberta Innovates Health Solutions	This study was funded by the Shaikh Family Research Award, an endowment held by the Alberta Children's Hospital Foundation and granted to Brian Brooks by the Alberta Children's Hospital Research Institute. Additional support for the study was provided from the Ronald and Irene Ward Chair in Pediatric Brain Injury (awarded to Keith Yeates). Christianne Laliberte Durish received funding from Alberta Innovates Health Solutions and Alberta Children's Hospital Research Institute in the form of graduate studentships. Brian Brooks received salary support from the CIHR Embedded Clinical Research Award.	Association for the Advancement of Automotive Medicine-AAAM, 2008, ABBREVIATED INJURY S; Babcock L, 2013, JAMA PEDIAT, V156, P161; Barker Trevor, 2017, BMC Psychol, V5, P14, DOI 10.1186/s40359-017-0184-1; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; IBM Corp, 2016, IBM SPSS STAT WIND V; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnston MC, 2015, PSYCHOSOMATICS, V56, P168, DOI 10.1016/j.psym.2014.10.005; Koupernik, 1974, CHILD HIS FAMILY CHI, P529; Laliberte Durish C, 2017, J INT NEUROPSYCHO S1, V23, P294; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sherman E.M.S., 2015, CHILD ADOLESCENT MEM; Sherman EMS, 2015, MEMORY VALIDITY PROF; Sherman EMS, 2017, MULTIDIMENSIONAL EVE; Steinhardt M. A., 2008, J AM COLL HEALTH, V445, P453; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomsen DK, 2003, PERS INDIV DIFFER, V34, P1293, DOI 10.1016/S0191-8869(02)00120-4; Van Dyk TR, 2016, J PEDIATR PSYCHOL, V41, P983, DOI 10.1093/jpepsy/jsw040; WERNER EE, 1989, SCI AM, V260, P106, DOI 10.1038/scientificamerican0489-106; Werner EE, 1997, ACTA PAEDIATR, V86, P103; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	43	10	10	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2018	24	8					759	768		10.1017/S1355617718000437			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	HG6MJ	WOS:000455095800001	30189908				2022-02-06	
J	Hagos, FT; Empey, PE; Wang, PC; Ma, XC; Poloyac, SM; Bayir, H; Kochanek, PM; Bell, MJ; Clark, RSB				Hagos, Fanuel T.; Empey, Philip E.; Wang, Pengcheng; Ma, Xiaochao; Poloyac, Samuel M.; Bayir, Hulya; Kochanek, Patrick M.; Bell, Michael J.; Clark, Robert S. B.			Exploratory Application of Neuropharmacometabolomics in Severe Childhood Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						cerebrospinal fluid; head injury; metabolomics; n-acetylcysteine; neurocritical care; probenecid	HUMAN METABOLOME DATABASE; ANION TRANSPORTER 1; ALPHA-KETOGLUTARATE; KYNURENIC ACID; CELLS; PLASMA; HMDB; NUCLEOTIDES; MORPHINE; KIDNEY	Objectives: To employ metabolomics-based pathway and network analyses to evaluate the cerebrospinal fluid metabolome after severe traumatic brain injury in children and the capacity of combination therapy with probenecid and N-acetylcysteine to impact glutathione-related and other pathways and networks, relative to placebo treatment. Design: Analysis of cerebrospinal fluid obtained from children enrolled in an Institutional Review Board-approved, randomized, placebo-controlled trial of a combination of probenecid and N-acetylcysteine after severe traumatic brain injury (Trial Registration NCT01322009). Setting: Thirty-six-bed PICU in a university-affiliated children's hospital. Patients and Subjects: Twelve children 2-18 years old after severe traumatic brain injury and five age-matched control subjects. Intervention: Probenecid (25mg/kg) and N-acetylcysteine (140mg/kg) or placebo administered via naso/orogastric tube. Measurements and Main Results: The cerebrospinal fluid metabolome was analyzed in samples from traumatic brain injury patients 24 hours after the first dose of drugs or placebo and control subjects. Feature detection, retention time, alignment, annotation, and principal component analysis and statistical analysis were conducted using XCMS-online. The software mummichog was used for pathway and network analyses. A two-component principal component analysis revealed clustering of each of the groups, with distinct metabolomics signatures. Several novel pathways with plausible mechanistic involvement in traumatic brain injury were identified. A combination of metabolomics and pathway/network analyses showed that seven glutathione-centered pathways and two networks were enriched in the cerebrospinal fluid of traumatic brain injury patients treated with probenecid and N-acetylcysteine versus placebo-treated patients. Several additional pathways/networks consisting of components that are known substrates of probenecid-inhibitable transporters were also identified, providing additional mechanistic validation. Conclusions: This proof-of-concept neuropharmacometabolomics assessment reveals alterations in known and previously unidentified metabolic pathways and supports therapeutic target engagement of the combination of probenecid and N-acetylcysteine treatment after severe traumatic brain injury in children.	[Hagos, Fanuel T.; Empey, Philip E.; Poloyac, Samuel M.] Univ Pittsburgh, Ctr Clin Pharmaceut Sci, Pittsburgh, PA USA; [Empey, Philip E.; Poloyac, Samuel M.] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA; [Empey, Philip E.; Poloyac, Samuel M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA 15260 USA; [Wang, Pengcheng; Ma, Xiaochao] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Bayir, Hulya; Kochanek, Patrick M.; Bell, Michael J.; Clark, Robert S. B.] Univ Pittsburgh, Dept Crit Care Med, Sch Med, Pittsburgh, PA 15260 USA; [Bayir, Hulya; Kochanek, Patrick M.; Bell, Michael J.; Clark, Robert S. B.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Bayir, Hulya; Kochanek, Patrick M.; Bell, Michael J.; Clark, Robert S. B.] Childrens Hosp Pittsburgh UPMC, Brain Care Inst, Pittsburgh, PA 15224 USA; [Bayir, Hulya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Bell, Michael J.] Childrens Natl Hlth Syst, Dept Pediat, Washington, DC USA		Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA 15260 USA.; Clark, RSB (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Sch Med, Pittsburgh, PA 15260 USA.; Clark, RSB (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.; Clark, RSB (corresponding author), Childrens Hosp Pittsburgh UPMC, Brain Care Inst, Pittsburgh, PA 15224 USA.; Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.	clarkrs@ccm.upmc.edu	Empey, Philip/L-9604-2019	Empey, Philip/0000-0001-7474-2339	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS069247, 1TL1 TR001858-01]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; University of Pittsburgh Clinical and Translational Science InstituteUniversity of Pittsburgh; Society of Critical Care Medicine; World Federation of Pediatric Intensive and Critical Care Societies; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069247] Funding Source: NIH RePORTER	Supported, in part, by the National Institutes of Health grants R01 NS069247 (to Drs. Empey, Bell, and Clark), 1TL1 TR001858-01 (to Dr. Hagos).; Mr. Hagos, Drs. Empey, Poloyac, Bayir, Bell, and Clark received support for article research from the National Institutes of Health (NIH). Mr. Hagos received funding from NIH and University of Pittsburgh Clinical and Translational Science Institute. Mr. Hagos, Drs. Empey, and Bell disclosed off-label product use of probenecid and N-acetylcysteine for pediatric traumatic brain injury. Drs. Empey's, Kochanek's, and Bell's institutions received funding from the NIH. Dr. Kochanek received funding from the Society of Critical Care Medicine and World Federation of Pediatric Intensive and Critical Care Societies (Editor-in-Chief of Pediatric Critical Care Medicine) and he has served as an expert witness on a number of cases and has given numerous lectures as a guest professor. The remaining authors have disclosed that they do not have any potential conflicts of interest.	ANGEL C, 1976, BIOL PSYCHIAT, V11, P743; Bahn A, 2005, AM J PHYSIOL-CELL PH, V289, pC1075, DOI 10.1152/ajpcell.00619.2004; Battaglia E, 1996, BBA-BIOMEMBRANES, V1283, P223, DOI 10.1016/0005-2736(96)00098-3; Benton HP, 2015, ANAL CHEM, V87, P884, DOI 10.1021/ac5025649; BODE U, 1980, CANCER RES, V40, P2184; Boettcher C, 2005, P NATL ACAD SCI USA, V102, P8495, DOI 10.1073/pnas.0503244102; Carr KR, 2015, INT J NEUROSCI, V125, P486, DOI 10.3109/00207454.2014.957760; CHRISTJANSON LJ, 1993, GLIA, V7, P176, DOI 10.1002/glia.440070207; Clark RSB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180280; Deo RC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000692; GARELIS E, 1974, BRAIN RES, V79, P1, DOI 10.1016/0006-8993(74)90562-9; Gowda H, 2014, ANAL CHEM, V86, P6931, DOI 10.1021/ac500734c; Hadley B, 2014, COMPUT STRUCT BIOTEC, V10, P23, DOI 10.1016/j.csbj.2014.05.003; Hagos FT, 2017, XENOBIOTICA, V47, P346, DOI 10.1080/00498254.2016.1187777; Ingraham L, 2014, MOL PHARMACOL, V86, P86, DOI 10.1124/mol.114.091777; Johnson CH, 2016, NAT REV MOL CELL BIO, V17, P451, DOI 10.1038/nrm.2016.25; Kaddurah-Daouk R, 2009, NEUROPSYCHOPHARMACOL, V34, P173, DOI 10.1038/npp.2008.174; Kalapos MP, 2013, DIABETES RES CLIN PR, V99, P260, DOI 10.1016/j.diabres.2012.11.003; Leong SC, 2016, TOXINS, V8, DOI 10.3390/toxins8120358; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Nagai J, 1998, J PHARMACOL EXP THER, V285, P422; Ng KH, 2003, KIDNEY INT, V63, P976, DOI 10.1046/j.1523-1755.2003.00818.x; Patti GJ, 2013, ANAL CHEM, V85, P798, DOI 10.1021/ac3029745; Pieroh P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087364; Pineda-Farias JB, 2013, EUR J PAIN, V17, P1365, DOI 10.1002/j.1532-2149.2013.00305.x; Poeaknapo C, 2004, P NATL ACAD SCI USA, V101, P14091, DOI 10.1073/pnas.0405430101; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; RENNICK BR, 1977, AM J PHYSIOL, V233, pF133, DOI 10.1152/ajprenal.1977.233.2.F133; Samyn B, 2015, NAT METHODS, V2, P1; Santamaria A, 1996, NEUROPHARMACOLOGY, V35, P23, DOI 10.1016/0028-3908(95)00145-X; Sugawara M, 2003, BBA-BIOMEMBRANES, V1609, P39, DOI 10.1016/S0005-2736(02)00634-X; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Uwai Y, 2012, PHARMACOL RES, V65, P254, DOI 10.1016/j.phrs.2011.11.003; VECSEI L, 1992, BRAIN RES BULL, V28, P233, DOI 10.1016/0361-9230(92)90184-Y; WEINER IM, 1979, AM J PHYSIOL, V237, pF85, DOI 10.1152/ajprenal.1979.237.2.F85; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wolahan SM, 2016, NEUROSURG CLIN N AM, V27, P465, DOI 10.1016/j.nec.2016.05.006; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Zhang MY, 2013, J MOL NEUROSCI, V51, P57, DOI 10.1007/s12031-012-9948-5; Zhu ZJ, 2013, NAT PROTOC, V8, P451, DOI 10.1038/nprot.2013.004	43	10	10	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2018	46	9					1471	1479		10.1097/CCM.0000000000003203			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ2VN	WOS:000441517100025	29742587	Green Accepted			2022-02-06	
J	Legarreta, AD; Brett, BL; Solomon, GS; Zuckerman, SL				Legarreta, Andrew D.; Brett, Benjamin L.; Solomon, Gary S.; Zuckerman, Scott L.			The role of family and personal psychiatric history in postconcussion syndrome following sport-related concussion: a story of compounding risk	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						family psychiatric history; postconcussion syndrome; personal psychiatric history; sport-related concussion; trauma	PROLONGED RECOVERY; HIGH-SCHOOL; SYMPTOMS; PREDICTORS; ADOLESCENTS; MANAGEMENT; CHILDREN; INJURY; CONSENSUS; DISORDER	OBJECTIVE Sport-related concussion (SRC) has become a major public health concern. Prolonged recovery after SRC, named postconcussion syndrome (PCS), has been associated with several biopsychosocial factors, yet the role of both family and personal psychiatric histories requires investigation. In a cohort of concussed high school athletes, the authors examined the role(s) of family and personal psychiatric histories in the risk of developing PCS. METHODS A retrospective cohort study of 154 high school athletes with complete documentation of postconcussion symptom resolution or persistence at 6 weeks was conducted. PCS was defined as 3 or more symptoms present 6 weeks after SRC. Three groups were defined: 1) positive family psychiatric history and personal psychiatric history (FPH/PPH), 2) positive FPH only, and 3) negative family and personal psychiatric histories (controls). Three bivariate regression analyses were conducted: FPH/PPH to controls, FPH only to controls, and FPH/PPH to FPH. Post hoc bivariate regression analyses examined specific FPH pathologies and PCS. RESULTS Athletes with FPH/PPH compared with controls had an increased risk of PCS (chi(2) = 8.90, p = 0.018; OR 5.06, 95% CI 1.71-14.99). Athletes with FPH only compared with controls also had an increased risk of PCS (chi(2) = 6.04, p = 0.03; OR 2.52, 95% CI 1.20-5.30). Comparing athletes with FPH/PPH to athletes with FPH only, no added PCS risk was noted (chi(2) = 1.64, p = 0.247; OR 2.01, 95% CI 0.68-5.94). Among various FPH diagnoses, anxiety (chi(2) = 7.48, p = 0.021; OR 2.99, 95% CI 1.36-6.49) and bipolar disorder (chi(2) = 5.13, p = 0.036; OR 2.74, 95% CI 1.14-6.67) were significantly associated with the presence of PCS. CONCLUSIONS Concussed high school athletes with FPH/PPH were greater than 5 times more likely to develop PCS than controls. Athletes with only FPH were over 2.5 times more likely to develop PCS than controls. Those with an FPH of anxiety or bipolar disorder are specifically at increased risk of PCS. These results suggest that not only are athletes with FPH/PPH at risk for slower recovery after SRC, but those with an FPH only-especially anxiety or bipolar disorder-may also be at risk. Overall, this study supports taking a detailed FPH and PPH in the management of SRC.	[Legarreta, Andrew D.; Brett, Benjamin L.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Brett, Benjamin L.] Vet Affairs Connecticut Healthcare Syst, Dept Psychol, West Haven, CT USA; [Brett, Benjamin L.] Univ Memphis, Dept Counseling Educ Psychol & Res, Memphis, TN 38152 USA; [Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, 221 Kirkland Hall, Nashville, TN 37235 USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.	scott.zuckerman@vumc.org	Solomon, Gary/K-9011-2019		athletic departments of Tennessee Tech University; University of Tennessee	G. S. Solomon is a consultant for the Nashville Predators, Tennessee Titans, and the athletic departments of Tennessee Tech University and the University of Tennessee, fees paid to institution. He is also a consultant to the National Football League Department of Health and Safety.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Balasundaram AP, 2016, ARCH CLIN NEUROPSYCH, V31, P197, DOI 10.1093/arclin/acw001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kerr ZY, 2018, J SCI MED SPORT, V21, P447, DOI 10.1016/j.jsams.2017.08.025; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Moser RS, 2015, BRAIN INJURY, V29, P58, DOI 10.3109/02699052.2014.964771; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; TURNER SM, 1987, J CONSULT CLIN PSYCH, V55, P229, DOI 10.1037/0022-006X.55.2.229; World Health Organization, 2004, ICD 10 INT STAT CLAS; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	43	10	10	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	SEP	2018	22	3					238	243		10.3171/2018.3.PEDS1850			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	GS1QD	WOS:000443304500005	29856298	Bronze			2022-02-06	
J	Madan, S; Kron, B; Jin, ZX; Al Shamy, G; Campeau, PM; Sun, Q; Chen, S; Cherian, L; Chen, YQ; Munivez, E; Jiang, MM; Robertson, C; Goodman, C; Ratan, RR; Lee, B				Madan, Simran; Kron, Bettina; Jin, Zixue; Al Shamy, George; Campeau, Philippe M.; Sun, Qin; Chen, Shan; Cherian, Leela; Chen, Yuqing; Munivez, Elda; Jiang, Ming-Ming; Robertson, Claudia; Goodman, Clay; Ratan, Rajiv R.; Lee, Brendan			Arginase overexpression in neurons and its effect on traumatic brain injury	MOLECULAR GENETICS AND METABOLISM			English	Article						Traumatic brain injury; Arginine; Nitric oxide; Arginase; Nitric oxide synthase	CORTICAL IMPACT INJURY; NITRIC-OXIDE SYNTHASE; L-ARGININE; PEROXYNITRITE; SUPEROXIDE; RATS; NOS	Arginine is a semi-essential amino acid which serves as a substrate for nitric oxide (NO) production by nitric oxide synthase (NOS) and a precursor for various metabolites including ornithine, creatine, polyamines, and agmatine. Arginase competes with nitric oxide synthase for substrate arginine to produce orthinine and urea. There is contradictory evidence in the literature on the role of nitric oxide in the pathophysiology of traumatic brain injury (TB!). These contradictory perspectives are likely due to different NOS isoforms endothelial (eNOS), inducible (iNOS) and neuronal (nNOS) which are expressed in the central nervous system. Of these, the role of nNOS in acute injury remains less clear. This study aimed to employ a genetic approach by overexpressing arginase isoforms specifically in neurons using a Thy-1 promoter to manipulate cell autonomous NO production in the context of TBI. The hypothesis was that increased arginase would divert arginine from pathological NO production. We generated 2 mouse lines that overexpress arginase I (a cytoplasmic enzyme) or arginase II (a mitochondrial enzyme) in neurons of FVB mice. We found that two-weeks after induction of controlled cortical injury, overexpressing arginase I but not arginase II in neurons significantly reduced contusion size and contusion index compared to wild-type (WT) mice. This study establishes enhanced neuronal arginase levels as a strategy to affect the course of TBI and provides support for the potential role of neuronal NO production in this condition.	[Madan, Simran; Kron, Bettina; Jin, Zixue; Al Shamy, George; Campeau, Philippe M.; Sun, Qin; Chen, Shan; Chen, Yuqing; Munivez, Elda; Jiang, Ming-Ming; Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Madan, Simran; Lee, Brendan] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Cherian, Leela; Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Goodman, Clay] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Ratan, Rajiv R.] Cornell Univ, Dept Neurol, Weill Med Coll, New York, NY 10021 USA		Lee, B (corresponding author), 1 Baylor Plaza,Room R814, Houston, TX 77030 USA.	blee@bcm.edu	Campeau, Philippe/J-8614-2015	Campeau, Philippe/0000-0001-9713-7107	Baylor College of Medicine (BCM) Intellectual and Developmental Disabilities Research Center from the Eunice Kennedy Shriver National Institute Of Child Health & Human Development [HD024064]; BCM Advanced Technology Cores; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AI036211, CA125123, RR024574]; Howard Hughes Med into Grad Scholarship - Translational Biology and Molecular Medicine Graduate Program at Baylor College of Medicine;  [NIHR01DK102641]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK102641] Funding Source: NIH RePORTER	This work was supported by the NIHR01DK102641 (B. Lee), the Baylor College of Medicine (BCM) Intellectual and Developmental Disabilities Research Center (HD024064) from the Eunice Kennedy Shriver National Institute Of Child Health & Human Development, the BCM Advanced Technology Cores with funding from the NIH (AI036211, CA125123, and RR024574). Simran Madan was supported by Howard Hughes Med into Grad Scholarship awarded through the Translational Biology and Molecular Medicine Graduate Program at Baylor College of Medicine.	ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Cederbaum SD, 2004, MOL GENET METAB, V81, pS38, DOI 10.1016/j.ymgme.2003.10.012; Chan J, 2014, FASEB J, V28; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cherian L, 2003, J PHARMACOL EXP THER, V304, P617, DOI 10.1124/JPET.102.043430; Jeter C. B., 2012, HUMAN TRAUMATIC BRAI; Khan M, 2016, BRAIN RES, V1630, P159, DOI 10.1016/j.brainres.2015.11.015; Lu YC, 1997, MOL CHEM NEUROPATHOL, V30, P125, DOI 10.1007/BF02815154; Lundblad C., 2009, HEMODYNAMIC HISTOLOG, V1962, P1953; Luo SX, 2014, CURR PHARM DESIGN, V20, P3548, DOI 10.2174/13816128113196660746; Ochoa J.B., 2001, ARGINASE I EXPRESSIO; Ochoa J.B., 2012, J PARENTER ENTER NUT, V36, P53; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Sharma HS, 2006, ACTA NEUROCHIR SUPPL, V96, P288; Sullivan JC, 2006, CIRC RES, V98, P717, DOI 10.1161/01.RES.0000217594.97174.c2; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Tisdall MM, 2013, NEUROCRIT CARE, V19, P65, DOI 10.1007/s12028-011-9633-5; Villalba N, 2017, J NEUROTRAUM, V34, P192, DOI 10.1089/neu.2015.4340; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Yu H, 2001, J NEUROSCI RES, V66, P406, DOI 10.1002/jnr.1233; Zawada RJX, 2009, BIOCHEM CELL BIOL, V87, P541, DOI [10.1139/O09-011, 10.1139/o09-011]	27	10	10	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	SEP	2018	125	1-2					112	117		10.1016/j.ymgme.2018.07.007			6	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	GX4FL	WOS:000447682900014	30055993	Green Accepted, Bronze			2022-02-06	
J	Siebert, DM; Rao, AL				Siebert, David M.; Rao, Ashwin L.			The Use and Abuse of Human Growth Hormone in Sports	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						human growth hormone; athlete; performance-enhancing drugs; athletic performance; drug testing	GH-DEFICIENT ADULTS; BODY-COMPOSITION; ENDOCRINE-SOCIETY; PHYSICAL PERFORMANCE; CONSENSUS GUIDELINES; REPLACEMENT THERAPY; DIAGNOSIS; STATEMENT; STANDARDS; CAPACITY	Context: Recombinant human growth hormone (rHGH) has become a target of abuse in the sporting world. Conversely, sports medicine clinicians may encounter athletes using rHGH to achieve normalcy in the context of growth hormone (GH) deficiency. Evidence Acquisition: Medline and PubMed databases were queried using the following keywords: GH, GH physiology, GH deficiency, acromegaly, GH athlete, GH sports, GH athletic performance, and GH deficiency concussion. Articles focusing on GH physiology, deficiency, excess, and its effects in both deficient and healthy patients were included. Study Design: Clinical review. Level of Evidence: Level 3. Results: GH is a naturally occurring hormone with important roles in human physiology. Patients with GH deficiency (GHD) present variably, and GHD has numerous etiologies. rHGH treatment has substantial therapeutic benefits for patients with GHD. The benefits of rHGH treatment in otherwise-healthy adults are uncertain. GH excess may cause health problems such as acromegaly. Professional, collegiate, and international sports leagues and associations have banned rHGH use to maintain athlete health, safety, and fair play. Athletes misusing GH may face prolonged suspensions from competition. Implementing GH abuse testing is challenging, but new methods, such as the biomarker testing procedure, are being finalized. Conclusion: rHGH is not only an important therapeutic agent for GH-deficient patients but also a target of abuse in competitive athletics. Its benefits in a healthy, adult population are uncertain. A safe exercise and competition plan, developed with a physician knowledgeable of GH use, physiology, and abuse potential, should be of benefit to a longitudinal clinician-patient relationship.	[Siebert, David M.; Rao, Ashwin L.] Univ Washington, Dept Family Med, Sports Med Sect, 3800 Montlake Blvd, Seattle, WA 98195 USA		Siebert, DM (corresponding author), Univ Washington, Dept Family Med, Sports Med Sect, 3800 Montlake Blvd, Seattle, WA 98195 USA.	siebert@uw.edu			AMSSM MSK ultrasound course teacher	The following author declared potential conflicts of interest: Ashwin L. Rao, MD, has received payment for serving as an AMSSM MSK ultrasound course teacher.	Ayyar Vageesh S, 2011, Indian J Endocrinol Metab, V15 Suppl 3, pS162, DOI 10.4103/2230-8210.84852; Baker JS, 2006, EUR J INTERN MED, V17, P479, DOI 10.1016/j.ejim.2006.04.010; Barake M, 2014, J CLIN ENDOCR METAB, V99, P852, DOI 10.1210/jc.2013-3921; Baumann GP, 2012, ENDOCR REV, V33, P155, DOI 10.1210/er.2011-1035; Bollerslev J, 2005, EUR J ENDOCRINOL, V153, P379, DOI 10.1530/eje.1.01971; Brennan BP, 2011, AM J ADDICTION, V20, P9, DOI 10.1111/j.1521-0391.2010.00093.x; Burt MG, 2008, GROWTH HORM IGF RES, V18, P55, DOI 10.1016/j.ghir.2007.07.005; Buzzini SRR, 2007, PEDIATR CLIN N AM, V54, P823, DOI 10.1016/j.pcl.2007.07.002; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Chinoy A, 2016, BEST PRACT RES CL EN, V30, P737, DOI 10.1016/j.beem.2016.11.002; CUNEO RC, 1991, J APPL PHYSIOL, V70, P695, DOI 10.1152/jappl.1991.70.2.695; CUNEO RC, 1991, J APPL PHYSIOL, V70, P688, DOI 10.1152/jappl.1991.70.2.688; CUNEO RC, 1990, HORM RES, V33, P55, DOI 10.1159/000181585; Drug Enforcement Administration, HUM GROWTH HORM; Dubourg J, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11182; Elliot Diane L, 2008, J Alcohol Drug Educ, V52, P73; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Goldberg L, 1996, ARCH PEDIAT ADOL MED, V150, P713, DOI 10.1001/archpedi.1996.02170320059010; Gotherstrom G, 2001, J CLIN ENDOCR METAB, V86, P4657, DOI 10.1210/jc.86.10.4657; Gunawardane K, 2000, ENDOTEXT; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Holt Richard I G, 2013, Indian J Endocrinol Metab, V17, pS18, DOI 10.4103/2230-8210.119494; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Ives JC, 2007, J ATHL TRAINING, V42, P431; James J S, 1996, AIDS Treat News, P1; JORGENSEN JOL, 1994, EUR J ENDOCRINOL, V130, P224, DOI 10.1530/eje.0.1300224; Katznelson L, 2014, J CLIN ENDOCR METAB, V99, P3933, DOI 10.1210/jc.2014-2700; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Langelier DM, 2017, CLIN J SPORT MED, V27, pE78, DOI 10.1097/JSM.0000000000000408; LINDSAY R, 1994, J PEDIATR-US, V125, P29, DOI 10.1016/S0022-3476(94)70117-2; Liu H, 2008, ANN INTERN MED, V148, P747, DOI 10.7326/0003-4819-148-10-200805200-00215; Meazza Cristina, 2004, Pediatr Endocrinol Rev, V1 Suppl 3, P490; Meinhardt U, 2010, ANN INTERN MED, V152, P568, DOI 10.7326/0003-4819-152-9-201005040-00007; Mitchell G., REPORT COMMISSIONER; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; NASS R, 1995, J CLIN ENDOCR METAB, V80, P552, DOI 10.1210/jc.80.2.552; National Basketball Association, NBPA ADD HGH TEST AN; National Collegiate Athletic Association, NCAA MED EXC DOC REP; National Collegiate Athletic Association, DRUG TEST EXC PROC; National Collegiate Athletic Association, FREQ ASK QUEST DRUG; National Football League Players Association, DRUG PROGR RES; Oregon Health and Science University School of Medicine Health Promotion and Sports Medicine, ATLAS; Oregon Health and Science University School of Medicine Health Promotion and Sports Medicine, ATHENA; Cenci MCP, 2009, PITUITARY, V12, P322, DOI 10.1007/s11102-009-0182-2; POWELLJACKSON J, 1985, LANCET, V2, P244; Red C., EFFECTIVENESS NFLS H; Richmond EJ, 2008, PITUITARY, V11, P115, DOI 10.1007/s11102-008-0105-7; RICKERT VI, 1992, CLIN PEDIATR, V31, P723, DOI 10.1177/000992289203101206; Rodriguez-Arnao J, 1999, CLIN ENDOCRINOL, V51, P53, DOI 10.1046/j.1365-2265.1999.00737.x; Rokkas T, 2008, WORLD J GASTROENTERO, V14, P3484, DOI 10.3748/wjg.14.3484; SARTORIO A, 1994, CLIN PHYSIOL, V14, P527, DOI 10.1111/j.1475-097X.1994.tb00411.x; Saugy M, 2006, BRIT J SPORT MED, V40, P35, DOI 10.1136/bjsm.2006.027573; Stanley T, 2012, CURR OPIN ENDOCRINOL, V19, P47, DOI 10.1097/MED.0b013e32834ec952; TANNER JM, 1970, ARCH DIS CHILD, V45, P755, DOI 10.1136/adc.45.244.755; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Trence, 2000, ENDOTEXT; United States Anti Doping Agency, THER US EX TUES; Vilar L, 2017, PITUITARY, V20, P22, DOI 10.1007/s11102-016-0772-8; Widdowson WM, 2008, J CLIN ENDOCR METAB, V93, P4413, DOI 10.1210/jc.2008-1239; Widdowson WM, 2010, CLIN ENDOCRINOL, V72, P787, DOI 10.1111/j.1365-2265.2009.03716.x; Wolinski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088787; Woodhouse LJ, 1999, J CLIN ENDOCR METAB, V84, P4570, DOI 10.1210/jc.84.12.4570; World Anti Doping Agency, HUM GROWTH HORM HGH; World Anti Doping Agency, THER US EX; World Anti Doping Agency Guidelines, GUID HUM GROWTH HORM; World Anti-Doping Agency, PROH LIST; World Anti-Doping-Agency, MED INF SUPP DEC TUE; Xue P, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/216107	70	10	10	5	30	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	SEP-OCT	2018	10	5					419	426		10.1177/1941738118782688			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	GS2EF	WOS:000443353500006	29932857	Green Published			2022-02-06	
J	Walker, AL; Imam, SZ; Roberts, RA				Walker, Abigail L.; Imam, Syed Z.; Roberts, Ruth A.			Drug discovery and development: Biomarkers of neurotoxicity and neurodegeneration	EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						Biomarkers; central nervous system; drug development; drug safety; neurodegeneration; toxicology	TRAUMATIC BRAIN-INJURY; EXPRESSION; ATTRITION; PATHOLOGY; SAFETY	The discovery and development of new drugs are vital if we are to improve and expand treatment options available to improve outcomes for patients. Overall, therapeutic strategies fall into two broad categories: small molecules and biologics, although more recently there has been a growth in novel platforms such as miRNAs and oligonucleotides. On average, the development of a small molecule drug takes around 12 years and costs around $50m. Despite this huge investment of time and money, attrition remains a major challenge and very few molecules actually make it through to the market. Here, we look at reasons for attrition in the small molecule field with a focus on neurotoxicology and efforts being made to improve success via the development of imaging and fluidic biomarkers. We also look at learnings from other models of CNS damage and degeneration such as Parkinson's disease, traumatic brain injury, and multiple sclerosis since these may offer the opportunity to improve tools available to nonclinical toxicologists in the early detection of potential neurotoxicity. Reciprocally, learnings from studies of animal neurotoxicity may offer better ways to potentially monitor patients during clinical development of new drugs for neurodegeneration.	[Walker, Abigail L.] Univ Glasgow, Brain Sci Masters Programme, Dept Neurosci & Psychol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Imam, Syed Z.] US FDA, Div Neurotoxicol, NCTR, Jefferson, AR 72079 USA; [Roberts, Ruth A.] Apconix, Alderley Pk SK10 4TG, England; [Roberts, Ruth A.] Univ Birmingham, Edgbaston B15 2TT, England		Roberts, RA (corresponding author), Apconix, Alderley Pk SK10 4TG, England.; Roberts, RA (corresponding author), Univ Birmingham, Edgbaston B15 2TT, England.	r.roberts.4@bham.ac.uk					Arnhold M, 2016, CLIN AUTON RES, V26, P211, DOI 10.1007/s10286-016-0358-6; BALABAN CD, 1988, NEUROSCIENCE, V26, P337, DOI 10.1016/0306-4522(88)90150-9; Blesa J, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00155; Boretius S, 2012, NEUROIMAGE, V59, P2678, DOI 10.1016/j.neuroimage.2011.08.051; Brennan R., 2017, DRUG SAFETY EVALUATI, V1641; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Ellwardt E, 2014, EXP NEUROL, V262, P8, DOI 10.1016/j.expneurol.2014.02.006; Fang H, 2016, DRUG DISCOV TODAY, V21, P1566, DOI 10.1016/j.drudis.2016.06.006; Holmberg B, 2014, PARKINSONISM RELAT D, V20, P382; Hoye ML, 2017, J NEUROSCI, V37, P5574, DOI 10.1523/JNEUROSCI.3582-16.2017; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Imam SZ, 2018, EXP BIOL MED, V243, P228, DOI 10.1177/1535370217739859; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Olsen JA, 2016, EBIOMEDICINE, V10, P227, DOI 10.1016/j.ebiom.2016.06.031; Rivers TM, 1933, J EXP MED, V58, P39, DOI 10.1084/jem.58.1.39; Roberts RA, 2018, DRUG DISCOV TODAY, V23, P1925, DOI 10.1016/j.drudis.2018.05.028; Roberts RA, 2015, TOXICOL SCI, V148, P332, DOI 10.1093/toxsci/kfv188; Roberts RA, 2014, DRUG DISCOV TODAY, V19, P341, DOI 10.1016/j.drudis.2013.11.014; Roullet FI, 2013, NEUROTOXICOL TERATOL, V36, P47, DOI 10.1016/j.ntt.2013.01.004; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Stefanik P, 2015, PHARMACOL BIOCHEM BE, V131, P42, DOI 10.1016/j.pbb.2015.01.021; Waring MJ, 2015, NAT REV DRUG DISCOV, V14, P475, DOI 10.1038/nrd4609	25	10	11	2	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1535-3702	1535-3699		EXP BIOL MED	Exp. Biol. Med.	SEP	2018	243	13					1037	1045		10.1177/1535370218801309			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	HD7CR	WOS:000452708400003	30253665	Green Published, Bronze			2022-02-06	
J	Wilkerson, GB; Nabhan, DC; Prusmack, CJ; Moreau, WJ				Wilkerson, Gary B.; Nabhan, Dustin C.; Prusmack, Chad J.; Moreau, William J.			Detection of Persisting Concussion Effects on Neuromechanical Responsiveness	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						MILD TRAUMATIC BRAIN INJURY; DUAL-TASK CLINICAL ASSESSMENT; NEUROMECHANICS; PERCEPTION-ACTION COUPLING	ATTENTIONAL CONTROL; REACTION-TIME; INJURY RISK; FMRI; CONNECTIVITY; INTEGRATION; CORTEX; PERFORMANCE; MODALITIES; HANDEDNESS	Purpose Assessment of various indices of neuromechanical responsiveness for association with concussion history. Methods An observational cohort study included 48 elite athletes (34 males: 23.8 4.4 yr; 14 females: 25.4 4.5 yr) who performed visuomotor reaction time (VMRT) tests involving rapid manual contact with illuminated target buttons that included two dual-task conditions: 1) simultaneous oral recitation of scrolling text (VMRT+ST) and 2) simultaneous verbal responses to identify the right or left direction indicated by the center arrow of the Eriksen flanker test (VMRT+FT). A whole-body reactive agility (WBRA) test requiring side-shuffle movements in response to visual targets was used to assess reaction time, speed, acceleration, and deceleration. Results Concussion occurrence at 2.0 +/- 2.3 yr before testing was reported by 21 athletes. Strong univariable associations were found for VMRT+FT left minus right difference 15 ms (odds ratio [OR], 7.14), VMRT+ST outer two-ring to inner three-ring ratio 1.28 (OR, 4.58), and WBRA speed asymmetry 7.7% (OR, 4.67). A large VMRT+FT by VMRT+ST interaction effect was identified (OR, 25.00). Recursive partitioning identified a three-way VMRT+FT by VMRT+ST by WBRA interaction that had 100% positive predictive value for identification of athletes with concussion history, whereas negative status on all three factors had 90% negative predictive value. Conclusions Performance on dual-task VMRT tests and the WBRA test identified neuromechanical responsiveness deficiencies among elite athletes who reported a history of concussion.	[Wilkerson, Gary B.] Univ Tennessee, Chattanooga, TN USA; [Nabhan, Dustin C.; Moreau, William J.] US Olymp Comm, US Coalit Prevent Illness & Injury Sport, Colorado Springs, CO USA; [Prusmack, Chad J.] Rocky Mt Spine Clin, Englewood, CO USA		Wilkerson, GB (corresponding author), Univ Tennessee, Dept 6606, 615 McCallie Ave, Chattanooga, TN 37403 USA.	Gary-Wilkerson@utc.edu	Wilkerson, Gary B./AAG-4103-2021	Wilkerson, Gary B./0000-0001-8433-7329	International Olympic Committee (IOC)	Conflicts of interest and source of funding: The research was conducted in facilities of the US Coalition for the Prevention of Illness and Injury in Sport, which is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee (IOC). One of the authors (G.B.W.) has previously received a speaking honorarium and travel expense reimbursement from Dynavision International, and he has previously provided consulting services to Traq Global, Ltd.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Araujo D, 2019, INT REV SPORT EXER P, V12, P1, DOI 10.1080/1750984X.2017.1349826; Asanowicz D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00452; Carlei C, 2017, LATERALITY, P1; Chaumillon R, 2014, CORTEX, V58, P86, DOI 10.1016/j.cortex.2014.05.009; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Clark JF, 2017, CLIN J SPORT MED, V27, P457, DOI 10.1097/JSM.0000000000000381; Corballis PM, 2003, BRAIN COGNITION, V53, P171, DOI 10.1016/S0278-2626(03)00103-9; Dassonville P, 1997, P NATL ACAD SCI USA, V94, P14015, DOI 10.1073/pnas.94.25.14015; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; de Graaf TA, 2010, J COGNITIVE NEUROSCI, V22, P2012, DOI 10.1162/jocn.2009.21345; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Erickson KI, 2005, COGNITIVE BRAIN RES, V22, P349, DOI 10.1016/j.cogbrainres.2004.09.004; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; Heekeren HR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00010; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iacoboni M, 2004, NEUROPSYCHOLOGIA, V42, P419, DOI 10.1016/j.neuropsychologia.2003.10.007; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Leone C, 2017, NEUROSCI BIOBEHAV R, V75, P348, DOI 10.1016/j.neubiorev.2017.01.010; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Sack AT, 2007, CEREB CORTEX, V17, P2841, DOI 10.1093/cercor/bhm013; Serrien DJ, 2007, PROG NEUROBIOL, V82, P95, DOI 10.1016/j.pneurobio.2007.02.003; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Teel E, 2016, NEUROPSYCHOLOGY, V30, P474, DOI 10.1037/neu0000261; Teel EF, 2016, CLIN J SPORT MED, V26, P162, DOI 10.1097/JSM.0000000000000210; Ting LH, 2015, NEURON, V86, P38, DOI 10.1016/j.neuron.2015.02.042; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Wahn B, 2017, ADV COGN PSYCHOL, V13, P83, DOI 10.5709/acp-0209-2; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wilkerson GB, 2017, CURR SPORT MED REP, V16, P419, DOI 10.1249/JSR.0000000000000430; Wilkerson GB, 2017, J SPORT REHABIL, V26, P26, DOI 10.1123/jsr.2015-0068; Wilkerson GB, 2016, CLIN J SPORT MED, V26, P423, DOI 10.1097/JSM.0000000000000280; Wu T, 2013, NEUROIMAGE, V65, P466, DOI 10.1016/j.neuroimage.2012.10.004	40	10	10	1	40	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	SEP	2018	50	9					1750	1756		10.1249/MSS.0000000000001647			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	GQ5HM	WOS:000441712100004	29683918	Bronze			2022-02-06	
J	Yasen, AL; Smith, J; Christie, AD				Yasen, Alia L.; Smith, Jolinda; Christie, Anita D.			Glutamate and GABA concentrations following mild traumatic brain injury: a pilot study	JOURNAL OF NEUROPHYSIOLOGY			English	Article						GABA; glutamate; mild traumatic brain injury; proton magnetic resonance spectroscopy	CONCUSSION; SPORT; SPECTROSCOPY; RELIABILITY; SEVERITY	Animal models of mild traumatic brain injury (mTBI) suggest that metabolic changes in the brain occur immediately after a mechanical injury to the head. Proton magnetic resonance spectroscopy (H-1-MRS) can be used to determine relative concentrations of metabolites in vivo in the human brain. The purpose of this study was to determine concentrations of glutamate and GABA in the brain acutely after mTBI and throughout 2 mo of recovery. Concentrations of glutamate and GABA were obtained using H-1-MRS in nine individuals who had suffered an mTBI and nine control individuals in two brain regions of interest: the primary motor cortex (M1), and the dorsolateral prefrontal cortex (DLPFC), and at three different time points postinjury: 72 h, 2 wk, and 2 mo postinjury. There were no differences between groups in concentrations of glutamate or GABA, or the ratio of glutamate to GABA, in M1. In the DLPFC, glutamate concentration was lower in the mTBI group compared with controls at 72 h postinjury (d = 1.02), and GABA concentration was lower in the mTBI group at 72 h and 2 wk postinjury (d = 0.81 and d = 1.21, respectively). The ratio of glutamate to GABA in the DLPFC was higher in the mTBI group at 2 wk postinjury (d = 1.63). These results suggest that changes in glutamate and GABA concentrations in the brain may be region-specific and may depend on the amount of time that has elapsed postinjury. NEW & NOTEWORTHY To our knowledge, this is the first study to examine neurotransmitter concentrations in vivo at multiple time points throughout recovery from mild traumatic brain injury in humans.	[Yasen, Alia L.; Christie, Anita D.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [Smith, Jolinda] Univ Oregon, Robert & Beverly Lewis Ctr Neurolmaging, Eugene, OR 97403 USA		Christie, AD (corresponding author), Univ Western Ontario, Sch Kinesiol, 1151 Richmond St, London, ON, Canada.	achris95@uwo.ca			Eugene and Clarissa Evonuk Graduate Fellowship; Center for the Study of Women in Society Graduate Student Grant	A. L. Yasen was supported by the Eugene and Clarissa Evonuk Graduate Fellowship and a Center for the Study of Women in Society Graduate Student Grant.	Brizuela M, 2017, J NEUROTRAUM, V34, P2504, DOI 10.1089/neu.2017.4977; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Cantu RC, 2006, NEUROSURG FOCUS, V21, P1, DOI [10.3171/foc.2006.21.4.4, DOI 10.3171/FOC.2006.21.4.4]; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cohen J., 2013, STAT POWER ANAL BEHA; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gray C, 1998, BRAIN INJURY, V12, P429, DOI 10.1080/026990598122548; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Yasen AL, 2017, NEUROSCI LETT, V643, P121, DOI 10.1016/j.neulet.2017.02.039	20	10	11	0	3	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	SEP	2018	120	3					1318	1322		10.1152/jn.00896.2017			5	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	GX3UY	WOS:000447653800003	29924705	Bronze			2022-02-06	
J	Yang, Y; Zhang, KY; Zhong, J; Wang, J; Yu, ZY; Lei, XJ; Chen, X; Quan, YZ; Xian, JS; Chen, YJ; Liu, X; Feng, H; Tan, L				Yang, Yang; Zhang, Kaiyuan; Zhong, Jun; Wang, Ju; Yu, Zhongyuan; Lei, Xuejiao; Chen, Xuezhu; Quan, Yulian; Xian, Jishu; Chen, Yujie; Liu, Xin; Feng, Hua; Tan, Liang			Stably maintained microtubules protect dopamine neurons and alleviate depression-like behavior after intracerebral hemorrhage	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; POSTSTROKE DEPRESSION; RAT HIPPOCAMPUS; SYSTEM; PATHOPHYSIOLOGY; DEGENERATION; METABOLISM; DEFICITS; THERAPY	Mesolimbic dopamine (DA) system lesion plays a key role in the pathophysiology of depression, and our previous study demonstrated that reduced microtubule (MT) stability aggravated nigrostriatal pathway impairment after intracerebral hemorrhage (ICH). This study aimed to further investigate the occurrence regularity of depression-like behavior after ICH and determine whether maintaining MT stabilization could protect DA neurons in ventral tegmental area (VTA) and alleviate depression-like behavior after ICH. An intrastriatal injection of 20 mu l of autologous blood or MT depolymerization reagent nocodazole (Noco) was used to mimic the pathology of ICH model in mice. The concentration of DA, number of DA neurons and acetylated a-tubulin (a marker for stable MT) in VTA were checked, and depression-related behavior tests were performed after ICH. A MT-stabilizing agent, epothilone B (EpoB), was administered to explore the effects of MT stabilization on DA neurons and depression-like behavior after ICH. The results showed that obvious depression-like behavior occurred at 7, 14, and 28 days (P < 0.01) after ICH. These time-points were related to significant decreases in the concentration of DA (P < 0.01) and number of DA neurons (P < 0.01) in VTA. Moreover, The decrease of acetylated a-tubulin expression after ICH and Noco injection contributed to DA neurons' impairment in VTA, and Noco injecton also aggravate ICH-induced depression-like behaviors and DA neurons' injury. Furthermore, EpoB treatment significantly ameliorated ICH and Noco-induced depression-like behaviors (P < 0.05) and increased the concentration of DA (P < 0.05) and number of DA neurons (P < 0.05) in VTA by increasing the level of acetylated a-tubulin. The results indicate that EpoB can protect DA neurons by enhancing MT stability, and alleviate post-ICH depressive behaviors. This MT-targeted therapeutic strategy shows promise as a bench-to-bedside translational method for treating depression after ICH.	[Yang, Yang; Zhang, Kaiyuan; Zhong, Jun; Wang, Ju; Lei, Xuejiao; Chen, Xuezhu; Quan, Yulian; Xian, Jishu; Chen, Yujie; Liu, Xin; Feng, Hua; Tan, Liang] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Neurosurg, 29 Gaotanyan St, Chongqing 400038, Peoples R China; [Yu, Zhongyuan] Third Mil Med Univ, Army Med Univ, Cadet Brigade, 29 Gaotanyan St, Chongqing 400038, Peoples R China		Feng, H; Tan, L (corresponding author), Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Neurosurg, 29 Gaotanyan St, Chongqing 400038, Peoples R China.	fenghua8888@vip.163.com; tracy200712@hotmail.com	Chen, Yujie/AAS-6995-2021; Yang, Yang/AAC-6532-2022; Feng, Hua/AAX-4121-2021; Tan, Liang/AAS-3997-2020	Chen, Yujie/0000-0002-9905-9138; Yang, Yang/0000-0001-6472-5578; Feng, Hua/0000-0003-4489-9217; 	National Basic Research Program of China (973 Program)National Basic Research Program of China [2014CB541600]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601026]; Military Medical Science and Technology Innovation Plan of Southwest Hospital [SWH2017JSZD-10]	This study was supported by the National Basic Research Program of China (973 Program, No. 2014CB541600), the National Natural Science Foundation of China (No. 81601026) and the Military Medical Science and Technology Innovation Plan of Southwest Hospital (No. SWH2017JSZD-10).	Bakhtiarzadeh F, 2018, PHYSIOL BEHAV, V194, P9, DOI 10.1016/j.physbeh.2018.04.029; Bianchi M, 2006, EUR J NEUROSCI, V24, P2894, DOI 10.1111/j.1460-9568.2006.05170.x; Bianchi M., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P597; Bianchi M, 2009, SYNAPSE, V63, P359, DOI 10.1002/syn.20614; Chang CH, 2014, BIOL PSYCHIAT, V76, P223, DOI 10.1016/j.biopsych.2013.09.020; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Elsworth JD, 1997, EXP NEUROL, V144, P4, DOI 10.1006/exnr.1996.6379; Feng J, 2006, NEUROSCIENTIST, V12, P469, DOI 10.1177/1073858406293853; Gilsanz P, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001923; Grace AA, 2016, NAT REV NEUROSCI, V17, P524, DOI 10.1038/nrn.2016.57; Hoops D., 2018, ADOLESCENCE, V5, DOI [10.1523/eneuro.0372-17.2017, DOI 10.1523/ENEURO.0372-17.2017]; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Jesulola E, 2018, BEHAV BRAIN RES, V341, P79, DOI 10.1016/j.bbr.2017.12.025; Jiang WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126673; KAPUR S, 1992, BIOL PSYCHIAT, V32, P1, DOI 10.1016/0006-3223(92)90137-O; Kim YR, 2015, BEHAV BRAIN RES, V287, P294, DOI 10.1016/j.bbr.2015.03.062; Koivunen RJ, 2015, ACTA NEUROL SCAND, V132, P179, DOI 10.1111/ane.12367; Lenzi GL, 2008, REV NEUROL-FRANCE, V164, P837, DOI 10.1016/j.neurol.2008.07.010; Liang YJ, 2008, J NEUROCHEM, V106, P1815, DOI 10.1111/j.1471-4159.2008.05526.x; Liu L, 2016, ONCOTARGET, V7, P56045, DOI 10.18632/oncotarget.11178; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Nagatsu T, 2009, PARKINSONISM RELAT D, V15, pS3, DOI 10.1016/S1353-8020(09)70004-5; Naranjo CA, 2001, PROG NEURO-PSYCHOPH, V25, P781, DOI 10.1016/S0278-5846(01)00156-7; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Neumann B, 2014, CELL REP, V6, P93, DOI 10.1016/j.celrep.2013.12.004; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Steinkellner T, 2018, J CLIN INVEST, V128, P774, DOI 10.1172/JCI95795; Stern-Nezer S, 2017, NEUROREHABILITATION, V41, P179, DOI 10.3233/NRE-171470; Tan L, 2015, BEHAV BRAIN RES, V279, P274, DOI 10.1016/j.bbr.2014.10.037; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Valenti O, 2012, EUR J NEUROSCI, V35, P1312, DOI 10.1111/j.1460-9568.2012.08038.x; Villa RF, 2018, PHARMACOL THERAPEUT, V184, P131, DOI 10.1016/j.pharmthera.2017.11.005; Wang PW, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00288; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Xie ZY, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005198; Yang Y, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007626; Yang Y, 2014, MOL NEUROBIOL, V49, P176, DOI 10.1007/s12035-013-8510-y; Yang YR, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005811; Zhang B, 2012, J NEUROSCI, V32, P3601, DOI 10.1523/JNEUROSCI.4922-11.2012; Zhao HL, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0940-4; Zhong Q, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004340	45	10	10	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 23	2018	8								12647	10.1038/s41598-018-31056-7			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR3XD	WOS:000442530000011	30140021	Green Published, gold			2022-02-06	
J	Bohart, S; Egerod, I; Bestle, MH; Overgaard, D; Christensen, DF; Jensen, JF				Bohart, Sos; Egerod, Ingrid; Bestle, Morten H.; Overgaard, Dorthe; Christensen, Doris F.; Jensen, Janet F.			Recovery programme for ICU survivors has no effect on relatives' quality of life: Secondary analysis of the RAPIT-study	INTENSIVE AND CRITICAL CARE NURSING			English	Article						Aftercare; Family; Follow-up; ICU clinic; Intensive care; Mental health; Multicentre; Quality of life; Randomised controlled trial; Relatives	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE DIARIES; FAMILY-MEMBERS; CRITICAL ILLNESS; COHERENCE; SYMPTOMS; SENSE; CAREGIVERS; DEPRESSION	Background: Relatives of intensive care patients are at risk of developing symptoms of anxiety, depression and posttraumatic stress resulting in reduced health-related quality of life. Recovery programmes for patients have been implemented, but their effect on relatives is uncertain. Aim: To determine whether relatives benefit from a recovery programme intended for intensive care survivors. Research design: A randomised controlled trial of 181 adult relatives: intervention group (n = 87), control group (n = 94). Setting: Ten intensive care units in Denmark. Main outcome measures: Primary outcome: health-related quality of life (HRQOL). Secondary outcomes: Sense of coherence (SOC), and symptoms of anxiety, depression and posttraumatic stress, compared to standard care at 12 months after intensive care discharge. Results: No difference in HRQOL between groups was observed at 12 months (mean difference in mental component summary score, 1.35 [CI 95%: -3.13; 5.82], p = 0.55; and physical component summery score, 1.86 [CI 95%: - 1.88; 5.59], p = 0.33). No differences were found in secondary outcomes. Conclusion: The recovery programme intended for intensive care survivors did not have an effect on the relatives. Future recovery programmes should be targeted to help both patient and family, and future research should be conducted on a larger scale to make conclusions with higher probability. (C) 2018 Elsevier Ltd. All rights reserved.	[Bohart, Sos] Univ Copenhagen, Herlev Hosp, Dept Anesthesiol, Herlev Ringvej 75, DK-2730 Herlev, Denmark; [Egerod, Ingrid] Univ Copenhagen, Hlth & Med Sci, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Egerod, Ingrid] Univ Copenhagen, Rigshosp, Intens Care Unit 4131, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Bestle, Morten H.; Christensen, Doris F.] Nordsjaellands Hosp, Dyrehavevej 29, DK-3400 Hillerod, Denmark; [Overgaard, Dorthe] Metropolitan Univ Coll, Inst Nursing, Tagensvej 86, DK-2200 Copenhagen, Denmark; [Jensen, Janet F.] Holbaek Cent Hosp, Dept Anesthesiol, Smedelundsgade 60, DK-4300 Holbaek, Denmark; [Jensen, Janet F.] Univ Copenhagen, Nordsjaellands Hosp, Dyrehavevej 29, DK-3400 Hillerod, Denmark		Bohart, S (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Anesthesiol, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	soes.bohart@regionh.dk; Ingrid.egerod@regionh.dk; morten.bestle@regionh.dk; doov@phmetropol.dk; jfje@regionsjaelland.dk		Egerod, Ingrid/0000-0002-9576-4390; Bohart, Sos/0000-0002-1502-4916; Bestle, Morten/0000-0001-6585-2659	Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited [NNF13OC0006107]; Danish Nursing Organization; Nordsjaellands Hospital, University of Copenhagen, Denmark	The study was supported by The Novo Nordisk Foundation [NNF13OC0006107], the Danish Nursing Organization, and Nordsjaellands Hospital, University of Copenhagen, Denmark.	Aitken LM, 2017, J CRIT CARE, V38, P263, DOI 10.1016/j.jcrc.2016.12.003; Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; ASHBY M, 1995, J MED ETHICS, V21, P135, DOI 10.1136/jme.21.3.135; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BjOrner JB., 1997, DANSK MANUAL SF 36 S; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Carson SS, 2016, JAMA-J AM MED ASSOC, V316, P51, DOI 10.1001/jama.2016.8474; Davidson JE, 2012, CRIT CARE MED, V40, P618, DOI 10.1097/CCM.0b013e318236ebf9; Due E P, 1998, Ugeskr Laeger, V160, P7424; Elklit A, 2005, SCAND J PSYCHOL, V46, P439, DOI 10.1111/j.1467-9450.2005.00475.x; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; Frivold G, 2016, J CLIN NURS, V25, P392, DOI 10.1111/jocn.13059; Goldfarb M. J, 2017, CRIT CARE MED; Jensen JF, 2016, INTENS CARE MED, V42, P1733, DOI 10.1007/s00134-016-4522-1; Jones C, 2004, INTENS CARE MED, V30, P456, DOI 10.1007/s00134-003-2149-5; Khanjari S, 2012, CANCER NURS, V35, P148, DOI 10.1097/NCC.0b013e31821f1dda; Lasiter S, 2016, CLIN NURSE SPEC, V30, P227, DOI 10.1097/NUR.0000000000000219; Fumis RRL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115332; Long AC, 2016, CURR OPIN CRIT CARE, V22, P613, DOI 10.1097/MCC.0000000000000360; Matt B, 2017, J CRIT CARE, V39, P172, DOI 10.1016/j.jcrc.2017.02.036; McAdam JL, 2012, AM J CRIT CARE, V21, P386, DOI 10.4037/ajcc2012582; Mizuno E, 2012, ARCH PSYCHIAT NURS, V26, P295, DOI 10.1016/j.apnu.2012.01.003; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Nilsson KW, 2010, J EPIDEMIOL COMMUN H, V64, P347, DOI 10.1136/jech.2008.081174; Pochard F, 2005, J CRIT CARE, V20, P90, DOI 10.1016/j.jcrc.2004.11.004; Rodriguez AM, 2005, J PSYCHOSOM RES, V58, P447, DOI 10.1016/j.jpsychores.2004.11.011; Rueckriegel SM, 2015, ACTA NEUROCHIR, V157, P1329, DOI 10.1007/s00701-015-2470-0; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Svenningsen H, 2017, NURS CRIT CARE, V22, P212, DOI 10.1111/nicc.12165; Ullman AJ, 2015, INT J NURS STUD, V52, P1243, DOI 10.1016/j.ijnurstu.2015.03.020; van Beusekom I, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1185-9	33	10	10	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0964-3397	1532-4036		INTENS CRIT CARE NUR	Intensive Crit. Care Nurs.	AUG	2018	47						39	45		10.1016/j.iccn.2018.03.002			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	GK9ZU	WOS:000436619800007	29606480				2022-02-06	
J	Chen, HJC; Spiers, JG; Sernia, C; Lavidis, NA				Chen, Hsiao-Jou Cortina; Spiers, Jereme G.; Sernia, Conrad; Lavidis, Nickolas A.			Inhibition of Fatty Acid Amide Hydrolase by PF-3845 Alleviates the Nitrergic and Proinflammatory Response in Rat Hippocampus Following Acute Stress	INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY			English	Article						acute stress; endocannabinoids; fatty acid amide hydrolase inhibitor; inducible nitric oxide synthase; neuroinflammatory response	NF-KAPPA-B; PITUITARY-ADRENAL AXIS; RECEPTOR-GAMMA ACTIVATION; NITRIC-OXIDE PRODUCTION; MICROGLIAL ACTIVATION; INFLAMMATORY PAIN; GLUCOCORTICOIDS; BRAIN; EXPRESSION; SYSTEM	Background: Long-term exposure to stress has been demonstrated to cause neuroinflammation through a sustained overproduction of free radicals, including nitric oxide, via an increased inducible nitric oxide synthase activity. We previously demonstrated that inducible nitric oxide synthase activity and mRNA are significantly upregulated in the rat hippocampus following just 4 hours of restraint stress. Similar to nitric oxide, endocannabinoids are synthesized on demand, with preclinical observations suggesting that cannabinoid receptor agonists and endocannabinoid enhancers inhibit nitrergic activity. Specifically, previous work has shown that enhancement of endocannabinoids via inhibition of fatty acid amide hydrolase with PF-3845 reduced inducible nitric oxide synthase-expressing microglia following traumatic brain injury. However, this describes cannabinoid modulation following physical injury, and therefore the present study aimed to examine the effects of PF-3845 in the modulation of nitrergic and inflammatory-related genes within the hippocampus after acute stress exposure. Methods: Following vehicle or PF-3845 injections (5 mg/kg; i.p.), male Wistar rats were exposed to 0 (control), 60, 240, or 360 minutes of restraint stress after which plasma and dorsal hippocampus were isolated for further biochemical and gene expression analysis. Results: The results demonstrate that pretreatment with PF-3845 rapidly ameliorates plasma corticosterone release at 60 minutes of stress. An increase in endocannabinoid signalling also induces an overall attenuation in inducible nitric oxide synthase, tumor necrosis factor-alpha convertase, interleukin-6, cyclooxygenase-2, peroxisome proliferator-activated receptor gamma mRNA, and the transactivation potential of nuclear factor kappa-light-chain-enhancer of activated B cells in the hippocampus. Conclusions: These results suggest that enhanced endocannabinoid levels in the dorsal hippocampus have an overall antinitrosative and antiinflammatory effect following acute stress exposure.	[Chen, Hsiao-Jou Cortina; Spiers, Jereme G.; Lavidis, Nickolas A.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia; [Sernia, Conrad] Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England		Chen, HJC (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia.	h.chen6@uq.edu.au	Chen, Hsiao-Jou Cortina/AAF-2662-2019; Spiers, Jereme G/I-4585-2019	Chen, Hsiao-Jou Cortina/0000-0001-6315-9850; Spiers, Jereme/0000-0001-5872-8983	University of Queensland Research Grant; APA scholarship; UQRS scholarship	This work was supported by a University of Queensland Research Grant. H.-J.C. Chen and J.G. Spiers were recipients of APA and UQRS scholarships. These funding bodies have no further role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Albrecht U, 2007, CELL SIGNAL, V19, P1866, DOI 10.1016/j.cellsig.2007.04.007; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P1632, DOI 10.1016/j.drudis.2014.06.007; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Bethin KE, 2000, P NATL ACAD SCI USA, V97, P9317, DOI 10.1073/pnas.97.16.9317; Blandino P, 2006, J NEUROIMMUNOL, V173, P87, DOI 10.1016/j.jneuroim.2005.11.021; Blandino P, 2009, BRAIN BEHAV IMMUN, V23, P958, DOI 10.1016/j.bbi.2009.04.013; Bluett RJ, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.53; Bottero Virginie, 2003, Mol Diagn, V7, P187, DOI 10.2165/00066982-200307030-00008; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Cancedda C, 2002, ANN NY ACAD SCI, V966, P49, DOI 10.1111/j.1749-6632.2002.tb04201.x; Chen HJC, 2016, FREE RADICAL BIO MED, V90, P219, DOI 10.1016/j.freeradbiomed.2015.11.023; Chen HJC, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00003; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cota D, 2007, ENDOCRINOLOGY, V148, P1574, DOI 10.1210/en.2005-1649; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; D'Agostino G, 2007, J PHARMACOL EXP THER, V322, P1137, DOI 10.1124/jpet.107.123265; de Pablos RM, 2006, J NEUROSCI, V26, P5709, DOI 10.1523/JNEUROSCI.0802-06.2006; de Paiva VN, 2010, BEHAV BRAIN RES, V215, P146, DOI 10.1016/j.bbr.2010.07.015; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Duan TT, 2017, J PSYCHIATR NEUROSCI, V42, P230, DOI 10.1503/jpn.160116; Esposito G, 2001, J NEUROCHEM, V78, P835, DOI 10.1046/j.1471-4159.2001.00465.x; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Frank MG, 2012, BRAIN BEHAV IMMUN, V26, P337, DOI 10.1016/j.bbi.2011.10.005; Garcia-Bueno B, 2005, BIOL PSYCHIAT, V57, P885, DOI 10.1016/j.biopsych.2005.01.007; Garcia-Bueno B, 2008, ENDOCRINOLOGY, V149, P1969, DOI 10.1210/en.2007-0482; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Hermanson DJ, 2014, TRENDS PHARMACOL SCI, V35, P358, DOI 10.1016/j.tips.2014.04.006; Hill MN, 2011, J NEUROSCI, V31, P10506, DOI 10.1523/JNEUROSCI.0496-11.2011; Hill MN, 2009, NEUROPSYCHOPHARMACOL, V34, P2733, DOI 10.1038/npp.2009.114; Johnson JD, 2002, BRAIN BEHAV IMMUN, V16, P461, DOI 10.1006/brbi.2001.0638; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Ma YB, 2013, BRAIN RES, V1508, P23, DOI 10.1016/j.brainres.2013.02.042; Madrigal JLM, 2002, NEUROPSYCHOPHARMACOL, V26, P155, DOI 10.1016/S0893-133X(01)00292-5; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Moss ML, 2001, DRUG DISCOV TODAY, V6, P417, DOI 10.1016/S1359-6446(01)01738-X; Naidu PS, 2010, J PHARMACOL EXP THER, V334, P182, DOI 10.1124/jpet.109.164806; O'Sullivan SE, 2016, BRIT J PHARMACOL, V173, P1899, DOI 10.1111/bph.13497; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-20; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Ramarao MK, 2005, ANAL BIOCHEM, V343, P143, DOI 10.1016/j.ab.2005.04.032; Rettori E, 2012, NEUROIMMUNOMODULAT, V19, P293, DOI 10.1159/000339113; Rivera P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00098; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Sorrells SF, 2009, NEURON, V64, P33, DOI 10.1016/j.neuron.2009.09.032; Spiers JG, 2016, PSYCHONEUROENDOCRINO, V67, P104, DOI 10.1016/j.psyneuen.2016.02.005; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Steiner MA, 2008, PSYCHONEUROENDOCRINO, V33, P1165, DOI 10.1016/j.psyneuen.2008.06.004; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Sugama S, 2007, NEUROSCIENCE, V146, P1388, DOI 10.1016/j.neuroscience.2007.02.043; Sugama S, 2011, J NEUROIMMUNOL, V233, P29, DOI 10.1016/j.jneuroim.2010.11.002; Sugama S, 2009, J NEUROIMMUNOL, V207, P24, DOI 10.1016/j.jneuroim.2008.11.007; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Teeling JL, 2010, BRAIN BEHAV IMMUN, V24, P409, DOI 10.1016/j.bbi.2009.11.006; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; Udechukwu MC, 2017, RSC ADV, V7, P26361, DOI 10.1039/c6ra26678a; Ulrich-Lai YM, 2013, EXP GERONTOL, V48, P671, DOI 10.1016/j.exger.2012.08.011; Wade MR, 2006, EUR J PHARMACOL, V551, P162, DOI 10.1016/j.ejphar.2006.08.083; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Won JS, 2004, FREE RADICAL BIO MED, V37, P1834, DOI 10.1016/j.freeradbiomed.2004.08.017	69	10	10	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1461-1457	1469-5111		INT J NEUROPSYCHOPH	Int. J. Neuropsychopharmacol.	AUG	2018	21	8					786	795		10.1093/ijnp/pyy033			10	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	GV5WA	WOS:000446174500009	29579222	Green Submitted, Green Published, gold			2022-02-06	
J	Huang, BL; Xu, QS; Ye, R; Xu, J				Huang, Beilei; Xu, Qiusheng; Ye, Ru; Xu, Jun			Influence of tranexamic acid on cerebral hemorrhage: A meta-analysis of randomized controlled trials	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Tranexamic acid; Cerebral hemorrhage; Randomized controlled trials; Systematic review; Meta-analysis	TRAUMATIC BRAIN-INJURY; ANTIFIBRINOLYTIC TREATMENT; SUBARACHNOID HEMORRHAGE; QUALITY; CRASH-2	Tranexamic acid might be beneficial for cerebral hemorrhage. However, the results remained controversial. We conducted a systematic review and meta-analysis to explore the influence of tranexamic acid on cerebral hemorrhage. PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases were systematically searched. Randomized controlled trials (RCTs) assessing the effect of tranexamic acid on cerebral hemorrhage were included. Two investigators independently searched articles, extracted data, and assessed the quality of included studies. This meta-analysis was performed using the random-effect model. Seven RCTs involving 1702 patients were included in the meta-analysis. Overall, compared with control intervention in cerebral hemorrhage, tranexamic acid could significantly reduce growth of hemorrhagic mass (RR = 0.78; 95% CI = 0.61-0.99; P = 0.04) and unfavorable outcome (RR = 0.75; 95% CI = 0.61-0.93; P = 0.008), but demonstrated no substantial influence on volume of hemorrhagic lesion (Std. MD = - 0.10; 95% CI = - 0.27 to 0.08; P = 0.28), neurologic deterioration (RR = 1.25; 95% CI = 0.60-2.60; P = 0.56), rebleeding (RR = 0.62; 95% CI = 0.35-1.09; P = 0.10), surgery requirement (RR = 0.78; 95% CI = 0.40-1.51; P = 0.46), and mortality (RR = 0.86; 95% CI = 0.69-1.05; P = 0.14). Compared to control intervention in cerebral hemorrhage, tranexamic acid was found to significantly decrease growth of hemorrhagic mass and unfavorable outcome, but showed no notable impact on volume of hemorrhagic lesion, neurologic deterioration, rebleeding, surgery requirement and mortality.	[Huang, Beilei; Xu, Qiusheng; Ye, Ru; Xu, Jun] Wenzhou Med Univ, Clin Inst 3, Wenzhou Maternal & Child Hlth Care Hosp, Emergency Dept,Wenzhou Peoples Hosp, Wenzhou 400700, Zhejiang, Peoples R China		Xu, J (corresponding author), Wenzhou Med Univ, Clin Inst 3, Wenzhou Maternal & Child Hlth Care Hosp, Emergency Dept,Wenzhou Peoples Hosp, Wenzhou 400700, Zhejiang, Peoples R China.	hblhl3@163.com; 179188321@qq.com; 30374686@qq.com; 969130435@qq.com					Alajmi Turki, 2017, J Spine Surg, V3, P531, DOI 10.21037/jss.2017.08.17; AlMatter M, 2018, CLIN NEUROL NEUROSUR, V167, P106, DOI 10.1016/j.clineuro.2018.02.022; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Asehnoune K, 2017, INTENS CARE MED, V43, P1340, DOI 10.1007/s00134-017-4895-9; Boudreau RM, 2017, J SURG RES, V215, P47, DOI 10.1016/j.jss.2017.03.031; Carothers C, 2018, J SURG RES, V223, P183, DOI 10.1016/j.jss.2017.11.008; Dollman AK, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00121; Edwards P, 2005, LANCET, V365, P1957; Fakharian E, 2018, WORLD NEUROSURG, V109, pE748, DOI 10.1016/j.wneu.2017.10.075; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hollig A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00694; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Kanser RJ, 2018, The Clinical Neuropsychologist, V33, P1, DOI 10.1080/13854046.2018.1440006; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Moher D, 2009, BMJ, V339; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Roberts I, 2012, BMJ, V345; Roos Y, 2000, NEUROLOGY, V54, P77, DOI 10.1212/WNL.54.1.77; Roos YB, 2003, COCHRANE DB SYST REV, V2, DOI [DOI 10.1002/14651858.CD001245, 10.1002/14651858.CD001245]; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sprigg N, 2014, J STROKE CEREBROVASC, V23, P1312, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.007; VERMEULEN M, 1984, NEW ENGL J MED, V311, P432, DOI 10.1056/NEJM198408163110703; Wang WD, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009396; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; Yen SH, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9105645; Yu WQ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008542; Yuksen C, 2017, NEUROL RES INT, V2017, DOI 10.1155/2017/5385613; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	30	10	10	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2018	171						174	178		10.1016/j.clineuro.2018.06.017			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GO0YR	WOS:000439673100028	29929173				2022-02-06	
J	Ortega-Perez, S; Amaya-Rey, MC				Ortega-Perez, Stefany; Consuelo Amaya-Rey, Maria			Secondary Brain Injury: A Concept Analysis	JOURNAL OF NEUROSCIENCE NURSING			English	Article						concept analysis; nursing interventions; secondary brain injury; traumatic brain injury	EMERGENCY NURSING MANAGEMENT; INTRACRANIAL-PRESSURE; SUBARACHNOID HEMORRHAGE; NEUROINTENSIVE CARE; INTERVENTIONS; INSULTS; NURSES; IMPACT; BUNDLE	Background: Traumatic brain injury and cerebrovascular disease may lead to motor, behavioral, and/or cognitive disabilities. The associated neurologic and vascular damage triggers a chain of events that lead to a secondary brain injury (SBI), a preventable cause of adverse neurological outcomes. Proper prevention of these factors may limit undesirable outcomes. This article presents a concept analysis that aims to form a single definition of the term secondary brain injury for nursing personnel. Methodology: Concept analysis was used to clarify the concept of SBI. An electronic search was performed on existing nursing literature dating from 1995 to 2016 on PubMed, MEDLINE, Ovid Journal, Wiley, and ProQuest. Results: A clear definition and description of the attributes, antecedents, and consequences of SBI increases the knowledge and level of recognition of the secondary injuries. This may lead to strategies that reduce the risk of long-term effects (disability) and poor clinical outcomes. Conclusions: This concept analysis contributes to the endeavor of identifying phenomena that are pertinent for nursing; it also provides a basis for future research that leads to improving nursing interventions and creating educational programs and healthcare policies that prevent or eliminate the consequences of SBI.	[Ortega-Perez, Stefany] Univ Norte, Nursing Sch, Barranquilla, Colombia; [Ortega-Perez, Stefany] Univ Nacl Colombia, Bogota, Colombia; [Consuelo Amaya-Rey, Maria] Univ Nacl Colombia, Nursing Sch, Bogota, Colombia		Ortega-Perez, S (corresponding author), Univ Norte, Nursing Sch, Barranquilla, Colombia.; Ortega-Perez, S (corresponding author), Univ Nacl Colombia, Bogota, Colombia.	srortega@uninorte.edu.co	ORTEGA-PEREZ, STEFANY/I-9311-2019	ORTEGA-PEREZ, STEFANY/0000-0003-3058-5161	Colciencias grantDepartamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias [757]; Universidad Nacional de Colombia; Universidad del Norte (Barranquilla-Colombia)	The authors express their thanks to Colciencias grant 757, Universidad Nacional de Colombia (internship travel grant), and the Universidad del Norte (Barranquilla-Colombia) and its academic development program.	Alexander Sheila A, 2008, Crit Care Nurs Clin North Am, V20, P203, DOI 10.1016/j.ccell.2008.01.001; Lopez EA, 2009, MED INTENSIVA, V33, P16; [Anonymous], 2018, CAMBRIDGE ADV LEARNE; Blissitt PA, 2006, AACN ADV CRIT CARE, V17, P327, DOI 10.1097/01256961-200607000-00012; Chamberlain D J, 1998, Aust Crit Care, V11, P123, DOI 10.1016/S1036-7314(98)70499-0; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Damkliang J, 2015, J CLIN NURS, V24, P3365, DOI 10.1111/jocn.12923; Damkliang J, 2015, INT EMERG NURS, V23, P299, DOI 10.1016/j.ienj.2015.04.004; Damkliang J, 2013, AUSTRALAS EMERG NURS, V16, P127, DOI 10.1016/j.aenj.2013.09.001; Duric Amira, 2006, Med Arh, V60, P120; Enblad P, 1997, J NEUROL NEUROSUR PS, V62, P512, DOI 10.1136/jnnp.62.5.512; Ibarra Pedro, 2005, Rev. colomb. anestesiol., V33, P259; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Ledwith MB, 2010, J NEUROSCI NURS, V42, P280, DOI 10.1097/JNN.0b013e3181ecafd4; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; McNett M, 2010, AM J CRIT CARE, V19, P250, DOI 10.4037/ajcc2009293; McNett MM, 2010, J NEUROSCI NURS, V42, P71, DOI 10.1097/JNN.0b013e3181ce5b8a; Mitchell PH, 2015, ANNU REV NURS RES-SE, V33, P111, DOI 10.1891/0739-6686.33.111; Mrozek S, 2014, CRIT CARE, V18, DOI 10.1186/cc13841; Nyholm L, 2014, J NEUROSCI NURS, V46, P285, DOI 10.1097/JNN.0000000000000077; Olson DM, 2013, AM J CRIT CARE, V22, P431, DOI 10.4037/ajcc2013751; Presciutti Mary, 2006, J Neurosci Nurs, V38, P296; Rhudy LM, 2013, J NEUROSCI NURS, V45, P262, DOI 10.1097/JNN.0b013e31829db987; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; Snedden TR, 2013, J SPEC PEDIATR NURS, V18, P211, DOI 10.1111/jspn.12038; Walker LO., 2011, STRATEGIES THEORY CO, V5. ed; Wong F W, 2000, Crit Care Nurse, V20, P18; Wuchner SS, 2012, J NEUROSCI NURS, V44, P177, DOI 10.1097/JNN.0b013e318252763f; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460	29	10	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	AUG	2018	50	4					220	224		10.1097/JNN.0000000000000384			5	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	GM9BD	WOS:000438535200007	29985274				2022-02-06	
J	Salberg, S; Christensen, J; Yamakawa, GR; Lengkeek, C; Malik, H; Tabor, J; Hazari, A; Mychasiuk, R				Salberg, Sabrina; Christensen, Jennaya; Yamakawa, Glenn R.; Lengkeek, Connor; Malik, Haris; Tabor, Jason; Hazari, Ali; Mychasiuk, Richelle			A Bump on the Head or Late to Bed: Behavioral and Pathophysiological Effects of Sleep Deprivation after Repetitive Mild Traumatic Brain Injury in Adolescent Rats	JOURNAL OF NEUROTRAUMA			English	Article						anterior cingulate cortex; concussion; cytokine; hippocampus; hypothalamus; mRNA; pre-frontal cortex; telomere	TELOMERE LENGTH; POSTCONCUSSION SYNDROME; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; GENE-EXPRESSION; PAIN PERCEPTION; CHILDREN; CONCUSSION; SYSTEM; MODEL	An old wives' tale, and strongly held dogma, maintains that one should be kept awake after a mild traumatic brain injury (mTBI) to prevent a coma. This, however, conflicts with the known benefits of sleep: repair and restoration. We therefore sought to examine the effects of sleep deprivation (SD) in the post -traumatic sleep period on post -concussion symptomology (PCS). Adolescent male and female rats were administered repetitive mTBIs (RmTBI) or sham injuries and were then assigned to 5 h of SD or left undisturbed. All animals were then tested using seven behavioral tasks validated to examine PCS, followed by analysis of serum cytokines, and quantitative real-time PCR for messenger RNA (mRNA) expression. Exposure to 3 SD epochs significantly impaired behavior in 4 of 7 of the measures, while RmTBI also produced dysfunction in 5 of 7 tests, but the effects of SD and RmTBI were not cumulative. SD induced long-lasting changes in serum levels of Tnf-a, IL6, and IL -113. mRNA expression in the pre -frontal cortex, hippocampus, hypothalamus, and anterior cingulate cortex was modified in response to SD and RmTBI; but similar to the behavioral measures, the mRNA changes were not cumulative. Consequently, we report that SD often produced impairments similar or worse than RmTBI, and sleep hygiene should become a priority for adolescent health.	[Salberg, Sabrina; Christensen, Jennaya; Yamakawa, Glenn R.; Lengkeek, Connor; Malik, Haris; Tabor, Jason; Hazari, Ali; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada		Mychasiuk, R (corresponding author), Alberta Childrens Prov Gen Hosp, Res Inst, Hotchkiss Brain Inst, Heritage Med Res Bldg 274,3330 Hosp Dr NW, Calgary, AB T2N 1N4, Canada.	rmmychas@ucalgary.ca		Yamakawa, Glenn/0000-0003-3079-6532			Abe K, 2016, NEUROL RES, V38, P358, DOI 10.1080/01616412.2015.1110402; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beebe DW, 2011, PEDIATR CLIN N AM, V58, P649, DOI 10.1016/j.pcl.2011.03.002; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Brooks J, 2005, J ANAT, V207, P19, DOI 10.1111/j.1469-7580.2005.00428.x; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Carskadon MA, 1999, PHI DELTA KAPPAN, V80, P348; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colrain IM, 2011, NEUROPSYCHOL REV, V21, P5, DOI 10.1007/s11065-010-9155-5; Dahl R E, 1996, Semin Pediatr Neurol, V3, P44, DOI 10.1016/S1071-9091(96)80028-3; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Eitan E, 2014, TRENDS NEUROSCI, V37, P256, DOI 10.1016/j.tins.2014.02.010; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; HORNE JA, 1993, BRIT J PSYCHIAT, V162, P413, DOI 10.1192/bjp.162.3.413; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Irwin MR, 2016, BIOL PSYCHIAT, V80, P40, DOI 10.1016/j.biopsych.2015.05.014; Jackowska M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047292; James S, 2017, J PEDIATR-US, V187, P247, DOI 10.1016/j.jpeds.2017.05.014; Jan JE, 2010, EUR J PAEDIATR NEURO, V14, P380, DOI 10.1016/j.ejpn.2010.05.001; Jeong Hey-Kyeong, 2013, Exp Neurobiol, V22, P59, DOI 10.5607/en.2013.22.2.59; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Klapper W, 2001, MECH AGEING DEV, V122, P695, DOI 10.1016/S0047-6374(01)00223-8; Kopasz M, 2010, SLEEP MED REV, V14, P167, DOI 10.1016/j.smrv.2009.10.006; Leung A, 2016, MOL PAIN, V12, DOI 10.1177/1744806916662661; LLorens-Martin M, 2009, NEUROSCIENTIST, V15, P134, DOI 10.1177/1073858408331371; Lorton D, 2006, NEUROIMMUNOMODULAT, V13, P357, DOI 10.1159/000104864; Lucke-Wold BP, 2015, NEUROSCI BIOBEHAV R, V55, P68, DOI 10.1016/j.neubiorev.2015.04.010; Mendelsohn AR, 2013, REJUV RES, V16, P518, DOI 10.1089/rej.2013.1530; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Moore M, 2009, J PEDIATR PSYCHOL, V34, P1175, DOI 10.1093/jpepsy/jsp039; Mychasiuk R, 2016, NEUROSCI BIOBEHAV R, V70, P189, DOI 10.1016/j.neubiorev.2016.07.013; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Novati A, 2011, NEUROSCIENCE, V190, P145, DOI 10.1016/j.neuroscience.2011.06.027; O'Brien LM, 2009, CHILD ADOL PSYCH CL, V18, P813, DOI 10.1016/j.chc.2009.04.008; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Pace-Schott E., 2002, NAT REV NEUROSCI, V3, P591; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Roman V, 2005, SLEEP, V28, P1505; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	69	10	11	2	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2018	35	16					1895	1905		10.1089/neu.2018.5744			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GQ2YY	WOS:000441527400008	30074871				2022-02-06	
J	Chevin, M; Guiraut, C; Sebire, G				Chevin, Mathilde; Guiraut, Clemence; Sebire, Guillaume			Effect of hypothermia on interleukin-1 receptor antagonist pharmacodynamics in inflammatory-sensitized hypoxic-ischemic encephalopathy of term newborns	JOURNAL OF NEUROINFLAMMATION			English	Article						Cerebral palsy; HT; IL-1Ra; Neonatal encephalopathy; Inflammation	THERAPEUTIC HYPOTHERMIA; CEREBROSPINAL-FLUID; CEREBRAL-PALSY; CISTERNA-MAGNA; ADULT RATS; LIPOPOLYSACCHARIDE; MODEL; INJURY; DEFICITS; OUTCOMES	Background: Hypothermia is increasingly tested in several neurological conditions, such as neonatal encephalopathy, stroke, traumatic brain injury, subarachnoid hemorrhage, spinal cord injury, and neurological outcomes of cardiac arrest Current studies aim to increase benefits of hypothermia with new add-on therapies including immunomodulatory agents. Hypothermia has been shown to affect the metabolism of commonly used drugs, including those acting on neuroimmune pathways. Objective: This study focuses on the effect of hypothermia on interleukin-1 receptor antagonist pharmacodynamics in a model of neonatal encephalopathy. Methods: The effect of hypothermia on (i) the tissue concentration of the interleukin-1 receptor antagonist (ii) the interleukin-1 inflammatory cascade, and (iii) the neuroprotective potential of interleukin-1 receptor antagonist has been assessed on our rat model of neonatal encephalopathy resulting from inflammation induced by bacterial compound plus hypoxia-ischemia. Results: Hypothermia reduced the surface of core and penumbra lesions, as well as alleviated the brain weight loss induced by LPS+HI exposure. Hypothermia compared to normothermia significantly increased (range 50-65%) the concentration of the interleukin-1 receptor antagonist within the central nervous system. Despite this increase of intracerebral interleukin-1 receptor antagonist concentration, the intracerebral interleukin-1-induced tumor necrosis factor-alpha cascade was upregulated. In hypothermic condition, the known neuroprotective effect of interleukin-1 receptor antagonist was neutralized (50 mg/kg/12 h for 72 h) or even reversed (200 mg/kg/12 h for 72 h) as compared to normothermic condition. Conclusion: Hypothermia interferes with the pharmacodynamic parameters of the interleukin-1 receptor antagonist, through a bioaccumulation of the drug within the central nervous system and a paradoxical upregulation of the interleukin-1 pathway. These effects seem to be at the origin of the loss of efficiency or even toxicity of the interleukin-1 receptor antagonist when combined with hypothermia. Such bioaccumulation could happen similarly with the use of other drugs combined to hypothermia in a clinical context.	[Chevin, Mathilde; Guiraut, Clemence; Sebire, Guillaume] McGill Univ, Dept Pediat, Res Inst, Ctr Hlth, 1001 Decarie Blvd,Glen Site,Block E,M0-3211, Montreal, PQ H4A 3J1, Canada		Sebire, G (corresponding author), McGill Univ, Dept Pediat, Res Inst, Ctr Hlth, 1001 Decarie Blvd,Glen Site,Block E,M0-3211, Montreal, PQ H4A 3J1, Canada.	Guillaume.Sebire@mcgill.ca			Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Foundation of Stars; Montreal Children Hospital Foundation; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; Health Canada; Brain Canada Foundation through the Canada Brain Research Fund	This work was supported by grants from the Canadian Institute of Health Research, Foundation of Stars, Montreal Children Hospital Foundation (Hoppenheim Fund), and Heart and Stroke Foundation of Canada. This project has been made possible by Brain Canada Foundation through the Canada Brain Research Fund, with the financial support of Health Canada and the funding partners. The views expressed herein do not necessarily represent the views of the Minister of Health or the Government of Canada.	Azzopardi D, 2014, NEW ENGL J MED, V371, P140, DOI 10.1056/NEJMoa1315788; Berry CA, 2011, REPROD SCI, V18, P1092, DOI 10.1177/1933719111404609; Brochu ME, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-55; Chevin M, 2016, INT J DEV NEUROSCI, V55, P1, DOI 10.1016/j.ijdevneu.2016.09.002; Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8; Consiglio AR, 2000, BRAIN RES PROTOC, V5, P109, DOI 10.1016/S1385-299X(99)00062-8; Davidson JO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00198; de Haan TR, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-45; Durkan Anne M, 2011, J Pediatr, V158, pe29, DOI 10.1016/j.jpeds.2010.11.010; Ezzati M, 2017, DEV NEUROSCI-BASEL, V39, P156, DOI 10.1159/000458438; Girard S, 2009, NEUROSCIENCE, V158, P673, DOI 10.1016/j.neuroscience.2008.10.032; Girard S, 2012, BRAIN BEHAV IMMUN, V26, P1331, DOI 10.1016/j.bbi.2012.09.001; Han ZP, 2015, EXP NEUROL, V272, P67, DOI 10.1016/j.expneurol.2015.06.006; Hassell KJ, 2015, ARCH DIS CHILD-FETAL, V100, pF541, DOI 10.1136/archdischild-2014-306284; Karnatovskaia LV, 2014, NEUROHOSPITALIST, V4, P153, DOI 10.1177/1941874413519802; Lan KM, 2015, TOXICOL LETT, V234, P30, DOI 10.1016/j.toxlet.2015.02.002; Leitner K, 2014, AM J REPROD IMMUNOL, V71, P418, DOI 10.1111/aji.12216; Liu DY, 2011, J PHARMACOKINET PHAR, V38, P769, DOI 10.1007/s10928-011-9219-z; Mahat MYA, 2012, J NEUROSCI METH, V211, P272, DOI 10.1016/j.jneumeth.2012.09.013; Medel-Matus JS, 2014, INT J DEV NEUROSCI, V38, P232, DOI 10.1016/j.ijdevneu.2014.09.006; Pang Y, 2015, INT J MOL SCI, V16, P8635, DOI 10.3390/ijms16048635; Rocha-Ferreira E, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0821-x; Rosenzweig JM, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00108; Savard A, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-110; Savard A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0330-8; Sweetman DU, 2013, ACTA PAEDIATR, V102, P233, DOI 10.1111/apa.12116; van den Broek MPH, 2010, CLIN PHARMACOKINET, V49, P277, DOI 10.2165/11319360-000000000-00000; Zhang XW, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1133-0; Zhou JQ, 2011, EXPERT OPIN DRUG MET, V7, P803, DOI 10.1517/17425255.2011.574127; Zuurmond AM, 2011, REGUL TOXICOL PHARM, V59, P461, DOI 10.1016/j.yrtph.2011.01.014	30	10	10	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JUL 30	2018	15								214	10.1186/s12974-018-1258-6			9	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	GO8TX	WOS:000440371200001	30060742	Green Published, gold			2022-02-06	
J	Vissoci, JRN; Vaca, SD; El-Gabri, D; de Oliveira, LP; Mvungi, M; Mmbaga, BT; Haglund, M; Staton, C				Vissoci, Joao Ricardo Nickenig; Vaca, Silvia Daniela; El-Gabri, Deena; de Oliveira, Leonardo Pestillo; Mvungi, Mark; Mmbaga, Blandina Theophil; Haglund, Michael; Staton, Catherine			Cross-cultural adaptation and psychometric properties of the Kessler Scale of Psychological Distress to a traumatic brain injury population in Swahili and the Tanzanian Setting	HEALTH AND QUALITY OF LIFE OUTCOMES			English	Article						Anxiety; Scale Validation; Psychometrics; Stress	COMMON MENTAL-DISORDERS; K10 SCREENING SCALES; ANXIETY DISORDERS; GENERAL-POPULATION; COEFFICIENT ALPHA; VALIDITY; DEPRESSION; HEALTH; K6; MOOD	Background: To evaluate the psychometric properties of a Swahili version of the Kessler Psychological Distress scale in an injury population in Tanzania. Methods: Swahili version of the Kessler Psychological Distress scale was developed by translation and back translation by a panel of native speakers of both English and Swahili. The translated instruments were administered to a sample of Tanzanian adults from a traumatic brain injury registry. The content validity, construct validity, reliability, internal structure, and external reliability were analyzed using standard statistical methods. Results: Both translated versions of the Kessler Psychological Distress scale were found to be reliable (>0.85) for all tested versions. Confirmatory factor analysis of one and two factor solution showed adequate results. Kessler Psychological Distress scale scores were strongly correlated to depression and quality of life (R>0.50). Conclusions: This paper presents the first Swahili adaptations of the Kessler Psychological Distress scale as well as the first validation of these questionnaires in Tanzania. The instrument was found to have acceptable psychometric properties, resulting in a new useful tool for medical and social research in this setting.	[Vissoci, Joao Ricardo Nickenig; Staton, Catherine] Duke Univ, Med Ctr, Duke Emergency Med, 8 Duke Univ Med Ctr Greenspace, Durham, NC 27703 USA; [Vaca, Silvia Daniela] Stanford Univ, Dept Neurosurg, Palo Alto, CA 94304 USA; [Vissoci, Joao Ricardo Nickenig; El-Gabri, Deena; Haglund, Michael; Staton, Catherine] Duke Univ, Duke Global Hlth Inst, Durham, NC 27703 USA; [de Oliveira, Leonardo Pestillo] UniCesumar, Maringa, Parana, Brazil; [Mvungi, Mark; Mmbaga, Blandina Theophil] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Mmbaga, Blandina Theophil] Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Vissoci, Joao Ricardo Nickenig; Haglund, Michael] Duke Univ, Dept Neurosurg, Durham, NC USA		Vissoci, JRN (corresponding author), Duke Univ, Med Ctr, Duke Emergency Med, 8 Duke Univ Med Ctr Greenspace, Durham, NC 27703 USA.; Vissoci, JRN (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27703 USA.	jnv4@duke.edu	OLIVEIRA, LEONARDO P/L-7300-2018; Oliveira, Leonardo/O-5281-2019; Mmbaga, Blandina Theophil/AAR-8707-2021	OLIVEIRA, LEONARDO P/0000-0001-5278-0676; Oliveira, Leonardo/0000-0001-5278-0676; Mmbaga, Blandina Theophil/0000-0002-5550-1916; Staton, Catherine/0000-0002-6468-2894	HRSAUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [T84HA21123-02]; U.S. National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Duke Division of Emergency Medicine; Fogarty International Center of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01TW010000]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01TW010000] Funding Source: NIH RePORTER	This project was made possible by the Mentored Research Training Program in collaboration with the HRSA-funded KCMC MEPI grant # T84HA21123-02; U.S. National Institutes of Health and the Duke Division of Emergency Medicine. Dr. Staton would like to acknowledge salary support provided by the Fogarty International Center of the National Institutes of Health under Award Number K01TW010000 (PI, Staton).	Abeloff M. D., 2000, CLIN ONCOLOGY; Andersen LS, 2011, INT J METH PSYCH RES, V20, P215, DOI 10.1002/mpr.351; Arnaud B, 2010, ALCOHOL CLIN EXP RES, V34, P1235, DOI 10.1111/j.1530-0277.2010.01201.x; Baggaley RF, 2007, TROP MED INT HEALTH, V12, P1225, DOI 10.1111/j.1365-3156.2007.01906.x; Blunch N., 2008, INTRO STRUCTURAL EQU; Brooks RT, 2006, PSYCHOL ASSESSMENT, V18, P62, DOI 10.1037/1040-3590.18.1.62; Browne MAO, 2010, AUST NZ J PSYCHIAT, V44, P314, DOI 10.3109/00048670903279820; Bu XQ, 2017, CANCER NURS, V40, P297, DOI 10.1097/NCC.0000000000000392; Carra G, 2011, EUR PSYCHIAT, V26, P122, DOI 10.1016/j.eurpsy.2010.04.008; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; DeVellis RF., 2012, SCALE DEV THEORY APP, V34; Donker T, 2010, PSYCHIAT RES, V176, P45, DOI 10.1016/j.psychres.2009.01.012; Fassaert T, 2009, INT J METH PSYCH RES, V18, P159, DOI 10.1002/mpr.288; Fernandes MC, 2011, ARCH WOMEN MENT HLTH, V14, P209, DOI 10.1007/s00737-010-0190-2; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Kline R. B, 2012, PRINCIPLES PRACTICE; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; Luoma JB, 2010, SUBST USE MISUSE, V45, P47, DOI 10.3109/10826080902864712; Maroco J., 2010, ANALISE EQUACOES EST; Nunnally J, 1994, THEORY P; Osburn HG, 2000, PSYCHOL METHODS, V5, P343, DOI 10.1037//1082-989X.5.3.343; Patel V, 2008, PSYCHOL MED, V38, P221, DOI 10.1017/S0033291707002334; Peterson RA, 2013, J APPL PSYCHOL, V98, P194, DOI 10.1037/a0030767; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ridner SH, 2004, J ADV NURS, V45, P536, DOI 10.1046/j.1365-2648.2003.02938.x; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Shafiei E, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.29729; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Sikkema KJ, 2011, JAIDS-J ACQ IMM DEF, V57, P230, DOI 10.1097/QAI.0b013e3182167e7a; Spies G, 2009, AIDS CARE, V21, P1163, DOI 10.1080/09540120902729965; Spies G, 2009, ARCH WOMEN MENT HLTH, V12, P69, DOI 10.1007/s00737-009-0050-0; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Tesfaye M, 2010, J AFFECT DISORDERS, V122, P102, DOI 10.1016/j.jad.2009.06.020; Ware JE, 2001, SCORE INTERPRET SING, V15, P5	39	10	10	2	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1477-7525			HEALTH QUAL LIFE OUT	Health Qual. Life Outcomes	JUL 27	2018	16								147	10.1186/s12955-018-0973-0			8	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	GO5AK	WOS:000440029700001	30053816	gold, Green Published			2022-02-06	
J	Novakovic-Agopian, T; Kornblith, E; Abrams, G; Burciaga-Rosales, J; Loya, F; D'Esposito, M; Chen, AJW				Novakovic-Agopian, Tatjana; Kornblith, Erica; Abrams, Gary; Burciaga-Rosales, Joaquin; Loya, Fred; D'Esposito, Mark; Chen, Anthony J. W.			Training in Goal-Oriented Attention Self-Regulation Improves Executive Functioning in Veterans with Chronic Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive rehabilitation; traumatic brain injury; veterans	POSTTRAUMATIC-STRESS-DISORDER; FRONTAL-LOBE; REHABILITATION; BEHAVIOR; INTELLIGENCE; AFGHANISTAN; DYSFUNCTION; CONFLICTS; IRAQ; CARE	Deficits in executive control functions are some of the most common and disabling consequences of both military and civilian brain injury. However, effective interventions are scant. The goal of this study was to assess whether cognitive rehabilitation training that was successfully applied in chronic civilian brain injury would be effective for military veterans with traumatic brain injury (TBI). In a prior study, participants with chronic acquired brain injury significantly improved after training in Goal-Oriented Attentional Self-Regulation (GOALS) on measures of attention/executive function, functional task performance, and goal-directed control over neural processing on functional magnetic resonance imaging. The objective of this study was to assess effects of GOALS training in veterans with chronic TBI. A total of 33 veterans with chronic TBI and executive difficulties in their daily life completed either 5 weeks of manualized GOALS training or Brain-Health Education (BHE) matched by time and intensity. Evaluator-blinded assessments at baseline and post-training included neuropsychological and complex functional task performance and self-report measures of emotional regulation. After GOALS, but not BHE training, participants significantly improved from baseline on primary outcome measures of Overall Complex Attention/Executive Function composite neuropsychological performance score (F=7.10, p=0.01; partial eta(2)=0.19), and on overall complex functional task performance (Goal Processing Scale Overall Performance; F=6.92, p=0.01, partial eta(2)=0.20). Additionally, post-GOALS participants indicated significant improvement on emotional regulation self-report measures (Profile of Mood States Confusion Score; F=6.05, p=0.02, partial eta(2)=0.20). Training in attentional self-regulation applied to participant-defined goals may improve cognitive functioning in veterans with chronic TBI. Attention regulation training may not only impact executive control functioning in real-world complex tasks, but also may improve emotional regulation and functioning. Implications for treatment of veterans with TBI are discussed.	[Novakovic-Agopian, Tatjana; Kornblith, Erica; Abrams, Gary; Burciaga-Rosales, Joaquin] Vet Adm Med Ctr, San Francisco, CA 94121 USA; [Novakovic-Agopian, Tatjana; Abrams, Gary; Chen, Anthony J. W.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Novakovic-Agopian, Tatjana; Loya, Fred; D'Esposito, Mark; Chen, Anthony J. W.] Vet Adm Northern Calif Hlth Care Syst, Martinez, CA USA; [D'Esposito, Mark; Chen, Anthony J. W.] Univ Calif Berkeley, Berkeley, CA 94720 USA		Novakovic-Agopian, T (corresponding author), Univ Calif San Francisco, SFVA Med Ctr, Rehabil Neuropsychol, 4150 Clement St,Mail Code 127, San Francisco, CA 94121 USA.	tatjana.novakovic-agopian@va.gov		KORNBLITH, ERICA/0000-0002-2802-7454	Department of Veterans Affairs Rehabilitation Research and Development Service Merit Review Awards (VANCHS Project) [B7467I, VA 1IO1RX001111-01A1]	This material is based upon work supported by the Department of Veterans Affairs Rehabilitation Research and Development Service Merit Review Awards (VANCHS Project # B7467I and VA 1IO1RX001111-01A1).	Beck A.T., 1996, BECK DEPRESSION INVE, pTX; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Binder D., 2009, BRAIN HLTH ED WORKSH; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Cattran C, 2011, J CLIN EXP NEUROPSYC, V33, P672, DOI 10.1080/13803395.2010.550603; Chen A., 2012, TRAUMATIC BRAIN INJU, pYork; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Cohen Jacob, 2013, APPL MULTIPLE REGRES; Cornis-Pop M, 2012, J REHABIL RES DEV, V49, pXI, DOI 10.1682/JRRD.2012.03.0048; Delis DC., 2001, DELIS KAPLAN EXECUTI; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Evans J, 2005, EFFECTIVENESS REHABI, P247; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Heaton RK, 2004, COMPREHENSIVE NORMS; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; IBM Corp, 2015, IBM SPSS STAT WIND V; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Loya F, 2017, REHABIL RES PRACT, V2017, DOI 10.1155/2017/8379347; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Malec J., 2005, MAYO PORTLAND ADAPTA; McNair D., 1992, MANUAL PROFILE MOOD, pCA; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; Nezu CM., 2007, SOLVING LIFES PROBLE; Novakovic-Agopian T., 2007, INSTRUCTOR PARTICIPA; Novakovic-Agopian T., 2016, 9 WORLD C NEUR PHIL; Novakovic-Agopian T, 2014, J HEAD TRAUMA REHAB, V29, P136, DOI 10.1097/HTR.0b013e3182691b15; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Peter Watson, 2017, FAQ EFFECT SIZE; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Reiber GE, 2010, J REHABIL RES DEV, V47, P275, DOI 10.1682/JRRD.2010.01.0009; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P421, DOI 10.1097/HTR.0b013e3181c13439; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Stuss D., 1998, CLIN NEUROPSYCHOL, V1, P139; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling J., 2007, RES QUART, P18; Vasterling J., 2005, NEUROPSYCHOLOGY PTSD; Vasterling JJ, 2012, PTSD MILD TRAUMATIC; Weathers F.W., 1994, PTSD CHECKLIST MILIT; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	56	10	11	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2018	35	23					2784	2795		10.1089/neu.2017.5529		JUL 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HB1WO	WOS:000439663600001	29717652	Green Published			2022-02-06	
J	Wu, HJ; Li, J; Xu, DX; Zhang, QS; Cui, T				Wu, Hongjie; Li, Jing; Xu, Dongxiao; Zhang, Qiansheng; Cui, Tao			Growth Differentiation Factor 5 Improves Neurogenesis and Functional Recovery in Adult Mouse Hippocampus Following Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						growth differentiation factor 5; hippocampus; neurogenesis; traumatic brain injury; functional recovery	MIDBRAIN DOPAMINERGIC-NEURONS; NERVOUS-SYSTEM; IN-VITRO; CREB; RAT; PROTEIN; PHOSPHORYLATION; NEUROPROTECTION; INFLAMMATION; MECHANISMS	The aim of this study was to investigate the therapeutic effect of growth differentiation factor 5 (GDF-5) on traumatic brain injury (TBI) in mice. We utilized a controlled cortical impact to establish a mouse TBI model, and then stereotaxically administered 25 or 100 ng GDF-5 into the bilateral hippocampal dentate gyrus (DG) of each of the animals. Seven days after the injury, some of the animals were sacrificed for immunohistochemical and immunofluorescence examination of 5-bromo-2'-deoxyuridine (BrdU), Sox-2, doublecortin (DCX) and phosphorylated cAMP response element binding protein (p-CREB). Dendrite quantification was also performed using DCX positive cells. Activation of newborn neurons was assessed 35 days after the injury. The remaining animals were subjected to open field, Y maze and contextual fear conditioning tests 2 months after TBI. As a result, we found that post-injury stereotaxical administration of GDF-5 can improve neural stem cell proliferation and differentiation in the DG of the hippocampus, evidenced by the increase in BrdU, Sox-2, and DCX-labeled cells, as well as the improvement in dendrite arborization and newborn neuron activation in response to GDF-5 treatment. Mechanistically, these effects of GDF-5 may be mediated by the CREB pathway, manifested by the recovery of TBI-induced dephosphorylation of CREB upon GDF-5 administration. Behavioral tests further verified the effects of GDF-5 on improving cognitive and behavioral dysfunction after TBI. Collectively, these results reveal that direct injection of GDF-5 into the hippocampus can stimulate neurogenesis and improve functional recovery in a mouse TBI model, indicating the potential therapeutic effects of GDF-5 on TBI.	[Cui, Tao] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Neurosurg, Luoyang, Peoples R China; Henan Univ Sci & Technol, Coll Clin Med, Luoyang, Peoples R China		Cui, T (corresponding author), Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Neurosurg, Luoyang, Peoples R China.	lycuitao@outlook.com					Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Bono J, 2017, CURR OPIN NEUROBIOL, V46, P136, DOI 10.1016/j.conb.2017.08.013; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Hegarty SV, 2014, NEUROMOL MED, V16, P473, DOI 10.1007/s12017-014-8299-5; Hegarty SV, 2013, PROG NEUROBIOL, V109, P28, DOI 10.1016/j.pneurobio.2013.07.002; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Hylin MJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7125057; Joo JY, 2016, NAT NEUROSCI, V19, P75, DOI 10.1038/nn.4170; Kandasamy M, 2010, J NEUROPATH EXP NEUR, V69, P717, DOI 10.1097/NEN.0b013e3181e4f733; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Moore AN, 1996, J BIOL CHEM, V271, P14214, DOI 10.1074/jbc.271.24.14214; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; O'Keeffe GW, 2004, J NEUROCYTOL, V33, P479, DOI 10.1007/s11068-004-0511-y; Osorio C, 2013, DEVELOPMENT, V140, P4751, DOI 10.1242/dev.101378; Patel K, 2016, BRAIN RES, V1640, P104, DOI 10.1016/j.brainres.2016.01.055; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sullivan AM, 2005, J ANAT, V207, P219, DOI 10.1111/j.1469-7580.2005.00447.x; Tobin MK, 2014, J CEREBR BLOOD F MET, V34, P1573, DOI 10.1038/jcbfm.2014.130; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Vogel T, 2010, CEREB CORTEX, V20, P661, DOI 10.1093/cercor/bhp134; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616; Zhao YZ, 2017, NEUROSCI LETT, V651, P36, DOI 10.1016/j.neulet.2017.04.055; Zhong J, 2014, CURR OPIN NEUROBIOL, V27, P127, DOI 10.1016/j.conb.2014.03.009	39	10	11	0	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 23	2018	9								592	10.3389/fneur.2018.00592			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GN8VQ	WOS:000439454600001	30083129	Green Published, gold			2022-02-06	
J	Wang, YY; Wang, CL; Zhang, D; Wang, HH; Bo, LL; Deng, XM				Wang, Yuanyuan; Wang, Changli; Zhang, Dan; Wang, Huihui; Bo, Lulong; Deng, Xiaoming			Dexmedetomidine Protects Against Traumatic Brain Injury-Induced Acute Lung Injury in Mice	MEDICAL SCIENCE MONITOR			English	Article						Acute Lung Injury; Brain Injuries; Dexmedetomidine	LIPOPOLYSACCHARIDE; SEPSIS; EXPRESSION; ANTIBODY; RECEPTOR; IMPACT; MOUSE; HMGB1	Background: Traumatic brain injury (TBI) leads to acute lung injury (ALI), in which the inflammatory response plays an important role in its pathophysiology. Recent studies suggest that dexmedetomidine (Dex) plays a protective role in acute inflammatory diseases. However, whether Dex has a protective effect on TBI-induced ALI is not clear. The aim of this study was to investigate the effect of Dex on TBI-induced ALI in mice. Material/Methods: Mice were randomly divided into 5 groups: 1) sham group; 2) TBI group; 3) TBI+Dex group; 4) TBI+atipamezole (Atip) group; and 5) TBI+Dex+Atip group. Dex (50 mu g/kg) was intraperitoneal injected immediately after TBI. The alpha(2) adrenergic antagonist Atip (250 mu g/kg) was intraperitoneal injected 15 minutes prior to Dex treatment. Then 24 hours later, the protein concentration in the bronchoalveolar lavage fluid (BALE), lung wet to dry weight ratio, hematoxylin and eosin (H&E) staining of lungs, the level of high-mobility group box protein 1(HMGB1) in serum, and the receptor for advanced glycation end products (RAGE) expression in lung were detected. Results: Dex ameliorated the score of lung histological examination, as well as the severity of pulmonary edema and permeability. Moreover, Dex was observed to significantly suppress the expression of HMGBI and RAGE. However, the protective effects of Dex were partially reversed by the administration of Atip. Conclusions: Dex may protect against TBI-induced ALI via the HMGB1-RAGE signal pathway, and this protective effect is partly dependent on its alpha(2) adrenoceptor agonist action.	[Wang, Yuanyuan; Wang, Changli; Zhang, Dan; Bo, Lulong; Deng, Xiaoming] Naval Med Univ, Changhai Hosp, Fac Anesthesiol, Shanghai, Peoples R China; [Wang, Yuanyuan; Zhang, Dan; Wang, Huihui; Deng, Xiaoming] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China		Bo, LL; Deng, XM (corresponding author), Naval Med Univ, Changhai Hosp, Fac Anesthesiol, Shanghai, Peoples R China.; Deng, XM (corresponding author), Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China.	nbastars@126.com; deng_x@yahoo.com	Deng, Xiaoming/E-2876-2010		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471845, 81671887]; Shanghai Outstanding Youth Medical Professionals Training Program [2017YQ015]	This work was supported by the National Natural Science Foundation of China (No. 81471845; 81671887) and Shanghai Outstanding Youth Medical Professionals Training Program (2017YQ015).	Banjara M, 2017, INT J INFLAMM, V2017, DOI 10.1155/2017/8385961; Bao SH, 2015, INT IMMUNOPHARMACOL, V28, P429, DOI 10.1016/j.intimp.2015.06.022; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Chi XJ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0554-5; Christaki E, 2011, SHOCK, V35, P492, DOI 10.1097/SHK.0b013e31820b2e1c; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Diener KR, 2013, IMMUNOL CELL BIOL, V91, P443, DOI 10.1038/icb.2013.25; Gao SQ, 2015, INT J CLIN EXP PATHO, V8, P3144; Goettel N, 2016, BRIT J ANAESTH, V116, P811, DOI 10.1093/bja/aew024; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Hara M, 2016, ANESTHESIOLOGY, V125, P535, DOI 10.1097/ALN.0000000000001213; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hu HY, 2017, AM J TRANSL RES, V9, P5245; Jiang LL, 2014, MOL MED REP, V9, P419, DOI 10.3892/mmr.2013.1867; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Matalon S, 2014, AM J PHYSIOL-LUNG C, V307, pL911, DOI 10.1152/ajplung.00330.2014; Mrozek Segolene, 2015, World J Crit Care Med, V4, P163, DOI 10.5492/wjccm.v4.i3.163; Nicolls MR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010259; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Weber DJ, 2015, ANTIOXID REDOX SIGN, V23, P1316, DOI 10.1089/ars.2015.6299; Weber DJ, 2014, SCI TRANSL MED, V6, P252; Xie Chunyan, 2015, Zhonghua Jie He He Hu Xi Za Zhi, V38, P761; Xu YZ, 2015, FUND CLIN PHARMACOL, V29, P462, DOI 10.1111/fcp.12138; Yan XR, 2015, J SURG RES, V199, P592, DOI 10.1016/j.jss.2015.06.013	31	10	11	0	2	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	JUL 17	2018	24						4961	4967		10.12659/MSM.908133			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GN9OU	WOS:000439533800001	30013022	Green Published, Green Submitted			2022-02-06	
J	Leon, AMC; Cicuendez, M; Navarro, B; Munarriz, PM; Cepeda, S; Paredes, I; Hilario, A; Ramos, A; Gomez, PA; Lagares, A				Castano Leon, Ana Maria; Cicuendez, Marta; Navarro, Blanca; Munarriz, Pablo M.; Cepeda, Santiago; Paredes, Igor; Hilario, Amaya; Ramos, Ana; Antonio Gomez, Pedro; Lagares, Alfonso			What Can Be Learned from Diffusion Tensor Imaging from a Large Traumatic Brain Injury Cohort?: White Matter Integrity and Its Relationship with Outcome	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; DTI; outcome measures; TBI	CORPUS-CALLOSUM; AXONAL INJURY; FRACTIONAL ANISOTROPY; HEAD-INJURY; MR; EPIDEMIOLOGY; MEMORY; MILD; DTI; CT	Traumatic axonal injury (TAI) contributes significantly to mortality and morbidity after traumatic brain injury (TBI), but its identification is still a diagnostic challenge because of the limitations of conventional imaging techniques to characterized it. Diffusion tensor imaging (DTI) can indirectly identify areas of damaged white matter (WM) integrity by detecting water molecule diffusion alterations. Therefore, DTI may improve detection and description of TAI lesions after TBI. We have obtained DTI data from 217 patients with moderate to severe TBI acquired at a median of 19 days after TBI, and patient DTI metrics were compared with data obtained from 58 age-matched healthy controls. Region of interest (ROI) method was applied to obtain mean fractional anisotropy (FA) value in 28 WM fiber bundles susceptible to TAI. Our main results were that when we compared patients with controls, patients, regardless of TBI severity, showed significantly reduced mean FA in almost all ROI measured. We found statistically significant correlation between FA metrics and some demographic, clinical, and conventional imaging characteristics. Additionally, these FA metrics were highly associated with outcome assessed at hospital discharge and at 6 and 12 months after TBI. We conclude that FA reduction in the subacute stage after TBI assessed by DTI may be a useful prognostic factor for long-term unfavorable outcome.	[Castano Leon, Ana Maria; Cicuendez, Marta; Navarro, Blanca; Munarriz, Pablo M.; Cepeda, Santiago; Paredes, Igor; Antonio Gomez, Pedro; Lagares, Alfonso] Univ Complutense Madrid, Octubre Univ Hosp 12, Dept Neurosurg, Madrid, Spain; [Hilario, Amaya; Ramos, Ana] Univ Complutense, Octubre Univ Hosp 12, Dept Radiol, Madrid, Spain		Leon, AMC (corresponding author), Univ Complutense Madrid, Octubre Univ Hosp 12, Dept Neurosurg, Madrid, Spain.	ana.maria.castano.leon@gmail.com	Lagares, Alfonso/B-2969-2011; Munarriz, Pablo M/S-3398-2018; Cepeda, Santiago/AAE-3200-2021; Sansinenea, Igor Paredes/S-6281-2019; Gomez, Pedro/N-5051-2019; Paredes, Igor/AAW-6313-2021; Castano-Leon, Ana M/ABF-6322-2020	Lagares, Alfonso/0000-0003-3996-0554; Munarriz, Pablo M/0000-0002-9888-7046; Cepeda, Santiago/0000-0003-1667-8548; Gomez, Pedro/0000-0002-4185-5238; Paredes, Igor/0000-0002-3846-4164; Castano-Leon, Ana M/0000-0002-7918-5049	ISCIII European institution; FEDER European institution; FISInstituto de Salud Carlos III [PI14/0157]	This research was jointly funded by the ISCIII and FEDER European institutions, with FIS project number PI14/0157. The sponsor had no role in the design or conduct of this research.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Cicuendez M, 2017, ACTA NEUROCHIR, V159, P25, DOI 10.1007/s00701-016-3000-4; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Douglas David B, 2015, Top Magn Reson Imaging, V24, P241, DOI 10.1097/RMR.0000000000000062; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; JENNETT B, 1975, LANCET, V1, P480; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lebel C, 2012, MAGN RESON MED, V68, P474, DOI 10.1002/mrm.23254; Mateer CA, 1996, J LEARN DISABIL, V29, P618, DOI 10.1177/002221949602900606; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Shiramizu H, 2008, NEUROL MED-CHIR, V48, P1, DOI 10.2176/nmc.48.1; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Strauss Sara, 2015, Top Magn Reson Imaging, V24, P353, DOI 10.1097/RMR.0000000000000071; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Veenith TV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065941	29	10	12	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2365	2376		10.1089/neu.2018.5691		JUL 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000437803600001	29786464				2022-02-06	
J	Crowe, LM; Hearps, S; Anderson, V; Borland, ML; Phillips, N; Kochar, A; Dalton, S; Cheek, JA; Gilhotra, Y; Furyk, J; Neutze, J; Lytle, MD; Bressan, S; Donath, S; Molesworth, C; Oakley, E; Dalziel, SR; Babl, FE				Crowe, Louise M.; Hearps, Stephen; Anderson, Vicki; Borland, Meredith L.; Phillips, Natalie; Kochar, Amit; Dalton, Sarah; Cheek, John A.; Gilhotra, Yuri; Furyk, Jeremy; Neutze, Jocelyn; Lytle, Mark D.; Bressan, Silvia; Donath, Susan; Molesworth, Charlotte; Oakley, Ed; Dalziel, Stuart R.; Babl, Franz E.			Investigating the Variability in Mild Traumatic Brain Injury Definitions: A Prospective Cohort Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Child; Rehabilitation	POST-CONCUSSIVE SYMPTOMS; CLOSED-HEAD INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; POSTCONCUSSIVE SYMPTOMS; COMPUTED-TOMOGRAPHY; CHILDREN; RECOVERY; OUTCOMES; CHILDHOOD	Objective: To prospectively compare the proportion of traumatic brain injuries (TBIs) that would be classified as mild by applying different published definitions of mild TBI to a large prospectively collected dataset, and to examine the variability in the proportions included by various definitions. Design: Prospective observational study. Setting: Hospital emergency departments. Participants: Children (N=11,907) aged 3 to 16 years (mean age, 8.2 +/- 3.9y). Of the participants, 3868 (32.5%) were girls, and 7374 (61.9%) of the TBIs were the result of a fall. Median Glasgow Coma Scale score was 15. Main Outcome Measures: We applied 17 different definitions of mild TBI, identified through a published systematic review, to children aged 3 to 16 years. Adjustments and clarifications were made to some definitions. The number and percentage identified for each definition is presented. Results: Adjustments had to be made to the 17 definitions to apply to the dataset: none in 7, minor to substantial in 10. The percentage classified as mild TBI across definitions varied from 7.1% (n = 841) to 98.7% (n = 11,756) and varied by age group. Conclusions: When applying the 17 definitions of mild TBI to a large prospective multicenter dataset of TBI, there was wide variability in the number of cases classified. Clinicians and researchers need to be aware of this variability when examining literature concerning children with mild TBI. (C) 2018 by the American Congress of Rehabilitation Medicine	[Crowe, Louise M.; Hearps, Stephen; Anderson, Vicki; Cheek, John A.; Lytle, Mark D.; Bressan, Silvia; Donath, Susan; Molesworth, Charlotte; Oakley, Ed; Babl, Franz E.] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Crowe, Louise M.; Anderson, Vicki] Univ Melbourne, Melboume Sch Psychol Sci, Melbourne, Vic, Australia; [Crowe, Louise M.; Anderson, Vicki] Royal Childrens Hosp, Psychol Dept, Melbourne, Vic, Australia; [Borland, Meredith L.; Donath, Susan; Oakley, Ed; Babl, Franz E.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Borland, Meredith L.] Princess Margaret Hosp Children, Emergency Dept, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Paediat, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Emergency Med, Perth, WA, Australia; [Phillips, Natalie; Gilhotra, Yuri] Lady Cilento Childrens Hosp, Emergency Dept, Brisbane, Qld, Australia; [Kochar, Amit] Womens & Childrens Hosp, Emergency Dept, Adelaide, SA, Australia; [Dalton, Sarah] Childrens Hosp Westmead, Emergency Dept, Sydney, NSW, Australia; [Cheek, John A.; Oakley, Ed; Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Cheek, John A.] Monash Med Ctr, Melbourne, Vic, Australia; [Furyk, Jeremy] Townsville Hosp, Emergency Dept, Townsville, Qld, Australia; [Neutze, Jocelyn] Kidzfirst Middlemore Hosp, Emergency Dept, Auckland, New Zealand; [Lytle, Mark D.] Bristol Royal Hosp Children, Bristol, Avon, England; [Lytle, Mark D.] Univ West England, Acad Dept Emergency Care, Bristol, Avon, England; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Dalziel, Stuart R.] Starship Childrens Hlth, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Liggins Inst, Auckland, New Zealand		Crowe, LM (corresponding author), Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic 3052, Australia.	louise.crowe@mcri.edu.au	Hearps, Stephen/L-6853-2016	Donath, Susan/0000-0003-2489-3977; Hearps, Stephen/0000-0003-2984-1172; Lyttle, Mark/0000-0002-8634-7210; Crowe, Louise/0000-0003-4619-9708	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [1046727]; Emergency Medicine Foundation; Perpetual Philanthropic Services; WA Health Targeted Research Funds; Townsville Hospital Private Practice Fund; Auckland Medical Research Foundation; A + Trust; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council Early Career FellowshipNational Health and Medical Research Council of Australia [GNT1071544]	Supported by the National Health and Medical Research Council of Australia (grant no. 1046727), the Emergency Medicine Foundation, Perpetual Philanthropic Services, WA Health Targeted Research Funds, Townsville Hospital Private Practice Fund. the Auckland Medical Research Foundation, A + Trust, Victorian Government's Operational Infrastructure Support Program, and a National Health and Medical Research Council Early Career Fellowship (award no. GNT1071544).	AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; British Society of Rehabilitation Medicine, 1998, WORK PART REP BRIT S; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS101, DOI 10.1016/j.apmr.2013.12.001; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, 2016, UPD MILD TRAUM BRAIN; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Da Dalt L, 2007, J PEDIATR-US, V150, P274, DOI 10.1016/j.jpeds.2006.11.060; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Halley Michelle K, 2004, Pediatr Crit Care Med, V5, P230, DOI 10.1097/01.PCC.0000123543.40224.73; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2005, BRAIN INJURY, V19, P109, DOI 10.1080/02699050410001720095; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kenardy J, 2012, J CLIN CHILD ADOLESC, V41, P5, DOI 10.1080/15374416.2012.632348; Khetani A, 2016, PEDIAT EMERG CARE; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Spencer MT, 2003, AM J EMERG MED, V21, P111, DOI 10.1053/ajem.2003.50031; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TEASDALE G, 1974, LANCET, V2, P81; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	64	10	10	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2018	99	7					1360	1369		10.1016/j.apmr.2017.12.026			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GL9JZ	WOS:000437552100014	29407521				2022-02-06	
J	Han, KW; Martinez, D; Chapman, SB; Krawczyk, DC				Han, Kihwan; Martinez, David; Chapman, Sandra B.; Krawczyk, Daniel C.			Neural correlates of reduced depressive symptoms following cognitive training for chronic traumatic brain injury	HUMAN BRAIN MAPPING			English	Article						depression; intervention; mental health; neural marker; neuroplasticity	RANDOMIZED CONTROLLED-TRIAL; INTRINSIC FUNCTIONAL CONNECTIVITY; SURFACE-BASED ANALYSIS; RESTING HUMAN BRAIN; BEHAVIORAL THERAPY; MAJOR DEPRESSION; INVENTORY-II; SUPPORTIVE PSYCHOTHERAPY; PSYCHIATRIC-DISORDERS; CORTICAL THICKNESS	Depression is the most frequent comorbid psychiatric condition among individuals with traumatic brain injury (TBI). Yet, little is known about changes in the brain associated with reduced depressive symptoms following rehabilitation for TBI. We identified whether cognitive training alleviates comorbid depressive symptoms in chronic TBI (>6months post-injury) as a secondary effect. Further, we elucidated neural correlates of alleviated depressive symptoms following cognitive training. A total of seventy-nine individuals with chronic TBI (53 depressed and 26 non-depressed individuals, measured using the Beck Depressive Inventory [BDI]), underwent either strategy- or information-based cognitive training in a small group for 8weeks. We measured psychological functioning scores, cortical thickness, and resting-state functional connectivity (rsFC) for these individuals before training, immediately post-training, and 3months post-training. After confirming that changes in BDI scores were independent of training group affiliation, we identified that the depressive-symptoms group showed reductions in BDI scores over time relative to the non-depressed TBI controls (p<.01). Within the depressive-symptoms group, reduced BDI scores was associated with improvements in scores for post-traumatic stress disorder, TBI symptom awareness, and functional status (p<.00625), increases in cortical thickness in four regions within the right prefrontal cortex (p(vertex)<.01, p(cluster)<.05), and decreases in rsFC with each of these four prefrontal regions (p(vertex)<.01, p(cluster)<.0125). Overall, these findings suggest that cognitive training can reduce depressive symptoms in TBI even when the training does not directly target psychiatric symptoms. Importantly, cortical thickness and brain connectivity may offer promising neuroimaging markers of training-induced improvement in mental health status in TBI.	[Han, Kihwan; Martinez, David; Chapman, Sandra B.; Krawczyk, Daniel C.] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr BrainHlth, Dallas, TX USA; [Krawczyk, Daniel C.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA		Han, KW (corresponding author), Sch Behav & Brain Sci, Ctr BrainHlth, 2200 West Mockingbird Lane,Mail Stop CBH, Dallas, TX 75235 USA.	kihwan.han98@gmail.com	Han, Kihwan/I-1984-2019	Han, Kihwan/0000-0002-4574-7306	U.S. Department of DefenseUnited States Department of Defense [W81XWH-11-2-0194, W81XWH-11-2-0195]; Meadows Foundation; Friends of BrainHealth Distinguished New Scientist Award	U.S. Department of Defense, Grant/Award Numbers: W81XWH-11-2-0194 and W81XWH-11-2-0195; Meadows Foundation; Friends of BrainHealth Distinguished New Scientist Award	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Barbey AK, 2014, BRAIN, V137, P2823, DOI 10.1093/brain/awu207; Beck A.T., 1990, COGNITIVE THERAPY PE; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Beck AT., 1979, COGNITIVE THERAPY DE; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Beevers CG, 2015, J ABNORM PSYCHOL, V124, P463, DOI 10.1037/abn0000049; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; Binder D, 2008, BRAIN HLTH WORKSH TO; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Buckley TC, 2001, J SUBST ABUSE TREAT, V20, P197, DOI 10.1016/S0740-5472(00)00169-0; Carlson MC, 2009, J GERONTOL A-BIOL, V64, P1275, DOI 10.1093/gerona/glp117; Chattopadhyay S, 2017, EBIOMEDICINE, V17, P216, DOI 10.1016/j.ebiom.2017.02.010; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cruwys T, 2014, J AFFECT DISORDERS, V159, P139, DOI 10.1016/j.jad.2014.02.019; Cruwys T, 2013, SOC SCI MED, V98, P179, DOI 10.1016/j.socscimed.2013.09.013; D'Antonio E, 2013, NEUROPSYCHIATRY-LOND, V3, P601, DOI 10.2217/npy.13.75; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; De Giglio L, 2016, RADIOLOGY, V280, P202, DOI 10.1148/radiol.2016150710; Delis D. C., 2001, D KEFS EXECUTIVE FUN; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; Esterman M, 2013, J INT NEUROPSYCH SOC, V19, P835, DOI 10.1017/S135561771300057X; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gertler P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009871.pub2; Goverover Y, 2014, BRAIN INJURY, V28, P174, DOI 10.3109/02699052.2013.860474; Guerra-Carrillo B, 2014, NEUROSCIENTIST, V20, P522, DOI 10.1177/1073858414524442; Han K, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.687; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Han K, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00231; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kelly C, 2014, NEUROPSYCHOL REV, V24, P63, DOI 10.1007/s11065-014-9252-y; Krawczyk DC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-29; Kupferberg A, 2016, NEUROSCI BIOBEHAV R, V69, P313, DOI 10.1016/j.neubiorev.2016.07.002; Leaver AM, 2016, CEREB CORTEX, V26, P4337, DOI 10.1093/cercor/bhv207; Levan A, 2016, BRAIN IMAGING BEHAV, V10, P1090, DOI 10.1007/s11682-015-9472-7; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Li BJ, 2013, BIOL PSYCHIAT, V74, P48, DOI 10.1016/j.biopsych.2012.11.007; Li H, 2016, PSYCHOL MED, V46, P909, DOI 10.1017/S003329171500238X; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mollica RF, 2009, ARCH GEN PSYCHIAT, V66, P1221, DOI 10.1001/archgenpsychiatry.2009.127; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Motter JN, 2016, J AFFECT DISORDERS, V189, P184, DOI 10.1016/j.jad.2015.09.022; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Palmer GA, 2014, MIL MED, V179, P879, DOI 10.7205/MILMED-D-14-00048; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Peterson BS, 2009, P NATL ACAD SCI USA, V106, P6273, DOI 10.1073/pnas.0805311106; Phillips JL, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv037; Pirnia T, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.102; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schmaal L, 2017, MOL PSYCHIATR, V22, P900, DOI 10.1038/mp.2016.60; Sehm B, 2014, NEUROBIOL AGING, V35, P232, DOI 10.1016/j.neurobiolaging.2013.06.021; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sherer M., 2004, AWARENESS QUESTIONAI; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Tu PC, 2012, PSYCHIAT RES-NEUROIM, V202, P206, DOI 10.1016/j.pscychresns.2011.07.011; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; van Eijndhoven P, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.139; van Tol MJ, 2014, PSYCHOL MED, V44, P2053, DOI 10.1017/S0033291713002742; Vanheule S, 2008, ASSESSMENT, V15, P177, DOI 10.1177/1073191107311261; Vas A, 2016, NEUROPSYCHOL REHABIL, V26, P502, DOI 10.1080/09602011.2015.1044013; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Wang L, 2012, J AFFECT DISORDERS, V142, P6, DOI 10.1016/j.jad.2012.04.013; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2008, WECHSLER MEMORY SCAL; WechslerD, 2001, WECHSLER TEST ADULT; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	104	10	10	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JUL	2018	39	7					2955	2971		10.1002/hbm.24052			17	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GL9TM	WOS:000437682100020	29573026	Green Published, hybrid			2022-02-06	
J	Logan, LM; Semrau, JA; Debert, CT; Kenzie, JM; Scott, SH; Dukelow, SP				Logan, Lindsey M.; Semrau, Jennifer A.; Debert, Chantel T.; Kenzie, Jeffrey M.; Scott, Stephen H.; Dukelow, Sean P.			Using Robotics to Quantify Impairments in Sensorimotor Ability, Visuospatial Attention, Working Memory, and Executive Function After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						motor skills; neurological rehabilitation; proprioception; robotics; sensory feedback; traumatic brain injuries	MONTREAL COGNITIVE ASSESSMENT; ICE HOCKEY PLAYERS; MOTOR RECOVERY; STROKE; PERFORMANCE; THERAPY; TRAIL; MILD; REHABILITATION; RELIABILITY	Objective: To investigate the use of a robotic assessment tool to quantify sensorimotor, visuospatial attention, and executive function impairments in individuals with traumatic brain injury (TBI). Setting: Foothills Hospital (Calgary, Canada). Participants: Twenty-three subjects with first-time TBI in the subacute to chronic phase participated in this study. Normative data were collected from 275 to 494 neurologically intact control subjects for each robotic task. Design: A prospective observational case series. Subjects with TBI completed brief clinical cognitive and motor assessments followed by robotic assessments of upper limb reaching, position sense, bimanual motor ability, attention, and visuospatial skills. Scores of subjects with TBI were compared with normative data. Main Measures: Robotic task performance was computed for each subject on each task, as well as performance on specific task parameters. Clinical assessments included the Montreal Cognitive Assessment, Fugl-Meyer upper extremity assessment, and Purdue Peg Board. Results: Subjects with TBI demonstrated a variety of deficits on robotic tasks. The proportion of TBI subjects who were significantly different from controls ranged from 36% (dominant arm reaching) to 60% (bimanual object hitting task). Conclusion: Robotic measures allowed us to quantify a range of impairments specific to each subject, and offer an objective tool with which to examine these abilities after TBI.	[Logan, Lindsey M.; Dukelow, Sean P.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Semrau, Jennifer A.; Debert, Chantel T.; Kenzie, Jeffrey M.; Dukelow, Sean P.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Debert, Chantel T.; Dukelow, Sean P.] Univ Calgary, Cumming Sch Med, Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Scott, Stephen H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada		Dukelow, SP (corresponding author), Univ Calgary, Cumming Sch Med, Clin Neurosci, Calgary, AB T2N 4N1, Canada.	spdukelo@ucalgary.ca		Debert, Chantel/0000-0002-2704-0438; Dukelow, Sean/0000-0002-0609-981X	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP 106662]; Alberta Innovates Health Solutions summer studentship	This research was made possible by a project grant from Canadian Institutes of Health Research (CIHR, MOP 106662). Lindsey Logan was supported by an Alberta Innovates Health Solutions summer studentship.	Alwis DS, 2013, CLIN EXP PHARMACOL P, V40, P473, DOI 10.1111/1440-1681.12100; BKIN Technologies, 2016, DEXT E TM 3 6 US GUI, P57; Bourke TC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0201-2; Box GEP, 2010, J R STAT SOC, V26, P211; CDC National Centre for Health Statistics, 2010, NAT VIT STAT SYST NV; Charalambous CP, 2014, CLASSIC PAPERS ORTHO, P415, DOI DOI 10.1007/978-1-4471-5451-8_105; Cinnera AM, 2016, FUNCT NEUROL, V31, P117; Coderre AM, 2010, NEUROREHAB NEURAL RE, V24, P528, DOI 10.1177/1545968309356091; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Debert CT, 2012, J NEUROL PHYS THER, V36, P58, DOI 10.1097/NPT.0b013e318254bd4f; Di Russo F, 2005, J NEUROTRAUM, V22, P297; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Failla M.D., 2015, BRAIN NEUROTRAUMA MO; Faul M, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Goble DJ, 2008, J NEUROPHYSIOL, V99, P3063, DOI 10.1152/jn.90259.2008; Goble DJ, 2010, PHYS THER, V90, P1176, DOI 10.2522/ptj.20090399; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Herter TM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-43; Hirayama K, 1999, J NEUROL SCI, V167, P45, DOI 10.1016/S0022-510X(99)00136-7; Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; JENNETT B, 1977, LANCET, V1, P878; Lincoln N.B., 1991, CLIN REHABIL, V5, P273, DOI [DOI 10.1177/026921559100500403, 10.1177/026921559100500403]; Little CE, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0195-9; Little CE, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0070-0; Middleton A, 2014, NEUROREHABILITATION, V35, P741, DOI 10.3233/NRE-141178; Min K, 2013, RESTOR NEUROL NEUROS, V31, P397, DOI 10.3233/RNN-120289; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; O'Brien M., 2010, AIDS EX PER NERV SYS; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Salthouse TA, 2011, INTELLIGENCE, V39, P222, DOI 10.1016/j.intell.2011.03.001; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Saywell N, 2017, CLIN REHABIL, V31, P145, DOI 10.1177/0269215516631384; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Semrau JA, 2015, STROKE, V46, P3459, DOI 10.1161/STROKEAHA.115.010750; Semrau JA, 2013, STROKE, V44, P3414, DOI 10.1161/STROKEAHA.113.002058; Shaw SE, 2005, J REHABIL RES DEV, V42, P769, DOI 10.1682/JRRD.2005.06.0094; Squeri Valentina, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975500, DOI 10.1109/ICORR.2011.5975500; Stienen Arno H A, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975460, DOI 10.1109/ICORR.2011.5975460; Subbian V, 2016, ACAD EMERG MED, V23, P382, DOI 10.1111/acem.12906; TEASDALE G, 1974, LANCET, V2, P81; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Tyryshkin K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-47; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158	49	10	10	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2018	33	4					E61	E73		10.1097/HTR.0000000000000349			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GR6GT	WOS:000442745900007	29084099				2022-02-06	
J	Salazar, K; Martinez, F; Perez-Martin, M; Cifuentes, M; Trigueros, L; Ferrada, L; Espinoza, F; Saldivia, N; Bertinat, R; Forman, K; Oviedo, MJ; Lopez-Gambero, AJ; Bonansco, C; Bongarzone, ER; Nualart, F				Salazar, Katterine; Martinez, Fernando; Perez-Martin, Margarita; Cifuentes, Manuel; Trigueros, Laura; Ferrada, Luciano; Espinoza, Francisca; Saldivia, Natalia; Bertinat, Romina; Forman, Katherine; Jose Oviedo, Maria; Lopez-Gambero, Antonio J.; Bonansco, Christian; Bongarzone, Ernesto R.; Nualart, Francisco			SVCT2 Expression and Function in Reactive Astrocytes Is a Common Event in Different Brain Pathologies	MOLECULAR NEUROBIOLOGY			English	Article						SVCT2; Vitamin C; Astrocytes; Reactive astrogliosis; Adenovirus transduction; Neuraminidase; Cortical injury; Epileptic disorder; Kindled brain; Alzheimer's disease	L-ASCORBIC-ACID; VITAMIN-C TRANSPORTERS; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; DEHYDROASCORBIC ACID; OXIDATIVE STRESS; STEM-CELLS; RAT-BRAIN; NEURONS; DISEASE	Ascorbic acid (AA), the reduced form of vitamin C, acts as a neuroprotector by eliminating free radicals in the brain. Sodium/vitamin C co-transporter isoform 2 (SVCT2) mediates uptake of AA by neurons. It has been reported that SVCT2 mRNA is induced in astrocytes under ischemic damage, suggesting that its expression is enhanced in pathological conditions. However, it remains to be established if SVCT expression is altered in the presence of reactive astrogliosis generated by different brain pathologies. In the present work, we demonstrate that SVCT2 expression is increased in astrocytes present at sites of neuroinflammation induced by intracerebroventricular injection of a GFP-adenovirus or the microbial enzyme, neuraminidase. A similar result was observed at 5 and 10 days after damage in a model of traumatic injury and in the hippocampus and cerebral cortex in the in vivo kindling model of epilepsy. Furthermore, we defined that cortical astrocytes maintained in culture for long periods acquire markers of reactive gliosis and express SVCT2, in a similar way as previously observed in situ. Finally, by means of second harmonic generation and 2-photon fluorescence imaging, we analyzed brain necropsied material from patients with Alzheimer's disease (AD), which presented with an accumulation of amyloid plaques. Strikingly, although AD is characterized by focalized astrogliosis surrounding amyloid plaques, SVCT2 expression at the astroglial level was not detected. We conclude that SVCT2 is heterogeneously induced in reactive astrogliosis generated in different pathologies affecting the central nervous system (CNS).	[Salazar, Katterine; Martinez, Fernando; Trigueros, Laura; Ferrada, Luciano; Espinoza, Francisca; Saldivia, Natalia; Bertinat, Romina; Forman, Katherine; Jose Oviedo, Maria; Nualart, Francisco] Univ Concepcion, Fac Biol Sci, Dept Cellular Biol, Ctr Adv Microscopy CMA BIO BIO,Lab Neurobiol & St, Concepcion, Chile; [Salazar, Katterine; Martinez, Fernando; Nualart, Francisco] Univ Concepcion, Fac Ciencias Biol, Dept Biol Celular, Casilla 160-C, Concepcion, Chile; [Perez-Martin, Margarita; Cifuentes, Manuel; Trigueros, Laura; Lopez-Gambero, Antonio J.] Univ Malaga, Dept Cell Biol Genet & Physiol, Andalusian Ctr Nanomed & Biotechnol, IBIMA BIONAND, Malaga, Spain; [Perez-Martin, Margarita; Cifuentes, Manuel; Trigueros, Laura; Lopez-Gambero, Antonio J.] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Malaga, Spain; [Bonansco, Christian] Univ Valparaiso, Inst Fisiol, Fac Ciencias, CNPC, Gran Bretana Ave 1111, Valparaiso 2360102, Chile; [Bongarzone, Ernesto R.] Univ Illinois, Coll Med, Dept Anat & Cell Biol, Chicago, IL USA; [Bongarzone, Ernesto R.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, Buenos Aires, DF, Argentina		Nualart, F (corresponding author), Univ Concepcion, Fac Biol Sci, Dept Cellular Biol, Ctr Adv Microscopy CMA BIO BIO,Lab Neurobiol & St, Concepcion, Chile.; Nualart, F (corresponding author), Univ Concepcion, Fac Ciencias Biol, Dept Biol Celular, Casilla 160-C, Concepcion, Chile.	frnualart@udec.cl	Bertinat, Romina/H-9199-2019; Martin, Margarita Perez/L-1556-2017; Martin, Margarita Perez/AAS-9326-2021; Salazar, Katterine/AAE-3316-2021; Nualart, Francisco/AAB-9342-2021; Cifuentes Rueda, Manuel/I-6922-2018	Bertinat, Romina/0000-0002-0929-133X; Martin, Margarita Perez/0000-0001-8791-3862; Martin, Margarita Perez/0000-0001-8791-3862; Ferrada, Luciano/0000-0001-5478-2325; Lopez Gambero, Antonio Jesus/0000-0001-7716-9056; Espinoza Romero, Francisca/0000-0001-7059-6741; Cifuentes Rueda, Manuel/0000-0003-1414-469X	FONDECYTComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT [1140477, 1130491]; CONICYT PIA ECM-12 grant; National Institutes of Health grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS065808]; CONICYT-ChileComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [1130491]; DIPUV [CID 1/2006]; Fondecyt grantComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT [11140405, 11150678]	This work was partially supported by a FONDECYT grant 1140477 and CONICYT PIA ECM-12 grant (both to Francisco Nualart), the National Institutes of Health grant (R01 NS065808) to Ernesto R. Bongarzone, grants 1130491 from FONDECYT, CONICYT-Chile, and CID 1/2006 from DIPUV to Christian Bonansco, Fondecyt grant 11140405 to Katterine Salazar and Fondecyt grant 11150678 to Fernando Martinez. The funders had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript. We thank Ms. Ximena Koch for technical support.	Abramov AY, 2004, BBA-MOL CELL RES, V1742, P81, DOI 10.1016/j.bbamcr.2004.09.006; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Alvarez-Ferradas C, 2015, GLIA, V63, P1507, DOI 10.1002/glia.22817; Angelow S, 2003, BRAIN RES, V988, P105, DOI 10.1016/S0006-8993(03)03350-X; Astuya A, 2005, J NEUROSCI RES, V79, P146, DOI 10.1002/jnr.20326; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Belanger Mireille, 2009, Dialogues Clin Neurosci, V11, P281; Berger UV, 2003, J NEUROCHEM, V86, P896, DOI 10.1046/j.1471-4159.2003.01891.x; Burzle M, 2012, CURR TOP MEMBR, V70, P357, DOI 10.1016/B978-0-12-394316-3.00011-9; Caprile T, 2009, J NEUROCHEM, V108, P563, DOI 10.1111/j.1471-4159.2008.05788.x; Cisternas P, 2014, J NEUROCHEM, V129, P663, DOI 10.1111/jnc.12663; Cole-Edwards KK, 2006, J NEUROSCI, V26, P8295, DOI 10.1523/JNEUROSCI.1986-05.2006; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Garcia MDL, 2005, GLIA, V50, P32, DOI 10.1002/glia.20133; Garcia-Krauss A, 2016, MOL NEUROBIOL, V53, P5847, DOI 10.1007/s12035-015-9497-3; Gess B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017139; Gess B, 2010, GLIA, V58, P287, DOI 10.1002/glia.20923; Granados-Duran P, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00014; Iwata N, 2014, NUTRIENTS, V6, P1554, DOI 10.3390/nu6041554; Joshi Gururaj, 2012, Recent Pat CNS Drug Discov, V7, P218; Kandratavicius L, 2014, NEUROPSYCH DIS TREAT, V10, P1693, DOI 10.2147/NDT.S50371; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; May JM, 1998, ARCH BIOCHEM BIOPHYS, V349, P281, DOI 10.1006/abbi.1997.0473; Meredith ME, 2011, BIOCHEM BIOPH RES CO, V414, P737, DOI 10.1016/j.bbrc.2011.09.146; Morales JC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00200; Mun GH, 2006, J NEUROSCI RES, V83, P919, DOI 10.1002/jnr.20751; Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8; Nualart FJ, 2003, J BIOL CHEM, V278, P10128, DOI 10.1074/jbc.M210686200; Nualart Francisco, 2014, J Stem Cell Res Ther, V4, P209; Nualart F, 2012, BIOL RES, V45, P243, DOI 10.4067/S0716-97602012000300006; Oyarce K, 2018, MOL NEUROBIOL, V55, P1136, DOI 10.1007/s12035-016-0366-5; Pastor P, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00119; Pihlaja R, 2008, GLIA, V56, P154, DOI 10.1002/glia.20599; Portugal CC, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal2005; Portugal CC, 2012, J BIOL CHEM, V287, P3860, DOI 10.1074/jbc.M111.260166; Qiu S, 2007, J NEUROSCI RES, V85, P1046, DOI 10.1002/jnr.21204; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; RICE ME, 1995, J NEUROCHEM, V64, P1790; Salazar K, 2014, J NEUROCHEM, V130, P693, DOI 10.1111/jnc.12793; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Savini I, 2007, BIOCHEM BIOPH RES CO, V361, P385, DOI 10.1016/j.bbrc.2007.07.007; Shi LH, 2007, EPILEPSY RES, V73, P85, DOI 10.1016/j.eplepsyres.2006.08.008; Silva-Alvarez C, 2017, MOL NEUROBIOL, V54, P5449, DOI 10.1007/s12035-016-0081-2; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; STEWARD O, 1991, P NATL ACAD SCI USA, V88, P6819, DOI 10.1073/pnas.88.15.6819; Tian H, 2016, FREE RADICAL BIO MED, V96, P362, DOI 10.1016/j.freeradbiomed.2016.03.039; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Ulloa V, 2013, J NEUROCHEM, V127, P403, DOI 10.1111/jnc.12295; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838	51	10	10	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUL	2018	55	7					5439	5452		10.1007/s12035-017-0762-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GI8VY	WOS:000434805100003	28942474				2022-02-06	
J	Wilkerson, GB; Gupta, A; Colston, MA				Wilkerson, Gary B.; Gupta, Ashish; Colston, Marisa A.			Mitigating Sports Injury Risks Using Internet of Things and Analytics Approaches	RISK ANALYSIS			English	Article						Football; injuries; Internet of Things; predictive analytics; sports analytics	COLLEGIATE FOOTBALL PLAYERS; FUNCTIONAL MOVEMENT SCREEN; LOWER-EXTREMITY INJURY; HIGH-SCHOOL FOOTBALL; MUSCULOSKELETAL INJURY; CONCUSSION; PREDICTION; FRAMEWORK; CORE; PATTERNS	Sport injuries restrict participation, impose a substantial economic burden, and can have persisting adverse effects on health-related quality of life. The effective use of Internet of Things (IoT), when combined with analytics approaches, can improve player safety through identification of injury risk factors that can be addressed by targeted risk reduction training activities. Use of IoT devices can facilitate highly efficient quantification of relevant functional capabilities prior to sport participation, which could substantially advance the prevailing sport injury management paradigm. This study introduces a framework for using sensor-derived IoT data to supplement other data for objective estimation of each individual college football player's level of injury risk, which is an approach to injury prevention that has not been previously reported. A cohort of 45 NCAA Division I-FCS college players provided data in the form of self-ratings of persisting effects of previous injuries and single-leg postural stability test. Instantaneous change in body mass acceleration (jerk) during the test was quantified by a smartphone accelerometer, with data wirelessly transmitted to a secure cloud server. Injuries sustained from the beginning of practice sessions until the end of the 13-game season were documented, along with the number of games played by each athlete over the course of a 13-game season. Results demonstrate a strong prediction model. Our approach may have strong relevance to the estimation of injury risk for other physically demanding activities. Clearly, there is great potential for improvement of injury prevention initiatives through identification of individual athletes who possess elevated injury risk and targeted interventions.	[Wilkerson, Gary B.] Univ Tennessee Chattanooga, Grad Athlet Training Program, Chattanooga, TN USA; [Gupta, Ashish] Auburn Univ, Raymond J Harbert Coll Business, Dept Syst & Technol, Auburn, AL 36849 USA; [Colston, Marisa A.] Univ Tennessee Chattanooga, Hlth & Human Performance, Chattanooga, TN USA		Gupta, A (corresponding author), Auburn Univ, Raymond J Harbert Coll Business, Dept Syst & Technol, Auburn, AL 36849 USA.	Ashish.gupta@auburn.edu	Wilkerson, Gary B./AAG-4103-2021	Wilkerson, Gary B./0000-0001-8433-7329			Adams ST, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8312; Alamar B.C., 2013, SPORTS ANAL GUIDE CO; American Academy of Orthopaedic Surgeons, 2011, US BON JOINT IN BURD; [Anonymous], 2016, GAT OUTL SPORTS MARK; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Bahr R, 2014, BRIT J SPORT MED, V48, P1265, DOI 10.1136/bjsports-2014-093832; Borotikar BS, 2008, CLIN BIOMECH, V23, P81, DOI 10.1016/j.clinbiomech.2007.08.008; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Cokins G., 2017, ORMS TODAY, V44, P28; Creighton DW, 2010, CLIN J SPORT MED, V20, P379, DOI 10.1097/JSM.0b013e3181f3c0fe; Dallinga JM, 2012, SPORTS MED, V42, P791, DOI 10.2165/11632730-000000000-00000; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; DiFiori JP, 2014, CLIN J SPORT MED, V24, P3, DOI 10.1097/JSM.0000000000000060; Dorrel BS, 2015, SPORTS HEALTH, V7, P532, DOI 10.1177/1941738115607445; Grooms D, 2015, J ORTHOP SPORT PHYS, V45, P381, DOI 10.2519/jospt.2015.5549; Gruetzemacher R., 2016, P INT C INF RES MAN; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Hamilton GM, 2011, AM J EPIDEMIOL, V173, P941, DOI 10.1093/aje/kwq461; Hides J, 2008, J ORTHOP SPORT PHYS, V38, P101, DOI 10.2519/jospt.2008.2658; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Liu W, 2012, GAIT POSTURE, V36, P614, DOI 10.1016/j.gaitpost.2012.06.005; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Maffulli N, 2010, BRIT J SPORT MED, V44, P21, DOI 10.1136/bjsm.2009.069526; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; Mokha M, 2016, J ATHL TRAINING, V51, P276, DOI 10.4085/1062-6050-51.2.07; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Needle AR, 2014, SCAND J MED SCI SPOR, V24, P737, DOI 10.1111/sms.12181; Nielsen RO, 2016, J ORTHOP SPORT PHYS, V46, P300, DOI 10.2519/jospt.2016.6510; Ofoghi B, 2013, MEAS PHYS EDUC EXERC, V17, P171, DOI 10.1080/1091367X.2013.805137; Ofoghi B, 2010, IFIP ADV INF COMM TE, V331, P67; Onate JA, 2016, CLIN J SPORT MED, V26, P435, DOI 10.1097/JSM.0000000000000284; Patterson JA, 2014, INT J SPORTS PHYS TH, V9, P135; Pietrosimone BG, 2012, SPORTS HEALTH, V4, P31, DOI 10.1177/1941738111428251; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Schiller JS, 2010, VITAL HLTH STAT, V2012, P1; Sciascia A, 2015, INT J SPORTS PHYS TH, V10, P655; Teyhen Deydre S, 2012, J Strength Cond Res, V26 Suppl 2, pS61, DOI 10.1519/JSC.0b013e31825d80e6; Wilkerson G. B., 2016, SPORTS INJURIES PREV, P1; Wilkerson GB, 2016, CLIN J SPORT MED, V26, P423, DOI 10.1097/JSM.0000000000000280; Wilkerson GB, 2016, J STRENGTH COND RES, V30, P2369, DOI 10.1519/JSC.0000000000001370; Wilkerson GB, 2015, J ATHL TRAINING, V50, P643, DOI 10.4085/1062-6050-50.2.04; Wilkerson GB, 2012, J ATHL TRAINING, V47, P264, DOI 10.4085/1062-6050-47.3.17; Willson JD, 2006, MED SCI SPORT EXER, V38, P945, DOI 10.1249/01.mss.0000218140.05074.fa; Yard EE, 2009, RES SPORTS MED, V17, P35, DOI 10.1080/15438620802678495; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	46	10	11	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0272-4332	1539-6924		RISK ANAL	Risk Anal.	JUL	2018	38	7					1348	1360		10.1111/risa.12984			13	Public, Environmental & Occupational Health; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Mathematics; Mathematical Methods In Social Sciences	GM7KD	WOS:000438363300004	29529346				2022-02-06	
J	Yi, HG; Corrigan, JD; Singichetti, B; Bogner, JA; Manchester, K; Guo, JH; Yang, JZ				Yi, Honggang; Corrigan, John D.; Singichetti, Bhavna; Bogner, Jennifer A.; Manchester, Kara; Guo, Jinhong; Yang, Jingzhen			Lifetime History of Traumatic Brain Injury and Current Disability Among Ohio Adults	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adults; disability; health surveillance data; traumatic brain injury	TBI IDENTIFICATION METHOD; TRACK-TBI; HEALTH; RELIABILITY; VALIDITY; PREVALENCE; OUTCOMES; SAMPLE; COHORT	Objective: To examine the associations between lifetime history of traumatic brain injury (TBI) with loss of consciousness (LOC) and several types of current disability among adult, noninstitutionalized residents of Ohio. Participants: 2014 Ohio Behavioral Risk Factors Surveillance System participants (n = 6998). Design: Statewide population-based survey. Main Measures: Lifetime history of TBI with LOC (number and severity of injury, age of first injury), and number and type of disability (vision, cognition, mobility, self-care, and/or independent living). Results: Of the 6998 participants, 1325 reported lifetime history of TBI with LOC, and 1959 reported currently having one or more disabilities. When weighted, these represented 21.7% and 23.7% of Ohio's noninstitutionalized adult population, respectively. Adults with a history of TBI with LOC showed greater odds of any disability compared with adults with no history (odds ratio = 2.49; 95% confidence interval = 1.97-3.15). The likelihood of having any and each type of disability increased as the number of TBIs or the severity of worst TBI increased, regardless of sustaining first TBI before or after the age of 15 years. Conclusions: Lifetime history of TBI with LOC is significantly associated with disability among Ohio adults. Further research on the natural course of the relation and preventive strategies is warranted.	[Yi, Honggang; Singichetti, Bhavna; Guo, Jinhong; Yang, Jingzhen] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr,RB3 WB5403, Columbus, OH 43205 USA; [Yi, Honggang; Yang, Jingzhen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Corrigan, John D.; Bogner, Jennifer A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Yi, Honggang] Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, Nanjing, Jiangsu, Peoples R China; [Manchester, Kara] Ohio Dept Hlth, Violence & Injury Prevent Program, Columbus, OH 43266 USA		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr,RB3 WB5403, Columbus, OH 43205 USA.; Yang, JZ (corresponding author), Ohio State Univ, Coll Med, Dept Pediat, 700 Childrens Dr,RB3 WB5403, Columbus, OH 43205 USA.	Ginger.Yang@nationwidechildrens.org		Singichetti, Bhavna/0000-0002-2188-3979	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRRUnited States Department of Health & Human Services [90DP0040]	Drs. Corrigan's and Bogner's effort on this project were funded in part by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR #90DP0040). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health & Human Services (HHS). The contents of this report do not necessarily represent the policy of NIDILRR, ACL, HHS, and endorsement by the Federal Government should not be assumed.	ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dennis M, 2013, NEUROSCI BIOBEHAV R, V37, P2760, DOI 10.1016/j.neubiorev.2013.09.010; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Dyer JR, 2016, J HEAD TRAUMA REHAB, V31, P225, DOI 10.1097/HTR.0000000000000177; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Konigs M, 2017, NEUROPSYCHOLOGY, V31, P137, DOI 10.1037/neu0000302; Krishnamoorthy V, 2015, J TRAUMA NURS, V22, P204, DOI 10.1097/JTN.0000000000000135; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2017, DISABIL REHABIL, V39, P1296, DOI 10.1080/09638288.2016.1193905; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Pierannunzi C, 2004, BMC MED RES METHODOL, V2013, P13, DOI DOI 10.1186/1471-2288-13-49; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Scott KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080573; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Short ME, 2009, J OCCUP ENVIRON MED, V51, P786, DOI 10.1097/JOM.0b013e3181a86671; Stevens AC, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160080; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Tranel D, 2000, DEV NEUROPSYCHOL, V18, P273, DOI 10.1207/S1532694201Tranel; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140	35	10	10	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2018	33	4					E24	E32		10.1097/HTR.0000000000000352			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GR6GT	WOS:000442745900004	29084102				2022-02-06	
J	Zupan, B; Neumann, D; Babbage, D; Willer, B				Zupan, Barbra; Neumann, Dawn; Babbage, Duncan; Willer, Barry			Sex-Based Differences in Affective and Cognitive Empathy Following Severe Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						empathy; affective empathy; cognitive empathy; sex; traumatic brain injury	INTERPERSONAL REACTIVITY INDEX; GENDER-DIFFERENCES; SOCIAL COGNITION; EMOTIONAL CONTAGION; SELF-AWARENESS; INDIVIDUAL-DIFFERENCES; FACIAL EXPRESSIONS; AFFECT RECOGNITION; FEMALE ADVANTAGE; DEFICITS	Objective: To examine sex differences in self-ratings for affective and cognitive empathy for males and females with traumatic brain injury (TBI) and compare these to observer ratings. Method: Self and observer (e.g., spouse) ratings of affective and cognitive empathy were obtained for 160 participants (116 males) with severe TBI, using the Interpersonal Reactivity Index Empathic Concern (EC) and Perspective Taking (PT) subscales, respectively. Results: When compared to sex norms, female self-ratings were significantly lower for both subscales, whereas men's self-report ratings were only lower for PT. For EC, more women (44%) were found to be substantially below the normative means (>= 2 SDs) than men (17%), p < .001. When comparing women and men with TBI, self-report and observer ratings indicated both sexes had similar empathy levels (both subscales). Self versus observer ratings showed that women's self-ratings were significantly higher than observer's ratings on PT (p < .001); men's self-ratings were significantly higher than observer's ratings on PT (p < .001) and EC (p = .009). Conclusions: In contrast to the typically observed superior female empathy, this study suggests this advantage may disappear after a TBI, and possibly result in a disadvantage compared to their uninjured female peers. Theoretical implications of self-awareness and cultural gender expectations for empathy are discussed. General Scientific Summary Empathy allows us to care about, understand, and share another person's emotional experience, so it is important for successful social interactions. Compared to their uninjured female peers, women with traumatic brain injury (TBI) were found to have significant difficulty with affective empathy, indicating that in social interactions, they will struggle to share in and appropriately respond to someone else's feelings. This is especially problematic for women because we generally expect them to show more warmth and concern than men. Even though men and women with TBI had similar scores for both affective and cognitive empathy, the authors concluded that this is a larger problem for women and puts them at a greater social disadvantage because uninjured women generally show much stronger empathy than uninjured men. Thus, our cultural expectations would likely lead us to judge women with TBI more harshly when they do not demonstrate expected empathy.	[Zupan, Barbra] Cent Queensland Univ, Dept Speech Pathol, Rockhampton, Qld, Australia; [Neumann, Dawn] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Neumann, Dawn] Rehabil Hosp Indiana, Indianapolis, IN USA; [Babbage, Duncan] Auckland Univ Technol, Ctr Person Ctr Res, Auckland, New Zealand; [Babbage, Duncan] Auckland Univ Technol, Ctr eHlth, Auckland, New Zealand; [Willer, Barry] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA		Zupan, B (corresponding author), Cent Queensland Univ, Dept Speech Pathol, Sch Hlth & Med Sci, Bruce Highway, North Rockhampton, Qld 4702, Australia.	barbrazupan@gmail.com		Barbra, Zupan/0000-0002-4603-333X	National Institute on Disability and Rehabilitation Research [H133G080043]	This work was supported by the National Institute on Disability and Rehabilitation Research (H133G080043).	Baldner C, 2014, MOTIV EMOTION, V38, P727, DOI 10.1007/s11031-014-9417-2; Barker LA, 2011, BRAIN INJURY, V25, P997, DOI 10.3109/02699052.2011.597046; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Brookshire R. H., 1993, DISCOURSE COMPREHENS; Campanella S, 2004, NEUROSCI LETT, V367, P14, DOI 10.1016/j.neulet.2004.05.097; Chopik WJ, 2017, J CROSS CULT PSYCHOL, V48, P23, DOI 10.1177/0022022116673910; Christov-Moore L, 2014, NEUROSCI BIOBEHAV R, V46, P604, DOI 10.1016/j.neubiorev.2014.09.001; Cliffordson C, 2001, EUR J PSYCHOL ASSESS, V17, P36, DOI 10.1027//1015-5759.17.1.36; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Collignon O, 2010, NEUROPSYCHOLOGIA, V48, P220, DOI 10.1016/j.neuropsychologia.2009.09.007; Coplan A, 2004, J AESTHET ART CRITIC, V62, P141, DOI 10.1111/j.1540-594X.2004.00147.x; Coplan A., 2006, FILM STUD, V8, P26, DOI DOI 10.7227/FS.8.5; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Corte K, 2007, PSYCHOL BELG, V47, P235, DOI 10.5334/pb-47-4-235; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Eichstaedt KE, 2013, NEUROREHABILITATION, V32, P693, DOI 10.3233/NRE-130893; Farace E, 2000, Neurosurg Focus, V8, pe6; Faul M, 2010, TRAUMATIC BRAIN INJU; Gleichgerrcht E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061526; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Hall, 2004, INT J FORENSIC PSYCH, V1, P33; Hatfield E, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P19; Hillis AE, 2014, BRAIN, V137, P981, DOI 10.1093/brain/awt317; Hodgson LK, 2007, J SOC PERS RELAT, V24, P931, DOI 10.1177/0265407507084191; Holm S., 1979, SCANDINAVIAN J STAT, V75, P800; Hooker CI, 2010, BRAIN RES, V1308, P100, DOI 10.1016/j.brainres.2009.10.006; Killgore WDS, 2001, NEUROREPORT, V12, P427, DOI 10.1097/00001756-200102120-00047; Klein KJK, 2001, PERS SOC PSYCHOL B, V27, P720, DOI 10.1177/0146167201276007; Krach S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-9; Lauterbach O, 2007, SWISS J PSYCHOL, V66, P91, DOI 10.1024/1421-0185.66.2.91; Lee TMC, 2002, NEUROSCI LETT, V333, P13, DOI 10.1016/S0304-3940(02)00965-5; Li H, 2008, NEUROIMAGE, V40, P1921, DOI 10.1016/j.neuroimage.2008.01.033; LUNDQVIST LO, 1995, SCAND J PSYCHOL, V36, P130, DOI 10.1111/j.1467-9450.1995.tb00974.x; MacDonald, 2003, BRAIN WORK, V13, P1; Fernandez AM, 2011, EUR J PSYCHOL ASSESS, V27, P179, DOI 10.1027/1015-5759/a000065; Marzoli D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014595; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Mehrabian A., 2000, MANUAL BALANCED EMOT; Meltzoff AN, 2003, PHILOS T R SOC B, V358, P491, DOI 10.1098/rstb.2002.1261; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Nalder E, 2016, ARCH PHYS MED REHAB, V97, pS46, DOI 10.1016/j.apmr.2014.07.428; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Oswald PA, 2003, PERCEPT MOTOR SKILL, V97, P1184, DOI 10.2466/PMS.97.8.1184-1186; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; Pelphrey KA, 2004, J COGNITIVE NEUROSCI, V16, P1706, DOI 10.1162/0898929042947900; Prentice DA, 2002, PSYCHOL WOMEN QUART, V26, P269, DOI 10.1111/1471-6402.t01-1-00066; Reniers RLEP, 2011, J PERS ASSESS, V93, P84, DOI 10.1080/00223891.2010.528484; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rosip JC, 2004, J NONVERBAL BEHAV, V28, P267, DOI 10.1007/s10919-004-4159-6; Rueckert L, 2008, BRAIN COGNITION, V67, P162, DOI 10.1016/j.bandc.2008.01.002; Rushby JA, 2016, NEUROIMAGE-CLIN, V12, P607, DOI 10.1016/j.nicl.2016.09.017; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Silani G, 2008, SOC NEUROSCI-UK, V3, P97, DOI 10.1080/17470910701577020; Sonnby-Borgstrom M, 2003, J NONVERBAL BEHAV, V27, P3, DOI 10.1023/A:1023608506243; Sonnby-Borgstrom M, 2008, SCAND J PSYCHOL, V49, P111, DOI 10.1111/j.1467-9450.2008.00626.x; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wildgruber D, 2002, NEUROIMAGE, V15, P856, DOI 10.1006/nimg.2001.0998; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Wood W, 2000, AM PSYCHOL, V55, P1062, DOI 10.1037/0003-066X.55.9.1062; Yarnold P.R., 1996, PSYCHOL HEALTH MED, V1, P207, DOI [10.1080/13548509608400019, DOI 10.1080/13548509608400019]; Zupan B, 2017, BRAIN IMPAIR, V18, P36, DOI 10.1017/BrImp.2016.22	80	10	10	1	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2018	32	5					554	563		10.1037/neu0000462			10	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GK8VT	WOS:000436509600004	29952609	Bronze			2022-02-06	
J	Dailey, NS; Smith, R; Bajaj, S; Alkozei, A; Gottschlich, MK; Raikes, AC; Satterfield, BC; Killgore, WDS				Dailey, Natalie S.; Smith, Ryan; Bajaj, Sahil; Alkozei, Anna; Gottschlich, Melissa K.; Raikes, Adam C.; Satterfield, Brieann C.; Killgore, William D. S.			Elevated Aggression and Reduced White Matter Integrity in Mild Traumatic Brain Injury: A DTI Study	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						mild traumatic brain injury; aggression; white matter integrity; diffusion tensor imaging; corpus callosum; post-concussive symptoms	CORPUS-CALLOSUM; SEX-DIFFERENCES; SPATIAL STATISTICS; DIFFUSION; ABNORMALITIES; PREVALENCE; DEPRESSION; INVENTORY; SCHIZOPHRENIA; INDIVIDUALS	Mild traumatic brain injury (mTBI) remains the most commonly reported head injury in the United States, and is associated with a wide range of post-concussive symptoms including physical, cognitive and affective impairments. Elevated aggression has been documented in mTBI; however, the neural mechanisms associated with aggression at the chronic stage of recovery remain poorly understood. In the present study, we investigated the association between white matter integrity and aggression in mTBI using diffusion tensor imaging (DTI). Twenty-six age-matched adults participated in the study, including 16 healthy controls (HCs) and 10 individuals in the chronic stage of recovery (either 6-months or 12 months post-mTBI). Psychological measures of aggression included the Buss-Perry Aggression Questionnaire and the Personality Assessment Inventory (PAI). Axonal pathways implicated in affective processing were studied, including the corpus callosum, anterior thalamic radiation, cingulum and uncinate fasciculus, and measures of white matter integrity included fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and axial diffusivity (AD). We found that adults with mTBI in the chronic stage of recovery had higher levels aggression. Individuals with mTBI also had greater RD in the corpus callosum compared to HCs, indicating reduced fiber integrity. Furthermore, we observed a significant association between reduced white matter integrity in the corpus callosum and greater aggression. Our findings provide additional evidence for underlying neuroanatomical mechanisms of aggression, although future research will be necessary to characterize the specific relationship between aggression and the white matter pathways we identified.	[Dailey, Natalie S.; Smith, Ryan; Bajaj, Sahil; Alkozei, Anna; Gottschlich, Melissa K.; Raikes, Adam C.; Satterfield, Brieann C.; Killgore, William D. S.] Univ Arizona, Coll Med, Dept Psychiat, Social Cognit & Affect Neurosci Lab, Tucson, AZ 85721 USA		Killgore, WDS (corresponding author), Univ Arizona, Coll Med, Dept Psychiat, Social Cognit & Affect Neurosci Lab, Tucson, AZ 85721 USA.	killgore@psychiatry.arizona.edu	Bajaj, Sahil/C-6580-2016; Satterfield, Brieann/AAC-1475-2022; Raikes, Adam/M-2600-2019	Bajaj, Sahil/0000-0003-0629-6036; Raikes, Adam/0000-0002-1609-6727; Satterfield, Brieann C/0000-0002-8688-2416; Smith, Ryan/0000-0002-4448-185X; Dailey, Natalie S./0000-0003-4800-4118	Office of the Assistant Secretary of Defense for Health Affairs; Defense Health Agency J9, Research and Development Directorate, through the US Army Medical Research and Materiel Command (USAMRMC) [W81XWH-12-0386]	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs and the Defense Health Agency J9, Research and Development Directorate, through the US Army Medical Research and Materiel Command (USAMRMC) under Award No. (W81XWH-12-0386) to WK. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bailie JM, 2015, J HEAD TRAUMA REHAB, V30, P12, DOI 10.1097/HTR.0000000000000024; Barrett LF, 2013, CURR OPIN NEUROBIOL, V23, P361, DOI 10.1016/j.conb.2012.12.012; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benjamini Y, 2001, ANN STAT, V29, P1165; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; CDC, 2003, REP C MILD TRAUM BRA; Chan SCY, 2016, J NEUROSCI, V36, P7817, DOI 10.1523/JNEUROSCI.0659-16.2016; Cleverley K, 2012, J AM ACAD CHILD PSY, V51, P1037, DOI 10.1016/j.jaac.2012.07.010; Coccaro EF, 2007, BIOL PSYCHIAT, V62, P168, DOI 10.1016/j.biopsych.2006.08.024; Concha L, 2009, J NEUROL NEUROSUR PS, V80, P312, DOI 10.1136/jnnp.2007.139287; de Groot M, 2013, NEUROIMAGE, V76, P400, DOI 10.1016/j.neuroimage.2013.03.015; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; Epstein DJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.581; GERSHMAN SJ, 2013, FRONT BEHAV NEUROSCI, V7, DOI DOI 10.3389/FNBEH.2013.00164; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Harris JA, 1997, BEHAV RES THER, V35, P1047, DOI 10.1016/S0005-7967(97)00064-8; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Johansson SH, 2008, BRAIN INJURY, V22, P999, DOI 10.1080/02699050802530573; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kalisch R, 2006, NEUROIMAGE, V30, P1458, DOI 10.1016/j.neuroimage.2005.11.011; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Kubota M, 2012, SCHIZOPHR RES, V141, P137, DOI 10.1016/j.schres.2012.08.026; Lasa L, 2000, J AFFECT DISORDERS, V57, P261, DOI 10.1016/S0165-0327(99)00088-9; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McGlade E, 2015, BRAIN IMAGING BEHAV, V9, P535, DOI 10.1007/s11682-015-9379-3; Morey, 1991, PERSONALITY ASSESSME; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Paul LK, 2004, ARCH CLIN NEUROPSYCH, V19, P215, DOI 10.1016/S0887-6177(03)00024-6; Paul LK, 2011, J NEURODEV DISORD, V3, P3, DOI 10.1007/s11689-010-9059-y; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Schutter DJLG, 2013, NEUROSCI BIOBEHAV R, V37, P2481, DOI 10.1016/j.neubiorev.2013.07.013; Smith R, 2017, NEUROSCI BIOBEHAV R, V75, P274, DOI 10.1016/j.neubiorev.2017.02.003; Smith R, 2015, NEUROSCI BIOBEHAV R, V57, P1, DOI 10.1016/j.neubiorev.2015.08.003; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; Sundram F, 2012, CORTEX, V48, P216, DOI 10.1016/j.cortex.2011.06.005; Sussmann JE, 2009, BIPOLAR DISORD, V11, P11, DOI 10.1111/j.1399-5618.2008.00646.x; Till C, 2009, BRAIN INJURY, V23, P655, DOI 10.1080/02699050902970794; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn	58	10	10	0	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	JUN 27	2018	12								118	10.3389/fnbeh.2018.00118			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	GK9PC	WOS:000436582800001	30013466	Green Published, gold			2022-02-06	
J	Lu, J; Roe, C; Sigurdardottir, S; Andelic, N; Forslund, M				Lu, Juan; Roe, Cecilie; Sigurdardottir, Solrun; Andelic, Nada; Forslund, Marit			Trajectory of Functional Independent Measurements during First Five Years after Moderate and Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						functional independent measurements; outcome trajectory; traumatic brain injury	LONG-TERM DISABILITY; NATIONAL INSTITUTE; UNITED-STATES; LONGITUDINAL DESCRIPTION; SAS PROCEDURE; REHABILITATION; OUTCOMES; HEALTH; POPULATION; CONSCIOUSNESS	A better understanding of long-term functional recovery process for patients with traumatic brain injury (TBI) facilitates effective rehabilitations. The aim of this study was to classify and characterize patients with moderate-to-severe TBI based on their functional trajectories up to 5 years post-injury. The study included 121 patients with moderate-to-severe TBIs (International Classification of Diseases, Tenth Revision [ICD-10], S06.0-S06.9), 16-55 years of age, and admitted at Trauma Referral Hospital within 24h of injury between 2005 and 2007. Demographics and injury characteristics were documented at the admission, and functional status was recorded at 3 months and 1 and 5 years post-injury using Functional Independence Measure motor (FIM-M) and cognitive (FIM-C) subscales. We used group-based trajectory models to classify patients' functional trajectories over a 5-year period. For FIM-M, three trajectories were identified: 8.2% of patients showed stable low recovery (13.6 +/- 1.5, 17.9 +/- 8.8, and 21.0 +/- 17.9), 9.2% elevated good recovery (35.8 +/- 14.5, 75.5 +/- 12.4, and 85.5 +/- 8.1), and 82.6% stable good recovery (89.0 +/- 3.6, 90.3 +/- 1.9, and 90.8 +/- 1.0) at the three follow-up points, respectively. For FIM-C, four trajectories were revealed: 4.1% of patients showed stable low recovery (5.0 +/- 0, 5.0 +/- 0, and 5.0 +/- 0), 12.6% delayed moderate recovery (8.9 +/- 3.5, 20.6 +/- 4.6, and 28.3 +/- 3.8), 28.7% elevated good recovery (27.0 +/- 3.8, 30.4 +/- 7.3, and 31.1 +/- 2.3), and 54.6% stable good recovery (32.8 +/- 2.3, 34.6 +/- 1.0, and 34.7 +/- 1.0). The results suggest that three FIM-M and four FIM-C trajectories described various patterns of functional recovery 5 years after moderate-to-severe TBI, with stable good recovery being the most common trajectory. Identifying and characterizing the trajectory memberships should enable targeted rehabilitation programs, inform patient-centered care, and improve long-term outcomes.	[Lu, Juan] Virginia Commonwealth Univ, Div Epidemiol, Dept Family Med & Populat Hlth, 830 East Main St,8th Floor,Box 980212, Richmond, VA 23298 USA; [Roe, Cecilie; Andelic, Nada; Forslund, Marit] Oslo Univ Hosp, Dept Phys Med & Rehabil, Ulleval, Norway; [Roe, Cecilie] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Sigurdardottir, Solrun; Andelic, Nada] Univ Oslo, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, Oslo, Norway		Lu, J (corresponding author), Virginia Commonwealth Univ, Div Epidemiol, Dept Family Med & Populat Hlth, 830 East Main St,8th Floor,Box 980212, Richmond, VA 23298 USA.	juan.lu@vcuhealth.org		Andelic, Nada/0000-0002-3719-4406; Lu, Juan/0000-0002-5389-7603	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002649] Funding Source: NIH RePORTER		Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Forslund MV, 2017, BRAIN INJURY, V31, P329, DOI 10.1080/02699052.2016.1255778; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hart T, 2014, ARCH PHYS MED REHAB, V95, P2103, DOI 10.1016/j.apmr.2014.07.001; Howrey BT, 2017, ARCH PHYS MED REHAB, V98, P1606, DOI 10.1016/j.apmr.2017.03.009; Jeffreys H., 1961, THEORY PROBABILITY, V3; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Jones BL, 2013, SOCIOL METHOD RES, V42, P608, DOI 10.1177/0049124113503141; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Maas A, 2016, CHIN J TRAUMATOL, V19, P3, DOI 10.1016/j.cjtee.2016.01.001; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Muthen B, 1999, BIOMETRICS, V55, P463, DOI 10.1111/j.0006-341X.1999.00463.x; Nagin DS, 2014, ANN NUTR METAB, V65, P205, DOI 10.1159/000360229; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2478, DOI 10.1016/j.apmr.2013.06.019; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Schwab K.A., 2015, HDB CLIN NEUROLOGY, V128; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sigurdardottir S, 2014, BRAIN INJURY, V28, P1542, DOI 10.3109/02699052.2014.934285; TEASDALE G, 1974, LANCET, V2, P81; Uniform Data System for Medical Rehabilitation (UDSMR), 2012, FIMTM INSTR ITS BACK; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	40	10	10	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	14					1596	1603		10.1089/neu.2017.5299		JUN 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GK9FP	WOS:000434469700001	29466920	Green Published			2022-02-06	
J	Bachynski, KE; Goldberg, DS				Bachynski, Kathleen E.; Goldberg, Daniel S.			Time out: NFL conflicts of interest with public health efforts to prevent TBI	INJURY PREVENTION			English	Article						brain injuries; athletic injuries; ethics; conflict of interest; public health	INDUSTRY; CONCUSSION; FOOTBALL; CHILDREN; SPORTS; INJURY		[Bachynski, Kathleen E.] Amer Acad Arts & Sci, Cambridge, MA USA; [Goldberg, Daniel S.] Univ Colorado, Dept Family Med, Anschutz Med Campus, Aurora, CO USA		Bachynski, KE (corresponding author), NYU, Dept Med, New York, NY 10016 USA.	kathleen.bachynski@nyumc.org					[Anonymous], 2016, CHILDS PLAY SPORT KI; Babor TF, 2013, AM J PUBLIC HEALTH, V103, P206, DOI 10.2105/AJPH.2012.300847; Bachynski K. E., 2016, THESIS; Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Belzer J, 2016, THANKS R GOODELL NFL; Bero L, 2013, JAMA INTERN MED, V173, P580, DOI 10.1001/jamainternmed.2013.4190; Brandt AM, 2012, AM J PUBLIC HEALTH, V102, P63, DOI 10.2105/AJPH.2011.300292; Brody H, 2011, AM J BIOETHICS, V11, P23, DOI [10.1080/15265161.2010.534530, 10.1080/15265161.2011.568587]; Cain DM, 2011, J CONSUM RES, V37, P836, DOI 10.1086/656252; CDC Foundation, OUR STORY; CDC Foundation, NFL CDC PARTN ED CLI; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Fainaru S, 2016, C REPORT SAYS NFL WA; Fainaru-Wada M, 2013, LEAGUE DENIAL N F L; Friedman LC, 2015, AM J PUBLIC HEALTH, V105, P250, DOI 10.2105/AJPH.2014.302226; Galea S, 2017, JAMA-J AM MED ASSOC, V317, P1735, DOI 10.1001/jama.2017.1659; Hawkins B, 2013, CRIT POLICY STUD, V7, P53, DOI 10.1080/19460171.2013.766023; Jenkin GL, 2011, OBES REV, V12, P1022, DOI 10.1111/j.1467-789X.2011.00918.x; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Krimsky S, 2003, SCI PRIVATE INTEREST; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Lenzer J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2362; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McDonald CC, 2015, INJURY PREV, V21, P214, DOI 10.1136/injuryprev-2015-041651; Menashe CL, 1998, J HEALTH COMMUN, V3, P307, DOI 10.1080/108107398127139; Michaels D., 2008, DOUBT IS THEIR PRODU; National Football League, 2016, NFL RESP NEW YORK TI; National Institute on Drug Abuse, NIDA IRP TOB IND POL; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Robertson C, 2012, J LAW MED ETHICS, V40, P452, DOI 10.1111/j.1748-720X.2012.00678.x; Schafer A, 2004, J MED ETHICS, V30, P8, DOI 10.1136/jme.2003.005702; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Schwarz A, 2016, N F L BACKED YOUTH P; Schwarz A., 2016, NY TIMES; Stark Andrew, 2000, CONFLICT INTEREST AM; Tobbell Dominique, 2011, PILLS POWER POLICY S; US Centers for Disease Control and Prevention, CONC MUST READ YOUNG; USA Football, 2014, US FOOTB 2014 ANN RE; USCenters for Disease Control and Prevention, PARTN SPOTL NFL; USHouse of Representatives Committee on Energy and Commerce Democratic Staff Report, NAT FOOTB LEAG ATT I	42	10	10	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	JUN	2018	24	3					180	184		10.1136/injuryprev-2017-042404			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	GH2NQ	WOS:000433239000003	29142020				2022-02-06	
J	Cobb, BR; Tyson, AM; Rowson, S				Cobb, Bryan R.; Tyson, Abigail M.; Rowson, Steven			Head acceleration measurement techniques: Reliability of angular rate sensor data in helmeted impact testing	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Instrumentation; football helmets; nine accelerometer array; Hybrid III headform; injury biomechanics	NATIONAL OPERATING COMMITTEE; TRAUMATIC BRAIN-INJURY; HYBRID III; PROFESSIONAL FOOTBALL; HOCKEY HELMETS; PERFORMANCE; CONCUSSION; STANDARDS; RISK; KINEMATICS	This study sought to evaluate the suitability of angular rate sensors for quantifying angular acceleration in helmeted headform impacts. A helmeted Hybrid III headform, instrumented with a 3-2-2-2 nine accelerometer array and angular rate sensors, was impacted (n=90) at six locations and three velocities (3.1, 4.9, and 6.4m/s). Data were low-pass filtered using Butterworth four-pole phaseless digital filters which conform to the specifications described in the Society of Automotive Engineers J211 standard on instrumentation for impact tests. Nine accelerometer array data were filtered using channel frequency class 180, which corresponds to a -3db cutoff frequency of 300Hz. Angular rate sensor data were filtered using channel frequency class values ranging from 5 to 1000Hz in increments of 5Hz, which correspond to -3db cutoff frequencies of 8 to 1650Hz. Root-mean-square differences in peak angular acceleration between the two instrumentation schemes were assessed for each channel frequency class value. Filtering angular rate sensor data with channel frequency class values between 120 and 205 all produced mean differences within +/- 5%. The minimum root-mean-square difference of 297rad/s(2) was found when the angular rate sensor data were filtered using channel frequency class 175. This filter specification resulted in a mean difference of 28 +/- 297rad/s(2) (1.8%+/- 8.6%). Condition-specific differences (=0.05) were observed for 11 of 18 test conditions. A total of 4 of those 11 conditions were within +/- 5%, and 10 were within +/- 10%. Furthermore, the nine accelerometer array and angular rate sensor methods demonstrated similar levels of repeatability. These data suggest that angular rate sensor may be an appropriate alternative to the nine accelerometer array for measuring angular head acceleration in helmeted head impact tests with impactor velocities of 3.1-6.4m/s and impact durations of approximately 10ms.	[Cobb, Bryan R.; Tyson, Abigail M.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Cobb, Bryan R.] North Pk Univ, 3305 W Foster Ave, Chicago, IL 60625 USA		Cobb, BR (corresponding author), North Pk Univ, 3305 W Foster Ave, Chicago, IL 60625 USA.	brcobb@northpark.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596			[Anonymous], J21112007 SAE; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bendjellal F, 1992, 922511 SAE; Bussone WR, 2010, 2010011017 SAE; Cobb BR, 2016, P I MECH ENG P-J SPO, V230, P50, DOI 10.1177/1754337115599133; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Hoshizaki TB, 2017, P I MECH ENG P-J SPO, V231, P83, DOI 10.1177/1754337116633376; Kang YS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005427; MARTIN PG, 1997, 970575 SAE; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2006, STAND LIN IMP TEST M; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NOCSAE, 2011, STAND PERF SPEC NEWL; NOCSAE (National Operating Committee on Standards for Athletic Equipment), 2011, STAND TEST METH EQ U; NUSHOLTZ GS, 1993, EXP MECH, V33, P153, DOI 10.1007/BF02322492; Ouckama R, 2012, P I MECH ENG P-J SPO, V226, P185, DOI 10.1177/1754337111435625; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Siegmund GP, 2014, ANN BIOMED ENG, V42, P1834, DOI 10.1007/s10439-014-1052-2; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Takhounts EG, 2009, ESV 2009, V2009; Viano DC, 2012, ANN BIOMED ENG, V40, P97, DOI 10.1007/s10439-011-0377-3; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Yoganandan N, 2006, J BIOMECH, V39, P1347, DOI 10.1016/j.jbiomech.2005.03.016	32	10	10	0	11	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	JUN	2018	232	2					176	181		10.1177/1754337117708092			6	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	GG3VX	WOS:000432622900012					2022-02-06	
J	Forrest, RHJ; Henry, JD; McGarry, PJ; Marshall, RN				Forrest, Rachel H. J.; Henry, Janis D.; McGarry, Penelope J.; Marshall, Robert N.			Mild traumatic brain injury in New Zealand: factors influencing post-concussion symptom recovery time in a specialised concussion service	JOURNAL OF PRIMARY HEALTH CARE			English	Article						Concussion; mild traumatic brain injury; mTBI; recovery; Rivermead Post-Concussion Questionnaire; Rivermead Symptom Checklist	MINOR HEAD-INJURY; RISK-FACTORS; POPULATION; PREDICTORS; EPIDEMIOLOGY; DEPRESSION; COMPLAINTS; DISORDERS; OUTCOMES; PEOPLE	INTRODUCTION: By 2020, traumatic brain injuries (TBIs) are predicted to become the third largest cause of disease burden globally; 90% of these being mild traumatic brain injury (mTBI). Some patients will develop post-concussion syndrome. AIM: To determine whether the time between sustaining a mTBI and the initial assessment by a specialised concussion service, along with the post-concussion symptoms reported at the assessment, affected recovery time. METHODS: A retrospective medical record review of clients who had completed the Rivermead Post-Concussion Questionnaire (RPQ) at their initial assessment and were discharged from a large metropolitan concussion service in New Zealand was undertaken over a 6-month period in 2014 (n = 107). Using correlations, General Linear Mixed-effects Models (GLMM) and linear regressions, we explored associations between factors including ethnicity, gender and accident type, along with individual RPQ symptom scores and cluster scores, with time from injury to initial assessment by the specialised concussion service and initial assessment to discharge. RESULTS: Time from injury to initial assessment by a specialist concussion service was correlated with proportionally more psychological symptoms present at initial assessments (r = 0.222, P = 0.024); in particular, feeling depressed or tearful (r = 0.292, P = 0.003). Time to discharge was correlated with individual RPQ symptom proportions present at initial assessment for headaches (r = -0.238, P = 0.015), sensitivity to noise (r = 0.220, P = 0.026), feeling depressed or tearful (r = 0.193, P = 0.051) and feeling frustrated or impatient (r = 0.252, P = 0.003), along with the psychological cluster proportion (r = 0.235, P = 0.017) and the total RPQ score (r = 0.425, P < 0.001). CONCLUSION: Prompt diagnosis and treatment of mTBI may minimise the severity of post-concussion symptoms, especially symptoms associated with mental health and wellbeing.	[Forrest, Rachel H. J.] Eastern Inst Technol, Fac Educ Humanities & Hlth Sci, Hawkes Bay Campus,501 Gloucester St, Taradale 4112, Napier, New Zealand; [Henry, Janis D.; McGarry, Penelope J.] Auckland Concuss Serv, Auckland, New Zealand; [Marshall, Robert N.] Eastern Inst Technol, Hawkes Bay Campus, Taradale, Napier, New Zealand		Forrest, RHJ (corresponding author), Eastern Inst Technol, Fac Educ Humanities & Hlth Sci, Hawkes Bay Campus,501 Gloucester St, Taradale 4112, Napier, New Zealand.	rforrest@eit.ac.nz	Forrest, Rachel/D-1184-2010	Forrest, Rachel/0000-0002-5086-0493			Accident Compensation Corporation, CONC SERV OP GUID OC; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; IBM Corporation, 2016, IBM SPSS SOFTW VERS; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; King NS, 2013, BRAIN IMPAIR, V14, P235, DOI 10.1017/BrImp.2013.17; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Landon J, 2012, NEUROPSYCHOL REHABIL, V22, P391, DOI 10.1080/09602011.2011.652496; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lannsjo M, 2012, MILD TRAUMATIC BRAIN; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Obermann M, 2010, HEADACHE, V50, P710, DOI 10.1111/j.1526-4610.2010.01644.x; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Proactive, 2015, AUCKL CONC SERV; Rees RJ, 2007, NEUROREHABILITATION, V22, P229; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Vassar M, 2013, J EDUC EVAL HEALTH P, V10, DOI 10.3352/jeehp.2013.10.12; World Health Organization, 1993, ICD 10 CLASS MENT BE; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8	41	10	10	1	5	CSIRO PUBLISHING	CLAYTON	UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA	1172-6164	1172-6156		J PRIM HEALTH CARE	J. Prim. Health Care	JUN	2018	10	2					159	166		10.1071/HC17071			8	Primary Health Care	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	GZ0CB	WOS:000449022700011	30068471	Green Submitted, gold			2022-02-06	
J	Kaimal, G; Walker, MS; Herres, J; French, LM; DeGraba, TJ				Kaimal, Girija; Walker, Melissa S.; Herres, Joanna; French, Louis M.; DeGraba, Thomas J.			Observational study of associations between visual imagery and measures of depression, anxiety and post-traumatic stress among active-duty military service members with traumatic brain injury at the Walter Reed National Military Medical Center	BMJ OPEN			English	Article							ART-THERAPY TREATMENT; SYMPTOM PROVOCATION; WAR VETERANS; DISORDER; PERSONNEL; HEALTH; PTSD; POPULATIONS; READINESS; COHESION	Objectives The study aimed tocompare recurring themes in the artistic expression of military service members (SMs) with post-traumatic stress disorder (PTSD), traumatic brain injury and psychological health (PH) conditions with measurable psychiatric diagnoses. Affective symptoms and struggles related to verbally expressing information can limit communication in individuals with symptoms of PTSD and deployment-related health conditions. Visual self-expression through art therapy is an alternative way for SMs with PTSD and other PH conditions to communicate their lived experiences. This study offers the first systematic examination of the associations between visual self-expression and standardised clinical self-report measures. Design Observational study of correlations between clinical symptoms of post-traumatic stress, depression and anxiety and visual themes in mask imagery. Setting The National Intrepid Center of Excellence at the Walter Reed National Military Medical Center, Bethesda, Maryland, USA. Participants Active-duty military SMs (n=370) with a history of traumatic brain injury, post-traumatic stress symptoms and related PH conditions. Intervention The masks used for analysis were created by the SMs during art therapy sessions in week 1 of a 4-week integrative treatment programme. Primary outcomes Associations between scores on the PTSD Checklist-Military, Patient Health Questionnaire-9 and Generalized Anxiety Disorder 7-item scale on visual themes in depictions of aspects of individual identity (psychological injury, military symbols, military identity and visual metaphors). Results Visual and clinical data comparisons indicate that SMs who depicted psychological injury had higher scores for post-traumatic stress and depression. The depiction of military unit identity, nature metaphors, sociocultural metaphors, and cultural and historical characters was associated with lower post-traumatic stress, depression and anxiety scores. Colour-related symbolism and fragmented military symbols were associated with higher anxiety, depression and post-traumatic stress scores. Conclusions Emergent patterns of resilience and risk embedded in the use of images created by the participants could provide valuable information for patients, clinicians and caregivers.	[Kaimal, Girija] Drexel Univ, Coll Nursing & Hlth Profess, Creat Arts Therapies, Philadelphia, PA 19104 USA; [Walker, Melissa S.; French, Louis M.; DeGraba, Thomas J.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Herres, Joanna] Coll New Jersey, Dept Psychol, Stockton, NJ USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Kaimal, G (corresponding author), Drexel Univ, Coll Nursing & Hlth Profess, Creat Arts Therapies, Philadelphia, PA 19104 USA.	gk27@drexel.edu	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604; Kaimal, Girija/0000-0002-7316-0473; Walker, Melissa/0000-0001-9375-567X	National Endowment for the Arts' Creative Forces: The NEA Military Healing Arts Network	We are grateful to the National Endowment for the Arts' Creative Forces: The NEA Military Healing Arts Network for providing funding to support this study.	Ahronson A, 2007, MIL PSYCHOL, V19, P9, DOI 10.1080/08995600701323277; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Baker D. G., 2009, MIL MED, V174, P733, DOI DOI 10.7205/MILMED-D-03-3808; Bar-Sela G, 2007, PSYCHO-ONCOLOGY, V16, P980, DOI 10.1002/pon.1175; Barker V.L., 1991, MUSIC THERAPY PERSPE, V9, P26; Blomdahl C, 2013, ART PSYCHOTHER, V40, P322, DOI 10.1016/j.aip.2013.05.009; Bryan CJ, 2015, DEPRESS ANXIETY, V32, P349, DOI 10.1002/da.22372; Chambala A, 2008, ART THER, V25, P187, DOI 10.1080/07421656.2008.10129540; Coleman JA, 2016, J AGGRESS MALTREAT T, V25, P561, DOI 10.1080/10926771.2016.1157842; Collie K, 2006, ART THER, V23, P157, DOI 10.1080/07421656.2006.10129335; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Engel CC, 2008, MIL MED, V173, P935, DOI 10.7205/MILMED.173.10.935; Fiet L., 2014, CARIBBEAN Q, V60, P58, DOI [10.1080/00086495.2014.11672526, DOI 10.1080/00086495.2014.11672526]; Gantt L, 2009, ART PSYCHOTHER, V36, P148, DOI 10.1016/j.aip.2008.12.005; Gibbons SW, 2014, JNP-J NURSE PRACT, V10, P365, DOI 10.1016/j.nurpra.2014.03.021; GOLUB D, 1985, ART PSYCHOTHER, V12, P285, DOI 10.1016/0197-4556(85)90041-3; Gonzalez-Dolginko B., 2002, ART THERAPY J AM ART, V19, P120, DOI DOI 10.1080/07421656.2002.10129408; Griffith J, 2002, MIL PSYCHOL, V14, P217, DOI 10.1207/S15327876MP1403_3; Gussak D, 2007, INT J OFFENDER THER, V51, P444, DOI 10.1177/0306624X06294137; Hall-Clark B, 2016, CURR PSYCHIATRY REV, V12, P124, DOI 10.2174/1573400512666160505150257; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hines-Martin V P, 1993, J Psychosoc Nurs Ment Health Serv, V31, P29; Hoops JR, 2012, MASTER SOCIAL WORK C, V39; Jansen D.J., 2013, POSTTRAUMATIC STRESS; Kim S, 2014, ART PSYCHOTHER, V41, P519, DOI 10.1016/j.aip.2014.10.002; Kimport ER, 2015, ART THER, V32, P184, DOI 10.1080/07421656.2015.1092802; Kline A, 2010, AM J PUBLIC HEALTH, V100, P276, DOI 10.2105/AJPH.2009.162925; Kopytin A, 2013, ART THER, V30, P20, DOI 10.1080/07421656.2013.757758; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lande RG, 2010, ART PSYCHOTHER, V37, P42, DOI 10.1016/j.aip.2009.09.007; Lobban J., 2014, INT J ART THER, V19, P3, DOI [https://doi.org/10.1080/17454832.2012.725547, DOI 10.1080/17454832.2012.725547]; Malchiodi, 2012, HDB ART THERAPY; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Morris FJ, 2014, ART PSYCHOTHER, V41, P343, DOI 10.1016/j.aip.2014.07.002; Nanda U, 2010, ENVIRON BEHAV, V42, P376, DOI 10.1177/0013916510361874; Oliver LW, 1999, MIL PSYCHOL, V11, P57, DOI 10.1207/s15327876mp1101_4; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Reger MA, 2009, J CLIN PSYCHIAT, V70, P1266, DOI 10.4088/JCP.08m04361; Salmon P.R., 1999, ART THERAPY J AM ART, V16, P17, DOI [10.1080/07421656.1999.10759347, DOI 10.1080/07421656.1999.10759347]; Sargent PD, 2013, PSYCHIAT ANN, V43, P181, DOI 10.3928/00485713-20130403-10; Sarid O, 2017, ARCH WOMEN MENT HLTH, V20, P229, DOI 10.1007/s00737-016-0668-7; Shin LM, 1997, ANN NY ACAD SCI, V821, P521, DOI 10.1111/j.1749-6632.1997.tb48320.x; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tanielian T., 2008, INVISIBLE WOUNDS WAR; U.S. Government Accountability Office, 2011, GAO1212; van der Kolk B.A., 2014, BODY KEEPS SCORE BRA; Walker MS, 2017, INT J QUAL STUD HEAL, V12, DOI 10.1080/17482631.2016.1267317; Walker MS, 2016, ART PSYCHOTHER, V49, P10, DOI 10.1016/j.aip.2016.05.015; Wall PLH, 2012, J AM PSYCHIAT NURSES, V18, P278, DOI 10.1177/1078390312460578; Weathers F. W., 1991, PCL M FOR DSM 4; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Zinzow HM, 2013, MIL PSYCHOL, V25, P514, DOI 10.1037/mil0000015	54	10	10	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUN	2018	8	6							e021448	10.1136/bmjopen-2017-021448			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GJ7LG	WOS:000435567900086	29895656	gold, Green Published			2022-02-06	
J	Liu, CB; Yang, DG; Li, JJ; Li, DP; Yang, ML; Sun, W; Meng, QR; Zhang, WH; Cai, C; Du, LJ; Li, J; Gao, F; Gu, R; Feng, YT; Dong, XC; Miao, Q; Yang, XH; Zuo, ZT				Liu, Changbin; Yang, Degang; Li, Jianjun; Li, Dapeng; Yang, Mingliang; Sun, Wei; Meng, Qianru; Zhang, Wenhao; Cai, Chang; Du, Liangjie; Li, Jun; Gao, Feng; Gu, Rui; Feng, Yutong; Dong, Xuechao; Miao, Qi; Yang, Xinghua; Zuo, Zhentao			Dynamic diffusion tensor imaging of spinal cord contusion: A canine model	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						diffusion tensor imaging; dogs; dynamic changes; model; histopathology; RRID: AB_650102; RRID: AB_880202	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; AXONAL INJURY; FUNCTIONAL RECOVERY; CORPUS-CALLOSUM; MILD; RAT; MR; TRACTOGRAPHY; EPIDEMIOLOGY	This study aimed to explore the dynamic diffusion tensor imaging (DTI) of changes in spinal cord contusion using a canine model of injury involving rostral and caudal levels. In this study, a spinal cord contusion model was established in female dogs using a custom-made weight-drop lesion device. DTI was performed on dogs with injured spinal cords (n=7) using a Siemens 3.0T MRI scanner at pre-contusion and at 3h, 24h, 6 weeks and 12 weeks post-injury. The tissue sections were stained for immunohistochemical analysis. Canine models of spinal cord contusion were created successfully using the weight-drop lesion device. The fractional anisotropy (FA) value of lesion epicenter decreased, while the apparent diffusion coefficient (ADC), mean diffusivity (MD), and radial diffusivity (RD) values increased, and the extent of the curve was apparent gradually. The site and time affected the DTI parameters significantly in the whole spinal cord, ADC (site, P<0.001 and time, P=0.077, respectively); FA (site, P<0.001 and time, P=0.002, respectively). Immunohistological analysis of GFAP and NF revealed the pathologic changes of reactive astrocytes and axons, as well as the cavity and glial scars occurring during chronic SCI. DTI is a sensitive and noninvasive imaging tool useful to assess edema, hemorrhage, cavity formation, structural damage and reconstruction of axon, and myelin in dogs. The DTI parameters after contusion vary. However, the curves of ADC, MD, and RD were nearly similar and the FA curve was distinct. All the DTI parameters were affected by distance and time.	[Liu, Changbin; Yang, Degang; Li, Jianjun; Li, Dapeng; Yang, Mingliang; Sun, Wei; Meng, Qianru; Zhang, Wenhao; Cai, Chang; Du, Liangjie; Li, Jun; Gao, Feng; Gu, Rui; Feng, Yutong; Dong, Xuechao] Capital Med Univ, Sch Rehabil Med, 10 Jiaomen North Rd, Beijing 100068, Peoples R China; [Liu, Changbin; Yang, Degang; Li, Jianjun; Li, Dapeng; Yang, Mingliang; Meng, Qianru; Zhang, Wenhao; Cai, Chang; Du, Liangjie; Li, Jun; Gao, Feng; Feng, Yutong; Dong, Xuechao] China Rehabil Res Ctr, Dept Spinal & Neural Funct Reconstruct, 10 Jiaomen North Rd, Beijing 100068, Peoples R China; [Liu, Changbin; Yang, Degang; Li, Jianjun; Li, Dapeng; Yang, Mingliang; Sun, Wei; Meng, Qianru; Zhang, Wenhao; Cai, Chang; Du, Liangjie; Li, Jun; Gao, Feng; Gu, Rui; Feng, Yutong; Dong, Xuechao] Beijing Inst Brain Disorders, Ctr Neural Injury & Repair, 10 Jiaomen North Rd, Beijing 100068, Peoples R China; [Liu, Changbin; Yang, Degang; Li, Jianjun; Li, Dapeng; Yang, Mingliang; Sun, Wei; Meng, Qianru; Zhang, Wenhao; Cai, Chang; Du, Liangjie; Li, Jun; Gao, Feng; Gu, Rui; Feng, Yutong; Dong, Xuechao] China Rehabil Sci Inst, Beijing 100068, Peoples R China; [Liu, Changbin; Yang, Degang; Li, Jianjun; Li, Dapeng; Yang, Mingliang; Sun, Wei; Meng, Qianru; Zhang, Wenhao; Cai, Chang; Du, Liangjie; Li, Jun; Gao, Feng; Gu, Rui; Feng, Yutong; Dong, Xuechao] Beijing Key Lab Neural Injury & Rehabil, 10 Jiaomen North Rd, Beijing 100068, Peoples R China; [Miao, Qi] Zibo Shanhang Med Engn Co Ltd, Zibo 255000, Shandong, Peoples R China; [Yang, Xinghua] Capital Med Univ, Sch Publ Hlth, 10 Xitoutiao, Beijing 100069, Peoples R China; [Zuo, Zhentao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China; [Zuo, Zhentao] Chinese Acad Sci, Innovat Ctr Excellence Brain Sci, Beijing, Peoples R China; [Zuo, Zhentao] Univ Chinese Acad Sci, Sino Danish Coll, Beijing 100049, Peoples R China		Li, JJ (corresponding author), Capital Med Univ, Sch Rehabil Med, 10 Jiaomen North Rd, Beijing 100068, Peoples R China.; Li, JJ (corresponding author), China Rehabil Res Ctr, Dept Spinal & Neural Funct Reconstruct, 10 Jiaomen North Rd, Beijing 100068, Peoples R China.; Li, JJ (corresponding author), Beijing Inst Brain Disorders, Ctr Neural Injury & Repair, 10 Jiaomen North Rd, Beijing 100068, Peoples R China.; Li, JJ (corresponding author), Beijing Key Lab Neural Injury & Rehabil, 10 Jiaomen North Rd, Beijing 100068, Peoples R China.	13718331416@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81272164]; Special Fund for Basic Scientific Research of Central Public Research Institutes [2015CZ-6, 2016CZ-4]; Beijing Institute for Brain Disorders [201601]; Supporting Program of the 'Twelve Five-year Plan' for Science & Technology Research of China [2012BAI34B02]; Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2012CB825500]; National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30921064, 91132302, 90820307]	This work was supported by the National Natural Science Foundation of China, grant number 81272164; the Special Fund for Basic Scientific Research of Central Public Research Institutes, grant number: 2015CZ-6, 2016CZ-4; Beijing Institute for Brain Disorders (201601) and the Supporting Program of the 'Twelve Five-year Plan' for Science & Technology Research of China, grant number: 2012BAI34B02; in part by the Ministry of Science and Technology of China, grant number: 2012CB825500; and the National Nature Science Foundation of China grant numbers: 30921064, 91132302, 90820307	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Boekhoff TM, 2012, J SPINAL DISORD TECH, V25, pE81, DOI 10.1097/BSD.0b013e31823f2f55; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Chiu WT, 2010, ASIA-PAC J PUBLIC HE, V22, P9, DOI 10.1177/1010539509355470; Deo AA, 2006, J NEUROSCI RES, V83, P801, DOI 10.1002/jnr.20783; Dong X, 2016, SPINAL CORD, V54, P947, DOI 10.1038/sc.2016.35; Ellingson BM, 2010, J NEUROSURG-SPINE, V13, P181, DOI 10.3171/2010.3.SPINE09523; Ellingson BM, 2008, J MAGN RESON IMAGING, V28, P1068, DOI 10.1002/jmri.21578; Fukuda S, 2005, BRAIN RES PROTOC, V14, P171, DOI 10.1016/j.brainresprot.2005.01.001; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Grace CE, 2010, NEUROTOXICOL TERATOL, V32, P346, DOI 10.1016/j.ntt.2010.01.006; Hobert MK, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-36; Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jeffery ND, 2006, SPINAL CORD, V44, P584, DOI 10.1038/sj.sc.3101912; Jirjis MB, 2013, J NEUROTRAUM, V30, P1577, DOI 10.1089/neu.2013.2897; KHAN M, 1983, CAN J NEUROL SCI, V10, P161, DOI 10.1017/S031716710004484X; KULKARNI MV, 1987, RADIOLOGY, V164, P837, DOI 10.1148/radiology.164.3.3615885; Lee JW, 2011, SKELETAL RADIOL, V40, P1543, DOI 10.1007/s00256-011-1161-z; Leong D, 2015, NEURORADIOL J, V28, P12, DOI 10.15274/NRJ-2014-10110; Lin M, 2016, MAGN RESON MED, V76, P290, DOI 10.1002/mrm.25816; Loy DN, 2007, J NEUROTRAUM, V24, P979, DOI 10.1089/neu.2006.0253; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Martin AR, 2016, NEUROIMAGE-CLIN, V10, P192, DOI 10.1016/j.nicl.2015.11.019; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Onose G, 2009, SPINAL CORD, V47, P716, DOI 10.1038/sc.2009.52; Patel SP, 2016, J NEUROTRAUM, V33, P917, DOI 10.1089/neu.2015.4185; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Purdy PD, 2004, AM J NEURORADIOL, V25, P1435; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Spatz M, 2010, ACTA NEUROCHIR SUPPL, V106, P21, DOI 10.1007/978-3-211-98811-4_3; Tay B, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/276589; Wang F, 2014, NEUROREPORT, V25, P1386, DOI 10.1097/WNR.0000000000000278; Wang F, 2015, MAGN RESON MED, V74, P1125, DOI 10.1002/mrm.25488; Webb AA, 2010, CAN VET J, V51, P598; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Xiangshui M, 2010, CLIN RADIOL, V65, P465, DOI 10.1016/j.crad.2010.01.019; Xu JC, 2011, J NEUROTRAUM, V28, P1921, DOI 10.1089/neu.2011.1783; Young W, 2002, PROG BRAIN RES, V137, P231; Zhao C, 2016, NEURORADIOLOGY, V58, P607, DOI 10.1007/s00234-016-1660-7; Zhao FY, 2006, ACTA NEUROCHIR SUPPL, V96, P168	50	10	10	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2018	96	6					1093	1103		10.1002/jnr.24222			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC9IT	WOS:000430111400013	29485189				2022-02-06	
J	Lou, DD; Du, Y; Huang, DC; Cai, F; Zhang, Y; Li, TY; Zhou, WH; Gao, HC; Song, WH				Lou, Dandan; Du, Yao; Huang, Daochao; Cai, Fang; Zhang, Yun; Li, Tinyu; Zhou, Weihui; Gao, Hongchang; Song, Weihong			Traumatic Brain Injury Alters the Metabolism and Facilitates Alzheimer's Disease in a Murine Model	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Alzheimer's disease; Metabolomics	MAGNETIC-RESONANCE-SPECTROSCOPY; CEREBROSPINAL-FLUID; AMYLOID-BETA; MOUSE MODEL; A-BETA; THERAPEUTIC TARGETS; INSULIN-RESISTANCE; OXIDATIVE STRESS; HEAD-INJURY; ACCUMULATION	A majority of Alzheimer's disease (AD) cases are sporadic without known cause. People who suffered from traumatic brain injury (TBI) are more likely to develop neurodegeneration and cognitive impairments. However, the role of TBI in pathophysiology of AD remains elusive. The present study intended to explore the effect of TBI on metabolism and its role in AD pathogenesis. We subjected double transgenic AD model mice APP23/PS45 to TBI. We found that TBI promoted beta-secretase cleavage of amyloid beta precursor protein and amyloid beta protein deposition, and exuberated the cognitive impairments in AD mouse models. H-1 nuclear magnetic resonance (H-1-NMR)-based metabolomics with multivariate analysis was performed to investigate the characteristic metabolites and the related metabolic pathways in the serum and urine samples of the mice. TBI affected the metabolic patterns, methylamine metabolism, and amino acid metabolism in serum samples. Urinary metabolites showed that glycolysis and the tricarboxylic acid (TCA) cycle were perturbed. The results indicate that TBI might facilitate Alzheimer's pathogenesis by altering metabolism and inducing mitochondrial dysfunction. The study suggests that metabolite changes could also serve as biomarkers for TBI-induced neurodegeneration.	[Lou, Dandan; Huang, Daochao; Li, Tinyu; Zhou, Weihui; Song, Weihong] Chongqing Med Univ, Childrens Hosp, Chongqing City Key Lab Translat Med Res Cognit De, Chongqing 400014, Peoples R China; [Lou, Dandan; Huang, Daochao; Li, Tinyu; Zhou, Weihui] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China; [Du, Yao; Gao, Hongchang] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Peoples R China; [Cai, Fang; Zhang, Yun; Song, Weihong] Univ British Columbia, Dept Psychiat, Townsend Family Labs, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada		Song, WH (corresponding author), Chongqing Med Univ, Childrens Hosp, Chongqing City Key Lab Translat Med Res Cognit De, Chongqing 400014, Peoples R China.; Gao, HC (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Peoples R China.; Song, WH (corresponding author), Univ British Columbia, Dept Psychiat, Townsend Family Labs, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	gaohc27@wmu.edu.cn; weihong@mail.ubc.ca	Song, Weihong/O-7623-2017	Song, Weihong/0000-0001-9928-889X; Du, Yao/0000-0001-8945-150X	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [21175099, 21575105]; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [CEN-132387]; Michael Smith Foundation for Health Research/The Pacific Alzheimer Research FoundationMichael Smith Foundation for Health Research	We thank Ye Song for experimental assistance. This work was supported by the National Natural Science Foundation of China (NSFC) Grants 21175099 and 21575105 (H.G.), and the Canadian Institutes of Health Research (CIHR) Grant CEN-132387 (W.S.). W.S. is the holder of the Tier 1 Canada Research Chair in Alzheimer's Disease, and Y. Z. is the recipient of Michael Smith Foundation for Health Research/The Pacific Alzheimer Research Foundation Post-Doctoral Fellowship Award.	Amenta F, 2001, MECH AGEING DEV, V122, P2025, DOI 10.1016/S0047-6374(01)00310-4; Association As, 2016, ALZHEIMERS DEMENT, V12; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; BLASS JP, 1990, ARCH NEUROL-CHICAGO, V47, P864, DOI 10.1001/archneur.1990.00530080046009; Bromley-Brits K, 2011, JOVE-J VIS EXP, DOI 10.3791/2920; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Coen M, 2003, CHEM RES TOXICOL, V16, P295, DOI 10.1021/tx0256127; Collins JM, 2015, EXP NEUROL, V267, P219, DOI 10.1016/j.expneurol.2015.02.034; Davies P, 1999, JAMA-J AM MED ASSOC, V281, P1433, DOI 10.1001/jama.281.15.1433; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Deng Y, 2013, EUR J NEUROSCI, V37, P1962, DOI 10.1111/ejn.12235; Dervilly-Pinel G, 2011, ANAL CHIM ACTA, V700, P144, DOI 10.1016/j.aca.2011.02.008; Faul MXL., 2010, TRAUMATIC BRAIN INJU, P2002; FERKO AP, 1986, PHARMACOL BIOCHEM BE, V24, P543, DOI 10.1016/0091-3057(86)90555-1; Gao HC, 2008, ANAL CHIM ACTA, V624, P269, DOI 10.1016/j.aca.2008.06.051; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Gonzalez-Dominguez R, 2015, J PHARMACEUT BIOMED, V107, P75, DOI 10.1016/j.jpba.2014.10.010; Gonzalez-Dominguez R, 2014, BBA-MOL BASIS DIS, V1842, P2395, DOI 10.1016/j.bbadis.2014.09.014; Graham SF, 2013, ANAL CHEM, V85, P1803, DOI 10.1021/ac303163f; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Guan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060409; Ichimura H, 2003, J CLIN INVEST, V111, P691, DOI 10.1172/JCI200317271; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jimenez-Jimenez FJ, 1998, J NEURAL TRANSM, V105, P269, DOI 10.1007/s007020050056; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kang Y, 2017, CURR ALZHEIMER RES, V14, P841, DOI 10.2174/1567205014666170425112331; Kokiko-Cochran O, 2016, J NEUROTRAUM, V33, P625, DOI 10.1089/neu.2015.3970; Kuusisto J, 1997, BRIT MED J, V315, P1045, DOI 10.1136/bmj.315.7115.1045; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Ly P. T. T., 2011, J VIS EXP, V53; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Marcello E, 2013, J CLIN INVEST, V123, P2523, DOI 10.1172/JCI65401; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; Mayeux R, 2010, NEW ENGL J MED, V362, P2194, DOI 10.1056/NEJMcp0910236; Myint KT, 2009, ANAL CHEM, V81, P1121, DOI 10.1021/ac802259r; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Nieuwenhuys RD, 1998, CENTRAL NERVOUS SYST, V1, P11; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Poly C, 2011, AM J CLIN NUTR, V94, P1584, DOI 10.3945/ajcn.110.008938; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Radhakrishnan R, 2016, LANCET PSYCHIAT, V3, P1166, DOI 10.1016/S2215-0366(16)30266-8; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Sekhar RV, 2011, AM J CLIN NUTR, V94, P847, DOI 10.3945/ajcn.110.003483; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shishido H, 2016, NEUROSCI LETT, V629, P62, DOI 10.1016/j.neulet.2016.06.066; Silverstone Peter H, 2008, Ann Gen Psychiatry, V7, P19, DOI 10.1186/1744-859X-7-19; Sinclair AJ, 2010, NMR BIOMED, V23, P123, DOI 10.1002/nbm.1428; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Sun XL, 2012, J NEUROCHEM, V120, P62, DOI 10.1111/j.1471-4159.2011.07515.x; Szabados T, 2004, BEHAV BRAIN RES, V154, P31, DOI 10.1016/j.bbr.2004.01.016; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tang HR, 2004, ANAL BIOCHEM, V325, P260, DOI 10.1016/j.ab.2003.10.033; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tilg H, 2016, NEW ENGL J MED, V374, P2494, DOI 10.1056/NEJMcibr1604458; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Waters NJ, 2002, BIOCHEM PHARMACOL, V64, P67, DOI 10.1016/S0006-2952(02)01016-X; Zeng J., 2017, ACTA NEUROPATHOL BER, P1; Zhang MM, 2012, J NEUROCHEM, V120, P1129, DOI 10.1111/j.1471-4159.2011.07644.x; Zhang Y, 2017, NEUROBIOL PROG; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108; Zhao LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27194; Zhao LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108678	76	10	10	1	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2018	55	6					4928	4939		10.1007/s12035-017-0687-z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF5FI	WOS:000431991500032	28776265				2022-02-06	
J	Mosti, C; Coccaro, EF				Mosti, Caterina; Coccaro, Emil F.			Mild Traumatic Brain Injury and Aggression, Impulsivity, and History of Other- and Self-Directed Aggression	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							LIFE-HISTORY; PREVALENCE; QUESTIONNAIRE; BEHAVIOR; METAANALYSIS; POPULATION; OFFENDERS; SOLDIERS; VALIDITY; TBI	Mild traumatic brain injury (mTBI) is highly prevalent, with an estimated occurrence in the United States of more than 1.3 million per year. While one consequence of mTBI is impulsive aggressive behavior, very few studies have examined the relationship between history of mTBI and aggressive behavior in impulsively aggressive individuals. The authors examined the relationship between history of mTBI in a healthy control group (HC; N=453), a control group with psychiatric disorders (PC; N=486), and individuals with intermittent explosive disorder (IED; N=695), a disorder of primary impulsive aggression. Results demonstrated that IED study participants were significantly more likely to have a history of mTBI (with or without history of a brief loss of consciousness [LOC]) compared with both HC and PC participants. A similar observation was made with regard to self-directed aggression (i.e., suicidal or self-injurious behavior), although group differences were only among those with mTBI with LOC. For both other-and self-directed aggression variables, the authors observed a stepwise increase in dimensional aggression and impulsivity scores across participants as a function of mTBI history. Given that impulsive aggressive behavior begins very early in life, these data are consistent with the hypothesis that lifelong presence of an impulsive aggressive temperament places impulsive aggressive individuals in circumstances that put them at greater risk for mTBI compared with other individuals with and without nonimpulsive aggressive psychopathology.	[Mosti, Caterina; Coccaro, Emil F.] Univ Chicago, Pritzker Sch Med, Dept Psychiat & Behav Neurosci, Clin Neurosci Res Unit, Chicago, IL 60637 USA		Coccaro, EF (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Psychiat & Behav Neurosci, Clin Neurosci Res Unit, Chicago, IL 60637 USA.	ecoccaro@bsd.uchicago.edu			NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [RO1 MH60836, RO1 MH66984, RO1 MH104673]; Pritzker-Pucker Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH060836, R01MH104673, R01MH066984] Funding Source: NIH RePORTER	Supported in part by NIMH grants RO1 MH60836, RO1 MH66984, and RO1 MH104673 (to Dr. Coccaro) and a grant from the Pritzker-Pucker Family Foundation (to Dr. Coccaro).	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; [Anonymous], 2009, VA DOD CLIN PRACT GU; [Anonymous], 1994, DIAGNOSTIC STAT MANU; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Coccaro EF, 1997, PSYCHIAT RES, V73, P147, DOI 10.1016/S0165-1781(97)00119-4; Coccaro Emil F, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P32, DOI 10.1016/j.bpsc.2015.09.006; Coccaro EF, 2012, COMPR PSYCHIAT, V53, P907, DOI 10.1016/j.comppsych.2012.03.007; Coccaro EF, 2012, AM J PSYCHIAT, V169, P577, DOI 10.1176/appi.ajp.2012.11081259; Coccaro EF, 2012, J PSYCHIATR RES, V46, P346, DOI 10.1016/j.jpsychires.2011.11.008; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Elbogen Eric B, 2012, J Clin Psychiatry, V73, pe767, DOI 10.4088/JCP.11m07593; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; Epstein DJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.581; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; First M., 1997, STRUCTURED CLIN INTE; Gallaway MS, 2012, AGGRESSIVE BEHAV, V38, P357, DOI 10.1002/ab.21436; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; MacManus D, 2012, PSYCHOL MED, V42, P1663, DOI 10.1017/S0033291711002327; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pfohl B., 1997, STRUCTURED INTERVIEW; Ramesh D, 2015, AM J ADDICTION, V24, P341, DOI 10.1111/ajad.12192; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rosellini AJ, 2016, PSYCHOL MED, V46, P303, DOI 10.1017/S0033291715001774; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tremblay Richard E, 2014, Curr Top Behav Neurosci, V17, P315, DOI 10.1007/7854_2013_262; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	42	10	10	2	13	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2018	30	3					220	227		10.1176/appi.neuropsych.17070141			8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	GN3XZ	WOS:000438947300114	29505319	Green Accepted, Bronze			2022-02-06	
J	Odgaard, L; Aadal, L; Eskildsen, M; Poulsen, I				Odgaard, Lene; Aadal, Lena; Eskildsen, Marianne; Poulsen, Ingrid			Nursing Sensitive Outcomes After Severe Traumatic Brain Injury: A Nationwide Study	JOURNAL OF NEUROSCIENCE NURSING			English	Article						complications; deep venous thrombosis; fundamentals of care; joint contractures; nursing-sensitive outcomes; pneumonia; pressure ulcers; quality of healthcare; rehabilitation; traumatic brain injury; urinary tract infection	MEDICAL COMPLICATIONS; INPATIENT REHABILITATION; CONSCIOUSNESS; DISORDERS; MODERATE	Background: Complications such as infections and conditions after immobilization are frequent after severe traumatic brain injury (TBI) due to compromised bodily functions. Traditionally, bodily functions are core elements in nursing, and therefore nurses in the rehabilitation departments are pivotal in the prevention of complications. Hence, the frequency of complications is an indicator of nursing care quality, which can be included in nursing-sensitive outcome indicators. To do so, it is necessary to know the frequency of the selected complications. Objective: The aim of this study was to quantify complications during the first year after severe TBI. Participants: This study included patients 15 years or older who received subacute neurorehabilitation after severe TBI from 2011 to 2015 (N = 469). Design: This is a register-based follow-up study using data from the Danish Head Trauma Database, a national clinical quality database aimed at monitoring and improving the quality of rehabilitation for patients with severe TBI. Main Measures: The following complications were assessed: urinary tract infection, pneumonia, pressure ulcers, joint contractures, and deep venous thrombosis. The prevalence of each complication was calculated at admission, discharge, and 1 year postinjury and for the period from admission and during subacute rehabilitation. In addition, the frequency of complications that certainly developed during subacute rehabilitation was calculated. Complications were compared between age-specific subgroups using multivariable binominal regression analyses. Results: Urinary tract infections (53%) and pneumonia (32%) were the most common complications in the period from admission and during subacute rehabilitation. Pressure ulcers (18%), joint contractures (18%), and deep venous thrombosis (4%) were less frequent. At discharge and 1 year postinjury, the prevalence was less than 4% for all complications, except for joint contractures (16% and 13% at discharge and 1 year postinjury, respectively). Conclusion: The prevalence of complications was high. The findings are important for future quality improvement of the rehabilitation trajectory and for further studies that explore the high frequency of complications.	[Odgaard, Lene] Hammel Neurorehabil Ctr, Hammel, Denmark; [Odgaard, Lene; Aadal, Lena] Univ Res Clin, Hammel, Denmark; [Aadal, Lena] Hammel Neurorehabil Ctr, Clin Nursing Res, Hammel, Denmark; [Eskildsen, Marianne] Copenhagen Univ Hosp, Rigshosp, Dept Neurorehabil, Traumat Brain Injury, Hvidovre, Denmark; [Poulsen, Ingrid] Copenhagen Univ Hosp, Rigshosp, RUBRIC Res Unit Brain Injury Rehabil, Dept Neurorehabil,Traumat Brain Injury, Hvidovre, Denmark; [Poulsen, Ingrid] Aarhus Univ, Sect Nursing Sci, Aarhus, Denmark		Odgaard, L (corresponding author), Hammel Neurorehabil Ctr, Hammel, Denmark.; Odgaard, L (corresponding author), Univ Res Clin, Hammel, Denmark.	lene.odgaard@midt.rm.dk	Poulsen, ingrid/AAH-2052-2019; Aadal, Lena/R-3444-2019; Odgaard, Lene/AAF-1909-2020	Poulsen, ingrid/0000-0002-0342-017X; Aadal, Lena/0000-0001-7365-3916; Odgaard, Lene/0000-0002-9830-3282			Dhandapani M, 2014, J CLIN NURS, V23, P1114, DOI 10.1111/jocn.12396; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; Feo R, 2016, INT J NURS STUD, V57, P1, DOI 10.1016/j.ijnurstu.2016.01.006; Francis, 2013, REPORT MIDSTAFFORDSH, V947; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Garling P, 2008, SPECIAL COMMISSION I; HENDERSON V, 1964, AM J NURS, V64, P62, DOI 10.2307/3419278; International Council of Nurses (ICN), NURS SENS OUTC IND; Kitson A., 2013, RECLAIMING REDEFININ; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; National Pressure Ulcer Advisory Panel European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance, 2014, PREV TREATM PRESS UL; Ng YS, 2005, NEUROREHABILITATION, V20, P97; Odgaard L, 2015, CLIN EPIDEMIOL, V7, P225, DOI 10.2147/CLEP.S78141; Romaniello C, 2016, AM J MED SCI, V351, P563, DOI 10.1016/j.amjms.2016.01.024; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Singer BJ, 2004, ARCH PHYS MED REHAB, V85, P1465, DOI 10.1016/j.apmr.2003.08.103; TEASDALE G, 1974, LANCET, V2, P81; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358	21	10	11	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	JUN	2018	50	3					149	154		10.1097/JNN.0000000000000365			6	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	GF8AE	WOS:000432188900006	29652735				2022-02-06	
J	Rattan, R; Joseph, DK; Dente, CJ; Klein, EN; Kimbrough, MK; Nguyen, J; Simmons, JD; O'Keeffe, T; Crandall, M				Rattan, Rishi; Joseph, D'Andrea K.; Dente, Christopher J.; Klein, Eric N.; Kimbrough, Mary K.; Nguyen, Jonathan; Simmons, Jon D.; O'Keeffe, Terence; Crandall, Marie			Prevention of all-terrain vehicle injuries: A systematic review from The Eastern Association for the Surgery of Trauma	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	29th Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 12-18, 2014	Naples, FL	Eastern Assoc Surg Trauma		Injury prevention; all-terrain vehicle; brain injury; guideline; evidence-based medicine	BELT LAWS; CHILDREN; STATE; HELMETS; LEGISLATION; REGULATIONS; ACCIDENTS; CRASHES; IMPACT; SAFETY	BACKGROUND Despite increasing usage since their introduction, there exist no evidence-based guidelines on all-terrain vehicles (ATVs) and injury prevention. While the power and speed of these vehicles has increased over time, advancements in ATV safety have been rare. METHODS A priori questions about ATV injury pattern and the effect of helmet and safety equipment use and legislation mandating use were developed. A query of MEDLINE, PubMed, Cochrane Library, and Embase for all-terrain vehicle injury was performed. Letters to the editor, case reports, book chapters, and review articles were excluded. Grading of Recommendations Assessment, Development, and Evaluation methodology was used to perform a systematic review and create recommendations. RESULTS Twenty-eight studies were included. Helmet use reduced traumatic brain injury (TBI). However, studies examining whether legislation mandating helmet use reduced TBI had mixed results. When ATV safety legislation was enforced, overall injury rates and mortality decreased. However, enforcement varied widely and lack of enforcement led to decreased compliance with legislation and mixed results. There was not enough evidence to determine the effectiveness of non-helmet-protective equipment. CONCLUSION Helmet use when riding an ATV reduced the rate of TBI. ATV safety legislation, when enforced, also reduced morbidity and mortality. Compliance with laws is often low, however, possibly due to poor enforcement. We recommend helmet use when riding on an ATV to reduce TBI. We conditionally recommend implementing ATV safety legislation as a means to reduce ATV injuries, noting that enforcement must go hand in hand with enactment to ensure compliance.	[Rattan, Rishi] Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, Miami, FL 33136 USA; [Joseph, D'Andrea K.] New York Univ Winthrop, Dept Surg, Mineola, NY USA; [Dente, Christopher J.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Klein, Eric N.] Hofstra Univ, Zucker Sch Med, Dept Surg, East Garden, NY USA; [Kimbrough, Mary K.] Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA; [Nguyen, Jonathan] Morehouse Sch Med, Dept Surg, Atlanta, GA 30310 USA; [Simmons, Jon D.] Univ S Alabama, Sch Med, Dept Surg, Mobile, AL USA; [O'Keeffe, Terence] Univ Arizona, Dept Surg, Tucson, AZ USA; [Crandall, Marie] Univ Florida, Coll Med Jacksonville, Dept Surg, Jacksonville, FL USA		Rattan, R (corresponding author), 1800 NW 10th Ave,Ste T215 D-40, Miami, FL 33136 USA.	rrattan@miami.edu	Crandall, Marie/L-9066-2019	Crandall, Marie/0000-0002-6536-3123; Rattan, Rishi/0000-0003-1403-1249; Kimbrough, Mary/0000-0002-3855-2156	American College of Surgeons Clowes Award; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM109113-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM109113] Funding Source: NIH RePORTER	J.D.S. is supported by a National Institutes of Health K08 grant (GM109113-01A1) and the American College of Surgeons Clowes Award.	Alawi Khalid, 2006, CJEM, V8, P277; American College of Emergency Physicians (ACEP), 2013, Ann Emerg Med, V61, P725, DOI 10.1016/j.annemergmed.2013.03.035; American College of Surgeons, 2009, Bull Am Coll Surg, V94, P37; [Anonymous], 1987, Pediatrics, V79, P306; Anson K, 2009, NEW ZEAL MED J, V122, P11; Beaudin M, 2014, PEDIATR EMERG CARE, V30, P169, DOI 10.1097/PEC.0000000000000087; Beidler Stephanie K, 2009, N C Med J, V70, P503; Bowman SM, 2009, INJURY PREV, V15, P3, DOI 10.1136/ip.2008.019372; Bull MJ, 2000, PEDIATRICS, V105, P1352, DOI 10.1542/peds.105.6.1352; Burd R, 2009, J PEDIATR SURG, V44, P1638, DOI 10.1016/j.jpedsurg.2009.03.026; Cain Loretta, 2010, W V Med J, V106, P26; Carr AM, 2004, NEUROSURGERY, V54, P861, DOI 10.1227/01.NEU.0000114922.46342.38; Center UoNCHSR, 2011, COUNT WORK HIGHW SAF; Commission USCPS, 1998, ALL TERR VEH EXP INJ; Commission USCPS, 2006, 2005 ANN REP ALL TER; Commission USCPS, 2017, 2015 ANN REP ATV REL; Commission USCPS, 2014, ATV SAF INF CTR QUIC; Finn MA, 2010, NEUROSURGERY, V67, P993, DOI 10.1227/NEU.0b013e3181f209db; Fonseca AH, 2005, AM SURGEON, V71, P937; Franklin RC, 2014, RURAL REMOTE HEALTH, V14; Gilbert H, 2008, TRAFFIC TECH TECHNOL; Gittelman MA, 2006, PEDIATRICS, V117, P2190, DOI 10.1542/peds.2005-2603; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Helmkamp JC, 2012, PUBLIC HEALTH REP, V127, P364, DOI 10.1177/003335491212700404; Helmkamp JC, 2001, AM J PUBLIC HEALTH, V91, P1792, DOI 10.2105/AJPH.91.11.1792; Jaeschke R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a744; Kanny D, 2001, AM J EPIDEMIOL, V154, P1072, DOI 10.1093/aje/154.11.1072; Keenan HT, 2004, PEDIATRICS, V113, pE330, DOI 10.1542/peds.113.4.e330; Kerwin AJ, 2012, J TRAUMA ACUTE CARE, V73, pS283, DOI 10.1097/TA.0b013e31827013e9; Lee LK, 2015, ANN INTERN MED, V163, P184, DOI 10.7326/M14-2368; MacLeod JBA, 2010, J TRAUMA, V69, P1101, DOI 10.1097/TA.0b013e3181f8a9cc; Mahida JB, 2015, J PEDIATR SURG, V50, P1188, DOI 10.1016/j.jpedsurg.2014.10.047; Mazotas I, 2014, J TRAUMA ACUTE CARE, V77, P103, DOI 10.1097/TA.0000000000000266; McBride AS, 2011, PEDIATR EMERG CARE, V27, P97, DOI 10.1097/PEC.0b013e31820942f8; Merrigan TL, 2011, TRAFFIC INJ PREV, V12, P251, DOI 10.1080/15389588.2011.561455; Miller Miryam, 2012, W V Med J, V108, P96; Pelletier JS, 2012, CAN J SURG, V55, P249, DOI 10.1503/cjs.036210; Preusser D. F., 2003, EVALUATION REPEAL MO; Rivara FP, 1998, ANNU REV PUBL HEALTH, V19, P293, DOI 10.1146/annurev.publhealth.19.1.293; Rodgers GB, 2002, INJ PREV, V8, P42, DOI 10.1136/ip.8.1.42; RODGERS GB, 1993, ACCIDENT ANAL PREV, V25, P335, DOI 10.1016/0001-4575(93)90027-T; Ross RT, 1999, AM SURGEON, V65, P870; Rostas Jack W, 2014, J Trauma Acute Care Surg, V76, P201, DOI 10.1097/TA.0b013e3182a994ff; Rotondo MF, 2005, AM SURGEON, V71, P940; Shults RA, 2004, J SAFETY RES, V35, P189, DOI 10.1016/j.jsr.2004.03.002; Smith LM, 2005, J TRAUMA, V58, P783, DOI 10.1097/01.TA.0000158252.11002.6E; Stiles PJ, 2015, AM SURGEON, V81, P103; Testerman George M, 2013, Am Surg, V79, pE204; Thepyasuwan N, 2009, AM SURGEON, V75, P1004; Trauma Comm Canadian Assoc Pediat, 2008, J PEDIATR SURG, V43, P938, DOI 10.1016/j.jpedsurg.2007.12.044; Upperman JS, 2003, J PEDIATR SURG, V38, P1284, DOI 10.1016/S0022-3468(03)00383-X; Winfield RD, 2010, AM SURGEON, V76, P149; Yanchar NL, 2012, PAED CHILD HEALT-CAN, V17, P513, DOI 10.1093/pch/17.9.513	53	10	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2018	84	6					1017	1026		10.1097/TA.0000000000001828			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GJ4LE	WOS:000435351800025	29389840	Green Accepted			2022-02-06	
J	Roy, A; Kefi, MZ; Bellaj, T; Fournet, N; Le Gall, D; Roulin, JL				Roy, A.; Kefi, M. -Z.; Bellaj, T.; Fournet, N.; Le Gall, D.; Roulin, J. -L.			The Stroop test: A developmental study in a French children sample aged 7 to 12 years	PSYCHOLOGIE FRANCAISE			English	Article						Stroop; Inhibition; Executive function; Neuropsychology; Child	EXECUTIVE FUNCTION MEASURES; TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE; COGNITIVE CONTROL; SUSTAINED ATTENTION; PRESCHOOL-CHILDREN; INHIBITORY CONTROL; EDUCATIONAL-LEVEL; UNIFIED THEORY; INTERFERENCE	The Stroop test is a commonly used task in psychology to assess executive function and more specifically inhibition. International studies consistently show improved Stroop task performance with age, whereas available French normative data displays the opposite pattern, with poor clinical sensibility (Albaret & Migliore, 1999). To provide an alternative and useful Stroop test for children, we examined developmental data based on a well-known French protocol validated in adult (GREFEX study group, 2001). The three-standard conditions of the Stroop task (i.e. naming, reading and interference) were administered to 120 typically developing school children (7-12 years), while taking into account the effects of gender, parental educational level and intelligence (both crystallized and fluid intelligence, as measured by the Wechsler intelligence scale). The time to complete each condition (in seconds) was recorded, as well as the number of uncorrected and corrected errors. Results show a continuous increase of performance in "reading" and "naming" control conditions between 7 and 12 years, suggesting an improvement in the lexical access speed and the automation of decoding abilities during reading. Most importantly, a significant reduction of time Stroop effect with age was found (difference between interference and naming conditions), but no interaction with gender. Stroop performances are related to fluid intelligence once age is statistically controlled, but not to parental educational level. The developmental pattern found from the Stroop GREFEX version is consistent with international data and more broadly with executive function and inhibition development. These findings open the prospect of useful normative standardization of this task, with valuable clinical applications perspectives. (C) 2016 Societe Francaise de Psychologie. Published by Elsevier Masson SAS. All rights reserved.	[Roy, A.; Kefi, M. -Z.; Bellaj, T.; Le Gall, D.] Univ Angers, Univ Bretagne Loire, EA4638, Lab Psychol Pays de la Loire, F-49045 Angers 01, France; [Roy, A.] CHU Nantes, Ctr Competence Nantais Neurofibromatose, Ctr Referent Troubles Apprentissage, F-44093 Nantes 1, France; [Bellaj, T.] Qatar Univ, Dept Social Sci, Psychol Program, Doha, Qatar; [Fournet, N.; Roulin, J. -L.] Univ Savoie, Lab Psychol & Neurocognit, BP 1103, F-73011 Chambery, France		Roy, A (corresponding author), Univ Angers, Univ Bretagne Loire, EA4638, Lab Psychol Pays de la Loire, F-49045 Angers 01, France.; Roy, A (corresponding author), CHU Nantes, Ctr Competence Nantais Neurofibromatose, Ctr Referent Troubles Apprentissage, F-44093 Nantes 1, France.	arnaud.roy@univ-angers.fr	Bellaj, Tarek/R-6170-2019	Bellaj, Tarek/0000-0001-6673-5040			Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Albaret J, 1999, TEST STROOP MANUEL; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Archibald SJ, 1999, CHILD NEUROPSYCHOL, V5, P115, DOI 10.1076/chin.5.2.115.3167; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P31, DOI 10.1016/S0887-6177(98)00159-0; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Ardila A, 2006, INT J PSYCHOL, V41, P324, DOI 10.1080/00207590500345542; Arffa S, 2007, ARCH CLIN NEUROPSYCH, V22, P969, DOI 10.1016/j.acn.2007.08.001; Armengol CG, 2002, CLIN NEUROPSYCHOL, V16, P67, DOI 10.1076/clin.16.1.67.8337; Azouvi P, 2001, REV NEUROPSYCHOL, V11, P383; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bellaj T, 2016, CHILD NEUROPSYCHOL, V22, P919, DOI 10.1080/09297049.2015.1058349; Benson D.F., 1986, FRONTAL LOBES; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Bindman SW, 2013, EARLY CHILD RES Q, V28, P529, DOI 10.1016/j.ecresq.2013.03.003; Blair C, 2006, BEHAV BRAIN SCI, V29, P109; BLAIR C, 2006, BEHAV BRAIN SCI, V29, P125, DOI DOI 10.1017/S0140525X06009034; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Bub DN, 2006, PSYCHOL SCI, V17, P351, DOI 10.1111/j.1467-9280.2006.01710.x; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Catale C, 2012, EUR REV APPL PSYCHOL, V62, P161, DOI 10.1016/j.erap.2012.04.003; Catale C, 2014, CAN J BEHAV SCI, V46, P66, DOI 10.1037/a0031006; Chevalier H, 2000, BRAIN COGNITION, V43, P86; Christakou A, 2009, NEUROIMAGE, V48, P223, DOI 10.1016/j.neuroimage.2009.06.070; Clark JM, 1996, BRAIN COGNITION, V30, P127, DOI 10.1006/brcg.1996.0008; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; Dennis M, 2006, SER INT NEUROPSYCHOL, P128, DOI 10.1017/CBO9780511545917.007; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Emslie H., 2003, BEHAV ASSESSMENT DYS; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Galambos NL, 2005, DEV NEUROPSYCHOL, V28, P473, DOI 10.1207/s15326942dn2801_2; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; Hernandez MT, 2002, NEUROPSYCHOLOGIA, V40, P384, DOI 10.1016/S0028-3932(01)00130-0; Johnson SE, 2011, J PERS SOC PSYCHOL, V100, P838, DOI 10.1037/a0021956; Krasnegor N.A., 1996, ATTENTION MEMORY EXE, P263; Lansbergen MM, 2007, NEUROPSYCHOLOGY, V21, P251, DOI 10.1037/0894-4105.21.2.251; Lee K, 2013, CHILD DEV, V84, P1933, DOI 10.1111/cdev.12096; Lehto JE, 2003, BRIT J DEV PSYCHOL, V21, P59, DOI 10.1348/026151003321164627; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Petrill SA, 2004, INTELLIGENCE, V32, P403, DOI 10.1016/j.intell.2004.05.001; Roberts RJ, 1996, DEV NEUROPSYCHOL, V12, P105, DOI 10.1080/87565649609540642; Roy Roulin, 2007, REV NEUROPSYCHOL, V17, P59; Schroeter ML, 2004, NEUROIMAGE, V23, P1317, DOI 10.1016/j.neuroimage.2004.08.001; SEIDENBERG M, 1983, J CONSULT CLIN PSYCH, V51, P406, DOI 10.1037/0022-006X.51.3.406; Senn TE, 2004, DEV NEUROPSYCHOL, V26, P445, DOI 10.1207/s15326942dn2601_5; Sevino O, 1998, THESIS; Shallice T, 2002, DEV NEUROPSYCHOL, V21, P43, DOI 10.1207/S15326942DN2101_3; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; Taconnat L, 2014, PSYCHOL FR, V59, P89, DOI 10.1016/j.psfr.2013.03.007; Talarowska Monika, 2013, Pol Merkur Lekarski, V34, P29; Waber DP, 2006, DEV NEUROPSYCHOL, V29, P459, DOI 10.1207/s15326942dn2903_5; Wechsler D., 1996, ECHELLE INTELLIGENCE; Weglage J, 1996, EUR J PEDIATR, V155, P200, DOI 10.1007/BF01953938; Yucel M, 2012, NEUROPSYCHOLOGY, V26, P347, DOI 10.1037/a0027693; Zalonis I, 2009, ARCH CLIN NEUROPSYCH, V24, P81, DOI 10.1093/arclin/acp011	61	10	10	0	10	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0033-2984			PSYCHOL FR	Psychol. Fr.	JUN	2018	63	2					129	143		10.1016/j.psfr.2016.08.001			15	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	GK9WJ	WOS:000436608100002					2022-02-06	
J	Schack, T; Muma, M; Feng, ML; Guan, CT; Zoubir, AM				Schack, Tim; Muma, Michael; Feng, Mengling; Guan, Cuntai; Zoubir, Abdelhak M.			Robust Nonlinear Causality Analysis of Nonstationary Multivariate Physiological Time Series	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Arterial blood pressure (ABP); biomedical signal processing; connectivity analysis; directed coherence; generalized partial directed coherence (gPDC); Kalman filter; multivariate autoregressive modeling; partial directed coherence (PDC); time-varying autoregressive (TVAR); time-varying moving-average (TVMA); intracranial pressure (ICP); traumatic brain injuries (TBI)	PARTIAL DIRECTED COHERENCE; GRANGER CAUSALITY; KALMAN FILTER; EEG SIGNALS; HEART-RATE; B-WAVES; PRESSURE; CONNECTIVITY; MODELS; VARIABILITY	Goal: An important research area in biomedical signal processing is that of quantifying the relationship between simultaneously observed time series and to reveal interactions between the signals. Since biomedical signals are potentially nonstationary and the measurements may contain outliers and artifacts, we introduce a robust time-varying generalized partial directed coherence (rTV-gPDC) function. Methods: The proposed method, which is based on a robust estimator of the time-varying autoregressive (TVAR) parameters, is capable of revealing directed interactions between signals. By definition, the rTV-gPDC only displays the linear relationships between the signals. We therefore suggest to approximate the residuals of the TVAR process, which potentially carry information about the non-linear causality by a piece-wise linear time-varying moving-average model. Results: The performance of the proposed method is assessed via extensive simulations. To illustrate the method's applicability to real-world problems, it is applied to a neurophysiological study that involves intracranial pressure, arterial blood pressure, and brain tissue oxygenation level (PtiO2) measurements. Conclusion and Significance: The rTV-gPDC reveals causal patterns that are in accordance with expected cardiosudoral meachanisms and potentially provides new insights regarding traumatic brain injuries. The rTV-gPDC is not restricted to the above problem but can be useful in revealing interactions in a broad range of applications.	[Schack, Tim; Muma, Michael; Zoubir, Abdelhak M.] Tech Univ Darmstadt, Inst Telecommun, Signal Proc Grp, D-64283 Darmstadt, Germany; [Feng, Mengling] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Guan, Cuntai] Nanyang Technol Univ, Coll Engn, Sch Comp Sci & Engn, Singapore, Singapore		Schack, T (corresponding author), Tech Univ Darmstadt, Inst Telecommun, Signal Proc Grp, D-64283 Darmstadt, Germany.	t.schaeck@spg.tu-darmstadt.de	Guan, Cuntai/G-7835-2016; Muma, Michael/AAG-6399-2021; Zoubir, Abdelhak M/AAW-6349-2021	Guan, Cuntai/0000-0002-0872-3276; 	Biomedical Engineering Program of A*STAR Singapore	This was one of the outcomes from the iSyNCC project funded by the Biomedical Engineering Program of A*STAR Singapore. The authors would like to thank the staff at Neuro-ICU of National Neuroscience Institute, Singapore for their efforts in collecting medical data and for their clinical advice, and the anonymous reviewers for their useful comments on this study.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AUER LM, 1983, ACTA NEUROCHIR, V68, P93, DOI 10.1007/BF01406205; Baccala LA, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0158; Baccala L. A., 1998, Applied Signal Processing, V5, P40, DOI 10.1007/s005290050005; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Baccala LA, 2007, PROCEEDINGS OF THE 2007 15TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING, P163, DOI 10.1109/ICDSP.2007.4288544; Bendat J. S., 2011, RANDOM DATA ANAL MEA, V729; Boashash B, 2013, IEEE SIGNAL PROC MAG, V30, P108, DOI 10.1109/MSP.2013.2265914; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; CARTER GC, 1987, P IEEE, V75, P236, DOI 10.1109/PROC.1987.13723; Chowdhury FN, 2000, IEEE T AUTOMAT CONTR, V45, P1355, DOI 10.1109/9.867047; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Faes L, 2006, IEEE T BIO-MED ENG, V53, P65, DOI 10.1109/TBME.2005.859788; Faes L, 2004, BIOL CYBERN, V90, P390, DOI 10.1007/s00422-004-0488-0; Faes L, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/140513; Faes L, 2010, BIOL CYBERN, V103, P387, DOI 10.1007/s00422-010-0406-6; Faes L, 2010, IEEE T BIO-MED ENG, V57, P1897, DOI 10.1109/TBME.2010.2042715; Feng ML, 2011, IEEE ENG MED BIO, P797, DOI 10.1109/IEMBS.2011.6090182; Giannakakis GA, 2008, IEEE ENG MED BIO, P3512, DOI 10.1109/IEMBS.2008.4649963; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; Han B, 2013, INT CONF ACOUST SPEE, P6239, DOI 10.1109/ICASSP.2013.6638865; Havlicek M, 2010, NEUROIMAGE, V53, P65, DOI 10.1016/j.neuroimage.2010.05.063; He F, 2014, J NEUROSCI METH, V225, P71, DOI 10.1016/j.jneumeth.2014.01.013; Heritier S, 2009, ROBUST METHODS BIOST; Hesse W, 2003, J NEUROSCI METH, V124, P27, DOI 10.1016/S0165-0270(02)00366-7; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Holler Y, 2014, CLIN NEUROPHYSIOL, V125, P1545, DOI 10.1016/j.clinph.2013.12.095; Huber P.J., 2009, ROBUST STAT; Kaipio JP, 1997, IEEE T BIO-MED ENG, V44, P649, DOI 10.1109/10.605421; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; KAMINSKI MJ, 1991, BIOL CYBERN, V65, P203, DOI 10.1007/BF00198091; KRAUSS JK, 1995, ACTA NEUROCHIR, V136, P195, DOI 10.1007/BF01410626; Leistritz L, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0616; Li Y, 2012, PHYS REV E, V85, DOI [10.1103/PhysRevE.85.041906, 10.1103/PhysRevE.85.049908]; Marinazzo D, 2011, NEUROIMAGE, V58, P330, DOI 10.1016/j.neuroimage.2010.01.099; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; Maronna R. A., 2006, WILEY SERIES IN PROB; Milde T, 2010, NEUROIMAGE, V50, P960, DOI 10.1016/j.neuroimage.2009.12.110; Moller E, 2003, BIOL CYBERN, V89, P303, DOI 10.1007/s00422-003-0394-x; Moller E, 2001, J NEUROSCI METH, V105, P143, DOI 10.1016/S0165-0270(00)00350-2; Muma M, 2010, IEEE T BIO-MED ENG, V57, P373, DOI 10.1109/TBME.2009.2032531; Nicolaou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033869; Omidvarnia AH, 2011, IEEE ENG MED BIO, P1423, DOI 10.1109/IEMBS.2011.6090335; Omidvarnia A, 2014, IEEE T BIO-MED ENG, V61, P680, DOI 10.1109/TBME.2013.2286394; Orini M, 2012, PHYSIOL MEAS, V33, P315, DOI 10.1088/0967-3334/33/3/315; Orini M, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-214; Orini M, 2012, IEEE T BIO-MED ENG, V59, P663, DOI 10.1109/TBME.2011.2171959; Pelaez-Coca MD, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/631978; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Saito Y, 1981, RECENT ADV EEG EMG D, P133; Sato JR, 2009, HUM BRAIN MAPP, V30, P452, DOI 10.1002/hbm.20513; Schack T, 2018, IEEE T BIO-MED ENG, V65, P1213, DOI 10.1109/TBME.2017.2708609; Simon D, 2006, EMBED SYST DES, V19, P38; Sommerlade L, 2009, J PHYSIOLOGY-PARIS, V103, P348, DOI 10.1016/j.jphysparis.2009.07.005; Strasser F, 2012, EUR SIGNAL PR CONF, P899; van Mierlo P, 2011, NEUROIMAGE, V56, P1122, DOI 10.1016/j.neuroimage.2011.02.009; Varotto G, 2012, EPILEPSIA, V53, P359, DOI 10.1111/j.1528-1167.2011.03352.x; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang ZG, 2011, IEEE T BIO-MED ENG, V58, P557, DOI 10.1109/TBME.2010.2089686; Zoubir AM, 2012, IEEE SIGNAL PROC MAG, V29, P61, DOI 10.1109/MSP.2012.2183773; Zoubir AM, 1998, IEEE SIGNAL PROC MAG, V15, P56, DOI 10.1109/79.647043; Zoubir AM, 2004, BOOTSTRAP TECHNIQUES	65	10	12	2	21	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	JUN	2018	65	6					1213	1225		10.1109/TBME.2017.2708609			13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	GG8XJ	WOS:000432982200004	28574340				2022-02-06	
J	Zhang, P; Zhu, SS; Zhao, MZ; Dai, YL; Zhang, L; Ding, SJ; Zhao, P; Li, JB				Zhang, Peng; Zhu, Shisheng; Zhao, Minzhu; Dai, Yalei; Zhang, Li; Ding, Shijia; Zhao, Peng; Li, Jianbo			Integration of H-1 NMR-and UPLC-Q-TOF/MS-based plasma metabonomics study to identify diffuse axonal injury biomarkers in rat	BRAIN RESEARCH BULLETIN			English	Article						Diffuse axonal injury; Metabonomics; UPLC-Q-TOF/MS; NMR; Biomarkers	METABOLOMICS APPROACH; BRAIN; MODEL; VALIDATION; GLUTAMATE; TOXICITY; OUTCOMES; DISEASE; DAMAGE; URINE	Diffuse axonal injury (DAI) is much common during traumatic brain injury (TBI) and is associated with high mortality and poor neurological outcome. Although many studies have been examined, there are still no reliable objective diagnostic modalities available for clinicians to make an early diagnosis of DAI. Therefore, we established a rat model of DAI, applying an integrated H-1 NMR- and UPLC-Q-TOF/MS-based metabonomics approach to identify differentially changed metabolites in plasma. A total of twenty-two metabolites in the injury group were identified as differentially changed. Among them, four metabolites, glutamine, pyruvate, glycerol and phosphocholine, were identified as candidate biomarkers based on their high fold-changes and biological functions, and may play important roles in axonal injury progression in DAI. Our study not only identified several novel biomarkers that improved our understanding of the metabolic events underlying DAI, but also may provide some potential novel therapeutic targets for preventing axonal injury in DAI.	[Zhang, Peng; Zhao, Minzhu; Dai, Yalei; Zhang, Li; Li, Jianbo] Chongqing Med Univ, Fac Basic Med Sci, Dept Forens Med, Chongqing 400016, Peoples R China; [Zhu, Shisheng] Chongqing Med & Pharmaceut Coll, Fac Med Technol, Chongqing 401331, Peoples R China; [Ding, Shijia] Chongqing Med Univ, Coll Lab Med, Minist Educ, Key Lab Clin Lab Diagnost, Chongqing 400016, Peoples R China; [Zhao, Peng] Zunyi Med & Pharmaceut Coll, Fac Basic Med Sci, Zunyi 563006, Peoples R China		Li, JB (corresponding author), Yixueyuan Rd 1, Chongqing 400016, Peoples R China.	ljb2032008@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81273344]; Shanghai Key Laboratory of Forensic Medicine [KF1105]; Science and Technology Projects of Chongqing Education Commission [KJ1502703]; Science and Technology Cooperation Projects of Guizhou [2015-7572]; Medical Scientific Research Projects of Chongqing [20142121]	This work was supported by the National Natural Science Foundation of China (81273344), the Open project of Shanghai Key Laboratory of Forensic Medicine (KF1105), the Science and Technology Projects of Chongqing Education Commission (KJ1502703), the Science and Technology Cooperation Projects of Guizhou (2015-7572) and the Medical Scientific Research Projects of Chongqing (20142121).	Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Andre D Furtado, 2013, CAFFEYS PEDIAT DIAGN, V39, P417; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Budczies J, 2015, INT J CANCER, V136, P1619, DOI 10.1002/ijc.29152; Chen JZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06872; Cui Y, 2014, J NEUROPATH EXP NEUR, V73, P954, DOI 10.1097/NEN.0000000000000116; Dong F, 2015, ANAL BIOANAL CHEM, V407, P4683, DOI 10.1007/s00216-015-8670-x; Du CM, 2015, NEUROTOX RES, V28, P290, DOI 10.1007/s12640-015-9539-7; Freidin MB, 2018, BBA-MOL BASIS DIS, V1864, P601, DOI 10.1016/j.bbadis.2017.11.025; Guo PP, 2014, MOL BIOSYST, V10, P2426, DOI 10.1039/c4mb00251b; He Y, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.76; Huang Y, 2013, ANAL BIOANAL CHEM, V405, P4811, DOI 10.1007/s00216-013-6842-0; Jia HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063624; Jung J, 2011, TOXICOL LETT, V200, P1, DOI 10.1016/j.toxlet.2010.09.020; Kokkoz C., 2017, AM J EMERG MED, V35; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Mallouhi A, 2014, RADIOLOGE, V54, P907, DOI 10.1007/s00117-013-2640-0; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Moenninghoff C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122329; Moro N, 2016, BRAIN RES, V1642, P270, DOI 10.1016/j.brainres.2016.04.005; Ripoll MA, 2003, ACTA RADIOL, V44, P199, DOI 10.1034/j.1600-0455.2003.00038.x; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Sun LM, 2018, J PHARMACEUT BIOMED, V151, P75, DOI 10.1016/j.jpba.2017.12.053; Thelin EP, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00159; van der Lee S. J., 2018, ALZHEIMERS DEMENT; Wei SW, 2013, MOL ONCOL, V7, P297, DOI 10.1016/j.molonc.2012.10.003; Wesseling H, 2013, NEUROPSYCHOPHARMACOL, V38, P2532, DOI 10.1038/npp.2013.160; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yang BY, 2018, CANCER SCI, V109, P777, DOI 10.1111/cas.13500; Yang G, 2016, ANAL BIOANAL CHEM, V408, P4275, DOI 10.1007/s00216-016-9524-x; Yen TA, 2018, MICROCHEM J, V137, P85, DOI 10.1016/j.microc.2017.09.024; Zeiler FA, 2017, ACTA NEUROCHIR, V159, P2245, DOI 10.1007/s00701-017-3338-2; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030181; Zhang P, 2016, J PROTEOMICS, V133, P93, DOI 10.1016/j.jprot.2015.12.014; Zhang Y, 2014, CRIT CARE, V18, DOI 10.1186/cc13999; Zhou Y, 2014, J NEURAL TRANSM, V121, P799, DOI 10.1007/s00702-014-1180-8	42	10	10	2	33	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JUN	2018	140						19	27		10.1016/j.brainresbull.2018.03.012			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO0ZR	WOS:000439675700003	29605486				2022-02-06	
J	Efrati, S; Hadanny, A; Daphna-Tekoah, S; Bechor, Y; Tiberg, K; Pik, N; Suzin, G; Lev-Wiesel, R				Efrati, Shai; Hadanny, Amir; Daphna-Tekoah, Shir; Bechor, Yair; Tiberg, Kobi; Pik, Nimrod; Suzin, Gil; Lev-Wiesel, Rachel			Recovery of Repressed Memories in Fibromyalgia Patients Treated With Hyperbaric Oxygen - Case Series Presentation and Suggested Bio-Psycho-Social Mechanism	FRONTIERS IN PSYCHOLOGY			English	Article						hyperbaric oxygen; repressed memories; fibromyalgia; biopsychophysical mechanism; childhood sexual abuse	POST-CONCUSSION SYNDROME; TRAUMATIC BRAIN-INJURY; MAMMALIAN HIBERNATION; RHEUMATOID-ARTHRITIS; NERVE REGENERATION; ISCHEMIC PENUMBRA; PROTEIN-SYNTHESIS; CHILDHOOD ABUSE; THERAPY; DAMAGE	Fibromyalgia Syndrome (FMS) is a condition considered to represent a prototype of central sensitization syndrome, characterized by chronic widespread pain and along with symptoms of fatigue, non-restorative sleep and cognitive difficulties. FMS can be induced by trauma, infection or emotional stress with cumulative evidence that dissociation is relatively frequent in FMS patients. Two randomized controlled trials have shown that hyperbaric oxygen therapy (HBOT) can induce neuroplasticity and be effective in patients suffering from FMS. In this paper we present, for the first time, case series of female fibromyalgia patients who, in the course of HBOT, suddenly recalled repressed traumatic memories of childhood sexual abuse (CSA). The surfacing of the repressed (dissociative) memories decades after the sexual abuse events was sudden and utterly surprising. No psychological intervention was involved. As the memories surfaced, the physical pain related to FMS subsided. In one patient who had brain single photon emission CT (SPECT) before and after HBOT, the prefrontal cortex appeared suppressed before and reactivated after. The 3 cases reported in this article are representative of a total of nine fibromyalgia patients who experienced a retrieval of repressed memory during HBOT. These cases provide insights on dissociative amnesia and suggested mechanism hypothesis that is further discussed in the article. Obviously, prospective studies cannot be planned since patients are not aware of their repressed memories. However, it is very important to keep in mind the possibility of surfacing memories when treating fibromyalgia patients with HBOT or other interventions capable of awakening dormant brain regions.	[Efrati, Shai; Hadanny, Amir; Bechor, Yair; Suzin, Gil] Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, Zerifin, Israel; [Efrati, Shai; Hadanny, Amir] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Efrati, Shai] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Daphna-Tekoah, Shir] Ashkelon Acad Coll, Ashqelon, Israel; [Daphna-Tekoah, Shir] Social Work Dept, Kaplan Med Ctr, Rehovot, Israel; [Tiberg, Kobi] Loewenstein Hosp Rehabil Ctr, Dept Psychol, Raanana, Israel; [Pik, Nimrod] Assaf Harofeh Med Ctr, Psychiat Serv, Zerifin, Israel; [Lev-Wiesel, Rachel] Univ Haifa, Grad Sch Creat Arts Therapies, Emili Sagol CAT Res Ctr, Haifa, Israel		Efrati, S (corresponding author), Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, Zerifin, Israel.; Efrati, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Efrati, S (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.	efratishai@013.net					Ablin JN, 2016, CLIN EXP RHEUMATOL, V34, pS3; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Vilela DSA, 2008, ACTA OTO-LARYNGOL, V128, P1048, DOI 10.1080/00016480701827525; American Psychiatric Association, 2013, DSM 5 TASK FORC DIAG, DOI [10.1126/science.1089504, DOI 10.1126/SCIENCE.1089504]; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Andrews B, 1999, BRIT J PSYCHIAT, V175, P141, DOI 10.1192/bjp.175.2.141; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; Azzam NA, 2000, NATURE, V407, P317, DOI 10.1038/35030294; Baron JC, 2001, BRAIN, V124, P2, DOI 10.1093/brain/124.1.2; Berkol TD, 2017, NEUROSCIENCES, V22, P198, DOI 10.17712/nsj.2017.3.20160538; Bohn D, 2013, J TRAUMA DISSOCIATIO, V14, P342, DOI 10.1080/15299732.2012.736930; Boussi-Gross R, 2015, NEUROPSYCHOLOGY, V29, P610, DOI 10.1037/neu0000149; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Bowman ES, 2011, J TRAUMA DISSOCIATIO, V12, P446, DOI 10.1080/15299732.2011.570233; Bradshaw PO, 1996, UNDERSEA HYPERBAR M, V23, P107; Branco JC, 2010, SEMIN ARTHRITIS RHEU, V39, P448, DOI 10.1016/j.semarthrit.2008.12.003; Buskila D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2720; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chang CC, 2009, J NEUROTRAUM, V26, P1263, DOI [10.1089/neu.2008.0619, 10.1089/neu.2008-0619]; Che XW, 2015, BIOL PSYCHOL, V112, P20, DOI 10.1016/j.biopsycho.2015.09.011; Chu JA, 1999, AM J PSYCHIAT, V156, P749; Ciccone DS, 2005, CLIN J PAIN, V21, P378, DOI 10.1097/01.ajp.0000149796.08746.ea; Clauw DJ, 2014, JAMA-J AM MED ASSOC, V311, P1547, DOI 10.1001/jama.2014.3266; Clauw DJ, 2011, MAYO CLIN PROC, V86, P907, DOI 10.4065/mcp.2011.0206; Culmsee C, 2007, EMBO REP, V8, P129, DOI 10.1038/sj.embor.7400892; DeGracia DJ, 2004, J NEUROSCI RES, V77, P771, DOI 10.1002/jnr.20225; Drew KL, 2007, J NEUROCHEM, V102, P1713, DOI 10.1111/j.1471-4159.2007.04675.x; Ebinger M, 2009, J CLIN NEUROSCI, V16, P178, DOI 10.1016/j.jocn.2008.04.002; Efrati S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127012; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Fergusson DM, 2013, CHILD ABUSE NEGLECT, V37, P664, DOI 10.1016/j.chiabu.2013.03.013; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Haapaniemi T, 1998, EXP NEUROL, V149, P433, DOI 10.1006/exnr.1997.6745; Hadanny A, 2015, RESTOR NEUROL NEUROS, V33, P471, DOI 10.3233/RNN-150517; Hadanny A, 2016, EXPERT REV NEUROTHER, V16, P875, DOI 10.1080/14737175.2016.1205487; Hadanny A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1034-2; Heiss WD, 2000, J CEREBR BLOOD F MET, V20, P1276, DOI 10.1097/00004647-200009000-00002; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Im JJ, 2016, EXP NEUROBIOL, V25, P277, DOI 10.5607/en.2016.25.6.277; Jiao J, 2015, RHEUMATOL INT, V35, P547, DOI 10.1007/s00296-014-3113-0; Jones GT, 2015, ARTHRITIS RHEUMATOL, V67, P568, DOI 10.1002/art.38905; Kilic O, 2014, J TRAUMA DISSOCIATIO, V15, P285, DOI 10.1080/15299732.2013.844218; Kuhl BA, 2008, COGN AFFECT BEHAV NE, V8, P211, DOI 10.3758/CABN.8.2.211; Lev-Wiesel R, 2014, J CHILD SEX ABUS, V23, P824, DOI 10.1080/10538712.2014.950399; Masaki Y, 2006, PSYCHIAT CLIN NEUROS, V60, pS46, DOI 10.1111/j.1440-1819.2006.01527.x-i1; McNally RJ, 2003, BIOL PSYCHIAT, V53, P779, DOI 10.1016/S0006-3223(02)01663-3; Meerwaldt R, 2010, EUR J RADIOL, V74, P104, DOI 10.1016/j.ejrad.2009.01.034; Mu J, 2013, NEUROBIOL DIS, V51, P133, DOI 10.1016/j.nbd.2012.11.003; MUKOYAMA M, 1975, EXP NEUROL, V47, P371, DOI 10.1016/0014-4886(75)90070-9; Naring GWB, 2007, CLIN EXP RHEUMATOL, V25, P872; Nijenhuis ERS, 2011, J TRAUMA DISSOCIATIO, V12, P416, DOI 10.1080/15299732.2011.570592; Ortiz R, 2016, CLIN EXP RHEUMATOL, V34, pS59; Romans S, 2002, PSYCHOTHER PSYCHOSOM, V71, P141, DOI 10.1159/000056281; Sancassiani F, 2017, INT REV PSYCHIATR, V29, P473, DOI 10.1080/09540261.2017.1320982; Scaer RC, 2001, APPL PSYCHOPHYS BIOF, V26, P73, DOI 10.1023/A:1009571806136; Schmidt-Wilcke T, 2011, NAT REV RHEUMATOL, V7, P518, DOI 10.1038/nrrheum.2011.98; Schore AN, 2011, DISSOCIATION AND THE DISSOCIATIVE DISORDERS: DSM-V AND BEYOND, P107; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Siddique MS, 2002, J NEUROSURG, V96, P736, DOI 10.3171/jns.2002.96.4.0736; Spiegel DR, 2015, HEALTH SERV RES MANA, V2, DOI 10.1177/2333392814567920; Staniloiu A, 2014, LANCET PSYCHIAT, V1, P226, DOI 10.1016/S2215-0366(14)70279-2; Tal S, 2015, RESTOR NEUROL NEUROS, V33, P943, DOI 10.3233/RNN-150585; van der Kolk BA, 2005, J TRAUMA STRESS, V18, P389, DOI 10.1002/jts.20047; Vera P, 1996, J NUCL MED, V37, P1976; Yamauchi H, 2005, J NUCL MED, V46, P1973; Yang YJ, 2008, UNDERSEA HYPERBAR M, V35, P113; Yavne Y, 2018, SEMIN ARTHRITIS RHEU, V48, P121, DOI 10.1016/j.semarthrit.2017.12.011; Yildiz S, 2004, J INT MED RES, V32, P263; Yin W, 2002, BRAIN RES, V926, P165, DOI 10.1016/S0006-8993(01)03304-2; Yunus MB, 2007, BEST PRACT RES CL RH, V21, P481, DOI 10.1016/j.berh.2007.03.006; Yunus MB, 2007, SEMIN ARTHRITIS RHEU, V36, P339, DOI 10.1016/j.semarthrit.2006.12.009	72	10	10	2	24	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	MAY 29	2018	9								848	10.3389/fpsyg.2018.00848			8	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	GH4SS	WOS:000433395000001	29896150	Green Published, gold			2022-02-06	
J	Babikian, T; Alger, JR; Ellis-Blied, MU; Giza, CC; Dennis, E; Olsen, A; Mink, R; Babbitt, C; Johnson, J; Thompson, PM; Asarnow, RF				Babikian, Talin; Alger, Jeffry R.; Ellis-Blied, Monica U.; Giza, Christopher C.; Dennis, Emily; Olsen, Alexander; Mink, Richard; Babbitt, Christopher; Johnson, Jeff; Thompson, Paul M.; Asarnow, Robert F.			Whole Brain Magnetic Resonance Spectroscopic Determinants of Functional Outcomes in Pediatric Moderate/Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognition; MK spectroscopy; neuropsychology; pediatric brain injury	CORPUS-CALLOSUM; CHILDREN; DIFFUSION; DISTRIBUTIONS; UCLA	Diffuse axonal injury contributes to the long-term functional morbidity observed after pediatric moderate/severe traumatic brain injury (msTBI). Whole-brain proton magnetic resonance echo-planar spectroscopic imaging was used to measure the neurometabolite levels in the brain to delineate the course of disruption/repair during the first year post-msTBI. The association between metabolite biomarkers and functional measures (cognitive functioning and corpus callosum [CC] function assessed by interhemispheric transfer time [IHTT] using an event related potential paradigm) was also explored. Pediatric patients with msTBI underwent assessments at two times (post-acutely at a mean of three months post-injury, n=31, and chronically at a mean of 16 months post-injury, n=24). Healthy controls also underwent two evaluations, approximately 12 months apart. Post-acutely, in patients with msTBI, there were elevations in choline (Cho; marker for inflammation and/or altered membrane metabolism) in all four brain lobes and the CC and decreases in N-acetylaspartate (NAA; marker for neuronal and axonal integrity) in the CC compared with controls, all of which normalized by the chronic time point. Subgroups of TBI showed variable patterns chronically. Patients with slow IHTT had lower lobar Cho chronically than those with normal IHTT; they also did not show normalization in CC NAA whereas those with normal IHTT showed significantly higher levels of CC NAA relative to controls. In the normal IHTT group only, chronic CC Cho and NAA together explained 70% of the variance in long-term cognitive functioning. MR based whole brain metabolic evaluations show different patterns of neurochemistry after msTBI in two subgroups with different outcomes. There is a dynamic relationship between prolonged inflammatory responses to brain damage, reparative processes/remyelination, and subsequent neurobehavioral outcomes. Multimodal studies allow us to test hypotheses about degenerative and reparative processes in patient groups that have divergent functional outcome, with the ultimate goal of developing targeted therapeutic agents.	[Babikian, Talin] Univ Calif Los Angeles, Mattel Childrens Hosp, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Babikian, Talin] Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA 90095 USA; [Alger, Jeffry R.] NeuroSpectroScopics LLC, Sherman Oaks, CA USA; [Ellis-Blied, Monica U.] VA Loma Linda Healthcare Syst, Hlth Promot & Dis Prevent Program, Redlands, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Neurosurg, Brain Injury Res Ctr, Steve Tisch BrainSPORT Program,Mattel Childrens H, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Div Pediat Neurol, Steve Tisch BrainSPORT Program, Los Angeles, CA USA; [Dennis, Emily; Thompson, Paul M.] Univ Southern Calif, Keck Sch Med, Mark & Mary Stevens Neuroimaging & Informat Inst, Imaging Genet Ctr, Marina Del Rey, CA USA; [Olsen, Alexander] Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway; [Olsen, Alexander] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Mink, Richard] Harbor UCLA Med Ctr, Pediat Crit Care Med, Torrance, CA 90509 USA; [Mink, Richard] Los Angeles BioMed Res Inst, Dept Pediat, Torrance, CA USA; [Babbitt, Christopher] Miller Childrens & Womens Hosp, Long Beach, CA USA; [Johnson, Jeff] LAC USC Med Ctr, Dept Pediat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Pediat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Ophthalmol, Los Angeles, CA USA; [Asarnow, Robert F.] David Geffen Sch Med, Dept Psychol, Los Angeles, CA USA; [Asarnow, Robert F.] David Geffen Sch Med, Dept Psychiat, Los Angeles, CA USA; [Asarnow, Robert F.] David Geffen Sch Med, Brain Res Inst, Los Angeles, CA USA		Babikian, T (corresponding author), Univ Calif Los Angeles, Semel Inst, 760 Westwood Plaza,Room 47-438B, Los Angeles, CA 90095 USA.	tbabikian@mednet.ucla.edu	Thompson, Paul M/C-4194-2018; Dennis, Emily/AAD-5223-2021; Olsen, Alexander/P-5235-2019	Thompson, Paul M/0000-0002-4720-8867; Dennis, Emily/0000-0001-7112-4009; Olsen, Alexander/0000-0001-8691-3860	UCLA Brain Injury Research Center; UCLA Faculty Research Grant; UCLA Steve Tisch BrainSPORT Program;  [R01HD061504];  [R01NS27544];  [R01NS072308];  [K99NS096116];  [U54EB020403];  [R01AG040060];  [R01NS080655]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99NS096116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG040060] Funding Source: NIH RePORTER	This work was supported in part by: R01HD061504; R01NS27544; R01NS072308; K99NS096116; U54EB020403; R01AG040060; R01NS080655; UCLA Brain Injury Research Center; UCLA Faculty Research Grant; UCLA Steve Tisch BrainSPORT Program. We thank the families who participated, and for our research coordinators Alma Martinez and Alma Ramirez, who diligently worked to ensure the success of this project.	Akpinar E, 2007, J COMPUT ASSIST TOMO, V31, P657, DOI 10.1097/RCT.0b013e318033df1a; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Croall Iain, 1800, Top Magn Reson Imaging, V24, P267, DOI 10.1097/RMR.0000000000000063; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Dennis EL, 2016, J NEUROTRAUM, V33, P840, DOI 10.1089/neu.2015.4012; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Ellis MU, 2016, J NEUROTRAUM, V33, P990, DOI 10.1089/neu.2015.4023; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Hoon AH, 2000, J DEV BEHAV PEDIATR, V21, P291, DOI 10.1097/00004703-200008000-00007; Larson EB, 1997, NEUROPSYCHOLOGIA, V35, P573; Maudsley AA, 2006, NMR BIOMED, V19, P492, DOI 10.1002/nbm.1025; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; McKenna MC, 2015, NEUROCHEM RES, V40, P2527, DOI 10.1007/s11064-015-1600-7; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nordengen K, 2015, BRAIN STRUCT FUNCT, V220, P899, DOI 10.1007/s00429-013-0691-7; Parry L, 2004, CHILD NEUROPSYCHOL, V10, P248, DOI 10.1080/09297040490909279; Sabati M, 2015, MAGN RESON MED, V74, P1209, DOI 10.1002/mrm.25510; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427	32	10	10	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	14					1637	1645		10.1089/neu.2017.5366		MAY 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GK9FP	WOS:000432677000001	29649959	Green Published			2022-02-06	
J	Fidan, E; Foley, LM; New, LA; Alexander, H; Kochanek, PM; Hitchens, TK; Bayir, H				Fidan, Emin; Foley, Lesley M.; New, Lee Ann; Alexander, Henry; Kochanek, Patrick M.; Hitchens, T. Kevin; Bayir, Hulya			Metabolic and Structural Imaging at 7 Tesla After Repetitive Mild Traumatic Brain Injury in Immature Rats	ASN NEURO			English	Article						repetitive; mild head injury; neuroimaging; children; magnetic resonance imaging; diffuse tensor imaging	MAGNETIC-RESONANCE-SPECTROSCOPY; VIVO H-1-NMR SPECTROSCOPY; DIFFUSE AXONAL INJURY; CORPUS-CALLOSUM; HEAD-INJURY; CONCUSSION; MODEL; ABNORMALITIES; EPIDEMIOLOGY; CHILDREN	Mild traumatic brain injury (mTBI) in children is a common and serious public health problem. Traditional neuroimaging findings in children who sustain mTBI are often normal, putting them at risk for repeated mTBI (rmTBI). There is a need for more sensitive imaging techniques capable of detecting subtle neurophysiological alterations after injury. We examined neurochemical and white matter changes using diffusion tensor imaging of the whole brain and proton magnetic resonance spectroscopy of the hippocampi at 7 Tesla in 18-day-old male rats at 7 days after mTBI and rmTBI. Traumatic axonal injury was assessed by beta-amyloid precursor protein accumulation using immunohistochemistry. A significant decrease in fractional anisotropy and increase in axial and radial diffusivity were observed in several brain regions, especially in white matter regions, after a single mTBI versus sham and more prominently after rmTBI. In addition, we observed accumulation of beta-amyloid precursor protein in the external capsule after mTBI and rmTBI. mTBI and rmTBI reduced the N-acetylaspartate/creatine ratio (NAA/Cr) and increased the myoinositol/creatine ratio (Ins/Cr) versus sham. rmTBI exacerbated the reduction in NAA/Cr versus mTBI. The choline/creatine (Cho/Cr) and (lipid/Macro Molecule I)/creatine (Lip/ Cr) ratios were also decreased after rmTBI versus sham. Diffusion tensor imaging findings along with the decrease in Cho and Lip after rmTBI may reflect damage to axonal membrane. NAA and Ins are altered at 7 days after mTBI and rmTBI likely reflecting neuro-axonal damage and glial response, respectively. These findings may be relevant to understanding the extent of disability following mTBI and rmTBI in the immature brain and may identify possible therapeutic targets.	[Fidan, Emin; New, Lee Ann; Alexander, Henry; Kochanek, Patrick M.; Bayir, Hulya] Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15224 USA; [Foley, Lesley M.; Hitchens, T. Kevin] Carnegie Mellon Univ, Pittsburgh NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; [Foley, Lesley M.; Hitchens, T. Kevin] Univ Pittsburgh, Anim Imaging Ctr, Pittsburgh, PA 15224 USA; [Bayir, Hulya] Childrens Neurosci Inst, Pittsburgh, PA USA		Bayir, H (corresponding author), Univ Pittsburgh, Dept Crit Care Med, 4401 Penn Ave, Pittsburgh, PA 15224 USA.; Bayir, H (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	bayihx@ccm.upmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS061817, NS076511]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work is supported, in part, by grants from the National Institutes of Health (NS061817, NS076511).	Aaen GS, 2010, PEDIATRICS, V125, P295, DOI 10.1542/peds.2008-3312; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRIAN IN; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Duarte JMN, 2012, NEUROIMAGE, V61, P342, DOI 10.1016/j.neuroimage.2011.12.038; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrazzano P, 2013, CNS NEUROL DISORD-DR, V12, P338, DOI 10.2174/1871527311312030007; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henry ME, 2011, J MAGN RESON, V208, P210, DOI 10.1016/j.jmr.2010.11.003; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKenna MC, 2015, NEUROCHEM RES, V40, P2527, DOI 10.1007/s11064-015-1600-7; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mountford CE, 2010, CHEM REV, V110, P3060, DOI 10.1021/cr900250y; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Otani N., 2011, J EXPT CLIN MED, V3, P22; Povazan M, 2015, NEUROIMAGE, V121, P126, DOI 10.1016/j.neuroimage.2015.07.042; Price WS, 1996, J MAGN RESON SER B, V112, P190, DOI 10.1006/jmrb.1996.0129; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thuen M, 2009, J MAGN RESON IMAGING, V29, P39, DOI 10.1002/jmri.21606; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2012, NEUROREHABILITATION, V31, P245, DOI 10.3233/NRE-2012-0794; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569	61	10	11	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro	MAY 9	2018	10									10.1177/1759091418770543			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF5ZD	WOS:000432045600001	29741097	Green Published, gold			2022-02-06	
J	Corbin-Berrigan, LA; Kowalski, K; Faubert, J; Christie, B; Gagnon, I				Corbin-Berrigan, Laurie-Ann; Kowalski, Kristina; Faubert, Jocelyn; Christie, Brian; Gagnon, Isabelle			Three-dimensional multiple object tracking in the pediatric population: the NeuroTracker and its promising role in the management of mild traumatic brain injury	NEUROREPORT			English	Article						children; concussion; mild traumatic brain injury; NeuroTracker; object tracking; pediatrics; perceptual-cognitive training; return to activities; three-dimensional multiple object tracking	COGNITIVE FUNCTION; CONCUSSION; BIOMARKERS; SPORT	As mild traumatic brain injury (mTBI) affects hundreds of thousands of children and their families each year, investigation of potential mTBI assessments and treatments is an important research target. Three-dimensional multiple object tracking (3D-MOT), where an individual must allocate attention to moving objects within 3D space, is one potentially promising assessment and treatment tool. To date, no research has looked at 3D-MOT in a pediatric mTBI population. Thus, the aim of this study was to examine 3D-MOT learning in children and youth with and without mTBI. Thirty-four participants (mean age=14.69 +/- 2.46 years), with and without mTBI, underwent six visits of 3D-MOT. A two-way repeated-measures analysis of variance (ANOVA) showed a significant time effect, a nonsignificant group effect, and a nonsignificant group-by-time interaction on absolute speed thresholds. In contrast, significant group and time effects and a significant group-by-time interaction on normalized speed thresholds were found. Individuals with mTBI showed smaller training gains at visit 2 than healthy controls, but the groups did not differ on the remaining visits. Although youth can significantly improve their 3D-MOT performance following mTBI, similar to noninjured individuals, they show slower speed of processing in the first few training sessions. This preliminary work suggests that using a 3D-MOT paradigm to train visual perception after mTBI may be beneficial for both stimulating recovery and informing return to activity decisions.	[Corbin-Berrigan, Laurie-Ann; Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy Pediat Emergency Med, 3630 Promenade Sir William Osler, Montreal, PQ H3G 1Y5, Canada; [Faubert, Jocelyn] Univ Montreal, Faubert Lab, Montreal, PQ, Canada; [Gagnon, Isabelle] Trauma Montreal Childrens Hosp, Montreal, PQ, Canada; [Kowalski, Kristina] Univ Calgary, Calgary, AB, Canada; [Christie, Brian] Univ Victoria, Victoria, BC, Canada		Gagnon, I (corresponding author), McGill Univ, Sch Phys & Occupat Therapy Pediat Emergency Med, 3630 Promenade Sir William Osler, Montreal, PQ H3G 1Y5, Canada.	isabelle.gagnon8@mcgill.ca	Christie, Brian Ross/AAF-3766-2019; Faubert, Jocelyn/E-2207-2011	Christie, Brian Ross/0000-0002-6830-0160; Gagnon, Isabelle/0000-0003-2043-1644			Beauchamp P, 2011, HIGH PERFOR IN PRESS; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Faubert J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01154; Faubert J, 2012, J CLIN SPORT PSYCHOL, V6, P85, DOI 10.1123/jcsp.6.1.85; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Legault I, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00323; Legault I, 2012, NEUROREPORT, V23, P469, DOI 10.1097/WNR.0b013e328353e48a; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Parsons B, 2014, CLIN EEG NEUROSCI, V47, P304; Parsons B, 2016, CLIN EEG NEUROSCI, V47, P37, DOI 10.1177/1550059414563746; Romeas T, 2016, PSYCHOL SPORT EXERC, V22, P1, DOI 10.1016/j.psychsport.2015.06.002; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	19	10	10	1	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	MAY 2	2018	29	7					559	563		10.1097/WNR.0000000000000988			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GD4LT	WOS:000430475400007	29481522				2022-02-06	
J	Feng, MJ; Ning, WB; Wang, W; Lv, ZH; Liu, XB; Zhu, Y; Gao, W; Jin, HZ; Gao, SS				Feng, Ma-Jing; Ning, Wei-Bin; Wang, Wei; Lv, Zhong-Hua; Liu, Xin-Bing; Zhu, Yong; Gao, Wei; Jin, Hong-Ze; Gao, Shu-Shan			Serum S100A12 as a prognostic biomarker of severe traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; S100A12; Inflammation; Prognosis; Severity	GLYCATION END-PRODUCTS; POSTTRAUMATIC CEREBRAL INFARCTION; ACUTE LUNG INJURY; MULTIPLE BIOMARKERS; SOLUBLE RECEPTOR; PLASMA COPEPTIN; ADVERSE EVENTS; DISEASE; COAGULOPATHY; MODERATE	Background: S100A12 is related to acute brain injury and inflammation. We investigated the clinical prognostic value of serum S100A12 in patients with severe traumatic brain injury (sTBI). Methods: Serum S100A12, S100B, C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) concentrations were measured in 102 healthy controls and 102 sTBI patients. We recorded 30-day mortality and in-hospital major adverse events (IMAEs) including acute lung injury, acute traumatic coagulopathy, progressive hemorrhagic injury and posttraumatic cerebral infarction. Trauma severity was assessed by admission Glasgow Coma Scale scores. Results: When compared to the controls, serum S100A12, S100B, CRP, IL-6 and TNF-alpha concentrations were significantly increased in the patients. Serum concentrations of S100A12 significantly correlated with admission Glasgow Coma Scale scores and serum concentrations of S100B, CRP, IL-6 and TNF-alpha. Patients with any IMAEs or non-survivors within 30 days had obviously higher serum concentrations of S100A12, S100B, CRP, IL-6 and TNF-alpha than other remaining ones. Serum S100A2 was independently associated with IMAEs and 30-day mortality and overall survival. Receiver operating characteristic curve analysis showed that S100A12 concentrations had significant discriminatory ability for patients at risk of any IMAEs and death within 30 days. Conclusion S100A12 might be associated with brain inflammation and evaluation of serum concentrations of S100A12 could be helpful in the early prognostic prediction in sTBI patients.	[Feng, Ma-Jing; Ning, Wei-Bin; Wang, Wei; Lv, Zhong-Hua; Liu, Xin-Bing; Zhu, Yong; Gao, Wei; Jin, Hong-Ze; Gao, Shu-Shan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg,Changxing Peoples Hosp, Changxing Campus,66 Taihu Middle Rd, Changxing 313100, Peoples R China		Feng, MJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg,Changxing Peoples Hosp, Changxing Campus,66 Taihu Middle Rd, Changxing 313100, Peoples R China.	ongiangang@163.com					Achouiti A, 2013, SHOCK, V40, P188, DOI 10.1097/SHK.0b013e31829fbc38; Adams H, 2016, NEUROSURG CLIN N AM, V27, P519, DOI 10.1016/j.nec.2016.05.007; Asehnoune K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1918-4; Bae CB, 2014, J RHEUMATOL, V41, P2403, DOI 10.3899/jrheum.140651; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Capone-Neto A, 2009, CURR OPIN CRIT CARE, V15, P290, DOI 10.1097/MCC.0b013e32832e383e; Cohen MJ, 2014, THROMB RES, V133, pS25, DOI 10.1016/j.thromres.2014.03.013; Dong XQ, 2017, CLIN CHIM ACTA, V469, P75, DOI 10.1016/j.cca.2017.03.024; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; Fremont RD, 2010, J TRAUMA, V68, P1121, DOI 10.1097/TA.0b013e3181c40728; Harris T, 2012, POSTGRAD MED J, V88, P595, DOI 10.1136/postgradmedj-2011-130285; He YY, 2015, CLIN BIOCHEM, V48, P329, DOI 10.1016/j.clinbiochem.2014.11.016; Hemmila MR, 2017, CRIT CARE CLIN, V33, P193, DOI 10.1016/j.ccc.2016.08.010; Isoyama N, 2016, PERITON DIALYSIS INT, V36, P269, DOI 10.3747/pdi.2014.00121; Isoyama N, 2015, NEPHROL DIAL TRANSPL, V30, P84, DOI 10.1093/ndt/gfu259; Jung ES, 2017, J KOREAN MED SCI, V32, P54, DOI 10.3346/jkms.2017.32.1.54; Khorramdelazad Hossein, 2015, Asian Pac J Cancer Prev, V16, P2725; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Latronico N, 2009, J TRAUMA, V66, P1745, DOI 10.1097/TA.0b013e3181a56c8b; Li D, 2015, NEUROSCI LETT, V609, P109, DOI 10.1016/j.neulet.2015.10.035; Li H, 2017, MOL NEUROBIOL, V54, P755, DOI 10.1007/s12035-016-9703-y; Lou MQ, 2013, CLIN NEUROL NEUROSUR, V115, P904, DOI 10.1016/j.clineuro.2012.09.001; Lu HY, 2017, WORLD J PEDIATR, V13, P228, DOI 10.1007/s12519-016-0077-z; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Petrone AB, 2017, NEUROREHABILITATION, V40, P501, DOI 10.3233/NRE-171437; Prabhakaran K, 2017, J SURG RES, V219, P66, DOI 10.1016/j.jss.2017.05.103; Qian SQ, 2018, CLIN CHIM ACTA, V477, P1, DOI 10.1016/j.cca.2017.11.032; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Shrestha Ajit, 2017, Asian J Neurosurg, V12, P648, DOI 10.4103/ajns.AJNS_192_14; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Wakisaka Y, 2014, J NEUROL SCI, V340, P75, DOI 10.1016/j.jns.2014.02.031; Wu GQ, 2016, CLIN CHIM ACTA, V458, P124, DOI 10.1016/j.cca.2016.05.001; Yang DB, 2017, CLIN CHIM ACTA, V469, P99, DOI 10.1016/j.cca.2017.03.030; Yu WH, 2014, CLIN CHIM ACTA, V433, P174, DOI 10.1016/j.cca.2014.03.014; Zammit Christopher, 2013, Emerg Med Pract, V15, P1; Zhang ZY, 2014, PEPTIDES, V60, P13, DOI 10.1016/j.peptides.2014.07.016; Zhao B, 2016, J DIGEST DIS, V17, P475, DOI 10.1111/1751-2980.12364; Zhao P, 2013, J INVEST MED, V61, P861, DOI 10.2310/JIM.0b013e318292fb1e; Zheng YK, 2017, CLIN CHIM ACTA, V475, P64, DOI 10.1016/j.cca.2017.10.009	45	10	11	2	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	MAY	2018	480						84	91		10.1016/j.cca.2018.01.044			8	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	GB1QU	WOS:000428826100012	29408171				2022-02-06	
J	Grinblat, GA; Khan, RS; Dine, K; Wessel, H; Brown, L; Shindler, KS				Grinblat, Gabriela A.; Khan, Reas S.; Dine, Kimberly; Wessel, Howard; Brown, Larry; Shindler, Kenneth S.			RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						traumatic optic neuropathy; retinal ganglion cells; neuroprotection; ST266; amnion cell-derived therapy; intranasal drug delivery	MULTIPLE-SCLEROSIS; CYTOKINE SOLUTION; BRAIN-INJURY; RAT MODEL; NEURITIS; APOPTOSIS; INSULIN; DAMAGE; NEUROPATHY; CRUSH	PURPOSE. Intranasally delivered ST266, the biological, proteinaceous secretome of amnion-derived multipotent progenitor cells, reduces retinal ganglion cell (RGC) loss, optic nerve inflammation, and demyelination in experimental optic neuritis. This unique therapy and novel administration route delivers numerous cytokines and growth factors to the eye and optic nerve, suggesting a potential to also treat other optic neuropathies. Thus, ST266-mediated neuroprotection was examined following traumatic optic nerve injury. METHODS. Optic nerve crush injury was surgically induced in C57BL/6J mice. Mice were treated daily with intranasal PBS or ST266. RGC function was assessed by optokinetic responses (OKRs), RGCs were counted, and optic nerve sections were stained with luxol fast blue and anti-neurofilament antibodies to assess myelin and RGC axon damage. RESULTS. Intranasal ST266 administered daily for 5 days, beginning at the time that a 1-second optic nerve crush was performed, significantly attenuated OKR decreases. Furthermore, ST266 treatment reduced damage to RGC axons and myelin within optic nerves, and blocked RGC loss. Following a 4-second optic nerve crush, intranasal ST266 increased RGC survival and showed a trend toward reduced RGC axon and myelin damage. Ten days following optic nerve crush, ST266 prevented myelin damage, while also inducing a trend toward increased RGC survival and visual function. CONCLUSIONS. ST266 significantly attenuates traumatic optic neuropathy. Neuroprotective effects of this unique combination of biologic molecules observed here and previously in optic neuritis suggest potential broad application for preventing neuronal damage in multiple optic nerve disorders. Furthermore, results support intranasal delivery as a novel, noninvasive therapeutic modality for eyes and optic nerves.	[Grinblat, Gabriela A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Khan, Reas S.; Dine, Kimberly; Shindler, Kenneth S.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Khan, Reas S.; Dine, Kimberly; Shindler, Kenneth S.] Univ Penn, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Wessel, Howard; Brown, Larry] Noveome Biotherapeut Inc, Pittsburgh, PA USA		Shindler, KS (corresponding author), Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Dept Ophthalmol,Stellar Chance Labs, 3rd Floor,422 Curie Blvd, Philadelphia, PA 19104 USA.	Kenneth.Shindler@uphs.upenn.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY019014]; Research to Prevent Blindness Physician Scientist AwardResearch to Prevent Blindness (RPB); F.M. Kirby Foundation; US NavyUnited States Department of Defense [N62645-13-C-4014]; Cell-Based Wound Therapeutics for Combat Casualties; State of Pennsylvania Bio-Technology Grant SAP [4100068500]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY019014] Funding Source: NIH RePORTER	Supported by National Institutes of Health grant EY019014, Research to Prevent Blindness Physician Scientist Award, and the F.M. Kirby Foundation. Portions of this work were subcontracted from grants to Noveome through US Navy Contract N62645-13-C-4014, Cell-Based Wound Therapeutics for Combat Casualties; and The State of Pennsylvania 2014 Bio-Technology Grant SAP#4100068500.	Al-Abdulla NA, 1998, AM J PATHOL, V153, P447, DOI 10.1016/S0002-9440(10)65588-5; Alcala-Barraza SR, 2010, J DRUG TARGET, V18, P179, DOI 10.3109/10611860903318134; Arnold AC, 2005, AM J OPHTHALMOL, V139, P1101, DOI 10.1016/j.ajo.2005.01.031; Banas R, 2014, CELL TRANSPLANT, V23, P1111, DOI 10.3727/096368913X670165; Castagne V, 1996, P ROY SOC B-BIOL SCI, V263, P1193, DOI 10.1098/rspb.1996.0175; Cho RI, 2012, COMBAT CASULTY CARE, P299; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Deng-Bryant Y, 2015, RESTOR NEUROL NEUROS, V33, P189, DOI 10.3233/RNN-140455; Deng-Bryant Y, 2012, J TRAUMA ACUTE CARE, V73, pS156, DOI 10.1097/TA.0b013e3182625f5f; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Fonseca-Kelly Zoe, 2012, Front Neurol, V3, P84, DOI 10.3389/fneur.2012.00084; Franz Michael G, 2008, Eplasty, V8, pe21; Guan L, 2017, CLIN COSMET INV DERM, V10, P459, DOI 10.2147/CCID.S147112; Khan RS, 2017, SCI REP-UK, V7, DOI 10.1038/srep41768; Khan RS, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-3; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Meyer CH, 2016, DEV OPHTHALMOL, V55, P63, DOI 10.1159/000431143; Meyer R, 2001, J NEUROSCI, V21, P6214, DOI 10.1523/JNEUROSCI.21-16-06214.2001; Payne WG, 2010, WORLD J SURG, V34, P1663, DOI 10.1007/s00268-010-0420-9; POTTER NT, 1992, INVEST OPHTH VIS SCI, V33, P1717; Quinn Thomas A, 2011, Front Neurol, V2, P50, DOI 10.3389/fneur.2011.00050; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Renner DB, 2012, J PHARM PHARMACOL, V64, P1709, DOI 10.1111/j.2042-7158.2012.01555.x; Shindler KS, 2008, EXP EYE RES, V87, P208, DOI 10.1016/j.exer.2008.05.017; Shindler KS, 2007, INVEST OPHTH VIS SCI, V48, P3602, DOI 10.1167/iovs.07-0131; Shindler KS, 2010, J NEURO-OPHTHALMOL, V30, P328, DOI 10.1097/WNO.0b013e3181f7f833; Steed D. L., 2008, EPLASTY, V8, P157; Steinsapir KD, 2011, AM J OPHTHALMOL, V151, P928, DOI 10.1016/j.ajo.2011.02.007; Thorne RG, 2008, NEUROSCIENCE, V152, P785, DOI 10.1016/j.neuroscience.2008.01.013; Uberti MG, 2010, ANN PLAS SURG, V64, P632, DOI 10.1097/SAP.0b013e3181c39351; Uberti MG, 2001, ANN PLAST SURG, V66, P575; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Zuo L, 2013, INVEST OPHTH VIS SCI, V54, P5097, DOI 10.1167/iovs.13-12157	35	10	11	2	6	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	MAY	2018	59	6					2470	2477		10.1167/iovs.18-24096			8	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	GH0GL	WOS:000433080400007	29847652	Green Submitted, gold, Green Published			2022-02-06	
J	Karakula-Juchnowicz, H; Galecka, M; Rog, J; Bartnicka, A; Lukaszewicz, Z; Krukow, P; Morylowska-Topolska, J; Skonieczna-Zydecka, K; Krajka, T; Jonak, K; Juchnowicz, D				Karakula-Juchnowicz, Hanna; Galecka, Miroslawa; Rog, Joanna; Bartnicka, Anna; Lukaszewicz, Zuzanna; Krukow, Pawel; Morylowska-Topolska, Justyna; Skonieczna-Zydecka, Karolina; Krajka, Tomasz; Jonak, Kamil; Juchnowicz, Dariusz			The Food-Specific Serum IgG Reactivity in Major Depressive Disorder Patients, Irritable Bowel Syndrome Patients and Healthy Controls	NUTRIENTS			English	Article						major depressive disorder; irritable bowel syndrome; immunoglobulin G antibody; food antigen; low-grade inflammation; gut-brain axis; food hypersensitivity; food allergy; intestinal permeability	IMMUNOGLOBULIN-G ANTIBODIES; CELIAC WHEAT SENSITIVITY; TRAUMATIC BRAIN-INJURY; LOW-GRADE INFLAMMATION; GLUTEN-FREE DIET; QUALITY-OF-LIFE; INTESTINAL PERMEABILITY; GASTROINTESTINAL SYMPTOMS; ELIMINATION DIET; CONTROLLED-TRIAL	There is an increasing amount of evidence which links the pathogenesis of irritable bowel syndrome (IBS) with food IgG hyperreactivity. Some authors have suggested that food IgG hyperreactivity could be also involved in the pathophysiology of major depressive disorder (MDD). The aim of this study was to compare levels of serum IgG against 39 selected food antigens between three groups of participants: patients with MDD (MDD group), patients with IBS (IBS group) and healthy controls (HC group). The study included 65 participants (22 in the MDD group, 22 in the IBS group and 21 in the HC group). Serum IgG levels were examined using enzyme-linked immunosorbent assay (ELISA). Medical records, clinical data and laboratory results were collected for the analysis. IgG food hyperreactivity (interpreted as an average of levels of IgG antibodies above 7.5 mu g/mL) was detected in 28 (43%) participants, including 14 (64%) from the MDD group, ten (46%) from the IBS group and four (19%) from the HC group. We found differences between extreme IgG levels in MDD versus HC groups and in IBS versus HC groups. Patients with MDD had significantly higher serum levels of total IgG antibodies and IgG against celery, garlic and gluten compared with healthy controls. The MDD group also had higher serum IgG levels against gluten compared with the IBS group. Our results suggest dissimilarity in immune responses against food proteins between the examined groups, with the highest immunoreactivity in the MDD group. Further studies are needed to repeat and confirm these results in bigger cohorts and also examine clinical utility of IgG-based elimination diet in patients with MDD and IBS.	[Karakula-Juchnowicz, Hanna; Rog, Joanna; Jonak, Kamil] Med Univ Lublin, Dept Psychiat Psychotherapy & Early Intervent 1, Gluska St 1, PL-20439 Lublin, Poland; [Karakula-Juchnowicz, Hanna; Krukow, Pawel; Morylowska-Topolska, Justyna] Med Univ Lublin, Dept Clin Neuropsychiat, Gluska St 1, PL-20439 Lublin, Poland; [Galecka, Miroslawa; Bartnicka, Anna; Lukaszewicz, Zuzanna] Inst Microecol, Sielska St 10, PL-60129 Poznan, Poland; [Skonieczna-Zydecka, Karolina] Pomeranian Med Univ, Dept Biochem & Human Nutr, Broniewskiego St 24, PL-71460 Szczecin, Poland; [Krajka, Tomasz] Lublin Univ Technol, Dept Math, Fac Mech Engn, Nadbystrzycka St 36, PL-20618 Lublin, Poland; [Jonak, Kamil] Lublin Univ Technol, Dept Biomed Engn, Nadbystrzycka St 38D, PL-20618 Lublin, Poland; [Juchnowicz, Dariusz] Med Univ Lublin, Dept Psychiat Nursing, Szkolna St 18, PL-20124 Lublin, Poland		Karakula-Juchnowicz, H; Rog, J (corresponding author), Med Univ Lublin, Dept Psychiat Psychotherapy & Early Intervent 1, Gluska St 1, PL-20439 Lublin, Poland.; Karakula-Juchnowicz, H (corresponding author), Med Univ Lublin, Dept Clin Neuropsychiat, Gluska St 1, PL-20439 Lublin, Poland.	karakula.hanna@gmail.com; drgalecka@instytut-mikroekologii.pl; rog.joann@gmail.com; anna.bartnicka@instytut-mikroekologii.pl; dietetyk@instytut-mikroekologii.pl; pawelkrukow@umlub.pl; justynamorylowska@op.pl; karzyd@pum.edu.pl; t.krajka@pollub.pl; jonak.kamil@gmail.com; juchnowiczdariusz@wp.pl	Skonieczna-Zydecka, Karolina/K-7252-2014; Jonak, Kamil/C-6258-2017; Juchnowicz, Dariusz/S-1900-2019; Krajka, Tomasz/C-2329-2017; Krukow, Pawel/AAB-1955-2019; Rog, Joanna/AAJ-5495-2021	Skonieczna-Zydecka, Karolina/0000-0002-3430-9079; Jonak, Kamil/0000-0002-9975-1458; Juchnowicz, Dariusz/0000-0003-2027-5469; Krajka, Tomasz/0000-0001-6513-1253; Krukow, Pawel/0000-0001-9497-2713; Rog, Joanna/0000-0003-4057-9507; Karakula-Juchnowicz, Hanna/0000-0002-5971-795X; Morylowska-Topolska, Justyna/0000-0002-2966-1983	Medical University of Lublin [DS 192/18]	The authors would like to thank Ewa Wisniewska-Ligeza for excellent language and technical assistance. This study was supported by a research grant from the Medical University of Lublin (DS 192/18).	Abautret-Daly A, 2018, ACTA NEUROPSYCHIATR, V30, P275, DOI 10.1017/neu.2017.3; Aljada A, 2004, AM J CLIN NUTR, V79, P682; Alpay K, 2010, CEPHALALGIA, V30, P829, DOI 10.1177/0333102410361404; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Anthoni S, 2009, WORLD J GASTROENTERO, V15, P4915, DOI 10.3748/wjg.15.4915; Atkinson W, 2004, GUT, V53, P1459, DOI 10.1136/gut.2003.037697; Aydinlar EI, 2013, HEADACHE, V53, P514, DOI 10.1111/j.1526-4610.2012.02296.x; Barmeyer C, 2017, INT J COLORECTAL DIS, V32, P29, DOI 10.1007/s00384-016-2663-x; Bentz S, 2010, DIGESTION, V81, P252, DOI 10.1159/000264649; Bohmer CJM, 2001, EUR J GASTROEN HEPAT, V13, P941, DOI 10.1097/00042737-200108000-00011; Bohn L, 2013, AM J GASTROENTEROL, V108, P634, DOI 10.1038/ajg.2013.105; Cai CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112154; Carr S, 2012, ALLERGY ASTHMA CL IM, V8, DOI 10.1186/1710-1492-8-12; Catassi C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111268; Chabane H, 2018, REV FR ALLERGOL, V58, P334, DOI 10.1016/j.reval.2018.01.007; Clairembault T, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0196-0; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Dahl J, 2016, ACTA PSYCHIAT SCAND, V134, P40, DOI 10.1111/acps.12576; Dantzer R, 2017, CURR TOP BEHAV NEURO, V31, P117, DOI 10.1007/7854_2016_6; Defrees DN, 2017, PRIMARY CARE, V44, P655, DOI 10.1016/j.pop.2017.07.009; Delaney S, 2018, CURR ENV HLTH REP, V5, P158, DOI 10.1007/s40572-018-0186-z; Drisko J, 2006, J AM COLL NUTR, V25, P514, DOI 10.1080/07315724.2006.10719567; Dunn EC, 2015, HARVARD REV PSYCHIAT, V23, P1, DOI 10.1097/HRP.0000000000000054; Engelhart S, 2017, SEMIN ARTHRITIS RHEU, V47, P276, DOI 10.1016/j.semarthrit.2017.03.021; Esnafoglu E, 2017, J PEDIATR-US, V188, P240, DOI 10.1016/j.jpeds.2017.04.004; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; Foxx-Orenstein AE, 2016, THER ADV GASTROENTER, V9, P354, DOI 10.1177/1756283X16633050; Fritscher-Ravens A, 2014, GASTROENTEROLOGY, V147, P1012, DOI 10.1053/j.gastro.2014.07.046; Genton L, 2015, CLIN NUTR, V34, P341, DOI 10.1016/j.clnu.2014.10.003; Gummesson A, 2011, OBESITY, V19, P2280, DOI 10.1038/oby.2011.251; Guo H, 2012, J INT MED RES, V40, P204, DOI 10.1177/147323001204000121; Halmos EP, 2017, J GASTROEN HEPATOL, V32, P69, DOI 10.1111/jgh.13701; Hart G.R., 2017, BAOJ NUTR, V3, P45; Hayes P, 2014, J HUM NUTR DIET, V27, P36, DOI 10.1111/jhn.12114; Hill Peta, 2017, Gastroenterol Hepatol (N Y), V13, P36; Hole GJ., 2002, DESIGN REPORT EXPT; Hossain MI, 2010, J PEDIATR GASTR NUTR, V51, P638, DOI 10.1097/MPG.0b013e3181eb3128; Ikechi R., 2017, IRRITABLE BOWEL SYND, P21; Isolauri E, 2004, GUT, V53, P1391, DOI 10.1136/gut.2004.044990; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Karakula-Juchnowicz H, 2017, PSYCHIATR POL, V51, P859, DOI 10.12740/PP/65308; Karakula-Juchnowicz H, 2017, NUTR NEUROSCI, V20, P110, DOI 10.1179/1476830514Y.0000000158; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Klein DN, 2015, PSYCHOL INQ, V26, P247, DOI 10.1080/1047840X.2015.1032873; Kohler CA, 2017, ACTA PSYCHIAT SCAND, V135, P373, DOI 10.1111/acps.12698; Kohler O, 2014, JAMA PSYCHIAT, V71, P1381, DOI 10.1001/jamapsychiatry.2014.1611; Lacouture Y, 2008, TUTOR QUANT METHODS, V4, P35, DOI 10.20982/tqmp.04.1.p035; Lamers F, 2013, MOL PSYCHIATR, V18, P692, DOI 10.1038/mp.2012.144; Lee HS, 2017, J NEUROGASTROENTEROL, V23, P578, DOI 10.5056/jnm17054; Li FX, 2003, CAN J GASTROENTEROL, V17, P259, DOI 10.1155/2003/706891; Li H, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13260; Ligaarden SC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-166; Lin R, 2015, INT J CLIN EXP PATHO, V8, P5153; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lopresti AL, 2014, PROG NEURO-PSYCHOPH, V48, P102, DOI 10.1016/j.pnpbp.2013.09.017; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P117; Mansueto P, 2015, WORLD J GASTROENTERO, V21, P7089, DOI 10.3748/wjg.v21.i23.7089; Marsh A, 2016, EUR J NUTR, V55, P897, DOI 10.1007/s00394-015-0922-1; McKenzie YA, 2016, J HUM NUTR DIET, V29, P549, DOI 10.1111/jhn.12385; Monsbakken KW, 2006, EUR J CLIN NUTR, V60, P667, DOI 10.1038/sj.ejcn.1602367; Okusaga O, 2016, PSYCHOSOM MED, V78, P931, DOI 10.1097/PSY.0000000000000352; Pariante CM, 2017, EUR NEUROPSYCHOPHARM, V27, P554, DOI 10.1016/j.euroneuro.2017.04.001; Piche T, 2014, NEUROGASTROENT MOTIL, V26, P296, DOI 10.1111/nmo.12315; Powell N, 2017, NAT REV GASTRO HEPAT, V14, P143, DOI 10.1038/nrgastro.2016.191; Quigley EMM, 2018, J CLIN MED, V7, DOI 10.3390/jcm7010006; Rees T., 2005, HEADACHE CARE, V2, P105, DOI DOI 10.1185/174234305X14962; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Rudzki L, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1431-y; Ruiz-Nunez B, 2013, J NUTR BIOCHEM, V24, P1183, DOI 10.1016/j.jnutbio.2013.02.009; Seganfredo FB, 2017, OBES REV, V18, P832, DOI 10.1111/obr.12541; SENTSOVA TB, 2014, EKSP KLIN GASTROENTE, V7, P13; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Severance EG, 2014, BIPOLAR DISORD, V16, P230, DOI 10.1111/bdi.12159; Shih David Q, 2007, Gastroenterol Rep, V1, P56; Sicherer SH, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0194; Sinagra E, 2016, WORLD J GASTROENTERO, V22, P2242, DOI 10.3748/wjg.v22.i7.2242; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Spiller RC, 2004, CLIN GASTROENTEROL H, V2, P445, DOI 10.1016/S1542-3565(04)00159-4; Stapel SO, 2008, ALLERGY, V63, P793, DOI 10.1111/j.1398-9995.2008.01705.x; Stevens BR, 2018, GUT, V67, P1555, DOI 10.1136/gutjnl-2017-314759; Szachta P., 2015, J EXP INTEGR MED, V5, P117, DOI [10.5455/jeim.160615.rw.013, DOI 10.5455/JEIM.160615.RW.013]; Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002; Torres-Platas SG, 2014, BRAIN BEHAV IMMUN, V42, P50, DOI 10.1016/j.bbi.2014.05.007; Uher R, 2014, SOC PSYCH PSYCH EPID, V49, P3, DOI 10.1007/s00127-013-0801-0; Vazquez-Roque MI, 2013, GASTROENTEROLOGY, V144, P903, DOI 10.1053/j.gastro.2013.01.049; Whorwell Peter, 2004, Curr Treat Options Gastroenterol, V7, P307, DOI 10.1007/s11938-004-0017-1; Wilders-Truschnig M, 2008, EXP CLIN ENDOCR DIAB, V116, P241, DOI 10.1055/s-2007-993165; World Health Organization, DEPRESSION; Young JJ, 2014, J AFFECT DISORDERS, V169, P15, DOI 10.1016/j.jad.2014.07.032; Zar S, 2005, SCAND J GASTROENTERO, V40, P800, DOI 10.1080/00365520510015593; Zeng Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053612; Zunszain PA, 2011, PROG NEURO-PSYCHOPH, V35, P722, DOI 10.1016/j.pnpbp.2010.04.011; Zuo XL, 2007, CLIN EXP ALLERGY, V37, P823, DOI 10.1111/j.1365-2222.2007.02727.x	95	10	10	0	13	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2072-6643			NUTRIENTS	Nutrients	MAY	2018	10	5							548	10.3390/nu10050548			16	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nutrition & Dietetics	GJ3LI	WOS:000435196000022	29710769	Green Submitted, Green Published, gold			2022-02-06	
J	Rigon, A; Turkstra, LS; Mutlu, B; Duff, MC				Rigon, Arianna; Turkstra, Lyn S.; Mutlu, Bilge; Duff, Melissa C.			Facial-Affect Recognition Deficit as a Predictor of Different Aspects of Social-Communication Impairment in Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						social communication; emotion recognition; facial affect; traumatic brain injury; partner sensitivity	EMOTION PERCEPTION; HEAD-INJURY; ABILITY; QUESTIONNAIRE; VALIDITY; MODERATE; ADULTS; EXPRESSIONS; ADOLESCENTS; RELIABILITY	Objective: To examine the relationship between facial-affect recognition and different aspects of self-and proxy-reported social-communication impairment following moderate-severe traumatic brain injury (TBI). Method: Forty-six adults with chronic TBI (>6 months postinjury) and 42 healthy comparison (HC) adults were administered the La Trobe Communication Questionnaire (LCQ) Self and Other forms to assess different aspects of communication competence and the Emotion Recognition Test (ERT) to measure their ability to recognize facial affects. Results: Individuals with TBI underperformed HC adults in the ERT and self-reported, as well as were reported by close others, as having more communication problems than did HC adults. TBI group ERT scores were significantly and negatively correlated with LCQ-Other (but not LCQ-Self) scores (i.e., participants with lower emotion-recognition scores were rated by close others as having more communication problems). Multivariate regression analysis revealed that adults with higher ERT scores self-reported more problems with disinhibition-impulsivity and partner sensitivity and had fewer other-reported problems with disinhibition-impulsivity and conversational effectiveness. Conclusions: Our findings support growing evidence that emotion-recognition deficits play a role in specific aspects of social-communication outcomes after TBI and should be considered in treatment planning.	[Rigon, Arianna; Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA; [Turkstra, Lyn S.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Mutlu, Bilge] Univ Wisconsin Madison, Dept Comp Sci, Madison, WI USA		Rigon, A (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA.	arianna.rigon@vanderbilt.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)-National Center for Medical Rehabilitation Research (NCMRR) [R01 HD071089]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER	This work was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)-National Center for Medical Rehabilitation Research (NCMRR) Grant R01 HD071089.	ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mathersul D, 2009, J CLIN EXP NEUROPSYC, V31, P278, DOI 10.1080/13803390802043619; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Rigon A, 2017, NEUROIMAGE-CLIN, V13, P370, DOI 10.1016/j.nicl.2016.12.010; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; SHEWAN CM, 1980, J SPEECH HEAR DISORD, V45, P308, DOI 10.1044/jshd.4503.308; Smith MJL, 2010, NEUROPSYCHOLOGIA, V48, P2777, DOI 10.1016/j.neuropsychologia.2010.03.008; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; Ylvisaker M., 1989, MILD MODERATE HEAD I, P203; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	43	10	10	0	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2018	32	4					476	483		10.1037/neu0000368			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GH1GU	WOS:000433151900009	29809034	Bronze, Green Accepted			2022-02-06	
J	Ropacki, S; Nakase-Richardson, R; Farrell-Carnahan, L; Lamberty, GJ; Tang, XY				Ropacki, Susan; Nakase-Richardson, Risa; Farrell-Carnahan, Leah; Lamberty, Greg J.; Tang, Xinyu			Descriptive Findings of the VA Polytrauma Rehabilitation Centers TBI Model Systems National Database	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injury; chronic; Multiple trauma; Rehabilitation; Veterans; United States Department of Veterans Affairs	TRAUMATIC BRAIN-INJURY; COMPREHENSIVE DAY TREATMENT; POSTTRAUMATIC AMNESIA; GALVESTON ORIENTATION; FUNCTIONAL OUTCOMES; SERVICE MEMBERS; PRACTICAL SCALE; HEAD-INJURY; CONSCIOUSNESS; VETERANS	Objectives: To present initial descriptive findings from the Veterans Affairs (VA) Polytrauma Rehabilitation Centers (PRC) Traumatic Brain Injury (TBI) Model Systems (MS) National Database. Design: Prospective cohort study. Setting: VA PRC TBIMS National Database. Participants: 712 service members and veterans with TBI who consented to participate between January 2010 and June 2015. Interventions: Not applicable. Main Outcome Measures: Demographics, preinjury characteristics, injury characteristics, rehabilitation course, functional outcomes, and discharge disposition by TBI severity level. Results: The study cohort was predominantly male with moderate to severe TBI secondary to vehicular accident or blast injury. Sixty-five percent were active duty service members; one-third had been injured during deployment. One-third reported mental health treatment and/or alcohol use problems in the year predating the index TBI. The median number of days between injury and PRC admission was 42.5. Nearly 25% reported clinical levels of posttraumatic stress disorder; 75% reported mild to moderate neurobehavioral symptomatology. The median length of stay in the PRC was 36 days; those with severe TBI had the longest lengths of stay. Functional independence ratings improved from admission to discharge across all TBI severity levels. A majority were discharged to urban areas to reside with spouses or other residents in private residences or adult homes, with some variability by injury severity. Conclusions: The VA PRC TBIMS national database is a rich source of information on a unique group of individuals with TBI and promises to complement existing knowledge on TBI in the civilian population. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Ropacki, Susan] VA Palo Alto Hlth Care Syst, Polytrauma Syst Care, Palo Alto, CA USA; [Nakase-Richardson, Risa] Univ S Florida, James A Haley Vet Hosp, Dept Med, Tampa, FL USA; [Farrell-Carnahan, Leah] Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, McGuire Vet Affairs Med Ctr,Mental Hlth & Phys Me, Richmond, VA USA; [Lamberty, Greg J.] Univ Minnesota, Dept Psychiat, Mental Hlth Serv Line, Minneapolis VA Hlth Care Syst,Med Sch, Minneapolis, MN 55455 USA; [Tang, Xinyu] Univ Arkansas Med Sci, Dept Pediat, Biostat Program, Little Rock, AR 72205 USA		Ropacki, S (corresponding author), VA Palo Alto Hlth Care Syst, Polytrauma Transit Rehabil Program, MB2-241 PSC117 PAD,3801 Miranda Ave, Palo Alto, CA 94304 USA.	Susan.Ropacki@va.gov			Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research); VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research). This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (no. W91YTZ-13-C-0015 [R.N-R.]) from the Defense and Veterans Brain Injury Center within the Defense Health Agency. The authors acknowledge Joyce Chung, PhD, Nitin R. Patel, MPH, and Scott Barnett, PhD, for their contributions to data analytics and interpretation; the Defense and Veterans Brain Injury Center for its support and collaboration with TBI MS staff; and the National Data and Statistical Center for their outstanding data management and analytical support.	Bagalman E, 2013, MENTAL DISORDERS OEF; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bergquist TF, 2012, BRAIN INJURY, V26, P1307, DOI 10.3109/02699052.2012.706355; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Congressional Budget Office, 2012, VET HLTH ADM TREATM; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2003, PROBLEMATIC SUBSTANC; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Dunn L, 2003, J NEUROL NEUROSUR PS, V74, P1060, DOI 10.1136/jnnp.74.8.1060; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; McNamee S, 2012, J HEAD TRAUMA REHAB, V27, P244, DOI 10.1097/HTR.0b013e31825e12c8; Micklewright JL, 2011, ARCH PHYS MED REHAB, V92, P1974, DOI 10.1016/j.apmr.2011.07.199; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; TEASDALE G, 1974, LANCET, V2, P81; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Weathers FW, 1991, PTSD CHECKLIST CIVIL; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	34	10	10	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2018	99	5					952	959		10.1016/j.apmr.2017.12.035			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GE7CG	WOS:000431387000018	29425697				2022-02-06	
J	Spreng, RN; Madore, KP; Schacter, DL				Spreng, R. Nathan; Madore, Kevin P.; Schacter, Daniel L.			Better imagined: Neural correlates of the episodic simulation boost to prospective memory performance	NEUROPSYCHOLOGIA			English	Article							FRONTOPARIETAL CONTROL NETWORK; FUTURE EVENT SIMULATION; TRAUMATIC BRAIN-INJURY; PARTIAL LEAST-SQUARES; DEFAULT MODE NETWORK; IMPLEMENTATION INTENTIONS; WORKING-MEMORY; OLDER-ADULTS; RETRIEVAL; ACTIVATION	Episodic simulation is an adaptive process that can support goal-directed activity and planning success. We investigated the neural architecture associated with the episodic simulation improvement to the likelihood of carrying out future actions by isolating the brain regions associated with this facilitation in a prospective memory paradigm. Participants performed a lexical decision task by making word/non-word judgments, with rarely occurring prospective memory target words requiring a pre-specified manual response. Prior to scanning, participants were given exposure to two lists of prospective memory targets: animals and tools. In a fully counterbalanced design, participants generated a rhyme to one target list and imagined their subsequent encounter (episodic simulation) with target words on the other list. Replicating prior behavioral work, episodic simulation improved subsequent prospective memory performance. Brain activation was assessed in a multivariate partial least squares analysis. Relative to lexical decision blocks with no prospective memory demand, sustained prospective memory replicated prior observations of frontal polar activation. Critically, maintaining the intention to respond to simulated targets, over and above rhyme targets, engaged middle frontal and angular gyri, and medial parietal and prefrontal cortices. Transient activity associated with prospective memory target hits revealed activation for simulated targets in medial prefrontal cortex, posterior cingulate, lateral temporal lobe and inferior parietal lobule. In contrast, rhyme target hits engaged more left lateralized dorsolateral prefrontal cortex and anterior insula. Episodic simulation, thus effectively shifts executive control strategy and boosts task performance. These results are consistent with a growing body of evidence implicating executive control and default network region interactions in adaptive, goal-directed behavior.	[Spreng, R. Nathan] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Lab Brain & Cognit, Montreal, PQ, Canada; [Spreng, R. Nathan] Cornell Univ, Dept Human Dev, Human Neurosci Inst, Ithaca, NY USA; [Madore, Kevin P.] Stanford Univ, Dept Psychol, Stanford, CA USA; [Schacter, Daniel L.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA		Spreng, RN (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	nathan.spreng@gmail.com	Spreng, R. Nathan/AAF-4145-2019	Spreng, R. Nathan/0000-0003-1530-8916	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH060941]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH060941] Funding Source: NIH RePORTER	We thank Clifford Robbins for assistance with stimulus preparation and data collection and the Harvard Center for Brain Science Neuroimaging Core and the Harvard Neuroinformatics Research Group for imaging support. This work was supported by NIH grant MH060941 to D.L.S.	Altgassen M, 2015, Q J EXP PSYCHOL, V68, P192, DOI 10.1080/17470218.2014.956127; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Benoit RG, 2015, NEUROPSYCHOLOGIA, V75, P450, DOI 10.1016/j.neuropsychologia.2015.06.034; Brewer GA, 2010, COGN NEUROSCI-UK, V1, P81, DOI 10.1080/17588920903373960; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Chasteen AL, 2001, PSYCHOL SCI, V12, P457, DOI 10.1111/1467-9280.00385; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; D'Argembeau A, 2011, APPL COGNITIVE PSYCH, V25, P96, DOI 10.1002/acp.1647; Dixon ML, 2018, P NATL ACAD SCI USA, V115, pE1598, DOI 10.1073/pnas.1715766115; Einstein, 2007, PROSPECTIVE MEMORY O; Einstein GO, 2010, J EXP PSYCHOL LEARN, V36, P1082, DOI 10.1037/a0019184; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Gerlach KD, 2014, SOC COGN AFFECT NEUR, V9, P1942, DOI 10.1093/scan/nsu001; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; INGVAR DH, 1979, ACTA NEUROL SCAND, V60, P12, DOI 10.1111/j.1600-0404.1979.tb02947.x; Irish M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00027; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Jing HG, 2017, COGNITION, V169, P118, DOI 10.1016/j.cognition.2017.08.010; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kopp UA, 2003, INT J PSYCHOL, V38, P229, DOI 10.1080/00207590344000150; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Landsiedel J, 2015, NEUROIMAGE, V104, P231, DOI 10.1016/j.neuroimage.2014.10.021; Marsh RL, 2002, J EXP PSYCHOL LEARN, V28, P652, DOI 10.1037//0278-7393.28.4.652; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McFarland C, 2012, MEM COGNITION, V40, P62, DOI 10.3758/s13421-011-0126-8; McIntosh AR, 2004, NEUROIMAGE, V23, P764, DOI 10.1016/j.neuroimage.2004.05.018; Meyer ML, 2012, P NATL ACAD SCI USA, V109, P1883, DOI 10.1073/pnas.1121077109; Mioni G, 2017, BRIT J CLIN PSYCHOL, V56, P130, DOI 10.1111/bjc.12126; Neroni MA, 2014, CONSCIOUS COGN, V23, P53, DOI 10.1016/j.concog.2013.12.001; Park DC, 2007, J GERONTOL B-PSYCHOL, V62, P45, DOI 10.1093/geronb/62.special_issue_1.45; Platt B, 2016, PSYCHOPHARMACOLOGY, V233, P499, DOI 10.1007/s00213-015-4145-1; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2017, CURR OPIN BEHAV SCI, V17, P41, DOI 10.1016/j.cobeha.2017.06.002; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schacter DL, 2012, AM PSYCHOL, V67, P603, DOI 10.1037/a0029869; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Spreng RN, 2015, J COGNITIVE NEUROSCI, V27, P2147, DOI 10.1162/jocn_a_00846; Spreng RN, 2014, J NEUROSCI, V34, P14108, DOI 10.1523/JNEUROSCI.2815-14.2014; Spreng RN, 2013, MEMORY, V21, P458, DOI 10.1080/09658211.2012.736524; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Szpunar K. K., 2016, SEEING FUTURE THEORE, P21, DOI DOI 10.1093/ACPROF:0S0/9780190241537.003.0002; Szpunar KK, 2014, P NATL ACAD SCI USA, V111, P18414, DOI 10.1073/pnas.1417144111; Webb TL, 2008, BRIT J SOC PSYCHOL, V47, P373, DOI 10.1348/014466607X267010; Xu XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep21001	48	10	10	1	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	MAY	2018	113						22	28		10.1016/j.neuropsychologia.2018.03.025			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	GG3QV	WOS:000432608600004	29572062	Green Accepted, Bronze			2022-02-06	
J	Thompson, EJ; Beauchamp, MH; Darling, SJ; Hearps, SJC; Brown, A; Charalambous, G; Crossley, L; Darby, D; Dooley, JJ; Greenham, M; Jaimangal, M; McDonald, S; Muscara, F; Turkstra, L; Anderson, VA				Thompson, Emma J.; Beauchamp, Miriam H.; Darling, Simone J.; Hearps, Stephen J. C.; Brown, Amy; Charalambous, George; Crossley, Louise; Darby, David; Dooley, Julian J.; Greenham, Mardee; Jaimangal, Mohinder; McDonald, Skye; Muscara, Frank; Turkstra, Lyn; Anderson, Vicki A.			Protocol for a prospective, school-based standardisation study of a digital social skills assessment tool for children: The Paediatric Evaluation of Emotions, Relationships, and Socialisation (PEERS) study	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; DIFFICULTIES QUESTIONNAIRE; LEARNING-DISABILITIES; ADOLESCENTS; COMPETENCE; COGNITION; STRENGTHS	Background Humans are by nature a social species, with much of human experience spent in social interaction. Unsurprisingly, social functioning is crucial to wellbeing and quality of life across the lifespan. While early intervention for social problems appears promising, our ability to identify the specific impairments underlying their social problems (eg, social communication) is restricted by a dearth of accurate, ecologically valid and comprehensive child-direct assessment tools. Current tools are largely limited to parent and teacher ratings scales, which may identify social dysfunction, but not its underlying cause, or adult-based experimental tools, which lack age-appropriate norms. The present study describes the development and standardisation of Paediatric Evaluation of Emotions, Relationships, and Socialisation (PEERS (R)), an iPad-based social skills assessment tool. Methods The PEERS project is a cross-sectional study involving two groups: (1) a normative group, recruited from early childhood, primary and secondary schools across metropolitan and regional Victoria, Australia; and (2) a clinical group, ascertained from outpatient services at The Royal Children's Hospital Melbourne (RCH). The project aims to establish normative data for PEERS (R), a novel and comprehensive app-delivered child-direct measure of social skills for children and youth. The project involves recruiting and assessing 1000 children aged 4.0-17.11 years. Assessments consist of an intellectual screen, PEERS (R) subtests, and PEERS-Q, a self-report questionnaire of social skills. Parents and teachers also complete questionnaires relating to participants' social skills. Main analyses will comprise regression-based continuous norming, factor analysis and psychometric analysis of PEERS (R) and PEERS-Q. Ethics and dissemination Ethics approval has been obtained through the RCH Human Research Ethics Committee (34046), the Victorian Government Department of Education and Early Childhood Development (002318), and Catholic Education Melbourne (2166). Findings will be disseminated through international conferences and peer-reviewed journals. Following standardisation of PEERS (R), the tool will be made commercially available.	[Thompson, Emma J.; Darling, Simone J.; Hearps, Stephen J. C.; Brown, Amy; Crossley, Louise; Darby, David; Greenham, Mardee; Muscara, Frank; Anderson, Vicki A.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] St Justine Hosp, Res Ctr, Brain Dev Res Axis, Montreal, PQ, Canada; [Darling, Simone J.; Muscara, Frank] Univ Melbourne, Dept Pediat, Parkville, Vic, Australia; [Charalambous, George; Jaimangal, Mohinder] Curve Tomorrow, Melbourne, Vic, Australia; [Darby, David] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Darby, David] Eastern Hlth Neurosci, Box Hill, Parkville, Vic, Australia; [Darby, David] Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Dooley, Julian J.] Cuyahoga Cty Court Common Pleas, Court Psychiat Clin, Cleveland, OH USA; [McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Turkstra, Lyn] McMaster Univ, Sch Rehabil Sci, Speech Language Pathol Program, Hamilton, ON, Canada; [Anderson, Vicki A.] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic, Australia; [Anderson, Vicki A.] Royal Childrens Hosp, Psychol Serv, Parkville, Vic, Australia		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.; Beauchamp, MH (corresponding author), St Justine Hosp, Res Ctr, Brain Dev Res Axis, Montreal, PQ, Canada.	miriam.beauchamp@umontreal.ca	Greenham, Mardee/AAR-1711-2020; Turkstra, Lyn/ABC-5831-2021; Hearps, Stephen/L-6853-2016	Hearps, Stephen/0000-0003-2984-1172; Brown, Amy/0000-0001-6566-0227; Turkstra, Lyn/0000-0002-6948-6921	Australian National Health and Medical Research Council Development Grant SchemeNational Health and Medical Research Council of Australia [GNT1093528]	This work was supported by the Australian National Health and Medical Research Council Development Grant Scheme (GNT1093528).	Australian Curriculum Assessment and Reporting Authority, 2014, ICSEA 2013 TECHN REP; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Beer JS, 2006, BRAIN RES, V1079, P98, DOI 10.1016/j.brainres.2006.01.002; Blakemore SJ, 2010, NEURON, V65, P744, DOI 10.1016/j.neuron.2010.03.004; Bryan T, 2004, LEARN DISABILITY Q, V27, P45, DOI 10.2307/1593631; Chiasson V, 2017, CLIN NEUROPSYCHOL, V31, P515, DOI 10.1080/13854046.2016.1268650; Crick NR, 1996, CHILD DEV, V67, P993, DOI 10.1111/j.1467-8624.1996.tb01778.x; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crowe LM, 2011, CLIN PSYCHOL REV, V31, P767, DOI 10.1016/j.cpr.2011.03.008; Denham SA, 2009, J EPIDEMIOL COMMUN H, V63, pI37, DOI 10.1136/jech.2007.070797; Dooley JJ, 2010, BRAIN IMPAIR, V11, P152, DOI 10.1375/brim.11.2.152; Ekman P., 1971, NEBRASKA S MOTIVATIO, V19, P207; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Gonzalez LM, 2008, J INT NEUROPSYCH SOC, V14, P337, DOI 10.1017/S135561770808020X; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Gresham F., 2008, SOCIAL SKILLS IMPROV; Hamiwka LD, 2011, EPILEPSY BEHAV, V21, P238, DOI 10.1016/j.yebeh.2011.03.033; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Kavale KA, 2004, LEARN DISABILITY Q, V27, P31, DOI 10.2307/1593630; Kohlberg L., 1984, PSYCHOL MORAL DEV ES, P2; Manly T., 2016, TEST EVERYDAY ATTENT; Martinez W, 2011, J PEDIATR PSYCHOL, V36, P878, DOI 10.1093/jpepsy/jsr035; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McDonald S., 2002, AWARENESS SOCIAL INF; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Muscara F., 2012, DEV SOCIAL NEUROSCIE, P119; Muscara F, 2010, BRAIN IMPAIR, V11, P162, DOI 10.1375/brim.11.2.162; OECD, 2015, SKILLS SOC PROGR POW; PARKER JG, 1987, PSYCHOL BULL, V102, P357, DOI 10.1037/0033-2909.102.3.357; Rapee RM, 2004, CLIN PSYCHOL REV, V24, P737, DOI 10.1016/j.cpr.2004.06.004; Reichow B, 2012, EVID BASED CHILD HLT, P266, DOI DOI 10.1002/EBCH.1902; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Shonkoff J. B., 2000, NEURONS NEIGHBORHOOD; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Uekermann J, 2010, NEUROSCI BIOBEHAV R, V34, P734, DOI 10.1016/j.neubiorev.2009.10.009; Webster-Stratton C, 2004, INFANT YOUNG CHILD, V17, P96, DOI 10.1097/00001163-200404000-00002; Wehmeier PM, 2010, J ADOLESCENT HEALTH, V46, P209, DOI 10.1016/j.jadohealth.2009.09.009; Weschler D., 2011, WECHSLER ABBREVIATED, V2nd; Weschler D., 2012, WECHSLER PRESCHOOL P	43	10	10	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAY	2018	8	2							e016633	10.1136/bmjopen-2017-016633			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH0ZB	WOS:000433129800159	29439065	Green Published, gold			2022-02-06	
J	Urban, MW; Ghosh, B; Strojny, LR; Block, CG; Blazejewski, SM; Wright, MC; Smith, GM; Lepore, AC				Urban, Mark W.; Ghosh, Biswarup; Strojny, Laura R.; Block, Cole G.; Blazejewski, Sara M.; Wright, Megan C.; Smith, George M.; Lepore, Angelo C.			Cell-type specific expression of constitutively-active Rheb promotes regeneration of bulbospinal respiratory axons following cervical SCI	EXPERIMENTAL NEUROLOGY			English	Article						Cervical spinal cord injury; Diaphragm; Respiratory; Breathing; Axon; Regeneration; Regrowth; Rheb; mTOR; AAV2	SPINAL-CORD-INJURY; CORTICOSPINAL TRACT AXONS; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL REGENERATION; PTEN DELETION; GLIAL SCAR; NEURONS; GROWTH; CNS; RECOVERY	Damage to respiratory neural circuitry and consequent loss of diaphragm function is a major cause of morbidity and mortality in individuals suffering from traumatic cervical spinal cord injury (SCI). Repair of CNS axons after SCI remains a therapeutic challenge, despite current efforts. SCI disrupts inspiratory signals originating in the rostral ventral respiratory group (rVRG) of the medulla from their phrenic motor neuron (PhMN) targets, resulting in loss of diaphragm function. Using a rat model of cervical hemisection SCI, we aimed to restore rVRG-PhMN-diaphragm circuitry by stimulating regeneration of injured rVRG axons via targeted induction of Rheb (ras homolog enriched in brain), a signaling molecule that regulates neuronal-intrinsic axon growth potential. Following C2 hemisection, we performed intra-rVRG injection of an adeno-associated virus serotype-2 (AAV2) vector that drives expression of a constitutively-active form of Rheb (cRheb). rVRG neuron-specific cRheb expression robustly increased mTOR pathway activity within the transduced rVRG neuron population ipsilateral to the hemisection, as assessed by levels of phosphorylated ribosomal S6 kinase. By co-injecting our novel AAV2-mCherry/WGA anterograde/trans-synaptic axonal tracer into rVRG, we found that cRheb expression promoted regeneration of injured rVRG axons into the lesion site, while we observed no rVRG axon regrowth with AAV2-GFP control. AAV2-cRheb also significantly reduced rVRG axonal dieback within the intact spinal cord rostral to the lesion. However, cRheb expression did not promote any recovery of ipsilateral bend-diaphragm function, as assessed by inspiratory electromyography (EMG) burst amplitudes. This lack of functional recovery was likely because regrowing rVRG fibers did not extend back into the caudal spinal cord to synaptically reinnervate PhMNs that we retrogradely-labeled with cholera toxin B from the ipsilateral hemi-diaphragm. Our findings demonstrate that enhancing neuronal-intrinsic axon growth capacity can promote regeneration of injured bulbospinal respiratory axons after SCI, but this strategy may need to be combined with other manipulations to achieve reconnection of damaged neural circuitry and ultimately recovery of diaphragm function.	[Urban, Mark W.; Ghosh, Biswarup; Strojny, Laura R.; Block, Cole G.; Blazejewski, Sara M.; Lepore, Angelo C.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Vickie & Jack Farber Inst Neurosci, Dept Neurosci, 233 South 10th St,BLSB 245, Philadelphia, PA 19107 USA; [Wright, Megan C.] Arcadia Univ, Dept Biol, 450 S Easton Rd,220 Boyer Hall, Glenside, PA 19038 USA; [Smith, George M.] Temple Univ, Sch Med, Shril Hosp Pediat Res Ctr, Dept Neurosci, 3500 North Board St, Philadelphia, PA 19140 USA		Lepore, AC (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Vickie & Jack Farber Inst Neurosci, Dept Neurosci, 233 South 10th St,BLSB 245, Philadelphia, PA 19107 USA.	mark.urban@jefferson.edu; bxg033@jefferson.edu; smb538@drexel.edu; wright@arcadia.edu; tue44530@temple.edu; angelo.lepore@jefferson.edu			Craig H. Neilsen Foundation [476686]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS079702]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079702] Funding Source: NIH RePORTER	This work was supported by the Craig H. Neilsen Foundation (grant #476686 to A.C.L.) and the NINDS (grant #1R01NS079702 to A.C.L.).	Al-Ali H, 2017, J NEUROSCI, V37, P7079, DOI 10.1523/JNEUROSCI.0931-17.2017; Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Boulenguez P, 2007, BRAIN RES, V1148, P96, DOI 10.1016/j.brainres.2007.02.060; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Danilov CA, 2015, EXP NEUROL, V266, P147, DOI 10.1016/j.expneurol.2015.02.012; Dell'Anno MT, 2017, NEUROSCI LETT, V652, P25, DOI 10.1016/j.neulet.2016.12.002; DOBBINS EG, 1994, J COMP NEUROL, V347, P64, DOI 10.1002/cne.903470106; Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Geoffroy CG, 2016, CELL REP, V15, P238, DOI 10.1016/j.celrep.2016.03.028; Gervasi NM, 2008, REGEN MED, V3, P907, DOI 10.2217/17460751.3.6.907; Ghali MGZ, 2017, NEUROSCI RES, V121, P7, DOI 10.1016/j.neures.2017.03.004; Goshgarian HG, 2009, RESP PHYSIOL NEUROBI, V169, P85, DOI 10.1016/j.resp.2009.06.005; Gutilla EA, 2016, NEURAL REGEN RES, V11, P1201, DOI 10.4103/1673-5374.189160; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Lewandowski G, 2014, J NEUROSCI, V34; LIPSKI J, 1994, BRAIN RES, V640, P171, DOI 10.1016/0006-8993(94)91871-6; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Lu Y, 2014, CURR OPIN NEUROBIOL, V27, P135, DOI 10.1016/j.conb.2014.03.007; Mantilla CB, 2017, EXP NEUROL, V287, P261, DOI 10.1016/j.expneurol.2016.09.014; Mantilla CB, 2012, EXP NEUROL, V234, P191, DOI 10.1016/j.expneurol.2011.12.036; MITCHELL GS, 1992, NEUROSCI LETT, V141, P75, DOI 10.1016/0304-3940(92)90338-8; Nicaise C, 2012, J NEUROTRAUM, V29, P2748, DOI 10.1089/neu.2012.2467; Nicaise C, 2012, EXP NEUROL, V235, P539, DOI 10.1016/j.expneurol.2012.03.007; Ohtake Y, 2015, NEURAL REGEN RES, V10, P1363, DOI 10.4103/1673-5374.165496; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Ribas VT, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00231; Silver J., 2014, COLD SPRING HARB PER, V7; Steinmetz MP, 2005, J NEUROSCI, V25, P8066, DOI 10.1523/JNEUROSCI.2111-05.2005; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; University of Alabama Birmingham 2016. The National Spinal Cord Injury Statistical Center, 2016, ANN STAT REP; Vinit S, 2006, J NEUROTRAUM, V23, P1137, DOI 10.1089/neu.2006.23.1137; Vinit S, 2009, RESP PHYSIOL NEUROBI, V169, P115, DOI 10.1016/j.resp.2009.08.004; Willenberg R, 2016, J COMP NEUROL, V524, P2654, DOI 10.1002/cne.23987; Wright MC, 2007, EXP NEUROL, V205, P437, DOI 10.1016/j.expneurol.2007.03.011; Wu D, 2017, MOL THER, V25, P2715, DOI 10.1016/j.ymthe.2017.08.011; Wu D, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00049; Wu D, 2015, J NEUROSCI, V35, P11068, DOI 10.1523/JNEUROSCI.0719-15.2015; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Ylera B, 2009, CURR BIOL, V19, P930, DOI 10.1016/j.cub.2009.04.017; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhou SY, 2001, J APPL PHYSIOL, V91, P2665, DOI 10.1152/jappl.2001.91.6.2665; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013; Zukor KA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-1	48	10	10	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2018	303						108	119		10.1016/j.expneurol.2018.02.007			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC8HQ	WOS:000430034800010	29453976	Green Accepted, Bronze			2022-02-06	
J	Willmott, C; McIntosh, AS; Howard, T; Mitra, B; Dimech-Betancourt, B; Donovan, J; Rosenfeld, JV				Willmott, Catherine; McIntosh, Andrew S.; Howard, Teresa; Mitra, Biswadev; Dimech-Betancourt, Bleydy; Donovan, Jarrod; Rosenfeld, Jeffrey V.			SCAT3 changes from baseline and associations with X2 Patch measured head acceleration in amateur Australian football players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Head injuries/concussion; Football; Australian; Biomechanics; General; Head impact	HIGH-SCHOOL FOOTBALL; ICE HOCKEY PLAYERS; CLINICAL MEASURES; DIAGNOSED CONCUSSION; NEUROLOGIC FUNCTION; IMPACTS; BIOMECHANICS; SOCCER; SEASON	Objectives: To investigate changes from baseline on SCAT3 as a result of football game exposure, and association with X2 Patch measured head acceleration events in amateur Australian footballers. Design: Prospective cohort. Methods: Peak linear acceleration (PLA) of the head (>10 g) was measured by wearable head acceleration sensor X2 Biosystems X-Patch in male (n = 34) and female (n = 19) Australian footballers. SCAT3 was administered at baseline (B) and post-game (PG). Results: 1394 head acceleration events (HEA) >10 g were measured. Mean and median HEA PLA were recorded as 15.2 g (SD = 9.2, range = 10.0-115.8) and 12.4 g (IQR = 11.0-15.6) respectively. No significant difference in median HEA PLA (g) was detected across gender (p = 0.55), however, more HEAs were recorded in males (p = 0.03). A greater number (p = 0.004) and severity (p < 0.001) of symptoms were reported PG than at B. No significant association between number of HEA or median PLA, and SCAT3 change scores (p > 0.05 for all), was identified for either gender. Conclusions: Increase in symptom severity post game was not associated with X2 measured HEA. Males sustained more HEA, however HEA PLA magnitude did not differ across gender. Further work on the validation of head acceleration sensors is required and their role in sports concussion research and medical management. (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Willmott, Catherine; Dimech-Betancourt, Bleydy] Monash Univ, Sch Psychol Sci, Monash Inst Cognit & Clin Neurosci, Clayton, Vic 3800, Australia; [Willmott, Catherine; Dimech-Betancourt, Bleydy] Monash Epworth Rehabil Res Ctr, Clayton, Vic, Australia; [McIntosh, Andrew S.] Federat Univ, Australian Collaborat Res Injury Sport & Its Prev, Ballarat, Vic, Australia; [McIntosh, Andrew S.] Monash Univ, Accid Res Ctr, Clayton, Vic, Australia; [Howard, Teresa; Mitra, Biswadev; Donovan, Jarrod] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Mitra, Biswadev] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic, Australia; [Mitra, Biswadev; Donovan, Jarrod] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Monash Inst Med Engn, Clayton, Vic, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Clayton, Vic, Australia; [Rosenfeld, Jeffrey V.] Uniformed Serv Univ Hlth Sci, Dept Surg, F Edward Hebert Sch Med, Bethesda, MD 20814 USA		Willmott, C (corresponding author), Monash Univ, Sch Psychol Sci, Monash Inst Cognit & Clin Neurosci, Clayton, Vic 3800, Australia.; Willmott, C (corresponding author), Monash Epworth Rehabil Res Ctr, Clayton, Vic, Australia.	catherine.willmott@monash.edu	Willmott, Catherine/AAA-5105-2019; Mitra, Biswadev/AAC-3724-2019	Willmott, Catherine/0000-0001-8517-9035; Mitra, Biswadev/0000-0002-0508-2450; Howard, Teresa/0000-0002-2253-5087; Dimech-Betancourt, Bleydy/0000-0001-6990-7338	Monash University Faculty of Medicine, Nursing & Health Sciences Strategic Grant [SGS15-196]	This pilot project was supported by a Monash University Faculty of Medicine, Nursing & Health Sciences Strategic Grant - SGS15-196. The X2 Biosystems X-Patch devices were purchased on a commercial basis. The authors wish to thank the staff and players at Melbourne High School Old Boys and Eastern Devils football clubs for their willing participation and genuine interest in the study findings. We also acknowledge the assistance of: Nicole Stefanac, Karen Richardson, Ebony Lindor, & James Brennan in data collection and coding. X2 Biosystems provided technical product support.	Balasundaram AP, 2013, PHYS THER SPORT, V14, P253, DOI 10.1016/j.ptsp.2013.06.002; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Fortington Lauren V, 2015, Inj Epidemiol, V2, P20; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; King D, 2017, INT J SPORTS SCI COA, V12, P359, DOI 10.1177/1747954117710512; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McIntosh A, 2017, BRIT J SPORT MED, V51, P361; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	30	10	10	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2018	21	5					442	446		10.1016/j.jsams.2017.09.591			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GF8NY	WOS:000432230800003	29037609				2022-02-06	
J	Zhang, ZG; Wang, X; Zai, JH; Sun, CH; Yan, BC				Zhang Zi-gang; Wang Xin; Zai Jin-hai; Sun Cai-hua; Yan Bing-chun			Icariin Improves Cognitive Impairment after Traumatic Brain Injury by Enhancing Hippocampal Acetylation	CHINESE JOURNAL OF INTEGRATIVE MEDICINE			English	Article						icariin; traumatic brain injury; cognitive impairment; acetylation; hippocampus	HISTONE ACETYLATION; MEMORY IMPAIRMENT; NEURONAL CELLS; RATS; MICE; MODULATION; EPIMEDIUM; DEFICITS; CORTEX; MODEL	Objective: To examine the effect of icariin (ICA) on the cognitive impairment induced by traumatic brain injury (TBI) in mice and the underlying mechanisms related to changes in hippocampal acetylation level. Methods: The modified free-fall method was used to establish the TBI mouse model. Mice with post-TBI cognitive impairment were randomly divided into 3 groups using the randomised block method (n=7): TBI (vehicle-treated), low-dose (75 mg/kg) and high-dose (150 mg/kg) of ICA groups. An additional sham-operated group (vehicle-treated) was employed. The vehicle or ICA was administrated by gavage for 28 consecutive days. The Morris water maze (MWM) test was conducted. Acetylcholine (ACh) content, mRNA and protein levels of choline acetyltransferase (ChAT), and protein levels of acetylated H3 (Ac-H3) and Ac-H4 were detected in the hippocampus. Results: Compared with the sham-operated group, the MWM performance, hippocampal ACh content, mRNA and protein levels of ChAT, and protein levels of Ac-H3 and Ac-H4 were significantly decreased in the TBI group (P < 0.05). High-dose of ICA significantly ameliorated the TBI-induced weak MWM performance, increased hippocampal ACh content, and mRNA and protein levels of ChAT, as well as Ac-H3 protein level compared with the TBI group (P < 0.05). Conclusion: ICA improved post-TBI cognitive impairment in mice by enhancing hippocampal acetylation, which improved hippocampal cholinergic function and ultimately improved cognition.	[Zhang Zi-gang; Zai Jin-hai] Jiangyin Hosp Tradit Chinese Med, Dept Neurol, Jiangyin 214400, Jiangsu, Peoples R China; [Zhang Zi-gang] Jiangsu Univ, Dept Pathogeny Microbiol, Zhenjiang 212013, Jiangsu, Peoples R China; [Wang Xin; Sun Cai-hua] Northern Jiangsu Peoples Hosp, Dept Rehabil, Yangzhou 225001, Jiangsu, Peoples R China; [Wang Xin; Yan Bing-chun] Jiangsu Key Lab Integrated Tradit Chinese & Weste, Yangzhou 225001, Jiangsu, Peoples R China; [Yan Bing-chun] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China		Yan, BC (corresponding author), Jiangsu Key Lab Integrated Tradit Chinese & Weste, Yangzhou 225001, Jiangsu, Peoples R China.; Yan, BC (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China.	bcyan@yzu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401005]; Natural Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK20140494]; University Natural Science Research Major Project of Jiangsu Province, China [16KJA310006]	Supported by the National Natural Science Foundation of China (No. 81401005), the Natural Science Foundation of Jiangsu Province, China (No. BK20140494), and the University Natural Science Research Major Project of Jiangsu Province, China (No. 16KJA310006)	Aizawa S, 2010, NEUROCHEM INT, V56, P627, DOI 10.1016/j.neuint.2010.01.007; Bennouna M, 2007, ENCEPHALE, V33, P616; Bentley P, 2011, PROG NEUROBIOL, V94, P360, DOI 10.1016/j.pneurobio.2011.06.002; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Huang YJ, 2010, NEUROCHEM RES, V35, P1038, DOI 10.1007/s11064-010-0152-0; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Khodaie B, 2015, BEHAV BRAIN RES, V278, P55, DOI 10.1016/j.bbr.2014.09.034; Kumar Sri, 2012, Biomed Sci Instrum, V48, P239; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li F, 2010, PHARMACOL BIOCHEM BE, V96, P301, DOI 10.1016/j.pbb.2010.05.021; Liu JJ, 2006, J CHROMATOGR A, V1103, P344, DOI 10.1016/j.chroma.2005.11.036; McDonald AJ, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00046; Ostberg A, 2011, NEUROLOGY, V76, P1046, DOI 10.1212/WNL.0b013e318211c1c4; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Scremin OU, 2012, J NEUROTRAUM, V29, P2457, DOI 10.1089/neu.2012.2465; Sharma SK, 2010, NEUROSCI BIOBEHAV R, V34, P1234, DOI 10.1016/j.neubiorev.2010.02.009; Sze SCW, 2010, MOLECULES, V15, P7861, DOI 10.3390/molecules15117861; Uchida H, 2010, CELL MOL NEUROBIOL, V30, P1125, DOI 10.1007/s10571-010-9545-5; Uchida S, 2011, EUR J PHARMACOL, V654, P235, DOI 10.1016/j.ejphar.2010.12.029; Urano T, 2010, PHYTOTHER RES, V24, P1658, DOI 10.1002/ptr.3183; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Velazquez R, 2013, NEUROBIOL DIS, V58, P92, DOI 10.1016/j.nbd.2013.04.016; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang X, 2013, NEUROSCIENCE, V236, P281, DOI 10.1016/j.neuroscience.2012.12.074; Wang Z, 2007, NEUROSCIENCE, V145, P911, DOI 10.1016/j.neuroscience.2006.12.059; Wu JF, 2011, PHARMACOL BIOCHEM BE, V98, P273, DOI 10.1016/j.pbb.2011.01.008; Yan BC, 2012, EXP BRAIN RES, V223, P271, DOI 10.1007/s00221-012-3257-7; Young-Bernier M, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-17; Zheng M, 2008, PHYTOTHER RES, V22, P597, DOI 10.1002/ptr.2276	34	10	11	1	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1672-0415	1993-0402		CHIN J INTEGR MED	Chin. J. Integr. Med.	MAY	2018	24	5					366	371		10.1007/s11655-018-2823-z			6	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	GF5CJ	WOS:000431982600008	29327125				2022-02-06	
J	Brian, MS; Matthews, EL; Watso, JC; Babcock, MC; Wenner, MM; Rose, WC; Stocker, SD; Farquhar, WB				Brian, Michael S.; Matthews, Evan L.; Watso, Joseph C.; Babcock, Matthew C.; Wenner, Megan M.; Rose, William C.; Stocker, Sean D.; Farquhar, William B.			The influence of acute elevations in plasma osmolality and serum sodium on sympathetic outflow and blood pressure responses to exercise	JOURNAL OF NEUROPHYSIOLOGY			English	Article						blood pressure regulation; handgrip exercise; osmolality	ROSTRAL VENTROLATERAL MEDULLA; INCREASED DIETARY SALT; HYPERTONIC SALINE RESUSCITATION; TRAUMATIC BRAIN-INJURY; NERVE ACTIVITY; CARDIOVASCULAR-RESPONSES; ORGANUM-VASCULOSUM; HUMANS; INCREASES; NEURONS	Elevated plasma osmolality (pOsm) has been shown to increase resting sympathetic nerve activity in animals and humans. The present study tested the hypothesis that increases in pOsm and serum sodium (sNa(+)) concentration would exaggerate muscle sympathetic nerve activity (MSNA) and blood pressure (BP) responses to handgrip (HG) exercise and postexercise ischemia (PEI). BP and MSNA were measured during HG followed by PEI before and after a 23-min hypertonic saline infusion (HSI-3% NaCl). Eighteen participants (age 23 +/- 1 yr; BMI 24 +/- 1 kg/m(2)) completed the protocol; pOsm and sNa +/- increased from pre-to post-HSI (285 +/- 1 to 291 +/- 1 mosmol/kg H2O; 138.2 +/- 0.3 to 141.3 +/- 0.4 mM; P < 0.05 for both). Resting mean BP (90 +/- 2 vs. 92 +/- 1 mmHg) and MSNA (11 +/- 2 vs. 15 +/- 2 bursts/min) were increased pre-to post-HSI (P < 0.05 for both). Mean BP responses to HG (106 +/- 2 vs. 111 +/- 2 mmHg, P < 0.05) and PEI (102 +/- 2 vs. 107 +/- 2 mmHg, P < 0.05) were higher post-HSI. Similarly, MSNA during HG (20 +/- 2 vs. 29 +/- 2 bursts/min, P < 0.05) and PEI (19 +/- 2 vs. 24 +/- 3 bursts/min, P < 0.05) were greater post-HSI. In addition, the change in MSNA was greater post-HSI during HG (Delta 9 +/- 2 vs. Delta 13 +/- 3 bursts/min, P < 0.05). A second set of participants (n = 13, age 23 +/- 1 yr; BMI 24 +/- 1 kg/m(2)) completed a time control (TC) protocol consisting of quiet rest instead of an infusion. The TC condition yielded no change in resting sNa(+), pOsm, mean BP, or MSNA (all P > 0.05); responses to HG and PEI were not different pre-to post-quiet rest (P > 0.05). In summary, acutely increasing pOsm and sNa(+) exaggerates BP and MSNA responses during HG exercise and PEI. NEW & NOTEWORTHY Elevated plasma osmolality has been shown to increase resting sympathetic activity and blood pressure. This study provides evidence that a cute elevations in plasma osmolality and serum sodium exaggerated muscle sympathetic nerve activity and blood pressure responses during exercise pressor reflex activation in healthy young adults.	[Brian, Michael S.; Matthews, Evan L.; Watso, Joseph C.; Babcock, Matthew C.; Wenner, Megan M.; Rose, William C.; Farquhar, William B.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19713 USA; [Brian, Michael S.] Plymouth State Univ, Dept Hlth & Human Performance, Plymouth, NH USA; [Matthews, Evan L.] Montclair State Univ, Dept Exercise Sci & Phys Educ, Montclair, NJ USA; [Stocker, Sean D.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA		Farquhar, WB (corresponding author), Univ Delaware, STAR Hlth Sci Complex,540 South Coll Ave,Ste 201, Newark, DE 19713 USA.	wbf@udel.edu	Babcock, Matthew/AAC-3415-2019; Matthews, Evan/AAG-1149-2019; Stocker, Sean/K-1848-2016	Babcock, Matthew/0000-0002-8047-4411; Matthews, Evan/0000-0001-5499-2429; Watso, Joseph/0000-0001-7840-0643; Stocker, Sean/0000-0001-6317-6300	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1R01HL128388]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL128388] Funding Source: NIH RePORTER	This research was funded by National Heart, Lung, and Blood Institute Grant 1R01HL128388.	Adams JM, 2008, HYPERTENSION, V52, P932, DOI 10.1161/HYPERTENSIONAHA.108.118935; Adams JM, 2007, HYPERTENSION, V50, P354, DOI 10.1161/HYPERTENSIONAHA.107.091843; Adams JM, 2009, HYPERTENSION, V54, P308, DOI 10.1161/HYPERTENSIONAHA.108.127803; Antunes VR, 2006, J PHYSIOL-LONDON, V576, P569, DOI 10.1113/jphysiol.2006.115766; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Brooks VL, 2004, AM J PHYSIOL-REG I, V287, pR1359, DOI 10.1152/ajpregu.00104.2004; Brooks VL, 2004, AM J PHYSIOL-HEART C, V286, pH1642, DOI 10.1152/ajpheart.01004.2003; Charkoudian N, 2005, AM J PHYSIOL-HEART C, V289, pH2456, DOI 10.1152/ajpheart.00601.2005; Charkoudian N, 2003, J PHYSIOL-LONDON, V552, P635, DOI 10.1113/jphysiol.2003.048629; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dickinson KM, 2014, ATHEROSCLEROSIS, V232, P211, DOI 10.1016/j.atherosclerosis.2013.10.032; DLIN RA, 1983, AM HEART J, V106, P316, DOI 10.1016/0002-8703(83)90198-9; FAGIUS J, 1989, HYPERTENSION, V14, P511, DOI 10.1161/01.HYP.14.5.511; Fairfax ST, 2013, AM J PHYSIOL-HEART C, V304, pH759, DOI 10.1152/ajpheart.00842.2012; Farquhar WB, 2006, AM J PHYSIOL-HEART C, V291, pH2181, DOI 10.1152/ajpheart.00191.2006; Frithiof R, 2014, AM J PHYSIOL-REG I, V306, pR567, DOI 10.1152/ajpregu.00460.2013; Greaney JL, 2010, AM J PHYSIOL-REG I, V299, pR1091, DOI 10.1152/ajpregu.00341.2010; HOBERG E, 1990, AM J CARDIOL, V65, P583, DOI 10.1016/0002-9149(90)91034-4; Ito S, 1999, AM J PHYSIOL-REG I, V276, pR1600, DOI 10.1152/ajpregu.1999.276.6.R1600; Kaufman MP, 2002, CLIN AUTON RES, V12, P429, DOI 10.1007/s10286-002-0059-1; Kinsman BJ, 2017, J PHYSIOL-LONDON, V595, P6187, DOI 10.1113/JP274537; Kinsman BJ, 2017, HYPERTENSION, V69, P163, DOI 10.1161/HYPERTENSIONAHA.116.08372; Kokkinos Peter F, 2002, J Cardiopulm Rehabil, V22, P178, DOI 10.1097/00008483-200205000-00009; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; MARK AL, 1985, CIRC RES, V57, P461, DOI 10.1161/01.RES.57.3.461; MATTHEWS KA, 1993, HYPERTENSION, V22, P479, DOI 10.1161/01.HYP.22.4.479; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; Oliveira RP, 2002, CRIT CARE, V6, P418, DOI 10.1186/cc1541; PAWLOSKIDAHM CM, 1993, HYPERTENSION, V22, P929, DOI 10.1161/01.HYP.22.6.929; PENAZ J, 1992, PHYSIOL RES, V41, P5; Shi P, 2007, AM J PHYSIOL-REG I, V293, pR2279, DOI 10.1152/ajpregu.00160.2007; Simmonds SS, 2014, HYPERTENSION, V64, P583, DOI 10.1161/HYPERTENSIONAHA.114.03250; Smith SA, 2006, EXP PHYSIOL, V91, P89, DOI 10.1113/expphysiol.2005.032367; SPINELLI L, 1987, ANN CLIN LAB SCI, V17, P350; Stocker SD, 2015, HYPERTENSION, V66, P1184, DOI 10.1161/HYPERTENSIONAHA.115.05936; Stocker SD, 2013, CURR HYPERTENS REP, V15, P538, DOI 10.1007/s11906-013-0385-9; Suckling RJ, 2012, KIDNEY INT, V81, P407, DOI 10.1038/ki.2011.369; Weiss ML, 1996, J AUTONOM NERV SYST, V57, P109, DOI 10.1016/0165-1838(95)00108-5; Wenner MM, 2007, AM J PHYSIOL-HEART C, V293, pH2313, DOI 10.1152/ajpheart.01383.2006; WESSELING KH, 1993, J APPL PHYSIOL, V74, P2566, DOI 10.1152/jappl.1993.74.5.2566; Yamauchi K, 2014, AM J PHYSIOL-HEART C, V306, pH450, DOI 10.1152/ajpheart.00813.2013	41	10	10	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	APR	2018	119	4					1257	1265		10.1152/jn.00559.2017			9	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	GC5DE	WOS:000429804800003	29357474	Bronze, Green Published			2022-02-06	
J	Chong, SA; Balosso, S; Vandenplas, C; Szczesny, G; Hanon, E; Claes, K; Van Damme, X; Danis, B; Van Eyll, J; Wolff, C; Vezzani, A; Kaminski, RM; Niespodziany, I				Chong, Seon-Ah; Balosso, Silvia; Vandenplas, Catherine; Szczesny, Gregory; Hanon, Etienne; Claes, Kasper; Van Damme, Xavier; Danis, Benedicte; Van Eyll, Jonathan; Wolff, Christian; Vezzani, Annamaria; Kaminski, Rafal M.; Niespodziany, Isabelle			Intrinsic Inflammation Is a Potential Anti-Epileptogenic Target in the Organotypic Hippocampal Slice Model	NEUROTHERAPEUTICS			English	Article						Neuroinflammation; TBI; epileptogenesis; TNF alpha; OHSCs; MEA	NECROSIS-FACTOR-ALPHA; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; RAT HIPPOCAMPUS; IN-VITRO; EPILEPTIFORM ACTIVITY; TNF-ALPHA; INDUCED SEIZURES; POSTTRAUMATIC SEIZURES; NEURONAL EXCITABILITY	Understanding the mechanisms of epileptogenesis is essential to develop novel drugs that could prevent or modify the disease. Neuroinflammation has been proposed as a promising target for therapeutic interventions to inhibit the epileptogenic process that evolves from traumatic brain injury. However, it remains unclear whether cytokine-related pathways, particularly TNF alpha signaling, have a critical role in the development of epilepsy. In this study, we investigated the role of innate inflammation in an in vitro model of post-traumatic epileptogenesis. We combined organotypic hippocampal slice cultures, representing an in vitro model of post-traumatic epilepsy, with multi-electrode array recordings to directly monitor the development of epileptiform activity and to examine the concomitant changes in cytokine release, cell death, and glial cell activation. We report that synchronized ictal- and interictal-like activities spontaneously evolve in this culture. Dynamic changes in the release of the pro-inflammatory cytokines IL-1 beta, TNF alpha, and IL-6 were observed throughout the culture period (3 to 21 days in vitro) with persistent activation of microglia and astrocytes. We found that neutralizing TNF alpha with a polyclonal antibody significantly reduced ictal discharges, and this effect lasted for 1 week after antibody washout. Neither phenytoin nor an anti-IL-6 polyclonal antibody was efficacious in inhibiting the development of epileptiform activity. Our data show a sustained effect of the anti-TNF alpha antibody on the ictal progression in organotypic hippocampal slice cultures supporting the critical role of inflammatory mediators in epilepsy and establishing a proof-of-principle evidence for the utility of this preparation to test the therapeutic effects of anti-inflammatory treatments.	[Chong, Seon-Ah; Vandenplas, Catherine; Szczesny, Gregory; Hanon, Etienne; Claes, Kasper; Van Damme, Xavier; Danis, Benedicte; Van Eyll, Jonathan; Wolff, Christian; Kaminski, Rafal M.; Niespodziany, Isabelle] UCB Biopharma SPRL, Chemin Foriest, B-1420 Braine Lalleud, Belgium; [Balosso, Silvia; Vezzani, Annamaria] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, I-20156 Milan, Italy		Chong, SA; Niespodziany, I (corresponding author), UCB Biopharma SPRL, Chemin Foriest, B-1420 Braine Lalleud, Belgium.	Seon-Ah.Chong@ucb.com; Isabelle.Niespodziany@ucb.com	Vezzani, Annamaria/AAB-1882-2020; Balosso, Silvia/AAB-1887-2020	Vezzani, Annamaria/0000-0003-0573-6175; Balosso, Silvia/0000-0001-6712-8023; van Eyll, Jonathan/0000-0002-9949-0526	Walloon Region (Belgium) - DGO6 [6533]	We thank Dr. Dries Braeken (Imec) for kindly offering the polydimethylsiloxane mini-wells and Prof. Yevgeny Berdichevsky (Lehigh University) for his help to develop the organotypic hippocampal slice cultures. Seon-Ah Chong is the recipient of a grant from the Walloon Region (Belgium) - DGO6 (Convention 6533). The authors declare no potential conflicts of interest.	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Avoli M, 2016, J NEUROSCI METH, V260, P26, DOI 10.1016/j.jneumeth.2015.10.006; Balosso S, 2005, ANN NEUROL, V57, P804, DOI 10.1002/ana.20480; Balosso S, 2013, EXP NEUROL, V247, P267, DOI 10.1016/j.expneurol.2013.05.010; Baune BT, 2008, AM J MED GENET B, V147B, P1056, DOI 10.1002/ajmg.b.30712; Bausch SB, 2000, J NEUROPHYSIOL, V84, P2918, DOI 10.1152/jn.2000.84.6.2918; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Benson MJ, 2015, EPILEPSIA, V56, P895, DOI 10.1111/epi.12960; Berdichevsky Y, 2016, ANN CLIN TRANSL NEUR, V3, P908, DOI 10.1002/acn3.364; Berdichevsky Y, 2013, J NEUROSCI, V33, P9056, DOI 10.1523/JNEUROSCI.3870-12.2013; Berdichevsky Y, 2012, NEUROBIOL DIS, V45, P774, DOI 10.1016/j.nbd.2011.11.001; Berdichevsky Y, 2009, J NEUROSCI METH, V178, P59, DOI 10.1016/j.jneumeth.2008.11.016; BERGER T, 1994, J NEUROCYTOL, V23, P61, DOI 10.1007/BF01189817; Bernardino L, 2005, J NEUROSCI, V25, P6734, DOI 10.1523/JNEUROSCI.1510-05.2005; Chip S, 2013, J CEREBR BLOOD F MET, V33, P508, DOI 10.1038/jcbfm.2012.190; COLTMAN BW, 1995, J COMP NEUROL, V362, P209, DOI 10.1002/cne.903620205; Correa JD, 2011, ISRN DENT, V2011, P497850, DOI DOI 10.5402/2011/497850; Curia G, 2014, CURR MED CHEM, V21, P663, DOI 10.2174/0929867320666131119152201; De Sarro G, 2004, PHARMACOL BIOCHEM BE, V77, P761, DOI 10.1016/j.pbb.2004.01.012; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; DELRIO JA, 1991, NEUROSCIENCE, V43, P335, DOI 10.1016/0306-4522(91)90298-3; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; Dey A, 2016, TRENDS PHARMACOL SCI, V37, P463, DOI 10.1016/j.tips.2016.03.001; DILL RE, 1993, J PERIODONTOL, V64, P169, DOI 10.1902/jop.1993.64.3.169; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Dyhrfjeld-Johnsen J, 2010, J CLIN NEUROPHYSIOL, V27, P418, DOI 10.1097/WNP.0b013e3181fe0709; Dzhala V, 2015, CNS NEUROSCI THER, V21, P173, DOI 10.1111/cns.12369; East E, 2010, TISSUE ENG PT A, V16, P3173, DOI 10.1089/ten.tea.2010.0017; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Fukuda M, 2007, BRAIN DEV-JPN, V29, P644, DOI 10.1016/j.braindev.2007.04.007; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gilbride CJ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12889; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; Gutierrez R, 1999, BRAIN RES, V815, P304, DOI 10.1016/S0006-8993(98)01101-9; Hailer NP, 1996, GLIA, V18, P319, DOI 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S; Hakkoum D, 2007, J NEUROCHEM, V100, P747, DOI 10.1111/j.1471-4159.2006.04257.x; Heinemann U, 2014, ADV EXP MED BIOL, V813, P25, DOI 10.1007/978-94-017-8914-1_2; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Holtman L, 2013, EPILEPSIA, V54, P589, DOI 10.1111/epi.12112; Huuskonen J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-25; Iori V, 2016, CURR OPIN PHARMACOL, V26, P118, DOI 10.1016/j.coph.2015.11.002; Kalueff AV, 2004, NEUROSCI LETT, V365, P106, DOI 10.1016/j.neulet.2004.04.061; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Karr L, 2008, EPILEPSY RES, V81, P14, DOI 10.1016/j.eplepsyres.2008.04.005; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Kato K, 2009, NEUROSCIENCE, V160, P492, DOI 10.1016/j.neuroscience.2009.02.038; Kovacs R, 2011, CARDIOVASC PSYCHIAT, V2011, DOI DOI 10.1155/2011/646958; Lagarde S, 2016, EPILEPSIA, V57, P956, DOI 10.1111/epi.13387; Le Duigou C, 2008, J PHYSIOL-LONDON, V586, P4891, DOI 10.1113/jphysiol.2008.156281; Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Maroso M, 2011, NEUROTHERAPEUTICS, V8, P304, DOI 10.1007/s13311-011-0039-z; MCBAIN CJ, 1989, J NEUROSCI METH, V27, P35, DOI 10.1016/0165-0270(89)90051-4; McNamara James O, 2006, Sci STKE, V2006, pre12, DOI 10.1126/stke.3562006re12; Merbl Y, 2014, J VET INTERN MED, V28, P1775, DOI 10.1111/jvim.12462; Murashima YL, 2008, GENE REGUL SYST BIO, V2, P267; Obien MEJ, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00423; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Park KI, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0027-14.2015; Penkowa M, 2001, NEUROSCIENCE, V102, P805, DOI 10.1016/S0306-4522(00)00515-7; Pernot F, 2011, EPILEPSIA, V52, P2315, DOI 10.1111/j.1528-1167.2011.03273.x; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Ravizza T, 2008, NEUROBIOL DIS, V31, P327, DOI 10.1016/j.nbd.2008.05.007; SAKAGUCHI T, 1994, NEUROSCI RES, V20, P157, DOI 10.1016/0168-0102(94)90033-7; Savin C, 2009, J R SOC INTERFACE, V6, P655, DOI 10.1098/rsif.2008.0387; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schmidt D, 2012, EPILEPTIC DISORD, V14, P105, DOI 10.1684/epd.2012.0512; Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vezzani A, 1999, J NEUROSCI, V19, P5054; Vezzani A, 2002, EPILEPSIA, V43, P30, DOI 10.1046/j.1528-1157.43.s.5.14.x; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Weinberg MS, 2013, EXP NEUROL, V247, P429, DOI 10.1016/j.expneurol.2013.01.011; Willmore LJ, 2005, EPILEPSY BEHAV, V7, pS25, DOI 10.1016/j.yebeh.2005.08.006; Wong M, 2001, DEV BRAIN RES, V128, P113, DOI 10.1016/S0165-3806(01)00149-3; Xu D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00195; Yamamoto A, 2006, EXP NEUROL, V202, P410, DOI 10.1016/j.expneurol.2006.07.003; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; ZIMMER J, 1984, J COMP NEUROL, V228, P432, DOI 10.1002/cne.902280310	93	10	11	2	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	APR	2018	15	2					470	488		10.1007/s13311-018-0607-6			19	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	GE8VV	WOS:000431510200020	29464573	Green Published, hybrid			2022-02-06	
J	Dhandapani, S; Bajaj, A; Gendle, C; Saini, I; Kaur, I; Chaudhary, I; Jasandeep; Kaur, J; Kalyan, G; Dhandapani, M; Gupta, SK				Dhandapani, Sivashanmugam; Bajaj, Ankur; Gendle, Chandrasekar; Saini, Inderjeet; Kaur, Irwanjeet; Chaudhary, Isha; Jasandeep; Kaur, Jaspinder; Kalyan, Geetanjali; Dhandapani, Manju; Gupta, Sunil K.			Independent impact of plasma homocysteine levels on neurological outcome following head injury	NEUROSURGICAL REVIEW			English	Article						Head injury; Homocysteine; Outcome; CT scan; Prognosis	TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; PRACTICAL SCALE	Homocysteine (tHcy) has been hardly studied among patients with head injury. This study was to evaluate whether there is any independent impact of tHcy levels on neurological outcome following head injury in a multivariate model. Patients admitted within 24 h of injury were included in the study, along with 20 age- and gender-matched controls. Plasma levels of tHcy were measured at admission using direct immunoassay. All the variables were analyzed with respect to tHcy levels and outcome according to Glasgow Outcome Score (GOS) at 3 months. Univariate and multivariate analyses were performed using SPSS 21. There were a total of 72 patients in the study. tHcy levels were significantly higher after head injury (mean 24.03[SD +/- 16.0] mu mol/L), compared to matched controls (mean 16.62 [SD +/- 10.4] mu mol/L) (p = 0.05). Patients with severe head injury, acute SDH, or diffuse higher radiological grades had greater levels of tHcy compared to others. There was a significant relationship between tHcy level and neurological outcome. tHcy levels were significantly higher in patients who had unfavorable GOS (mean 36.22[+/- 25.3] mu mol/L), compared to those with favorable GOS (mean 22.71[+/- 14.3] mu mol/L) (P = 0.03). In multivariate analysis, tHcy level (adj. odds ratio [OR] 1.17, P = 0.05) and Glasgow Coma Scale (adj. OR 5.17, P = 0.01) had significant association with neurological outcome at 3 months independent of age, dietary habit, radiological grading and of each other. tHcy level has significant independent impact on neurological outcome and may be useful as a prognostic marker following head injury.	[Dhandapani, Sivashanmugam; Bajaj, Ankur; Gendle, Chandrasekar; Gupta, Sunil K.] PGIMER, Dept Neurosurg, Chandigarh 12, India; [Saini, Inderjeet; Kaur, Irwanjeet; Chaudhary, Isha; Jasandeep; Kaur, Jaspinder; Kalyan, Geetanjali; Dhandapani, Manju] PGIMER, NINE, Chandigarh 12, India		Dhandapani, S; Bajaj, A (corresponding author), PGIMER, Dept Neurosurg, Chandigarh 12, India.	ssdhandapani.neurosurg@gmail.com	Dhandapani, Sivashanmugam/I-2395-2013	Dhandapani, Sivashanmugam/0000-0002-3497-4255			Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Bonetti F, 2016, NEURODEGENER DIS MAN, V6, P133, DOI 10.2217/nmt-2015-0008; Dash PK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00036; Dhandapani SS, 2010, INDIAN J NEUROTRAUM, V7, P23, DOI 10.1016/S0973-0508(10)80007-3; Dhandapani SS, 2007, INDIAN J NEUROTRAUM, V4, P35, DOI 10.1016/S0973-0508(07)80009-8; Dhandapani S, 2016, WORLD NEUROSURG, V96, P36, DOI 10.1016/j.wneu.2016.08.088; Dhandapani Sivashanmugam, 2015, Surg Neurol Int, V6, pS543, DOI 10.4103/2152-7806.168067; Dhandapani S, 2015, WORLD NEUROSURG, V84, P1244, DOI 10.1016/j.wneu.2015.05.058; Dhandapani S, 2015, NEUROL INDIA, V63, P531, DOI 10.4103/0028-3886.162026; Dhandapani S, 2015, ACTA NEUROCHIR, V157, P399, DOI 10.1007/s00701-014-2297-0; Dhandapani S, 2013, NEUROL INDIA, V61, P406, DOI 10.4103/0028-3886.117616; Hannibal L, 2017, MOL ASPECTS MED, V53, P36, DOI 10.1016/j.mam.2016.11.003; Hatefi M, 2017, WORLD NEUROSURG, V97, P70, DOI 10.1016/j.wneu.2016.09.080; JENNETT B, 1975, LANCET, V1, P480; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; Rahmani A, 2016, WORLD NEUROSURG, V87, P507, DOI 10.1016/j.wneu.2015.09.016; Schalinske KL, 2012, ADV NUTR, V3, P755, DOI 10.3945/an.112.002758; Skovierova H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101733; Srinivasan A, 2016, WORLD NEUROSURG, V90, P91, DOI 10.1016/j.wneu.2016.02.049; TEASDALE G, 1974, LANCET, V2, P81; Wang JF, 2014, NEUROCHEM INT, V64, P37, DOI 10.1016/j.neuint.2013.11.002; Zhang MY, 2013, J MOL NEUROSCI, V51, P57, DOI 10.1007/s12031-012-9948-5	24	10	11	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	APR	2018	41	2					513	517		10.1007/s10143-017-0880-6			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FZ5EU	WOS:000427615500016	28741220				2022-02-06	
J	Egan, KP; Duque, G; Keenan, MA; Pignolo, RJ				Egan, Kevin P.; Duque, Gustavo; Keenan, Mary Ann; Pignolo, Robert J.			Circulating osteogentic precursor cells in non-hereditary heterotopic ossification	BONE			English	Article						Heterotopic ossification; Injury; Traumatic brain injury; Cerebrovascular accident; Trauma; Spinal cord injury; Circulating osteogenic precursor (COP) cells	OSTEOBLAST PROGENITOR CELLS; BONE-FORMATION; INJURY; MICE	Non-hereditary heterotopic ossification (NHHO) may occur after musculoskeletal trauma, central nervous system (CNS) injury, or surgery. We previously described circulating osteogenic precursor (COP) cells as a bone marrow-derived type 1 collagen(+)CD45(+) subpopulation of mononuclear adherent cells that are able of producing extraskeletal ossification in a murine in vivo implantation assay. In the current study, we performed a tissue analysis of COP cells in NHHO secondary to defined conditions, including traumatic brain injury, spinal cord injury, cerebrovascular accident, trauma without neurologic injury, and joint arthroplasty. All bone specimens revealed the presence of COP cells at 2-14 cells per high power field. COP cells were localized to early fibroproliferative and neovascular lesions of NHHO with evidence for their circulatory status supported by their presence near blood vessels in examined lesions. This study provides the first systematic evaluation of COP cells as a contributory histopathological finding associated with multiple forms of NHHO. These data support that circulating, hematopoietic-derived cells with osteogenic potential can seed inflammatory sites, such as those subject to soft tissue injury, and due to their migratory nature, may likely be involved in seeding sites distant to CNS injury. (C) 2018 Elsevier Inc. All rights reserved.	[Egan, Kevin P.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Duque, Gustavo] Univ Melbourne, Australian Inst Musculoskeletal Sci AIMSS, Melbourne, Vic, Australia; [Duque, Gustavo] Western Hlth, Melbourne, Vic, Australia; [Duque, Gustavo] Univ Melbourne, Melbourne Med Sch, Dept Med, Western Hlth, Melbourne, Vic, Australia; [Keenan, Mary Ann] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Pignolo, Robert J.] Mayo Clin, Mayo Clin Sch Med, Dept Med, Rochester, MN USA		Pignolo, RJ (corresponding author), Mayo Clin, Coll Med, Div Geriatr Med & Gerontol, Geriatr Med, 200 First St SW, Rochester, MN 55905 USA.	kevinpe@upenn.edu; gustavo.duque@unimelb.edu.au; Pignolo.Robert@mayo.edu	Keenan, Mary Ann/ABB-1551-2020; Duque, Gustavo/T-1538-2017	Duque, Gustavo/0000-0001-8126-0637	Ian Cali Distinguished Clinician-Scientist award at the University of Pennsylvania; Robert and Arlene Professorship in Geriatric Medicine at the Mayo Clinic	This work was supported by the Ian Cali Distinguished Clinician-Scientist award at the University of Pennsylvania and the Robert and Arlene Professorship in Geriatric Medicine at the Mayo Clinic.	Alm JJ, 2010, J ORTHOP RES, V28, P1634, DOI 10.1002/jor.21167; Egan KP, 2011, ARTERIOSCL THROM VAS, V31, P2965, DOI 10.1161/ATVBAHA.111.234724; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; Foley K. L, 2017, BONE; Gunawardene P, 2017, EXP GERONTOL, V96, P68, DOI 10.1016/j.exger.2017.06.004; Macias MP, 2001, J CLIN INVEST, V107, P949, DOI 10.1172/JCI11232; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Otsuru S, 2007, BIOCHEM BIOPH RES CO, V354, P453, DOI 10.1016/j.bbrc.2006.12.226; Otsuru S, 2017, BONE, V94, P1, DOI 10.1016/j.bone.2016.10.003; Pignolo RJ, 2005, CLIN REV BONE MINER, V3, P261, DOI 10.1385/BMM:3:3-4:261; Pignolo RJ, 2011, J BONE MINER RES, V26, P1685, DOI 10.1002/jbmr.370; Pignolo RJ, 2010, CRIT REV EUKAR GENE, V20, P171, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.70; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; Suda RK, 2009, STEM CELLS, V27, P2209, DOI 10.1002/stem.150	14	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	APR	2018	109				SI		61	64		10.1016/j.bone.2017.12.028			4	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	GB5DK	WOS:000429082400010	29305336				2022-02-06	
J	Kenney, K; Amyot, F; Moore, C; Haber, M; Turtzo, LC; Shenouda, C; Silverman, E; Gong, YH; Qu, BX; Harburg, L; Wassermann, EM; Lu, HZ; Diaz-Arrastia, R				Kenney, Kimbra; Amyot, Franck; Moore, Carol; Haber, Margalit; Turtzo, L. Christine; Shenouda, Christian; Silverman, Erika; Gong, Yunhua; Qu, Bao-Xi; Harburg, Leah; Wassermann, Eric M.; Lu, Hanzhang; Diaz-Arrastia, Ramon			Phosphodiesterase-5 inhibition potentiates cerebrovascular reactivity in chronic traumatic brain injury	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							BIOGENIC-AMINE CONTENT; HEAD-INJURY; CEREBRAL METABOLISM; UNITED-STATES; RECOVERY; STROKE; ANGIOGENESIS; CONSEQUENCES; HYPOTHERMIA; HYPERCAPNIA	BackgroundTraumatic cerebrovascular injury (TCVI), a common consequence of traumatic brain injury (TBI), presents an attractive therapeutic target. Because phosphodiesterase-5 (PDE5) inhibitors potentiate the action of nitric oxide (NO) produced by endothelial cells, they are candidate therapies for TCVI. This study aims to: (1) measure cerebral blood flow (CBF), cerebrovascular reactivity (CVR), and change in CVR after a single dose of sildenafil (CVR) in chronic TBI compared to uninjured controls; (2) examine the safety and tolerability of 8-week sildenafil administration in chronic symptomatic moderate/severe TBI patients; and as an exploratory aim, (3) assess the effect of an 8-week course of sildenafil on chronic TBI symptoms. MethodsForty-six subjects (31 chronic TBI, 15 matched healthy volunteers) were enrolled. Baseline CBF and CVR before and after administration of sildenafil were measured. Symptomatic TBI subjects then completed an 8-week double-blind, placebo-controlled, crossover trial of sildenafil. A neuropsychological battery and neurobehavioral symptom questionnaires were administered at each study visit. ResultsAfter a single dose of sildenafil, TBI subjects showed a significant increase in global CVR compared to healthy controls (P < 0.001, d = 0.9). Post-sildenafil CVR maps showed near-normalization of CVR in many regions where baseline CVR was low, predominantly within areas without structural abnormalities. Sildenafil was well tolerated. Clinical Global Impression (CGI) scale showed a trend toward clinical improvement while on sildenafil treatment. FindingsSingle-dose sildenafil improves regional CVR deficits in chronic TBI patients. CVR and CVR are potential predictive and pharmacodynamic biomarkers of PDE5 inhibitor therapy for TCVI. Sildenafil is a potential therapy for TCVI.	[Kenney, Kimbra; Amyot, Franck; Moore, Carol; Qu, Bao-Xi; Harburg, Leah] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Haber, Margalit; Silverman, Erika; Gong, Yunhua; Diaz-Arrastia, Ramon] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Turtzo, L. Christine] NIH, Radiol & Imaging Sci, Bldg 10, Bethesda, MD 20892 USA; [Shenouda, Christian] NIH, Dept Phys Med & Rehabil, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Wassermann, Eric M.] NINDS, Behav Neurol Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Lu, Hanzhang] Johns Hopkins Univ, Baltimore, MD USA		Diaz-Arrastia, R (corresponding author), Univ Penn, Perelman Sch Med, Penn Presbyterian Med Ctr, Dept Neurol, 51 North 39th St, Philadelphia, PA 19104 USA.	Ramon.Diaz-Arrastia@uphs.upenn.edu	Wassermann, Eric M./AAC-9064-2020	Wassermann, Eric M./0000-0003-0628-0210	Center for Neuroscience and Regenerative Medicine (CNRM), Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD; Military Clinical Neuroscience Center of Excellence (MCNCoE), Department of Neurology, USUHS; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002977] Funding Source: NIH RePORTER	Work in the authors' laboratory was supported by the Center for Neuroscience and Regenerative Medicine (CNRM), Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD, by the Military Clinical Neuroscience Center of Excellence (MCNCoE), Department of Neurology, USUHS, and by the Intramural Research Program of the National Institutes of Health.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; [Anonymous], 2015, PACKAGE INSERT SILDE; Atalay B, 2006, NEUROSURGERY, V59, P1102, DOI 10.1227/01.NEU.0000245605.22817.44; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Bellando-Randone S, 2016, CLIN RHEUMATOL, V35, P127, DOI 10.1007/s10067-015-3119-3; Ding GL, 2008, J CEREBR BLOOD F MET, V28, P1440, DOI 10.1038/jcbfm.2008.33; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Faul M, TRAUMATIC BRAIN INJU; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; INOUE M, 1991, J CEREBR BLOOD F MET, V11, P242, DOI 10.1038/jcbfm.1991.56; Kassner Andrea, 2004, Top Magn Reson Imaging, V15, P58, DOI 10.1097/00002142-200402000-00006; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lu H, 2014, JOVE-J VIS EXP, V94, P1; Mandosi E, 2015, EXPERT OPIN THER TAR, V19, P1617, DOI 10.1517/14728222.2015.1066337; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; National Research Council, 2008, GULF WAR AND HLTH, V7; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P1354, DOI 10.1038/jcbfm.2011.43; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P200, DOI 10.1038/jcbfm.2010.78; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PAPPIUS HM, 1988, J CEREBR BLOOD F MET, V8, P324, DOI 10.1038/jcbfm.1988.67; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Pifarre P, 2010, J NEUROCHEM, V112, P807, DOI 10.1111/j.1471-4159.2009.06518.x; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sperandio PA, 2012, AM J PHYSIOL-HEART C, V303, pH1474, DOI 10.1152/ajpheart.00435.2012; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Wang JY, 2014, NEUROBIOL DIS, V68, P91, DOI 10.1016/j.nbd.2014.04.014; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; Wu JY, 2016, AM J EMERG MED, V34, P162, DOI 10.1016/j.ajem.2015.09.033; Yezhuvath US, 2012, NEUROBIOL AGING, V33, P75, DOI 10.1016/j.neurobiolaging.2010.02.005; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhu YS, 2013, J CEREBR BLOOD F MET, V33, P1190, DOI 10.1038/jcbfm.2013.66; [No title captured]	46	10	10	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	APR	2018	5	4					418	428		10.1002/acn3.541			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC9EY	WOS:000430101500004	29687019	Green Published, gold			2022-02-06	
J	Loris, ZB; Hynton, JR; Pieper, AA; Dietrich, WD				Loris, Zachary B.; Hynton, Justin R.; Pieper, Andrew A.; Dietrich, W. Dalton			Beneficial Effects of Delayed P7C3-A20 Treatment After Transient MCAO in Rats	TRANSLATIONAL STROKE RESEARCH			English	Article						Aminopropyl carbazole; Ischemic stroke; Neuroprotection; P7C3-A20; Therapeutic window	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; NEUROPROTECTIVE EFFICACY; MOUSE MODEL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; AMINOPROPYL CARBAZOLES; CEREBRAL-ISCHEMIA; COMPOUND; WINDOW; NEUROGENESIS	Despite ischemic stroke being the fifth leading cause of death in the USA, there are few therapeutic options available. We recently showed that the neuroprotective compound P7C3-A20 reduced brain atrophy, increased neurogenesis, and improved functional recovery when treatment was initiated immediately post-reperfusion after a 90-min middle cerebral artery occlusion (MCAO). In the present study, we investigated a more clinically relevant therapeutic window for P7C3-A20 treatment after ischemic stroke. MCAO rats were administered P7C3-A20 for 1 week, beginning immediately or at a delayed point, 6 h post-reperfusion. Delayed P7C3-A20 treatment significantly improved stroke-induced sensorimotor deficits in motor coordination and symmetry, as well as cognitive deficits in hippocampal-dependent spatial learning, memory retention, and working memory. In the cerebral cortex, delayed P7C3-A20 treatment significantly increased tissue sparing 7 weeks after stroke and reduced hemispheric infarct volumes 48 h after reperfusion. Despite no reduction in striatal infarct volumes acutely, there was a significant increase in spared tissue volume chronically. In the hippocampus, only immediately treated P7C3-A20 animals had a significant increase in tissue sparing compared to vehicle-treated stroke animals. This structural protection translated into minimal hippocampal-dependent behavioral improvements with delayed P7C3-A20 treatment. However, all rats treated with delayed P7C3-A20 demonstrated a significant improvement in both sensorimotor tasks compared to vehicle controls, suggesting a somatosensory-driven recovery. These results demonstrate that P7C3-A20 improves chronic functional and histopathological outcomes after ischemic stroke with an extended therapeutic window.	[Loris, Zachary B.; Hynton, Justin R.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Dept Neurol Surg, Neurosci Program, Miami, FL 33136 USA; [Loris, Zachary B.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Pieper, Andrew A.] Univ Iowa, Carver Coll Med, Coll Med, Dept Psychiat, 169 Newton Rd, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Univ Iowa, Carver Coll Med, Dept Neurol, 169 Newton Rd, Iowa City, IA 52242 USA; [Pieper, Andrew A.] Univ Iowa, Dept Free Rad & Radiat Biol Program, Dept Radiat Oncol, Comprehens Canc Ctr,Dept Vet Affairs,Carver Coll, 169 Newton Rd, Iowa City, IA 52242 USA; [Dietrich, W. Dalton] Univ Miami, Leonard M Miller Sch Med, Dept Neurol Surg, 1095 NW 14th Terrace,Suite 2-30, Miami, FL 33136 USA		Dietrich, WD (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Neurosci Program, Miami, FL 33136 USA.; Dietrich, WD (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.; Pieper, AA (corresponding author), Univ Iowa, Carver Coll Med, Coll Med, Dept Psychiat, 169 Newton Rd, Iowa City, IA 52242 USA.; Pieper, AA (corresponding author), Univ Iowa, Carver Coll Med, Dept Neurol, 169 Newton Rd, Iowa City, IA 52242 USA.; Pieper, AA (corresponding author), Univ Iowa, Dept Free Rad & Radiat Biol Program, Dept Radiat Oncol, Comprehens Canc Ctr,Dept Vet Affairs,Carver Coll, 169 Newton Rd, Iowa City, IA 52242 USA.; Dietrich, WD (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Neurol Surg, 1095 NW 14th Terrace,Suite 2-30, Miami, FL 33136 USA.	Andrew-Pieper@uiowa.edu; ddietrich@miami.edu	Pieper, Andrew A/R-5552-2016	Pieper, Andrew/0000-0001-6299-6577	American Heart AssociationAmerican Heart Association [16PRE27050003]; Florida Department of Health [7JK03]; Titan Neurology Research Fund; Department of Veterans Affairs Merit AwardUS Department of Veterans Affairs [1I01BX00244]	The authors would like to thank Dr. Melissa Carballosa-Gautam, Ofelia Furones-Alonso, Ryan Treu, and William Javier Moreno for their technical contributions to this study. This work was funded with the support of the American Heart Association Grant No. 16PRE27050003 and the Florida Department of Health #7JK03 Miami Project to Cure Paralysis. A.A.P. was supported for this work by funds from an anonymous donor to the Mary Alice Smith Fund for Neuropsychiatry Research, the Titan Neurology Research Fund, and a Department of Veterans Affairs Merit Award 1I01BX00244.	Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bi J, 2012, J NEUROCHEM, V120, P334, DOI 10.1111/j.1471-4159.2011.07566.x; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Chauhan A, 2017, CLIN SCI, V131, P533, DOI 10.1042/CS20160841; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; DeMars KM, 2017, J EXP NEUROSCI, V11, DOI 10.1177/1179069517701741; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fonarow GC, 2011, STROKE, V42, P2983, DOI 10.1161/STROKEAHA.111.621342; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Hacke W, 2004, LANCET, V363, P768; Kemp SWP, 2015, NEUROSCIENCE, V284, P202, DOI 10.1016/j.neuroscience.2014.10.005; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koronowski KB, 2015, STROKE, V46, P2293, DOI 10.1161/STROKEAHA.115.009876; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; Liu F, 2009, J NEUROSCI METH, V179, P1, DOI 10.1016/j.jneumeth.2008.12.028; Liu Katherine A., 2016, Pharmacy Pract (Granada), V14, DOI 10.18549/PharmPract.2016.01.708; Liu R, 2013, BRAIN RES, V1514, P83, DOI 10.1016/j.brainres.2013.01.023; Liu R, 2012, NEUROL RES, V34, P331, DOI 10.1179/1743132812Y.0000000020; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Loris ZB, 2017, EXP NEUROL, V290, P63, DOI 10.1016/j.expneurol.2017.01.006; Lyden PD, 2006, INT J STROKE, V1, P9, DOI 10.1111/j.1747-4949.2005.00011.x; Majersik JJ, 2007, STROKE, V38, P3213, DOI 10.1161/STROKEAHA.107.491852; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Miller DJ, 2011, NEUROHOSPITALIST, V1, P138, DOI 10.1177/1941875211408731; Pieper AA, 2014, CHEM SOC REV, V43, P6716, DOI 10.1039/c3cs60448a; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Sacco RL, 2007, LANCET, V369, P331, DOI 10.1016/S0140-6736(07)60155-X; Sakai H, 2007, ANESTHESIOLOGY, V106, P92, DOI 10.1097/00000542-200701000-00017; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Stevens SL, 2008, J CEREBR BLOOD F MET, V28, P1040, DOI 10.1038/sj.jcbfm.9600606; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; Walker AK, 2015, MOL PSYCHIATR, V20, P500, DOI 10.1038/mp.2014.34; Wang P, 2015, TRENDS PHARMACOL SCI, V36, P891, DOI 10.1016/j.tips.2015.08.012; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; Wang SN, 2016, CNS NEUROSCI THER, V22, P782, DOI 10.1111/cns.12576; Yang J, 2015, BRAIN RES, V1629, P231, DOI 10.1016/j.brainres.2015.10.032; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030; Zhang WP, 2010, J CEREBR BLOOD F MET, V30, P1962, DOI 10.1038/jcbfm.2010.71; Zhao SS, 2013, STROKE, V44, P1698, DOI 10.1161/STROKEAHA.111.000361	46	10	10	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	APR	2018	9	2					146	156		10.1007/s12975-017-0565-z			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FZ3VB	WOS:000427517600008	28842830				2022-02-06	
J	Mannino, C; Glenn, TC; Hovda, DA; Vespa, PM; McArthur, DL; Van Horn, JD; Wright, MJ				Mannino, Christina; Glenn, Thomas C.; Hovda, David A.; Vespa, Paul M.; McArthur, David L.; Van Horn, John D.; Wright, Matthew J.			Acute glucose and lactate metabolism are associated with cognitive recovery following traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; brain metabolism; cognition; neuropsychology; glucose; lactate	POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL-BLOOD-FLOW; SELECTIVE REMINDING TEST; CLOSED-HEAD-INJURY; MEMORY; DYSFUNCTION; CRISIS; MICRODIALYSIS; MODERATE; ATROPHY	Traumatic brain injury (TBI) is associated with acute cerebral metabolic crisis (ACMC). ACMC-related atrophy appears to be prominent in frontal and temporal lobes following moderate-to-severe TBI. This atrophy is correlated with poorer cognitive outcomes in TBI. The current study investigated ability of acute glucose and lactate metabolism to predict long-term recovery of frontal-temporal cognitive function in participants with moderate-to-severe TBI. Cerebral metabolic rate of glucose and lactate were measured by the Kety-Schmidt method on days 0-7 post-injury. Indices of frontal-temporal cognitive processing were calculated for six months post-injury; 12 months post-injury; and recovery (the difference between the six-and 12-month scores). Glucose and lactate metabolism were included in separate regression models, as they were highly intercorrelated. Also, glucose and lactate values were centered and averaged and included in a final regression model. Models for the prediction frontal-temporal cognition at six and 12 months post-injury were not significant. However, average glucose and lactate metabolism predicted recovery of frontal-temporal cognition, accounting for 23% and 22% of the variance, respectively. Also, maximum glucose metabolism, but not maximum lactate metabolism, was an inverse predictor in the recovery of frontal-temporal cognition, accounting for 23% of the variance. Finally, the average of glucose and lactate metabolism predicted frontal-temporal cognitive recovery, accounting for 22% of the variance. These data indicate that acute glucose and lactate metabolism both support cognitive recovery from TBI. Also, our data suggest that control of endogenous fuels and/or supplementation with exogenous fuels may have therapeutic potential for cognitive recovery from TBI.	[Mannino, Christina] Loma Linda Univ, Dept Psychol, Loma Linda, CA 92350 USA; [Glenn, Thomas C.; Hovda, David A.; Vespa, Paul M.; McArthur, David L.] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90024 USA; [Vespa, Paul M.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Van Horn, John D.] Univ Southern Calif, Dept Neurol, Inst Neuroimaging Informat, Lab Neuro Imaging, Los Angeles, CA 90089 USA; [Wright, Matthew J.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Wright, Matthew J.] Univ Calif Los Angeles, Med Ctr, Los Angeles Biomed Res Inst Harbor, Los Angeles, CA 90024 USA		Wright, MJ (corresponding author), Harbor UCLA, Med Ctr, 1124 W Carson St,B-4 South,Box 490, Torrance, CA 90502 USA.	mwright@labiomed.org		Glenn, Thomas/0000-0003-4273-3408; Van Horn, John/0000-0003-1537-0816	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS049471, NS02089]; California State Neurotrauma Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049471, K08NS002089] Funding Source: NIH RePORTER	This research was supported by the NIH, grant numbers: NS049471, NS02089; and the California State Neurotrauma Initiative.	AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Bernard F, 2001, NEUROREPORT, V12, P1737, DOI 10.1097/00001756-200106130-00044; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Glenn TC, 2015, J NEUROTRAUM, V32, P811, DOI 10.1089/neu.2014.3482; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; Hattori N, 2003, J NUCL MED, V44, P1709; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; MARTIN RC, 1990, NEUROPSYCHOLOGIA, V28, P823, DOI 10.1016/0028-3932(90)90006-A; Meyers JE, 2009, APPL NEUROPSYCHOL, V16, P237, DOI 10.1080/09084280903098752; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Nybo L, 2002, J APPL PHYSIOL, V93, P58, DOI 10.1152/japplphysiol.00049.2002; Obrist W.D., 1996, NEUROTRAUMA, P471; OBRIST WD, 1990, CEREBROVAS BRAIN MET, V2, P283; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; Schell RM, 2000, ANESTH ANALG, V90, P559, DOI 10.1097/00000539-200003000-00012; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2004, BRAIN PATHOL, V14, P210, DOI 10.1111/j.1750-3639.2004.tb00055.x; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Yang M, 2009, INT J NURS STUD, V46, P753, DOI 10.1016/j.ijnurstu.2009.01.004	40	10	10	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		696	701		10.1002/jnr.24097			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FV2DK	WOS:000424374300019	28609544	Green Accepted			2022-02-06	
J	Nichols, J; Bjorklund, GR; Newbern, J; Anderson, T				Nichols, Joshua; Bjorklund, George Reed; Newbern, Jason; Anderson, Trent			Parvalbumin fast-spiking interneurons are selectively altered by paediatric traumatic brain injury	JOURNAL OF PHYSIOLOGY-LONDON			English	Article						traumatic brain injury; cortex; pediatric; parvalbumin; interneuron	GABAERGIC INTERNEURONS; GABA TRANSPORTER; CRITICAL PERIOD; VISUAL-CORTEX; HEAD-INJURY; NEURONS; INHIBITION; MOUSE; IMMUNOREACTIVITY; SCHIZOPHRENIA	Traumatic brain injury (TBI) in children remains a leading cause of death and disability and it remains poorly understood why children have worse outcomes and longer recover times. TBI has shown to alter cortical excitability and inhibitory drive onto excitatory neurons, yet few studies have directly examined changes to cortical interneurons. This is addressed in the present study using a clinically relevant model of severe TBI (controlled cortical impact) in interneuron cell type specific Cre-dependent mice. Mice subjected to controlled cortical impact exhibit specific loss of parvalbumin (PV) but not somatostatin immunoreactivity and cell density in the peri-injury zone. PV interneurons are primarily of a fast-spiking (FS) phenotype that persisted in the peri-injury zone but received less frequent inhibitory and stronger excitatory post-synaptic currents. The targeted loss of PV-FS interneurons appears to be distinct from previous reports in adult mice suggesting that TBI-induced pathophysiology is dependent on the age at time of impact. Paediatric traumatic brain injury (TBI) is a leading cause of death and disability in children. Traditionally, ongoing neurodevelopment and neuroplasticity have been considered to confer children with an advantage following TBI. However, recent findings indicate that the paediatric brain may be more sensitive to brain injury. Inhibitory interneurons are essential for proper cortical function and are implicated in the pathophysiology of TBI, yet few studies have directly investigated TBI-induced changes to interneurons themselves. Accordingly, in the present study, we examine how inhibitory neurons are altered following controlled cortical impact (CCI) in juvenile mice with targeted Cre-dependent fluorescence labelling of interneurons (Vgat:Cre/Ai9 and PV:Cre/Ai6). Although CCI failed to alter the number of excitatory neurons or somatostatin-expressing interneurons in the peri-injury zone, it significantly decreased the density of parvalbumin (PV) immunoreactive cells by 71%. However, PV:Cre/Ai6 mice subjected to CCI showed a lower extent of fluorescence labelled cell loss. PV interneurons are predominantly of a fast-spiking (FS) phenotype and, when recorded electrophysiologically from the peri-injury zone, exhibited intrinsic properties similar to those of control neurons. Synaptically, CCI induced a decrease in inhibitory drive onto FS interneurons combined with an increase in the strength of excitatory events. The results of the present study indicate that CCI induced both a loss of PV interneurons and an even greater loss of PV expression. This suggests caution is required when interpreting changes in PV immunoreactivity alone as direct evidence of interneuronal loss. Furthermore, in contrast to reports in adults, TBI in the paediatric brain selectively alters PV-FS interneurons, primarily resulting in a loss of interneuronal inhibition.	[Nichols, Joshua; Anderson, Trent] Univ Arizona, Coll Med Phoenix, 425 N 5th St, Phoenix, AZ 85004 USA; [Nichols, Joshua; Bjorklund, George Reed; Newbern, Jason] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA		Anderson, T (corresponding author), Univ Arizona, Coll Med Phoenix, 425 N 5th St, Phoenix, AZ 85004 USA.	andersot@email.arizona.edu		Anderson, Trent/0000-0002-3541-7741; Newbern, Jason/0000-0003-2865-0112; Bjorklund, George/0000-0002-8113-2739	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS087031, R01-NS097537, R21-EB020767]; NSFNational Science Foundation (NSF) [IOS-1353804];  [R00-NS07661]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087031, R01NS097537, R00NS076661] Funding Source: NIH RePORTER	TA is supported by R01-NS087031, R01-NS097537 and R21-EB020767 from the NIH and IOS-1353804 from the NSF. JNe is supported by R00-NS07661 and R01-NS097537.	Anderson TR, 2010, J PHYSIOL-LONDON, V588, P4401, DOI 10.1113/jphysiol.2010.191858; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Aurora SK, 2005, HEADACHE, V45, P546, DOI 10.1111/j.1526-4610.2005.05108.x; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Caillard O, 2000, P NATL ACAD SCI USA, V97, P13372, DOI 10.1073/pnas.230362997; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Cauli B, 1997, J NEUROSCI, V17, P3894; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chow A, 1999, J NEUROSCI, V19, P9332; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Cook LG, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00087; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; de Lecea L, 1995, Brain Res Mol Brain Res, V32, P1; DELRIO JA, 1994, DEV BRAIN RES, V81, P247, DOI 10.1016/0165-3806(94)90311-5; Dong, 2008, ALLEN REFERENCE ATLA; Erickson SL, 2002, J COMP NEUROL, V448, P186, DOI 10.1002/cne.10249; Fujihara K, 2015, NEUROPSYCHOPHARMACOL, V40, P2475, DOI 10.1038/npp.2015.117; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Grundy D, 2015, J PHYSIOL-LONDON, V593, P2547, DOI 10.1113/JP270818; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; Jin XM, 2014, J NEUROPHYSIOL, V112, P1703, DOI 10.1152/jn.00854.2013; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Judson MC, 2016, NEURON, V90, P56, DOI 10.1016/j.neuron.2016.02.040; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kobayashi Y, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00168; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Ma YY, 2012, NEUROBIOL DIS, V47, P102, DOI 10.1016/j.nbd.2012.03.027; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Nassarlt M, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00020; Nichols J, 2015, CNS NEUROSCI THER, V21, P193, DOI 10.1111/cns.12351; OLESEN SP, 1987, ACTA PHYSIOL SCAND, V130, P63, DOI 10.1111/j.1748-1716.1987.tb08112.x; Orduz D, 2013, J PHYSIOL-LONDON, V591, P3215, DOI 10.1113/jphysiol.2012.250795; Palmer JE, 2000, CEPHALALGIA, V20, P525, DOI 10.1046/j.1468-2982.2000.00075.x; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Philpot BD, 1997, J COMP NEUROL, V387, P12; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Prinz A, 2013, EXP NEUROL, V248, P236, DOI 10.1016/j.expneurol.2013.06.015; Puig MV, 2008, P NATL ACAD SCI USA, V105, P8428, DOI 10.1073/pnas.0712219105; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; Sirven JI, 2006, INTRO EPILEPSY; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; SUTOR B, 1995, PERSPECT DEV NEUROBI, V2, P409; Tamas G, 1998, J NEUROSCI, V18, P4255; Tanahira C, 2009, NEUROSCI RES, V63, P213, DOI 10.1016/j.neures.2008.12.007; Trevelyan AJ, 2015, J CLIN NEUROPHYSIOL, V32, P227, DOI 10.1097/WNP.0000000000000160; Trevelyan AJ, 2013, NEUROPHARMACOLOGY, V69, P45, DOI 10.1016/j.neuropharm.2012.06.015; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Uematsu M, 2008, CEREB CORTEX, V18, P315, DOI 10.1093/cercor/bhm056; van Zundert B, 2012, J CELL BIOCHEM, V113, P3301, DOI 10.1002/jcb.24234; Vanhooren V, 2013, AGEING RES REV, V12, P8, DOI 10.1016/j.arr.2012.03.010; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Wohr M, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.19; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xing L, 2016, ELIFE, V5, DOI 10.7554/elite.11123; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Yanagi M, 2014, MOL PSYCHIATR, V19, P573, DOI 10.1038/mp.2013.49; Yuste R, 2005, NEURON, V48, P524, DOI 10.1016/j.neuron.2005.11.012	91	10	10	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	APR 1	2018	596	7					1277	1293		10.1113/JP275393			17	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	GB2AJ	WOS:000428852500019	29333742	Bronze, Green Published			2022-02-06	
J	Schussler, E; Jagacinski, RJ; White, SE; Chaudhari, AM; Buford, JA; Onate, JA				Schussler, Eric; Jagacinski, Richard J.; White, Susan E.; Chaudhari, Ajit M.; Buford, John A.; Onate, James A.			THE EFFECT OF TACKLING TRAINING ON HEAD ACCELERATIONS IN YOUTH AMERICAN FOOTBALL	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Biomechanics; concussion; head injury; prevention	HIGH-SCHOOL; IMPACT EXPOSURE; PROFESSIONAL FOOTBALL; CONCUSSION; PLAYERS; BIOMECHANICS; SPORTS	Background: Many organizations have introduced frameworks to reduce the incidence of football related concussions through proper equipment fitting, coach education, and alteration of tackling technique. Purpose: The purpose of this study was to examine the effects of training in a vertical, head up tackling style on the number of head accelerations experienced while tackling in a controlled laboratory situation. The authors hypothesized that training in a head up tackling technique would reduce the severity of head acceleration experienced by participants. Design: Controlled Laboratory Study. Methods: Twenty-four participants (11.5 +/- 0.6 years old, 60.5 +/- 2.2 in, 110 +/- 18.4 lbs.) with previous playing experience completed a one-day training session on tackling technique utilizing a tackling dummy. A subgroup of these participants completed an additional two days of training with a 48 hour retention test. Head accelerations were analyzed at baseline and end of training. Feedback consisted of verbal feedback utilizing the Qualitative Youth Tackling Scale (QYTS) and video tackling playback. Results: A significant reduction in the number of peak linear head accelerations over 10 g and peak rotational head accelerations over 1885 deg/s(2) were found in dummy tackling after training in both the one day and three day training regimens. A significant change in QYTS tackling form score was found between pretest and post-test (p=0.004). Participants with larger steps had a 2.28, 4.42 and 4.14 increased odds ratio of sustaining head accelerations over 10, 15 and 20 g respectively. Conclusions: Training in a vertical, head up tackling style decreased the number of head accelerations over threshold values sustained while tackling; decreased step length may be the driving factor in the effectiveness of this tackling form.	[Schussler, Eric] Old Dominion Univ, Norfolk, VA USA; [Jagacinski, Richard J.; White, Susan E.; Chaudhari, Ajit M.; Buford, John A.; Onate, James A.] Ohio State Univ, Columbus, OH 43210 USA		Schussler, E (corresponding author), Sch Phys Therapy & Athlet Training, Norfolk, VA 23529 USA.	eschussl@odu.edu	Schussler, Eric/AAF-3444-2020; Chaudhari, Ajit/N-5831-2019; Chaudhari, Ajit M/E-2875-2011	Chaudhari, Ajit/0000-0001-5071-7147; Chaudhari, Ajit M/0000-0001-5071-7147; Schussler, Eric/0000-0002-0101-0986			Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Schussler E, 2017, INT J SPORTS PHYS TH, V12, P592; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; USAFootball, HEADS UP TACKL; van Rooyen M, 2014, EUR J SPORT SCI, V14, P123, DOI 10.1080/17461391.2012.738710; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	24	10	10	0	3	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	APR	2018	13	2					229	237		10.26603/ijspt20180229			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	GR1UQ	WOS:000442338500011	30090681	Green Published			2022-02-06	
J	Wang, CC; Wee, HY; Hu, CY; Chio, CC; Kuo, JR				Wang, Che-Chuan; Wee, Hsiao-Yue; Hu, Chiao-Ya; Chio, Chung-Ching; Kuo, Jinn-Rung			The Effects of Memantine on Glutamic Receptor-Associated Nitrosative Stress in a Traumatic Brain Injury Rat Model	WORLD NEUROSURGERY			English	Article						Apoptosis; Memantine; Nitrosative stress; NMDA receptor; Traumatic brain injury	NITRIC-OXIDE SYNTHASE; DIFFERENTIAL ROLES; NMDA RECEPTORS; ISCHEMIA; APOPTOSIS; EXCITOTOXICITY; COMBINATION; EXPRESSION; OXYGEN; DEATH	BACKGROUND: The main aim of this study is to elucidate whether the neuroprotective effect of memantine, a noncompetitive N-methyl-D-aspartate receptor 2B (NR2B) antagonist, affects neuronal nitrosative stress, apoptosis, and NR2B expression and improves functional outcomes. METHODS: Immediately after the onset of fluid percussion traumatic brain injury (TBI), anesthetized male Sprague-Dawley rats were divided into sham-operated, TBI + vehicle, and TBI + memantine groups. TBI rats were treated with a memantine intraperitoneal injection dose of 20 mg/kg intraperitoneally and then 1 mg/kg every 12 hours intraperitoneally for 6 doses. The motor function, proprioception, infarction volume, and neuronal apoptosis were then measured. Immunofluorescence was used to evaluate astrogliosis, microgliosis, nitrosative stress, and NR2A and NR2B expression in cortical cells. All the parameters were assessed 72 hours after TBI. RESULTS: Compared with the sham-operated controls, the TBI-induced motor and proprioception deficits, and increased infraction volume after TBI were significantly attenuated by memantine therapy. The TBI-induced neuronal apoptosis, astrogliosis, and microgliosis, the numbers of neuronal NO synthase and 3-nitro-L-tyrosine expression in neurons, and inducible NO synthase expression in microglia and astrocyte cells in the ischemic cortex after TBI were significantly improved by memantine therapy. Simultaneously, without affecting the NR2A expression in neuronal cells, the NR2B expression significantly decreased after memantine therapy, as evaluated by an immunofluorescence stain. CONCLUSIONS: Intraperitoneal injection of memantine in the acute stage may ameliorate TBI in rats by affecting NR2B expression and decreasing neuronal apoptosis and nitrosative stress in the injured cortex. These effects might represent 1 mechanism by which functional recovery occurred.	[Wang, Che-Chuan; Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Hu, Chiao-Ya; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wee, Hsiao-Yue] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Wee, Hsiao-Yue; Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Ctr Gen Educ, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.; Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	kuojinnrung@gmail.com					Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; Block F, 1996, NEUROSCI LETT, V208, P41, DOI 10.1016/0304-3940(96)12545-3; Brassai A, 2015, BRAIN RES BULL, V112, P1, DOI 10.1016/j.brainresbull.2014.12.007; Cardenas A, 2000, J NEUROCHEM, V74, P2041, DOI 10.1046/j.1471-4159.2000.0742041.x; Charier D, 2015, ACS CHEM NEUROSCI, V6, P393, DOI 10.1021/cn500303k; Chen HSV, 1998, NEUROSCIENCE, V86, P1121, DOI 10.1016/S0306-4522(98)00163-8; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehrlich M, 1999, J THORAC CARDIOV SUR, V117, P285, DOI 10.1016/S0022-5223(99)70424-1; Foley LM, 2008, J NEUROTRAUM, V25, P299, DOI 10.1089/neu.2007.0471; Huang CY, 2015, MOL NEUROBIOL, V51, P1038, DOI 10.1007/s12035-014-8767-9; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; Ito K, 2017, EUR J PHARMACOL, V798, P16, DOI 10.1016/j.ejphar.2017.02.001; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Kuo JR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/145214; Kutzing MK, 2012, ANN BIOMED ENG, V40, P1170, DOI 10.1007/s10439-011-0494-z; Lamprecht MR, 2015, J NEUROTRAUM, V32, P1361, DOI 10.1089/neu.2015.3912; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lu YF, 1999, J NEUROSCI, V19, P10250; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nakamura T, 2016, TRENDS PHARMACOL SCI, V37, P73, DOI 10.1016/j.tips.2015.10.002; Nakamura T, 2010, CELL CALCIUM, V47, P190, DOI 10.1016/j.ceca.2009.12.009; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; PELLEGRINI JW, 1993, ANN NEUROL, V33, P403, DOI 10.1002/ana.410330414; Peluffo H, 2004, J NEUROCHEM, V89, P602, DOI 10.1046/j.1471-4159.2004.02363.x; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Rajasekar N, 2016, MOL NEUROBIOL, V53, P6730, DOI 10.1007/s12035-015-9576-5; Rammes G, 2008, CURR NEUROPHARMACOL, V6, P55, DOI 10.2174/157015908783769671; Rao VLR, 2001, BRAIN RES, V911, P96; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Saha RN, 2006, ANTIOXID REDOX SIGN, V8, P929, DOI 10.1089/ars.2006.8.929; Sencer A, 2008, NEUROL RES, V30, P497, DOI 10.1179/016164107X251664; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Sudoh Y, 2003, PAIN, V103, P49, DOI 10.1016/S0304-3959(02)00375-5; Takahashi H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20750; THALHAMMER JG, 1995, ANESTHESIOLOGY, V82, P1013, DOI 10.1097/00000542-199504000-00026; Trotman M, 2015, J CEREBR BLOOD F MET, V35, P230, DOI 10.1038/jcbfm.2014.188; Vizi ES, 2013, BRAIN RES BULL, V93, P32, DOI 10.1016/j.brainresbull.2012.10.005; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang F, 2017, J MOL NEUROSCI, V62, P123, DOI 10.1007/s12031-017-0917-x; Wang F, 2015, MOL NEUROBIOL, V52, P1458, DOI 10.1007/s12035-014-8949-5; Wang Y, 1997, J NEUROSCI, V17, P4341; Wee HY, 2015, J SURG RES, V197, P382, DOI 10.1016/j.jss.2015.04.052; Wilcock G, 2002, INT CLIN PSYCHOPHARM, V17, P297, DOI 10.1097/00004850-200211000-00005; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Yuste JE, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00322	49	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2018	112						E719	E731		10.1016/j.wneu.2018.01.140			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8FH	WOS:000432932700086	29382619				2022-02-06	
J	Yin, J; Zhang, HX; Chen, H; Lv, QP; Jin, XH				Yin, Jian; Zhang, Haixiao; Chen, Huai; Lv, Qingping; Jin, Xuhong			Hypertonic Saline Alleviates Brain Edema After Traumatic Brain Injury via Downregulation of Aquaporin 4 in Rats	MEDICAL SCIENCE MONITOR			English	Article						Apoptosis Inducing Factor; Aquaporin 4; Brain Edema; Saline Solution, Hypertonic	PATHOPHYSIOLOGY; MODEL	Background: Hypertonic saline (HS) has been successfully used for treatment of various forms of brain edema. Decreased expression of aquaporin (AQP) 4 and pro-inflammatory cytokines such as tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta have been linked to edema pathogenesis. This study examined the effect of 3% HS on brain edema in a rat model of traumatic brain injury (TBI). Material/Methods: Sprague-Dawley rats were subjected to TBI induced by a controlled cortical impactor. The HS group was injected with 3% NaCl until the end of the study period. AQP4, TNF-alpha, IL-1 beta, and caspase-3 levels were measured by Western blotting, immunohistochemistry, enzyme-linked immunosorbent assay, and quantitative real-time PCR. Brain water content was also measured. Apoptotic cells in brain tissue were detected with terminal deoxynucleotidyl transferase dUTP nick-end labeling. Brain water content decreased following treatment with 3% HS relative to the TBI group. Results: This was accompanied by decreases in AQP4, TNF-alpha, and IL-1 beta mRNA and protein levels. TBI resulted in increases in caspase-3 mRNA expression and the number of apoptotic cells; treatment with 3% HS suppressed apoptosis as compared to the TBI group. Conclusions: Treatment with 3% HS ameliorated TBI-induced brain edema, possibly by suppressing brain edema, pro-inflammatory cytokine expression, and apoptosis.	[Yin, Jian; Zhang, Haixiao; Chen, Huai; Lv, Qingping; Jin, Xuhong] Hangzhou Red Cross Hosp, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China		Yin, J (corresponding author), Hangzhou Red Cross Hosp, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China.	doctor_yinj@163.com			Science and Technology Commission [20150633B28]	This research was supported in part by the Science and Technology Commission-funded projects of Hangzhou [grant number 20150633B28]	Alexander JJ, 2008, NEUROCHEM INT, V52, P447, DOI 10.1016/j.neuint.2007.08.006; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Badaut J, 2014, BBA-GEN SUBJECTS, V1840, P1554, DOI 10.1016/j.bbagen.2013.10.032; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Cao C, 2012, CRIT CARE, V16, DOI 10.1186/cc11670; Croker BA, 2011, P NATL ACAD SCI USA, V108, P13135, DOI 10.1073/pnas.1110358108; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Jin BJ, 2013, J GEN PHYSIOL, V141, P119, DOI 10.1085/jgp.201210883; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Li YK, 2012, NEUROPSYCHOPHARMACOL, V37, P1867, DOI 10.1038/npp.2012.34; Liu S, 2011, CRIT CARE MED, V39, P1467, DOI 10.1097/CCM.0b013e3182120d13; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; MOLGAARD CA, 1990, NEUROEPIDEMIOLOGY, V9, P233, DOI 10.1159/000110778; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Robertson CS, 2013, J NEUROTRAUM, V30, P765, DOI 10.1089/neu.2012.2431; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simon-O'Brien E, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0687-3; Szu JI, 2016, FRONT INTEGR NEUROSC, V10, DOI 10.3389/fnint.2016.00008; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Tang YP, 2010, EXP NEUROL, V223, P485, DOI 10.1016/j.expneurol.2010.01.015; Tsai RK, 2008, EXP EYE RES, V87, P242, DOI 10.1016/j.exer.2008.06.004; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Yang LQ, 2004, WORLD J GASTROENTERO, V10, P22; Zeng HK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-153; Zhao ZA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02505-6; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048	34	10	12	1	7	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	MAR 30	2018	24						1863	1870		10.12659/MSM.907212			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GB6HK	WOS:000429169900002	29600800	Green Published, Green Submitted			2022-02-06	
J	Yuan, WH; Dudley, J; Foss, KDB; Ellis, JD; Thomas, S; Galloway, RT; DiCesare, CA; Leach, JL; Adams, J; Maloney, T; Gadd, B; Smith, D; Epstein, JN; Grooms, DR; Logan, K; Howell, DR; Altaye, M; Myer, GD				Yuan, Weihong; Dudley, Jonathan; Foss, Kim D. Barber; Ellis, Jonathan D.; Thomas, Staci; Galloway, Ryan T.; DiCesare, Christopher A.; Leach, James L.; Adams, Janet; Maloney, Thomas; Gadd, Brooke; Smith, David; Epstein, Jeff N.; Grooms, Dustin R.; Logan, Kelsey; Howell, David R.; Altaye, Mekibib; Myer, Gregory D.			Mild Jugular Compression Collar Ameliorated Changes in Brain Activation of Working Memory after One Soccer Season in Female High School Athletes	JOURNAL OF NEUROTRAUMA			English	Article						female soccer athletes; fMRI; head impact; N-Back task; neck collar; working memory	HEAD IMPACT EXPOSURE; SPORTS-RELATED CONCUSSION; SEX-DIFFERENCES; AXONAL INJURY; FMRI; SYMPTOMS; RECOVERY; FOOTBALL; TIME; MICROSTRUCTURE	Recent neuroimaging studies have suggested that repetitive subconcussive head impacts, even after only one sport season, may lead to pre- to post-season structural and functional alterations in male high school football athletes. However, data on female athletes are limited. In the current investigation, we aimed to (1) assess the longitudinal pre- to post-season changes in functional MRI (fMRI) of working memory and working memory performance, (2) quantify the association between the pre- to post-season change in fMRI of working memory and the exposure to head impact and working memory performance, and (3) assess whether wearing a neck collar designed to reduce intracranial slosh via mild compression of the jugular veins can ameliorate the changes in fMRI brain activation observed in the female high school athletes who did not wear collars after a full soccer season. A total of 48 female high school soccer athletes (age range: 14.00-17.97 years) were included in the study. These athletes were assigned to the non-collar group (n = 21) or to the collar group (n = 27). All athletes undewent MRI at both pre-season and post-season. In each session, a fMRI verbal N-Back task was used to engage working memory. A significant pre- to post-season increase in fMRI blood oxygen level dependent (BOLD) signal was demonstrated when performing the N-back working memory task in the non-collar group but not in the collar group, despite the comparable exposure to head impacts during the season between the two groups. The collar group demonstrated significantly smaller pre- to post-season change in fMRI BOLD signal than the non-collar group, suggesting a potential protective effect from the collar device. Significant correlations were also found between the pre- to post-season increase in fMRI brain activation and the decrease in task accuracy in the non-collar group, indicating an association between the compensatory mechanism in underlying neurophysiology and the alteration in the behavioral outcomes.	[Yuan, Weihong; Dudley, Jonathan; Maloney, Thomas] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Foss, Kim D. Barber; Ellis, Jonathan D.; Thomas, Staci; Galloway, Ryan T.; DiCesare, Christopher A.; Gadd, Brooke; Smith, David; Logan, Kelsey; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, ESPORT Ctr, Div Sports Med, Dept Pediat, Cincinnati, OH 45229 USA; [Leach, James L.; Adams, Janet] Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Cincinnati, OH 45229 USA; [Epstein, Jeff N.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Altaye, Mekibib] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Yuan, Weihong; Ellis, Jonathan D.; Leach, James L.; Epstein, Jeff N.; Logan, Kelsey; Altaye, Mekibib] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Grooms, Dustin R.] Ohio Univ, Ohio Musculoskeletal & Neurol Inst, Sch Appl Hlth Sci & Wellness, Div Athlet Training,Coll Hlth Sci & Profess, Athens, OH 45701 USA; [Howell, David R.; Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.; Myer, Gregory D.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Myer, Gregory D.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.] Univ Penn, Dept Orthopaed, Philadelphia, PA 19104 USA		Myer, GD (corresponding author), Cincinnati Childrens Hosp, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA.	Greg.Myer@cchmc.org	DiCesare, Christopher/ABH-9573-2020; DiCesare, Christopher/AAA-3327-2021; Myer, Gregory/H-6572-2016	DiCesare, Christopher/0000-0002-6576-4904; Myer, Gregory/0000-0002-9983-8422; Dudley, Jonathan/0000-0002-5189-9568; Maloney, Thomas/0000-0002-2643-9009	Heidt Family Foundation; Robert S. Heidt, Sr.-Wellington Foundation; Q30 Sports Sciences, LLC; Q30 Innovations, LLC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T35DK060444] Funding Source: NIH RePORTER	We thank: from Seton High School Ron Quinn, Lisa Larosa, Holly Laiveling, and the entire soccer coaching staff as well as the Seton administration and Athletic Director Wendy Smith; and from Madeira High School Soccer Head Coach Dan Brady, Athletic Director Joe Kimling, and Principal David Kennedy for their support and assistance to conduct this study. We also thank the soccer parents and players for participating and supporting the efforts to complete the project. We appreciate their patience with the testing, scheduling, and follow-up testing. Their enthusiastic support made this study possible. Special acknowledgement goes to the athletic trainers Cindy Busse at Seton High School and Glenna Knapp at Madeira High School. Without their time, commitment, and passion for the health and well-being of their student athletes, this study would not have been possible. We also thank University of Cincinnati interns Casey McCall, Danielle Reddington, Preston Heath, and Jacob Snyder for their assistance with the daily accelerometer tracking. Funding for this study was provided by The Heidt Family Foundation, Robert S. Heidt, Sr.-Wellington Foundation and Q30 Sports Sciences, LLC. Funding for this study was provided to Cincinnati Children's Hospital Medical Center from Q30 Innovations, LLC.	American Association of Neurological Surgeons, 2017, SPORTS REL HEAD INJ; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Bazarian J.J., 2014, PLOS ONE, V8; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; DONALDSON W, 1992, J EXP PSYCHOL GEN, V121, P275, DOI 10.1037/0096-3445.121.3.275; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gordon EM, 2012, HUM BRAIN MAPP, V33, P1536, DOI 10.1002/hbm.21306; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Kontos AP, 2017, BRIT J SPORT MED, V51, P1118, DOI 10.1136/bjsports-2016-096276; Lejbak L, 2011, BRAIN COGNITION, V76, P191, DOI 10.1016/j.bandc.2010.12.002; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MILLER DI, 2014, SCI ENG ETHICS, V18, P37, DOI DOI 10.1016/J.TICS.2013.10.011; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Newsome MR, 2009, BRAIN IMAGING BEHAV, V3, P298, DOI 10.1007/s11682-009-9072-5; Niedfeldt MW, 2011, CURR SPORT MED REP, V10, P324, DOI 10.1249/JSR.0b013e318237be53; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Repovs G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00137; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; Shenk TE, 2015, DEV NEUROPSYCHOL, V40, P63, DOI 10.1080/87565641.2015.1014088; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Spear LP, 2013, J ADOLESCENT HEALTH, V52, pS7, DOI 10.1016/j.jadohealth.2012.05.006; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Szeszko PR, 2003, NEUROREPORT, V14, P2469, DOI 10.1097/00001756-200312190-00035; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Veltman DJ, 2003, NEUROIMAGE, V18, P247, DOI 10.1016/S1053-8119(02)00049-6; Wallis G, 2015, J COGNITIVE NEUROSCI, V27, P2019, DOI 10.1162/jocn_a_00838; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Yuan WH, 2017, J NEUROTRAUM, V34, P2432, DOI 10.1089/neu.2016.4834	74	10	10	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2018	35	11					1248	1259		10.1089/neu.2017.5262		MAR 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GG7EW	WOS:000428596200001	29334834	Green Published			2022-02-06	
J	Garimella, HT; Kraft, RH; Przekwas, AJ				Garimella, Harsha T.; Kraft, Reuben H.; Przekwas, Andrzej J.			Do blast induced skull flexures result in axonal deformation?	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODEL; HUMAN HEAD MODEL; COMPUTATIONAL APPROACH; DYNAMIC-RESPONSE; IMPACT; THRESHOLDS; MITIGATION; STRAIN; TISSUE	Subject-specific computer models (male and female) of the human head were used to investigate the possible axonal deformation resulting from the primary phase blast-induced skull flexures. The corresponding axonal tractography was explicitly incorporated into these finite element models using a recently developed technique based on the embedded finite element method. These models were subjected to extensive verification against experimental studies which examined their pressure and displacement response under a wide range of loading conditions. Once verified, a parametric study was developed to investigate the axonal deformation for a wide range of loading overpressures and directions as well as varying cerebrospinal fluid (CSF) material models. This study focuses on early times during a blast event, just as the shock transverses the skull (< 5 milliseconds). Corresponding boundary conditions were applied to eliminate the rotation effects and the resulting axonal deformation. A total of 138 simulations were developed- 128 simulations for studying the different loading scenarios and 10 simulations for studying the effects of CSF material model variance-leading to a total of 10,702 simulation core hours. Extreme strains and strain rates along each of the fiber tracts in each of these scenarios were documented and presented here. The results suggest that the blast-induced skull flexures result in strain rates as high as 150-378 s(-1). These high-strain rates of the axonal fiber tracts, caused by flexural displacement of the skull, could lead to a rate dependent micro-structural axonal damage, as pointed by other researchers.	[Garimella, Harsha T.; Kraft, Reuben H.] Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA; [Garimella, Harsha T.; Przekwas, Andrzej J.] CFD Res Corp, Computat Med & Biol Div, Huntsville, AL USA		Kraft, RH (corresponding author), Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA.	reuben.kraft@psu.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Garimella, Harsha/0000-0003-3084-1989	Department of Defense, Department of Health [W81XWH-14-C-0045]	This project is in collaboration with CFDRC under the project titled "Physics and Physiology based Human Body Model of Blast Injury and Protection" under a subcontract funded by Department of Defense, Department of Health program through contract W81XWH-14-C-0045.	Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Baker W.E., 1973, EXPLOSIONS AIR; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bir C., 2011, MEASURING BLAST RELA; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chafi MS, 2011, INT J APPL MECH, V3, P803, DOI 10.1142/S175882511100124X; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chen Y, 2011, BIOMECHANICAL ANAL T; Choi HY, 2001, KSME INT J, V15, P995, DOI 10.1007/BF03185277; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Cronin D. S., 2008, P PERS ARM SYST S, P84; Dagro AM, 2013, DTIC DOCUMENT; Dixit P., 2016, ARCH COMPUT METHODS, V24, P1; Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Garimella HT, 2017, NEURAL REGEN RES, V12, P23, DOI 10.4103/1673-5374.198967; Garimella HT, 2016, ASME 2016 INT MECH E, P1; Garimella HT, 2014, ASME 2014 INT MECH E, P1, DOI [10.1115/IMECE2014-39107, DOI 10.1115/IMECE2014-39107]; Gehre C., 2009, 21 ESV C STUTTG, V1, P09; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; Gruss E, 2006, J TRAUMA, V60, P1284, DOI 10.1097/01.ta.0000220015.21948.ec; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Gupta RK, 2017, DEF LIFE SCI J, V2, P3, DOI DOI 10.14429/dlsj.2.10369; GUY J, 1989, J COMP NEUROL, V287, P446, DOI 10.1002/cne.902870404; Haiyan Li, 2007, International Journal of Vehicle Safety, V2, P345, DOI 10.1504/IJVS.2007.016747; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Ho J, 2008, GENERATION PATIENT S; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Itoh S, 2002, 12 INT DET S CIT; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Kleiven, 2002, FINITE ELEMENT MODEL; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Lahiri S. K., 2011, P NAFEMS WORLD C; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Morrison B, 2011, STUD MECHANOBIOL TIS, V3, P247, DOI 10.1007/8415_2011_79; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nahum AM, 1977, SAE TECHNICAL PAPER; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer MB, 2010, PERS ARM SYST S QUEB; Patten E, 2011, WOMEN US MILITARY GR; Pearce CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114292; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Ruan JS, 1996, IMPACT BIOMECHANICS; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Stuhmiller JH, 1996, J BIOMECH, V29, P227, DOI 10.1016/0021-9290(95)00039-9; Tan KT, 2014, INT J IMPACT ENG, V64, P20, DOI 10.1016/j.ijimpeng.2013.09.003; Tan XG, 2016, ASME 2016 INT MECH E; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Wittek A, 2003, JSME INT J C-MECH SY, V46, P1388, DOI 10.1299/jsmec.46.1388; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Yang JK, 2011, COMPUTATIONAL BIOMECHANICS FOR MEDICINE: SOFT TISSUES AND THE MUSCULOSKELETAL SYSTEM, P5, DOI 10.1007/978-1-4419-9619-0_2; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; Zhou C., 1995, SAE TECHNICAL PAPER; Zhou C., 1997, P INT RES COUNC BIOM, V24, P35; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015	77	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2018	13	3							e0190881	10.1371/journal.pone.0190881			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ6JH	WOS:000427703500002	29547663	gold, Green Published, Green Submitted			2022-02-06	
J	Danna-Dos-Santos, A; Mohapatra, S; Santos, M; Degani, AM				Danna-Dos-Santos, Alessander; Mohapatra, Sambit; Santos, Maria; Degani, Adriana M.			Long-term effects of mild traumatic brain injuries to oculomotor tracking performances and reaction times to simple environmental stimuli	SCIENTIFIC REPORTS			English	Article							EYE-MOVEMENTS; HEAD-INJURY; VISUAL INFORMATION; MUSCLE MODES; CONCUSSION; DEFICITS; ADULTS; SWAY; COORDINATION; SYNERGIES	Understanding the long-term effects of concussive events remains a challenge for the development of modern medical practices and the prevention of recurrent traumas. In this study, we utilized indices of oculomotor performance and the ability to react to simple environmental stimuli to assess the long-term motor effects of traumatic brain injury in its mildest form (mTBI). We performed analysis of eye movement accuracy, investigated the presence of abnormal eye movements, and quantified time to react to simple environmental stimuli on long-term mTBI survivors. Results indicated the presence of impairments to basic neural functions used to explore and respond to environmental demands long after the occurrence of mTBIs. Specifically, the result revealed the presence of abnormal saccadic eye movements while performing horizontal smooth pursuit, diminished accuracy of primary saccadic horizontal eye movement, and a widespread slower reaction to both visual and auditory stimuli. The methodology used in this study indicated to be potentially useful in aiding future investigations of neural circuitry impaired by mTBI and provide indices of recovery in future clinical trials testing mTBI-related clinical interventions.	[Danna-Dos-Santos, Alessander; Santos, Maria; Degani, Adriana M.] Univ Montana, Dr Charles T Leonard Motor Control Lab, Missoula, MT 59812 USA; [Danna-Dos-Santos, Alessander; Degani, Adriana M.] Univ Montana, Neural Injury Ctr, Missoula, MT 59812 USA; [Mohapatra, Sambit] Univ Vermont, Dept Rehabil & Movement Sci, Burlington, VT USA		Danna-Dos-Santos, A (corresponding author), Univ Montana, Dr Charles T Leonard Motor Control Lab, Missoula, MT 59812 USA.; Danna-Dos-Santos, A (corresponding author), Univ Montana, Neural Injury Ctr, Missoula, MT 59812 USA.	alex.santos@umontana.edu	Mohapatra, Sambit/AAJ-6657-2021		Clinical Translational Research-Infrastructure Network [U54GM104944]; Montana University System Research Initiative [51030-MUSRI2015-01]; Montana State University Veterans office; MT Baldridge Family; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104944] Funding Source: NIH RePORTER	All authors acknowledge support from Clinical Translational Research-Infrastructure Network (U54GM104944), Montana University System Research Initiative (51030-MUSRI2015-01), Montana State University Veterans office, and the MT Baldridge Family for their financial support.	ALLUM JHJ, 1985, EXP BRAIN RES, V58, P82; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Baddeley A., 2015, MEMORY, P41; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Danna-dos-Santos A, 2008, EXP BRAIN RES, V189, P171, DOI 10.1007/s00221-008-1413-x; Danna-dos-Santos A, 2007, EXP BRAIN RES, V179, P533, DOI 10.1007/s00221-006-0812-0; Danna-Dos-Santos A, 2015, EXP BRAIN RES, V233, P657, DOI 10.1007/s00221-014-4145-0; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; FITZPATRICK RC, 1992, J PHYSIOL-LONDON, V458, P69, DOI 10.1113/jphysiol.1992.sp019406; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gooijers J, 2014, NEUROSCI BIOBEHAV R, V43, P1, DOI 10.1016/j.neubiorev.2014.03.008; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johansson B, 2014, INT J PHYS MED REHAB, V2; KANDEL ER, 2000, PRINCIPLES NEURAL SC, P653; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Latash M. L, 2008, SYNERGY, P51; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Lewis MM, 2016, NEUROTOXICOLOGY, V56, P76, DOI 10.1016/j.neuro.2016.06.016; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Mullen SJ, 2014, CAN J NEUROL SCI, V41, P58, DOI 10.1017/S0317167100016279; PAPO I, 1982, ACTA NEUROCHIR, V62, P47, DOI 10.1007/BF01402210; Park J, 2013, EXP BRAIN RES, V231, P51, DOI 10.1007/s00221-013-3665-3; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Piponnier JC, 2016, J NEUROTRAUM, V33, P242, DOI 10.1089/neu.2014.3832; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; POSNER MI, 1984, J NEUROSCI, V4, P1863; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schulz R, 2015, BRAIN, V138, P1949, DOI 10.1093/brain/awv100; SCHUMANN T, 1995, J BIOMECH, V28, P603, DOI 10.1016/0021-9290(94)00113-I; Shen K, 2015, P NATL ACAD SCI USA, V112, P6473, DOI 10.1073/pnas.1503436112; SIMONEAU GG, 1992, J GERONTOL, V47, pM151, DOI 10.1093/geronj/47.5.M151; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2; Wood JM, 2009, INVEST OPHTH VIS SCI, V50, P482, DOI 10.1167/iovs.08-1942	49	10	10	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 15	2018	8								4583	10.1038/s41598-018-22825-5			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FZ3BV	WOS:000427461900001	29545567	gold, Green Published			2022-02-06	
J	Adiguzel, E; Yasar, E; Kesikburun, S; Demir, Y; Aras, B; Safaz, I; Alaca, R; Tan, AK				Adiguzel, Emre; Yasar, Evren; Kesikburun, Serdar; Demir, Yasin; Aras, Berke; Safaz, Ismail; Alaca, Ridvan; Tan, Arif K.			Are rehabilitation outcomes after severe anoxic brain injury different from severe traumatic brain injury? A matched case-control study	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						anoxic-ischemic encephalopathy; hypoxic-ischemic encephalopathy; rehabilitation outcome	ISCHEMIC ENCEPHALOPATHY; FUNCTIONAL OUTCOMES; CEREBRAL ANOXIA; RELIABILITY; DAMAGE	Many reports have investigated rehabilitation outcomes after a traumatic brain injury (TBI); however, comparably less is known about whether they differ from outcomes of an anoxic brain injury (ABI). Thus, we aimed to compare the rehabilitation outcomes of patients with ABI with control patients who have TBI. Forty participants with ABI and 40 participants with TBI were included in this retrospective study. Participants with ABI were matched with participants with TBI who had similar clinical characteristics such as age, initial Functional Independence Measurement (FIM) score, and duration of coma. FIM and Functional Ambulation Classification (FAC) scores on rehabilitation admission and on rehabilitation discharge were recorded. The FIM score in the ABI group was 41.7 +/- 28.5 on rehabilitation admission and increased to 57.1 +/- 31.4 on rehabilitation discharge. The FIM score in the TBI group was 40.8 +/- 24.0 on rehabilitation admission and increased to 65.9 +/- 35.3 on rehabilitation discharge. There was no statistically significant difference in the FIM scores on rehabilitation discharge between groups. Initial FAC was similar in both groups and there was no statistically significant difference in the FAC scores on rehabilitation discharge. The multiple linear regression analysis showed that intensive care unit length of stay had an inverse relationship with the FAC change. We did not find significant differences in the rehabilitation outcomes of participants with ABI compared with participants with TBI. Considering the lack of information in the literature on ABI rehabilitation, this study may be important to guide rehabilitation teams.	[Adiguzel, Emre; Demir, Yasin] Gaziler Phys Med & Rehabil Educ & Res Hosp, Ankara, Turkey; [Yasar, Evren; Kesikburun, Serdar; Safaz, Ismail; Tan, Arif K.] Hlth Sci Univ, Gulhane Med Sch, Dept Phys Med & Rehabil, Ankara, Turkey; [Alaca, Ridvan] Medicana Hosp, Dept Phys Med & Rehabil, Ankara, Turkey; [Aras, Berke] Kastamonu Phys Med & Rehabil Hosp, Kastamonu, Turkey		Adiguzel, E (corresponding author), Univ Mah Gaziler FTR EA Hastanesi, TR-06530 Ankara, Turkey.	dremreadiguzel@gmail.com	demir, yasin/AAP-7124-2021; kesikburun, serdar/AAO-1445-2020	kesikburun, serdar/0000-0001-9400-4683			Arbelaez A, 1999, AM J NEURORADIOL, V20, P999; Bachman D., 1997, NEUROLOGIC REHABILIT, P145; Busl KM, 2010, NEUROREHABILITATION, V26, P5, DOI 10.3233/NRE-2010-0531; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; Chalela JA, 2001, NEUROLOGY, V56, P481, DOI 10.1212/WNL.56.4.481; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Dodds TA, 1992, STROKE, V7, P65; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; GROSWASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; Gualtieri CT, 2002, BRAIN INJURY MENTAL; Heinz Ute E, 2015, BMC Res Notes, V8, P243, DOI 10.1186/s13104-015-1175-z; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; Khot S, 2006, SEMIN NEUROL, V26, P422, DOI 10.1055/s-2006-948323; Lishman WA, 1998, PSYCHOL CONSEQUENCES, P546; PARKIN AJ, 1987, CORTEX, V23, P655, DOI 10.1016/S0010-9452(87)80055-2; Ravaud JF, 1999, SCAND J REHABIL MED, V31, P31; Schmidt JG, 1997, J NEUROL REHABIL, V11, P189; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Shah MK, 2007, J NEUROL SCI, V260, P95, DOI 10.1016/j.jns.2007.04.012; Smania N, 2013, J HEAD TRAUMA REHAB, V28, P131, DOI 10.1097/HTR.0b013e31823c0127; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6	23	10	10	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	MAR	2018	41	1					47	51		10.1097/MRR.0000000000000261			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GA7UJ	WOS:000428542700007	29200410				2022-02-06	
J	Brown, J; Thiessen, A				Brown, Jessica; Thiessen, Amber			Using Images With Individuals With Aphasia: Current Research and Clinical Trends	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							WRITTEN HEALTH INFORMATION; VISUAL-ATTENTION PATTERNS; TRAUMATIC BRAIN-INJURY; OLDER-ADULTS USE; COMMUNICATIONS TECHNOLOGY; NEUROLOGICAL CONDITIONS; AUDITORY COMPREHENSION; READING-COMPREHENSION; PEOPLE; COMMUNICATION	Purpose: Visuographic supports in the form of images are utilized during assessment and treatment for individuals with aphasia to supplement speech, language, and cognitive losses limiting communication. Clinicians rely on prior experience and intuition to make decisions regarding image-based support design and selection (e.g., augmentative and alternative communication strategies). Researchers have begun to focus on the relationship between the images and the benefits they provide for adults with aphasia. Method: The aim of this review-resulting from a roundtable discussion at the 2016 Clinical Aphasiology Conference-was to disseminate summaries of current and past researches regarding image use by individuals with aphasia and to highlight areas of need within research and practice. Results: Review of the literature illuminated 4 major themes: (a) image creation, capture, and sharing; (b) image characteristics; (c) image use across linguistic domains and contexts; and (d) implications for clinical and research practices. Conclusions: Reviewing current knowledge and practice regarding the use of visual supports for individuals with aphasia is essential to advancing therapeutic practices and providing evidence-based protocols for creating, selecting, and implementing images within augmentative and alternative communication strategies. Several gaps in knowledge were identified as future research needs (e.g., caregiver training and enhanced image feature investigation).	[Brown, Jessica] Univ Minnesota, Dept Speech Language Hearing Sci, Minneapolis, MN 55455 USA; [Thiessen, Amber] Univ Houston, Dept Commun Sci & Disorders, Houston, TX 77004 USA; [Brown, Jessica] Univ Arizona, Tucson, AZ 85721 USA		Brown, J (corresponding author), Univ Minnesota, Dept Speech Language Hearing Sci, Minneapolis, MN 55455 USA.; Brown, J (corresponding author), Univ Arizona, Tucson, AZ 85721 USA.	jessicabrown@email.arizona.edu					Al Mahmud A, 2013, UNIVERSAL ACCESS INF, V12, P309, DOI 10.1007/s10209-012-0286-8; Allen M., 2008, ACM T ACCESSIBLE COM, V1; Auther LL, 2000, APHASIOLOGY, V14, P461, DOI 10.1080/026870300401243; Beeson PM, 1998, J INT NEUROPSYCH SOC, V4, P621, DOI 10.1017/S1355617798466116; Bellaire KJ, 1991, CLIN APHASIOL, V19, P219; Beukelman D., 2013, COMMUNICATION SUPPOR, P326; Beukelman D.R., 1998, AUGMENTATIVE ALTERNA, V14, P261, DOI [10.1080/07434619812331278436, DOI 10.1080/07434619812331278436]; Beukelman D.R., 1985, AUGMENTATIVE COMMUNI; Beukelman DR, 2007, AUGMENT ALTERN COMM, V23, P230, DOI 10.1080/07434610701553668; Bisiach E., 1966, CORTEX, V2, P90, DOI DOI 10.1016/S0010-9452(66)80030-8; Blackstone S, 2004, AUGMENTATIVE COMMUNI, V16, P1; Brennan AD, 2005, APHASIOLOGY, V19, P693, DOI 10.1080/02687030444000958; Brown K, 2010, APHASIOLOGY, V24, P1267, DOI 10.1080/02687031003755429; Chapey R, 2001, Language interventions strategies in aphasia and related neurogenic communication disorders, P279; Cherney LR, 2008, AM J SPEECH-LANG PAT, V17, P19, DOI 10.1044/1058-0360(2008/003); Creswell J. W., 2016, QUAL INQ; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Cruice M, 2003, APHASIOLOGY, V17, P333, DOI 10.1080/02687030244000707; DeDe G, 2013, AM J SPEECH-LANG PAT, V22, P579, DOI 10.1044/1058-0360(2013/12-0111); Dickey MW, 2007, BRAIN LANG, V100, P1, DOI 10.1016/j.bandl.2006.06.004; Dietz A., 2006, PERSPECTIVES AUGMENT, V15, P13, DOI 10.1044/aac15.1.13; Dietz A., 2014, J MED SPEECH-LANG PA, V21, P319; Dietz A. R., 2013, 43 CLIN APH C TUCS A; Dietz A, 2014, AUGMENT ALTERN COMM, V30, P314, DOI 10.3109/07434618.2014.966207; Dietz A, 2009, APHASIOLOGY, V23, P1053, DOI 10.1080/02687030802635832; Duchan J, 2001, TOP LANG DISORD, V22, P37, DOI 10.1097/00011363-200111000-00005; Engebretsen K, 2014, PERSPECT AUGMENTATIV, V23, P55, DOI [10.1044/aac23.1.55, DOI 10.1044/AAC23.1.55]; Fox L., 1996, AUGMENT ALTERN COMM, V12, P257, DOI [10.1080/07434619612331277718, DOI 10.1080/07434619612331277718]; Francis DR, 2003, APHASIOLOGY, V17, P723, DOI 10.1080/02687030344000201; Garrett KL, 2000, AUG ALTER COMMUN SER, P339; Garrett KL, 2002, APHASIOLOGY, V16, P523, DOI 10.1080/02687030244000149; Garrett KL, 1995, CLIN APHASIOL, V23, P237; Garrett KL., 2005, AUGMENTATIVE ALTERNA, P467; Gialanella B, 2016, EUR J PHYS REHAB MED, V52, P782; Gosnell J., 2011, PERSPECTIVES AUGMENT, V20, P87, DOI DOI 10.1044/AAC20.3.87; Griffith J, 2014, AM J SPEECH-LANG PAT, V23, P213, DOI 10.1044/2014_AJSLP-13-0089; Hall N, 2013, INT J TELEREHABILITA, V5, P27, DOI 10.5195/ijt.2013.6119; Hanson EK, 2013, AUGMENT ALTERN COMM, V29, P310, DOI 10.3109/07434618.2013.848934; Heuer S, 2007, APHASIOLOGY, V21, P883, DOI 10.1080/02687030600695194; Heuer S, 2016, APHASIOLOGY, V30, P943, DOI 10.1080/02687038.2015.1081138; Hogrefe K, 2012, CORTEX, V48, P952, DOI 10.1016/j.cortex.2011.02.022; Howland J, 2004, APHASIOLOGY, V18, P1005, DOI 10.1080/02687030444000318; Humphreys GW, 1999, PSYCHOL RES-PSYCH FO, V62, P118, DOI 10.1007/s004260050046; Hux K, 2010, APHASIOLOGY, V24, P643, DOI 10.1080/02687030902869299; Jacobs B, 2004, DISABIL REHABIL, V26, P1231, DOI 10.1080/09638280412331280244; Johnson CJ, 1996, PSYCHOL BULL, V120, P113, DOI 10.1037/0033-2909.120.1.113; Johnson RK, 2008, AUGMENT ALTERN COMM, V24, P269, DOI 10.1080/07434610802463957; Kagan A, 1998, APHASIOLOGY, V12, P816, DOI 10.1080/02687039808249575; Kaplan E., 2000, BOSTON NAMING TEST; Kertesz A., 2006, W APHASIA BATTERY RE; Kimbarow ML, 2007, TOP LANG DISORD, V27, P318, DOI 10.1097/01.TLD.0000299886.16617.25; Kimberly MHA, 2005, AUGMENT ALTERN COMM, V21, P218, DOI 10.1080/07434610400016694; King J., 2013, COMMUNICATION SUPPOR, P51; Knollman-Porter K, 2016, TOP STROKE REHABIL, V23, P269, DOI 10.1080/10749357.2016.1155276; Knollman-Porter K, 2015, APHASIOLOGY, V29, P1448, DOI 10.1080/02687038.2015.1041093; Koul R., 1998, AUGMENTATIVE ALTERNA, V14, DOI [10.1080/07434619812331278166, DOI 10.1080/07434619812331278166]; Kozleski E., 1991, EXCEPTIONALITY, V2, P173, DOI DOI 10.1080/09362839109524782; LaPointe L., 1998, READING COMPREHENSIO; Laska AC, 2001, J INTERN MED, V249, P413, DOI 10.1046/j.1365-2796.2001.00812.x; Lasker J., 1997, AUGMENT ALTERN COMM, V13, P108, DOI [10.1080/07434619712331277908, DOI 10.1080/07434619712331277908]; Lasker JP, 2006, APHASIOLOGY, V20, P217, DOI 10.1080/02687030500473411; Lasker JP, 2001, AAC AUGMENTATIVE ALT, V17, P141, DOI DOI 10.1080/AAC.17.3.141.153; Light J., 1988, AUGMENT ALTERN COMM, V4, P66, DOI [10.1080/07434618812331274657, DOI 10.1080/07434618812331274657]; Lynch KE, 2013, APHASIOLOGY, V27, P723, DOI 10.1080/02687038.2012.748182; Ma XJ, 2009, ASSETS'09: PROCEEDINGS OF THE 11TH INTERNATIONAL ACM SIGACCESS CONFERENCE ON COMPUTERS AND ACCESSIBILITY, P163; Marangolo P, 2010, NEUROPSYCHOLOGIA, V48, P3824, DOI 10.1016/j.neuropsychologia.2010.09.025; Marshall J, 2012, J SPEECH LANG HEAR R, V55, P726, DOI 10.1044/1092-4388(2011/11-0219); Martens, 2010, P 12 INT C HUM COMP, P391, DOI 10.1145/1851600.1851680; Mayer JF, 2002, APHASIOLOGY, V16, P727, DOI 10.1080/02687030143000870; McKelvey ML, 2010, AM J SPEECH-LANG PAT, V19, P22, DOI 10.1044/1058-0360(2009/08-0021); McNeil M.R, 1991, CLIN APHASIOLOGY C; McNeil MR, 2004, APHASIOLOGY, V18, P521, DOI 10.1080/02687030444000138; McNeil MR, 2001, APHASIOLOGY, V15, P901, DOI 10.1080/02687040143000276; Merriam S.B., 2009, QUALITATIVE RES GUID, V4th ed.; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Miller Greg, 2006, Issues Ment Health Nurs, V27, P1051, DOI 10.1080/01612840600943697; MIRENDA P, 1989, J SPEECH HEAR DISORD, V54, P131, DOI 10.1044/jshd.5402.131; Moineau S, 2005, J SPEECH LANG HEAR R, V48, P884, DOI 10.1044/1092-4388(2005/061); Rose TA, 2011, APHASIOLOGY, V25, P1579, DOI 10.1080/02687038.2011.626845; Rose TA, 2012, INT J SPEECH-LANG PA, V14, P11, DOI 10.3109/17549507.2011.631583; Rose TA, 2011, INT J SPEECH-LANG PA, V13, P335, DOI 10.3109/17549507.2011.560396; Schlosser R. W., 2002, AUGMENT ALTERN COMM, V18, P102, DOI [DOI 10.1080/07434610212331281201, 10.1080/07434610212331281201]; Selwyn N, 2004, J AGING STUD, V18, P369, DOI 10.1016/j.jaging.2004.06.008; Selwyn N, 2003, AGEING SOC, V23, P561, DOI 10.1017/S0144686X03001302; Shane H., 1994, ANN CONV AM SPEECH L; Sherratt S, 2011, INT J SPEECH-LANG PA, V13, P317, DOI 10.3109/17549507.2011.584632; Swinburn K., 2004, COMPREHENSIVE APHASI; Thiessen A, 2017, AM J SPEECH-LANG PAT, V26, P428, DOI 10.1044/2016_AJSLP-16-0024; Thiessen A, 2016, J SPEECH LANG HEAR R, V59, P290, DOI 10.1044/2015_JSLHR-L-14-0115; Thiessen A, 2014, AUGMENT ALTERN COMM, V30, P120, DOI 10.3109/07434618.2014.905798; Van Dijck J, 2008, VISUAL COMMUN-US, V7, P57, DOI 10.1177/1470357207084865; Wallace SE, 2014, APHASIOLOGY, V28, P713, DOI 10.1080/02687038.2014.891095; Wallace SE, 2014, DISABIL REHABIL-ASSI, V9, P173, DOI 10.3109/17483107.2013.799237; Wallace SE, 2012, APHASIOLOGY, V26, P162, DOI 10.1080/02687038.2011.628004; Wallace SE, 2010, AUGMENT ALTERN COMM, V26, P242, DOI 10.3109/07434618.2010.521895; Waller A, 1998, INT J LANG COMM DIS, V33, P45, DOI 10.1080/136828298247929; Wambaugh JL, 2007, APHASIOLOGY, V21, P632, DOI 10.1080/02687030701192133; Weissling K., 2006, SIG 12 PERSPECTIVES, V15, P15; Wilson S., 2012, P 12 PART DES C RES, V1, P51, DOI [DOI 10.1145/2347635.2347643, 10.1145/2347635.2347643]; Worrall L, 2005, APHASIOLOGY, V19, P923, DOI 10.1080/02687030544000137; Worrall L, 2011, APHASIOLOGY, V25, P309, DOI 10.1080/02687038.2010.508530	101	10	10	0	11	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAR	2018	27	1		S	SI		504	515		10.1044/2017_AJSLP-16-0190			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	GI1TU	WOS:000434154300016	29497760				2022-02-06	
J	Chao, PC; Chien, WC; Chung, CH; Chu, CW; Yeh, CB; Huang, SY; Lu, RB; Chang, HA; Kao, YC; Yeh, HW; Chiang, WS; Chou, YC; Tzeng, NS				Chao, Pei-Chun; Chien, Wu-Chien; Chung, Chi-Hsiang; Chu, Ching-Wen; Yeh, Chin-Bin; Huang, San-Yuan; Lu, Ru-Band; Chang, Hsin-An; Kao, Yu-Chen; Yeh, Hui-Wen; Chiang, Wei-Shan; Chou, Yu-Ching; Tzeng, Nian-Sheng			Cognitive enhancers associated with decreased risk of injury in patients with dementia: a nationwide cohort study in Taiwan	JOURNAL OF INVESTIGATIVE MEDICINE			English	Article						dementia; national health insurance research database; cohort study; cognitive enhancers	INSURANCE RESEARCH DATABASE; ACUTE MYOCARDIAL-INFARCTION; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; ANTIDEMENTIA DRUGS; SOUTHERN TAIWAN; ISCHEMIC-STROKE; NURSING-HOME; OLDER-ADULTS; OPEN-LABEL	This study aimed to investigate the associations among dementia, psychotropic medications and the risk of overall injuries. In this nationwide matched cohort study, a total of 144008 enrolled patients age of 50, with 36002 study subjects who suffered from dementia and 108006 controls matched for sex and age, from the Inpatient Dataset, for the period 2000-2010 in Taiwan were selected from the National Health Insurance Research Database, according to International Classification of Diseases, 9th Revision, Clinical Modification. When adjusting for the confounding factors, a Cox proportional hazards analysis was used to compare the risk of developing psychiatric disorders during the 10 years of follow-up. Of the study subjects, 6701 (18.61%) suffered injury when compared with 20919 (19.37%) in the control group. The Cox regression analysis revealed that the study subjects were more likely to develop an injury (HR: 2.294, 95% CI=2.229 to 2.361, P<0.001) after adjusting for sex, age, monthly income, urbanization level, geographic region, and comorbidities. Psychotropic medications in the subjects with dementia were associated with the risk of injury (adjusted HR=0.217, 95%CI: 0.206 to 0.228, P<0.001). Cognitive enhancers, including acetylcholinesterase inhibitors and memantine, were associated with the risk of injury in the study subjects after being adjusted for all comorbidities and medications (adjusted HR=0.712(95% CI=0.512 to 0.925, P<0.01)). In conclusion, patients who suffered dementia had a higher risk of developing injury, and the cognitive enhancers were associated with the decreased risk of injury.	[Chao, Pei-Chun; Chu, Ching-Wen; Yeh, Chin-Bin; Huang, San-Yuan; Lu, Ru-Band; Chang, Hsin-An; Kao, Yu-Chen; Yeh, Hui-Wen; Chiang, Wei-Shan; Tzeng, Nian-Sheng] Tri Serv Gen Hosp, Sch Med, Dept Psychiat, Natl Def Med Ctr, Taipei 114, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Tri Serv Gen Hosp, Dept Med Res, Natl Def Med Ctr, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Div Clin Psychol, Coll Med, Tainan, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Dept Psychiat, Coll Med, Tainan, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Inst Behav Med, Coll Med, Tainan, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ Hosp, Dept Psychiat, Tainan, Taiwan; [Lu, Ru-Band] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan Township, Miaoli County, Taiwan; [Chang, Hsin-An; Tzeng, Nian-Sheng] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan; [Kao, Yu-Chen] Tri Serv Gen Hosp, Natl Def Med Ctr, Song Shan Branch, Dept Psychiat, Taipei, Taiwan; [Yeh, Hui-Wen] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Nursing, Taipei, Taiwan; [Yeh, Hui-Wen] Sch Nursing, Taipei, Taiwan; [Yeh, Hui-Wen] Natl Ciao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Chiang, Wei-Shan] Tamkang Univ, Dept & Inst Math, New Taipei, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan		Tzeng, NS (corresponding author), Tri Serv Gen Hosp, Sch Med, Dept Psychiat, Natl Def Med Ctr, Taipei 114, Taiwan.	pierrens@mail.ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021; Tzeng, Nian-Sheng/AAU-4945-2021	Chang, Hsin-An/0000-0001-5572-7109	Tri-Service General Hospital Research Foundation [TSGH-C105-003, TSGH-C105-130, TSGHC106-002]	This work was supported by the Tri-Service General Hospital Research Foundation under the grants TSGH-C105-003, TSGH-C105-130, and TSGHC106-002.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Beauchet O, 2015, CURR ALZHEIMER RES, V12, P761, DOI 10.2174/1567205012666150710111341; Beauchet O, 2014, DRUG AGING, V31, P363, DOI 10.1007/s40266-014-0175-3; Beauchet O, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-184; Berry SD, 2016, J GERONTOL A-BIOL, V71, P273, DOI 10.1093/gerona/glv091; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Chang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089867; Chen HL, 1995, TAIWAN J PUBLIC HLTH, V14, P103; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chinese Hospital Association, 2000, ICD 9 900 ENGL CHIN; Chou IC, 2013, J DEV BEHAV PEDIATR, V34, P181, DOI 10.1097/DBP.0b013e3182829f2b; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Coelho FGD, 2012, AGING NEUROPSYCHOL C, V19, P644, DOI 10.1080/13825585.2012.661398; Fuh Jong-Ling, 2008, Acta Neurol Taiwan, V17, P153; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Harvey L, 2016, INJURY, V47, P226, DOI 10.1016/j.injury.2015.09.021; Hsieh C.Y., 2013, J FORMOS MED ASSOC, V114, P254; International Alzheimer's Disease, 2015, WORLD ALZHEIMER REPO; Kang Dong-Yoon, 2012, J Prev Med Public Health, V45, P219, DOI 10.3961/jpmph.2012.45.4.219; Kim DH, 2011, J AM GERIATR SOC, V59, P1019, DOI 10.1111/j.1532-5415.2011.03450.x; Li-Ting C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-380; Liang JA, 2011, CANCER EPIDEM BIOMAR, V20, P473, DOI 10.1158/1055-9965.EPI-10-1280; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin RT, 1998, J NEUROL SCI, V160, P67, DOI 10.1016/S0022-510X(98)00225-1; Liu CK, 1998, NEUROLOGY, V50, P1572, DOI 10.1212/WNL.50.6.1572; LIU HC, 1995, J AM GERIATR SOC, V43, P144, DOI 10.1111/j.1532-5415.1995.tb06379.x; Manes F, 2016, LANCET NEUROL, V15, P29, DOI 10.1016/S1474-4422(15)00360-9; Maravic M, 2016, OSTEOPOROSIS INT, V27, P1665, DOI 10.1007/s00198-015-3429-y; Meuleners LB, 2017, J AM GERIATR SOC, V65, P520, DOI 10.1111/jgs.14523; Michalowsky B, 2016, INT PSYCHOGERIATR, V28, P359, DOI 10.1017/S1041610215001453; Montero-Odasso M, 2009, J AM GERIATR SOC, V57, P359, DOI 10.1111/j.1532-5415.2009.02085.x; National Health Insurance Administration, 2015, NAT HLTH INS REIMB R; Schroeck JL, 2016, CLIN THER, V37, P2340, DOI 10.1016/j.clinthera.2016.09.010; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100303; Sung SF, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1769-8; Sung SF, 2016, INT J CARDIOL, V215, P277, DOI 10.1016/j.ijcard.2016.04.069; Tamimi I, 2012, J BONE MINER RES, V27, P1518, DOI 10.1002/jbmr.1616; Tang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146030; Tseng HP, 2015, J STROKE CEREBROVASC, V24, P1179, DOI 10.1016/j.jstrokecerebrovasdis.2015.01.010; Tzeng N-S., 2015, J MED SCI, V35, P239, DOI [10.4103/1011-4564.172999, DOI 10.4103/1011-4564.172999]; Wei YJ, 2017, J GERONTOL A-BIOL, V72, P695, DOI 10.1093/gerona/glw095; Wimo A, 2017, ALZHEIMERS DEMENT, V13, P1, DOI 10.1016/j.jalz.2016.07.150; Wortmann M, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt143; Wu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130993; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548; Wu YH, 2015, PSYCHOGERIATRICS, V15, P7, DOI 10.1111/psyg.12067; Yang CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117323; Yang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154627; Yu ST, 2009, J CLIN EPIDEMIOL, V62, P1316, DOI 10.1016/j.jclinepi.2009.01.016	52	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1081-5589	1708-8267		J INVEST MED	J. Invest. Med.	MAR	2018	66	3					684	692		10.1136/jim-2017-000595			9	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Research & Experimental Medicine	GB2WI	WOS:000428916200007	29141875				2022-02-06	
J	Fox, A; Helmer, D; Tseng, CL; Patrick-DeLuca, L; Osinubi, O				Fox, Apollonia; Helmer, Drew; Tseng, Chin-Lin; Patrick-DeLuca, Lydia; Osinubi, Omowunmi			Report of Autonomic Symptoms in a Clinical Sample of Veterans with Gulf War Illness	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HEART-RATE-VARIABILITY; TRAUMATIC BRAIN-INJURY; BLOOD-PRESSURE; DYSFUNCTION; POPULATION; DEPRESSION; ASSOCIATION; SEVERITY; FATIGUE	Introduction: Previous studies suggest that autonomic dysfunction may be an underlying factor in Gulf War Illness. This study examined self-reported symptoms of autonomic dysfunction and their relationship with physical functioning among veterans with Gulf War Illness. Materials and Methods: We abstracted medical records of Gulf War Veterans clinically evaluated at the New Jersey War Related Illness and Injury Study Center between 2010 and 2016. The outcome measure was the Veteran version of the Short Form Health Survey (VR-36) physical functioning scale. Autonomic function was assessed using a composite variable constructed from the chart abstraction to mimic the Composite Autonomic Symptom Scale (COMPASS-31). Results: Seventy-six veterans were included in the final analysis. The autonomic symptom burden score was 45 (+/- 14). Increased autonomic symptom burden, greater mental health burden (PTSD/depression), and greater body mass index were individually associated with poorer physical functioning. A general linear regression containing these variables revealed that patients with both PTSD and depression (b = -15.2, p = 0.03) or either PTSD or depression (b = -22.7, p < 0.01) had lower physical functioning than those without; the other variables became not significant (body mass index: p = 0.07; autonomic function: p = 0.89). Conclusion: The average autonomic function score indicated significant burden in Gulf War Veterans, consistent with published research. We did not detect an independent association between autonomic symptom burden and physical functioning, likely due to the non-specific nature of the measure used to capture autonomic symptoms or the stronger association between mental health conditions and physical functioning. Future work utilizing valid and standardized instruments to clinically evaluate autonomic function is warranted.	[Fox, Apollonia; Helmer, Drew; Tseng, Chin-Lin; Patrick-DeLuca, Lydia; Osinubi, Omowunmi] VA New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, 385 Tremont Ave,Mailstop 129, E Orange, NJ 07018 USA		Fox, A (corresponding author), VA New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, 385 Tremont Ave,Mailstop 129, E Orange, NJ 07018 USA.				DVA/US Government	This research received support from DVA/US Government.	[Anonymous], 1994, RAND HLTH R 36 ITEM; Asmundson GJG, 2000, BEHAV RES THER, V38, P203, DOI 10.1016/S0005-7967(99)00061-3; BLANCHARD EB, 1991, J NERV MENT DIS, V179, P371, DOI 10.1097/00005053-199106000-00012; Dhingra SS, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-11; Flores S, 2013, WORKPLACE HEALTH SAF, V61, P299, DOI [10.3928/21650799-20130617-12, 10.1177/216507991306100705]; Galatzer-Levy IR, 2014, J PSYCHIATR RES, V56, P36, DOI 10.1016/j.jpsychires.2014.04.020; Haley RW, 2013, JAMA NEUROL, V70, P191, DOI 10.1001/jamaneurol.2013.596; Hilz MJ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0584-5; Jangpangi D, 2016, J CLIN DIAGN RES, V10, pCM4, DOI 10.7860/JCDR/2016/22882.9063; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Kuhn E, 2006, J TRAUMA STRESS, V19, P735, DOI 10.1002/jts.20150; Lange G, 2013, MIL MED, V178, P705, DOI 10.7205/MILMED-D-13-00053; Latvala A, 2016, JAMA PSYCHIAT, V73, P1268, DOI 10.1001/jamapsychiatry.2016.2717; Li M, 2014, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00269; Macey PM, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00513; Minassian A, 2014, PSYCHOSOM MED, V76, P292, DOI 10.1097/PSY.0000000000000056; Park HE, 2016, J GERIATR PSYCH NEUR, V29, P11, DOI 10.1177/0891988715598234; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; Post LM, 2016, PSYCHOL PSYCHOTHER-T, V89, P418, DOI 10.1111/papt.12087; Rosique-Esteban N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172253; Schneiderman AI, 2006, MIL MED, V171, P577, DOI 10.7205/MILMED.171.7.577; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Searle AK, 2015, INT J METH PSYCH RES, V24, P32, DOI 10.1002/mpr.1460; Sheng T, 2016, J REHABIL RES DEV, V53, P781, DOI 10.1682/JRRD.2015.07.0146; Sletten DM, 2012, MAYO CLIN PROC, V87, P1196, DOI 10.1016/j.mayocp.2012.10.013; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Steele L, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-4; Steele L, 2012, ENVIRON HEALTH PERSP, V120, P112, DOI 10.1289/ehp.1003399; Sung CW, 2016, PSYCHOPHYSIOLOGY, V53, P455, DOI 10.1111/psyp.12575; Tan G, 2009, PAIN MED, V10, P1237, DOI 10.1111/j.1526-4637.2009.00712.x; VA/DoD Clinical Practice Guidellines, 2014, VA DOD CLIN PRACT GU; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013	33	10	10	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183	3-4					E179	E185		10.1093/milmed/usx052			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF9BF	WOS:000432270400013	29514346	hybrid			2022-02-06	
J	Hearn, MC; Levy, SS; Baweja, HS; Goble, DJ				Hearn, Mason C.; Levy, Susan S.; Baweja, Harsimran S.; Goble, Daniel J.			BTrackS Balance Test for Concussion Management is Resistant to Practice Effects	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						BTrackS; practice effects; balance; postural sway; concussion; force plate	ERROR SCORING SYSTEM	Objective: Recent guidelines advocate for ongoing balance testing in the assessment of management of concussion injuries. This study sought to determine whether the Balance Tracking System (BTrackS) provides stable balance results over repeated administration and, thus, is a reliable tool for concussion management. Design: Repeated measures and test-retest reliability. Setting: University Biomechanics Laboratory. Participants: Random sample of 20 healthy young adults. Interventions: Force plate balance testing using BTrackS on days 1, 3, 8, and 15. Main Outcome Measures: Practice-induced changes in the average center of pressure excursion over 4 repeated administrations of the BTrackS Balance Test (BBT). Test-retest reliability of center of pressure excursion from day 1 to day 15. Results: No significant practice-induced balance differences were found across testing days (P > 0.4), and test-retest reliability of the BBT was excellent from day 1 to day 15 (R 0.92). Conclusions: These findings indicate that the BBT does not elicit a practice effect over repeat administrations. BTrackS provides excellent reliability and objectivity, which can increase clinician accuracy when monitoring sportrelated concussions.	[Hearn, Mason C.; Levy, Susan S.; Baweja, Harsimran S.; Goble, Daniel J.] San Diego State Univ, Sch Exercise & Nutr Sci, 5500 Campanile Dr, San Diego, CA 92182 USA		Goble, DJ (corresponding author), San Diego State Univ, Sch Exercise & Nutr Sci, 5500 Campanile Dr, San Diego, CA 92182 USA.	dgoble@mail.sdsu.edu	Goble, Daniel/A-1317-2007	Goble, Daniel/0000-0002-8027-6722			Byard RW, 2009, FORENSIC SCI MED PAT, V5, P36, DOI 10.1007/s12024-008-9063-7; Goble DJ, 2016, INT J SPORTS PHYS TH, V11, P149; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Susco TM, 2004, J ATHL TRAINING, V39, P241; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Williams DSB, 2016, J SPORT HEALTH SCI, V5, P70, DOI 10.1016/j.jshs.2016.01.010	10	10	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2018	28	2					177	179		10.1097/JSM.0000000000000435			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	GP1HC	WOS:000440564900015	28452829				2022-02-06	
J	Prasad, GL; Anmol, N; Menon, GR				Prasad, G. Lakshmi; Anmol, N.; Menon, Girish R.			Outcome of Traumatic Brain Injury in the Elderly Population: A Tertiary Center Experience in a Developing Country	WORLD NEUROSURGERY			English	Article						Conservative; Contusion; Elderly; Head injury; Road traffic accident; Subdural hematoma; Surgery; Traumatic brain injury	NEUROTRAUMA DATA-BANK; SEVERE HEAD-INJURY; OLDER-ADULTS; CONSECUTIVE PATIENTS; AGE; MORTALITY; RISK; MICE; EPIDEMIOLOGY; HEMATOMA	BACKGROUND: The growing elderly population has contributed to an increasing incidence of traumatic brain injury (TBI) in this cohort worldwide. Here we describe our institutional experience in the management of TBI in elderly Indian patients. METHODS: This was a 3-year retrospective analysis of 73 consecutive patients age >= 65 years admitted to our university hospital with TBI. Exclusion criteria included a history of concussion injury, chronic subdural hematoma (SDH), discharge against medical advice, and declared dead within 6 hours after arrival. Mode of injury, clinicoradiologic features, management, and outcomes were analyzed. The Glasgow Outcome Scale (GOS) was used to assess outcome. RESULTS: Our cohort was predominately male (82%). The mean patient age was 72.1 years (range, 65-97 years), and 20 were age >= 75 years. Head injuries (HIs) were mild in 37 patients, moderate in 18, and severe in 18. The majority of injuries were contusions. Fifty-five patients (75%) were managed conservatively, and 18 (25%) underwent surgery. There were 7 deaths (9.5%). The rate of poor outcome was 26% overall, and 45% in patients age >= 75 years. Poor outcome in severe HI was seen in 83% (15 of 18) of the entire cohort but in 100% (7 of 7) of the very elderly patients. On univariate analysis, age >= 75 years, severe HI, acute SDH, and surgical management were significantly associated with poor outcome while acute SDH and surgical management were significant on multilogistic regression analysis. CONCLUSIONS: Age >= 75 years, severe HI, and acute SDH are poor prognostic factors in patients with TBI. The benefit of surgery in these patients is unlikely, and surgery needs to weighed judiciously, keeping in mind the economics involved and the fate of caregivers, especially in developing countries.	[Prasad, G. Lakshmi; Anmol, N.; Menon, Girish R.] Manipal Univ, Kasturba Med Coll, Dept Neurosurg, Manipal, Karnataka, India		Prasad, GL (corresponding author), Manipal Univ, Kasturba Med Coll, Dept Neurosurg, Manipal, Karnataka, India.	lakshmi.prasad@manipal.edu		Prasad, G Lakshmi/0000-0002-9264-5943; Menon, Girish/0000-0002-1849-0453; N, Anmol/0000-0002-6998-2976			Borkar SA, 2011, INDIAN J NEUROTRAUM, V8, P77, DOI 10.1016/S0973-0508(11)80004-3; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Cartagena LJ, 2017, AGING CLIN EXP RES, V29, P427, DOI 10.1007/s40520-016-0579-5; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; FINELLI FC, 1989, J TRAUMA, V29, P541, DOI 10.1097/00005373-198905000-00001; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; GALBRAITH S, 1976, BMJ-BRIT MED J, V1, P1438, DOI 10.1136/bmj.1.6023.1438; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Hanif S, 2009, Ir Med J, V102, P255; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jagnoor J, 2012, INJURY, V43, P1996, DOI 10.1016/j.injury.2011.08.004; JAMJOOM A, 1992, BRIT J NEUROSURG, V6, P27, DOI 10.3109/02688699209002898; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Le Roux AA, 2007, BRIT J NEUROSURG, V21, P16, DOI 10.1080/02688690601170692; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mehan ND, 2012, NEUROBIOL AGING, V33, P1857, DOI 10.1016/j.neurobiolaging.2011.09.029; MILLER J D, 1989, Neurosurgical Review, V12, P441; Mitra B, 2008, ANZ J SURG, V78, P588, DOI 10.1111/j.1445-2197.2008.04579.x; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P793; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROY CW, 1986, INJURY, V17, P220, DOI 10.1016/0020-1383(86)90222-6; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Sinha VD, 2008, INDIAN J NEUROTRAUM, V5, P69; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Timiras P., 2003, PHYSL BASIS AGING GE, P99, DOI DOI 10.1161/01.ATV.0000173418.42264.19; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; United States Census Bureau, 2014, US POP PROJ 2014 206; Ushewokunze S, 2004, BRIT J NEUROSURG, V18, P604, DOI 10.1080/02688690400022763; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Yokobori S, 2016, WORLD NEUROSURG, V86, P127, DOI 10.1016/j.wneu.2015.09.105; Yokobori S, 2011, NEUROL MED-CHIR, V51, P265, DOI 10.2176/nmc.51.265; Yu F, 2005, J NURS SCHOLARSHIP, V37, P229, DOI 10.1111/j.1547-5069.2005.00040.x	46	10	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2018	111						E221	E227		10.1016/j.wneu.2017.12.034			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG7WI	WOS:000432908700029	29258949				2022-02-06	
J	Rasmussen, KW; Berntsen, D				Rasmussen, Katrine W.; Berntsen, Dorthe			Deficits in remembering the past and imagining the future in patients with prefrontal lesions	JOURNAL OF NEUROPSYCHOLOGY			English	Article						episodic memory; episodic future thinking; mental time travel; prefrontal cortex; focal brain lesions	MENTAL TIME-TRAVEL; TRAUMATIC BRAIN-INJURY; MEDIAL TEMPORAL-LOBES; SELF-MEMORY SYSTEM; LONG-TERM-MEMORY; AUTOBIOGRAPHICAL MEMORY; EPISODIC MEMORY; RETROGRADE-AMNESIA; SEMANTIC DEMENTIA; FRONTAL LOBES	ObjectiveNeuroimaging studies suggest that remembering the past and imagining the future engage a common brain network including several areas of the prefrontal cortex. Although patients with prefrontal damage often are described as blind to the future consequences of their decisions, and inclined to live in the here and now', little is known as to how the prefrontal cortex mediates past and future mental time travel. MethodNine patients with prefrontal lesions and nine healthy controls generated past and future events in response to different time periods. Event transcriptions were scored using the Autobiographical Interview protocol (Levine, Svoboda, Hay, Winocur, & Moscovitch, 2002), which provides a reliable system for categorizing internal (episodic) and external (semantic) information. For each event, participants answered a series of questions to assess self-reported phenomenal characteristics. ResultsPatients with prefrontal lesions exhibited deficits in both remembering past events and imagining future events by generating fewer internal details than controls. This effect of group was larger in the past condition than in the future condition. In contrast, no group differences were seen in the number of external details, which were at the same level for patients and controls for both temporal conditions. There were no group differences in ratings of phenomenal characteristics. ConclusionOur findings suggest that damage to prefrontal structures adversely affects the retrieval of past and the construction of future events. In particular, prefrontal structures are critical for the production of episodic event-specific details when engaging in past and future mental time travel.	[Rasmussen, Katrine W.; Berntsen, Dorthe] Aarhus Univ, Dept Psychol & Behav Sci, Ctr Autobiog Memory Res, Aarhus, Denmark		Rasmussen, KW (corresponding author), Aarhus Univ, Bartholins Alle 9, DK-8000 Aarhus C, Denmark.	katrine@psy.au.dk		Rasmussen, Katrine/0000-0001-7275-6059	Danish National Research FoundationDanmarks Grundforskningsfond [DNRF89]; Danish Council for Independent Research: Humanities (FKK)Det Frie Forskningsrad (DFF)	This work was supported by the Danish National Research Foundation Grant DNRF89 and the Danish Council for Independent Research: Humanities (FKK).	Abraham A, 2008, BRAIN RES, V1233, P106, DOI 10.1016/j.brainres.2008.07.084; Abraham A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00325; Abram M, 2014, CONSCIOUS COGN, V29, P76, DOI 10.1016/j.concog.2014.07.011; Addis DR, 2008, PSYCHOL SCI, V19, P33, DOI 10.1111/j.1467-9280.2008.02043.x; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Addis DR, 2010, PSYCHOL AGING, V25, P369, DOI 10.1037/a0017280; Anderson RJ, 2012, J EXP PSYCHOL LEARN, V38, P356, DOI 10.1037/a0025451; Anderson RJ, 2009, MEMORY, V17, P367, DOI 10.1080/09658210902751669; Arnold KM, 2011, MEM COGNITION, V39, P954, DOI 10.3758/s13421-011-0076-1; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Atance CM, 2009, J EXP CHILD PSYCHOL, V102, P379, DOI 10.1016/j.jecp.2009.01.001; BADDELEY AD, 1986, AUTOBIOGRAPHICAL MEM, P225; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Berntsen D, 2010, MEM COGNITION, V38, P265, DOI 10.3758/MC.38.3.265; Berntsen D, 2008, CONSCIOUS COGN, V17, P1093, DOI 10.1016/j.concog.2008.03.001; Berryhill ME, 2010, NEUROPSYCHOLOGIA, V48, P1385, DOI 10.1016/j.neuropsychologia.2010.01.004; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Botzung A, 2008, BRAIN COGNITION, V66, P202, DOI 10.1016/j.bandc.2007.07.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burgess PW, 1996, MEMORY, V4, P359, DOI 10.1080/096582196388906; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Busby J, 2005, COGNITIVE DEV, V20, P362, DOI 10.1016/j.cogdev.2005.05.002; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Cole SN, 2013, Q J EXP PSYCHOL, V66, P1687, DOI 10.1080/17470218.2012.758157; Conway M. A., 2000, HDB NEUROPSYCHOLOGY, V2, P281; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Cooper JM, 2011, NEUROPSYCHOLOGIA, V49, P1843, DOI 10.1016/j.neuropsychologia.2011.03.008; Coste C, 2015, NEUROPSYCHOLOGIA, V71, P133, DOI 10.1016/j.neuropsychologia.2015.03.014; D'Argembeau A, 2004, CONSCIOUS COGN, V13, P844, DOI 10.1016/j.concog.2004.07.007; D'Argembeau A, 2006, CONSCIOUS COGN, V15, P342, DOI 10.1016/j.concog.2005.09.001; D'Argembeau A, 2011, J EXP PSYCHOL GEN, V140, P258, DOI 10.1037/a0022581; D'Argembeau A, 2011, APPL COGNITIVE PSYCH, V25, P96, DOI 10.1002/acp.1647; Dalgleish T, 2007, J EXP PSYCHOL GEN, V136, P23, DOI 10.1037/0096-3445.136.1.23; Dalsgaard I, 1998, DANISH ADULT READING; de Vito S, 2012, NEUROPSYCHOLOGIA, V50, P1494, DOI 10.1016/j.neuropsychologia.2012.03.001; DELLASALA S, 1993, NEUROPSYCHOLOGIA, V31, P823; Dimitrov M, 1999, BRAIN COGNITION, V41, P213, DOI 10.1006/brcg.1999.1121; Duarte A, 2005, J NEUROSCI, V25, P8333, DOI 10.1523/JNEUROSCI.1392-05.2005; Duval C, 2012, NEUROPSYCHOLOGIA, V50, P254, DOI 10.1016/j.neuropsychologia.2011.11.019; Field A., 2017, DISCOVERING STAT USI, V5th; Gade A., 1994, RIGSHOSPITALET UNPUB; Gamboz N, 2010, NEUROPSYCHOLOGIA, V48, P2091, DOI 10.1016/j.neuropsychologia.2010.03.030; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Golden C. J., 1998, STROOP COLOR WORD TE; Gott C, 2014, CHILD NEUROPSYCHOL, V20, P625, DOI 10.1080/09297049.2013.840362; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hurley NC, 2011, NEUROPSYCHOLOGIA, V49, P3620, DOI 10.1016/j.neuropsychologia.2011.09.015; INGVAR DH, 1985, HUM NEUROBIOL, V4, P127; Irish M, 2013, CORTEX, V49, P2377, DOI 10.1016/j.cortex.2013.03.002; Irish M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00027; Irish M, 2012, NEUROPSYCHOLOGIA, V50, P3488, DOI 10.1016/j.neuropsychologia.2012.09.012; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; JOrgensen K, 2012, DANSKE NORMER NEUROP; Klein SB, 2013, WIRES COGN SCI, V4, P63, DOI 10.1002/wcs.1210; Kopelman MD, 1998, NEUROPSYCHOLOGIA, V36, P785, DOI 10.1016/S0028-3932(97)00167-X; Kopelman MD, 2001, PHILOS T R SOC B, V356, P1409, DOI 10.1098/rstb.2001.0942; Kopelman MD, 1999, NEUROPSYCHOLOGIA, V37, P939, DOI 10.1016/S0028-3932(98)00143-2; Kurczek J, 2015, NEUROPSYCHOLOGIA, V73, P116, DOI 10.1016/j.neuropsychologia.2015.05.002; Kwan D, 2010, NEUROPSYCHOLOGIA, V48, P3179, DOI 10.1016/j.neuropsychologia.2010.06.011; Larsen SF, 1998, AUTOBIOGRAPHICAL MEMORY, P163; Levine B, 2004, J COGNITIVE NEUROSCI, V16, P1633, DOI 10.1162/0898929042568587; Levine B, 2004, BRAIN COGNITION, V55, P54, DOI 10.1016/s0278-2626(03)00280-x; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Maguire EA, 1999, HIPPOCAMPUS, V9, P54, DOI 10.1002/(SICI)1098-1063(1999)9:1<54::AID-HIPO6>3.0.CO;2-O; Maguire EA, 2011, P NATL ACAD SCI USA, V108, pE39, DOI 10.1073/pnas.1018876108; Maguire EA, 2010, NEUROPSYCHOLOGIA, V48, P3187, DOI 10.1016/j.neuropsychologia.2010.06.037; Martinelli P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082385; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; McKinnon C., 2007, HUMAN FRONTAL LOBES, P227; Metcalfe J., 2005, MISSING LINK COGNITI, P4, DOI DOI 10.1093/ACPROF:OSO/9780195161564.003.0001; Meyers J., 1995, REY COMPLEX FIGURE R; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Moscovitch M., 2002, HDB MEMORY DISORDERS, V2, P315; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Newby-Clark IR, 2003, PERS SOC PSYCHOL B, V29, P807, DOI 10.1177/0146167203029007001; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Picard L, 2009, CONSCIOUS COGN, V18, P864, DOI 10.1016/j.concog.2009.07.008; Piolino P, 2003, BRAIN, V126, P2203, DOI 10.1093/brain/awg222; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Piolino P, 2010, NEUROPSYCHOLOGIA, V48, P429, DOI 10.1016/j.neuropsychologia.2009.09.035; Race E, 2011, J NEUROSCI, V31, P10262, DOI 10.1523/JNEUROSCI.1145-11.2011; Rasmussen KW, 2014, J NEUROPSYCHOL, V8, P34, DOI 10.1111/jnp.12003; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rubin DC, 2014, J EXP PSYCHOL GEN, V143, P612, DOI 10.1037/a0032638; Rubin DC, 2003, MEM COGNITION, V31, P887, DOI 10.3758/BF03196443; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; SCHACTER DL, 1984, J VERB LEARN VERB BE, V23, P593, DOI 10.1016/S0022-5371(84)90373-6; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sheldon S, 2011, NEUROPSYCHOLOGIA, V49, P2439, DOI 10.1016/j.neuropsychologia.2011.04.021; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; Simons JS, 2002, BRAIN, V125, P2523, DOI 10.1093/brain/awf247; Squire LR, 2010, P NATL ACAD SCI USA, V107, P19044, DOI 10.1073/pnas.1014391107; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [https://doi.org/10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355]; Suddendorf T, 2005, LEARN MOTIV, V36, P110, DOI 10.1016/j.lmot.2005.02.010; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Szpunar KK, 2014, P NATL ACAD SCI USA, V111, P18414, DOI 10.1073/pnas.1417144111; Szpunar KK, 2011, CORTEX, V47, P409, DOI 10.1016/j.cortex.2010.07.008; Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Wechsler D., 2008, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLERS MEMORY SCA; Weiler J, 2011, J COGNITIVE NEUROSCI, V23, P3037, DOI 10.1162/jocn.2011.21633; Wheeler M A, 1995, J Int Neuropsychol Soc, V1, P525; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Wheeler MA, 2003, CORTEX, V39, P827, DOI 10.1016/S0010-9452(08)70866-9; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122; Williams JMG, 1996, MEM COGNITION, V24, P116, DOI 10.3758/BF03197278	116	10	10	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	MAR	2018	12	1					78	100		10.1111/jnp.12108			23	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FY2GG	WOS:000426632900005	27339103	Green Accepted			2022-02-06	
J	Shahrokhi, N; Khaksari, M; AsadiKaram, G; Soltani, Z; Shahrokhi, N				Shahrokhi, Nader; Khaksari, Mohammad; AsadiKaram, Gholamreza; Soltani, Zahra; Shahrokhi, Nava			Role of melatonin receptors in the effect of estrogen on brain edema, intracranial pressure and expression of aquaporin 4 after traumatic brain injury	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Aquaporin 4; Brain edema; Estrogen; Intracranial pressure; Melatonin; Traumatic brain injury	SEX STEROID-HORMONES; CLOSED-HEAD INJURY; CEREBRAL-ISCHEMIA; INDUCED NEUROPROTECTION; INFLAMMATORY CYTOKINES; BARRIER PERMEABILITY; FEMALE RATS; IN-VITRO; KAPPA-B; ACTIVATION	yy Objective(s): Traumatic brain injury (TBI) is one of the most common causes of death and disability in modern societies. The role of steroids and melatonin is recognized as a neuroprotective factor in traumatic injuries. This study examined the role of melatonin receptors in the neuroprotective effects of estrogen. Materials and Methods: Seventy female ovariectomized Wistar rats were divided into five groups and two subgroups. All animals underwent brain trauma. The groups were as follow: 1) trauma, 2) melatonin receptor antagonist vehicle + estrogen, 3) MT1 melatonin receptor antagonist + estrogen, 4) MT2 melatonin receptor antagonist+ estrogen, 5) MT3 melatonin receptor antagonist + estrogen. Brain edema (24 hr), intracranial pressure (ICP) (-1, 0, 1, 4 and 24 hr) and blood-brain barrier (BBB) permeability (5 hr) and aquaporin (AQP4) expression (24 hr) were evaluated after TBI. Results: MT1, MT2 and MT3 melatonin receptors had anti-edema effects while MT1 and MT2 have a role in protecting BBB by estrogen. Furthermore, the activity of MT3 and MT2 melatonin receptors weakened the effect of estrogen on ICP. However, melatonin receptors had no role in the effect of estrogen on AQP4 protein. Conclusion: Based on the above results, it seems that melatonin receptors appear to influence the effect of estrogen in TBI without altering AQP4 expression. The role of the receptors is different in this interaction.	[Shahrokhi, Nader] Kerman Univ Med Sci, Physiol Res Ctr, Kerman, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Neurosci Res Ctr, Kerman, Iran; [AsadiKaram, Gholamreza; Soltani, Zahra] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Kerman, Iran; [Shahrokhi, Nava] Kerman Univ Med Sci, Kerman, Iran		Khaksari, M (corresponding author), Kerman Univ Med Sci, Neurosci Res Ctr, Kerman, Iran.	mkhaksari@kmu.ac.ir	Haddad, Mohammad Khaksari/AAB-9025-2019; Shahrokhi, Nader/AAV-3747-2020; Asadikaram, Gholamreza/AAG-4437-2021; Soltani, Zahra/AAC-1350-2019	Haddad, Mohammad Khaksari/0000-0003-0770-4281; Shahrokhi, Nader/0000-0002-0149-7819; Asadikaram, Gholamreza/0000-0002-9100-0756; Soltani, Zahra/0000-0002-8423-6189	Neuroscience Research Centre in Kerman University of Medical Sciences, Kerman, Iran	The present study was supported by the Neuroscience Research Centre in Kerman University of Medical Sciences, Kerman, Iran. The results described in this paper were part of student thesis.	Badaut J, 2007, METAB BRAIN DIS, V22, P251, DOI 10.1007/s11011-007-9057-2; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; BENITEZKING G, 1993, EXPERIENTIA, V49, P635; Borlongan CV, 2000, FASEB J, V14, P1307, DOI 10.1096/fj.14.10.1307; Boutin JA, 2005, TRENDS PHARMACOL SCI, V26, P412, DOI 10.1016/j.tips.2005.06.006; Cagnacci A, 2000, J PINEAL RES, V29, P152, DOI 10.1034/j.1600-079X.2000.290304.x; Chuffa LGA, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-108; Cos S, 2000, FRONT NEUROENDOCRIN, V21, P133, DOI 10.1006/frne.1999.0194; Cos S., 1988, PINEAL GLAND CANCER, P221; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; Ding ZY, 2013, CELL BIOCHEM BIOPHYS, V67, P615, DOI 10.1007/s12013-013-9549-0; Doolen S, 1998, EUR J PHARMACOL, V345, P67, DOI 10.1016/S0014-2999(98)00064-8; Dubocovich ML, 2003, FRONT BIOSCI-LANDMRK, V8, pD1093, DOI 10.2741/1089; Ekmekcioglu C, 2006, BIOMED PHARMACOTHER, V60, P97, DOI 10.1016/j.biopha.2006.01.002; Fazel MR, 2012, ARCH TRAUMA RES, V1, P63, DOI 10.5812/atr.6770; Gilad E, 1997, LIFE SCI, V60, pPL169, DOI 10.1016/S0024-3205(97)00008-8; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Haldar C, 2003, DEV BRAIN RES, V145, P71, DOI 10.1016/S0165-3806(03)00215-3; Harrod CG, 2005, MED HYPOTHESES, V64, P725, DOI 10.1016/j.mehy.2004.06.035; Herrera F, 2001, J PINEAL RES, V31, P356, DOI 10.1034/j.1600-079X.2001.310411.x; Izzo G, 2004, J EXP BIOL, V207, P437, DOI 10.1242/jeb.00786; Kabbaj M, 2007, EUR J NEUROSCI, V25, P3312, DOI 10.1111/j.1460-9568.2007.05585.x; Kondoh T, 2002, LIFE SCI, V72, P583, DOI 10.1016/S0024-3205(02)02256-7; Koyama Y, 2004, EUR J PHARMACOL, V489, P193, DOI 10.1016/j.ejphar.2004.03.018; Kusaka G, 2004, J NEUROSCI METH, V135, P121, DOI 10.1016/j.jneumeth.2003.12.013; Laredo SA, 2014, PHYSIOL BEHAV, V128, P86, DOI 10.1016/j.physbeh.2014.01.039; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Luboshitzky R, 1997, J CLIN ENDOCR METAB, V82, P977, DOI 10.1210/jc.82.3.977; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mazurais D, 2000, GEN COMP ENDOCR, V118, P344, DOI 10.1006/gcen.2000.7472; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Rato AG, 1999, FASEB J, V13, P857, DOI 10.1096/fasebj.13.8.857; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sanchez-Barcelo EJ, 2005, J PINEAL RES, V38, P217, DOI 10.1111/j.1600-079X.2004.00207.x; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Saw MM, 2014, NEUROCRIT CARE, V20, P209, DOI 10.1007/s12028-013-9933-z; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Tai SH, 2011, J PINEAL RES, V50, P292, DOI 10.1111/j.1600-079X.2010.00839.x; Turgut M, 2007, BRAIN RES, V1175, P117, DOI 10.1016/j.brainres.2007.07.056; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Wang LM, 2005, EUR J NEUROSCI, V22, P2231, DOI 10.1111/j.1460-9568.2005.04408.x; Wen Y, 2004, BRAIN RES, V1008, P147, DOI 10.1016/j.brainres.2004.02.019; Yu CX, 2000, NEUROSCI LETT, V282, P161, DOI 10.1016/S0304-3940(00)00883-1	49	10	11	0	5	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	MAR	2018	21	3					301	308		10.22038/ijbms.2018.25928.6377			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	GB0EO	WOS:000428718100010	29511497				2022-02-06	
J	Armistead-Jehle, P; Cole, WR; Stegman, RL				Armistead-Jehle, Patrick; Cole, Wesley R.; Stegman, Robert L.			Performance and Symptom Validity Testing as a Function of Medical Board Evaluation in US Military Service Members with a History of Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Performance validity test; Symptom validity test; Military; Word Memory Test	NEUROPSYCHOLOGICAL ASSESSMENT; RESPONSE BIAS; SAMPLE	Objective: The study was designed to replicate and extend pervious findings demonstrating the high rates of invalid neuropsychological testing in military service members (SMs) with a history of mild traumatic brain injury (mTBI) assessed in the context of a medical evaluation board (MEB). Method: Two hundred thirty-one active duty SMs (61 of which were undergoing an MEB) underwent neuropsychological assessment. Performance validity (Word Memory Test) and symptom validity (MMPI-2-RF) test data were compared across those evaluated within disability (MEB) and clinical contexts. Results: As with previous studies, there were significantly more individuals in an MEB context that failed performance (MEB = 57%, non-MEB = 31%) and symptom validity testing (MEB = 57%, non-MEB = 22%) and performance validity testing had a notable affect on cognitive test scores. Performance and symptom validity test failure rates did not vary as a function of the reason for disability evaluation when divided into behavioral versus physical health conditions. Conclusions: These data are consistent with past studies, and extends those studies by including symptom validity testing and investigating the effect of reason for MEB. This and previous studies demonstrate that more than 50% of SMs seen in the context of an MEB will fail performance validity tests and over-report on symptom validity measures. These results emphasize the importance of using both performance and symptom validity testing when evaluating SMs with a history of mTBI, especially if they are being seen for disability evaluations, in order to ensure the accuracy of cognitive and psychological test data.	[Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Concuss Clin, 550 Pope Ave, Ft Leavenworth, KS 66027 USA; [Cole, Wesley R.] Def & Vet Brain Injury Ctr, Womack Army Med Ctr, Ft Bragg, NC USA; [Stegman, Robert L.] Womack Army Med Ctr, Ft Bragg, NC USA		Armistead-Jehle, P (corresponding author), Munson Army Hlth Ctr, Concuss Clin, 550 Pope Ave, Ft Leavenworth, KS 66027 USA.	patrick.j.armistead-jehle.civ@mail.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432			Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Ben-Porath Y. S., 2011, MMPI 2 RF MINNESOTA; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Casscells S. W., 2007, ASSISTANT SECRETARY; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Grills CE, 2016, APPL NEUROPSYCH-ADUL, V23, P295, DOI 10.1080/23279095.2015.1079713; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Meyers JE., 1995, REY COMPLEX FIGURE T; Morey, 1991, PERSONALITY ASSESSME; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL	18	10	10	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2018	33	1					120	124		10.1093/arclin/acx031			5	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FU8XL	WOS:000424139500010	28430849	hybrid			2022-02-06	
J	Baker, DR; Kulick, ER; Boehme, AK; Noble, JM				Baker, David R.; Kulick, Erin R.; Boehme, Amelia K.; Noble, James M.			Effects of the New York State Concussion Management and Awareness Act ("Lystedt Law") on Concussion-Related Emergency Health Care Utilization Among Adolescents, 2005-2015	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; sports-related concussion; health policy; health care legislation; epidemiology	SCHOOL FOOTBALL PLAYERS; BRAIN-INJURY; HEAD-INJURY; EPIDEMIOLOGY; LEGISLATION; COLLEGIATE; RADIATION; DIAGNOSIS; CHILDREN; IMPACT	Background: All states have enacted legislation addressing the management of sports-related concussions (SRCs) in adolescent athletes. The effect of these laws on health care utilization is uncertain. Hypothesis/Purpose: The purpose was to evaluate the effects of New York's 2011 Concussion Management and Awareness Act ("Lystedt Law") on emergency department (ED) concussion health care visits (EDCHVs) and brain imaging utilization. It was hypothesized that New York concussion legislation would have a significant temporal effect on EDCHVs. Study Design: Descriptive epidemiology study. Methods: Using the New York State Department of Health Statewide Planning and Research Cooperative System (SPARCS) database, trends in EDCHVs from 2005 to 2015 were identified among 12- to 18-year-old patients, comprising 5,740,403 total ED visits. Results: Overall, 208,024 EDCHVs, including 54,669 for an SRC, occurred during the study period. EDCHVs increased from 13,664 (2.74% of all ED visits) in 2005 to a peak of 21,374 (4.26%) in 2013, with greatest relative increases from 2008 to 2013. SRCs followed a similar trend: 3213 (0.64%) in 2005 to a peak of 6197 (1.24%) in 2013. Brain imaging utilization decreased by 5.3% for EDCHVs and 15.4% for SRCs (all comparisons year-by-year and for trends; P < .001). Conclusion: The period of greatest increases in EDCHVs and decreases in brain imaging utilization for SRCs preceded New York concussion legislation by several years, suggesting a minimal direct effect on emergency care-seeking behavior for concussions. Instead, increased public awareness of SRCs and imaging guidelines may have driven EDCHV trends and imaging practices.	[Baker, David R.; Kulick, Erin R.; Boehme, Amelia K.; Noble, James M.] Columbia Univ, New York, NY USA; [Kulick, Erin R.; Boehme, Amelia K.; Noble, James M.] Columbia Univ, Dept Neurol, 710 West 168th St,Box 176, New York, NY 10032 USA; [Baker, David R.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Kulick, Erin R.; Boehme, Amelia K.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Noble, James M.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Noble, James M.] Columbia Univ, GH Sergievsky Ctr, New York, NY USA		Noble, JM (corresponding author), Columbia Univ, Dept Neurol, 710 West 168th St,Box 176, New York, NY 10032 USA.	jn2054@columbia.edu	Noble, James/AAA-4218-2020	Noble, James/0000-0003-0648-6702; Kulick, Erin/0000-0001-8650-5357	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL134625] Funding Source: NIH RePORTER		Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Concannon LG, 2016, PHYS MED REH CLIN N, V27, P513, DOI 10.1016/j.pmr.2015.12.006; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mackenzie B, 2015, PEDIATR EMERG CARE, V31, P25, DOI 10.1097/PEC.0000000000000325; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097699., DOI 10.1136/BJSPORTS-2017-097699.]; McLean ACL, 2016, WORLD NEUROSURG, V90, P179, DOI 10.1016/j.wneu.2016.02.045; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; National Federation of State High School Associations, PART STAT; New York State Department of Health, STAT PLANN RES COOP; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	29	10	10	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	FEB	2018	46	2					396	401		10.1177/0363546517738742			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FU4EY	WOS:000423807500019	29135276				2022-02-06	
J	Carlson, KF; Pogoda, TK; Gilbert, TA; Resnick, SG; Twarnley, EW; O'Neil, ME; Sayer, NA				Carlson, Kathleen F.; Pogoda, Terri K.; Gilbert, Tess A.; Resnick, Sandra G.; Twarnley, Elizabeth W.; O'Neil, Maya E.; Sayer, Nina A.			Supported Employment for Veterans With Traumatic Brain Injury: Patient Perspectives	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Annual Conference of the American-Congress-of-Rehabilitation-Medicine	OCT 25-30, 2015	Dallas, TX	Amer Congress Rehabil Med		Brain injuries, traumatic; Community integration; Employment, supported; Rehabilitation; Veterans	POSTTRAUMATIC-STRESS-DISORDER; ENDURING FREEDOM; WORK; ATTITUDES; HOMELESS; OUTCOMES; IMPACT; PAIN; IRAQ	Objectives: To quantify the need for, and interest in, supported employment (SE) among recent military veterans with traumatic brain injury (TBI); and to examine characteristics associated with veterans' interest in SE. Design: Stratified random sample of Iraq and Afghanistan War veterans confirmed to have TBI through the Veterans Health Administration (VHA) screening and evaluation system. Setting: Community-based via mailed survey. Participants: We recruited 1800 veterans with clinician-confirmed TBI (mild TBI: n=1080; moderate/severe TBI: n=720) through multiple mailings. Among 1451 surveys that were not returned undeliverable, N=616 (42%) responded. Interventions: Not applicable. Main Outcome Measures: Veterans rated their interest in SE after reading a script describing the program. Additional measures assessed mental health and pain-related comorbidities, employment, financial/housing difficulties, demographics, and military service characteristics. Estimates were weighted to represent the population of veterans with VHA clinician-confirmed TBI. Results: Unemployment was reported by 45% (95% confidence interval [CI], 43-47) of veterans with TBI. Although 42% (95% CI, 40-44) reported they would be interested in using SE if it were offered to them, only 12% had heard of SE (95% CI, 11-14) and <1% had used it. TBI severity and comorbidities were not associated with veterans' interest in SE. However, those who were unemployed, looking for work, experiencing financial strain, or at risk for homelessness were more likely to be interested in SE. Conclusions: Our research highlights an important gap between veterans' vocational needs and interests and their use of SE. Systematically identifying and referring those with employment and financial/housing difficulties may help close this gap. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Carlson, Kathleen F.; Gilbert, Tess A.; O'Neil, Maya E.] Vet Affairs Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, Portland, OR USA; [Carlson, Kathleen F.] Portland Hlth Care Syst, Natl Ctr Rehabilitat Auditory Res, Vet Affairs, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, OHSU PSU Sch Publ Hlth, Portland, OR 97201 USA; [Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA; [Resnick, Sandra G.] VA Connecticut Healthcare Syst, New England Mental Illness Res & Clin Ctr, West Haven, CT USA; [Resnick, Sandra G.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Twarnley, Elizabeth W.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Twarnley, Elizabeth W.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Twarnley, Elizabeth W.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [O'Neil, Maya E.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [O'Neil, Maya E.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Sayer, Nina A.] Minneapolis VA Healthcare Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Sayer, Nina A.] Univ Minnesota, Dept Med & Psychiat, Minneapolis, MN USA		Carlson, KF (corresponding author), VA Portland Hlth Care Syst R&D 66, HSR&D Ctr Improve Vet Involvement Care, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	kathleen.carlson@va.gov	Resnick, Sandra G/F-3883-2014; Pogoda, Terri/F-6243-2012	Resnick, Sandra G/0000-0001-6373-1482; Pogoda, Terri/0000-0003-1397-8780	Veterans Health Administration, Health Services Research and Development ServiceUS Department of Veterans Affairs [PPO 13-123, CDA 08-025]; American Congress of Rehabilitation Medicine	Supported by the Veterans Health Administration, Health Services Research and Development Service (PPO 13-123; CDA 08-025).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Bond GR, 2008, PSYCHIATR REHABIL J, V31, P280, DOI 10.2975/31.4.2008.280.290; Bond GR, 2014, ADM POLICY MENT HLTH, V41, P69, DOI 10.1007/s10488-012-0444-6; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cochran W. G., 1977, SAMPLING TECHNIQUES, V3; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Davis LL, 2014, PSYCHIATR REHABIL J, V37, P107, DOI 10.1037/prj0000058; Davis LL, 2012, PSYCHIAT SERV, V63, P464, DOI 10.1176/appi.ps.201100340; Department of Health and Human Services, 2006, INT CLASS DIS; Department of Health and Human Services (Office of the Secretary), 2016, FED REG ANN UPD HHS; Department of Veterans Affairs,, 2011, VHA HDB; Dillman DA., 2000, MAIL INTERNET SURVEY; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784; Kashner TM, 2002, ARCH GEN PSYCHIAT, V59, P938, DOI 10.1001/archpsyc.59.10.938; Kukla M, 2015, J REHABIL RES DEV, V52, P477, DOI 10.1682/JRRD.2014.11.0289; Kukla M, 2012, J NERV MENT DIS, V200, P214, DOI 10.1097/NMD.0b013e318247cb29; Little R. J., 2019, STAT ANAL MISSING DA, V793; LITTLE RJA, 1986, INT STAT REV, V54, P139, DOI 10.2307/1403140; Mares AS, 2006, AM J PSYCHIATR REHAB, V9, P145, DOI 10.1080/15487760600961451; McCrea M., 2008, MILD TRAUMATIC BRAIN; Montgomery AE, 2013, AM J PUBLIC HEALTH, V103, pS210, DOI 10.2105/AJPH.2013.301398; Morel JG., 1989, SURV METHODOL, V15, P203; Ottomanelli L, 2012, ARCH PHYS MED REHAB, V93, P740, DOI 10.1016/j.apmr.2012.01.002; Petersen S., 2011, THESIS; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Pogoda TK, 2017, ARCH PHYS MED REHABI; Resnick SG, 2007, J REHABIL RES DEV, V44, P867, DOI 10.1682/JRRD.2007.02.0043; ROSS CE, 1995, J HEALTH SOC BEHAV, V36, P230, DOI 10.2307/2137340; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tanielian T.L., 2008, INVISIBLE WOUNDS WAR, V1; Taylor B., 2015, FISCAL YEAR 2014 VA; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; VINOKUR A, 1987, J APPL SOC PSYCHOL, V17, P1007, DOI 10.1111/j.1559-1816.1987.tb02345.x; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	39	10	10	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2		1			S4	S13		10.1016/j.apmr.2017.06.027			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	FU7YY	WOS:000424069900002	28782542				2022-02-06	
J	Elnitsky, CA; Blevins, C; Findlow, JW; Aimed, T; Wiese, D				Elnitsky, Christine A.; Blevins, Cara; Findlow, Jan Warren; Aimed, Tabitha; Wiese, Dennis			Student Veterans Reintegrating From the Military to the University With Traumatic Injuries: How Does Service Use Relate to Health Status?	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Education; Rehabilitation; Veterans	PREVALENCE; EDUCATION; SYMPTOMS; IRAQ	Objective: To examine the effects of campus services on the health of veterans with traumatic injuries and comorbidities as they return from military service and enter college. Design: Cross-sectional Internet survey using a mixed-methods analysis approach. Setting: Four-year urban research university. Participants: Veterans returning from active military duty (N=127). Interventions: None. Main Outcome Measures: Surveys included standardized measures of health status, traumatic injuries, and functional impairment (PTSD Checklist, Civilian version; Veterans Health Administration traumatic brain injury [TBI] screen; and Veterans RAND-12 item Health Survey); use of campus services and perceived effectiveness of these services in supporting reintegration to the university; and recommendations for additional services. Results: Quantitative and qualitative data revealed that student veterans experience high rates of chronic pain that interfere with their daily functioning (92.7%), symptoms of posttraumatic stress disorder (PTSD) (77.9%), symptoms of TBI (26.0%), and comorbidities as the polytrauma clinical triad (14.2%). Despite the high prevalence of pain, PTSD, and TBI, few students used disability services (5.2%), counseling services (18.8%), or student health services (36.5%). Students experienced challenges accessing needed health services when reintegrating from the military to the university, including mutable university service factors. Conclusions: Findings indicate the need for campus services to address the particular needs of student veterans and the need for determining what particular services should be offered to help this population cope with injuries and succeed in college. (C) 2017 by the American Congress of Rehabilitation Medicine	[Elnitsky, Christine A.] Univ North Carolina Charlotte, Sch Nursing, 9201 Univ City Blvd, Charlotte, NC 28223 USA; [Blevins, Cara] Univ North Carolina Charlotte, Hlth Psychol Program, Charlotte, NC 28223 USA; [Findlow, Jan Warren] Univ North Carolina Charlotte, Dept Publ Hlth Sci, Charlotte, NC 28223 USA; [Aimed, Tabitha] Univ North Carolina Charlotte, Dept Psychol, Charlotte, NC 28223 USA; [Wiese, Dennis] Univ North Carolina Charlotte, Charlotte, NC 28223 USA		Elnitsky, CA (corresponding author), Univ North Carolina Charlotte, Sch Nursing, 9201 Univ City Blvd, Charlotte, NC 28223 USA.	Celnitsky1@gmail.com		Warren-Findlow, Jan/0000-0002-4855-8260	University of North Carolina at Charlotte, Veteran Student Services (UNC Charlotte IRE) [13-12-30]; University of North Carolina at Charlotte, College of Health and Human Services; American Congress of Rehabilitation Medicine	Supported by the University of North Carolina at Charlotte, Veteran Student Services (UNC Charlotte IRE no. 13-12-30); and the University of North Carolina at Charlotte, College of Health and Human Services.; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Barry AE, 2014, J STUD AFF RES PRACT, V51, P30, DOI 10.1515/jsarp-2014-0003; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Chickering A., 2002, GETTING MOST OUT COL; Church TE, 2009, J POSTSECOND EDUC DI, V22, P43; Department of Veterans Affairs, 2012, NAT CTR PTSD ADV SCI; Dillman D.A., 2009, INTERNET MAIL MIXED, V3rd ed.; DiRamio D, 2008, J STUD AFF RES PRACT, V45, P73; Durdella NR., 2012, J STUD ED, V2, P109; Ellison ML, 2012, PSYCHIATR REHABIL J, V35, P209, DOI 10.2975/35.3.2012.209.217; Elnitsky CA, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00369; Elnitsky CA, 2017, AM J ORTHOPSYCHIAT, V87, P114, DOI 10.1037/ort0000244; Elnitsky CA, 2013, REHABIL NURS, V38, P32, DOI 10.1002/rnj.62; Glaser B., 1967, DISCOVERY GROUNDED T; Guba EG, 1994, HDB QUALITATIVE RES, P105; Kazis LE, 2006, J AMBUL CARE MANAG, V29, P310, DOI 10.1097/00004479-200610000-00007; Kim Y., 2009, SOLDIER STUDENT EASI; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Madaus JW, 2009, J POSTSECOND EDUC DI, V22, P10; Norman SB, 2015, J REHABIL RES DEV, V52, P701, DOI 10.1682/JRRD.2015.01.0013; Office of the Deputy Undersecretary of Defense, 2009, DEM 2009 PROF MIL CO; Osborne NJ, 2014, INNOV HIGH EDUC, V39, P247, DOI 10.1007/s10755-013-9274-z; RADFORD AW, 2009, MILITARY SERVICE MEM; Rossi P. H., 2004, EVALUATION SYSTEMATI; Schlossberg J, 1995, COUNSELING ADULTS TR; Shackelford AL, 2009, J POSTSECOND EDUC DI, V22, P36; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Weathers F, OCT 1993 9 ANN C IST; Wells TS, 2011, INT REV PSYCHIATR, V23, P144, DOI 10.3109/09540261.2011.558833	29	10	10	1	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2		1			S58	S64		10.1016/j.apmr.2017.10.008			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FU7YY	WOS:000424069900008	29097180				2022-02-06	
J	Furman, NET; Prabhakara, KS; Bedi, S; Cox, CS; Olson, SD				Furman, Naama E. Toledano; Prabhakara, Karthik S.; Bedi, Supinder; Cox, Charles S.; Olson, Scott D.			OMIP-041: Optimized multicolor immunofluorescence panel rat microglial staining protocol	CYTOMETRY PART A			English	Article						rat microglia; M1 polarized microglia; M2 polarized microglia; traumatic brain injury; spinal cord injury; neuro-immuno-phenotyping	ACTIVATION; ALZHEIMERS; MOUSE; PHENOTYPES; DISEASE; MODELS; GAMMA		[Furman, Naama E. Toledano; Prabhakara, Karthik S.; Bedi, Supinder; Cox, Charles S.; Olson, Scott D.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, McGovern Med Sch, Houston, TX 77030 USA		Olson, SD (corresponding author), Dept Pediat Surg, 6431 Fannin St MSB 5-230, Houston, TX 77030 USA.	Scott.D.Olson@uth.tmc.edu		Olson, Scott/0000-0001-8032-3755	Clare A. Glassell Family Pediatric Stem Cell Research Fund	Grant sponsor: Clare A. Glassell Family Pediatric Stem Cell Research Fund	Abdanipour Alireza, 2013, Iranian Biomedical Journal, V17, P214, DOI 10.6091/ibj.1213.2013; Bedi SS, 2013, J NEUROSCI METH, V219, P176, DOI 10.1016/j.jneumeth.2013.07.017; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Hayakawa K, 2014, J NEUROSCI RES, V92, P1647, DOI 10.1002/jnr.23448; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Le Roy C, 2009, CYTOM PART A, V75A, P882, DOI 10.1002/cyto.a.20774; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Moore CS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000106; Peferoen LAN, 2015, J NEUROPATH EXP NEUR, V74, P48, DOI 10.1097/NEN.0000000000000149; PERESS NS, 1993, J NEUROIMMUNOL, V48, P71, DOI 10.1016/0165-5728(93)90060-C; Pey PX, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-21; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Sipe GO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10905; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Van den Heuvel MM, 1999, J LEUKOCYTE BIOL, V66, P858, DOI 10.1002/jlb.66.5.858; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Voulgaraki D, 2005, IMMUNOLOGY, V115, P337, DOI 10.1111/j.1365-2567.2005.02161.x; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Wilcock DM, 2014, NEURODEGENER DIS, V13, P183, DOI 10.1159/000354228; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zotova E, 2013, BRAIN, V136, P2677, DOI 10.1093/brain/awt210	28	10	10	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4922	1552-4930		CYTOM PART A	Cytom. Part A	FEB	2018	93A	2					182	185		10.1002/cyto.a.23267			4	Biochemical Research Methods; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FX4PX	WOS:000426061500006	29030991	Bronze			2022-02-06	
J	Guenette, JP; Shenton, ME; Koerte, IK				Guenette, Jeffrey P.; Shenton, Martha E.; Koerte, Inga K.			Imaging of Concussion in Young Athletes	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Concussion; Mild traumatic brain injury; Head trauma; Sports; Pediatrics; MR imaging; Diffusion tensor imaging; Susceptibility-weighted imaging	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; CEREBRAL-BLOOD-FLOW; DIFFUSION-TENSOR MRI; HIGH-SCHOOL; EMERGENCY-DEPARTMENT; UNITED-STATES; ICE HOCKEY; RECOVERY; PERFUSION	Conventional neuroimaging examinations are typically normal in concussed young athletes. A current focus of research is the characterization of subtle abnormalities after concussion using advanced neuroimaging techniques. These techniques have the potential to identify biomarkers of concussion. In the future, such biomarkers will likely provide important clinical information regarding the appropriate time interval before return to play, as well as the risk for prolonged postconcussive symptoms and long-term cognitive impairment. This article discusses results from advanced imaging techniques and emphasizes imaging modalities that will likely become available in the near future for the clinical evaluation of concussed young athletes.	[Guenette, Jeffrey P.; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA; [Guenette, Jeffrey P.; Shenton, Martha E.; Koerte, Inga K.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02215 USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton Div, 940 Belmont St, Brockton, MA 02301 USA; [Shenton, Martha E.; Koerte, Inga K.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, 55 Fruit St, Boston, MA 02114 USA; [Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Nussbaumstr 5A, D-80336 Munich, Germany		Koerte, IK (corresponding author), Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02215 USA.	ikoerte@bwh.harvard.edu	Shenton, Martha/V-8780-2019; Koerte, Inga Katharina/AAW-3031-2021	Guenette, Jeffrey/0000-0002-4684-5469	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1U01NS093334-01, R01NS100952]; VA Merit AwardUS Department of Veterans Affairs [I01 RX00928]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100952, U01NS093334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG019610] Funding Source: NIH RePORTER	J.P. Guenette has nothing to disclose. M.E. Shenton is supported by NIH 1U01NS093334-01 and VA Merit Award I01 RX00928. I.K. Koerte is supported by NIH R01NS100952.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Conturo TE, 2005, J MAGN RESON IMAGING, V22, P697, DOI 10.1002/jmri.20457; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haller S, 2016, RADIOLOGY, V281, P337, DOI 10.1148/radiol.2016150789; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Oz G, 2014, RADIOLOGY, V270, P658, DOI 10.1148/radiol.13130531; Parker RS, 2002, NEUROREHABILITATION, V17, P131; Peng SP, 2016, NEURAL REGEN RES, V11, P257, DOI 10.4103/1673-5374.177733; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Spilt A, 2002, J MAGN RESON IMAGING, V16, P1, DOI 10.1002/jmri.10133; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Vitte E, 1996, EXP BRAIN RES, V112, P523; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	64	10	10	0	21	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	FEB	2018	28	1					43	+		10.1016/j.nic.2017.09.004			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FR3UA	WOS:000418990900006	29157852	Green Accepted			2022-02-06	
J	Guerriero, RM; Kuemmerle, K; Pepin, MJ; Taylor, AM; Wolff, R; Meehan, WP				Guerriero, Rejean M.; Kuemmerle, Karameh; Pepin, Michael J.; Taylor, Alex M.; Wolff, Robert; Meehan, William P., III			The Association Between Premorbid Conditions in School-Aged Children With Prolonged Concussion Recovery	JOURNAL OF CHILD NEUROLOGY			English	Article						concussion; mild traumatic brain injury; headache; psychiatric comorbidities	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; HEAD-INJURIES; ADOLESCENTS; SYMPTOMS; PREDICTORS; EPIDEMIOLOGY	The association between preexisting anxiety, depression, and/or neurodevelopmental disorders and symptom duration among younger children who sustain concussions is not well known. The authors conducted a prospective cohort study of 569 patients presenting to a pediatric neurology clinic with the diagnosis of concussion. The authors measured associations between symptom duration and premorbid conditions, as well as gender, age, mechanism of injury, and other factors. Premorbid conditions were common in both age groups. On univariate modeling female gender, age > 12 years, and premorbid conditions were associated with longer symptom duration. On multivariable modeling, females and patients <= 12 years old with a history of headaches, migraines, or a history of psychiatric conditions took significantly longer to recover than those without such conditions. Premorbid conditions are associated with a prolonged recovery from concussion among those patients <= 12 years old.	[Guerriero, Rejean M.; Kuemmerle, Karameh; Taylor, Alex M.; Wolff, Robert] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Guerriero, Rejean M.; Kuemmerle, Karameh; Pepin, Michael J.; Taylor, Alex M.; Wolff, Robert; Meehan, William P., III] Harvard Med Sch, Boston, MA USA; [Guerriero, Rejean M.] Washington Univ, Sch Med, Dept Neurol, Div Pediat & Dev Neurol, St Louis, MO 63110 USA; [Guerriero, Rejean M.; Kuemmerle, Karameh; Taylor, Alex M.; Wolff, Robert; Meehan, William P., III] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Pepin, Michael J.; Meehan, William P., III] Boston Childrens Hosp, Dept Pediat, Div Sports Med, Boston, MA USA; [Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Guerriero, RM (corresponding author), Dept Neurol, Div Pediat & Dev Neurol, Campus Box 8111,660 S Euclid Ave, St Louis, MO 63110 USA.	r.guerriero@wustl.edu		Guerriero, Rejean/0000-0001-7788-6661	National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; Football Players Health Study at Harvard University - NFL Players Association	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: William P. Meehan: Receives royalties from (1) ABC-Clio publishing for the sale of his books, Kids, Sports, and Concussion: A Guide for Coaches and Parents, and Concussions; (2) Springer International for the book Head and Neck Injuries in Young Athlete; and (3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and by a grant from the Football Players Health Study at Harvard University, which is funded by the NFL Players Association.	Albers L, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0477-0; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Bomyea J, 2012, CLIN PSYCHOL REV, V32, P630, DOI 10.1016/j.cpr.2012.06.008; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cortiella C., 2014, STATE LEARNING DISAB; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Foley C, 2014, CURR SPORT MED REP, V13, P390, DOI 10.1249/JSR.0000000000000104; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; LeResche L, 2005, PAIN, V118, P201, DOI 10.1016/j.pain.2005.08.011; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Merikangas KR, 2013, HEADACHE, V53, P230, DOI 10.1111/head.12038; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Mong JA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0110; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Sox HC, 2015, ACAD MED, V90, P129, DOI 10.1097/ACM.0000000000000509; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008	34	10	10	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	FEB	2018	33	2					168	173		10.1177/0883073817749655			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	GC0VU	WOS:000429496800008	29334854				2022-02-06	
J	Hayes, JP; Reagan, A; Logue, MW; Hayes, SM; Sadeh, N; Miller, DR; Verfaellie, M; Wolf, EJ; McGlinchey, RE; Milberg, WP; Stone, A; Schichman, SA; Miller, MW				Hayes, J. P.; Reagan, A.; Logue, M. W.; Hayes, S. M.; Sadeh, N.; Miller, D. R.; Verfaellie, M.; Wolf, E. J.; McGlinchey, R. E.; Milberg, W. P.; Stone, A.; Schichman, S. A.; Miller, M. W.			BDNF genotype is associated with hippocampal volume in mild traumatic brain injury	GENES BRAIN AND BEHAVIOR			English	Article						Alzheimer's disease; functional connectivity; neurodegenerative disease; rs1157659; synaptic plasticity; veterans	POSTTRAUMATIC-STRESS-DISORDER; FACTOR VAL66MET POLYMORPHISM; GENOME-WIDE ASSOCIATION; HUMAN CEREBRAL-CORTEX; NEUROTROPHIC FACTOR; ALZHEIMERS-DISEASE; CORTICAL SURFACE; RISK-FACTOR; GEOMETRICALLY ACCURATE; MEMORY	The negative long-term effects of mild traumatic brain injury (mTBI) have been a growing concern in recent years, with accumulating evidence suggesting that mTBI combined with additional vulnerability factors may induce neurodegenerative-type changes in the brain. However, the factors instantiating risk for neurodegenerative disease following mTBI are unknown. This study examined the link between mTBI and brain-derived neurotrophic factor (BDNF) genotype, which has previously been shown to regulate processes involved in neurodegeneration including synaptic plasticity and facilitation of neural survival through its expression. Specifically, we examined nine BDNF single-nucleotide polymorphisms (SNPs; rs908867, rs11030094, rs6265, rs10501087, rs1157659, rs1491850, rs11030107, rs7127507 and rs12273363) previously associated with brain atrophy or memory deficits in mTBI. Participants were 165 white, non-Hispanic Iraq and Afghanistan war veterans between the ages of 19 and 58, 110 of whom had at least one mTBI in their lifetime. Results showed that the BDNF SNP rs1157659 interacted with mTBI to predict hippocampal volume. Furthermore, exploratory analysis of functional resting state data showed that rs1157659 minor allele homozygotes with a history of mTBI had reduced functional connectivity in the default mode network compared to major allele homozygotes and heterozygotes. Apolipoprotein E (APOE) was not a significant predictor of hippocampal volume or functional connectivity. These results suggest that rs1157659 minor allele homozygotes may be at greater risk for neurodegeneration after exposure to mTBI and provide further evidence for a potential role for BDNF in regulating neural processes following mTBI.	[Hayes, J. P.; Reagan, A.; Logue, M. W.; Sadeh, N.; Miller, D. R.; Wolf, E. J.; Miller, M. W.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Hayes, J. P.; Hayes, S. M.; Miller, D. R.; Verfaellie, M.; Wolf, E. J.; Miller, M. W.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Hayes, J. P.; Hayes, S. M.] VA Boston Healthcare Syst, Neuroimaging Res Vet Ctr, Boston, MA USA; [Logue, M. W.] Boston Univ, Sch Med, Biomed Genet, Boston, MA 02118 USA; [Logue, M. W.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Hayes, S. M.; Verfaellie, M.] VA Boston Healthcare Syst, Memory Disorders Res Ctr, Boston, MA USA; [Sadeh, N.] Univ Delaware, Dept Psychol & Brain Studies, Newark, DE USA; [McGlinchey, R. E.; Milberg, W. P.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [McGlinchey, R. E.; Milberg, W. P.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, Boston, MA USA; [McGlinchey, R. E.; Milberg, W. P.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Stone, A.; Schichman, S. A.] Cent Arkansas Vet Healthcare Syst, Pharmacogen Anal Lab, Res Serv, Little Rock, AR USA		Hayes, JP (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD 116B 2, 150 South Huntington Ave, Boston, MA 02130 USA.	jphayes@bu.edu	Hayes, Scott M./AAL-8682-2020; Hayes, Jasmeet/AAN-4150-2020; Miller, Mark Webber/G-7322-2011	Hayes, Scott M./0000-0002-1185-5149; Hayes, Jasmeet/0000-0002-5157-0666; Miller, Mark Webber/0000-0001-6393-8563; Verfaellie, Mieke/0000-0001-5535-4584; Wolf, Erika/0000-0003-2666-2435	Rehabilitation Research and Development Service (VA Rehabilitation Research and Development) [I21RX001594]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH102834, T32MH019836-01]; TRACTS, a Rehabilitation Research and Development Service (VA Rehabilitation Research and Development) National Network Research Center [B9254-C]; VA Clinical Science Research and Development Service; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH102834, T32MH019836] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I21RX001594] Funding Source: NIH RePORTER	We thank the TRACTS team for their assistance with data collection and management, in particular, Drs Fortier, Amick, Kenna, Corbo and Robinson, and Mr Musto. This research was supported by Rehabilitation Research and Development Service (VA Rehabilitation Research and Development) I21RX001594, National Institute of Mental Health grant R21MH102834 and National Institute of Mental Health grant T32MH019836-01, and the TRACTS, a Rehabilitation Research and Development Service (VA Rehabilitation Research and Development) National Network Research Center (B9254-C) and the VA Clinical Science Research and Development Service. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US government.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bekinschtein P, 2008, NEUROSCIENTIST, V14, P147, DOI 10.1177/1073858407305850; Benjamin S, 2010, AM J GERIAT PSYCHIAT, V18, P323, DOI 10.1097/JGP.0b013e3181cabd2b; Benson JH, 2013, J HOPKINS APL TECH D, V31, P301; Bergman K, 2010, J EMERG NURS, V36, P221, DOI 10.1016/j.jen.2009.07.001; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Brooks SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082707; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Dretsch MN, 2017, J NEUROTRAUM, V34, P869, DOI 10.1089/neu.2016.4480; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Felmingham KL, 2013, BIOL PSYCHIAT, V73, P1059, DOI 10.1016/j.biopsych.2012.10.033; First M.B., 1997, STRUCTURAL CLIN INTE; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Gruber O, 2012, EUR ARCH PSY CLIN N, V262, P23, DOI 10.1007/s00406-011-0214-6; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Harrisberger F, 2014, NEUROSCI BIOBEHAV R, V42, P267, DOI 10.1016/j.neubiorev.2014.03.011; Hashimoto R, 2009, GENES BRAIN BEHAV, V8, P43, DOI 10.1111/j.1601-183X.2008.00440.x; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Hayes JP, 2017, J PSYCHIATR NEUROSCI, V42, P95, DOI 10.1503/jpn.150339; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Honea RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076001; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; Kanellopoulos D, 2011, AM J GERIAT PSYCHIAT, V19, P13, DOI 10.1097/JGP.0b013e3181f61d62; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Karnik MS, 2010, PSYCHIAT RES, V178, P425, DOI 10.1016/j.psychres.2009.09.008; Kim A, 2015, COGN AFFECT BEHAV NE, V15, P625, DOI 10.3758/s13415-015-0343-x; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Levy-Gigi E, 2015, NEUROPSYCHOLOGY, V29, P151, DOI 10.1037/neu0000131; Lim YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086498; Lin PH, 2016, ONCOTARGET, V7, P54200, DOI 10.18632/oncotarget.11027; Little DM, 2014, ALZHEIMERS DEMENT, V10, pS188, DOI 10.1016/j.jalz.2014.04.002; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Miller DR, 2017, BIOL PSYCHIAT-COGN N, V2, P363, DOI 10.1016/j.bpsc.2016.12.006; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Molendijk ML, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.72; Molendijk ML, 2012, AM J MED GENET B, V159B, P731, DOI 10.1002/ajmg.b.32078; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mulder ER, 2014, NEUROIMAGE, V92, P169, DOI 10.1016/j.neuroimage.2014.01.058; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Richter-Schmidinger T, 2011, J NEURAL TRANSM, V118, P249, DOI 10.1007/s00702-010-0539-8; Sadeh N, 2016, MOL PSYCHIATR, V21, P357, DOI 10.1038/mp.2015.134; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Sanchez MM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.47; Schofield PR, 2009, BIOL PSYCHOL, V80, P176, DOI 10.1016/j.biopsycho.2008.09.001; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith GN, 2012, SCHIZOPHR RES, V134, P253, DOI 10.1016/j.schres.2011.11.022; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thomason ME, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.055.2009; WechslerD, 2001, WECHSLER TEST ADULT; Weinstein G, 2014, JAMA NEUROL, V71, P55, DOI 10.1001/jamaneurol.2013.4781; Yan H, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6353845; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	87	10	10	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1601-1848	1601-183X		GENES BRAIN BEHAV	Genes Brain Behav.	FEB	2018	17	2					107	117		10.1111/gbb.12403			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	FW7PD	WOS:000425515200002	28755387	Bronze, Green Accepted			2022-02-06	
J	Lundine, JP; Harnish, SM; McCauley, RJ; Zezinka, AB; Blackett, DS; Fox, RA				Lundine, Jennifer P.; Harnish, Stacy M.; McCauley, Rebecca J.; Zezinka, Alexandra B.; Blackett, Deena Schwen; Fox, Robert A.			Exploring Summarization Differences for Two Types of Expository Discourse in Adolescents With Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							LANGUAGE IMPAIRMENTS; CHILDREN; MEMORY; TERM; REHABILITATION; CONSTRUCTION; PREDICTORS; STUDENTS; TRIAL; TEXT	Purpose: Annually, nearly 700,000 U.S. children and adolescents experience a traumatic brain injury (TBI). Many of them struggle academically, despite failing to qualify for special education services because their cognitive communication impairments are subtle. Method: In this exploratory study, five adolescents with TBI provided verbal summaries of two expository lectures (compare-contrast, cause-effect) and participated in cognitive and expressive syntax testing. Their performance on these tasks was compared descriptively to that of 50 adolescents with typical development. Results: For adolescents with TBI, mean summary quality scores for both exposition types were at least 1 SD lower than those of adolescents with typical development and notably 2 SDs below for the cause-effect passage. The adolescents with TBI who had below-average cognitive scores showed better performance on compare-contrast summaries compared to cause-effect, whereas the majority of adolescents with typical development showed the opposite tendency. Conclusions: These results provide preliminary evidence that students with TBI, particularly those with cognitive deficits, may struggle with expository discourse despite acceptable performance on a measure of expressive syntax. This study also indicates that researchers should explore how students with TBI perform on academically relevant discourse tasks in order to inform future assessment and intervention efforts.	[Lundine, Jennifer P.; Harnish, Stacy M.; McCauley, Rebecca J.; Zezinka, Alexandra B.; Blackett, Deena Schwen; Fox, Robert A.] Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Div Clin Therapies, Columbus, OH USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Inpatient Rehabil Program, Columbus, OH USA		Lundine, JP (corresponding author), Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA.	Lundine.4@osu.edu	Lundine, Jennifer P/P-5184-2018	Lundine, Jennifer P/0000-0002-9113-7875	Ohio State UniversityOhio State University	This research was supported in part by the Alumni Grant for Graduate Research and Scholarship from The Ohio State University (awarded to Jennifer Lundine). The authors are grateful for the assistance of Megan Blackburn, Mackenzie Chalifoux, Nicole Delay, Monica Fox, Erin Rundio, and Monique Mills.	Bauer PJ, 2013, MONOGR SOC RES CHILD, V78, P133, DOI 10.1111/mono.12039; Berman RA, 2007, DISCOURSE PROCESS, V43, P79, DOI 10.1207/s15326950dp4302_1; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; COOK LG, 2011, SIG 2 PERSPECTIVES N, V21, P33; Dettmer JL, 2007, J HEAD TRAUMA REHAB, V22, P339, DOI 10.1097/01.HTR.0000300229.13490.c7; Faul M, 2010, TRAUMATIC BRAIN INJU; Gillam RB, 2002, TOP LANG DISORD, V22, P30, DOI 10.1097/00011363-200205000-00005; Gillam RB, 1999, TOP LANG DISORD, V20, P33, DOI 10.1097/00011363-199911000-00005; Graesser AC, 2004, BEHAV RES METH INS C, V36, P193, DOI 10.3758/BF03195564; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); Hunt K. W., 1965, 3 NAT COUNC TEACH EN; KINTSCH W, 1988, PSYCHOL REV, V95, P163, DOI 10.1037/0033-295X.95.2.163; Koutsoftas AD, 2012, LANG SPEECH HEAR SER, V43, P395, DOI 10.1044/0161-1461(2012/11-0018); Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Lundine J. P., 2016, THESIS; McNamara D. S., 2014, AUTOMATED EVALUATION; Miller J. F., 2010, SYSTEMATIC ANAL LANG; Moran C. A, 2010, EXPOSITORY DISCOURSE, P275; Morse S, 1999, Pediatr Rehabil, V3, P139; National Institutes of Health, 2012, NIH TOOLB REAS ACC G; NIPPOLD MA, 2010, NEW DIRECTIONS COMMU, P00001; Nippold MA, 2008, AM J SPEECH-LANG PAT, V17, P356, DOI 10.1044/1058-0360(2008/07-0049); Nippold MA, 2007, AM J SPEECH-LANG PAT, V16, P179, DOI 10.1044/1058-0360(2007/022); Nippold MA, 2009, AM J SPEECH-LANG PAT, V18, P241, DOI 10.1044/1058-0360(2008/08-0022); Schutz LE, 2010, INT J SPEC EDUC, V25, P55; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; SCOTT C. M., 2010, EXPOSITORY DISCOURSE, P191; Scott CM, 2000, J SPEECH LANG HEAR R, V43, P324, DOI 10.1044/jslhr.4302.324; Snyder L., 2010, EXPOSITORY DISCOURSE, P13; TEASDALE G, 1974, LANCET, V2, P81; Tlustos SJ, 2016, REHABIL PSYCHOL, V61, P347, DOI 10.1037/rep0000098; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Walz NC, 2012, J NEUROPSYCHOL, V6, P143, DOI 10.1111/j.1748-6653.2011.02020.x; Ward-Lonergan J. M., 2010, EXPOSITORY DISCOURSE, P155; Ward-Lonergan JM, 1999, J LEARN DISABIL-US, V32, P213, DOI 10.1177/002221949903200303; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Westby C, 2010, TOP LANG DISORD, V30, P275, DOI 10.1097/TLD.0b013e3181ff5a88; Wiig EH, 2013, CLIN EVALUATION LANG, V5th; Wolf D.P., 2004, FIRST LANG, V24, DOI [10.1177/0142723704042369, DOI 10.1177/0142723704042369]; Wolfe MBW, 2007, BRIT J EDUC PSYCHOL, V77, P541, DOI 10.1348/000709906X143902; Wolfe MBW, 2010, BRIT J EDUC PSYCHOL, V80, P341, DOI 10.1348/000709910X485700; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	51	10	10	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	FEB	2018	27	1					247	257		10.1044/2017_AJSLP-16-0131			11	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	FX1XA	WOS:000425847000020	29121200				2022-02-06	
J	Lyons, DN; Zhang, LP; Pandya, JD; Danaher, RJ; Ma, F; Miller, CS; Sullivan, PG; Sirbu, C; Westlund, KN				Lyons, Danielle N.; Zhang, Liping; Pandya, Jignesh D.; Danaher, Robert J.; Ma, Fei; Miller, Craig S.; Sullivan, Patrick G.; Sirbu, Cristian; Westlund, Karin N.			Combination Drug Therapy of Pioglitazone and D-cycloserine Attenuates Chronic Orofacial Neuropathic Pain and Anxiety by Improving Mitochondrial Function Following Trigeminal Nerve Injury	CLINICAL JOURNAL OF PAIN			English	Article						trigeminal inflammatory compression (TIC) injury; mice; 2; 4-DNP; light-dark box place preference test; mechanical allodynia; mitochondrial electron transport chain; mitochondrial bioenergetics; bioscience seahorse XFe24 flux analyzer; respiratory control ratio; clinical translational	TRAUMATIC BRAIN-INJURY; NATIONALLY REPRESENTATIVE SAMPLE; RECEPTOR-GAMMA AGONISTS; PERIPHERAL NEUROPATHY; ELECTRON-TRANSPORT; EXPOSURE THERAPY; DYSFUNCTION; MECHANISMS; ACTIVATION; INHIBITION	Objectives:The study aim was to determine how peripheral trigeminal nerve injury affects mitochondrial respiration and to test efficacy of combined treatment with 2 Federal Drug Administration approved drugs with potential for improving mitochondrial bioenergetics, pain and anxiety-related behaviors in a chronic orofacial neuropathic pain mouse model.Methods:Efficacy of (R)-(+)-4-amino-3-isoxazolidinone (D-cycloserine, DCS), an N-Methyl-D-aspartate antagonist/agonist, and Pioglitazone (PIO), a selective agonist of nuclear receptor peroxisome proliferator-activated receptor gamma was investigate in the trigeminal inflammatory compression (TIC) neuropathic nerve injury mouse model. Combined low doses of these drugs (80 mg/kg DCS and 100 mg/kg PIO) were given as a single bolus or daily for 7 days post-TIC to test ability to attenuate neuropathic nociceptive and associated cognitive dependent anxiety behaviors. In addition, beneficial effects of the DCS/PIO drug combination were explored ex vivo in isolated cortex/brainstem mitochondria at 28 weeks post-TIC.Results:The DCS/PIO combination not only attenuated orofacial neuropathic pain and anxiety-related behaviors associated with trigeminal nerve injury, but it also improved mitochondrial bioenergetics.Discussion:The DCS/PIO combination uncoupled mitochondrial respiration in the TIC model to improve cortical mitochondrial dysfunction, as well as reduced nociceptive and anxiety behaviors present in mice with centralized chronic neuropathic nerve injury. Combining these drugs could be a beneficial treatment for patients with depression, anxiety, or other psychological conditions due to their chronic pain status.	[Lyons, Danielle N.; Zhang, Liping; Ma, Fei; Westlund, Karin N.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Danaher, Robert J.; Miller, Craig S.] Univ Kentucky, Dept Oral Hlth Practice, Lexington, KY USA; [Pandya, Jignesh D.; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Sirbu, Cristian] West Virginia Univ, Charleston Area Med Ctr Hlth Educ & Res Inst, Dept Behav Med & Psychiat, Sch Med,Charleston Div, Morgantown, WV USA; [Pandya, Jignesh D.] WRAIR, Brain Trauma Neuroprotect & Neurorestorat BTNN Br, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Westlund, Karin N.] Univ New Mexico, Albuquerque, NM 87131 USA; [Westlund, Karin N.] New Mexico VA Hlth Care Syst, Albuquerque, NM USA; [Pandya, Jignesh D.] Walter Reed Army Inst Res, Silver Spring, MD USA		Westlund, KN (corresponding author), Univ New Mexico, Sch Med, Dept Anesthesiol & Crit Care Med, MSC10 6000,2211 Lomas Blvd NE, Albuquerque, NM 87131 USA.	khigh@salud.unm.edu	Westlund, Karin/R-6960-2019	Westlund High, Karin/0000-0002-7388-4834; Zhang, Liping/0000-0002-4628-2950	NIH COBREUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2P20RR020145]; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01039041]; VAUS Department of Veterans Affairs [BX002695]; institutional Wethington Award; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS062993, NS069633]; VAUS Department of Veterans Affairs [7I01BX002695-02] Funding Source: Federal RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR020145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [K18DE022324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS062993, R01NS039041, R01NS069633] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002695] Funding Source: NIH RePORTER	K.N.W. is currently with the University of New Mexico (khigh@salud.unm.edu) and the New Mexico VA Health Care System. J.D.P. is currently employed at Walter Reed Army Institute of Research (WRAIR). Material has been reviewed by WRAIR. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the author (J.D.P.), and are not to be construed as official, or as reflecting true views of the Department of the Army of the Department of Defense. The animal studies were funded by NIH COBRE 2P20RR020145 (Ebersole, Project 5 RJD), NIH NINDS R01039041 (K.N.W.), VA Merit BX002695 (K.N.W.) and an institutional Wethington Award (K.N.W.). The mitochondrial work was supported by NIH grants NS062993 (P.G.S.) and NS069633 (P.G.S.). The authors declare no conflict of interest.	Antal A, 2011, BRAIN STIMUL, V4, P117, DOI 10.1016/j.brs.2010.09.003; Baad-Hansen L, 2017, CEPHALALGIA, V37, P670, DOI 10.1177/0333102417706310; Bouillot S, 2002, J PERIPHER NERV SYST, V7, P213, DOI 10.1046/j.1529-8027.2002.02027.x; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BRAND MD, 1978, FEBS LETT, V95, P125, DOI 10.1016/0014-5793(78)80066-0; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; BRAND MD, 1990, BIOCHIM BIOPHYS ACTA, V1018, P128, DOI 10.1016/0005-2728(90)90232-S; CHANCE B, 1955, J BIOL CHEM, V217, P383; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Davis M, 2006, BIOL PSYCHIAT, V60, P369, DOI 10.1016/j.biopsych.2006.03.084; De Leeuw R., 2008, OROFACIAL PAIN GUIDE; Dellarole A, 2014, BRAIN BEHAV IMMUN, V41, P65, DOI 10.1016/j.bbi.2014.04.003; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Geldenhuys WJ, 2014, DRUG DISCOV TODAY, V19, P1601, DOI 10.1016/j.drudis.2014.05.001; Ghosh S, 2007, MOL PHARMACOL, V71, P1695, DOI 10.1124/mol.106.033845; Griggs RB, 2015, PAIN, V156, P469, DOI 10.1097/01.j.pain.0000460333.79127.be; Heaton Lisa J, 2010, SAAD Dig, V26, P27; Heresco-Levy U, 1998, EUR NEUROPSYCHOPHARM, V8, P141, DOI 10.1016/S0924-977X(97)00050-3; HOOD WF, 1989, NEUROSCI LETT, V98, P91, DOI 10.1016/0304-3940(89)90379-0; Joseph EK, 2006, PAIN, V121, P105, DOI 10.1016/j.pain.2005.12.010; Korde AS, 2012, J BIOL CHEM, V287, P35192, DOI 10.1074/jbc.M111.322032; Kushner MG, 2007, BIOL PSYCHIAT, V62, P835, DOI 10.1016/j.biopsych.2006.12.020; LANTHORN TH, 1994, AMINO ACIDS, V6, P247, DOI 10.1007/BF00813745; Lim TKY, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0057-7; Lipton RB, 2000, NEUROLOGY, V55, P629, DOI 10.1212/WNL.55.5.629; Lyons DN, 2017, CLIN J PAIN; Ma F, 2015, NEUROSCIENCE, V300, P493, DOI 10.1016/j.neuroscience.2015.05.046; Ma F, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-44; McWilliams LA, 2004, PAIN, V111, P77, DOI 10.1016/j.pain.2004.06.002; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Millecamps M, 2007, PAIN, V132, P108, DOI 10.1016/j.pain.2007.03.003; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Morgenweck J, 2013, NEUROPHARMACOLOGY, V70, P236, DOI 10.1016/j.neuropharm.2013.01.020; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Norberg MM, 2008, BIOL PSYCHIAT, V63, P1118, DOI 10.1016/j.biopsych.2008.01.012; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2016, METHODS MOL BIOL, V1462, P597, DOI 10.1007/978-1-4939-3816-2_32; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Park SW, 2007, J PHARMACOL EXP THER, V320, P1002, DOI 10.1124/jpet.106.113472; Sadeghian M, 2012, J NEUROIMMUNOL, V246, P69, DOI 10.1016/j.jneuroim.2012.03.010; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Starkov AA, 2006, CHEM-BIOL INTERACT, V163, P133, DOI 10.1016/j.cbi.2006.08.015; Sui BD, 2013, POSTGRAD MED J, V89, P709, DOI 10.1136/postgradmedj-2012-131068; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Tomek SE, 2013, PHARMACEUTICALS, V6, P251, DOI 10.3390/ph6020251; Viggiano E, 2010, MOL CELL BIOCHEM, V339, P149, DOI 10.1007/s11010-009-0378-9; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Yalcin I, 2011, BIOL PSYCHIAT, V70, P946, DOI 10.1016/j.biopsych.2011.07.017	51	10	11	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-8047	1536-5409		CLIN J PAIN	Clin. J. Pain	FEB	2018	34	2					168	177		10.1097/AJP.0000000000000515			10	Anesthesiology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	GA7FR	WOS:000428501500010	28542026	Green Accepted			2022-02-06	
J	Pogoda, TK; Carlson, KF; Gormley, KE; Resnick, SG				Pogoda, Terri K.; Carlson, Kathleen F.; Gormley, Katelyn E.; Resnick, Sandra G.			Supported Employment for Veterans With Traumatic Brain Injury: Provider Perspectives	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury Summit	SEP 13, 2016	Falls Church, VA			Brain injuries, traumatic; Community integration; Employment, supported; Rehabilitation; Veterans	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; RANDOMIZED CONTROLLED-TRIAL; POLYTRAUMA REHABILITATION; VOCATIONAL-REHABILITATION; FREEDOM VETERANS; FOLLOW-UP; RETURN; AFFAIRS; WORK	Objective: To identify any pilot and nonpilot site differences regarding current (1) provision of supported employment (SE) to veterans with traumatic brain injury (TBI); (2) staffing and communication between the SE and polytrauma/TBI teams; and (3) provider perceptions on facilitators and barriers to providing, and suggestions for improving, SE. Design: Mixed methods cross-sectional survey study. Setting: Veterans Health Administration SE programs. Participants: Respondents (N=144) included 54 SE supervisors and 90 vocational rehabilitation specialists. Interventions: Not applicable. Main Outcome Measures: Web-based surveys of forced-choice and open-ended items included questions on SE team characteristics, communication with polytrauma/TBI teams, and experiences with providing SE to veterans with TBI history. Results: SE was provided to veterans with TBI at 100% of pilot and 59.2% of nonpilot sites (P=.09). However, vocational rehabilitation specialists at pilot sites reported that communication with the polytrauma/TBI team about SE referrals was more frequent than at nonpilot sites (P=.003). In open-ended items, suggestions for improving SE were similar across pilot and nonpilot sites, and included increasing staffing for vocational rehabilitation specialists and case management, enhancing communication and education between SE and polytrauma/TBI teams, and expanding the scope of the SE program so that eligibility is based on employment support need, rather than diagnosis. Conclusions: These findings may contribute to an evidence base that informs SE research and clinical directions on service provision, resource allocation, team integration efforts, and outreach to veterans with TBI who have employment support needs. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Pogoda, Terri K.; Gormley, Katelyn E.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Bldg 9,Off 218,150 S Huntington Ave,152M, Boston, MA 02130 USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA; [Carlson, Kathleen F.] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, Portland, OR USA; [Carlson, Kathleen F.] VA Portland Hlth Care Syst, Natl Ctr Rehabilitat Auditory Res, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Portland State Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Resnick, Sandra G.] VA Connecticut Healthcare Syst, Res & Clin Ctr, New England Mental Illness, West Haven, CT USA; [Resnick, Sandra G.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA		Pogoda, TK (corresponding author), VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Bldg 9,Off 218,150 S Huntington Ave,152M, Boston, MA 02130 USA.	terri.pogoda@va.gov	Resnick, Sandra G/F-3883-2014; Pogoda, Terri/F-6243-2012	Resnick, Sandra G/0000-0001-6373-1482; Pogoda, Terri/0000-0003-1397-8780	VA Health Services Research & Development Center for Healthcare Organization and Implementation Research; American Congress of Rehabilitation Medicine	Supported by the VA Health Services Research & Development Center for Healthcare Organization and Implementation Research.; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Amara J, 2014, WOMEN HEALTH ISS, V24, pE171, DOI 10.1016/j.whi.2013.12.004; Becker DR, 2007, J VOCAT REHABIL, V27, P13; Bond GR, 2014, ADM POLICY MENT HLTH, V41, P69, DOI 10.1007/s10488-012-0444-6; Bond GR, 2012, PSYCHIAT SERV, V63, P758, DOI 10.1176/appi.ps.201100476; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Carlson KF, 2018, ARCH PHYS MED REHAB, V99, pS4, DOI 10.1016/j.apmr.2017.06.027; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cotner BA, 2017, DISABIL REHABIL, P1; Davis LL, 2012, PSYCHIAT SERV, V63, P464, DOI 10.1176/appi.ps.201100340; Defense and Veterans Brain Injury Center, 2016, DOD NUMB TRAUM BRAIN; Defense & Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBI; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Dillman D. A., 2000, MAIL INTERNET SURVEY, V2; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Drake RE, 2012, INDIVIDUAL PLACEMENT; Ellison ML, 2012, PSYCHIATR REHABIL J, V35, P209, DOI 10.2975/35.3.2012.209.217; Epidemiology Program Post-Deployment Health Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2015, AN VA HLTH CAR UT OP; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; O'Connor MK, 2016, J REHABIL RES DEV, V53, P307, DOI 10.1682/JRRD.2014.10.0231; Ottomanelli L, 2012, ARCH PHYS MED REHAB, V93, P740, DOI 10.1016/j.apmr.2012.01.002; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Pogoda TK, 2011, PSYCHIAT SERV, V62, P1289, DOI 10.1176/ps.62.11.pss6211_1289; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Powell BJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0209-1; Resnick SG, 2007, J REHABIL RES DEV, V44, P867, DOI 10.1682/JRRD.2007.02.0043; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Smith-Osborne A, 2012, J REHABIL, V78, P4; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strasser DC, 2008, ARCH PHYS MED REHAB, V89, P179, DOI 10.1016/j.apmr.2007.06.774; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; Weham P, 1997, SUPPORTED EMPLOYMENT; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; WEHMAN P, 1994, AM J PHYS MED REHAB, V73, P280, DOI 10.1097/00002060-199407000-00010; WEHMAN P, 1989, J APPL BEHAV ANAL, V22, P395, DOI 10.1901/jaba.1989.22-395; WEHMAN PH, 1991, ARCH PHYS MED REHAB, V72, P101; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	57	10	10	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2		1			S14	S22		10.1016/j.apmr.2017.06.029			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	FU7YY	WOS:000424069900003	28784357	Green Submitted			2022-02-06	
J	Tamura, K; Kocher, M; Finer, L; Murata, N; Stickley, C				Tamura, Kaori; Kocher, Morgan; Finer, Liana; Murata, Nathan; Stickley, Christopher			Reliability of clinically feasible dual-task tests: Expanded timed get up and go test as a motor task on young healthy individuals	GAIT & POSTURE			English	Article						Concussion; Attention capacity; Walking; Gait	GAIT BALANCE CONTROL; TEST-RETEST RELIABILITY; COGNITIVE TASK; CONCUSSION ASSESSMENT; EXECUTIVE FUNCTION; PERFORMANCE; ADOLESCENTS; STABILITY; DISEASE; ADULTS	Dual-Task testing has been reported to have a higher sensitivity to deficits associated with concussion; however, the feasibility as a clinical or field test is questionable due to the requirements of laboratory-based equipment. With an overarching goal of exploration of clinically feasible Dual-Task testing options, the specific aims of this study were 1) to evaluate the reliability of Dual-Task testing methods using the Expanded Timed Get-Up-and-Go (ETGUG) paired with Backward Digit Recall (BDR), Serial Seven (SS), and Auditory Pure Switch Task (APST), and 2) to determine the effects of Dual-Task testing on motor and cognitive performance in healthy college-aged individuals. Fifty-four healthy young adults completed two separate testing sessions, which consisted of Single-Task tests in a randomized order followed by 3 pairs of Dual-Task tests in a randomized order. Test-retest reliability for ETGUG time to completion was excellent for all Single-and Dual-Task conditions (ICC 0.89-0.92); however, ETGUGBDR and ETGUGSS were associated with learning effects (p = 0.002 and 0.007, respectively). Test-retest reliability for Response Rate of the cognitive tasks was lower than those of motor task and all outcomes were associated with learning effects. The completion time of the ETGUG(APST) pair indicated excellent reliability with no learning effect. Performance level declined in all tasks under Dual-Task conditions compared to Single-Task; however, motor tasks showed larger deficits indicating the prioritization of the cognitive task compared to the motor task.	[Tamura, Kaori; Kocher, Morgan; Finer, Liana; Murata, Nathan; Stickley, Christopher] Univ Hawaii Manoa, Dept Kinesiol & Rehabil Sci, 1337 Lower Campus Rd,PE-A 231, Honolulu, HI 96822 USA		Tamura, K (corresponding author), 1337 Lower Campus Rd,PE-A 231, Honolulu, HI 96822 USA.	ktamura@hawaii.edu; morganhk@hawaii.edu; lfiner@ahct.k12.hi.us; nmurata@hawaii.edu; cstickle@hawaii.edu					ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Bleom BR, 2006, J NEUROL SCI, V248, P196, DOI 10.1016/j.jns.2006.05.010; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; MANNING RT, 1982, ARCH INTERN MED, V142, P1192; Muhaidat J, 2013, GAIT POSTURE, V38, P43, DOI 10.1016/j.gaitpost.2012.10.011; Okumura MS, 2013, MED SCI SPORT EXER, V45, P1038, DOI 10.1249/MSS.0b013e318281e1fb; Patel P, 2014, NEUROSCIENCE, V260, P140, DOI 10.1016/j.neuroscience.2013.12.016; Plummer P, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00225; Plummer P, 2015, GAIT POSTURE, V41, P964, DOI 10.1016/j.gaitpost.2015.03.348; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Ross LM, 2011, J SPORT REHABIL, V20, P296, DOI 10.1123/jsr.20.3.296; Sheridan PL, 2003, J AM GERIATR SOC, V51, P1633, DOI 10.1046/j.1532-5415.2003.51516.x; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Strouwen C, 2016, PHYS THER, V96, P1276, DOI 10.2522/ptj.20150244; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; TORGESEN JK, 1980, J EDUC PSYCHOL, V72, P141, DOI 10.1037/0022-0663.72.2.141; Toulotte C, 2006, CLIN REHABIL, V20, P269, DOI 10.1191/0269215506cr929oa; Wall JC, 2000, J REHABIL RES DEV, V37, P109	29	10	12	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	FEB	2018	60						22	27		10.1016/j.gaitpost.2017.11.002			6	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	FW2JQ	WOS:000425129400005	29132071				2022-02-06	
J	Vogt, N; Herden, C; Roeb, E; Roderfeld, M; Eschbach, D; Steinfeldt, T; Wulf, H; Ruchholtz, S; Uhl, E; Scholler, K				Vogt, Nina; Herden, Christiane; Roeb, Elke; Roderfeld, Martin; Eschbach, Daphne; Steinfeldt, Thorsten; Wulf, Hinnerk; Ruchholtz, Steffen; Uhl, Eberhard; Schoeller, Karsten			CEREBRAL ALTERATIONS FOLLOWING EXPERIMENTAL MULTIPLE TRAUMA AND HEMORRHAGIC SHOCK	SHOCK			English	Article						Biomarker; cerebral monitoring; hypothermia; microglia; porcine trauma model	NEURON-SPECIFIC-ENOLASE; BRAIN-INJURY; VALPROIC ACID; RESUSCITATION; MODEL; HYPOTHERMIA; RECOVERY; SURVIVAL; PLASMA; SWINE	Multiple trauma (MT) associated with hemorrhagic shock (HS) might lead to cerebral hypoperfusion and brain damage. We investigated cerebral alterations using a new porcine MT/HS model without traumatic brain injury (TBI) and assessed the neuroprotective properties of mild therapeutic hypothermia. Male pigs underwent standardized MT with HS (45% or 50% loss of blood volume) and resuscitation after 90/120 min (T90/T120). In additional groups (TH90/TH120) mild hypothermia (33 degrees C) was induced following resuscitation. Normothermic or hypothermic sham animals served as controls. Intracranial pressure, cerebral perfusion pressure (CPP), and cerebral oxygenation (PtiO2) were recorded up to 48.5 h. Serum protein S-100B and neuron-specific enolase (NSE) were measured by ELISA. Cerebral inflammation was quantified on hematoxylin and eosin-stained brain slices; Iba1, S100, and inducible nitric oxide synthase (iNOS) expression was assessed using immunohistochemistry. Directly after MT/HS, CPP and PtiO2 were significantly lower in T90/T120 groups compared with sham. After resuscitation both parameters showed a gradual recovery. Serum protein S-100B and NSE increased temporarily as a result of MT/HS in T90 and T90/T120 groups, respectively. Cerebral inflammation was found in all groups. Iba1-staining showed significant microgliosis in T90 and T120 animals. iNOS-staining indicated a M1 polarization. Mild hypothermia reduced cerebral inflammation in the TH90 group, but resulted in increased iNOS activation. In this porcine long-term model, we did not find evidence of gross cerebral damage when resuscitation was initiated within 120 min after MT/HS without TBI. However, trauma-related microglia activation and M1 microglia polarization might be a consequence of temporary hypoxia/ischemia and further research is warranted to detail underlying mechanisms. Interestingly, mild hypothermia did not exhibit neuroprotective properties when initiated in a delayed fashion.	[Vogt, Nina; Uhl, Eberhard; Schoeller, Karsten] Justus Liebig Univ, Dept Neurosurg, Giessen Klin Str 33, D-35392 Giessen, Germany; [Herden, Christiane] Justus Liebig Univ Giessen, Inst Vet Pathol, Giessen, Germany; [Roeb, Elke; Roderfeld, Martin] Justus Liebig Univ, Dept Gastroenterol, Giessen, Germany; [Eschbach, Daphne; Ruchholtz, Steffen] Univ Hosp Marburg, Dept Hand Traumatol & Reconstruct Surg, Marburg, Germany; [Steinfeldt, Thorsten; Wulf, Hinnerk] Univ Hosp Marburg, Dept Anesthesiol, Marburg, Germany		Vogt, N (corresponding author), Justus Liebig Univ, Dept Neurosurg, Giessen Klin Str 33, D-35392 Giessen, Germany.	nina.k.vogt@neuro.med.uni-giessen.de		Roderfeld, Martin/0000-0002-3232-1277			Bambakidis T, 2016, J NEUROTRAUM, V33, P1514, DOI 10.1089/neu.2015.4163; Cavus E, 2010, RESUSCITATION, V81, P1183, DOI 10.1016/j.resuscitation.2010.05.018; Chien JC, 2011, J CHIN MED ASSOC, V74, P448, DOI 10.1016/j.jcma.2011.08.015; Debus F, 2015, DTSCH ARZTEBL INT, V112, P823, DOI 10.3238/arztebl.2015.0823; Dengl M, 2012, Acta Neurochir Suppl, V114, P165, DOI 10.1007/978-3-7091-0956-4_31; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Eschbach D, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0162-0; Frohlich M, 2014, J TRAUMA ACUTE CARE, V76, P1425, DOI 10.1097/TA.0000000000000224; Genet GF, 2017, J NEUROTRAUM, V34, P1054, DOI 10.1089/neu.2016.4574; Pinto FCG, 2015, ARQ NEURO-PSIQUIAT, V73, P499, DOI 10.1590/0004-282X20150039; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Hildebrand F, 2013, SHOCK, V40, P247, DOI 10.1097/SHK.0b013e3182a3cd74; Hoque N, 2015, PEDIATR RES, V77, P674, DOI 10.1038/pr.2015.31; Horst K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154788; Horst K, 2016, EUR J TRAUMA EMERG S, V42, P67, DOI 10.1007/s00068-015-0504-1; Horst K, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/126060; Hussmann B, 2014, INJURY, V45, pS39, DOI 10.1016/j.injury.2014.08.016; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Lee JH, 2016, NEUROBIOL DIS, V96, P248, DOI 10.1016/j.nbd.2016.09.013; Meybohm P, 2008, RESUSCITATION, V76, P449, DOI 10.1016/j.resuscitation.2007.09.002; Mutschler W, 2016, UNFALLCHIRURG, V119, P546, DOI 10.1007/s00113-016-0185-1; Ohrt-Nissen S, 2011, EMERG MED J, V28, P941, DOI 10.1136/emj.2010.091363; Orakcioglu B, 2010, NEUROSURGERY, V67, P1716, DOI 10.1227/NEU.0b013e3181f9bb5b; Pelinka LE, 2004, SHOCK, V22, P88, DOI 10.1097/01.shk.0000130157.34382.3f; Pelinka LE, 2003, SHOCK, V19, P422, DOI 10.1097/01.shk.0000055345.58165.52; Pfortmueller CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152822; Purins K, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00064; Purins K, 2012, NEUROCRIT CARE, V16, P462, DOI 10.1007/s12028-012-9675-3; Rehberg SC, 2013, EUR J TRAUMA EMERG S, V39, P405, DOI 10.1007/s00068-013-0279-1; Rice J, 2006, J TRAUMA, V61, P1085, DOI 10.1097/01.ta.0000236640.62893.fa; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Seo JW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-164; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Visser T, 2011, EUR J TRAUMA EMERG S, V37, P177, DOI 10.1007/s00068-010-0041-x; Wenzel V, 2000, J AM COLL CARDIOL, V35, P527, DOI 10.1016/S0735-1097(99)00562-8; Weuster M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/829195; Wong YC, 2015, SHOCK, V43, P157, DOI 10.1097/SHK.0000000000000279; Wutzler S, 2014, INJURY, V45, pS29, DOI 10.1016/j.injury.2014.08.014; Xanthos T, 2009, AM J EMERG MED, V27, P651, DOI 10.1016/j.ajem.2008.05.004; Yao B, 2014, NEUROCHEM RES, V39, P1263, DOI 10.1007/s11064-014-1308-0; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127	46	10	10	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	FEB	2018	49	2					164	173		10.1097/SHK.0000000000000943			10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	GC0RF	WOS:000429484600009	28682946				2022-02-06	
J	Bai, W; Li, W; Ning, YL; Li, P; Zhao, Y; Yang, N; Jiang, YL; Liang, ZP; Jiang, DP; Wang, Y; Zhang, M; Zhou, YG				Bai, Wei; Li, Wei; Ning, Ya-Lei; Li, Ping; Zhao, Yan; Yang, Nan; Jiang, Yu-Lin; Liang, Ze-Ping; Jiang, Dong-Po; Wang, Ying; Zhang, Meng; Zhou, Yuan-Guo			Blood glutamate levels are closely related to acute lung injury and Prognosis after stroke	FRONTIERS IN NEUROLOGY			English	Article						stroke; acute lung injury; blood glutamate; predictor; prognosis	RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; END-EXPIRATORY PRESSURE; SYMPTOM ONSET; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; BERLIN DEFINITION; PLASMA GLUTAMATE; HUMAN VOLUNTEERS	Background: Acute lung injury (ALI) is a serious complication of stroke that occurs with a high incidence. Our preclinical results indicated that ALI might be related to blood glutamate levels after brain injury. The purpose of this study was to assess dynamic changes in blood glutamate levels in patients with stroke and to determine the correlation between blood glutamate levels, ALI, and long-term prognosis after stroke. Methods: Venous blood samples were collected from controls and patients with stroke at admission and on the third and seventh day after the onset of stroke. Patients were followed for 3 months. The correlations among blood glutamate levels, severities of stroke and ALI, and long-term outcomes were analyzed, and the predictive values of blood glutamate levels and severity scores for ALI were assessed. Results: In this study, a total of 384 patients with stroke were enrolled, with a median age of 59 years. Patients showed significantly increased blood glutamate levels within 7 days of stroke onset (p < 0.05), and patients with more severe injuries showed higher blood glutamate levels. Moreover, blood glutamate levels were closely related to the occurrence (adjusted odds ratio, 3.022, p = 0.003) and severity (p < 0.001) of ALI and the long-term prognosis after stroke (p < 0.05), and they were a more accurate predictor of ALI than the more commonly used severity scores (p < 0.01). Conclusion: These results indicated that an increased blood glutamate level was closely related to the development of ALI and a poor prognosis after stroke.	[Bai, Wei; Ning, Ya-Lei; Li, Ping; Zhao, Yan; Yang, Nan; Jiang, Yu-Lin; Zhou, Yuan-Guo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Mol Biol Ctr, Chongqing, Peoples R China; [Bai, Wei; Li, Wei; Ning, Ya-Lei; Li, Ping; Zhao, Yan; Yang, Nan; Jiang, Yu-Lin; Liang, Ze-Ping; Jiang, Dong-Po; Wang, Ying; Zhang, Meng; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Li, Wei; Wang, Ying; Zhang, Meng] Third Mil Med Univ, Inst Surg Res, Dept Neurol, Chongqing, Peoples R China; [Liang, Ze-Ping; Jiang, Dong-Po] Third Mil Med Univ, Inst Surg Res, Dept ICU, Chongqing, Peoples R China		Zhou, YG (corresponding author), Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Mol Biol Ctr, Chongqing, Peoples R China.; Zhang, M; Zhou, YG (corresponding author), Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China.; Zhang, M (corresponding author), Third Mil Med Univ, Inst Surg Res, Dept Neurol, Chongqing, Peoples R China.	zhangmeng861@gmail.com; ygzhou@tmmu.edu.cn	Li, ping/J-6507-2019		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31171022]	This study was partially supported by the National Natural Science Foundation of China (31171022).	Aggarwal A, 2018, NEUROSURG REV, V41, P241, DOI 10.1007/s10143-017-0843-y; Aliprandi A, 2005, J CEREBR BLOOD F MET, V25, P513, DOI 10.1038/sj.jcbfm.9600039; Boehme AK, 2017, CIRC RES, V120, P472, DOI 10.1161/CIRCRESAHA.116.308398; Brosnan JT, 2000, J NUTR, V130, p988S, DOI 10.1093/jn/130.4.988S; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1387, DOI 10.1038/jcbfm.2011.4; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chow S-C, 2007, SAMPLE SIZE CALCULAT; Collard CD, 2002, J BIOL CHEM, V277, P14801, DOI 10.1074/jbc.M110557200; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Grasso S, 2007, AM J RESP CRIT CARE, V176, P761, DOI 10.1164/rccm.200702-193OC; Hankey GJ, 2017, LANCET, V389, P641, DOI 10.1016/S0140-6736(16)30962-X; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Lou MQ, 2013, CLIN NEUROL NEUROSUR, V115, P904, DOI 10.1016/j.clineuro.2012.09.001; MARRS TC, 1978, TOXICOLOGY, V11, P101, DOI 10.1016/S0300-483X(78)90739-4; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Meyer DM, 2015, J AM ASSOC NURSE PRA, V27, P351, DOI 10.1002/2327-6924.12198; Morrell CN, 2008, J EXP MED, V205, P575, DOI 10.1084/jem.20071474; Motyer R, 2017, J INTERN MED, V282, P537, DOI 10.1111/joim.12680; Muchada M, 2014, STROKE, V45, P1059, DOI 10.1161/STROKEAHA.113.004307; Newby LK, 1996, J AM COLL CARDIOL, V27, P1646; Oda S, 1996, ACTA NEUROCHIR, V138, P1050, DOI 10.1007/BF01412307; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Rogachev B, 2013, J NEUROSURG ANESTH, V25, P262, DOI 10.1097/ANA.0b013e318283f86a; Rogachev B, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.07.002; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Sahetya SK, 2017, AM J RESP CRIT CARE, V195, P1429, DOI 10.1164/rccm.201610-2035CI; Schaefer PW, 2015, AM J NEURORADIOL, V36, P259, DOI 10.3174/ajnr.A4103; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wang H, 2016, ONCOTARGET, V7, P52404, DOI 10.18632/oncotarget.10497; Wang YY, 2011, AM J PHYSIOL-ENDOC M, V300, pE155, DOI 10.1152/ajpendo.00301.2010; Wouters A, 2016, INT J STROKE, V11, P127, DOI 10.1177/1747493015607503; Young NH, 2011, NEUROCRIT CARE, V15, P623, DOI 10.1007/s12028-011-9550-7; Zlotnik A, 2011, J NEUROSURG ANESTH, V23, P45, DOI 10.1097/ANA.0b013e3181f82a8f	42	10	11	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 19	2018	8								755	10.3389/fneur.2017.00755			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT2RD	WOS:000422992800001	29403427	gold, Green Published			2022-02-06	
J	Zhang, W; Liu, LF; Xiong, YJ; Liu, YF; Yu, SB; Wu, CW; Guo, W				Zhang, Wei; Liu, Li-fu; Xiong, Yue-jiao; Liu, Yi-fan; Yu, Sheng-bo; Wu, Cheng-wei; Guo, Weihong			Effect of in vitro storage duration on measured mechanical properties of brain tissue	SCIENTIFIC REPORTS			English	Article							INJURY; SHEAR; ISCHEMIA; BEHAVIOR; DEFORMATION; COMPRESSION; TEMPERATURE; FEATURES; TENSION; MATTER	Accurate characterization of the mechanical properties of brain tissue is essential for understanding the mechanisms of traumatic brain injuries and developing protective gears or facilities. However, how storage conditions might affect the mechanical properties of brain tissue remains unclear. The objective of this study is to investigate the effect of in vitro storage duration on the mechanical performance of brain tissue since measurements are usually carried out in vitro. Differential Scanning Calorimetry (DSC) measurements and uniaxial compression mechanical experiments are carried out. The results indicate that, for brain tissue stored at 1 degrees C without any liquid medium, the bio-molecular interactions and the mechanical strength of both white and grey matter deteriorate with prolonged storage duration. Transmission Electron Microscopy (TEM) results reveal the degeneration of myelin sheaths and the vacuolization of cristae with prolonged storage duration, suggesting that the in vitro storage duration should be carefully controlled. The findings from this study might facilitate the development of guidelines and standards for the in vitro storage of brain tissue.	[Zhang, Wei; Liu, Li-fu; Xiong, Yue-jiao; Liu, Yi-fan; Wu, Cheng-wei] Dalian Univ Technol, Dept Engn Mech, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China; [Yu, Sheng-bo] Dalian Med Univ, Coll Basic Med Sci, Dept Anat, Dalian 116044, Peoples R China; [Guo, Weihong] Rutgers State Univ, Dept Ind & Syst Engn, Piscataway, NJ 08854 USA		Wu, CW (corresponding author), Dalian Univ Technol, Dept Engn Mech, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China.; Guo, W (corresponding author), Rutgers State Univ, Dept Ind & Syst Engn, Piscataway, NJ 08854 USA.	cwwu@dlut.edu.cn; wg152@rutgers.edu	WU, ChengWei/B-2590-2019; Guo, Weihong/AAW-7547-2020	WU, ChengWei/0000-0003-1284-9442; Guo, Weihong/0000-0001-8433-6326; Zhang, Wei/0000-0002-8475-3143	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [11572080, 51775541, 11772086]; NSFC of Liaoning Province [2015020198]; National Basic Research Program of ChinaNational Basic Research Program of China [2015CB057306]; Fundamental Research Funds for the Central Universities in China [DUT17ZD229]	This work was supported by the National Natural Science Foundation of China (NSFC Grant Nos 11572080, 51775541, 11772086), the NSFC of Liaoning Province (Grant No. 2015020198), the National Basic Research Program of China (Grant No. 2015CB057306), and the Fundamental Research Funds for the Central Universities in China (Grant No. DUT17ZD229). The sheep brain samples were provided by Dalian Shun Feng Farm, China.	Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Bognar G, 2009, J THERM ANAL CALORIM, V95, P769, DOI 10.1007/s10973-008-9413-4; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Carole B., 2008, THESIS; CHING TM, 1966, CRYOBIOLOGY, V2, P321, DOI 10.1016/S0011-2240(66)80120-7; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s; Estes M. S., 1970, RESPONSE BRAIN TISSU, V92; Ferencz A, 2011, THERMOCHIM ACTA, V525, P161, DOI 10.1016/j.tca.2011.08.005; Forte AE, 2017, BIOMECH MODEL MECHAN, V16, P907, DOI 10.1007/s10237-016-0860-8; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Garo A, 2007, BIORHEOLOGY, V44, P51; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; HERTZ L, 1981, J CEREBR BLOOD F MET, V1, P143, DOI 10.1038/jcbfm.1981.17; HEUSER D, 1985, BRIT J ANAESTH, V57, P23, DOI 10.1093/bja/57.1.23; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Ignatieva NY, 2004, THERMOCHIM ACTA, V422, P43, DOI 10.1016/j.tca.2004.04.030; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; Li K., 2015, PLOS ONE, V10; Li YF, 2017, SCI REP-UK, V7, DOI 10.1038/srep45192; Mcelhaney J. H., 1973, DYNAMIC CHARACTERIST, P215; METZ H, 1970, J BIOMECH, V3, P453, DOI 10.1016/0021-9290(70)90017-5; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Morell P., 1999, MYELIN FORMATION STR; Nicolle S, 2010, J MECH BEHAV BIOMED, V3, P630, DOI 10.1016/j.jmbbm.2010.07.010; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Nie X, 2013, INT J IMPACT ENG, V53, P56, DOI 10.1016/j.ijimpeng.2012.07.012; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Norberto A. M. D., 2016, MAYFIELD CLIN; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; PAMIDI MR, 1978, J BIOMECH ENG-T ASME, V100, P44, DOI 10.1115/1.3426188; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Rashid B, 2013, J BIOMECH, V46, P1276, DOI 10.1016/j.jbiomech.2013.02.014; Rashid B, 2012, J MECH BEHAV BIOMED, V14, P113, DOI 10.1016/j.jmbbm.2012.04.005; Sanborn B, 2012, J BIOMECH, V45, P434, DOI 10.1016/j.jbiomech.2011.12.017; Sasaki K, 2006, MEAT SCI, V72, P789, DOI 10.1016/j.meatsci.2005.09.020; Shen F, 2006, J BIOMECH ENG-T ASME, V128, P797, DOI 10.1115/1.2264393; Shreiber DI, 2009, BIOMECH MODEL MECHAN, V8, P311, DOI 10.1007/s10237-008-0137-y; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; Skrzynski S, 2009, J BIOPHYS; Susuki K., 2010, NATURE ED, V3, P59; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Weickenmeier J, 2017, J MECH BEHAV BIOMED, V76, P119, DOI 10.1016/j.jmbbm.2017.04.017; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024; Zhang W, 2016, J BIOMECH, V49, P3990, DOI 10.1016/j.jbiomech.2016.10.032; Zhang W, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/35/355708	60	10	10	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JAN 19	2018	8								1247	10.1038/s41598-018-19687-2			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1JJ	WOS:000422891000077	29352260	Green Published, gold			2022-02-06	
J	Park, S; Ryu, SH; Yoo, Y; Yang, JJ; Kwon, H; Youn, JH; Lee, JM; Cho, SJ; Lee, JY				Park, Soowon; Ryu, Seung-Ho; Yoo, Yongjoon; Yang, Jin-Ju; Kwon, Hunki; Youn, Jung-Hae; Lee, Jong-Min; Cho, Seong-Jin; Lee, Jun-Young			Neural predictors of cognitive improvement by multi-strategic memory training based on metamemory in older adults with subjective memory complaints	SCIENTIFIC REPORTS			English	Article							AUTOMATED 3-D EXTRACTION; TRAUMATIC BRAIN-INJURY; WHITE-MATTER INTEGRITY; ALZHEIMERS-DISEASE; CORTICAL THICKNESS; CORPUS-CALLOSUM; FUNCTIONAL CONNECTIVITY; INDIVIDUAL-DIFFERENCES; CEREBRAL-CORTEX; MRI DATA	Previous studies have indicated that memory training may help older people improve cognition. However, evidence regarding who will benefit from such memory trainings has not been fully discovered yet. Understanding the clinical and neural inter-individual differences for predicting cognitive improvement is important for maximizing the training efficacy of memory-training programs. The purpose of this study was to find the individual characteristics and brain morphological characteristics that predict cognitive improvement after a multi-strategic memory training based on metamemory concept. Among a total of 49 older adults, 39 participated in the memory-training program and 10 did not. All of them underwent brain MRIs at the entry of the training and received the neuropsychological tests twice, before and after the training. Stepwise regression analysis showed that lower years of education predicted cognitive improvement in the training group. In MRI, thinner cortices of precuneus, cuneus and posterior cingulate gyrus and higher white matter anisotropy of the splenium of corpus callosum predicted cognitive improvement in the training group. Old age, lower education level and individual differences in cortical thickness and white matter microstructure of the episodic memory network may predict outcomes following multi-strategic training.	[Park, Soowon] Sejong Univ, Dept Educ, Seoul, South Korea; [Ryu, Seung-Ho] Konkuk Univ, Med Ctr, Sch Med, Dept Psychiat, Seoul, South Korea; [Yoo, Yongjoon] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Yang, Jin-Ju; Kwon, Hunki; Lee, Jong-Min] Hanyang Univ, Dept Biomed Engn, Seoul, South Korea; [Kwon, Hunki] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Youn, Jung-Hae] CHA Univ, Grad Sch Clin Counseling Psychol, Pochon, South Korea; [Cho, Seong-Jin] Gachon Univ, Gil Med Ctr, Dept Psychiat, Incheon, South Korea; [Lee, Jun-Young] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Lee, Jun-Young] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea; [Lee, Jun-Young] SMG SNU Boramae Med Ctr, Dept Psychiat, Seoul, South Korea		Lee, JY (corresponding author), Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea.; Lee, JY (corresponding author), Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea.; Lee, JY (corresponding author), SMG SNU Boramae Med Ctr, Dept Psychiat, Seoul, South Korea.	benji@snu.ac.kr	Lee, Jun-Young/N-5963-2019; Lee, Jeong Min/V-3429-2019; Yoo, Yongjoon/P-6767-2016	Lee, Jun-Young/0000-0002-5893-3124; Lee, Jeong Min/0000-0003-0561-8777; Park, Soowon/0000-0002-3348-940X; Yoo, Yongjoon/0000-0001-6193-5262	National Research Foundation of Korea (NRF) - Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of KoreaNational Research Foundation of Korea [2010-0025695]; National Research Foundation of Korea (NRF) - Korea government(MSIP) [2016R1A2B3016609]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant No. 2010-0025695). This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government(MSIP) (2016R1A2B3016609). All data created during this research are openly available from the data archive.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P495, DOI 10.1016/S0887-6177(99)00040-2; Arenaza-Urquijo EM, 2013, NEUROIMAGE, V83, P450, DOI 10.1016/j.neuroimage.2013.06.053; Baldassarre A, 2012, P NATL ACAD SCI USA, V109, P3516, DOI 10.1073/pnas.1113148109; Belleville S, 2006, DEMENT GERIATR COGN, V22, P486, DOI 10.1159/000096316; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chey J., 2007, ELDERLY MEMORY DISOR; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Chung T, 2013, PSYCHOL ADDICT BEHAV, V27, P533, DOI 10.1037/a0026716; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; de Lange FP, 2008, BRAIN, V131, P2172, DOI 10.1093/brain/awn140; Delazer M, 2005, NEUROIMAGE, V25, P838, DOI 10.1016/j.neuroimage.2004.12.009; Di Paola M, 2010, J ALZHEIMERS DIS, V20, P67, DOI 10.3233/JAD-2010-1370; Engvig A, 2012, NEUROIMAGE, V61, P188, DOI 10.1016/j.neuroimage.2012.02.072; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frisoni GB, 2011, NAT REV NEUROL, V7, P429, DOI 10.1038/nrneurol.2011.99; Fryer SL, 2008, BRAIN COGNITION, V67, P225, DOI 10.1016/j.bandc.2008.01.009; Jaeggi SM, 2014, MEM COGNITION, V42, P464, DOI 10.3758/s13421-013-0364-z; Kabani N, 2001, NEUROIMAGE, V13, P375, DOI 10.1006/nimg.2000.0652; Kaszniak AW, 1996, LEARN INDIVID DIFFER, V8, P355, DOI 10.1016/S1041-6080(96)90023-0; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kondo Y, 2005, NEUROIMAGE, V24, P1154, DOI 10.1016/j.neuroimage.2004.10.033; Kotter R, 2000, PHILOS T ROY SOC B, V355, P127, DOI 10.1098/rstb.2000.0553; Lachman ME, 2006, CURR DIR PSYCHOL SCI, V15, P282, DOI 10.1111/j.1467-8721.2006.00453.x; Lee JK, 2006, NEUROIMAGE, V31, P572, DOI 10.1016/j.neuroimage.2005.12.044; 이동영, 2002, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V41, P508; Legge ELG, 2012, ACTA PSYCHOL, V141, P380, DOI 10.1016/j.actpsy.2012.09.002; Lerch JP, 2005, CEREB CORTEX, V15, P995, DOI 10.1093/cercor/bhh200; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Lindauer RJL, 2005, PSYCHOL MED, V35, P1421, DOI 10.1017/S0033291705005246; Luo J, 2003, CHINESE SCI BULL, V48, P144, DOI 10.1360/03tb9029; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Madden DJ, 2009, J COGNITIVE NEUROSCI, V21, P289, DOI 10.1162/jocn.2009.21047; Mesulam M, 2000, BRAIN COGNITION, V42, P4, DOI 10.1006/brcg.1999.1145; Nelson T.O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Penke L, 2010, BEHAV GENET, V40, P146, DOI 10.1007/s10519-009-9318-4; Petersen R C, 1997, Int Psychogeriatr, V9 Suppl 1, P65, DOI 10.1017/S1041610297004717; Robbins S, 2004, MED IMAGE ANAL, V8, P311, DOI 10.1016/j.media.2004.06.009; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Sexton CE, 2010, PSYCHIAT RES-NEUROIM, V184, P57, DOI 10.1016/j.pscychresns.2010.07.005; Shin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121702; Singh V, 2006, BRAIN, V129, P2885, DOI 10.1093/brain/awl256; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; SNOW RE, 1991, J CONSULT CLIN PSYCH, V59, P205, DOI 10.1037/0022-006X.59.2.205; Sorg SF, 2012, BIOL PSYCHIAT, V71, P262, DOI 10.1016/j.biopsych.2011.09.022; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Supekar K, 2013, P NATL ACAD SCI USA, V110, P8230, DOI 10.1073/pnas.1222154110; Ventura-Campos N, 2013, J NEUROSCI, V33, P9295, DOI 10.1523/JNEUROSCI.4655-12.2013; VERHAEGHEN P, 1992, PSYCHOL AGING, V7, P242, DOI 10.1037/0882-7974.7.2.242; Ward N., 2017, SCI REP, V7, P1; Wolk DA, 2010, BEHAV NEUROL, V16, P15; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yamashita M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07622; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Youn JH, 2011, PSYCHIAT INVEST, V8, P354, DOI 10.4306/pi.2011.8.4.354; Zijdenbos A, 1996, LECT NOTES COMPUT SC, V1131, P439; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283	65	10	11	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JAN 18	2018	8								1095	10.1038/s41598-018-19390-2			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS9LI	WOS:000422739300058	29348440	gold, Green Published			2022-02-06	
J	Tu, TW; Ibrahim, WG; Jikaria, N; Munasinghe, JP; Witko, JA; Hammoud, DA; Frank, JA				Tu, Tsang-Wei; Ibrahim, Wael G.; Jikaria, Neekita; Munasinghe, Jeeva P.; Witko, Jaclyn A.; Hammoud, Dima A.; Frank, Joseph A.			On the detection of cerebral metabolic depression in experimental traumatic brain injury using Chemical Exchange Saturation Transfer (CEST)-weighted MRI	SCIENTIFIC REPORTS			English	Article							AMIDE PROTON-TRANSFER; INTENSIVE INSULIN THERAPY; GLUCOSE-METABOLISM; TRANSFER CEST; IN-VIVO; COMBINED MICRODIALYSIS; MAGNETIZATION-TRANSFER; EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; DIFFUSION TENSOR	Metabolic abnormalities are commonly observed in traumatic brain injury (TBI) patients exhibiting long-term neurological deficits. This study investigated the feasibility and reproducibility of using chemical exchange saturation transfer (CEST) MRI to detect cerebral metabolic depression in experimental TBI. Phantom and in vivo CEST experiments were conducted at 9.4 Tesla to optimize the selective saturation for enhancing the endogenous contrast-weighting of the proton exchanges over the range of glucose proton chemical shifts (glucoCEST) in the resting rat brain. The optimized glucoCEST-weighted imaging was performed on a closed-head model of diffuse TBI in rats with 2-deoxy-D-[C-14]-glucose (2DG) autoradiography validation. The results demonstrated that saturation duration of 1-2 seconds at pulse powers 1.5-2 mu T resulted in an improved contrast-to-noise ratio between the gray and white matter comparable to 2DG autoradiographs. The intrasubject (n = 4) and intersubject (n = 3) coefficient of variations for repeated glucoCEST acquisitions (n = 4) ranged between 8-16%. Optimization for the TBI study revealed that glucoCEST-weighted images with 1.5 mu T power and 1 s saturation duration revealed the greatest changes in contrast before and after TBI, and positively correlated with 2DG autoradiograph (r = 0.78, p < 0.01, n = 6) observations. These results demonstrate that glucoCEST-weighted imaging may be useful in detecting metabolic abnormalities following TBI.	[Tu, Tsang-Wei; Jikaria, Neekita; Witko, Jaclyn A.; Frank, Joseph A.] NIH, Frank Lab, Radiol & Imaging Sci, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA; [Tu, Tsang-Wei; Jikaria, Neekita; Witko, Jaclyn A.] Henry Jackson Fdn, Ctr Neurosci & Regenerat Med, Bethesda, MD 20817 USA; [Tu, Tsang-Wei] Howard Univ, Dept Radiol, Mol Imaging Lab, Washington, DC 20059 USA; [Ibrahim, Wael G.; Hammoud, Dima A.] NIH, Ctr Infect Dis Imaging Radiol & Imaging Sci, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA; [Jikaria, Neekita] NINDS, Acute Stroke Res Sect, NIH, Bethesda, MD 20892 USA; [Munasinghe, Jeeva P.] NINDS, Mouse Imaging Facil, NIH, Bethesda, MD 20892 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA		Tu, TW (corresponding author), NIH, Frank Lab, Radiol & Imaging Sci, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA.; Tu, TW (corresponding author), Henry Jackson Fdn, Ctr Neurosci & Regenerat Med, Bethesda, MD 20817 USA.; Tu, TW (corresponding author), Howard Univ, Dept Radiol, Mol Imaging Lab, Washington, DC 20059 USA.	tut@howard.edu	Frank, Joseph/W-2021-2019; frank, joseph/AAJ-6680-2020; Hammoud, Dima A/C-2286-2015	Hammoud, Dima/0000-0001-7406-7871	Department of Defense through the Center for Neuroscience and Regenerative Medicine (USU) [CNRM-89-3899]; Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation) [308049-10.01-60855]; National Institute of Biomedical Imaging and Bioengineering at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Intramural Research Programs of the Clinical Center at the National Institutes of Health; CLINICAL CENTER [ZIACL040014, ZICCL040013, ZIACL090020] Funding Source: NIH RePORTER	The author would like to thank Dr. Dana D. Dean and Dr. Maria M. Hipolito for constructive criticism of the manuscript. Thanks to Ms. Rashida A. Williams for her assistance in data acquisition. This work was supported by funding from the Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation Award #308049-10.01-60855, USU Site No. CNRM-89-3899) and from the Intramural Research Programs of the Clinical Center and of the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health.	Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bonvento G, 2017, J CEREBR BLOOD F MET, V37, P1927, DOI 10.1177/0271678X17697989; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; Chan KWY, 2012, MAGN RESON MED, V68, P1764, DOI 10.1002/mrm.24520; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; Desmond KL, 2014, MAGN RESON MED, V71, P1841, DOI 10.1002/mrm.24822; Dula AN, 2015, RADIOLOGY, V275, P255, DOI 10.1148/radiol.14140762; Dula AN, 2013, J NEUROIMAGING, V23, P526, DOI 10.1111/j.1552-6569.2012.00751.x; Dula AN, 2013, MAGN RESON MED, V70, P216, DOI 10.1002/mrm.24450; Dula AN, 2011, MAGN RESON MED, V66, P831, DOI 10.1002/mrm.22862; Duncan GE, 1999, BRAIN RES, V843, P171, DOI 10.1016/S0006-8993(99)01776-X; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Guivel-Scharen V, 1998, J MAGN RESON, V133, P36, DOI 10.1006/jmre.1998.1440; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Haris M, 2011, NEUROIMAGE, V54, P2079, DOI 10.1016/j.neuroimage.2010.10.017; Hattori N, 2003, J NUCL MED, V44, P1709; Heo HY, 2017, MAGN RESON MED, V77, P1853, DOI 10.1002/mrm.26264; Heo HY, 2016, J MAGN RESON IMAGING, V44, P41, DOI 10.1002/jmri.25108; Heo HY, 2016, MAGN RESON MED, V75, P1630, DOI 10.1002/mrm.25795; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jin T, 2014, J CEREBR BLOOD F MET, V34, P1402, DOI 10.1038/jcbfm.2014.97; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kim J, 2015, CONTRAST MEDIA MOL I, V10, P163, DOI 10.1002/cmmi.1628; Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873; Klomp DWJ, 2013, NMR BIOMED, V26, P1271, DOI 10.1002/nbm.2947; Kogan Feliks, 2013, Curr Radiol Rep, V1, P102; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Liu GS, 2013, NMR BIOMED, V26, P810, DOI 10.1002/nbm.2899; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Messier C, 1996, BEHAV BRAIN RES, V75, P1, DOI 10.1016/0166-4328(95)00153-0; Moro N, 2016, BRAIN RES, V1642, P270, DOI 10.1016/j.brainres.2016.04.005; Nasrallah FA, 2013, J CEREBR BLOOD F MET, V33, P1270, DOI 10.1038/jcbfm.2013.79; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Prieto E, 2011, EUR J NUCL MED MOL I, V38, P2228, DOI 10.1007/s00259-011-1905-y; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00091; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; SCHWARTZ WJ, 1978, J COMP NEUROL, V177, P335, DOI 10.1002/cne.901770210; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; SILVER IA, 1994, J NEUROSCI, V14, P5068; Singh A, 2013, MAGN RESON MED, V69, P818, DOI 10.1002/mrm.24290; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sun PZ, 2013, PHYS MED BIOL, V58, pN229, DOI 10.1088/0031-9155/58/17/N229; Sun PZ, 2005, J MAGN RESON, V175, P193, DOI 10.1016/j.jmr.2005.04.005; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Tu TW, 2014, J NEUROPATH EXP NEUR, V73, P1152, DOI 10.1097/NEN.0000000000000140; van Zijl PCM, 2007, P NATL ACAD SCI USA, V104, P4359, DOI 10.1073/pnas.0700281104; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vissing J, 1996, J CEREBR BLOOD F MET, V16, P729, DOI 10.1097/00004647-199607000-00025; Walker-Samuel S, 2013, NAT MED, V19, P1067, DOI 10.1038/nm.3252; Wang F, 2016, MAGN RESON MED, V76, P1531, DOI 10.1002/mrm.26045; Wang JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30618; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Xu X, 2015, TOMOGRAPHY, V1, P105, DOI 10.18383/j.tom.2015.00175; Zafar SN, 2011, J NEUROTRAUM, V28, P1307, DOI 10.1089/neu.2010.1724; Zaiss M, 2011, J MAGN RESON, V211, P149, DOI 10.1016/j.jmr.2011.05.001; Zhuang HM, 2001, J NUCL MED, V42, P1412; Zu ZL, 2014, MAGN RESON IMAGING, V32, P1078, DOI 10.1016/j.mri.2014.06.002	83	10	10	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JAN 12	2018	8								669	10.1038/s41598-017-19094-z			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS6YX	WOS:000419945400110	29330386	Green Published, gold			2022-02-06	
J	Bedard, M; Taler, V; Steffener, J				Bedard, Marc; Taler, Vanessa; Steffener, Jason			Long-term prospective memory impairment following mild traumatic brain injury with loss of consciousness: findings from the Canadian Longitudinal Study on Aging	CLINICAL NEUROPSYCHOLOGIST			English	Article						Mild traumatic brain injury; loss of consciousness; cognitive impairment; prospective memory; executive functions	OLDER-ADULTS; GOOGLE CALENDAR; METAANALYSES; TASK; REHABILITATION; INVOLVEMENT; LIMITATIONS; INTENTIONS; RETRIEVAL; SYMPTOMS	Objective: We aimed to examine the extent to which loss of consciousness (LOC) following mild traumatic brain injury (mTBI) may be associated with impairments in time- and event-based prospective memory (PM). PM is thought to involve executive processes and be subserved by prefrontal regions. Neuroimaging research suggests alterations to these areas of the brain several years after mTBI, particularly if LOC was experienced. However, it remains unclear whether impairments in time- or event-based functioning may persist more than a year after mTBI, and what the link with duration of LOC may be. Method: Analyses were run on data from the Canadian Longitudinal Study on Aging, a nationwide study on health and aging involving individuals between the ages of 45-85. The present study consisted of 1937 participants who experienced mTBI more than 12 months prior, of whom 1146 reported spending less than 1 min unconscious, and 791 had LOC between 1 and 20 min, and 13,525 cognitively healthy adults. Participants were administered the Miami Prospective Memory Test, and tests of retrospective memory and executive functioning. Results: Both mTBI groups were impaired in time-based PM relative to people with no history of TBI. Time- and event-based impairments were predicted by older age, and executive dysfunction among those who spent more time unconscious. Conclusions: Those with mTBI with LOC may experience impairments in PM, particularly in conditions of high demand on executive processes (time-based PM). Implications for interventions aimed at ameliorating PM among those who have experienced mTBI are discussed.	[Bedard, Marc; Taler, Vanessa] Bruyere Res Inst, Ottawa, ON, Canada; [Bedard, Marc; Taler, Vanessa] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Steffener, Jason] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada		Taler, V (corresponding author), Univ Ottawa, Sch Psychol, Ottawa, ON, Canada.	vtaler@uottawa.ca			Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	This work was supported by the Canada Foundation for Innovation; Canadian Institutes of Health Research (CIHR).	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Baldwin VN, 2015, NEUROPSYCHOL REHABIL, V25, P617, DOI 10.1080/09602011.2014.956764; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; Gordon BA, 2011, NEUROPSYCHOLOGIA, V49, P3795, DOI 10.1016/j.neuropsychologia.2011.09.035; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hashimoto T, 2011, NEUROIMAGE, V54, P645, DOI 10.1016/j.neuroimage.2010.07.047; Hernandez Cardenache Rene, 2014, ISRN Neurol, V2014, P805929, DOI 10.1155/2014/805929; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kinsella GJ, 2014, J INT NEUROPSYCH SOC, V20, P663, DOI 10.1017/S1355617714000447; Kliegel M, 2008, PSYCHOL AGING, V23, P203, DOI 10.1037/0882-7974.23.1.203; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lowenstein D., 2004, PROSPECTIVE MEMORY T; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Maylor EA, 1996, PSYCHOL AGING, V11, P74, DOI 10.1037/0882-7974.11.1.74; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moscovitch Morris, 1994, P269; Neulinger K., 2002, BRAIN IMPAIR, V3, P1, DOI [10.1375/brim.3.1.1, DOI 10.1375/BRIM.3.1.1]; Oksanen KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092123; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Potvin MJ, 2011, NEUROPSYCHOL REHABIL, V21, P899, DOI 10.1080/09602011.2011.630882; Raina PS, 2009, CAN J AGING, V28, P221, DOI 10.1017/S0714980809990055; Regard M., 1981, THESIS; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Segev S, 2016, NEUROPSYCHOLOGY, V30, P800, DOI 10.1037/neu0000299; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Smith RE, 2006, J EXP PSYCHOL LEARN, V32, P623, DOI 10.1037/0278-7393.32.3.623; Smith RE, 2014, CONSCIOUS COGN, V27, P213, DOI 10.1016/j.concog.2014.05.003; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tabachnick B.G., 2013, USING MULTIVARIATE S; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Teng E.L., 1994, MENTAL ALTERNATION T; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thone-Otto A. I. T., 2008, PROSPECTIVE MEMORY C, P321; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z	66	10	10	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2018	32	5			SI		1002	1018		10.1080/13854046.2017.1404644			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GK3YK	WOS:000436086900013	29249173				2022-02-06	
J	Bier, G; Bongers, MN; Othman, A; Hempel, JM; Vieth, V; Heindel, W; Ernemann, U; Burg, MC				Bier, Georg; Bongers, Malte N.; Othman, Ahmed; Hempel, Johann-Martin; Vieth, Volker; Heindel, Walter; Ernemann, Ulrike; Burg, Matthias C.			Impact of helmet use in equestrian-related traumatic brain injury: a matched-pairs analysis	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Head trauma; computed tomography; equestrian-related injury; helmet; matched pairs analysis	HORSE-RELATED INJURIES; UNITED-STATES; COHORT METHODS; PATTERNS; SPORTS	Purpose: Traumatic brain injury is an important health concern in equestrian sports. Nevertheless, the use of safety helmets, especially in recreational riding, is reported to be rare. The purpose of this study was to perform the first matched-pairs analysis of traumatic brain injury with regard to the use of helmets. Materials and methods: In a multicenter retrospective database analysis 40 patients (mean age: 35 +/- 17.13 years; 34 female & 6 male) were combined in 20 matched pairs based on age group, gender and trauma mechanism. Admission trauma computed tomography was qualitatively analyzed for the presence or absence of fractures or intracranial hemorrhage. Quantitatively, in patients with intracranial hemorrhage dedicated volumetry of the blood volume was performed. Odds ratio and relative risk were calculated for the endpoints fractures and intracranial hemorrhage. Crude risk ratio and lesion volume differences between helmeted and unhelmeted riders were compared. Results: Concerning skull fractures, in this cohort 6 patients (85.7% of all patients with fractures) did not wear a helmet and only one (14.3%) wore a helmet (p = .068).and fractures were considered more complex in the unhelmeted subgroup. Intracranial hemorrhage occurred significantly more often in the unhelmeted subgroup (10 vs. 2; p =.008). Moreover, the total lesion volume with 19.31 +/- 23.93ml in the unhelmeted subgroup, presenting with intracranial hemorrhage, was significantly higher than in the control group (0.65 +/- 0.35m1; p -.002). Odds ratios were 9 for intracranial hemorrhage (p = .014) and 8.14 for skull fractures without helmet (p = .09). Altogether, the relative risk for intracranial bleeding for unhelmeted riders was 5-fold higher and the relative risk reduction was 96% by wearing a safety helmet. Conclusions: Under consideration of comparable trauma mechanisms, horseback riders that do not wear a safety helmet are at risk to suffer significantly more severe brain injury than helmeted riders. Therefore, safety helmets are recommendable for all horseback riders.	[Bier, Georg; Hempel, Johann-Martin; Ernemann, Ulrike] Eberhard Karls Univ Tuebingen, Dept Diagnost & Intervent Neuroradiol, Tubingen, Germany; [Bier, Georg; Heindel, Walter; Burg, Matthias C.] Univ Munster, Dept Clin Radiol, Munster, Germany; [Bongers, Malte N.; Othman, Ahmed] Eberhard Karls Univ Tuebingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Vieth, Volker] Hosp Ibbenbueren, Dept Radiol, Ibbenburen, Germany		Bier, G (corresponding author), Eberhard Karls Univ Tuebingen, Dept Diagnost & Intervent Neuroradiol, Tubingen, Germany.; Bier, G (corresponding author), Univ Munster, Dept Clin Radiol, Munster, Germany.	georg.bier@med.uni-tuebingen.de		Othman, Ahmed/0000-0002-3827-8695; othman, ahmed mohamed abdel ghany/0000-0002-0405-8918			Abu-Kishk Ibrahim, 2013, Isr Med Assoc J, V15, P169; Abu-Zidan FM, 2003, INJURY, V34, P897, DOI 10.1016/S0020-1383(03)00054-8; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; Bilaniuk JW, 2014, AM SURGEON, V80, P396; BOND GR, 1995, PEDIATRICS, V95, P487; CHRISTEY GL, 1994, J FAM PRACTICE, V39, P148; Cummings P, 2003, ACCIDENT ANAL PREV, V35, P131, DOI 10.1016/S0001-4575(01)00108-7; Cummings P, 2003, ACCIDENT ANAL PREV, V35, P143, DOI 10.1016/S0001-4575(01)00087-2; Fleming PRI, 2001, CLIN EXP OPHTHALMOL, V29, P208, DOI 10.1046/j.1442-9071.2001.00430.x; Ghosh A, 2000, J PEDIATR SURG, V35, P1766, DOI 10.1053/jpsu.2000.19247; Griffen M, 2002, SOUTHERN MED J, V95, P441, DOI 10.1097/00007611-200204000-00013; Hasler Rebecca M, 2011, J Trauma Manag Outcomes, V5, P4, DOI 10.1186/1752-2897-5-4; Havlik HS, 2010, CURR SPORT MED REP, V9, P299, DOI 10.1249/JSR.0b013e3181f32056; Loder RT, 2008, J TRAUMA, V65, P447, DOI 10.1097/TA.0b013e31817dac43; McGhee C N, 1987, Br J Neurosurg, V1, P131, DOI 10.3109/02688698709034348; Norvell DC, 2002, AM J EPIDEMIOL, V156, P483, DOI 10.1093/aje/kwf081; Petridou E, 2004, J TRAUMA, V56, P643, DOI 10.1097/01.TA.0000053470.38129.F4; Rathor MY, 2012, J RES MED SCI, V17, P1056; Ross DS, 2010, CURR SPORT MED REP, V9, P342, DOI 10.1249/JSR.0b013e3181fc7357; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Schroter C, 2017, UNFALLCHIRURG, V120, P129, DOI 10.1007/s00113-015-0074-z; Sorli J M, 2000, Inj Prev, V6, P59, DOI 10.1136/ip.6.1.59; Srinivasan V, 2014, NEUROL RES, V36, P873, DOI 10.1179/1743132814Y.0000000373; Starling M, 2016, ANIMALS, V6, DOI 10.3390/ani6030015; Thomas KE, 2006, BRIT J SPORT MED, V40, P619, DOI 10.1136/bjsm.2006.025858; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; Watt GM, 1996, SPORTS MED, V22, P187, DOI 10.2165/00007256-199622030-00005; Whitlock M R, 1987, Br J Sports Med, V21, P25; Winkler EA, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15613; Zuckerman SL, 2015, WORLD NEUROSURG, V83, P1098, DOI 10.1016/j.wneu.2014.12.030	30	10	10	2	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2018	32	1					37	43		10.1080/02688697.2017.1409874			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GH0WQ	WOS:000433123300008	29205071				2022-02-06	
J	Chen, ST; Siddarth, P; Merrill, DA; Martinez, J; Emerson, ND; Liu, J; Wong, KP; Satyamurthy, N; Giza, CC; Huang, SC; Fitzsimmons, RP; Bailes, J; Omalu, B; Barrio, JR; Small, GW				Chen, Stephen T.; Siddarth, Prabha; Merrill, David A.; Martinez, Jacqueline; Emerson, Natacha D.; Liu, Jie; Wong, Koon-Pong; Satyamurthy, Nagichettiar; Giza, Christopher C.; Huang, Sung-Cheng; Fitzsimmons, Robert P.; Bailes, Julian; Omalu, Bennet; Barrio, Jorge R.; Small, Gary W.			FDDNP-PET Tau Brain Protein Binding Patterns in Military Personnel with Suspected Chronic Traumatic Encephalopathy	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; brain tau and amyloid; chronic traumatic encephalopathy; FDDNP-PET; mild traumatic brain injury; military personnel; retired professional football players	POSTTRAUMATIC-STRESS-DISORDER; MILD COGNITIVE IMPAIRMENT; DISEASE; INJURY; NEUROPATHOLOGY; TAUOPATHIES; DEPRESSION; DIAGNOSIS; IRAQ	Background: Our group has shown that in vivo tau brain binding patterns from FDDNP-PET scans in retired professional football players with suspected chronic traumatic encephalopathy differ from those of tau and amyloid aggregate binding observed in Alzheimer's disease (AD) patients and cognitively-intact controls. Objective: To compare these findings with those from military personnel with histories of mild traumatic brain injury (mTBI). Methods: FDDNP-PET brain scans were compared among 7 military personnel and 15 retired players with mTBI histories and cognitive and/or mood symptoms, 24 AD patients, and 28 cognitively-intact controls. Nonparametric ANCOVAs with Tukey-Kramer adjusted post-hoc comparisons were used to test for significant differences in regional FDDNP binding among subject groups. Results: FDDNP brain binding was higher in military personnel compared to controls in the amygdala, midbrain, thalamus, pons, frontal and anterior and posterior cingulate regions (p < 0.01-0.0001). Binding patterns in the military personnel were similar to those of the players except for the amygdala and striatum (binding higher in players; p = 0.02-0.003). Compared with the AD group, the military personnel showed higher binding in the midbrain (p = 0.0008) and pons (p = 0.002) and lower binding in the medial temporal, lateral temporal, and parietal regions (all p = 0.02). Conclusion: This first study of in vivo tau and amyloid brain signals in military personnel with histories of mTBI shows binding patterns similar to those of retired football players and distinct from the binding patterns in AD and normal aging, suggesting the potential value of FDDNP-PET for early detection and treatment monitoring in varied at-risk populations.	[Chen, Stephen T.; Siddarth, Prabha; Merrill, David A.; Martinez, Jacqueline; Emerson, Natacha D.; Small, Gary W.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Siddarth, Prabha; Merrill, David A.; Martinez, Jacqueline; Emerson, Natacha D.; Small, Gary W.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, UCLA Longev Ctr, Los Angeles, CA 90024 USA; [Liu, Jie; Wong, Koon-Pong; Satyamurthy, Nagichettiar; Huang, Sung-Cheng; Barrio, Jorge R.] Univ Calif Los Angeles, Dept Med & Mol Pharmacol, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Fitzsimmons, Robert P.] Fitzsimmons Law Off, Wheeling, WV USA; [Bailes, Julian] North Shore Univ Hlth Syst, Dept Neurosurg, Evanston, IL USA; [Bailes, Julian] Univ Chicago, Pritzker Sch Med, Evanston, IL USA; [Omalu, Bennet] Univ Calif Davis, Sch Med, Dept Med Pathol & Lab Med, Sacramento, CA 95817 USA		Small, GW (corresponding author), Semel Inst, 760 Westwood Plaza, Los Angeles, CA 90024 USA.	gsmall@mednet.ucla.edu	Wong, Koon-Pong/AAI-3780-2020		Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research; Parlow-Solomon Professorship; Plott Professorship; Ahmanson Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01-AG025831, AG13308, P50 AG 16570, MH/AG58156, MH52453, AG10123, M01-RR00865]; UCLA CTSI [UL1TR000124]; NCAA; U.S. Department of DefenseUnited States Department of Defense; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); UCLA Steve Tisch Brain-SPORT Program; UCLA Easton Labs for Brain Injury; Avanir Pharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001881] Funding Source: NIH RePORTER	We thank John Williams, University of California, Los Angeles, Nuclear Medicine Clinic, for performing the PET scans; Vladimir Kepe, Cleveland Clinic, for developing the FDDNP PET analysis procedures for proteinopathies in patients with neurodegenerative diseases, including CTE; and Billy West, and Bus Cook for guidance with subject referral and for their helpful input. This study was supported by the Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research; the Parlow-Solomon (GWS) and Plott (JRB) Professorships; Bob and Marion Wilson; the Ahmanson Foundation; and the following grants: P01-AG025831, AG13308, P50 AG 16570, MH/AG58156, MH52453, AG10123, and M01-RR00865 from the National Institutes of Health; and the UCLA CTSI (grant no. UL1TR000124). CCG is supported by grants from NCAA, U.S. Department of Defense, NIH/NINDS, UCLA Steve Tisch Brain-SPORT Program, the UCLA Easton Labs for Brain Injury and Avanir Pharmaceuticals. These agencies were not involved in the approval and review of the manuscript or in the decision to submit the manuscript for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Barrio JR, 2009, ACCOUNTS CHEM RES, V42, P842, DOI 10.1021/ar800189x; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Boxer AL, 2007, NEUROLOGY, V69, P283, DOI 10.1212/01.wnl.0000265815.38958.b6; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hall B, 2017, AGEING RES REV, V36, P50, DOI 10.1016/j.arr.2017.03.002; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kepe V, 2013, J ALZHEIMERS DIS, V36, P145, DOI 10.3233/JAD-130032; Kepe V, 2010, BRAIN PATHOL, V20, P419, DOI 10.1111/j.1750-3639.2009.00306.x; Lavretsky H, 2009, AM J GERIAT PSYCHIAT, V17, P493, DOI 10.1097/JGP.0b013e3181953b82; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Marquie M, 2017, ANN NEUROL, V81, P117, DOI 10.1002/ana.24844; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Muller N, 2014, NEUROIMMUNOMODULAT, V21, P123, DOI 10.1159/000356540; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rabinak Christine A, 2011, Front Psychiatry, V2, P62, DOI 10.3389/fpsyt.2011.00062; Rowe CC, 2011, J NUCL MED, V52, P1733, DOI 10.2967/jnumed.110.076315; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Small GW, 2008, LANCET NEUROL, V7, P161, DOI 10.1016/S1474-4422(08)70019-X; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Small GW, 2012, ARCH NEUROL-CHICAGO, V69, P215, DOI 10.1001/archneurol.2011.559; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Smid LM, 2006, BRAIN PATHOL, V16, P124, DOI 10.1111/j.1750-3639.2006.00006.x; Sripada RK, 2012, J PSYCHIATR NEUROSCI, V37, P241, DOI 10.1503/jpn.110069; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vermeiren C., 2015, ALZHEIMERS DEMENTI S, V11, P283, DOI DOI 10.1016/J.JALZ.2015.07.381; Wieck A, 2014, NEUROIMMUNOMODULAT, V21, P145, DOI 10.1159/000356552; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	40	10	10	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2018	65	1					79	88		10.3233/JAD-171152			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GQ0TG	WOS:000441331600007	30040711	Green Accepted, Green Published			2022-02-06	
S	Debacker, J; Ventura, R; Galetta, SL; Balcer, LJ; Rucker, JC		Hainline, B; Stern, RA		Debacker, Julie; Ventura, Rachel; Galetta, Steven L.; Balcer, Laura J.; Rucker, Janet C.			Neuro-ophthalmologic disorders following concussion	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							VISUAL SCREENING TOOL; KING-DEVICK; OCULOMOTOR DEFICITS; EYE-MOVEMENTS; MILD; SACCADES; VISION; TESTS; DYSFUNCTION; SIDELINE	Visual symptoms, such as photophobia and blurred vision, are common in patients with concussion. Such symptoms may be accompanied by abnormalities of specific eye movements, such as saccades and convergence, or accommodation deficits. The high frequency of visual involvement in concussion is not surprising, since more than half of the brain's pathways are dedicated to vision and eye movement control. These areas include many that are most vulnerable to head trauma, including the frontal and temporal lobes. Vision and eye movement testing is important at the bedside and on the sidelines of athletic events, where brief performance measures that require eye movements, such as rapid number naming, are reliable and sensitive measures for concussion detection. Tests of vision and eye movements are also being explored clinically to identify and monitor patients with symptoms of both sport- and nonsport-related concussion. Evaluation of vision and eye movements can assist in making important decisions after concussion, including the prognosis for symptom recovery, and to direct further visual rehabilitation as necessary.	[Debacker, Julie; Ventura, Rachel; Galetta, Steven L.; Balcer, Laura J.; Rucker, Janet C.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Galetta, Steven L.; Balcer, Laura J.; Rucker, Janet C.] NYU, Sch Med, Ophthalmol, New York, NY 10003 USA; [Balcer, Laura J.] NYU, Sch Med, Populat Hlth, New York, NY 10003 USA		Rucker, JC (corresponding author), NYU, Sch Med, 240 East 38th St, New York, NY 10016 USA.	Janet.rucker@nyumc.org		Ventura, Rachel/0000-0001-8155-0546; Rucker, Janet/0000-0002-0397-0999			Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Capo-Aponte J.E., 2013, J SPINE, V4, DOI [10.4172/2165-7939.S4-004, DOI 10.4172/2165-7939.S4-004]; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cobbs L, 2017, J NEUROL SCI, V372, P393, DOI 10.1016/j.jns.2016.10.044; Crevits L, 2000, J NEUROL, V247, P179, DOI 10.1007/s004150050559; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta K.M., 2015, CONCUSSION, V1, P1; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Harrold GK, 2017, J NEUROL SCI, V379, P312, DOI 10.1016/j.jns.2017.06.038; Hasanaj L, 2018, J NEURO-OPHTHALMOL, V38, P24, DOI 10.1097/WNO.0000000000000533; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2001, J ATHL TRAINING, V36, P274; Mulhall LE, 1999, J NEURO-OPHTHALMOL, V19, P160; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5	38	10	10	0	3	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						145	152		10.1016/B978-0-444-63954-7.00015-X			8	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100017	30482342				2022-02-06	
J	Dewar, BK; Kapur, N; Kopelman, M				Dewar, Bonnie-Kate; Kapur, Narinder; Kopelman, Michael			Do memory aids help everyday memory? A controlled trial of a Memory Aids Service	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Memory; rehabilitation; compensatory aid; training	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; MILD COGNITIVE IMPAIRMENT; HEALTH-CARE-SYSTEM; PAGING SYSTEM; ASSISTIVE TECHNOLOGY; TRAINING-PROGRAM; SELF-AWARENESS; FOLLOW-UP; REHABILITATION	There is a growing body of knowledge about the use of compensatory memory aids in memory rehabilitation, but relatively few controlled trials on how to train the use of such aids. This study investigated the effects of systematic training in the use of compensatory memory aids on everyday memory functioning within a Memory Aids Service. In a controlled clinical trial, a comparison was made between treatment participants and waiting list controls. Participants had everyday memory problems secondary to progressive or non-progressive neurological conditions. Following baseline assessment and goal setting, treatment participants underwent three training sessions, in which memory aids were matched to goals, across a six week period, with a follow-up assessment 12 weeks later. Outcome was measured by a goal attainment diary, neuropsychological test performance, psychosocial questionnaires and a problem solving inventory. There was a significant treatment effect of training on the goal attainment diary but only at 12 weeks follow-up. A post-hoc analysis indicated that treatment was effective for participants with a non-progressive condition but not for participants with a progressive condition. We conclude that a Memory Aids Service can be beneficial for patients with a non-progressive neurological condition, and make suggestions that might inform future applications of memory aids with those who have a progressive neurological disorder.	[Dewar, Bonnie-Kate; Kopelman, Michael] Kings Coll London, Inst Psychiat Psychol & Neurosci, Psychol Med CAG, Acad Neuropsychiat, London, England; [Kapur, Narinder] UCL, Res Dept Clin Educ & Hlth Psychol, London, England		Dewar, BK (corresponding author), Neuropsychol Serv Ltd, 10 Harley St, London W1G 9PF, England.	bonnie-kate@npsychservices.com		Kopelman, Michael/0000-0003-0526-3160	KCL/IoPPN Biomedical Research Centre	The authors would like to acknowledge the clinical team of the St Thomas' Neuropsychiatry and Memory Disorders clinic, in particular Dr. Eli Jaldow, Consultant Clinical Psychologist for additional data from the memory clinic, and Dr. Mervi Pitkanen, Consultant Neuropsychiatrist. We would also like to thank Dr. Hana Laing, Consultant Clinical Psychologist at St Thomas' Hospital for provision of baseline data; Ms. Sue Grant for her administration of the Memory Aids Service; Dr. Peter Watson for statistical advice; and the participants in the current study. Professor Kopelman is supported by the KCL/IoPPN Biomedical Research Centre.	Baldwin VN, 2011, NEUROPSYCHOL REHABIL, V21, P484, DOI 10.1080/09602011.2011.582378; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Clare L, 2008, NEUROPSYCHOLOG REHAB, P1; Clare L, 2000, J CLIN EXP NEUROPSYC, V22, P132, DOI 10.1076/1380-3395(200002)22:1;1-8;FT132; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; Clare L, 2009, NEUROCASE, V15, P318, DOI 10.1080/13554790902783116; Dewar BK, 2009, NEUROPSYCHOL REHABIL, V19, P383, DOI 10.1080/09602010802278152; Duff P., 2007, TECHNOL DISABIL, V19, P79, DOI [10.3233/TAD-2007-192-305, DOI 10.3233/TAD-2007-192-305]; Ehlhardt-Powell L. A., 2012, NEUROPSYCHOL REHABIL, V22, P85, DOI [10.1080/09602011.2011.640466, DOI 10.1080/09602011.2011.640466]; Emslie H, 2007, NEUROPSYCHOL REHABIL, V17, P567, DOI 10.1080/09602010701381933; Evans N, 2011, BRIT J OCCUP THER, V74, P249, DOI 10.4276/030802211X13046730116614; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Fish J, 2008, J INT NEUROPSYCH SOC, V14, P154, DOI 10.1017/S1355617708080120; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; GILES GM, 1989, AM J OCCUP THER, V43, P409, DOI 10.5014/ajot.43.6.409; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Gillette Y, 2004, NEUROREHABILITATION, V19, P233; Gitlin LN, 1996, J AGING HEALTH, V8, P554, DOI 10.1177/089826439600800405; Greenaway MC, 2013, INT J GERIATR PSYCH, V28, P402, DOI 10.1002/gps.3838; Greenaway MC, 2008, AM J ALZHEIMERS DIS, V23, P451, DOI 10.1177/1533317508320352; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P563, DOI 10.1080/09602011.2012.676284; Hurn J, 2006, CLIN REHABIL, V20, P756, DOI 10.1177/0269215506070793; Kapur N., 2009, MEMORY REHABILITATIO, P52; Kapur N., 2001, CAMBRIDGE MEMORY MAN; Kennedy MRT, 2006, NEUROPSYCHOL REV, V16, P151, DOI 10.1007/s11065-006-9012-8; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Kime S. K., 2006, COMPENSATING MEMORY; Kinsella GJ, 2009, J NEUROL NEUROSUR PS, V80, P730, DOI 10.1136/jnnp.2008.148346; Kopelman M, 1996, NEUROPSYCHOL REHABIL, V6, P187, DOI 10.1080/713755504; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Martin-Saez M, 2011, NEUROPSYCHOL REHABIL, V21, P769, DOI 10.1080/09602011.2011.614378; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; O'Connell ME, 2003, NEUROREHABILITATION, V18, P9; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Phillips B, 1993, Assist Technol, V5, P36; Prigatano GP, 2003, NEUROREHABILITATION, V18, P47; Robertson I., 1994, TEST EVERYDAY ATTENT; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Scherer MJ, 2005, DISABIL REHABIL, V27, P1321, DOI 10.1080/09638280500164800; Schmitter-Edgecombe M, 2008, AM J ALZHEIMERS DIS, V23, P477, DOI 10.1177/1533317508320794; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; Shum D, 2011, J REHABIL MED, V43, P216, DOI 10.2340/16501977-0647; Sohlberg M. M., 2006, REHABILITATION TRAUM, P47; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Sohlberg MM, 1996, J HEAD TRAUMA REHAB, V11, P65, DOI 10.1097/00001199-199604000-00007; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Stapleton S, 2007, BRAIN INJURY, V21, P401, DOI 10.1080/02699050701252030; Stark C, 2005, NEUROPSYCHOLOGY, V19, P139, DOI 10.1037/0894-4105.19.2.139; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Troyer AK, 2001, AGING NEUROPSYCHOL C, V8, P256, DOI 10.1076/anec.8.4.256.5642; Troyer AK, 2008, NEUROPSYCHOL REHABIL, V18, P65, DOI 10.1080/09602010701409684; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; Wessels R., 2003, TECHNOL DISABIL, V15, P231; Wilson B, 2009, MEMORY REHABILITATIO; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 2003, NEUROREHABILITATION, V18, P3; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 1996, MEMORY, V4, P465, DOI 10.1080/741940776; Wilson~ BA, 2005, CAMBRIDGE TEST PROSP; Wilson BA, 1999, RIVERMEAD BEHAV MEMO; World Health Organization, 2007, INT CLASS FUNCT DIS; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161	76	10	10	1	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	4					614	632		10.1080/09602011.2016.1189342			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GA4CA	WOS:000428276000008	27267491				2022-02-06	
J	Di Battista, AP; Rhind, SG; Baker, AJ; Jetly, R; Debad, JD; Richards, D; Hutchison, MG				Di Battista, Alex P.; Rhind, Shawn G.; Baker, Andrew J.; Jetly, Rakesh; Debad, Jeff D.; Richards, Doug; Hutchison, Michael G.			An investigation of neuroinjury biomarkers after sport-related concussion: from the subacute phase to clinical recovery	BRAIN INJURY			English	Article						Athletes; inflammation; MCP-1; mTBI; PRDX-6; T-tau	TRAUMATIC BRAIN-INJURY; ICE HOCKEY PLAYERS; INTERNATIONAL-CONFERENCE; POTENTIAL BIOMARKER; CONSENSUS STATEMENT; GLUCOSE-METABOLISM; BASE-LINE; TAU; BLOOD; PLASMA	Objectives: To characterise a panel of neuroinjury-related blood biomarkers after sport-related concussion (SRC). We hypothesised significant differences in biomarker profiles between athletes with SRC and healthy controls at both subacute and medical clearance time points.Methods: Thirty-eight interuniversity athletes were recruited over two athletic seasons (n=19 SRC; n=19 healthy matched-control). High-sensitivity immunoassay was used to evaluate 11 blood analytes at both the subacute phase after SRC and at medical clearance.Results: Univariate analysis identified elevated circulating peroxiredoxin-6 (PRDX-6) in athletes with SRC compared to healthy controls at the subacute time point. Multivariate analyses yielded similar results in the subacute phase, but identified both PRDX-6 and T-tau as significant contributors to class separation between athletes with SRC and controls at medical clearance.Conclusions: Our results are consistent with the increasing recognition that physiological recovery after SRC extends beyond clinical recovery. Blood biomarkers appear to be useful in elucidating the biology of brain restitution after SRC. However, their implementation requires mindfulness of factors such as academic stress, exercise, and injury heterogeneity.	[Di Battista, Alex P.; Baker, Andrew J.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Di Battista, Alex P.; Rhind, Shawn G.] Def Res & Dev Canada, Toronto Res Ctr, Toronto, ON, Canada; [Rhind, Shawn G.; Richards, Doug; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, St Michaels Hosp, Dept Crit Care, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, St Michaels Hosp, Dept Anesthesia, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, St Michaels Hosp, Dept Surg, Toronto, ON, Canada; [Baker, Andrew J.; Hutchison, Michael G.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Neurosci Program, Toronto, ON, Canada; [Jetly, Rakesh] Canadian Forces Hlth Serv, Directorate Mental Hlth, Ottawa, ON, Canada; [Jetly, Rakesh] Univ Ottawa, Dept Psychiat, Ottawa, ON, Canada; [Debad, Jeff D.] Meso Scale Diagnost LLC, Rockville, MD USA		Hutchison, MG (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.	michael.hutchison@utoronto.ca		Rhind, Shawn/0000-0003-2300-0620			Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bellavance MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00136; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Buonora JE, 2015, J NEUROTRAUM, V32, P1805, DOI 10.1089/neu.2014.3736; Buonora JE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00068; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Garber BG, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010780; Gill J, 2016, J HEAD TRAUMA REHAB, V31, P269, DOI 10.1097/HTR.0000000000000191; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Larres DT, 2016, MIL MED, V181, P23, DOI 10.7205/MILMED-D-15-00152; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Manevich Y, 2014, FREE RADICAL BIO MED, V72, P210, DOI 10.1016/j.freeradbiomed.2014.04.002; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Oliver JM, 2017, J NEUROTRAUM, V34, P3295, DOI 10.1089/neu.2017.5064; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Papa L, 2016, SPORTS MED ARTHROSC, V24, P108, DOI 10.1097/JSA.0000000000000117; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pavlov VA, 2004, CELL MOL LIFE SCI, V61, P2322, DOI 10.1007/s00018-004-4102-3; Plog BA, 2015, EXPERT REV NEUROTHER, V15, P465, DOI 10.1586/14737175.2015.1031112; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	63	10	10	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					575	582		10.1080/02699052.2018.1432892			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200008	29420083	Bronze			2022-02-06	
S	Giza, C; Greco, T; Prins, ML		Hainline, B; Stern, RA		Giza, Christopher; Greco, Tiffany; Prins, Mayumi Lynn			Concussion: pathophysiology and clinical translation	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; POSTTRAUMATIC-STRESS-DISORDER; DEVELOPMENTAL SEX-DIFFERENCES; STATES HIGH-SCHOOL; GLUCOSE-UTILIZATION; FUNCTIONAL CONNECTIVITY; PSYCHIATRIC-DISORDERS; COGNITIVE DYSFUNCTION; FOOTBALL PLAYERS	The majority of the 3.8 million estimated annual traumatic brain injuries (TBI) in the United States are mild TBIs, or concussions, and they occur primarily in adolescents and young adults. A concussion is a brain injury associated with rapid brain movement and characteristic clinical symptoms, with no associated objective biomarkers or overt pathologic brain changes, thereby making it difficult to diagnose by neuroimaging or other objective diagnostic tests. Most concussion symptoms are transient and resolve within 1-2 weeks. Concussions share similar acute pathophysiologic perturbations to more severe TBI: there is a rapid release of neurotransmitters, which causes ionic disequilibrium across neuronal membranes. Re-establishing ionic homeostasis consumes energy and leads to dynamic changes in cerebral glucose uptake. The magnitude and duration of these changes are related to injury severity, with milder injuries showing faster normalization. Cerebral sex differences add further variation to concussion manifestation. Relative to the male brain, the female brain has higher overall cerebral blood flow, and demonstrates regional differences in glucose metabolism, inflammatory responses, and connectivity. Understanding the pathophysiology and clinical translation of concussion can move research towards management paradigms that will minimize the risk for prolonged recovery and repeat injury.	[Giza, Christopher; Greco, Tiffany; Prins, Mayumi Lynn] Univ Calif Los Angeles, Dept Neurosurg, 300 Stein Plaza,Suite 532, Los Angeles, CA 90095 USA		Prins, ML (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, 300 Stein Plaza,Suite 532, Los Angeles, CA 90095 USA.	mprins@mednet.ucla.edu	Greco, Tiffany/ABA-3519-2021				Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Alarcon G, 2015, NEUROIMAGE, V115, P235, DOI 10.1016/j.neuroimage.2015.04.013; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; BAXTER LR, 1987, PSYCHIAT RES, V21, P237, DOI 10.1016/0165-1781(87)90028-X; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Biswal BB, 2010, CEREB CORTEX, V20, P2188, DOI 10.1093/cercor/bhp284; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Bluhm RL, 2008, NEUROREPORT, V19, P887, DOI 10.1097/WNR.0b013e328300ebbf; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; DANIEL DG, 1989, PSYCHIAT RES, V27, P55, DOI 10.1016/0165-1781(89)90009-7; Davatzikos C, 1998, CEREB CORTEX, V8, P635, DOI 10.1093/cercor/8.7.635; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Drijkoningen D, 2015, J NEUROTRAUM, V32, P1324, DOI 10.1089/neu.2014.3787; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Eckner JT, 2012, PSYCHOL ASSESSMENT, V24, P249, DOI 10.1037/a0025042; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Gaignard P, 2015, ENDOCRINOLOGY, V156, P2893, DOI 10.1210/en.2014-1913; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist MJ, 2009, DEV DYNAM, V238, P1379, DOI 10.1002/dvdy.21940; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Green REA, 2006, BRAIN COGNITION, V60, P199; GUR RC, 1982, SCIENCE, V217, P659, DOI 10.1126/science.7089587; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hovda DA, 1996, J CEREBR BLOOD F MET, V16, P134, DOI 10.1097/00004647-199601000-00016; HOVDA DA, 1990, ACT NEUR S, V51, P331; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Ives JC, 2007, J ATHL TRAINING, V42, P431; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Khalifa ARM, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13125; Kim IJ, 2009, ACTA RADIOL, V50, P1169, DOI 10.3109/02841850903258058; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; KOZNIEWSKA E, 1995, CIRC RES, V76, P551, DOI 10.1161/01.RES.76.4.551; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; La Fountaine MF, 2016, J NEUROTRAUM, V33, P904, DOI 10.1089/neu.2015.3968; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Liu WJ, 2016, NEURORADIOLOGY, V58, P943, DOI 10.1007/s00234-016-1713-y; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Lu GP, 1996, MICROVASC RES, V51, P393, DOI 10.1006/mvre.1996.0035; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lungu O, 2015, PSYCHONEUROENDOCRINO, V62, P180, DOI 10.1016/j.psyneuen.2015.08.012; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Maugans TA, 2010, NEUROSURGERY, V66, P319, DOI 10.1227/01.NEU.0000363183.78323.D7; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; NEHLIG A, 1985, J CEREBR BLOOD F MET, V5, P393, DOI 10.1038/jcbfm.1985.54; Nelson LH, 2017, J NEUROSCI RES, V95, P447, DOI 10.1002/jnr.23821; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Povlishock JT, 1996, ACT NEUR S, V66, P81; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Pyter LM, 2013, BRAIN BEHAV IMMUN, V30, P88, DOI 10.1016/j.bbi.2013.01.075; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; RODRIGUEZ G, 1988, J CEREBR BLOOD F MET, V8, P783, DOI 10.1038/jcbfm.1988.133; Ryman SG, 2014, NEUROIMAGE, V101, P380, DOI 10.1016/j.neuroimage.2014.07.027; Salmond CH, 2006, NEUROPSYCHOLOGIA, V44, P1995, DOI 10.1016/j.neuropsychologia.2006.03.013; Satterthwaite TD, 2015, CEREB CORTEX, V25, P2383, DOI 10.1093/cercor/bhu036; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Schmithorst VJ, 2009, INTELLIGENCE, V37, P164, DOI 10.1016/j.intell.2008.07.001; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schoning M, 1996, J CEREBR BLOOD F MET, V16, P827, DOI 10.1097/00004647-199609000-00007; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Terwilliger V. K., 2015, J NEUROTRAUM, V33, P4082; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; VAGNOZZI R, 2007, NEUROSURGERY, V61, P388, DOI DOI 10.1227/01.NEU.0000280002.41696; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wang G, 2014, PAIN, V155, P755, DOI 10.1016/j.pain.2014.01.005; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Wilde EA, 2016, J NEUROTRAUM, V33, P672, DOI 10.1089/neu.2015.4035; Wu C.-M., 2016, CHEM ENG, V7, P61; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yoshizawa H, 2014, PSYCHIAT RES-NEUROIM, V221, P78, DOI 10.1016/j.pscychresns.2013.10.009; Zhang C, 2016, BRAIN CONNECT, V6, P700, DOI 10.1089/brain.2016.0429; Zheng YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063332	135	10	10	0	0	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						51	61		10.1016/B978-0-444-63954-7.00006-9			11	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100008	30482375				2022-02-06	
J	Hewetson, R; Cornwell, P; Shum, D				Hewetson, Ronelle; Cornwell, Petrea; Shum, David			Social participation following right hemisphere stroke: influence of a cognitive-communication disorder	APHASIOLOGY			English	Article						Right hemisphere stroke; cognitive-communication disorder; social participation; Sydney Psychosocial Reintegration Scale	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; COMMUNITY INTEGRATION; HEALTH; OUTCOMES; SUPPORT; PEOPLE; REHABILITATION; INDIVIDUALS; AGREEMENT	Background: The ability to return to social activities and roles is an important focus of rehabilitation for people affected by stroke. Rehabilitation professionals currently have limited evidence on the impact of a cognitive-communication disorder (CCD) following right hemispheric (RH) stroke on social participation, and how to support return to social activities and roles. Aims: This study describes (1) social participation change as reported by people with RH stroke; (2) compares social participation change across two groups based on the presence or absence of CCD following RH stroke; and (3) compares self and proxy reports of changes in participation. Methods & Procedures: A telephone survey was conducted with randomly selected people with first onset, unilateral RH stroke, and with matched significant others (proxies). The Sydney Psychosocial Reintegration Scale (SPRS-2) was utilised to explore change associated with stroke across Occupational Activities (OA), Interpersonal Relationships (IR) and Independent Living Skills (LS). Survey responses were compared utilising independent t-tests across two groups based on the presence or absence of CCD. Participant-proxy agreement was established using inter-rater correlation coefficient. Outcomes & Results: Change in social participation was reported for thirty-six participants with an average age of 65.95 years (SD = 13.09), of whom 58.3% were male and 38.9% employed at the time of the stroke. Time post-stroke to completion of the SPRS-2 ranged from six to 33 months. Most participants (94.4%, n = 34) reported change in at least one of the SPRS-2 domains. The presence of CCD had an impact on social participation as measured on the SPRS-2, which was significantly different to what was reported by participants without a communication impairment post-RH stroke (p = 0.02.) Inter-rater agreement statistic (Kappa) indicated a fair participant-proxy dyad agreement in the group with CCD, and a moderate agreement in the group without CCD across the SPRS-2 domains. Conclusions: Changes in social participation following RH stroke occur across Occupational Activities, Interpersonal Relationships and Independent Living Skills for the majority of people and occur with greater frequency and degree where a CCD is present. This exploratory study highlights the importance of rehabilitation goals that address social participation to reduce potential social isolation in people with CCD post-RH stroke. Further identification of risk factors for social participation restriction in this population is required to better inform rehabilitation timing and focus.	[Hewetson, Ronelle] Prince Charles Hosp, Speech Pathol Dept, Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia; [Hewetson, Ronelle; Cornwell, Petrea; Shum, David] Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia; [Cornwell, Petrea] Allied Hlth Res Collaborat, Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia		Hewetson, R (corresponding author), Prince Charles Hosp, Speech Pathol Dept, Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia.; Hewetson, R (corresponding author), Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia.	ronelle.hewetson@health.qld.gov.au	Cornwell, Petrea/AAE-5547-2019; Shum, David H. K./A-3914-2008	Shum, David H. K./0000-0002-4810-9262; Hewetson, Ronelle/0000-0003-1872-9943			Abusamra V, 2009, LIFE SPAN DISABIL, V12, P69; Baron-Cohen S., 2000, UNDERSTANDING OTHER, P164; Baylor C, 2011, AM J SPEECH-LANG PAT, V20, P269, DOI 10.1044/1058-0360(2011/10-0084); Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Blake M.L., 2016, PERSPECTIVES ASHA SP, V1, P63, DOI [10.1044/persp1.SIG2.63, DOI 10.1044/PERSP1.SIG2.63]; Blake M. L., 2011, COGNITIVE COMMUNICAT; Borod Joan C, 2002, Appl Neuropsychol, V9, P23, DOI 10.1207/S15324826AN0901_4; Brady MC, 2011, DISABIL REHABIL, V33, P178, DOI 10.3109/09638288.2010.517897; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Cooper CL, 2014, BRAIN INJURY, V28, P122, DOI 10.3109/02699052.2013.848379; Cote H, 2007, APHASIOLOGY, V21, P739, DOI 10.1080/02687030701192331; Cruice M, 2001, THESIS; Cruice M, 2006, APHASIOLOGY, V20, P1210, DOI 10.1080/02687030600790136; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dai CY, 2014, EUR J NEUROL, V21, P797, DOI 10.1111/ene.12413; Dalemans RJP, 2010, DISABIL REHABIL, V32, P1678, DOI 10.3109/09638281003649938; Douglas H, 2005, J REHABIL MED, V37, P325, DOI 10.1080/16501970510035089; Egbert N, 2006, HEALTH COMMUN, V20, P45, DOI 10.1207/s15327027hc2001_5; Haley WE, 2011, QUAL LIFE RES, V20, P799, DOI 10.1007/s11136-010-9810-6; Hilari K, 2006, APHASIOLOGY, V20, P17, DOI 10.1080/02687030500279982; Hilari K, 2007, J NEUROL NEUROSUR PS, V78, P1072, DOI 10.1136/jnnp.2006.111476; Hilari K, 2010, CLIN REHABIL, V24, P181, DOI 10.1177/0269215509346090; Kagan A., 2011, ASSESSMENT LIVING AP; King Rosemarie B, 2002, Top Stroke Rehabil, V9, P46; Klonoff PS, 1990, NEUROPSYCHOLOGY, V4, P147, DOI 10.1037/0894-4105.4.3.147; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Laliberte MP, 2016, APHASIOLOGY, V30, P1117, DOI 10.1080/02687038.2015.1100708; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le Dorze G, 2014, APHASIOLOGY, V28, P421, DOI 10.1080/02687038.2013.869305; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; MACKENZIE C, 2001, ADV SPEECH LANGUAGE, V3, P81, DOI DOI 10.3109/14417040109003716; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McDonald S, 2014, SOCIAL COMMUNICATION; Myers P. S., 1978, CLIN APHASIOLOGY C P, V8, P49; Northcott S, 2011, INT J LANG COMM DIS, V46, P524, DOI 10.1111/j.1460-6984.2011.00079.x; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Parr S., 1997, TALKING ABOUT APHASI; Perry A, 2004, INT J QUAL HEALTH C, V16, P285, DOI 10.1093/intqhc/mzh059; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Salzer MS., 2006, COMMUNITY INTEGRATIO; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; SCHULING J, 1993, STROKE, V24, P1173, DOI 10.1161/01.STR.24.8.1173; Tate R, 2011, MANUAL SYDNEY UNPUB; Tsouna-Hadjis E, 2000, ARCH PHYS MED REHAB, V81, P881, DOI 10.1053/apmr.2000.4435; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036; Viscogliosi C, 2011, APPL NEUROPSYCHOL, V18, P117, DOI 10.1080/09084282.2010.547779; World Health Organization, 2007, INT CLASS FUNCT DIS	54	10	10	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2018	32	2					164	182		10.1080/02687038.2017.1315045			19	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	FY9PQ	WOS:000427199100003		Green Submitted			2022-02-06	
J	Hosomi, S; Watabe, T; Mori, Y; Koyama, Y; Adachi, S; Hoshi, N; Ohnishi, M; Ogura, H; Yoshioka, Y; Hatazawa, J; Yamashita, T; Shimazu, T				Hosomi, Sanae; Watabe, Tadashi; Mori, Yuki; Koyama, Yoshihisa; Adachi, Soichiro; Hoshi, Namiko; Ohnishi, Mitsuo; Ogura, Hiroshi; Yoshioka, Yoshichika; Hatazawa, Jun; Yamashita, Toshihide; Shimazu, Takeshi			Inflammatory projections after focal brain injury trigger neuronal network disruption: An F-18-DPA714 PET study in mice	NEUROIMAGE-CLINICAL			English	Article						Translocator protein-positron emission tomography; Traumatic brain injury; Neurodegeneration; Neuroinflammation	MULTIPLE-SCLEROSIS; SPINAL-CORD; MICROGLIAL ACTIVATION; TSPO LIGAND; TRAUMA; NEUROINFLAMMATION; REHABILITATION; TRACTOGRAPHY; MACROPHAGES; DISABILITY	Due to the heterogeneous pathology of traumatic brain injury (TBI), the exact mechanism of how initial brain damage leads to chronic inflammation and its effects on the whole brain remain unclear. Here, we report on long-term neuroinflammation, remote from the initial injury site, even after subsiding of the original inflammatory response, in a focal TBI mouse model. The use of translocator protein-positron emission tomography in conjunction with specialised magnetic resonance imaging modalities enabled us to visualize "previously undetected areas" of spreading inflammation after focal cortical injury. These clinically available modalities further revealed the pathophysiology of thalamic neuronal degeneration occurring as resident microglia sense damage to corticothalamic neuronal tracts and become activated. The resulting microglial activation plays a major role in prolonged inflammatory processes, which are deleterious to the thalamic network. In light of the association of this mechanism with neuronal tracts, we propose it can be termed "brain injury related inflammatory projection". Our findings on multiple spatial and temporal scales provide insight into the chronic inflammation present in neurodegenerative diseases after TBI.	[Hosomi, Sanae; Ohnishi, Mitsuo; Ogura, Hiroshi; Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-15 Yamada Oka, Suita, Osaka 5650871, Japan; [Watabe, Tadashi; Hatazawa, Jun] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, 2-15 Yamada Oka, Suita, Osaka 5650871, Japan; [Watabe, Tadashi; Hatazawa, Jun] Osaka Univ, Grad Sch Med, Med Imaging Ctr Translat Res, 2-15 Yamada Oka, Suita, Osaka 5650871, Japan; [Mori, Yuki; Yoshioka, Yoshichika] Natl Inst Informat & Commun Technol NICT, Ctr Informat & Neural Networks CiNet, 1-4 Yamada Oka, Suita, Osaka 5650871, Japan; [Mori, Yuki; Yoshioka, Yoshichika] Osaka Univ, 1-4 Yamada Oka, Suita, Osaka 5650871, Japan; [Koyama, Yoshihisa; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, 2-15 Yamada Oka, Suita, Osaka 5650871, Japan; [Adachi, Soichiro; Hoshi, Namiko] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol,Chuo Ku, 5-2 Kusunoki Cho 7, Kobe, Hyogo 6500017, Japan		Hosomi, S (corresponding author), 2-15 Yamada Oka, Suita, Osaka 5650871, Japan.	s-hosomi@hp-emerg.med.osaka-u.ac.jp	Mori, Yuki/AAH-9283-2020; Hosomi, Sanae/M-1838-2019; Hoshi, Namiko/V-8370-2019	Mori, Yuki/0000-0003-4208-0005; 	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [25861719, 16K20388]; General Insurance Association of Japan; ZENKYOREN (National Mutual Insurance Federation of Agricultural Cooperatives)	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (25861719 and 16K20388), a grant from the General Insurance Association of Japan, and a grant from ZENKYOREN (National Mutual Insurance Federation of Agricultural Cooperatives) to S. H.	Arlicot N, 2012, NUCL MED BIOL, V39, P570, DOI 10.1016/j.nucmedbio.2011.10.012; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Boutin H, 2007, J NUCL MED, V48, P573, DOI 10.2967/jnumed.106.036764; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chauveau F, 2009, J NUCL MED, V50, P468, DOI 10.2967/jnumed.108.058669; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cho ZH, 2015, WORLD NEUROSURG, V83, P54, DOI 10.1016/j.wneu.2013.08.022; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cselenyi Z, 2015, J CEREBR BLOOD F MET, V35, P1485, DOI 10.1038/jcbfm.2015.66; Doorduin J, 2009, MOL IMAGING BIOL, V11, P386, DOI 10.1007/s11307-009-0211-6; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Fujiyoshi K, 2013, EXP NEUROL, V242, P74, DOI 10.1016/j.expneurol.2012.07.015; Fulci G, 2007, CANCER RES, V67, P9398, DOI 10.1158/0008-5472.CAN-07-1063; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Israel I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0604-9; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kashiyama N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165748; Kobayashi M, 2018, J CEREBR BLOOD F MET, V38, P393, DOI 10.1177/0271678X17699223; Koyama Y, 2013, J NEUROSCI METH, V218, P103, DOI 10.1016/j.jneumeth.2013.05.004; Kreisl WC, 2010, NEUROIMAGE, V49, P2924, DOI 10.1016/j.neuroimage.2009.11.056; Lavisse S, 2012, J NEUROSCI, V32, P10809, DOI 10.1523/JNEUROSCI.1487-12.2012; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Martin A, 2010, J CEREBR BLOOD F MET, V30, P230, DOI 10.1038/jcbfm.2009.205; Mori Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06997; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; O'Brien ER, 2014, J NUCL MED, V55, P275, DOI 10.2967/jnumed.113.127449; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rominger A, 2013, J NUCL MED, V54, P1127, DOI 10.2967/jnumed.112.114660; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Saito S, 2012, NEUROSCI RES, V73, P337, DOI 10.1016/j.neures.2012.05.004; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Takkinen JS, 2017, J CEREBR BLOOD F MET, V37, P2870, DOI 10.1177/0271678X16677990; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vicidomini C, 2015, NUCL MED BIOL, V42, P309, DOI 10.1016/j.nucmedbio.2014.11.009; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Wang MH, 2014, J NEUROSCI, V34, P3793, DOI 10.1523/JNEUROSCI.3153-13.2014; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; West DC, 2006, CEREB CORTEX, V16, P200, DOI 10.1093/cercor/bhi098; Zaffaroni M, 1999, EUR J NEUROL, V6, P579, DOI 10.1046/j.1468-1331.1999.650579.x	51	10	11	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	20						946	954		10.1016/j.nicl.2018.09.031			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB1QI	WOS:000450799000102	30312938	Green Published, gold			2022-02-06	
J	Jacobsson, J; Bergin, D; Timpka, T; Nyce, JM; Dahlstrom, O				Jacobsson, J.; Bergin, D.; Timpka, T.; Nyce, J. M.; Dahlstrom, O.			Injuries in youth track and field are perceived to have multiple-level causes that call for ecological (holistic-developmental) interventions: A national sporting community perceptions and experiences	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						athletics; child; safe sport; sports injury prevention	COMMITTEE CONSENSUS STATEMENT; PHYSICAL-ACTIVITY LEVELS; PREVENTION; CONCUSSION; RECOMMENDATIONS; BEHAVIORS; PROMOTION; PATTERNS; COACHES; ATHLETE	Engaging in competitive sports as a youth can have many health benefits, but recent studies also report a high risk for injury. The long-term purpose of this Swedish research program is to develop a framework for safe track and field training for young athletes (aged 12-15years). The aim of this study was to establish what is perceived to contribute and cause injuries in youth track and field by compiling the best available experiential knowledge about the underlying factors and use this knowledge to identify appropriate areas to handle these in practical ways. Nine focus group interviews with in total 74 participants and confirming interviews with five individuals were performed in seven Swedish regions. Qualitative research methods were used for data analysis. Injuries in youth athletes were not considered to be strictly the result of individual factors but rather the result of the interactions between factors at different levels. Three major factors emerged as follows: Insufficient knowledge for athletic development in daily practice; shortsighted communities of practice and sports policies not adjusted to youth; and societal health behaviors. The experiential knowledge in the national sporting community suggests that if effective and sustainable injury prevention processes are to be implemented for youth track and field, an ecological (holistic-developmental) approach to injury prevention is needed. Such an approach allows a longitudinal development-focused strategy for prevention that spans an athlete's entire career.	[Jacobsson, J.; Timpka, T.; Nyce, J. M.; Dahlstrom, O.] Linkoping Univ, Athlet Res Ctr, Linkoping, Sweden; [Jacobsson, J.; Bergin, D.] Swedish Athlet Assoc, Stockholm, Sweden; [Jacobsson, J.; Timpka, T.; Nyce, J. M.] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Timpka, T.] Reg Ostergotland, Ctr Healthcare Dev, Linkoping, Sweden; [Dahlstrom, O.] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden		Jacobsson, J (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Linkoping, Sweden.	jenny.jacobsson@liu.se	Timpka, Toomas/E-8065-2018	Jacobsson, Jenny/0000-0002-1551-1722	Swedish Athletics Association; Folksam Insurance Company	The study was supported by grants from the Swedish Athletics Association and the Folksam Insurance Company.	Bahr R, 2014, BRIT J SPORT MED, V48, P1265, DOI 10.1136/bjsports-2014-093832; Bergeron MF, 2015, BRIT J SPORT MED, V49, P843, DOI 10.1136/bjsports-2015-094962; Blom LC, 2013, J SPORT PSYCHOL ACTI, V4, P86, DOI [10.1080/21520704.2012.763078, 10.1080/21520704.2012.733910]; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Carter N, 2014, ONCOL NURS FORUM, V41, P545, DOI 10.1188/14.ONF.545-547; Cote J, 2016, INT J SPORT POLICY P, V8, P51, DOI 10.1080/19406940.2014.919338; Dahlstrom O, 2015, SCAND J MED SCI SPOR, V25, pe414, DOI 10.1111/sms.12327; DiFiori JP, 2014, CLIN J SPORT MED, V24, P3, DOI 10.1097/JSM.0000000000000060; Donaldson A, 2016, J SPORT HEALTH SCI, V5, P334, DOI 10.1016/j.jshs.2016.08.003; Edouard P, 2012, INT J SPORTS MED, V33, P824, DOI 10.1055/s-0031-1301332; Eime R, 2004, SPORTS MED, V34, P629, DOI 10.2165/00007256-200434100-00001; Evans MB, 2015, BRIT J SPORT MED, V49, P871, DOI 10.1136/bjsports-2015-094634; Faigenbaum AD, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-094621; Ford P, 2011, J SPORT SCI, V29, P389, DOI 10.1080/02640414.2010.536849; Fremont P, 2015, BRIT J SPORT MED, V49, P88, DOI 10.1136/bjsports-2014-093961; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hanson D, 2014, BRIT J SPORT MED, V48, P682, DOI 10.1136/bjsports-2012-091434; Hauw D, 2009, REFLECT PRACT, V10, P341, DOI 10.1080/14623940903034671; Henderson ZP, 1995, HUM ECOL, V23, P55; Hughes C, 2009, REFLECT PRACT, V10, P367, DOI 10.1080/14623940903034895; Huxley DJ, 2014, EUR J SPORT SCI, V14, P185, DOI 10.1080/17461391.2013.809153; Jacobsson J, 2013, BRIT J SPORT MED, V47, DOI 10.1136/bjsports-2012-091651; Jacobsson J, 2012, AM J SPORT MED, V40, P163, DOI 10.1177/0363546511425467; Kokko S, 2016, GLOB HEALTH PROMOT, V23, P75, DOI 10.1177/1757975915601615; LaPrade RF, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116644241; Mountjoy M, 2015, BRIT J SPORT MED, V49, P883, DOI 10.1136/bjsports-2015-094619; Mountjoy M, 2016, BRIT J SPORT MED, V50, P1019, DOI 10.1136/bjsports-2016-096121; Newton JD, 2014, J SCI MED SPORT, V17, P469, DOI 10.1016/j.jsams.2013.10.240; Norberg JR, 2016, STATENS STOD IDROTTE, P3; Raustorp A, 2015, ACTA PAEDIATR, V104, P808, DOI 10.1111/apa.13027; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Rossler R, 2014, SPORTS MED, V44, P1733, DOI 10.1007/s40279-014-0234-2; Skille EA, 2008, INT REV SOCIOL SPORT, V43, P181, DOI 10.1177/1012690208096035; Steffen K, 2010, BRIT J SPORT MED, V44, P485, DOI 10.1136/bjsm.2010.073833; Suppiah HT, 2015, BRIT J SPORT MED, V49, P878, DOI 10.1136/bjsports-2015-094648; Tamminen KA, 2012, PSYCHOL SPORT EXERC, V13, P69, DOI 10.1016/j.psychsport.2011.07.006; Timpka T, 2006, SPORTS MED, V36, P733, DOI 10.2165/00007256-200636090-00002; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; White P, 2016, BRIT J SPORT MED, V50, P569, DOI 10.1136/bjsports-2015-095105; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; World Health Organization (WHO), 1986, WHO OTT CHART HLTH P	41	10	10	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	JAN	2018	28	1					348	355		10.1111/sms.12929			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FS7ZX	WOS:000422630100039	28605065				2022-02-06	
J	King, AR; Breen, CM; Russell, TD; Nerpel, BP; Pogalz, CR				King, Alan R.; Breen, Cody M.; Russell, Tiffany D.; Nerpel, Brady P.; Pogalz, Colton R.			Self-reported executive functioning competencies and lifetime aggression	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Aggression; Buss-Perry aggression questionnaire; conduct disturbance; executive functioning index; lifetime acts of violence assessment; trait aggression	TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; BEHAVIOR RATING INVENTORY; FUNCTION-ADULT VERSION; TEMPORAL-LOBE LESIONS; FRONTAL-LOBE; ANTISOCIAL-BEHAVIOR; MECHANICAL TURK; IMPULSIVE AGGRESSION; FUNCTION INDEX	Neuropsychological research can be advanced through a better understanding of relationships between executive functioning (EF) behavioral competencies and the expression of aggressive behavior. While performance-based EF measures have been widely examined, links between self-report indices and practical real-life outcomes have not yet been established. Executive Functioning Index subscale scores in this sample (N=579) were linked to trait hostility (Buss-Perry Aggression Questionnaire), aggression in the natural environment (Lifetime Acts of Violence Assessment), and conduct disorder symptoms prior to age 15. Significant associations were found between all of the EFI subscales (Motivational Drive, Organization, Strategic Planning, Impulse Control, and Empathy), trait aggression, and conduct disturbance. Lifetime acts of aggression were predicted by all but Organization scores. Physical injuries inflicted on other(s) were 2 to 4 times more likely to occur among respondents generating low (z<-1) EFI subscale scores. While these EFI relationships were modest in size, they are pervasive in scope. These findings provide support for the potential role of perceived EF deficits in moderating lifetime aggression.	[King, Alan R.; Breen, Cody M.; Russell, Tiffany D.; Nerpel, Brady P.; Pogalz, Colton R.] Univ North Dakota, Psychol Dept, POB 8380, Grand Forks, ND 58202 USA		King, AR (corresponding author), Univ North Dakota, Psychol Dept, POB 8380, Grand Forks, ND 58202 USA.	alan.king@und.edu	Russell, Tiffany D./AAC-3667-2020	Russell, Tiffany D./0000-0002-4481-3754			Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Archer J, 2006, AGGRESSIVE BEHAV, V32, P464, DOI 10.1002/ab.20146; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barratt ES, 1997, BIOL PSYCHIAT, V41, P1045, DOI 10.1016/S0006-3223(96)00175-8; Barratt ES, 1998, BEHAV SCI LAW, V16, P285, DOI 10.1002/(SICI)1099-0798(199822)16:3<285::AID-BSL308>3.0.CO;2-4; Barratt ES, 1994, VIOLENCE MENTAL DISO; Benton A.L., 1967, CORTEX, V3, P32, DOI [10.1016/s0010-9452(67)80005-4, DOI 10.1016/S0010-9452(67)80005-4]; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Buss AH, 2000, AGGRESSION QUESTIONN; Carlson A. A., 2008, DISS ABSTR INT B, V69, P1944; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Conners C. K., 2000, CONNERS CONTINUOUS P; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Duggan E. C., 2014, THESIS; Duke LM, 2000, NEUROPSYCHOL REV, V10, P75, DOI 10.1023/A:1009096603879; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Ferguson G. A., 1981, STAT ANAL PSYCHOL ED; FOSTER HG, 1993, PROG NEURO-PSYCHOPH, V17, P939, DOI 10.1016/0278-5846(93)90021-J; Giancola PR, 2012, PSYCHOL ADDICT BEHAV, V26, P201, DOI 10.1037/a0025207; GIANCOLA PR, 1994, J ABNORM PSYCHOL, V103, P832, DOI 10.1037/0021-843X.103.4.832; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Grane VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115227; Hadjiefthyvoulou F, 2012, COGN BEHAV NEUROL, V25, P128, DOI 10.1097/WNN.0b013e318261459c; Hoaken PNS, 2003, AGGRESSIVE BEHAV, V29, P15, DOI 10.1002/ab.10023; Janssen GTL, 2009, INT J NEUROSCI, V119, P792, DOI 10.1080/00207450802333979; Kim E, 2002, NEUROREHABILITATION, V17, P297; King A. R., VIOLENCE VICTIMS; Kronenberger WG, 2005, J CLIN PSYCHOL, V61, P725, DOI 10.1002/jclp.20022; Lovstad M, 2016, J INT NEUROPSYCH SOC, V22, P682, DOI 10.1017/S135561771600031X; McMurran M, 2002, AGGRESSIVE BEHAV, V28, P439, DOI 10.1002/ab.80017; Miller BL, 1997, BRIT J PSYCHIAT, V170, P150, DOI 10.1192/bjp.170.2.150; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Mugge JR, 2016, APPL NEUROPSYCH-CHIL, V5, P67, DOI 10.1080/21622965.2014.986327; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; O'Connor DB, 2001, AGGRESSIVE BEHAV, V27, P79, DOI 10.1002/ab.2; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Raine A, 2008, CURR DIR PSYCHOL SCI, V17, P323, DOI 10.1111/j.1467-8721.2008.00599.x; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Reid RC, 2012, INT J NEUROSCI, V122, P500, DOI 10.3109/00207454.2012.673516; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roth R.M., 2014, HDB EXECUTIVE FUNCTI, P301, DOI DOI 10.1007/978-1-4614-8106-5_18; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Santor DA, 2003, AGGRESSIVE BEHAV, V29, P475, DOI 10.1002/ab.10058; Scott JG, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P219, DOI 10.1007/978-0-387-76978-3_10; Seguin J., 2005, DEV ORIGINS AGGRESSI, P207; Seguin JR, 2007, COGNITIVE DEV, V22, P530, DOI 10.1016/j.cogdev.2007.08.006; Seguin JR, 2004, J ABNORM PSYCHOL, V113, P603, DOI 10.1037/0021-843X.113.4.603; Serper M, 2008, J CLIN EXP NEUROPSYC, V30, P700, DOI 10.1080/13803390701684554; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shiroma Eric J, 2010, J Correct Health Care, V16, P273, DOI 10.1177/1078345810378253; Spinella M, 2005, INT J NEUROSCI, V115, P649, DOI 10.1080/00207450590524304; STIP E, 1995, J NEUROPSYCH CLIN N, V7, P116, DOI 10.1176/jnp.7.1.116; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wain O, 2007, INT J NEUROSCI, V117, P135, DOI 10.1080/00207450500534068; Weidacker K, 2017, Q J EXP PSYCHOL, V70, P473, DOI 10.1080/17470218.2015.1135350; Wood RL, 2006, J NEUROPSYCH CLIN N, V18, P333, DOI 10.1176/appi.neuropsych.18.3.333; Zelazo P. D., 2002, HDB CHILDHOOD COGNIT, P445, DOI DOI 10.1002/9780470996652.CH20	72	10	10	1	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2018	25	5					400	409		10.1080/23279095.2017.1320555			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GK9MN	WOS:000436574500003	28481122				2022-02-06	
J	Lin, CE; Chen, LF; Chou, PH; Chung, CH				Lin, Ching-En; Chen, Li-Fen; Chou, Po-Han; Chung, Chi-Hsiang			Increased prevalence and risk of anxiety disorders in adults with tinnitus: A population-based study in Taiwan	GENERAL HOSPITAL PSYCHIATRY			English	Article						Anxiety disorder; Tinnitus; Prevalence; National Health Insurance Research Database; NHIRD	MAJOR DEPRESSIVE DISORDER; DORSAL COCHLEAR NUCLEUS; PSYCHIATRIC COMORBIDITIES; MENTAL-DISORDERS; PANIC DISORDER; HEARING-LOSS; ASSOCIATION; STRESS; STROKE; HEALTH	Objective: Tinnitus is a common disorder that may cause psychological distress and anxiety. The aim of this study was to investigate the association between anxiety disorders (ADs) and tinnitus in a large population. Method: We conducted a cross-sectional study using the National Health Insurance Research Database in Taiwan. Study subjects included 14,772 patients with tinnitus and 709,963 people in the general population who sought treatment in 2005. Distributions in ADs, age, sex, and medical comorbidities were compared between groups using chi-squared tests. Multivariate logistic regression models adjusted for age, sex, and medical comorbidities were used to analyze the association between tinnitus and ADs. Results: Prevalence of ADs in tinnitus and general population groups was 3.9% and 1.5%, respectively, and this difference was significant (P < 0.001). Diabetes mellitus, hypertension, hyperlipidemia, concussion or head injury, Meniere's disease, sensorineural hearing impairment, renal disease, coronary artery disease, and cerebrovascular disease were significantly more prevalent in the tinnitus group (all P-values < 0.001). Multivariate logistic regression model demonstrated that patients with tinnitus were significantly associated with increased risk of ADs (adjusted OR = 1.99; 95% CI = 1.81-2.19; P < 0.001). Conclusion: Because the risk of ADs was significantly higher in patients with tinnitus than in the general population, physicians should be aware of the importance of psychological factors in tinnitus management.	[Lin, Ching-En] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, 289 Jianguo Rd, New Taipei, Taiwan; [Lin, Ching-En] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chen, Li-Fen] Triserv Gen Hosp, Penghu Branch, Taipei, Taiwan; [Chen, Li-Fen] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chou, Po-Han] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA; [Chou, Po-Han] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Chou, Po-Han] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chung, Chi-Hsiang] Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan		Lin, CE (corresponding author), Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, 289 Jianguo Rd, New Taipei, Taiwan.; Chou, PH (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	chingen_lin@tzuchi.com.tw; pchou@hsph.havard.edu	Chung, Chi-Hsiang/AAY-3386-2021				Alonso J, 2007, J CLIN PSYCHIAT, V68, P3; Asnaani A, 2010, J NERV MENT DIS, V198, P551, DOI 10.1097/NMD.0b013e3181ea169f; Ayerbe L, 2013, AGE AGEING; Baigi A, 2011, EAR HEARING, V32, P787, DOI 10.1097/AUD.0b013e31822229bd; Belli S, 2008, EUR ARCH OTO-RHINO-L, V265, P279, DOI 10.1007/s00405-007-0440-8; Bhatt JM, 2017, LARYNGOSCOPE, V127, P466, DOI 10.1002/lary.26107; Borghi C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-80; Chen YH, 2010, CAN J PSYCHIAT, V55, P43, DOI 10.1177/070674371005500107; Cheng TM, 2010, 6 COUNTRIES 6 REFORM, P171; Chien IC, 2013, J PSYCHOSOM RES, V75, P270, DOI 10.1016/j.jpsychores.2013.06.003; Chou PH, 2014, PSYCHOSOMATICS, V55, P155, DOI 10.1016/j.psym.2013.06.003; Chou PH, 2013, EUR CHILD ADOLES PSY, V22, P301, DOI 10.1007/s00787-012-0369-3; Chou PH, 2012, PSYCHOSOMATICS, V53, P463, DOI 10.1016/j.psym.2012.03.007; Chung SD, 2015, EUR ARCH OTO-RHINO-L, V272, P2673, DOI 10.1007/s00405-014-3235-8; Cukor D, 2008, CLIN J AM SOC NEPHRO, V3, P1752, DOI 10.2215/CJN.01120308; Dortland AKBV, 2010, ACTA PSYCHIAT SCAND, V122, P30, DOI 10.1111/j.1600-0447.2010.01565.x; Figueiredo RR, 2017, MENIERES DIS TINNITU; Fure B, 2006, INT J GERIATR PSYCH, V21, P382, DOI 10.1002/gps.1482; Furukawa M, 2013, ACTA OTO-LARYNGOL, V133, P584, DOI 10.3109/00016489.2012.759274; Granjeiro RC, 2013, OTOLARYNG HEAD NECK, V148, P658, DOI 10.1177/0194599812473554; Gul AI, 2015, NEUROPSYCH DIS TREAT, V11, P413, DOI 10.2147/NDT.S77786; Hafeez F, 1999, J Stroke Cerebrovasc Dis, V8, P217, DOI 10.1016/S1052-3057(99)80070-6; Ho CH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005269; Holmes S, 2008, REV CLIN GERONTOL, V18, P269, DOI 10.1017/S0959259809002883; Huang CJ, 2011, GEN HOSP PSYCHIAT, V33, P8, DOI 10.1016/j.genhosppsych.2010.10.008; Jacques D, 2013, PSYCHIAT DANUB, V25, pS102; Jalessi Maryam, 2013, Acta Med Iran, V51, P886; Kaltenbach JA, 2006, HEARING RES, V216, P224, DOI 10.1016/j.heares.2006.01.002; Kaltenbach JA, 2008, AM J AUDIOL, V17, pS148, DOI 10.1044/1059-0889(2008/08-0004); Kanzaki J, 2015, ACTA OTO-LARYNGOL, V135, P447, DOI 10.3109/00016489.2014.990581; Kazmierczak H, 2001, Int Tinnitus J, V7, P54; Kim HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127578; Liao SC, 2012, PSYCHOL MED, V42, P1227, DOI 10.1017/S0033291711002364; Minen MT, 2014, J NEUROL NEUROSUR PS, V85, P1138, DOI 10.1136/jnnp-2013-307339; Olafiranye O, 2011, Mind Brain, V2, P32; Pattyn T, 2015, HEARING RES, V30, pe11; Preljevic VT, 2013, GEN HOSP PSYCHIAT, V35, P619, DOI 10.1016/j.genhosppsych.2013.05.006; Schmieder RE, 2013, J HYPERTENS, V31, P610, DOI 10.1097/HJH.0b013e32835d6e53; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Shargorodsky M, 2003, AM J HYPERTENS, V16, P617, DOI 10.1016/S0895-7061(03)00911-7; Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013; Snow J, 2004, TINNITUS THEORY MANA, P16; SPSS, 2013, IBM SPSS STAT 22; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Strumila R, 2017, PSYCHIAT QUART, P1; Tully PJ, 2013, PSYCHOL HEALTH MED, V18, P627, DOI 10.1080/13548506.2012.749355; TYLER RS, 1983, J SPEECH HEAR DISORD, V48, P150, DOI 10.1044/jshd.4802.150; VANREEDT DAK, 2013, PSYCHONEUROENDOCRINO, V38, P209, DOI DOI 10.1016/J.PSYNEUEN.2012.05.017; Wallhausser-Franke E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034583	50	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	JAN-FEB	2018	50						131	136		10.1016/j.genhosppsych.2017.11.006			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FV1RU	WOS:000424343000020	29190572				2022-02-06	
S	MacFarlane, PM; Di Fiore, JM		Gauda, EB; Prabhakar, N; Schultz, HD; Monteiro, ME; Wyatt, C		MacFarlane, Peter M.; Di Fiore, Juliann M.			Myo-inositol Effects on the Developing Respiratory Neural Control System	ARTERIAL CHEMORECEPTORS: NEW DIRECTIONS AND TRANSLATIONAL PERSPECTIVES	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	20th Meeting of the International-Society-for-Arterial-Chemoreceptors (ISAC)	JUL 23-27, 2017	Johns Hopkins Univ, Baltimore, MD	Int Soc Arterial Chemoreceptors	Johns Hopkins Univ	Myo-inositol; Respiratory neural development; Control of breathing	SODIUM/MYO-INOSITOL COTRANSPORTER-1; CAROTID-BODY; METABOLISM; GENE; PHOSPHOINOSITIDES; HEXAKISPHOSPHATE; REGULATORS; INFECTION; HYPOXIA; INFANTS	Myo-inositol is a highly abundant stcrcoisomer of the inositol family of sugar alcohols and forms the structural basis for a variety of polyphosphate derivatives including second messengers and membrane phospholipids. These derivatives regulate numerous cell processes including gene transcription, membrane excitability, vesicular trafficking, intracellular calcium signaling, and neuronal growth and development. Myo-inositol can be formed endogenously from the breakdown of glucose, is found in a variety of foods including breastmilk and is commercially available as a nutritional supplement. Abnormal myo-inositol metabolism has been shown to underlie the pathophysiology of a variety of clinical conditions including Down Syndrome, traumatic brain injury, bronchopulmonary dysplasia (BPD), and respiratory distress syndrome (RDS). Several animal studies have shown that myo-inositol may play a critical role in development of both the central and peripheral respiratory neural control system; a notable example is the neonatal apnea and respiratory insufficiency that manifests in a mouse model of myo-inositol depletion, an effect that is also postnatally lethal. This review focuses on myo-inositol (and some of its derivatives) and how it may play a role in respiratory neural control; we also discuss clinical evidence demonstrating a link between serum myo-inositol levels and the incidence of intermittent hypoxemia (IH) events (a surrogate measure of apnea of prematurity (AOP)) in preterm infants. Further, there are both animal and human infant studies that have demonstrated respiratory benefits following supplementation with myo-inositol, which highlights the prospects that nutritional requirements are important for appropriate development and maturation of the respiratory system.	[MacFarlane, Peter M.; Di Fiore, Juliann M.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA		MacFarlane, PM (corresponding author), Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA.	pmm71@case.edu			Gerber Foundation [1082-4005]	P.M.M. and J.M.D. are supported by the Gerber Foundation. Reference#1082-4005.	BARRACO RA, 1989, EUR J PHARMACOL, V173, P75, DOI 10.1016/0014-2999(89)90010-1; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRY GT, 1995, GENOMICS, V25, P507, DOI 10.1016/0888-7543(95)80052-N; Berry GT, 2003, J BIOL CHEM, V278, P18297, DOI 10.1074/jbc.M213176200; Buccafusca R, 2008, MOL GENET METAB, V95, P81, DOI 10.1016/j.ymgme.2008.05.008; Chau JFL, 2005, FASEB J, V19, P1887, DOI 10.1096/fj.05-4192fje; Chen J, 2000, RESP PHYSIOL, V121, P13, DOI 10.1016/S0034-5687(00)00113-4; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conrad MS, 2015, BRAIN BEHAV IMMUN, V48, P326, DOI 10.1016/j.bbi.2015.05.001; Crowder EA, 2007, J PHYSIOL-LONDON, V582, P1047, DOI 10.1113/jphysiol.2007.134577; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Di Fiore JM, 2012, J PEDIATR-US, V161, P1047, DOI 10.1016/j.jpeds.2012.05.046; Di Fiore JM, 2010, J PEDIATR-US, V157, P69, DOI 10.1016/j.jpeds.2010.01.046; GODFREY DA, 1982, J NEUROCHEM, V38, P939, DOI 10.1111/j.1471-4159.1982.tb05333.x; Greer JJ, 1999, J APPL PHYSIOL, V86, P779, DOI 10.1152/jappl.1999.86.3.779; HALLMAN M, 1992, NEW ENGL J MED, V326, P1233, DOI 10.1056/NEJM199205073261901; HANLEY MR, 1988, PHILOS T R SOC B, V320, P381, DOI 10.1098/rstb.1988.0083; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; He L, 1996, ADV EXP MED BIOL, V410, P305; Hofstetter AO, 2008, ACTA PAEDIATR, V97, P285, DOI 10.1111/j.1651-2227.2007.00618.x; HOLUB BJ, 1986, ANNU REV NUTR, V6, P563, DOI 10.1146/annurev.nu.06.070186.003023; Kumar P, 2012, COMPR PHYSIOL, V2, P141, DOI 10.1002/cphy.c100069; MCQUEEN DS, 1995, J AUTONOM NERV SYST, V53, P115, DOI 10.1016/0165-1838(94)00179-N; MORATALLA R, 1988, BRAIN RES, V450, P398, DOI 10.1016/0006-8993(88)91583-1; Ogimoto G, 2000, P NATL ACAD SCI USA, V97, P3242, DOI 10.1073/pnas.97.7.3242; Poets CF, 2015, JAMA-J AM MED ASSOC, V314, P595, DOI 10.1001/jama.2015.8841; POKORSKI M, 1993, ADV EXP MED BIOL, V337, P191; Raman L, 2005, DEV BRAIN RES, V156, P202, DOI 10.1016/j.devbrainres.2005.02.013; Rigual R, 1999, PFLUG ARCH EUR J PHY, V437, P839, DOI 10.1007/s004240050853; Roll P, 2002, GENE, V285, P141, DOI 10.1016/S0378-1119(02)00416-X; Serra A, 2001, J APPL PHYSIOL, V91, P1298, DOI 10.1152/jappl.2001.91.3.1298; Stock C, 2010, AUTON NEUROSCI-BASIC, V156, P90, DOI 10.1016/j.autneu.2010.03.012; VALLEJO M, 1987, NATURE, V330, P656, DOI 10.1038/330656a0; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129	34	10	11	2	4	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-319-91137-3	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2018	1071						159	166		10.1007/978-3-319-91137-3_20			8	Biology; Cardiac & Cardiovascular Systems; Medicine, Research & Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Cardiovascular System & Cardiology; Research & Experimental Medicine	BL9PL	WOS:000457996700022	30357747				2022-02-06	
J	Magasi, S; Wong, A; Miskovic, A; Tulsky, D; Heinemann, AW				Magasi, Susan; Wong, Alex; Miskovic, Ana; Tulsky, David; Heinemann, Allen W.			Mobility Device Quality Affects Participation Outcomes for People With Disabilities: A Structural Equation Modeling Analysis	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries, traumatic; Outcome and process assessment (health care); Rehabilitation; Social participation; Spinal cord injuries; Stroke; Walkers; Wheelchairs	ADVERSE CONSEQUENCES; ENVIRONMENTAL-FACTORS; INSIDER PERSPECTIVE; WHEELCHAIR REPAIRS; EQUIPMENT; HEALTH	Objective: To test the effect that indicators of mobility device quality have on participation outcomes in community-dwelling adults with spinal cord injury, traumatic brain injury, and stroke by using structural equation modeling. Design: Survey, cross-sectional study, and model testing. Setting: Clinical research space at 2 academic medical centers and 1 free-standing rehabilitation hospital. Participants: Community-dwelling adults (N = 250; mean age, 48 +/- 14.3y) with spinal cord injury, traumatic brain injury, and stroke. Interventions: Not applicable. Main Outcomes Measures: The Mobility Device Impact Scale, Patient-Reported Outcomes Measurement Information System Social Function (version 2.0) scale, including Ability to Participate in Social Roles and Activities and Satisfaction with Social Roles and Activities, and the 2 Community Participation Indicators' enfranchisement scales. Details about device quality (reparability, reliability, ease of maintenance) and device type were also collected. Results: Respondents used ambulation aids (30%), manual (34%), and power wheelchairs (30%). Indicators of device quality had a moderating effect on participation outcomes, with 3 device quality variables (repairability, ease of maintenance, device reliability) accounting for 20% of the variance in participation. Wheelchair users reported lower participation enfranchisement than did ambulation aid users. Conclusions: Mobility device quality plays an important role in participation outcomes. It is critical that people have access to mobility devices and that these devices be reliable. (C) 2017 by the American Congress of Rehabilitation Medicine	[Magasi, Susan] Univ Illinois, Dept Occupat Therapy, 1919 W Taylor,Room 327, Chicago, IL 60612 USA; [Magasi, Susan] Univ Illinois, Dept Disabil Studies, 1919 W Taylor,Room 327, Chicago, IL 60612 USA; [Wong, Alex] Washington Univ, Sch Med, Dept Occupat Therapy, St Louis, MO USA; [Wong, Alex] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Miskovic, Ana; Heinemann, Allen W.] Shirley Ryan Abil Lab, Chicago, IL USA; [Tulsky, David] Univ Delaware, Ctr Assessment Res & Translat, Dept Phys Therapy, Newark, DE USA; [Tulsky, David] Univ Delaware, Ctr Assessment Res & Translat, Dept Psychol & Brain Sci, Newark, DE USA; [Heinemann, Allen W.] Northwestern Univ, Ctr Rehabil Outcomes Res, Shirley Ryan Abil Lab, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Magasi, S (corresponding author), Univ Illinois, Dept Occupat Therapy, 1919 W Taylor,Room 327, Chicago, IL 60612 USA.; Magasi, S (corresponding author), Univ Illinois, Dept Disabil Studies, 1919 W Taylor,Room 327, Chicago, IL 60612 USA.	smagas1@uic.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Wong, Alex/0000-0002-4423-2685; Tulsky, David/0000-0002-4335-4509	Rehabilitation Research and Training Center grant from the National Institute on Disability, Independent Living, and Rehabilitation Research [H133B090024]	Supported by a Rehabilitation Research and Training Center grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (grant no. H133B090024).	Aminzadeh F, 2000, PUBLIC HEALTH NURS, V17, P474, DOI 10.1046/j.1525-1446.2000.00474.x; Badley EM, 2008, SOC SCI MED, V66, P2335, DOI 10.1016/j.socscimed.2008.01.026; Brandt A, 2008, J REHABIL MED, V40, P766, DOI 10.2340/16501977-0244; Brown M.W., 1993, SOCIOL METHOD RES, P136; Byrne BM, 2004, STRUCT EQU MODELING, V11, P272, DOI 10.1207/s15328007sem1102_8; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Clarke PJ, 2014, J GERONTOL B-PSYCHOL, V69, pS8, DOI 10.1093/geronb/gbu121; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Hahn Elizabeth A, 2016, Psychol Test Assess Model, V58, P403; Hahn EA, 2014, HEALTH PSYCHOL, V33, P490, DOI 10.1037/hea0000055; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Heinemann AW, 2013, ARCH PHYS MED REHAB, V94, P2157, DOI 10.1016/j.apmr.2013.05.017; Heinemann AW, 2011, ARCH PHYS MED REHAB, V92, P564, DOI 10.1016/j.apmr.2010.07.220; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jutai J, 2007, ARCH PHYS MED REHAB, V88, P1268, DOI 10.1016/j.apmr.2007.06.773; Kaye HS, 2000, MOBILITY DEVICE US U, V14; Kirschner KL, 2014, PM&R, V6, P643, DOI 10.1016/j.pmrj.2014.06.001; Kline R.B., 2005, PRINCIPLES PRACTICE; LaPlante MP, 2010, ASSIST TECHNOL, V22, P3, DOI 10.1080/10400430903501413; Toro ML, 2016, ARCH PHYS MED REHAB, V97, P1753, DOI 10.1016/j.apmr.2016.03.032; Magasi S, 2015, ARCH PHYS MED REHAB, V96, P569, DOI 10.1016/j.apmr.2014.12.002; Magasi S, 2009, J REHABIL MED, V41, P936, DOI 10.2340/16501977-0450; Mayer S., 2015, DEPAUL J HLTH CARE L, V17, P149; Medicare. gov, WHATS COMP BIDD PROG; Medicare Payment Advisory Commission, 2016, REP C MED PAYM POL M; Pettersson I, 2016, DISABIL REHABIL-ASSI, V11, P558, DOI 10.3109/17483107.2015.1027301; Rehabiltation Engineering and Assistive Technology Society of North American (RESNA), 2015, RESNA POL POS STAT; Reschovsky JD, 2012, HEALTH AFFAIR, V31, P956, DOI 10.1377/hlthaff.2011.0243; Salminen AL, 2009, J REHABIL MED, V41, P697, DOI 10.2340/16501977-0427; Smith RM, 2004, INTRO RASCH MEASUREM; Sund T, 2015, PM&R, V7, P859, DOI 10.1016/j.pmrj.2015.02.001; United Nations, 2008, CONV RIGHTS PERS DIS; Wang H, 2010, DISABIL REHABIL-ASSI, V5, P318, DOI 10.3109/17483100903391137; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; WHO, 2001, IR DDEFICIENCY AN AS, P1; *WHO, 2005, 58 WORLD HLTH ASS DI; Wilson Mark., 2004, CONSTRUCTING MEASURE; World Health Organization, 2008, GUIDELINES PROVISION; World Health Organization, 1982, UN STAND RUL EQ OPP; Worobey L, 2014, ARCH PHYS MED REHAB, V95, P597, DOI 10.1016/j.apmr.2013.11.022; Worobey L, 2012, AM J PHYS MED REHAB, V91, P463, DOI 10.1097/PHM.0b013e31825ab5ec	45	10	10	0	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2018	99	1					1	8		10.1016/j.apmr.2017.06.030			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FR9VQ	WOS:000419421600001	28784356				2022-02-06	
J	Mahooti, N				Mahooti, Navid			Sports-Related Concussion: Acute Management and Chronic Postconcussive Issues	CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Sports-related concussion; Concussion treatment; Vestibular therapy; Postconcussive syndrome; Return-to-learn; Return-to-play (return-to-sport); Neuropsychological testing	TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; HIGH-SCHOOL; MEDICINE PHYSICIANS; RADIATION-EXPOSURE; PEDIATRIC-PATIENTS; HYPERBARIC-OXYGEN; SYMPTOMS; EPIDEMIOLOGY; THERAPIES	Sports-related concussion (SRC) is a common problem in youth sports. Concussion may occur after a forceful hit to the body or head, resulting in transient neuropathologic changes that spontaneously resolve with relative rest and activity modification in most patients. Most SRCs are effectively managed by primary care physicians and sports medicine specialists. In some cases, symptoms may persist and the child and adolescent psychiatrist may be consulted. This article reviews important background information regarding SRC and highlights a variety of pharmacologic and nonpharmacologic treatment options that consultant psychiatrists should know.	[Mahooti, Navid] North Shore Phys Grp, Mass Gen North Shore, 104 Endicott St,Suite 104, Danvers, MA 01923 USA		Mahooti, N (corresponding author), North Shore Phys Grp, Mass Gen North Shore, 104 Endicott St,Suite 104, Danvers, MA 01923 USA.	NMahooti@partners.org					Anderson Pauline, 2015, INCIDENTAL MRI FINDI; Arrieux J.P., 2017, REV VALIDITY COMPUTE; Ashbaugh A, 2016, CURR SPORT MED REP, V15, P16, DOI 10.1249/JSR.0000000000000219; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; EI-Chammas K, 2013, JAMA PEDIAT, V167, P250; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellis MJ, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15600; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Generali Joyce A, 2015, Hosp Pharm, V50, P367, DOI 10.1310/hpj5005-367; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Halstead ME, 2016, SPORTS HEALTH, V8, P50, DOI 10.1177/1941738115622158; Hawkins JR, 2017, J SPORT REHABIL, V26, P290, DOI 10.1123/jsr.2015-0087; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN SPORT MED, V30, P201, DOI 10.1016/j.csm.2010.08.002; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Petraglia Anthony L, 2011, Surg Neurol Int, V2, P146, DOI 10.4103/2152-7806.85987; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Reddy CC, 2004, BRAIN INJURY PROFESS, V4, P24; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Strelzik J, 2017, PEDIATR ANN, V46, pE139, DOI 10.3928/19382359-20170320-02; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zaremski JL, 2015, CURR SPORT MED REP, V14, P16, DOI 10.1249/JSR.0000000000000121	46	10	10	0	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1056-4993	1558-0490		CHILD ADOL PSYCH CL	Child Adolesc. Psychiatr. N. Am.	JAN	2018	27	1					93	+		10.1016/j.chc.2017.08.005			17	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	FR3UC	WOS:000418991100009	29157505				2022-02-06	
J	Mc Fie, S; Abrahams, S; Patricios, J; Suter, J; Posthumus, M; September, AV				Mc Fie, Sarah; Abrahams, Shameemah; Patricios, Jon; Suter, Jason; Posthumus, Michael; September, Alison, V			The association between &ITCOMT&IT rs4680 and 5-HTTLPR genotypes and concussion history in South African rugby union players	JOURNAL OF SPORTS SCIENCES			English	Article						Concussion; rugby; personality; COMT; SLC6A4	SEROTONIN TRANSPORTER GENE; CATECHOL-O-METHYLTRANSFERASE; CHRONIC TRAUMATIC ENCEPHALOPATHY; COMT VAL(158)MET POLYMORPHISM; PERSONALITY-TRAITS; PROMOTER POLYMORPHISM; SENSATION-SEEKING; IMPULSIVITY; ANXIETY; RISK	The objective was to investigate the relationship between Catechol-O-methyltransferase (COMT) rs4680 and serotonin-transporter-linked polymorphic region (5-HTTLPR) genotypes with concussion history and personality traits. Rugby players ("all levels": n = 303), from high schools ("junior", n = 137), senior amateur, and professional teams ("senior", n = 166), completed a self-reported concussion history questionnaire, Cloninger's Tridimensional Personality Questionnaire, and donated a DNA sample. Participants were allocated into control (non-concussed, n = 140), case (all) (previous suspected or diagnosed concussions, n = 163), or case (diagnosed only) (previous diagnosed concussion, n = 140) groups. COMT rs4680 Val/Val genotypes were over-represented in controls in all levels (P = 0.013, OR:2.00, 95% 0:1.15-3.57) and in juniors (P = 0.003, OR:3.57, 95% CI:1.45-9.09). Junior Val/Val participants displayed increased "anticipatory worry" (P = 0.023). The 5-HTTLPR low expressing group was under-represented in controls when all levels were considered (P = 0.032; OR:2.02, 95% CI:1.05-3.90) and in juniors (P = 0.021; OR:3.36, 95% CI:1.16-9.72). Junior 5-HTTLPR low and intermediate expressing groups displayed decreased "harm avoidance" (P = 0.009), "anticipatory worry" (P = 0.041), and "fear of uncertainty" (P < 0.001). This study provides preliminary indications that personality associated genetic variants can influence concussion in rugby.	[Mc Fie, Sarah; Abrahams, Shameemah; Posthumus, Michael; September, Alison, V] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Div Exercise Sci & Sports Med, Cape Town, South Africa; [Patricios, Jon] Morningside Sports Med Clin, Johannesburg, South Africa; [Patricios, Jon] Univ Pretoria, Fac Hlth Sci, Sect Sports Med, Pretoria, South Africa; [Patricios, Jon] Univ Witwatersrand, Fac Hlth Sci, Dept Emergency Med, Johannesburg, South Africa; [Suter, Jason] Sports Sci & Exercise Med Clin, Cape Town, South Africa		September, AV (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Div Exercise Sci & Sports Med, Cape Town, South Africa.	alison.september@uct.ac.za		Abrahams, Shameemah/0000-0002-1120-678X; Patricios, Jon/0000-0002-6829-4098; September, Alison V/0000-0003-0950-286X	South African National Research FoundationNational Research Foundation - South Africa [90942, 93416:2015, 85534:2015]; South African National Research FoundationNational Research Foundation - South Africa; University of Cape Town	This study was funded by the South African National Research Foundation (A.V.S., grant number 90942), (M.P., grant numbers 93416:2015, 85534:2015). The South African National Research Foundation and the University of Cape Town funded S.A. and S.M.	Aluja A, 2009, J PSYCHIATR RES, V43, P906, DOI 10.1016/j.jpsychires.2008.11.008; Amstadter AB, 2012, J PSYCHIATR RES, V46, P940, DOI 10.1016/j.jpsychires.2012.04.010; Balestri M, 2014, INT CLIN PSYCHOPHARM, V29, P1, DOI 10.1097/YIC.0b013e328364590b; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Beidler E., 2016, THESIS; BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250; Carver CS, 2006, PSYCHIAT RES, V144, P1, DOI 10.1016/j.psychres.2006.03.013; Chen CH, 2011, NEUROPSYCHOPHARMACOL, V36, P1593, DOI 10.1038/npp.2011.39; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Dalley JW, 2012, NEUROSCIENCE, V215, P42, DOI 10.1016/j.neuroscience.2012.03.065; Davidson RJ, 2001, ANN NY ACAD SCI, V935, P191, DOI 10.1111/j.1749-6632.2001.tb03481.x; Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Fresan A, 2011, COMPR PSYCHIAT, V52, P774, DOI 10.1016/j.comppsych.2010.11.003; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; Freixanet MGI, 2012, AN PSICOL-SPAIN, V28, P223; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Gouttebarge V., 2017, BRIT J SPORT MED, V51, P324; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hallikainen T, 1999, MOL PSYCHIATR, V4, P385, DOI 10.1038/sj.mp.4000526; Hashimoto R, 2007, NEUROSCI LETT, V428, P17, DOI 10.1016/j.neulet.2007.09.036; Heils A, 1996, J NEUROCHEM, V66, P2621; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Kennis M, 2013, NEUROSCI BIOBEHAV R, V37, P73, DOI 10.1016/j.neubiorev.2012.10.012; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kim SJ, 2006, NEUROSCI LETT, V401, P154, DOI 10.1016/j.neulet.2006.03.006; Kogan SM, 2010, HEALTH PSYCHOL, V29, P471, DOI 10.1037/a0020594; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Lage GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016927; Lee LO, 2014, PSYCHIAT GENET, V24, P52, DOI 10.1097/YPG.0000000000000018; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Little J, 2009, EUR J CLIN INVEST, V39, P247, DOI 10.1111/j.1365-2362.2009.02125.x; Malloy-Diniz LF, 2011, J AFFECT DISORDERS, V133, P221, DOI 10.1016/j.jad.2011.03.051; Mc Fie S, 2016, CLIN J SPORT MED, V26, P398, DOI 10.1097/JSM.0000000000000276; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Minelli A, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-50; Montag C, 2012, CNS NEUROL DISORD-DR, V11, P236, DOI 10.2174/187152712800672382; Morrongiello BA, 2007, J PEDIATR PSYCHOL, V32, P926, DOI 10.1093/jpepsy/jsm027; Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808; Munafo MR, 2005, MOL PSYCHIATR, V10, P415, DOI 10.1038/sj.mp.4001627; Munafo MR, 2003, MOL PSYCHIATR, V8, P471, DOI 10.1038/sj.mp.4001326; Nordquist N, 2010, UPSALA J MED SCI, V115, P2, DOI 10.3109/03009730903573246; Paaver M, 2008, PROG NEURO-PSYCHOPH, V32, P1263, DOI 10.1016/j.pnpbp.2008.03.021; Paaver M, 2007, PSYCHOPHARMACOLOGY, V194, P545, DOI 10.1007/s00213-007-0867-z; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; Patkar AA, 2002, PSYCHIAT RES, V110, P103, DOI 10.1016/S0165-1781(02)00098-7; Pine A, 2010, J NEUROSCI, V30, P8888, DOI 10.1523/JNEUROSCI.6028-09.2010; R Development Core Team, 2012, R LANG ENV STAT COMP; Raftery M, 2014, BRIT J SPORT MED, V48, P79, DOI 10.1136/bjsports-2013-093051; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Riba J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002479; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schinka JA, 2004, MOL PSYCHIATR, V9, P197, DOI 10.1038/sj.mp.4001405; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; SIEGEL AW, 1994, J EMOT BEHAV DISORD, V2, P89, DOI 10.1177/106342669400200203; Soeiro-De-Souza MG, 2013, MOL MED REP, V7, P1067, DOI 10.3892/mmr.2013.1336; Sonuga-Barke EJS, 2011, BIOL PSYCHIAT, V70, P230, DOI 10.1016/j.biopsych.2011.01.040; Stein MB, 2005, NEUROPSYCHOPHARMACOL, V30, P2092, DOI 10.1038/sj.npp.1300787; Stoltenberg Scott F., 2011, Frontiers in Genetics, V2, P33, DOI 10.3389/fgene.2011.00033; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Thomas D. C., 2001, CANCER EPIDEM BIOMAR, V11, P505; van Breda K, 2015, PHYSIOL BEHAV, V151, P279, DOI 10.1016/j.physbeh.2015.07.039; Walderhaug E, 2010, NEUROSCI LETT, V473, P208, DOI 10.1016/j.neulet.2010.02.048; Warnes G., 2011, GENETICS PACKAGE POP; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789	71	10	10	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2018	36	8					920	933		10.1080/02640414.2017.1346274			14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	GB4QV	WOS:000429046700009	28665765	Green Submitted			2022-02-06	
J	Sarmiento, K; Donnell, Z; Hoffman, R; Tennant, B				Sarmiento, Kelly; Donnell, Zoe; Hoffman, Rosanne; Tennant, Bethany			Healthcare providers' attitudes and behaviours related to paediatric mild traumatic brain injury: results from the 2014 DocStyles survey	BRAIN INJURY			English	Article						concussion; healthcare providers; attitudes; behaviors	CLINICAL PRACTICES; SPORTS CONCUSSION; MANAGEMENT; KNOWLEDGE; GUIDELINES; PHYSICIANS	Objective: Explore healthcare providers' experiences managing mTBI and better understand their use of mTBI assessment tools and guidelines.Cross-sectional Methods: A random sample of 1,760 healthcare providers responded to the web-based DocStyles survey between June 18 and 30, 2014. The sample included family/general practitioners, internists, pediatricians, and nurse practitioners who reported seeing pediatric patients. We examined their experiences with mTBI to identify opportunities to increase preparedness and improve management of mTBI.Results: Fifty-nine percent of healthcare providers reported that they diagnosed or managed pediatric patients with mTBI within the last 12months. Of those, 44.4% felt very prepared' to make decisions about when pediatric patients can safety return to activities, such as school and sports after a mTBI. When asked how often they use screening or assessment tools to assess pediatric patients with mTBI, almost half reported that they seldom' or never' use those resources (24.6% and 22.0%, respectively).Conclusion: Most healthcare providers reported seeing pediatric patients with mTBI, yet most feel only somewhat prepared to manage this injury in their practise. Broader use of screening tools and guidelines, that include clinical decision support tools, may be useful for healthcare providers who care for pediatric patients with mTBI.	[Sarmiento, Kelly] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA USA; [Donnell, Zoe; Hoffman, Rosanne; Tennant, Bethany] ICF, Social Mkt, Rockville, MD USA		Donnell, Z (corresponding author), 100 Cambridgepark Dr,Suite 501, Cambridge, MA 02140 USA.	zoe.donnell@icf.com	Tennant, Bethany/AAM-3538-2020		Intramural CDC HHS [CC999999] Funding Source: Medline		[Anonymous], 2013, MED SCI SPORT EXER, V45, P1618, DOI 10.1249/MSS.0b013e31829ba437; Broshek DK, 2014, J CHILD NEUROL, V29, P17, DOI 10.1177/0883073812464525; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Giebel S, 2011, J EMERG MED, V41, P649, DOI 10.1016/j.jemermed.2011.03.021; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; U. S. Department of Health and Human Services Centers for Disease Control and Prevention, 2010, WHAT IS CONC; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	13	10	11	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	7					889	893		10.1080/02699052.2018.1466197			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GH6GT	WOS:000433542900009	29683728	Green Accepted			2022-02-06	
J	Sharma, A; Muresanu, DF; Lafuente, JV; Sjoquist, PO; Patnaik, R; Tian, ZR; Ozkizilcik, A; Sharma, HS				Sharma, Aruna; Muresanu, Dafin F.; Vicente Lafuente, Jose; Sjoquist, Per-Ove; Patnaik, Ranjana; Tian, Z. Ryan; Ozkizilcik, Asya; Sharma, Hari S.			Cold Environment Exacerbates Brain Pathology and Oxidative Stress Following Traumatic Brain Injuries: Potential Therapeutic Effects of Nanowired Antioxidant Compound H-290/51	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury (TBI); Oxidative stress; Luminol; Lucigenin; Malondialdehyde; Glutathione; H-290/51; Nanodelivery; Blood-brain barrier; Brain edema; Neuronal damage; Cold environment	SPINAL-CORD-INJURY; NITRIC-OXIDE SYNTHASE; DEPLOYED MILITARY PERSONNEL; NERVOUS-SYSTEM INJURY; CEREBRAL BLOOD-FLOW; NANOPARTICLES EXACERBATE; BARRIER PERMEABILITY; HYPERTHERMIA WORSENS; HOT ENVIRONMENTS; EDEMA FORMATION	The possibility that traumatic brain injury (TBI) occurring in a cold environment exacerbates brain pathology and oxidative stress was examined in our rat model. TBI was inflicted by making a longitudinal incision into the right parietal cerebral cortex (2 mm deep and 4 mm long) in cold-acclimatized rats (5 degrees C for 3 h daily for 5 weeks) or animals at room temperature under Equithesin anesthesia. TBI in cold-exposed rats exhibited pronounced increase in brain lucigenin (LCG), luminol (LUM), and malondialdehyde (MDA) and marked pronounced decrease in glutathione (GTH) as compared to identical TBI at room temperature. The magnitude and intensity of BBB breakdown to radioiodine and Evans blue albumin, edema formation, and neuronal injuries were also exacerbated in cold-exposed rats after injury as compared to room temperature. Nanowired delivery of H-290/51 (50 mg/kg) 6 and 8 h after injury in cold-exposed group significantly thwarted brain pathology and oxidative stress whereas normal delivery of H-290/51 was neuroprotective after TBI at room temperature only. These observations are the first to demonstrate that (i) cold aggravates the pathophysiology of TBI possibly due to an enhanced production of oxidative stress, (ii) and in such conditions, nanodelivery of antioxidant compound has superior neuroprotective effects, not reported earlier.	[Sharma, Aruna; Sharma, Hari S.] Uppsala Univ, Uppsala Univ Hosp, Dept Surg Sci Anesthesiol & Intens Care Med, SE-75185 Uppsala, Sweden; [Sharma, Aruna; Sharma, Hari S.] Uppsala Univ, Int Expt CNS Injury & Repair, Univ Hosp, Frodingsgatan 12,Bldg 28, SE-75421 Uppsala, Sweden; [Sharma, Aruna; Vicente Lafuente, Jose; Sharma, Hari S.] Univ Basque Country UPV EHU, Dept Neurosci, LaNCE, Leioa, Bizkaia, Spain; [Muresanu, Dafin F.] RoNeuro Inst Neurol Res & Diagnost, 37 Mircea Eliade St, Cluj Napoca 400364, Romania; [Muresanu, Dafin F.] Univ Med & Pharm, Dept Clin Neurosci, Cluj Napoca, Romania; [Vicente Lafuente, Jose] BioCruces Hlth Res Inst, Nanoneurosurg Grp, Baracaldo 48903, Bizkaia, Spain; [Vicente Lafuente, Jose] Univ Autonoma Chile, Fac Hlth Sci, Santiago, Chile; [Sjoquist, Per-Ove] Karolinska Univ Hosp, Karolinska Inst, Div Cardiol, Dept Med, Stockholm, Sweden; [Patnaik, Ranjana] Banaras Hindu Univ, Sch Biomed Engn, Dept Biomat, Indian Inst Technol, Varanasi, Uttar Pradesh, India; [Tian, Z. Ryan] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Ozkizilcik, Asya] Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA		Sharma, HS (corresponding author), Uppsala Univ, Uppsala Univ Hosp, Dept Surg Sci Anesthesiol & Intens Care Med, SE-75185 Uppsala, Sweden.; Sharma, HS (corresponding author), Uppsala Univ, Int Expt CNS Injury & Repair, Univ Hosp, Frodingsgatan 12,Bldg 28, SE-75421 Uppsala, Sweden.; Sharma, HS (corresponding author), Univ Basque Country UPV EHU, Dept Neurosci, LaNCE, Leioa, Bizkaia, Spain.	Sharma@surgsci.uu.se	Patnaik, Ranjana/AAZ-4440-2020; Lafuente, Jose-Vicente/O-6395-2014; Tian, Z. Ryan/R-6671-2016; Muresanu, Fior-Dafin/AAI-8120-2021	Patnaik, Ranjana/0000-0002-8131-177X; Lafuente, Jose-Vicente/0000-0001-7246-0987; Tian, Z. Ryan/0000-0002-5644-8483; Ozkizilcik, Asya/0000-0002-6261-9533	Air Force Office of Scientific Research (EOARD, London, UK)United States Department of DefenseAir Force Office of Scientific Research (AFOSR); Air Force Material Command, USAF [FA8655-05-1-3065]; Alzheimer's AssociationAlzheimer's Association [IIRG-09-132087]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG028679]; Dr. Robert M. Kohrman Memorial Fund; Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [2710-HSS]; Goran Gustafsson Foundation, Stockholm, Sweden; Astra Zeneca, Molndal, SwedenAstraZeneca; University Grants Commission, New Delhi, IndiaUniversity Grants Commission, India; Ministry of Science & Technology, Govt. of India; Indian Medical Research Council, New Delhi, India; India-EU [IT 901/16]; Government of Basque Country; University of Basque Country, Spain [PPG 17/51, UFI 11/32]; Society for Neuroprotection and Neuroplasticity (SSNN), Romania; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG028679] Funding Source: NIH RePORTER	This study is supported by grants from the Air Force Office of Scientific Research (EOARD, London, UK) and Air Force Material Command, USAF, under grant number FA8655-05-1-3065; the Alzheimer's Association (IIRG-09-132087), the National Institutes of Health (R01 AG028679) and the Dr. Robert M. Kohrman Memorial Fund (MAS, RJC); Swedish Medical Research Council (Nr 2710-HSS), Goran Gustafsson Foundation, Stockholm, Sweden (HSS), Astra Zeneca, Molndal, Sweden (HSS/AS), The University Grants Commission, New Delhi, India (HSS/AS), Ministry of Science & Technology, Govt. of India (HSS/AS), Indian Medical Research Council, New Delhi, India (HSS/AS) and India-EU Co-operation Program (RP/AS/HSS) and IT 901/16 (JVL), Government of Basque Country and UFI 11/32 and PPG 17/51 (JVL) University of Basque Country, Spain, and Society for Neuroprotection and Neuroplasticity (SSNN), Romania. We thank Suraj Sharma, Uppsala, Sweden, for computer and graphic support. The US government is authorized to reproduce and distribute reprints for government purpose notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the Air Force Office of Scientific Research or the US government.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Agarwal R, 1999, NEUROCHEM RES, V24, P1507, DOI 10.1023/A:1021191729865; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Alm P, 2000, AMINO ACIDS, V19, P383, DOI 10.1007/s007260070069; Blagojevic Dusko P, 2011, Front Biosci (Schol Ed), V3, P416, DOI 10.2741/s161; BRIGHTMA.MW, 1970, J NEUROL SCI, V10, P215, DOI 10.1016/0022-510X(70)90151-6; Bryan CJ, 2013, BRAIN INJURY, V27, P1333, DOI 10.3109/02699052.2013.823651; Chen KX, 2014, J THERM BIOL, V44, P35, DOI 10.1016/j.jtherbio.2014.06.005; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; DAHLE LK, 1962, ARCH BIOCHEM BIOPHYS, V98, P253, DOI 10.1016/0003-9861(62)90181-9; DEY P K, 1984, Indian Journal of Physiology and Pharmacology, V28, P177; DEY PK, 1983, INDIAN J MED RES, V77, P554; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; ELLIOTT KAC, 1949, AM J PHYSIOL, V157, P122, DOI 10.1152/ajplegacy.1949.157.1.122; Ganesan S, 2016, J APPL TOXICOL, V36, P554, DOI 10.1002/jat.3224; Guzik TJ, 2005, METH MOLEC MED, V108, P73; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hanisch UK, 2004, J BIOL CHEM, V279, P51880, DOI 10.1074/jbc.M408318200; Ismailov Rovshan M, 2016, J Spec Oper Med, V16, P67; Katsuragi H, 2000, LUMINESCENCE, V15, P1, DOI 10.1002/(SICI)1522-7243(200001/02)15:1<1::AID-BIO561>3.0.CO;2-7; Khaldi A, 2002, ANN NY ACAD SCI, V962, P53, DOI 10.1111/j.1749-6632.2002.tb04055.x; Kiyatkin EA, 2009, NEUROSCIENCE, V161, P926, DOI 10.1016/j.neuroscience.2009.04.004; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; Kleikers PWM, 2012, J MOL MED, V90, P1391, DOI 10.1007/s00109-012-0963-3; KUROIWA T, 1985, ACTA NEUROPATHOL, V66, P3, DOI 10.1007/BF00698288; La Fata G, 2014, NUTRIENTS, V6, P5453, DOI 10.3390/nu6125453; Liu DD, 2013, ACS APPL MATER INTER, V5, P13295, DOI 10.1021/am404276r; Liu HT, 2015, REV NEUROSCIENCE, V26, P105, DOI 10.1515/revneuro-2014-0041; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Mahapatra C, 2017, ACTA BIOMATER, V50, P142, DOI 10.1016/j.actbio.2016.12.014; Marshall SA, 2012, COMBAT CASUALTY CARE, P347; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; MOHANTY S, 1989, J NEUROL SCI, V90, P87, DOI 10.1016/0022-510X(89)90048-8; Nakamura Y, 2000, J NEUROCHEM, V75, P2309, DOI 10.1046/j.1471-4159.2000.0752309.x; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pan WH, 2003, J NEUROIMMUNOL, V134, P111, DOI 10.1016/S0165-5728(02)00426-5; Pulli B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067976; Ranaivo HR, 2010, EXP NEUROL, V226, P310, DOI 10.1016/j.expneurol.2010.09.005; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Ryu J, 2000, J BIOL CHEM, V275, P29955, DOI 10.1074/jbc.M001220200; Sajja RK, 2016, J CEREBR BLOOD F MET, V36, P539, DOI 10.1177/0271678X15616978; Sakurai A, 2012, J NEUROTRAUM, V29, P313, DOI 10.1089/neu.2011.2152; SanMartin A, 2014, J NANOSCI NANOTECHNO, V14, P4880, DOI 10.1166/jnn.2014.8669; Schissel DJ, 1998, MIL MED, V163, P568, DOI 10.1093/milmed/163.8.568; Schulz-Heik RJ, 2016, BRAIN INJURY, V30, P271, DOI 10.3109/02699052.2015.1113567; Sharma A, 2016, CNS NEUROL DISORD-DR, V15, P1092, DOI 10.2174/1871527315666160819123059; Sharma HS, 2006, ACTA NEUROCHIR SUPPL, V96, P322; Sharma HS, 2015, MOL NEUROBIOL, V52, P882, DOI 10.1007/s12035-015-9297-9; Sharma HS, 2007, PROG BRAIN RES, V162, P173, DOI 10.1016/S0079-6123(06)62010-4; Sharma HS, 2007, CURR PHARM DESIGN, V13, P1903; Sharma HS, 2016, CNS NEUROL DISORD-DR, V15, P1045, DOI 10.2174/1871527315666160902145145; Sharma HS, 2015, MOL NEUROBIOL, V52, P1023, DOI 10.1007/s12035-015-9252-9; Sharma Hari Shanker, 2005, Curr Protoc Toxicol, VChapter 11, DOI 10.1002/0471140856.tx1114s23; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5073, DOI 10.1166/jnn.2009.GR10; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P4970, DOI 10.1166/jnn.2009.1717; Sharma HS, 2006, J NEURAL TRANSM, V113, P521, DOI 10.1007/s00702-005-0405-2; Sharma HS, 2003, ACT NEUR S, V86, P415; SHARMA HS, 1987, NEUROPHARMACOLOGY, V26, P85, DOI 10.1016/0028-3908(87)90049-9; Sharma HS, 2002, AMINO ACIDS, V23, P261, DOI 10.1007/s00726-001-0137-z; Sharma HS, 1997, ANN NY ACAD SCI, V813, P581, DOI 10.1111/j.1749-6632.1997.tb51749.x; Sharma HS, 1998, PROG BRAIN RES, V115, P297; SHARMA HS, 1987, BRAIN RES, V424, P153, DOI 10.1016/0006-8993(87)91205-4; SHARMA HS, 1993, ACTA NEUROPATHOL, V85, P145; Stanley IH, 2017, J PSYCHIATR RES, V84, P161, DOI 10.1016/j.jpsychires.2016.10.004; Tian ZR, 2012, CNS NEUROL DISORD-DR, V11, P86; Westerlund C, 1996, BIOCHEM PHARMACOL, V51, P1397, DOI 10.1016/0006-2952(96)00080-9; ZLOKOVIC BV, 1995, PHARM RES-DORDR, V12, P1395, DOI 10.1023/A:1016254514167	72	10	10	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2018	55	1					276	285		10.1007/s12035-017-0740-y			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV6PC	WOS:000424702600028	28856566				2022-02-06	
J	Todis, B; McCart, M; Glang, A				Todis, Bonnie; McCart, Melissa; Glang, Ann			Hospital to school transition following traumatic brain injury: A qualitative longitudinal study	NEUROREHABILITATION			English	Article						Brain injury; qualitative; pediatric; hospital-to-school transition; service deliver; education	CHILDREN; SERVICES; STUDENTS; CARE; TBI	BACKGROUND: The transition from hospital to school is regarded by researchers as a key factor in the educational success of students with traumatic brain injury (TBI). OBJECTIVES: The objective of this study is to look closely at what transition services consist of, how they are delivered, and how they are received by educators. METHODS: Parents and educators of 21 students with TBI participated in a qualitative study of the delivery of transition services and implementation of hospital recommendations. RESULTS: This paper presents two themes that emerged from interview and observational data collected over a 7-year period: 1) provision of hospital-school transition services is inconsistent and 2) teachers lack sufficient awareness of and training in TBI to implement hospital transition recommendations. Regardless of the type and quality of transition support, most educators in the students' schools remained unaware of the students' needs and how to meet them. CONCLUSION: Recommendations include more consistent and specific communication between hospital and school for all students with TBI, long-term tracking of the injury in student files, and increased training of educators in how to meet the needs of students with TBI.	[Todis, Bonnie; McCart, Melissa; Glang, Ann] Univ Oregon, Ctr Brain Injury Res & Training, 1600 Millrace,Suite 202, Eugene, OR 97403 USA		Todis, B (corresponding author), Univ Oregon, Ctr Brain Injury Res & Training, 1600 Millrace,Suite 202, Eugene, OR 97403 USA.	todisb@cbirt.org	McCart, Melissa/AAN-1506-2020		US Department of EducationUS Department of Education [H324C010113, H324C040148]	This project was completed with funding from the US Department of Education, grants # H324C010113 and # H324C040148. We thank Emily Havel for her contribution to data collection and analysis.	Blosser J, 1997, J HEAD TRAUMA REHAB, V12, P21, DOI 10.1097/00001199-199704000-00004; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; Gioia G. A., 2015, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.00000000000, DOI 10.1097/HTR.00000000000]; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Glang A, 2008, NEUROREHABILITATION, V23, P477; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Katz E R, 1992, Child Health Care, V21, P69, DOI 10.1207/s15326888chc2102_1; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Savage R. C., 2003, BRAIN INJ SOURCE, V6, P8; Savage RC, 2001, NEUROREHABILITATION, V16, P49; Schwartz H., 1979, QUALITATIVE METHODOL; Semrud-Clikeman M, 2010, APPL NEUROPSYCHOL, V17, P116, DOI 10.1080/09084281003708985; Shaw SR, 2008, PSYCHOL SCHOOLS, V45, P74, DOI 10.1002/pits.20280; Stuart J. L., 1996, TEACHING EXCEPTIONAL, V28, P58, DOI DOI 10.1177/004005999602800212; Worchel-Prevatt FF, 1998, J SCHOOL PSYCHOL, V36, P261, DOI 10.1016/S0022-4405(98)00012-0; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P25, DOI 10.1097/00001199-199512000-00006; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006	22	10	10	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	42	3					269	276		10.3233/NRE-172383			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE2RW	WOS:000431063300003	29660964				2022-02-06	
J	Veeh, CA; Renn, T; Vaughn, MG; DeLisi, M				Veeh, Christopher A.; Renn, Tanya; Vaughn, Michael G.; DeLisi, Matt			Traumatic brain injury, temperament, and violence in incarcerated youth: a mediation analysis based on Delisi and Vaughn's theory of temperament and antisocial behavior	PSYCHOLOGY CRIME & LAW			English	Article						Temperament; traumatic brain injury; violence; delinquency; mediation	ADVERSE CHILDHOOD EXPERIENCES; REACTIVE CRIMINAL THINKING; SELF-CONTROL; JUVENILE-OFFENDERS; SUBSTANCE USE; NEGATIVE EMOTIONALITY; PERSONALITY-CHANGE; PREVALENCE; ASSOCIATION; ADOLESCENTS	Traumatic brain injury (TBI) is associated with violent behavior. A possible key mechanism to explain the relationship between TBI and violence is DeLisi and Vaughn's temperament-based theory of antisocial behavior. Accordingly, the current study investigates whether temperament - the combination of effortful control and negative emotionality - mediates the relationship between TBI and violent behavior within incarcerated youth. A non-probability sample of youth (N = 227) incarcerated in two long-term residential facilities completed a comprehensive assessment tool that collected data on TBI, temperament, childhood trauma, substance use, mental illness, and a variety of demographic characteristics. Preliminary results showed TBI significantly increased violent behavior, adjusting for confounds. Then, mediation analysis found that temperament accounted for 54% of the total effect between TBI and violence. The study findings show the potency of DeLisi and Vaughn's temperamental construct in explaining the relationship between TBI and violent behavior within a sample of incarcerated youth. The dynamic interplay between effortful control and negative emotionality appears to be an important mechanism related to violent behavior. Both temperament constructs should be the focus of future assessment and intervention among incarcerated youth with TBI.	[Veeh, Christopher A.] Univ Iowa, Sch Social Work, 308 North Hall, Iowa City, IA 52242 USA; [Renn, Tanya] Florida State Univ, Coll Social Work, St Louis, MO USA; [Vaughn, Michael G.] St Louis Univ, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA; [DeLisi, Matt] Iowa State Univ, Dept Sociol, Ames, IA USA		Veeh, CA (corresponding author), Univ Iowa, Sch Social Work, 308 North Hall, Iowa City, IA 52242 USA.	veeh1221@gmail.com	Renn, Tanya/ABD-5469-2021; DeLisi, Matt/U-9128-2019; Vaughn, Michael/W-2694-2019	DeLisi, Matt/0000-0001-5964-5848; Veeh, Christopher/0000-0002-2341-2636			Abram KM, 2004, ARCH GEN PSYCHIAT, V61, P403, DOI 10.1001/archpsyc.61.4.403; Baglivio MT, 2016, J FORENSIC PSYCHI PS, V27, P376, DOI 10.1080/14789949.2016.1145720; Baglivio MT, 2017, CRIME DELINQUENCY, V63, P166, DOI 10.1177/0011128715570628; Baglivio MT, 2015, J CRIM JUST, V43, P229, DOI 10.1016/j.jcrimjus.2015.04.012; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Beaver KM, 2007, CRIM JUSTICE BEHAV, V34, P1345, DOI 10.1177/0093854807302049; Behnken MP, 2015, ROUT INT HANDB, P418; Bernstein D., 1998, MANUAL CHILDHOOD TRA; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; DeLisi M, 2006, J CRIM JUST, V34, P153, DOI 10.1016/j.jcrimjus.2006.01.005; DeLisi M, 2015, ROUT INT HANDB, P331; DeLisi M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030331; DeLisi M, 2015, J CRIM JUST, V43, P290, DOI 10.1016/j.jcrimjus.2015.05.005; DeLisi M, 2014, J CRIM JUST, V42, P10, DOI 10.1016/j.jcrimjus.2013.11.001; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; ELLIOTT DS, 1989, MULTIPLE PROBLEM YOU; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fishbein D, 2016, INT J OFFENDER THER, V60, P575, DOI 10.1177/0306624X14554778; Fox BH, 2015, CHILD ABUSE NEGLECT, V46, P163, DOI 10.1016/j.chiabu.2015.01.011; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Garofalo C, 2017, J CRIM JUST, V51, P9, DOI 10.1016/j.jcrimjus.2017.05.015; Hicks R, 2011, STATA J, V11, P605, DOI 10.1177/1536867X1101100407; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kisser J, 2017, BRAIN INJURY, V31, P620, DOI 10.1080/02699052.2017.1283057; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; McDonald S., 2014, UNDERSTANDING TRAUMA, P133; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P205, DOI 10.1097/HTR.0000000000000261; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Pollock W, 2015, J CRIM JUST, V43, P69, DOI 10.1016/j.jcrimjus.2014.12.004; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Raine A, 2005, J ABNORM PSYCHOL, V114, P38, DOI 10.1037/0021-843X.114.1.38; Rudasill KM, 2010, J SCHOOL PSYCHOL, V48, P389, DOI 10.1016/j.jsp.2010.05.001; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Schwartz JA, 2017, J RES CRIME DELINQ, V54, P869, DOI 10.1177/0022427817710287; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Stoddard SA, 2011, PEDIATRICS, V127, P1074, DOI 10.1542/peds.2010-2453; Tarter RE, 2003, AM J PSYCHIAT, V160, P1078, DOI 10.1176/appi.ajp.160.6.1078; TARTER RE, 1988, J CONSULT CLIN PSYCH, V56, P189, DOI 10.1037/0022-006X.56.2.189; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Vitaro F, 2006, J ABNORM CHILD PSYCH, V34, P685, DOI 10.1007/s10802-006-9055-6; Walters GD, 2016, J CRIM JUST, V46, P45, DOI 10.1016/j.jcrimjus.2016.03.003; Walters GD, 2015, J CRIM JUST, V43, P369, DOI 10.1016/j.jcrimjus.2015.07.001; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wolff KT, 2016, YOUTH VIOLENCE JUV J, V14, P350, DOI 10.1177/1541204015599042; Yoleri S, 2012, INT J GLOBAL ED, V1, P54	64	10	10	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1068-316X	1477-2744		PSYCHOL CRIME LAW	Psychol. Crime Law		2018	24	10					1016	1029		10.1080/1068316X.2018.1497632			14	Criminology & Penology; Law; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Criminology & Penology; Government & Law; Psychology	GU5QM	WOS:000445343700003					2022-02-06	
J	Wang, N; Lu, Y; Wang, K; Li, WS; Lu, P; Lei, S; Li, R; Zhang, H; Zheng, J; Lu, HX; Chen, XL; Liu, Y; Zhang, PB				Wang, Ning; Lu, Yang; Wang, Kui; Li, Wei-song; Lu, Pan; Lei, Shan; Li, Rong; Zhang, Hong; Zheng, Juan; Lu, Hai-xia; Chen, Xin-lin; Liu, Yong; Zhang, Peng-bo			Simvastatin Attenuates Neurogenetic Damage and Improves Neurocongnitive Deficits Induced by Isoflurane in Neonatal Rats	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Simvastatin; Isoflurane; Neural stem cells; Akt; GSK-3 beta; Caspase-3	NEURAL STEM-CELLS; NEURONAL PROGENITOR CELLS; CATENIN SIGNALING PATHWAY; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; SUBVENTRICULAR ZONE; GENERAL-ANESTHESIA; SUBARACHNOID HEMORRHAGE; NEUROCOGNITIVE OUTCOMES; ACADEMIC-PERFORMANCE	Background/Aims: Isoflurane inhibited neurogenesis and induced subsequent neurocognitive deficits in developing brain. Simvastatin exerts neuroprotection in a wide range of brain injury models. In the present study, we investigated whether simvastatin could attenuate neurogenetic inhibition and cognitive deficits induced by isoflurane exposure in neonatal rats. Methods: Sprague-Dawley rats at postnatal day (PND) 7 and neural stem cells (NSCs) were treated with either gas mixture, isoflurane, or simvastatin 60 min prior to isoflurane exposure, respectively. The rats were decapitated at PND 8 and PND 10 for detection of neurogenesis in the subventricular zone (SVZ) and subgranular zone (SGZ) of the hippocampus by immunostaining. NSC proliferation, viability and apoptosis were assessed by immunohistochemistry, CCK-8 and TUNEL, respectively. The protein expressions of caspase-3, p-Akt and p-GSK-3 beta both in vivo and vitro were assessed by western blotting. Cognitive functions were assessed by Morris Water Maze test and context fear conditioning test at the adult. Results: Isoflurane exposure inhibited neurogenesis in the SVZ and SGZ, decreased NSC proliferation and viability, promoted NSC apoptosis and led to late cognitive deficits. Furthermore, isoflurane increased caspase-3 expression and decreased protein expressions of p-Akt and p-GSK-3 beta both in vivo and in vitro. Pretreatment with simvastatin attenuated isoflurane-elicited changes in NSCs and cognitive function. Co-treatment with LY294002 reversed the effect of simvastatin on NSCs in vitro. Conclusion: We for the first time showed that simvastatin, by upregulating Akt/GSK-3 beta signaling pathway, alleviated isoflurane-induced neurogenetic damage and neurocognitive deficits in developing rat brain. (C) 2018 The Author(s) Published by S. Karger AG, Basel	[Wang, Ning; Lu, Yang; Wang, Kui; Li, Wei-song; Lu, Pan; Lei, Shan; Li, Rong; Zhang, Hong; Zheng, Juan; Zhang, Peng-bo] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Anesthesiol, 157 West 5 Rd, Xian, Shaanxi, Peoples R China; [Lu, Hai-xia; Chen, Xin-lin; Liu, Yong] Xi An Jiao Tong Univ, Natl Key Acad Subject Physiol, Inst Neurobiol, Xian, Shaanxi, Peoples R China		Zhang, PB (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Anesthesiol, 157 West 5 Rd, Xian, Shaanxi, Peoples R China.	zhpbo@xjtu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81071071, 81171247]; Key Science and Technology Innovation Team of Shaanxi Province [2014KCT-22]; Science and Technology Development Project of Shaanxi Province grants [2013KTCL03-09]	This work was supported by the National Natural Science Foundation of China (81071071, 81171247), Key Science and Technology Innovation Team of Shaanxi Province (2014KCT-22) and Science and Technology Development Project of Shaanxi Province grants (2013KTCL03-09). We thank Jian-shui Zhang and Kun Zhu for their assistance with collecting behavioral data. We would also like to thank Prof. Malgorzata Garstka for reading this manuscript.	Bai XW, 2013, SEMIN CARDIOTHORAC V, V17, P276, DOI 10.1177/1089253213495923; Balduini W, 2001, STROKE, V32, P2185, DOI 10.1161/hs0901.094287; Block RI, 2012, ANESTHESIOLOGY, V117, P494, DOI 10.1097/ALN.0b013e3182644684; Bong CL, 2013, ANESTH ANALG, V117, P1419, DOI 10.1213/ANE.0b013e318299a7c2; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Creeley C, 2013, BRIT J ANAESTH, V110, P29, DOI 10.1093/bja/aet173; Culley DJ, 2011, ANESTHESIOLOGY, V115, P754, DOI 10.1097/ALN.0b013e318223b78b; Davidson AJ, 2016, LANCET, V387, P239, DOI 10.1016/S0140-6736(15)00608-X; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fuchs C, 2014, NEUROBIOL DIS, V70, P53, DOI 10.1016/j.nbd.2014.06.006; Gao C, 2010, VASC PHARMACOL, V52, P77, DOI 10.1016/j.vph.2009.12.001; Gao K, 2016, J NEUROCHEM, V138, P139, DOI 10.1111/jnc.13382; Guerout N, 2014, EXP CELL RES, V321, P77, DOI 10.1016/j.yexcr.2013.10.003; Hansen HH, 2004, NEUROBIOL DIS, V16, P440, DOI 10.1016/j.nbd.2004.03.013; Hou LC, 2015, MOL MED REP, V12, P7412, DOI 10.3892/mmr.2015.4387; Huang C, 2015, NEUROCHEM RES, V40, P1319, DOI 10.1007/s11064-015-1614-1; Huang H, 2015, CELL PHYSIOL BIOCHEM, V35, P315, DOI 10.1159/000369698; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Kang E, 2017, NEUROTOXICOL TERATOL, V60, P33, DOI 10.1016/j.ntt.2016.10.001; Karki K, 2009, STROKE, V40, P3384, DOI 10.1161/STROKEAHA.108.544395; Kramer J, 2012, TOXICOL IN VITRO, V26, P1170, DOI 10.1016/j.tiv.2012.06.013; Lee BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105340; Li AP, 2010, NEUROL RES, V32, P945, DOI 10.1179/016164110X12670144737774; Li CL, 2014, J NEUROSCI, V34, P4027, DOI 10.1523/JNEUROSCI.4677-12.2014; Li GH, 2015, TOXICOL LETT, V233, P102, DOI 10.1016/j.toxlet.2014.11.026; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Lu Y, 2017, NEUROSCIENCE, V352, P144, DOI 10.1016/j.neuroscience.2017.03.057; Luskin MB, 1997, MOL CELL NEUROSCI, V8, P351, DOI 10.1006/mcne.1996.0592; Lynch JR, 2005, STROKE, V36, P2024, DOI 10.1161/01.STR.0000177879.11607.10; Menezes JRL, 1995, MOL CELL NEUROSCI, V6, P496, DOI 10.1006/mcne.1995.0002; Muramatsu R, 2007, NEUROSCIENCE, V148, P593, DOI 10.1016/j.neuroscience.2007.06.040; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Ponten E, 2012, ACTA ANAESTH SCAND, V56, P1058, DOI 10.1111/j.1399-6576.2012.02722.x; Ponti G, 2013, P NATL ACAD SCI USA, V110, pE1045, DOI 10.1073/pnas.1219563110; Ramage TM, 2013, BRIT J ANAESTH, V110, P39, DOI 10.1093/bja/aet103; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sall JW, 2009, ANESTHESIOLOGY, V110, P826, DOI 10.1097/ALN.0b013e31819b62e2; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; Slikker W, 2007, TOXICOL SCI, V98, P145, DOI 10.1093/toxsci/kfm084; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Sun LS, 2016, JAMA-J AM MED ASSOC, V315, P2312, DOI 10.1001/jama.2016.6967; Tamm C, 2017, BIOCHEM BIOPH RES CO, V482, P408, DOI 10.1016/j.bbrc.2016.10.087; Tao G, 2016, BIOMED RES INT BIOME, V2016, P2016, DOI DOI 10.1155/2016/7919640; Wang CH, 2015, NEUROPHARMACOLOGY, V97, P122, DOI 10.1016/j.neuropharm.2015.05.020; Wong MJ, 2016, AM J PHYSIOL-LUNG C, V311, pL985, DOI 10.1152/ajplung.00345.2016; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xie CC, 2015, BRAIN RES, V1602, P1, DOI 10.1016/j.brainres.2014.03.021; Xu YQ, 2013, CNS NEUROSCI THER, V19, P170, DOI 10.1111/cns.12053; Xu ZP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03766; Yang Dongmei, 2012, World J Neurosci, V2, P74; Zhang YY, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00014; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhong T, 2016, NEUROSCIENCE, V316, P378, DOI 10.1016/j.neuroscience.2015.12.049; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	59	10	12	1	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2018	46	2					618	632		10.1159/000488630			15	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	GE3ZF	WOS:000431151400017	29617679	gold			2022-02-06	
J	Zhong, YY; Luo, JK; Tang, T; Li, PF; Liu, T; Cui, HJ; Wang, Y; Huang, ZB				Zhong, Yuanyuan; Luo, Jiekun; Tang, Tao; Li, Pengfei; Liu, Tao; Cui, Hanjin; Wang, Yang; Huang, Zebing			Exploring Pharmacological Mechanisms of Xuefu Zhuyu Decoction in the Treatment of Traumatic Brain Injury via a Network Pharmacology Approach	EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article							TRADITIONAL CHINESE MEDICINE; SYSTEMS PHARMACOLOGY; MAJOR CONSTITUENTS; ACTIVATED RECEPTORS; PRECURSOR PROTEIN; DRUG DISCOVERY; KAPPA-B; NEUROPROTECTION; SIGNAL; PROLIFERATION	Objectives. Xuefu Zhuyu decoction (XFZYD), a traditional Chinese medicine (TCM) formula, has been demonstrated to be effective for the treatment of traumatic brain injury (TBI). However, the underlying pharmacological mechanisms remain unclear. This study aims to explore the potential action mechanisms of XFZYD in the treatment of TBI and to elucidate the combination principle of this herbal formula. Methods. A network pharmacology approach including ADME (absorption, distribution, metabolism, and excretion) evaluation, target prediction, known therapeutic targets collection, network construction, and molecule docking was used in this study. Results. A total of 119 bioactive ingredients from XFZYD were predicted to act on 47 TBI associated specific proteins which intervened in several crucial pathological processes including apoptosis, inflammation, antioxidant, and axon genesis. Almost each of the bioactive ingredients targeted more than one protein. The molecular docking simulation showed that 91 pairs of chemical components and candidate targets had strong binding efficiencies. The "Jun", "Chen", and "Zuo-Shi" herbs from XFZYD triggered their specific targets regulation, respectively. Conclusion. Our work successfully illuminates the "multicompounds, multitargets" therapeutic action of XFZYD in the treatment of TBI by network pharmacology with molecule docking method. The present work may provide valuable evidence for further clinical application of XFZYD as therapeutic strategy for TBI treatment.	[Zhong, Yuanyuan; Luo, Jiekun; Tang, Tao; Li, Pengfei; Liu, Tao; Cui, Hanjin; Wang, Yang] Cent South Univ, Xiangya Hosp, Inst Integrat Med, Changsha 410008, Hunan, Peoples R China; [Liu, Tao] Xinjiang Med Univ, Tradit Chinese Med Hosp, Dept Gerontol, Urumqi 830000, Peoples R China; [Wang, Yang; Huang, Zebing] Cent South Univ, Xiangya Hosp, Hunan Key Lab Viral Hepatitis, Dept Infect Dis, Changsha 410008, Hunan, Peoples R China		Wang, Y (corresponding author), Cent South Univ, Xiangya Hosp, Inst Integrat Med, Changsha 410008, Hunan, Peoples R China.; Wang, Y; Huang, ZB (corresponding author), Cent South Univ, Xiangya Hosp, Hunan Key Lab Viral Hepatitis, Dept Infect Dis, Changsha 410008, Hunan, Peoples R China.	wangyang_xy87@csu.edu.cn; huangabing0330@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673719, 81874409, 81603670, 81803948]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2016M600639, 2017T100614]	This work was supported by the National Natural Science Foundation of China (Nos. 81673719, 81874409, 81603670, and 81803948), Project funded by China Postdoctoral Science Foundation (Nos. 2016M600639 and 2017T100614).	Adachi K, 2007, STEM CELLS, V25, P2827, DOI 10.1634/stemcells.2007-0177; Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Alsulaim HA, 2017, AM J SURG, V214, P207, DOI 10.1016/j.amjsurg.2016.07.012; Awad AB, 2000, J NUTR, V130, P2127, DOI 10.1093/jn/130.9.2127; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Bongiovanni GA, 2007, FOOD CHEM TOXICOL, V45, P971, DOI 10.1016/j.fct.2006.12.002; Bonini JS, 2007, NEUROSCIENCE, V147, P37, DOI 10.1016/j.neuroscience.2007.04.013; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Cai QY, 1997, CANCER LETT, V119, P99, DOI 10.1016/S0304-3835(97)00261-9; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093167; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheung F, 2011, NATURE, V480, pS82, DOI 10.1038/480S82a; Craske ML, 2005, J CELL BIOL, V170, P1147, DOI 10.1083/jcb.200503118; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.t01-1-00251.x; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devi KP, 2015, PHARMACOL RES, V99, P1, DOI 10.1016/j.phrs.2015.05.002; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Du GL, 2016, NEUROL RES, V38, P1012, DOI 10.1080/01616412.2016.1240393; Esposito L, 2004, J NEUROCHEM, V91, P1260, DOI 10.1111/j.1471-4159.2004.02816.x; Farber K, 2006, GLIA, V54, P656, DOI 10.1002/glia.20412; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fu CY, 2016, J SEP SCI, V39, P3457, DOI 10.1002/jssc.201600083; Geddis MS, 2003, J NEUROSCI RES, V74, P210, DOI 10.1002/jnr.10741; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gibson RM, 2005, MOL CELL NEUROSCI, V28, P588, DOI 10.1016/j.mcn.2004.11.004; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hirabayashi Y, 2005, NEUROSCI RES, V51, P331, DOI 10.1016/j.neures.2005.01.004; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Kitagishi Y, 2013, ALZHEIMERS RES THER, V5, DOI [10.1186/alzrt208, 10.1186/1758-9193-5-42]; Kong DX, 2009, DRUG DISCOV TODAY, V14, P115, DOI 10.1016/j.drudis.2008.07.002; Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee CF, 2016, INT J ONCOL, V48, P2007, DOI 10.3892/ijo.2016.3420; Lee JJ, 2011, J ETHNOPHARMACOL, V134, P824, DOI 10.1016/j.jep.2011.01.033; Lee JW, 2004, MOL CELLS, V17, P188; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; Li HW, 2016, BIOMED PHARMACOTHER, V83, P967, DOI 10.1016/j.biopha.2016.08.011; Li S, 2016, CHIN J INTEGR MED, V22, P647, DOI 10.1007/s11655-016-2499-9; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.1016/S1875-5364(13)60037-0, 10.3724/SP.J.1009.2013.00110]; Li Y, 2014, J ETHNOPHARMACOL, V151, P452, DOI 10.1016/j.jep.2013.10.067; Liu CM, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00003; Liu DZ, 2014, J NEUROTRAUM, V31, P1268, DOI 10.1089/neu.2013.3250; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lu Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178098; Lu Zhong, 2011, Chinese Archives of Traditional Chinese Medicine, V29, P1552; Luo C, 2015, INT IMMUNOPHARMACOL, V28, P744, DOI 10.1016/j.intimp.2015.07.018; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Matsuoka Y, 2001, AM J PATHOL, V158, P1345, DOI 10.1016/S0002-9440(10)64085-0; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Murakami A, 2008, CANCER LETT, V269, P315, DOI 10.1016/j.canlet.2008.03.046; Muscella A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181114; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qihua L.S.W.J., 2015, MOD J INTEGR TRAD CH, V24, P350; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Salehi A, 2018, J CEREBR BLOOD F MET, V38, P274, DOI 10.1177/0271678X17744124; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen YC, 2015, J ETHNOPHARMACOL, V173, P370, DOI 10.1016/j.jep.2015.07.018; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Sun M, 2008, CHIN J INTEGR MED, V14, P137, DOI 10.1007/s11655-008-0137-x; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Turner JV, 2004, PHARM RES-DORDR, V21, P68, DOI 10.1023/B:PHAM.0000012154.09631.26; Walters WP, 2002, ADV DRUG DELIVER REV, V54, P255, DOI 10.1016/S0169-409X(02)00003-0; Wang J, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/896467; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37098; Wei XB, 2005, NEUROSCI LETT, V386, P58, DOI 10.1016/j.neulet.2005.05.069; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xu X, 2012, INT J MOL SCI, V13, P6964, DOI 10.3390/ijms13066964; Xue-hai F., 2017, CHINESE J BIOCH PHAR, P55; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176; Yang CS, 2001, ANNU REV NUTR, V21, P381, DOI 10.1146/annurev.nutr.21.1.381; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yang L, 2014, INT J BIOL SCI, V10, P677, DOI 10.7150/ijbs.8430; Yang XC, 2014, COMPLEMENT THER MED, V22, P391, DOI 10.1016/j.ctim.2014.01.003; Yao L, 2016, J CONTROL RELEASE, V226, P1, DOI 10.1016/j.jconrel.2016.01.055; Yao Y, 2013, J ETHNOPHARMACOL, V150, P619, DOI 10.1016/j.jep.2013.09.018; YOUNG W, 1992, J NEUROTRAUM, V9, pS9; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037608; Zhang A, 2017, INFLAMMATION, V40, P745, DOI 10.1007/s10753-017-0518-4; Zhang B, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/456747; Zhang HJ, 2006, BIOMED CHROMATOGR, V20, P821, DOI 10.1002/bmc.607; Zhang L, 2012, J PHARMACEUT BIOMED, V62, P203, DOI 10.1016/j.jpba.2011.12.026; Zhang QR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171628; Zhou J., 2017, ONCOTARGET, V8; Zhou MJ, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/481405; Zohar O, 2011, NEUROBIOL DIS, V41, P329, DOI 10.1016/j.nbd.2010.10.001	108	10	10	6	25	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1741-427X	1741-4288		EVID-BASED COMPL ALT	Evid.-based Complement Altern. Med.		2018	2018								8916938	10.1155/2018/8916938			20	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	GX1FE	WOS:000447459100001	30402137	Green Submitted, Green Published, gold			2022-02-06	
J	Alzoubi, KH; Rawashdeh, NQ; Khabour, OF; El-Elimat, T; Albataineh, H; Al-Zghool, HM; Alali, FQ				Alzoubi, Karem H.; Rawashdeh, Nasab Q.; Khabour, Omar F.; El-Elimat, Tamam; Albataineh, Hanan; Al-Zghool, Hamzeh M.; Alali, Feras Q.			Evaluation of the Effect of Moringa peregrina Extract on Learning and Memory: Role of Oxidative Stress	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Moringa peregrina; Cognition; Learning; Memory; Hippocampus; Antioxidant	TRAUMATIC BRAIN-INJURY; NERVE GROWTH-FACTOR; VITAMIN-E; COGNITIVE IMPAIRMENT; RAT MODEL; METAANALYSIS; DEMENTIA; MODERATE; MICE	Oxidative stress interferes with the functional roles of the hippocampus and results in cognitive decline. Antioxidant supplementation has a cognitive enhancing activity through protecting hippocampus brain cells from the damaging effects of the reactive oxygen species. The dried methanolic extract of the aboveground parts of Moringa peregrina (Forssk.) Fiori (Moringaceae) was hypothesized to have memory-enhancing activity via its antioxidative properties. HPLC and LC-MS methods were used for qualitative analysis of the marker compounds. Six major compounds of the methanolic extract of M. peregrina were identified, namely, rutin, myricetin, alpha-amyrin, beta-amyrin, lupeol acetate, and beta-sitosterol. Male Wistar rats were administered via oral gavage three dose levels (50, 100, and 500 mg/kg) of M. peregrina methanolic extract for 2 months. The radial arm water maze (RAWM) was used to test spatial learning and memory. In addition, ELISA was used to analyze the levels of brain-derived neurotrophic factor (BDNF) and to assess the level of some oxidative stress markers. M. peregrina (150 mg/kg) resulted in short- and long-term memory enhancement (P < 0.05). Moreover, M. peregrina administration elevated BDNF levels in the hippocampus (P < 0.05) and caused favorable changes in oxidative stress biomarkers. In particular, an increase in glutathione (GSH), a decrease in oxidized glutathione (GSSG), and an increase in the antioxidant enzyme glutathione peroxidase (GPx) levels in the hippocampus were elicited after treatment with M. peregrina. Taken together, our data show that oral administration of M. peregrina enhances both short- and long-term memory functions via combating oxidative stress and increasing BDNF levels in the hippocampus. Consuming this safe plant may thus help promote spatial learning and improve memory.	[Alzoubi, Karem H.] Jordan Univ Sci & Technol, Dept Clin Pharm, Fac Pharm, Irbid 22110, Jordan; [Rawashdeh, Nasab Q.] Natl Ctr Agr Res & Extens, Amman, Jordan; [Khabour, Omar F.] Jordan Univ Sci & Technol, Dept Med Lab Sci, Irbid 22110, Jordan; [Khabour, Omar F.] Taibah Univ, Fac Appl Med Sci, Medina, Saudi Arabia; [El-Elimat, Tamam; Albataineh, Hanan] Jordan Univ Sci & Technol, Dept Med Chem & Pharmacognosy, Fac Pharm, Irbid 22110, Jordan; [Al-Zghool, Hamzeh M.] Hashemite Univ, Fac Med, Zarqa, Jordan; [Alali, Feras Q.] Qatar Univ, Coll Pharm, Doha 2713, Qatar		Alali, FQ (corresponding author), Qatar Univ, Coll Pharm, Doha 2713, Qatar.	Feras.alali@qu.edu.qa	El-Elimat, Tamam/ABE-8818-2020	El-Elimat, Tamam/0000-0002-9246-4974	Ministry of Higher Education and Scientific Research, Amman, Jordan [Agr/2/02/2010]	This research was supported by the Scientific Research Support Fund (project Agr/2/02/2010), Ministry of Higher Education and Scientific Research, Amman, Jordan.	Al-Eisawi D. M., 1998, FIELD GUIDE WILD FLO; Alzoubi K.H., 2015, MOL NEUROBIOL, P1; Alzoubi KH, 2016, BRAIN RES BULL, V120, P144, DOI 10.1016/j.brainresbull.2015.11.017; Alzoubi KH, 2015, J MOL NEUROSCI, V57, P249, DOI 10.1007/s12031-015-0613-7; Alzoubi KH, 2013, HIPPOCAMPUS, V23, P812, DOI 10.1002/hipo.22135; Alzoubi KH, 2013, PHYSIOL BEHAV, V119, P72, DOI 10.1016/j.physbeh.2013.06.011; Alzoubi KH, 2013, J MOL NEUROSCI, V50, P124, DOI 10.1007/s12031-012-9881-7; Alzoubi KH, 2012, BEHAV BRAIN RES, V226, P205, DOI 10.1016/j.bbr.2011.09.017; Bickford P.C., 2007, BRAIN AGING MODELS M, P353; Boulos L., 2000, FLORA EGYPT, V1-4; Choi JG, 2011, BEHAV BRAIN RES, V216, P652, DOI 10.1016/j.bbr.2010.09.008; Eduviere AT, 2015, LIFE SCI, V132, P20, DOI 10.1016/j.lfs.2015.04.007; Elbatran S. A., 2005, Natural Product Sciences, V11, P199; Farooqui T, 2009, MECH AGEING DEV, V130, P203, DOI 10.1016/j.mad.2008.11.006; Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765; Fukui K, 2002, ANN NY ACAD SCI, V959, P275, DOI 10.1111/j.1749-6632.2002.tb02099.x; Fukumoto K, 2014, BEHAV BRAIN RES, V268, P88, DOI 10.1016/j.bbr.2014.03.046; Hedden T, 2016, CEREB CORTEX, V26, P1388, DOI 10.1093/cercor/bhu238; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Khabour OF, 2010, HIPPOCAMPUS, V20, P637, DOI 10.1002/hipo.20657; Kim HG, 2013, BRIT J NUTR, V110, P86, DOI 10.1017/S0007114512004710; Leal SL, 2013, AGEING RES REV, V12, P823, DOI 10.1016/j.arr.2013.01.006; Martin R, 2011, AGING CLIN EXP RES, V23, P255, DOI [10.1007/BF03337752, 10.3275/7229]; Marwah RG, 2007, FOOD CHEM, V101, P465, DOI 10.1016/j.foodchem.2006.02.001; Mhaidat NM, 2015, BRAIN RES BULL, V113, P41, DOI 10.1016/j.brainresbull.2015.02.002; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nunomura Akihiko, 2013, Rinsho Shinkeigaku, V53, P1043; Nuseir KQ, 2015, PHYSIOL BEHAV, V145, P84, DOI 10.1016/j.physbeh.2015.04.002; Ortiz JB, 2014, EUR J NEUROSCI, V40, P3351, DOI 10.1111/ejn.12703; Padayachee B., 2012, Journal of Medicinal Plants Research, V6, P5831; Ritu Paliwal, 2011, Asian Journal of Biotechnology, V3, P317, DOI 10.3923/ajbkr.2011.317.328; Roskov Y, 2016, 2016 ANN CHECKLIST; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Tahany M., 2010, J YEAST FUNGAL RES, V1, P15; Tan MS, 2015, J ALZHEIMERS DIS, V43, P589, DOI 10.3233/JAD-140837; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122415; Zhao RR, 2015, NEUROSCI LETT, V587, P113, DOI 10.1016/j.neulet.2014.12.037	41	10	10	3	21	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	DEC	2017	63	3-4					355	363		10.1007/s12031-017-0986-x			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FN4NM	WOS:000415983800010	29082469				2022-02-06	
J	dos Reis, HFC; Gomes-Neto, M; Almeida, MLO; da Silva, MF; Guedes, LBA; Martinez, BP; Rocha, MD				Correia dos Reis, Helena Franca; Gomes-Neto, Mansueto; Oliveira Almeida, Monica Lajana; da Silva, Mario Ferreira; Arruda Guedes, Lorena Barreto; Martinez, Bruno Prata; Rocha, Mario de Seixas			Development of a risk score to predict extubation failure in patients with traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						Extubation, traumatic brain injury; Ventilator weaning	INTENSIVE-CARE; GENDER; DECISION; OUTCOMES; TRIAL; COUGH	Purpose: To identify predictors and develop a risk score for the prediction of extubation failure in TBI patients. Materials and methods: We prospectively evaluated 311 TBI adults receiving mechanical ventilation for >48 h in the intensive care unit. Epidemiological, ventilatory, airway protective, laboratory, and hemodynamic predictors were evaluated. A multiple logistic regression model was developed to predict the extubation failure risk. A score was developed using the arithmetic sum of the points for each independent predictor, whose scores were proportional to the regression coefficient. The accuracy of the model was determined using the C statistic. Results: Extubation failure occurred in 43 patients (13.8%). Five independent predictors were identified: female sex (4 points) Glasgow Coma Scale motor score <= 5 (4 points), moderate-to-large secretion volume (4 points), absent or weak cough (3 points), and mechanical ventilation >= 10 days (2 points). We calculated the risk score for patients and three risk categorieswere defined: low(0-3 points), moderate (4-7 points), high (8-17 points). The extubation failure rates in the three groups were 3.5%, 21.2%, and 42.9%, respectively. Conclusion: The score developed to predict extubation failure in TBI patients can identify three risk categories and can be easily applied in the ICU. (c) 2017 Elsevier Inc. All rights reserved.	[Correia dos Reis, Helena Franca; Gomes-Neto, Mansueto; Martinez, Bruno Prata] Univ Fed Bahia, Salvador, BA, Brazil; [Oliveira Almeida, Monica Lajana; da Silva, Mario Ferreira] Hosp Geral Estado Bahia, Salvador, BA, Brazil; [Arruda Guedes, Lorena Barreto; Martinez, Bruno Prata] Univ Estado Bahia, Salvador, BA, Brazil; [Rocha, Mario de Seixas] Escola Bahiana Med Saude Publ, Programa Posgrad Med Saude Humana, Salvador, BA, Brazil		dos Reis, HFC (corresponding author), Ave Reitor Miguel Calmon,S-N Vale Canela, BR-40110100 Salvador, BA, Brazil.	helena.correia@ufba.br	Gomes-NETO, Mansueto MGN/I-5235-2014; Martinez, Bruno Prata/D-3541-2017	Gomes-NETO, Mansueto MGN/0000-0002-0717-9694; Martinez, Bruno Prata/0000-0002-4673-8698			Anderson CD, 2011, NEUROCRIT CARE, V15, P490, DOI 10.1007/s12028-010-9369-7; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; dos Reis HFC, 2013, J BRAS PNEUMOL, V39, P330, DOI 10.1590/S1806-37132013000300010; Reis Helena Franca Correia dos, 2013, Rev. bras. ter. intensiva, V25, P212, DOI 10.5935/0103-507X.20130037; Epstein SK, 2009, CRIT CARE, V13, DOI 10.1186/cc8121; Epstein SK, 2009, CURR OPIN CRIT CARE, V15, P36, DOI 10.1097/MCC.0b013e3283220e07; Epstein SK, 2002, INTENS CARE MED, V28, P535, DOI 10.1007/s00134-002-1268-8; Epstein SK, 1997, CHEST, V112, P186, DOI 10.1378/chest.112.1.186; Epstein SK, 2004, CRIT CARE, V8, P310, DOI 10.1186/cc2927; Esteban A, 1999, AM J RESP CRIT CARE, V159, P512, DOI 10.1164/ajrccm.159.2.9803106; Frutos-Vivar F, 2006, CHEST, V130, P1664, DOI 10.1378/chest.130.6.1664; Frutos-Vivar F, 2011, J CRIT CARE, V26, P502, DOI 10.1016/j.jcrc.2010.12.015; Gowardman John R, 2006, Crit Care Resusc, V8, P328; Karanjia N, 2011, NEUROCRIT CARE, V15, P4, DOI 10.1007/s12028-011-9528-5; Khamiees M, 2001, CHEST, V120, P1262, DOI 10.1378/chest.120.4.1262; King CS, 2010, RESP CARE, V55, P56; Ko R, 2009, NEUROCRIT CARE, V10, P269, DOI 10.1007/s12028-008-9181-9; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Krinsley JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11185; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Mahmood K, 2012, CRIT CARE, V16, DOI [10.1186/CC11355, 10.1186/cc11355]; Mokhlesi B, 2007, RESP CARE, V52, P1710; Nachtigall I, 2011, CRIT CARE, V15, DOI 10.1186/cc10277; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; Navalesi P, 2008, CRIT CARE MED, V36, P2986, DOI 10.1097/CCM.0b013e31818b35f2; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Penuelas O, 2011, AM J RESP CRIT CARE, V184, P430, DOI 10.1164/rccm.201011-1887OC; Perren A, 2010, INTENS CARE MED, V36, P2045, DOI 10.1007/s00134-010-1984-4; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Rothaar Robert C, 2003, Curr Opin Crit Care, V9, P59, DOI 10.1097/00075198-200302000-00011; Salam A, 2004, INTENS CARE MED, V30, P1334, DOI 10.1007/s00134-004-2231-7; Savi A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.07.079; Seymour CW, 2004, CRIT CARE, V8, pR322, DOI 10.1186/cc2913; Smina M, 2003, CHEST, V124, P262, DOI 10.1378/chest.124.1.262; Tanios MA, 2006, CRIT CARE MED, V34, P2530, DOI 10.1097/01.CCM.0000236546.98861.25; Valentin A, 2003, CRIT CARE MED, V31, P1901, DOI 10.1097/01.CCM.0000069347.78151.50; Vidotto MC, 2012, RESP CARE, V14, pPG222; Vidotto MC, 2008, NEUROCRIT CARE, V9, P83, DOI 10.1007/s12028-008-9059-x; Wendell LC, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/248789	40	10	10	10	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2017	42						218	222		10.1016/j.jcrc.2017.07.051			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ7CN	WOS:000418520500038	28780488				2022-02-06	
J	Dekker, SE; de Vries, HM; Lubbers, WD; de Ven, PMV; Toor, EJ; Bloemers, FW; Geeraedts, LMG; Schober, P; Boer, C				Dekker, S. E.; de Vries, H. -M.; Lubbers, W. D.; de Ven, P. M. van; Toor, E. J.; Bloemers, F. W.; Geeraedts, L. M. G., Jr.; Schober, P.; Boer, C.			Lactate clearance metrics are not superior to initial lactate in predicting mortality in trauma	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Neurotrauma; Polytrauma; Lactate; Mortality; Prognosis	CONCENTRATION-GRADIENT MISINTERPRETATION; MULTIPLE ORGAN FAILURE; BLOOD LACTATE; COGNITIVE DEFICITS; SEVERE SEPSIS; BRAIN-INJURY; THERAPY; GLYCOLYSIS; ARTERIAL	Despite the availability of different lactate clearance (LC) metrics for clinical use, it remains unknown which metric is superior as a clinical predictor for outcome, particularly in trauma patients. This retrospective study compared four previously described metrics of LC and examined the association between LC and outcome in trauma patients. Lactate values of trauma patients admitted to a level I trauma center between 2010 and 2013 were retrieved from patient records. LC was calculated according to Huckabee, Regnier et al., Billeter et al. and Zhang et al. Patients were categorized as isolated traumatic brain injury (TBI), trauma with TBI, and trauma without TBI. The primary study outcome was in-hospital mortality. 367 trauma patients were eligible for LC calculation. Only LC by Zhang et al. [area under the curve (AUC) > 0.622, p < 0.01], and Billeter et al. (AUC > 0.616, p < 0.05) were predictive for mortality in trauma patients with and without TBI. However, both were equally prognostic as the initial lactate value for in-hospital mortality. The prognostic value of initial lactate and lactate clearance for in-hospital mortality were not found to differ between isolated TBI, polytrauma with TBI, and trauma without TBI. LC metrics based on the methods of Zhang et al. and Billeter et al. predicted mortality in trauma patients, and their prognostic value did not differ between patients with and without TBI. However, initial lactate value was equally prognostic as these LC metrics. Our findings suggest that a single initial lactate measurement may be a more clinically useful tool to predict mortality than the calculation of lactate clearance.	[Dekker, S. E.; de Vries, H. -M.; Lubbers, W. D.; Schober, P.; Boer, C.] Vrije Univ Amsterdam, Med Ctr, Dept Anesthesiol, Inst Cardiovasc Res, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [de Ven, P. M. van] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Toor, E. J.] VU Med Ctr Reg, Ctr Acute Care, Amsterdam, Netherlands; [Bloemers, F. W.; Geeraedts, L. M. G., Jr.] Vrije Univ Amsterdam, Med Ctr, Dept Trauma Surg, Amsterdam, Netherlands		Dekker, SE (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Anesthesiol, Inst Cardiovasc Res, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	sxd503@case.edu	Bloemers, Frank/P-5436-2019; Schober, Patrick/G-7400-2012	Bloemers, Frank/0000-0002-8393-4946; Schober, Patrick/0000-0003-0814-081X; Boer, Christa/0000-0002-7781-6951			ABRAMSON D, 1993, J TRAUMA, V35, P584, DOI 10.1097/00005373-199310000-00014; Bakker J, 1996, AM J SURG, V171, P221, DOI 10.1016/S0002-9610(97)89552-9; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; Billeter A, 2009, WORLD J SURG, V33, P558, DOI 10.1007/s00268-008-9896-y; Bisri Tatang, 2016, Asian J Neurosurg, V11, P151, DOI 10.4103/1793-5482.145375; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; de Vries HM, 2014, J TRAUMA ACUTE CARE, V77, P183, DOI 10.1097/TA.0000000000000252; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Dienel GA, 2014, J CEREBR BLOOD F MET, V34, P1736, DOI 10.1038/jcbfm.2014.153; Dubendorfer C, 2013, EUR J TRAUMA EMERG S, V39, P25, DOI 10.1007/s00068-012-0212-z; Durham RM, 2003, J TRAUMA, V55, P608, DOI 10.1097/01.TA.0000092378.10660.D1; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; HUCKABEE WE, 1961, AM J MED, V30, P840, DOI 10.1016/0002-9343(61)90172-3; Jalloh I, 2014, J NEUROTRAUM, V31, P1529, DOI 10.1089/neu.2013.3316; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Kobayashi S, 2001, SURG TODAY, V31, P853, DOI 10.1007/s005950170022; Lavery RF, 2000, J AM COLL SURGEONS, V190, P656, DOI 10.1016/S1072-7515(00)00271-4; Middleton P, 2006, EMERG MED J, V23, P622, DOI 10.1136/emj.2006.035915; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Nordstrom CH, 2014, J NEUROTRAUM, V31, P1528, DOI 10.1089/neu.2013.3229; Odom SR, 2013, J TRAUMA ACUTE CARE, V74, P999, DOI 10.1097/TA.0b013e3182858a3e; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Regnier MA, 2012, ANESTHESIOLOGY, V117, P1276, DOI 10.1097/ALN.0b013e318273349d; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Zhang ZJ, 2015, J SENSORS, V2015, DOI 10.1155/2015/503852	29	10	11	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	DEC	2017	43	6					841	851		10.1007/s00068-016-0733-y			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FO1PF	WOS:000416534600014	27738727				2022-02-06	
J	Eroglua, O; Deniz, T; Kisa, U; Atasoy, P; Aydinuraz, K				Eroglua, Oguz; Deniz, Turgut; Kisa, Ucler; Atasoy, Pinar; Aydinuraz, Kuzey			Effect of hypothermia on apoptosis in traumatic brain injury and hemorrhagic shock model	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Animal study; Caspase; Experimental; Hemorrhagic shock; Traumatic brain injury; Hypothermia; Proteoglycan-4	MODERATE HYPOTHERMIA; LIPID-PEROXIDATION; CELL-DEATH; TEMPERATURE; SURVIVAL; RATS; ACTIVATION; CASPASE-3; ISCHEMIA; IMPROVES	Introduction: The neuroprotective mechanisms of therapeutic hypothermia against trauma-related injury have not been fully understood yet. In this study, we aimed to investigate the effects of therapeutic hypothermia on biochemical and histopathological markers of apoptosis using Traumatic brain injury (TBI) and hemorrhagic shock (HS) model. Methods: A total of 50 male albino-wistar rats were divided into five groups: Group isolated TBI, Group NT (HT + HS + normothermia), Group MH (HT + HS + mild hypothermia), Group MoH (HT + HS + moderate hypothermia) and Group C (control). Neurological deficit scores were assessed at baseline and at 24 h. The rats were, then, sacrificed to collect serum and brain tissue samples. Levels of Caspase-3,6,8, proteoglycan-4 (PG-4), malondialdehyde (MDA), and nitric oxide (NO) were measured in serum and brain tissue samples. Histopathological examination was performed in brain tissue. Results: There were significant differences in the serum levels of Caspase-3 between Group NT and Group C (p = 0.018). The serum levels of Caspase-6 in Group NT (0.70 +/- 0.58) were lower than Group MH (1.39 +/- 0.28), although the difference was not statistically significant (p = 0.068). There were significant differences in the brain tissue samples for Caspase-3 levels between Group NT and Group C (p = 0.049). A significant difference in the Caspase-8 brain tissue levels was also observed between Group NT and Group C (p = 0.022). Group NT had significantly higher scores of all the pathological variables (for edema p < 0.017; for gliosis p < 0.001; for congestion p < 0.003, for hemorrhage p < 0.011) than Group C. Conclusion: Our study results suggest that hypothermia may exert its neuroprotective effects by reducing markers of apoptotic pathway, particularly Caspase-3 on TBI and HS. (c) 2017 Elsevier Ltd. All rights reserved.	[Eroglua, Oguz; Deniz, Turgut] Kirikkale Univ, Fac Med, Dept Emergency Med, TR-71850 Kirikkale, Turkey; [Kisa, Ucler] Kirikkale Univ, Fac Med, Med Biochem, Kirikkale, Turkey; [Atasoy, Pinar] Kirikkale Univ, Fac Med, Pathol, Kirikkale, Turkey; [Aydinuraz, Kuzey] Kirikkale Univ, Fac Med, Dept Gen Surg, Kirikkale, Turkey		Eroglua, O (corresponding author), Kirikkale Univ, Fac Med, Dept Emergency Med, TR-71850 Kirikkale, Turkey.	oguzerogluacil@gmail.com; turgutdeniz@yahoo.com; uclerkisa@hotmail.com; pinara33@yahoo.com; kuzeyaydinuraz@gmail.com	KISA, Ucler/V-5443-2017	KISA, Ucler/0000-0002-8131-6810			Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Deniz T, 2010, J SURG RES, V158, P121, DOI 10.1016/j.jss.2008.08.029; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; Drury PP, 2014, CLIN PERINATOL, V41, P161, DOI 10.1016/j.clp.2013.10.005; Dyck SM, 2015, EXP NEUROL, V269, P169, DOI 10.1016/j.expneurol.2015.04.006; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Geocadin RG, 2000, CLIN NEUROPHYSIOL, V111, P1779, DOI 10.1016/S1388-2457(00)00379-5; Guven H, 2002, J TRAUMA, V53, P66, DOI 10.1097/00005373-200207000-00014; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Higgins RD, 2006, J PEDIATR-US, V148, P170, DOI 10.1016/j.jpeds.2005.12.009; Hildebrand F, 2004, AM J SURG, V187, P363, DOI 10.1016/j.amjsurg.2003.12.016; Jin YC, 2016, WORLD NEUROSURG, V88, P433, DOI 10.1016/j.wneu.2015.10.055; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Lin KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165406; Lo MY, 2004, J ORTHOPAED RES, V22, P140, DOI 10.1016/S0736-0266(03)00117-7; Lo MY, 2004, J ORTHOP RES, V22, P1120, DOI 10.1016/j.orthres.2003.12.022; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P660, DOI 10.1016/j.joca.2006.01.005; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0485-z; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mizushima Y, 2000, ARCH SURG-CHICAGO, V135, P175, DOI 10.1001/archsurg.135.2.175; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Petrosyan HA, 2013, J NEUROSCI, V33, P4032, DOI 10.1523/JNEUROSCI.4702-12.2013; Prueckner S, 2001, J TRAUMA, V50, P253, DOI 10.1097/00005373-200102000-00010; Roelfsema V, 2004, J CEREBR BLOOD F MET, V24, P877, DOI 10.1097/01.WCB.0000123904.17746.92; Shabanzadeh AP, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.272; Shankaran S., 2010, NEOREVIEWS, V11, P85; Sinclair HL, 2010, CRIT CARE, V14, DOI 10.1186/cc8220; SORI AJ, 1987, AM SURGEON, V53, P706; Ulger H, 2014, THORAC CARDIOV SURG, V62, P716, DOI 10.1055/s-0034-1394103; YAGI K, 1994, ADV EXP MED BIOL, V366, P165; Yang D, 2009, FEBS LETT, V583, P2500, DOI 10.1016/j.febslet.2009.07.006	36	10	11	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	DEC	2017	48	12					2675	2682		10.1016/j.injury.2017.09.032			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FQ0VM	WOS:000418074900009	29061477				2022-02-06	
J	Liu, XZ; Ren, WB; Jiang, ZM; Su, ZG; Ma, XF; Li, YX; Jiang, RC; Zhang, JN; Yang, XY				Liu, Xiaozhi; Ren, Wenbo; Jiang, Zhongmin; Su, Zhiguo; Ma, Xiaofang; Li, Yanxia; Jiang, Rongcai; Zhang, Jianing; Yang, Xinyu			Hypothermia inhibits the proliferation of bone marrow-derived mesenchymal stem cells and increases tolerance to hypoxia by enhancing SUMOylation	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						small ubiquitin-like modifiers; SUMO ylation; therapeutic hypothermia; stress; bone marrow-derived mesenchymal stem cells	TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; SUMO; UBIQUITIN; NEUROPROTECTION; DISEASES; STABILITY; REPAIR	Hypothermia therapy has a positive effect on patients with severe brain injury. Recent studies have shown that mild hypothermia increases the survival of bone marrow-derived mesenchymal stem cells (BMSCs) in a hypoxic environment; however, the underlying mechanisms are not yet fully understood. Small ubiquitin-like modifiers (SUMOs) are sensitive to temperature stress reactions and are considered to exert a protective effect. In this study, we examined the protective effects of hypothermia on BMSCs in terms of SUMO protein modification. First, we found that mild hypothermia inhibited the proliferation and differentiation of BMSCs and increased cell tolerance to a hypoxic environment. Second, hypothermia significantly increased the levels of SUMO modification of multiple proteins in BMSCs. The knockdown of SUMO 1/2/3 induced the rapid aging of the BMSCs, while the inhibition of the SUMO-conjugating enzyme, Ubc9, reduced cell proliferation and increased the proportion of BMSCs differentiating into nerve cells. Moreover, the tolerance of BMSCs to the hypoxic environment was significantly decreased. Lastly, we investigated 4 reported SUMO target proteins, anti-proliferating cell nuclear antigen, octamer-binding transcription factor 4, p53 and hypoxia-inducible factor-1 alpha, to confirm that SUMO modification was indeed involved in maintaining the proliferation, inhibiting differentiation and enhancing the resistance of BMSCs against adverse conditions. Taken together, our results indicate that the SUMO pathway is involved in the response to hypothermic stress, and that SUMOylation may be an important protective mechanism against hypothermia for the survival of BMSCs under unfavorable conditions.	[Liu, Xiaozhi; Jiang, Rongcai; Zhang, Jianing; Yang, Xinyu] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Liu, Xiaozhi; Ma, Xiaofang; Li, Yanxia] Fifth Cent Hosp Tianjin, Cent Lab, Tianjin 300450, Peoples R China; [Liu, Xiaozhi; Ren, Wenbo] Fifth Cent Hosp Tianjin, Dept Neurol, Tianjin 300450, Peoples R China; [Jiang, Zhongmin] Fifth Cent Hosp Tianjin, Dept Pathol, Tianjin 300450, Peoples R China; [Su, Zhiguo] Fifth Cent Hosp Tianjin, Dept Neurosurg, Tianjin 300450, Peoples R China		Yang, XY (corresponding author), Tianjin Med Univ, Dept Neurosurg, Gen Hosp, 154 Anshan Rd, Tianjin 300052, Peoples R China.	chnxyyang@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471175]; Tianjin Health Bureau Science and Technology Projects [2014KY23]	This study was supported by the National Natural Science Foundation of China (no. 81471175), and the Tianjin Health Bureau Science and Technology Projects (no. 2014KY23).	Ahmed AI, 2016, NEUROSURG CLIN N AM, V27, P489, DOI 10.1016/j.nec.2016.05.004; Benarroch EE, 2013, NEUROLOGY, V81, P1079, DOI 10.1212/WNL.0b013e3182a4a577; Blogowski W, 2016, STEM CELL TRANSL MED, V5, P938, DOI 10.5966/sctm.2015-0291; Chang E, 2016, METABOLISM, V65, P623, DOI 10.1016/j.metabol.2016.01.007; Chang EH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00332; Craig TJ, 2012, CURR OPIN NEUROBIOL, V22, P480, DOI 10.1016/j.conb.2011.10.017; Dailey T, 2013, NEUROREPORT, V24, P1067, DOI 10.1097/WNR.0000000000000062; Dieckman Lynne M, 2012, Subcell Biochem, V62, P281, DOI 10.1007/978-94-007-4572-8_15; Hirohama M, 2013, ACS CHEM BIOL, V8, P2635, DOI 10.1021/cb400630z; Kumar A, 2015, COMPUT STRUCT BIOTEC, V13, P204, DOI 10.1016/j.csbj.2015.03.001; Laura MV, 2015, CELL CYCLE, V14, P277, DOI 10.4161/15384101.2014.980657; Lazaridis C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0681-2; Lee YJ, 2016, J NEUROCHEM, V138, P101, DOI 10.1111/jnc.13643; Lee YJ, 2013, NEUROMOL MED, V15, P771, DOI 10.1007/s12017-013-8239-9; Leshnower BG, 2012, ANN THORAC SURG, V93, P1910, DOI 10.1016/j.athoracsur.2012.02.069; Limpastan Kriengsak, 2013, Journal of the Medical Association of Thailand, V96, P678; Liu ZL, 2014, INT J ONCOL, V44, P1571, DOI 10.3892/ijo.2014.2322; Lynch K, 2014, ORGANOGENESIS, V10, P289, DOI 10.4161/15476278.2014.970089; Masoudi Mohammad Sadegh, 2016, Bull Emerg Trauma, V4, P161; McAdams RM, 2016, CLIN PERINATOL, V43, P485, DOI 10.1016/j.clp.2016.04.007; Mezey E, 2015, IMMUNOL LETT, V168, P208, DOI 10.1016/j.imlet.2015.05.020; Parker JL, 2012, NUCLEIC ACIDS RES, V40, P11380, DOI 10.1093/nar/gks892; Parker Joanne L, 2012, Methods Mol Biol, V920, P569, DOI 10.1007/978-1-61779-998-3_37; Pietrini D, 2012, CURR DRUG TARGETS, V13, P925, DOI 10.2174/138945012800675641; Ross CL, 2015, STEM CELL RES, V15, P96, DOI 10.1016/j.scr.2015.04.009; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Shankaran S, 2014, INDIAN J PEDIATR, V81, P578, DOI 10.1007/s12098-014-1468-6; Shi J, 2014, J ALZHEIMERS DIS, V38, P1, DOI 10.3233/JAD-130623; Stehmeier P, 2009, DNA REPAIR, V8, P491, DOI 10.1016/j.dnarep.2009.01.002; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tahmasebi S, 2014, STEM CELLS, V32, P1012, DOI 10.1002/stem.1600; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; Wang F, 2016, OSTEOARTHR CARTILAGE, V24, P1113, DOI 10.1016/j.joca.2016.01.134; Wang LL, 2012, J NEUROCHEM, V123, P349, DOI 10.1111/j.1471-4159.2012.07916.x; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wilson VG, 2012, BIOMOLECULES, V2, P203, DOI 10.3390/biom2020203; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11; Yamasaki S, 2014, CARTILAGE, V5, P196, DOI 10.1177/1947603514534681; Yang FK, 2012, J BIOL CHEM, V287, P38600, DOI 10.1074/jbc.M112.391441; Yang W, 2015, PROTEOMICS, V15, P1181, DOI 10.1002/pmic.201400298; Yang W, 2009, J CEREBR BLOOD F MET, V29, P886, DOI 10.1038/jcbfm.2009.16; Yang ZZ, 2014, NEUROSCI BULL, V30, P524, DOI 10.1007/s12264-013-1431-y	43	10	12	0	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	DEC	2017	40	6					1631	1638		10.3892/ijmm.2017.3167			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FQ2ZJ	WOS:000418226300003	29039464	hybrid, Green Submitted, Green Published			2022-02-06	
J	Mion, G; Le Masson, J; Granier, C; Hoffmann, C				Mion, G.; Le Masson, J.; Granier, C.; Hoffmann, C.			A retrospective study of ketamine administration and the development of acute or post-traumatic stress disorder in 274 war-wounded soldiers	ANAESTHESIA			English	Article						ketamine; post-traumatic stress disorder; stress disorders; war	DEPRESSION; SYMPTOMS	The objective of this study was to explore whether ketamine prevents or exacerbates acute or post-traumatic stress disorders in military trauma patients. We conducted a retrospective study of a database from the French Military Health Service, including all soldiers surviving a war injury in Afghanistan (2010-2012). The diagnosis of post-traumatic stress disorder was made by a psychiatrist and patients were analysed according to the presence or absence of this condition. Analysis included the following covariables: age; sex; acute stress disorder; blast injury; associated fatality; brain injury; traumatic amputation; Glasgow coma scale; injury severity score; administered drugs; number of surgical procedures; physical, neurosensory or aesthetic sequelae; and the development chronic pain. Covariables related to post-traumatic and acute stress disorders with a p <= 0.10 were included in a multivariable logistic regression model. The data from 450 soldiers were identified; 399 survived, of which 274 were analysed. Among these, 98 (36%) suffered from post-traumatic stress disorder and 89 (32%) had received ketamine. Fifty-four patients (55%) in the post-traumatic stress disorder group received ketamine vs. 35 (20%) in the no PTSD group (p<0.001). The 89 injured soldiers who received ketamine had a median (IQR [range]) injury severity score of 5 (3-13 [1-26]) vs. 3 (2-4 [1-6] in the 185 patients who did not (p<0.001). At multivariable analysis, only acute stress disorder and total number of surgical procedures were independently associated with the development of post-traumatic stress disorder. In this retrospective study, ketamine administration was not a risk factor for the development of post-traumatic stress disorder in the military trauma setting.	[Mion, G.] Cochin Hosp, Anaesthesia Dept, Paris, France; [Le Masson, J.] French Navy Med Serv, Brest, France; [Granier, C.] Paul Guiraud Hosp, Psychiat Dept, Villejuif, France; [Hoffmann, C.] Percy Mil Teaching Hosp, Burn Ctr, Clamart, France		Mion, G (corresponding author), Cochin Hosp, Anaesthesia Dept, Paris, France.	Mion.georges@bbox.fr	Mion, Georges/I-7867-2019	Mion, Georges/0000-0001-8606-0415			APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bisson JI, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6161; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brachman RA, 2016, BIOL PSYCHIAT, V79, P776, DOI 10.1016/j.biopsych.2015.04.022; Chambers R A, 1999, Semin Clin Neuropsychiatry, V4, P274; D'Andrea D, 2013, BIOL PSYCHIAT, V74, pE13, DOI 10.1016/j.biopsych.2013.04.019; Domino EF, 2010, ANESTHESIOLOGY, V113, P678, DOI 10.1097/ALN.0b013e3181ed09a2; Donoghue AC, 2015, PEDIATRICS, V136, pE694, DOI 10.1542/peds.2014-4152; Duclot F, 2016, NEUROPHARMACOLOGY, V109, P293, DOI 10.1016/j.neuropharm.2016.06.022; Eidenbenz D, 2016, ANAESTHESIA, V71, P779, DOI 10.1111/anae.13462; Feder A, 2014, JAMA PSYCHIAT, V71, P681, DOI 10.1001/jamapsychiatry.2014.62; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Granry J C, 2000, Curr Opin Anaesthesiol, V13, P299, DOI 10.1097/00001503-200006000-00011; Inta D, 2016, EUR NEUROPSYCHOPHARM, V26, P1692, DOI 10.1016/j.euroneuro.2016.08.002; Ito W, 2015, NEUROPSYCHOPHARMACOL, V40, P2536, DOI 10.1038/npp.2015.100; Kishimoto A, 2012, BIOL PSYCHIAT, V71, pE7, DOI 10.1016/j.biopsych.2011.10.014; Liu RJ, 2015, NEUROPSYCHOPHARMACOL, V40, P2066, DOI 10.1038/npp.2015.70; McGhee LL, 2008, J TRAUMA, V64, pS195, DOI 10.1097/TA.0b013e318160ba1d; McGhee LL, 2014, MIL MED, V179, P41, DOI 10.7205/MILMED-D-13-00481; Murrough JW, 2016, BIOL PSYCHIAT, V80, P416, DOI 10.1016/j.biopsych.2016.07.005; Perrine SA, 2014, PROG NEURO-PSYCHOPH, V51, P9, DOI 10.1016/j.pnpbp.2013.11.003; Price RB, 2016, BIOL PSYCHIAT, V79, pE57, DOI 10.1016/j.biopsych.2016.02.011; Ray SM, 2016, PRIMARY CARE COMPANI, V18, P4; Salat K, 2015, NEUROPHARMACOLOGY, V99, P301, DOI 10.1016/j.neuropharm.2015.07.037; Schonenberg M, 2008, J PSYCHOPHARMACOL, V22, P493, DOI 10.1177/0269881107082481; Schonenberg M, 2005, PSYCHOPHARMACOLOGY, V182, P420, DOI 10.1007/s00213-005-0094-4; Winter H, 2004, AM J PSYCHIAT, V161, P2194, DOI 10.1176/appi.ajp.161.12.2194; Womble Arthur L, 2013, AANA J, V81, P118; Zarate CA, 2015, WORLD PSYCHIATRY, V14, P348, DOI 10.1002/wps.20269; Zeng MC, 2013, BIOL PSYCHIAT, V73, pE37, DOI 10.1016/j.biopsych.2012.10.017; Zhang LM, 2015, PSYCHOPHARMACOLOGY, V232, P663, DOI 10.1007/s00213-014-3697-9	32	10	10	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	DEC	2017	72	12					1476	1483		10.1111/anae.14079			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	FM4KV	WOS:000414986700007	28972278	Bronze			2022-02-06	
J	Napoli, A; Glass, SM; Tucker, C; Obeid, I				Napoli, Alessandro; Glass, Stephen M.; Tucker, Carole; Obeid, Iyad			The Automated Assessment of Postural Stability: Balance Detection Algorithm	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Mild traumatic brain injury; Concussion detection; Field-expedient balance test; Automated BEES; Automatic balance error scoring detection; Kinect; Return-toduty evaluation; On-field automatic balance detection	ERROR SCORING SYSTEM; TRAUMATIC BRAIN-INJURY; MICROSOFT KINECT; CONCURRENT VALIDITY; CONCUSSION; RELIABILITY; PERFORMANCE; VARIABLES	Impaired balance is a common indicator of mild traumatic brain injury, concussion and musculoskeletal injury. Given the clinical relevance of such injuries, especially in military settings, it is paramount to develop more accurate and reliable on-field evaluation tools. This work presents the design and implementation of the automated assessment of postural stability (AAPS) system, for on-field evaluations following concussion. The AAPS is a computer system, based on inexpensive off-the-shelf components and custom software, that aims to automatically and reliably evaluate balance deficits, by replicating a known on-field clinical test, namely, the Balance Error Scoring System (BESS). The AAPS main innovation is its balance error detection algorithm that has been designed to acquire data from a Microsoft Kinect(A (R)) sensor and convert them into clinically-relevant BESS scores, using the same detection criteria defined by the original BESS test. In order to assess the AAPS balance evaluation capability, a total of 15 healthy subjects (7 male, 8 female) were required to perform the BESS test, while simultaneously being tracked by a Kinect 2.0 sensor and a professional-grade motion capture system (Qualisys AB, Gothenburg, Sweden). High definition videos with BESS trials were scored off-line by three experienced observers for reference scores. AAPS performance was assessed by comparing the AAPS automated scores to those derived by three experienced observers. Our results show that the AAPS error detection algorithm presented here can accurately and precisely detect balance deficits with performance levels that are comparable to those of experienced medical personnel. Specifically, agreement levels between the AAPS algorithm and the human average BESS scores ranging between 87.9% (single-leg on foam) and 99.8% (double-leg on firm ground) were detected. Moreover, statistically significant differences in balance scores were not detected by an ANOVA test with alpha equal to 0.05. Despite some level of disagreement between human and AAPS-generated scores, the use of an automated system yields important advantages over currently available human-based alternatives. These results underscore the value of using the AAPS, that can be quickly deployed in the field and/or in outdoor settings with minimal set-up time. Finally, the AAPS can record multiple error types and their time course with extremely high temporal resolution. These features are not achievable by humans, who cannot keep track of multiple balance errors with such a high resolution. Together, these results suggest that computerized BESS calculation may provide more accurate and consistent measures of balance than those derived from human experts.	[Napoli, Alessandro; Tucker, Carole; Obeid, Iyad] Temple Univ, Dept Elect & Comp Engn, Philadelphia, PA 19122 USA; [Glass, Stephen M.; Tucker, Carole] Temple Univ, Dept Phys Therapy, Philadelphia, PA 19140 USA		Napoli, A (corresponding author), Temple Univ, Dept Elect & Comp Engn, Philadelphia, PA 19122 USA.	a.napoli@temple.edu		Obeid, Iyad/0000-0002-5796-843X; Napoli, Alessandro/0000-0002-4061-3747; Glass, Stephen/0000-0001-6263-527X	Office of the Assistant Secretary of Defense for Health Affairs through the Neurosensory and Rehabilitation Research Award Program [W81XWH-15-1-0045]	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Neurosensory and Rehabilitation Research Award Program under Award No. W81XWH-15-1-0045. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office.	Alsalaheen BA, 2015, PHYSICIAN SPORTSMED, V43, P221, DOI 10.1080/00913847.2015.1040717; Amick R. Z., 2015, ATHL TRAIN SPORT HLT, V7, P89, DOI DOI 10.3928/19425864-20150422-04; Azad AM., 2016, BMJ OPEN SPORT EXERC, V2, pe000117, DOI [10.1136/bmjsem-2016-000117, DOI 10.1136/BMJSEM-2016-000117]; Azimi M., MICROSOFT DEVELOPER; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Clark RA, 2013, J BIOMECH, V46, P2722, DOI 10.1016/j.jbiomech.2013.08.011; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Clinical Practice Guideline, 2009, CLIN PRACT GUID MAN; Dolatabadi E, 2016, MED ENG PHYS, V38, P952, DOI 10.1016/j.medengphy.2016.06.015; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Galna B, 2014, GAIT POSTURE, V39, P1062, DOI 10.1016/j.gaitpost.2014.01.008; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Lim D, 2015, CLIN INTERV AGING, V10, P1077, DOI 10.2147/CIA.S85299; McCrory P., 2013, PHYS THER SPORT, V14, P250; Mentiplay BF, 2015, J BIOMECH, V48, P2166, DOI 10.1016/j.jbiomech.2015.05.021; Microsoft, KIN WIND SDK 2 0 PRO; Napoli A, 2017, BIOMED SIGNAL PROCES, V38, P265, DOI 10.1016/j.bspc.2017.06.006; Napoli A, 2016, IEEE ENG MED BIO, P6090, DOI 10.1109/EMBC.2016.7592118; Onate JA, 2007, J ATHL TRAINING, V42, P446; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pfister A, 2014, J MED ENG TECHNOL, P1; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Starling A. J., 2015, CONCUSSION, V1, P1; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Yeung LF, 2014, GAIT POSTURE, V40, P532, DOI 10.1016/j.gaitpost.2014.06.012	35	10	10	1	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2017	45	12					2784	2793		10.1007/s10439-017-1911-8			10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FN1DS	WOS:000415726200007	28856486				2022-02-06	
J	Oliver, JM; Jones, MT; Anzalone, AJ; Kirk, KM; Gable, DA; Repshas, JT; Johnson, TA; Hoglund, K; Blennow, K; Zetterberg, H				Oliver, Jonathan M.; Jones, Margaret T.; Anzalone, Anthony J.; Kirk, K. Michele; Gable, David A.; Repshas, Justin T.; Johnson, Torie A.; Hoglund, Kina; Blennow, Kaj; Zetterberg, Henrik			A Season of American Football Is Not Associated with Changes in Plasma Tau	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; biomarkers; mild traumatic brain injury; sub-concussion; traumatic brain injury	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; HEAD IMPACT EXPOSURE; HIGH-SCHOOL FOOTBALL; ICE HOCKEY PLAYERS; PROFESSIONAL FOOTBALL; CONCUSSION; ENCEPHALOPATHY; BLOOD; BIOMARKERS	American football athletes are routinely exposed to sub-concussive impacts over the course of the season. This study sought to examine the effect of a season of American football on plasma tau, a potential marker of axonal damage. Nineteen National Collegiate Athletic Association (NCAA) football athletes underwent serial blood sampling over the course of the 2014-2015 season at those times in which the number and magnitude of head impacts likely changed. Non-contact sport controls (NCAA men's swim athletes; n = 19) provided a single plasma sample for comparison. No significant differences were observed between control swim athletes and football athletes following a period of non-contact (p = 0.569) or a period of contact (p = 0.076). Football athletes categorized as starters (n = 11) had higher tau concentrations than non-starters (n = 8) following a period of non-contact (p = 0.039) and contact (p = 0.036), but not higher than swimmers (p = 1.000 and p = 1.000, respectively). No difference was noted over the course of the season in football athletes, irrespective of starter status. Despite routine head impacts common to the sport of American football, no changes were observed over the course of the season in football athletes, irrespective of starter status. Further, no difference was observed between football athletes and non-contact control swim athletes following a period of non-contact or contact. These data suggest that plasma tau is not sensitive enough to detect damage associated with repetitive sub-concussive impacts sustained by collegiate-level football athletes.	[Oliver, Jonathan M.; Anzalone, Anthony J.; Kirk, K. Michele; Gable, David A.; Repshas, Justin T.; Johnson, Torie A.] Texas Christian Univ, Sports Concuss Res Grp, Dept Kinesiol, TCU Box 297730, Ft Worth, TX 76129 USA; [Kirk, K. Michele; Gable, David A.] Texas Christian Univ, Dept Sport Med, Ft Worth, TX 76129 USA; [Jones, Margaret T.] George Mason Univ, Div Hlth & Human Performance, Manassas, VA USA; [Kirk, K. Michele] John Peter Smith Hosp, Dept Sport Med, Ft Worth, TX 76104 USA; [Hoglund, Kina; Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England		Oliver, JM (corresponding author), Texas Christian Univ, Sports Concuss Res Grp, Dept Kinesiol, TCU Box 297730, Ft Worth, TX 76129 USA.	jonathan.oliver@tcu.edu		Hoglund, Kina/0000-0002-1213-9953			Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Neselius S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099870; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Shahim P., 2014, ALZHEIMERS DEMENT, V4, P655; Shahim P, 2015, BRAIN INJURY, V29, P872, DOI 10.3109/02699052.2015.1018324; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	35	10	11	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2017	34	23					3295	3300		10.1089/neu.2017.5064			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FN9HM	WOS:000416341700011	28614998	Green Submitted			2022-02-06	
J	Rolfe, AJ; Bosco, DB; Broussard, EN; Ren, Y				Rolfe, Alyssa J.; Bosco, Dale B.; Broussard, Erynn N.; Ren, Yi			In Vitro Phagocytosis of Myelin Debris by Bone Marrow-Derived Macrophages	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neurobiology; Bone marrow-derived macrophage; phagocytosis; myelin debris; oil red O; carboxyfluorescein succinimidyl ester; spinal cord injury; neurotrauma	SPINAL-CORD-INJURY; QUANTITATION; PHENOTYPE; LIPIDS	Bone marrow-derived macrophages (BMDMs) are mature leukocytes that serve a critical physiological role as professional phagocytes capable of clearing a variety of particles. Normally, BMDMs are restricted from the central nervous system (CNS), but following an injury, they can readily infiltrate. Once within the injured CNS tissue, BMDMs are the primary cell type responsible for the clearance of injury-derived cellular debris, including large quantities of lipid rich myelin debris. The neuropathological ramifications of BMDM infiltration and myelin debris phagocytosis within the CNS are complex and not well understood. The protocols described here, allow for the direct in vitro study of BMDMs in the context of CNS injury. We cover murine BMDM isolation and culture, myelin debris preparation, and assays to assess BMDM myelin debris phagocytosis. These techniques produce robust quantifiable results without the need for significant specialized equipment or materials, yet can be easily customized to meet the needs of researchers.	[Rolfe, Alyssa J.; Bosco, Dale B.; Broussard, Erynn N.; Ren, Yi] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA		Ren, Y (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	yi.ren@med.fsu.edu		Rolfe, Alyssa/0000-0002-1427-549X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01GM100474, R01GM072611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM072611, R01GM100474] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (R01GM100474 and R01GM072611).	Bosco DB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172925; BOURRE JM, 1977, BIOCHIMIE, V59, P819, DOI 10.1016/S0300-9084(77)80213-7; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; Chen SD, 2015, J IMMUNOL METHODS, V426, P56, DOI 10.1016/j.jim.2015.08.001; Deutsch MJ, 2014, ANAL BIOCHEM, V445, P87, DOI 10.1016/j.ab.2013.10.001; Fang HQ, 2004, J IMMUNOL, V173, P360, DOI 10.4049/jimmunol.173.1.360; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; GOODRUM JF, 1994, J NEUROSCI, V14, P357; Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014; Guo L, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0233-3; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Larocca J. N., 2001, CURRENT PROTOCOLS CE; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ren Y, 1998, CELL DEATH DIFFER, V5, P563, DOI 10.1038/sj.cdd.4400407; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; Trouplin V, 2013, JOVE-J VIS EXP, DOI 10.3791/50966; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; Wang X, 2015, GLIA, V63, P635, DOI 10.1002/glia.22774; Wang XQ, 2005, ACTA BIOCH BIOPH SIN, V37, P379, DOI 10.1111/j.1745-7270.2005.00051.x; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	25	10	10	0	8	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	DEC	2017		130							e56322	10.3791/56322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6CN	WOS:000423240800037	29364206	Green Published			2022-02-06	
J	Sandweiss, AJ; Azim, A; Ibraheem, K; Largent-Milnes, TM; Rhee, P; Vanderah, TW; Joseph, B				Sandweiss, Alexander J.; Azim, Asad; Ibraheem, Kareem; Largent-Milnes, Tally M.; Rhee, Peter; Vanderah, Todd W.; Joseph, Bellal			Remote ischemic conditioning preserves cognition and motor coordination in a mouse model of traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	47th Annual Meeting of the Western-Trauma-Association (WTA)	MAR 05-10, 2017	Snowbird, UT	Western Trauma Assoc		Traumatic brain injury; biomarkers; blood-brain barrier; inflammation; microglia	NEURON-SPECIFIC ENOLASE; NECROSIS-FACTOR-ALPHA; INFLAMMATORY RESPONSE; STROKE; S100B; MICE; IMPAIRMENT; EXPRESSION; INCREASES; SURGERY	INTRODUCTION Management of traumatic brain injury (TBI) is focused on minimizing or preventing secondary brain injury. Remote ischemic conditioning (RIC) is an established treatment modality that has been shown to improve patient outcomes in different clinical settings by influencing inflammatory insults. In a clinical trial, RIC showed amelioration of SB100 and neuron-specific enolase. The aim of our study was to further elucidate the mechanisms and outcome when applying RIC in a mouse model of traumatic brain injury. METHODS We subjected 100 male C57BL mice to a closed-skull cortical-controlled impact injury. Two hours after the TBI, the animals were allocated to either the RIC group (n = 50) or the sham group (n = 50). By clamping the exposed femoral artery, we induced RIC by six 4-minute cycles of ischemia and reperfusion. Circulating levels of S100-B, neuron-specific enolase, and glial fibrillary acidic protein were measured at multiple time points. Animals were additionally observed daily for cognition and motor coordination via novel object recognition and rotarod. Brain sections were stained and evaluated for neuronal injury at post-TBI Day 5. RESULTS The RIC animals had a significantly higher recognition index than did sham at 24, 48, and 72 hours after intervention. Rotarod latency was higher in the RIC animals compared to the sham animals at all-time points, and statistically significant at 120 hours after intervention. The RIC group demonstrated preserved cognitive function and motor coordination compared to the sham. On hematoxylin and eosin and immunohistochemical staining of brain sections, there was less area of neuronal degeneration and astrocytosis, respectively, in the RIC group compared to the sham group. There was no significant difference in systemic neuronal markers between the RIC and sham animals. CONCLUSION Remote ischemic conditioning 2 hours after injury preserved cognitive functions and motor coordination in a mouse model of TBI. Remote ischemic conditioning can preserve viability of neurons and astrocytes after TBI and has potential as a clinically noninvasive and relatively easy method to improve outcome after TBI. LEVEL OF EVIDENCE Therapeutic studies, randomized controlled trial, level I.	[Sandweiss, Alexander J.; Largent-Milnes, Tally M.; Vanderah, Todd W.] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA; [Azim, Asad; Ibraheem, Kareem; Joseph, Bellal] Univ Arizona, Coll Med, Dept Surg, Tucson, AZ USA; [Rhee, Peter] Grady Mem Hosp, Dept Surg, Atlanta, GA USA		Joseph, B (corresponding author), Univ Arizona, Div Trauma Crit Care & Emergency Surg, Dept Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu	Sandweiss, Alexander/AAR-3587-2020	Sandweiss, Alexander/0000-0002-8213-2941	US Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL); Defense Advanced Research Projects AgencyUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [W911NF-15-1-0093]	This research was sponsored by the US Army Research Laboratory and Defense Advanced Research Projects Agency under grant number W911NF-15-1-0093. The views, opinions, and/or findings contained in this material are those of the authors and should not be presented as representing the official views or policies of the department of defense or the US Government. The authors declare no conflicts of interests.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Brevoord D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042179; Curry A, 2010, NEUROL RES, V32, P756, DOI 10.1179/174313209X459101; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Gonzalez NR, 2013, ACTA NEUROCHIR SUPPL, V115, P193, DOI 10.1007/978-3-7091-1192-5_36; Hay M, 2017, BEHAV NEUROSCI, V131, P99, DOI 10.1037/bne0000182; Heusch G, 2015, J AM COLL CARDIOL, V65, P177, DOI 10.1016/j.jacc.2014.10.031; Hougaard KD, 2013, INT J STROKE, V8, P141, DOI 10.1111/j.1747-4949.2012.00786.x; Hougaard KD, 2014, STROKE, V45, P159, DOI 10.1161/STROKEAHA.113.001346; Jensen HA, 2011, CIRCULATION, V123, P714, DOI 10.1161/CIRCULATIONAHA.110.986497; Ji XR, 2017, BRAIN RES, V1659, P88, DOI 10.1016/j.brainres.2016.12.031; Jia JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121972; Johnsson P, 2000, ANN THORAC SURG, V69, P750, DOI 10.1016/S0003-4975(99)01393-4; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Joseph B, 2015, J TRAUMA, V78, P703; Joseph B, 2017, J SURG RES, V213, P131, DOI 10.1016/j.jss.2016.01.033; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P698, DOI 10.1097/TA.0000000000000584; Kabadi SV, 2015, J CEREBR BLOOD F MET, V35, P2010, DOI 10.1038/jcbfm.2015.165; Kim YH, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-16; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Lesniak A, 2016, NEUROPHARMACOLOGY, V101, P506, DOI 10.1016/j.neuropharm.2015.10.014; Leung CH, 2015, ANN SURG, V261, P1215, DOI 10.1097/SLA.0000000000000877; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Moojen VKM, 2012, BRAIN RES, V1466, P82, DOI 10.1016/j.brainres.2012.05.041; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; Popescu C, 2015, J Med Life, V8, P272; Prevention CfDCa, 2016, INJ PREV CONTR TRAUM; Ramagiri S, 2017, EUR J PHARMACOL, V803, P84, DOI 10.1016/j.ejphar.2017.03.028; Ren CH, 2015, RESTOR NEUROL NEUROS, V33, P369, DOI 10.3233/RNN-140413; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; TIBBLING G, 1977, SCAND J CLIN LAB INV, V37, P385, DOI 10.3109/00365517709091496; Vanderah TW, 2008, EUR J PHARMACOL, V583, P62, DOI 10.1016/j.ejphar.2008.01.011; Wang HC, 2014, BRAIN INJURY, V28, P1491, DOI 10.3109/02699052.2014.943288; Wolf H, 2016, BRAIN INJURY, V30, P1220, DOI 10.3109/02699052.2016.1170883; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	38	10	10	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2017	83	6					1074	1081		10.1097/TA.0000000000001626			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	FO4RL	WOS:000416832700011	28609381				2022-02-06	
J	Santo, A; Lynall, RC; Guskiewicz, KM; Mihalik, JP				Santo, Ashley; Lynall, Robert C.; Guskiewicz, Kevin M.; Mihalik, Jason P.			Clinical Utility of the Sport Concussion Assessment Tool 3 (SCAT3) Tandem-Gait Test in High School Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; dynamic balance; adolescents; functional movement	NORMATIVE VALUES; FOOTBALL PLAYERS; POSTURAL CONTROL; BALANCE; STABILITY; RECOVERY; ADULTS; AGE; ASSOCIATIONS; ADOLESCENTS	Context: Dynamic balance during functional movement may provide important clinical information after concussion. The Sport Concussion Assessment Tool, version 3 (SCAT3), includes a timed tandem-gait test (heel-to-toe walking) administered with a pass-fail scoring system. Minimal evidence supports inclusion of the tandem-gait test in the SCAT3, especially in high school athletes. Objective: To determine (1) the percentage of healthy high school athletes who passed (best trial <= 14 seconds) the tandem-gait test at baseline, (2) the association between sex and test performance (pass versus fail), and (3) the relationships among sex, age, height, and tandem-gait test score. Design: Cross-sectional study. Setting: High school sports medicine center. Patients or Other Participants: Two hundred athletes from 4 high schools (age = 15.8 +/- 1.2 years, height = 170.3 +/- 10.3 cm, weight = 64.8 +/- 14.5 kg). Main Outcome Measure(s): Healthy participants completed 4 trials of the SCAT3 tandem-gait test and a demographic questionnaire. Outcome measures were passing rate at baseline on the tandem-gait test and tandem-gait test score (time). Results: Overall, 24.5% (49/200) of participants passed the test. Sex and performance were associated (v(2) = 15.15,P < .001), with a passing rate of 38.6% (32/83) for males and 14.5% (17/ 117) for females. The regression model including predictor variables of sex and height, with the outcome variable of tandem-gait test score and time, was significant (R-2 = 0.20, P < .01). Conclusions: Our findings suggest that the tandem-gait test had a high false-positive rate in high school athletes. Given that more than 75% of healthy participants failed the tandem-gait test, the 14-second cutoff appears to have limited clinical utility in the adolescent population. Functional movement deficits after concussion need to be accounted for, but the 14-second cutoff for the SCAT3 tandem-gait test does not appear to be an ideal way to assess these deficits in high school athletes.	[Santo, Ashley] Towson Univ, Dept Kinesiol, 8000 York Rd, Towson, MD 21252 USA; [Lynall, Robert C.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Exercise & Sport Sci, Chapel Hill, NC 27515 USA		Santo, A (corresponding author), Towson Univ, Dept Kinesiol, 8000 York Rd, Towson, MD 21252 USA.	asanto@towson.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640			Alsalaheen BA, 2014, PEDIATR PHYS THER, V26, P191, DOI 10.1097/PEP.0000000000000037; Bohannon RW, 2015, ARCH PHYS MED REHAB, V96, P472, DOI 10.1016/j.apmr.2014.10.006; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Butler RJ, 2012, J ATHL TRAINING, V47, P616, DOI 10.4085/1062-6050-47.5.14; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Ericksen H, 2012, J ATHL TRAINING, V47, P143; Froehle AW, 2013, GAIT POSTURE, V38, P14, DOI 10.1016/j.gaitpost.2012.10.005; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Muehlbauer T, 2015, SPORTS MED, V45, P1671, DOI 10.1007/s40279-015-0390-z; Olchowik G, 2014, ACTA BIOENG BIOMECH, V16, P53, DOI 10.5277/ABB-00001-2014-02; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pawar Rohini M, 2012, Foot (Edinb), V22, P31, DOI 10.1016/j.foot.2011.10.002; Peacock L, 2014, J AGING PHYS ACTIV, V22, P276, DOI [10.1123/JAPA.2012-0333, 10.1123/japa.2012-0333]; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Schneiders AG, 2010, J SCI MED SPORT, V13, P382, DOI 10.1016/j.jsams.2010.01.003; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Schultz AB, 1997, MUSCLE NERVE, pS60; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; Vereeck L, 2008, INT J AUDIOL, V47, P67, DOI 10.1080/14992020701689688	33	10	10	0	9	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2017	52	12					1096	1100		10.4085/1062-6050-52.11.26			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FR9BQ	WOS:000419368900002	29172647	Green Published, Bronze			2022-02-06	
J	Xu, D; Peng, Y				Xu, D.; Peng, Y.			Apolipoprotein E 4 triggers multiple pathway-mediated Ca2+ overload, causes CaMK II phosphorylation abnormity and aggravates oxidative stress caused cerebral cortical neuron damage	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Apolipoprotein E4; APOE4; Oxidative stress; Cortical neuron damage; CaMK II; NMDAR; Apoptosis	TRAUMATIC BRAIN-INJURY; PROTEIN-KINASE-II; ALZHEIMERS-DISEASE; DEFICIENT MICE; EXPRESSION; APOE4; POLYMORPHISM; APOPTOSIS; ATHEROSCLEROSIS; SUSCEPTIBILITY	OBJECTIVE: Apolipoprotein E (APOE) gene polymorphism is correlated closely with resistance to brain damage. This study aims to investigate the effects of APOE4 on oxidative stress damaged cerebral cortical neuron. MATERIALS AND METHODS: Primary cerebral cortical neurons were isolated from APOE gene knock-out mice (APOE(-/-) mice). Oxidative stress damaged APOE(-/-) mouse cerebral cortical neuron model was established. Three experimental designs (experiment 1, 2, 3) were conducted by employing several methods. Lactate dehydrogenase (LDH) and superoxide dismutase (SOD) analysis were employed for neurotoxicity assessment. Flow cytometry and transferase-mediated deoxyuridine-triphosphate-biotin nick end labeling (TUNEL) were used to examine neuron apoptosis. Immunohistochemistry and Nissl staining were used to identify neuron morphology. Western blot was used to detect phosphorylated CaMK II (p-CaMK II) and cleaved caspase 3 expression. Ca2+ levels in neurons were also examined by detecting fluorescence intensity. RESULTS: APOE4 treatment (Vehicle + APOE4) significantly aggravates oxidative stress damaged cerebral cortical neuron by increasing LDH levels and decreasing SOD activities, induces neuron apoptosis compared to Vehicle group (p < 0.05). APOE4 treatment significantly enhanced Ca2+ levels compared to Sham group (p < 0.05), MK801 treatment (Vehicle + APOE4 + MK801) significantly decreased Ca2+ levels compared to the Vehicle+APOE4 group at 12 h and 24 h (p < 0.05). APOE4 triggers CaMK II phosphorylation, caspase 3 activation and neurons apoptosis. Both of MK801 and KN93 inhibit CaMK II phosphorylation, decreases caspase 3 activation, and suppresses neurons apoptosis CONCLUSIONS: APOE triggers Ca2+ overload through NMDAR and CaMK II signaling pathway, both of which cause Ca2+ concentration increasing, CaMK II phosphorylation abnormity, and finally aggravate oxidative stress damaged neurons apoptosis.	[Xu, D.] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing, Peoples R China; [Peng, Y.] Chongqing Med Univ, Sch Basic Med Sci, Dept Histol & Embryol, Chongqing, Peoples R China		Peng, Y (corresponding author), Chongqing Med Univ, Sch Basic Med Sci, Dept Histol & Embryol, Chongqing, Peoples R China.	xuuedandr@hainan.net					Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Chen K, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-94; Chen LG, 2015, EXP CELL RES, V334, P294, DOI 10.1016/j.yexcr.2015.03.004; Correa DD, 2014, NEUROLOGY, V83, P320, DOI 10.1212/WNL.0000000000000617; Fu YH, 2010, EPILEPSY RES, V91, P253, DOI 10.1016/j.eplepsyres.2010.07.020; Hammer C, 2014, MOL PSYCHIATR, V19, P1143, DOI 10.1038/mp.2013.110; Hanci D, 2016, EUR REV MED PHARMACO, V20, P3469; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Horiuchi-Hirose M, 2014, ACTA NEUROBIOL EXP, V74, P242; Hu J, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0001-3; Huang YD, 2011, BIOCHEM SOC T, V39, P924, DOI 10.1042/BST0390924; Huisman HW, 2013, AM J HYPERTENS, V26, P68, DOI 10.1093/ajh/hps007; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Jiang L, 2011, NEUROSCI LETT, V505, P160, DOI 10.1016/j.neulet.2011.10.011; Jing Y, 2017, J ETHNOPHARMACOL, V208, P185, DOI 10.1016/j.jep.2017.06.052; Kang MK, 2015, BIOSENS BIOELECTRON, V72, P197, DOI 10.1016/j.bios.2015.05.017; Kimura A, 2005, TOXICOL APPL PHARM, V203, P53, DOI 10.1016/j.taap.2004.07.013; Kunda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081405; Lauderback CM, 2001, BIOCHEMISTRY-US, V40, P2548, DOI 10.1021/bi002312k; Lee HK, 2003, NEUROSCI LETT, V348, P93, DOI 10.1016/S0304-3940(03)00752-3; Levi O, 2007, J NEUROCHEM, V100, P202, DOI 10.1111/j.1471-4159.2006.04189.x; Lin YJ, 2014, MED SCI MONITOR, V20, P1596, DOI 10.12659/MSM.892111; Liu Y, 2014, EXP THER MED, V7, P171, DOI 10.3892/etm.2013.1375; Liu Y, 2014, PHARMACOL BIOCHEM BE, V124, P19, DOI 10.1016/j.pbb.2014.05.003; McCarron MO, 2003, ACTA NEUROL SCAND, V107, P106, DOI 10.1034/j.1600-0404.2003.01365.x; Mori T, 2003, J NEUROPATH EXP NEUR, V62, P280, DOI 10.1093/jnen/62.3.280; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; RADOJICIC C, 1990, J TRAUMA, V30, P211; Sen A, 2012, J BIOL CHEM, V287, P15947, DOI 10.1074/jbc.M111.312710; Song Y, 2017, EUR REV MED PHARMACO, V21, P1522; Vandame D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081004; Wu QC, 2017, VASC PHARMACOL, V91, P18, DOI 10.1016/j.vph.2017.02.002; Yardimoglu M, 2008, INT J NEUROSCI, V118, P981, DOI 10.1080/00207450701769232; Zhang YY, 2014, J ATHEROSCLER THROMB, V21, P119, DOI 10.5551/jat.19174; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	35	10	10	0	2	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	DEC	2017	21	24					5717	5728					12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FT6BX	WOS:000423238900027	29272008				2022-02-06	
J	Yoon, H; Radulovic, M; Walters, G; Paulsen, AR; Drucker, K; Starski, P; Wu, JM; Fairlie, DP; Scarisbrick, IA				Yoon, Hyesook; Radulovic, Maja; Walters, Grant; Paulsen, Alex R.; Drucker, Kristen; Starski, Phillip; Wu, Jianmin; Fairlie, David P.; Scarisbrick, Isobel A.			Protease activated receptor 2 controls myelin development, resiliency and repair	GLIA			English	Article						development; myelination; oligodendrocyte; remyelination	SPINAL-CORD-INJURY; OLIGODENDROCYTE DIFFERENTIATION; MULTIPLE-SCLEROSIS; SERINE-PROTEASE; NERVOUS-SYSTEM; THROMBIN RECEPTOR; AXONAL INTEGRITY; ERK1/2 MAPK; REMYELINATION; BRAIN	Oligodendrocytes are essential regulators of axonal energy homeostasis and electrical conduction and emerging target cells for restoration of neurological function. Here we investigate the role of protease activated receptor 2 (PAR2), a unique protease activated G protein-coupled receptor, in myelin development and repair using the spinal cord as a model. Results demonstrate that genetic deletion of PAR2 accelerates myelin production, including higher proteolipid protein (PLP) levels in the spinal cord at birth and higher levels of myelin basic protein and thickened myelin sheaths in adulthood. Enhancements in spinal cord myelin with PAR2 loss-of-function were accompanied by increased numbers of Olig2- and CC1-positive oligodendrocytes, as well as in levels of cyclic adenosine monophosphate (cAMP), and extracellular signal related kinase 1/2 (ERK1/2) signaling. Parallel promyelinating effects were observed after blocking PAR2 expression in purified oligodendrocyte cultures, whereas inhibiting adenylate cyclase reversed these effects. Conversely, PAR2 activation reduced PLP expression and this effect was prevented by brain derived neurotrophic factor (BDNF), a promyelinating growth factor that signals through cAMP. PAR2 knockout mice also showed improved myelin resiliency after traumatic spinal cord injury and an accelerated pattern of myelin regeneration after focal demyelination. These findings suggest that PAR2 is an important controller of myelin production and regeneration, both in the developing and adult spinal cord.	[Yoon, Hyesook; Radulovic, Maja; Walters, Grant; Paulsen, Alex R.; Drucker, Kristen; Wu, Jianmin; Scarisbrick, Isobel A.] Rehabil Med Res Ctr, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; [Yoon, Hyesook; Scarisbrick, Isobel A.] Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Radulovic, Maja; Starski, Phillip; Scarisbrick, Isobel A.] Mayo Clin, Neurobiol Dis Program, Rochester, MN 55905 USA; [Fairlie, David P.] Univ Queensland, ARC Ctr Excellence Adv Mol Imaging, Inst Mol Biosci, Brisbane, Qld 4072, Australia		Scarisbrick, IA (corresponding author), Mayo Clin Rochester, Neurobiol Dis Program, Phys Med & Rehabil, Rehabil Med Res Ctr, 642B Guggenheim Bldg,200 First St SW, Rochester, MN 55905 USA.	Scarisbrick.Isobel@mayo.edu	Fairlie, David P/F-8865-2014; Drucker, Kristen L/J-9573-2013	Fairlie, David P/0000-0002-7856-8566; Walters, Grant/0000-0001-5081-3104	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS052741]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG4958]; Australian Research CouncilAustralian Research Council [CE140100011]; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1084083, 1047759, 1027369]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052741] Funding Source: NIH RePORTER	National Institutes of Health, Grant Number: R01NS052741, National Multiple Sclerosis Society, Grant Number: RG4958, Australian Research Council, Grant Number: CE140100011, National Health and Medical Research Council, Grant Number(s) 1084083, 1047759, 1027369 (DPF)	Arai T, 2006, J NEUROPATH EXP NEUR, V65, P19, DOI 10.1097/01.jnen.0000196133.74087.cb; Barry GD, 2010, J MED CHEM, V53, P7428, DOI 10.1021/jm100984y; Burda JE, 2013, GLIA, V61, P1456, DOI 10.1002/glia.22534; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen B, 2012, J NEUROSCI, V32, P7622, DOI 10.1523/JNEUROSCI.0369-12.2012; Citron BA, 2000, J NEUROTRAUM, V17, P1191, DOI 10.1089/neu.2000.17.1191; Czopka T, 2010, J NEUROSCI, V30, P12310, DOI 10.1523/JNEUROSCI.4957-09.2010; D'Andrea MR, 1998, J HISTOCHEM CYTOCHEM, V46, P157; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Fulmer CG, 2014, J NEUROSCI, V34, P8186, DOI 10.1523/JNEUROSCI.4267-13.2014; Furusho M, 2012, J NEUROSCI, V32, P6631, DOI 10.1523/JNEUROSCI.6005-11.2012; Fyffe-Maricich SL, 2013, J NEUROSCI, V33, P18402, DOI 10.1523/JNEUROSCI.2381-13.2013; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Guardiola-Diaz HM, 2012, GLIA, V60, P476, DOI 10.1002/glia.22281; Harrington EP, 2010, ANN NEUROL, V68, P703, DOI 10.1002/ana.22090; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Ishii A, 2013, J NEUROSCI, V33, P175, DOI 10.1523/JNEUROSCI.4403-12.2013; Ishii A, 2012, J NEUROSCI, V32, P8855, DOI 10.1523/JNEUROSCI.0137-12.2012; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; Kremer D, 2016, TRENDS NEUROSCI, V39, P246, DOI 10.1016/j.tins.2016.02.004; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Lohman RJ, 2012, FASEB J, V26, P2877, DOI 10.1096/fj.11-201004; Lohman RJ, 2012, J PHARMACOL EXP THER, V340, P256, DOI 10.1124/jpet.111.187062; Noorbakhsh F, 2006, J EXP MED, V203, P425, DOI 10.1084/jem.20052148; Noorbakhsh F, 2005, J IMMUNOL, V174, P7320, DOI 10.4049/jimmunol.174.11.7320; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Radulovic M, 2016, NEUROBIOL DIS, V93, P226, DOI 10.1016/j.nbd.2016.04.010; Radulovic M, 2015, NEUROBIOL DIS, V83, P75, DOI 10.1016/j.nbd.2015.08.021; Radulovic Maja, 2013, J Neuropathol Exp Neurol, V72, P1072, DOI 10.1097/NEN.0000000000000007; RAIBLE DW, 1990, J NEUROSCI RES, V27, P43, DOI 10.1002/jnr.490270107; Robertson G.S., 2011, CURR DRUG DISCOV TEC, V7, P137; Scarisbrick IA, 2006, J NEUROIMMUNOL, V178, P167, DOI 10.1016/j.jneuroim.2006.05.022; Scarisbrick IA, 2006, EUR J NEUROSCI, V24, P1457, DOI 10.1111/j.1460-9568.2006.05021.x; Scarisbrick IA, 2000, GLIA, V30, P219, DOI 10.1002/(SICI)1098-1136(200005)30:3<219::AID-GLIA2>3.0.CO;2-2; Scarisbrick IA, 2002, BRAIN, V125, P1283, DOI 10.1093/brain/awf142; Scarisbrick IA, 2001, J COMP NEUROL, V431, P347; Scarisbrick IA, 1997, J NEUROSCI, V17, P8156; Scarisbrick IA, 2008, BIOL CHEM, V389, P739, DOI 10.1515/BC.2008.085; Schutzer SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066117; Simon K, 2016, J BIOL CHEM, V291, P705, DOI 10.1074/jbc.M115.683953; Singh V, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000155; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; Sriwai W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066743; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Suen JY, 2014, BRIT J PHARMACOL, V171, P4112, DOI 10.1111/bph.12757; Vandell AG, 2008, J NEUROCHEM, V107, P855, DOI 10.1111/j.1471-4159.2008.05658.x; Yang HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10884; Yoon H, 2015, GLIA, V63, P846, DOI 10.1002/glia.22788; Yoon H, 2013, J NEUROCHEM, V127, P283, DOI 10.1111/jnc.12293; Yu WR, 2011, ACTA NEUROPATHOL, V122, P747, DOI 10.1007/s00401-011-0882-3	53	10	10	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	DEC	2017	65	12					2070	2086		10.1002/glia.23215			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FJ8SF	WOS:000413038200014	28921694	Green Submitted, Green Accepted, Bronze			2022-02-06	
J	Ben Shimon, M; Zeimer, T; Stein, ES; Artan-Furman, A; Harnof, S; Chapman, J; Eisenkraft, A; Pick, CG; Maggio, N				Ben Shimon, Marina; Zeimer, Talya; Stein, Efrat Shavit; Artan-Furman, Avital; Harnof, Sagi; Chapman, Joab; Eisenkraft, Arik; Pick, Chaim G.; Maggio, Nicola			Recovery from trauma induced amnesia correlates with normalization of thrombin activity in the mouse hippocampus	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ACTIVATED RECEPTOR 1; BLOOD-BRAIN-BARRIER; SYNAPTIC PLASTICITY; ISCHEMIC-STROKE; NMDA RECEPTORS; INJURY; MICE; DISEASE; HEALTH	Transient amnesia is a common consequence of minimal traumatic brain injury (mTBI). However, while recent findings have addressed the mechanisms involved in its onset, the processes contributing to its recovery have not yet been addressed. Recently, we have found that thrombin is detected at high concentrations in the brain of mice after exposure to mTBI and that in such settings amnesia is rescued by either inhibiting thrombin activity or by blockade of PAR1. Here, we report that mice spontaneously recover from amnesia after two weeks from mTBI exposure. At this time point, long term potentiation was equally evoked in injured vs. control animals with thrombin concentration in the brain being normalized at this stage. These findings, which refer to the specific aspect of memory retrieval upon mTBI, together with our previous work, hint to a strong correlation between cognitive defects in the context of mTBI and thrombin concentrations in the brain. This may suggest that a possible scavenging of thrombin in the brain at early phases following mTBI may improve memory function.	[Ben Shimon, Marina; Zeimer, Talya; Stein, Efrat Shavit; Artan-Furman, Avital; Chapman, Joab; Maggio, Nicola] Chaim Sheba Med Ctr, Dept Neurol, Ramat Gan, Israel; [Ben Shimon, Marina; Harnof, Sagi; Chapman, Joab; Maggio, Nicola] Tel Aviv Univ, Dept Neurol & Neurosurg, Sackler Fac Med, Tel Aviv, Israel; [Harnof, Sagi] Rabin Med Ctr, Dept Neurosurg, Petah Tiqwa, Israel; [Chapman, Joab; Pick, Chaim G.; Maggio, Nicola] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Eisenkraft, Arik] Hebrew Univ Jerusalem, Inst Res Mil Med, Fac Med, Jerusalem, Israel; [Pick, Chaim G.] Tel Aviv Univ, Dept Anat, Sackler Fac Med, Tel Aviv, Israel; [Maggio, Nicola] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Ramat Gan, Israel		Maggio, N (corresponding author), Chaim Sheba Med Ctr, Dept Neurol, Ramat Gan, Israel.; Maggio, N (corresponding author), Tel Aviv Univ, Dept Neurol & Neurosurg, Sackler Fac Med, Tel Aviv, Israel.; Maggio, N (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.; Maggio, N (corresponding author), Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Ramat Gan, Israel.	Nicola.maggio@sheba.health.gov.il	Chapman, Joab/E-4598-2010		Institute of Military Medicine at the Hebrew University of Jerusalem [4440691738]; Kamin research program grant from the Israeli Ministry of Economy and Industry [56338]; Talpiot Medical Leadership Program Fellowship from the Chaim Sheba Medical Center	This work was supported by a grant from the Institute of Military Medicine at the Hebrew University of Jerusalem (#4440691738) to NM and CGP and a Kamin research program grant (#56338) from the Israeli Ministry of Economy and Industry to NM. NM is the recipient of a Talpiot Medical Leadership Program Fellowship from the Chaim Sheba Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the Institute of Military Medicine at the Hebrew University of Jerusalem (#4440691738) to NM and CGP and a Kamin research program grant (#56338) from the Israeli Ministry of Economy and Industry to NM. NM is the recipient of a Talpiot Medical Leadership Program Fellowship from the Chaim Sheba Medical Center. This work was performed in partial fulfillment of the requirements for a Ph.D degree of Marina Ben Shimon.	Becker D, 2014, NEUROPHARMACOLOGY, V86, P212, DOI 10.1016/j.neuropharm.2014.07.013; Ben Shimon M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00151; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Bushi D, 2013, J MOL NEUROSCI, V51, P844, DOI 10.1007/s12031-013-0072-y; Chen B, 2012, J NEUROSCI, V32, P7622, DOI 10.1523/JNEUROSCI.0369-12.2012; Cole W, 2016, NEUROCOGNITIVE PSYCH; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; CUNNINGHAM DD, 1993, THROMB HAEMOSTASIS, V70, P168; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Flynn Frederick G, 2010, Continuum (Minneap Minn), V16, P79, DOI 10.1212/01.CON.0000391454.15052.e4; Friedman A, 2015, SEMIN CELL DEV BIOL, V38, P1, DOI 10.1016/j.semcdb.2015.03.006; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Funahashi S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7050049; Garcia PS, 2015, NEUROCHEM RES, V40, P2220, DOI 10.1007/s11064-015-1711-1; Gershman SJ, 2017, ANNU REV PSYCHOL, V68, P101, DOI 10.1146/annurev-psych-122414-033625; Han KS, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-32; Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146; Itzekson Z, 2014, J MOL NEUROSCI, V53, P87, DOI 10.1007/s12031-013-0200-8; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee SY, 2007, J PHYSIOL-LONDON, V581, P887, DOI 10.1113/jphysiol.2007.134676; Lunko O O, 2015, Fiziol Zh, V61, P5; Maggio N, 2014, NEUROSCIENCE, V281, P135, DOI 10.1016/j.neuroscience.2014.09.041; Maggio N, 2013, EXP NEUROL, V247, P595, DOI 10.1016/j.expneurol.2013.02.011; Maggio N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00019; Maggio N, 2013, NEUROBIOL DIS, V50, P171, DOI 10.1016/j.nbd.2012.10.017; Maggio N, 2012, HIPPOCAMPUS, V22, P267, DOI 10.1002/hipo.20893; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Oh SJ, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-38; Stein ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep07912; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Veksler R, 2014, ARCH MED RES, V45, P646, DOI 10.1016/j.arcmed.2014.11.016; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188524	10.1371/journal.pone.0188524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN9ZL	WOS:000416402000033	29182653	Green Published, gold, Green Submitted			2022-02-06	
J	Huijben, JA; van der Jagt, M; Cnossen, MC; Kruip, MJHA; Haitsma, IK; Stocchetti, N; Maas, AIR; Menon, DK; Ercole, A; Maegele, M; Stanworth, SJ; Citerio, G; Polinder, S; Steyerberg, EW; Lingsma, HF				Huijben, Jilske A.; van der Jagt, Mathieu; Cnossen, Maryse C.; Kruip, Marieke J. H. A.; Haitsma, Iain K.; Stocchetti, Nino; Maas, Andrew I. R.; Menon, David K.; Ercole, Ari; Maegele, Marc; Stanworth, Simon J.; Citerio, Giuseppe; Polinder, Suzanne; Steyerberg, Ewout W.; Lingsma, Hester F.		CTR-TBI Investigators & Particip	Variation in Blood Transfusion and Coagulation Management in Traumatic Brain Injury at the Intensive Care Unit: A Survey in 66 Neurotrauma Centers Participating in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Study	JOURNAL OF NEUROTRAUMA			English	Article						coagulopathy; Europe; intensive care unit; transfusion; traumatic brain injury	PROTHROMBIN COMPLEX CONCENTRATE; CLINICAL-PRACTICE; CELL TRANSFUSION; COAGULOPATHY; MORTALITY; ANTICOAGULATION; ASSOCIATION; PROPHYLAXIS; OXYGENATION; HEMORRHAGE	Our aim was to describe current approaches and to quantify variability between European intensive care units (ICUs) in patients with traumatic brain injury (TBI). Therefore, we conducted a provider profiling survey as part of the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. The ICU Questionnaire was sent to 68 centers from 20 countries across Europe and Israel. For this study, we used ICU questions focused on 1) hemoglobin target level (Hb-TL), 2) coagulation management, and 3) deep venous thromboembolism (DVT) prophylaxis. Seventy-eight participants, mostly intensivists and neurosurgeons of 66 centers, completed the ICU questionnaire. For ICU-patients, half of the centers (N=34; 52%) had a defined Hb-TL in their protocol. For patients with TBI, 26 centers (41%) indicated an Hb-TL between 70 and 90g/L and 38 centers (59%) above 90g/L. To treat trauma-related hemostatic abnormalities, the use of fresh frozen plasma (N=48; 73%) or platelets (N=34; 52%) was most often reported, followed by the supplementation of vitamin K (N=26; 39%). Most centers reported using DVT prophylaxis with anticoagulants frequently or always (N=62; 94%). In the absence of hemorrhagic brain lesions, 14 centers (21%) delayed DVT prophylaxis until 72h after trauma. If hemorrhagic brain lesions were present, the number of centers delaying DVT prophylaxis for 72h increased to 29 (46%). Overall, a lack of consensus exists between European ICUs on blood transfusion and coagulation management. The results provide a baseline for the CENTER-TBI study, and the large between-center variation indicates multiple opportunities for comparative effectiveness research.	[Huijben, Jilske A.; Cnossen, Maryse C.; Polinder, Suzanne; Steyerberg, Ewout W.; Lingsma, Hester F.] Univ Med Ctr Rotterdam, Erasmus MC, Ctr Med Decis Sci, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [van der Jagt, Mathieu] Univ Med Ctr Rotterdam, Dept Intens Care, Off H 611, Rotterdam, Netherlands; [van der Jagt, Mathieu] Univ Med Ctr Rotterdam, Erasmus MC Stroke Ctr, Rotterdam, Netherlands; [Kruip, Marieke J. H. A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Hematol, Rotterdam, Netherlands; [Haitsma, Iain K.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplants, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Anesthesia & Crit Care, Neurosci Intens Care Unit, Milan, Italy; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Menon, David K.; Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England; [Maegele, Marc] Univ Witten Herdecke, CMMC, Dept Traumatol Orthoped Surg & Sportsmed, Cologne, Germany; [Maegele, Marc] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany; [Stanworth, Simon J.] Oxford Univ Hosp NHS Trust, John Radcliffe Hosp, NHS Blood & Transplant, Oxford, England; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] ASST Monza, San Gerardo Hosp, Monza, Italy; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands		Huijben, JA (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Ctr Med Decis Sci, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.a.huijben@erasmusmc.nl	Badenes, Rafael/K-6628-2019; Citerio, Giuseppe/B-1839-2015; Ercole, Ari/B-6288-2009; Cooper, D. James/G-7961-2013; Maas, Andrew IR/C-5584-2013; Castano-Leon, Ana M/ABF-6322-2020; Sahuquillo, Juan/B-3577-2008	Badenes, Rafael/0000-0001-7017-0150; Citerio, Giuseppe/0000-0002-5374-3161; Ercole, Ari/0000-0001-8350-8093; Cooper, D. James/0000-0002-5872-9051; Maas, Andrew IR/0000-0003-1612-1264; Castano-Leon, Ana M/0000-0002-7918-5049; Sahuquillo, Juan/0000-0003-0713-5875; Sakowitz, Oliver/0000-0003-3248-6335; Van Essen, Thomas/0000-0003-4657-5283; Huijben, Jilske (Antonia)/0000-0002-2892-5406; Coles, Jonathan/0000-0003-4013-679X; Newcombe, Virginia/0000-0001-6044-9035; Dippel, Diederik/0000-0002-9234-3515; Sanchez-Porras, Renan/0000-0002-9084-8114	European Commission FP7 Framework Program [602150]	This work was supported by European Commission FP7 Framework Program 602150.; Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Commission 7th Framework program (602150). The funder had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Abdel-Aziz H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0814-z; Albrecht V, 2017, EUR J TRAUMA EMERG S, V43, P201, DOI 10.1007/s00068-015-0608-7; Badenes R, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1748-4; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185; Carson JL, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub4; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Cook D, 2011, NEW ENGL J MED, V364, P1305, DOI 10.1056/NEJMoa1014475; Driessen A, 2015, EUR J TRAUMA EMERG S, V41, P413, DOI 10.1007/s00068-014-0455-y; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; European Comission, 2007, REM RES PUBL PRIV SE; Gaist D, 2017, JAMA-J AM MED ASSOC, V317, P836, DOI 10.1001/jama.2017.0639; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Hallet J, 2013, CRIT CARE MED, V41, P2800, DOI 10.1097/CCM.0b013e31829a6ecb; Hamada SR, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1092-5; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; IBM Corp, 2012, REL 2012 IBM SPSS ST; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lelubre C, 2016, MINERVA ANESTESIOL, V82, P112; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Ngwenya L. B., 2017, J NEUROSURG, P1; Nyquist P, 2017, CRIT CARE MED, V45, P476, DOI 10.1097/CCM.0000000000002247; Pakraftar S, 2014, WORLD J CLIN CASES, V2, P362, DOI 10.12998/wjcc.v2.i8.362; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, pS122, DOI 10.1097/TA.0b013e3182606327; Reddy GD, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0379-9; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Schafer N, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0147-6; Schochl H, 2014, CRIT CARE, V18, DOI 10.1186/cc13982; Schochl H, 2014, SHOCK, V41, P44, DOI 10.1097/SHK.0000000000000093; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Vedantam A, 2016, J NEUROSURG, V125, P1229, DOI 10.3171/2015.11.JNS151515; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Yamal JM, 2015, J TRAUMA ACUTE CARE, V79, P843, DOI 10.1097/TA.0000000000000834; Yuan Q, 2015, J CRIT CARE, V30, P116, DOI 10.1016/j.jcrc.2014.07.009; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	45	10	10	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					323	332		10.1089/neu.2017.5194		NOV 2017	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000417151000001	28825511	Green Accepted, Green Submitted			2022-02-06	
J	Cheng, YH; Eby, JM; LaPorte, HM; Volkman, BF; Majetschak, M				Cheng, You-Hong; Eby, Jonathan M.; LaPorte, Heather M.; Volkman, Brian F.; Majetschak, Matthias			Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; MOTIF RECEPTOR 4; PROTEASE-ACTIVATED RECEPTORS; TRAUMATIC BRAIN-INJURY; RECRUITS BETA-ARRESTIN; FACTOR-I; EXOGENOUS UBIQUITIN; CXCL12; THROMBIN; FACTOR-1-ALPHA	Recent evidence suggests that chemokine CXCL12, the cognate agonist of chemokine receptors CXCR4 and ACKR3, reduces thrombin-mediated impairment of endothelial barrier function. A detailed characterization of the effects of CXCL12 on thrombin-mediated human lung endothelial hyperpermeability is lacking and structure-function correlations are not available. Furthermore, effects of other CXCR4/ACKR3 ligands on lung endothelial barrier function are unknown. Thus, we tested the effects of a panel of CXCR4/ACKR3 ligands (CXCL12, CXCL11, ubiquitin, AMD3100, TC14012) and compared the CXCR4/ACKR3 activities of CXCL12 variants (CXCL12 alpha/beta, CXCL12(3-68), CXCL121, CXCL122, CXCL12S-S4V, CXCL12-R47E, CXCL12-K27A/R41A/R47A) with their effects on human lung endothelial barrier function in permeability assays. CXCL12 alpha enhanced human primary pulmonary artery endothelial cell (hPPAEC) barrier function, whereas CXCL11, ubiquitin, AMD3100 and TC14012 were ineffective. Pre-treatment of hPPAEC with CXCL12 alpha and ubiquitin reduced thrombin-mediated hyperpermeability. CXCL12 alpha-treatment of hPPAEC after thrombin exposure reduced barrier function impairment by 70% (EC50 0.05-0.5 mu M), which could be antagonized with AMD3100; ubiquitin (0.03-3 mu M) was ineffective. In a human lung microvascular endothelial cell line (HULEC5 alpha), CXCL12 alpha and ubiquitin posttreatment attenuated thrombin-induced hyperpermeability to a similar degree. CXCL12(3- 68) was inefficient to activate CXCR4 in Presto-Tango beta-arrestin2 recruitment assays; CXCL12-S-S4V, CXCL12-R47E and CXCL12-K27A/R41A/R47A showed significantly reduced potencies to activate CXCR4. While the potencies of all proteins in ACKR3 PrestoTango assays were comparable, the efficacy of CXCL12(3-68) to activate ACKR3 was significantly reduced. The potencies to attenuate thrombin-mediated hPPAEC barrier function impairment were: CXCL12 alpha/beta, CXCL121, CXCL12-K27A/R41A/R47A > CXCL12-S-S4V, CXCL12-R47E > CXCL122 > CXCL12(3-68). Our findings indicate that CXCR4 activation attenuates thrombin-induced lung endothelial barrier function impairment and suggest that protective effects of CXCL12 are dictated by its CXCR4 agonist activity and interactions of distinct protein moieties with heparan sulfate on the endothelial surface. These data may facilitate development of compounds with improved pharmacological properties to attenuate thrombin-induced vascular leakage in the pulmonary circulation.	[Cheng, You-Hong; Eby, Jonathan M.; LaPorte, Heather M.; Majetschak, Matthias] Loyola Univ Chicago, Stritch Sch Med, Dept Surg, Burn & Shock Trauma Res Inst, Maywood, IL 60153 USA; [Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Majetschak, Matthias] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA		Majetschak, M (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Surg, Burn & Shock Trauma Res Inst, Maywood, IL 60153 USA.; Majetschak, M (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA.	mmajetschak@luc.edu	Volkman, Brian F./ABE-7306-2020; Volkman, Brian F./ABE-7312-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Eby, Jonathan/0000-0002-0691-4044	Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program [W81XWH-15-1-0262]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM107495]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI058072, R37AI058072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM107495] Funding Source: NIH RePORTER	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program under Award No. W81XWH-15-1-0262 and by the National Institute of General Medical Sciences (Awards R01GM107495). The content is solely the responsibility of the authors. The authors declare that they have no conflict of interest.	Albee LJ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006575; Alberelli MA, 2014, VASC PHARMACOL, V62, P72, DOI 10.1016/j.vph.2014.06.001; Arachiche A, 2013, J BIOL CHEM, V288, P32553, DOI 10.1074/jbc.M113.472373; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Baker TA, 2012, CRIT CARE MED, V40, P2376, DOI 10.1097/CCM.0b013e3182514ed9; Blank R, 2011, CRIT CARE CLIN, V27, P439, DOI 10.1016/j.ccc.2011.05.005; Chen TJ, 2016, CLIN CHIM ACTA, V454, P6, DOI 10.1016/j.cca.2015.12.033; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108; Dushianthan A, 2011, POSTGRAD MED J, V87, P612, DOI 10.1136/pgmj.2011.118398; Earle SA, 2005, SURGERY, V138, P431, DOI 10.1016/j.surg.2005.06.026; Eby JM, 2017, MOL CELL BIOCHEM, V434, P143, DOI 10.1007/s11010-017-3044-7; Ethier MF, 1996, AM J PHYSIOL-LUNG C, V270, pL199, DOI 10.1152/ajplung.1996.270.2.L199; Evans AE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060971; Franchini S, 2015, AM J EMERG MED, V33, P1802, DOI 10.1016/j.ajem.2015.08.047; Garcia-Covarrubias L, 2008, CRIT CARE MED, V36, P979, DOI 10.1097/CCM.0B013E318164E417; Gifford AN, 1999, J PHARMACOL EXP THER, V288, P478; Gonzales J.N., 2015, AUSTIN J VASC MED, V2; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Guo C.X., 2015, ECAM, V2015, P1, DOI DOI 10.2119/M0LMED.2015.00240; Guo WX, 2014, BIOCHEM BIOPH RES CO, V452, P191, DOI 10.1016/j.bbrc.2014.07.033; Gur-Cohen S, 2016, ANN NY ACAD SCI, V1370, P65, DOI 10.1111/nyas.13013; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Janssens R, 2017, BIOCHEM PHARMACOL, V132, P92, DOI 10.1016/j.bcp.2017.03.009; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kobayashi K, 2014, ARTERIOSCL THROM VAS, V34, P1716, DOI 10.1161/ATVBAHA.114.303890; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Majetschak M, 2011, J LEUKOCYTE BIOL, V89, P205, DOI 10.1189/jlb.0510316; Mihara K, 2016, MOL PHARMACOL, V89, P606, DOI 10.1124/mol.115.102723; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Nassoiy SP, 2017, CLIN EXP PHARM PHYSL; Proost P, 1998, FEBS LETT, V432, P73, DOI 10.1016/S0014-5793(98)00830-8; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Saini V, 2011, J BIOL CHEM, V286, P44145, DOI 10.1074/jbc.M111.298505; Saini V, 2011, J BIOL CHEM, V286, P33466, DOI 10.1074/jbc.M111.233742; Saini Vikas, 2010, Commun Integr Biol, V3, P608, DOI 10.4161/cib.3.6.13375; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Tripathi A, 2015, NAUNYN SCHMIEDEBERGS; Tripathi A, 2015, P NATL ACAD SCI USA, V112, pE1659, DOI 10.1073/pnas.1417564112; Tripathi A, 2013, BIOCHEMISTRY-US, V52, P4184, DOI 10.1021/bi400254f; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2016, METHOD ENZYMOL, V570, P539, DOI 10.1016/bs.mie.2015.09.031; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Verkaar F, 2014, J IMMUNOL, V192, P3908, DOI 10.4049/jimmunol.1302159; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288; Zhang P, 2012, CIRCULATION, V126, P83, DOI 10.1161/CIRCULATIONAHA.112.091918; Ziarek JJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah5756; Ziarek JJ, 2013, ACS CHEM BIOL, V8, P1955, DOI 10.1021/cb400274z; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064	59	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2017	12	11							e0187949	10.1371/journal.pone.0187949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM2XM	WOS:000414866000031	29125867	gold, Green Submitted, Green Published			2022-02-06	
J	Fucci, N; Campobasso, CP; Mastrogiuseppe, L; Puccinelli, C; Marcheggiani, S; Mancini, L; Marino, L; Pascali, VL				Fucci, Nadia; Campobasso, Carlo P.; Mastrogiuseppe, L.; Puccinelli, C.; Marcheggiani, S.; Mancini, L.; Marino, L.; Pascali, V. L.			Diatoms in drowning cases in forensic veterinary context: a preliminary study	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Diatoms; Forensic veterinary; Drowning; Forensic pathology	DIAGNOSTIC-VALUE; FRESH; IDENTIFICATION; POSTMORTEM; SUBMERSION; INDICATOR; PATHOLOGY; VICTIMS; TISSUES; BODIES	In this preliminary study, a digestive method used in forensic context to extract diatoms has been applied in organs taken from ten wildlife animals belonging three species of mammals (a deer, a roe and five otters) and one species of birds (two magpies). Only four carcasses were recovered from aquatic environments (bath trough for animals, bathtub irrigation, river) and only in three cases out of ten that the cause of death was ruled out as drowning. In seven cases, the death was due to other causes: gunshot injuries for one otter, blunt trauma for a magpie, and traumatic injuries followed by motor vehicle collision in other four otters and a roe. Post-mortem examination was performed in all carcasses. The diatom test protocol was performed according to the Italian guidelines for analysis of benthic diatoms for ecological status assessment of inland waters. Five grams of lung, liver, and kidney was taken from all the animal carcasses. In some cases, additional tissue samples were also available among which brain, heart, spleen, and bone marrow. In all four cases found in water, the drowning medium was also available. Hydrogen peroxide (H2O2) digestion was performed, and identification of 21 genera of diatoms was obtained. The method proved to be suitable for the identification of diatoms in the organs of the animals drowned supporting the final diagnosis of drowning. Only in otters, all died for causes other than drowning, diatoms did not prove to be suitable for the diagnosis of drowning since their presence in the internal organs was mainly related to their main diet based on fishmeal. The authors believe that this first trial is very promising, and the results suggest that diatom test can be easily applied in forensic veterinary context.	[Fucci, Nadia; Pascali, V. L.] Univ Cattolica S Cuore, Inst Publ Hlth, Sect Legal Med, L Go F Vito 1, I-00168 Rome, Italy; [Campobasso, Carlo P.] Univ L Vanvitelli Campania, Dept Expt Med, Via Santa Maria Costantinopoli Snc, I-80138 Naples, Italy; [Mastrogiuseppe, L.] ASREM, Dipartimento Prevenz, Serv Vet, Piazza Vittoria 14, I-86100 Campobasso, Italy; [Puccinelli, C.; Marcheggiani, S.; Mancini, L.] Ist Super Sanita, Environm & Hlth Dept, V Regina Elena 299, I-00161 Rome, Italy; [Marino, L.] Ist Zooprofilatt Sperimentale Abruzzo & Molise, I-64100 Teramo, Italy		Fucci, N (corresponding author), Univ Cattolica S Cuore, Inst Publ Hlth, Sect Legal Med, L Go F Vito 1, I-00168 Rome, Italy.; Campobasso, CP (corresponding author), Univ L Vanvitelli Campania, Dept Expt Med, Via Santa Maria Costantinopoli Snc, I-80138 Naples, Italy.	nadia.fucci@unicatt.it; carlopietro.campobasso@unina2.it	pascali, vincenzo lorenzo/AAC-8436-2022; marcheggiani, stefania/ABH-4965-2020; Campobasso, Carlo Pietro/G-3920-2011	Campobasso, Carlo Pietro/0000-0003-2865-0673; marcheggiani, stefania/0000-0002-2021-3893; mancini, laura/0000-0003-3667-5221			Adamo M, 1963, ED MINERVA MED, P76; AUER A, 1991, AM J FOREN MED PATH, V12, P213, DOI 10.1097/00000433-199109000-00009; Azparren JE, 2007, FORENSIC SCI INT, V168, P138, DOI 10.1016/j.forsciint.2006.07.003; Bajanowski T, 1998, INT J LEGAL MED, V111, P57, DOI 10.1007/s004140050115; Benson CJ, 2013, VET CLIN PATH, V42, P221, DOI 10.1111/vcp.12037; Cattaneo C, 2015, FORENSIC SCI INT, V254, pE29, DOI 10.1016/j.forsciint.2015.06.024; Coe J I, 1974, J Forensic Sci, V19, P13; CONN AW, 1995, CRIT CARE MED, V23, P2029, DOI 10.1097/00003246-199512000-00012; Cooper JE, 2007, INTRO VET COMPARATIV; Cooper JE, 2008, FORENSIC SCI MED PAT, V4, P75, DOI 10.1007/s12024-008-9036-x; De Donno A, 2014, SCI JUSTICE, V54, P439, DOI 10.1016/j.scijus.2014.10.003; de la Grandmaison GL, 2006, FORENSIC SCI INT, V157, P117, DOI 10.1016/j.forsciint.2005.03.016; Di Giancamillo A, 2010, LEGAL MED-TOKYO, V12, P13, DOI 10.1016/j.legalmed.2009.09.007; DiGiancamillo A, 2011, LEGAL MED-TOKYO, V13, P268, DOI 10.1016/j.legalmed.2011.05.005; Filograna L, 2015, MED SCI LAW, V55, P304, DOI 10.1177/0025802414568045; Fucci N, 2012, CLIN EXPER PHARM, V2, P1; Fucci N, 2015, FORENSIC SCI MED PAT, V11, P601, DOI 10.1007/s12024-015-9708-2; GILBERTSON L, 1982, CRIT CARE MED, V10, P216, DOI 10.1097/00003246-198203000-00065; Heffner GG, 2008, JAVMA-J AM VET MED A, V232, P244, DOI 10.2460/javma.232.2.244; HENDEY NI, 1973, MED SCI LAW, V13, P23, DOI 10.1177/002580247301300103; Hurlimann J, 2000, INT J LEGAL MED, V114, P6, DOI 10.1007/s004149900122; Introna F, 2013, INT J LEGAL MED, V127, P871, DOI 10.1007/s00414-012-0807-2; ISPRA, 2007, MET BIOL ACQ MAN L 1; ISPRA, 2014, MET BIOL ACQ SUP INT; JEANMONOD R, 1992, FORENSIC SCI INT, V52, P171, DOI 10.1016/0379-0738(92)90105-6; Kakizaki E, 2012, FORENSIC SCI INT, V220, P135, DOI 10.1016/j.forsciint.2012.02.010; Kakizaki Eiji, 2009, Leg Med (Tokyo), V11 Suppl 1, pS350, DOI 10.1016/j.legalmed.2009.01.046; Kakizaki Eiji, 2009, Legal Medicine, V11, P91, DOI 10.1016/j.legalmed.2008.10.004; KNIGHT B, 1992, FORENSIC SCI INT, V57, P1, DOI 10.1016/0379-0738(92)90039-Y; Leary S, 2013, AM VET MED ASS GUID; Lucci A, 2008, FORENSIC SCI INT, V182, P20, DOI 10.1016/j.forsciint.2008.09.004; Luders JW, 1999, WILDLIFE SOC B, V27, P666; Ludes B, 1999, INT J LEGAL MED, V112, P163, DOI 10.1007/s004140050224; LUDES B, 1994, INT J LEGAL MED, V107, P37, DOI 10.1007/BF01247273; Lunetta P, 2005, FOREN PATHOL REV, V3, P3, DOI 10.1007/978-1-59259-910-3_1; Lunetta P, 1998, INT J LEGAL MED, V111, P229, DOI 10.1007/s004140050159; Lunetta P, 2013, LEGAL MED-TOKYO, V15, P229, DOI 10.1016/j.legalmed.2013.03.002; Martinez-Giron R, 2003, CYTOPATHOLOGY, V14, P70, DOI 10.1046/j.1365-2303.2003.00022.x; McEwen BJ, 2016, VET PATHOL, V53, P1049, DOI 10.1177/0300985815625757; Ming M, 2007, FORENSIC SCI INT, V170, P29, DOI 10.1016/j.forsciint.2006.08.022; MODELL JH, 1967, ANN INTERN MED, V67, P68, DOI 10.7326/0003-4819-67-1-68; MODELL JH, 1966, ANESTHESIOLOGY, V27, P662, DOI 10.1097/00000542-196609000-00018; Moritz AR, 1944, PHYSIOL REV, V24, P0070; Munro R, 2013, J COMP PATHOL, V149, P57, DOI 10.1016/j.jcpa.2012.10.001; PACHAR JV, 1993, MED SCI LAW, V33, P291, DOI 10.1177/002580249303300404; PEABODY AJ, 1980, MED SCI LAW, V20, P254, DOI 10.1177/002580248002000406; PIETTE M, 1989, MED SCI LAW, V29, P162, DOI 10.1177/002580248902900213; Piette MHA, 2006, FORENSIC SCI INT, V163, P1, DOI 10.1016/j.forsciint.2004.10.027; Pollanen MS, 1997, J FORENSIC SCI, V42, P281; Pollanen MS, 1998, FORENSIC DIATOMOLOGY, P1; Recommendation no. R (99) 3 of the Committee of Ministers to member states on the harmonization of medico-legal autopsy rules, 2000, FORENSIC SCI INT, V111, P5; Round FE, 1990, DIATOMS BIOL MORPHOL, P1; Sasidharan A, 2014, HLTH SCI, V3, P1; Saukko P., 2004, KNIGHTS FORENSIC PAT, P406; SCHNEIDER V, 1980, Z RECHTSMED, V85, P315; Spitz WU, 2004, SPITZ FISCHERS MEDIC; Suto M., 2003, LEG MED, V5, P142; TAYLOR JJ, 1994, MED SCI LAW, V34, P78, DOI 10.1177/002580249403400113; Uchiyama T, 2012, FORENSIC SCI INT, V222, P11, DOI 10.1016/j.forsciint.2012.04.029; Verma K., 2013, J FORENSIC RES, V4, P2, DOI DOI 10.4172/2157-7145.1000181; Vieira DN, 2011, FORENSIC MED OLD PRO; Vinayak V, 2013, J FORENSIC RES, V4, P207, DOI DOI 10.4172/2157-7145.1000207; Yen LY, 2007, FORENSIC SCI INT, V170, P1, DOI 10.1016/j.forsciint.2006.08.020; Zhu BL, 2003, LEG MED TOKYO S1, V5, P298, DOI DOI 10.1016/S1344-6223(02)00155-4; Zimmerman KA, 2008, J FORENSIC SCI, V53, P935, DOI 10.1111/j.1556-4029.2008.00748.x	65	10	10	3	19	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	NOV	2017	131	6					1573	1580		10.1007/s00414-017-1565-y			8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Legal Medicine	FJ5VK	WOS:000412821200012	28314903				2022-02-06	
J	Pruitt, P; Van Ornam, J; Borczuk, P				Pruitt, Peter; Van Ornam, Jonathan; Borczuk, Pierre			A Decision Instrument to Identify Isolated Traumatic Subdural Hematomas at Low Risk of Neurologic Deterioration, Surgical Intervention, or Radiographic Worsening	ACADEMIC EMERGENCY MEDICINE			English	Article							BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; METHODOLOGIC STANDARDS; PREDICTION RULES; ADULT PATIENTS; ICU; MEDICINE; OUTCOMES; RATES; CT	ObjectivesSubdural hematoma (SDH) is the most common form of traumatic intracranial hemorrhage. Severity of disease in patients with SDH varies widely. It was hypothesized that a decision rule could identify patients with SDH who are at very low risk for neurologic decline, neurosurgical intervention, or radiographic worsening. MethodsRetrospective chart review of consecutive patients age 16 with Glasgow Coma Score (GCS) 13 and computed tomography (CT)-documented isolated SDH presenting to a university-affiliated, urban, 100,000-annual-visit ED from 2009 to 2015. Demographic, historical, and physical examination variables were collected. Primary outcome was a composite of neurosurgical intervention, worsening repeat CT, and neurologic decline. Univariate analysis was performed and statistically important variables were utilized to create a logistic regression model. ResultsA total of 644 patients with isolated SDH were reviewed, 340 in the derivation group and 304 in the validation set. Mortality was 2.2%. A total 15.5% of patients required neurosurgery. A decision instrument was created: patients were low risk if they had none of the following factorsSDH thickness 5mm, warfarin use, clopidogrel use, GCS<14, and presence of midline shift. This model had a sensitivity of 98.6% for the composite endpoint, specificity of 37.1%, and a negative likelihood ratio of 0.037. In the validation cohort, sensitivity was 96.3%, specificity was 31.5%, and negative likelihood ratio was 0.127. ConclusionSubdural hematomas are amenable to risk stratification analysis. With prospective validation, this decision instrument may aid in triaging these patients, including reducing the need for transfer to tertiary centers.	[Pruitt, Peter] Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL USA; [Van Ornam, Jonathan] Harvard Affiliated Emergency Med Residency, Boston, MA USA; [Van Ornam, Jonathan; Borczuk, Pierre] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Van Ornam, Jonathan; Borczuk, Pierre] Harvard Med Sch, Dept Emergency Med, Boston, MA USA		Pruitt, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL USA.	peter.pruitt@northwestern.edu			Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [T-32 HS 000078]	Dr. Pruitt is a National Research Service Award postdoctoral fellow supported by Agency for Healthcare Research and Quality (AHRQ) T-32 HS 000078 (PI: Jane L. Holl, MD, MPH). AHRQ was not involved in the design or execution of this research.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; American College of Surgeons, 2015, BEST PRACT MAN TRAUM; Aujesky D, 2005, AM J MED, V118, P384, DOI 10.1016/j.amjmed.2005.01.006; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Chisholm KM, 2010, AM J FOREN MED PATH, V31, P350, DOI 10.1097/PAF.0b013e3181f69c87; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; Corsinovi L, 2009, ARCH GERONTOL GERIAT, V49, P142, DOI 10.1016/j.archger.2008.06.004; El-Fiki M, 2012, WORLD NEUROSURG, V78, P228, DOI 10.1016/j.wneu.2012.02.049; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; FRANCIS J, 1990, JAMA-J AM MED ASSOC, V263, P1097, DOI 10.1001/jama.263.8.1097; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Green SM, 2014, ANN EMERG MED, V64, P286, DOI 10.1016/j.annemergmed.2014.01.016; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Ledic Darko, 2014, Coll Antropol, V38, P1195; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; Nishijima DK, 2015, WEST J EMERG MED, V16, P284, DOI 10.5811/westjem.2015.1.23356; Nishijima DK, 2014, ANN EMERG MED, V63, P448, DOI 10.1016/j.annemergmed.2013.11.003; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Robert R, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0099-z; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tobias A., 2000, STATA TECH B, V56, P16; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wu C, 2015, WEST J EMERG MED, V16, P707, DOI 10.5811/westjem.2015.7.27458	32	10	10	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	NOV	2017	24	11					1377	1386		10.1111/acem.13306			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FM4IA	WOS:000414977200008	28871614	Bronze			2022-02-06	
J	Ellenberger, C; Garofano, N; Barcelos, G; Diaper, J; Pavlovic, G; Licker, M				Ellenberger, Christoph; Garofano, Najia; Barcelos, Gleicy; Diaper, John; Pavlovic, Gordana; Licker, Marc			Assessment of Haemostasis in patients undergoing emergent neurosurgery by rotational Elastometry and standard coagulation tests: a prospective observational study	BMC ANESTHESIOLOGY			English	Article						Brain injury; Trauma; Transfusion; Anesthesia; Bleeding	ACUTE TRAUMATIC COAGULOPATHY; TRANSFUSION REQUIREMENTS; BLOOD-TRANSFUSION; CARDIAC-SURGERY; THROMBOELASTOMETRY; POINT; COMPLICATIONS; PREDICTION; MANAGEMENT; THERAPY	Background: Rotational elastometry (ROTEM) has been shown useful to monitor coagulation in trauma patients and in major elective surgery. In this study, we aimed to evaluate the utility of ROTEM to identify hemostatic disturbances and to predict the need for transfusion, compared with standard coagulation tests (SCTs) in patients undergoing emergent neurosurgery. Methods: Over a four-year period, adult patients who met criteria for emergent neurosurgery lasting more than 90 min were included in the study. Blood was collected preoperatively and analyzed with SCTs (international normalized ratio [INR], fibrinogen concentration, prothrombin time [PT or Quick], partial thromboplastine time [PTT], fibrinogen concentration and platelet count), and ROTEM assays. Correlations between SCTs and ROTEM parameters as well as receiver operating characteristic curves were performed to detect a coagulopathic pattern based on standard criteria and the need for transfusing at least 3 units of packed red blood cells (PRBCs). Results: In a cohort of 92 patients, 39 (42%) required >= 3 PRBCs and a coagulopathic pattern was identified in 32 patients based on SCTs and in 19 based on ROTEM. There was a strong correlation between PTT and INTEM coagulation time (R = 0.76) as well as between fibrinogen concentrations and FIBTEM maximal clot firmess (R = 0.70). The need for transfusion (>= 3 PRBCs) was best predicted by the maximal clot firmess of EXTEM and FIBTEM (AUC of 0. 72 and 0.71, respectively) and by fibrinogen concentration (AUC of 0.70). Conclusions: In patients undergoing emergent neurosurgery, ROTEM analysis provides valid markers of early coagulopathy and predictors of blood transfusion requirements.	[Ellenberger, Christoph; Garofano, Najia; Barcelos, Gleicy; Diaper, John; Pavlovic, Gordana; Licker, Marc] Univ Hosp Geneva, Dept Anesthesiol Pharmacol & Intens Care, CH-1211 Geneva, Switzerland; [Licker, Marc] Univ Geneva, Fac Med, CH-1211 Geneva, Switzerland		Licker, M (corresponding author), Univ Hosp Geneva, Dept Anesthesiol Pharmacol & Intens Care, CH-1211 Geneva, Switzerland.; Licker, M (corresponding author), Univ Geneva, Fac Med, CH-1211 Geneva, Switzerland.	marc-joseph.licker@hcuge.ch		licker, marc/0000-0002-3691-4440	department of Anesthesiology, Pharmacology & Intensive Care of the University Hospital of Geneva	This study was supported by the Research Fund of the department of Anesthesiology, Pharmacology & Intensive Care of the University Hospital of Geneva.	Abrahams JM, 2002, SURG NEUROL, V58, P5, DOI 10.1016/S0090-3019(02)00777-2; Bagwe S, 2017, CLIN NEUROL NEUROSUR, V155, P83, DOI 10.1016/j.clineuro.2017.02.006; Beynon C, 2015, J CLIN NEUROSCI, V22, P252, DOI 10.1016/j.jocn.2014.07.029; Chandler WL, 2013, INT J LAB HEMATOL, V35, P339, DOI 10.1111/ijlh.12071; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Cywinski JB, 2014, ANESTH ANALG, V118, P428, DOI 10.1213/ANE.0b013e3182a76f19; Da Luz LT, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0518-9; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Deppe AC, 2016, J SURG RES, V203, P424, DOI 10.1016/j.jss.2016.03.008; Eappen S, 2013, JAMA-J AM MED ASSOC, V309, P1599, DOI 10.1001/jama.2013.2773; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Fowler A, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12919; Gaberel T, 2012, ACTA NEUROCHIR, V154, P1, DOI 10.1007/s00701-011-1179-y; Gerlach R, 2009, ACTA NEUROCHIR, V151, P873, DOI 10.1007/s00701-009-0409-z; Goh KYC, 2005, CLIN NEUROL NEUROSUR, V107, P296, DOI 10.1016/j.clineuro.2004.09.010; Goudie R, 2015, BRIT J ANAESTH, V114, P757, DOI 10.1093/bja/aeu483; Gruenbaum SE, 2014, CURR OPIN ANESTHESIO, V27, P470, DOI 10.1097/ACO.0000000000000109; Haas T, 2012, BRIT J ANAESTH, V108, P36, DOI 10.1093/bja/aer342; Hagemo JS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0823-y; Hans GA, 2016, BRIT J HAEMATOL, V173, P37, DOI 10.1111/bjh.13930; Hooda B, 2017, J CLIN NEUROSCI, V41, P132, DOI 10.1016/j.jocn.2017.02.053; KER K, 2015, COCHRANE DB SYST REV, V9; Lang T, 2005, BLOOD COAGUL FIBRIN, V16, P301, DOI 10.1097/01.mbc.0000169225.31173.19; Le Roux PD, 2001, NEUROSURGERY, V49, P1068, DOI 10.1097/00006123-200111000-00009; Palmer CS, 2016, INJURY, V47, P109, DOI 10.1016/j.injury.2015.07.003; Rahe-Meyer N, 2009, BLOOD COAGUL FIBRIN, V20, P218, DOI 10.1097/MBC.0b013e328327355d; Raman VV, 2015, BRIT J HOSP MED, V76, P690, DOI 10.12968/hmed.2015.76.12.690; Rolston JD, 2014, J NEUROSURG, V120, P736, DOI 10.3171/2013.10.JNS122419; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Sartorius D, 2014, ANN CARD ANAESTH, V17, P100, DOI 10.4103/0971-9784.129829; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Seicean A, 2012, J NEUROSURG, V116, P1097, DOI 10.3171/2012.1.JNS111760; Simmons JW, 2016, BRIT J ANAESTH, V117, P31, DOI 10.1093/bja/aew328; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Toulon P, 2009, THROMB HAEMOSTASIS, V101, P394, DOI 10.1160/TH08-06-0383; Weber CF, 2014, CLIN LAB, V60, P1059, DOI 10.7754/Clin.Lab.2013.130903; Weber CF, 2012, ANESTHESIOLOGY, V117, P531, DOI 10.1097/ALN.0b013e318264c644; Weil IA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139139	39	10	10	1	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2253			BMC ANESTHESIOL	BMC Anesthesiol.	OCT 24	2017	17								146	10.1186/s12871-017-0440-1			11	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	FK8MO	WOS:000413763000001	29065860	Green Published, gold			2022-02-06	
J	Dvorak, MF; Cheng, CL; Fallah, N; Santos, A; Atkins, D; Humphreys, S; Rivers, CS; White, BAB; Ho, C; Ahn, H; Kwon, BK; Christie, S; Noonan, VK				Dvorak, Marcel F.; Cheng, Christiana L.; Fallah, Nader; Santos, Argelio; Atkins, Derek; Humphreys, Suzanne; Rivers, Carly S.; White, Barry A. B.; Ho, Chester; Ahn, Henry; Kwon, Brian K.; Christie, Sean; Noonan, Vanessa K.			Spinal Cord Injury Clinical Registries: Improving Care across the SCI Care Continuum by Identifying Knowledge Gaps	JOURNAL OF NEUROTRAUMA			English	Article						clinical registry; data quality; healthcare system; knowledge gaps; spinal cord injury	TRAUMATIC BRAIN-INJURY; SEVERITY SYSTEM SAVES; CAUDA-EQUINA-SYNDROME; NEUROLOGICAL CLASSIFICATION; INTERNATIONAL STANDARDS; ADVERSE EVENTS; BLADDER DYSFUNCTION; ICCP PANEL; COMPLICATIONS; QUALITY	Timely access and ongoing delivery of care and therapeutic interventions is needed to maximize recovery and function after traumatic spinal cord injury (tSCI). To ensure these decisions are evidence-based, access to consistent, reliable, and valid sources of clinical data is required. The Access to Care and Timing Model used data from the Rick Hansen SCI Registry (RHSCIR) to generate a simulation of healthcare delivery for persons after tSCI and to test scenarios aimed at improving outcomes and reducing the economic burden of SCI. Through model development, we identified knowledge gaps and challenges in the literature and current health outcomes data collection throughout the continuum of SCI care. The objectives of this article were to describe these gaps and to provide recommendations for bridging them. Accurate information on injury severity after tSCI was hindered by difficulties in conducting neurological assessments and classifications of SCI (e.g., timing), variations in reporting, and the lack of a validated SCI-specific measure of associated injuries. There was also limited availability of reliable data on patient factors such as multi-morbidity and patient-reported measures. Knowledge gaps related to structures (e.g., protocols) and processes (e.g., costs) at each phase of care have prevented comprehensive evaluation of system performance. Addressing these knowledge gaps will enhance comparative and cost-effectiveness evaluations to inform decision-making and standards of care. Recommendations to do so were: standardize data element collection and facilitate database linkages, validate and adopt more outcome measures for SCI, and increase opportunities for collaborations with stakeholders from diverse backgrounds.	[Dvorak, Marcel F.; Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, Sauder Sch Business, 6180-818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada; [Atkins, Derek] Univ British Columbia, Operat & Logist Div, Sauder Sch Business, Vancouver, BC, Canada; [Cheng, Christiana L.; Fallah, Nader; Santos, Argelio; Humphreys, Suzanne; Rivers, Carly S.; White, Barry A. B.; Noonan, Vanessa K.] Rick Hansen Inst, Vancouver, BC, Canada; [Ho, Chester] Univ Calgary, Div Phys Med & Rehabil, Dept Clin Neurosci, Calgary, AB, Canada; [Ahn, Henry] Univ Toronto, Spine Program, Toronto, ON, Canada; [Christie, Sean] Dalhousie Univ, Res Div Neurosurg, Halifax, NS, Canada		Dvorak, MF (corresponding author), Univ British Columbia, Dept Orthopaed, Sauder Sch Business, 6180-818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada.	marcel.dvorak@ubc.ca	Fallah, Nader/D-4145-2012	Fallah, Nader/0000-0002-7746-4773; Ho, Chester/0000-0002-4238-5506; Christie, Sean/0000-0002-3540-6022; Dvorak, Marcel/0000-0002-9404-8448	Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Ontario Neurotrauma Foundation (ONF)	The authors thank the Canadian Institutes for Health Research (CIHR) and the Ontario Neurotrauma Foundation (ONF) for their financial support for the ACT Workshop; Elaine Chan and Sophia Park for research assistance; the Rick Hansen Institute RHSCIR Team (Daniel Rogers, Kristen Walden, Jayson Shurgold, Jessica Eapen, Jerome Buenaventura, Tova Plashkes, Arlene Aspinall, Cynthia Morin, and Shannon Sproule); and the RHSCIR Network and all of the participating facilities: Vancouver General Hospital, G.F. Strong Rehabilitation Centre, Foothills Medical Centre, Royal Alexandra Hospital, University of Alberta Hospital, Glenrose Rehabilitation Hospital, Royal University Hospital, Saskatoon City Hospital, Winnipeg Health Sciences Centre, St. Michael's Hospital, Sunnybrook Health Sciences Centre, Toronto Western Hospital, Toronto Rehabilitation Institute - Lyndhurst Centre, Hamilton General Hospital, Hamilton Health Sciences - Regional Rehabilitation Centre, University Hospital, Victoria Hospital, Parkwood Hospital, The Ottawa Hospital - Civic Campus, The Ottawa Hospital Rehabilitation Centre, Hospital de l'Enfant Jesus, Institut de readaptation en deficience physique de Quebec, Hospital du Sacre-Coeur de Montreal, Centre de readaptation Lucie-Bruneau, Institut de readaptation Gingras-Lindsay-de-Montreal, QEII Health Sciences Centre, Nova Scotia Rehabilitation Centre, Saint John Regional Hospital, Stan Cassidy Centre for Rehabilitation, St. John's Health Sciences Centre, and Dr. Leonard A. Miller Rehabilitation Centre.	Accreditation Canada, 2017, QMENT PROGR SPIN COR; Ahn H, 2017, J NEUROTRAUM, V34, P2917, DOI 10.1089/neu.2016.4936; Ahn H, 2011, J NEUROTRAUM, V28, P1341, DOI 10.1089/neu.2009.1168; Atkins Derek, 2012, Top Spinal Cord Inj Rehabil, V18, P57, DOI 10.1310/sci1801-57; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barrable B, 2014, J HEALTHC LEADERSH, V6, P15, DOI 10.2147/JHL.S58649; Biering-Sorensen F, 2015, SPINAL CORD, V53, P265, DOI 10.1038/sc.2014.246; Biering-Sorensen F, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030029; Bowers J, 2001, Health Bull (Edinb), V59, P381; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Brain and Spinal Injury Center UCSF, 2014, TRACK TBI TRANSF RES; Burns AS, 2017, J NEUROTRAUM, V34, P2910, DOI 10.1089/neu.2016.4935; Canadian Institute for Health Information, 2017, LENGTH STAY LENGTH S; Chan E., 2014, ACT WORKSH P; Chandra B. P., 2014, SPINAL CORD INJURY R, P1; Coleman William P, 2004, Spine J, V4, P373, DOI 10.1016/j.spinee.2003.12.006; Consortium Spinal Cord Med, 2008, J SPINAL CORD MED, V31, P403; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; DeVivo MJ, 2011, SPINAL CORD, V49, P596, DOI 10.1038/sc.2010.172; DeVivo Michael J, 2002, J Spinal Cord Med, V25, P335; Dryden DM, 2005, J TRAUMA, V59, P441, DOI 10.1097/01.ta.0000174732.90517.df; Dvorak M., 2015, 4 ISCOS ASIA JOINT S; Dvorak MF, 2014, J NEUROTRAUM, V31, P1540, DOI 10.1089/neu.2013.3278; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Feeny D, 2013, J CLIN EPIDEMIOL, V66, P706, DOI 10.1016/j.jclinepi.2012.12.013; Fehlings MG, 2017, J NEUROTRAUM, V34, P2841, DOI 10.1089/neu.2016.4926; FLETCHER DJ, 1995, SPINE, V20, P1136, DOI 10.1097/00007632-199505150-00005; Geisler FH, 2001, SPINE, V26, pS68, DOI 10.1097/00007632-200112151-00014; Glennie RA, 2014, SPINAL CORD, V52, P758, DOI 10.1038/sc.2014.116; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Graham JE, 2014, AM J PHYS MED REHAB, V93, P231, DOI 10.1097/PHM.0b013e3182a92c58; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P119, DOI 10.3171/2012.5.AOSPINE12127; Gruen RL, 2012, BRIT J SURG, V99, P97, DOI 10.1002/bjs.7754; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Hagen EM, 2009, SPINAL CORD, V47, P367, DOI 10.1038/sc.2008.118; Hellsten EK, 2013, SPINE J, V13, P44, DOI 10.1016/j.spinee.2013.01.003; Hosack K., 2014, SPINAL CORD INJURY R; Institut national d'excellence en sante et en services sociaux (INESSS), 2015, TRAUM CAR CONT; Jones JGA, 2013, AM J NEURORADIOL, V34, P471, DOI 10.3174/ajnr.A3199; Kalpakjian CZ, 2007, J SPINAL CORD MED, V30, P131, DOI 10.1080/10790268.2007.11753924; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; LaVela SL, 2014, PATIENT EXPERIENCE J, V1, P28; Levin SR, 2008, AM HEART J, V156, P1202, DOI 10.1016/j.ahj.2008.07.007; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; McCarthy MJH, 2007, SPINE, V32, P207, DOI 10.1097/01.brs.0000251750.20508.84; McGirt MJ, 2014, SPINE, V39, pS117, DOI 10.1097/BRS.0000000000000552; Miller D, 2015, PATIENT, V8, P293, DOI 10.1007/s40271-014-0095-7; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Munce SEP, 2013, SPINAL CORD, V51, P64, DOI 10.1038/sc.2012.81; New PW, 2015, ARCH PHYS MED REHAB, V96, P76, DOI 10.1016/j.apmr.2014.08.013; New PW, 2010, SPINE, V35, P796, DOI 10.1097/BRS.0b013e3181be76f5; Noonan V., 2016, CAN J SURG, V59, pS45; Noonan VK, 2012, SPINAL CORD, V50, P22, DOI 10.1038/sc.2011.109; Noonan VK, 2017, J NEUROTRAUM, V34, P2848, DOI 10.1089/neu.2016.4928; Noonan VK, 2013, J NEUROTRAUM, V30, P173, DOI 10.1089/neu.2012.2441; Noonan VK, 2012, J NEUROTRAUM, V29, P2272, DOI 10.1089/neu.2012.2317; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Noreau L, 2013, ARCH PHYS MED REHAB, V94, P1753, DOI 10.1016/j.apmr.2013.03.006; Oliver M, 2012, INJURY, V43, P1296, DOI 10.1016/j.injury.2012.04.021; One Mind, 2017, ON MIND PORT; Parent S, 2011, J NEUROTRAUM, V28, P1363, DOI 10.1089/neu.2009.1151; Podnar S, 2006, NEUROUROL URODYNAM, V25, P23, DOI 10.1002/nau.20188; Rehabilitation Outcome Measures, 2010, REH MEAS DAT; Rick Hansen Institute, 2016, PRAX 2016 CONF REP; Santos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072552; Schuld C, 2012, J NEUROTRAUM, V29, P453, DOI 10.1089/neu.2011.2085; Shi JG, 2010, ACTA ORTHOP, V81, P391, DOI 10.3109/17453674.2010.483985; Spinal Cord Injury Research Evidence, 2017, OUTC MEAS TOOLK; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Street JT, 2013, SPINAL CORD, V51, P472, DOI 10.1038/sc.2012.173; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Taichman DB, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001950; TEASDALE G, 1974, LANCET, V2, P81; THURMAN DJ, 1994, PARAPLEGIA, V32, P665, DOI 10.1038/sc.1994.107; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Tulsky DS, 2015, J SPINAL CORD MED, V38, P257, DOI [10.1179/2045772315Y.0000000023, 10.1179/2045772315Y.0000000035]; Tulsky DS, 2012, ARCH PHYS MED REHAB, V93, P1722, DOI 10.1016/j.apmr.2012.05.007; Walden K, 2016, SPINAL CORD, V54, P197, DOI 10.1038/sc.2015.137; Wardle G, 2012, HEALTH SERV RES, V47, P984, DOI 10.1111/j.1475-6773.2011.01340.x; Watanabe T, 1998, J UROLOGY, V159, P965, DOI 10.1016/S0022-5347(01)63786-8; White B. A., 2016, HLTH EC AGENDA SCI R; White BAB, 2017, J NEUROTRAUM, V34, P2892, DOI 10.1089/neu.2016.4934; Whitehurst DGT, 2013, SPINAL CORD, V51, P586, DOI 10.1038/sc.2013.47; World Health Organization, 2017, REH HLTH SYST; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Zariffa J, 2012, SPINE J, V12, P389, DOI 10.1016/j.spinee.2012.03.028	88	10	10	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2017	34	20					2924	2933		10.1089/neu.2016.4937			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FJ8YG	WOS:000413053900012	28745934	hybrid, Green Published			2022-02-06	
J	Carlson, SW; Henchir, J; Dixon, CE				Carlson, Shaun W.; Henchir, Jeremy; Dixon, C. Edward			Lateral Fluid Percussion Injury Impairs Hippocampal Synaptic Soluble N-Ethylmaleimide Sensitive Factor Attachment Protein Receptor Complex Formation	FRONTIERS IN NEUROLOGY			English	Article						sensitive factor attachment protein receptor; alpha-synuclein; traumatic brain injury; synapse; neurobehavioral function	TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; REDUCED EVOKED RELEASE; RAT FRONTAL-CORTEX; TYROSINE-HYDROXYLASE; VESICLE DOCKING; HEAD TRAUMA; CSP-ALPHA; IN-VITRO; MODEL	Traumatic brain injury (TBI) and the activation of secondary injury mechanisms have been linked to impaired cognitive function, which, as observed in TBI patients and animal models, can persist for months and years following the initial injury. Impairments in neurotransmission have been well documented in experimental models of TBI, but the mechanisms underlying this dysfunction are poorly understood. Formation of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex facilitates vesicular docking and neurotransmitter release in the synaptic cleft. Published studies highlight a direct link between reduced SNARE complex formation and impairments in neurotransmitter release. While alterations in the SNARE complex have been described following severe focal TBI, it is not known if deficits in SNARE complex formation manifest in a model with reduced severity. We hypothesized that lateral fluid percussion injury (IFPI) reduces the abundance of SNARE proteins, impairs SNARE complex formation, and contributes to impaired neurobehavioral function. To this end, rats were subjected to IFPI or sham injury and tested for acute motor performance and cognitive function at 3 weeks post-injury. IFPI resulted in motor impairment between 1 and 5 days post-injury. Spatial acquisition and spatial memory, as assessed by the Morris water maze, were significantly impaired at 3 weeks after IFPI. To examine the effect of IFPI on synaptic SNARE complex formation in the injured hippocampus, a separate cohort of rats was generated and brains processed to evaluate hippocampal synaptosomal-enriched lysates at 1 week post-injury. IFPI resulted in a significant reduction in multiple monomeric SNARE proteins, including VAMP2, and alpha-synuclein, and SNARE complex abundance. The findings in this study are consistent with our previously published observations suggesting that impairments in hippocampal SNARE complex formation may contribute to neurobehavioral dysfunction associated with TBI.	[Carlson, Shaun W.; Henchir, Jeremy; Dixon, C. Edward] Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Neurosurg, Pittsburgh, PA 15260 USA; [Carlson, Shaun W.; Henchir, Jeremy; Dixon, C. Edward] VA Pittsburgh Healthcare Syst, Pittsburgh, PA 15213 USA		Dixon, CE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Neurosurg, Pittsburgh, PA 15260 USA.; Dixon, CE (corresponding author), VA Pittsburgh Healthcare Syst, Pittsburgh, PA 15213 USA.	dixonec@upmc.edu		Carlson, Shaun/0000-0002-1413-5075	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH-NS079061, NIH-NS091062, F32NS090748]; VA Pittsburgh Healthcare System [VAI01RX001127]; Pittsburgh Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079061, R01NS091062] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX001127] Funding Source: NIH RePORTER	This study was funded by National Institutes of Health NIH-NS079061, NIH-NS091062, F32NS090748, VA Pittsburgh Healthcare System VAI01RX001127, and Walter L. Copeland Fund of The Pittsburgh Foundation.	Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carlson SW, 2017, EXP NEUROL, V289, P55, DOI 10.1016/j.expneurol.2016.12.006; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hayes R L, 1988, Brain Inj, V2, P31, DOI 10.3109/02699058809150930; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reeves TM, 1997, NEUROSCIENCE, V77, P431, DOI 10.1016/S0306-4522(96)00486-1; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Stalhammar D, 1987, Brain Inj, V1, P73, DOI 10.3109/02699058709034448; SUDHOF TC, 2011, CSH PERSPECT BIOL, V3, DOI DOI 10.1101/cshperspect.a005637; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Vardar G, 2016, J NEUROSCI, V36, P7911, DOI 10.1523/JNEUROSCI.1314-16.2016; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009	56	10	10	0	1	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 10	2017	8								532	10.3389/fneur.2017.00532			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FJ2DD	WOS:000412531400001	29067000	Green Published, gold			2022-02-06	
J	Chen, YH; Cheng, ZY; Shao, LH; Shentu, HS; Fu, B				Chen, Yi-Hua; Cheng, Zhen-Yu; Shao, Lin-Hua; Shentu, Hua-Song; Fu, Bing			Macrophage migration inhibitory factor as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage	CLINICA CHIMICA ACTA			English	Article						Aneurysm; Subarachnoid hemorrhage; Macrophage migration inhibitory factor; Inflammation; Severity; Outcome	TRAUMATIC BRAIN-INJURY; FACTOR MIF; PROTEIN-LEVELS; INFLAMMATION; BIOMARKERS; ACTIVATION; EXPRESSION; REGULATOR; VASOSPASM; SCALE	Background: Macrophage migration inhibitory factor (MIF) has been implicated in inflammation. We clarified whether serum MIF could be used as a marker of inflammation, brain damage and outcome after aneurysmal subarachnoid hemorrhage (aSAH). Methods: Serum samples from 102 aSAH adults and 102 healthy controls were determined. The World Federation of Neurological Surgeons (WFNS) scale was used for neurological evaluation and radiological severity was estimated in accordance with the Fisher scale. Results: Serum MIF, C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) and S100B concentrations were significantly higher in patients than in controls. Serum MIF concentrations correlated with WFNS scores and Fisher scores and serum concentrations of CRP, IL-6, TNF-alpha and S100B. Serum MIF was identified as an independent predictor for 6-month unfavorable outcome (defined as Extended Glasgow Outcome Scale score of 1-4). Area under receiver operating characteristic curve of serum MIF concentrations was similar to those of WFNS scores, Fisher scores and serum S100B concentrations and significantly exceeded those of serum CRP, IL-6 and TNF-alpha concentrations. Conclusions: Serum MIF provides information about inflammation, brain injury severity and outcome after aSAH, which can be useful as a complement to clinical data.	[Chen, Yi-Hua; Cheng, Zhen-Yu; Shao, Lin-Hua; Shentu, Hua-Song; Fu, Bing] Jinhua Peoples Hosp, Dept Neurosurg, 228 Xinhua St, Jinhua 321000, Peoples R China		Chen, YH (corresponding author), Jinhua Peoples Hosp, Dept Neurosurg, 228 Xinhua St, Jinhua 321000, Peoples R China.	qqzzhuzhu@yeah.net					Assis DN, 2014, HEPATOLOGY, V59, P580, DOI 10.1002/hep.26664; Bernhagen Juergen, 1994, Trends in Microbiology, V2, P198, DOI 10.1016/0966-842X(94)90111-H; Calandra T, 1997, CRIT REV IMMUNOL, V17, P77, DOI 10.1615/CritRevImmunol.v17.i1.30; Chuang TY, 2014, INT J INFECT DIS, V20, P13, DOI 10.1016/j.ijid.2013.12.006; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; DRAKE CG, 1988, J NEUROSURG, V68, P985; Etminan N, 2017, HAND CLINIC, V140, P195, DOI 10.1016/B978-0-444-63600-3.00012-X; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Frontera JA, 2017, NEUROCRIT CARE, V26, P48, DOI 10.1007/s12028-016-0292-4; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Garg R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0716-3; Grasso Giovanni, 2017, Surg Neurol Int, V8, P11, DOI 10.4103/2152-7806.198738; Grimm JW, 2015, J EMERG NURS, V41, P281, DOI 10.1016/j.jen.2014.12.018; Hu YY, 2010, SHOCK, V33, P134, DOI 10.1097/SHK.0b013e3181ad5c88; Inacio AR, 2011, J CEREBR BLOOD F MET, V31, P1093, DOI 10.1038/jcbfm.2010.194; Kim KW, 2016, KOREAN J INTERN MED, V31, P634, DOI 10.3904/kjim.2016.098; Koda M, 2004, ACTA NEUROPATHOL, V108, P31, DOI 10.1007/s00401-004-0853-z; Li Y, 2016, ADV MATER TECHNOL-US, V1, DOI 10.1002/admt.201600102; Lin Q, 2017, CLIN CHIM ACTA, V472, P58, DOI 10.1016/j.cca.2017.07.016; Lolis E, 1996, P ASSOC AM PHYSICIAN, V108, P415; Lv W, 2016, CANCER LETT, V375, P245, DOI 10.1016/j.canlet.2016.02.005; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Provencio JJ, 2005, SEMIN NEUROL, V25, P435, DOI 10.1055/s-2005-923537; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Sehba Fatima A, 2015, Acta Neurochir Suppl, V120, P23, DOI 10.1007/978-3-319-04981-6_4; Serrone JC, 2015, EXPERT REV NEUROTHER, V15, P367, DOI 10.1586/14737175.2015.1018892; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Su Y, 2017, ONCOTARGET, V8, P2719, DOI 10.18632/oncotarget.13739; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Turtzo LC, 2013, NEUROBIOL DIS, V54, P421, DOI 10.1016/j.nbd.2013.01.016; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu A, 2015, INT J CLIN EXP MED, V8, P14316; Yang DB, 2017, CLIN CHIM ACTA, V469, P99, DOI 10.1016/j.cca.2017.03.030; Zhang ZY, 2014, PEPTIDES, V60, P13, DOI 10.1016/j.peptides.2014.07.016; Zis O, 2015, MOL NEUROBIOL, V51, P155, DOI 10.1007/s12035-014-8727-4	35	10	10	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	OCT	2017	473						60	64		10.1016/j.cca.2017.08.018			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	FJ3FJ	WOS:000412615600011	28823650				2022-02-06	
J	Graban, J; Hlavacova, N; Jezova, D				Graban, J.; Hlavacova, N.; Jezova, D.			INCREASED GENE EXPRESSION OF SELECTED VESICULAR AND GLIAL GLUTAMATE TRANSPORTERS IN THE FRONTAL CORTEX IN RATS EXPOSED TO VOLUNTARY WHEEL RUNNING	JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY			English	Article						brain derived neurotrophic factor; corticosterone; glutamate transporters; vesicular glutamate transporter 3; wheel running; voluntary exercise	CHRONIC UNPREDICTABLE STRESS; TRAUMATIC BRAIN-INJURY; PHYSICAL-EXERCISE; ADOLESCENT RATS; LEWIS RATS; HIPPOCAMPUS; DEPRESSION; RESPONSES; RECOVERY; ANXIETY	Though positive effects of exercise on mood and well being are well recognised, the central regulatory mechanisms are still not fully understood. The present study was aimed to testing the hypothesis that voluntary wheel miming activates the gene expression of glutamate transporters in the brain cortex of rats. The animals were assigned to the control and voluntary wheel running groups. Voluntary wheel miming rats had free access to a stainless steel activity wheel for 3 weeks. The daily running distance gradually increased to 6.21 +/- 1.05 km by day 21. Vesicular glutamate transporter 3 (VGLUT3) mRNA levels in the frontal cortex were significantly elevated in the group of running animals compared to the values in sedentary controls, while the expression of other vesicular transporters were unchanged. The concentrations of mRNA coding for glial glutamate transporter 1 (GLT-1), but not glutamate aspartate transporter (GLAST) were increased by miming. Voluntary wheel miming resulted in an elevation of plasma corticosterone and increased expression of brain derived neurotrophic factor (BDNF) in the frontal cortex. In conclusion, chronic voluntary wheel running results in increased gene expression of VGLUT3 and GLT-1 in the brain cortex without changes in other glutamate transporter subtypes.	[Graban, J.; Hlavacova, N.; Jezova, D.] Slovak Acad Sci, Biomed Res Ctr, Inst Expt Endocrinol, Lab Pharmacol Neuroendocrinol, 9 Dubrayska Cesta St, Bratislava 84505, Slovakia		Jezova, D (corresponding author), Slovak Acad Sci, Biomed Res Ctr, Inst Expt Endocrinol, Lab Pharmacol Neuroendocrinol, 9 Dubrayska Cesta St, Bratislava 84505, Slovakia.	daniela.jezova@savba.sk	Graban, Jan/F-4025-2018; Jezova, Daniela/F-3975-2018; Hlavacova, Natasa/F-3911-2018	Jezova, Daniela/0000-0003-1932-2950; Hlavacova, Natasa/0000-0001-6216-6856	Slovak Research and Development AgencySlovak Research and Development Agency [APVV-15-0388]; Slovak Academy of Sciences; Hungarian Academy of SciencesHungarian Academy of Sciences	This work was supported by the grant of Slovak Research and Development Agency (APVV-15-0388) and by bilateral project between Slovak and Hungarian Academy of Sciences.	Arnold JC, 2016, ACS CHEM NEUROSCI, V7, P227, DOI 10.1021/acschemneuro.5b00282; Auer MK, 2015, J CEREBR BLOOD F MET, V35, P554, DOI 10.1038/jcbfm.2014.231; Babic S, 2015, J ENDOCRINOL, V225, P9, DOI 10.1530/JOE-14-0560; Bakos J, 2009, NEUROSCIENCE, V164, P788, DOI 10.1016/j.neuroscience.2009.08.054; Biedermann S, 2012, NEUROIMAGE, V61, P1206, DOI 10.1016/j.neuroimage.2012.04.010; Boa BCS, 2017, BRIT J PHARMACOL, V174, P3466, DOI 10.1111/bph.13732; Brancato A, 2017, NEUROSCIENCE, V350, P180, DOI 10.1016/j.neuroscience.2017.03.014; Caffino L, 2015, ADDICT BIOL, V20, P158, DOI 10.1111/adb.12089; Churchill MJ, 2017, NEUROSCIENCE, V359, P224, DOI 10.1016/j.neuroscience.2017.07.031; Dremencov E, 2017, INT J NEUROPSYCHOPH, V20, P585, DOI 10.1093/ijnp/pyx024; Grace PM, 2016, PAIN, V157, P2012, DOI 10.1097/j.pain.0000000000000607; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hearing C M, 2016, Curr Behav Neurosci Rep, V3, P350, DOI 10.1007/s40473-016-0089-y; Hofmann T, 2016, J PHYSIOL PHARMACOL, V67, P195; Horvath HR, 2018, CELL MOL NEUROBIOL, V38, P37, DOI 10.1007/s10571-017-0528-7; Ishide T, 2003, BRAIN RES, V977, P80, DOI 10.1016/S0006-8993(03)02761-6; JEZOVA D, 1985, EUR J APPL PHYSIOL, V54, P62, DOI 10.1007/BF00426300; Jezova D, 1994, Endocr Regul, V28, P163; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Kvam S, 2016, J AFFECT DISORDERS, V202, P67, DOI 10.1016/j.jad.2016.03.063; Liu WX, 2016, PSYCHOPHARMACOLOGY, V233, P405, DOI 10.1007/s00213-015-4128-2; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; Makatsori A, 2003, PSYCHONEUROENDOCRINO, V28, P702, DOI 10.1016/S0306-4530(02)00062-8; McMahon EM, 2017, EUR CHILD ADOLES PSY, V26, P111, DOI 10.1007/s00787-016-0875-9; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Moutsimilli L, 2005, NEUROPHARMACOLOGY, V49, P890, DOI 10.1016/j.neuropharm.2005.06.017; Ondkova S, 2010, GEN COMP ENDOCR, V165, P304, DOI 10.1016/j.ygcen.2009.07.012; Pokusa M, 2016, GEN PHYSIOL BIOPHYS, V35, P379, DOI 10.4149/gpb_2016020; Rappeneau V, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00231; Raudensky J, 2007, BRAIN RES, V1135, P129, DOI 10.1016/j.brainres.2006.12.002; Reagan LP, 2004, P NATL ACAD SCI USA, V101, P2179, DOI 10.1073/pnas.0307294101; Schwendt M, 2003, NEUROCHEM RES, V28, P653, DOI 10.1023/A:1022854213991; Shigeri Y, 2004, BRAIN RES REV, V45, P250, DOI 10.1016/j.brainresrev.2004.04.004; Swiatkiewicz M, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00019; Turner PV, 2014, J AM ASSOC LAB ANIM, V53, P161; Uysal N, 2015, BIOTECH HISTOCHEM, V90, P55, DOI 10.3109/10520295.2014.946968; Verbickas V, 2017, J PHYSIOL PHARMACOL, V68, P125; Vigas M, 1998, PHYSIOL RES, V47, P191; Vrettou M, 2017, ADDICT BIOL, V22, P369, DOI 10.1111/adb.12331; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zare Z, 2017, NEUROTOXICOL TERATOL, V62, P20, DOI 10.1016/j.ntt.2017.06.001; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739	42	10	11	0	1	POLISH PHYSIOLOGICAL SOC	GRZEGORZECKA	JAGIELLONIAN UNIV SCHOOL MED, INST PHYSIOLOGY, 31-531 KRAKOW, 16 GRZEGORZECKA, POLAND	0867-5910			J PHYSIOL PHARMACOL	J. Physiol. Pharmacol.	OCT	2017	68	5					709	714					6	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	GL1YE	WOS:000436909100007	29375045				2022-02-06	
J	Lynall, RC; Campbell, KR; Wasserman, EB; Dompier, TP; Kerr, ZY				Lynall, Robert C.; Campbell, Kody R.; Wasserman, Erin B.; Dompier, Thomas P.; Kerr, Zachary Y.			Concussion Mechanisms and Activities in Youth, High School, and College Football	JOURNAL OF NEUROTRAUMA			English	Article						injury prevention; injury risk factors; mild traumatic brain injury; sports medicine	HEAD-IMPACT EXPOSURE; NATIONAL ATHLETIC TREATMENT; SPORTS-RELATED CONCUSSION; OUTCOMES NETWORK NATION; INJURY; PLAYERS; EPIDEMIOLOGY; SKILLS; BRAIN	Our purpose was to determine concussion mechanism and activity differences among three cohorts of football players: youth, high school, and college. Participants in this prospective cohort study were youth (ages 5-14 years, 118 teams, 310 team-seasons), high school (96 teams, 184 team-seasons), and college (34 teams, 71 team-seasons) football players. Athletic trainers collected athlete-exposure (AE) and concussion data during the 2012-2014 seasons. Injury mechanism referred to the object that made contact with the concussed player, resulting in the concussion. Injury activity referred to the type of football-specific activity that the player was involved in when the concussion was sustained. Injury proportion ratios (IPR) compared distributions of concussion mechanisms and activities among age levels. A total of 1429 concussions were reported over 1,981,284 AE across all levels (Rate: 0.72/1000AE). Overall, most concussions were caused by player contact (84.7%). During games, a greater proportion of youth football concussions (14.7%) were caused by surface contact than high school (7.3%, IPR = 2.02; 95% confidence interval [CI]: 1.10-3.72) and college (7.1%, IPR = 2.07, 95% CI: 1.02-4.23) football. Compared with college football concussions (90.2%), a smaller proportion of youth (80.0%, IPR = 0.89, 95% CI: 0.79-0.99) and high school (83.2%, IPR = 0.92, 95% CI: 0.86-0.99) football concussions were caused by player contact. A greater proportion of game youth football concussions (42.1%) occurred while an individual was being tackled than occurred in high school (23.2%,IPR = 1.81, 95% CI: 1.34-2.45) and college (23.0%, IPR = 1.83, 95% CI: 1.29-2.62) football. Findings were similar during practices. Compared with college football game concussions (15.8%), a smaller proportion of youth (6.3%, IPR = 0.40, 95% CI: 0.17-0.93) and high school (9.5%, IPR = 0.60, 95% CI: 0.38-0.95) football game concussions occurred while an individual was being blocked. Concussion mechanism and activity differences should be considered when developing concussion prevention and sport-safety methods specific to different age levels, in order to maximize effectiveness.	[Lynall, Robert C.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA; [Campbell, Kody R.] Univ N Carolina, Dept Allied Hlth Sci, Chapel Hill, NC USA; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Wasserman, Erin B.; Dompier, Thomas P.] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN USA		Lynall, RC (corresponding author), Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30677 USA.	rlynall@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640; Campbell, Kody/0000-0002-4534-5497; Wasserman, Erin/0000-0001-5957-5878	USA Football; National Athletic Trainers' Association Research and Education Foundation; BioCrossroads; Central Indiana Corporate; National Collegiate Athletic Association	Funding for this study was provided by USA Football, the National Athletic Trainers' Association Research and Education Foundation, BioCrossroads in partnership with the Central Indiana Corporate Partnership Foundation, and the National Collegiate Athletic Association. The funding agreements ensured the authors' independence in designing the study, interpreting the data, and publishing the report.	Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2016, MED SCI SPORT EXER, V48, P815, DOI 10.1249/01.mss.0000487445.54288.d3; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Cobb Bryan R, 2014, Biomed Sci Instrum, V50, P285; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Liao S, 2016, MED SCI SPORT EXER, V48, P1239, DOI 10.1249/MSS.0000000000000896; Lubans DR, 2010, SPORTS MED, V40, P1019, DOI 10.2165/11536850-000000000-00000; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Parsons J., 2013, GUIDELINE 2I SPORT R, V63; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Zuckerman Scott L, 2016, Neurosurgery, V63 Suppl 1, P102, DOI 10.1227/NEU.0000000000001280; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	30	10	10	0	42	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2684	2690		10.1089/neu.2017.5032			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700002	28490228				2022-02-06	
J	Singh, K; Trivedi, R; Verma, A; D'souza, MM; Koundal, S; Rana, P; Baishya, B; Khushu, S				Singh, Kavita; Trivedi, Richa; Verma, Ajay; D'souza, Maria M.; Koundal, Sunil; Rana, Poonam; Baishya, Bikash; Khushu, Subash			Altered metabolites of the rat hippocampus after mild and moderate traumatic brain injury - a combined in vivo and in vitro H-1-MRS study	NMR IN BIOMEDICINE			English	Article						hippocampus; in vitro MRS; in vivo MRS; mild TBI; moderate TBI; proton magnetic resonance spectroscopy	MAGNETIC-RESONANCE-SPECTROSCOPY; METABOLOMIC DATA-ANALYSIS; FLUID PERCUSSION INJURY; CORTICAL IMPACT INJURY; TIME-COURSE; GLUTAMATE; EXCITOTOXICITY; METABOANALYST; MECHANISMS; EXPRESSION	Traumatic brain injury (TBI) has been shown to affect hippocampus-associated learning, memory and higher cognitive functions, which may be a consequence of metabolic alterations. Hippocampus-associated disorders may vary depending on the severity of injury [mild TBI (miTBI) and moderate TBI (moTBI)] and time since injury. The underlying hippocampal metabolic irregularities may provide an insight into the pathological process following TBI. In this study, in vivo and in vitro proton magnetic resonance spectroscopy (H-1-MRS) data were acquired from the hippocampus region of controls and TBI groups (miTBI and moTBI) at D0 (pre-injury), 4 h, Day 1 and Day 5 post-injury (PI). In vitro MRS results indicated trauma-induced changes in both miTBI and moTBI; however, in vivo MRS showed metabolic alterations in moTBI only. miTBI and moTBI showed elevated levels of osmolytes indicating injury-induced edema. Altered levels of citric acid cycle intermediates, glutamine/glutamate and amino acid metabolism indicated injury-induced aberrant bioenergetics, excitotoxicity and oxidative stress. An overall similar pattern of pathological process was observed in both miTBI and moTBI, with the distinction of depleted N-acetylaspartate levels (indicating neuronal loss) at 4 h and Day 1 and enhanced lactate production (indicating heightened energy depletion leading to the commencement of the anaerobic pathway) at Day 5 in moTBI. To the best of our knowledge, this is the first study to investigate the hippocampus metabolic profile in miTBI and moTBI simultaneously using in vivo and in vitro MRS.	[Singh, Kavita; Trivedi, Richa; D'souza, Maria M.; Koundal, Sunil; Rana, Poonam; Khushu, Subash] Inst Nucl Med & Allied Sci, NMR Res Ctr, Delhi 110054, India; [Verma, Ajay; Baishya, Bikash] CBMR, SGPGIMS Campus, Lucknow, Uttar Pradesh, India		Trivedi, R (corresponding author), Inst Nucl Med & Allied Sci, NMR Res Ctr, Delhi 110054, India.	triricha@gmail.com	SINGH, KAVITA/AAW-9612-2021; koundal, sunil/AAY-4106-2020	SINGH, KAVITA/0000-0002-4772-372X; koundal, sunil/0000-0003-3969-1091	Department of Science and technology, IndiaDepartment of Science & Technology (India) [INSPIRE fellowship]	Department of Science and technology, India, Grant/Award Number: INSPIRE fellowship	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bernal F, 2000, EXP NEUROL, V161, P686, DOI 10.1006/exnr.1999.7293; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Capizzano AA, 2010, J NEUROPSYCH CLIN N, V22, P370, DOI 10.1176/appi.neuropsych.22.4.370; CERDAN S, 1985, FEBS LETT, V187, P167, DOI 10.1016/0014-5793(85)81235-7; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; De Simone R, 2013, BBA-MOL BASIS DIS, V1832, P650, DOI 10.1016/j.bbadis.2013.02.001; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Graber JJ, 2009, PHARMACOL THERAPEUT, V121, P147, DOI 10.1016/j.pharmthera.2008.10.001; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Lin Alexander, 2005, NeuroRx, V2, P197, DOI 10.1602/neurorx.2.2.197; Lopez-Redondo F, 2000, MOL BRAIN RES, V76, P429, DOI 10.1016/S0169-328X(00)00022-X; Lyeth B, 2015, SOURCE BRAIN NEUROTR, P549; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Moffett JR, 2006, ADV EXP MED BIOL, V576, P7; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Perera TD, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/875307; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; van der Graaf M, 2010, EUR BIOPHYS J BIOPHY, V39, P527, DOI 10.1007/s00249-009-0517-y; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zou J, 2010, NEUROCHEM INT, V56, P577, DOI 10.1016/j.neuint.2009.12.021; [No title captured]	50	10	10	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	OCT	2017	30	10							e3764	10.1002/nbm.3764			11	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	FO1AN	WOS:000416489200011	28759166				2022-02-06	
J	Vidal-Jorge, M; Sanchez-Guerrero, A; Mur-Bonet, G; Castro, L; Radoi, A; Riveiro, M; Fernandez-Prado, N; Baena, J; Poca, MA; Sahuquillo, J				Vidal-Jorge, Marian; Sanchez-Guerrero, Angela; Mur-Bonet, Gemma; Castro, Lidia; Radoi, Andreea; Riveiro, Marilyn; Fernandez-Prado, Natalia; Baena, Jacinto; Poca, Maria-Antonia; Sahuquillo, Juan			Does Normobaric Hyperoxia Cause Oxidative Stress in the Injured Brain? A Microdialysis Study Using 8-Iso-Prostaglandin F2 alpha as a Biomarker	JOURNAL OF NEUROTRAUMA			English	Article						8-iso-PGF2 alpha; microdyalisis; NBO; oxidative stress; TBI	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; TISSUE-OXYGENATION; INTRACRANIAL-PRESSURE; ARTERIAL HYPEROXIA; HYPERBARIC-OXYGEN; INSPIRED OXYGEN; METABOLISM; LACTATE; ASSOCIATION	Significant controversy exists regarding the potential clinical benefit of normobaric hyperoxia (NBO) in patients with traumatic brain injury (TBI). This study consisted of two aims: 1) to assess whether NBO improves brain oxygenation and metabolism and 2) to determine whether this therapy may increase the risk of oxidative stress (OxS), using 8-isoProstaglandin F2 alpha (PGF2 alpha) as a biomarker. Thirty-one patients with a median admission Glasgow Coma Scale score of 4 (min: 3, max: 12) were monitored with cerebral microdialysis and brain tissue oxygen sensors and treated with fraction of inspired oxygen (FiO(2)) of 1.0 for 4 h. Patients were divided into two groups according to the area monitored by the probes: normal injured brain and traumatic penumbra/traumatic core. NBO maintained for 4 h did not induce OxS in patients without preOxS at baseline, except in one case. However, for patients in whom OxS was detected at baseline, NBO induced a significant increase in 8-iso-PGF2 alpha. The results of our study showed that NBO did not change energy metabolism in the whole group of patients. In the five patients with brain lactate concentration ([Lac](brain)) > 3.5 mmol/L at baseline, NBO induced a marked reduction in both [Lac] brain and lactate-to-pyruvate ratio. Although these differences were not statistically significant, together with the results of our previous study, they suggest that TBI patients would benefit from receiving NBO when they show indications of disturbed brain metabolism. These findings, in combination with increasing evidence that TBI metabolic crises are common without brain ischemia, open new possibilities for the use of this accessible therapeutic strategy in TBI patients.	[Vidal-Jorge, Marian; Sanchez-Guerrero, Angela; Mur-Bonet, Gemma; Castro, Lidia; Radoi, Andreea; Poca, Maria-Antonia; Sahuquillo, Juan] VHIR, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain; [Riveiro, Marilyn; Fernandez-Prado, Natalia; Baena, Jacinto] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Neurotraumatol Intens Care Unit, Barcelona, Spain; [Poca, Maria-Antonia; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain		Sahuquillo, J (corresponding author), Univ Autonoma Barcelona, Dept Neurosurg & Neurotraumatol, Vall dHebron Univ Hosp, Paseo Vall Hebron 119-129, Barcelona 08035, Spain.	sahuquillo@neurotrauma.net	Sahuquillo, Juan/B-3577-2008; Poca, Maria A./B-8475-2008; Radoi, Andreea/N-5613-2019; Vidal-Jorge, Marian/D-4402-2017; Riveiro, Marilyn/S-5242-2016; Castro, Lidia/J-3976-2017	Sahuquillo, Juan/0000-0003-0713-5875; Poca, Maria A./0000-0002-3831-0536; Radoi, Andreea/0000-0002-0677-3544; Vidal-Jorge, Marian/0000-0002-3459-9336; Riveiro, Marilyn/0000-0002-1645-3720; Castro, Lidia/0000-0001-8513-7388	Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya [SGR2014-844]; Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III)Instituto de Salud Carlos III [FIS PI11/00700, FIS PI13/02397]; European Regional Development Fund (ERDF)European Commission; ISCIIIInstituto de Salud Carlos III [FI12/00074]; Fundacio Institut de Recerca HUVH [PRED-VHIR-2012-26]	We gratefully acknowledge the contribution of the nursing staff, and the technical and research staff of the Neurotraumatology Intensive Care Unit. We greatly appreciate the help of Dennis R. Helsel of Practical Stats (Denver, CO) for orienting us in the nondetect management of the 8-iso-PGF2a data. The Neurotraumatology and Neurosurgery Research Unit is supported by a grant from the Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya (SGR2014-844). This work has been supported in part by the Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) with grants FIS PI11/00700 (J. Sahuquillo) and grant FIS PI13/02397 (M.A. Poca), which were co-financed by the European Regional Development Fund (ERDF). A. Sanchez-Guerrero and A. Ra. doi are recipients of pre-doctoral grants from the ISCIII (FI12/00074) and from Fundacio Institut de Recerca HUVH (PRED-VHIR-2012-26), respectively.	[Anonymous], 2002, OFFICIAL J EUROPEAN, P8; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Arikan F, 2014, J NEUROSURG ANESTH, V26, P328, DOI 10.1097/ANA.0000000000000033; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI 10.1089/ars.2007.1956; BENNETT MH, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004609.PUB3; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Deng J, 2014, PROG NEUROBIOL, V115, P210, DOI 10.1016/j.pneurobio.2014.01.001; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Finnegan D., 2014, REFERENCEINTERVALS R; Ghosh A., 2016, J CEREB BLOOD FLOW M, DOI [10.1177/0271678X16674222, DOI 10.1177/0271678X16674222]; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Helsel, 2012, STAT CENSORED ENV DA; Horn PS, 2001, CLIN CHEM, V47, P2137; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Horn PS, 1998, CLIN CHEM, V44, P622; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; JACOBSON I, 1964, SURG GYNECOL OBSTET, V119, P737; Janicka M, 2013, INT J MOL SCI, V14, P6157, DOI 10.3390/ijms14036157; Jeon SB, 2014, J NEUROL NEUROSUR PS, V85, P1301, DOI 10.1136/jnnp-2013-307314; Jodicke A, 2003, J NEUROSURG, V98, P515, DOI 10.3171/jns.2003.98.3.0515; Johnston AJ, 2003, BRIT J ANAESTH, V90, P774, DOI 10.1093/bja/aeg104; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Liu W, 2009, FREE RADICAL BIO MED, V47, P1101, DOI 10.1016/j.freeradbiomed.2009.07.028; Llitjos JF, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0126-8; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Marshall LF, 1991, J NEUROSURG S, V75, P14; Martinez-Valverde T., 2016, J NEUROTRAUMA; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P7, DOI 10.1089/neu.2014.3473; Massabuau JC, 2001, RESP PHYSIOL, V128, P249, DOI 10.1016/S0034-5687(01)00305-X; Meixensberger J, 2004, NEUROL RES, V26, P414, DOI 10.1179/016164104225014094; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Patet C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0638-5; Poca MA, 2002, J NEUROTRAUM, V19, P439, DOI 10.1089/08977150252932398; Pryor WA, 2000, FREE RADICAL BIO MED, V29, P387, DOI 10.1016/S0891-5849(00)00377-4; Puccio AM, 2009, J NEUROTRAUM, V26, P1241, DOI [10.1089/neu.2008.0624, 10.1089/neu.2008-0624]; Quintard H, 2015, NEUROCRIT CARE, V22, P243, DOI 10.1007/s12028-014-0062-0; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reiber H, 2003, CLIN CHEM LAB MED, V41, P331, DOI 10.1515/CCLM.2003.053; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rosenthal G, 2008, J NEUROSURG, V108, P59, DOI 10.3171/JNS/2008/108/01/0059; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sahuquillo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102540; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Sanchez-Guerrero A, 2017, J CEREBR BLOOD F MET, V37, P2742, DOI 10.1177/0271678X16674222; Spickett CM, 2010, FREE RADICAL RES, V44, P1172, DOI 10.3109/10715762.2010.498476; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Starke RM, 2014, J NEUROL NEUROSUR PS, V85, P1292, DOI 10.1136/jnnp-2014-308326; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Taher A, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.26772; Tatarkova Z, 2011, NEUROCHEM RES, V36, P1475, DOI 10.1007/s11064-011-0473-7; Taylor AW, 2006, ANAL BIOCHEM, V350, P41, DOI 10.1016/j.ab.2005.12.003; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vilalta A, 2011, J NEUROTRAUM, V28, P1139, DOI 10.1089/neu.2010.1720; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Yu GF, 2013, CLIN CHIM ACTA, V421, P7, DOI 10.1016/j.cca.2013.02.030	75	10	11	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2731	2742		10.1089/neu.2017.4992			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700008	28323516				2022-02-06	
J	Xie, F; Min, S; Chen, JY; Yang, J; Wang, X				Xie, Fei; Min, Su; Chen, Jingyuan; Yang, Jun; Wang, Xin			Ulinastatin inhibited sepsis-induced spinal inflammation to alleviate peripheral neuromuscular dysfunction in an experimental rat model of neuromyopathy	JOURNAL OF NEUROCHEMISTRY			English	Article						microglia/macrophage; neuroinflammation; nicotinic acetylcholine receptor; spinal cord; Toll-like receptor 4	NICOTINIC ACETYLCHOLINE-RECEPTOR; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; DENERVATION; MICROGLIA; CELLS	Sepsis initiates a neuroinflammatory cascade that contributes to spinal cord inflammation and behavioral impairment, and Toll-like receptor 4 (TLR4) is an important mediator of this cascade. In this study, we tested the hypothesis that ulinastatin (ULI) inhibits sepsis-induced spinal inflammation to alleviate peripheral neuromuscular dysfunction through the TLR4/myeloid differentiation factor 88 (MyD88)NF-kappa B signaling pathway. Muscular function, spinal cord water content, and cytokine levels of spinal cord were tested in TLR4-inhibited rats subjected to cecal ligation and puncture (CLP). The normal rats were intrathecally injected with different concentrations of ULI or normal saline 60 min before CLP. At 24 h after CLP, the activation of microglia/macrophage was detected by immunofluorescence staining; and the cytokines were assayed by ELISA. The protein expression level of the TLR4 and its downstream effectors (MyD88 and NF-kappa B), the neuregulin-1, and the gamma- and alpha 7-nicotinic acetylcholine receptor was measured using western blotting. The protein expression of TLR4 in the spinal cord reached a maximum at 24 h post-CLP. Compared to the sham rats, the TLR4-inhibited rats showed attenuated functional impairment and cytokine release. ULI (5000 U/kg) treatment pre-CLP significantly reduced the number of TLR4-positive microglia/macrophages as well as inflammatory mediator release in septic rats. Furthermore, the levels of TLR4, MyD88, and NF-kappa B and the expression level of gamma-/alpha 7-nicotinic acetylcholine receptors also decreased after ULI treatment. ULI administration may improve patient outcome by reducing the spinal inflammation through a mechanism involving the TLR4/MyD88/NF-kappa B signaling in sepsis.	[Xie, Fei; Min, Su; Chen, Jingyuan; Yang, Jun; Wang, Xin] Chongqing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Friendship Rd 1, Chongqing 400016, Peoples R China		Min, S (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Friendship Rd 1, Chongqing 400016, Peoples R China.	ms89011068@163.com		Xie, Fei/0000-0002-0050-8993; SU, MlN/0000-0002-8906-681X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471282]; TIANPU [UF201302]; Foundation of Postgraduate Innovation Project of Chongqing province, China [CYB16102]	This work was supported by the National Natural Science Foundation of China (No. 81471282), the TIANPU research program (UF201302) and the Foundation of Postgraduate Innovation Project of Chongqing province, China (CYB16102). The authors declare that they have no competing interests.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Baskar J. S. J., 2014, PLOS ONE, V9; Dubovy P, 2011, ANN ANAT, V193, P267, DOI 10.1016/j.aanat.2011.02.011; Ebert S, 2005, J NEUROIMMUNOL, V159, P87, DOI 10.1016/j.jneuroim.2004.10.005; Feng M, 2014, NEUROCHEM INT, V64, P64, DOI 10.1016/j.neuint.2013.11.007; Gao CJ, 2012, J TRAUMA ACUTE CARE, V72, P169, DOI 10.1097/TA.0b013e318223c20f; Graber DJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-8; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Jia HB, 2016, EXP THER MED, V12, P2644, DOI 10.3892/etm.2016.3643; Kano O, 2012, NEUROLOGY, V78, P833, DOI 10.1212/WNL.0b013e318249f776; Kim HG, 2013, J NEUROCHEM, V124, P502, DOI 10.1111/jnc.12109; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Li XF, 2017, NEUROL RES, V39, P367, DOI 10.1080/01616412.2017.1286541; Liu L, 2014, BRIT J ANAESTH, V112, P159, DOI 10.1093/bja/aet253; Liu L, 2016, J SURG RES, V200, P523, DOI 10.1016/j.jss.2015.09.012; Loram LC, 2010, BRAIN BEHAV IMMUN, V24, P959, DOI 10.1016/j.bbi.2010.03.008; Ma JJ, 2007, J ORTHOP RES, V25, P1498, DOI 10.1002/jor.20414; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; O'Keefe GM, 1999, EUR J IMMUNOL, V29, P1275, DOI 10.1002/(SICI)1521-4141(199904)29:04<1275::AID-IMMU1275>3.0.CO;2-T; Park JH, 2010, KOREAN J ANESTHESIOL, V58, P334, DOI 10.4097/kjae.2010.58.4.334; Perry VH, 2003, NAT REV NEUROSCI, V4, P103, DOI 10.1038/nrn1032; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Ritzel RM, 2015, NEUROBIOL AGING, V36, P2153, DOI 10.1016/j.neurobiolaging.2015.02.016; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Vallieres N, 2006, GLIA, V53, P103, DOI 10.1002/glia.20266; Van Den Bergh PYK, 2004, MUSCLE NERVE, V29, P565, DOI 10.1002/mus.20022; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Wang XY, 2009, J IMMUNOL, V183, P7471, DOI 10.4049/jimmunol.0900762; Wu WP, 2004, J NEUROSCI METH, V133, P65, DOI 10.1016/j.jneumeth.2003.09.015; Xie F, 2016, ARCH GERONTOL GERIAT, V65, P1, DOI 10.1016/j.archger.2016.02.005; Yano T, 2003, ANESTHESIOLOGY, V98, P465, DOI 10.1097/00000542-200302000-00028; Zanotti-Cavazzoni SL, 2009, CRIT CARE CLIN, V25, P703, DOI 10.1016/j.ccc.2009.08.005	35	10	13	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	OCT	2017	143	2					225	235		10.1111/jnc.14145			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FJ1KX	WOS:000412476500007	28796387	Bronze			2022-02-06	
J	Kunkel, D; Kaizar, EE				Kunkel, Deborah; Kaizar, Eloise E.			A comparison of existing methods for multiple imputation in individual participant data meta-analysis	STATISTICS IN MEDICINE			English	Article						chained equations; fully conditional specification; joint model; systematic missingness		Multiple imputation is a popular method for addressing missing data, but its implementation is difficult when data have a multilevel structure and one or more variables are systematically missing. This systematic missing data pattern may commonly occur in meta-analysis of individual participant data, where some variables are never observed in some studies, but are present in other hierarchical data settings. In these cases, valid imputation must account for both relationships between variables and correlation within studies. Proposed methods for multilevel imputation include specifying a full joint model and multiple imputation with chained equations (MICE). While MICE is attractive for its ease of implementation, there is little existing work describing conditions under which this is a valid alternative to specifying the full joint model. We present results showing that for multilevel normal models, MICE is rarely exactly equivalent to joint model imputation. Through a simulation study and an example using data from a traumatic brain injury study, we found that in spite of theoretical differences, MICE imputations often produce results similar to those obtained using the joint model. We also assess the influence of prior distributions in MICE imputation methods and find that when missingness is high, prior choices in MICE models tend to affect estimation of across-study variability more than compatibility of conditional likelihoods. Copyright (c) 2017 John Wiley & Sons, Ltd.	[Kunkel, Deborah; Kaizar, Eloise E.] Ohio State Univ, Dept Stat, 1958 Neil Ave,Cockins Hall,Room 404, Columbus, OH 43210 USA		Kaizar, EE (corresponding author), Ohio State Univ, Dept Stat, 1958 Neil Ave,Cockins Hall,Room 404, Columbus, OH 43210 USA.	kaizar.1@osu.edu			Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD080033]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD080033] Funding Source: NIH RePORTER	The authors thank Drs. Terry Stancin, H. Gerry Taylor, Shari Wade, and Keith Yeates for providing data and assistance related to the example. This work was supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development under award number R03HD080033. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achenbach T.M., 2001, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Andridge RR, 2011, BIOMETRICAL J, V53, P57, DOI 10.1002/bimj.201000140; [Anonymous], 2009, STAT MED, V28, P1218, DOI 10.1002/sim.3540; Arnold BC, 2001, STAT SCI, V16, P249; ARNOLD BC, 1989, J AM STAT ASSOC, V84, P152, DOI 10.2307/2289858; Bartlett JW, 2015, STAT METHODS MED RES, V24, P462, DOI 10.1177/0962280214521348; Carpenter J, 2013, MULTIPLE IMUPTATION; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; DEMIDENKO E, 2004, MIXED MODELS; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Enders CK, 2016, PSYCHOL METHODS, V21, P222, DOI 10.1037/met0000063; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Hughes RA, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-28; Jolani S, 2015, STAT MED, V34, P1841, DOI 10.1002/sim.6451; Joshi S, 2017, 2017 INTERNATIONAL CONFERENCE ON CURRENT TRENDS IN COMPUTER, ELECTRICAL, ELECTRONICS AND COMMUNICATION (CTCEEC), P1, DOI 10.1109/CTCEEC.2017.8455156; Kline D, 2016, THESIS; Kline D, 2017, RES SYNTH METHODS, V8, P136, DOI 10.1002/jrsm.1192; Liu J, 2013, BIOMETRIKA, V101, P1; Resche-Rigon M, 2013, STAT MED, V32, P4890, DOI 10.1002/sim.5894; Rubin D., 2002, STAT ANAL MISSING DA, VSecond; SCHAFER J, 1997, IMPUTATION MISSING C; Schafer JL, 2002, J COMPUT GRAPH STAT, V11, P437, DOI 10.1198/106186002760180608; Siddique J, 2015, STAT MED, V34, P3399, DOI 10.1002/sim.6562; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; vansBuuren S., 2011, J STAT SOFTW, V45, P1, DOI DOI 10.18637/JSS.V045.I03; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yucel RM, 2008, PHILOS T R SOC A, V366, P2389, DOI 10.1098/rsta.2008.0038; Zhao J.H., 2016, PAN MULTIPLE IMPUTAT	30	10	10	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-6715	1097-0258		STAT MED	Stat. Med.	SEP 30	2017	36	22					3507	3532		10.1002/sim.7388			26	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Medicine, Research & Experimental; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Research & Experimental Medicine; Mathematics	FF5CO	WOS:000408991500005	28695667	Green Accepted			2022-02-06	
J	Zhou, J; Liu, T; Cui, HJ; Fan, R; Zhang, CH; Peng, WJ; Yang, A; Zhu, L; Wang, Y; Tang, T				Zhou, Jing; Liu, Tao; Cui, Hanjin; Fan, Rong; Zhang, Chunhu; Peng, Weijun; Yang, Ali; Zhu, Lin; Wang, Yang; Tang, Tao			Xuefu zhuyu decoction improves cognitive impairment in experimental traumatic brain injury via synaptic regulation	ONCOTARGET			English	Article						xuefu zhuyu decoction; traditional Chinese medicine; traumatic brain injury; cognitive impairment; synaptic regulation	TRADITIONAL CHINESE MEDICINE; D-ASPARTATE RECEPTORS; RAT MODEL; HYDROXYSAFFLOR YELLOW; GAP-43 EXPRESSION; MICE; LTP; PROGESTERONE; PLASTICITY; MEMORY	An overarching consequence of traumatic brain injury (TBI) is the cognitive impairment. It may hinder individual performance of daily tasks and determine people's subjective well-being. The damage to synaptic plasticity, one of the key mechanisms of cognitive dysfunction, becomes the potential therapeutic strategy of TBI. In this study, we aimed to investigate whether Xuefu Zhuyu Decoction (XFZYD), a traditional Chinese medicine, provided a synaptic regulation to improve cognitive disorder following TBI. Morris water maze and modified neurological severity scores were performed to assess the neurological and cognitive abilities. The PubChem Compound IDs of the major compounds of XFZYD were submitted into BATMAN-TCM, an online bioinformatics analysis tool, to predict the druggable targets related to synaptic function. Furthermore, we validated the prediction through immunohistochemical, RT-PCR and western blot analyses. We found that XFZYD enhanced neuroprotection, simultaneously improved learning and memory performances in controlled cortical impact rats. Bioinformatics analysis revealed that the improvements of XFZYD implied the Long-term potentiation relative proteins including NMDAR1, CaMKII and GAP-43. The further confirmation of molecular biological studies confirmed that XFZYD upregulated the mRNA and protein levels of NMDAR1, CaMKII and GAP-43. Pharmacological synaptic regulation of XFZYD could provide a novel therapeutic strategy for cognitive impairment following TBI.	[Zhou, Jing; Liu, Tao; Cui, Hanjin; Fan, Rong; Zhang, Chunhu; Zhu, Lin; Wang, Yang; Tang, Tao] Cent S Univ, Inst Integrated Tradit Chinese & Western Med, Xiangya Hosp, Lab Ethnopharmacol, Changsha 410008, Hunan, Peoples R China; [Liu, Tao] Xinjiang Med Univ, Dept Gerontol, Tradit Chinese Med Hosp, Urumqi 830000, Peoples R China; [Peng, Weijun] Cent S Univ, Xiangya Hosp 2, Dept Tradit Chinese Med, Changsha 410011, Hunan, Peoples R China; [Yang, Ali] Henan Prov People Hosp, Dept Neurol, Zhengzhou 450003, Henan, Peoples R China		Wang, Y; Tang, T (corresponding author), Cent S Univ, Inst Integrated Tradit Chinese & Western Med, Xiangya Hosp, Lab Ethnopharmacol, Changsha 410008, Hunan, Peoples R China.	wangyang_xy87@csu.edu.cn; falcontang@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673719, 81303074, 81603670, 81403259]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2016M600639, 2017T100614]	This work was supported by the National Natural Science Foundation of China (Nos. 81673719, 81303074, 81603670 and 81403259), Project funded by China Postdoctoral Science Foundation (Nos. 2016M600639 and 2017T100614).	Adefegha S.A., 2016, J EVID-BASED COMPLEM, V21, P56; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bouet V, 2011, MECH AGEING DEV, V132, P240, DOI 10.1016/j.mad.2011.04.006; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Buta A, 2015, J MED CHEM, V58, P4449, DOI 10.1021/jm5017329; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen X, 2006, BRIT J PHARMACOL, V149, P1092, DOI 10.1038/sj.bjp.0706945; Chu FY, 2010, CHIN J INTEGR MED, V16, P399, DOI 10.1007/s11655-010-9999-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Foster TC, 2012, PROG NEUROBIOL, V96, P283, DOI 10.1016/j.pneurobio.2012.01.007; Fu CY, 2016, J SEP SCI, V39, P3457, DOI 10.1002/jssc.201600083; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; He Songming, 2015, Shanghai Arch Psychiatry, V27, P289, DOI 10.11919/j.issn.1002-0829.215109; Huang Q, 2007, BIOORG MED CHEM LETT, V17, P1779, DOI 10.1016/j.bmcl.2006.12.078; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Kang H, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-28; Khalin I, 2016, DRUG DELIV, V23, P3520, DOI 10.1080/10717544.2016.1199609; Liu F, 2014, MOL MED REP, V9, P1225, DOI 10.3892/mmr.2014.1967; Liu ZL, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.593; Liu ZX, 2016, SCI REP-UK, V6, DOI 10.1038/srep39808; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; Lv YN, 2015, EUR J PHARMACOL, V769, P324, DOI 10.1016/j.ejphar.2015.11.036; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Mirzaie B, 2013, ARCH MED SCI, V9, P68, DOI 10.5114/aoms.2012.30833; Nguyen L, 2009, MOL CELL NEUROSCI, V41, P62, DOI 10.1016/j.mcn.2009.01.011; Ogier M, 2017, J NEUROTRAUM, V34, P1645, DOI 10.1089/neu.2016.4741; Park J, 2016, NEURON, V92, P75, DOI 10.1016/j.neuron.2016.09.002; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sarkaki A, 2015, CAN J PHYSIOL PHARM, V93, P687, DOI 10.1139/cjpp-2014-0546; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Su KY, 2007, J NEUROSCI, V27, P2513, DOI 10.1523/JNEUROSCI.4497-06.2007; Sucher NJ, 2013, EXPERT OPIN DRUG DIS, V8, P21, DOI 10.1517/17460441.2013.739602; Tanner DC, 2008, HIPPOCAMPUS, V18, P814, DOI 10.1002/hipo.20442; Tao XG, 2017, CHINESE MED J-PEKING, V130, P187, DOI 10.4103/0366-6999.198001; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Viberg H, 2008, NEUROTOXICOLOGY, V29, P152, DOI 10.1016/j.neuro.2007.10.007; Wang GQ, 2017, PLANT CELL PHYSL, P29; Wang GH, 2015, MED SCI MONITOR, V21, P2613, DOI 10.12659/MSM.895075; Wang H, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0095-0; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wang X R, 1994, Zhongguo Zhong Xi Yi Jie He Za Zhi, V14, P349; Wang XR, 1994, ZHONGGUO ZHONG XI YI, V14, P325; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Wu N, 2017, CLIN EXP HYPERTENS, V23, P1; Xing MY, 2016, BRAIN RES, V1642, P419, DOI 10.1016/j.brainres.2016.04.030; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yang JM, 2014, CELL REP, V7, P796, DOI 10.1016/j.celrep.2014.03.040; Zhang H., 2014, MATH PROBL ENG, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0088909; Zhang JF, 2013, METAB BRAIN DIS, V28, P697, DOI 10.1007/s11011-013-9424-0; Zhao CC, 2017, J NEUROTRAUM, V34, P1636, DOI 10.1089/neu.2016.4759	66	10	11	0	33	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	SEP 22	2017	8	42					72069	72081		10.18632/oncotarget.18895			13	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Cell Biology	FH9DW	WOS:000411509400057	29069769	Green Published, gold			2022-02-06	
J	Levine, JM; Cohen, ND; Fandel, TM; Levine, GJ; Mankin, J; Griffin, JF; Kerwin, SC; Boudreau, CE; Trivedi, A; Noble-Haeusslein, LJ				Levine, Jonathan M.; Cohen, Noah D.; Fandel, Thomas M.; Levine, Gwendolyn J.; Mankin, Joseph; Griffin, John F.; Kerwin, Sharon C.; Boudreau, C. Elizabeth; Trivedi, Alpa; Noble-Haeusslein, Linda J.			Early Blockade of Matrix Metalloproteinases in Spinal-Cord-Injured Dogs Results in a Long-Term Increase in Bladder Compliance	JOURNAL OF NEUROTRAUMA			English	Article						canine; cystometry; neurotrauma; recovery; urologic	URINARY-TRACT DYSFUNCTION; CEREBROSPINAL-FLUID; CLINICAL-TRIALS; DISK HERNIATION; CANINE MODELS; SMOOTH-MUSCLE; MANAGEMENT; RECOVERY; EXTRUSIONS; DISEASE	Spinal cord injury (SCI) is often accompanied by reduced bladder compliance, which contributes to adverse conditions including urinary tract infections and vesicoureteral reflux. Reduced compliance is, in part, attributed to extensive remodeling of the bladder wall, including the extracellular matrix (ECM). Here, we tested the hypothesis that blockade of matrix metalloproteinases (MMPs), known for their ability to remodel the ECM, improves bladder compliance in dogs with SCI. We first evaluated dogs with naturally occurring SCIs resulting from intervertebral disc herniation (IVDH). After characterizing the natural history of urological recovery by cystometry in healthy dogs (n = 10) and dogs with SCIs (n = 20), we conducted a randomized, double-blinded, placebo-controlled clinical trial in dogs with IVDH-associated SCIs to assess the efficacy of the broad-spectrum MMP inhibitor, GM6001, given within 48 h post-injury. The primary outcomes were bladder compliance, as measured by cystometry, and an ordinal gait score (Texas Spinal Cord Injury Score; TSCIS) at day 42 post-SCI. Dogs (n = 93) were randomized to receive either dimethyl sulfoxide (DMSO) or GM6001+DMSO. There were transient, but significantly (p = 0.023) greater, adverse events (31 of 42; 74%) in the GM6001-treated group relative to vehicle controls (22 of 46; 48%). Whereas there were no differences in TSCIS between treatment groups at day 42 (p = 0.9679), bladder compliance was significantly higher in dogs treated with GM6001+DMSO compared to controls (p = 0.0272). Further studies are needed to determine whether this inhibition results from a direct interaction with the bladder wall or indirectly through neural-based mechanisms.	[Levine, Jonathan M.; Mankin, Joseph; Kerwin, Sharon C.; Boudreau, C. Elizabeth] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA; [Cohen, Noah D.; Griffin, John F.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA; [Levine, Gwendolyn J.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Trivedi, Alpa; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA		Levine, JM (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA.	jlevine@cvm.tamu.edu					Aikawa T, 2012, JAVMA-J AM VET MED A, V241, P1617, DOI 10.2460/javma.241.12.1617; Aitken KJ, 2006, AM J PATHOL, V169, P459, DOI 10.2353/ajpath.2006.050969; [Anonymous], 2016, VET COMP ONCOL, V14, P417, DOI 10.1111/vco.283; Atalan G, 1999, RES VET SCI, V67, P295, DOI 10.1053/rvsc.1999.0336; Atalan G, 2002, BERL MUNCH TIERARZTL, V115, P303; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bellucci CHS, 2013, J UROLOGY, V189, P1369, DOI 10.1016/j.juro.2012.10.013; Bu SY, 2014, ARCH BIOCHEM BIOPHYS, V564, P197, DOI 10.1016/j.abb.2014.09.012; BUTLER M R, 1978, Urology, V11, P308, DOI 10.1016/0090-4295(78)90145-0; Davis GJ, 2002, VET SURG, V31, P513, DOI 10.1053/jvet.2002.36015; Deveaud CM, 1998, J UROLOGY, V160, P1518, DOI 10.1016/S0022-5347(01)62606-5; Gomez-Amaya SM, 2015, NAT REV UROL, V12, P100, DOI 10.1038/nrurol.2015.4; Granger N, 2012, BRAIN, V135, P3227, DOI 10.1093/brain/aws268; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P6, DOI 10.3171/2012.4.AOSPINE1294; Hoffman AM, 2016, STEM CELLS, V34, P1709, DOI 10.1002/stem.2377; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Hu HZ, 2016, J VET INTERN MED, V30, P1575, DOI 10.1111/jvim.14557; Hutchinson JW, 1998, J BONE JOINT SURG BR, V80B, P907, DOI 10.1302/0301-620X.80B5.8464; Jeffery ND, 2013, J VET INTERN MED, V27, P1318, DOI 10.1111/jvim.12183; Jeffery ND, 2016, JAVMA-J AM VET MED A, V248, P386, DOI 10.2460/javma.248.4.386; Krzeski P, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2315; Lammertse D, 2007, SPINAL CORD, V45, P232, DOI 10.1038/sj.sc.3102010; LeBlanc AK, 2016, NEURO-ONCOLOGY, V18, P1209, DOI 10.1093/neuonc/now051; Levine GJ, 2014, VET CLIN PATH, V43, P437, DOI 10.1111/vcp.12165; Levine GJ, 2009, PREV VET MED, V89, P121, DOI 10.1016/j.prevetmed.2009.02.016; Levine JM, 2009, J VET INTERN MED, V23, P1220, DOI 10.1111/j.1939-1676.2009.0393.x; Levine JM, 2006, AM J VET RES, V67, P283, DOI 10.2460/ajvr.67.2.283; Levine JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096408; Levine JM, 2011, J NEUROTRAUM, V28, P675, DOI 10.1089/neu.2010.1645; Lim JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116139; McMahill BG, 2015, STEM CELL REV REP, V11, P180, DOI 10.1007/s12015-014-9553-9; MIMATA H, 1993, UROL INT, V51, P89, DOI 10.1159/000282520; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Nichols TC, 2016, J THROMB HAEMOST, V14, P894, DOI 10.1111/jth.13301; Noble LJ, 2002, J NEUROSCI, V22, P7526; Olby N, 2004, J NEUROTRAUM, V21, P49, DOI 10.1089/089771504772695940; Olby N, 2003, J AM VET MED ASSOC, V222, P762, DOI 10.2460/javma.2003.222.762; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pavese C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002041; Rawlings CA, 2001, AM J VET RES, V62, P167, DOI 10.2460/ajvr.2001.62.167; Renkiewicz R, 2003, ARTHRITIS RHEUM, V48, P1742, DOI 10.1002/art.11030; Ruddle TL, 2006, VET COMP ORTHOPAED, V19, P29; Samson Gregory, 2007, Phys Med Rehabil Clin N Am, V18, P255; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Shearin AL, 2010, DIS MODEL MECH, V3, P27, DOI 10.1242/dmm.004358; Simpson LA, 2012, J NEUROTRAUM, V29, P1548, DOI 10.1089/neu.2011.2226; Spitzbarth I, 2011, J NEUROPATH EXP NEUR, V70, P703, DOI 10.1097/NEN.0b013e3182270f8e; Tai CF, 2006, RESTOR NEUROL NEUROS, V24, P69; Taylor AR, 2014, J NEUROTRAUM, V31, P1561, DOI 10.1089/neu.2014.3405; Trivedi A., 2005, INT J NEUROPROTECT N, V2, P30; Trivedi A, 2016, EXP NEUROL, V284, P50, DOI 10.1016/j.expneurol.2016.07.018; Weld KJ, 2000, J UROLOGY, V163, P1228, DOI 10.1016/S0022-5347(05)67730-0; Wyndaele JJ, 2011, NEUROUROL URODYNAM, V30, P714, DOI 10.1002/nau.21129; Wyndaele JJ, 2016, NAT REV UROL, V13, P705, DOI 10.1038/nrurol.2016.206	54	10	10	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2017	34	18					2656	2667		10.1089/neu.2017.5001			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FG5SC	WOS:000410395200007	28520505				2022-02-06	
J	Miles, SR; Harik, JM; Hundt, NE; Mignogna, J; Pastorek, NJ; Thompson, KE; Freshour, JS; Yu, HJ; Cully, JA				Miles, Shannon R.; Harik, Juliette M.; Hundt, Natalie E.; Mignogna, Joseph; Pastorek, Nicholas J.; Thompson, Karin E.; Freshour, Jessica S.; Yu, Hong J.; Cully, Jeffrey A.			Delivery of mental health treatment to combat veterans with psychiatric diagnoses and TBI histories	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE PROCESSING THERAPY; POSTCONCUSSIVE SYMPTOMS; ENDURING FREEDOM; IRAQI FREEDOM; PTSD; AFGHANISTAN; ASSOCIATION; SOLDIERS	Traumatic brain injury (TBI) and mental health (MH) disorders are prevalent in combat veterans returning from Afghanistan and/or Iraq (hereafter referred to as returning veterans). Accurate estimates of service utilization for veterans with and without TBI exposure (referred to as TBI history) are imperative in order to provide high quality healthcare to returning veterans. We examined associations between TBI history and MH service utilization in a subsample of returning veterans who were newly diagnosed with posttraumatic stress disorder (PTSD), depression, and/or anxiety in the 2010 fiscal year (N = 55,458). Data were extracted from the Veterans Health Administration (VHA) National Patient Care Database. Veterans with MH diagnoses and TBI histories attended significantly more psychotherapy visits, (M = 8.32 visits, SD = 17.15) and were more likely to attend at least 8 psychotherapy visits, (15.7%) than veterans with MH diagnoses but no TBI history (M = 6.48 visits, SD = 12.12; 10.1% attended at least 8 sessions). PTSD and TBI history, but not depression or anxiety, were associated with a greater number of psychotherapy visits when controlling for demographic and clinical variables. PTSD, anxiety, depression, and TBI history were associated with number of psychotropic medication-management visits. TBI history was related to greater MH service utilization, independent of MH diagnoses. Future research should examine what MH services are being utilized and if these services are helping veterans recover from their disorders.	[Miles, Shannon R.] James A Haley Vet Hosp, Hlth Serv Res & Dev Ctr Innovat Disabil & Rehabil, Tampa, FL 33612 USA; [Miles, Shannon R.] Univ S Florida, Morsani Coll Med, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Harik, Juliette M.] VA Med Ctr, Natl Ctr PTSD, Execut Div, 116D, White River Jct, VT USA; [Harik, Juliette M.] Geisel Sch Med Dartmouth, Hanover, NH USA; [Hundt, Natalie E.; Thompson, Karin E.; Freshour, Jessica S.; Yu, Hong J.; Cully, Jeffrey A.] Michael E DeBakey VA Med Ctr MEDVAMC 152, VA South Cent Mental Illness Res Educ & Clin Ctr, Houston, TX USA; [Hundt, Natalie E.; Thompson, Karin E.; Freshour, Jessica S.; Cully, Jeffrey A.] Baylor Coll Med, One Baylor Plaza, Houston, TX 77030 USA; [Hundt, Natalie E.; Cully, Jeffrey A.] MEDVAMC 152, VA HSR&D, Houston Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA; [Mignogna, Joseph] Ctr Excellence Res Returning War Vet, Waco, TX USA; [Mignogna, Joseph] TX Texas A&M Hlth Sci Ctr, Cent Texas Vet Healthcare Syst, Temple, TX USA; [Mignogna, Joseph] Texas A&M Hlth Sci Ctr, Temple, TX USA; [Pastorek, Nicholas J.] MEDVAMC, Rehabil & Extended Care Line, Houston, TX USA		Miles, SR (corresponding author), James A Haley Vet Hosp, Hlth Serv Res & Dev Ctr Innovat Disabil & Rehabil, Tampa, FL 33612 USA.; Miles, SR (corresponding author), Univ S Florida, Morsani Coll Med, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA.	shannon.miles@va.gov	Miles, Shannon/AAS-2173-2021	Miles, Shannon/0000-0001-8925-1321; Pastorek, Nicholas/0000-0002-9290-380X	Office of Academic Affiliations VA Advanced Fellowship Program in Mental Illness Research and Treatment; Department of Veterans Affairs South Central Mental Illness Research Education and Clinical Center (MIRECC); Houston VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety [CIN 13-413]	This research was supported by the Office of Academic Affiliations VA Advanced Fellowship Program in Mental Illness Research and Treatment, the Department of Veterans Affairs South Central Mental Illness Research Education and Clinical Center (MIRECC), and partly supported by resources and facilities of the Houston VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety (CIN 13-413). The views expressed reflect those of the authors and not necessarily those of the Department of Veterans Affairs/Baylor College of Medicine.	Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Bay E, 2009, CURR TREAT OPTION NE, V11, P377, DOI 10.1007/s11940-009-0042-4; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brooks E, 2012, PSYCHIAT SERV, V63, P862, DOI 10.1176/appi.ps.201100444; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll LJ, 2004, J REHABIL MED, V36, P11, DOI 10.1080/16501960410023660; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Deb S, 1999, AM J PSYCHIAT, V156, P374; Defense Medical Surveillance System, 2014, DOD NUMB TRAUM BRAIN; Department of Veterans' Affairs, 2016, NOT VET SERV MEMB EV; Epstein RS, 1994, NEUROPSYCHIATRY TRAU, P3; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Galovski TE, 2012, J CONSULT CLIN PSYCH, V80, P968, DOI 10.1037/a0030600; Griffen J, 2014, HDB NEUROPSYCHOLOGY; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOWARD KI, 1986, AM PSYCHOL, V41, P159, DOI 10.1037/0003-066X.41.2.159; Hundt Natalie E, 2015, Psychol Trauma, V7, P539, DOI 10.1037/tra0000035; Kehle SM, 2011, J PSYCHIATR RES, V45, P126, DOI 10.1016/j.jpsychires.2010.05.013; Kelley AM, 2012, J PSYCHIATR RES, V46, P582, DOI 10.1016/j.jpsychires.2012.01.017; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Maguen S, 2013, J NEUROTRAUM, V30, P1123, DOI 10.1089/neu.2012.2744; McNally RJ, 2013, J ANXIETY DISORD, V27, P520, DOI 10.1016/j.janxdis.2013.07.002; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Olfson M, 2010, AM J PSYCHIAT, V167, P1456, DOI 10.1176/appi.ajp.2010.10040570; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rockefeller College, 2004, PAD 705 HANDOUT STAN; Rosenheck RA, 2007, HEALTH AFFAIR, V26, P1720, DOI 10.1377/hlthaff.26.6.1720; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Spoont MR, 2010, PSYCHIAT SERV, V61, P58, DOI 10.1176/appi.ps.61.1.58; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Veterans Affairs Information Resource Center (VIReC), 2012, DATA QUALITY; Veterans Affairs Information Resource Center (VIReC). VA Information Resource Center (VIReC), 2014, MED SAS DAT DOC; Veterans Health Administration, 2013, AN VA HLTH CAR UT OP; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730	50	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184265	10.1371/journal.pone.0184265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	WOS:000410001100089	28886114	Green Published, gold, Green Submitted			2022-02-06	
J	Agoston, DV				Agoston, Denes V.			Modeling the Long-Term Consequences of Repeated Blast-Induced Mild Traumatic Brain Injuries	JOURNAL OF NEUROTRAUMA			English	Article						animal modeling; chronic neurodegenerative disorders; explosive blast; mild traumatic brain injury; pathomechanism; physics	PERSISTENT POSTCONCUSSIVE SYMPTOMS; U.S. MILITARY PERSONNEL; TIME-DEPENDENT CHANGES; SERUM BIOMARKER LEVELS; CLOSED-HEAD INJURY; INDUCED NEUROTRAUMA; EXPLOSIVE BLAST; MOUSE MODEL; RAT MODEL; ENCEPHALOPATHY PATHOLOGY	Repeated mild traumatic brain injury (rmTBI) caused by playing collision sports or by exposure to blasts during military operations can lead to late onset, chronic diseases such as chronic traumatic encephalopathy (CTE), a progressive neurodegenerative condition that manifests in increasingly severe neuropsychiatric abnormalities years after the last injury. Currently, because of the heterogeneity of the clinical presentation, confirmation of a CTE diagnosis requires post-mortem examination of the brain. The hallmarks of CTE are abnormal accumulation of phosphorylated tau protein, TDP-43 immunoreactive neuronal cytoplasmic inclusions, and astroglial abnormalities, but the pathomechanism leading to these terminal findings remains unknown. Animal modeling can play an important role in the identification of CTE pathomechanisms, the development of early stage diagnostic and prognostic biomarkers, and pharmacological interventions. Modeling the long-term consequences of blast rmTBI in animals is especially challenging because of the complexities of blast physics and animal-to-human scaling issues. This review summarizes current knowledge about the pathobiologies of CTE and rmbTBI and discusses problems as well as potential solutions related to high-fidelity modeling of rmbTBI and determining its long-term consequences.	[Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Agoston, Denes V.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden		Agoston, DV (corresponding author), Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	denes.agoston@usuhs.edu					Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Agoston DV, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00092; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; [Anonymous], 2013, DOD WORLDWIDE NUMBER; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Dekker SE, 2014, SURGERY, V156, P556, DOI 10.1016/j.surg.2014.04.016; DeWalt GJ, 2017, J COMP NEUROL, V525, P2955, DOI 10.1002/cne.24252; DOUGHERTY PJ, 1990, MIL MED, V155, P417; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Garcia-Bueno B, 2008, NEUROSCI BIOBEHAV R, V32, P1136, DOI 10.1016/j.neubiorev.2008.04.001; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Gilmore CS, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.454; Goldstein L.E., 2012, SCI TRANSL MED, V4; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Gregory E, 2017, CONTEMP CLIN TRIALS, V52, P95, DOI 10.1016/j.cct.2016.11.005; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kamnaksh A., 2014, TRANSL PROTEOM, V3, P22, DOI [10.1016/j.trprot.2013.11.001, DOI 10.1016/J.TRPROT.2013.11.001]; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovacs GG, 2017, J NEUROPATH EXP NEUR, V76, P270, DOI 10.1093/jnen/nlx007; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Ling G, 2015, Handb Clin Neurol, V127, P173, DOI 10.1016/B978-0-444-52892-6.00011-8; Ling G, 2007, J TRAUMA, V62, pS102, DOI 10.1097/TA.0b013e318065b442; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Makinde HM, 2017, SHOCK, V48, P276, DOI 10.1097/SHK.0000000000000859; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Masel BE, 2012, J NEUROTRAUM, V29, P2143, DOI 10.1089/neu.2011.2258; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Povlishock JT, 2013, J NEUROTRAUM, V30, P1, DOI 10.1089/neu.2013.9942; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Ramasamy A, 2009, J R Army Med Corps, V155, P258; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Ritzel D., 2011, P HFM207 NATO S SURV; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Rozenfeld M, 2016, ANN SURG, V263, P1228, DOI 10.1097/SLA.0000000000001338; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; SHETTY AK, 2014, FRONT CELL NEUROSCI, V0008; Shively S. B., 2016, LANCET NEUROL, V15; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Singleton JAG, 2013, J TRAUMA ACUTE CARE, V75, pS269, DOI 10.1097/TA.0b013e318299d93e; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Tang SY, 2017, J NEUROTRAUM, V34, P1972, DOI 10.1089/neu.2016.4650; Tchantchou F, 2017, EXP NEUROL, V289, P9, DOI 10.1016/j.expneurol.2016.12.001; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00223; Valiyaveettil M, 2013, NEUROSCI LETT, V539, P1, DOI 10.1016/j.neulet.2013.01.028; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; Walcott BP, 2011, NEW ENGL J MED, V365, P860, DOI 10.1056/NEJMc1107891; Wang Y, 2014, J NEUROTRAUM, V31, P498, DOI [10.1089/NEU.2013.3074, 10.1089/neu.2013.3074]; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Yarnell AM, 2013, CURR PROTOC NEUROSCI, V9, P9, DOI DOI 10.1002/0471142301.NS0941S62; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P706, DOI 10.1038/jcbfm.2014.247; Zhao H, 2009, J CEREBR BLOOD F MET, V29, P873, DOI 10.1038/jcbfm.2009.13; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518	143	10	10	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34			1			S44	S52		10.1089/neu.2017.5317			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FI2DA	WOS:000411746000006	28937952	Green Published, Bronze			2022-02-06	
J	Beirne, K; Rozanowska, M; Votruba, M				Beirne, Kathy; Rozanowska, Malgorzata; Votruba, Marcela			Photostimulation of mitochondria as a treatment for retinal neurodegeneration	MITOCHONDRION			English	Article						Red light; Near infrared light; Retina; Neurodegeneration; Photostimulation; Low-level light therapy; Photobiomodulation	NEAR-INFRARED LIGHT; LEVEL LASER THERAPY; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; DOPAMINERGIC CELL-SURVIVAL; LIPID-PEROXIDATION; REACTIVE OXYGEN; MOUSE MODEL; VISIBLE RADIATION; INDUCED DAMAGE	Absorption of photon energy by neuronal mitochondria leads to numerous downstream neuroprotective effects. Red and near infrared (NIR) light are associated with significantly less safety concerns than light of shorter wavelengths and they are therefore, the optimal choice for irradiating the retina. Potent neuroprotective effects have been demonstrated in various models of retinal damage, by red/NIR light, with limited data from human studies showing its ability to improve visual function. Improved neuronal mitochondrial function, increased blood flow to neural tissue, upregulation of cell survival mediators and restoration of normal microglial function have all been proposed as potential underlying mechanisms of red/NIR light.	[Beirne, Kathy; Rozanowska, Malgorzata; Votruba, Marcela] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales; [Beirne, Kathy; Rozanowska, Malgorzata; Votruba, Marcela] Cardiff Univ, Cardiff Inst Tissue Engn & Repair, Cardiff, S Glam, Wales; [Votruba, Marcela] Univ Wales Hosp, Cardiff Eye Unit, Cardiff, S Glam, Wales		Votruba, M (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales.	BeirneK@cardiff.ac.uk; RozanowskaMB@cardiff.ac.uk; VotrubaM@cardiff.ac.uk	Rozanowska, Malgorzata/AAD-4806-2021; Rozanowska, Malgorzata B/B-7860-2014; Votruba, Marcela/B-7306-2015	Rozanowska, Malgorzata/0000-0003-2913-8954; Rozanowska, Malgorzata B/0000-0003-2913-8954; Votruba, Marcela/0000-0002-7680-9135	Fight for Sight UK [505025]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0700949] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700949] Funding Source: researchfish; Fight for Sight [1423/24] Funding Source: researchfish	This research was funded by Fight for Sight UK (505025).	Albarracin R, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-125; Albarracin R, 2012, PHOTOCHEM PHOTOBIOL, V88, P1418, DOI 10.1111/j.1751-1097.2012.01130.x; Albarracin R, 2011, INVEST OPHTH VIS SCI, V52, P3582, DOI 10.1167/iovs.10-6664; Andersen JK, 2004, OXIDATIVE STRESS NEU; Aslan M, 2004, CURR ALZHEIMER RES, V1, P111, DOI 10.2174/1567205043332162; Barolet D., 2008, SEMINARS CUTANEOUS M; Begum R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057828; Beirne K, 2016, PHOTOCHEM PHOTOBIOL, V92, P624, DOI 10.1111/php.12606; Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Darlot F, 2016, ANN NEUROL, V79, P59, DOI 10.1002/ana.24542; Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121; Dong TT, 2015, J CEREBR BLOOD F MET, V35, P1435, DOI 10.1038/jcbfm.2015.87; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Ferger AI, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-45; Ferraresi C, 2015, J BIOPHOTONICS, V8, P740, DOI 10.1002/jbio.201400087; Ferraresi C, 2015, LASER MED SCI, V30, P1259, DOI 10.1007/s10103-015-1723-8; Finsen N R, 1901, PHOTOTHERAPY, P73; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; FRIEDMAN E, 1968, ARCH OPHTHALMOL-CHIC, V80, P265, DOI 10.1001/archopht.1968.00980050267022; Gavish L, 2008, LASER SURG MED, V40, P371, DOI 10.1002/lsm.20635; Giacci MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104565; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Hamblin M. R., 2016, HDB LOW LEVEL LASER, P371; Hamblin MR, 2006, PROC SPIE, V6140, DOI 10.1117/12.646294; HARTWIG HG, 1979, J COMP PHYSIOL, V130, P277, DOI 10.1007/BF00614615; HARWERTH RS, 1975, VISION RES, V15, P1193, DOI 10.1016/0042-6989(75)90162-5; Huang YY, 2014, J BIOPHOTONICS, V7, P656, DOI 10.1002/jbio.201300125; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Innamorato NG, 2009, CURR OPIN NEUROL, V22, P308, DOI 10.1097/WCO.0b013e32832a3225; Ivandic BT, 2008, PHOTOMED LASER SURG, V26, P241, DOI 10.1089/pho.2007.2132; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Johnstone DM, 2014, NEUROSCIENCE, V274, P93, DOI 10.1016/j.neuroscience.2014.05.023; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kang KW, 2002, NITRIC OXIDE-BIOL CH, V7, P244, DOI 10.1016/S1089-8603(02)00117-9; Karu H. Tina, 2013, HDB PHOTOMEDICINE, P521; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Karu T., 2008, PHOTOBIOLOGICAL SCI; Keszler A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00305; Kokkinopoulos I, 2013, NEUROBIOL AGING, V34, P602, DOI 10.1016/j.neurobiolaging.2012.04.014; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Leung MCP, 2002, LASER SURG MED, V31, P283, DOI 10.1002/lsm.10096; Liaudet Lucas, 2009, Front Biosci (Landmark Ed), V14, P4809; Lim J, 2010, J PHOTOCH PHOTOBIO B, V99, P105, DOI 10.1016/j.jphotobiol.2010.03.002; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; McDonagh A. F., 2001, J PERINATOL, V21; Merry G, 2013, PROCEEDINGS OF THE 9TH WORLD ASSOCIATION FOR LASER THERAPY CONGRESS (WALT), P81; Merry GF., 2016, ACTA OPHTHALMOL; Mester E, 1971, ACTA CHIR HUNG, V13, P315; Muili KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067358; Muili KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030655; Naeser MA, 2016, PHOTOMED LASER SURG, V34, P610, DOI 10.1089/pho.2015.4037; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Nguyen LMD, 2014, MITOCHONDRION, V14, P42, DOI 10.1016/j.mito.2013.11.001; Niziolek M, 2006, FREE RADICAL BIO MED, V40, P1323, DOI 10.1016/j.freeradbiomed.2005.11.022; Niziolek M, 2005, PHOTOCHEM PHOTOBIOL, V81, P299, DOI 10.1562/2004-10-25-RA-351.1; Niziolek M, 2003, PHOTOCHEM PHOTOBIOL, V78, P262, DOI 10.1562/0031-8655(2003)078<0262:CAACAO>2.0.CO;2; Niziolek M, 2003, FREE RADICAL BIO MED, V34, P997, DOI 10.1016/S0891-5849(03)00026-1; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oueslati A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140880; Peoples C, 2012, PARKINSONISM RELAT D, V18, P469, DOI 10.1016/j.parkreldis.2012.01.005; Plass CA, 2012, ANN THORAC SURG, V93, P1181, DOI 10.1016/j.athoracsur.2011.12.062; Purushothuman S, 2013, BRAIN RES, V1535, P61, DOI 10.1016/j.brainres.2013.08.047; Purushothurnan S, 2015, NEUROSCI LETT, V591, P155, DOI 10.1016/j.neulet.2015.02.037; Ramesh G., 2013, MEDIAT INFLAMM, V2013; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Rizzi CF, 2006, LASER SURG MED, V38, P704, DOI 10.1002/lsm.20371; Roelandts R, 2002, J AM ACAD DERMATOL, V46, P926, DOI 10.1067/mjd.2002.121354; Rozanowska M., 2009, PHOTOBIOLOGICAL SCI; Rozanowska MB, 2012, PHOTOCHEM PHOTOBIOL, V88, P1303, DOI 10.1111/j.1751-1097.2012.01240.x; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-257; Samoilova KA, 2008, PHOTOMED LASER SURG, V26, P443, DOI 10.1089/pho.2007.2205; Shaw VE, 2010, J COMP NEUROL, V518, P25, DOI 10.1002/cne.22207; Tafur J, 2008, PHOTOMED LASER SURG, V26, P323, DOI 10.1089/pho.2007.2184; Tang J, 2013, INVEST OPHTH VIS SCI, V54, P3681, DOI 10.1167/iovs.12-11018; Tengan CH, 2012, INT J MOL SCI, V13, P17160, DOI 10.3390/ijms131217160; Thunshelle C, 2016, PHOTOMED LASER SURG, V34, P587, DOI 10.1089/pho.2015.4051; Torreilles F, 1999, BRAIN RES REV, V30, P153, DOI 10.1016/S0165-0173(99)00014-4; Vogel A, 1992, LASERS LIGHT OPHTHAL, V5, P9; Whitcup S. M., 2013, INT J INFLAMM, V2013; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xuan WJ, 2016, J BIOPHOTONICS, V9, P1263, DOI 10.1002/jbio.201500336; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Ying R, 2008, BRAIN RES, V1243, P167, DOI 10.1016/j.brainres.2008.09.057; Youssef PN, 2011, EYE, V25, P1, DOI 10.1038/eye.2010.149; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707; Zhao BL, 2005, FRONT BIOSCI-LANDMRK, V10, P454, DOI 10.2741/1541; Zielke A, 2014, PROC SPIE, V8932, DOI 10.1117/12.2037141; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	100	10	13	2	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1567-7249	1872-8278		MITOCHONDRION	Mitochondrion	SEP	2017	36				SI		85	95		10.1016/j.mito.2017.05.002			11	Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Genetics & Heredity	FL0FW	WOS:000413888000013	28499983	Green Accepted			2022-02-06	
J	Bombardier, CH; Fann, JR; Ludman, EJ; Vannoy, SD; Dyer, JR; Barber, JK; Temkin, NR				Bombardier, Charles H.; Fann, Jesse R.; Ludman, Evette J.; Vannoy, Steven D.; Dyer, Joshua R.; Barber, Jason K.; Temkin, Nancy R.			The Relations of Cognitive, Behavioral, and Physical Activity Variables to Depression Severity in Traumatic Brain Injury: Reanalysis of Data From a Randomized Controlled Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						behavior therapy; brain injuries; cognitive therapy; depression; physical activity; surveys and questionnaires	SCHEDULED TELEPHONE INTERVENTION; ACTIVITY QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; MAJOR DEPRESSION; NORMATIVE DATA; HEAD-INJURY; THERAPY; EXERCISE; PREDICTORS; SYMPTOMS	Objective: To explore the relations of cognitive, behavioral, and physical activity variables to depression severity among people with traumatic brain injury (TBI) undergoing a depression treatment trial. Setting: Community. Participants: Adults (N = 88) who sustained complicated mild to severe TBI within the past 10 years, met criteria for major depressive disorder, and completed study measures. Design: Randomized controlled trial. Methods: Participants were randomized to cognitive-behavioral therapy (n = 58) or usual care (n = 42). Outcomes were measured at baseline and 16 weeks. We combined the groups and used regressions to explore the relations among theoretical variables and depression outcomes. Main Measures: Depression severity was measured with the Hamilton Depression Rating Scale and Symptom Checklist-20. Theory-based measures were the Dysfunctional Attitudes Scale (DAS), Automatic Thoughts Questionnaire (ATQ), Environmental Rewards Observation Scale (EROS), and the International Physical Activity Questionnaire (IPAQ). Results: Compared with non-TBI norms, baseline DAS and ATQ scores were high and EROS and IPAQ scores were low. All outcomes improved from baseline to 16 weeks except the DAS. The ATQ was an independent predictor of baseline depression. An increase in EROS scores was correlated with decreased depression. Conclusions: Increasing participation in meaningful roles and pleasant activities may be a promising approach to treating depression after TBI.	[Bombardier, Charles H.; Fann, Jesse R.; Dyer, Joshua R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Ludman, Evette J.] Grp Hlth Res Inst, Seattle, WA USA; [Vannoy, Steven D.] Univ Massachusetts, Counseling & Sch Psychol, Boston, MA 02125 USA; [Barber, Jason K.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA		Bombardier, CH (corresponding author), Harborview Med Ctr, Dept Rehabil Med, Box 359612,325 9th Ave, Seattle, WA 98104 USA.	chb@uw.edu	Bombardier, Charles H./AAZ-3260-2021; vannoy, steven/W-2737-2019	Bombardier, Charles H./0000-0003-4758-6283; 	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21HD53736]; Department of Education, National Institute on Disability and Rehabilitation Research [H133G070016]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD053736] Funding Source: NIH RePORTER	Supported by the National Institutes of Health (grant R21HD53736) and the Department of Education, National Institute on Disability and Rehabilitation Research (grant H133G070016). Study funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Armento MEA, 2007, BEHAV THER, V38, P107, DOI 10.1016/j.beth.2006.05.003; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Barker-Collo S, 2013, BRAIN INJURY, V27, P1124, DOI 10.3109/02699052.2013.801513; Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Bedard Michel, 2012, Adv Mind Body Med, V26, P14; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bertheussen GF, 2013, SUPPORT CARE CANCER, V21, P449, DOI 10.1007/s00520-012-1530-8; Blatt SJ, 1998, J CONSULT CLIN PSYCH, V66, P423, DOI 10.1037/0022-006X.66.2.423; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Brosse AL, 2002, SPORTS MED, V32, P741, DOI 10.2165/00007256-200232120-00001; Conn VS, 2010, ANN BEHAV MED, V39, P128, DOI 10.1007/s12160-010-9172-x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daley A, 2008, J CLIN PSYCHOL MED S, V15, P140, DOI 10.1007/s10880-008-9105-z; Daughters SB, 2008, J CLIN PSYCHIAT, V69, P122, DOI 10.4088/JCP.v69n0116; DOBSON KS, 1986, COGNITIVE THER RES, V10, P13, DOI 10.1007/BF01173379; Dozois DJA, 2003, J CONSULT CLIN PSYCH, V71, P71, DOI 10.1037/0022-006X.71.1.71; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Dyer JR, 2016, J HEAD TRAUMA REHAB, V31, P225, DOI 10.1097/HTR.0000000000000177; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; First Michael B, 2001, USERS GUIDE STRUCTUR; Garratt G, 2007, CLIN PSYCHOL-SCI PR, V14, P224, DOI 10.1111/j.1468-2850.2007.00081.x; Glass CR, 1997, J CONSULT CLIN PSYCH, V65, P911, DOI 10.1037/0022-006X.65.6.911; Hamilton KE, 2002, CLIN PSYCHOL REV, V22, P875, DOI 10.1016/S0272-7358(02)00106-X; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hoffman JM, 2011, ARCH PHYS MED REHAB, V92, P411, DOI 10.1016/j.apmr.2010.10.036; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; HOLLON SD, 1980, COGNITIVE THER RES, V4, P383, DOI 10.1007/BF01178214; Jacobson NS, 1996, J CONSULT CLIN PSYCH, V64, P295, DOI 10.1037/0022-006X.64.2.295; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; JARRETT RB, 1991, PSYCHIAT RES, V37, P245, DOI 10.1016/0165-1781(91)90061-S; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kwon SM, 2003, J BEHAV THER EXP PSY, V34, P73, DOI 10.1016/S0005-7916(03)00021-1; Lavori PW, 2001, BIOL PSYCHIAT, V50, P792, DOI 10.1016/S0006-3223(01)01223-9; LEWINSOHPM, 1973, J CONSULT CLIN PSYCH, V41, P261, DOI DOI 10.1037/H0035142; Losada A, 2011, INT J GERIATR PSYCH, V26, P1119, DOI 10.1002/gps.2648; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Martell C.R., 2001, DEPRESSION CONTEXT S; OLIVER JM, 1985, COGNITIVE THER RES, V9, P161, DOI 10.1007/BF01204847; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Quilty LC, 2008, PSYCHOL MED, V38, P1531, DOI 10.1017/S0033291708003772; Ricker, 1994, Assessment, V1, P47, DOI 10.1177/1073191194001001007; Rush AJ, 2009, CNS DRUGS, V23, P627, DOI 10.2165/00023210-200923080-00001; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Segal Z. V., 2002, MINDFULNESS BASED CO; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Silveira H, 2013, NEUROPSYCHOBIOLOGY, V67, P61, DOI [10.1159/000345160, 10.1159/0]; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Teychenne M, 2008, PREV MED, V46, P397, DOI 10.1016/j.ypmed.2008.01.009; Teychenne M, 2011, INT J BEHAV MED, V17, P246, DOI 10.1007/s12529-010-9075-z; The Psychological Corporation, 1997, WECHSLER ADULT INTEL; Walker J, 2010, J PSYCHOSOM RES, V68, P313, DOI 10.1016/j.jpsychores.2009.11.002; Weissman M, 1979, THESIS; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Zimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028; Zuroff DC, 1999, J ABNORM PSYCHOL, V108, P76, DOI 10.1037/0021-843X.108.1.76	67	10	10	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2017	32	5					343	353		10.1097/HTR.0000000000000288			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FG2DW	WOS:000409893800014	28195952	Green Accepted			2022-02-06	
J	Bomyea, J; Lang, AJ; Schnurr, PP				Bomyea, Jessica; Lang, Ariel J.; Schnurr, Paula P.			TBI and Treatment Response in a Randomized Trial of Acceptance and Commitment Therapy	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Acceptance and Commitment Therapy; concussion; PTSD; trauma; traumatic brain injury; treatment	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; CONCUSSION SYMPTOMS QUESTIONNAIRE; COGNITIVE-BEHAVIORAL THERAPY; PROLONGED EXPOSURE THERAPY; CLINICAL-TRIALS; SOCIAL PHOBIA; DEPRESSION; OUTCOMES; PTSD	Objective: Traumatic brain injury (TBI) occurs in a substantial minority of military personnel, and commonly is associated with mental health disorders and postconcussive symptoms (PCS). The implications of TBI for mental health treatment are not well understood. The present study sought to describe psychotherapy response in veterans with and without TBI. Design: This is a secondary analysis from a 2-group randomized controlled trial. Setting, Participants, and Measures: One hundred and sixtymale and female veterans participated in a multisite randomized controlled trial of Acceptance and Commitment Therapy versus Present Centered Therapy; a subset of 129 veterans were included in these analyses. Outcomes included the Brief Symptom Inventory-18 (BSI), Short Form 12 Health Survey (SF-12), Rivermead Postconcussion Symptoms Questionnaire (RPQ), and Sheehan Disability Scale (SDS). Results: Regardless of the intervention, treatment response in those with and without TBI did not differ for the BSI, physical health-related SF-12, or SDS. Those with TBI showed less improvement on the mental health SF-12 subscale. The RPQ did not show significant improvement over time. Conclusion: Results did not suggest a need for differential psychotherapy treatment based on TBI history. In spite of evidence suggesting high correspondence between emotional symptoms and PCS, PCS did not respond to the current interventions.	[Bomyea, Jessica; Lang, Ariel J.] VA San Diego Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Bomyea, Jessica; Lang, Ariel J.] Univ Calif San Diego, San Diego, CA 92103 USA; [Schnurr, Paula P.] Natl Ctr PTSD, White River Jct, VT USA; [Schnurr, Paula P.] Geisel Sch Med Dartmouth, Hanover, NH USA		Bomyea, J (corresponding author), 9500 Gilman Dr,MC 8505, La Jolla, CA 92037 USA.	jbomyea@ucsd.edu			DoDUnited States Department of Defense [W81XWH-10-2-0104]; Office of Academic Affiliations, Department of veterans AffairsUS Department of Veterans Affairs	This work was supported by DoD Contract #W81XWH-10-2-0104 (A. Lang, Initiating PI). This material is based upon work supported by the Office of Academic Affiliations, Department of veterans Affairs (J. Bomyea).	Amir N, 2011, J CONSULT CLIN PSYCH, V79, P533, DOI 10.1037/a0023808; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Bach P, 2002, J CONSULT CLIN PSYCH, V70, P1129, DOI 10.1037//0022-006X.70.5.1129; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bell KR, 2017, J NEUROTRAUM, V34, P313, DOI 10.1089/neu.2016.4444; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Campbell JS, 2012, TRAUMATIC BRAIN INJU; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Craske MG, 2014, J CONSULT CLIN PSYCH, V82, P1034, DOI 10.1037/a0037212; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Derogatis L.R, 2001, BRIEF SYMPTOM INVENT, V18; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fournier JC, 2009, J CONSULT CLIN PSYCH, V77, P775, DOI 10.1037/a0015401; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hoge CW, 2008, NEW ENGL J MED, V358, P2179; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Lang A, PSYCHOL TRAUMA; Lang AJ, 2012, BEHAV MODIF, V36, P759, DOI 10.1177/0145445512441200; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lundgren T, 2006, EPILEPSIA, V47, P2173, DOI 10.1111/j.1528-1167.2006.00892.x; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Morris SB, 2000, BRIT J MATH STAT PSY, V53, P17, DOI 10.1348/000711000159150; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Schnurr PP, 2005, CONTEMP CLIN TRIALS, V26, P626, DOI 10.1016/j.cct.2005.09.001; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Walser RD, 2010, ACCEPTANCE COMMITMEN; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f	46	10	10	2	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2017	32	5					E35	E43		10.1097/HTR.0000000000000278			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FG2DW	WOS:000409893800004	28060206				2022-02-06	
J	Catenaccio, E; Mu, WY; Kaplan, A; Fleysher, R; Kim, N; Bachrach, T; Sears, MZ; Jaspan, O; Caccese, J; Kim, M; Wagshul, M; Stewart, WF; Lipton, RB; Lipton, ML				Catenaccio, Eva; Mu, Weiya; Kaplan, Atira; Fleysher, Roman; Kim, Namhee; Bachrach, Tamar; Sears, Malka Zughaft; Jaspan, Oren; Caccese, Jaclyn; Kim, Mimi; Wagshul, Mark; Stewart, Walter F.; Lipton, Richard B.; Lipton, Michael L.			Characterization of Neck Strength in Healthy Young Adults	PM&R			English	Article							MUSCLE STRENGTH; RETEST RELIABILITY; ISOMETRIC STRENGTH; CERVICAL FLEXOR; WOMEN; PAIN; BIOMECHANICS; MUSCULATURE; VOLUNTEERS; CONCUSSION	Background: The role of cervical muscle (neck) strength in traumatic brain and spine injury and chronic neck pain disorders is an area of active research. Characterization of the normal ranges of neck strength in healthy young adults is essential to designing future investigations of how strength may act as a modifier for risk and progression in head and neck disorders. Objective: To develop a normative reference database of neck strength in a healthy young adult population, and to evaluate the relationship of neck strength to anthropometric measurements. Design: Cross-sectional. Setting: An academic medical center research institution. Participants: A total of 157 healthy young adults (18-35 years of age) had their neck strength measured with fixed frame dynamometry (FFD) during 1 visit to establish a normative neck strength database. Interventions: Not applicable. Main Outcome Measurements: Peak and average strength of the neck muscles were measured in extension, forward flexion, and right and left lateral flexion using FFD. The ranges of peak and average neck strength were characterized and correlated with anthropometric characteristics. Results: In all, 157 subjects (84 male, 73 female; average age 27 years) were included in the normative sample. Neck strength ranged from 38 to 383 Newtons in men and from 15 to 223 Newtons in women. Normative data are provided for each gender in all 4 directions. Weight, body mass index, neck circumference, and estimated neck muscle volume were modestly correlated with neck strength in multiple directions (correlation coefficients <.4). In a multivariate regression model, weight in women and neck volume in men were significant predictors of neck strength. Conclusions: Neck strength in healthy young adults exhibits a broad range, is significantly different in men from that in women, and correlates only modestly with anthropometric characteristics.	[Catenaccio, Eva; Mu, Weiya; Fleysher, Roman; Kim, Namhee; Bachrach, Tamar; Sears, Malka Zughaft; Jaspan, Oren; Wagshul, Mark; Lipton, Richard B.; Lipton, Michael L.] Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, New York, NY USA; [Kaplan, Atira] Montefiore Med Ctr, Dept Phys Med & Rehabil, New York, NY USA; [Fleysher, Roman; Kim, Namhee; Wagshul, Mark; Lipton, Michael L.] Albert Einstein Coll Med, Dept Radiol, New York, NY USA; [Caccese, Jaclyn] Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE USA; [Kim, Mimi; Lipton, Richard B.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Wagshul, Mark] Albert Einstein Coll Med, Dept Physiol & Biophys, New York, NY USA; [Stewart, Walter F.] Sutter Hlth, Sacramento, CA USA; [Lipton, Richard B.] Montefiore Med Ctr, Dept Neurol, New York, NY USA; [Lipton, Richard B.; Lipton, Michael L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, New York, NY 10461 USA; [Lipton, Michael L.] Montefiore Med Ctr, Dept Radiol, New York, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY 10461 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Jack & Pearl Resnick Campus,1300 Morris Pk Ave, Bronx, NY 10461 USA		Lipton, ML (corresponding author), Albert Einstein Coll Med, Dept Radiol, New York, NY USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dept Psychiat & Behav Sci, New York, NY 10461 USA.; Lipton, ML (corresponding author), Montefiore Med Ctr, Dept Radiol, New York, NY 10467 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY 10461 USA.; Lipton, ML (corresponding author), Albert Einstein Coll Med, Jack & Pearl Resnick Campus,1300 Morris Pk Ave, Bronx, NY 10461 USA.	michael.lipton@einstein.yu.edu	Buckley, Thomas A/B-7525-2016; Jaspan, Oren/AAN-9439-2020; Caccese, Jaclyn B./AAH-4571-2020; Lipton, Richard B/B-5060-2011; Catenaccio, Eva/M-7250-2019; Lipton, Richard Bruce/AAY-2818-2021	Buckley, Thomas A/0000-0002-0515-0150; Caccese, Jaclyn B./0000-0003-2329-3603; Catenaccio, Eva/0000-0003-0550-207X; Kim, Namhee/0000-0003-1618-1363; Jaspan, Oren/0000-0003-2447-2718	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS082432]; Dana Foundation David Mahoney Neuroimaging Program; Einstein Research Fellowship; NIH/National Center for Advancing Translational Science (NCATS) Einstein-Montefiore CTSA GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001073]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082432] Funding Source: NIH RePORTER	The authors thank Liane Hunter for her feedback on the manuscript. The authors also acknowledge funding from the following sources: NIH R01 NS082432; Dana Foundation David Mahoney Neuroimaging Program; Einstein Research Fellowship; NIH/National Center for Advancing Translational Science (NCATS) Einstein-Montefiore CTSA Grant Number UL1TR001073.	Almosnino S, 2010, J ATHL TRAINING, V45, P453, DOI 10.4085/1062-6050-45.5.453; Cagnie B, 2007, ARCH PHYS MED REHAB, V88, P1441, DOI 10.1016/j.apmr.2007.06.776; Chiu TTW, 2002, CLIN REHABIL, V16, P772, DOI 10.1191/0269215502cr552oa; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Dvir Z, 2008, J MANIP PHYSIOL THER, V31, P518, DOI 10.1016/j.jmpt.2008.08.008; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Jordan A, 1999, SPINE, V24, P1343, DOI 10.1097/00007632-199907010-00012; Jull G, 2004, MANUAL THER, V9, P89, DOI 10.1016/S1356-689X(03)00086-9; Jull GA, 2008, J MANIP PHYSIOL THER, V31, P525, DOI 10.1016/j.jmpt.2008.08.003; Lavallee AV, 2013, J BIOMECH, V46, P527, DOI 10.1016/j.jbiomech.2012.09.029; O'Leary SP, 2005, PHYS THER, V85, P556, DOI 10.1093/ptj/85.6.556; Pelland, 2015, J ATHL ENHANCE, V4, P1; Salo PK, 2006, J ORTHOP SPORT PHYS, V36, P495, DOI 10.2519/jospt.2006.2122; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Staudte H W, 1994, Eur Spine J, V3, P155, DOI 10.1007/BF02190578; VERNON HT, 1992, J MANIP PHYSIOL THER, V15, P343; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Ylinen J, 2004, ARCH PHYS MED REHAB, V85, P1303, DOI 10.1016/j.apmr.2003.09.018	22	10	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	SEP	2017	9	9					884	891		10.1016/j.pmrj.2017.01.005			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FL7PN	WOS:000414440500006	28167302	Green Accepted			2022-02-06	
J	Clarke, D; Penrose, MA; Harvey, AR; Rodger, J; Bates, KA				Clarke, Darren; Penrose, Marissa A.; Harvey, Alan R.; Rodger, Jennifer; Bates, Kristyn A.			Low intensity rTMS has sex-dependent effects on the local response of glia following a penetrating cortical stab injury	EXPERIMENTAL NEUROLOGY			English	Article						Repetitive transcranial magnetic stimulation; Central nervous system injury; Astrocytes; Microglia; Proteoglycans; Aging; Sex differences	TRANSCRANIAL MAGNETIC STIMULATION; PULSED ELECTROMAGNETIC-FIELDS; BRAIN-INJURY; RAT-BRAIN; NEURITE OUTGROWTH; REACTIVE GLIOSIS; LOW-FREQUENCY; CNS INJURY; EXPRESSION; ASTROCYTES	Repetitive transcranial magnetic stimulation (rTMS), a non-invasive form of brain stimulation, has shown experimental and clinical efficacy in a range of neuromodulatory models, even when delivered at low intensity (i.e. subthreshold for action potential generation). After central nervous system (CNS) injury, studies suggest that reactive astrocytes and microglia can have detrimental but also beneficial effects; thus modulating glial activity, for example through application of rTMS, could potentially be a useful therapeutic tool following neurotrauma. Immunohistochemistry was used to measure the effect of low intensity rTMS (LI-rTMS) on GFAP (astrocyte), IBM (microglial), and CS56 (proteoglycan) expression in a unilateral penetrating cortical stab injury model of glial scarring in young adult and aged male and female C57BL6/J mice. Mice received contralateral low frequency, ipsilateral low frequency, ipsilateral high frequency or sham LI-rTMS (4-5 mT intensity), for two weeks following injury. There was no significant difference in the overall volume of tissue containing GFAP positive (+) astrocytes, IBA1(+) microglia, or proteoglycan expression, between sham and LI-rTMS-treated mice of all ages and sex. Importantly however, the density of GFAP(+) astrocytes and IBA1(+) microglia immediately adjacent to the injury was significantly reduced following ipsilateral low and high frequency stimulation in adult and aged females (p <= 0.05), but was significantly increased in adult and aged males (p <= 0.05). LI-rTMS effects were generally of greater magnitude in aged mice compared to young adult mice. These results suggest that sex differences need to be factored into therapeutic rTMS protocols. In particular, more work analyzing frequency and intensity specific effects, especially in relation to age and sex, is required to determine how rTMS can best be used to modify glial reactivity and phenotype following neurotrauma. (C) 2017 Elsevier Inc. All rights reserved.	[Clarke, Darren; Penrose, Marissa A.; Rodger, Jennifer; Bates, Kristyn A.] Univ Western Australia, Sch Biol Sci, 35 Stirling Hwy, Crawley, WA 6009, Australia; [Clarke, Darren; Harvey, Alan R.] Univ Western Australia, Sch Human Sci, 35 Stirling Hwy, Crawley, WA 6009, Australia; [Harvey, Alan R.; Rodger, Jennifer] Perron Inst Neurol & Translat Sci, Perth, WA, Australia		Bates, KA (corresponding author), Univ Western Australia, MBDP Sch Biol Sci 317, 35 Stirling Hwy, Perth, WA 6009, Australia.	kristyn.bates@uwa.edu.au	Rodger, Jennifer/H-5735-2014	Rodger, Jennifer/0000-0003-3413-4229; , Alan/0000-0002-2590-831X	Neurotrauma Research Program [47605600]	This work was supported by the Neurotrauma Research Program (47605600).	Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; Bates KA, 2012, BRAIN RES, V1458, P76, DOI 10.1016/j.brainres.2012.04.006; BERTONIFREDDARI C, 1986, BRAIN RES, V366, P187, DOI 10.1016/0006-8993(86)91294-1; Bestmann S, 2003, NEUROIMAGE, V20, P1685, DOI 10.1016/j.neuroimage.2003.07.028; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cotrina ML, 2002, J NEUROSCI RES, V67, P1; Cullen CL, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00026; Epstein CM, 2002, J CLIN NEUROPHYSIOL, V19, P376, DOI 10.1097/00004691-200208000-00010; Fang ZY, 2010, ELECTROMAGN BIOL MED, V29, P113, DOI 10.3109/15368378.2010.500568; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Gao F, 2010, EUR J NUCL MED MOL I, V37, P954, DOI 10.1007/s00259-009-1342-3; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; GEORGE MS, 1995, NEUROREPORT, V6, P1853, DOI 10.1097/00001756-199510020-00008; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Grehl S, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00085; Hao ZL, 2013, SAO PAULO MED J, V131, P440, DOI [10.1590/1516-3180.20131316T2, 10.1002/14651858.CD008862.pub2]; HARVEY AR, 1992, MOL BRAIN RES, V12, P339, DOI 10.1016/0169-328X(92)90137-Z; HARVEY AR, 1993, INT J DEV NEUROSCI, V11, P569, DOI 10.1016/0736-5748(93)90046-G; Inghilleri M, 2004, CLIN NEUROPHYSIOL, V115, P1063, DOI 10.1016/j.clinph.2003.12.003; JANECZKO K, 1988, BRAIN RES, V456, P280, DOI 10.1016/0006-8993(88)90229-6; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; Kim JY, 2013, J KOREAN MED SCI, V28, P295, DOI 10.3346/jkms.2013.28.2.295; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liebetanz D, 2003, J PSYCHIATR RES, V37, P277, DOI 10.1016/S0022-3956(03)00017-7; Makowiecki K, 2014, J NEUROSCI, V34, P10780, DOI 10.1523/JNEUROSCI.0723-14.2014; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martiny K, 2010, BIOL PSYCHIAT, V68, P163, DOI 10.1016/j.biopsych.2010.02.017; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MURRAY JC, 1985, BIOCHIM BIOPHYS ACTA, V838, P98, DOI 10.1016/0304-4165(85)90255-7; Norton WT, 1999, NEUROCHEM RES, V24, P213, DOI 10.1023/A:1022505903312; Pannasch U, 2013, TRENDS NEUROSCI, V36, P405, DOI 10.1016/j.tins.2013.04.004; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; Pena-Philippides JC, 2014, TRANSL STROKE RES, V5, P491, DOI 10.1007/s12975-014-0334-1; Penrose M., 2017, REPETITIVE MAGNETIC; Perea G, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/1ncel.2014.00378, 10.3389/fncel.2014.00378]; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Raus S, 2013, NEUROTOX RES, V23, P79, DOI 10.1007/s12640-012-9333-8; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Rodger J, 2012, FASEB J, V26, P1593, DOI 10.1096/fj.11-194878; Ross CL, 2016, BIOTECHNOL PROG; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Sasso V, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0616-5; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sykes M, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00080; Takeuchi N, 2005, STROKE, V36, P2681, DOI 10.1161/01.STR.0000189658.51972.34; Tang AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126949; Todd G, 2010, CLIN NEUROPHYSIOL, V121, P441, DOI 10.1016/j.clinph.2009.11.089; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Vlachos A, 2012, J NEUROSCI, V32, P17514, DOI 10.1523/JNEUROSCI.0409-12.2012; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wiese S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00120; Xie YF, 2016, BONE, V93, P22, DOI 10.1016/j.bone.2016.09.008; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yue L, 2009, BRAIN RES, V1260, P94, DOI 10.1016/j.brainres.2009.01.009	70	10	11	0	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2017	295						233	242		10.1016/j.expneurol.2017.06.019			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC4OS	WOS:000406820900023	28624361				2022-02-06	
J	Craton, N; Ali, H; Lenoski, S				Craton, Neil; Ali, Haitham; Lenoski, Stephane			COACH CV: The Seven Clinical Phenotypes of Concussion	BRAIN SCIENCES			English	Article						concussion; assessment; phenotype; trajectory; clinical; physical examination; whiplash	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; MOTOR SCREENING VOMS; CONVERGENCE; DEPRESSION; SYMPTOMS; HEADACHE; YOUTH; SPINE; RISK	Our understanding of the diverse physiological manifestations of concussion is changing rapidly. This has an influence on the clinical assessment of patients who have sustained a concussion. The 2017 Consensus Statement on Concussion in Sport states that numerous post-injury clinical findings, such as cognitive deficits, post-traumatic headaches, dizziness, difficulties with oculomotor function, and depression have all been associated with a poorer prognosis in concussed patients. This demonstrates that there are several potential clinical manifestations after head injury warranting clinical evaluation. We have developed an acronym to guide the office-based assessment of concussed patients to consider each of the potential clinical phenotypes. COACH CV prompts the clinician to evaluate for cognitive problems, oculomotor dysfunction, affective disturbances, cervical spine disorders, headaches, and cardiovascular and vestibular anomalies.	[Craton, Neil; Ali, Haitham; Lenoski, Stephane] Univ Manitoba, Fac Med, 14-160 Meadowood Dr, Winnipeg, MB R2M 5L6, Canada; [Craton, Neil] Univ Winnipeg, Sch Kinesiol & Appl Hlth, Winnipeg, MB R3B 2E9, Canada		Craton, N (corresponding author), Univ Manitoba, Fac Med, 14-160 Meadowood Dr, Winnipeg, MB R2M 5L6, Canada.; Craton, N (corresponding author), Univ Winnipeg, Sch Kinesiol & Appl Hlth, Winnipeg, MB R3B 2E9, Canada.	craton@shaw.ca; dr.haithamali@hotmail.com; umlenoss@myumanitoba.ca					Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Bogduk N, 2009, LANCET NEUROL, V8, P959, DOI 10.1016/S1474-4422(09)70209-1; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Eckner J. T., 2016, J SPORT MED, V27, P266, DOI [10.1097/JSM.000000000000034627428679, DOI 10.1097/JSM.000000000000034627428679]; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Findling O, 2011, GAIT POSTURE, V34, P473, DOI 10.1016/j.gaitpost.2011.06.021; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Goldberg M, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0518-8; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Hinds A, 2016, J NEUROL NEUROPHYSIO, V7, P388, DOI DOI 10.4172/2155-9562.1000388; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Leslie O, 2013, CLIN J SPORT MED, V23, P331, DOI 10.1097/JSM.0b013e318295bbb1; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrory P., 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-09769928446457, DOI 10.1136/BJSPORTS-2017-09769928446457]; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Piovesan Elcio J, 2003, Curr Pain Headache Rep, V7, P377, DOI 10.1007/s11916-003-0037-x; Pryor James, 2016, J Lifestyle Med, V6, P7, DOI 10.15280/jlm.2016.6.1.7; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Seifert T, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0568-6; Silva AG, 2013, PHYSIOTHER THEOR PR, V29, P1, DOI 10.3109/09593985.2012.677111; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Stiell IG, 2003, NEW ENGL J MED, V349, P2510, DOI 10.1056/NEJMoa031375; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yorke A. M., 2016, VALIDITY RELIABILITY, V9, DOI [10.1177/194173811667841127834667, DOI 10.1177/194173811667841127834667]	37	10	10	0	12	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-3425			BRAIN SCI	Brain Sci.	SEP	2017	7	9							119	10.3390/brainsci7090119			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FI5VZ	WOS:000412056000009	28926944	Green Published, Green Submitted, gold			2022-02-06	
J	Dyson, K; Bray, JE; Smith, K; Bernard, S; Straney, L; Nair, R; Finn, J				Dyson, Kylie; Bray, Janet E.; Smith, Karen; Bernard, Stephen; Straney, Lahn; Nair, Resmi; Finn, Judith			Paramedic Intubation Experience Is Associated With Successful Tube Placement but Not Cardiac Arrest Survival	ANNALS OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	Paramedics Australasia International Conference	NOV, 2016	Auckland, NEW ZEALAND				PREHOSPITAL ENDOTRACHEAL INTUBATION; RAPID-SEQUENCE INTUBATION; ADVANCED AIRWAY MANAGEMENT; TRAUMATIC BRAIN-INJURY; PATIENT SURVIVAL; EXPOSURE; REGISTRY; RESUSCITATION; METAANALYSIS; TRIAL	Study objective: Paramedic experience with intubation may be an important factor in skill performance and patient outcomes. Our objective is to examine the association between previous intubation experience and successful intubation. In a subcohort of out-of-hospital cardiac arrest cases, we also measure the association between patient survival and previous paramedic intubation experience. Methods: We analyzed data from Ambulance Victoria electronic patient care records and the Victorian Ambulance Cardiac Arrest Registry for January 1, 2008, to September 26, 2014. For each patient case, we defined intubation experience as the number of intubations attempted by each paramedic in the previous 3 years. Using logistic regression, we estimated the association between intubation experience and (1) successful intubation and (2) first-pass success. In the out-of-hospital cardiac arrest cohort, we determined the association between previous intubation experience and patient survival. Results: During the 6.7-year study period, 769 paramedics attempted intubation in 14,857 patients. Paramedics typically performed 3 intubations per year (interquartile range 1 to 6). Most intubations were successful (95%), including 80% on the first attempt. Previous intubation experience was associated with intubation success (odds ratio 1.04; 95% confidence interval 1.03 to 1.05) and intubation first-pass success (odds ratio 1.02; 95% confidence interval 1.01 to 1.03). In the out-of hospital cardiac arrest subcohort (n=9,751), paramedic intubation experience was not associated with patient survival. Conclusion: Paramedics in this Australian cohort performed few intubations. Previous experience was associated with successful intubation. Among out-of-hospital cardiac arrest patients for whom intubation was attempted, previous paramedic intubation experience was not associated with patient survival.	[Dyson, Kylie; Bray, Janet E.; Smith, Karen; Bernard, Stephen; Straney, Lahn; Finn, Judith] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Dyson, Kylie; Smith, Karen; Bernard, Stephen; Nair, Resmi] Ambulance Victoria, Doncaster, Vic, Australia; [Smith, Karen; Finn, Judith] Univ Western Australia, Discipline Emergency Med, Perth, WA, Australia; [Bray, Janet E.; Bernard, Stephen] Alfred Hosp, Melbourne, Vic, Australia; [Bray, Janet E.; Finn, Judith] Curtin Univ, Sch Nursing Midwifery & Paramed, Perth, WA, Australia		Dyson, K (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.; Dyson, K (corresponding author), Ambulance Victoria, Doncaster, Vic, Australia.	Kylie.dyson@monash.edu	Dyson, Kylie/AAA-5115-2019; Finn, Judith C/B-2678-2010; Bray, Janet/H-7089-2014	Dyson, Kylie/0000-0002-0037-3195; Finn, Judith C/0000-0002-7307-7944; Smith, Karen/0000-0002-9057-0685; Bray, Janet/0000-0002-1559-5882	National Health and Medical Research Council (NHMRC) Public Health Postgraduate Research ScholarshipNational Health and Medical Research Council of Australia [1075456]; NHMRC Australian Resuscitation Outcomes Consortium (Aus-ROC) Centre of Research Excellence (CRE)National Health and Medical Research Council of Australia [1029983]; NHMRC and the Heart FoundationNational Health and Medical Research Council of Australia [1069985/100136]; NHMRC Aus-ROC CRENational Health and Medical Research Council of Australia; St John Ambulance Western Australia	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). Dr. Dyson is supported by a National Health and Medical Research Council (NHMRC) Public Health Postgraduate Research Scholarship (ID 1075456) and a scholarship funded through the NHMRC Australian Resuscitation Outcomes Consortium (Aus-ROC) Centre of Research Excellence (CRE; ID 1029983; https://www.ausroc.org.au). Dr. Bray receives an early career researcher fellowship from the NHMRC and the Heart Foundation (ID 1069985/100136). Drs. Bray, Straney, and Finn receive salary support from the NHMRC Aus-ROC CRE. Dr. Finn receives salary support from St John Ambulance Western Australia. Drs. Dyson, Smith, Bernard, and Nair are employed by Ambulance Victoria.	Ambulance Victoria, 2014, CLIN PRACT GUID AMB; Australian Bureau of Statistics, POP AG SEX REG AUSTR; Benoit JL, 2015, RESUSCITATION, V93, P124, DOI 10.1016/j.resuscitation.2015.06.005; Benoit JL, 2015, RESUSCITATION, V93, P20, DOI 10.1016/j.resuscitation.2015.05.007; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Buis ML, 2016, RESUSCITATION, V99, P63, DOI 10.1016/j.resuscitation.2015.11.005; Cady CE, 2005, AM J EMERG MED, V23, P868, DOI 10.1016/j.ajem.2005.07.013; Clarke RC, 2008, ANAESTH INTENS CARE, V36, P513; Cox S, 2013, AUST HEALTH REV, V37, P54, DOI 10.1071/AH11161; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Deakin CD, 2010, EMERG MED J, V27, P226, DOI 10.1136/emj.2009.082115; Doran J V, 1995, Prehosp Disaster Med, V10, P259; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Dyson K, 2016, CIRC-CARDIOVASC QUAL, V9, P154, DOI 10.1161/CIRCOUTCOMES.115.002317; Dyson K, 2015, RESUSCITATION, V89, P93, DOI 10.1016/j.resuscitation.2015.01.023; Dyson K, 2014, RESUSCITATION, V85, P1134, DOI 10.1016/j.resuscitation.2014.05.020; Garza AG, J EMERG MED; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Hanif MA, 2010, ACAD EMERG MED, V17, P926, DOI 10.1111/j.1553-2712.2010.00829.x; Hasegawa K, 2012, ANN EMERG MED, V60, P749, DOI 10.1016/j.annemergmed.2012.04.005; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P377, DOI 10.3109/10903121003790173; Kang K, 2016, AM J EMERG MED, V34, P128, DOI 10.1016/j.ajem.2015.09.036; Kim J, 2014, RESUSCITATION, V85, P623, DOI 10.1016/j.resuscitation.2014.01.017; Lossius HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11189; McMullan J, 2014, RESUSCITATION, V85, P617, DOI 10.1016/j.resuscitation.2014.02.007; Nehme Z, 2015, CIRC-CARDIOVASC QUAL, V8, P56, DOI 10.1161/CIRCOUTCOMES.114.001185; Pepe PE, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0808-x; Perkins GD, CARDIAC ARREST CARDI; STEWART RD, 1984, ANN EMERG MED, V13, P1032, DOI 10.1016/S0196-0644(84)80064-5; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2003, RESUSCITATION, V58, P49, DOI 10.1016/S0300-9572(03)00058-3; Wang HE, 2012, RESUSCITATION, V83, P1061, DOI 10.1016/j.resuscitation.2012.05.018; Wang HE, 2010, ANN EMERG MED, V55, P527, DOI 10.1016/j.annemergmed.2009.12.020; Warner KJ, 2010, PREHOSP EMERG CARE, V14, P103, DOI 10.3109/10903120903144858; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	36	10	10	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	SEP	2017	70	3					382	390		10.1016/j.annemergmed.2017.02.002			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	FG4SH	WOS:000410255300020	28347556				2022-02-06	
J	Esenaliev, RO				Esenaliev, Rinat O.			Optoacoustic diagnostic modality: from idea to clinical studies with highly compact laser diode-based systems	JOURNAL OF BIOMEDICAL OPTICS			English	Article						optoacoustic; photoacoustic; monitoring; imaging; cancer detection; thermotherapy; oxygenation	CEREBRAL BLOOD OXYGENATION; REAL-TIME; IN-VIVO; HEMOGLOBIN CONCENTRATION; TOMOGRAPHY; ULTRASOUND; ABLATION; SENSITIVITY; ARRAY	Optoacoustic (photoacoustic) diagnostic modality is a technique that combines high optical contrast and ultrasound spatial resolution. We proposed using the optoacoustic technique for a number of applications, including cancer detection, monitoring of thermotherapy (hyperthermia, coagulation, and freezing), monitoring of cerebral blood oxygenation in patients with traumatic brain injury, neonatal patients, fetuses during late-stage labor, central venous oxygenation monitoring, and total hemoglobin concentration monitoring as well as hematoma detection and characterization. We developed and built optical parametric oscillator-based systems and multiwavelength, fiber-coupled highly compact, laser diode-based systems for optoacoustic imaging, monitoring, and sensing. To provide sufficient output pulse energy, a specially designed fiber-optic system was built and incorporated in ultrasensitive, wideband optoacoustic probes. We performed preclinical and clinical tests of the systems and the optoacoustic probes in backward mode for most of the applications and in forward mode for the breast cancer and cerebral applications. The high pulse energy and repetition rate allowed for rapid data acquisition with high signal-to-noise ratio from cerebral blood vessels, such as the superior sagittal sinus, central veins, and peripheral veins and arteries, as well as from intracranial hematomas. The optoacoustic systems were capable of automatic, real-time, continuous measurements of blood oxygenation in these blood vessels. (C) The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License.	[Esenaliev, Rinat O.] Univ Texas Med Branch, Dept Anesthesiol, Ctr Biomed Engn, Lab Opt Sensing & Monitoring,Dept Neurosci & Cell, Galveston, TX 77555 USA		Esenaliev, RO (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Ctr Biomed Engn, Lab Opt Sensing & Monitoring,Dept Neurosci & Cell, Galveston, TX 77555 USA.	riesenal@utmb.edu	Esenaliev, Rinat/Y-4361-2019	Esenaliev, Rinat/0000-0002-2848-5906	NIH from the National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB00763, U54EB007954]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044345, R21NS40531]; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R41HD076568, R43HD075551]; National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R41HL10309501]; Noninvasix, Inc.; Texas Emerging Technology Fund; Moody Center for Brain and Spinal Cord Injury Research/Mission Connect of UTMB; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R41HD076568, R43HD075551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB000763, U54EB007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044345] Funding Source: NIH RePORTER	The author thanks Drs. Donald S. Prough, Yuriy Petrov, Irene Y. Petrov, Claudia S. Robertson, C. Joan Richardson, other members of the Department of Anesthesiology, Department of Pediatrics and Neonatal Intensive Care Unit at UTMB, and the Department of Neurosurgery and Neurointensive Care Unit of Baylor College of Medicine. Grant support: NIH grants # R01EB00763 and # U54EB007954 from the National Institute of Biomedical Imaging and Bioengineering, # R01NS044345 and # R21NS40531 from the National Institute of Neurological Disorders and Stroke, # R41HD076568 and # R43HD075551 from Eunice Kennedy Shriver National Institute of Child Health and Human Development, and # R41HL10309501 from the National Heart, Lung and Blood Institute, contracts from Noninvasix, Inc., Texas Emerging Technology Fund, and Moody Center for Brain and Spinal Cord Injury Research/Mission Connect of UTMB. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIBIB or NIH.	Bourantas CV, 2017, EUR HEART J, V38, P400, DOI 10.1093/eurheartj/ehw097; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Bratton S, 2007, J NEUROTRAUM, V24, P7; Brecht HP, 2007, OPT EXPRESS, V15, P16261, DOI 10.1364/OE.15.016261; Cai CZ, 2016, CYTOM PART A, V89A, P531, DOI 10.1002/cyto.a.22854; Choi SSS, 2016, BIOMED OPT EXPRESS, V7, P2586, DOI 10.1364/BOE.7.002586; Daoudi K, 2014, OPT EXPRESS, V22, P26365, DOI 10.1364/OE.22.026365; Ellwood R, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.12.126012; Esenaliev R., 2000, U.S. Patent, Patent No. [6,165,440, 6165440, US6165440]; Esenaliev R. O., 2002, Proceedings of the SPIE - The International Society for Optical Engineering, V4707, P158, DOI 10.1117/12.475583; Esenaliev R. O., 2003, Proceedings of the SPIE - The International Society for Optical Engineering, V5068, P217, DOI 10.1117/12.518769; Esenaliev RO, 2007, PROC SPIE, V6437, DOI 10.1117/12.714302; Esenaliev R. O., 1994, Lasers in the Life Sciences, V6, P153; Esenaliev R. O., 2016, U. S. Patent No, Patent No. [9, 504, 824, 9504824]; Esenaliev R. O., 2004, Continuous optoacoustic monitoring of hemoglobin concentration and hematorcit, Patent No. [6, 751, 490, 6751490]; Esenaliev R. O., 2016, Systems and methods for measuring fetal cerebral oxygenation, Patent No. [9, 380, 967, 9380967]; Esenaliev R. O., 2002, Patent No, Patent No. [6, 498, 942, 6498942]; Esenaliev R. O., 1998, P SOC PHOTO-OPT INS, V3726, P560; Esenaliev RO, 1997, P SOC PHOTO-OPT INS, V2979, P71, DOI 10.1117/12.280213; Esenaliev RO, 1999, IEEE J SEL TOP QUANT, V5, P981, DOI 10.1109/2944.796320; ESENALIEV RO, 1994, APPL PHYS B-LASERS O, V59, P73, DOI 10.1007/BF01081730; Esenaliev RO, 1998, P SOC PHOTO-OPT INS, V3254, P294, DOI 10.1117/12.308176; Esenaliev RO, 2004, APPL OPTICS, V43, P3401, DOI 10.1364/AO.43.003401; Esenaliev RO, 2002, APPL OPTICS, V41, P4722, DOI 10.1364/AO.41.004722; ESENALIEV RO, 1993, LASER SURG MED, V13, P470, DOI 10.1002/lsm.1900130412; Esenaliev RO, 1999, P SOC PHOTO-OPT INS, V3601, P166, DOI 10.1117/12.350000; Esenaliev RO, 1996, P SOC PHOTO-OPT INS, V2676, P84, DOI 10.1117/12.238817; GOLOVLYOV VV, 1993, APPL PHYS B-PHOTO, V57, P451, DOI 10.1007/BF00357391; Jaeger M, 2013, PHOTOACOUSTICS, V1, P19, DOI 10.1016/j.pacs.2013.07.002; Larin K, 2001, PROC SPIE, V4256, P147, DOI 10.1117/12.429301; Larin KV, 2005, J PHYS D APPL PHYS, V38, P2645, DOI 10.1088/0022-3727/38/15/017; Larin KV, 2002, QUANTUM ELECTRON+, V32, P953, DOI 10.1070/QE2002v032n11ABEH002327; Larina IV, 2005, J PHYS D APPL PHYS, V38, P2633, DOI 10.1088/0022-3727/38/15/015; Li G, 2015, QUANT IMAGING MED SU, V5, P57, DOI 10.3978/j.issn.2223-4292.2014.11.09; O'Donnell M, 2013, ANN BIOMED ENG, V41, P2237, DOI 10.1007/s10439-013-0901-8; Oraevsky A, 1996, P SOC PHOTO-OPT INS, V2681, P277, DOI 10.1117/12.239584; Oraevsky AA, 1998, U. S. patent, Patent No. [5, 840, 023, 5840023, 5,840,023]; Paproski RJ, 2016, SMALL, V12, P371, DOI 10.1002/smll.201502450; Patrikeev I, 2007, APPL OPTICS, V46, P4820, DOI 10.1364/AO.46.004820; Patterson MP, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.056008; Petrov A, 2014, PHOTOACOUSTICS, V2, P75, DOI 10.1016/j.pacs.2014.04.001; Petrov IY, 2012, OPT EXPRESS, V20, P4159, DOI 10.1364/OE.20.004159; Petrov IY, 2012, BIOMED OPT EXPRESS, V3, P125, DOI 10.1364/BOE.3.000125; Petrov IY, 2016, PROC SPIE, V9708, DOI 10.1117/12.2218919; Petrov YY, 2006, OPT LETT, V31, P1827, DOI 10.1364/OL.31.001827; Petrov YY, 2005, ANESTHESIOLOGY, V102, P69, DOI 10.1097/00000542-200501000-00014; Petrova IY, 2009, OPT EXPRESS, V17, P7285, DOI 10.1364/OE.17.007285; Petrova IY, 2005, OPT LETT, V30, P1677, DOI 10.1364/OL.30.001677; Su R, 2013, NUCL INSTRUM METH A, V720, P58, DOI 10.1016/j.nima.2012.12.035; Taruttis A, 2015, CANCER RES, V75, P1548, DOI 10.1158/0008-5472.CAN-14-2522; Tuchin V., 2016, HDB OPTICAL BIOMEDIC, V2; Tuchin V.V., 2016, HDB OPTICAL BIOMEDIC, V1; Valluru KS, 2016, ULTRASONOGRAPHY, V35, P267, DOI 10.14366/usg.16035; Yao JJ, 2014, PHOTOACOUSTICS, V2, P87, DOI 10.1016/j.pacs.2014.04.002	54	10	10	2	5	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	SEP	2017	22	9							091512	10.1117/1.JBO.22.9.091512			8	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	FK5VL	WOS:000413570000013	28444150	gold, Green Published			2022-02-06	
J	Firsching, R; Rickels, E; Mauer, UM; Sakowitz, OW; Messing-Junger, M; Engelhard, K; Schwenkreis, P; Linn, J; Schwerdtfeger, K				Firsching, R.; Rickels, E.; Mauer, U. M.; Sakowitz, O. W.; Messing-Juenger, M.; Engelhard, K.; Schwenkreis, P.; Linn, J.; Schwerdtfeger, K.			Guidelines for the Treatment of Head Injury in Adults	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						head injury; guidelines; adults	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; GLASGOW COMA SCALE; INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; PREDICTIVE-VALUE; HYPOTHERMIA; MANAGEMENT; OUTCOMES; HYPOPITUITARISM	The workshop of scientific medical faculties (Arbeitsgemeinschaft wissenschaftlicher medizinischer Fakultaten [AWMF]) of Germany has asked societies of specific medical disciplines to jointly publish guidelines on the treatment of diseases and injuries. On behalf of the Deutsche Gesellschaft fur Neurochirurgie, its commission on guidelines initiated an interdisciplinary approach to publish guidelines on the treatment of head injury in adults. These guidelines were published in German by the AWMF in late 2015. Because these guidelines have received widespread attention in Germany and became fundamental for research in head injuries, we have translated the German version into English to make it accessible to the international scientific community.	[Firsching, R.] Klin Neurochirurg, Leipziger Str 44, D-39120 Magdeburg, Germany; [Rickels, E.] AKH Celle, Med Versorgungszentrum, Neurochirurg, Celle, Germany; [Mauer, U. M.] Bundeswehrkrankenhaus Ulm, Neurochirurg Klin, Ulm, Germany; [Sakowitz, O. W.] Neurochirurg Univ Klin, Neurochirurg Klin, Heidelberg, Germany; [Messing-Juenger, M.] Asklepios Klin Sankt Augustin, Chefarztin Kinderneurochirurg, St Augustin, Germany; [Engelhard, K.] Univ Med Johannes Gutenberg Univ Mainz, Anasthesiol Klin, Mainz, Germany; [Schwenkreis, P.] Berufsgenossenschaftliches Univ Bergmannsheil, Neurol Univ Klin & Poliklin, Bochum, Germany; [Linn, J.] Techn Univ Dresden, Arztliche Direktorin Inst & Poliklin Neuroradiol, Anstalt Offentlichen Rechts Freistaates Sachsen, Dresden, Germany; [Schwerdtfeger, K.] Klin Univ Klinikum Saarlandes, Klin Neurochirurg, Homburg, Germany		Firsching, R (corresponding author), Klin Neurochirurg, Leipziger Str 44, D-39120 Magdeburg, Germany.	Raimund.Firsching@medizin.uni-magdeburg.de	Linn, Jennifer/AAE-1567-2021	Sakowitz, Oliver/0000-0003-3248-6335			Adelson PD, 2003, PEDIAT CRIT CARE M S; Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; [Anonymous], 2004, ATLS ADV TRAUM LIF S; [Anonymous], 2004, NATL PROGRAMM VERSOR; [Anonymous], 2009, OXFORD CTR EVIDENCE; Archavlis E, 2012, ACTA NEUROCHIR, V154, P1055, DOI 10.1007/s00701-012-1333-1; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bennett M, 2004, COCHRANE DB SYST REV, V1; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Biberthaler P, 2004, UNFALLCHIRURG, V107, P197, DOI 10.1007/s00113-004-0730-1; Bijlenga P, 2007, J NEUROL NEUROSUR PS, V78, P430, DOI 10.1136/jnnp.2006.099242; Blaha M, 2003, PEDIATR NEUROSURG, V39, P27, DOI 10.1159/000070877; Bock W, 2006, SCHADEL HIRN VERLETZ; Bourdeaux CP, 2011, NEUROCRIT CARE, V15, P42, DOI 10.1007/s12028-011-9512-0; *BRAIN TRAUM FDN A, 2000, MAN PROGN SEV TRAUM; Brain Trauma Foundation American Association of Neurological Surgeons Joint Section on Neurotrauma and Critical Care, 2007, GUID MAN SEV TRAUM B; BRIHAYE J, 1978, ACTA NEUROCHIR, V40, P181, DOI 10.1007/BF01773126; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; Bulger E M, 2010, JAMA-J AM MED ASSOC, V304, P13; Bullock MR, 2006, NEUROSURGERY, V58, pS1; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Edwards P, 2005, LANCET, V365, P1957; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Fernandez R, 1997, ZBL NEUROCHIR, V58, P72; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Firsching R, 1997, NEUROL RES, V19, P257, DOI 10.1080/01616412.1997.11740810; Firsching RJ, 2010, CENT EUR NEUROSURG, V71, P134, DOI 10.1055/s-0030-1248256; Forsyth R, 2010, COCHRANE DB SYST REV, V2; Frowein R, 1990, HDB CLIN NEUROLOGY, V13, P101; Frowein R A, 1988, Acta Neurochir Suppl (Wien), V44, P70; Frowein R A, 1992, Acta Neurochir Suppl (Wien), V55, P72; FROWEIN RA, 1976, ACTA NEUROCHIR, V34, P5, DOI 10.1007/BF01405858; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gurdjian E S, 1979, ACTA NEUROCHIR W S25; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Karimi A, 2004, DTSCH INTERDISZIPLIN, V5; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lane PL, 2000, CAN J SURG, V43, P442; Langham J, 2004, COCHRANE DB SYST REV, V04; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Lorenz R, 1990, NEUROTRAUMATOLOGIE; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marion D W, 1994, J TRAUMA, V86, P89; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Plotz FB, 2007, INTENS CARE MED, V33, P1675, DOI 10.1007/s00134-007-0643-x; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; ROBERTS I, 2000, COCHRANE DB SYST REV, V2; Roberts I, 2000, COCHRANE DB SYST REV, V04; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Roberts IG, 2003, COCHRANE DB SYST REV, V2; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Schierhout G, 2012, COCHRANE DB SYST REV, V6; Schneider HJ, 2006, ACTA NEUROCHIR, V148, P449, DOI 10.1007/s00701-005-0724-y; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; Vos PE, 2006, EUROPEAN HDB NEUROLO; Wakai A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub5; Willis C, 2004, COCHRANE DB SYST REV; Yanagawa T, 2002, COCHRANE DB SYST REV, V3, DOI 10.1002/14651858.CD001530; [No title captured]; [No title captured]	85	10	13	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	SEP	2017	78	5					478	487		10.1055/s-0037-1599239			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FD5IN	WOS:000407564200009	28482371	Bronze			2022-02-06	
J	Gil, JA; DeFroda, SF; Kriz, P; Owens, BD				Gil, Joseph A.; DeFroda, Steven F.; Kriz, Peter; Owens, Brett D.			Epidemiology of Snow Skiing- Versus Snowboarding-Related Concussions Presenting to the Emergency Department in the United States from 2010 to 2014	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						snow skiing; snowboarding; concussions; epidemiology; emergency department	VIDEO INCIDENT ANALYSIS; HEAD-INJURIES; HIGH-SCHOOL; SAFETY HELMETS; SKIERS; COLLEGIATE; FOOTBALL; LACROSSE; RISK	Objectives: To examine the trend of concussions in skiers and snowboarders from 2010 to 2014; and to quantify and compare the incidence of concussions injuries in skiers and snowboarders who presented to emergency departments in the United States in 2014. Design: Cross-sectional study of concussions in skiers and snowboarders who were evaluated in emergency departments in the United States. Main Outcomes Measure: Incidence of concussions. Results: The trend of the annual incidence of concussions for skiers and snowboarders remained stable from 2010 to 2014. An estimated total of 5388 skiing-related concussions and 5558 snowboarding-related concussions presented to emergency departments in the United States between January 1st, 2014, and December 31st, 2014. This represented an incidence of 16.9 concussions per 1 000 000 person-years for skiers and 17.4 concussions per 1 000 000 person-years for snowboarders. The incidence of concussions in the pediatric and young adult population of skiers was significantly higher than the incidence in the adult population. Similarly, the incidence of concussions in the pediatric and young adult population of snowboarders was significantly higher than the incidence in the adult population. The incidence of concussions was significantly higher in males compared with females in both skiing and snow-boarding. Conclusions: The incidence of concussions from 2010 to 2014 plateaued in both skiers and snowboarders. Pediatric and young adult skiers and snowboarders had significantly higher incidences of concussion than the adult population. In contrast to the higher incidence of concussions in females in several sports including ice hockey, soccer, and basketball, the incidence of concussions was higher in males compared with females in both skiing and snowboarding.	[Gil, Joseph A.; DeFroda, Steven F.; Kriz, Peter; Owens, Brett D.] Brown Univ, Warren Alpert Sch Med, Dept Orthopaed Surg, 593 Eddy St, Providence, RI 02903 USA		Gil, JA (corresponding author), Brown Univ, Warren Alpert Sch Med, Dept Orthopaed Surg, 593 Eddy St, Providence, RI 02903 USA.	joseph_gil@brown.edu					Baschera D, 2015, J NEUROTRAUM, V32, P557, DOI 10.1089/neu.2014.3604; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Dickson TJ, 2015, SCAND J MED SCI SPOR; Fukuda O, AM J SPORTS MED, V29, P437; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Graves JM, 2013, INJURY PREV, V19, P399, DOI 10.1136/injuryprev-2012-040727; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Kwiatkowski Tomasz, 2015, Przegl Lek, V72, P428; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Levy AS, 2000, SEMIN NEUROL, V20, P233, DOI 10.1055/s-2000-9833; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; McCall D, 2009, BRIT J SPORT MED, V43, P987, DOI 10.1136/bjsm.2009.068767; Patrick E, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115588280; Ruedl G, 2015, SCAND J MED SCI SPOR, V25, P125, DOI 10.1111/sms.12139; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Scott MD, 2007, INJURY PREV, V13, P173, DOI 10.1136/ip.2006.014142; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Thomson CJ, 2015, ACCIDENT ANAL PREV, V75, P179, DOI 10.1016/j.aap.2014.11.024	21	10	10	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2017	27	5					499	502		10.1097/JSM.0000000000000395			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	FG2HS	WOS:000409915300018	27787350				2022-02-06	
J	Godo, S; Irino, S; Nakagawa, A; Kawazoe, Y; Fujita, M; Kudo, D; Nomura, R; Shimokawa, H; Kushimoto, S				Godo, Shigeo; Irino, Shigemi; Nakagawa, Atsuhiro; Kawazoe, Yu; Fujita, Motoo; Kudo, Daisuke; Nomura, Ryosuke; Shimokawa, Hiroaki; Kushimoto, Shigeki			Diagnosis and Management of Patients with Paroxysmal Sympathetic Hyperactivity following Acute Brain Injuries Using a Consensus-Based Diagnostic Tool: A Single Institutional Case Series	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						acquired brain injury; critical care; dysautonomia; paroxysmal sympathetic hyperactivity; sympathetic storm		Paroxysmal sympathetic hyperactivity (PSH) is a distinct syndrome of episodic sympathetic hyperactivities following severe acquired brain injury, characterized by paroxysmal transient fever, tachycardia, hypertension, tachypnea, excessive diaphoresis and specific posturing. PSH remains to be an under recognized condition with a diagnostic pitfall especially in the intensive care unit (ICU) settings due to the high prevalence of concomitant diseases that mimic PSH. A consensus set of diagnostic criteria named PSH-Assessment Measure (PSH-AM) has been developed recently, which is consisted of two components: a diagnosis likelihood tool derived from clinical characteristics of PSH, and a clinical feature scale assigned to the severity of each sympathetic hyperactivity. We herein present a case series of patients with PSH who were diagnosed and followed by using PSH-AM in our tertiary institutional medical and surgical ICU between April 2015 and March 2017 in order to evaluate the clinical efficacy of PSH-AM. Among 394 survivors of 521 patients admitted with acquired brain injury defined as acute brain injury at all levels of severity regardless of the presence of altered consciousness, including traumatic brain injury, stroke, infectious disease, and encephalopathy, 6 patients (1.5%) were diagnosed as PSH by using PSH-AM. PSH-AM served as a useful scoring system for early objective diagnosis, assessment of severity, and serial evaluation of treatment efficacy in the management of PSH in the ICU settings. In conclusion, critical care clinicians should consider the possibility of PSH and can use PSH-AM as a useful diagnostic and guiding tool in the management of PSH.	[Godo, Shigeo; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi, Japan; [Godo, Shigeo; Irino, Shigemi; Nakagawa, Atsuhiro; Kawazoe, Yu; Fujita, Motoo; Kudo, Daisuke; Nomura, Ryosuke; Kushimoto, Shigeki] Tohoku Univ Hosp, Dept Emergency & Crit Care Med, Sendai, Miyagi, Japan; [Irino, Shigemi] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi, Japan; [Nakagawa, Atsuhiro] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi, Japan; [Kudo, Daisuke; Kushimoto, Shigeki] Tohoku Univ, Grad Sch Med, Div Emergency & Crit Care Med, Sendai, Miyagi, Japan		Godo, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	s-godo@cardio.med.tohoku.ac.jp	Kudo, Daisuke/AAE-4019-2020	Kudo, Daisuke/0000-0001-8213-5176; Shimokawa, Hiroaki/0000-0001-7534-4826; Godo, Shigeo/0000-0002-4985-7828			Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Fujimoto T., 2016, TOKUSHIMA RED CROSS, V21, P81; Hinson HE, 2017, J HEAD TRAUMA REHAB, V32, pE50, DOI 10.1097/HTR.0000000000000271; Hughes JD, 2014, NEUROCRIT CARE, V20, P454, DOI 10.1007/s12028-013-9877-3; Kumagai K, 2016, J JAPANESE ASS ACUTE, V27, P776; Meyer Kimberly S, 2014, Surg Neurol Int, V5, pS490, DOI 10.4103/2152-7806.144632; Okada Y, 2014, J JPN SOC INTENSIVE, V21, P268; Penfield W, 1954, EPILEPSY FUNCTIONAL, P412; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Samuel S, 2016, J NEUROSCI NURS, V48, P82, DOI 10.1097/JNN.0000000000000207; Takahashi Courtney, 2015, Handb Clin Neurol, V128, P539, DOI 10.1016/B978-0-444-63521-1.00034-0; Wang VY, 2008, J TRAUMA, V64, P500, DOI 10.1097/TA.0b013e31804a5738	16	10	13	0	1	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	SEP	2017	243	1					11	18		10.1620/tjem.243.11			8	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	FJ4MV	WOS:000412715400002	28890524	gold			2022-02-06	
